PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chandrachud, U; Walker, MW; Simas, AM; Heetveld, S; Petcherski, A; Klein, M; Oh, H; Wolf, P; Zhao, WN; Norton, S; Haggarty, SJ; Lloyd-Evans, E; Cotman, SL				Chandrachud, Uma; Walker, Mathew W.; Simas, Alexandra M.; Heetveld, Sasja; Petcherski, Anton; Klein, Madeleine; Oh, Hyejin; Wolf, Pavlina; Zhao, Wen-Ning; Norton, Stephanie; Haggarty, Stephen J.; Lloyd-Evans, Emyr; Cotman, Susan L.			Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEROID-LIPOFUSCINOSIS; INTRACELLULAR CALCIUM; BIOMETAL HOMEOSTASIS; ENDOCYTIC PATHWAY; BRAIN MICROSOMES; IMAGE-ANALYSIS; LYSOSOMAL PH; MOUSE MODEL; MITOCHONDRIAL; LINK	Abnormal accumulation of undigested macromolecules, often disease-specific, is a major feature of lysosomal and neurodegenerative disease and is frequently attributed to defective autophagy. The mechanistic underpinnings of the autophagy defects are the subject of intense research, which is aided by genetic disease models. To gain an improved understanding of the pathways regulating defective autophagy specifically in juvenile neuronal ceroid lipofuscinosis (JNCL or Batten disease), a neurodegenerative disease of childhood, we developed and piloted a GFP-microtubule-associated protein 1 light chain 3 (GFP-LC3) screening assay to identify, in an unbiased fashion, genotype-sensitive small molecule autophagy modifiers, employing a JNCL neuronal cell model bearing the most common disease mutation in CLN3. Thapsigargin, a sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) Ca2+ pump inhibitor, reproducibly displayed significantly more activity in the mouse JNCL cells, an effect that was also observed in human-induced pluripotent stem cell-derived JNCL neural progenitor cells. The mechanism of thapsigargin sensitivity was Ca2+-mediated, and autophagosome accumulation in JNCL cells could be reversed by Ca2+ chelation. Interrogation of intracellular Ca2+ handling highlighted alterations in endoplasmic reticulum, mitochondrial, and lysosomal Ca2+ pools and in store-operated Ca2+ uptake in JNCL cells. These results further support an important role for the CLN3 protein in intracellular Ca2+ handling and in autophagic pathway flux and establish a powerful new platform for therapeutic screening.	[Chandrachud, Uma; Simas, Alexandra M.; Heetveld, Sasja; Petcherski, Anton; Klein, Madeleine; Oh, Hyejin; Wolf, Pavlina; Zhao, Wen-Ning; Norton, Stephanie; Haggarty, Stephen J.; Cotman, Susan L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Walker, Mathew W.; Lloyd-Evans, Emyr] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Harvard University; Harvard Medical School; Massachusetts General Hospital; Cardiff University	Cotman, SL (corresponding author), Ctr Human Genet Res, Dept Neurol, 185 Cambridge St, Boston, MA 02114 USA.	cotman@helix.mgh.harvard.edu	Petcherski, Anton/AAC-2509-2019; Haggarty, Stephen J/M-9495-2016	Petcherski, Anton/0000-0002-3143-3867; Haggarty, Stephen J/0000-0002-7872-168X; Simas, Alexandra/0000-0003-0242-1442	National Institutes of Health from NINDS [R01NS073813]; National Institutes of Health from National Institute of Mental Health [R33MH087896]; Batten Disease Support and Research Association; National Tay-Sachs and Allied Diseases Association, Inc.; Tau Consortium; National Contest for Life Foundation (NCL Stiftung) fellowship; Finnish Foundation for JNCL Research fellowship; Knowledge Economy Skills Scholarship; Research Councils UK Fellowship; Basil O'Connor Starter Scholarship; Royal Society project grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073813] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institutes of Health from National Institute of Mental Health; Batten Disease Support and Research Association; National Tay-Sachs and Allied Diseases Association, Inc.; Tau Consortium; National Contest for Life Foundation (NCL Stiftung) fellowship; Finnish Foundation for JNCL Research fellowship; Knowledge Economy Skills Scholarship; Research Councils UK Fellowship(UK Research & Innovation (UKRI)); Basil O'Connor Starter Scholarship; Royal Society project grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS073813 from NINDS (to S. L. C.) and R33MH087896 from National Institute of Mental Health (to S. J. H.). This work was also supported by the Batten Disease Support and Research Association (to S. L. C.), the National Tay-Sachs and Allied Diseases Association, Inc. (to S. L. C.), the Tau Consortium (to S. J. H.), National Contest for Life Foundation (NCL Stiftung) fellowship (to A. P.), the Finnish Foundation for JNCL Research fellowship (to A. P.), a Knowledge Economy Skills Scholarship (to M. W. W.), a Research Councils UK Fellowship (to E. L. E.), a Basil O'Connor Starter Scholarship (to E. L. E.), and a Royal Society project grant (to E. L. E.) S. L. C. is a member of the Batten Disease Support and Research Association Advisory Board. P. W. is currently an employee of Sanofi.	[Anonymous], 1995, Cell, V82, P949; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Chang JW, 2007, HUM MOL GENET, V16, P317, DOI 10.1093/hmg/ddl466; Cotman SL, 2002, HUM MOL GENET, V11, P2709, DOI 10.1093/hmg/11.22.2709; Cotman SL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0366-z; Cotman SL, 2012, CLIN LIPIDOL, V7, P79, DOI 10.2217/CLP.11.70; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; East DA, 2013, AUTOPHAGY, V9, P1710, DOI 10.4161/auto.25367; Engedal N, 2013, AUTOPHAGY, V9, P1475, DOI 10.4161/auto.25900; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Golabek AA, 2000, MOL GENET METAB, V70, P203, DOI 10.1006/mgme.2000.3006; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Grubman A, 2014, CHEM SCI, V5, P2503, DOI 10.1039/c4sc00316k; Grubman A, 2014, METALLOMICS, V6, P932, DOI 10.1039/c4mt00032c; Haack KA, 2011, BBA-GEN SUBJECTS, V1810, P186, DOI 10.1016/j.bbagen.2010.09.004; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Kang S, 2013, NEUROCHEM INT, V62, P931, DOI 10.1016/j.neuint.2013.03.007; Kanninen KM, 2013, BIOL OPEN, V2, P635, DOI 10.1242/bio.20134804; Kim Y, 2003, P NATL ACAD SCI USA, V100, P15458, DOI 10.1073/pnas.2136651100; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kollmann K, 2013, BBA-MOL BASIS DIS, V1832, P1866, DOI 10.1016/j.bbadis.2013.01.019; Kong SMY, 2014, HUM MOL GENET, V23, P2816, DOI 10.1093/hmg/ddu099; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Lloyd-Evans E, 2003, BIOCHEM J, V375, P561, DOI 10.1042/BJ20030613; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lojewski X, 2014, HUM MOL GENET, V23, P2005, DOI 10.1093/hmg/ddt596; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Luiro K, 2006, J NEUROSCI RES, V84, P1124, DOI 10.1002/jnr.21015; Vidal-Donet JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055526; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Misquitta CM, 1999, CELL CALCIUM, V25, P277, DOI 10.1054/ceca.1999.0032; Mole S., 2011, NEURONAL CEROID LIPO, DOI DOI 10.1093/MED/9780199590018.003.0018; Park JS, 2014, HUM MOL GENET, V23, P2802, DOI 10.1093/hmg/ddt623; Pearce DA, 1999, MOL GENET METAB, V66, P320, DOI 10.1006/mgme.1999.2819; Pelled D, 2003, J BIOL CHEM, V278, P29496, DOI 10.1074/jbc.M302964200; Persaud-Sawin DA, 2004, PEDIATR RES, V56, P449, DOI 10.1203/01.PDR.0000136152.54638.95; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096647; Smaili SS, 2013, CURR MOL MED, V13, P252; Tecedor L, 2013, J NEUROSCI, V33, P18065, DOI 10.1523/JNEUROSCI.0498-13.2013; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; Uusi-Rauva K, 2008, EXP CELL RES, V314, P2895, DOI 10.1016/j.yexcr.2008.06.016; Uusi-Rauva K, 2012, CELL MOL LIFE SCI, V69, P2075, DOI 10.1007/s00018-011-0913-1; Vella F, 2002, IUBMB LIFE, V54, P89, DOI 10.1080/15216540214307; Warnock A, 2013, BIOCHEM BIOPH RES CO, V436, P645, DOI 10.1016/j.bbrc.2013.04.113; Warrier V, 2013, BBA-MOL BASIS DIS, V1832, P1827, DOI 10.1016/j.bbadis.2013.03.017; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wu D, 2014, BIOCHEM BIOPH RES CO, V447, P115, DOI 10.1016/j.bbrc.2014.03.120; Yasuma T, 1998, J MED CHEM, V41, P4301, DOI 10.1021/jm9803065; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	61	64	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14361	14380		10.1074/jbc.M114.621706	http://dx.doi.org/10.1074/jbc.M114.621706			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25878248	Green Published, hybrid			2022-12-26	WOS:000355754600009
J	Samelson, BK; Gore, BB; Whiting, JL; Nygren, PJ; Purkey, AM; Colledge, M; Langeberg, LK; Dell'Acqua, ML; Zweifel, LS; Scott, JD				Samelson, Bret K.; Gore, Bryan B.; Whiting, Jennifer L.; Nygren, Patrick J.; Purkey, Alicia M.; Colledge, Marcie; Langeberg, Lorene K.; Dell'Acqua, Mark L.; Zweifel, Larry S.; Scott, John D.			A-kinase Anchoring Protein 79/150 Recruits Protein Kinase C to Phosphorylate Roundabout Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES SYNAPTIC PLASTICITY; COMMISSURAL AXON GUIDANCE; AKAP79 SIGNALING COMPLEX; NERVE GROWTH CONES; FUNCTIONAL DIVERSITY; DEPENDENT REGULATION; DYNAMIC REGULATION; SCAFFOLD PROTEIN; AMPA RECEPTORS; CAMP SYNTHESIS	Anchoring proteins direct protein kinases and phosphoprotein phosphatases toward selected substrates to control the efficacy, context, and duration of neuronal phosphorylation events. The A-kinase anchoring protein AKAP79/150 interacts with protein kinase A (PKA), protein kinase C (PKC), and protein phosphatase 2B (calcineurin) to modulate second messenger signaling events. In a mass spectrometry-based screen for additional AKAP79/150 binding partners, we have identified the Roundabout axonal guidance receptor Robo2 and its ligands Slit2 and Slit3. Biochemical and cellular approaches confirm that a linear sequence located in the cytoplasmic tail of Robo2 (residues 991-1070) interfaces directly with sites on the anchoring protein. Parallel studies show that AKAP79/150 interacts with the Robo3 receptor in a similar manner. Immunofluorescent staining detects overlapping expression patterns for murine AKAP150, Robo2, and Robo3 in a variety of brain regions, including hippocampal region CA1 and the islands of Calleja. In vitro kinase assays, peptide spot array mapping, and proximity ligation assay staining approaches establish that human AKAP79-anchored PKC selectively phosphorylates the Robo3.1 receptor subtype on serine 1330. These findings imply that anchored PKC locally modulates the phosphorylation status of Robo3.1 in brain regions governing learning and memory and reward.	[Samelson, Bret K.; Whiting, Jennifer L.; Nygren, Patrick J.; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Gore, Bryan B.; Zweifel, Larry S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Gore, Bryan B.; Zweifel, Larry S.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Purkey, Alicia M.; Dell'Acqua, Mark L.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Colledge, Marcie] Yellow Scope LLC, Portland, OR 97212 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus	Scott, JD (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, 1959 NE Pacific St,Box 357280,HSB E-417, Seattle, WA 98195 USA.	scottjdw@uw.edu	Regan, Clinton/E-6250-2012; Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Purkey, Alicia/0000-0002-1865-1421	National Institutes of Health [DK105542, DK54441, MH094536, NS40701]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105542, P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635, T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701, R56NS040701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK105542 and DK54441 (to J. D. S.), MH094536 (to L. S. Z.), and NS40701 (to M. L. D.).	Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Cheng EP, 2011, CIRC RES, V109, P255, DOI 10.1161/CIRCRESAHA.111.248252; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Evans TA, 2010, CURR BIOL, V20, P567, DOI 10.1016/j.cub.2010.02.021; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hinke SA, 2012, EMBO J, V31, P3991, DOI 10.1038/emboj.2012.244; Horn KE, 2013, CELL REP, V3, P173, DOI 10.1016/j.celrep.2012.12.005; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Ke RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069813; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Logue JS, 2011, J BIOL CHEM, V286, P22113, DOI 10.1074/jbc.M111.232660; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Nystoriak MA, 2014, CIRC RES, V114, P607, DOI 10.1161/CIRCRESAHA.114.302168; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Smith FD, 2013, ELIFE, V2, DOI 10.7554/eLife.01319; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	71	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14107	14119		10.1074/jbc.M115.637470	http://dx.doi.org/10.1074/jbc.M115.637470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882844	Green Published, hybrid			2022-12-26	WOS:000355313000039
J	Tsai, CH; Lin, YC; Wiegand, T; Nakazawa, T; Su, SH; Hsieh, CH; Ding, TS				Tsai, Cheng-Han; Lin, Yi-Ching; Wiegand, Thorsten; Nakazawa, Takefumi; Su, Sheng-Hsin; Hsieh, Chih-Hao; Ding, Tzung-Su			Individual Species-Area Relationship of Woody Plant Communities in a Heterogeneous Subtropical Monsoon Rainforest	PLOS ONE			English	Article							NEGATIVE DENSITY-DEPENDENCE; TROPICAL FORESTS; SPATIAL-PATTERNS; DIVERSITY; ECTOMYCORRHIZAL; ASSOCIATIONS; INFORMATION; POPULATIONS; STATISTICS; MECHANISMS	The spatial structure of species richness is often characterized by the species-area relationship (SAR). However, the SAR approach rarely considers the spatial variability of individual plants that arises from species interactions and species' habitat associations. Here, we explored how the interactions of individual plants of target species influence SAR patterns at a range of neighborhood distances. We analyzed the data of 113,988 woody plants of 110 species from the Fushan Forest Dynamics Plot (25 ha), northern Taiwan, which is a subtropical rainforest heavily influenced by typhoons. We classified 34 dominant species into 3 species types (i.e., accumulator, repeller, or no effect) by testing how the individual speciesarea relationship (i.e., statistics describing how neighborhood species richness changes around individuals) of target species departs (i.e., positively, negatively, or with no obvious trend) from a null model that accounts for habitat association. Deviation from the null model suggests that the net effect of species' interactions increases (accumulate) or decreases (repel) neighborhood species richness. We found that (i) accumulators were dominant at small interaction distances (<10-30 m); (ii) the detection of accumulator species was lower at large interaction distances (>30 m); (iii) repellers were rarely detected; and (iv) largesized and abundant species tended to be accumulators. The findings suggest that positive species interactions have the potential to accumulate neighborhood species richness, particularly through size- and density-dependent mechanisms. We hypothesized that the frequently disturbed environment of this subtropical rainforest (e.g., typhoon-driven natural disturbances such as landslides, soil erosion, flooding, and windthrow) might create the spatial heterogeneity of species richness and promote positive species interactions.	[Tsai, Cheng-Han; Ding, Tzung-Su] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan; [Tsai, Cheng-Han; Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Lin, Yi-Ching] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Wiegand, Thorsten] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Nakazawa, Takefumi] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Su, Sheng-Hsin] Taiwan Forestry Res Inst, Taipei, Taiwan; [Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Tunghai University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); National Cheng Kung University; National Taiwan University	Ding, TS (corresponding author), Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan.	ding@ntu.edu.tw	DING, Tzung-Su/AAG-7712-2019; Wiegand, Thorsten/H-5877-2016; Hsieh, Chih-hao/B-3797-2008; Su, Sheng-Hsin/AAC-3596-2021; Wiegand, Thorsten/AAP-9709-2021	Wiegand, Thorsten/0000-0002-3721-2248; Hsieh, Chih-hao/0000-0001-5935-7272; Su, Sheng-Hsin/0000-0003-1337-3335; Wiegand, Thorsten/0000-0002-3721-2248; DING, Tzung-Su/0000-0002-1102-3879	Ministry of Science and Technology of Taiwan [NSC101-2923-I-002-001-MY2]; European Research Council [233066]; YCL	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); European Research Council(European Research Council (ERC)European Commission); YCL	This study was supported by the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw) (NSC101-2923-I-002-001-MY2) to TSD. The European Research Council (http://erc.europa.eu) awarded grant 233066 to TW and supported travel expenses of YCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2005, ECOL LETT, V8, P438, DOI 10.1111/j.1461-0248.2005.00741.x; Balvanera P, 2006, BIOTROPICA, V38, P479, DOI 10.1111/j.1744-7429.2006.00161.x; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Dale M, 2005, SPATIAL PATTERN ANAL; Diggle P., 2003, STAT ANAL SPATIAL PO; Gardner RH, 2008, PERSPECT PLANT ECOL, V9, P211, DOI 10.1016/j.ppees.2007.08.003; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Grilli J, 2012, J THEOR BIOL, V313, P87, DOI 10.1016/j.jtbi.2012.07.030; He FL, 1996, J BIOGEOGR, V23, P57, DOI 10.1046/j.1365-2699.1996.00976.x; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Horvitz CC, 1998, ECOL APPL, V8, P947, DOI 10.1890/1051-0761(1998)008[0947:FROINI]2.0.CO;2; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hyatt LA, 2003, OIKOS, V103, P590, DOI 10.1034/j.1600-0706.2003.12235.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Kubota Y, 2004, J ECOL, V92, P230, DOI 10.1111/j.0022-0477.2004.00875.x; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Lin TC, 2011, ECOSYSTEMS, V14, P127, DOI 10.1007/s10021-010-9399-1; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Luo ZR, 2012, OIKOS, V121, P1239, DOI 10.1111/j.1600-0706.2011.20079.x; McGuire KL, 2007, ECOLOGY, V88, P567, DOI 10.1890/05-1173; McGuire KL, 2010, OECOLOGIA, V164, P785, DOI 10.1007/s00442-010-1686-1; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Plotkin JB, 2002, AM NAT, V160, P629, DOI 10.1086/342823; Rayburn AP, 2012, ECOGRAPHY, V35, P341, DOI 10.1111/j.1600-0587.2011.07058.x; Ricklefs RE., 1990, ECOLOGY; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Su S-H., 2007, FUSHAN SUBTROPICAL F; Su ShengHsin, 2010, Taiwan Journal of Forest Science, V25, P63; Volkov I, 2009, P NATL ACAD SCI USA, V106, P13854, DOI 10.1073/pnas.0903244106; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Weiner J, 2001, AM NAT, V158, P438, DOI 10.1086/321988; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2014, J BIOGEOGR, V41, P209, DOI 10.1111/jbi.12256; Wiegand T, 2014, CH HALL CRC APP ENV, P1; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Wiegand T, 2007, P NATL ACAD SCI USA, V104, P19029, DOI 10.1073/pnas.0705621104; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063192; Zhu Y, 2010, OIKOS, V119, P109, DOI 10.1111/j.1600-0706.2009.17758.x	47	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124539	10.1371/journal.pone.0124539	http://dx.doi.org/10.1371/journal.pone.0124539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884405	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000137
J	Belter, JT; Dollar, AM				Belter, Joseph T.; Dollar, Aaron M.			Strengthening of 3D Printed Fused Deposition Manufactured Parts Using the Fill Compositing Technique	PLOS ONE			English	Article								In this paper, we present a technique for increasing the strength of thermoplastic fused deposition manufactured printed parts while retaining the benefits of the process such as ease, speed of implementation, and complex part geometries. By carefully placing voids in the printed parts and filling them with high-strength resins, we can improve the overall part strength and stiffness by up to 45% and 25%, respectively. We discuss the process parameters necessary to use this strengthening technique and the theoretically possible strength improvements to bending beam members. We then show three-point bend testing data comparing solid printed ABS samples with those strengthened through the fill compositing process, as well as examples of 3D printed parts used in real-world applications.	[Belter, Joseph T.; Dollar, Aaron M.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA	Yale University	Belter, JT (corresponding author), Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA.	joseph.belter@yale.edu		Dollar, Aaron/0000-0002-2409-4668	Defense Advanced Research Projects Agency (DARPA) [W91CRB-10-C-0141]; Gustavus and Louise Pfeiffer Research Foundation	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gustavus and Louise Pfeiffer Research Foundation	This work was supported in part by the Defense Advanced Research Projects Agency (DARPA) under grand W91CRB-10-C-0141, and the Gustavus and Louise Pfeiffer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ING TECHN B NATUREWO; [Anonymous], SMOOTH CAST 300 SER; [Anonymous], 2013, ABSPLUS P430 PROD GR; [Anonymous], 2013, 105 EP RES 205 FAST; [Anonymous], 2013, FDM NYL 12 PROD GRAD; [Anonymous], 2010, D79010 ASTM, DOI [10.1520/D0790-10, DOI 10.1520/D0790-10]; Belter JT, 2014, INT C INT ROB SYST I; De Laurentis K.J., 2002, P ASME 2002 INT DESI, P1239, DOI [10.1115/DETC2002/MECH-34350, DOI 10.1115/DETC2002/MECH-34350]; Duty C., 2012, CARBON FIBER REINFOR; Graybill B., 2011, P ICMET INT C MECH E; Hans A Eschenauer Niels Olhoff, 2001, APPL MECH REV, V54, P331, DOI [10.1115/1.1388075, DOI 10.1115/1.1388075]; Hibbeler Russell Charles, 2004, STATICS MECH MAT, V2; Hossain M. S., 2013, INT SOL FREEF FABR S, V2013, P380; Innothane, IE 3076 POL 300 SER; Jamalabad V. R., 1996, P SOL FREEF FABR S A; Laliberte T, 2001, IEEE ROBOT AUTOM MAG, V8, P43, DOI 10.1109/100.956813; Lee CS, 2007, J MATER PROCESS TECH, V187, P627, DOI 10.1016/j.jmatprotec.2006.11.095; Lohmann S, 2012, P 13 INT C SYNTH SIM; Ma RR, 2013, P 2013 IEEE INT C RO; Masood SH, 2004, MATER DESIGN, V25, P587, DOI 10.1016/j.matdes.2004.02.009; Masood SH, 1996, RAPID PROTOTYPING J, V2, P24, DOI 10.1108/13552549610109054; Sella, 2013, PRECISION PROTOTYPIN; Smith WC, 2013, POLYM TEST, V32, P1306, DOI 10.1016/j.polymertesting.2013.07.014; Stava O, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185544; Thryft AR, 2012, DESIGN NEWS; Vona M, 2006, P INT S EXP ROB, P431; Won J, 2000, ROB AUT 2000 P ICRA, V4, P3077, DOI [10.1109/ROBOT.2000.845136, DOI 10.1109/ROBOT.2000.845136]; Zirox, WOLL LOW HIGH ASP RA	29	76	80	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122915	10.1371/journal.pone.0122915	http://dx.doi.org/10.1371/journal.pone.0122915			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880807	Green Submitted, gold, Green Published			2022-12-26	WOS:000353016500032
J	Gornish, ES; Miller, TE				Gornish, Elise S.; Miller, Thomas E.			Plant Community Responses to Simultaneous Changes in Temperature, Nitrogen Availability, and Invasion	PLOS ONE			English	Article							CLIMATE-CHANGE; FIT INDEXES; GROWTH; METAANALYSIS; PHENOLOGY; IMPACTS; CARBON; DEPOSITION; ECOSYSTEMS; DIVERSITY	Background Increasing rates of change in climate have been observed across the planet and have contributed to the ongoing range shifts observed for many species. Although ecologists are now using a variety of approaches to study how much and through what mechanisms increasing temperature and nutrient pollution may influence the invasions inherent in range shifts, accurate predictions are still lacking. Methods and Results In this study, we conducted a factorial experiment, simultaneously manipulating warming, nitrogen addition and introduction of Pityopsis aspera, to determine how range-shifting species affect a plant community. We quantified the resident community using ordination scores, then used structural equation modeling to examine hypotheses related to how plants respond to a network of experimental treatments and environmental variables. Variation in soil pH explained plant community response to nitrogen addition in the absence of invasion. However, in the presence of invasion, the direct effect of nitrogen on the community was negligible and soil moisture was important for explaining nitrogen effects. We did not find effects of warming on the native plant community in the absence of invasion. In the presence of invasion, however, warming had negative effects on functional richness directly and invasion and herbivory explained the overall positive effect of warming on the plant community. Conclusions and Significance This work highlights the variation in the biotic and abiotic factors responsible for explaining independent and collective climate change effects over a short time scale. Future work should consider the complex and non-additive relationships among factors of climate change and invasion in order to capture more ecologically relevant features of our changing environment.	[Gornish, Elise S.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Miller, Thomas E.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of California System; University of California Davis; State University System of Florida; Florida State University	Gornish, ES (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	egornish@ucdavis.edu			Tall Timbers Research Reserve	Tall Timbers Research Reserve	The authors would like to thank the many volunteers that helped to set up the experiment and collect data. Jessica Hellmann provided helpful comments on earlier drafts of the manuscript. This work was supported, in part, by Tall Timbers Research Reserve.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Ainsworth A, 2010, BIOTROPICA, V42, P647, DOI 10.1111/j.1744-7429.2010.00636.x; Arbuckle J. L., 2006, AMOS VERSION 7 0 COM; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Blankinship JC, 2011, OECOLOGIA, V165, P553, DOI 10.1007/s00442-011-1909-0; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Brook BW, 2008, WILDLIFE RES, V35, P249, DOI 10.1071/WR07116; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cleland EE, 2006, P NATL ACAD SCI USA, V103, P13740, DOI 10.1073/pnas.0600815103; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Dijkstra FA, 2010, NEW PHYTOL, V187, P426, DOI 10.1111/j.1469-8137.2010.03293.x; Dullinger S, 2012, GLOBAL ECOL BIOGEOGR, V21, P829, DOI 10.1111/j.1466-8238.2011.00732.x; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Eisenhauer N, 2012, OIKOS, V121, P1121, DOI 10.1111/j.1600-0706.2011.19807.x; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Giesler R, 1998, ECOLOGY, V79, P119, DOI 10.1890/0012-9658(1998)079[0119:SCAPIF]2.0.CO;2; Gornish ES, 2014, POPULATION ECOLOGY, V5, P545; Grace JB., 2015, STRUCTURAL EQUATION; Grace JB., 2003, STRUCTURAL EQUATION; Grime JP, 2002, J VEG SCI, V13, P457, DOI 10.1111/j.1654-1103.2002.tb02072.x; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Holland EA, 2005, ECOL APPL, V15, P38, DOI 10.1890/03-5162; Hovenden MJ, 2008, GLOBAL CHANGE BIOL, V14, P1018, DOI 10.1111/j.1365-2486.2008.01558.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Kareiva PM, 1993, BIOTIC INTERACTIONS, P559; Kidron GJ, 2009, EARTH SURF PROC LAND, V34, P123, DOI 10.1002/esp.1706; Kobayashi O, 2010, SOIL SCI PLANT NUTR, V56, P407, DOI 10.1111/j.1747-0765.2010.00470.x; Le Guigo P, 2012, OECOLOGIA, V169, P753, DOI 10.1007/s00442-011-2241-4; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Maskell LC, 2006, J VEG SCI, V17, P499, DOI 10.1111/j.1654-1103.2006.tb02471.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Norby RJ, 1998, NEW PHYTOL, V139, P189, DOI 10.1046/j.1469-8137.1998.00183.x; Parmesan C., 2006, PRINCIPLES CONSERVAT, P333; Parsons WFJ, 1998, RESTOR ECOL, V6, P280, DOI 10.1046/j.1526-100X.1998.06310.x; Pavlovkin J, 2009, J PLANT PHYSIOL, V166, P1479, DOI 10.1016/j.jplph.2009.03.005; Pino J, 2006, HYDROBIOLOGIA, V570, P257, DOI 10.1007/s10750-006-0189-x; Post ES, 2008, ECOLOGY, V89, P363, DOI 10.1890/06-2138.1; RICHARDS JH, 1987, OECOLOGIA, V73, P486, DOI 10.1007/BF00379405; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schurch S, 2004, EVOL ECOL, V18, P1, DOI 10.1023/B:EVEC.0000017673.12192.3c; Sharp BR, 2003, J BIOGEOGR, V30, P783, DOI 10.1046/j.1365-2699.2003.00840.x; Sheppard CS, 2014, INVAS PLANT SCI MANA, V7, P237, DOI 10.1614/IPSM-D-13-00038.1; Siemann E, 2007, GLOBAL CHANGE BIOL, V13, P2184, DOI 10.1111/j.1365-2486.2007.01425.x; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Verheyen K, 2009, PLANT BIOLOGY, V11, P49, DOI 10.1111/j.1438-8677.2009.00214.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Weligama C, 2010, PLANT SOIL, V328, P119, DOI 10.1007/s11104-009-0087-x; White PCL, 2008, WILDLIFE RES, V35, P171, DOI 10.1071/WR08058; Wolkovich EM, 2009, J VEG SCI, V20, P1121, DOI 10.1111/j.1654-1103.2009.01110.x; Woodward FI, 2008, ECOL LETT, V11, P1229, DOI 10.1111/j.1461-0248.2008.01240.x; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia JY, 2013, ANN BOT-LONDON, V111, P1207, DOI 10.1093/aob/mct079; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	64	5	5	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123715	10.1371/journal.pone.0123715	http://dx.doi.org/10.1371/journal.pone.0123715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879440	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500060
J	Grossini, E; Bellofatto, K; Farruggio, S; Sigaudo, L; Marotta, P; Raina, G; De Giuli, V; Mary, D; Pollesello, P; Minisini, R; Pirisi, M; Vacca, G				Grossini, Elena; Bellofatto, Kevin; Farruggio, Serena; Sigaudo, Lorenzo; Marotta, Patrizia; Raina, Giulia; De Giuli, Veronica; Mary, David; Pollesello, Piero; Minisini, Rosalba; Pirisi, Mario; Vacca, Giovanni			Levosimendan Inhibits Peroxidation in Hepatocytes by Modulating Apoptosis/Autophagy Interplay	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; ISCHEMIA-REPERFUSION INJURY; CORONARY ENDOTHELIAL-CELLS; K-ATP CHANNEL; NITRIC-OXIDE; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; REACTIVE OXYGEN; RAT HEPATOCYTES; HEART-FAILURE	Background Levosimendan protects rat liver against peroxidative injuries through mechanisms related to nitric oxide (NO) production and mitochondrial ATP-dependent K (mitoK(ATP)) channels opening. However, whether levosimendan could modulate the cross-talk between apoptosis and autophagy in the liver is still a matter of debate. Thus, the aim of this study was to examine the role of levosimendan as a modulator of the apoptosis/autophagy interplay in liver cells subjected to peroxidation and the related involvement of NO and mitoK(ATP). Methods and Findings In primary rat hepatocytes that have been subjected to oxidative stress, Western blot was performed to examine endothelial and inducible NO synthase isoforms (eNOS, iNOS) activation, apoptosis/autophagy and survival signalling detection in response to levosimendan. In addition, NO release, cell viability, mitochondrial membrane potential and mitochondrial permeability transition pore opening (MPTP) were examined through specific dyes. Some of those evaluations were also performed in human hepatic stellate cells (HSC). Pretreatment of hepatocytes with levosimendan dose-dependently counteracted the injuries caused by oxidative stress and reduced NO release by modulating eNOS/iNOS activation. In hepatocytes, while the autophagic inhibition reduced the effects of levosimendan, after the pan-caspases inhibition, cell survival and autophagy in response to levosimendan were increased. Finally, all protective effects were prevented by both mitoK(ATP) channels inhibition and NOS blocking. In HSC, levosimendan was able to modulate the oxidative balance and inhibit autophagy without improving cell viability and apoptosis. Conclusions Levosimendan protects hepatocytes against oxidative injuries by autophagic-dependent inhibition of apoptosis and the activation of survival signalling. Such effects would involve mitoKATP channels opening and the modulation of NO release by the different NOS isoforms. In HSC, levosimendan would also play a role in cell activation and possible evolution toward fibrosis. These findings highlight the potential of levosimendan as a therapeutic agent for the treatment or prevention of liver ischemia/reperfusion injuries.	[Grossini, Elena; Bellofatto, Kevin; Farruggio, Serena; Sigaudo, Lorenzo; Marotta, Patrizia; Raina, Giulia; De Giuli, Veronica; Mary, David; Pollesello, Piero; Vacca, Giovanni] Univ Eastern Piedmont Amedeo Avogadro, Azienda Osped Univ Maggiore Carita, Dept Translat Med, Lab Physiol & Expt Surg, Novara, Italy; [Minisini, Rosalba; Pirisi, Mario] Univ Eastern Piedmont Amedeo Avogadro, Azienda Osped Univ Maggiore Carita, Dept Translat Med, Internal Med, Novara, Italy	Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro	Grossini, E (corresponding author), Univ Eastern Piedmont Amedeo Avogadro, Azienda Osped Univ Maggiore Carita, Dept Translat Med, Lab Physiol & Expt Surg, Via Solaroli 17,Corso Mazzini 36, Novara, Italy.	grossini@med.unipmn.it	Pirisi, Mario/ABF-2102-2020; Minisini, Rosalba/ABF-9724-2021; Pollesello, Piero/I-6884-2019	Pollesello, Piero/0000-0001-6994-768X; Pirisi, Mario/0000-0001-9740-0155; Grossini, Elena/0000-0002-3012-259X; Vacca, Giovanni/0000-0002-0864-1887				Basel H, 2013, TOXICOL IND HEALTH, V29, P435, DOI 10.1177/0748233712436643; Bhogal RH, 2012, AUTOPHAGY, V8, P545, DOI 10.4161/auto.19012; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Caimmi PP, 2011, EUR J CARDIO-THORAC, V39, pE59, DOI 10.1016/j.ejcts.2010.11.044; Cappellano G, 2013, CAN J CARDIOL, V29, P499, DOI 10.1016/j.cjca.2012.06.003; Chowdhury AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073672; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Crabtree MJ, 2013, J BIOL CHEM, V288, P561, DOI 10.1074/jbc.M112.415992; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Diesen DL, 2011, J SURG RES, V167, P96, DOI 10.1016/j.jss.2009.10.006; Gecit I, 2014, TOXICOL IND HEALTH, V30, P47, DOI 10.1177/0748233712451773; Grossini E, 2009, BRIT J PHARMACOL, V156, P250, DOI 10.1111/j.1476-5381.2008.00024.x; Grossini E, 2014, VASC PHARMACOL, V60, P127, DOI 10.1016/j.vph.2014.01.008; Grossini E, 2014, LIVER TRANSPLANT, V20, P361, DOI 10.1002/lt.23799; Grossini E, 2012, J PHARMACOL EXP THER, V342, P376, DOI 10.1124/jpet.112.193961; Grossini E, 2012, MOL CELL ENDOCRINOL, V350, P20, DOI 10.1016/j.mce.2011.11.018; Guan LY, 2014, WORLD J GASTRO SURG, V6, P122, DOI 10.4240/wjgs.v6.i7.122; Gupta NA, 2014, AM J PHYSIOL-GASTR L, V307, pG1088, DOI 10.1152/ajpgi.00210.2014; Hai S, 2005, TRANSPL P, V37, P428, DOI 10.1016/j.transproceed.2004.12.112; Hamacher-Brady A, 2006, CARDIOVASC DRUG THER, V20, P445, DOI 10.1007/s10557-006-0583-7; Ibrahim MA, 2014, EUR J PHARMACOL, V741, P64, DOI 10.1016/j.ejphar.2014.07.047; Jaeschke H, 2000, J GASTROEN HEPATOL, V15, P718, DOI 10.1046/j.1440-1746.2000.02207.x; Kim JS, 2004, HEPATOLOGY, V39, P1533, DOI 10.1002/hep.20197; Lee HS, 2014, MOLECULES, V19, P8189, DOI 10.3390/molecules19068189; Lenz K, 2014, MED KLIN-INTENSIVMED, V109, P267, DOI 10.1007/s00063-013-0326-z; Lepran I, 2006, J CARDIOVASC PHARM, V48, P148, DOI 10.1097/01.fjc.0000246151.39758.2a; Levijoki J, 2001, EUR J PHARMACOL, V419, P243, DOI 10.1016/S0014-2999(01)00997-9; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; Mallat A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869390; MARRA F, 1995, FEBS LETT, V376, P141, DOI 10.1016/0014-5793(95)01261-0; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Maruyama R, 2008, AM J PHYSIOL-HEART C, V295, pH1599, DOI 10.1152/ajpheart.91449.2007; Memis D, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.008; Onody P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073758; Papp Z, 2012, INT J CARDIOL, V159, P82, DOI 10.1016/j.ijcard.2011.07.022; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perrelli MG, 2011, WORLD J CARDIOL, V3, P186, DOI 10.4330/wjc.v3.i6.186; Raza H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036325; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shulman Maria, 2013, Methods Mol Biol, V945, P287, DOI 10.1007/978-1-62703-125-7_17; Svegliati-Baroni G, 2001, LIVER, V21, P1, DOI 10.1034/j.1600-0676.2001.210101.x; Thirunavukkarasu C, 2006, HEPATOLOGY, V44, P389, DOI 10.1002/hep.21254; Uberti F, 2011, J CARDIOVASC PHARM, V57, P246, DOI 10.1097/FJC.0b013e318204bb55; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076538; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zeng Z, 2012, WORLD J GASTROENTERO, V18, P1765, DOI 10.3748/wjg.v18.i15.1765; Zhang X, 2013, FREE RADICAL BIO MED, V63, P243, DOI 10.1016/j.freeradbiomed.2013.05.004	52	26	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124742	10.1371/journal.pone.0124742	http://dx.doi.org/10.1371/journal.pone.0124742			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880552	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500110
J	Kao, CF; Liu, JR; Hung, H; Kuo, PH				Kao, Chung-Feng; Liu, Jia-Rou; Hung, Hung; Kuo, Po-Hsiu			A Robust GWSS Method to Simultaneously Detect Rare and Common Variants for Complex Disease	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; TESTS; GENES; RISK	The rapid advances in sequencing technologies and the resulting next-generation sequencing data provide the opportunity to detect disease-associated variants with a better solution, in particular for low-frequency variants. Although both common and rare variants might exert their independent effects on the risk for the trait of interest, previous methods to detect the association effects rarely consider them simultaneously. We proposed a class of test statistics, the generalized weighted-sum statistic (GWSS), to detect disease associations in the presence of common and rare variants with a case-control study design. Information of rare variants was aggregated using a weighted sum method, while signal directions and strength of the variants were considered at the same time. Permutations were performed to obtain the empirical p-values of the test statistics. Our simulation showed that, compared to the existing methods, the GWSS method had better performance in most of the scenarios. The GWSS (in particular VDWSS-t) method is particularly robust for opposite association directions, association strength, and varying distributions of minor-allele frequencies. It is therefore promising for detecting disease-associated loci. For empirical data application, we also applied our GWSS method to the Genetic Analysis Workshop 17 data, and the results were consistent with the simulation, suggesting good performance of our method. As re-sequencing studies become more popular to identify putative disease loci, we recommend the use of this newly developed GWSS to detect associations with both common and rare variants.	[Kao, Chung-Feng; Liu, Jia-Rou; Hung, Hung; Kuo, Po-Hsiu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Dept Publ Hlth, Taipei 10764, Taiwan; [Liu, Jia-Rou] Chang Gung Univ, Dept Publ Hlth, Taoyuan, Taiwan; [Hung, Hung; Kuo, Po-Hsiu] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; Chang Gung University; National Taiwan University	Hung, H (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Dept Publ Hlth, Taipei 10764, Taiwan.	hhung@ntu.edu.tw; phkuo@ntu.edu.tw		Kuo, Po-Hsiu/0000-0003-0365-3587; HUNG, HUNG/0000-0003-4022-2081	National Science Council [NSC 99-2314-B-002-140-MY3, 102-2628-M-002-005-MY2]; National Health Research Institute [NHRI-EX102-9918NC]; GAW grant [R01 GM031575]; NIH [R01 MH059490]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490] Funding Source: NIH RePORTER	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); GAW grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Science Council (NSC 99-2314-B-002-140-MY3 and 102-2628-M-002-005-MY2) and National Health Research Institute (NHRI-EX102-9918NC) grants to Dr. P-H Kuo (PI). The authors would also like to acknowledge the GAW grant, R01 GM031575. Preparation of the Genetic Analysis Workshop 17 Simulated Exome Data Set was supported in part by NIH R01 MH059490 and used sequencing data from the 1000 Genomes Project (www.1000genomes.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Brisbin Abra, 2012, Frontiers in Genetics, V3, P173, DOI 10.3389/fgene.2012.00173; Chang HW, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-26; Evans D, 2011, EXPERT REV CARDIOVAS, V9, P637, DOI [10.1586/ERC.11.53, 10.1586/erc.11.53]; Feng T, 2011, GENET EPIDEMIOL, V35, P398, DOI 10.1002/gepi.20588; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pan W, 2011, GENET EPIDEMIOL, V35, P381, DOI 10.1002/gepi.20586; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wessel J, 2010, NEUROPSYCHOPHARMACOL, V35, P2392, DOI 10.1038/npp.2010.120; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang L, 2012, ANN HUM GENET, V76, P74, DOI 10.1111/j.1469-1809.2011.00684.x	32	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120873	10.1371/journal.pone.0120873	http://dx.doi.org/10.1371/journal.pone.0120873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880329	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500008
J	Liu, Q; Chen, Y; Chen, Y; Wang, YY; Chen, JJ; Zhang, TZ; Zhou, BL				Liu, Quan; Chen, Yu; Chen, Yu; Wang, Yingying; Chen, Jinjin; Zhang, Tianzhen; Zhou, Baoliang			A New Synthetic Allotetraploid (A(1)A(1)G(2)G(2)) between Gossypium herbaceum and G-australe: Bridging for Simultaneously Transferring Favorable Genes from These Two Diploid Species into Upland Cotton	PLOS ONE			English	Article							HIRSUTUM L.; ADDITION LINES; LINKAGE MAP; CHROMOSOME; DIVERSITY; GERMPLASM; INTROGRESSION; EXPRESSION; EVOLUTION; STERILITY	Gossypium herbaceum, a cultivated diploid cotton species (2n = 2x = 26, A(1)A(1)), has favorable traits such as excellent drought tolerance and resistance to sucking insects and leaf curl virus. G. australe, a wild diploid cotton species (2n = 2x = 26, G(2)G(2)), possesses numerous economically valuable characteristics such as delayed pigment gland morphogenesis (which is conducive to the production of seeds with very low levels of gossypol as a potential food source for humans and animals) and resistance to insects, wilt diseases and abiotic stress. Creating synthetic allotetraploid cotton from these two species would lay the foundation for simultaneously transferring favorable genes into cultivated tetraploid cotton. Here, we crossed G. herbaceum (as the maternal parent) with G. australe to produce an F-1 interspecific hybrid and doubled its chromosome complement with colchicine, successfully generating a synthetic tetraploid. The obtained tetraploid was confirmed by morphology, cytology and molecular markers and then self-pollinated. The S-1 seedlings derived from this tetraploid gradually became flavescent after emergence of the fifth true leaf, but they were rescued by grafting and produced S-2 seeds. The rescued S-1 plants were partially fertile due to the existence of univalents at Metaphase I of meiosis, leading to the formation of unbalanced, nonviable gametes lacking complete sets of chromosomes. The S-2 plants grew well and no flavescence was observed, implying that interspecific incompatibility, to some extent, had been alleviated in the S-2 generation. The synthetic allotetraploid will be quite useful for polyploidy evolutionary studies and as a bridge for transferring favorable genes from these two diploid species into Upland cotton through hybridization.	[Liu, Quan; Chen, Yu; Chen, Yu; Wang, Yingying; Chen, Jinjin; Zhang, Tianzhen; Zhou, Baoliang] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, MOE, Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, Q (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, MOE, Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China.	baoliangzhou@njau.edu.cn			National Natural Science Foundation of China [30571184, 31271771]; National Key Technology Support Program of China during the twelfth Five-year Plan Period [2013BAD01B03-04]; Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [CX (14) 2065]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Modern Crop Production of Collaborative Innovation in Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program of China during the twelfth Five-year Plan Period; Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Modern Crop Production of Collaborative Innovation in Jiangsu Province	BZ: This program was financially supported in part by the National Natural Science Foundation of China [grant numbers 30571184 and 31271771] (http://www.nsfc.gov.cn/), National Key Technology Support Program of China during the twelfth Five-year Plan Period [grant number 2013BAD01B03-04] (http://www.moa.gov.cn/), the Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [grant number CX (14) 2065], the Priority Academic Program Development of Jiangsu Higher Education Institutions, and Modern Crop Production of Collaborative Innovation in Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2004, BIOL J LINN SOC, V82, P573, DOI 10.1111/j.1095-8312.2004.00342.x; Ahoton L, 2003, CROP SCI, V43, P1999, DOI 10.2135/cropsci2003.1999; ALTMAN DW, 1987, CROP SCI, V27, P880, DOI 10.2135/cropsci1987.0011183X002700050008x; Azhar MT, 2013, J ANIM PLANT SCI, V23, P1436; Beasley JO, 1940, AM NAT, V74, P285, DOI 10.1086/280895; Bi IV, 1999, THEOR APPL GENET, V99, P1233; Bi IV, 1999, EUPHYTICA, V106, P243, DOI 10.1023/A:1003539924238; Brubaker CL, 1999, EUPHYTICA, V108, P199, DOI 10.1023/A:1003641217653; Campbell BT, 2010, CROP SCI, V50, P1161, DOI 10.2135/cropsci2009.09.0551; Campbell BT, 2009, EUPHYTICA, V169, P285, DOI 10.1007/s10681-009-9917-4; Chen Y, 2014, THEOR APPL GENET, V127, P1105, DOI 10.1007/s00122-014-2283-1; CULP TW, 1973, CROP SCI, V13, P686, DOI 10.2135/cropsci1973.0011183X001300060030x; DILDAY RH, 1986, CROP SCI, V26, P639, DOI 10.2135/cropsci1986.0011183X002600030046x; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; Flagel LE, 2009, J HERED, V100, P487, DOI 10.1093/jhered/esp003; Forrester NW, 1995, CHALLENGING FUTURE, P313; Fryxell P.A., 1992, RHEEDEA, V2, P108; Gingle AR, 2006, CROP SCI, V46, P1998, DOI 10.2135/cropsci2005.09.0328; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Gutierrez OA, 2002, CROP SCI, V42, P1841, DOI 10.2135/cropsci2002.1841; He J, 1993, ACTA GENET SINICA, V21, P52; Hu GJ, 2010, GENOME, V53, P599, DOI [10.1139/g10-038, 10.1139/G10-038]; HUTCHINSON JB, 1947, EVOLUTION GOSSYPIUM; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; Jena SN, 2012, THEOR APPL GENET, V124, P565, DOI 10.1007/s00122-011-1729-y; Konan ON, 2007, PLANT BREEDING, V126, P176, DOI 10.1111/j.1439-0523.2007.01325.x; Kulkarni Venkatesh N., 2009, V3, P69, DOI 10.1007/978-0-387-70810-2_4; Li B. L., 1987, Acta Genetica Sinica, V14, P121; Mergeai G., 1997, BASE: Biotechnologie, Agronomie, Societe et Environnement, V1, P272; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OAKES AJ, 1966, CAN J GENET CYTOL, V8, P830, DOI 10.1139/g66-099; OAKES AJ, 1966, CAN J GENET CYTOL, V8, P818, DOI 10.1139/g66-098; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Peng S, 2000, SEED, V109, P65; PRENTICE AN, 1972, COTTON SPECIAL REFER; Qian SY, 1992, SCI AGR SINICA, V25, P44, DOI [DOI 10.1093/GENETICS/51.5.689, 10.1093/genetics/51.5.689]; Ram SG, 2008, PLANT BREEDING, V127, P295, DOI 10.1111/j.1439-0523.2007.01453.x; Renny-Byfield S, 2014, GENOME BIOL EVOL, V6, P559, DOI 10.1093/gbe/evu037; Romano GB, 2009, THEOR APPL GENET, V120, P139, DOI 10.1007/s00122-009-1165-4; ROONEY WL, 1991, J HERED, V82, P151, DOI 10.1093/oxfordjournals.jhered.a111050; ROONEY WL, 1991, CROP SCI, V31, P337, DOI 10.2135/cropsci1991.0011183X003100020024x; Sacks EJ, 2008, PLANT CELL TISS ORG, V93, P15, DOI 10.1007/s11240-007-9316-2; Sacks EJ, 2009, FIELD CROP RES, V112, P1, DOI 10.1016/j.fcr.2009.01.006; Sarr D, 2011, PLANT BREEDING, V130, P60, DOI 10.1111/j.1439-0523.2010.01819.x; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Van Becelaere G, 2005, CROP SCI, V45, P2281, DOI 10.2135/cropsci2004.0715; VROH BI, 1998, PLANT BREEDING, V117, P235; Wang K, 2006, THEOR APPL GENET, V113, P73, DOI 10.1007/s00122-006-0273-7; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; ZHANG BJ, 1994, CHINESE SCI BULL, V39, P1567; Zhang J, 2002, THEOR APPL GENET, V105, P1166, DOI 10.1007/s00122-002-1100-4; Zhang J, 2000, COTTON SCI, V12, P267, DOI DOI 10.3969/J.ISSN.1002-7807.2000.05.012; Zhu SJ, 2004, CHINESE SCI BULL, V49, P2470, DOI 10.1360/982004-255	54	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123209	10.1371/journal.pone.0123209	http://dx.doi.org/10.1371/journal.pone.0123209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879660	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500042
J	Rokem, A; Yeatman, JD; Pestilli, F; Kay, KN; Mezer, A; van der Walt, S; Wandell, BA				Rokem, Ariel; Yeatman, Jason D.; Pestilli, Franco; Kay, Kendrick N.; Mezer, Aviv; van der Walt, Stefan; Wandell, Brian A.			Evaluating the Accuracy of Diffusion MRI Models in White Matter	PLOS ONE			English	Article							FIBER ORIENTATION; TENSOR; BRAIN; UNCERTAINTY; BALL; DECONVOLUTION; TRACTOGRAPHY; VALIDATION; REGRESSION; ANISOTROPY	Models of diffusion MRI within a voxel are useful for making inferences about the properties of the tissue and inferring fiber orientation distribution used by tractography algorithms. A useful model must fit the data accurately. However, evaluations of model-accuracy of commonly used models have not been published before. Here, we evaluate model-accuracy of the two main classes of diffusion MRI models. The diffusion tensor model (DTM) summarizes diffusion as a 3-dimensional Gaussian distribution. Sparse fascicle models (SFM) summarize the signal as a sum of signals originating from a collection of fascicles oriented in different directions. We use cross-validation to assess model- accuracy at different gradient amplitudes (b-values) throughout the white matter. Specifically, we fit each model to all the white matter voxels in one data set and then use the model to predict a second, independent data set. This is the first evaluation of model- accuracy of these models. In most of the white matter the DTM predicts the data more accurately than test-retest reliability; SFM model- accuracy is higher than test-retest reliability and also higher than the DTM model- accuracy, particularly for measurements with (a) a b-value above 1000 in locations containing fiber crossings, and (b) in the regions of the brain surrounding the optic radiations. The SFM also has better parameter-validity: it more accurately estimates the fiber orientation distribution function (fODF) in each voxel, which is useful for fiber tracking.	[Rokem, Ariel; Yeatman, Jason D.; Pestilli, Franco; Kay, Kendrick N.; Mezer, Aviv; Wandell, Brian A.] Stanford, Dept Psychol, Stanford, CA USA; [Yeatman, Jason D.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Pestilli, Franco] Indiana Univ, Dept Psychol & Brain Sci, Program Neurosci, Bloomington, IN USA; [Kay, Kendrick N.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Mezer, Aviv] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [van der Walt, Stefan] Univ Stellenbosch, Div Appl Math, ZA-7600 Stellenbosch, South Africa	Stanford University; University of Washington; University of Washington Seattle; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); Hebrew University of Jerusalem; Stellenbosch University	Rokem, A (corresponding author), Stanford, Dept Psychol, Stanford, CA USA.	arokem@gmail.com	Kay, Kendrick/A-4344-2009	Kay, Kendrick/0000-0001-6604-9155; Pestilli, Franco/0000-0002-2469-0494; Yeatman, Jason/0000-0002-2686-1293; Mezer, Aviv/0000-0002-1916-1854	National Research Service award (National Eye Institute) [F32 EY022294]; National Science Foundation [BCS-1228397]; National Institutes of Health [EY-15000]; NATIONAL EYE INSTITUTE [F32EY022294, R01EY015000] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1228397] Funding Source: National Science Foundation	National Research Service award (National Eye Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Grant support was provided through a National Research Service award to AR (National Eye Institute F32 EY022294) and grants from the National Science Foundation (BCS-1228397) and National Institutes of Health (EY-15000) to BW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2010, MAGN RESON MED, V64, P554, DOI 10.1002/mrm.22365; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chung SW, 2006, NEUROIMAGE, V33, P531, DOI 10.1016/j.neuroimage.2006.07.001; Cote M.A, 2013, MED IMAGE ANAL; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dell'acqua F, 2012, HUM BRAIN MAPP; Dell'Acqua F, 2007, IEEE T BIO-MED ENG, V54, P462, DOI 10.1109/TBME.2006.888830; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Donoho DL, 2010, BIOSTATISTICS, V11, P385, DOI 10.1093/biostatistics/kxq028; Dougherty RF, 2005, P NATL ACAD SCI USA, V102, P7350, DOI 10.1073/pnas.0500003102; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Ekanadham C, 2011, IEEE T SIGNAL PROCES, V59, P4735, DOI 10.1109/TSP.2011.2160058; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Hoerl AE, 2000, TECHNOMETRICS, V42, P80, DOI 10.2307/1271436; Jeurissen B, 2012, HUM BRAIN MAPP; Jezzard P, 1995, MAGN RESON MED; Jones Derek K, 2010, Top Magn Reson Imaging, V21, P87, DOI 10.1097/RMR.0b013e31821e56ac; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK, 2003, MAGN RESON MED, V49, P7, DOI 10.1002/mrm.10331; Koay CG, 2006, J MAGN RESON, V182, P115, DOI 10.1016/j.jmr.2006.06.020; Maas L. C., 2005, APPL RADIOL, V34, P44; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; Moody JE, 1992, ADV NEURAL INF PROCE; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Parker GD, 2013, NEUROIMAGE, V65, P433, DOI 10.1016/j.neuroimage.2012.10.022; Peled S, 2006, MAGN RESON IMAGING, V24, P1263, DOI 10.1016/j.mri.2006.07.009; Pestilli F, 2014, NAT METHODS, P1; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Sherbondy AJ, 2010, LECT NOTES COMPUT SC, V6361, P183; Sotiropoulos SN, 2012, NEUROIMAGE, V60, P1412, DOI 10.1016/j.neuroimage.2012.01.056; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stikov N, 2011, NEUROIMAGE, V54, P1112, DOI 10.1016/j.neuroimage.2010.08.068; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Van Anh T, 2010, Top Magn Reson Imaging, V21, P339, DOI 10.1097/RMR.0b013e31823e6303; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Whitcher B, 2008, HUM BRAIN MAPP, V29, P346, DOI 10.1002/hbm.20395; Yeatman JD, 2012, P NATL ACAD SCI USA, V109, pE3045, DOI 10.1073/pnas.1206792109; Yeatman JD, 2011, J COGNITIVE NEUROSCI, V23, P3304, DOI 10.1162/jocn_a_00061; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	60	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123272	10.1371/journal.pone.0123272	http://dx.doi.org/10.1371/journal.pone.0123272			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879933	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500045
J	Teixeira-Carvalho, A; Campos, FMF; Geiger, SM; Rocha, RDR; de Araujo, FF; Vitelli-Avelar, DM; Andrade, MC; Araujo, MSS; Lemos, EM; Proietti, ABDC; Sabino, EC; Caldas, RG; Freitas, CRC; Campi-Azevedo, AC; Eloi-Santos, SM; Martins, OA				Teixeira-Carvalho, Andrea; Freire Campos, Fernanda Magalhaes; Geiger, Stefan Michael; Rodrigues Rocha, Roberta Dias; de Araujo, Fernanda Fortes; Vitelli-Avelar, Danielle Marquete; Andrade, Marileia Chaves; Silva Araujo, Marcio Sobreira; Lemos, Elenice Moreira; de Freitas Carneiro Proietti, Anna Barbara; Sabino, Ester Cerdeira; Caldas, Rafaella Gaiotti; Camargos Freitas, Carolina Renata; Campi-Azevedo, Ana Carolina; Eloi-Santos, Silvana Maria; Martins-Filho, Olindo Assis			FC-TRIPLEX Chagas/Leish IgG1: A Multiplexed Flow Cytometry Method for Differential Serological Diagnosis of Chagas Disease and Leishmaniasis	PLOS ONE			English	Article							AMERICAN VISCERAL LEISHMANIASIS; POSTTHERAPEUTIC CURE ASSESSMENT; CRUZI IMMUNOGLOBULIN-G; TRYPANOSOMA-CRUZI; BLOOD-DONORS; CHEMOTHERAPEUTIC TREATMENT; SOUTHERN BRAZIL; ANTIBODIES; DEFINITION; PROGNOSIS	Differential serological diagnosis of Chagas disease and leishmaniasis is difficult owing to cross-reactivity resulting from the fact that the parasites that cause these pathologies share antigenic epitopes. Even with optimized serological assays that use parasite-specific recombinant antigens, inconclusive test results continue to be a problem. Therefore, new serological tests with high sensitivity and specificity are needed. In the present work, we developed and evaluated the performance of a new flow cytometric serological method, referred to as FC-TRIPLEX Chagas/Leish IgG1, for the all-in-one classification of inconclusive tests. The method uses antigens for the detection of visceral leishmaniasis, localized cutaneous leishmaniasis, and Chagas disease and is based on an inverted detuned algorithm for analysis of anti-Trypanosomatidae IgG1 reactivity. First, parasites were label with fluorescein isothiocyanate or Alexa Fluor 647 at various concentrations. Then serum samples were serially diluted, the dilutions were incubated with suspensions of mixed labeled parasites, and flow cytometric measurements were performed to determine percentages of positive fluorescent parasites. Using the new method, we obtained correct results for 76 of 80 analyzed serum samples (95% overall performance), underscoring the outstanding performance of the method. Moreover, we found that the fluorescently labeled parasite suspensions were stable during storage at room temperature, 4 degrees C, and -20 degrees C for 1 year. In addition, two different lots of parasite suspensions showed equivalent antigen recognition; that is, the two lots showed equivalent categorical segregation of anti-Trypanosomatidae IgG1 reactivity at selected serum dilutions. In conclusion, we have developed a sensitive and selective method for differential diagnosis of Chagas disease, visceral leishmaniasis, and localized cutaneous leishmaniasis.	[Teixeira-Carvalho, Andrea; Freire Campos, Fernanda Magalhaes; Rodrigues Rocha, Roberta Dias; de Araujo, Fernanda Fortes; Vitelli-Avelar, Danielle Marquete; Silva Araujo, Marcio Sobreira; Caldas, Rafaella Gaiotti; Camargos Freitas, Carolina Renata; Campi-Azevedo, Ana Carolina; Martins-Filho, Olindo Assis] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil; [Geiger, Stefan Michael] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Helmintoses Intestinais, Belo Horizonte, MG, Brazil; [Andrade, Marileia Chaves] Univ Estadual Montes Claros, Ctr Ciencias Biol & Saude, Dept Fisiopatol, Montes Claros, Brazil; [Lemos, Elenice Moreira] Univ Fed Espirito Santo, Ctr Biomed, Nucleo Doencas Infecciosas, Vitoria, Brazil; [de Freitas Carneiro Proietti, Anna Barbara] Fundacao Ctr Hematol & Hemoterapia Minas Gerais H, Serv Pesquisa, Belo Horizonte, MG, Brazil; [Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Med Trop, Dept Doencas Infecciosas, Sao Paulo, Brazil; [Eloi-Santos, Silvana Maria] Univ Fed Minas Gerais, Fac Med, Dept Posgrad Patol Geral, Belo Horizonte, MG, Brazil; [Eloi-Santos, Silvana Maria] Univ Fed Minas Gerais, Fac Med, Dept Propedeut Complementar, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Estadual de Montes Claros; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Teixeira-Carvalho, A (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil.	andreat@cpqrr.fiocruz.br	Martins-Filho, Olindo Assis/ABE-6278-2021; Sabino, Ester C/F-7750-2010; Geiger, Stefan M/E-6748-2016; Araujo, Marcio Sobreira Silva/ABE-7105-2021; Campi-Azevedo, Ana Carolina/ABE-8321-2021; Andrade, Marileia/GOE-5633-2022; Campos, Fernanda/GRR-6776-2022	Martins-Filho, Olindo Assis/0000-0002-5494-4889; Sabino, Ester C/0000-0003-2623-5126; Araujo, Marcio Sobreira Silva/0000-0002-7532-3360; Campi-Azevedo, Ana Carolina/0000-0001-6306-3605; Geiger, Stefan/0000-0002-9741-2727	CPqRR/Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Encouraging Inovation Program-Minas Gerais Government (Inventiva Project/FAPEMIG); Programa Ciencias Sem Fronteiras-Atracao de Jovens Talentos-BJT (MEC/MCTI/CAPES/CNPq/FAPs); CNPq	CPqRR/Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Encouraging Inovation Program-Minas Gerais Government (Inventiva Project/FAPEMIG); Programa Ciencias Sem Fronteiras-Atracao de Jovens Talentos-BJT (MEC/MCTI/CAPES/CNPq/FAPs); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the grants of the CPqRR/Fundacao Oswaldo Cruz (FIOCRUZ), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Encouraging Inovation Program-Minas Gerais Government (Inventiva Project/FAPEMIG). FFA thanks Programa Ciencias Sem Fronteiras-Atracao de Jovens Talentos-BJT (MEC/MCTI/CAPES/CNPq/FAPs) for a fellowship. ATC and OAMF thank CNPq for fellowships (PQ/CNPq). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Pereira VRA, 2012, DIAGN MICR INFEC DIS, V74, P292, DOI 10.1016/j.diagmicrobio.2012.06.025; Araujo AB, 2008, BRAZ J INFECT DIS, V12, P480, DOI 10.1590/S1413-86702008000600007; Araujo AB, 2013, BRAZ J INFECT DIS, V17, P174, DOI 10.1016/j.bjid.2012.10.013; Wendling APB, 2011, J IMMUNOL METHODS, V370, P24, DOI 10.1016/j.jim.2011.05.003; BRACHO CG, 1998, REV PANAM SALUD PUBL, V4, P94; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Cordeiro FD, 2001, CLIN DIAGN LAB IMMUN, V8, P112, DOI 10.1128/CDLI.8.1.112-118.2001; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; da Saude MS-Ministerio, 2005, REV SOC BRAS MED S3, V38, P12; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Ferreira-Silva MM, 2010, MEM I OSWALDO CRUZ, V105, P800, DOI 10.1590/S0074-02762010000600012; Flores-Chavez M, 2010, ENFERM INFEC MICR CL, V28, P284, DOI 10.1016/j.eimc.2009.07.005; Furucho CR, 2008, TROP MED INT HEALTH, V13, P1527, DOI 10.1111/j.1365-3156.2008.02172.x; Garcia LM, 2009, J IMMUNOL METHODS, V350, P36, DOI 10.1016/j.jim.2009.07.004; Gomes YM, 2009, MEM I OSWALDO CRUZ, V104, P115, DOI 10.1590/S0074-02762009000900017; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Ker HG, 2013, DIAGN MICR INFEC DIS, V76, P470, DOI 10.1016/j.diagmicrobio.2013.04.007; Leiby DA, 2000, J CLIN MICROBIOL, V38, P639, DOI 10.1128/JCM.38.2.639-642.2000; Lemos EM, 2007, CLIN VACCINE IMMUNOL, V14, P569, DOI 10.1128/CVI.00354-06; MARTINS-FILHO OA, 1995, CLIN DIAGN LAB IMMUN, V2, P569, DOI 10.1128/CDLI.2.5.569-573.1995; Matos CS, 2011, J IMMUNOL METHODS, V369, P22, DOI 10.1016/j.jim.2011.03.007; Picka MCM, 2007, BRAZ J INFECT DIS, V11, P226, DOI 10.1590/S1413-86702007000200012; Moncayo A, 2003, MEM I OSWALDO CRUZ, V98, P577, DOI 10.1590/S0074-02762003000500001; Otani MM, 2009, TRANSFUSION, V49, P1076, DOI 10.1111/j.1537-2995.2009.02107.x; Panamerican Health Organization-Iniciativa del Cono Sur, 1997, 98102 OPSHPCHCT PAN; Sabino EC, 2010, TRANSFUSION, V50, P2628, DOI 10.1111/j.1537-2995.2010.02756.x; Salles NA, 1996, TRANSFUSION, V36, P969, DOI 10.1046/j.1537-2995.1996.36111297091740.x; Vitelli-Avelar DM, 2007, J IMMUNOL METHODS, V318, P102, DOI 10.1016/j.jim.2006.10.009; Wendel S, 2010, ACTA TROP, V115, P28, DOI 10.1016/j.actatropica.2009.12.006	29	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122938	10.1371/journal.pone.0122938	http://dx.doi.org/10.1371/journal.pone.0122938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875961	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800083
J	Wagner, J; Damaschke, N; Yang, B; Truong, M; Guenther, C; McCormick, J; Huang, W; Jarrard, D				Wagner, Jennifer; Damaschke, Nathan; Yang, Bing; Truong, Matthew; Guenther, Chad; McCormick, Johnathon; Huang, Wei; Jarrard, David			Overexpression of the Novel Senescence Marker beta-Galactosidase (GLB1) in Prostate Cancer Predicts Reduced PSA Recurrence	PLOS ONE			English	Article							THERAPY-INDUCED SENESCENCE; CELLULAR SENESCENCE; INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; BIOMARKER; ARREST; CELLS; VITRO	Purpose Senescence is a terminal growth arrest that functions as a tumor suppressor in aging and precancerous cells and is a response to selected anticancer compounds. Lysosomal-beta-alactosidase (GLB1) hydrolyzes beta-galactose from glycoconjugates and is the origin of senescence-associated beta-gal activity (SA-beta-gal). Using a new GLB1 antibody, senescence biology was investigated in prostate cancer (PCa) tissues. Experimental Design In vitro characterization of GLB1 was determined in primary prostate epithelial cell cultures passaged to replicative senescence and in therapy-induced senescence in PCa lines using chemotherapeutic agents. FFPE tissue microarrays were subjected to immunofluorescent staining for GLB1, Ki67 and HP1. and automated quantitative imaging initially using AQUA in exploratory samples and Vectra in a validation series. Results GLB1 expression accumulates in replicative and induced senescence and correlates with senescent morphology and P16 (CDKN2) expression. In tissue arrays, quantitative imaging detects increased GLB1 expression in high-grade prostatic intraepithelial neoplasia (HGPIN), known to contain senescent cells, and cancer compared to benign prostate tissues (p<0.01) and senescent cells contain low Ki67 and elevated HP1 gamma. Within primary tumors, elevated GLB1 associates with lower T stage (p=0.01), localized versus metastatic disease (p=0.0003) and improved PSA-free survival (p=0.03). Increased GLB1 stratifies better PSA-free survival in intermediate grade PCa (0.01). Tissues that elaborate higher GLB1 display increased uniformity of expression. Conclusion Increased GLB1 is a valuable marker in formalin-fixed paraffin-embedded (FFPE) tissues for the senescence-like phenotype and associates with improved cancer outcomes. This protein addresses a lack of senescence markers and should be applicable to study the biologic role of senescence in other cancers.	[Wagner, Jennifer; Damaschke, Nathan; Yang, Bing; Truong, Matthew; Guenther, Chad; McCormick, Johnathon; Jarrard, David] Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA; [Huang, Wei] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jarrard, D (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA.	jarrard@urology.wisc.edu	Ramon y Cajal, Santiago/H-4955-2016	Ramon y Cajal, Santiago/0000-0002-3867-1390; McCormick, Johnathon/0000-0002-1344-7886; Truong, Matthew/0000-0002-0562-6972	Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK062709] Funding Source: NIH RePORTER	Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Prostate Cancer Foundation (http://www.pcf.org/site/c.leJRIROrEpH/b.5699537/k.BEF4/Home.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Boyd LK, 2012, GENE CHROMOSOME CANC, V51, P579, DOI 10.1002/gcc.21944; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Choi J, 2000, UROLOGY, V56, P160, DOI 10.1016/S0090-4295(00)00538-0; Cicione A, 2012, UROL ONCOL; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Melo FDE, 2013, EMBO REP, V14, P686, DOI 10.1038/embor.2013.92; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Doganavsargil B, 2006, BJU INT, V97, P644, DOI 10.1111/j.1464-410X.2006.06054.x; Ewald JA, 2013, PROSTATE, V73, P337, DOI 10.1002/pros.22571; Ewald JA, 2012, TRANSL ONCOL, V5, P278, DOI 10.1593/tlo.12181; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Ewald JA, 2009, J BIOMOL SCREEN, V14, P853, DOI 10.1177/1087057109340314; GLB1 galactosidase, 2013, PUBMED GENE DATABASE; Hassona Y, 2013, CARCINOGENESIS, V34, P1286, DOI 10.1093/carcin/bgt035; Haugstetter AM, 2010, BRIT J CANCER, V103, P505, DOI 10.1038/sj.bjc.6605784; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huang W, 2013, HUM PATHOL, V44, P29, DOI 10.1016/j.humpath.2012.05.009; Jarrard DF, 1999, CANCER RES, V59, P2957; Kolesar J, 2009, CANCER CHEMOTH PHARM, V64, P79, DOI 10.1007/s00280-008-0845-0; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250; Schwarze SR, 2001, ONCOGENE, V20, P8184, DOI 10.1038/sj.onc.1205049; Slezak J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-148; Warren M, 2009, APPL IMMUNOHISTO M M, V17, P23, DOI 10.1097/PAI.0b013e31817c3334; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	33	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124366	10.1371/journal.pone.0124366	http://dx.doi.org/10.1371/journal.pone.0124366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876105	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800139
J	Geneva, AJ; Muirhead, CA; Kingan, SB; Garrigan, D				Geneva, Anthony J.; Muirhead, Christina A.; Kingan, Sarah B.; Garrigan, Daniel			A New Method to Scan Genomes for Introgression in a Secondary Contact Model	PLOS ONE			English	Article							GENETIC-VARIATION; SPECIATION; DROSOPHILA; HYBRIDIZATION; POPULATIONS; SELECTION; DIVERSITY; FLOW	Secondary contact between divergent populations or incipient species may result in the exchange and introgression of genomic material. We develop a simple DNA sequence measure, called G(min), which is designed to identify genomic regions experiencing introgression in a secondary contact model. Gmin is defined as the ratio of the minimum between-population number of nucleotide differences in a genomic window to the average number of between- population differences. Although it is conceptually simple, one advantage of Gmin is that it is computationally inexpensive relative to model-based methods for detecting gene flow and it scales easily to the level of whole-genome analysis. We compare the sensitivity and specificity of Gmin to those of the widely used index of population differentiation, F-ST, and suggest a simple statistical test for identifying genomic outliers. Extensive computer simulations demonstrate that Gmin has both greater sensitivity and specificity for detecting recent introgression than does FST. Furthermore, we find that the sensitivity of Gmin is robust with respect to both the population mutation and recombination rates. Finally, a scan of Gmin across the X chromosome of Drosophila melanogaster identifies candidate regions of introgression between sub-Saharan African and cosmopolitan populations that were previously missed by other methods. These results show that Gmin is a biologically straightforward, yet powerful, alternative to FST, as well as to more computationally intensive model-based methods for detecting gene flow.	[Geneva, Anthony J.; Muirhead, Christina A.; Kingan, Sarah B.; Garrigan, Daniel] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Muirhead, Christina A.] Ronin Inst, Montclair, NJ USA	University of Rochester	Garrigan, D (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	dgarriga@ur.rochester.edu	Geneva, Anthony J/H-2471-2011; Garrigan, Daniel/N-6587-2013	Geneva, Anthony J/0000-0001-8253-6527; Garrigan, Daniel/0000-0002-7000-6788	National Institutes of Health [R01-ODO1054801]; University of Rochester River Campus Libraries	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester River Campus Libraries	This work was made possible by a grant from the National Institutes of Health to DG (R01-ODO1054801). Funds for data deposition were provided by the University of Rochester River Campus Libraries. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2002, GENETICS, V162, P2025; BIRKY CW, 1988, P NATL ACAD SCI USA, V85, P6414, DOI 10.1073/pnas.85.17.6414; Brand CL, 2013, MOL BIOL EVOL, V30, P2177, DOI 10.1093/molbev/mst123; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Garrigan D, 2014, MSMOVE A MODIFIED VE, DOI [10.6084/m9.figshare.1060474, DOI 10.6084/M9.FIGSHARE.1060474]; Garrigan D, 2013, EVOL BIOINFORM, V9, P343, DOI 10.4137/EBO.S12751; Geneva A, 2010, GENES-BASEL, V1, P124, DOI 10.3390/genes1010124; Gompert Z, 2012, PHILOS T R SOC B, V367, P439, DOI 10.1098/rstb.2011.0196; Gompert Z, 2011, MOL ECOL, V20, P2111, DOI 10.1111/j.1365-294X.2011.05074.x; Harris K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003521; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Langley CH, 2011, GENETICS, V188, P239, DOI 10.1534/genetics.111.127530; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Murray MC, 2006, MOL ECOL, V15, P4229, DOI 10.1111/j.1365-294X.2006.03060.x; Nadachowska-Brzyska K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003942; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pool JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003080; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Smith Joel, 2013, Biol Lett, V9, P20130503, DOI 10.1098/rsbl.2013.0503; Sousa V, 2013, NAT REV GENET, V14, P404, DOI 10.1038/nrg3446; TAKAHATA N, 1990, THEOR POPUL BIOL, V38, P331, DOI 10.1016/0040-5809(90)90018-Q; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yukilevich R, 2012, EVOLUTION, V66, P1430, DOI 10.1111/j.1558-5646.2011.01534.x	40	27	27	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0118621	10.1371/journal.pone.0118621	http://dx.doi.org/10.1371/journal.pone.0118621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874895	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700002
J	Kanwal, M; Alyas, S; Afzal, M; Mansoor, A; Abbasi, R; Tassone, F; Malik, S; Mazhar, K				Kanwal, Madiha; Alyas, Saadia; Afzal, Muhammad; Mansoor, Atika; Abbasi, Rashda; Tassone, Flora; Malik, Sajid; Mazhar, Kehkashan			Molecular Diagnosis of Fragile X Syndrome in Subjects with Intellectual Disability of Unknown Origin: Implications of Its Prevalence in Regional Pakistan	PLOS ONE			English	Article							MENTAL-RETARDATION; EXPANDED ALLELES; CGG REPEAT; GENE; PCR; IDENTIFICATION; CHILDREN; NEWBORN; FMR-1	Fragile-X syndrome (FXS) is the most common form of inherited intellectual disability (ID) and affects 0.7-3.0% of intellectually compromised population of unknown etiology world-wide. It is mostly caused by repeat expansion mutations in the FMR1 at chromosome Xq27.3. The present study aimed to develop molecular diagnostic tools for a better detection of FXS, to assess implementation of diagnostic protocols in a developing country and to estimate the prevalence of FXS in a cohort of intellectually disabled subjects from Pakistan. From a large pool of individuals with below normal IQ range, 395 subjects with intellectual disability of unknown etiology belonging to different regions of the country were recruited. Conventional-PCR, modified-PCR and Southern blot analysis methods were employed for the detection of CGG repeat polymorphisms in the FMR1 gene. Initial screening with conventional-PCR identified 13 suspected patients. Subsequent investigations through modified-PCR and Southern blot analyses confirmed the presence of the FMR1 mutation, suggesting a prevalence of 3.5% and 2.8% (mean 3.3%) among the male and female ID patients, respectively. These diagnostic methods were further customized with the in-house conditions to offer robust screening of referral patients/families for diagnostics and genetic counseling. Prescreening and early diagnosis are crucial for designing a prudent strategy for the management of subjects with ID. Outcome of the study recommends health practitioners for implementation of molecular based FXS diagnosis in routine clinical practice to give a better care for patients similar to the ones included in the study.	[Kanwal, Madiha; Alyas, Saadia; Afzal, Muhammad; Malik, Sajid] Quaid I Azam Univ, Dept Anim Sci, Human Genet Program, Islamabad 45320, Pakistan; [Mansoor, Atika; Abbasi, Rashda; Mazhar, Kehkashan] Inst Biomed & Genet Engn, Islamabad, Pakistan; [Tassone, Flora] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	Quaid I Azam University; University of California System; University of California Davis; University of California System; University of California Davis	Mazhar, K (corresponding author), Inst Biomed & Genet Engn, Islamabad, Pakistan.	kehkashan_mbhatti@yahoo.com	Kanwal, Madiha/S-2017-2019; Malik, Sajid/H-7816-2019	Kanwal, Madiha/0000-0003-2316-0368; Malik, Sajid/0000-0001-5563-9053	Pakistan Science Foundation [PSF/Res/Biotech/C-IBGE/Med (87)]	Pakistan Science Foundation	The work was supported by Pakistan Science Foundation grant no PSF/Res/Biotech/C-IBGE/Med (87).	Bhowmik DA, 2009, J CLIN DIAGN RES, V3, P1266; Charalsawadi Chariyawan, 2005, Journal of the Medical Association of Thailand, V88, P1057; Chen LJ, 2010, J MOL DIAGN, V12, P589, DOI 10.2353/jmoldx.2010.090227; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Durkin MS, 1998, AM J EPIDEMIOL, V147, P281; Dutta S, 2009, INDIAN J MED RES, V130, P714; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Maenner MJ, 2013, AM J MED GENET B, V162B, P466, DOI 10.1002/ajmg.b.32176; Mirza I, 2009, J INTELL DISABIL RES, V53, P559, DOI 10.1111/j.1365-2788.2009.01176.x; Nolin SL, 2013, AM J MED GENET A, V161A, P771, DOI 10.1002/ajmg.a.35833; Panagopoulos I, 1999, HUM MUTAT, V14, P71, DOI 10.1002/(SICI)1098-1004(1999)14:1<71::AID-HUMU9>3.0.CO;2-5; Reiss AL, 2003, DEV PSYCHOPATHOL, V15, P927, DOI 10.1017/S0954579403000464; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; Tassone F, 2012, GENOME MED, V4, DOI 10.1186/gm401; Thurman AJ, 2014, RES DEV DISABIL, V35, P1072, DOI 10.1016/j.ridd.2014.01.032; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang X., 2006, WORLD J PEDIATR, V2, P285; Yim SY, 2008, J KOREAN MED SCI, V23, P470, DOI 10.3346/jkms.2008.23.3.470; Yrigollen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021728	28	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122213	10.1371/journal.pone.0122213	http://dx.doi.org/10.1371/journal.pone.0122213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875842	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700013
J	Pernus, A; Langowski, J				Pernus, Agata; Langowski, Joerg			Imaging Fos-Jun Transcription Factor Mobility and Interaction in Live Cells by Single Plane Illumination-Fluorescence Cross Correlation Spectroscopy	PLOS ONE			English	Article							AP-1 SITE; C-FOS; BINDING; PROTEIN; DIFFUSION; RECEPTOR; DYNAMICS; COMPLEX; PRODUCT; GENE	We collected mobility and interaction maps of c-Fos-eGFP and c-Jun-mRFP1 transcription factors within living cell nuclei. c-Fos dimerizes with c-Jun to form the transcription activator protein-1 (AP-1) which binds to the specific recognition site. To monitor this process, we used fluorescence cross-correlation spectroscopy on a single plane illumination microscope (SPIM-FCCS), which provides diffusion coefficient and protein-protein interaction data in the whole image plane simultaneously, instead of just one point on conventional confocal FCS. We find a strong correlation between diffusional mobility and interaction: regions of strong interaction show slow mobility. Controls containing either an eGFP-mRFP dimer, separately expressing eGFP and mRPF, or c-Fos-eGFP and c-Jun-mRFP1 mutants lacking dimerization and DNA-binding domains, showed no such correlation. These results extend our earlier findings from confocal FCCS to include spatial information.	[Pernus, Agata; Langowski, Joerg] DKFZ, Div Biophys Macromol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Langowski, J (corresponding author), DKFZ, Div Biophys Macromol, Heidelberg, Germany.	jl@dkfz.de	Langowski, Jörg/A-1843-2011	Langowski, Jörg/0000-0001-8600-0666	NUS-BW (National University of Singapore/Baden Wurttemberg) grant	NUS-BW (National University of Singapore/Baden Wurttemberg) grant	This study was funded by a NUS-BW (National University of Singapore/Baden Wurttemberg) grant to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRETTO EA, 1990, J CELL BIOCHEM, V42, P193, DOI 10.1002/jcb.240420403; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bacia Kirsten, 2007, V398, P73, DOI 10.1007/978-1-59745-513-8_7; Bag N, 2012, CHEMPHYSCHEM, V13, P2784, DOI 10.1002/cphc.201200032; Baudendistel N, 2005, CHEMPHYSCHEM, V6, P984, DOI 10.1002/cphc.200400639; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Bestvater F, 2010, OPT EXPRESS, V18, P23818, DOI 10.1364/OE.18.023818; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Brazda P, 2014, MOL CELL BIOL, V34, P1234, DOI 10.1128/MCB.01097-13; Brazda P, 2011, J CELL SCI, V124, P3631, DOI 10.1242/jcs.086082; Burkhardt M, 2006, OPT EXPRESS, V14, P5013, DOI 10.1364/OE.14.005013; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; Glauner H, 2010, BRIT J PHARMACOL, V160, P958, DOI 10.1111/j.1476-5381.2010.00732.x; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Greger K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2428277; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Hwang LC, 2007, CELL BIOCHEM BIOPHYS, V49, P1, DOI 10.1007/s12013-007-0042-5; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kohl T, 2005, ADV BIOCHEM ENG BIOT, V95, P107; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; Krieger JW, 2014, OPT EXPRESS, V22, P2358, DOI 10.1364/OE.22.002358; Krieger JW, 2014, QUICKFIT 3 0 BETA SV; Krieger JW, 2014, THESIS U HEIDELBERG; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022962; Langowski J, 2008, METHOD CELL BIOL, V85, P471; Lee W, 2010, ANAL CHEM, V82, P1401, DOI 10.1021/ac9024768; Ma Xiaoxiao, 2011, Front Biosci (Elite Ed), V3, P22, DOI 10.2741/e216; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; McBride K, 1998, MOL CELL BIOL, V18, P5073, DOI 10.1128/MCB.18.9.5073; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; Nitsche JM, 2004, BIOPHYS J, V86, P2058, DOI 10.1016/S0006-3495(04)74267-8; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; Ries J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113009; Ries J, 2009, BIOPHYS J, V96, P1999, DOI 10.1016/j.bpj.2008.12.3888; Sadamoto Hisayo, 2013, Methods Mol Biol, V977, P229, DOI 10.1007/978-1-62703-284-1_18; Sankaran J, 2013, ANAL CHEM, V85, P3948, DOI 10.1021/ac303485t; Sankaran J, 2009, BIOPHYS J, V97, P2630, DOI 10.1016/j.bpj.2009.08.025; Singh AP, 2014, CURR OPIN CHEM BIOL, V20, P29, DOI 10.1016/j.cbpa.2014.04.006; Singh AP, 2013, OPT EXPRESS, V21, P8652, DOI 10.1364/OE.21.008652; TEWES M, 2001, Patent No. 0941470; Vamosi G, 2004, P NATL ACAD SCI USA, V101, P11082, DOI 10.1073/pnas.0403916101; Vamosi G, 2009, CURR PROTOC CYTOM, V2, P1; Vamosi G, 2008, BIOPHYS J, V94, P2859, DOI 10.1529/biophysj.107.120766; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wachsmuth M, 2001, THESIS U HEIDELBERG; Weidemann T, 2014, CURR OPIN STRUC BIOL, V28, P69, DOI 10.1016/j.sbi.2014.07.008; Wohland T, 2010, OPT EXPRESS, V18, P10627, DOI 10.1364/OE.18.010627; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	61	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123070	10.1371/journal.pone.0123070	http://dx.doi.org/10.1371/journal.pone.0123070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875593	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700026
J	Seto, KKY; Andrulis, IL				Seto, Kelly K. Y.; Andrulis, Irene L.			Atypical Protein Kinase C Zeta: Potential Player in Cell Survival and Cell Migration of Ovarian Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-I; PKC-ZETA; PANCREATIC-CANCER; EXPRESSION; INSULIN; RECEPTOR; ALPHA; PROLIFERATION; ISOFORMS; RHOA	Ovarian cancer is one of the most aggressive gynaecological cancers, thus understanding the different biological pathways involved in ovarian cancer progression is important in identifying potential therapeutic targets for the disease. The aim of this study was to investigate the potential roles of Protein Kinase C Zeta (PRKCZ) in ovarian cancer. The atypical protein kinase C isoform, PRKCZ, is involved in the control of various signalling processes including cell proliferation, cell survival, and cell motility, all of which are important for cancer development and progression. Herein, we observe a significant increase in cell survival upon PRKCZ over-expression in SKOV3 ovarian cancer cells; additionally, when the cells are treated with small interference RNA (siRNA) targeting PRKCZ, the motility of SKOV3 cells decreased. Furthermore, we demonstrate that over-expression of PRKCZ results in gene and/or protein expression alterations of insulin-like growth factor 1 receptor (IGF1R) and integrin beta 3 (ITGB3) in SKOV3 and OVCAR3 cells. Collectively, our study describes PRKCZ as a potential regulatory component of the IGF1R and ITGB3 pathways and suggests that it may play critical roles in ovarian tumourigenesis.	[Seto, Kelly K. Y.; Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Seto, Kelly K. Y.; Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Andrulis, IL (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	andrulis@lunenfeld.ca	Andrulis, Irene L./E-7267-2013		Canadian Institutes of Health Research; CIHR Collaborative Training Program in Molecular Medicine (KKYS); Kristi Piia Callum Memorial Fellowship in Ovarian Cancer Research (KKYS); Toronto Ovarian Cancer Research Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Collaborative Training Program in Molecular Medicine (KKYS); Kristi Piia Callum Memorial Fellowship in Ovarian Cancer Research (KKYS); Toronto Ovarian Cancer Research Network	This work was supported by the Canadian Institutes of Health Research (ILA;http://www.cihrirsc. gc.ca), the CIHR Collaborative Training Program in Molecular Medicine (KKYS), the Kristi Piia Callum Memorial Fellowship in Ovarian Cancer Research (KKYS) and Toronto Ovarian Cancer Research Network (KKYS;http://www.uhnres.utoronto.ca/ programs/tocrn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2009, ONKOLOGIE, V32, P638, DOI 10.1159/000242253; Baldwin RM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-233; BECK EP, 1994, GYNECOL ONCOL, V53, P196, DOI 10.1006/gyno.1994.1115; Chang WW, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3423; Cohen EEW, 2006, CANCER RES, V66, P6296, DOI 10.1158/0008-5472.CAN-05-3139; Della Peruta M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-61; Donson AM, 2000, J NEURO-ONCOL, V47, P109, DOI 10.1023/A:1006406208376; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Gest C, 2012, CANCER LETT, V317, P207, DOI 10.1016/j.canlet.2011.11.026; Ghosh PM, 2002, CANCER RES, V62, P2630; Grifoni D, 2007, ONCOGENE, V26, P5960, DOI 10.1038/sj.onc.1210389; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Inoue T, 2006, MOL ENDOCRINOL, V20, P3053, DOI 10.1210/me.2006-0033; Joung I, 2005, BIOCHEM BIOPH RES CO, V334, P654, DOI 10.1016/j.bbrc.2005.06.138; Kaur S, 2009, AM J PATHOL, V175, P2184, DOI 10.2353/ajpath.2009.090028; Kim DS, 2008, BIOCHEM BIOPH RES CO, V377, P479, DOI 10.1016/j.bbrc.2008.10.010; Liu Y, 2009, LUNG CANCER, V63, P210, DOI 10.1016/j.lungcan.2008.05.010; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Moscat J, 2001, ADV ENZYME REGUL, V41, P99, DOI 10.1016/S0065-2571(00)00009-1; Ouban A, 2003, HUM PATHOL, V34, P803, DOI 10.1016/S0046-8177(03)00291-0; Partheen K, 2008, INT J CANCER, V123, P2130, DOI 10.1002/ijc.23758; Partheen K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-336; Rodriguez EM, 2009, J CELL PHYSIOL, V221, P171, DOI 10.1002/jcp.21841; Sarkissyan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103534; Spentzos D, 2007, ENDOCR-RELAT CANCER, V14, P781, DOI 10.1677/ERC-06-0073; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tian XD, 2013, DIGEST DIS SCI, V58, P2705, DOI 10.1007/s10620-013-2673-2; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Valkov A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017507; Wang YM, 1999, J NEUROSCI RES, V55, P293, DOI 10.1002/(SICI)1097-4547(19990201)55:3<293::AID-JNR4>3.3.CO;2-0; Win HY, 2009, CELL PROLIFERAT, V42, P182, DOI 10.1111/j.1365-2184.2009.00582.x; Win HY, 2008, CANCER LETT, V270, P302, DOI 10.1016/j.canlet.2008.05.023; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8; XIAO HG, 1994, J NEUROSURG, V81, P734, DOI 10.3171/jns.1994.81.5.0734; YEE D, 1991, CANCER RES, V51, P5107; Yu LR, 2011, NEOPLASMA, V58, P491, DOI 10.4149/neo_2011_06_491; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527	45	16	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123528	10.1371/journal.pone.0123528	http://dx.doi.org/10.1371/journal.pone.0123528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874946	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700033
J	Li, HB; Yu, Y; Wang, ZZ; Geng, JL; Dai, Y; Xiao, W; Yao, XS				Li, Haibo; Yu, Yang; Wang, Zhenzhong; Geng, Jianliang; Dai, Yi; Xiao, Wei; Yao, Xinsheng			Chemical Profiling of Re-Du-Ning Injection by Ultra-Performance Liquid Chromatography Coupled with Electrospray Ionization Tandem Quadrupole Time-of-Flight Mass Spectrometry through the Screening of Diagnostic Ions in MSE Mode	PLOS ONE			English	Article							FLOS LONICERAE JAPONICAE; DIODE-ARRAY DETECTION; IRIDOID GLYCOSIDES; PHENOLIC-ACIDS; RAT PLASMA; CONSTITUENTS; IDENTIFICATION; FRAGMENTATION; METABOLITES; FLAVONOIDS	The broad applications and mechanism explorations of traditional Chinese medicine prescriptions (TCMPs) require a clear understanding of TCMP chemical constituents. In the present study, we describe an efficient and universally applicable analytical approach based on ultra-performance liquid chromatography coupled to electrospray ionization tandem quadrupole time-of-flight mass spectrometry (UPLC-ESI-Q/TOF-MS) with the MSE ((E) denotes collision energy) data acquisition mode, which allowed the rapid separation and reliable determination of TCMP chemical constituents. By monitoring diagnostic ions in the high energy function of MSE, target peaks of analogous compounds in TCMPs could be rapidly screened and identified. "Re-Du-Ning" injection (RDN), a eutherapeutic traditional Chinese medicine injection (TCMI) that has been widely used to reduce fever caused by viral infections in clinical practice, was studied as an example. In total, 90 compounds, including five new iridoids and one new sesquiterpene, were identified or tentatively characterized by accurate mass measurements within 5 ppm error. This analysis was accompanied by MS fragmentation and reference standard comparison analyses. Furthermore, the herbal sources of these compounds were unambiguously confirmed by comparing the extracted ion chromatograms (EICs) of RDN and ingredient herbal extracts. Our work provides a certain foundation for further studies of RDN. Moreover, the analytical approach developed herein has proven to be generally applicable for profiling the chemical constituents in TCMPs and other complicated mixtures.	[Li, Haibo; Wang, Zhenzhong; Xiao, Wei] Jiangsu Kanion Pharmaceut Co Ltd, Lianyungang, Peoples R China; [Li, Haibo; Yu, Yang; Dai, Yi; Yao, Xinsheng] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China; [Li, Haibo; Wang, Zhenzhong; Xiao, Wei] State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Peoples R China; [Geng, Jianliang; Yao, Xinsheng] Shenyang Pharmaceut Univ, Shenyang, Peoples R China	Jinan University; Shenyang Pharmaceutical University	Xiao, W (corresponding author), Jiangsu Kanion Pharmaceut Co Ltd, Lianyungang, Peoples R China.	kanionxw2010@126.com; tyaoxs@jnu.edu.cn			Natural Science Foundation of Jiangsu Province [BK20140441]; Jiangsu Province Postdoctoral Science Foundation [1401771C]; Programme of Introducing Talents of Discipline to Universities [B13038]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province Postdoctoral Science Foundation; Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by the Natural Science Foundation of Jiangsu Province (BK20140441); the Jiangsu Province Postdoctoral Science Foundation (1401771C) and the Programme of Introducing Talents of Discipline to Universities (B13038). The funders had no role in study design, data collection and analysis,	Bent S, 2004, AM J MED, V116, P478, DOI 10.1016/j.amjmed.2003.10.036; Castro-Perez JM, 2010, J PROTEOME RES, V9, P2377, DOI 10.1021/pr901094j; Cuyckens F, 2001, J MASS SPECTROM, V36, P1203, DOI 10.1002/jms.224; Fabre N, 2001, J AM SOC MASS SPECTR, V12, P707, DOI 10.1016/S1044-0305(01)00226-4; Hu ZP, 2005, DRUGS, V65, P1239, DOI 10.2165/00003495-200565090-00005; Huang X. M., 2006, CHIN J CLIN PHARM TH, V11, P470; Hvattum E, 2003, J MASS SPECTROM, V38, P43, DOI 10.1002/jms.398; Konishi Y, 2007, ANAL CHEM, V79, P1187, DOI 10.1021/ac061391o; Li HB, 2013, FITOTERAPIA, V88, P7, DOI 10.1016/j.fitote.2013.03.025; Liang X, 2010, J PHARMACEUT BIOMED, V51, P565, DOI 10.1016/j.jpba.2009.09.015; LOFFLER C, 1995, BIOCHEM SYST ECOL, V23, P121, DOI 10.1016/0305-1978(95)93846-U; March RE, 2004, RAPID COMMUN MASS SP, V18, P931, DOI 10.1002/rcm.1428; Ni SM, 2010, J CHROMATOGR B, V878, P2741, DOI 10.1016/j.jchromb.2010.08.014; Nordstrom A, 2006, ANAL CHEM, V78, P3289, DOI 10.1021/ac060245f; Pelkonen O, 2012, J ETHNOPHARMACOL, V140, P587, DOI 10.1016/j.jep.2012.01.035; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Qi LW, 2009, RAPID COMMUN MASS SP, V23, P3227, DOI 10.1002/rcm.4245; Qi Y, 2014, TALANTA, V118, P21, DOI 10.1016/j.talanta.2013.09.054; Rainville PD, 2007, J PROTEOME RES, V6, P552, DOI 10.1021/pr060611b; Ren L, 2007, RAPID COMMUN MASS SP, V21, P3039, DOI 10.1002/rcm.3189; Schutz K, 2005, RAPID COMMUN MASS SP, V19, P179, DOI 10.1002/rcm.1767; Stone R, 2008, SCIENCE, V319, P709, DOI 10.1126/science.319.5864.709; Sun L. M., 2011, CHINA MED HER, V8, P149; Tan GG, 2011, BIOMED CHROMATOGR, V25, P913, DOI 10.1002/bmc.1544; Yan JJ, 2011, CHINA MODERN DOCTOR, V49, P31; Yang B, 2011, J SEP SCI, V34, P3208, DOI 10.1002/jssc.201100632; Zhang JY, 2013, TALANTA, V104, P1, DOI 10.1016/j.talanta.2012.11.012; Zhang J, 2009, TALANTA, V78, P513, DOI 10.1016/j.talanta.2008.12.002; Zhang Y., 2011, GUIDE CHINA MED, V9, P33; Zhou TT, 2010, RAPID COMMUN MASS SP, V24, P2520, DOI 10.1002/rcm.4643; Zhou Y, 2008, ANAL CHIM ACTA, V629, P104, DOI 10.1016/j.aca.2008.09.044	31	16	18	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121031	10.1371/journal.pone.0121031	http://dx.doi.org/10.1371/journal.pone.0121031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875968	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100034
J	Svensson, A; Ozen, I; Genove, G; Paul, G; Bengzon, J				Svensson, Andreas; Ozen, Ilknur; Genove, Guillem; Paul, Gesine; Bengzon, Johan			Endogenous Brain Pericytes Are Widely Activated and Contribute to Mouse Glioma Microvasculature	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSELS; DETAILED CHARACTERIZATION; MURAL CELLS; STEM-CELLS; GLIOBLASTOMA; TUMORS; MODEL; ANGIOGENESIS; SURVIVAL	Glioblastoma multiforme (GBM) is the most common brain tumor in adults. It presents an extremely challenging clinical problem, and treatment very frequently fails due to the infiltrative growth, facilitated by extensive angiogenesis and neovascularization. Pericytes constitute an important part of the GBM microvasculature. The contribution of endogenous brain pericytes to the tumor vasculature in GBM is, however, unclear. In this study, we determine the site of activation and the extent of contribution of endogenous brain pericytes to the GBM vasculature. GL261 mouse glioma was orthotopically implanted in mice expressing green fluorescent protein (GFP) under the pericyte marker regulator of G protein signaling 5 (RGS5). Host pericytes were not only activated within the glioma, but also in cortical areas overlying the tumor, the ipsilateral subventricular zone and within the hemisphere contralateral to the tumor. The host-derived activated pericytes that infiltrated the glioma were mainly localized to the tumor vessel wall. Infiltrating GFP positive pericytes co-expressed the pericyte markers platelet-derived growth factor receptor-beta (PDGFR-beta) and neuron-glial antigen 2. Interestingly, more than half of all PDGFR-beta positive pericytes within the tumor were contributed by the host brain. We did not find any evidence that RGS5 positive pericytes adopt another phenotype within glioma in this paradigm. We conclude that endogenous pericytes become activated in widespread areas of the brain in response to an orthotopic mouse glioma. Host pericytes are recruited into the tumor and constitute a major part of the tumor pericyte population.	[Svensson, Andreas; Bengzon, Johan] Skane Univ Hosp, Lund Stem Cell Ctr, BMC B10, Lund, Sweden; [Svensson, Andreas; Bengzon, Johan] Skane Univ Hosp, Dept Clin Sci, Div Neurosurg, Lund, Sweden; [Ozen, Ilknur] Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Div Neurol,Translat Neurol Grp, Lund, Sweden; [Genove, Guillem] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Karolinska Institutet	Svensson, A (corresponding author), Skane Univ Hosp, Lund Stem Cell Ctr, BMC B10, Lund, Sweden.	andreas.svensson@med.lu.se		Genove, Guillem/0000-0002-8558-3107	Faculty of Medicine at Lund University [13404]; Swedish Cancer Society [2012/451, 2013-0782]; Gunnar Nilsson Cancer Foundation [35541]; Swedish Research Council [K2012-61X-22095-01-4]; Region Skane [13461]	Faculty of Medicine at Lund University; Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane	This work was supported by a donation from Viveca Jeppsson (JB), grants from Region Skane (grant number 13461, JB), ALF grants from the Faculty of Medicine at Lund University (grant number 13404, JB), grants from the Swedish Cancer Society (grant number 2012/451, JB and grant number 2013-0782, GG; http://www.cancerfonden.se), the Gunnar Nilsson Cancer Foundation (grant number 35541, JB; http://www.cancerstiftelsen.com) and the Swedish Research Council (grant number K2012-61X-22095-01-4, GP; http://www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Airley R, 2001, CLIN CANCER RES, V7, P928; AUSMAN JI, 1970, CANCER RES, V30, P2394; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bexell D, 2007, NEUROSCIENCE, V147, P824, DOI 10.1016/j.neuroscience.2007.04.058; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Castejon OJ, 2011, FOLIA NEUROPATHOL, V49, P162; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Crisan M, 2008, METHOD CELL BIOL, V86, P295, DOI 10.1016/S0091-679X(08)00013-7; Diaz-Flores L, 2009, FRONT BIOSCI-LANDMRK, V14, P1433, DOI 10.2741/3317; Dore-Duffy P, 2011, METHODS MOL BIOL, V686, P49, DOI 10.1007/978-1-60761-938-3_2; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Newcomb EW, 2009, CNS CANC MODELS MARK, V12, P227, DOI DOI 10.1007/978-1-60327-553-8; Nisancioglu MH, 2008, MOL CELL BIOL, V28, P2324, DOI 10.1128/MCB.01252-07; Ochs K, 2013, J NEUROIMMUNOL, V265, P106, DOI 10.1016/j.jneuroim.2013.09.011; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Ozen I, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-30; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Paul G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035577; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Scully S, 2012, J NEUROSCI, V32, P12950, DOI 10.1523/JNEUROSCI.2017-12.2012; Sharma V, 2012, J CEREBR BLOOD F MET, V32, P2055, DOI 10.1038/jcbfm.2012.107; Shibuya M, 2009, FEBS J, V276, P4636, DOI 10.1111/j.1742-4658.2009.07175.x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Yi L, 2013, INT J ONCOL, V43, P477, DOI 10.3892/ijo.2013.1962	38	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123553	10.1371/journal.pone.0123553	http://dx.doi.org/10.1371/journal.pone.0123553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875288	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100186
J	Tang, YY; Li, Y; Zhuo, KM; Wang, Y; Liao, LW; Song, ZH; Li, H; Fan, XD; Goff, DC; Wang, JJ; Xu, YF; Liu, DT				Tang, Yingying; Li, Yan; Zhuo, Kaiming; Wang, Yan; Liao, Liwei; Song, Zhenhua; Li, Hui; Fan, Xiaoduo; Goff, Donald C.; Wang, Jijun; Xu, Yifeng; Liu, Dengtang			Neural Correlates of the Preserved Inhibition of Return in Schizophrenia	PLOS ONE			English	Article							NEGATIVE SYNDROME SCALE; ATTENTIONAL ASYMMETRY; VISUOSPATIAL ATTENTION; DEFICIENT INHIBITION; BLUNTED INHIBITION; NEUROCOGNITION; INFORMATION	Inhibition of return (IOR) is an attentional mechanism that previously has been reported to be either intact or blunted in subjects with schizophrenia (SCZ). In the present study, we explored the neural mechanism of IOR in SCZ by comparing the target-locked N1 and P1 activity evoked by valid-cued trials with that evoked by invalid-cued trials. Twenty-seven schizophrenia patients and nineteen healthy controls participated in a task involving covert orienting of attention with two stimulus onset asynchronies (SOAs: 700 ms and 1200 ms) during which 64-channel EEG data were recorded. Behavioral reaction times (RTs) were longer in response to valid-cued trials than to invalid-cued ones, suggesting an intact IOR in SCZ. However, reduced N1 amplitude elicited by valid-cued trials suggested a stronger inhibition of attention from being oriented to a previously cued location, and therefore a relative inhibition of perceptual processing at that location in SCZ. These results indicate that altered N1 activity is associated with the preservation of IOR in SCZ and could be a sensitive marker to track the IOR effect.	[Tang, Yingying; Li, Yan; Zhuo, Kaiming; Liao, Liwei; Song, Zhenhua; Li, Hui; Wang, Jijun; Xu, Yifeng; Liu, Dengtang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr,Div Psychot Disorders, Episode Schizophrenia & Early Psychosis Program 1, Shanghai 200030, Peoples R China; [Tang, Yingying; Zhuo, Kaiming; Wang, Jijun; Xu, Yifeng; Liu, Dengtang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China; [Wang, Yan] E China Normal Univ, Dept Psychol, Shanghai 200062, Peoples R China; [Goff, Donald C.] Univ Massachusetts, Sch Med, UMass Mem Med Ctr, Psychot Disorders Program, Worcester, MA USA; [Fan, Xiaoduo] NYU, Med Ctr, Nathan Kline Inst Psychiat Res, New York, NY 10016 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China Normal University; University of Massachusetts System; University of Massachusetts Worcester; Nathan Kline Institute for Psychiatric Research; New York University	Xu, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr,Div Psychot Disorders, Episode Schizophrenia & Early Psychosis Program 1, Shanghai 200030, Peoples R China.	hyyyyb@gmail.com; erliu110@126.com	Fan, Xiaoduo/AAV-1268-2020; Xu, Yifeng/AAA-2064-2021	Fan, Xiaoduo/0000-0003-4299-8924; Xu, Yifeng/0000-0002-0403-1141	National Natural Science Foundation of China [81371479, 81171267, 61102020]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500, 14K03]; Shanghai Municipal Natural Science Foundation [07ZR14093, 11ZR1431600, 134119b0300]; Shanghai Municipal Health Bureau Foundation [024036]; Shanghai Clinical Center for Mental Disorders; National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health) [2011-873]; National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH) [2011-873]; Early Psychosis Program of Shanghai Mental Health Center [2013-YJTSZK-05]; Shanghai Mental Health Center [2014-FX-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Psychotic Disorders; Shanghai Municipal Natural Science Foundation; Shanghai Municipal Health Bureau Foundation; Shanghai Clinical Center for Mental Disorders; National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health); National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH); Early Psychosis Program of Shanghai Mental Health Center; Shanghai Mental Health Center	This work was supported by National Natural Science Foundation of China (81371479, 81171267, 61102020), Shanghai Key Laboratory of Psychotic Disorders (13dz2260500, 14K03), Shanghai Municipal Natural Science Foundation (07ZR14093, 11ZR1431600, 134119b0300), Shanghai Municipal Health Bureau Foundation (024036), Shanghai Clinical Center for Mental Disorders (2014), National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health, 2011-873; OMA-MH, 2011-873) and Early Psychosis Program of Shanghai Mental Health Center (2013-YJTSZK-05). Yingying Tang is supported by Shanghai Mental Health Center (2014-FX-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAFF DL, 1993, SCHIZOPHRENIA BULL, V19, P233, DOI 10.1093/schbul/19.2.233; CARTER CS, 1994, PROG NEURO-PSYCHOPH, V18, P661, DOI 10.1016/0278-5846(94)90075-2; CARTER CS, 1992, BIOL PSYCHIAT, V31, P909, DOI 10.1016/0006-3223(92)90117-I; Carter JD, 2010, SCHIZOPHR RES, V122, P104, DOI 10.1016/j.schres.2010.03.019; Fuentes LJ, 1999, SCHIZOPHR RES, V40, P75, DOI 10.1016/S0920-9964(99)00044-4; Fuentes LJ, 1999, NEUROPSYCHOLOGY, V13, P259, DOI 10.1037/0894-4105.13.2.259; Giuliano AJ, 2012, CURR PHARM DESIGN, V18, P399; Gouzoulis-Mayfrank E, 2006, PROG NEURO-PSYCHOPH, V30, P42, DOI 10.1016/j.pnpbp.2005.06.016; Gouzoulis-Mayfrank E, 2004, PROG NEURO-PSYCHOPH, V28, P389, DOI 10.1016/j.pnpbp.2003.11.010; Gouzoulis-Mayfrank E, 2007, SCHIZOPHR RES, V97, P35, DOI 10.1016/j.schres.2007.06.028; GUY W, 1976, MANUAL EDCEU ASSESSM; Hahn B, 2012, J ABNORM PSYCHOL, V121, P119, DOI 10.1037/a0023938; Hu FK, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00007; HUEY ED, 1994, SCHIZOPHR RES, V14, P57, DOI 10.1016/0920-9964(94)90009-4; KAY S R, 1989, British Journal of Psychiatry, V155, P59; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Kebir O, 2010, PSYCHIAT RES, V176, P17, DOI 10.1016/j.psychres.2008.10.010; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Lalanne L, 2012, BIOL PSYCHIAT, V71, P162, DOI 10.1016/j.biopsych.2011.09.018; Larrison-Faucher A, 2002, PROG NEURO-PSYCHOPH, V26, P505, DOI 10.1016/S0278-5846(01)00298-6; Liu DT, 2010, PROG NEURO-PSYCHOPH, V34, P961, DOI 10.1016/j.pnpbp.2010.05.002; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; Lupianez J, 1999, J GEN PSYCHOL, V126, P392, DOI 10.1080/00221309909595373; Lupianez J, 2006, COGN NEUROPSYCHOL, V23, P1003, DOI 10.1080/02643290600588095; MARUFF P, 1995, NEUROPSYCHOLOGIA, V33, P1205, DOI 10.1016/0028-3932(95)00037-4; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; MILLER GA, 1988, PSYCHOPHYSIOLOGY, V25, P241, DOI 10.1111/j.1469-8986.1988.tb00999.x; Moritz Steffen, 2007, Cogn Neuropsychiatry, V12, P381, DOI 10.1080/13546800601119982; Mushquash AR, 2012, SCHIZOPHR RES, V135, P55, DOI 10.1016/j.schres.2011.11.034; Nestor PG, 2010, J CLIN EXP NEUROPSYC, V32, P281, DOI 10.1080/13803390902984472; Nuechterlein KH, 2006, DEV PSYCHOPATHOL, V18, P831; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Prime DJ, 2006, BRAIN RES, V1072, P161, DOI 10.1016/j.brainres.2005.11.081; Prime DJ, 2004, PSYCHOL SCI, V15, P272, DOI 10.1111/j.0956-7976.2004.00665.x; Sapir A, 2001, NEUROPSYCHOLOGY, V15, P361, DOI 10.1037//0894-4105.15.3.361; Sapir A, 2007, NEUROPSYCHOLOGIA, V45, P3263, DOI 10.1016/j.neuropsychologia.2007.06.007; Satel J, 2013, ATTEN PERCEPT PSYCHO, V75, P29, DOI 10.3758/s13414-012-0381-1; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sostaric M, 2011, PSYCHIAT DANUB, V23, P251; Tassinari G, 2002, EXP BRAIN RES, V146, P523, DOI 10.1007/s00221-002-1192-8; Taylor TL, 1998, PSYCHON B REV, V5, P625, DOI 10.3758/BF03208839; Taylor TL, 2000, J EXP PSYCHOL HUMAN, V26, P1639, DOI 10.1037//0096-1523.26.5.1639; Tian Y, 2008, BIOL PSYCHOL, V79, P171, DOI 10.1016/j.biopsycho.2008.04.006; Vlcek P, 2014, NEUROPSYCH DIS TREAT, V10, P1309, DOI 10.2147/NDT.S64219; Zhou XL, 2008, NEUROPSYCHOLOGIA, V46, P2766, DOI 10.1016/j.neuropsychologia.2008.05.017	48	1	1	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							0119521	10.1371/journal.pone.0119521	http://dx.doi.org/10.1371/journal.pone.0119521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875486	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100015
J	Yamamoto, K; Kakino, A; Takeshita, H; Hayashi, N; Li, L; Nakano, A; Hanasaki-Yamamoto, H; Fujita, Y; Imaizumi, Y; Toyama-Yokoyama, S; Nakama, C; Kawai, T; Takeda, M; Hongyo, K; Oguro, R; Maekawa, Y; Itoh, N; Takami, Y; Onishi, M; Takeya, Y; Sugimoto, K; Kamide, K; Nakagami, H; Ohishi, M; Kurtz, TW; Sawamura, T; Rakugi, H				Yamamoto, Koichi; Kakino, Akemi; Takeshita, Hikari; Hayashi, Norihiro; Li, Lei; Nakano, Atsushi; Hanasaki-Yamamoto, Hiroko; Fujita, Yoshiko; Imaizumi, Yuki; Toyama-Yokoyama, Serina; Nakama, Chikako; Kawai, Tatsuo; Takeda, Masao; Hongyo, Kazuhiro; Oguro, Ryosuke; Maekawa, Yoshihiro; Itoh, Norihisa; Takami, Yoichi; Onishi, Miyuki; Takeya, Yasushi; Sugimoto, Ken; Kamide, Kei; Nakagami, Hironori; Ohishi, Mitsuru; Kurtz, Theodore W.; Sawamura, Tatsuya; Rakugi, Hiromi			Oxidized LDL (oxLDL) activates the angiotensin II type 1 receptor by binding to the lectin-like oxLDL receptor	FASEB JOURNAL			English	Article						G protein-coupled receptor; allosteric activation; vascular dysfunction; receptor multimerization	LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; ARTERY ENDOTHELIAL-CELLS; 3RD CYTOPLASMIC LOOP; NF-KAPPA-B; OXIDATIVE STRESS; KNOCKOUT MICE; NADPH OXIDASE; EGF RECEPTOR; G-PROTEINS	The angiotensin II type 1 receptor (AT1) is a 7-transmembrane domain GPCR that when activated by its ligand angiotensin II, generates signaling events promoting vascular dysfunction and the development of cardiovascular disease. Here, we show that the single-transmembrane oxidized LDL (oxLDL) receptor (LOX-1) resides in proximity to AT1 on cell-surface membranes and that binding of oxLDL to LOX-1 can allosterically activate AT1-dependent signaling events. oxLDL-induced signaling events in human vascular endothelial cells were abolished by knockdown of AT1 and inhibited by AT1 blockade (ARB). oxLDL increased cytosolic G protein by 350% in Chinese hamster ovary (CHO) cells with genetically induced expression of AT1 and LOX-1, whereas little increase was observed in CHO cells expressing only LOX-1. Immunoprecipitation and in situ proximity ligation assay (PLA) assays in CHO cells revealed the presence of cell-surface complexes involving LOX-1 and AT1. Chimeric analysis showed that oxLDL-induced AT1 signaling events are mediated via interactions between the intracellular domain of LOX-1 and AT1 that activate AT1. oxLDL-induced impairment of endothelium-dependent vascular relaxation of vascular ring from mouse thoracic aorta was abolished by ARB or genetic deletion of AT1. These findings reveal a novel pathway for AT1 activation and suggest a new mechanism whereby oxLDL may be promoting risk for cardiovascular disease.	[Yamamoto, Koichi; Takeshita, Hikari; Hayashi, Norihiro; Hanasaki-Yamamoto, Hiroko; Imaizumi, Yuki; Toyama-Yokoyama, Serina; Nakama, Chikako; Kawai, Tatsuo; Takeda, Masao; Hongyo, Kazuhiro; Oguro, Ryosuke; Maekawa, Yoshihiro; Itoh, Norihisa; Takami, Yoichi; Onishi, Miyuki; Takeya, Yasushi; Sugimoto, Ken; Kamide, Kei; Ohishi, Mitsuru; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Kakino, Akemi; Li, Lei; Nakano, Atsushi; Fujita, Yoshiko; Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Vasc Physiol, Suita, Osaka, Japan; [Kakino, Akemi; Sawamura, Tatsuya] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Mol Pathophysiol, Suita, Osaka 5650871, Japan; [Kakino, Akemi; Takeshita, Hikari; Sawamura, Tatsuya] Shinshu Univ, Sch Med, Dept Physiol, Asahi, Matsumo, Japan; [Nakagami, Hironori] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka 5650871, Japan; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University; Shinshu University; Osaka University; University of California System; University of California San Francisco	Yamamoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kyamamoto@geriat.med.osaka-u.ac.jp; ohishi@geriat.med.osaka-u.ac.jp	Sawamura, Tatsuya/E-7103-2010; Nakagami, Hironori/GLU-0570-2022; Takeshita, Hikari/L-9812-2014	Nakagami, Hironori/0000-0003-4494-3601; Takami, Yoichi/0000-0001-9018-6707; Rakugi, Hiromi/0000-0001-6508-4338; Yamamoto, Koichi/0000-0003-0107-9315	Kanae Foundation for the Promotion of Medical Science;  [23591102]; Grants-in-Aid for Scientific Research [15K01309, 25670133, 24601021] Funding Source: KAKEN	Kanae Foundation for the Promotion of Medical Science; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are most grateful to Kazuko Iwasa, Takako Baba, Asami Ihara, Aiko Kikuchi, Zhong Chongxia, and Yuka Nakao (Osaka University) for their excellent technical assistance. The authors thank Dr. Takahito Inoue (Asubio Pharma) and Takashi Shimosato (Nissei Bilis) for their technical guidance of the vascular experiments. This work was supported by a Grant-in-Aid for Scientific Research (No. 23591102) and by Kanae Foundation for the Promotion of Medical Science. K.Y. conceived of the idea of the study, designed and performed experiments, and wrote the manuscript. T.S. designed and performed experiments and helped with writing the manuscript with A.K., L.L., A.N., and Y.F. H.T. performed animal experiments. N.H., H.H.-Y., Y.I., S.T.-Y., C.N., T.K., M.T., K.H., R.O., Y.M., N.I., Y. Takami, M. Onishi, Y. Takeya, and K.S. performed experiments. K. K., H.N., M. Ohishi, and H.R. designed experiments. T.W.K. assisted with interpretation of the results and editing of the manuscript.	Aoyama T, 1999, BIOCHEM J, V339, P177, DOI 10.1042/0264-6021:3390177; Auge N, 2002, ARTERIOSCL THROM VAS, V22, P1990, DOI 10.1161/01.ATV.0000043453.21629.3B; Babnigg G, 2003, J BIOL CHEM, V278, P14872, DOI 10.1074/jbc.M210418200; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Eguchi S, 2001, J BIOL CHEM, V276, P7957, DOI 10.1074/jbc.M008570200; Erb L, 2001, J CELL BIOL, V153, P491, DOI 10.1083/jcb.153.3.491; Fujita Y, 2009, CLIN CHEM, V55, P285, DOI 10.1373/clinchem.2008.119750; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Haendeler J, 2000, CIRC RES, V86, P729, DOI 10.1161/01.RES.86.7.729; Heinloth A, 2000, J AM SOC NEPHROL, V11, P1819, DOI 10.1681/ASN.V11101819; Hernanz-Falcon P, 2001, IMMUNOGENETICS, V53, P288, DOI 10.1007/s002510100326; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Iwamoto S, 2011, J ATHEROSCLER THROMB, V18, P818, DOI 10.5551/jat.9142; Jing Q, 1999, CIRC RES, V84, P831; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Kusuhara M, 1997, ARTERIOSCL THROM VAS, V17, P141, DOI 10.1161/01.ATV.17.1.141; Lanctot PM, 2005, BIOCHEM J, V390, P367, DOI 10.1042/BJ20050189; Li DY, 2000, CIRCULATION, V102, P1970, DOI 10.1161/01.CIR.102.16.1970; Li DY, 2000, ARTERIOSCL THROM VAS, V20, P1116, DOI 10.1161/01.ATV.20.4.1116; Li DY, 2003, CIRCULATION, V107, P612, DOI 10.1161/01.CIR.0000047276.52039.FB; Maziere C, 1999, FEBS LETT, V448, P49, DOI 10.1016/S0014-5793(99)00324-5; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Morawietz H, 1999, CIRCULATION, V100, P899, DOI 10.1161/01.CIR.100.9.899; Nakano A, 2010, J HYPERTENS, V28, P1273, DOI 10.1097/HJH.0b013e32833835d4; Nickenig G, 2002, CIRCULATION, V105, P393, DOI 10.1161/hc0302.102618; Nickenig G, 2002, CIRCULATION, V105, P530, DOI 10.1161/hc0402.102619; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Patel TB, 2004, PHARMACOL REV, V56, P371, DOI 10.1124/pr.56.3.4; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Suc I, 1998, FASEB J, V12, P665, DOI 10.1096/fasebj.12.9.665; Tanigawa H, 2006, HYPERTENSION, V48, P294, DOI 10.1161/01.HYP.0000229825.98545.5e; Tanigawa H, 2006, ATHEROSCLEROSIS, V188, P245, DOI 10.1016/j.atherosclerosis.2005.10.046; Wang XW, 2014, CARDIOVASC DRUG THER, V28, P441, DOI 10.1007/s10557-014-6541-x; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF; WEISSER B, 1992, ARTERIOSCLER THROMB, V12, P231, DOI 10.1161/01.ATV.12.2.231; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Zhang M, 2000, J BIOL CHEM, V275, P15782, DOI 10.1074/jbc.M000198200; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	51	35	37	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3342	3356		10.1096/fj.15-271627	http://dx.doi.org/10.1096/fj.15-271627			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25877213				2022-12-26	WOS:000358796900022
J	Tebbi, A; Guittet, O; Tuphile, K; Cabrie, A; Lepoivre, M				Tebbi, Ali; Guittet, Olivier; Tuphile, Karine; Cabrie, Aimeric; Lepoivre, Michel			Caspase-dependent Proteolysis of Human Ribonucleotide Reductase Small Subunits R2 and p53R2 during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; NITRIC-OXIDE; CARBOXYL-TERMINUS; GENOME INTEGRITY; CELL-DEATH; PROTEIN R1; PATHWAYS; MOUSE; REPAIR; DEGRADATION	Ribonucleotide reductase (RnR) is a key enzyme synthesizing deoxyribonucleotides for DNA replication and repair. In mammals, the R1 catalytic subunit forms an active complex with either one of the two small subunits R2 and p53R2. Expression of R2 is S phase-specific and required for DNA replication. The p53R2 protein is expressed throughout the cell cycle and in quiescent cells where it provides dNTPs for mitochondrial DNA synthesis. Participation of R2 and p53R2 in DNA repair has also been suggested. In this study, we investigated the fate of the RnR subunits during apoptosis. The p53R2 protein was cleaved in a caspase-dependent manner in K-562 cells treated with inhibitors of the Bcr-Abl oncogenic kinase and in HeLa 229 cells incubated with TNF-alpha and cycloheximide. The cleavage site was mapped between Asp(342) and Asn(343). Caspase attack released a C-terminal p53R2 peptide of nine residues containing the conserved heptapeptide essential for R1 binding. As a consequence, the cleaved p53R2 protein was inactive. In vitro, purified caspase-3 and -8 could release the C-terminal tail of p53R2. Knocking down these caspases, but not caspase-2, -7, and -10, also inhibited p53R2 cleavage in cells committed to die via the extrinsic death receptor pathway. The R2 subunit was subjected to caspase-and proteasome-dependent proteolysis, which was prevented by siRNA targeting caspase-8. Knocking down caspase-3 was ineffective. Protein R1 was not subjected to degradation. Adding deoxyribonucleosides to restore dNTP pools transiently protected cells from apoptosis. These data identify RnR activity as a prosurvival function inactivated by proteolysis during apoptosis.	[Tebbi, Ali; Guittet, Olivier; Tuphile, Karine; Cabrie, Aimeric; Lepoivre, Michel] Univ Paris 11, Inst Mol & Cellular Biochem & Biophys, UMR 8619, F-91405 Orsay, France; [Tebbi, Ali; Guittet, Olivier; Tuphile, Karine; Cabrie, Aimeric; Lepoivre, Michel] CNRS, F-91405 Orsay, France; [Tebbi, Ali] Inst Pasteur, Dept Virol, Pathogenesis Hepatitis Virus B, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lepoivre, M (corresponding author), Univ Paris 11, CNRS, UMR 8619, IBBMC, F-91405 Orsay, France.	michel.lepoivre@u-psud.fr			Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris Ile-de-France; l'Association pour la Recherche sur le Cancer	Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris Ile-de-France; l'Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by a grant from the Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris Ile-de-France (to M. L.).; Supported by a fellowship from l'Association pour la Recherche sur le Cancer.	Arntzen MO, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010447; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Cooperman BS, 2003, BIOPOLYMERS, V71, P117, DOI 10.1002/bip.10397; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Devlin HL, 2008, MOL CANCER RES, V6, P808, DOI 10.1158/1541-7786.MCR-07-2027; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; FILATOV D, 1992, J BIOL CHEM, V267, P15816; Guittet O, 1998, J BIOL CHEM, V273, P22136, DOI 10.1074/jbc.273.34.22136; Guittet O, 2008, NITRIC OXIDE-BIOL CH, V19, P84, DOI 10.1016/j.niox.2008.04.011; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; LEPOIVRE M, 1994, J BIOL CHEM, V269, P21891; LYCKSELL PO, 1994, BIOCHEMISTRY-US, V33, P2838, DOI 10.1021/bi00176a013; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Niida H, 2010, CANCER SCI, V101, P2505, DOI 10.1111/j.1349-7006.2010.01719.x; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Nowsheen S., 2012, Experimental Oncology, V34, P243; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Prunet C, 2005, J BIOCHEM MOL TOXIC, V19, P311, DOI 10.1002/jbt.20096; Qiu WH, 2006, BIOCHEM BIOPH RES CO, V340, P428, DOI 10.1016/j.bbrc.2005.12.019; SJOBERG BM, 1987, J BIOL CHEM, V262, P9736; Smith P, 2009, BIOCHEMISTRY-US, V48, P11134, DOI 10.1021/bi9001425; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tebbi A, 2011, J BIOL CHEM, V286, P7873, DOI 10.1074/jbc.M110.184879; Thelander Lars, 1994, V30, P109; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; YANG FD, 1990, FEBS LETT, V272, P61, DOI 10.1016/0014-5793(90)80449-S	34	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14077	14090		10.1074/jbc.M115.649640	http://dx.doi.org/10.1074/jbc.M115.649640			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25878246	Green Published, hybrid			2022-12-26	WOS:000355313000037
J	Beretta-Piccoli, M; D'Antona, G; Barbero, M; Fisher, B; Dieli-Conwright, CM; Clijsen, R; Cescon, C				Beretta-Piccoli, Matteo; D'Antona, Giuseppe; Barbero, Marco; Fisher, Beth; Dieli-Conwright, Christina M.; Clijsen, Ron; Cescon, Corrado			Evaluation of Central and Peripheral Fatigue in the Quadriceps Using Fractal Dimension and Conduction Velocity in Young Females	PLOS ONE			English	Article							MUSCLE-FIBER-TYPE; VASTUS LATERALIS MUSCLE; SURFACE EMG PARAMETERS; UPPER TRAPEZIUS MUSCLE; SEX-DIFFERENCES; VOLUNTARY ACTIVATION; MYOELECTRIC MANIFESTATIONS; ISOMETRIC CONTRACTIONS; NEUROMUSCULAR FUNCTION; DYNAMIC CONTRACTIONS	Purpose Over the past decade, linear and non-linear surface electromyography descriptors for central and peripheral components of fatigue have been developed. In the current study, we tested fractal dimension (FD) and conduction velocity (CV) as myoelectric descriptors of central and peripheral fatigue, respectively. To this aim, we analyzed FD and CV slopes during sustained fatiguing contractions of the quadriceps femoris in healthy humans. Methods A total of 29 recreationally active women (mean age +/- standard deviation: 24 +/- 4 years) and two female elite athletes (one power athlete, age 24 and one endurance athlete, age 30 years) performed two knee extensions: (1) at 20% maximal voluntary contraction (MVC) for 30 s, and (2) at 60% MVC held until exhaustion. Surface EMG signals were detected from the vastus lateralis and vastus medialis using bidimensional arrays. Results Central and peripheral fatigue were described as decreases in FD and CV, respectively. A positive correlation between FD and CV (R=0.51, p<0.01) was found during the sustained 60% MVC, probably as a result of simultaneous motor unit synchronization and a decrease in muscle fiber CV during the fatiguing task. Conclusions Central and peripheral fatigue can be described as changes in FD and CV, at least in young, healthy women. The significant correlation between FD and CV observed at 60% MVC suggests that a mutual interaction between central and peripheral fatigue can arise during submaximal isometric contractions.	[Beretta-Piccoli, Matteo; Barbero, Marco; Cescon, Corrado] Univ Appl Sci & Arts Southern Switzerland, SUPSI, Dept Business Econ Hlth & Social Care, Rehabil Res Lab, Manno, Switzerland; [D'Antona, Giuseppe] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [D'Antona, Giuseppe] Univ Pavia, Sport Med Ctr Voghera, I-27100 Pavia, Italy; [Fisher, Beth; Dieli-Conwright, Christina M.] Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA USA; [Clijsen, Ron] Univ Appl Sci & Arts Southern Switzerland, SUPSI, Dept Business Econ Hlth & Social Care, Landquart, Switzerland	University of Pavia; University of Pavia; University of Southern California	Beretta-Piccoli, M (corresponding author), Univ Appl Sci & Arts Southern Switzerland, SUPSI, Dept Business Econ Hlth & Social Care, Rehabil Res Lab, Manno, Switzerland.	matteo.berettapiccoli@supsi.ch	Barbero, Marco/G-3667-2010; Barbero, Marco/AAF-9467-2020; Fisher, Beth E/G-5430-2012	Barbero, Marco/0000-0001-8579-0686; Barbero, Marco/0000-0001-8579-0686; D'Antona, Giuseppe/0000-0002-0683-5565; Cescon, Corrado/0000-0002-1632-6684; Beretta-Piccoli, Matteo/0000-0003-4794-2540	Thim van der Laan Foundation, Landquart, Switzerland; French Muscular Dystrophy Association, Paris, France [17191]	Thim van der Laan Foundation, Landquart, Switzerland; French Muscular Dystrophy Association, Paris, France	This study was supported by the Thim van der Laan Foundation, Landquart, Switzerland (to MBP, MB, RC, and CC), and by the French Muscular Dystrophy Association (http://www.afm-telethon.com), Paris, France (grant 17191 to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2003, J NEUROPHYSIOL, V90, P2919, DOI 10.1152/jn.00179.2003; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; ANMUTH CJ, 1994, MUSCLE NERVE, V17, P953, DOI 10.1002/mus.880170819; Barbero M., 2012, ATLAS MUSCLE INNERVA, DOI [10.1007/978-88-470-2463-2, DOI 10.1007/978-88-470-2463-2]; Bernardi M, 1997, Electromyogr Clin Neurophysiol, V37, P3; BIGLANDRITCHIE B, 1978, CLIN SCI MOL MED, V54, P609, DOI 10.1042/cs0540609; BIGLANDRITCHIE B, 1986, ACTA PHYSIOL SCAND, V128, P137; Bilodeau M, 1994, Electromyogr Clin Neurophysiol, V34, P149; Bilodeau M, 2003, J ELECTROMYOGR KINES, V13, P83, DOI 10.1016/S1050-6411(02)00050-0; Bilodeau M, 2006, MUSCLE NERVE, V34, P205, DOI 10.1002/mus.20572; Blijham PJ, 2006, J APPL PHYSIOL, V100, P1837, DOI 10.1152/japplphysiol.01009.2005; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BOUISSOU P, 1989, J APPL PHYSIOL, V67, P1245, DOI 10.1152/jappl.1989.67.3.1245; BRODY LR, 1991, J APPL PHYSIOL, V71, P1878, DOI 10.1152/jappl.1991.71.5.1878; BUCHTHAL F, 1955, ACTA PHYSIOL SCAND, V35, P174, DOI 10.1111/j.1748-1716.1955.tb01276.x; Clark BC, 2003, J APPL PHYSIOL, V94, P2263, DOI 10.1152/japplphysiol.00926.2002; de Haan A, 2009, J APPL PHYSIOL, V107, P355, DOI 10.1152/japplphysiol.91220.2008a; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; Debold EP, 2012, J APPL PHYSIOL, V113, P1413, DOI 10.1152/japplphysiol.00775.2012; Dedering A, 2000, J ELECTROMYOGR KINES, V10, P151, DOI 10.1016/S1050-6411(00)00009-2; Dimitrov GV, 2006, MED SCI SPORT EXER, V38, P1971, DOI 10.1249/01.mss.0000233794.31659.6d; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; EDGERTON VR, 1975, HISTOCHEM J, V7, P259, DOI 10.1007/BF01003594; Farina D, 2004, J APPL PHYSIOL, V97, P2035, DOI 10.1152/japplphysiol.00606.2004; Farina D, 2003, IEEE T BIO-MED ENG, V50, P1340, DOI 10.1109/TBME.2003.819847; Farina D, 2002, BIOL CYBERN, V86, P445, DOI 10.1007/s00422-002-0309-2; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Fitts RH, 2003, AM J PHYS MED REHAB, V82, P320, DOI 10.1097/01.PHM.0000059336.40487.9C; FROESE EA, 1985, J APPL PHYSIOL, V59, P309, DOI 10.1152/jappl.1985.59.2.309; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1995, ADV EXP MED BIOL, V384, P281; Gandevia SC, 1998, ACTA PHYSIOL SCAND, V162, P275, DOI 10.1046/j.1365-201X.1998.0299f.x; Gerdle B, 1997, ACTA PHYSIOL SCAND, V160, P341, DOI 10.1046/j.1365-201X.1997.00167.x; Gerdle B, 2000, EUR J APPL PHYSIOL O, V81, P2, DOI 10.1007/PL00013792; GITTER JA, 1995, J NEUROSCI METH, V58, P103, DOI 10.1016/0165-0270(94)00164-C; Gonzalez-Izal M, 2012, J ELECTROMYOGR KINES, V22, P501, DOI 10.1016/j.jelekin.2012.02.019; Gronlund C, 2009, J ELECTROMYOGR KINES, V19, P242, DOI 10.1016/j.jelekin.2007.07.012; Gupta V, 1997, INT J MED INFORM, V45, P185, DOI 10.1016/S1386-5056(97)00029-4; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Hunter SK, 2006, J APPL PHYSIOL, V101, P1036, DOI 10.1152/japplphysiol.00103.2006; Hunter SK, 2009, MUSCLE NERVE, V39, P42, DOI 10.1002/mus.21203; Hunter SK, 2004, J APPL PHYSIOL, V96, P195, DOI 10.1152/japplphysiol.00893.2003; Hunter SK, 2002, J NEUROPHYSIOL, V88, P3087, DOI 10.1152/jn.00232.2002; Jayaraman A, 2006, SPINAL CORD, V44, P680, DOI 10.1038/sj.sc.3101892; JOHNSON MA, 1973, J NEUROL SCI, V20, P345, DOI 10.1016/0022-510X(73)90169-X; Karlsson JS, 2003, J ELECTROMYOGR KINES, V13, P461, DOI 10.1016/S1050-6411(03)00063-4; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; KentBraun JA, 1996, MUSCLE NERVE, V19, P861, DOI 10.1002/(SICI)1097-4598(199607)19:7<861::AID-MUS8>3.0.CO;2-7; Kleine BU, 2001, J APPL PHYSIOL, V91, P1588, DOI 10.1152/jappl.2001.91.4.1588; Kollmitzer J, 1999, CLIN NEUROPHYSIOL, V110, P725, DOI 10.1016/S1388-2457(98)00050-9; KOMI PV, 1979, EUR J APPL PHYSIOL, V42, P41, DOI 10.1007/BF00421103; KRANZ H, 1985, J APPL PHYSIOL, V59, P821, DOI 10.1152/jappl.1985.59.3.821; KUPA EJ, 1995, J APPL PHYSIOL, V79, P23, DOI 10.1152/jappl.1995.79.1.23; LINSSEN WHJP, 1993, MUSCLE NERVE, V16, P849, DOI 10.1002/mus.880160808; Madhavan S, 2011, CLIN NEUROPHYSIOL, V122, P1588, DOI 10.1016/j.clinph.2011.01.011; Masuda K, 1999, J ELECTROMYOGR KINES, V9, P39, DOI 10.1016/S1050-6411(98)00021-2; MAUGHAN RJ, 1986, EUR J APPL PHYSIOL, V55, P395, DOI 10.1007/BF00422739; Merletti R, 1998, MUSCLE NERVE, V21, P184; Merletti R, 1996, J ORTHOP SPORT PHYS, V24, P342, DOI 10.2519/jospt.1996.24.6.342; Merletti R., 2004, ELECTROMYOGRAPHY PHY; Mesin L, 2009, J ELECTROMYOGR KINES, V19, P851, DOI 10.1016/j.jelekin.2008.08.003; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Millet GY, 2002, J APPL PHYSIOL, V92, P486, DOI 10.1152/japplphysiol.00122.2001; Ng JKF, 1996, ARCH PHYS MED REHAB, V77, P259, DOI 10.1016/S0003-9993(96)90108-2; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Piccoli MB, 2014, MUSCLE NERVE, V49, P413, DOI 10.1002/mus.23934; Place N, 2007, MUSCLE NERVE, V35, P486, DOI 10.1002/mus.20714; Rainoldi A, 2001, J ELECTROMYOGR KINES, V11, P425, DOI 10.1016/S1050-6411(01)00022-0; Rainoldi A, 2008, J ELECTROMYOGR KINES, V18, P1032, DOI 10.1016/j.jelekin.2007.05.008; Romani A, 2008, NEUROL SCI, V29, pS247, DOI 10.1007/s10072-008-0952-z; Russ DW, 2005, MUSCLE NERVE, V32, P647, DOI 10.1002/mus.20396; Russ DW, 2003, J APPL PHYSIOL, V94, P2414, DOI 10.1152/japplphysiol.01145.2002; SADOYAMA T, 1988, EUR J APPL PHYSIOL O, V57, P767, DOI 10.1007/BF01076001; Schillings ML, 2003, EUR J APPL PHYSIOL, V90, P562, DOI 10.1007/s00421-003-0913-4; Stalberg E, 1966, Acta Physiol Scand Suppl, V287, P1; STARON RS, 1984, J HISTOCHEM CYTOCHEM, V32, P146, DOI 10.1177/32.2.6229571; Tansey KE, 1996, J NEUROPHYSIOL, V75, P26, DOI 10.1152/jn.1996.75.1.26; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2009, J APPL PHYSIOL, V107, P354, DOI 10.1152/japplphysiol.91220.2008; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; TESCH PA, 1984, J APPL PHYSIOL, V56, P35, DOI 10.1152/jappl.1984.56.1.35; THOMAS CK, 1989, J APPL PHYSIOL, V67, P1835, DOI 10.1152/jappl.1989.67.5.1835; TRAVNIK L, 1995, J ANAT, V187, P403; Troiano A, 2008, GAIT POSTURE, V28, P179, DOI 10.1016/j.gaitpost.2008.04.002; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; von Tscharner V, 2011, J ELECTROMYOGR KINES, V21, P184, DOI 10.1016/j.jelekin.2010.10.004; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Xu LJ, 1997, J COLLOID INTERF SCI, V190, P357, DOI 10.1006/jcis.1997.4885; Zijdewind I, 2001, J NEUROPHYSIOL, V85, P1907, DOI 10.1152/jn.2001.85.5.1907	90	46	46	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123921	10.1371/journal.pone.0123921	http://dx.doi.org/10.1371/journal.pone.0123921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880369	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500068
J	Elewa, U; Fernandez-Fernandez, B; Alegre, R; Sanchez-Nino, MD; Mahillo-Fernandez, I; Perez-Gomez, MV; El-Fishawy, H; Belal, D; Ortiz, A				Elewa, Usama; Fernandez-Fernandez, Beatriz; Alegre, Raquel; Sanchez-Nino, Maria D.; Mahillo-Fernandez, Ignacio; Vanessa Perez-Gomez, Maria; El-Fishawy, Hussein; Belal, Dawlat; Ortiz, Alberto			Modifiable Risk Factors for Increased Arterial Stiffness in Outpatient Nephrology	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PULSE-WAVE VELOCITY; SERUM URIC-ACID; RANDOMIZED CONTROLLED-TRIAL; SYSTOLIC BLOOD-PRESSURE; MIDDLE-AGED MEN; CARDIOVASCULAR RISK; HYPERTENSIVE PATIENTS; MYOCARDIAL-INFARCTION; POTASSIUM SUPPLEMENTATION	Arterial stiffness, as measured by pulse wave velocity (PWV), is an independent predictor of cardiovascular events and mortality. Arterial stiffness increases with age. However, modifiable risk factors such as smoking, BP and salt intake also impact on PWV. The finding of modifiable risk factors may lead to the identification of treatable factors, and, thus, is of interest to practicing nephrologist. We have now studied the prevalence and correlates of arterial stiffness, assessed by PWV, in 191 patients from nephrology outpatient clinics in order to identify modifiable risk factors for arterial stiffness that may in the future guide therapeutic decision-making. PWV was above normal levels for age in 85/191 (44.5%) patients. Multivariate analysis showed that advanced age, systolic BP, diabetes mellitus, serum uric acid and calcium polystyrene sulfonate therapy or calcium-containing medication were independent predictors of PWV. A new parameter, Delta above upper limit of normal PWV (Delta PWV) was defined to decrease the weight of age on PWV values. Delta PWV was calculated as (measured PWV) - (upper limit of the age-adjusted PWV values for the general population). Mean +/- SD Delta PWV was 0.76 +/- 1.60 m/sec. In multivariate analysis, systolic blood pressure, active smoking and calcium polystyrene sulfonate therapy remained independent predictors of higher delta PWV, while age, urinary potassium and beta blocker therapy were independent predictors of lower delta PWV. In conclusion, arterial stiffness was frequent in nephrology outpatients. Systolic blood pressure, smoking, serum uric acid, calcium-containing medications, potassium metabolism and non-use of beta blockers are modifiable factors associated with increased arterial stiffness in Nephrology outpatients.	[Elewa, Usama; Fernandez-Fernandez, Beatriz; Alegre, Raquel; Mahillo-Fernandez, Ignacio; Vanessa Perez-Gomez, Maria; Ortiz, Alberto] Univ Autonoma Madrid, Sch Med, IIS Fdn Jimenez Diaz, Madrid, Spain; [Elewa, Usama; Fernandez-Fernandez, Beatriz; Alegre, Raquel; Vanessa Perez-Gomez, Maria; Ortiz, Alberto] Fdn Renal Inigo Alvarez Toledo IRSIN, Madrid, Spain; [Elewa, Usama; Fernandez-Fernandez, Beatriz; Alegre, Raquel; Vanessa Perez-Gomez, Maria; Ortiz, Alberto] REDINREN, Madrid, Spain; [Elewa, Usama; El-Fishawy, Hussein; Belal, Dawlat] Cairo Univ, Kasr El Aini Univ Hosp, Cairo, Egypt; [Sanchez-Nino, Maria D.] IDIPaz, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Egyptian Knowledge Bank (EKB); Cairo University	Elewa, U (corresponding author), Univ Autonoma Madrid, Sch Med, IIS Fdn Jimenez Diaz, Madrid, Spain.	aortiz@fjd.es	Elewa, Usama/ABE-1944-2021; ortiz, alberto/Y-7582-2018; Sanchez-Niño, Maria Dolores/B-7350-2019; Gomez, Maria Vanessa Perez/AAG-1595-2021; Mahillo-Fernandez, Ignacio/T-2042-2018	ortiz, alberto/0000-0002-9805-9523; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Gomez, Maria Vanessa Perez/0000-0003-4558-5236; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541	Fondo de Investigacion Sanitaria Instituto Carlos III (FIS ISCIII) [FIS PS09/00447, PI13/00047]; ISCIII-RETIC; FEDER funds [REDinREN/RD06/0016/, RD012/0021]; Comunidad de Madrid/CIFRA [S2010/BMD-2378]; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM); FIS; Europoean Renal association; IIS-FJD Biobank [RD09/0076/00101]	Fondo de Investigacion Sanitaria Instituto Carlos III (FIS ISCIII); ISCIII-RETIC(Instituto de Salud Carlos III); FEDER funds(European Commission); Comunidad de Madrid/CIFRA(Comunidad de Madrid); Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); Europoean Renal association; IIS-FJD Biobank	Grant support: 1) Fondo de Investigacion Sanitaria Instituto Carlos III (FIS ISCIII; www.isciii.es/) FIS PS09/00447, PI13/00047, ISCIII-RETIC, REDinREN/RD06/0016/ and RD012/0021 FEDER funds, Comunidad de Madrid/CIFRA S2010/BMD-2378. Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO. IIS-FJD Biobank RD09/0076/00101. Salary support: FIS to MDSN (Sara Borrell), Beatriz Fernandez-Fernandez (Rio Hortega), 2. Europoean Renal association. ERA-EDTA to UE. (www.era-edta.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rosei EA, 2007, DRUGS, V67, P1097; Agabiti-Rosei E, 2009, VASC HEALTH RISK MAN, V5, P353; Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Berry SE, 2010, BRIT J NUTR, V104, P1839, DOI 10.1017/S0007114510002904; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Boutouyrie P, 2014, NEPHROL DIAL TRANSPL, V29, P232, DOI 10.1093/ndt/gft309; BRATER DC, 1977, CLIN PHARMACOL THER, V22, P21; Briet M, 2011, J AM SOC NEPHROL, V22, P967, DOI 10.1681/ASN.2010080863; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Chan DT, 2013, AM J HYPERTENS, V26, P1155, DOI 10.1093/ajh/hpt077; Choo J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-5; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Cockcroft J, 2007, VASC HEALTH RISK MAN, V3, P909; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; Covic A, 2006, NEPHROL DIAL TRANSPL, V21, P2859, DOI 10.1093/ndt/gfl307; Crilly M, 2007, VASC MED, V12, P189, DOI 10.1177/1358863x07081134; DeLoach SS, 2008, CLIN J AM SOC NEPHRO, V3, P184, DOI 10.2215/CJN.03340807; Gosse P, 2008, J HYPERTENS, V26, P1138, DOI 10.1097/HJH.0b013e3282fa142b; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; HARRISON MR, 1989, AM J CARDIOL, V64, P905, DOI 10.1016/0002-9149(89)90840-0; Hozawa A, 2006, ATHEROSCLEROSIS, V187, P401, DOI 10.1016/j.atherosclerosis.2005.09.020; Hu JH, 2009, HYPERTENS RES, V32, P282, DOI 10.1038/hr.2009.7; Huybrechts SAM, 2011, J HYPERTENS, V29, P1577, DOI 10.1097/HJH.0b013e3283487841; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; KAPLAN NM, 1985, NEW ENGL J MED, V312, P746, DOI 10.1056/NEJM198503213121203; Kim EJ, 2014, HYPERTENS RES, V37, P50, DOI 10.1038/hr.2013.112; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051101; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Lilitkarntakul P, 2012, DIABETES CARE, V35, P1774, DOI 10.2337/dc11-2345; Lilitkarntakul P, 2011, ATHEROSCLEROSIS, V216, P217, DOI 10.1016/j.atherosclerosis.2011.01.045; Liu ZD, 2013, J CLIN HYPERTENS, V15, P485, DOI 10.1111/jch.12109; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; Mark PB, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-39; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McEniery CM, 2004, HYPERTENSION, V44, P305, DOI 10.1161/01.HYP.0000137983.45556.6e; McIntyre NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055444; McIntyre NJ, 2011, CLIN J AM SOC NEPHRO, V6, P2356, DOI 10.2215/CJN.02420311; Mitchell GF, 2005, CIRCULATION, V112, P194, DOI 10.1161/CIRCULATIONAHA.104.530675; Ng KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091961; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Oberleithner H, 2009, P NATL ACAD SCI USA, V106, P2829, DOI 10.1073/pnas.0813069106; ROUJOULEH H, 1987, NEPHROLOGIE, V8, P45; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Safar ME, 2001, CURR OPIN NEPHROL HY, V10, P257, DOI 10.1097/00041552-200103000-00015; Safar ME, 2000, CARDIOVASC RES, V46, P269, DOI 10.1016/S0008-6363(99)00426-5; Sengstock D, 2010, NEPHROL DIAL TRANSPL, V25, P853, DOI 10.1093/ndt/gfp559; Smith A, 2005, J AM SOC NEPHROL, V16, P1069, DOI 10.1681/ASN.2004090769; Soanker R, 2012, INDIAN J PHARMACOL, V44, P407, DOI 10.4103/0253-7613.96349; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Strozecki P, 2013, POL ARCH MED WEWN, V123, P609, DOI 10.20452/pamw.1974; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Temmar M, 2010, J HYPERTENS, V28, P163, DOI 10.1097/HJH.0b013e328331b81e; Tholen S, 2013, J CLIN HYPERTENS, V15, P833, DOI 10.1111/jch.12198; Tomlinson LA, 2012, CURR OPIN NEPHROL HY, V21, P655, DOI 10.1097/MNH.0b013e32835856e3; Townsend RR, 2015, CURR OPIN NEPHROL HY, V24, P47, DOI 10.1097/MNH.0000000000000086; Townsend RR, 2010, AM J HYPERTENS, V23, P282, DOI 10.1038/ajh.2009.240; Turak O, 2014, J CLIN HYPERTENS, V16, P530, DOI 10.1111/jch.12359; Upadhyay A, 2009, J AM SOC NEPHROL, V20, P2044, DOI 10.1681/ASN.2009010074; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Watson M, 2010, CLIN J AM SOC NEPHRO, V5, P1723, DOI 10.2215/CJN.03700410; Zhang J, 2014, J ENDOCRINOL INVEST, V37, P441, DOI 10.1007/s40618-013-0034-9; Zhang MH, 2011, CLIN CARDIOL, V34, P622, DOI 10.1002/clc.20956	70	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123903	10.1371/journal.pone.0123903	http://dx.doi.org/10.1371/journal.pone.0123903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880081	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500066
J	Kuszewska, K; Woyciechowski, M				Kuszewska, Karolina; Woyciechowski, Michal			Age at Which Larvae Are Orphaned Determines Their Development into Typical or Rebel Workers in the Honeybee (Apis mellifera L.)	PLOS ONE			English	Article							HYPOPHARYNGEAL GLAND ACTIVITY; DIFFERENTIAL GENE-EXPRESSION; REPRODUCTIVE COMPETITION; CASTE DETERMINATION; OVARY DEVELOPMENT; BEE; QUEEN; PHEROMONE; EVOLUTION; PLASTICITY	In the honeybee, diploid larvae fed with royal jelly develop into reproductive queens, whereas larvae fed with royal jelly for three days only and subsequently with honey and pollen develop into facultatively sterile workers. A recent study showed that worker larvae fed in a queenless colony develop into another female polyphenic form: rebel workers. These rebel workers are more queenlike and have greater reproductive potential than normal workers. However, it was unclear whether larvae orphaned at any time during their feeding period can develop into rebels. To answer this question, the anatomical features of newly emerged workers reared in queenless conditions at different ages during the larval period were evaluated. Our results showed that larvae orphaned during the final four or more days of their feeding life develop into rebel workers with more ovarioles in their ovaries, smaller hypo-pharyngeal glands, and larger mandibular and Dufour's glands compared with typical workers with low reproductive potential that were reared with a queen or orphaned at the third to last or a later day of feeding life.	[Kuszewska, Karolina; Woyciechowski, Michal] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Jagiellonian University	Kuszewska, K (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	k.kuszewska@uj.edu.pl		kuszewska, Karolina/0000-0001-8104-8740	Polish Ministry of Science and Higher Education - Iuventus Plus [IP2012 026072]; Jagiellonian University [DS/BiNoZ/INoS/761/12-14, DSC/MND/WBiNoZ/INoS/19/2013]; 7th EU FP Collaborative Project STEP (Status and Trends of European Pollinators) [244090]	Polish Ministry of Science and Higher Education - Iuventus Plus; Jagiellonian University; 7th EU FP Collaborative Project STEP (Status and Trends of European Pollinators)	This study was funded by the Polish Ministry of Science and Higher Education - Iuventus Plus (grant IP2012 026072), the Jagiellonian University (grant DS/BiNoZ/INoS/761/12-14 and grant DSC/MND/WBiNoZ/INoS/19/2013), and the 7th EU FP Collaborative Project STEP (Status and Trends of European Pollinators; 244090, www.STEP-project.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; [Anonymous], 1971, INSECT SOC; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Barchuk AR, 2004, INSECT MOL BIOL, V13, P459, DOI 10.1111/j.0962-1075.2004.00506.x; Begna D, 2012, J PROTEOME RES, V11, P1317, DOI 10.1021/pr200974a; BUTLER CG, 1957, EXPERIENTIA, V13, P256, DOI 10.1007/BF02157449; Cnaani J, 2000, BEHAV ECOL SOCIOBIOL, V47, P346, DOI 10.1007/s002650050675; Corona M, 1999, J EXP BIOL, V202, P929; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Gozansky Tamar Katzav, 1997, Invertebrate Neuroscience, V3, P239; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; HODIN J, 2009, PHENOTYPIC PLASTICIT, P65; Hoover SER, 2006, J COMP PHYSIOL B, V176, P55, DOI 10.1007/s00360-005-0032-0; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P929, DOI 10.1016/S0022-1910(98)00058-4; HUANG ZY, 1989, INSECT SOC, V36, P264, DOI 10.1007/BF02224880; KatzavGozansky T, 1997, NATURWISSENSCHAFTEN, V84, P238, DOI 10.1007/s001140050386; Kocher SD, 2009, BEHAV ECOL, V20, P1007, DOI 10.1093/beheco/arp090; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Kuszewska K, 2013, ANIM BEHAV, V85, P247, DOI 10.1016/j.anbehav.2012.10.033; KUWABARA M, 1947, J FAC SCI HOKKAIDO 6, V9, P359; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; Li JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013455; Linksvayer TA, 2011, J EVOLUTION BIOL, V24, P1939, DOI 10.1111/j.1420-9101.2011.02331.x; Makert GR, 2006, BEHAV ECOL SOCIOBIOL, V60, P815, DOI 10.1007/s00265-006-0225-x; Malka O, 2008, NATURWISSENSCHAFTEN, V95, P553, DOI 10.1007/s00114-008-0358-z; Malka O, 2007, BEHAV ECOL SOCIOBIOL, V61, P465, DOI 10.1007/s00265-006-0274-1; Martin SJ, 2005, APIDOLOGIE, V36, P543, DOI 10.1051/apido:2005041; Martin SJ, 2004, BEHAV ECOL, V15, P839, DOI 10.1093/beheco/arh089; Nakaoka T, 2008, J INSECT PHYSIOL, V54, P806, DOI 10.1016/j.jinsphys.2008.02.007; Nieh JC, 2012, CURR BIOL, V22, pR280, DOI 10.1016/j.cub.2012.03.018; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; PAGE RE, 1994, BEHAV ECOL SOCIOBIOL, V35, P99, DOI 10.1007/BF00171499; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; RATNIEKS FLW, 1995, J APICULT RES, V34, P31, DOI 10.1080/00218839.1995.11100883; Richard FJ, 2013, INSECT SOC, V60, P275, DOI 10.1007/s00040-013-0306-6; Richard FJ, 2011, J CHEM ECOL, V37, P1027, DOI 10.1007/s10886-011-9999-z; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P1141, DOI 10.1016/0022-1910(95)00051-U; Schwander T, 2010, TRENDS ECOL EVOL, V25, P275, DOI 10.1016/j.tree.2009.12.001; Shi YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018808; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; Traynor KS, 2015, ANIM BEHAV, V99, P1, DOI 10.1016/j.anbehav.2014.10.009; Traynor KS, 2014, BEHAV ECOL SOCIOBIOL, V68, P2059, DOI 10.1007/s00265-014-1811-y; VELTHUIS HH, 1970, ENTOMOL EXP APPL, V13, P377, DOI 10.1111/j.1570-7458.1970.tb00122.x; Wang Y, 2014, ANIM BEHAV, V92, P253, DOI 10.1016/j.anbehav.2014.02.012; WEAVER N, 1966, ANNU REV ENTOMOL, V11, P79, DOI 10.1146/annurev.en.11.010166.000455; Wegener J, 2009, J INSECT PHYSIOL, V55, P716, DOI 10.1016/j.jinsphys.2009.05.003; West-Eberhard Mary Jane, 2003, pi; Winston, 1987, BIOL HONEYBEE; WIRTZ P, 1972, ENTOMOL EXP APPL, V15, P517, DOI 10.1007/BF00293616; Woyciechowski M, 2012, CURR BIOL, V22, P707, DOI 10.1016/j.cub.2012.02.063; Woyke J, 1999, J APICULT RES, V38, P117, DOI 10.1080/00218839.1999.11101002	57	20	20	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123404	10.1371/journal.pone.0123404	http://dx.doi.org/10.1371/journal.pone.0123404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880669	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500051
J	Leskela, S; Serrano, A; de la Fuente, H; Rodriguez-Munoz, A; Ramos-Levi, A; Sampedro-Nunez, M; Sanchez-Madrid, F; Gonzalez-Amaro, R; Marazuela, M				Leskela, Susanna; Serrano, Ana; de la Fuente, Hortensia; Rodriguez-Munoz, Ana; Ramos-Levi, Ana; Sampedro-Nunez, Miguel; Sanchez-Madrid, Francisco; Gonzalez-Amaro, Roberto; Marazuela, Monica			Graves' Disease Is Associated with a Defective Expression of the Immune Regulatory Molecule Galectin-9 in Antigen-Presenting Dendritic Cells	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; T-CELLS; OPHTHALMOPATHY; PROLIFERATION; GLYCOSYLATION; INFLAMMATION; LYMPHOCYTES; SUPPRESSES; ACTIVATION; INDUCTION	Introduction Patients with autoimmune thyroid disease (AITD) show defects in their immune-regulatory mechanisms. Herein we assessed the expression and function of galectin-1 and galectin-9 (Gal-1, Gal-9) in dendritic cells (DCs) from patients with AITD. Materials and Methods Peripheral blood samples from 25 patients with Graves' disease (GD), 11 Hashimoto's thyroiditis (HT), and 24 healthy subjects were studied. Thyroid tissue samples from 44 patients with AITD and 22 patients with goiter were also analyzed. Expression and function of Gal-1 and Gal-9 was assessed by quantitative RT-PCR, immunofluorescence and flow cytometry. Results A diminished expression of Gal-9, but not of Gal-1, by peripheral blood DCs was observed in GD patients, mainly in those with Graves ' ophthalmopathy, and a significant negative association between disease severity and Gal-9 expression was detected. In addition, the mRNA levels of Gal-9 and its ligand TIM-3 were increased in thyroid tissue from AITD patients and its expression was associated with the levels of Th1/Th12/Th17 cytokines. Immunofluorescence studies proved that intrathyroidal Gal-9 expression was confined to DCs and macrophages. Finally, in vitro functional assays showed that exogenous Gal-9 had a suppressive effect on the release of Th1/Th2/Th17 cytokines by DC/lymphocyte autologous co-cultures from both AITD patients and healthy controls. Conclusions The altered pattern of expression of Gal-9 in peripheral blood DCs from GD patients, its correlation with disease severity as well as its ability to suppress cytokine release suggest that Gal-9 could be involved in the pathogenesis of AITD.	[Leskela, Susanna; Serrano, Ana; Rodriguez-Munoz, Ana; Ramos-Levi, Ana; Sampedro-Nunez, Miguel; Marazuela, Monica] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa, Hosp Univ La Princesa, Dept Endocrinol, Madrid, Spain; [de la Fuente, Hortensia; Sanchez-Madrid, Francisco] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa, Hosp Univ La Princesa, Dept Immunol,Ctr Nacl Invest Cardiovasc Carlos 3, Madrid, Spain; [Gonzalez-Amaro, Roberto] UASLP, Sch Med, Dept Immunol, San Luis Potosi, Slp, Mexico	Autonomous University of Madrid; Autonomous University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad Autonoma de San Luis Potosi	Leskela, S (corresponding author), Univ Autonoma Madrid, Inst Invest Sanitaria Princesa, Hosp Univ La Princesa, Dept Endocrinol, Madrid, Spain.	monica.marazuela@salud.madrid.org	Sanchez-Madrid, Francisco/M-7889-2016; Gonzalez-Amaro, Roberto/AAZ-1504-2020; de la Fuente, Hortensia/J-9890-2014	Sanchez-Madrid, Francisco/0000-0001-5303-0762; de la Fuente, Hortensia/0000-0001-8708-753X	Fondo de Investigaciones Sanitarias (FISS) (Comunidad de Madrid), Spain [PI10/02521, S2010/BMD-2328 TIRONET]; Fondo de Cooperacion Internacional en Ciencia y Tecnologia (FONCICYT) [95395]; European Union-Mexico	Fondo de Investigaciones Sanitarias (FISS) (Comunidad de Madrid), Spain; Fondo de Cooperacion Internacional en Ciencia y Tecnologia (FONCICYT); European Union-Mexico	This work was supported by grants from the Fondo de Investigaciones Sanitarias (FISS) PI10/ 02521 and S2010/BMD-2328 TIRONET (Comunidad de Madrid), Spain (to MM) and the Fondo de Cooperacion Internacional en Ciencia y Tecnologia (FONCICYT) 95395, European Union-Mexico (to RGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa T, 2009, CLIN IMMUNOL, V133, P382, DOI 10.1016/j.clim.2009.09.004; Bartalena L, 2008, EUR J ENDOCRINOL, V158, P273, DOI 10.1530/EJE-07-0666; Blaser C, 1998, EUR J IMMUNOL, V28, P2311, DOI 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; de la Fuente H, 2012, FEBS LETT, V586, P2897, DOI 10.1016/j.febslet.2012.07.032; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Figueroa-Vega N, 2010, J CLIN ENDOCR METAB, V95, P953, DOI 10.1210/jc.2009-1719; Figueroa-Vega N, 2009, J CLIN ENDOCR METAB, V94, P1145, DOI 10.1210/jc.2008-1571; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Kanzaki M, 2012, ENDOCRINOLOGY, V153, P612, DOI 10.1210/en.2011-1579; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Leskela S, 2013, J CLIN ENDOCR METAB, V98, P2822, DOI 10.1210/jc.2013-1273; Mao CM, 2011, J IMMUNOL, V186, P4734, DOI 10.4049/jimmunol.0904135; Marazuela M, 2006, J CLIN ENDOCR METAB, V91, P3639, DOI 10.1210/jc.2005-2337; Mascanfroni ID, 2011, INT IMMUNOPHARMACOL, V11, P833, DOI 10.1016/j.intimp.2011.01.021; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Norling LV, 2008, FASEB J, V22, P682, DOI 10.1096/fj.07-9268com; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Ruiz-Riol M, 2011, J AUTOIMMUN, V36, P189, DOI 10.1016/j.jaut.2011.01.002; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van der Leij J, 2004, J PATHOL, V204, P511, DOI 10.1002/path.1671; Weetman AP, 2004, CLIN ENDOCRINOL, V61, P405, DOI 10.1111/j.1365-2265.2004.02085.x; Wiersinga WM, 2011, J CLIN ENDOCR METAB, V96, P2386, DOI 10.1210/jc.2011-0307	28	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123938	10.1371/journal.pone.0123938	http://dx.doi.org/10.1371/journal.pone.0123938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880730	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500071
J	Stellmann, JP; Neuhaus, A; Gotze, N; Briken, S; Lederer, C; Schimpl, M; Heesen, C; Daumer, M				Stellmann, J. P.; Neuhaus, A.; Goetze, N.; Briken, S.; Lederer, C.; Schimpl, M.; Heesen, C.; Daumer, M.			Ecological Validity of Walking Capacity Tests in Multiple Sclerosis	PLOS ONE			English	Article							TIMED 25-FOOT WALK; 6-MINUTE WALK; CLINICALLY MEANINGFUL; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; CONTROLLED-TRIAL; MS; SPEED; MULTICENTER; PERFORMANCE	Background Ecological validity implicates in how far clinical assessments refer to real life. Short clinical gait tests up to ten meters and 2- or 6-Minutes Walking Tests (2MWT/6MWT) are used as performance-based outcomes in Multiple Sclerosis ( MS) studies and considered as moderately associated with real life mobility. Objective To investigate the ecological validity of 10 Meter Walking Test (10mWT), 2MWT and 6MWT. Methods Persons with MS performed 10mWT, 6MWT including 2MWT and 7 recorded days by accelerometry. Ecological validity was assumed if walking tests represented a typical walking sequence in real-life and correlations with accelerometry parameters were strong. Results In this cohort (n=28, medians: age=45, EDSS=3.2, disease duration=9 years), uninterrupted walking of 2 or 6 minutes occurred not frequent in real life (2.61 and 0.35 sequences/day). 10mWT correlated only with slow walking speed quantiles in real life. 2MWT and 6MWT correlated moderately with most real life walking parameters. Conclusion Clinical gait tests over a few meters have a poor ecological validity while validity is moderate for 2MWT and 6MWT. Mobile accelerometry offers the opportunity to control and improve the ecological validity of MS mobility outcomes.	[Stellmann, J. P.; Goetze, N.; Briken, S.; Heesen, C.] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS INIMS, Hamburg, Germany; [Stellmann, J. P.; Goetze, N.; Briken, S.; Heesen, C.] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Neuhaus, A.; Lederer, C.; Daumer, M.] Sylvia Lawry Ctr Multiple Sclerosis Res, Munich, Germany; [Neuhaus, A.; Schimpl, M.; Daumer, M.] Trium Anal Online GmbH, Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stellmann, JP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS INIMS, Hamburg, Germany.	j.stellmann@uke.uni-hamburg.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833	ECTRIMS; EU-FP7; BMBF; BWiMi; Hertie Foundation; Merck-Serono; Biogen-Idec; Teva-Sanofi-Aventis; Bayer-Schering	ECTRIMS; EU-FP7(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); BWiMi; Hertie Foundation; Merck-Serono(Merck & Company); Biogen-Idec(Biogen); Teva-Sanofi-Aventis(Sanofi-Aventis); Bayer-Schering(Bayer AG)	The authors of this manuscript have the following competing interests: Martin Daumer is an Academic Editor for PeerJ and has invented the "free heel running pad". He is also the Director of the Sylvia Lawry Centre for MS Research. He is one of the two managing directors of Trium Analysis Online GmbH, together with Michael Scholz (50% ownership each). Trium is a manufacturer of CTG monitoring systems. Dr. Daumer has served on the scientific advisory board for the EPOSA study; has received funding for travel from ECTRIMS; serves on the editorial board of MedNous; is coauthor with Michael Scholz on patents re: Apparatus for measuring activity (Trium Analysis Online GmbH), method and device for detecting a movement pattern (Trium Analysis Online GmbH), device and method to measure the activity of a person (Trium Analysis Online GmbH), co-Author with Christian Lederer of device and method to determine the fetal heart rate from ultrasound signals (Trium Analysis Online GmbH), author of method and device for detecting drifts, jumps and/or outliers of measurement values, coauthor of patent applications with Michael Scholz of device and method to determine the global alarm state of a patient monitoring system, method of communication of units in a patient monitoring system, and system and method for patient monitoring; serves as a consultant for University of Oxford, Imperial College London, University of Southampton, Charite, Berlin, University of Vienna, Greencoat Ltd, Biopartners, Biogen Idec, Bayer Schering Pharma, Roche, and Novartis; and receives/has received research support from the EU-FP7, BMBF, BWiMi, and Hertie Foundation. Christian Lederer and Anneke Neuhaus were employed at the SLC - The Human Motion Institute when the study was performed. Michaela Schimpl were employed at TRIUM GmBH when the study was performed. Sven Briken and Nele Gotze have declared that no competing interests exist. Jan-Patrick Stellmann and Christoph Heesen report study, travel and educational grants from Merck-Serono, Biogen-Idec, Teva-Sanofi-Aventis and Bayer-Schering. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; [Anonymous], 2010, R LANG ENV STAT COMP; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; Chabrol H, 2012, NEUROLOGY, V78, P323, DOI 10.1212/WNL.0b013e3182452985; Cohen JT, 2010, EXPERT REV PHARM OUT, V10, P595, DOI [10.1586/erp.10.60, 10.1586/ERP.10.60]; Coleman CI, 2012, CURR MED RES OPIN, V28, P49, DOI 10.1185/03007995.2011.639752; Daumer M, 2007, BIOMED TECH, V52, P149, DOI 10.1515/BMT.2007.028; Ekblom-bak E, 2013, IMPORTANCE NONEXERCI, DOI [10.1136/bjsports-2012-092038, DOI 10.1136/BJSPORTS-2012-092038]; Feys P, 2012, MULT SCLER J, V18, P351, DOI 10.1177/1352458511419881; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Gijbels D, 2011, MULT SCLER J, V17, P1269, DOI 10.1177/1352458511408475; Gijbels D, 2012, MULT SCLER J, V18, P364, DOI 10.1177/1352458511420598; Gijbels D, 2010, MULT SCLER J, V16, P618, DOI 10.1177/1352458510361357; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Goldman MD, 2013, NEUROLOGY, V81, P1856, DOI 10.1212/01.wnl.0000436065.97642.d2; Goodman AD, 2010, ANN NEUROL, V68, P494, DOI 10.1002/ana.22240; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Hobart J, 2013, NEUROLOGY, V80, P1509, DOI 10.1212/WNL.0b013e31828cf7f3; Kieseier BC, 2012, MULT SCLER J, V18, P914, DOI 10.1177/1352458512444498; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Motl RW, 2013, ACTA NEUROL SCAND, V127, P384, DOI 10.1111/ane.12036; Motl RW, 2012, GAIT POSTURE, V35, P192, DOI 10.1016/j.gaitpost.2011.09.005; Paltamaa J, 2006, J REHABIL MED, V38, P339, DOI 10.1080/16501970600731537; Sandroff BM, 2014, J NEUROL SCI, V340, P50, DOI 10.1016/j.jns.2014.02.024; Savci S, 2005, DISABIL REHABIL, V27, P1365, DOI 10.1080/09638280500164479; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023299; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023080; Schlesinger S, 2011, KLIN NEUROPHYSIOL, V42, P17, DOI 10.1055/s-0031-1271750; Soaz C., 2012, Biomedical Engineering-Biomedizinische Technik, V57, DOI 10.1515/bmt-2012-4415; Stellmann JP, 2011, MULT SCLER J, V17, pS13; Vogel T, 2009, INT J CLIN PRACT, V63, P303, DOI 10.1111/j.1742-1241.2008.01957.x; Wens I, 2013, MULT SCLER J, V19, P1556, DOI 10.1177/1352458513504252; Wetzel JL, 2011, PHYSIOTHER CAN, V63, P166, DOI 10.3138/ptc.2009-62	37	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123822	10.1371/journal.pone.0123822	http://dx.doi.org/10.1371/journal.pone.0123822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879750	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500063
J	Akin, EJ; Sole, L; Dib-Hajj, SD; Waxman, SG; Tamkun, MM				Akin, Elizabeth J.; Sole, Laura; Dib-Hajj, Sulayman D.; Waxman, Stephen G.; Tamkun, Michael M.			Preferential Targeting of Na(v)1.6 Voltage-Gated Na+ Channels to the Axon Initial Segment during Development	PLOS ONE			English	Article							SODIUM-CHANNEL; ANKYRIN-G; PERIMETER FENCE; BETA-1 SUBUNITS; BINDING MOTIF; MEMBRANE; PROTEINS; IDENTIFICATION; ESTABLISHMENT; ORGANIZATION	During axonal maturation, voltage-gated sodium (Na-v) channels accumulate at the axon initial segment (AIS) at high concentrations. This localization is necessary for the efficient initiation of action potentials. The mechanisms underlying channel trafficking to the AIS during axonal development have remained elusive due to a lack of Na-v reagents suitable for high resolution imaging of channels located specifically on the cell surface. Using an optical pulse-chase approach in combination with a novel Na(v)1.6 construct containing an extracellular biotinylation domain we demonstrate that Na(v)1.6 channels are preferentially inserted into the AIS membrane during neuronal development via direct vesicular trafficking. Singlemolecule tracking illustrates that axonal channels are immediately immobilized following delivery, while channels delivered to the soma are often mobile. Neither a Na(v)1.6 channel lacking the ankyrin-binding motif nor a chimeric K(v)2.1 channel containing the Na-v ankyrinGbinding domain show preferential AIS insertion. Together these data support a model where ankyrinG-binding is required for preferential Na(v)1.6 insertion into the AIS plasma membrane. In contrast, ankyrinG-binding alone does not confer the preferential delivery of proteins to the AIS.	[Akin, Elizabeth J.] Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA; [Sole, Laura; Tamkun, Michael M.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Tamkun, Michael M.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Akin, Elizabeth J.; Tamkun, Michael M.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Adm Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT USA; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University; Yale University	Tamkun, MM (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	michael.tamkun@colostate.edu	Waxman, Stephen/Z-2507-2019; Akin, Elizabeth/P-1182-2019; Sole, Laura/AAT-7332-2020	Waxman, Stephen/0000-0001-5718-7177; 	National Science Foundation Graduate Research Fellowship [DGE-1321845]; National Institutes of Health [RO1 NS085142]; Rehabilitation Research Service, the Veterans Administration, USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085142] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000605] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rehabilitation Research Service, the Veterans Administration, USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Science Foundation Graduate Research Fellowship award DGE-1321845 (http://www.nsfgrfp.org/) to EJA, National Institutes of Health RO1 NS085142 (http://grants.nih.gov/grants/guide/pa-files/PA-13-302.html) to MMT and Rehabilitation Research Service, the Veterans Administration, USA (http://www.rehab.research.va.gov/) to SDH and SGW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry J, 2014, DEV CELL, V28, P117, DOI 10.1016/j.devcel.2013.11.023; Boiko T, 2003, J NEUROSCI, V23, P2306; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Deutsch E, 2012, MOL BIOL CELL, V23, P2917, DOI 10.1091/mbc.E12-01-0047; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Gasser A, 2012, J NEUROSCI, V32, P7232, DOI 10.1523/JNEUROSCI.5434-11.2012; Gasser A, 2010, J BIOL CHEM, V285, P26149, DOI 10.1074/jbc.M109.098681; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jones SL, 2014, J CELL BIOL, V205, P67, DOI 10.1083/jcb.201401045; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Lee A, 2009, CHANNELS, V3, P171, DOI 10.4161/chan.3.3.8854; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Leterrier C, 2014, SEMIN CELL DEV BIOL, V27, P44, DOI 10.1016/j.semcdb.2013.11.001; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Smith MR, 1998, J NEUROSCI, V18, P6093; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742	36	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124397	10.1371/journal.pone.0124397	http://dx.doi.org/10.1371/journal.pone.0124397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874799	Green Submitted, gold, Green Published			2022-12-26	WOS:000353015800141
J	Bahl, K; Naslavsky, N; Caplan, S				Bahl, Kriti; Naslavsky, Naava; Caplan, Steve			Role of the EHD2 Unstructured Loop in Dimerization, Protein Binding and Subcellular Localization	PLOS ONE			English	Article							PLASMA-MEMBRANE; DOMAIN; TRAFFICKING; INTERACTS; CAVEOLAE; INSIGHTS; MOTIFS; ACTIN; NPF	The C-terminal Eps 15 Homology Domain proteins (EHD1-4) play important roles in regulating endocytic trafficking. EHD2 is the only family member whose crystal structure has been solved, and it contains an unstructured loop consisting of two proline-phenylalanine (PF) motifs: KPFRKLNPF. In contrast, despite EHD2 having nearly 70% amino acid identity with its paralogs, EHD1, EHD3 and EHD4, the latter proteins contain a single KPF or RPF motif, but no NPF motif. In this study, we sought to define the precise role of each PF motif in EHD2's homo-dimerization, binding with the protein partners, and subcellular localization. To test the role of the NPF motif, we generated an EHD2 NPF-to-NAF mutant to mimic the homologous sequences of EHD1 and EHD3. We demonstrated that this mutant lost both its ability to dimerize and bind to Syndapin2. However, it continued to localize primarily to the cytosolic face of the plasma membrane. On the other hand, EHD2 NPF-to-APA mutants displayed normal dimerization and Syndapin2 binding, but exhibited markedly increased nuclear localization and reduced association with the plasma membrane. We then hypothesized that the single PF motif of EHD1 (that aligns with the KPF of EHD2) might be responsible for both binding and localization functions of EHD1. Indeed, the EHD1 RPF motif was required for dimerization, interaction with MICAL-L1 and Syndapin2, as well as localization to tubular recycling endosomes. Moreover, recycling assays demonstrated that EHD1 RPF-to-APA was incapable of supporting normal receptor recycling. Overall, our data suggest that the EHD2 NPF phenylalanine residue is crucial for EHD2 localization to the plasma membrane, whereas the proline residue is essential for EHD2 dimerization and binding. These studies support the recently proposed model in which the EHD2 N-terminal region may regulate the availability of the unstructured loop for interactions with neighboring EHD2 dimers, thus promoting oligomerization.	[Bahl, Kriti; Naslavsky, Naava; Caplan, Steve] Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Dept Biochem & Mol Biol, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center	Naslavsky, N (corresponding author), Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Dept Biochem & Mol Biol, Omaha, NE 68182 USA.	nnaslavsky@unmc.edu; scaplan@unmc.edu			Institutional Development Award (IDeA) [5P30GM106397]; NIH from the National Institute of General Medical Sciences of the National Institutes of Health [R01GM087455, R01GM074876]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087455, P30GM106397, R01GM074876] Funding Source: NIH RePORTER	Institutional Development Award (IDeA); NIH from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award (IDeA; grant number 5P30GM106397) and by NIH grants R01GM087455 and R01GM074876 from the National Institute of General Medical Sciences of the National Institutes of Health.	Benjamin S, 2011, BIOCHEM J, V439, P433, DOI 10.1042/BJ20111010; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Henry GD, 2010, BIOCHEMISTRY-US, V49, P3381, DOI 10.1021/bi100065r; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Marg A, 2012, TRAFFIC, V13, P1286, DOI 10.1111/j.1600-0854.2012.01386.x; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Pekar O, 2012, BIOCHEM J, V444, P383, DOI 10.1042/BJ20111268; Posey AD, 2011, J BIOL CHEM, V286, P7379, DOI 10.1074/jbc.M110.157222; Reinecke JB, 2014, NOVEL FUNCTIONS ENDO; Shah C, 2014, STRUCTURE, V22, P409, DOI 10.1016/j.str.2013.12.015; Simone LC, 2014, HISTOL HISTOPATHOL, V29, P285, DOI 10.14670/HH-29.285; Simone LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074519; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Xie S, 2014, J BIOL CHEM	27	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123710	10.1371/journal.pone.0123710	http://dx.doi.org/10.1371/journal.pone.0123710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875965	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800112
J	Datta-Mitra, A; Kundu-Raychaudhuri, S; Mitra, A; Raychaudhuri, SP				Datta-Mitra, Ananya; Kundu-Raychaudhuri, Smriti; Mitra, Anupam; Raychaudhuri, Siba P.			Cross Talk between Neuroregulatory Molecule and Monocyte: Nerve Growth Factor Activates the Inflammasome	PLOS ONE			English	Article							NF-KAPPA-B; NLRP3 INFLAMMASOME; INTERLEUKIN-1-BETA; RECEPTOR; INNATE; EXPRESSION; PSORIASIS; DISEASE; SUSCEPTIBILITY; NEUROTROPHINS	Background Increasing evidence points to a role for the extra-neuronal nerve growth factor (NGF) in acquired immune responses. However, very little information is available about its role and underlying mechanism in innate immunity. The role of innate immunity in autoimmune diseases is becoming increasingly important. In this study, we explored the contribution of pleiotropic NGF in the innate immune response along with its underlying molecular mechanism with respect to IL-1 beta secretion. Methods Human monocytes, null and NLRP3 deficient THP-1 cell lines were used for this purpose. We determined the effect of NGF on secretion of IL-1 beta at the protein and mRNA levels. To determine the underlying molecular mechanism, the effect of NGF on NLRP1/NLRP3 inflammasomes and its downstream key protein, activated caspase-1, were evaluated by ELISA, immunoflorescence, flow cytometry, and real-time PCR. Results In human monocytes and null THP-1 cell line, NGF significantly upregulates IL-1 beta at protein and mRNA levels in a caspase-1 dependent manner through its receptor, TrkA. Furthermore, we observed that NGF induces caspase-1 activation through NLRP1/NLRP3 inflammasomes, and it is dependent on the master transcription factor, NF-kappa B. Conclusions To best of our knowledge, this is the first report shedding light on the mechanistic aspect of a neuroregulatory molecule, NGF, in innate immune response, and thus enriches our understanding regarding its pathogenic role in inflammation. These observations add further evidence in favor of anti-NGF therapy in autoimmune diseases and also unlock a new area of research about the role of NGF in IL-1 beta mediated diseases.	[Datta-Mitra, Ananya; Kundu-Raychaudhuri, Smriti; Raychaudhuri, Siba P.] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Datta-Mitra, Ananya; Kundu-Raychaudhuri, Smriti; Mitra, Anupam; Raychaudhuri, Siba P.] VA Med Ctr Sacramento, Mather, CA 95655 USA; [Mitra, Anupam] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Raychaudhuri, SP (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.	sraychaudhuri@ucdavis.edu	MITRA, ANANYA DATTA/AAE-4402-2019; Mitra, Anupam/AAM-6298-2020	MITRA, ANANYA DATTA/0000-0002-8097-4950; Mitra, Anupam/0000-0003-2385-7325	VA Merit grant [I01CX000201]	VA Merit grant	This project was supported by VA Merit grant, I01CX000201 awarded to Dr. Siba P. Raychaudhuri. Contents do not necessarily represent the views of the Department of Veterans Affairs or the United States Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloe L, 2001, Arch Physiol Biochem, V109, P354, DOI 10.1076/apab.109.3.354.9339; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Buerger C, 2012, J INVEST DERMATOL, V132, P2206, DOI 10.1038/jid.2012.123; Cao Y, 2005, ACTA PHARMACOL SIN, V26, P150, DOI 10.1111/j.1745-7254.2005.00525.x; Carlstrom M, 2012, EXP DERMATOL, V21, P932, DOI 10.1111/exd.12049; Carter BD, 1997, NEURON, V18, P187, DOI 10.1016/S0896-6273(00)80259-7; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Datta Mitra A, 2013, J INVESTIGATIVE DERM; Dieude P, 2011, ANN RHEUM DIS, V70, P668, DOI 10.1136/ard.2010.131243; FRANKLIN RA, 1995, J IMMUNOL, V154, P4965; Garcia-Rodriguez S, 2011, J EUROPEAN ACAD DERM; Gaspari AA, 2006, J AM ACAD DERMATOL, V54, pS67, DOI 10.1016/j.jaad.2005.10.057; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Grabarek Jerzy, 2002, Hum Cell, V15, P1, DOI 10.1111/j.1749-0774.2002.tb00094.x; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Jeong JG, 2004, BIOCHEM BIOPH RES CO, V324, P3, DOI 10.1016/j.bbrc.2004.09.011; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lachmann HJ, 2011, ARTHRITIS RHEUM-US, V63, P314, DOI 10.1002/art.30105; Lasiglie D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020014; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110; Loh NK, 2012, INTERN MED J, V42, P1358, DOI 10.1111/imj.12002; Mathews RJ, 2013, ANN RHEUMATIC DIS; Mitra AD, 2012, INDIAN J DERMATOL VE, V78, P394, DOI 10.4103/0378-6323.95474; Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316; Naik E, 2010, J CLIN IMMUNOL, V30, P485, DOI 10.1007/s10875-010-9383-8; Park HJ, 2012, J CLIN IMMUNOL, V32, P1148, DOI 10.1007/s10875-012-9815-8; Park MJ, 2007, J BIOL CHEM, V282, P30485, DOI 10.1074/jbc.M701081200; Pontillo A, 2012, AUTOIMMUNITY, V45, P271, DOI 10.3109/08916934.2011.637532; Prencipe G, 2014, J IMMUNOL, V192, P3345, DOI 10.4049/jimmunol.1300825; Raychaudhuri SP, 2008, AM J PATHOL, V172, P961, DOI 10.2353/ajpath.2008.070710; Raychaudhuri SP, 2012, MOL CELL BIOCHEM, V359, P419, DOI 10.1007/s11010-011-1036-6; Raychaudhuri SP, 2011, ARTHRITIS RHEUM-US, V63, P3243, DOI 10.1002/art.30564; Raychaudhuri SR, 2004, J INVEST DERMATOL, V122, P812, DOI 10.1111/j.0022-202X.2003.12602.x; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Susaki Y, 1996, BLOOD, V88, P4630, DOI 10.1182/blood.V88.12.4630.bloodjournal88124630; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; TWOMEY B, 1990, BRIT J PHARMACOL, V100, P819, DOI 10.1111/j.1476-5381.1990.tb14098.x; van de Veerdonk Frank L, 2011, Trends Immunol, V32, P110, DOI 10.1016/j.it.2011.01.003; Vega JA, 2003, J ANAT, V203, P1, DOI 10.1046/j.1469-7580.2003.00203.x; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang JJ, 2011, GYNECOL OBSTET INVES, V72, P163, DOI 10.1159/000327934	53	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121626	10.1371/journal.pone.0121626	http://dx.doi.org/10.1371/journal.pone.0121626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876154	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800025
J	Frank, DO; Dengjel, J; Wilfling, F; Kozjak-Pavlovic, V; Hacker, G; Weber, A				Frank, Daniel O.; Dengjel, Joern; Wilfling, Florian; Kozjak-Pavlovic, Vera; Haecker, Georg; Weber, Arnim			The Pro-Apoptotic BH3-Only Protein Bim Interacts with Components of the Translocase of the Outer Mitochondrial Membrane (TOM)	PLOS ONE			English	Article							BCL-2 PROTEINS; BH3 DOMAINS; IMPORT; BAX; PREPROTEINS; FAMILY; CELLS; PHOSPHORYLATION; DEGRADATION; PROTEOMICS	The pro-apoptotic Bcl-2-family protein Bim belongs to the BH3-only proteins known as initiators of apoptosis. Recent data show that Bim is constitutively inserted in the outer mitochondrial membrane via a C-terminal transmembrane anchor from where it can activate the effector of cytochrome c-release, Bax. To identify regulators of Bim-activity, we conducted a search for proteins interacting with Bim at mitochondria. We found an interaction of Bim with Tom70, Tom20 and more weakly with Tom40, all components of the Translocase of the Outer Membrane (TOM). In vitro import assays performed on tryptically digested yeast mitochondria showed reduced Bim insertion into the outer mitochondrial membrane (OMM) indicating that protein receptors may be involved in the import process. However, RNAi against components of TOM (Tom40, Tom70, Tom22 or Tom20) by siRNA, individually or in combination, did not consistently change the amount of Bim on HeLa mitochondria, either at steady state or upon de novo-induction. In support of this, the individual or combined knockdowns of TOM receptors also failed to alter the susceptibility of HeLa cells to Bim-induced apoptosis. In isolated yeast mitochondria, lack of Tom70 or the TOM-components Tom20 or Tom22 alone did not affect the import of Bim into the outer mitochondrial membrane. In yeast, expression of Bim can sensitize the cells to Bax-dependent killing. This sensitization was unaffected by the absence of Tom70 or by an experimental reduction in Tom40. Although thus the physiological role of the Bim-TOM-interaction remains unclear, TOM complex components do not seem to be essential for Bim insertion into the OMM. Nevertheless, this association should be noted and considered when the regulation of Bim in other cells and situations is investigated.	[Frank, Daniel O.; Haecker, Georg; Weber, Arnim] Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany; [Dengjel, Joern] Univ Freiburg, Med Ctr, Dept Dermatol, Freiburg, Germany; [Dengjel, Joern] Univ Freiburg, Ctr Biol Syst Anal ZBSA, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Wilfling, Florian] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Kozjak-Pavlovic, Vera] Univ Wurzburg, Bioctr, Dept Microbiol, D-97070 Wurzburg, Germany; [Dengjel, Joern; Haecker, Georg] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Frank, Daniel O.] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Frank, Daniel O.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; University of Wurzburg; University of Freiburg; University of Freiburg; University of Freiburg	Weber, A (corresponding author), Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany.	arnim.weber@uniklinik-freiburg.de	Dengjel, Joern/AAI-3682-2020; Wilfling, Florian/AAJ-8921-2021; Kozjak-Pavlovic, Vera/E-1494-2013	Kozjak-Pavlovic, Vera/0000-0001-9658-7018; Dengjel, Joern/0000-0002-9453-4614; Wilfling, Florian/0000-0002-6559-7261	Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); German Research Council (DFG) [FOR2036]	Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); German Research Council (DFG)(German Research Foundation (DFG))	This study was supported in part by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) and by a grant from the German Research Council (DFG, FOR2036, to G.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Clybouw C, 2012, CELL DEATH DIFFER, V19, P1060, DOI 10.1038/cdd.2011.198; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Geissler A, 2013, CELL DEATH DIFFER; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; MOCZKO M, 1994, J BIOL CHEM, V269, P9045; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Sherman F., 1986, METHODS YEAST GENETI; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Weber A, 2013, APOPTOSIS; Weber A, 2007, J CELL BIOL, V177, P625, DOI 10.1083/jcb.200610148; Weber K, 2013, CELL REPORTS; Wilfling F, 2012, CELL DEATH DIFFER, V19, P1328, DOI 10.1038/cdd.2012.9; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	36	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123341	10.1371/journal.pone.0123341	http://dx.doi.org/10.1371/journal.pone.0123341			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875815	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800093
J	Ossiboff, RJ; Raphael, BL; Ammazzalorso, AD; Seimon, TA; Newton, AL; Chang, TY; Zarate, B; Whitlock, AL; McAloose, D				Ossiboff, Robert J.; Raphael, Bonnie L.; Ammazzalorso, Alyssa D.; Seimon, Tracie A.; Newton, Alisa L.; Chang, Tylis Y.; Zarate, Brian; Whitlock, Alison L.; McAloose, Denise			Three Novel Herpesviruses of Endangered Clemmys and Glyptemys Turtles	PLOS ONE			English	Article							SEA-TURTLES; B-VIRUS; INFECTION; TORTOISES; DISEASE; SEQUENCES; REPTILES; MONKEYS	The rich diversity of the world's reptiles is at risk due to significant population declines of broad taxonomic and geographic scope. Significant factors attributed to these declines include habitat loss, pollution, unsustainable collection and infectious disease. To investigate the presence and significance of a potential pathogen on populations of critically endangered bog turtles (Glyptemys muhlenbergii) as well sympatric endangered wood (G. insculpta) and endangered spotted (Clemmys guttata) turtles in the northeastern United States, choanal and cloacal swabs collected from 230 turtles from 19 sites in 5 states were screened for herpesvirus by polymerase chain reaction. We found a high incidence of herpesvirus infection in bog turtles (51.5%; 105/204) and smaller numbers of positive wood (5) and spotted (1) turtles. Sequence and phylogenetic analysis revealed three previously uncharacterized alphaherpesviruses. Glyptemys herpesvirus 1 was the predominant herpesvirus detected and was found exclusively in bog turtles in all states sampled. Glyptemys herpesvirus 2 was found only in wood turtles. Emydid herpesvirus 2 was found in a small number of bog turtles and a single spotted turtle from one state. Based on these findings, Glyptemys herpesvirus 1 appears to be a common infection in the study population, whereas Glyptemys herpesvirus 2 and Emydid herpesvirus 2 were not as frequently detected. Emydid herpesvirus 2 was the only virus detected in more than one species. Herpesviruses are most often associated with subclinical or mild infections in their natural hosts, and no sampled turtles showed overt signs of disease at sampling. However, infection of host-adapted viruses in closely related species can result in significant disease. The pathogenic potential of these viruses, particularly Emydid herpesvirus 2, in sympatric chelonians warrants additional study in order to better understand the relationship of these viruses with their endangered hosts.	[Ossiboff, Robert J.; Raphael, Bonnie L.; Ammazzalorso, Alyssa D.; Seimon, Tracie A.; Newton, Alisa L.; McAloose, Denise] Wildlife Conservat Soc, Zool Hlth Program, Bronx, NY USA; [Ammazzalorso, Alyssa D.] Fordham Univ, Bronx, NY 10458 USA; [Chang, Tylis Y.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY USA; [Zarate, Brian] New Jersey Div Fish & Wildlife, Endangered & Nongame Species Program, Clinton, NJ USA; [Whitlock, Alison L.] US Fish & Wildlife Serv, Hadley, MA USA	Wildlife Conservation Society; Fordham University; Yeshiva University; Albert Einstein College of Medicine; United States Department of the Interior; US Fish & Wildlife Service	Ossiboff, RJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rjo23@cornell.edu	Ossiboff, Robert/AAB-8732-2019	Ossiboff, Robert/0000-0001-6951-6070	United States Fish and Wildlife Service through State Wildlife Grant and Cooperative Endangered Species Conservation Grant Programs; Delaware Division of Fish and Wildlife; New Jersey Division of Fish, Game and Wildlife	United States Fish and Wildlife Service through State Wildlife Grant and Cooperative Endangered Species Conservation Grant Programs; Delaware Division of Fish and Wildlife; New Jersey Division of Fish, Game and Wildlife	This study was funded in part by the United States Fish and Wildlife Service through State Wildlife Grant and Cooperative Endangered Species Conservation Grant Programs, the Delaware Division of Fish and Wildlife, the New Jersey Division of Fish, Game and Wildlife, and gifts from several private individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barragan AR, 1994, MAR TURT NEWSL, V67; Bicknese EJ, 2010, J ZOO WILDLIFE MED, V41, P353, DOI 10.1638/2009-0214R.1; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; CHELLMAN GJ, 1992, LAB ANIM SCI, V42, P146; COX WR, 1980, J WILDLIFE DIS, V16, P445, DOI 10.7589/0090-3558-16.3.445; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Dunowska M, 2001, J GEN VIROL, V82, P2785, DOI 10.1099/0022-1317-82-11-2785; Fonnesbeck CJ, 2003, J HERPETOL, V37, P602, DOI 10.1670/37-02N; FRYE FL, 1977, J AM VET MED ASSOC, V171, P882; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herbst Lawrence H., 1994, Annual Review of Fish Diseases, V4, P389, DOI 10.1016/0959-8030(94)90037-X; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huerta P., 2002, P 20 ANN S SEA TURTL, P193; Jacobson Elliott R., 2007, P395, DOI 10.1201/9781420004038.ch9; JACOBSON ER, 1986, J AM VET MED ASSOC, V189, P1020; JACOBSON ER, 1985, J AM VET MED ASSOC, V187, P1227; JACOBSON ER, 1982, J AM VET MED ASSOC, V181, P1322; Jungwirth N, 2014, VET MICROBIOL, V170, P403, DOI 10.1016/j.vetmic.2014.02.029; Landolfi JA, 2005, J VET DIAGN INVEST, V17, P369, DOI 10.1177/104063870501700412; Marschang RE, 2006, VET MICROBIOL, V117, P258, DOI 10.1016/j.vetmic.2006.06.009; McGeoch DJ, 2005, J VIROL, V79, P725, DOI 10.1128/JVI.79.2.725-731.2005; Origgi FC, 2004, VET PATHOL, V41, P50, DOI 10.1354/vp.41-1-50; Ostrowski SR, 1998, EMERG INFECT DIS, V4, P117, DOI 10.3201/eid0401.980117; PettanBrewer KCB, 1996, J WILDLIFE DIS, V32, P521, DOI 10.7589/0090-3558-32.3.521; Pinkerton ME, 2008, J WILDLIFE DIS, V44, P622, DOI 10.7589/0090-3558-44.3.622; Seigel RA, 2003, J HERPETOL, V37, P137, DOI 10.1670/0022-1511(2003)037[0137:SFOPUR]2.0.CO;2; Seminoff J. A., 2004, IUCN 2014 IUCN RED L; Sim RR, 2015, VET MICROBIOL, V175, P218, DOI 10.1016/j.vetmic.2014.11.029; Stacy BA, 2008, VET MICROBIOL, V126, P63, DOI 10.1016/j.vetmic.2007.07.002; Sutherland WJ, 2014, TRENDS ECOL EVOL, V29, P15, DOI 10.1016/j.tree.2013.11.004; Todd BD, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P47, DOI 10.1201/EBK1420064162-c3; Uetz P, 2014, REPTILE DATABASE; Van Dijk PP, 2013, IUCN 2014 IUCN RED L; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Williams EH, 2006, J VIROL, V80, P4643, DOI 10.1128/JVI.80.9.4643-4644.2006	39	20	21	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122901	10.1371/journal.pone.0122901	http://dx.doi.org/10.1371/journal.pone.0122901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875510	Green Submitted, gold, Green Published			2022-12-26	WOS:000353015800082
J	Wang, CY; Wang, JY; Teng, NC; Chao, TT; Tsai, SL; Chen, CL; Hsu, JY; Wu, CP; Lai, CC; Chen, L				Wang, Cheng-Yi; Wang, Jen-Yu; Teng, Nai-Chi; Chao, Ting-Ting; Tsai, Shu-Ling; Chen, Chi-Liang; Hsu, Jeng-Yuan; Wu, Chin-Pyng; Lai, Chih-Cheng; Chen, Likwang			The Secular Trends in the Incidence Rate and Outcomes of Out-of-Hospital Cardiac Arrest in Taiwan-A Nationwide Population-Based Study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; MYOCARDIAL-INFARCTION; UNITED-STATES; SURVIVAL; CARE; RISK; ASSOCIATION; VALIDATION; DIAGNOSIS; REGISTRY	Objective This study investigated the trends in incidence and mortality of out-of-hospital cardiac arrest (OHCA), as well as factors associated with OHCA outcomes in Taiwan. Methods Our study included OHCA patients requiring cardiopulmonary resuscitation (CPR) upon arrival at the hospital. We used national time-series data on annual OHCA incidence rates and mortality rates from 2000 to 2012, and individual demographic and clinical data for all OHCA patients requiring mechanical ventilation (MV) care from March of 2010 to September of 2011. Analytic techniques included the time-series regression and the logistic regression. Results There were 117,787 OHCAs in total. The overall incidence rate during the 13 years was 51.1 per 100,000 persons, and the secular trend indicates a sharp increase in the early 2000s and a decrease afterwards. The trend in mortality was also curvilinear, revealing a substantial increase in the early 2000s, a subsequent steep decline and finally a modest increase. Both the 30-day and 180-day mortality rates had a long-term decreasing trend over the period (p<0.01). For both incidence and mortality rates, a significant second-order auto-regressive effect emerged. Among OHCA patients with MV, 1-day, 30-day and 180-day mortality rates were 31.3%, 75.8%, and 86.0%, respectively. In this cohort, older age, the female gender, and a Charlson comorbidity index score >= 2 were associated with higher 180-day mortality; patients delivered to regional hospitals and those residing in non-metropolitan areas had higher death risk. Conclusions Overall, both the 30-day and the 180-day mortality rates after OHCA had a long-term decreasing trend, while the 1-day mortality had no long-term decline. Among OHCA patients requiring MV, those delivered to regional hospitals and those residing in non-metropolitan areas tended to have higher mortality, suggesting a need for effort to further standardize and improve in-hospital care across hospitals and to advance pre-hospital care in non-metropolitan areas.	[Wang, Cheng-Yi; Wang, Jen-Yu] Fu Jen Catholic Univ Coll Med, Cardinal Tien Hosp, Dept Internal Med, New Taipei City, Taiwan; [Teng, Nai-Chi; Chen, Likwang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan Town, Miaoli County, Taiwan; [Chao, Ting-Ting] Fu Jen Catholic Univ Coll Med, Cardinal Tien Hosp, Med Res Ctr, New Taipei City, Taiwan; [Tsai, Shu-Ling] Minist Hlth & Welf, Natl Hlth Insurance Adm, Taipei, Taiwan; [Chen, Chi-Liang] Chung Yuan Christian Univ, Coll Business, Dept Accounting, Taoyuan, Taiwan; [Hsu, Jeng-Yuan] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Wu, Chin-Pyng] Landseed Hosp, Dept Internal Med, Taoyuan, Taiwan; [Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan	Cardinal Tien Hospital; Fu Jen Catholic University; National Health Research Institutes - Taiwan; Cardinal Tien Hospital; Fu Jen Catholic University; Chung Yuan Christian University; Taichung Veterans General Hospital; Chi Mei Hospital	Lai, CC (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	dtmed141@gmail.com; likwang@nhri.org.tw	Wu, Chin-Pyng/W-8447-2019		National Health Research Institutes, Taiwan; National Health Insurance Administration, Ministry of Health and Welfare, Taiwan; Cardinal Tien Hospital	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Health Insurance Administration, Ministry of Health and Welfare, Taiwan; Cardinal Tien Hospital	The authors study was financially supported by the following three organizations: National Health Research Institutes, Taiwan; National Health Insurance Administration, Ministry of Health and Welfare, Taiwan; Cardinal Tien Hospital. The study is based on data provided by National Health Insurance Administration, Ministry of Health and Welfare, Taiwan. The interpretation and conclusions shown in this paper do not represent those of National Health Research Institutes, or National Health Insurance Administration, Ministry of Health and Welfare, Taiwan.	Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Axelsson C, 2012, RESUSCITATION, V83, P1253, DOI 10.1016/j.resuscitation.2012.01.043; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Buist M, 2014, RESUSCITATION, V85, P155, DOI 10.1016/j.resuscitation.2013.12.016; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheung W, 2013, CRIT CARE RESUSC, V15, P241; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112; Goto Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12812; Harnod D, 2013, INT J GERONTOL, V7, P216, DOI 10.1016/j.ijge.2013.08.001; Hasegawa K, 2013, RESUSCITATION, V84, P1099, DOI 10.1016/j.resuscitation.2013.03.007; Hung MC, 2011, CRIT CARE, V15, DOI 10.1186/cc10128; Kim JY, 2013, RESUSCITATION, V84, P1068, DOI 10.1016/j.resuscitation.2013.02.010; Kuo CW, 2014, J EMERG MED, V46, P782, DOI 10.1016/j.jemermed.2013.08.026; Kuo CF, 2013, RHEUMATOLOGY, V52, P111, DOI 10.1093/rheumatology/kes169; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; Lu HM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-100; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nielsen N, 2012, RESUSCITATION, V83, P669, DOI 10.1016/j.resuscitation.2012.03.015; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Ramjee V, 2013, RESUSCITATION, V84, P537, DOI 10.1016/j.resuscitation.2013.02.008; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Ro YS, 2013, RESUSCITATION, V84, P547, DOI 10.1016/j.resuscitation.2012.12.020; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Shen HN, 2011, CRIT CARE, V15, DOI 10.1186/cc10323; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu SC., 2010, TAIWAN J PUBLIC HLTH, V29, P191; Wu VC, 2014, J CLIN EPIDEMIOL, V67, P1139, DOI 10.1016/j.jclinepi.2014.05.012; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610	36	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122675	10.1371/journal.pone.0122675	http://dx.doi.org/10.1371/journal.pone.0122675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875921	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800070
J	Yu, YS; Wang, JP; Liu, JH; Ling, DS; Xia, J				Yu, Yongsheng; Wang, Jianpeng; Liu, Jiahui; Ling, Daishun; Xia, Jiang			Functional Assembly of Protein Fragments Induced by Spatial Confinement	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; FIREFLY LUCIFERASE; FOLDING LANDSCAPE; MESOPOROUS SILICA; ENZYME; CORONA; CELLS; RED; BIOLUMINESCENCE; IMMOBILIZATION	Natural proteins are often confined within their local microenvironments, such as three-dimensional confinement in organelles or two-dimensional confinement in lipid rafts on cytoplasmic membrane. Spatial confinement restricts proteins' entropic freedom, forces their lateral interaction, and induces new properties that the same proteins lack at the soluble state. So far, the phenomenon of environment-induced protein functional alteration still lacks a full illustration. We demonstrate here that engineered protein fragments, although being non-functional in solution, can be re-assembled within the nanometer space to give the full activity of the whole protein. Specific interaction between hexahistidine-tag (His-tag) and NiO surface immobilizes protein fragments on NiO nanoparticles to form a self-assembled protein "corona" on the particles inside the nanopores of mesoporous silica. Site-specific assembly forces a shoulder-by-shoulder orientation and promotes fragment-fragment interaction; this interaction together with spatial confinement of the mesopores results in functional re-assembly of the protein half fragments. To our surprise, a single half fragment of luciferase (non-catalytic in solution) exhibited luciferase activity when immobilized on NiO in the mesopores, in the absence of the complimentary half. This shows for the first time that spatial confinement can induce the folding of a half fragment, reconstitute the enzyme active site, and re-gain the catalytic capability of the whole protein. Our work thereby highlights the under-documented notion that aside from the chemical composition such as primary sequence, physical environment of a protein also determines its function.	[Yu, Yongsheng; Wang, Jianpeng; Liu, Jiahui; Xia, Jiang] Chinese Univ Hong Kong, Ctr Novel Biomat, Dept Chem, Shatin, Hong Kong, Peoples R China; [Ling, Daishun] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China	Chinese University of Hong Kong; Zhejiang University	Ling, DS (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	lingds@zju.edu.cn; jiangxia@cuhk.edu.hk	Xia, Jiang/AAT-2366-2020; Ling, Daishun/AAH-6088-2021; Ling, Daishun/J-4736-2014; YU, Yongsheng/O-6211-2015	Ling, Daishun/0000-0002-6814-7370; Xia, Jiang/0000-0001-8112-7625; YU, Yongsheng/0000-0001-5139-3439	University Grants Committee of Hong Kong [CUHK 404812, 403711, 404413, AoE/M-09/12]	University Grants Committee of Hong Kong	Financial support for this work came from the University Grants Committee of Hong Kong (ECS grant CUHK 404812, GRF grants 403711 and 404413, and AoE/M-09/12).	Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Bhattacharya A, 2012, BIOPHYS J, V103, P596, DOI 10.1016/j.bpj.2012.07.005; Branchini BR, 2001, BIOCHEMISTRY-US, V40, P2410, DOI 10.1021/bi002246m; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Fan JY, 2008, BIOCHEM BIOPH RES CO, V367, P47, DOI 10.1016/j.bbrc.2007.12.101; Foffi G, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/040301; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Gursoy G, 2014, NUCLEIC ACIDS RES, V42, P8223, DOI 10.1093/nar/gku462; Guo ZF, 2008, ORG LETT, V10, P649, DOI 10.1021/ol7030153; Guo ZF, 2010, BIOORG MED CHEM LETT, V20, P3855, DOI 10.1016/j.bmcl.2010.05.051; Hancock R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036045; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Javidpour L, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3641482; Jedlovszky-Hajdu A, 2012, LANGMUIR, V28, P14983, DOI 10.1021/la302446h; Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+; Kao KC, 2014, J PHYS CHEM C, V118, P6734, DOI 10.1021/jp4112684; Koutsioubas A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4723871; Latour RA, 2008, INFORM HEALTHCARE, V1, P270, DOI [10.3171/PED/2008/1/4/270, DOI 10.3171/PED/2008/1/4/270]; Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w; Ling DS, 2014, CHEM-EUR J, V20, P7916, DOI 10.1002/chem.201403071; Liu J, 2013, CHEM-EUR J, V19, P2711, DOI 10.1002/chem.201203833; Lucent D, 2007, P NATL ACAD SCI USA, V104, P10430, DOI 10.1073/pnas.0608256104; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Marino KA, 2012, J PHYS CHEM B, V116, P11872, DOI 10.1021/jp306727r; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Michnick SW, 2003, CURR OPIN BIOTECH, V14, P610, DOI 10.1016/j.copbio.2003.10.014; Minh DDL, 2006, J AM CHEM SOC, V128, P6006, DOI 10.1021/ja060483s; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Oba Y, 2003, FEBS LETT, V540, P251, DOI 10.1016/S0014-5793(03)00272-2; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Remy I, 2007, BIOTECHNIQUES, V42, P137, DOI 10.2144/000112396; Saha R, 2013, J MOL RECOGNIT, V26, P59, DOI 10.1002/jmr.2246; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Tan ZJ, 2012, BIOPHYS J, V103, P827, DOI 10.1016/j.bpj.2012.06.048; Wang W, 2009, P NATL ACAD SCI USA, V106, P5517, DOI 10.1073/pnas.0809649106; Warkentin PH, 1995, PROTEINS INTERFACES, P163; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	42	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122101	10.1371/journal.pone.0122101	http://dx.doi.org/10.1371/journal.pone.0122101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875003	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800039
J	Klarenbeek, J; Goedhart, J; van Batenburg, A; Groenewald, D; Jalink, K				Klarenbeek, Jeffrey; Goedhart, Joachim; van Batenburg, Aernoud; Groenewald, Daniella; Jalink, Kees			Fourth-Generation Epac-Based FRET Sensors for cAMP Feature Exceptional Brightness, Photostability and Dynamic Range: Characterization of Dedicated Sensors for FLIM, for Ratiometry and with High Affinity	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; YELLOW FLUORESCENT PROTEIN; ACTIVATION; INDICATORS; GFP	Epac-based FRET sensors have been widely used for the detection of cAMP concentrations in living cells. Originally developed by us as well as others, we have since then reported several important optimizations that make these sensors favourite among many cell biologists. We here report cloning and characterization of our fourth generation of cAMP sensors, which feature outstanding photostability, dynamic range and signal-to-noise ratio. The design is based on mTurquoise2, currently the brightest and most bleaching-resistant donor, and a new acceptor cassette that consists of a tandem of two cp(173)Venus fluorophores. We also report variants with a single point mutation, Q270E, in the Epac moiety, which decreases the dissociation constant of cAMP from 9.5 to 4 mu M, and thus increases the affinity similar to 2.5-fold. Finally, we also prepared and characterized dedicated variants with non-emitting (dark) acceptors for single-wavelength FLIM acquisition that display an exceptional near-doubling of fluorescence lifetime upon saturation of cAMP levels. We believe this generation of cAMP outperforms all other sensors and therefore recommend these sensors for all future studies.	[Klarenbeek, Jeffrey; van Batenburg, Aernoud; Groenewald, Daniella; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Goedhart, Joachim] Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, NL-1012 WX Amsterdam, Netherlands; [Klarenbeek, Jeffrey; Goedhart, Joachim; van Batenburg, Aernoud; Groenewald, Daniella; Jalink, Kees] van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam	Jalink, K (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	k.jalink@nki.nl		Jalink, Kees/0000-0001-7019-3440; Goedhart, Joachim/0000-0002-0630-3825	NanoNextNL; KWF [NKI 2010-4626]; Stichting Technische Wetenschappen	NanoNextNL; KWF; Stichting Technische Wetenschappen	JG is supported by NanoNextNL. KJ is supported by grants from KWF (NKI 2010-4626) and the Stichting Technische Wetenschappen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Polito M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00211; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Salonikidis PS, 2011, J BIOL CHEM, V286, P23419, DOI 10.1074/jbc.M111.236869; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916	19	164	164	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122513	10.1371/journal.pone.0122513	http://dx.doi.org/10.1371/journal.pone.0122513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875503	Green Submitted, gold, Green Published			2022-12-26	WOS:000353014700017
J	Mihelich, BL; Maranville, JC; Nolley, R; Peehl, DM; Nonn, L				Mihelich, Brittany L.; Maranville, Joseph C.; Nolley, Rosalie; Peehl, Donna M.; Nonn, Larisa			Elevated Serum MicroRNA Levels Associate with Absence of High-Grade Prostate Cancer in a Retrospective Cohort	PLOS ONE			English	Article							CIRCULATING MICRORNAS; TUMOR-SUPPRESSOR; PROGRESSION; CLUSTER; CELLS; RECURRENCE; EXPRESSION; BIOMARKERS; BIOPSY; ORIGIN	To reduce treatment of indolent prostate cancer (PCa), biomarkers are needed to improve identification of patients with a low-risk of having aggressive disease. Over-treatment of these patients occurs because of uncertainty in the aggressiveness of the entire tumor based on the biopsies, which do not accurately sample multifocal tumors. Circulating microRNAs (miRNAs) are stable serum markers and differential miRNA levels occur in men with PCa. The goal of this study was to identify circulating miRNAs that were associated with aggressive or indolent PCa. We measured circulating miRNAs in 150 patients prior to surgery and compared the miRNA levels to the pathology of the entire radical prostatectomy specimen. For this study we used an exceptionally well-characterized cohort of patients who had benign prostatic hyperplasia (BPH), low-grade or high-grade PCa. Low-grade was defined as patients with 100% Gleason grade 3 tumor as determined by step-wise sectioning. High-grade PCa patients had 30-90% Gleason grade 4+5 in the tumor. BPH patients had at least two biopsies negative for PCa. Twenty one miRNAs were selected for analysis. The miRNAs were quantified by RT-qPCR and analyzed by logistic regression. High levels of 14 miRNAs were exclusively present in the serum from patients with low-grade PCa or BPH, compared to men with high-grade PCa who had consistently low levels. The expression levels of the 14 miRNAs were combined into a "miR Score" which had a negative predictive value (NPV) of 0.939 to predict absence of high-grade PCa among PCa and BPH patients. Biochemical recurrence (BCR) was known for the PCa patients and a combined "miR Risk Score" accurately classified a subset of patients with low risk of BCR (NPV 0.941). In summary, measurement of serum miRNAs may have pre-surgical utility in combination with clinical risk calculators to identify patients with low risk of harboring aggressive PCa.	[Mihelich, Brittany L.; Nonn, Larisa] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Maranville, Joseph C.] Univ Chicago, Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA; [Nolley, Rosalie; Peehl, Donna M.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; Stanford University	Nonn, L (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60612 USA.	lnonn@uic.edu		Maranville, Joseph/0000-0002-1688-1573	National Institutes of Health [R01 CA121460, R01 CA166588]; NATIONAL CANCER INSTITUTE [R01CA121460, R01CA166588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, http://www.nih.gov, R01 CA121460, PI Peehl and National Institutes of Health, http://www.nih.gov, R01 CA166588, PI Nonn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Chen Q, 2015, MOL CARCINOGEN, V54, P1292, DOI 10.1002/mc.22204; Cooperberg MR, 2011, J CLIN ONCOL, V29, P228, DOI 10.1200/JCO.2010.31.4252; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Giangreco AA, 2013, CANCER PREV RES, V6, P483, DOI 10.1158/1940-6207.CAPR-12-0253; Goto Y, 2014, ONCOTARGET, V5, P7748, DOI 10.18632/oncotarget.2294; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Kachakova D, 2015, DNA CELL BIOL, V34, P189, DOI 10.1089/dna.2014.2663; Kan CWS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-627; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; McCann MJ, 2014, NUTRIENTS, V6, P4839, DOI 10.3390/nu6114839; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sanders I, 2012, INT J UROL, V19, P1017, DOI 10.1111/j.1442-2042.2012.03082.x; Sapre N, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/539680; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI [10.4161/rna.7.5.13141, 10.4161/rna.7.4.13141]; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Selth LA, 2013, BRIT J CANCER, V109, P641, DOI 10.1038/bjc.2013.369; Shen J, 2012, PROSTATE, V72, P1469, DOI 10.1002/pros.22499; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh PK, 2014, ONCOTARGET, V5, P824, DOI 10.18632/oncotarget.1776; Stamey TA, 1999, JAMA-J AM MED ASSOC, V281, P1395, DOI 10.1001/jama.281.15.1395; Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878; Thompson IM, 2013, NEW ENGL J MED, V369, P603, DOI 10.1056/NEJMoa1215932; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Wang SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098597; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; Westermann AM, 2014, ANTICANCER RES, V34, P665	39	56	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124245	10.1371/journal.pone.0124245	http://dx.doi.org/10.1371/journal.pone.0124245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874774	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700061
J	Wong, MCS; Ching, JYL; Chan, VCW; Bruggemann, R; Lam, TYT; Luk, AKC; Wu, JCY; Chan, FKL; Sung, JJY				Wong, Martin C. S.; Ching, Jessica Y. L.; Chan, Victor C. W.; Bruggemann, Renee; Lam, Thomas Y. T.; Luk, Arthur K. C.; Wu, Justin C. Y.; Chan, Francis K. L.; Sung, Joseph J. Y.			Regret on Choice of Colorectal Cancer Screening Modality Was Associated with Poorer Screening Compliance: A 4-Year Prospective Cohort Study	PLOS ONE			English	Article							TESTS; ASIA; DECISIONS; MORTALITY; BARRIERS; BEHAVIOR	Purpose Very few studies examined the issue of regret on choosing colorectal cancer (CRC) screening tests. We evaluated the determinants of regret and tested the hypothesis that regret over screening choices was associated with poorer screening compliance. Methods A bowel cancer screening centre invited all Hong Kong citizens aged 50-70 years who were asymptomatic of CRC to participate in free-of-charge screening programmes. Upon attendance they attended health seminars on CRC and its screening, and were offered an option to choose yearly faecal immunochemical test (FIT) for up to four years vs. one direct colonoscopy. They were not allowed to switch the screening option after decision. A self-administered, four-item validated survey was used to assess whether they regretted over their choice (> 2 = regretful from a scale of 0 [no regret]-5 [extreme regret]). A binary logistic regression model evaluated if initial regret over their choice was associated with poorer programme compliance. Results From 4,341 screening participants who have chosen FIT or colonoscopy, 120 (2.8%) regretted over their decision and 1,029 (23.7%) were non-compliant with the screening programme. Younger subjects and people who felt pressure when making their decision were associated with regret. People who regretted their decision were 2.189 (95% C. I. 1.3613.521, p = 0.001) times more likely to be non-compliant with the programme.	[Wong, Martin C. S.; Ching, Jessica Y. L.; Chan, Victor C. W.; Bruggemann, Renee; Lam, Thomas Y. T.; Luk, Arthur K. C.; Wu, Justin C. Y.; Chan, Francis K. L.; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Shatin, Hong Kong, Peoples R China; [Wong, Martin C. S.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Shatin, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wong, Martin/L-4568-2014; Sung, Joseph J. Y./R-3203-2018; Chan, Francis K. L./F-4851-2010	Wong, Martin/0000-0001-7706-9370; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Francis K. L./0000-0001-7388-2436; Chan, Victor/0000-0001-9178-5031	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	The authors are grateful for the full funding support by the Hong Kong Jockey Club Charities Trust for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, CANC FACTS FIG 2011; Baron RC, 2008, AM J PREV MED, V35, pS34, DOI 10.1016/j.amepre.2008.04.002; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Brehaut JC, 2003, MED DECIS MAKING, V23, P281, DOI 10.1177/0272989X03256005; Clark JA, 2001, J CLIN ONCOL, V19, P72, DOI 10.1200/JCO.2001.19.1.72; Connolly T, 2002, CURR DIR PSYCHOL SCI, V11, P212, DOI 10.1111/1467-8721.00203; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Koo JH, 2012, GASTROINTEST ENDOSC, V76, P126, DOI 10.1016/j.gie.2012.03.168; Koo JH, 2010, CANCER EPIDEMIOL, V34, P604, DOI 10.1016/j.canep.2010.05.013; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Ng SC, 2013, ALIMENT PHARM THER, V38, P835, DOI 10.1111/apt.12446; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; O'Connor AM., 1996, USER MANUAL DECISION; Pieters R, 2005, ORGAN BEHAV HUM DEC, V97, P18, DOI 10.1016/j.obhdp.2005.01.003; Sandberg T, 2008, BRIT J SOC PSYCHOL, V47, P589, DOI 10.1348/014466607X258704; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Sung JJY, 2008, AM J GASTROENTEROL, V103, P974, DOI 10.1111/j.1572-0241.2007.01649.x; Walsh JME, 2004, J GEN INTERN MED, V19, P156, DOI 10.1111/j.1525-1497.2004.30263.x; Wong MCS, 2010, ALIMENT PHARM THER, V32, P74, DOI 10.1111/j.1365-2036.2010.04312.x; Wong MCS, 2014, GUT, V63, P1130, DOI 10.1136/gutjnl-2013-305639; Wong MCS, 2013, PREV MED, V57, P227, DOI 10.1016/j.ypmed.2013.05.017; Wong MCS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070209, 10.1371/journal.pone.0084321]; Wong MCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060366; Wong MCS, 2012, CANCER CAUSE CONTROL, V23, P1541, DOI 10.1007/s10552-012-0031-x; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	28	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0125782	10.1371/journal.pone.0125782	http://dx.doi.org/10.1371/journal.pone.0125782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875160	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700077
J	Chan, DC; Yang, RS; Ho, CH; Tsai, YS; Wang, JJ; Tsai, KT				Chan, Ding-Cheng; Yang, Rong-Sen; Ho, Chung-Han; Tsai, Yau-Sheng; Wang, Jhi-Joung; Tsai, Kang-Ting			The Use of Alendronate Is Associated with a Decreased Incidence of Type 2 Diabetes Mellitus-A Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; UNDERCARBOXYLATED OSTEOCALCIN; OLDER MEN; MARKERS; SUPPLEMENTATION; OSTEOPOROSIS; PREVALENCE; TURNOVER; THERAPY	Purpose Bone remodeling has been linked to glucose metabolism in animal studies, but the results of human trials were inconclusive. Bisphosphonates may play a role in glucose metabolism through their impacts on bone remodeling enzymes. In this study, we aimed to examine the influence of alendronate usage on the incidence of type 2 diabetes mellitus (DM) among osteoporotic patients. Methods A retrospective cohort study was designed to include osteoporotic patients without DM from a population-based cohort containing 1,000,000 subjects. Patients treated with alendronate (exposed group, N=1,011) were compared with those who received no treatment (age and gender matched non-exposed group, N=3,033). Newly diagnosed DM was identified from medical records by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9CM) code. The incidence of DM in both groups was calculated for comparison. Results The non-exposed group had a significantly higher incidence of DM (Odds ratio 1.21, 95% confidence interval 1.03 similar to 1.41) when compared with the exposed group. In subgroup analysis, the DM risk reduction in exposed group was only significant among those younger than 65 years and those without hypertension or dyslipidemia. Patients who were prescribed alendronate more than or equal to 3 times had demonstrated a significant reduction in DM risk. Conclusions Our study showed alendronate might yield a protective effect for incident DM. This effect became insignificant in patients with older age, dyslipidemia or hypertension. The underlying mechanism needs further exploration with prospective data for confirmation of the observed findings.	[Chan, Ding-Cheng] Natl Taiwan Univ Hosp, Dept Gerontol & Geriatr, Taipei, Taiwan; [Chan, Ding-Cheng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chan, Ding-Cheng] Natl Taiwan Univ Hosp, Superintendent Off, JinShan Branch, New Taipei City, Taiwan; [Yang, Rong-Sen] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung] Chi Mei Med Ctr, Inst Med Res, Tainan, Taiwan; [Tsai, Yau-Sheng] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 70101, Taiwan; [Tsai, Kang-Ting] Chi Mei Med Ctr, Dept Geriatr, Tainan, Taiwan; [Tsai, Kang-Ting] Chi Mei Med Ctr, Dept Family Med, Tainan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chi Mei Hospital; National Cheng Kung University; Chi Mei Hospital; Chi Mei Hospital	Tsai, KT (corresponding author), Chi Mei Med Ctr, Dept Geriatr, Tainan, Taiwan.	irised57@yahoo.com.tw	Ting, Tsai Kang/J-1468-2019	CHAN, DING-CHENG/0000-0003-2215-2243; Yang, Rong-Sen/0000-0002-0553-4779; Ho, Chung-Han/0000-0001-5925-8477				Abdelazim IA, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0189-9; Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Chan WP, 2004, ACTA RADIOL, V45, P59, DOI 10.1080/02841850310003221; Chang CH, 2010, DIABETIC MED, V27, P636, DOI 10.1111/j.1464-5491.2010.03007.x; Choi HJ, 2008, MATURITAS, V60, P170, DOI 10.1016/j.maturitas.2008.05.003; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Hirao M, 2008, J BONE MINER METAB, V26, P260, DOI 10.1007/s00774-007-0823-3; Kumar R, 2010, AM J CLIN NUTR, V92, P1528, DOI 10.3945/ajcn.2010.30108; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Maugeri D, 2002, ARCH GERONTOL GERIAT, V34, P117, DOI 10.1016/S0167-4943(01)00202-3; Perifanis V, 2007, ANN HEMATOL, V86, P23, DOI 10.1007/s00277-006-0180-7; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Schafer AL, 2011, J CLIN ENDOCR METAB, V96, pE1982, DOI 10.1210/jc.2011-0587; Vestergaard P, 2011, CALCIFIED TISSUE INT, V89, P265, DOI 10.1007/s00223-011-9515-z; Yang NP, 2006, HEALTH POLICY, V75, P329, DOI 10.1016/j.healthpol.2005.04.009; Yeap BB, 2010, EUR J ENDOCRINOL, V163, P265, DOI 10.1530/EJE-10-0414; Yoshida M, 2008, DIABETES CARE, V31, P2092, DOI 10.2337/dc08-1204	20	20	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123279	10.1371/journal.pone.0123279	http://dx.doi.org/10.1371/journal.pone.0123279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874962	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100159
J	Chuan, FN; Tang, K; Jiang, P; Zhou, B; He, XQ				Chuan, Fengning; Tang, Kang; Jiang, Peng; Zhou, Bo; He, Xiaoqun			Reliability and Validity of the Perfusion, Extent, Depth, Infection and Sensation (PEDIS) Classification System and Score in Patients with Diabetic Foot Ulcer	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATION; VALIDATION; RISK; MANAGEMENT; DISEASE	Aims To validate the perfusion, extent, depth, infection and sensation (PEDIS) classification system and to make the clinical practice easier, we created a score system and compared this system with two previously published common score systems. Methods A retrospective cohort study was conducted on patients with diabetic foot ulcer (DFU) attending our hospital (n=364) from May 2007 to September 2013. Participants' characteristics and all variables composing the PEDIS classification system were assessed. Results During a median follow-up of 25 months (range 6-82), ulcers healed in 217 of the 364 patients (59.6%), remained unhealed in 37 patients (10.2%), and were resolved by amputation in 62 patients (17.0%); 48 patients (13.2%) died. When measured using the PEDIS classification system, the outcome of DFU deteriorated with increasing severity of each subcategory. Additionally, longer ulcer history, worse perfusion of lower limb, a larger extent of the ulcer, a deeper wound, more severe infection, and loss of protective sensation were independent predictors of adverse outcome. More importantly, the new PEDIS score system showed good diagnostic accuracy, especially when compared with the SINBAD and Wagner score systems. Conclusions The PEDIS classification system, which encompasses relevant variables that contribute to the outcome of DFU and has excellent capacity for predicting the ulcer outcome, demonstrated acceptable accuracy. The PEDIS classification system might be useful in clinical practice and research both for the anticipation of health care costs and for comparing patient subgroups.	[Chuan, Fengning; Tang, Kang; Jiang, Peng; Zhou, Bo; He, Xiaoqun] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China	Chongqing Medical University	Zhou, B (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China.	zhoubo915@126.com			National Key Clinical Department Construction Project	National Key Clinical Department Construction Project	This study was funded by the National Key Clinical Department Construction Project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2014, J AM ACAD DERMATOL, V70, DOI 10.1016/j.jaad.2013.06.055; Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855; Chu Y.-J., 2014, INT WOUND J; Donnelly R, 2000, BRIT MED J, V320, P1062, DOI 10.1136/bmj.320.7241.1062; Ince P, 2008, DIABETES CARE, V31, P964, DOI 10.2337/dc07-2367; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Karthikesalingam A, 2010, DIABETIC MED, V27, P544, DOI 10.1111/j.1464-5491.2010.02989.x; Lavery LA, 2007, CLIN INFECT DIS, V44, P562, DOI 10.1086/511036; Lee JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086515; Lipsky BA, 2011, DIABETES CARE, V34, P1695, DOI 10.2337/dc11-0331; Martins-Mendes D, 2014, J DIABETES COMPLICAT, V28, P632, DOI 10.1016/j.jdiacomp.2014.04.011; Monteiro-Soares M, 2012, EUR J ENDOCRINOL, V167, P401, DOI 10.1530/EJE-12-0279; Monteiro-Soares M, 2011, DIABETOLOGIA, V54, P1190, DOI 10.1007/s00125-010-2030-3; Oyibo SO, 2001, DIABETIC MED, V18, P133, DOI 10.1046/j.1464-5491.2001.00422.x; Oyibo SO, 2001, DIABETES CARE, V24, P84, DOI 10.2337/diacare.24.1.84; Reynolds T, 2001, ANN INTERN MED, V135, P637, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00023; Schaper NC, 2004, DIABETES-METAB RES, V20, pS90, DOI 10.1002/dmrr.464; Shahbazian H, 2013, PAK J MED SCI, V29, P730, DOI 10.12669/pjms.293.3473; Smith Robert G, 2003, Ostomy Wound Manage, V49, P54; Treece KA, 2004, DIABETIC MED, V21, P987, DOI 10.1111/j.1464-5491.2004.01275.x; Trignano E, 2015, MICROSURGERY; Wang Ai-hong, 2012, Zhonghua Yi Xue Za Zhi, V92, P224; Younes Nidal A, 2004, J Foot Ankle Surg, V43, P209, DOI 10.1053/j.jfas.2004.05.003	24	47	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124739	10.1371/journal.pone.0124739	http://dx.doi.org/10.1371/journal.pone.0124739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875097	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100270
J	Qu, YJ; Zhuo, L; Li, N; Hu, YQ; Chen, WH; Zhou, Y; Wang, JW; Tao, QM; Hu, J; Nie, XL; Zhan, SY				Qu, Yanji; Zhuo, Lin; Li, Na; Hu, Yiqing; Chen, Weihua; Zhou, Yun; Wang, Jinwei; Tao, Qingmei; Hu, Jing; Nie, Xiaolu; Zhan, Siyan			Prevalence of Post-Stroke Cognitive Impairment in China: A Community-Based, Cross-Sectional Study	PLOS ONE			English	Article							ISCHEMIC-STROKE; RISK-FACTORS; CLINICAL DETERMINANTS; 1ST-EVER STROKE; DEMENTIA; HEMORRHAGE; FREQUENCY; SURVIVORS; COHORT	International hospital-based studies have indicated a high risk of cognitive impairment after stroke, evidence from community-based studies in China is scarce. To determine the prevalence of post-stroke cognitive impairment (PSCI) and its subtypes in stroke survivors residing in selected rural and urban Chinese communities, we conducted a community-based, cross-sectional study in 599 patients accounting for 48% of all stroke survivors registered in the 4 communities, who had suffered confirmed strokes and had undergone cognitive assessments via the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), and Hachinski Ischemia Scale (HIS). Detection of PSCI was based on scores in these neuropsychological scales. Factors potentially impacting on occurrence of PSCI were explored by comparing demographic characteristics, stroke features, and cardiovascular risk factors between patients with and without PSCI. The overall prevalence of PSCI was 80.97% (95% CI: 77.82%-84.11%), while that of non-dementia PSCI (PSCI-ND) and post-stroke vascular dementia (PSD) was 48.91% (95% CI: 44.91%-52.92%) and 32.05% (95% CI: 28.32%-35.79%), respectively. Prior stroke and complications during the acute phase were independent risk factors for PSCI. The risk of recurrent stroke survivors having PSCI was 2.7 times higher than for first-episode survivors, and it was 3 times higher for those with complications during the acute phase than for those without. The higher prevalence of PSCI in this study compared with previous Chinese studies was possibly due to the combined effects of including rural stroke survivors, a longer period from stroke onset, and different assessment methods. There is an urgent need to recognize and prevent PSCI in stroke patients, especially those with recurrent stroke and complications during the acute phase.	[Qu, Yanji] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Qu, Yanji; Zhuo, Lin; Wang, Jinwei; Tao, Qingmei; Hu, Jing; Nie, Xiaolu; Zhan, Siyan] Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Li, Na] Fangshan Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Hu, Yiqing] Bansongyuan Ctr Community Hlth Serv, Shanghai, Peoples R China; [Chen, Weihua] East Nanjing Rd Ctr Community Hlth Serv, Shanghai, Peoples R China; [Zhou, Yun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Peking University; Capital Medical University	Zhan, SY (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Beijing, Peoples R China.	siyan-zhan@bjmu.edu.cn	Qu, Yanji/GSN-4453-2022	Nie, Xiaolu/0000-0001-8026-7845; Zhuo, Lin/0000-0001-9188-702X	Bayer HealthCare, China Ltd; National Twelve-Fifth Scientific Research Project [2011BAI08B01]	Bayer HealthCare, China Ltd; National Twelve-Fifth Scientific Research Project	Financial support for the study was provided by Bayer HealthCare, China Ltd and the National Twelve-Fifth Scientific Research Project (Grant No. 2011BAI08B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba R, 2000, STROKE, V31, P1494, DOI 10.1161/01.STR.31.7.1494; Desmond DW, 2000, NEUROLOGY, V54, P1124, DOI 10.1212/WNL.54.5.1124; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Fan B, 1989, SHANGHAI ARCH PSYCHI, V3, P131; Garcia PY, 2013, J STROKE CEREBROVASC, V22, P80, DOI 10.1016/j.jstrokecerebrovasdis.2011.06.013; Gong-wei J, 2008, NEURAL INJURY FUNCTI, V3, P41; Ihle-Hansen H, 2011, DEMENT GERIATR COGN, V32, P401, DOI 10.1159/000335361; Jacquin A, 2014, J ALZHEIMERS DIS, V40, P1029, DOI 10.3233/JAD-131580; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; Li JC, 2005, CHINESE J CLIN REHAB, V9, P156; Liu HJ, 2009, CHINESE J CEREBROVAS, V6, P514; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Madureira S, 2001, EUR J NEUROL, V8, P621, DOI 10.1046/j.1468-1331.2001.00332.x; Merino JG, 2002, STROKE, V33, P2261; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Mukhopadhyay Amita, 2012, J Assoc Physicians India, V60, P29; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pasi M, 2012, FRONT NEUROL NEUROSC, V30, P65, DOI 10.1159/000333412; Patel M, 2003, CLIN REHABIL, V17, P158, DOI 10.1191/0269215503cr596oa; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Pohjasvaara T, 1998, STROKE, V29, P75, DOI 10.1161/01.STR.29.1.75; Qu YJ, 2013, CHIN J GERIATR HEART, V15, P1294; Royal College of Physicians, NAT CLIN GUID STROK; Sachdev PS, 2006, DEMENT GERIATR COGN, V21, P275, DOI 10.1159/000091434; Srikanth VK, 2003, STROKE, V34, P1136, DOI 10.1161/01.STR.0000069161.35736.39; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Tang X, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-60; TATEMICHI TK, 1990, STROKE, V21, P858, DOI 10.1161/01.STR.21.6.858; Tham W, 2002, J NEUROL SCI, V203, P49, DOI 10.1016/S0022-510X(02)00260-5; [王海波 Wang Haibo], 2014, [中国全科医学, Chinese General Practice], V17, P4374; Wen Hong-Bo, 2008, Zhonghua Nei Ke Za Zhi, V47, P36; Wong GKC, 2012, J NEUROL NEUROSUR PS, V83, P1112, DOI 10.1136/jnnp-2012-302217; Wu ZS, 2001, CIRCULATION, V103, P462; Xu Qun, 2008, Zhonghua Nei Ke Za Zhi, V47, P981; [张立秀 Zhang Lixiu], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P123; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412; Zhang Y, 2012, J HUAZHONG U SCI-MED, V32, P906, DOI 10.1007/s11596-012-1056-9; Zhou DHD, 2005, NEUROEPIDEMIOLOGY, V24, P87, DOI 10.1159/000081055; Zhou JJ, 2011, SHANGHAI J PREVENTIV, V23, P224; 涂秋云, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P3576	41	59	80	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122864	10.1371/journal.pone.0122864	http://dx.doi.org/10.1371/journal.pone.0122864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874998	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100112
J	Yu, DN; Zhang, JY; Li, P; Zheng, RQ; Shao, C				Yu, Danna; Zhang, Jiayong; Li, Peng; Zheng, Rongquan; Shao, Chen			Do Cryptic Species Exist in Hoplobatrachus rugulosus? An Examination Using Four Nuclear Genes, the Cyt b Gene and the Complete MT Genome	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; COMPLETE NUCLEOTIDE-SEQUENCE; DNA-SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; 3-DIMENSIONAL STRUCTURES; FROGS; ANURA; EVOLUTION; AMPHIBIA; WEB	he Chinese tiger frog Hoplobatrachus rugulosus is widely distributed in southern China, Malaysia, Myanmar, Thailand, and Vietnam. It is listed in Appendix II of CITES as the only Class II nationally-protected frog in China. The bred tiger frog known as the Thailand tiger frog, is also identified as H. rugulosus. Our analysis of the Cyt b gene showed high genetic divergence (13.8%) between wild and bred samples of tiger frog. Unexpected genetic divergence of the complete mt genome (14.0%) was also observed between wild and bred samples of tiger frog. Yet, the nuclear genes (NCX1, Rag1, Rhod, Tyr) showed little divergence between them. Despite this and their very similar morphology, the features of the mitochondrial genome including genetic divergence of other genes, different three-dimensional structures of ND5 proteins, and gene rearrangements indicate that H. rugulosus may be a cryptic species complex. Using Bayesian inference, maximum likelihood, and maximum parsimony analyses, Hoplobatrachus was resolved as a sister clade to Euphlyctis, and H. rugulosus (BT) as a sister clade to H. rugulosus (WT). We suggest that we should prevent Thailand tiger frogs (bred type) from escaping into wild environments lest they produce hybrids with Chinese tiger frogs (wild type).	[Yu, Danna; Zhang, Jiayong; Zheng, Rongquan] Zhejiang Normal Univ, Inst Ecol, Jinhua 321004, Zhejiang, Peoples R China; [Zhang, Jiayong; Shao, Chen] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Zhejiang, Peoples R China; [Yu, Danna; Li, Peng] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Zheng, Rongquan] Zhejiang Normal Univ, Inst Special Aquaculture Source, Jinhua 321004, Zhejiang, Peoples R China	Zhejiang Normal University; Zhejiang Normal University; Nanjing Normal University; Zhejiang Normal University	Zhang, JY (corresponding author), Zhejiang Normal Univ, Inst Ecol, Jinhua 321004, Zhejiang, Peoples R China.	zhang3599533@163.com	Li, Peng/GYD-6748-2022; Zheng, Rongquan/AAR-5372-2021		Science Technology Commission of Zhejiang Province of China [2014C32068, 2011C22006, 2012R10026-07, 2013R404019]; National Natural Science Foundation of China [31172116, 31472015]	Science Technology Commission of Zhejiang Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Special thanks go to the Committee of Forest Administrative Bureau of Jinhua for samples. This research was supported by the Science Technology Commission of Zhejiang Province of China (No. 2014C32068, 2011C22006, 2012R10026-07 and 2013R404019) and the National Natural Science Foundation of China (No. 31172116 and 31472015).	Alam MS, 2008, MOL PHYLOGENET EVOL, V48, P515, DOI 10.1016/j.ympev.2008.04.020; Alam MS, 2010, GENES GENET SYST, V85, P219, DOI 10.1266/ggs.85.219; Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avise John C., 1994, pi; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BOORE JL, 1994, NAUTILUS, V108, P61; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brown W.M., 1983, P62; Burland T G, 2000, Methods Mol Biol, V132, P71; Cannatella DC, 1998, SYST BIOL, V47, P311, DOI 10.1080/106351598260932; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Channing A, 1999, T ROY SOC S AFR, V54, P121, DOI 10.1080/00359199909520407; Che J, 2007, MOL PHYLOGENET EVOL, V43, P1, DOI 10.1016/j.ympev.2006.11.032; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Chen GY, 2011, CURR ZOOL, V57, P785, DOI 10.1093/czoolo/57.6.785; Chen LQ, 2005, HERPETOL J, V15, P231; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Dubois Alain, 2005, Alytes (Paris), V23, P1; Dubois Alain, 1992, Bulletin Mensuel de la Societe Linneenne de Lyon, V61, P305; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; Fei L, 2010, COLORED ATLAS CHINES, P1; Freilich X, 2014, MOL PHYLOGENET EVOL, V71, P157, DOI 10.1016/j.ympev.2013.11.015; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; HAY JM, 1995, MOL BIOL EVOL, V12, P928; HEDGES SB, 1994, P NATL ACAD SCI USA, V91, P2621, DOI 10.1073/pnas.91.7.2621; Hoegg S, 2004, MOL BIOL EVOL, V21, P1188, DOI 10.1093/molbev/msh081; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iannelli F, 2007, TRENDS GENET, V23, P419, DOI 10.1016/j.tig.2007.07.001; Jia WZ, 2012, ACTA TROP, V123, P154, DOI 10.1016/j.actatropica.2012.04.006; Kosuch J, 2001, MOL PHYLOGENET EVOL, V21, P398, DOI 10.1006/mpev.2001.1034; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Kurabayashi A, 2010, MOL PHYLOGENET EVOL, V56, P543, DOI 10.1016/j.ympev.2010.01.022; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Macey JR, 2000, SYST BIOL, V49, P257, DOI 10.1093/sysbio/49.2.257; Matsui M, 2005, MOL PHYLOGENET EVOL, V37, P733, DOI 10.1016/j.ympev.2005.04.030; Pansook A, 2012, ZOOL SCI, V29, P54, DOI 10.2108/zsj.29.54; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ren ZM, 2009, GENE, V441, P148, DOI 10.1016/j.gene.2008.09.010; Sambrook J., 2001, MOL CLONING LAB MANU; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Su X, 2007, GENE, V394, P25, DOI 10.1016/j.gene.2007.01.022; Sumida M, 2001, GENES GENET SYST, V76, P311, DOI 10.1266/ggs.76.311; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-691; Yu DN, 2012, MITOCHONDR DNA, V23, P336, DOI 10.3109/19401736.2012.690748; Zhang JY, 2008, GENE, V424, P18, DOI 10.1016/j.gene.2008.07.037; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; Zhou Y, 2009, GENE, V447, P86, DOI 10.1016/j.gene.2009.07.009	63	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124825	10.1371/journal.pone.0124825	http://dx.doi.org/10.1371/journal.pone.0124825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875761	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100275
J	Weems, JC; Slaughter, BD; Unruh, JR; Hall, SM; McLaird, MB; Gilmore, JM; Washburn, MP; Florens, L; Yasukawa, T; Aso, T; Conaway, JW; Conaway, RC				Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Hall, Shawn M.; McLaird, Merry B.; Gilmore, Joshua M.; Washburn, Michael P.; Florens, Laurence; Yasukawa, Takashi; Aso, Teijiro; Conaway, Joan W.; Conaway, Ronald C.			Assembly of the Elongin A Ubiquitin Ligase Is Regulated by Genotoxic and Other Stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR-SIII; COUPLED DNA-REPAIR; PROTEIN IDENTIFICATION TECHNOLOGY; DAMAGE-INDUCED UBIQUITYLATION; SPECTRAL ABUNDANCE FACTORS; ELONGATION-FACTOR ELONGIN; INDUCED GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS	Elongin A performs dual functions in cells as a component of RNA polymerase II (Pol II) transcription elongation factor Elongin and as the substrate recognition subunit of a Cullin-RING E3 ubiquitin ligase that has been shown to target Pol II stalled at sites of DNA damage. Here we investigate the mechanism(s) governing conversion of the Elongin complex from its elongation factor to its ubiquitin ligase form. We report the discovery that assembly of the Elongin A ubiquitin ligase is a tightly regulated process. In unstressed cells, Elongin A is predominately present as part of Pol II elongation factor Elongin. Assembly of Elongin A into the ubiquitin ligase is strongly induced by genotoxic stress; by transcriptional stresses that lead to accumulation of stalled Pol II; and by other stimuli, including endoplasmic reticulum and nutrient stress and retinoic acid signaling, that activate Elongin A-dependent transcription. Taken together, our findings shed new light on mechanisms that control the Elongin A ubiquitin ligase and suggest that it may play a role in Elongin A-dependent transcription.	[Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Hall, Shawn M.; McLaird, Merry B.; Gilmore, Joshua M.; Washburn, Michael P.; Florens, Laurence; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Yasukawa, Takashi; Aso, Teijiro] Kochi Med Sch, Dept Funct Genom, Nankoku, Kochi 7838505, Japan	Stowers Institute for Medical Research; University of Kansas; University of Kansas; Kochi University	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org	Regan, Clinton/E-6250-2012	Unruh, Jay/0000-0003-3077-4990; Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585; Conaway, Joan/0000-0002-2786-0663	National Institutes of Health [GM041628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; KAKENHI [24590279, 24590357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM041628 (to R. C. C. and J. W. C.). This work was also supported by a grant from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation (to the Stowers Institute) and by KAKENHI Grants 24590279 (to T. Y.) and 24590357 (to T. A.).	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Banks CAS, 2014, MOL CELL PROTEOMICS, V13, P1510, DOI 10.1074/mcp.M113.033902; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; CHAFIN DR, 1995, J BIOL CHEM, V270, P19114, DOI 10.1074/jbc.270.32.19114; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fan AX, 2014, NUCLEIC ACIDS RES, V42, P7625, DOI 10.1093/nar/gku467; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Fong YW, 2013, MOL CELL, V52, P291, DOI 10.1016/j.molcel.2013.10.018; FRASER NW, 1978, NATURE, V272, P590, DOI 10.1038/272590a0; GARRETT KP, 1994, P NATL ACAD SCI USA, V91, P5237, DOI 10.1073/pnas.91.12.5237; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Gerber M, 2004, MOL CELL BIOL, V24, P9911, DOI 10.1128/MCB.24.22.9911-9919.2004; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Ju BG, 2006, CELL CYCLE, V5, P2557, DOI 10.4161/cc.5.22.3497; Jung Y, 2006, J BIOL CHEM, V281, P1361, DOI 10.1074/jbc.M509688200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kawauchi J, 2013, J BIOL CHEM, V288, P24302, DOI 10.1074/jbc.M113.496703; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lukas C, 2005, CHROMOSOMA, V114, P146, DOI 10.1007/s00412-005-0011-y; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Yang LY, 2003, INT J ONCOL, V22, P683; Yasukawa T, 2012, CELL REP, V2, P1129, DOI 10.1016/j.celrep.2012.09.031; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249; Yumimoto K, 2013, J BIOL CHEM, V288, P32766, DOI 10.1074/jbc.M113.511303; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	72	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15030	15041		10.1074/jbc.M114.632794	http://dx.doi.org/10.1074/jbc.M114.632794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25878247	hybrid, Green Published			2022-12-26	WOS:000356177300019
J	Ross, CT; Roodgarz, M; Smith, DG				Ross, Cody T.; Roodgarz, Morteza; Smith, David Glenn			Evolutionary Distance of Amino Acid Sequence Orthologs across Macaque Subspecies: Identifying Candidate Genes for SIV Resistance in Chinese Rhesus Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TRIM FAMILY PROTEINS; POSITIVE SELECTION; CDK9 INHIBITORS; HIV-1; EXPRESSION; TAT; GENOME; IDENTIFICATION; POLYMORPHISM	We use the Reciprocal Smallest Distance (RSD) algorithm to identify amino acid sequence orthologs in the Chinese and Indian rhesus macaque draft sequences and estimate the evolutionary distance between such orthologs. We then use GOanna to map gene function annotations and human gene identifiers to the rhesus macaque amino acid sequences. We conclude methodologically by cross-tabulating a list of amino acid orthologs with large divergence scores with a list of genes known to be involved in SIV or HIV pathogenesis. We find that many of the amino acid sequences with large evolutionary divergence scores, as calculated by the RSD algorithm, have been shown to be related to HIV pathogenesis in previous laboratory studies. Four of the strongest candidate genes for SIVmac resistance in Chinese rhesus macaques identified in this study are CDK9, CXCL12, TRIM21, and TRIM32. Additionally, ANKRD30A, CTSZ, GORASP2, GTF2H1, IL13RA1, MUC16, NMDAR1, Notch1, NT5M, PDCD5, RAD50, and TM9SF2 were identified as possible candidates, among others. We failed to find many laboratory experiments contrasting the effects of Indian and Chinese orthologs at these sites on SIVmac pathogenesis, but future comparative studies might hold fertile ground for research into the biological mechanisms underlying innate resistance to SIVmac in Chinese rhesus macaques.	[Ross, Cody T.; Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Ross, Cody T.; Roodgarz, Morteza; Smith, David Glenn] Univ Calif Davis, Mol Anthropol Lab, Davis, CA 95616 USA; [Roodgarz, Morteza; Smith, David Glenn] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Roodgarz, Morteza] Univ Calif Davis, Grad Grp Comparat Pathol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ross, CT (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	ctross@ucdavis.edu		Ross, Cody/0000-0002-0067-4799	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER; NIH HHS [P51 OD011107] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abdel-Mohsen M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-106; Agace WW, 2000, CURR BIOL, V10, P325, DOI 10.1016/S0960-9822(00)00380-8; Altenburg JD, 2007, J VIROL, V81, P8140, DOI 10.1128/JVI.00268-07; Amini S, 2002, ONCOGENE, V21, P5797, DOI 10.1038/sj.onc.1205754; Ammosova T, 2011, THE FASEB JOURNAL, V25, P756; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Atluri VSR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061399; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Biswas N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078814; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chan E, 2012, HUM GENE THER, V23, P1176, DOI 10.1089/hum.2012.083; Chinn LW, 2010, J INFECT DIS, V202, P1836, DOI 10.1086/657322; DeLuca TF, 2012, BIOINFORMATICS, V28, P715, DOI 10.1093/bioinformatics/bts006; Diaz-Griffero F, 2011, VIRUSES-BASEL, V3, P423, DOI 10.3390/v3050423; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; FRIDELL RA, 1995, VIROLOGY, V209, P347, DOI 10.1006/viro.1995.1266; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gupta P, 2014, VIROLOGY, V450, P336, DOI 10.1016/j.virol.2013.12.026; Habte HH, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-99; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kajaste-Rudnitski A, 2010, AMINO ACIDS, V39, P1, DOI 10.1007/s00726-009-0393-x; Kanthaswamy S, 2012, AM J PRIMATOL, V74, P747, DOI 10.1002/ajp.22025; Kar AK, 2008, J VIROL, V82, P11669, DOI 10.1128/JVI.01559-08; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Khan SZ, 2011, J BIOL CHEM, V286, P22943, DOI 10.1074/jbc.M110.201194; Khwaja SS, 2010, J CLIN INVEST, V120, P2537, DOI 10.1172/JCI41277; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Liu SJ, 2011, CURR HIV RES, V9, P112, DOI 10.2174/157016211795569113; Louboutin JP, 2012, SCI WORLD J, P1, DOI 10.1100/2012/482575; Mameli G, 2007, J GEN VIROL, V88, P631, DOI 10.1099/vir.0.82487-0; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mazzolini J, 2010, BLOOD, V115, P4226, DOI 10.1182/blood-2009-12-259473; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; Meisner F, 2010, THESIS; Meyerson NR, 2014, VIROLOGY, V454, P291, DOI 10.1016/j.virol.2014.02.029; Motomura K, 2004, INT IMMUNOPHARMACOL, V4, P1829, DOI 10.1016/j.intimp.2004.07.031; Narayanan A, 2012, VIROLOGY, V432, P219, DOI 10.1016/j.virol.2012.06.007; Naydenov NG, 2012, CELL CYCLE, V11, P4613, DOI 10.4161/cc.22885; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Petersen DC, 2005, JAIDS-J ACQ IMM DEF, V40, P521, DOI 10.1097/01.qai.0000186360.42834.28; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Pudney J, 2011, J REPROD IMMUNOL, V88, P219, DOI 10.1016/j.jri.2011.01.006; R Core Team, 2021, R LANGUAGE ENV STAT; Ryu YS, 2011, J BIOL CHEM, V286, P25729, DOI 10.1074/jbc.M111.241893; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sancineto L, 2013, CHEMMEDCHEM, V8, P1941, DOI 10.1002/cmdc.201300287; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Shalekoff S, 2013, CYTOKINE, V61, P792, DOI 10.1016/j.cyto.2013.01.003; Sharma M, 2010, AIDS, V24, P2161, DOI 10.1097/QAD.0b013e32833dbc31; Shoham N, 2003, VIRUS RES, V98, P57, DOI 10.1016/j.virusres.2003.08.016; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; SMITH JM, 1993, J THEOR BIOL, V164, P437, DOI 10.1006/jtbi.1993.1165; Smith JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-11; Solis M, 2006, VIROLOGY, V352, P86, DOI 10.1016/j.virol.2006.04.010; Stan Development Team, 2014, STAN A C LIBRARY FOR; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; SZATHMARY E, 1993, J THEOR BIOL, V164, P447, DOI 10.1006/jtbi.1993.1166; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Trask JS, 2011, J MED PRIMATOL, V40, P224, DOI 10.1111/j.1600-0684.2011.00486.x; Trichel AM, 2002, J MED PRIMATOL, V31, P171, DOI 10.1034/j.1600-0684.2002.02003.x; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Van Duyne R, 2013, J MOL BIOL, V425, P812, DOI 10.1016/j.jmb.2012.12.005; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wojcechowskyj JA, 2013, CELL HOST MICROBE, V13, P613, DOI 10.1016/j.chom.2013.04.011; Xin KQ, 1999, AIDS RES HUM RETROV, V15, P1461, DOI 10.1089/088922299309973; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yanez RJ, 2002, NUCLEIC ACIDS RES, V30, P4892, DOI 10.1093/nar/gkf614; Yilmaz S, 2010, GENOMICS, V96, P57, DOI 10.1016/j.ygeno.2010.03.011; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045200; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	95	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123624	10.1371/journal.pone.0123624	http://dx.doi.org/10.1371/journal.pone.0123624			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884674	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000079
J	Wang, JN; Ma, R; Sharma, A; He, MF; Xue, J; Wu, JZ; Dun, BY; Li, G; Wang, XX; Ji, MH; She, JX; Tang, JH				Wang, Jiangnan; Ma, Rong; Sharma, Ashok; He, Mingfang; Xue, Jing; Wu, Jianzhong; Dun, Boying; Li, Gang; Wang, Xiaoxiao; Ji, Minghua; She, Jin-Xiong; Tang, Jinhai			Inflammatory Serum Proteins Are Severely Altered in Metastatic Gastric Adenocarcinoma Patients from the Chinese Population	PLOS ONE			English	Article							C-REACTIVE-PROTEIN; SQUAMOUS-CELL CARCINOMA; AMYLOID-A; ALPHA-1-ACID GLYCOPROTEIN; PROSTATE-CANCER; TUMOR-MARKER; OSTEOPONTIN; EXPRESSION; BREAST; GROWTH	Background Inflammation is one of the major hallmarks of cancer. This study was designed to profile a panel of inflammatory mediators in gastric adenocarcinoma (GA) and to identify their potential differences separately in metastatic and non-metastatic patient subgroups. Methods Serum samples from 216 GA patients and 333 healthy controls from China were analyzed for six proteins using the Luminex multiplex assay. Results The serum levels for all the six proteins were significantly elevated in metastatic GA compared to non-metastatic GA. Two acute phase proteins (SAA and CRP) and a CXC chemokine (GRO) were significantly elevated in metastatic GA (p < 0.01) but smaller changes were observed in non-metastatic GA compared to healthy controls. OPN is moderately increased in non-metastatic GA (2.05-fold) and more severely elevated in metastatic GA (3.34-fold). Surprisingly, soluble VCAM1 and AGP were significantly lower in both non-metastatic and metastatic GA patients compared to controls. Several individual proteins were shown to possess moderate diagnostic value for non-metastatic GA (AUC = 0.786, 0.833, 0.823 for OPN, sVCAM1 and AGP, respectively) and metastatic GA (AUC = 0.931, 0.720, 0.834 and 0.737 for OPN, sVCAM1, SAA and CRP, respectively). However, protein combinations further improve the diagnostic potential for both non-metastatic GA (best AUC = 0.946) and metastatic GA ( best AUC = 0.963). The protein combination with best AUC value for both comparisons is OPN+sVCAM1+AGP+SAA. Conclusions These results suggest that several serum proteins are directly related to the severity of gastric cancer. Overall, stronger associations are observed with metastatic than non-metastatic GA as the protein changes are greater with the metastatic status. A combination of these serum proteins may serve as non-invasive markers to assess the severity status and stage of gastric cancer.	[Wang, Jiangnan; He, Mingfang; Xue, Jing; She, Jin-Xiong] Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Xue, Jing] Zhengjiang Jintai Biosci, Zhenjiang, Jiangsu, Peoples R China; [Ma, Rong; Wu, Jianzhong; Li, Gang; Ji, Minghua; Tang, Jinhai] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Sharma, Ashok; Dun, Boying; Li, Gang; Wang, Xiaoxiao; Ji, Minghua; She, Jin-Xiong] Georgia Regents Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA	Nanjing Tech University; Nanjing Medical University; University System of Georgia; Augusta University	She, JX (corresponding author), Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China.	jshe@hotmail.com; jschtjh@126.com	ma, rong/GVU-3096-2022; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Sharma, Ashok/0000-0001-9597-4374; Wu, Jian/0000-0002-3394-1507	Nanjing Tech University; Jiangsu Cancer Hospital	Nanjing Tech University; Jiangsu Cancer Hospital	This study was supported by the Nanjing Tech University and Jiangsu Cancer Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANISOWICZ A, 1987, P NATL ACAD SCI USA, V84, P7188, DOI 10.1073/pnas.84.20.7188; Bratt T, 2000, BBA-PROTEIN STRUCT M, V1482, P318, DOI 10.1016/S0167-4838(00)00154-0; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Chan DC, 2007, ANN SURG ONCOL, V14, P84, DOI 10.1245/s10434-006-9091-z; Cho WCS, 2010, BRIT J CANCER, V102, P1731, DOI 10.1038/sj.bjc.6605700; Cidon Esther Una, 2011, J Gastrointest Cancer, V42, P127, DOI 10.1007/s12029-010-9161-0; Cocco E, 2010, CANCER-AM CANCER SOC, V116, P843, DOI 10.1002/cncr.24838; Ding YB, 2003, WORLD J GASTROENTERO, V9, P1409, DOI 10.3748/wjg.v9.i7.1409; Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; GEWURZ H, 1982, ADV INTERNAL MED, V27, P345; Glojnaric I, 2001, CLIN CHEM LAB MED, V39, P129, DOI 10.1515/CCLM.2001.022; Gong MC, 2008, CANCER LETT, V272, P148, DOI 10.1016/j.canlet.2008.07.004; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hashimoto S, 2004, CANCER-AM CANCER SOC, V101, P2825, DOI 10.1002/cncr.20713; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Ishigami S, 2006, HEPATO-GASTROENTEROL, V53, P338; Jabs WJ, 2005, KIDNEY INT, V68, P2103, DOI 10.1111/j.1523-1755.2005.00666.x; Jing JX, 2013, INT J BIOL MARKER, V28, P192, DOI [10.5301/jbm.5000023, 10.5301/JBM.5000023]; Jung K, 2001, CLIN CHEM, V47, P2061; KANETI J, 1984, UROL RES, V12, P239; Kim DH, 2011, J SURG ONCOL, V104, P585, DOI 10.1002/jso.21919; Koch A.E., 1995, ANGIOGENESIS MEDIATE; Lai IR, 2002, HEPATO-GASTROENTEROL, V49, P1157; Lehrer S, 2005, BJU INT, V95, P961, DOI 10.1111/j.1464-410X.2005.05447.x; Li AH, 2004, CLIN EXP METASTAS, V21, P571; Li J, 2005, INT J CANCER, V117, P14, DOI 10.1002/ijc.21074; Lin YS, 2011, WORLD J GASTROENTERO, V17, P4421, DOI 10.3748/wjg.v17.i39.4421; Loukinova E, 2000, ONCOGENE, V19, P3477, DOI 10.1038/sj.onc.1203687; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Luan J, 1997, J LEUKOCYTE BIOL, V62, P588, DOI 10.1002/jlb.62.5.588; MACKIEWICZ A, 1995, GLYCOCONJUGATE J, V12, P241, DOI 10.1007/BF00731326; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Marrelli D, 2001, AM J SURG, V181, P16, DOI 10.1016/S0002-9610(00)00549-3; Mattar Rejane, 2002, Rev. Hosp. Clin., V57, P89, DOI 10.1590/S0041-87812002000300001; Nakata B, 1998, CANCER, V83, P2488, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2488::AID-CNCR12>3.0.CO;2-1; Nozoe T, 2003, CANCER LETT, V192, P89, DOI 10.1016/S0304-3835(02)00630-4; O'Hanlon DM, 2002, EUR J CANCER, V38, P2252, DOI 10.1016/S0959-8049(02)00218-6; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Ramankulov A, 2008, CANCER LETT, V269, P85, DOI 10.1016/j.canlet.2008.04.022; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schultz DR, 1990, SEMINARS ARTHRITIS R; Terry MB, 2002, SEM RAD ONC; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; WEINSTEIN PS, 1984, SCAND J IMMUNOL, V19, P193; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yuki M, 2011, VET RES COMMUN, V35, P1, DOI 10.1007/s11259-010-9445-7	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123985	10.1371/journal.pone.0123985	http://dx.doi.org/10.1371/journal.pone.0123985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884401	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000097
J	Dellinger, AL; Cunin, P; Lee, D; Kung, AL; Brooks, DB; Zhou, ZG; Nigrovic, PA; Kepley, CL				Dellinger, Anthony L.; Cunin, Pierre; Lee, David; Kung, Andrew L.; Brooks, D. Bradford; Zhou, Zhiguo; Nigrovic, Peter A.; Kepley, Christopher L.			Inhibition of Inflammatory Arthritis Using Fullerene Nanomaterials	PLOS ONE			English	Article							NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; SYNOVIAL MAST-CELLS; REACTIVE OXYGEN; RHEUMATOID-ARTHRITIS; IN-VITRO; PATHOGENESIS; LOCALIZATION; ANTIOXIDANTS; FIBROBLASTS	Inflammatory arthritis (e.g. rheumatoid arthritis; RA) is a complex disease driven by the interplay of multiple cellular lineages. Fullerene derivatives have previously been shown to have anti-inflammatory capabilities mediated, in part, by their ability to prevent inflammatory mediator release by mast cells (MC). Recognizing that MC can serve as a cellular link between autoantibodies, soluble mediators, and other effector populations in inflammatory arthritis, it was hypothesized that fullerene derivatives might be used to target this inflammatory disease. A panel of fullerene derivatives was tested for their ability to affect the function of human skin-derived MC as well as other lineages implicated in arthritis, synovial fibroblasts and osteoclasts. It is shown that certain fullerene derivatives blocked Fc gamma R-and TNF-alpha-induced mediator release from MC; TNF-alpha-induced mediator release from RA synovial fibroblasts; and maturation of human osteoclasts. MC inhibition by fullerene derivatives was mediated through the reduction of mitochondrial membrane potential and Fc gamma R-mediated increases in cellular reactive oxygen species and NF-kappa B activation. Based on these in vitro data, two fullerene derivatives (ALM and TGA) were selected for in vivo studies using K/BxN serum transfer arthritis in C57BL/6 mice and collagen-induced arthritis (CIA) in DBA/1 mice. Dye-conjugated fullerenes confirmed localization to affected joints in arthritic animals but not in healthy controls. In the K/BxN moldel, fullerenes attenuated arthritis, an effect accompanied by reduced histologic inflammation, cartilage/bone erosion, and serum levels of TNF-alpha. Fullerenes remained capable of attenuating K/BxN arthritis in mast cell-deficient mice Cre-Master mice, suggesting that lineages beyond the MC represent relevant targets in this system. These studies suggest that fullerene derivatives may hold promise both as an assessment tool and as anti-inflammatory therapy of arthritis.	[Dellinger, Anthony L.; Kepley, Christopher L.] Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA; [Cunin, Pierre; Nigrovic, Peter A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Cunin, Pierre; Nigrovic, Peter A.] Harvard Univ, Sch Med, Div Immunol, Boston Childrens Hosp, Boston, MA USA; [Lee, David] Novartis Inst Biomed Res, Basel, Switzerland; [Kung, Andrew L.] Dana Farber Inst, Boston, MA USA; [Brooks, D. Bradford; Zhou, Zhiguo] Luna Innovat Inc, Danville, VA USA	University of North Carolina; University of North Carolina Greensboro; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Novartis; Harvard University; Dana-Farber Cancer Institute	Kepley, CL (corresponding author), Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA.	clkepley@uncg.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; 	Novartis Institutes for Biomedical Research; Luna Innovations Incorporated	Novartis Institutes for Biomedical Research; Luna Innovations Incorporated	Novartis Institutes for Biomedical Research and Luna Innovations Incorporated provided support in the form of salaries for authors DL, DBB and ZZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adiseshaiah P, 2013, INVEST RADIOL, V48, P745, DOI 10.1097/RLI.0b013e318294de5d; Arab HH, 2013, TOXICOL APPL PHARM, V27, P00040; Avnet S, 2007, INT J ONCOL, V30, P469; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Bamborough P, 2010, DRUG NEWS PERSPECT, V23, P483, DOI 10.1358/dnp.2010.23.8.1447844; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Castor W., 2007, ARTHRITIS RHEUMATISM, V3, P140; Chirico F, 2007, EXP DERMATOL, V16, P429, DOI 10.1111/j.1600-0625.2007.00545.x; Choi Y, 2009, NAT REV RHEUMATOL, V5, P543, DOI 10.1038/nrrheum.2009.175; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; Dellinger AL, 2012, J NANOMED NANOTECHNO, V3, P8; Dellinger A, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-7; Dellinger A, 2010, NANOMED-NANOTECHNOL, V6, P575, DOI 10.1016/j.nano.2010.01.008; Dellinger A, 2009, EXP DERMATOL, V18, P1079, DOI 10.1111/j.1600-0625.2009.00904.x; Drafi Frantisek, 2012, Interdiscip Toxicol, V5, P84, DOI 10.2478/v10102-012-0015-4; Ehrich M, 2011, TOXICOL IN VITRO, V25, P301, DOI 10.1016/j.tiv.2010.09.010; Eklund KK, 2007, IMMUNOL REV, V217, P38, DOI 10.1111/j.1600-065X.2007.00504.x; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Foley S, 2002, BIOCHEM BIOPH RES CO, V294, P116, DOI 10.1016/S0006-291X(02)00445-X; Fumelli C, 2000, J INVEST DERMATOL, V115, P835, DOI 10.1046/j.1523-1747.2000.00140.x; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; GRUBER B, 1988, CLIN EXP IMMUNOL, V71, P289; GRUBER B, 1986, ARTHRITIS RHEUM, V29, P944, DOI 10.1002/art.1780290802; Handel ML, 2000, CLIN EXP PHARMACOL P, V27, P139, DOI 10.1046/j.1440-1681.2000.03216.x; Haqqi TM, 1999, P NATL ACAD SCI USA, V96, P4524, DOI 10.1073/pnas.96.8.4524; Holmdahl R, 2002, AGEING RES REV, V1, P135, DOI 10.1016/S0047-6374(01)00371-2; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; IRANI AMA, 1989, J HISTOCHEM CYTOCHEM, V37, P1509, DOI 10.1177/37.10.2674273; Jaswal S, 2003, CLIN CHIM ACTA, V338, P123, DOI 10.1016/j.cccn.2003.08.011; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kepley CL, 2005, INT ARCH ALLERGY IMM, V138, P29, DOI 10.1159/000087355; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Majumdar S, 2001, J IMMUNOL, V167, P2911, DOI 10.4049/jimmunol.167.5.2911; Malbec O, 2007, IMMUNOL REV, V217, P206, DOI 10.1111/j.1600-065X.2007.00510.x; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nam NH, 2006, MINI-REV MED CHEM, V6, P945, DOI 10.2174/138955706777934937; Niedermeier M, 2010, BEST PRACT RES CL RH, V24, P527, DOI 10.1016/j.berh.2010.02.002; Nigrovic PA, 2005, ARTHRITIS RES THER, V7, P1, DOI 10.1186/ar1446; Nigrovic PA, 2007, IMMUNOL REV, V217, P19, DOI 10.1111/j.1600-065X.2007.00506.x; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Nigrovic PA, 2010, ARTHRITIS RHEUM-US, V62, P3322, DOI 10.1002/art.27659; Norton SK, 2012, J ALLERGY CLIN IMMUN, V130, P761, DOI 10.1016/j.jaci.2012.04.023; Norton SK, 2010, CTS-CLIN TRANSL SCI, V3, P158, DOI 10.1111/j.1752-8062.2010.00212.x; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Park MK, 2012, IMMUNOL LETT, V148, P59, DOI 10.1016/j.imlet.2012.05.008; Phillips DC, 2010, ANTIOXID REDOX SIGN, V12, P743, DOI 10.1089/ars.2009.2607; Pitman N, 2011, ANN RHEUM DIS, V70, P1170, DOI 10.1136/ard.2010.134528; Porter AE, 2006, ACTA BIOMATER, V2, P409, DOI 10.1016/j.actbio.2006.02.006; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Roman-Blas JA, 2008, INT REV IMMUNOL, V27, P351, DOI 10.1080/08830180802295740; Ryan JJ, 2007, J IMMUNOL, V179, P665, DOI 10.4049/jimmunol.179.1.665; Schubert N, 2015, ARTHRITIS RHEUMATOL, V67, P903, DOI 10.1002/art.38996; Schwartz LB, 1993, BIOL MAST CELLS BASO, P135; Skoldstam L, 2003, ANN RHEUM DIS, V62, P208, DOI 10.1136/ard.62.3.208; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Solomon S, 2005, ARTHRITIS RES THER, V7, P129, DOI 10.1186/ar1761; STEINITZ K, 1947, Harefuah, V32, P174; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Swindle EJ, 2004, J BIOL CHEM, V279, P48751, DOI 10.1074/jbc.M409738200; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; Winyard PG, 2011, BIOCHEM SOC T, V39, P1226, DOI 10.1042/BST0391226; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Zhang W, 2012, INT IMMUNOPHARMACOL, V14, P27, DOI 10.1016/j.intimp.2012.06.001; Zhao W, 2006, J IMMUNOL, V177, P694, DOI 10.4049/jimmunol.177.1.694; Zhou ZG, 2010, BIOCONJUGATE CHEM, V21, P1656, DOI 10.1021/bc1001664; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	72	33	36	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0126290	10.1371/journal.pone.0126290	http://dx.doi.org/10.1371/journal.pone.0126290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879437	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500120
J	Xu, L; Gu, SY; Feng, QJ; Liang, CH; Xin, SX				Xu, Li; Gu, Shiyong; Feng, Qianjin; Liang, Changhong; Xin, Sherman Xuegang			Quantitative Study of Liver Magnetic Resonance Spectroscopy Quality at 3T Using Body and Phased Array Coils with Physical Analysis and Clinical Evaluation	PLOS ONE			English	Article							PROTON MR SPECTROSCOPY; RADIOFREQUENCY COIL; HEPATIC STEATOSIS; BIRDCAGE COIL; B-1 FIELD; 3.0 TESLA; H-1 MRS; SAR; QUANTIFICATION; OVERWEIGHT	This study aims to investigate the quality difference of short echo time (TE) breathhold 1H magnetic resonance spectroscopy (MRS) of the liver at 3.0T using the body and phased array coils, respectively. In total, 20 pairs of single-voxel proton spectra of the liver were acquired at 3.0T using the phased array and body coils as receivers. Consecutive stacks of breathhold spectra were acquired using the point resolved spectroscopy (PRESS) technique at a short TE of 30 ms and a repetition time (TR) of 1500 ms. The first spectroscopy sequence was "copied" for the second acquisition to ensure identical voxel positioning. The MRS prescan adjustments of shimming and water suppression, signal-to noise ratio (SNR), and major liver quantitative information were compared between paired spectra. Theoretical calculation of the SNR and homogeneity of the region of interest (ROI, 2 cmx2 cmx2 cm) using different coils loaded with 3D liver electromagnetic model of real human body was implemented in the theoretical analysis. The theoretical analysis showed that, inside the ROI, the SNR of the phase array coil was 2.8387 times larger than that of body coil and the homogeneity of the phase array coil and body coil was 80.10% and 93.86%, respectively. The experimental results showed excellent correlations between the paired data (all r > 0.86). Compared with the body coil group, the phased array group had slightly worse shimming effect and better SNR (all P values <.01). The discrepancy of the line width because of the different coils was approximately 0.8 Hz (0.00625 ppm). No significant differences of the major liver quantitative information of Cho/Lip2 height, Cho/Lip2 area, and lipid content were observed (all P values > 0.05). The theoretical analysis and clinical experiment showed that the phased array coil was superior to the body coil with respect to 3.0T breathhold hepatic proton MRS.	[Xu, Li] Guangzhou Univ Tradit Chinese Med, Dept Radiol, Guangdong Prov Tradit Chinese Med Hosp, Guangzhou, Guangdong, Peoples R China; [Xu, Li] Guangzhou Univ Tradit Chinese Med, Postdoctoral Mobile Res Stn, Guangzhou, Guangdong, Peoples R China; [Gu, Shiyong; Feng, Qianjin; Xin, Sherman Xuegang] So Med Univ, Biomed Engn Sch, Guangzhou, Guangdong, Peoples R China; [Liang, Changhong] Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Xin, Sherman Xuegang] NYU, Sch Med, Bernard & Irene Schwartz Ctr Biomed Imaging, New York, NY USA	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; New York University	Feng, QJ (corresponding author), So Med Univ, Biomed Engn Sch, Guangzhou, Guangdong, Peoples R China.	1271992826@qq.com; shermansheen@gmail.com	feng, qianjin/GNM-7856-2022; Liang, Chang Hong/L-1885-2016; Feng, Qianjin/Y-5438-2019	feng, qianjin/0000-0002-3830-5120; 	National Natural Science Foundation of China [61172034]; Science Foundation of Guangdong Province for Dr. Startup Project [S2012040006618]; Science and Technology Program of Guangzhou, China [2014J4100160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Guangdong Province for Dr. Startup Project; Science and Technology Program of Guangzhou, China	This research was partially supported by the National Natural Science Foundation of China (No. 61172034), the Science Foundation of Guangdong Province for Dr. Startup Project (No. S2012040006618), and the Science and Technology Program of Guangzhou, China (No.2014J4100160).	Carlsson A, 2011, MAGN RESON MATER PHY, V24, P97, DOI 10.1007/s10334-010-0239-2; Chabanova E, 2013, ABDOM IMAGING, V38, P315, DOI 10.1007/s00261-012-9930-2; Collins CM, 2011, MAGN RESON MED, V65, P1470, DOI 10.1002/mrm.22845; Collins CM, 2001, MAGN RESON MED, V45, P684, DOI 10.1002/mrm.1091; Fischbach F, 2008, EUR RADIOL, V18, P2549, DOI 10.1007/s00330-008-1040-8; Fischbach F, 2008, LIVER INT, V28, P297, DOI 10.1111/j.1478-3231.2007.01647.x; Gambarota G, 2011, BIOL MED, V24, P339, DOI [10.1007/s10334-011-0278-3, DOI 10.1007/S10334-011-0278-3]; Ibrahim TS, 2001, PHYS MED BIOL, V46, P609, DOI 10.1088/0031-9155/46/2/324; Katz-Brull R, 2003, MAGNET RESON MED, V50, P461, DOI 10.1002/mrm.10560; Keong Li B, 2005, MAGN RESON MED, V53, P1251; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Qayyum A, 2009, RADIOGRAPHICS, V29, P1653, DOI 10.1148/rg.296095520; Rial B, 2011, MAGN RESON MED, V66, P619, DOI 10.1002/mrm.23011; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; Sharma P, 2009, J MAGN RESON IMAGING, V29, P629, DOI 10.1002/jmri.21682; Solga SF, 2008, LIVER INT, V28, P675, DOI 10.1111/j.1478-3231.2008.01705.x; Su TH, 2012, CLIN RADIOL, V67, P633, DOI 10.1016/j.crad.2011.05.018; Tang L, 2011, CONCEPT MAGN RESON B, V39B, P11, DOI 10.1002/cmr.b.20185; ter Voert EGW, 2011, WORLD J GASTROENTERO, V17, P5133, DOI 10.3748/wjg.v17.i47.5133; van Werven JR, 2009, J MAGN RESON IMAGING, V30, P444, DOI 10.1002/jmri.21837; Wang CS, 2006, J MAGN RESON IMAGING, V24, P439, DOI 10.1002/jmri.20635; Welker KM, 2001, RADIOLOGY, V221, P11, DOI 10.1148/radiol.2211001537; Xin SX, 2013, IEEE T MICROW THEORY, V61, P2146, DOI 10.1109/TMTT.2013.2247053; Xin XG, 2012, NMR BIOMED, V25, P909, DOI 10.1002/nbm.1811; Xu L, 2013, WORLD J GASTROENTERO, V19, P1472, DOI 10.3748/wjg.v19.i9.1472; Xu L, 2012, SCI WORLD J, DOI 10.1100/2012/804698; Xu L, 2010, ACAD RADIOL, V17, P1462, DOI 10.1016/j.acra.2010.07.005; Zhu YD, 2012, MAGN RESON MED, V67, P1367, DOI 10.1002/mrm.23126	29	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122999	10.1371/journal.pone.0122999	http://dx.doi.org/10.1371/journal.pone.0122999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881016	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500034
J	Anund, A; Lahti, E; Fors, C; Genell, A				Anund, Anna; Lahti, Eva; Fors, Carina; Genell, Anders			The Effect of Low-Frequency Road Noise on Driver Sleepiness and Performance	PLOS ONE			English	Article							DRIVING SIMULATOR; RISK; FATIGUE	It is a well-known fact today that driver sleepiness is a contributory factor in crashes. Factors considered as sleepiness contributor are mostly related to time of the day, hours being awake and hours slept. Factors contributing to active and passive fatigue are mostly focusing on the level of cognitive load. Less is known what role external factors, e.g. type of road, sound/noise, vibrations etc., have on the ability to stay awake both under conditions of sleepiness and under active or passive fatigue. The aim of this moving base driving simulator study with 19 drivers participating in a random order day and night time, was to evaluate the effect of low-frequency road noise on driver sleepiness and performance, including both long-term and short-term effects. The results support to some extent the hypothesis that road-induced interior vehicle sound affects driving performance and driver sleepiness. Increased low-frequency noise helps to reduce speed during both day-and night time driving, but also contributes to increase the number of lane crossings during night time.	[Anund, Anna; Fors, Carina; Genell, Anders] Swedish Natl Rd & Transport Res Inst, Linkoping, Sweden; [Anund, Anna] Linkoping Univ, Rehabil Med, Linkoping, Sweden; [Lahti, Eva] Volvo Car Cooperat, Gothenburg, Sweden	VTI; Linkoping University; Volvo	Anund, A (corresponding author), Swedish Natl Rd & Transport Res Inst, Linkoping, Sweden.	anna.anund@vti.se		Anund, Anna/0000-0002-4790-7094	competence centre ViP (Virtual Prototyping and Assessment by Simulation); VINNOVA (the Swedish Governmental Agency for Innovation Systems) [2007-03083]; ViP; Volvo Car Cooperation	competence centre ViP (Virtual Prototyping and Assessment by Simulation); VINNOVA (the Swedish Governmental Agency for Innovation Systems)(Vinnova); ViP; Volvo Car Cooperation	This work was supported by the competence centre ViP (Virtual Prototyping and Assessment by Simulation, www.vipsimulation.se), co-financed by VINNOVA (the Swedish Governmental Agency for Innovation Systems; grant number 2007-03083) and the ViP partners. Volvo Car Cooperation provided support in the form of salaries for author Eva Lahti, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2005, J SLEEP RES, V14, P17, DOI 10.1111/j.1365-2869.2004.00437.x; Akerstedt T, 2001, J SLEEP RES, V10, P105, DOI 10.1046/j.1365-2869.2001.00248.x; [Anonymous], 2004, CONSUMER REPORTS, V69, P23; Anund A, 2009, IND HEALTH, V47, P393, DOI 10.2486/indhealth.47.393; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Filtness AJ, 2012, BIOL PSYCHOL, V89, P580, DOI 10.1016/j.biopsycho.2012.01.002; Ftouni S, 2013, J SLEEP RES, V22, P58, DOI 10.1111/j.1365-2869.2012.01038.x; Hanowski RJ, 2007, ACCIDENT ANAL PREV, V39, P169, DOI 10.1016/j.aap.2006.06.016; Hanowski RJ, 2003, ACCIDENT ANAL PREV, V35, P153, DOI 10.1016/S0001-4575(01)00098-7; Hartleip L.G., 2005, SAE TECHNICAL PAPERS; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; Horne JA, 1995, J SLEEP RES, V4, P23, DOI 10.1111/j.1365-2869.1995.tb00222.x; Ihs A, 2010, 6692010 VTI; James B, 2008, SOMNOLOGIE, V12, P227; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; Kjellberg A, 1997, ARBETE HALSA, V1; Klauer S.G., 2006, IMPACT DRIVER INATTE, DOI [10.1037/e729262011-001, DOI 10.1037/E729262011-001]; Landstrom U., 1987, Journal of Low Frequency Noise & Vibration, V6, P29; Lathi E, DRIV SIM C 2014 PAR, P21; Lofstedt P, 1988, ARBETSMILJOINSTITUTE, P15; Lowden A, 2009, ACCIDENT ANAL PREV, V41, P1001, DOI 10.1016/j.aap.2009.05.014; May JF, 2009, TRANSPORT RES F-TRAF, V12, P218, DOI 10.1016/j.trf.2008.11.005; Moren B, 1989, INVERKAN INFRALJUD B, P340; Philip P, 2009, SLEEP, V32, pA248; Soderberg L, 1988, ARBETSMILJOINSTITUTE, P25; Stutts JC, 2003, ACCIDENT ANAL PREV, V35, P321, DOI 10.1016/S0001-4575(02)00007-6	27	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123835	10.1371/journal.pone.0123835	http://dx.doi.org/10.1371/journal.pone.0123835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874883	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800118
J	Raymond, AA; Benhamouche, S; Neaud, V; Di Martino, J; Javary, J; Rosenbaum, J				Raymond, Anne-Aurelie; Benhamouche, Samira; Neaud, Veronique; Di Martino, Julie; Javary, Joaquim; Rosenbaum, Jean			Reptin Regulates DNA Double Strand Breaks Repair in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; CELL-CYCLE; DAMAGE; SENESCENCE; STABILITY; APOPTOSIS; PROTEINS; CANCER; HSP90; PHOSPHORYLATION	Reptin/RUVBL2 is overexpressed in most hepatocellular carcinomas and is required for the growth and viability of HCC cells. Reptin is involved in several chromatin remodeling complexes, some of which are involved in the detection and repair of DNA damage, but data on Reptin involvement in the repair of DNA damage are scarce and contradictory. Our objective was to study the effects of Reptin silencing on the repair of DNA double-strand breaks (DSB) in HCC cells. Treatment of HuH7 cells with etoposide (25 mu M, 30 min) or. irradiation (4 Gy) increased the phosphorylation of H2AX by 1.94 +/- 0.13 and 2.0 +/- 0.02 fold, respectively. These values were significantly reduced by 35 and 65% after Reptin silencing with inducible shRNA. Irradiation increased the number of BRCA1 (3-fold) and 53BP1 foci (7.5 fold). Depletion of Reptin reduced these values by 62 and 48%, respectively. These defects in activation and/or recruitment of repair proteins were not due to a decreased number of DSBs as measured by the COMET assay. All these results were confirmed in the Hep3B cell line. Protein expression of ATM and DNA-PKcs, the major H2AX kinases, was significantly reduced by 52 and 61% after Reptin depletion whereas their mRNA level remained unchanged. Phosphorylation of Chk2, another ATM target, was not significantly altered. Using co-immunoprecipitation, we showed an interaction between Reptin and DNA-PKcs. The half-life of newly-synthesized DNA-PKcs was reduced when Reptin was silenced. Finally, depletion of Reptin was synergistic with etoposide or. irradiation to reduce cell growth and colony formation. In conclusion, Reptin is an important cofactor for the repair of DSBs. Our data, combined with those of the literature suggests that it operates at least in part by regulating the expression of DNA-PKcs by a stabilization mechanism. Overexpression of Reptin in HCC could be a factor of resistance to treatment, consistent with the observed overexpression of Reptin in subgroups of chemo-resistant breast and ovarian cancers.	[Raymond, Anne-Aurelie; Benhamouche, Samira; Neaud, Veronique; Di Martino, Julie; Javary, Joaquim; Rosenbaum, Jean] INSERM, U1053, F-33076 Bordeaux, France; [Raymond, Anne-Aurelie; Benhamouche, Samira; Neaud, Veronique; Di Martino, Julie; Javary, Joaquim; Rosenbaum, Jean] Univ Bordeaux 2, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Rosenbaum, J (corresponding author), INSERM, U1053, F-33076 Bordeaux, France.	jean.rosenbaum@inserm.fr	Rosenbaum, Jean/F-5547-2013; Javary, Joaquim/AAR-5177-2021; di Martino, Julie Sandra/AAD-1430-2020	Rosenbaum, Jean/0000-0001-8585-5152; Javary, Joaquim/0000-0001-5423-6332; di Martino, Julie Sandra/0000-0002-2163-0736; RAYMOND, Anne-Aurelie/0000-0003-2697-9352	Equipe Labelisee Ligue Contre le Cancer; Institut National du Cancer [PLBIO10-155]; Grant "Institut National du Cancer - Direction Generale de l'Offre de Soins Institut National de la Sante et de la Recherche Medicale 6046"; Institut National du Cancer; Fondation pour la Recherche Medicale; Ligue Nationale Contre le Cancer	Equipe Labelisee Ligue Contre le Cancer; Institut National du Cancer(Institut National du Cancer (INCA) France); Grant "Institut National du Cancer - Direction Generale de l'Offre de Soins Institut National de la Sante et de la Recherche Medicale 6046"; Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	The study was supported by grants from Equipe Labelisee Ligue Contre le Cancer 2011 to Jean Rosenbaum (http://www.ligue-cancer.net/), Institut National du Cancer grant PLBIO10-155 to JR (http://www.e-cancer.fr/), and Grant "Institut National du Cancer - Direction Generale de l'Offre de Soins Institut National de la Sante et de la Recherche Medicale 6046" to JR (http://www.e-cancer.fr/). AAR was supported by a fellowship from Institut National du Cancer (http://www.e-cancer.fr/), SB by a fellowship from Fondation pour la Recherche Medicale (http://www.frm.org/) and JJ by a fellowship from Ligue Nationale Contre le Cancer (http://www.ligue-cancer.net/).	Ahmad Moaz, 2013, Communicative & Integrative Biology, V6, pe26005, DOI 10.4161/cib.26005; AJMANI AK, 1995, J EXP MED, V181, P2049, DOI 10.1084/jem.181.6.2049; Aoyama M, 2001, BIOCHEM PHARMACOL, V61, P49, DOI 10.1016/S0006-2952(00)00539-6; Benbahouche NE, 2014, J BIOL CHEM, V289, P6236, DOI 10.1074/jbc.M113.499608; Gospodinov A, 2009, INT J BIOCHEM CELL B, V41, P925, DOI 10.1016/j.biocel.2008.09.004; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; Grigoletto A, 2011, BIOCHIM BIOPHYS ACTA, V31, P91; Haurie V, 2009, HEPATOLOGY, V50, P1871, DOI 10.1002/hep.23215; Higgins GS, 2010, CANCER RES, V70, P2984, DOI 10.1158/0008-5472.CAN-09-4040; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huber O, 2008, CANCER RES, V68, P6873, DOI 10.1158/0008-5472.CAN-08-0547; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Izumi N, 2012, CANCER SCI, V103, P50, DOI 10.1111/j.1349-7006.2011.02112.x; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kubicka S, 1997, HEPATOLOGY, V25, P867, DOI 10.1002/hep.510250414; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-132; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menard L, 2010, J HEPATOL, V52, P681, DOI 10.1016/j.jhep.2009.12.029; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ni L, 2009, J CELL BIOCHEM, V106, P920, DOI 10.1002/jcb.22073; Osaki H, 2013, LEUKEMIA, V27, P1461, DOI 10.1038/leu.2013.42; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Potter AJ, 2005, MUTAT RES-FUND MOL M, V572, P27, DOI 10.1016/j.mrfmmm.2004.11.018; Ren JC, 2013, UROL ONCOL-SEMIN ORI, V31, P1358, DOI 10.1016/j.urolonc.2012.01.004; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Rousseau B, 2007, HEPATOLOGY, V46, P1108, DOI 10.1002/hep.21770; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Yang WS, 2012, J PROTEOME RES, V11, P1078, DOI 10.1021/pr2008187; Zhao L, 2013, P NATL ACAD SCI USA, V110, P12697, DOI 10.1073/pnas.1300968110; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	43	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123333	10.1371/journal.pone.0123333	http://dx.doi.org/10.1371/journal.pone.0123333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875766	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800092
J	Minarik, J; Pavlicek, P; Pour, L; Pika, T; Maisnar, V; Spicka, I; Jarkovsky, J; Krejci, M; Bacovsky, J; Radocha, J; Straub, J; Kessler, P; Wrobel, M; Walterova, L; Sykora, M; Obernauerova, J; Brozova, L; Gregora, E; Adamova, D; Gumulec, J; Adam, Z; Scudla, V; Hajek, R				Minarik, Jiri; Pavlicek, Petr; Pour, Ludek; Pika, Tomas; Maisnar, Vladimir; Spicka, Ivan; Jarkovsky, Jiri; Krejci, Marta; Bacovsky, Jaroslav; Radocha, Jakub; Straub, Jan; Kessler, Petr; Wrobel, Marek; Walterova, Lenka; Sykora, Michal; Obernauerova, Jarmila; Brozova, Lucie; Gregora, Evzen; Adamova, Dagmar; Gumulec, Jaromir; Adam, Zdenek; Scudla, Vlastimil; Hajek, Roman		Czech Myeloma Grp	Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy	PLOS ONE			English	Article							INITIAL TREATMENT; PHASE-III; IMPACT; REVERSIBILITY; PREDNISONE; MELPHALAN; SURVIVAL; EFFICACY; TRIAL	Objective Subcutaneous (SC) application of bortezomib has been recently introduced as a new application route in multiple myeloma (MM) patients. We performed an analysis to compare the outcomes of bortezomib-based therapy in multiple myeloma (MM) patients treated using either intravenous (IV) or subcutaneous (SC) route of administration. Patients and methods During January 2012 through December 2013, we performed a retrospective analysis of 446 patients with MM treated with bortezomib-based regimens (either once weekly -63% or twice weekly -27%) in both, the first line setting, and in relapse, with separate analysis of patients undergoing autologous stem cell transplantation. We assessed the response rates and toxicity profiles in both, IV and SC route of bortezomib administration. Results The response rates in both IV and SC arm were similar with overall response rate 71.7% vs 70.7%, complete remissions in 13.9% vs 8.6%, very good partial remissions in 30.8% vs 34.5% and partial remissions in 27% vs 27.6%. The most frequent grade >= 3 toxicities were anemia, thrombocytopenia and neutropenia, with no significant differences between IV and SC group. There were no significant differences in the rate of peripheral neuropathy (PN). PN of any grade was present in 48% in the IV arm and in 41% in the SC arm. PN grade >= 2 was present in 20% vs 18% and PN grade >= 3 was present in 6% vs 4%. Conclusions We conclude that subcutaneous application of bortezomib has similar therapeutic outcomes and toxicity profile as intravenous route of application. In our cohort there was no difference in the incidence of PN, suggesting that PN is dose dependent and might be reduced by lower intensity schemes rather than by the route of administration.	[Minarik, Jiri; Pika, Tomas; Bacovsky, Jaroslav; Scudla, Vlastimil] Palacky Univ, Univ Hosp Olomouc, Dept Hematooncol, CR-77147 Olomouc, Czech Republic; [Minarik, Jiri; Pika, Tomas; Bacovsky, Jaroslav; Scudla, Vlastimil] Palacky Univ, Fac Med, CR-77147 Olomouc, Czech Republic; [Pavlicek, Petr; Gregora, Evzen] Univ Hosp Kralovske Vinohrady, Dept Clin Hematol, Prague, Czech Republic; [Pour, Ludek; Krejci, Marta; Adam, Zdenek] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic; [Maisnar, Vladimir; Radocha, Jakub] Univ Hosp, Dept Clin Hematol, Hradec Kralove, Czech Republic; [Spicka, Ivan; Straub, Jan] Univ Hosp, Dept Internal Med, Prague, Czech Republic; [Jarkovsky, Jiri; Brozova, Lucie] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic; [Kessler, Petr] Gen Hosp, Dept Hematol & Transfus, Pelhrimov, Czech Republic; [Wrobel, Marek] Hosp Novy Jicin, Dept Oncol, Novy Jicin, Czech Republic; [Walterova, Lenka] Gen Hosp Liberec, Dept Clin Hematol, Liberec, Czech Republic; [Sykora, Michal] Gen Hosp, Dept Clin Hematol, Ceske Budejovice, Czech Republic; [Obernauerova, Jarmila] Claudian Hosp, Dept Hematol & Transfus, Mlada Boleslav, Czech Republic; [Adamova, Dagmar] Silesian Hosp, Dept Hematol & Transfusiol, Opava, Czech Republic; [Gumulec, Jaromir; Hajek, Roman] Univ Ostrava, Univ Hosp Ostrava, Dept Haematooncol, CZ-70103 Ostrava, Czech Republic; [Gumulec, Jaromir; Hajek, Roman] Univ Ostrava, Fac Med, CZ-70103 Ostrava, Czech Republic	Palacky University Olomouc; University Hospital Olomouc; Palacky University Olomouc; University Hospital Vinohrady; University Hospital Brno; University Hospital Hradec Kralove; General University Hospital Prague; Institute of Biostatistics & Analyses; Masaryk University Brno; University Hospital Ostrava; University of Ostrava; University of Ostrava	Minarik, J (corresponding author), Palacky Univ, Univ Hosp Olomouc, Dept Hematooncol, CR-77147 Olomouc, Czech Republic.	abretina@email.cz	Radocha, Jakub/AAK-4080-2021; Krejci, Marta/ABE-2414-2020; Maisnar, Vladimir/Q-8579-2017; Hajek, Roman/I-6639-2017; Radocha, Jakub/S-3708-2016; Minarik, Jiri/GWR-0249-2022; Jarkovsky, Jiri/G-5494-2017	Radocha, Jakub/0000-0002-5384-8238; Krejci, Marta/0000-0001-5216-8778; Maisnar, Vladimir/0000-0003-1738-4920; Hajek, Roman/0000-0001-6955-6267; Radocha, Jakub/0000-0002-5384-8238; Minarik, Jiri/0000-0003-0513-326X; Spicka, Ivan/0000-0002-5451-5283	Internal Grant Agency (IGA) of Ministry of Health of the Czech Republic (MZ CR) [IGA MZ CR NT 14393, IGA MZ CR NT 12215-4/2011, IGA MZ CR NT 14400, IGA MZ CR NT12451-5, MSM0021622434]	Internal Grant Agency (IGA) of Ministry of Health of the Czech Republic (MZ CR)	The paper was supported by the grant of Internal Grant Agency (IGA) of Ministry of Health of the Czech Republic (MZ CR) - IGA MZ CR NT 14393, IGA MZ CR NT 12215-4/2011, IGA MZ CR NT 14400, IGA MZ CR NT12451-5, and the grant MSM0021622434. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyriou AA, 2008, BLOOD, V112, P1593, DOI 10.1182/blood-2008-04-149385; Arnulf B, 2012, HAEMATOL-HEMATOL J, V97, P1925, DOI 10.3324/haematol.2012.067793; Bringhen S, 2010, BLOOD, V116, P4745, DOI 10.1182/blood-2010-07-294983; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Horvath N, EHA 2014 MIL IT; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kumar SK, 2012, COMMUN ONCOL, V9, P272; Kurtin Sandra, 2012, J Adv Pract Oncol, V3, P406; Larocca A, ASH 2013 NEW ORL LA; Maisnar V, 2011, ONKOLOGIE, V3, P138; Manochakian R, 2007, ONCOLOGIST, V12, P978, DOI 10.1634/theoncologist.12-8-978; Mateos MV, 2009, CLIN LYMPHOMA MYELOM, V9, pS30, DOI 10.1016/S1557-9190(11)70492-9; Mateos MV, 2012, THER ADV HEMATOL, V3, P117, DOI 10.1177/2040620711432020; Millennium Pharmaceuticals Inc, 2012, VELC BORT INJ PRESCR; Moreau P, 2012, CLIN PHARMACOKINET, V51, P823, DOI 10.1007/s40262-012-0010-0; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Moreau P, 2008, HAEMATOL-HEMATOL J, V93, P1908, DOI 10.3324/haematol.13285; National Cancer Institute, NAT CANC I CANC THER; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; Richardson PG, 2009, J CLIN ONCOL, V27, P3518, DOI 10.1200/JCO.2008.18.3087; Richardson PG, 2009, BRIT J HAEMATOL, V144, P895, DOI 10.1111/j.1365-2141.2008.07573.x; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Rifkin R, ASH 2013 NEW ORL LA; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Sidana S, 1975, ASH 2013 NEW ORL LA	26	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123866	10.1371/journal.pone.0123866	http://dx.doi.org/10.1371/journal.pone.0123866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875484	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700049
J	Silva, AKSE; Torres, DDC; Gomes, FOD; Silva, BD; Ribeiro, EL; Oliveira, AC; dos Santos, LAM; de Lima, MDA; Pitta, ID; Peixoto, CA				Soares e Silva, Amanda Karolina; Cipriano Torres, Dilenia de Oliveira; dos Santos Gomes, Fabiana Oliveira; Silva, Bruna dos Santos; Ribeiro, Edlene Lima; Oliveira, Amanda Costa; Martins dos Santos, Laise Aline; Alves de Lima, Maria do Carmo; Pitta, Ivan da Rocha; Peixoto, Christina Alves			LPSF/GQ-02 Inhibits the Development of Hepatic Steatosis and Inflammation in a Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD)	PLOS ONE			English	Article							NF-KAPPA-B; RECEPTOR-DEFICIENT MICE; NITRIC-OXIDE; ATHEROSCLEROTIC LESIONS; ACTIVATED RECEPTORS; GENE-EXPRESSION; ADIPOSE-TISSUE; PPAR-GAMMA; IN-VITRO; ALPHA	Non-alcoholic fatty liver disease (NAFLD) defines a wide spectrum of liver diseases that extends from simple steatosis to non-alcoholic steatohepatitis. Although the pathogenesis of NAFLD remains undefined, it is recognized that insulin resistance is present in almost all patients who develop this disease. Thiazolidinediones (TZDs) act as an insulin sensitizer and have been used in the treatment of patients with type 2 diabetes and other insulin-resistant conditions, including NAFLD. Hence, therapy of NAFLD with insulin-sensitizing drugs should ideally improve the key hepatic histological changes, while also reducing cardiometabolic and cancer risks. Controversially, TZDs are associated with the development of cardiovascular events and liver problems. Therefore, there is a need for the development of new therapeutic strategies to improve liver function in patients with chronic liver diseases. The aim of the present study was to assess the therapeutic effects of LPSF/GQ-02 on the liver of LDLR-/-mice after a high-fat diet. Eighty male mice were divided into 4 groups and two different experiments: 1-received a standard diet; 2-fed with a high-fat diet (HFD); 3-HFD+pioglitazone; 4-HFD+LPSF/GQ-02. The experiments were conducted for 10 or 12 weeks and in the last two or four weeks respectively, the drugs were administered daily by gavage. The results obtained with an NAFLD murine model indicated that LPSF/GQ-02 was effective in improving the hepatic architecture, decreasing fat accumulation, reducing the amount of collagen, decreasing inflammation by reducing IL-6, iNOS, COX-2 and F4/80, and increasing the protein expression of I kappa B alpha, cytoplasmic NF kappa B-65, eNOS and IRS-1 in mice LDLR -/-. These results suggest a direct action by LPSF/GQ-02 on the factors that affect inflammation, insulin resistance and fat accumulation in the liver of these animals. Further studies are being conducted in our laboratory to investigate the possible mechanism of action of LPSF/GQ-02 on hepatic lipid metabolism.	[Soares e Silva, Amanda Karolina; dos Santos Gomes, Fabiana Oliveira; Silva, Bruna dos Santos; Ribeiro, Edlene Lima; Oliveira, Amanda Costa; Martins dos Santos, Laise Aline; Peixoto, Christina Alves] Ctr Pesquisa Aggeu Magalhaes FIOCRUZ, Lab Ultraestrutura, Recife, PE, Brazil; [Cipriano Torres, Dilenia de Oliveira] Univ Pernambuco, Lab Anal Clin, Recife, PE, Brazil; [Alves de Lima, Maria do Carmo; Pitta, Ivan da Rocha] Univ Fed Pernambuco, Lab Planejamento & Sintese Farmacos, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco	Silva, AKSE (corresponding author), Ctr Pesquisa Aggeu Magalhaes FIOCRUZ, Lab Ultraestrutura, Recife, PE, Brazil.	kls.amanda@gmail.com	PEIXOTO, CHRISTINA/AAD-9608-2019; Alves de Lima, Maria do carmo/H-3520-2015	PEIXOTO, CHRISTINA/0000-0002-7008-5930; 	Brazilian fostering agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian fostering agency Fundacao Oswaldo Cruz (FIOCRUZ); Brazilian fostering agency Instituto Nacional de Biologia Estrutural e Bioimagem (INBEB)	Brazilian fostering agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian fostering agency Fundacao Oswaldo Cruz (FIOCRUZ); Brazilian fostering agency Instituto Nacional de Biologia Estrutural e Bioimagem (INBEB)	The authors would like to thank the Brazilian fostering agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Oswaldo Cruz (FIOCRUZ) and Instituto Nacional de Biologia Estrutural e Bioimagem (INBEB) for their support in the development of the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Ann N Y Acad Sci, V557, P1; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bedoucha M, 2001, J HEPATOL, V35, P17, DOI 10.1016/S0168-8278(01)00066-6; Bochem AE, 2013, EUR HEART J, V34, P286, DOI 10.1093/eurheartj/ehs376; Bradford MA, 1970, ANAL BIOCHEM, V72, P240; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Camp Heidi S, 2003, Curr Opin Investig Drugs, V4, P406; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Ciupinska-Kajor M, 2013, HEPATOL INT, V7, P233, DOI 10.1007/s12072-011-9320-9; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Leite LFCD, 2007, EUR J MED CHEM, V42, P1263, DOI 10.1016/j.ejmech.2007.02.015; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Dowman JK, 2011, DIABETES OBES METAB, V13, P692, DOI 10.1111/j.1463-1326.2011.01403.x; Esterson YB, 2013, J INVEST MED, V61, P1152, DOI 10.2310/JIM.0000000000000017; Game BA, 2007, ATHEROSCLEROSIS, V192, P85, DOI 10.1016/j.atherosclerosis.2006.06.025; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Girard J, 2001, DIABETES METAB, V27, P271; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Grumbach IM, 2005, J MOL CELL CARDIOL, V39, P595, DOI 10.1016/j.yjmcc.2005.06.012; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Iredale JP, 2003, BMJ-BRIT MED J, V327, P143, DOI 10.1136/bmj.327.7407.143; Kallwitz ER, 2008, WORLD J GASTROENTERO, V14, P22, DOI 10.3748/wjg.14.22; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Lalloyer F, 2011, ARTERIOSCL THROM VAS, V31, P1573, DOI 10.1161/ATVBAHA.110.220525; Langer DA, 2008, HEPATOLOGY, V47, P1983, DOI 10.1002/hep.22285; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; Liu W, 2014, J GASTROEN HEPATOL, V29, P614, DOI 10.1111/jgh.12430; Lutchman G, 2007, HEPATOLOGY, V46, P424, DOI 10.1002/hep.21661; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Mohapatra J, 2009, PHARMACOLOGY, V84, P203, DOI 10.1159/000235996; Montes GS, 1988, HISTOCHEMICAL LOCALI, P41; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Mourao RH, 2005, EUR J MED CHEM, V40, P1129, DOI 10.1016/j.ejmech.2005.06.002; Muriel P, 2009, J APPL TOXICOL, V29, P91, DOI 10.1002/jat.1393; Napoli C, 2002, CIRCULATION, V105, P1360, DOI 10.1161/01.CIR.0000013090.96919.FA; Nasir GA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-78; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ozasa H, 2011, ATHEROSCLEROSIS, V219, P141, DOI 10.1016/j.atherosclerosis.2011.07.113; Ratziu V, 2008, GASTROENTEROLOGY, V135, P100, DOI 10.1053/j.gastro.2008.03.078; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Salamone F, 2012, TRANSL RES, V159, P477, DOI 10.1016/j.trsl.2011.12.003; Savage DB, 2010, CURR OPIN LIPIDOL, V21, P329, DOI 10.1097/MOL.0b013e32833b7782; Schalm SW, 1997, J HEPATOL, V27, P1118, DOI 10.1016/S0168-8278(97)80159-6; Scheen Andre J., 2001, Drug Safety, V24, P873, DOI 10.2165/00002018-200124120-00002; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silva AKSE, 2013, CARDIOVASC PATHOL, V22, P81, DOI 10.1016/j.carpath.2012.05.006; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tian F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083819; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Varas-Lorenzo C, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-129; Wang HN, 2008, WORLD J GASTROENTERO, V14, P7240, DOI 10.3748/wjg.14.7240; Watkins PB, 2005, HEPATOLOGY, V41, P229, DOI 10.1002/hep.20598; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Wilkins T, 2013, AM FAM PHYSICIAN, V88, P35; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; YANG LY, 1995, J LIPID RES, V36, P125; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yoneda M, 2009, HEPATOL RES, V39, P963, DOI 10.1111/j.1872-034X.2009.00539.x; Yu J, 2006, HEPATOLOGY, V43, P826, DOI 10.1002/hep.21108; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zhang W, 2014, SCI WORLD J, DOI 10.1155/2014/603409	77	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123787	10.1371/journal.pone.0123787	http://dx.doi.org/10.1371/journal.pone.0123787			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875942	gold, Green Submitted, Green Published			2022-12-26	WOS:000353014700044
J	Chin, CY; Weng, MY; Lin, TC; Cheng, SY; Yang, YHK; Tseng, VS				Chin, Chu Yu; Weng, Meng Yu; Lin, Tzu Chieh; Cheng, Shyr Yuan; Yang, Yea Huei Kao; Tseng, Vincent S.			Mining Disease Risk Patterns from Nationwide Clinical Databases for the Assessment of Early Rheumatoid Arthritis Risk	PLOS ONE			English	Article							ASSOCIATION; PREVALENCE; PREDICTION	Rheumatoid arthritis (RA) is a chronic autoimmune rheumatic disease that can cause painful swelling in the joint lining, morning stiffness, and joint deformation/destruction. These symptoms decrease both quality of life and life expectancy. However, if RA can be diagnosed in the early stages, it can be controlled with pharmacotherapy. Although many studies have examined the possibility of early assessment and diagnosis, few have considered the relationship between significant risk factors and the early assessment of RA. In this paper, we present a novel framework for early RA assessment that utilizes data preprocessing, risk pattern mining, validation, and analysis. Under our proposed framework, two risk patterns can be discovered. Type I refers to well-known risk patterns that have been identified by existing studies, whereas Type II denotes unknown relationship risk patterns that have rarely or never been reported in the literature. These Type II patterns are very valuable in supporting novel hypotheses in clinical trials of RA, and constitute the main contribution of this work. To ensure the robustness of our experimental evaluation, we use a nationwide clinical database containing information on 1,314 RA-diagnosed patients over a 12-year follow-up period (1997-2008) and 965,279 non-RA patients. Our proposed framework is employed on this large-scale population-based dataset, and is shown to effectively discover rich RA risk patterns. These patterns may assist physicians in patient assessment, and enhance opportunities for early detection of RA. The proposed framework is broadly applicable to the mining of risk patterns for major disease assessments. This enables the identification of early risk patterns that are significantly associated with a target disease.	[Chin, Chu Yu; Tseng, Vincent S.] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan; [Weng, Meng Yu] Natl Cheng Kung Univ, Med Coll & Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Tainan 70101, Taiwan; [Lin, Tzu Chieh; Yang, Yea Huei Kao] Natl Cheng Kung Univ Hosp, Hlth Outcome Res Ctr, Tainan 70428, Taiwan; [Yang, Yea Huei Kao] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Tseng, Vincent S.] Natl Cheng Kung Univ, Inst Med Informat, Tainan 70101, Taiwan; [Chin, Chu Yu; Cheng, Shyr Yuan] Chunghwa Telecom Co Ltd, Telecommun Labs, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; Chunghwa Telecom	Tseng, VS (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan.	tsengsm@mail.ncku.edu.tw			National Science Council of Taiwan [101-3114-Y-006-001, 101-2221-E-006-255-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council of Taiwan (Grant No. 101-3114-Y-006-001 and 101-2221-E-006-255-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Telecommunication Laboratories, Chunghwa Telecom Co., Ltd. provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal R., 1994, P 20 INT C VER LARG, P487; Bedran Z, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/548502; Bing Liu, 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P80; Cader MZ, 2011, ANN RHEUM DIS, V70, P949, DOI 10.1136/ard.2010.143560; Chen HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/125943; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Cruz VA, 2012, REV BRAS REUMATOL, V52, P645, DOI 10.1590/S0482-50042012000400014; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Ebringer A, 2014, APMIS, V122, P363, DOI 10.1111/apm.12154; Fischer TW, 2003, DERMATOLOGY, V207, P386, DOI 10.1159/000074120; Fraser Kathleen, 2013, Skin Therapy Lett, V18, P5; Gibofsky Allan, 2012, Am J Manag Care, V18, pS295; Haikola B, 2013, ACTA ODONTOL SCAND, V71, P498, DOI 10.3109/00016357.2012.696692; Huizinga T. W. J., 2007, Rev.Colomb.Reumatol., V14, P106; Jaimes-Hernandez J, 2012, REUMATOL CLIN, V8, P145, DOI 10.1016/j.reuma.2011.09.005; Kapoor S, 2015, NEUROUROL URODYNAM, V34, P101, DOI 10.1002/nau.22500; Karadag O, 2012, RHEUMATOL INT, V32, P2313, DOI 10.1007/s00296-011-1957-0; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; LAWRY GV, 1984, ARTHRITIS RHEUM, V27, P873, DOI 10.1002/art.1780270806; Lee LY, 2012, BMJ CASE REPORTS; Li WM, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P369, DOI 10.1109/ICDM.2001.989541; Mathias JS, 2013, J AM MED INFORM ASSN, V20, pE118, DOI 10.1136/amiajnl-2012-001360; Matsuura E, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-47; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; McNally E, 2014, SEMIN ARTHRITIS RHEU, V43, P498, DOI 10.1016/j.semarthrit.2013.08.005; Monsarrat P, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-253; Ng T, 2012, J PALLIAT MED, V15, P863, DOI 10.1089/jpm.2011.0417; Nyirjesy Paul, 1994, Obstetrics and Gynecology, V84, P710; O'Connor PJ, 2013, SEMIN MUSCULOSKEL R, V17, P74, DOI 10.1055/s-0033-1333940; Quinlan JR, 1993, PROGRAMS MACHINE LEA; Sayers E., 2008, E UTILITIES QUICK ST; Shadick NA, 2006, ARCH INTERN MED, V166, P2490, DOI 10.1001/archinte.166.22.2490; Shang GF, 2013, J MED VIROL, V85, P1334, DOI 10.1002/jmv.23609; Skare TL, 2013, CLIN RHEUMATOL, V32, P1065, DOI 10.1007/s10067-013-2213-7; Smolik Irene, 2009, Compend Contin Educ Dent, V30, P188; Tai YM, 2009, INT J MED INFORM, V78, pE75, DOI 10.1016/j.ijmedinf.2009.09.005; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; Vapnik V., 2013, NATURE STAT LAERNING; Verweij KE, 2012, CASE REP MED, V2012, DOI 10.1155/2012/523218; Yin XX, 2003, SIAM PROC S, P331	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122508	10.1371/journal.pone.0122508	http://dx.doi.org/10.1371/journal.pone.0122508			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875441	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100079
J	Fuentes-Claramonte, P; Avila, C; Rodriguez-Pujadas, A; Ventura-Campos, N; Bustamante, JC; Costumero, V; Rosell-Negre, P; Barros-Loscertales, A				Fuentes-Claramonte, Paola; Avila, Cesar; Rodriguez-Pujadas, Aina; Ventura-Campos, Noelia; Bustamante, Juan C.; Costumero, Victor; Rosell-Negre, Patricia; Barros-Loscertales, Alfonso			Reward Sensitivity Modulates Brain Activity in the Prefrontal Cortex, ACC and Striatum during Task Switching	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; BEHAVIORAL ACTIVATION; ANTERIOR CINGULATE; COGNITIVE CONTROL; INHIBITORY CONTROL; NEURAL MECHANISMS; DOPAMINE; PERSONALITY; PUNISHMENT; MOTIVATION	Current perspectives on cognitive control acknowledge that individual differences in motivational dispositions may modulate cognitive processes in the absence of reward contingencies. This work aimed to study the relationship between individual differences in Behavioral Activation System (BAS) sensitivity and the neural underpinnings involved in processing a switching cue in a task-switching paradigm. BAS sensitivity was hypothesized to modulate brain activity in frontal regions, ACC and the striatum. Twenty-eight healthy participants underwent fMRI while performing a switching task, which elicited activity in fronto-striatal regions during the processing of the switch cue. BAS sensitivity was negatively associated with activity in the lateral prefrontal cortex, anterior cingulate cortex and the ventral striatum. Combined with previous results, our data indicate that BAS sensitivity modulates the neurocognitive processes involved in task switching in a complex manner depending on task demands. Therefore, individual differences in motivational dispositions may influence cognitive processing in the absence of reward contingencies.	[Fuentes-Claramonte, Paola; Avila, Cesar; Rodriguez-Pujadas, Aina; Ventura-Campos, Noelia; Costumero, Victor; Rosell-Negre, Patricia; Barros-Loscertales, Alfonso] Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Spain; [Bustamante, Juan C.] Univ Zaragoza, Fac Educ, Dept Psicol & Sociol, Zaragoza, Spain	Universitat Jaume I; University of Zaragoza	Barros-Loscertales, A (corresponding author), Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Spain.	barros@uji.es	Costumero, Víctor/A-5784-2019; Campos, Noelia Ventura/L-4877-2014; Avila, Cesar/B-4370-2011; Barros-Loscertales, Alfonso/D-7069-2013; Fuentes-Claramonte, Paola/AAC-1196-2021; Bustamante, Juan Carlos/J-7534-2015; Barrós-Loscertales, Alfonso/AAA-5611-2019	Costumero, Víctor/0000-0002-8743-5239; Campos, Noelia Ventura/0000-0002-0443-8048; Avila, Cesar/0000-0002-5840-605X; Fuentes-Claramonte, Paola/0000-0002-1428-7976; Bustamante, Juan Carlos/0000-0002-8201-0469; Barrós-Loscertales, Alfonso/0000-0002-2456-6653; Rosell Negre, Patricia/0000-0002-2440-8495	Brainglot Project of the CONSOLIDER-INGENIO Program [CSD2007-00012]; MINECO [PSI2012-33054]; Spanish National Drug Strategy [4623/2011]; Spanish Ministry of Health and Consumption; Generalitat Valenciana [GV/2012/042]; Universitat Jaume I [P1-1A2010-01]	Brainglot Project of the CONSOLIDER-INGENIO Program; MINECO(Spanish Government); Spanish National Drug Strategy; Spanish Ministry of Health and Consumption(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universitat Jaume I	This research was supported by the Brainglot Project of the 2010 CONSOLIDER-INGENIO Program (CSD2007-00012). The project was also supported by grants from MINECO (PSI2012-33054), the Spanish National Drug Strategy (4623/2011), the Spanish Ministry of Health and Consumption, the Generalitat Valenciana (GV/2012/042) and Universitat Jaume I (P1-1A2010-01) to ABL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00163; Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Armbruster DJN, 2012, J COGNITIVE NEUROSCI, V24, P2385, DOI 10.1162/jocn_a_00286; Avila C, 2003, COGNITION EMOTION, V17, P951, DOI 10.1080/02699930341000031; Avila C, 2002, PERS INDIV DIFFER, V33, P979, DOI 10.1016/S0191-8869(01)00207-0; Avila C, 2008, NEUROTOX RES, V14, P191, DOI 10.1007/BF03033810; AVILA C, 1995, PERS INDIV DIFFER, V18, P503, DOI 10.1016/0191-8869(94)00184-T; Avila C, 1997, PERS INDIV DIFFER, V23, P1055, DOI 10.1016/S0191-8869(97)00124-4; Avila C, 2001, J PERS SOC PSYCHOL, V80, P311, DOI 10.1037//0022-3514.80.2.311; Avila C, 2012, SOC COGN AFFECT NEUR, V7, P423, DOI 10.1093/scan/nsr028; Barcelo F, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.013.2007; Barros-Loscertales A, 2006, EUR J NEUROSCI, V24, P2071, DOI 10.1111/j.1460-9568.2006.05084.x; Braver TS, 2014, COGN AFFECT BEHAV NE, V14, P443, DOI 10.3758/s13415-014-0300-0; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Caseras X, 2003, PERS INDIV DIFFER, V34, P999, DOI 10.1016/S0191-8869(02)00084-3; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Congdon E, 2010, NEUROIMAGE, V53, P653, DOI 10.1016/j.neuroimage.2010.06.062; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Costumero V, 2013, EUR J NEUROSCI, V38, P2399, DOI 10.1111/ejn.12234; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Cubillo A, 2014, CEREB CORTEX, V24, P174, DOI 10.1093/cercor/bhs296; Cubillo A, 2010, J PSYCHIATR RES, V44, P629, DOI 10.1016/j.jpsychires.2009.11.016; De Baene W, 2013, NEUROIMAGE, V77, P207, DOI 10.1016/j.neuroimage.2013.03.057; de Ruiter MB, 2012, DRUG ALCOHOL DEPEN, V121, P81, DOI 10.1016/j.drugalcdep.2011.08.010; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; FOWLES DC, 1980, PSYCHOPHYSIOLOGY, V17, P87, DOI 10.1111/j.1469-8986.1980.tb00117.x; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gable SL, 2000, J PERS SOC PSYCHOL, V78, P1135, DOI 10.1037//0022-3514.78.6.1135; Grange JA, 2010, PSYCHOL RES-PSYCH FO, V74, P481, DOI 10.1007/s00426-009-0270-y; Gray JA, 1987, PSYCHOL FEAR STRESS, P241; Gray JA, 2000, THE NEUROPSYCHOLOGY; Gray JR, 2002, COGN AFFECT BEHAV NE, V2, P64, DOI 10.3758/CABN.2.1.64; Gray JR, 2005, COGN AFFECT BEHAV NE, V5, P182, DOI 10.3758/CABN.5.2.182; Gruber O, 2006, NEUROIMAGE, V31, P887, DOI 10.1016/j.neuroimage.2005.12.043; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; Hajek T, 2013, J PSYCHIATR RES, V47, P1955, DOI 10.1016/j.jpsychires.2013.08.015; Hakuri JG, 2012, BRAIN RES, V1451, P53, DOI 10.1016/j.brainres.2012.02.046; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Jost K, 2008, COGN AFFECT BEHAV NE, V8, P74, DOI 10.3758/CABN.8.1.74; Kenner NM, 2010, J NEUROSCI, V30, P8512, DOI 10.1523/JNEUROSCI.1096-10.2010; Kim C, 2012, BRAIN RES, P1; Kool W, 2014, J EXP PSYCHOL GEN, V143, P131, DOI 10.1037/a0031048; Lieberman MD, 2001, J PERS SOC PSYCHOL, V80, P294, DOI 10.1037//0022-3514.80.2.294; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Luijten M, 2014, J PSYCHIATR NEUROSCI, V39, P149, DOI 10.1503/jpn.130052; Matuskey D, 2013, PSYCHIAT RES-NEUROIM, V214, P116, DOI 10.1016/j.pscychresns.2013.06.009; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; PATTERSON CM, 1987, J PERS SOC PSYCHOL, V52, P565, DOI 10.1037/0022-3514.52.3.565; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Pickering AD., 1997, HDB PERS THEORY RES, P277; Rubia K, 2009, PHILOS T R SOC B, V364, P1919, DOI 10.1098/rstb.2009.0014; Ruge H, 2009, NEUROPSYCHOLOGIA, V47, P1670, DOI 10.1016/j.neuropsychologia.2009.02.004; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Torrubia R, 2008, THE REINFORCEMENT SE; van Holstein M, 2011, PSYCHOPHARMACOLOGY, V218, P567, DOI 10.1007/s00213-011-2340-2; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Woodward TS, 2006, BRAIN RES, V1068, P161, DOI 10.1016/j.brainres.2005.10.094; Yehene E, 2008, J COGNITIVE NEUROSCI, V20, P1079, DOI 10.1162/jocn.2008.20077	71	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123073	10.1371/journal.pone.0123073	http://dx.doi.org/10.1371/journal.pone.0123073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875640	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100132
J	Sato, APS; Antunes, JLF; Moura, RF; de Andrade, FB; Duarte, YAO; Lebrao, ML				Sayuri Sato, Ana Paula; Ferreira Antunes, Jose Leopoldo; Moura, Roudom Ferreira; de Andrade, Fabiola Bof; Oliveira Duarte, Yeda Aparecida; Lebrao, Maria Lucia			Factors Associated to Vaccination against Influenza among Elderly in a Large Brazilian Metropolis	PLOS ONE			English	Article							OLDER-ADULTS; PNEUMOCOCCAL VACCINATION; SELF-REPORT; A H1N1; HEALTH; PREVALENCE; PEOPLE; STATE	Background This study aimed to estimate coverage and identify factors associated to vaccination against influenza in the elderly population. Methods The study design was cross-sectional and population based. Data was collected in 2010 by the Health, Well-Being and Aging Study. Sample consisted of 1,341 community-dwelling elderly, in Sao Paulo, Brazil. Association between vaccination and covariates was evaluated by means of prevalence ratios estimated by Poisson regression models. Results Self-reported vaccination coverage was 74.2% (95% confidence interval: 71.3-76.9). Remaining physically active and having had recent interaction with health services, mainly with public units of healthcare, were the main incentives to increase vaccination coverage among the elderly; whereas lower age, living alone and absent interaction with health services were the main constraints to influenza vaccination at the community level. These covariates had already been reported to influence influenza vaccination of elders in previous years. Conclusion Previous knowledge already available on the main constraints to influenza vaccination has not allowed to remove them. Influenza campaigns should be strengthened to increase vaccination coverage, especially in the group more reticent to vaccination. Instructing healthcare providers to recommend vaccine uptake is an important piece of this puzzle.	[Sayuri Sato, Ana Paula; Ferreira Antunes, Jose Leopoldo; Lebrao, Maria Lucia] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil; [Moura, Roudom Ferreira] Ctr Epidemiol Surveillance Prof Alexandre Vranjac, Sao Paulo, Brazil; [de Andrade, Fabiola Bof] Fundacao Oswaldo Cruz, Rene Rachou Res Inst, Ctr Studies Publ Hlth & Aging, Belo Horizonte, MG, Brazil; [Oliveira Duarte, Yeda Aparecida] Univ Sao Paulo, Sch Nursing, Dept Med Surg Nursing, Sao Paulo, Brazil	Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Sato, APS (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil.	sah@usp.br	Sato, Ana Paula Sayuri/D-4111-2016; Duarte, Yeda/AAT-8935-2020; Antunes, Jose Leopoldo Ferreira/F-6969-2010; Moura, Roudom/AFL-9925-2022; de Andrade, Fabiola Bof/AAT-2885-2020; de Andrade, Fabiola Bof/D-8922-2012	Sato, Ana Paula Sayuri/0000-0001-8601-5884; Antunes, Jose Leopoldo Ferreira/0000-0003-3972-9723; de Andrade, Fabiola Bof/0000-0002-3467-3989; 	Sao Paulo Research Foundation - FAPESP [99/05125-7, 2005/54947-2, 2009/53778-3]; Ministry of Health, Brazil	Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministry of Health, Brazil	The Health, Wellbeing and Aging Study (SABE) was funded by the Sao Paulo Research Foundation - FAPESP (99/05125-7; 2005/54947-2; 2009/53778-3) - URL: http://www.fapesp.br and Ministry of Health, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew MK, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-36; [Anonymous], 2012, WKLY EPIDEMIOL REC; Antunes JLF, 2007, INT J EPIDEMIOL, V36, P1319, DOI 10.1093/ije/dym208; Ashbaugh AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058852; Avelino-Silva VI, 2011, CLINICS, V66, P2031, DOI 10.1590/S1807-59322011001200006; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Brasil. Ministerio da Saude, PROGR NAC IM SIST IN; Brasil. Ministerio da Saude, 2011, PROGR NAC IM INF TEC; Campos EC, 2012, CAD SAUDE PUBLICA, V28, P878, DOI 10.1590/S0102-311X2012000500007; Chang YC, 2013, VACCINE, V31, P410, DOI 10.1016/j.vaccine.2012.10.086; Chiatti C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-207; Ciblak MA, 2013, VACCINE, V31, P518, DOI 10.1016/j.vaccine.2012.11.022; Crawford VLS, 2011, AGE AGEING, V40, P35, DOI 10.1093/ageing/afq152; de Andrade FB, 2013, J AM GERIATR SOC, V61, P809, DOI 10.1111/jgs.12221; Dip RM, 2010, CAD SAUDE PUBLICA, V26, P1035, DOI 10.1590/S0102-311X2010000500025; Donalisio MR, 2006, REV SAUDE PUBL, V40, P115, DOI 10.1590/S0034-89102006000100018; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Heo JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064230; Kohlhammer Y, 2007, PUBLIC HEALTH, V121, P742, DOI 10.1016/j.puhe.2007.02.011; LEBRAO ML, 2003, SABE SAUDE BEM ESTAR; Lima-Costa MF, 2008, REV SAUDE PUBL, V42, P100, DOI 10.1590/S0034-89102008000100013; Lu PJ, 2013, AM J INFECT CONTROL, V41, P702, DOI 10.1016/j.ajic.2012.10.027; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Mangtani P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-249; Martinez-Baz I, 2012, PREV MED, V55, P246, DOI 10.1016/j.ypmed.2012.06.020; McIntyre A, 2014, CAN J AGING, V33, P92, DOI 10.1017/S0714980813000640; Monto AS, 2010, VACCINE, V28, pD33, DOI 10.1016/j.vaccine.2010.08.027; Moura RF., 2013, THESIS U SAO PAULO; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; Paulo Sao, 2005, DROP; Peng Y, 2013, PUBLIC HEALTH, V127, P930, DOI 10.1016/j.puhe.2013.06.007; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; Rolnick SJ, 2013, VACCINE, V31, P3928, DOI 10.1016/j.vaccine.2013.06.041; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Francisco PMSB, 2011, CAD SAUDE PUBLICA, V27, P417, DOI 10.1590/S0102-311X2011000300003; Takayama M, 2012, PREV MED, V54, P358, DOI 10.1016/j.ypmed.2012.03.008; Victor JF, 2014, REV ESC ENFERM USP, V48, P57, DOI 10.1590/S0080-623420140000100007; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wu SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-636; Zheng Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003662; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073724	42	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123840	10.1371/journal.pone.0123840	http://dx.doi.org/10.1371/journal.pone.0123840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874953	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100218
J	Chen, LP; Zhou, J; Zhang, YY; Chu, SS; He, WN; Li, Y; Su, XR				Chen, Liping; Zhou, Jun; Zhang, Yunyun; Chu, Shuangshuang; He, Weina; Li, Ye; Su, Xiurong			Preparation and Representation of Recombinant Mn-Ferritin Flower-Like Spherical Aggregates from Marine Invertebrates	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; PIG SPLEEN FERRITIN; AZOTOBACTER-VINELANDII; HORSE SPLEEN; H-CHAIN; IRON-BINDING; CDNA CLONING; MANGANESE; PHOSPHATE; RECONSTITUTION	Ferritin has important functions in the transition and storage of toxic metal ions, but its regulation and function in many invertebrate species are still largely unknown. In our previous work, the cDNA sequence of Sinonovacula constricta, Apostichopus japonicas and Acaudina leucoprocta were constructed and efficiently expressed in E. Coli BL21 under IPTG induction. In this follow-up study, the recombinant ferritins were exposed to heavy metal manganese. The manganese concentration levels in three recombinant ferritins were greater than horse spleen ferritin (HSF). Compared with HSF, the amount of manganese enrichment in the three recombinant ferritins was 1.75-fold, 3.25-fold and 2.42-fold increases in ScFER, AjFER, and AlFER, respectively. After phosphate stimulation, the concentration of manganese increased and was higher than the ordinary dialysis control groups. The ScFER was four times its baseline value. The AjFER and AlFER were 1.4- and 8-fold higher, respectively. The AlFER sample stimulated by phosphate was 22-fold that of HSF. The morphologies of the resulting Mn-Ferritin from different marine invertebrates were characterized with scanning electron microscopy. Surface morphologies were lamella flower-like and are consistent with changes in surface morphologies of the standard Mn-HSF. Invertebrate recombinant ferritin and HSF both can uptake manganese. We found that the structure of A. leucoproctarecombinant Mn-Ferritin aggregate changed over time. The surface formed lamella flower-like aggregate, but gradually merged to create a relatively uniform plate-like phase of aggregate spherically and fused without clear boundaries.	[Chen, Liping; Zhou, Jun; Zhang, Yunyun; Chu, Shuangshuang; He, Weina; Li, Ye; Su, Xiurong] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University	Zhou, J (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.	zhougundam@qq.com; suxiurong@nbu.edu.cn			National Natural Science Foundation of China [41176123, 40776075]; K. C. Wong Magna Fund at Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K. C. Wong Magna Fund at Ningbo University	This work was financially supported by the National Natural Science Foundation of China (No. 41176123and No. 40776075), and K. C. Wong Magna Fund at Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS SC, 1992, J INORG BIOCHEM, V47, P161, DOI 10.1016/0162-0134(92)84062-R; BAKKER GR, 1986, J BIOL CHEM, V261, P3182; Barbeau A, 1976, Adv Neurol, V14, P339; Brock SL, 1998, CHEM MATER, V10, P2619, DOI 10.1021/cm980227h; CHANDRA SV, 1981, CLIN TOXICOL, V18, P407, DOI 10.3109/15563658108990264; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; Feng Q, 1999, J MATER CHEM, V9, P319, DOI 10.1039/a805369c; FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046; Gay D, 2003, WATER RES, V37, P2173, DOI 10.1016/S0043-1354(02)00622-X; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hilton RJ, 2012, J INORG BIOCHEM, V108, P8, DOI 10.1016/j.jinorgbio.2011.12.004; Huang HQ, 2002, BIOPHYS CHEM, V97, P17, DOI 10.1016/S0301-4622(02)00007-8; Huang HQ, 1999, BIOELECTROCH BIOENER, V48, P87, DOI 10.1016/S0302-4598(98)00215-3; Huang HQ, 1999, J PROTEIN CHEM, V18, P497, DOI 10.1023/A:1020653028685; HUANG HQ, 1993, J INORG BIOCHEM, V52, P59, DOI 10.1016/0162-0134(93)85623-G; Huang TS, 1996, EUR J BIOCHEM, V236, P450, DOI 10.1111/j.1432-1033.1996.00450.x; Jiang YM, 2007, NEUROTOXICOLOGY, V28, P126, DOI 10.1016/j.neuro.2006.08.005; Khan N, 2014, FOOD CHEM, V158, P200, DOI 10.1016/j.foodchem.2014.02.103; Kim JW, 2007, J ELECTROANAL CHEM, V601, P8, DOI 10.1016/j.jelechem.2006.10.018; Laufberger V., 1937, B SOC CHIM BIOL, V19, P1575; Lawson DM, 1991, SOLVING STRUCTURE HU; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Li CR, 2009, BIOCHIMIE, V91, P1475, DOI 10.1016/j.biochi.2009.08.007; Li Cheng-Hua, 2011, Oceanologia et Limnologia Sinica, V42, P567; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P1147, DOI 10.1016/j.fsi.2011.02.017; Li M, 2008, COMP BIOCHEM PHYS B, V150, P263, DOI 10.1016/j.cbpb.2008.03.014; Liu GD, 2007, ANAL CHEM, V79, P5614, DOI 10.1021/ac070086f; LOBREAUX S, 1992, BIOCHEM J, V288, P931, DOI 10.1042/bj2880931; MACKLE P, 1993, J AM CHEM SOC, V115, P8471, DOI 10.1021/ja00071a076; MATHEIS G, 1991, FOOD CHEM, V39, P13, DOI 10.1016/0308-8146(91)90081-X; MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B; Morillo J, 2008, ECOTOX ENVIRON SAFE, V71, P851, DOI 10.1016/j.ecoenv.2008.01.016; Polanams J, 2005, INORG CHEM, V44, P3203, DOI 10.1021/ic048819r; Qiu GF, 2008, COMP BIOCHEM PHYS B, V150, P320, DOI 10.1016/j.cbpb.2008.03.016; Rakshit T, 2010, LANGMUIR, V26, P16005, DOI 10.1021/la101776m; Rakshit T, 2012, J COLLOID INTERF SCI, V388, P282, DOI 10.1016/j.jcis.2012.08.028; Rakshit T, 2011, LANGMUIR, V27, P9681, DOI 10.1021/la202045a; ROHRER JS, 1990, BIOCHEMISTRY-US, V29, P259, DOI 10.1021/bi00453a035; Sana B, 2012, CHEM COMMUN, V48, P862, DOI 10.1039/c1cc15189d; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; SHEN YF, 1993, SCIENCE, V260, P511, DOI 10.1126/science.260.5107.511; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; SRISUCHART B, 1987, J TOXICOL ENV HEALTH, V22, P91, DOI 10.1080/15287398709531053; STRANGE R, 1993, BIOCHIM BIOPHYS ACTA, V1164, P331, DOI 10.1016/0167-4838(93)90267-U; Suib SL, 1998, CURR OPIN SOLID ST M, V3, P63, DOI 10.1016/S1359-0286(98)80067-3; Suib SL, 2000, CHEMINFORM, V31; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Toner B, 2005, APPL ENVIRON MICROB, V71, P1300, DOI 10.1128/AEM.71.3.1300-1310.2005; TREFFRY A, 1989, FEBS LETT, V247, P268, DOI 10.1016/0014-5793(89)81350-X; Treffry A, 1997, BIOCHEMISTRY-US, V36, P432, DOI 10.1021/bi961830l; Uchida M, 2010, BBA-GEN SUBJECTS, V1800, P834, DOI 10.1016/j.bbagen.2009.12.005; Uygun DA, 2011, BIOTECHNOL BIOPROC E, V16, P173, DOI 10.1007/s12257-009-0162-4; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; VONDARL M, 1994, EUR J BIOCHEM, V222, P353; Wang D, 2009, COMP BIOCHEM PHYS B, V152, P20, DOI 10.1016/j.cbpb.2008.09.082; Wang WM, 2009, MICROBIOL-SGM, V155, P1989, DOI 10.1099/mic.0.024141-0; WATT GD, 1992, BIOCHEMISTRY-US, V31, P5672, DOI 10.1021/bi00139a035; WATT RK, 1992, BIOCHEMISTRY-US, V31, P9673, DOI 10.1021/bi00155a021; Yamashita I, 2010, BBA-GEN SUBJECTS, V1800, P846, DOI 10.1016/j.bbagen.2010.03.005; Yang XK, 2000, BIOPHYS J, V78, P2049, DOI 10.1016/S0006-3495(00)76752-X; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P43, DOI 10.1016/S1096-4959(03)00050-2; [周君 Zhou Jun], 2012, [海洋与湖沼, Oceanologia et Limnologia Sinica], V43, P713	66	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0119427	10.1371/journal.pone.0119427	http://dx.doi.org/10.1371/journal.pone.0119427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879665	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500002
J	Costa, M; Cruz, E; Oliveira, S; Benes, V; Ivacevic, T; Silva, MJ; Vieira, I; Dias, F; Fonseca, S; Goncalves, M; Lima, M; Leitao, C; Muckenthaler, MU; Pinto, J; Porto, G				Costa, Monica; Cruz, Eugenia; Oliveira, Susana; Benes, Vladimir; Ivacevic, Tomi; Silva, Maria Joao; Vieira, Ines; Dias, Francisco; Fonseca, Sonia; Goncalves, Marta; Lima, Margarida; Leitao, Catarina; Muckenthaler, Martina U.; Pinto, Jorge; Porto, Graca			Lymphocyte Gene Expression Signatures from Patients and Mouse Models of Hereditary Hemochromatosis Reveal a Function of HFE as a Negative Regulator of CD8(+) T-Lymphocyte Activation and Differentiation In Vivo	PLOS ONE			English	Article							IRON OVERLOAD; PERIPHERAL-BLOOD; HLA HAPLOTYPES; LOW NUMBERS; CELLS; MEMORY; APOPTOSIS; IMMUNITY; RECEPTORS; PHENOTYPE	Abnormally low CD8(+) T-lymphocyte numbers is characteristic of some patients with hereditary hemochromatosis (HH), a MHC-linked disorder of iron overload. Both environmental and genetic components are known to influence CD8(+) T-lymphocyte homeostasis but the role of the HH associated protein HFE is still insufficiently understood. Genome-wide expression profiling was performed in peripheral blood CD8(+) T lymphocytes from HH patients selected according to CD8(+) T-lymphocyte numbers and from Hfe(-/-)mice maintained either under normal or high iron diet conditions. In addition, T-lymphocyte apoptosis and cell cycle progression were analyzed by flow cytometry in HH patients. HH patients with low CD8(+) T-lymphocyte numbers show a differential expression of genes related to lymphocyte differentiation and maturation namely CCR7, LEF1, ACTN1, NAA50, P2RY8 and FOSL2, whose expression correlates with the relative proportions of naive, central and effector memory subsets. In addition, expression levels of LEF1 and P2RY8 in memory cells as well as the proportions of CD8(+) T cells in G2/M cell cycle phase are significantly different in HH patients compared to controls. Hfe(-/-) mice do not show alterations in CD8(+) T-lymphocyte numbers but differential gene response patterns. We found an increased expression of S100a8 and S100a9 that is most pronounced in high iron diet conditions. Similarly, CD8(+) T lymphocytes from HH patients display higher S100a9 expression both at the mRNA and protein level. Altogether, our results support a role for HFE as a negative regulator of CD8(+) T-lymphocyte activation. While the activation markers S100a8 and S100a9 are strongly increased in CD8(+) T cells from both, Hfe(-/-) mice and HH patients, a differential profile of genes related to differentiation/maturation of CD8(+) T memory cells is evident in HH patients only. This supports the notion that HFE contributes, at least in part, to the generation of low peripheral blood CD8(+) T lymphocytes in HH.	[Costa, Monica; Cruz, Eugenia; Oliveira, Susana; Vieira, Ines; Pinto, Jorge; Porto, Graca] Univ Porto, Inst Invest & Inovacao Saude I3S, P-4100 Oporto, Portugal; [Costa, Monica; Cruz, Eugenia; Oliveira, Susana; Vieira, Ines; Pinto, Jorge; Porto, Graca] Univ Porto, Inst Biol Mol & Celular, Basic & Clin Res Iron Biol, P-4100 Oporto, Portugal; [Costa, Monica] Univ Porto, Fac Med, Doctoral Program Biomed, P-4100 Oporto, Portugal; [Cruz, Eugenia; Silva, Maria Joao; Dias, Francisco; Fonseca, Sonia; Goncalves, Marta; Lima, Margarida; Porto, Graca] Santo Antonio Hosp Ctr Hosp Porto, Clin Hematol, Oporto, Portugal; [Benes, Vladimir; Ivacevic, Tomi] European Mol Biol Lab, Genom Core Facil, D-69012 Heidelberg, Germany; [Leitao, Catarina] Univ Porto, Inst Biol Mol & Celular, Adv Flow Cytometry Unit, P-4100 Oporto, Portugal; [Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Hematol, Heidelberg, Germany; [Muckenthaler, Martina U.] Heidelberg Univ, Dept Oncol & Immunol, Heidelberg, Germany; [Muckenthaler, Martina U.] Mol Med Partnership Unit, Heidelberg, Germany; [Porto, Graca] Univ Porto, Mol Immunol & Pathol, Inst Cirncias Biomed Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; European Molecular Biology Laboratory (EMBL); Universidade do Porto; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Universidade do Porto	Porto, G (corresponding author), Univ Porto, Inst Invest & Inovacao Saude I3S, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	gporto@ibmc.up.pt	Lima, Margarida/S-7466-2016; Porto, Graca/J-7939-2013	Lima, Margarida/0000-0001-9702-5260; Porto, Graca/0000-0002-1923-4638; Muckenthaler, Martina/0000-0002-3778-510X; Oliveira, Susana Joao/0000-0002-6834-8703; Cruz, Eugenia/0000-0002-4801-5047; Goncalves, Marta/0000-0002-3003-8734; Costa, Monica Isabel/0000-0002-6792-5687	FEDER funds through the Operational Competitiveness Programme - COMPETE; FCT -Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-008447 (PIC/IC/82785/2007), FCOMP-01-0124-FEDER-015823 (PTDC/SAU/MET/113011/2009)]; FEDER project [NORTE-07-0124-FEDER-000003]; program (ON.2 - O Novo Norte), under cover of Quadro de Referencia Estrategico Nacional (QREN); INOVA/APRF, USA; FCT [SFRH/BD/69186/2010]; Fundação para a Ciência e a Tecnologia [2021.05346.BD, PIC/IC/82785/2007] Funding Source: FCT	FEDER funds through the Operational Competitiveness Programme - COMPETE; FCT -Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FEDER project(European Commission); program (ON.2 - O Novo Norte), under cover of Quadro de Referencia Estrategico Nacional (QREN); INOVA/APRF, USA; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was funded by: a) FEDER funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT -Fundacao para a Ciencia e a Tecnologia under the projects: FCOMP-01-0124-FEDER-008447 (PIC/IC/82785/2007) and FCOMP-01-0124-FEDER-015823 (PTDC/SAU/MET/113011/2009); b) FEDER project - "NORTE-07-0124-FEDER-000003 - Cell Homeostasis Tissue Organization and Organism Biology" co-funded by the program (ON.2 - O Novo Norte), under cover of Quadro de Referencia Estrategico Nacional (QREN); c) INOVA/APRF, USA grant and d) Monica Costa is recipient of a FCT doctoral fellowship (SFRH/BD/69186/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian K, 2000, BBA-GENE STRUCT EXPR, V1492, P127, DOI 10.1016/S0167-4781(00)00094-4; Arezes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079870; Arosa FA, 1997, CLIN EXP IMMUNOL, V107, P548, DOI 10.1046/j.1365-2249.1997.d01-967.x; AROSA FA, 1994, SCAND J IMMUNOL, V39, P426, DOI 10.1111/j.1365-3083.1994.tb03396.x; Babich A, 2013, IMMUNOL REV, V256, P80, DOI 10.1111/imr.12123; Bahram S, 1999, P NATL ACAD SCI USA, V96, P13312, DOI 10.1073/pnas.96.23.13312; Bresgen N, 2007, J CELL PHYSIOL, V212, P157, DOI 10.1002/jcp.21009; Cardoso EM, 2002, BLOOD, V100, P4239, DOI 10.1182/blood-2002-05-1565; Cardoso EMP, 2001, EUR J CLIN INVEST, V31, P45, DOI 10.1046/j.1365-2362.2001.00744.x; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Costa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079990; Cruz E, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-16; Cruz E, 2006, BLOOD CELL MOL DIS, V37, P33, DOI 10.1016/j.bcmd.2006.04.004; Cruz E, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-97; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; DESOUSA M, 1988, ANN NY ACAD SCI, V526, P310; DESOUSA M, 1994, IMMUNOL LETT, V39, P105, DOI 10.1016/0165-2478(94)90094-9; DESOUSA M, 1991, CURR STUD HEMATOL BL, V58, P171; DESOUSA M, 1978, AM J PATHOL, V90, P497; Dhanji S, 2004, BLOOD, V104, P2116, DOI 10.1182/blood-2004-01-0150; Fabio G, 2002, J HEPATOL, V37, P753, DOI 10.1016/S0168-8278(02)00276-3; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Green A, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-15; HASKINS D, 1952, J CLIN INVEST, V31, P543, DOI 10.1172/JCI102639; Khammanivong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069395; Lim SC, 2011, YONSEI MED J, V52, P581, DOI 10.3349/ymj.2011.52.4.581; Lima M, 2000, Blood Cells Mol Dis, V26, P634, DOI 10.1006/bcmd.2000.0342; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Macedo MF, 2010, CLIN EXP IMMUNOL, V159, P363, DOI 10.1111/j.1365-2249.2009.04066.x; Mina-Osorio P, 2004, TRENDS IMMUNOL, V25, P529, DOI 10.1016/j.it.2004.08.008; Monteiro M, 2007, BLOOD, V109, P2863, DOI 10.1182/blood-2006-06-027060; Nakayama T, 2012, ANTICANCER RES, V32, P1367; Nielsen JS, 2012, SCAND J IMMUNOL, V75, P193, DOI 10.1111/j.1365-3083.2011.02613.x; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Pinto JP, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00024; Porto B, 2009, MUTAT RES-GEN TOX EN, V673, P37, DOI 10.1016/j.mrgentox.2008.11.016; PORTO G, 1994, EUR J HAEMATOL, V52, P283; Porto G, 1997, HEPATOLOGY, V25, P397, DOI 10.1002/hep.510250223; Porto G, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P51; Porto G, 2007, WORLD J GASTROENTERO, V13, P4707, DOI 10.3748/wjg.v13.i35.4707; REIMAO R, 1991, CR ACAD SCI III-VIE, V313, P481; Reuben A, 2014, EUR J IMMUNOL, V44, P1604, DOI 10.1002/eji.201343955; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Saadeldien HM, 2012, ULTRASTRUCT PATHOL, V36, P89, DOI 10.3109/01913123.2011.630125; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Schroll A, 2012, EUR J IMMUNOL, V42, P3346, DOI 10.1002/eji.201142351; SIMON M, 1987, AM J HUM GENET, V41, P89; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439	54	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124246	10.1371/journal.pone.0124246	http://dx.doi.org/10.1371/journal.pone.0124246			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880808	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500092
J	Ferrieri, AP; Appel, HM; Schultz, JC				Ferrieri, Abigail P.; Appel, Heidi M.; Schultz, Jack C.			Plant Vascular Architecture Determines the Pattern of Herbivore-Induced Systemic Responses in Arabidopsis thaliana	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; DEVELOPING LEAVES; OPTIMAL DEFENSE; WOUND RESPONSE; INDUCTION; ONTOGENY; PHLOEM; GROWTH; ACID; GENE	The induction of systemic responses in plants is associated with the connectivity between damaged and undamaged leaves, as determined by vascular architecture. Despite the widespread appreciation for studying variation in induced plant defense, few studies have characterized spatial variability of induction in the model species, Arabidopsis thaliana. Here we show that plant architecture generates fine scale spatial variation in the systemic induction of invertase and phenolic compounds. We examined whether the arrangement of leaves along the stem (phyllotaxy) produces predictable spatial patterns of cell-wall bound and soluble invertase activities, and downstream phenolic accumulation following feeding by the dietary specialist herbivore, Pieris rapae and the generalist, Spodoptera exigua. Responses were measured in leaves within and outside of the damaged orthostichy (leaves sharing direct vascular connections), and compared to those from plants where source-sink transport was disrupted by source leaf removal and by an insertional mutation in a sucrose transporter gene (suc2-1). Following herbivore damage to a single, middle-aged leaf, induction of cell-wall and soluble invertase was most pronounced in young and old leaves within the damaged orthostichy. The pattern of accumulation of phenolics was also predicted by these vascular connections and was, in part, dependent on the presence of source leaves and intact sucrose transporter function. Induction also occurred in leaves outside of the damaged orthostichy, suggesting that mechanisms may exist to overcome vascular constraints in this system. Our results demonstrate that systemic responses vary widely according to orthostichy, are often herbivore-specific, and partially rely on transport between source and sink leaves. We also provide evidence that patterns of induction are more integrated in A. thaliana than previously described. This work highlights the importance of plant vascular architecture in determining patterns of systemic induction, which is likely to be ecologically important to insect herbivores and plant pathogens.	[Ferrieri, Abigail P.] Max Planck Inst Chem Ecol, Root Herbivore Interact Grp, Jena, Germany; [Appel, Heidi M.; Schultz, Jack C.] Univ Missouri, Div Plant Sci, Bond Life Sci Ctr, Columbia, MO USA	Max Planck Society; University of Missouri System; University of Missouri Columbia	Ferrieri, AP (corresponding author), Max Planck Inst Chem Ecol, Root Herbivore Interact Grp, Jena, Germany.	aferrieri@ice.mpg.de	Schultz, Jack C./V-8661-2019		National Science Foundation [IOS-0805272]; University of Missouri Life Sciences Fellowship Program	National Science Foundation(National Science Foundation (NSF)); University of Missouri Life Sciences Fellowship Program	Research was supported by National Science Foundation grant IOS-0805272 to JCS and HMA, and the University of Missouri Life Sciences Fellowship Program, which supported APF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, J CHEM ECOL, V25, P2285, DOI 10.1023/A:1020821823794; Appel HM, 2001, J CHEM ECOL, V27, P761, DOI 10.1023/A:1010306103643; Appel HM, 2014, FRONT PLANT IN PRESS; Arnold T, 2004, NEW PHYTOL, V164, P157, DOI 10.1111/j.1469-8137.2004.01157.x; Arnold TM, 2012, PLANT SIGNAL BEHAV, V7, P1498, DOI 10.4161/psb.21900; Arnold TM, 2002, OECOLOGIA, V130, P585, DOI 10.1007/s00442-001-0839-7; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Bowles D, 1998, PHILOS T R SOC B, V353, P1495, DOI 10.1098/rstb.1998.0305; CALLOS JD, 1994, PLANT J, V6, P1, DOI 10.1046/j.1365-313X.1994.6010001.x; Choi S, 2009, PLANT SCI, V176, P678, DOI 10.1016/j.plantsci.2009.02.010; Cipollini DF, 2000, J CHEM ECOL, V26, P1411, DOI 10.1023/A:1005540107957; DAVIS JM, 1991, P NATL ACAD SCI USA, V88, P2393, DOI 10.1073/pnas.88.6.2393; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Ferrieri AP, 2013, PLANT PHYSIOL, V161, P692, DOI 10.1104/pp.112.208868; Ferrieri AP, 2012, NUCL MED BIOL, V39, P1152, DOI 10.1016/j.nucmedbio.2012.06.005; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Hanik N, 2010, J CHEM ECOL, V36, P1058, DOI 10.1007/s10886-010-9835-x; Haritatos E, 2000, PLANTA, V211, P105, DOI 10.1007/s004250000268; HARPER JL, 1989, OECOLOGIA, V80, P53, DOI 10.1007/BF00789931; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Kearsley MJC, 1998, ECOLOGY, V79, P178, DOI 10.1890/0012-9658(1998)079[0178:TDSOCA]2.0.CO;2; Kiefer IW, 2003, PLANT PHYSIOL, V132, P840, DOI 10.1104/pp.103.021709; Kozlowski T.T., 1997, GROWTH CONTROL WOODY, P352; LARSON PR, 1973, PLANTA, V111, P95, DOI 10.1007/BF00386270; McCartney N., 2007, ANAL PIERIS RAPAE SP; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; Orians C, 2005, J CHEM ECOL, V31, P2231, DOI 10.1007/s10886-005-7099-7; Orians CM, 2000, J CHEM ECOL, V26, P471, DOI 10.1023/A:1005469724427; Orians CM, 2001, OIKOS, V94, P493, DOI 10.1034/j.1600-0706.2001.940311.x; Rehrig EM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00407; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Rhodes JD, 1999, ANN BOT-LONDON, V84, P109, DOI 10.1006/anbo.1999.0900; Richard S, 2000, PLANT CELL PHYSIOL, V41, P982, DOI 10.1093/pcp/pcd017; Roberts K, 2007, NEW PHYTOL, V175, P707, DOI 10.1111/j.1469-8137.2007.02136.x; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Schittko U, 2003, J CHEM ECOL, V29, P763, DOI 10.1023/A:1022833022672; Schultz J.C., 1983, P61; Schultz JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00324; SCHULTZ JC, 1982, SCIENCE, V217, P149, DOI 10.1126/science.217.4555.149; Shao L, 2008, FUNCT PLANT BIOL, V35, P714, DOI 10.1071/FP08069; SHULAEV V, 1995, PLANT CELL, V7, P1691, DOI 10.1105/tpc.7.10.1691; Stadler R, 1996, BOT ACTA, V109, P299, DOI 10.1111/j.1438-8677.1996.tb00577.x; Steinbrenner AD, 2011, J CHEM ECOL, V37, P1294, DOI 10.1007/s10886-011-0042-1; Stratmann JW, 2003, TRENDS PLANT SCI, V8, P247, DOI 10.1016/S1360-1385(03)00106-7; Thorpe Michael, 2005, P201, DOI 10.1016/B978-012088457-5/50012-5; Thorpe MR, 2007, PLANTA, V226, P541, DOI 10.1007/s00425-007-0503-5; Turgeon R, 2006, BIOSCIENCE, V56, P15, DOI 10.1641/0006-3568(2006)056[0015:PLHLGT]2.0.CO;2; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; Viswanathan DV, 2004, J CHEM ECOL, V30, P531, DOI 10.1023/B:JOEC.0000018627.26420.e0; Whitham T.G., 1983, P15; WHITHAM TG, 1981, OECOLOGIA, V49, P287, DOI 10.1007/BF00347587	57	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123899	10.1371/journal.pone.0123899	http://dx.doi.org/10.1371/journal.pone.0123899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879926	gold, Green Submitted, Green Published			2022-12-26	WOS:000353016500065
J	Schriever, TA				Schriever, Tiffany A.			Food Webs in Relation to Variation in the Environment and Species Assemblage: A Multivariate Approach	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; COMMUNITY-WIDE MEASURES; CHAIN LENGTH; ECOSYSTEM SIZE; DELTA-N-15; HYDROPERIOD; TEMPERATURE; DISTURBANCE; MECHANISMS; ENRICHMENT	The abiotic environment has strong influences on the growth, survival, behavior, and ecology of aquatic organisms. Biotic interactions and species life histories interact with abiotic factors to structure the food web. One measure of food-web structure is food-chain length. Several hypotheses predict a linear relationship between one environmental variable (e.g., disturbance or ecosystem size) and food-chain length. However, many abiotic and biotic variables interact in diverse ways to structure a community, and may affect other measures of food web structure besides food-chain length. This study took a multivariate approach to test the influence of several important environmental variables on four food-web characteristics measured in nine ponds along a hydroperiod gradient over two years. This approach allowed for testing the ecosystem size and dynamic constraints hypotheses while in context of other possibly interacting environmental variables. The relationship between amphibian and invertebrate communities and pond habitat variables was assessed to understand the underlying food-web structure. Hydroperiod and pond area had a strong influence on amphibian and invertebrate communities, trophic diversity and delta N-15 range. The range in delta C-13 values responded strongly to dissolved oxygen. Food-chain length responded to multiple environmental variables. Invertebrate and amphibian communities were structured by pond hydroperiod which in turn influenced the trophic diversity of the food web. The results of this study suggest food-chain length is influenced by environmental variation and species assemblage and that a multivariate approach may allow us to better understand the dynamics within and across aquatic food webs.	[Schriever, Tiffany A.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	Schriever, TA (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	tiffany.schriever@gmail.com			Natural Sciences and engineering research council of Canada; Center for Global Change Science at the University of Toronto; Chicago Herpetological Society	Natural Sciences and engineering research council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Center for Global Change Science at the University of Toronto; Chicago Herpetological Society	The author was supported by Ph.D. advisor (DD Williams, Natural Sciences and engineering research council of Canada Discovery Grant) from 2007 to 2011 to complete the research detailed in this study. TAS received small grants including a graduate student research award in 2009 from the Center for Global Change Science at the University of Toronto and a grant from the Chicago Herpetological Society in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTIG R, 1984, HERPETOLOGICA, V40, P212; ALTIG R, 1970, Herpetologica, V26, P180; [Anonymous], 2010, SALAMANDERS US CANAD; Barber C., 2012, GEOMETRY MESH GENERA; Batzer DP, 1996, ANNU REV ENTOMOL, V41, P75, DOI 10.1146/annurev.en.41.010196.000451; Beveridge OS, 2010, J ANIM ECOL, V79, P693, DOI 10.1111/j.1365-2656.2010.01662.x; Blaustein L, 2001, ISR J ZOOL, V47, P303, DOI 10.1560/CKMU-Q2PM-HTGC-P9C8; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; FRY B, 1991, ECOLOGY, V72, P2293, DOI 10.2307/1941580; Gotelli NJ, 2013, ECOSIMR 1 00; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Hoeinghaus DJ, 2008, ECOLOGY, V89, P2353, DOI 10.1890/07-1143.1; Hoekman D, 2010, ECOLOGY, V91, P2819, DOI 10.1890/10-0260.1; JACKSON DA, 1993, CAN J FISH AQUAT SCI, V50, P2641, DOI 10.1139/f93-287; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Magnusson AK, 2006, ARCH HYDROBIOL, V165, P537, DOI 10.1127/0003-9136/2006/0165-0537; Marshall SA, 2006, INSECTS NATURAL HIST; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Merritt R.W., 1996, INTRO AQUATIC INSECT; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; O'Neill BJ, 2014, FRESHWATER BIOL, V59, P1462, DOI 10.1111/fwb.12358; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Persson Lennart, 1996, P396; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; PIMM SL, 1982, FOOD WEBS; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2007, OIKOS, V116, P775, DOI 10.1111/j.2007.0030-1299.15552.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; R Core Team, 2013, LANG ENV STAT COMP, DOI [DOI 10.3758/S13428-013-0330-5, 10.3758/s13428-013-0330-5]; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Schneider DW, 1996, J N AM BENTHOL SOC, V15, P64, DOI 10.2307/1467433; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Schriever TA, 2013, FRESHW SCI, V32, P964, DOI 10.1899/13-008.1; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; SYSTAT, 2007, MYSTAT; Takimoto G, 2012, ECOL RES, P1; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Walters AW, 2008, ECOLOGY, V89, P3261, DOI 10.1890/08-0273.1; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Williams DD., 2006, BIOL TEMPORARY WATER; Winemiller KO, 2007, MAR ECOL PROG SER, V343, P63, DOI 10.3354/meps06884	54	12	12	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122719	10.1371/journal.pone.0122719	http://dx.doi.org/10.1371/journal.pone.0122719			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880079	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500026
J	Garczyk, S; von Stillfried, S; Antonopoulos, W; Hartmann, A; Schrauder, MG; Fasching, PA; Anzeneder, T; Tannapfel, A; Ergonenc, Y; Knuchel, R; Rose, M; Dahl, E				Garczyk, Stefan; von Stillfried, Saskia; Antonopoulos, Wiebke; Hartmann, Arndt; Schrauder, Michael G.; Fasching, Peter A.; Anzeneder, Tobias; Tannapfel, Andrea; Ergoenenc, Yavuz; Knuechel, Ruth; Rose, Michael; Dahl, Edgar			AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection	PLOS ONE			English	Article							MONITORING TREATMENT RESPONSES; XENOPUS CEMENT GLAND; ANTERIOR GRADIENT-2; ESTROGEN-RECEPTOR; OVARIAN-CANCER; HUMAN HOMOLOG; PROTEIN; TUMOR; MAMMOGRAPHY; GENE	Blood-based early detection of breast cancer has recently gained novel momentum, as liquid biopsy diagnostics is a fast emerging field. In this study, we aimed to identify secreted proteins which are up-regulated both in tumour tissue and serum samples of breast cancer patients compared to normal tissue and sera. Based on two independent tissue cohorts (n = 75 and n = 229) and one serum cohort (n = 80) of human breast cancer and healthy serum samples, we characterised AGR3 as a novel potential biomarker both for breast cancer prognosis and early breast cancer detection from blood. AGR3 expression in breast tumours is significantly associated with oestrogen receptor a (P<0.001) and lower tumour grade (P<0.01). Interestingly, AGR3 protein expression correlates with unfavourable outcome in low (G1) and intermediate (G2) grade breast tumours (multivariate hazard ratio: 2.186, 95% CI: 1.008-4.740, P<0.05) indicating an independent prognostic impact. In sera analysed by ELISA technique, AGR3 protein concentration was significantly (P<0.001) elevated in samples from breast cancer patients (n = 40, mainly low stage tumours) compared to healthy controls (n = 40). To develop a suitable biomarker panel for early breast cancer detection, we measured AGR2 protein in human serum samples in parallel. The combined AGR3/AGR2 biomarker panel achieved a sensitivity of 64.5% and a specificity of 89.5% as shown by receiver operating characteristic (ROC) curve statistics. Thus our data clearly show the potential usability of AGR3 and AGR2 as biomarkers for blood-based early detection of human breast cancer.	[Garczyk, Stefan; von Stillfried, Saskia; Antonopoulos, Wiebke; Knuechel, Ruth; Rose, Michael; Dahl, Edgar] Rhein Westfal TH Aachen, Inst Pathol, Fac Med, Mol Oncol Grp, Aachen, Germany; [Hartmann, Arndt] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany; [Schrauder, Michael G.; Fasching, Peter A.] Univ Hosp Erlangen, Dept Obstet & Gynaecol, Erlangen, Germany; [Anzeneder, Tobias] Patients Tumor Bank Hope PATH Fdn, Munich, Germany; [Tannapfel, Andrea] Ruhr Univ Bochum, Inst Pathol, Bochum, Germany; [Ergoenenc, Yavuz] St Anna Hosp, Dept Senol, Herne, Germany	RWTH Aachen University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Ruhr University Bochum; Saint Anna Hospital	Dahl, E (corresponding author), Rhein Westfal TH Aachen, Inst Pathol, Fac Med, Mol Oncol Grp, Aachen, Germany.	edahl@ukaachen.de	Garczyk, Stefan/AAD-3755-2019; Fasching, Peter A/ABH-9912-2020	Fasching, Peter A/0000-0003-4885-8471; von Stillfried, Saskia/0000-0002-5260-8494	INTERREG IV-A MicroBioMed [EMR. INT4-1.2.-2009-11/058]	INTERREG IV-A MicroBioMed	Funding provided by INTERREG IV-A MicroBioMed EMR. INT4-1.2.-2009-11/058 (ED), http://www.interregemr.eu/, http://www.microbiomed.ulg.ac.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Barraclough DL, 2009, AM J PATHOL, V175, P1848, DOI 10.2353/ajpath.2009.090246; Berg WA, 2009, AM J ROENTGENOL, V192, P390, DOI 10.2214/AJR.08.1706; Bradley L, 1996, DEVELOPMENT, V122, P2739; Brychtova V, 2014, EXP MOL PATHOL, V96, P375, DOI 10.1016/j.yexmp.2014.04.002; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Chignard N, 2006, GASTROENTEROLOGY, V130, P2010, DOI 10.1053/j.gastro.2006.02.058; Chikkaveeraiah BV, 2012, ACS NANO, V6, P6546, DOI 10.1021/nn3023969; Chung K, 2011, CANCER BIOMARK, V10, P101, DOI 10.3233/CBM-2012-0234; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; DERSHAW DD, 1995, AM J ROENTGENOL, V164, P309, DOI 10.2214/ajr.164.2.7839960; Edgell TA, 2010, CLIN SCI, V118, P717, DOI 10.1042/CS20090537; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Graham LJ, 2014, J CANCER, V5, P58, DOI 10.7150/jca.7047; Gray TA, 2012, J IMMUNOL METHODS, V378, P20, DOI 10.1016/j.jim.2012.01.013; Guiu S, 2012, ANN ONCOL, V23, P2997, DOI 10.1093/annonc/mds586; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hooley RJ, 2011, ULTRASOUND Q, V27, P23, DOI 10.1097/RUQ.0b013e31820e15ac; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Innes HE, 2006, BRIT J CANCER, V94, P1057, DOI 10.1038/sj.bjc.6603065; Ivanova AS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01279; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kani K, 2013, PROSTATE, V73, P306, DOI 10.1002/pros.22569; King ER, 2011, AM J SURG PATHOL, V35, P904, DOI 10.1097/PAS.0b013e318212ae22; Kloten V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3375; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Makawita S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-404; Otieno BA, 2014, BIOSENS BIOELECTRON, V53, P268, DOI 10.1016/j.bios.2013.09.054; Park K, 2011, EXP MOL MED, V43, P91, DOI 10.3858/emm.2011.43.2.011; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pascal LE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-452; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; REMMELE W, 1987, PATHOLOGE, V8, P138; Shupe MP, 2014, J CANCER, V5, P69, DOI 10.7150/jca.7048; Sive H, 1996, DEV DYNAM, V205, P265, DOI 10.1002/(SICI)1097-0177(199603)205:3<265::AID-AJA7>3.0.CO;2-G; Sobin L. H., 1997, TNM CLASSIFICATION M; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Thuma F, 2013, MOL ONCOL, V7, P917, DOI 10.1016/j.molonc.2013.05.002; Waldmann A, 2014, GEBURTSH FRAUENHEILK, V74, P361, DOI 10.1055/s-0033-1360263; Ying L, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-76; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhang PJ, 2014, INT J CANCER, V134, P2646, DOI 10.1002/ijc.28584	58	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122106	10.1371/journal.pone.0122106	http://dx.doi.org/10.1371/journal.pone.0122106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875093	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800040
J	Gervasoni, C; Meraviglia, P; Minisci, D; Ferraris, L; Riva, A; Landonio, S; Cozzi, V; Charbe, N; Molinari, L; Rizzardini, G; Clementi, E; Galli, M; Cattaneo, D				Gervasoni, Cristina; Meraviglia, Paola; Minisci, Davide; Ferraris, Laurenzia; Riva, Agostino; Landonio, Simona; Cozzi, Valeria; Charbe, Nitin; Molinari, Lara; Rizzardini, Giuliano; Clementi, Emilio; Galli, Massimo; Cattaneo, Dario			Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?	PLOS ONE			English	Article							RITONAVIR-BOOSTED ATAZANAVIR; UNBOOSTED ATAZANAVIR; ANTIRETROVIRAL THERAPY; RENAL STONES; EFFICACY; PHARMACOKINETICS; HYPERBILIRUBINEMIA; TOLERABILITY; POLYMORPHISM; BILIRUBIN	Introduction Ritonavir-boosted atazanavir (ATV/r) is a relatively well tolerated antiretroviral drug. However, side effects including hyperbilirubinemia, dyslipidemia, nephrolithiasis and cholelithiasis have been reported in the medium and long term. Unboosted ATV may be selected for some patients because it has fewer gastrointestinal adverse effects, less hyperbilirubinemia and less impact on lipid profiles. Methods We investigated the distribution of ATV plasma trough concentrations according to drug dosage and the potential relationship between ATV plasma trough concentrations and drug-related adverse events in a consecutive series of 240 HIV-infected patients treated with ATV/r 300/100 mg (68%) or ATV 400 mg (32%). Results 43.9% of patients treated with ATV/r 300/100 mg had ATV concentrations exceeding the upper therapeutic threshold. A significant and direct association has been observed between the severity of hyperbilirubinemia and ATV plasma trough concentrations (ATV concentrations: 271 [77-555], 548 [206-902], 793 [440-1164], 768 [494-1527] and 1491 [1122-1798] ng/mL in patients with grade 0, 1, 2, 3 and 4 hyperbilirubinemia, respectively). In an exploratory analysis we found that patients with dyslipidemia or nephrolitiasis had ATV concentrations significantly higher (582 [266-1148], and 1098 [631-1238] ng/mL, respectively) (p<0.001), as compared with patients with no ATV-related complications (218 [77-541] ng/mL). Conclusions A significant proportion of patients treated with the conventional dosage of ATV (300/100) had plasma concentrations exceeding the upper therapeutic threshold. These patients that are at high risk to experience ATV-related complications may benefit from TDM-driven adjustments in ATV dosage with potential advantages in terms of costs and toxicity.	[Gervasoni, Cristina; Meraviglia, Paola; Minisci, Davide; Ferraris, Laurenzia; Riva, Agostino; Landonio, Simona; Molinari, Lara; Rizzardini, Giuliano; Galli, Massimo] L Sacco Univ Hosp, Dept Infect Dis, Milan, Italy; [Cozzi, Valeria; Charbe, Nitin; Cattaneo, Dario] L Sacco Univ Hosp, Clin Pharmacol Unit, Milan, Italy; [Clementi, Emilio] Univ Milan, L Sacco Univ Hosp, Dept Biomed & Clin Sci, Clin Pharmacol Unit,Consiglio Nazl Ric,Inst Neuro, Milan, Italy; [Clementi, Emilio] E Medea Sci Inst, Bosisio Parini, Italy; [Rizzardini, Giuliano] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; Consiglio Nazionale delle Ricerche (CNR); University of Milan; Luigi Sacco Hospital; IRCCS Eugenio Medea; University of Witwatersrand	Gervasoni, C (corresponding author), L Sacco Univ Hosp, Dept Infect Dis, Milan, Italy.	cristina.gervasoni@unimi.it	Cattaneo, Dario/J-9265-2016; charbe, nitin/ABH-3390-2020; GALLI, MASSIMO/L-7282-2017	charbe, nitin/0000-0001-6959-2305; FERRARIS, LAURENZIA/0000-0003-0721-512X; GALLI, MASSIMO/0000-0001-8887-6215; Riva, Agostino/0000-0003-3171-3049; meraviglia, paola/0000-0002-3356-7199				Anderson PL, 2007, AIDS, V21, P1060, DOI 10.1097/QAD.0b013e3280c56ae1; Anderson PL, 2009, J ANTIMICROB CHEMOTH, V64, P1071, DOI 10.1093/jac/dkp317; Carey D, 2010, J ANTIMICROB CHEMOTH, V65, P1878, DOI 10.1093/jac/dkq231; Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Chang HR, 2006, NEW ENGL J MED, V355, P2158, DOI 10.1056/NEJMc061892; Cleijsen RMM, 2007, J ANTIMICROB CHEMOTH, V60, P897, DOI 10.1093/jac/dkm298; De Nicolo A, 2014, ANTIMICROB AGENTS CH, V58, P4042, DOI 10.1128/AAC.00104-14; European AIDS Clinical Society, 2013, GUID VERS OCT 2013; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Fayet A, 2009, J CHROMATOGR B, V877, P1057, DOI 10.1016/j.jchromb.2009.02.057; FDA guidance for industry-Bioanalytical methdod validation, 2001, FDA GUID IND BIOAN M; Ferraris L, 2012, J ANTIMICROB CHEMOTH, V67, P2236, DOI 10.1093/jac/dks175; Foca E, 2012, DRUGS, V72, P1161, DOI 10.2165/11631070-000000000-00000; Gianotti N, 2005, NEW MICROBIOL, V28, P119; Gonzalez de Requena D, 2005, 12 C RETR OPP INF BO; Hamada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069845; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Jansen K, 2013, AIDS RES HUM RETROV, V29, P564, DOI [10.1089/aid.2012.0092, 10.1089/AID.2012.0092]; Laprise C, 2013, AIDS PATIENT CARE ST, V27, P378, DOI 10.1089/apc.2013.0009; Le Tiec C, 2005, CLIN PHARMACOKINET, V44, P1035, DOI 10.2165/00003088-200544100-00003; Lennox JL, 2014, ANN INTERN MED, V161, P461, DOI 10.7326/M14-1084; Nishijima T, 2013, J ANTIMICROB CHEMOTH; Pacanowski J, 2006, AIDS, V20, P2131, DOI 10.1097/01.aids.0000247571.88256.90; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Podzamczer D, 2011, HIV MED, V12, P374, DOI 10.1111/j.1468-1293.2011.00917.x; Rockwood N, 2011, AIDS, V25, P1671, DOI 10.1097/QAD.0b013e32834a1cd6; Rotger M, 2005, J INFECT DIS, V192, P1381, DOI 10.1086/466531; Schipani A, 2010, ANTIMICROB AGENTS CH, V54, P5242, DOI 10.1128/AAC.00781-10; Smith DE, 2006, HIV CLIN TRIALS, V7, P34, DOI 10.1310/0KX0-H9VH-99EE-5D0L; Solas C, 2008, THER DRUG MONIT, V30, P670, DOI 10.1097/FTD.0b013e3181897bff; Van Schaik RHN, 2002, CLIN CHEM, V48, P1668; Wempe MF, 2011, DRUG METAB DISPOS, V39, P522, DOI 10.1124/dmd.110.036178	32	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123670	10.1371/journal.pone.0123670	http://dx.doi.org/10.1371/journal.pone.0123670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875091	gold, Green Published			2022-12-26	WOS:000353015800109
J	Kamboj, SK; Krol, KM; Curran, HV				Kamboj, Sunjeev K.; Krol, Kathleen M.; Curran, H. Valerie			A Specific Association between Facial Disgust Recognition and Estradiol Levels in Naturally Cycling Women	PLOS ONE			English	Article							MENSTRUAL-CYCLE; EMOTION RECOGNITION; SEX-DIFFERENCES; PROGESTERONE; EXPRESSIONS; SENSITIVITY; DISCRIMINATION; ACCURACY; DISPLAYS; HORMONES	Subtle changes in social cognition are associated with naturalistic fluctuations in estrogens and progesterone over the course of the menstrual cycle. Using a dynamic emotion recognition task we aimed to provide a comprehensive description of the association between ovarian hormone levels and emotion recognition performance using a variety of performance metrics. Naturally cycling, psychiatrically healthy women attended a single experimental session during a follicular (days 7-13; n = 16), early luteal (days 15-19; n = 14) or late luteal phase (days 22-27; n = 14) of their menstrual cycle. Correct responses and reaction times to dynamic facial expressions were recorded and a two-high threshold analysis was used to assess discrimination and response bias. Salivary progesterone and estradiol were assayed and subjective measures of premenstrual symptoms, anxiety and positive and negative affect assessed. There was no interaction between cycle phase (follicular, early luteal, late luteal) and facial expression (sad, happy, fearful, angry, neutral and disgusted) on any of the recognition performance metrics. However, across the sample as a whole, progesterone levels were positively correlated with reaction times to a variety of facial expressions (anger, happiness, sadness and neutral expressions). In contrast, estradiol levels were specifically correlated with disgust processing on three performance indices (correct responses, response bias and discrimination). Premenstrual symptoms, anxiety and positive and negative affect were not associated with emotion recognition indices or hormone levels. The study highlights the role of naturalistic variations in ovarian hormone levels in modulating emotion recognition. In particular, progesterone seems to have a general slowing effect on facial expression processing. Our findings also provide the first behavioural evidence of a specific role for estrogens in the processing of disgust in humans.	[Kamboj, Sunjeev K.; Krol, Kathleen M.; Curran, H. Valerie] UCL, Res Dept Clin Educ & Hlth Psychol, London, England	University of London; University College London	Kamboj, SK (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.	sunjeev.kamboj@ucl.ac.uk	Krol, Kathleen/L-1817-2019	Krol, Kathleen/0000-0002-8098-3195; Kamboj, Sunjeev/0000-0003-2197-0826	UCL	UCL	The study was funded entirely by UCL. UCL had no role in study design data collection, analysis, decision to publish or preparation of the manuscript	Bao AM, 2003, EUR J ENDOCRINOL, V148, P227, DOI 10.1530/eje.0.1480227; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; Choleris E, 2012, FRONT NEUROENDOCRIN, V33, P140, DOI 10.1016/j.yfrne.2012.02.001; Conway CA, 2007, HORM BEHAV, V51, P202, DOI 10.1016/j.yhbeh.2006.10.002; Derntl B, 2008, PSYCHONEUROENDOCRINO, V33, P1031, DOI 10.1016/j.psyneuen.2008.04.014; Derntl B, 2008, HORM BEHAV, V53, P90, DOI 10.1016/j.yhbeh.2007.09.006; Derntl B, 2013, HORM BEHAV, V63, P97, DOI 10.1016/j.yhbeh.2012.10.009; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fessler DMT, 2003, EVOL HUM BEHAV, V24, P406, DOI 10.1016/S1090-5138(03)00054-0; Fleischman DS, 2011, HORM BEHAV, V59, P271, DOI 10.1016/j.yhbeh.2010.11.014; Guapo VG, 2009, PSYCHONEUROENDOCRINO, V34, P1087, DOI 10.1016/j.psyneuen.2009.02.007; Harmer CJ, 2011, J PSYCHOPHARMACOL, V25, P1148, DOI 10.1177/0269881110367722; Kamboj SK, 2013, PSYCHOPHARMACOLOGY, V227, P31, DOI 10.1007/s00213-012-2940-5; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Lee NC, 2013, EMOTION, V13, P1030, DOI 10.1037/a0033560; Liening SH, 2010, PHYSIOL BEHAV, V99, P8, DOI 10.1016/j.physbeh.2009.10.001; Little AC, 2013, FRONT NEUROENDOCRIN, V34, P315, DOI 10.1016/j.yfrne.2013.07.009; Lynn SK, 2014, PSYCHOL SCI; Maner JK, 2014, EVOL HUM BEHAV, V35, P9, DOI 10.1016/j.evolhumbehav.2013.09.001; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Pearson R, 2005, HORM BEHAV, V47, P267, DOI 10.1016/j.yhbeh.2004.11.003; Platt B, 2010, DRUG ALCOHOL DEPEN, V112, P27, DOI 10.1016/j.drugalcdep.2010.05.004; Pollak SD, 2000, DEV PSYCHOL, V36, P679, DOI 10.1037//0012-1649.36.5.679; Puts DA, 2006, HUM NATURE-INT BIOS, V17, P114, DOI 10.1007/s12110-006-1023-x; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Rubinow DR, 2007, J AFFECT DISORDERS, V104, P37, DOI 10.1016/j.jad.2007.01.031; Soni M, 2013, NEUROBIOL LEARN MEM, V104, P32, DOI 10.1016/j.nlm.2013.04.003; Spielberger C, 1983, STAI MANUAL STATE TR; Steiner M, 1997, ANNU REV MED, V48, P447, DOI 10.1146/annurev.med.48.1.447; Steiner M, 2011, J AFFECT DISORDERS, V135, P82, DOI 10.1016/j.jad.2011.06.058; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Toffoletto S, 2014, PSYCHONEUROENDOCRINO, V50, P28, DOI 10.1016/j.psyneuen.2014.07.025; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van Wingen G, 2007, J NEUROSCI, V27, P11416, DOI 10.1523/JNEUROSCI.1715-07.2007; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	38	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122311	10.1371/journal.pone.0122311	http://dx.doi.org/10.1371/journal.pone.0122311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874795	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800050
J	Swiatek-Polatynska, MA; Bucca, G; Laing, E; Gubbens, J; Titgemeyer, F; Smith, CP; Rigali, S; van Wezel, GP				Swiatek-Polatynska, Magdalena A.; Bucca, Giselda; Laing, Emma; Gubbens, Jacob; Titgemeyer, Fritz; Smith, Colin P.; Rigali, Sebastien; van Wezel, Gilles P.			Genome-Wide Analysis of In Vivo Binding of the Master Regulator DasR in Streptomyces coelicolor Identifies Novel Non-Canonical Targets	PLOS ONE			English	Article							AERIAL MYCELIUM FORMATION; N-ACETYLGLUCOSAMINE METABOLISM; CARBON CATABOLITE REPRESSION; AMP RECEPTOR PROTEIN; ANTIBIOTIC PRODUCTION; ESCHERICHIA-COLI; MORPHOLOGICAL-DIFFERENTIATION; PHOSPHOTRANSFERASE SYSTEM; BACILLUS-SUBTILIS; GLUCOSE KINASE	Streptomycetes produce a wealth of natural products, including over half of all known antibiotics. It was previously demonstrated that N-acetylglucosamine and secondary metabolism are closely entwined in streptomycetes. Here we show that DNA recognition by the N-acetylglucosamine-responsive regulator DasR is growth-phase dependent, and that DasR can bind to sites in the S. coelicolor genome that have no obvious resemblance to previously identified DasR-responsive elements. Thus, the regulon of DasR extends well beyond what was previously predicted and includes a large number of genes with functions far removed from N-acetylglucosamine metabolism, such as genes for small RNAs and DNA transposases. Conversely, the DasR regulon during vegetative growth largely correlates to the presence of canonical DasR-responsive elements. The changes in DasR binding in vivo following N-acetylglucosamine induction were studied in detail and a possible molecular mechanism by which the influence of DasR is extended is discussed. Discussion of DasR binding was further informed by a parallel transcriptome analysis of the respective cultures. Evidence is provided that DasR binds directly to the promoters of all genes encoding pathway-specific regulators of antibiotic production in S. coelicolor, thereby providing an exquisitely simple link between nutritional control and secondary metabolism.	[Swiatek-Polatynska, Magdalena A.; Gubbens, Jacob; van Wezel, Gilles P.] Leiden Univ, Inst Biol Leiden, Mol Biotechnol, NL-2300 RA Leiden, Netherlands; [Bucca, Giselda; Laing, Emma; Smith, Colin P.] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Guildford GU2 7XH, Surrey, England; [Titgemeyer, Fritz] Munster Univ Appl Sci, Dept Oecotrophol, D-48149 Munster, Germany; [Rigali, Sebastien] Univ Liege, Ctr Prot Engn, Inst Chim B6A, B-4000 Liege, Belgium	Leiden University; Leiden University - Excl LUMC; University of Surrey; University of Applied Sciences, Muenster; University of Liege	van Wezel, GP (corresponding author), Leiden Univ, Inst Biol Leiden, Mol Biotechnol, POB 9502, NL-2300 RA Leiden, Netherlands.	g.wezel@biology.leidenuniv.nl	Smith, Colin/AAL-4507-2021; van Wezel, Gilles/ABC-7854-2021	van Wezel, Gilles/0000-0003-0341-1561; Rigali, Sebastien/0000-0003-4022-7325; Bucca, Giselda/0000-0001-5286-7771; Smith, Colin/0000-0001-9042-2263	VENI grant of the Netherlands Technology Foundation STW; VICI grant of the Netherlands Technology Foundation STW; Belgian program of Interuniversity Attraction Poles; Federal Office for Scientific Technical and Cultural Affairs (PAI) [P7/44]; Biotechnology and Biological Sciences Research Council (UK) [BB/D011582]	VENI grant of the Netherlands Technology Foundation STW; VICI grant of the Netherlands Technology Foundation STW; Belgian program of Interuniversity Attraction Poles; Federal Office for Scientific Technical and Cultural Affairs (PAI); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by VENI and VICI grants of the Netherlands Technology Foundation STW to JG and GPvW, respectively, by the Belgian program of Interuniversity Attraction Poles initiated by the Federal Office for Scientific Technical and Cultural Affairs (PAI no. P7/44) and by the Biotechnology and Biological Sciences Research Council (UK) (BB/D011582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenby NEE, 2012, NUCLEIC ACIDS RES, V40, P9543, DOI 10.1093/nar/gks766; Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; ANGELL S, 1994, MOL GEN GENET, V244, P135, DOI 10.1007/BF00283514; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bertram R, 2011, J BACTERIOL, V193, P3525, DOI 10.1128/JB.00264-11; Bibb MJ, 2012, MOL MICROBIOL, V84, P1033, DOI 10.1111/j.1365-2958.2012.08070.x; Bibb MJ, 2000, J BACTERIOL, V182, P4606, DOI 10.1128/JB.182.16.4606-4616.2000; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Bucca G, 2003, MOL MICROBIOL, V50, P153, DOI 10.1046/j.1365-2958.2003.03696.x; Bucca G, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r5; Chakraburtty R, 1997, J BACTERIOL, V179, P5854, DOI 10.1128/jb.179.18.5854-5861.1997; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chater K. F., 1997, BACTERIA MULTICELLUL, P149; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; Claessen D, 2014, NAT REV MICROBIOL, V12, P115, DOI 10.1038/nrmicro3178; Colson S, 2008, MICROBIOL-SGM, V154, P373, DOI 10.1099/mic.0.2007/011940-0; Colson S, 2007, J MOL MICROB BIOTECH, V12, P60, DOI 10.1159/000096460; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Craig M, 2012, ENV MICROBIOL REP; Cruz-Morales P, 2013, GENOME BIOL EVOL, V5, P1165, DOI 10.1093/gbe/evt082; den Hengst CD, 2010, MOL MICROBIOL, V78, P361, DOI 10.1111/j.1365-2958.2010.07338.x; Derouaux A, 2004, J BACTERIOL, V186, P1893, DOI 10.1128/JB.186.6.1893-1897.2004; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Fowler-Goldsworthy K, 2011, MICROBIOL-SGM, V157, P1312, DOI 10.1099/mic.0.047555-0; Gao C, 2012, MBIO, V3, DOI 10.1128/mBio.00407-12; Gao ZY, 2012, INT J BIOL MACROMOL, V50, P1, DOI 10.1016/j.ijbiomac.2011.08.016; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; GRAMAJO HC, 1993, MOL MICROBIOL, V7, P837, DOI 10.1111/j.1365-2958.1993.tb01174.x; Hesketh A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-261; Higo A, 2012, DNA RES, V19, P259, DOI 10.1093/dnares/dss010; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hopwood DA, 2007, STREPTOMYCES NATURE; Hsiao NH, 2007, MICROBIOL-SGM, V153, P1394, DOI 10.1099/mic.0.2006/004432-0; Hutchings MI, 2004, MICROBIOL-SGM, V150, P2795, DOI 10.1099/mic.0.27181-0; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jakimowicz D, 2012, MOL MICROBIOL, V85, P393, DOI 10.1111/j.1365-2958.2012.08107.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Laing Emma, 2010, BMC Res Notes, V3, P221, DOI 10.1186/1756-0500-3-221; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Li WC, 2006, J BACTERIOL, V188, P8368, DOI 10.1128/JB.00933-06; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Mahr K, 2000, ANTON LEEUW INT J G, V78, P253, DOI 10.1023/A:1010234916745; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Nazari B, 2013, APPL ENVIRON MICROB, V79, P707, DOI 10.1128/AEM.02217-12; Nazari B, 2011, FEMS MICROBIOL ECOL, V77, P623, DOI 10.1111/j.1574-6941.2011.01143.x; Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x; Nodwell JR, 1998, J BACTERIOL, V180, P1334, DOI 10.1128/JB.180.5.1334-1337.1998; Noens EE, 2007, MOL MICROBIOL, V64, P1244, DOI 10.1111/j.1365-2958.2007.05732.x; Nothaft H, 2003, J BACTERIOL, V185, P7019, DOI 10.1128/JB.185.23.7019-7023.2003; Nothaft H, 2010, MOL MICROBIOL, V75, P1133, DOI 10.1111/j.1365-2958.2009.07020.x; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Pawlik K, 2007, ARCH MICROBIOL, V187, P87, DOI 10.1007/s00203-006-0176-7; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Piette A, 2005, J PROTEOME RES, V4, P1699, DOI 10.1021/pr050155b; Pullan ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-175; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rigali S, 2006, MOL MICROBIOL, V61, P1237, DOI 10.1111/j.1365-2958.2006.05319.x; Saito A, 2007, APPL ENVIRON MICROB, V73, P3000, DOI 10.1128/AEM.02612-06; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez S, 2010, J ANTIBIOT, V63, P442, DOI 10.1038/ja.2010.78; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Swiatek MA, 2012, J BACTERIOL, V194, P1136, DOI 10.1128/JB.06370-11; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; van Wezel GP, 2007, J MOL MICROB BIOTECH, V12, P67, DOI 10.1159/000096461; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; van Wezel GP, 2009, METHOD ENZYMOL, V458, P117, DOI 10.1016/S0076-6879(09)04805-8; van Wezel GP, 2005, MOL MICROBIOL, V55, P624, DOI 10.1111/j.1365-2958.2004.04413.x; VANWEZEL GP, 1991, NUCLEIC ACIDS RES, V19, P4399, DOI 10.1093/nar/19.16.4399; Vockenhuber MP, 2012, MICROBIOL-SGM, V158, P424, DOI 10.1099/mic.0.054205-0; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Wade JT, 2001, EMBO J, V20, P7160, DOI 10.1093/emboj/20.24.7160; Wang F, 2002, MOL GENET GENOMICS, V268, P344, DOI 10.1007/s00438-002-0749-3; Wang LY, 2003, FEMS MICROBIOL LETT, V220, P21, DOI 10.1016/S0378-1097(03)00044-2; WILLEY J, 1991, CELL, V65, P641, DOI 10.1016/0092-8674(91)90096-H; Wosten HAB, 2000, MICROBIOL-UK, V146, P767, DOI 10.1099/00221287-146-4-767; Zhang Li, 2007, Weishengwu Xuebao, V47, P849; Zhu H, 2014, J IND MICROBIOL BIOT, V41, P371, DOI 10.1007/s10295-013-1309-z	90	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122479	10.1371/journal.pone.0122479	http://dx.doi.org/10.1371/journal.pone.0122479			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875084	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800061
J	Avila, ML; Ward, LC; Feldman, BM; Montoya, MI; Stinson, J; Kiss, A; Brandao, LR				Avila, Maria Laura; Ward, Leigh C.; Feldman, Brian M.; Montoya, Madeline I.; Stinson, Jennifer; Kiss, Alex; Brandao, Leonardo R.			Normal Values for Segmental Bioimpedance Spectroscopy in Pediatric Patients (vol )	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE SPECTROSCOPY; POSTTHROMBOTIC SYNDROME; DIRECTIONAL ASYMMETRY; BILATERAL ASYMMETRY; UPPER-LIMB; VEIN THROMBOSIS; EARLY-DIAGNOSIS; LEG VOLUME; LYMPHEDEMA; CHILDREN	Introduction Localized limb edema is a clinically relevant sign in diseases such as post-thrombotic syndrome and lymphedema. Quantitative evaluation of localized edema in children is mainly done by measuring the absolute difference in limb circumference, which includes fat and fat-free mass. Bioimpedance spectroscopy (BIS) provides information on the fluid volume of a body segment. Our objective was to determine normal ranges for segmental (arm and leg) BIS measurements in healthy children. Additionally, we determined the normal ranges for the difference in arm and ankle circumference and explored the influence of handedness and the correlation between techniques. Methods Healthy children aged 1-18 years were recruited. The ratio of extracellular fluid content between contralateral limbs (estimated as the inter-arm and inter-leg extracellular impedance ratio), and the ratio of extracellular to intracellular fluid content for each limb (estimated as the intracellular to extracellular impedance ratio) were determined with a bioimpedance spectrometer. Arm and ankle circumference was determined with a Gulick II tape. Results We recruited 223 healthy children (48 infants, 54 preschoolers, 66 school-aged children, and 55 teenagers). Normal values for arm and leg BIS measurements, and for the difference in arm and ankle circumference were estimated for each age category. No influence of handedness was found. We found a statistically significant correlation between extracellular impedance ratio and circumference difference for arms among teenagers. Conclusion We determined normal BIS ranges for arms and legs and for the difference in circumference between arms and between ankles in children. There was no statistically significant correlation between extracellular impedance ratio and difference in circumference, except in the case of arms in adolescents. This may indicate that limb circumference measures quantities other than fluid, challenging the adequacy of this technique to determine the presence of localized edema in most age groups.	[Avila, Maria Laura; Feldman, Brian M.; Montoya, Madeline I.; Brandao, Leonardo R.] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Ward, Leigh C.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Feldman, Brian M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5G 1X8, Canada; [Stinson, Jennifer] Univ Toronto, Hosp Sick Children, Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Stinson, Jennifer] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON M5G 1X8, Canada; [Kiss, Alex] Sunnybrook Hlth Sci Ctr, Dept Res Design & Biostat, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Queensland; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Brandao, LR (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada.	leonardo.brandao@sickkids.ca	Ward, Leigh C/L-4461-2019; Ward, Leigh C/A-4834-2010	Ward, Leigh C/0000-0003-2378-279X; Avila, Laura/0000-0002-4340-9645	Physicians' Services Incorporated (PSI) Foundation	Physicians' Services Incorporated (PSI) Foundation	This study was supported by a Health Research Grant from the Physicians' Services Incorporated (PSI) Foundation. The funding institution had no role in the design of the study, data collection or analysis, or manuscript preparation.	Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Beebe HG, 1996, EUR J VASC ENDOVASC, V12, P487, DOI 10.1016/S1078-5884(96)80019-0; Blackburn A, 2011, AM J PHYS ANTHROPOL, V145, P639, DOI 10.1002/ajpa.21555; Boulden BM, 2007, J THROMB HAEMOST, V5, P1077, DOI 10.1111/j.1538-7836.2007.02445.x; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Brodovicz KG, 2009, CLIN MED RES, V7, P21, DOI 10.3121/cmr.2009.819; CDC, SAS PROG CDC GROWTH; Cornish BH, 2002, ANGIOLOGY, V53, P41, DOI 10.1177/000331970205300106; Cornish BH, 2001, LYMPHOLOGY, V34, P2; Cornish BH, 1999, PHYSIOL MEAS, V20, P241, DOI 10.1088/0967-3334/20/3/302; Cornish Bruce, 2006, Lymphatic Research and Biology, V4, P47, DOI 10.1089/lrb.2006.4.47; DARGENTPARE C, 1992, CORTEX, V28, P343, DOI 10.1016/S0010-9452(13)80144-X; Eberley C, FIGURE 8 METHOD MEAS; Edelstein S, 2009, LIFE CYCLE NUTR EVID, Vxxv; FAULKNER RA, 1993, CALCIFIED TISSUE INT, V53, P7, DOI 10.1007/BF01352007; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Ginsberg JS, 2000, ARCH INTERN MED, V160, P669, DOI 10.1001/archinte.160.5.669; Goldenberg NA, 2007, BLOOD, V110, P45, DOI 10.1182/blood-2006-12-061234; Goldenberg NA, 2010, J PEDIATR-US, V157, P852, DOI 10.1016/j.jpeds.2010.07.003; Kuhle S, 2003, THROMB RES, V111, P227, DOI 10.1016/j.thromres.2003.09.008; Lee BB, 2011, LYMPHEDEMA: A CONCISE COMPENDIUM OF THEORY AND PRACTICE, P1, DOI 10.1007/978-0-85729-567-5; Lohman TG, 1992, ADV BODY COMPOSITION, Vviii; Manco-Johnson MJ, 2003, BLOOD, V102, p553A; Neumann Susanne, 1992, Zeitschrift fuer Morphologie und Anthropologie, V79, P183; Ozener B, 2007, COLLEGIUM ANTROPOL, V31, P693; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P112, DOI 10.1002/ajpa.21300; PARKER DF, 1990, ANN HUM BIOL, V17, P199, DOI 10.1080/03014469000000962; Perrin M, 2000, ANGIOLOGY, V51, P9, DOI 10.1177/000331970005100103; Pesavento R, 2010, INTERN EMERG MED, V5, P185, DOI 10.1007/s11739-009-0336-2; PLATO CC, 1985, HUM BIOL, V57, P327; Ridner SH, 2007, LYMPHOLOGY, V40, P35; Ridner Sheila H., 2009, Lymphatic Research and Biology, V7, P11, DOI 10.1089/lrb.2008.1003; Round JM, 1999, ANN HUM BIOL, V26, P49, DOI 10.1080/030144699282976; Rutherford RB, 2000, J VASC SURG, V31, P1307, DOI 10.1016/S0741-5214(00)90143-5; Sabharwal S, 2008, CLIN ORTHOP RELAT R, V466, P2910, DOI 10.1007/s11999-008-0524-9; Sander AP, 2002, PHYS THER, V82, P1201, DOI 10.1093/ptj/82.12.1201; SCHELL LM, 1985, AM J PHYS ANTHROPOL, V67, P317, DOI 10.1002/ajpa.1330670404; STEELE J, 1995, INT J OSTEOARCHAEOL, V5, P39, DOI 10.1002/oa.1390050105; SUKUL DMKSK, 1993, J BIOMED ENG, V15, P477, DOI 10.1016/0141-5425(93)90062-4; Taylor R, 2006, PHYS THER, V86, P205, DOI 10.1093/ptj/86.2.205; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Villalta S, 1994, HAEMOSTASIS, V24, p57a; WAKI M, 1991, AM J PHYSIOL, V261, pE199, DOI 10.1152/ajpendo.1991.261.2.E199; Ward LC, 2011, LYMPHAT RES BIOL, V9, P43, DOI 10.1089/lrb.2010.0024; Ward LC, 2011, LYMPHAT RES BIOL, V9, P47, DOI 10.1089/lrb.2010.0014; Ward L, 2011, INT J GYNECOL CANCER, V21, P409, DOI 10.1097/IGC.0b013e31820866e1; Ward Leigh C., 2009, Lymphatic Research and Biology, V7, P81, DOI 10.1089/lrb.2008.1027; Winters RW, 1973, BODY FLUIDS PEDIAT L	48	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0126268	10.1371/journal.pone.0126268	http://dx.doi.org/10.1371/journal.pone.0126268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875618	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100304
J	Cao, HL; He, NN; Song, SL; Xu, MQ; Piao, MY; Yan, F; Wang, BM				Cao, Hailong; He, Nana; Song, Shuli; Xu, Mengque; Piao, Meiyu; Yan, Fang; Wang, Bangmao			Is Surveillance Colonoscopy Necessary for Patients with Sporadic Gastric Hyperplastic Polyps?	PLOS ONE			English	Article							HELICOBACTER-PYLORI; COLORECTAL NEOPLASIA; DISTRIBUTION TRENDS; EPITHELIAL POLYPS; DATABASE ANALYSIS; CANCER; RISK; ADENOMAS; SEROPREVALENCE; MULTICENTER	Background Gastric polyps, such as adenomas and hyperplastic polyps, can be found in various colonic polyposis syndromes. Unlike in sporadic gastric adenomas, in which the increased risk of colorectal neoplasia has been well characterized, information in sporadic gastric hyperplastic polyps was limited. Aim To evaluate the association of sporadic gastric hyperplastic polyps with synchronous colorectal neoplasia in a large cohort. Methods Patients with sporadic gastric hyperplastic polyps who underwent colonoscopy simultaneously or within six months were consecutively enrolled. Each patient was compared with two randomly selected age and sex matched controls without gastric polyps who also underwent colonoscopy in the same period. Data of patients' demographics and characteristics of the gastrointestinal polyps were documented. Results A total of 261 cases in 118,576 patients who underwent esophagogastroduodenoscopy were diagnosed as sporadic gastric hyperplastic polyps, and 192 of 261 (73.6%) patients underwent colonoscopy. Colorectal neoplasias were identified in 46 (24.0%) of 192 cases and in 40 (10.4%) of 384 controls (P<0.001). The mean size and distribution of colorectal neoplasias were not significantly different between the two groups. There was a significantly higher rate of colorectal adenoma (odds ratio [OR] 3.2, 95% confidence interval [CI] 1.9-5.3) in the gastric hyperplastic polyps group than in the control group, while the prevalence of colorectal cancer was similar in the two groups. Logistic regression analysis also suggested that the presence of gastric hyperplastic polyps (OR 2.5, 95% CI 1.5-4.0) was an independent risk factor for colorectal neoplasias. Conclusion The risk of colorectal adenoma increases in patients with sporadic gastric hyperplastic polyps, and surveillance colonoscopy for these patients should be considered.	[Cao, Hailong; He, Nana; Song, Shuli; Xu, Mengque; Piao, Meiyu; Yan, Fang; Wang, Bangmao] Tianjin Med Univ, Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China; [Cao, Hailong; Yan, Fang] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA	Tianjin Medical University; Vanderbilt University	Wang, BM (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China.	tjmughgi@hotmail.com	song, sl/GRS-1884-2022		National Natural Science Foundation of China [81300272, 81470796]; Research Fund for the Doctoral Program of Higher Education of China [20121202110018]; Tianjin Research Program of Application Foundation and Advanced Technology of China [13JCQNJC10600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tianjin Research Program of Application Foundation and Advanced Technology of China	This study is supported by grants (81300272 to H.L.C. and 81470796 to F.Y.) from the National Natural Science Foundation of China, a grant (20121202110018 to B.M.W.) from Research Fund for the Doctoral Program of Higher Education of China, and a grant (13JCQNJC10600 to H.L.C.) from Tianjin Research Program of Application Foundation and Advanced Technology of China.	Abraham SC, 2003, MODERN PATHOL, V16, P786, DOI 10.1097/01.MP.0000080349.37658.5E; Archimandritis A, 1996, ITAL J GASTROENTEROL, V28, P387; Attard TM, 2004, AM J GASTROENTEROL, V99, P681, DOI 10.1111/j.1572-0241.2004.04115.x; Bai Y, 2010, J GASTROEN HEPATOL, V25, P1668, DOI 10.1111/j.1440-1746.2010.06414.x; Betes M, 2003, AM J GASTROENTEROL, V98, P2648, DOI 10.1016/j.amjgastroenterol.2203.09.041; Cao HL, 2012, J GASTROEN HEPATOL, V27, P1175, DOI 10.1111/j.1440-1746.2012.07116.x; CAPPELL MS, 1995, J CLIN GASTROENTEROL, V21, P198, DOI 10.1097/00004836-199510000-00006; Carmack SW, 2009, NAT REV GASTRO HEPAT, V6, P331, DOI 10.1038/nrgastro.2009.70; Carmack SW, 2009, AM J GASTROENTEROL, V104, P1524, DOI 10.1038/ajg.2009.139; Chung WC, 2011, GUT LIVER, V5, P432, DOI 10.5009/gnl.2011.5.4.432; DEPPISCH LM, 1989, J CLIN GASTROENTEROL, V11, P110, DOI 10.1097/00004836-198902000-00028; Goddard AF, 2010, GUT, V59, P1270, DOI 10.1136/gut.2009.182089; Kang Hwa Mi, 2011, Korean J Gastroenterol, V58, P184; Lahner E, 2012, DIGEST LIVER DIS, V44, P793, DOI 10.1016/j.dld.2012.04.012; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Morais Drausio Jefferson, 2007, Arq. Gastroenterol., V44, P14; MOSS SF, 1995, J NATL CANCER I, V87, P762, DOI 10.1093/jnci/87.10.762; Murray MA, 2004, GUT, V53, P261, DOI 10.1136/gut.2003.025320; Niv Y, 2003, EUR J GASTROEN HEPAT, V15, P1361, DOI 10.1097/00042737-200312000-00016; Oberhuber G, 2000, VIRCHOWS ARCH, V437, P581, DOI 10.1007/s004280000330; Okamoto K, 2008, DIGESTION, V78, P82, DOI 10.1159/000165354; ORLOWSKA J, 1995, AM J GASTROENTEROL, V90, P2152; Park DI, 2010, J CLIN GASTROENTEROL, V44, P102, DOI 10.1097/MCG.0b013e3181a15849; Qing X, 2011, EXP MOL PATHOL, V90, P51, DOI 10.1016/j.yexmp.2010.09.005; Rokkas T, 2013, EUR J GASTROEN HEPAT, V25, P1286, DOI 10.1097/MEG.0b013e328363d3cd; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Shmuely H, 2001, AM J GASTROENTEROL, V96, P3406; Siddheshwar RK, 2001, AM J GASTROENTEROL, V96, P84, DOI 10.1111/j.1572-0241.2001.03355.x; STOLTE M, 1994, ENDOSCOPY, V26, P659, DOI 10.1055/s-2007-1009061; Udd L, 2010, AM J PATHOL, V176, P2467, DOI 10.2353/ajpath.2010.090519; Wang FL, 2014, IEEE T SEMICONDUCT M, V27, P246, DOI 10.1109/TSM.2014.2309591; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Wu ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091810; Yang MH, 2010, GASTROINTEST ENDOSC, V71, P774, DOI 10.1016/j.gie.2009.11.042; ZeaIriarte WL, 1996, DIGEST DIS SCI, V41, P377, DOI 10.1007/BF02093832	35	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122996	10.1371/journal.pone.0122996	http://dx.doi.org/10.1371/journal.pone.0122996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874940	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100125
J	Gouveia-Figueira, S; Nording, ML; Gaida, JE; Forsgren, S; Alfredson, H; Fowler, CJ				Gouveia-Figueira, Sandra; Nording, Malin L.; Gaida, Jamie E.; Forsgren, Sture; Alfredson, Hakan; Fowler, Christopher J.			Serum Levels of Oxylipins in Achilles Tendinopathy: An Exploratory Study	PLOS ONE			English	Article							LINOLEIC-ACID METABOLITES; GROWTH-FACTOR; TENDON TISSUE; PAIN; TRPV1; METABOLOMICS; CORRELATE; GLUTAMATE; OVERUSE; PLASMA	Background Linoleic acid-derived oxidation products are found in experimental pain models. However, little is known about the levels of such oxylipins in human pain. In consequence, in the present study, we have undertaken a lipidomic profiling of oxylipins in blood serum from patients with Achilles tendinopathy and controls. Methodology/Principal findings A total of 34 oxylipins were analysed in the serum samples. At a significance level of P < 0.00147 (<0.05/34), two linoleic acid-derived oxylipins, 13-hydroxy-10E, 12Z-octadecadienoic (13-HODE) and 12(13)-dihydroxy-9Z-octadecenoic acid (12,13-DiHOME) were present at significantly higher levels in the Achilles tendinopathy samples. This difference remained significant when the dataset was controlled for age, gender and body-mass index. In contrast, 0/21 of the arachidonic acid-and 0/4 of the dihomo-gamma-linolenic acid, eicosapentaenoic acid or docosahenaenoic acid-derived oxylipins were higher in the patient samples at this level of significance. The area under the Receiver-Operator Characteristic (ROC) curve for 12,13-DiHOME was 0.91 (P<0.0001). Levels of four N-acylethanolamines were also analysed and found not to be significantly different between the controls and the patients at the level of P<0.0125 (<0.05/4). Conclusions/Significance It is concluded from this exploratory study that abnormal levels of linoleic acid-derived oxylipins are seen in blood serum from patients with Achilles tendinopathy. Given the ability of two of these, 9-and 13-HODE to activate transient receptor potential vanilloid 1, it is possible that these changes may contribute to the symptoms seen in Achilles tendinopathy.	[Gouveia-Figueira, Sandra; Fowler, Christopher J.] Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Gouveia-Figueira, Sandra; Nording, Malin L.] Umea Univ, Dept Chem, Umea, Sweden; [Gaida, Jamie E.] Univ Canberra, Discipline Physiotherapy, Bruce, ACT, Australia; [Gaida, Jamie E.] Monash Univ, Dept Physiotherapy, Melbourne, Vic 3004, Australia; [Forsgren, Sture] Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden; [Alfredson, Hakan] Umea Univ, Sports Med Unit, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University; University of Canberra; Monash University; Umea University; Umea University	Fowler, CJ (corresponding author), Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019; Gaida, Jamie E/A-6062-2011	Fowler, Christopher J./0000-0002-6658-7874; Gaida, Jamie E/0000-0002-4504-9188; Nording, Malin/0000-0002-1732-8147	Swedish Research Council [12158]; Swedish Research Council Formas; Research Funds of the Medical Faculty, Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Research Funds of the Medical Faculty, Umea University	The authors thank the Swedish Research Council (Grant no. 12158, medicine), the Swedish Research Council Formas, and the Research Funds of the Medical Faculty, Umea University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredson H, 1999, KNEE SURG SPORT TR A, V7, P378, DOI 10.1007/s001670050184; Alsalem M, 2013, BRIT J PHARMACOL, V168, P1961, DOI 10.1111/bph.12092; Andersson G, 2011, BRIT J SPORT MED, V45, P1017, DOI 10.1136/bjsm.2010.082750; Asplund CA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1262; Bagge J, 2011, SCAND J MED SCI SPOR, V21, pE430, DOI 10.1111/j.1600-0838.2011.01358.x; Battery L, 2011, SPORTS MED ARTHROSC, V19, P213, DOI 10.1097/JSA.0b013e31820e6a92; BEETENS JR, 1986, BIOCHEM PHARMACOL, V35, P883, DOI 10.1016/0006-2952(86)90072-9; Bring DKI, 2012, WOUND REPAIR REGEN, V20, P50, DOI 10.1111/j.1524-475X.2011.00755.x; Caligiuri SPB, 2014, EXP GERONTOL, V59, P51, DOI 10.1016/j.exger.2014.04.005; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P355, DOI 10.1210/jc.86.1.355; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Gaida JE, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-41; Gaida JE, 2009, MED SCI SPORT EXER, V41, P1194, DOI 10.1249/MSS.0b013e31819794c3; Ghafouri N, 2013, PAIN, V154, P1649, DOI 10.1016/j.pain.2013.05.002; Gibson W, 2009, EXP BRAIN RES, V194, P173, DOI 10.1007/s00221-008-1683-3; GLASGOW WC, 1992, J BIOL CHEM, V267, P10771; Gouveia-Figueira S, 2014, ANAL CHEM, V86, P1186, DOI 10.1021/ac403352e; Green DP, 2013, PAIN, V154, P2512, DOI 10.1016/j.pain.2013.07.040; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; KOSAKA K, 1994, MOL CELL BIOCHEM, V139, P141, DOI 10.1007/BF01081737; Langberg H, 2001, J PHYSL, V542, P985; Nieman DC, 2014, AM J PHYSIOL-REG I, V307, pR68, DOI 10.1152/ajpregu.00092.2014; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Pufe T, 2001, VIRCHOWS ARCH, V439, P579, DOI 10.1007/s004280100422; Ramsden CE, 2012, PROSTAG LEUKOTR ESS, V87, P135, DOI 10.1016/j.plefa.2012.08.004; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Riley G, 2008, NAT CLIN PRACT RHEUM, V4, P82, DOI 10.1038/ncprheum0700; Ruparel S, 2013, PAIN, V154, P2363, DOI 10.1016/j.pain.2013.07.011; Ruparel S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-73; Schuchardt JP, 2014, PROSTAG OTH LIPID M, V109, P23, DOI 10.1016/j.prostaglandins.2014.03.001; Schuchardt JP, 2013, PROSTAG LEUKOTR ESS, V89, P19, DOI 10.1016/j.plefa.2013.04.001; Scott A, 2015, BRIT J SPORT MED, V49, P984, DOI 10.1136/bjsports-2014-093989; Sisignano M, 2014, PROG LIPID RES, V53, P93, DOI 10.1016/j.plipres.2013.11.002; Sisignano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081228; STEINHILBER D, 1993, P NATL ACAD SCI USA, V90, P5984, DOI 10.1073/pnas.90.13.5984; Stevens T, 2012, PANCREAS, V41, P518, DOI 10.1097/MPA.0b013e31823ca306; Tam VC, 2013, SEMIN IMMUNOL, V25, P240, DOI 10.1016/j.smim.2013.08.006; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n	41	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123114	10.1371/journal.pone.0123114	http://dx.doi.org/10.1371/journal.pone.0123114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875933	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100135
J	Martinez, O; Miranda, E; Ramirez, M; Santos, S; Rivera, C; Vazquez, L; Sanchez, T; Tremblay, RL; Rios-Olivares, E; Otero, M				Martinez, Osmarie; Miranda, Eric; Ramirez, Maite; Santos, Saritza; Rivera, Carlos; Vazquez, Luis; Sanchez, Tomas; Tremblay, Raymond L.; Rios-Olivares, Eddy; Otero, Miguel			Immunomodulator-Based Enhancement of Anti Smallpox Immune Responses	PLOS ONE			English	Article							DNA VACCINE; INNATE IMMUNITY; VIRUS; RESIQUIMOD; IMIQUIMOD; IMMUNIZATION; ADJUVANTS; IMMUNOGENICITY; OPTIMIZATION; PROTEINS	Background The current live vaccinia virus vaccine used in the prevention of smallpox is contraindicated for millions of immune-compromised individuals. Although vaccination with the current smallpox vaccine produces protective immunity, it might result in mild to serious health complications for some vaccinees. Thus, there is a critical need for the production of a safe virus-free vaccine against smallpox that is available to everyone. For that reason, we investigated the impact of imiquimod and resiquimod (Toll-like receptors agonists), and the codon-usage optimization of the vaccinia virus A27L gene in the enhancement of the immune response, with intent of producing a safe, virus-free DNA vaccine coding for the A27 vaccinia virus protein. Methods We analyzed the cellular-immune response by measuring the IFN-gamma production of spleno-cytes by ELISPOT, the humoral-immune responses measuring total IgG and IgG2a/IgG1 ratios by ELISA, and the TH1 and TH2 cytokine profiles by ELISA, in mice immunized with our vaccine formulation. Results The proposed vaccine formulation enhanced the A27L vaccine-mediated production of IFN-gamma on mouse spleens, and increased the humoral immunity with a TH1-biased response. Also, our vaccine induced a TH1 cytokine milieu, which is important against viral infections. Conclusion These results support the efforts to find a new mechanism to enhance an immune response against smallpox, through the implementation of a safe, virus-free DNA vaccination platform.	[Martinez, Osmarie; Miranda, Eric; Ramirez, Maite; Santos, Saritza; Otero, Miguel] Univ Puerto Rico, Dept Microbiol, San Juan, PR 00936 USA; [Rivera, Carlos; Vazquez, Luis; Sanchez, Tomas] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Miranda, Eric; Rios-Olivares, Eddy] Univ Cent Caribe, Sch Med, Dept Microbiol, Bayamon, PR USA; [Tremblay, Raymond L.] Univ Puerto Rico, Dept Biol, Humacao, PR USA; [Tremblay, Raymond L.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Tremblay, Raymond L.] Univ Puerto Rico, Ctr Appl Trop Ecol & Conservat, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Humacao; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Rio Piedras	Otero, M (corresponding author), Univ Puerto Rico, Dept Microbiol, Med Sci Campus, San Juan, PR 00936 USA.	miguel.otero2@upr.edu	Tremblay, Raymond L/Q-3763-2019	Tremblay, Raymond L/0000-0002-8588-4372; Martinez, Osmarie/0000-0002-3161-0210	National Institutes of Health [8P20GM103475]; National Center for Research Resources [G12RR003051, 5G12RR003035-27]; National Institute on Minority Health and Health Disparities [8G12MD007600, 8G12MD007583-27]; Minority Biomedical Research Support Research Initiative for Scientific Enhancement [R25GM061838]; Puerto Rico Science, Technology and Research Trust [2013-000022]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, P20GM103475] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600, G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Minority Biomedical Research Support Research Initiative for Scientific Enhancement; Puerto Rico Science, Technology and Research Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Puerto Rico Alliance for the Advancement of Biomedical Research Excellence National Institutes of Health 8P20GM103475, National Center for Research Resources G12RR003051, 5G12RR003035-27, National Institute on Minority Health and Health Disparities 8G12MD007600, 8G12MD007583-27, and the Minority Biomedical Research Support Research Initiative for Scientific Enhancement R25GM061838. The Puerto Rico Science, Technology and Research Trust, 2013-000022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Peter D, 2012, J Pharm Pract, V25, P521; Andre S, 1998, J VIROL, V72, P1497; [Anonymous], 2009, P P IMMUNE SYSTEM; Auckland C, 2005, VACCINE, V23, P4185, DOI 10.1016/j.vaccine.2004.10.052; Bendelac A, 2002, J EXP MED, V195, pF19, DOI 10.1084/jem.20020073; Buck Henry W, 2003, J Low Genit Tract Dis, V7, P290, DOI 10.1097/00128360-200310000-00011; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Calarota S, 1998, LANCET, V351, P1320, DOI 10.1016/S0140-6736(97)09440-3; Calarota SA, 1999, J IMMUNOL, V163, P2330; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cohen AD, 1998, FASEB J, V12, P1611, DOI 10.1096/fasebj.12.15.1611; Kohn William G, 2003, MMWR Recomm Rep, V52, P1; DEMKOWICZ WE, 1992, J VIROL, V66, P386, DOI 10.1128/JVI.66.1.386-398.1992; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Dropulic LK, 2003, CLIN INFECT DIS, V36, P786, DOI 10.1086/374716; Edghill-Smith Y, 2005, J INFECT DIS, V191, P372, DOI 10.1086/427265; Empig C, 2006, VACCINE, V24, P3686, DOI 10.1016/j.vaccine.2005.03.029; Fishman JA, 2003, AM J TRANSPLANT, V3, P786, DOI 10.1034/j.1600-6143.2003.00145.x; Gilbert J, 2001, ARCH DERMATOL, V137, P1015; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Hayden EC, 2011, NATURE, V477, P150, DOI 10.1038/477150a; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Henderson DA, 2011, VACCINE, V29, pD7, DOI 10.1016/j.vaccine.2011.06.080; Hooper JW, 2003, VIROLOGY, V306, P181, DOI 10.1016/S0042-6822(02)00038-7; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; Kim JJ, 1997, VACCINE, V15, P879, DOI 10.1016/S0264-410X(96)00260-5; Klimpel G.R., 1996, MED MICROBIOLOGY; Ko HJ, 2005, INFECT IMMUN, V73, P5666, DOI 10.1128/IAI.73.9.5666-5674.2005; Kochan G, 2008, CELL MICROBIOL, V10, P149, DOI 10.1111/j.1462-5822.2007.01026.x; Liu MA, 2005, ADV GENET, V55, P25, DOI 10.1016/S0065-2660(05)55002-8; LVOV DK, 2008, VOP VIRUSOL, V53, P4; MacGregor RR, 1998, J INFECT DIS, V178, P92, DOI 10.1086/515613; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; McNeel DG, 2012, CURR CANCER THER REV, V8, P245, DOI 10.2174/1573394711208040245; Meyer T, 2013, EXPERT OPIN INV DRUG, V22, P149, DOI 10.1517/13543784.2013.749236; Miller RL, 1999, INT J IMMUNOPHARMACO, V21, P1, DOI 10.1016/S0192-0561(98)00068-X; Napolitano PG, 2004, AM J OBSTET GYNECOL, V191, P1863, DOI 10.1016/j.ajog.2004.07.014; Narum DL, 2001, INFECT IMMUN, V69, P7250, DOI 10.1128/IAI.69.12.7250-7253.2001; Otero M, 2004, VACCINE, V22, P1782, DOI 10.1016/j.vaccine.2004.01.037; Prins RM, 2006, J IMMUNOL, V176, P157, DOI 10.4049/jimmunol.176.1.157; Qutaishat Salah S, 2003, Clin Med Res, V1, P85; Reimann J, 2000, VOX SANG, V78, P57; RODRIGUEZ JF, 1985, J VIROL, V56, P482, DOI 10.1128/JVI.56.2.482-488.1985; Rudraraju R, 2010, VACCINE, V28, P4997, DOI 10.1016/j.vaccine.2010.05.023; Sauder DN, 2000, J AM ACAD DERMATOL, V43, pS6; Schirmbeck R, 2001, BIOL CHEM, V382, P543, DOI 10.1515/BC.2001.068; Spruance SL, 2001, J INFECT DIS, V184, P196, DOI 10.1086/322007; Tang J, 2006, J VIROL, V80, P10010, DOI 10.1128/JVI.00601-06; Thomsen LL, 2004, VACCINE, V22, P1799, DOI 10.1016/j.vaccine.2003.09.052; van Seters M, 2008, NEW ENGL J MED, V358, P1465, DOI 10.1056/NEJMoa072685; Weinstein RS, 2011, EMERG INFECT DIS, V17, P681, DOI 10.3201/eid1704.101865; Zajac AJ, 2008, ENCY VIROLOGY, V3, P70	52	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123113	10.1371/journal.pone.0123113	http://dx.doi.org/10.1371/journal.pone.0123113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875833	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100134
J	Munoz, I; Henriques, D; Johnston, JS; Chavez-Galarza, J; Kryger, P; Pinto, MA				Munoz, Irene; Henriques, Dora; Johnston, J. Spencer; Chavez-Galarza, Julio; Kryger, Per; Pinto, M. Alice			Reduced SNP Panels for Genetic Identification and Introgression Analysis in the Dark Honey Bee (Apis mellifera mellifera)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ADMIXTURE PROPORTIONS; PROTECTED POPULATIONS; EVOLUTIONARY HISTORY; GENOME; ORIGIN; LOCI; HYBRIDIZATION; CONSERVATION; SIGNATURES	Beekeeping activities, especially queen trading, have shaped the distribution of honey bee (Apis mellifera) subspecies in Europe, and have resulted in extensive introductions of two eastern European C-lineage subspecies (A. m. ligustica and A. m. carnica) into the native range of the M-lineage A. m. mellifera subspecies in Western Europe. As a consequence, replacement and gene flow between native and commercial populations have occurred at varying levels across western European populations. Genetic identification and introgression analysis using molecular markers is an important tool for management and conservation of honey bee subspecies. Previous studies have monitored introgression by using microsatellite, PCR-RFLP markers and most recently, high density assays using single nucleotide polymorphism (SNP) markers. While the latter are almost prohibitively expensive, the information gained to date can be exploited to create a reduced panel containing the most ancestry-informative markers (AIMs) for those purposes with very little loss of information. The objective of this study was to design reduced panels of AIMs to verify the origin of A. m. mellifera individuals and to provide accurate estimates of the level of C-lineage introgression into their genome. The discriminant power of the SNPs using a variety of metrics and approaches including the Weir & Cockerham's F-ST, an F-ST-based outlier test, Delta, informativeness (I-n), and PCA was evaluated. This study shows that reduced AIMs panels assign individuals to the correct origin and calculates the admixture level with a high degree of accuracy. These panels provide an essential tool in Europe for genetic stock identification and estimation of admixture levels which can assist management strategies and monitor honey bee conservation programs.	[Munoz, Irene; Henriques, Dora; Chavez-Galarza, Julio; Pinto, M. Alice] Polytech Inst Braganca, Mt Res Ctr CIMO, P-5301855 Braganca, Portugal; [Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Kryger, Per] Aarhus Univ, Dept Agroecol, DK-4200 Slagelse, Denmark	Instituto Politecnico de Braganca; Texas A&M University System; Texas A&M University College Station; Aarhus University	Pinto, MA (corresponding author), Polytech Inst Braganca, Mt Res Ctr CIMO, Campus Sta Apol nia,Apartado 1172, P-5301855 Braganca, Portugal.	apinto@ipb.pt	Muñoz, Irene/G-6678-2017; Kryger, Per/H-4600-2019; Henriques, Dora/AAI-4556-2020; Pinto, Maria Alice/AAF-4226-2020; Kryger, Per/C-1773-2013	Muñoz, Irene/0000-0002-9234-3267; Kryger, Per/0000-0001-5306-3230; Kryger, Per/0000-0001-5306-3230; Pinto, Maria Alice/0000-0001-9663-8399; Henriques, Dora/0000-0001-7530-682X; Chavez Galarza, Julio Cesar/0000-0002-8899-2862	Fundacion Seneca (Murcia, Spain) [19149/PD/13-N]; Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/84195/2012, SFRH/BD/68682/2010]; Fundacao para a Ciencia e Tecnologia; COMPETE/QREN/EU [PTDC/BIA-BEC/099640/2008, BiodivERsA/0002/2014]; University Libraries; Office of the Vice President for Research; Fundação para a Ciência e a Tecnologia [BiodivERsA/0002/2014, PTDC/BIA-BEC/099640/2008] Funding Source: FCT	Fundacion Seneca (Murcia, Spain)(Fundacion Seneca); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE/QREN/EU(European Commission); University Libraries; Office of the Vice President for Research; Fundação para a Ciência e a Tecnologia	Munoz was supported by Fundacion Seneca (Murcia, Spain) through the Post-doctoral fellowship 19149/PD/13-N whereas Dora Henriques and Julio Chavez-Galarza were supported by Fundacao para a Ciencia e Tecnologia (Portugal) through the PhD scholarships SFRH/BD/84195/2012 and SFRH/BD/68682/2010, respectively. This research was funded by Fundacao para a Ciencia e Tecnologia and COMPETE/QREN/EU through the projects PTDC/BIA-BEC/099640/2008 and BiodivERsA/0002/2014. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Pinto MA, 2014, J APICULT RES, V53, P269, DOI 10.3896/IBRA.1.53.2.08; Allendorf F., 2007, CONSERVATION GENETIC; Anderson EC, 2010, MOL ECOL RESOUR, V10, P701, DOI 10.1111/j.1755-0998.2010.02846.x; Arias MC, 1996, MOL PHYLOGENET EVOL, V5, P557, DOI 10.1006/mpev.1996.0050; Bertrand B, 2014, MOL ECOL RES; Buchler R, 2014, J APICULT RES, V53, P205, DOI 10.3896/IBRA.1.53.2.03; Chavez-Galarza J, 2013, MOL ECOL, V22, P5890, DOI 10.1111/mec.12537; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; De la Rua P, 2009, APIDOLOGIE, V40, P263, DOI 10.1051/apido/2009027; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; DREHER K, 1946, HESSISCHE BIENE, V81, P62; Engel Michael S., 1999, Journal of Hymenoptera Research, V8, P165; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Francis RM, 2014, J APICULT RES, V53, P188, DOI 10.3896/IBRA.1.53.2.02; Frantz AC, 2006, MOL ECOL, V15, P3191, DOI 10.1111/j.1365-294X.2006.03022.x; Galanter JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002554; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; Garnery L, 1998, GENET SEL EVOL, V30, pS31, DOI 10.1051/gse:19980702; Garnery L, 1998, GENET SEL EVOL, V30, pS49, DOI 10.1051/gse:19980703; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harpur BA, 2014, P NATL ACAD SCI USA, V111, P2614, DOI 10.1073/pnas.1315506111; Harpur BA, 2013, MOL ECOL, V22, P3211, DOI 10.1111/mec.12332; HEPBURN HR, 1998, HONEY BEES AFRICA; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Jensen AB, 2005, MOL ECOL, V14, P93, DOI 10.1111/j.1365-294X.2004.02399.x; JENSEN AB, 2005, BEEKEEPING CONSERVIN, P142; Kalinowski S.T., 2007, ONCOR COMPUTER PROGR; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; MAUL V, 1994, APIDOLOGIE, V25, P119, DOI 10.1051/apido:19940201; Meixner M. D., 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.4.05, DOI 10.3896/IBRA.1.52.4.05]; Meixner MD, 2011, APIDOLOGIE, V42, P425, DOI 10.1007/s13592-011-0007-y; Meixner MD, 2010, J APICULT RES, V49, P85, DOI 10.3896/IBRA.1.49.1.12; Miguel I, 2007, APIDOLOGIE, V38, P141, DOI 10.1051/apido:2007007; Munoz I, 2009, APIDOLOGIE, V40, P617, DOI 10.1051/apido/2009041; Nedic N, 2014, J APICULT RES, V53, P303, DOI 10.3896/IBRA.1.53.2.12; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Oleksa A, 2011, J APICULT RES, V50, P116, DOI 10.3896/IBRA.1.50.2.03; Ozerov M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082434; Pardo-Seco J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-543; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pinto MA, 2012, APIDOLOGIE, V43, P663, DOI 10.1007/s13592-012-0141-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rortais A, 2011, CONSERV GENET RESOUR, V3, P383, DOI 10.1007/s12686-010-9351-x; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sheppard WS, 2003, APIDOLOGIE, V34, P367, DOI 10.1051/apido:2003037; Soland-Reckeweg G, 2009, J INSECT CONSERV, V13, P317, DOI 10.1007/s10841-008-9175-0; Storer CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049018; Strange JP, 2008, J INSECT CONSERV, V12, P527, DOI 10.1007/s10841-007-9093-6; Uzunov A, 2014, J APICULT RES, V53, P288, DOI 10.3896/IBRA.1.53.2.10; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; Wilkinson S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-580; Wilkinson S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-45; Wright S., 1978, EVOLUTION GENETICS P	68	42	44	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124365	10.1371/journal.pone.0124365	http://dx.doi.org/10.1371/journal.pone.0124365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875986	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100254
J	Wright, FA; Lu, JP; Sliter, DA; Dupre, N; Rouleau, GA; Wojcikiewicz, RJH				Wright, Forrest A.; Lu, Justine P.; Sliter, Danielle A.; Dupre, Nicolas; Rouleau, Guy A.; Wojcikiewicz, Richard J. H.			A Point Mutation in the Ubiquitin Ligase RNF170 That Causes Autosomal Dominant Sensory Ataxia Destabilizes the Protein and Impairs Inositol 1,4,5-Trisphosphate Receptor-mediated Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; ERLIN2; COMPLEX	RNF170 is an endoplasmic reticulum membrane ubiquitin ligase that contributes to the ubiquitination of activated inositol 1,4,5-trisphosphate (IP3) receptors, and also, when point mutated (arginine to cysteine at position 199), causes autosomal dominant sensory ataxia (ADSA), a disease characterized by neurodegeneration in the posterior columns of the spinal cord. Here we demonstrate that this point mutation inhibits RNF170 expression and signaling via IP3 receptors. Inhibited expression of mutant RNF170 was seen in cells expressing exogenous RNF170 constructs and in ADSA lymphoblasts, and appears to result from enhanced RNF170 autoubiquitination and proteasomal degradation. The basis for these effects was probed via additional point mutations, revealing that ionic interactions between charged residues in the transmembrane domains of RNF170 are required for protein stability. In ADSA lymphoblasts, platelet-activating factor-induced Ca2+ mobilization was significantly impaired, whereas neither Ca2+ store content, IP3 receptor levels, nor IP3 production were altered, indicative of a functional defect at the IP3 receptor locus, which may be the cause of neurodegeneration. CRISPR/Cas9-mediated genetic deletion of RNF170 showed that RNF170 mediates the addition of all of the ubiquitin conjugates known to become attached to activated IP3 receptors (monoubiquitin and Lys(48)-and Lys(63)-linked ubiquitin chains), and that wild-type and mutant RNF170 have apparently identical ubiquitin ligase activities toward IP3 receptors. Thus, the Ca2+ mobilization defect seen in ADSA lymphoblasts is apparently not due to aberrant IP3 receptor ubiquitination. Rather, the defect likely reflects abnormal ubiquitination of other substrates, or adaptation to the chronic reduction in RNF170 levels.	[Wright, Forrest A.; Lu, Justine P.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Sliter, Danielle A.] NINDS, NIH, Bethesda, MD 20892 USA; [Dupre, Nicolas] Univ Laval, CHU Quebec, Neuromuscular & Neurogenet Dis Clin, Quebec City, PQ G1J 1Z4, Canada; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada; [Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Laval University; McGill University; McGill University	Wojcikiewicz, RJH (corresponding author), 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu	Dupre, Nicolas/Y-1828-2019; Regan, Clinton/E-6250-2012		National Institutes of Health [DK049194]; National Ataxia Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194, R29DK049194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK049194 and the National Ataxia Foundation.	Al-Saif A, 2012, ANN NEUROL, V72, P510, DOI 10.1002/ana.23641; Alazami AM, 2011, NEUROGENETICS, V12, P333, DOI 10.1007/s10048-011-0291-8; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; Bezprozvanny I, 2011, NEUROCHEM RES, V36, P1186, DOI 10.1007/s11064-010-0393-y; Brown SA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00453; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Cui GY, 2013, J BIOL CHEM, V288, P20758, DOI 10.1074/jbc.M113.476226; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Foskett JK, 2010, PFLUG ARCH EUR J PHY, V460, P481, DOI 10.1007/s00424-010-0826-0; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matilla-Duenas A, 2012, ADV EXP MED BIOL, V724, P351, DOI 10.1007/978-1-4614-0653-2_27; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Moeller JJ, 2008, ACTA NEUROPATHOL, V116, P331, DOI 10.1007/s00401-008-0362-6; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Paulson HL, 2009, J NEURO-OPHTHALMOL, V29, P227, DOI 10.1097/WNO0b013e3181b416de; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Pietruck F, 1998, DIABETOLOGIA, V41, P94, DOI 10.1007/s001250050872; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rosskopf D, 1998, AM J PHYSIOL-CELL PH, V274, pC1573, DOI 10.1152/ajpcell.1998.274.6.C1573; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Sliter DA, 2011, J BIOL CHEM, V286, P1074, DOI 10.1074/jbc.M110.188383; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Stitham J, 2007, BRIT J PHARMACOL, V152, P513, DOI 10.1038/sj.bjp.0707413; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Valdmanis PN, 2011, BRAIN, V134, P602, DOI 10.1093/brain/awq329; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wakil SM, 2013, EUR J MED GENET, V56, P43, DOI 10.1016/j.ejmg.2012.10.003; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wojcikiewicz R.J.H., 2012, WILEY INTERDISCIPL R, V1, P126; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; WOJCIKIEWICZ RJH, 1994, J NEUROCHEM, V63, P177; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yildirim Y, 2011, HUM MOL GENET, V20, P1886, DOI 10.1093/hmg/ddr070	47	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13948	13957		10.1074/jbc.M115.655043	http://dx.doi.org/10.1074/jbc.M115.655043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882839	Green Published, hybrid			2022-12-26	WOS:000355313000026
J	Bartlett, D; Boyle, GM; Ziman, M; Medic, S				Bartlett, Danielle; Boyle, Glen M.; Ziman, Mel; Medic, Sandra			Mechanisms Contributing to Differential Regulation of PAX3 Downstream Target Genes in Normal Human Epidermal Melanocytes versus Melanoma Cells	PLOS ONE			English	Article							NORMAL SKIN MELANOCYTES; ALTERNATIVE ISOFORMS; EXPRESSION; PROTEIN; PHOSPHORYLATION; LINES; IDENTIFICATION; MELANOBLAST; MIGRATION; NO	Melanoma is a highly aggressive and drug resistant form of skin cancer. It arises from melanocytes, the pigment producing cells of the skin. The formation of these melanocytes is driven by the transcription factor PAX3 early during embryonic development. As a result of alternative splicing, the PAX3 gene gives rise to eight different transcripts which encode isoforms that have different structures and activate different downstream target genes involved in pathways of cell proliferation, migration, differentiation and survival. Furthermore, post-translational modifications have also been shown to alter the functions of PAX3. We previously identified PAX3 downstream target genes in melanocytes and melanoma cells. Here we assessed the effects of PAX3 down-regulation on this panel of target genes in primary melanocytes versus melanoma cells. We show that PAX3 differentially regulates various downstream target genes involved in cell proliferation in melanoma cells compared to melanocytes. To determine mechanisms behind this differential downstream target gene regulation, we performed immunoprecipitation to assess post-translational modifications of the PAX3 protein as well as RNAseq to determine PAX3 transcript expression profiles in melanocytes compared to melanoma cells. Although PAX3 was found to be post-translationally modified, there was no qualitative difference in phosphorylation and ubiquitination between melanocytes and melanoma cells, while acetylation of PAX3 was reduced in melanoma cells. Additionally, there were differences in PAX3 transcript expression profiles between melanocytes and melanoma cells. In particular the PAX3E transcript, responsible for reducing melanocyte proliferation and increasing apoptosis, was found to be down-regulated in melanoma cells compared to melanocytes. These results suggest that alternate transcript expression profiles activate different downstream target genes leading to the melanoma phenotype.	[Bartlett, Danielle; Ziman, Mel; Medic, Sandra] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Boyle, Glen M.] QIMR Berghofer Med Res Inst, Div Canc & Cell Biol, Canc Drug Mech Grp, Brisbane, Qld, Australia; [Ziman, Mel] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Medic, Sandra] Curtin Univ, Curtin Hlth Innovat Res Inst Ageing & Chron Dis, Perth, WA 6845, Australia	Edith Cowan University; QIMR Berghofer Medical Research Institute; University of Western Australia; Curtin University	Ziman, M (corresponding author), Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia.	m.ziman@ecu.edu.au	Boyle, Glen/G-1347-2013	Boyle, Glen/0000-0002-1385-529X; Ziman, Mel/0000-0001-7527-3538; Bartlett, Danielle/0000-0002-6096-3760	Cancer Council Western Australia; Edith Cowan University	Cancer Council Western Australia(Cancer Council Western Australia); Edith Cowan University	Funding was provided by Cancer Council Western Australia Early Career Investigators Grant, SM MZ; Edith Cowan University Early Career Researchers Grant SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; ALILECHE A, 1993, ONCOGENE, V8, P1791; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Baljinnyam E, 2010, CANCER RES, V70, P5607, DOI 10.1158/0008-5472.CAN-10-0056; Berlin I, 2012, MOL CELL BIOL, V32, P1237, DOI 10.1128/MCB.06257-11; Blake JA, 2005, DEV GROWTH DIFFER, V47, P627; Bonvin E, 2012, MOL CELL BIOL, V32, P4674, DOI 10.1128/MCB.01067-12; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Boutet SC, 2010, MOL CELL, V40, P749, DOI 10.1016/j.molcel.2010.09.029; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; CHENEVIXTRENCH G, 1990, ONCOGENE, V5, P1187; Dietz KN, 2011, INT J BIOCHEM CELL B, V43, P936, DOI 10.1016/j.biocel.2011.03.010; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; He SJ, 2010, J INVEST DERMATOL, V130, P1465, DOI 10.1038/jid.2009.434; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Ichi S, 2011, MOL BIOL CELL, V22, P503, DOI 10.1091/mbc.E10-06-0541; Kaiser P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-233; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lowen M, 2001, J BIOL CHEM, V276, P42565, DOI 10.1074/jbc.M106536200; Medic S, 2011, BIOCHEM BIOPH RES CO, V411, P832, DOI 10.1016/j.bbrc.2011.07.053; Medic S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009977; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Miller PJ, 2008, PROTEIN SCI, V17, P1979, DOI 10.1110/ps.035956.108; Miller PJ, 2007, BBA-GEN SUBJECTS, V1770, P1450, DOI 10.1016/j.bbagen.2007.06.016; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Russowsky D, 2006, BIOORG CHEM, V34, P173, DOI 10.1016/j.bioorg.2006.04.003; Sparrow L E, 1999, Australas J Dermatol, V40, P19, DOI 10.1046/j.1440-0960.1999.00310.x; Tucker MA, 2009, HEMATOL ONCOL CLIN N, V23, P383, DOI 10.1016/j.hoc.2009.03.010; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Wang QY, 2007, INT J CANCER, V120, P1223, DOI 10.1002/ijc.22316; Wang QY, 2006, CANCER RES, V66, P8574, DOI 10.1158/0008-5472.CAN-06-0947; White CA, 1998, INT J CANCER, V75, P590; Zhang XD, 1999, CANCER RES, V59, P2747	38	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124154	10.1371/journal.pone.0124154	http://dx.doi.org/10.1371/journal.pone.0124154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880082	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500086
J	Patarroyo, ME; Bermudez, A; Alba, MP; Vanegas, M; Moreno-Vranich, A; Poloche, LA; Patarroyo, MA				Elkin Patarroyo, Manuel; Bermudez, Adriana; Patricia Alba, Martha; Vanegas, Magnolia; Moreno-Vranich, Armando; Antonio Poloche, Luis; Alfonso Patarroyo, Manuel			IMPIPS: The Immune Protection-Inducing Protein Structure Concept in the Search for Steric-Electron and Topochemical Principles for Complete Fully-Protective Chemically Synthesised Vaccine Development	PLOS ONE			English	Article							T-CELL-RECEPTOR; MHC CLASS-II; PLASMODIUM-FALCIPARUM MALARIA; MAJOR HISTOCOMPATIBILITY COMPLEX; CRYSTAL-STRUCTURE; FIELD TRIAL; HLA-DR4 DRA-ASTERISK-0101; HEMAGGLUTININ PEPTIDE; SYNTHETIC VACCINE; HOST-CELLS	Determining immune protection-inducing protein structures (IMPIPS) involves defining the stereo-electron and topochemical characteristics which are essential in MHC-p-TCR complex formation. Modified high activity binding peptides (mHABP) were thus synthesised to produce a large panel of IMPIPS measuring 26.5 +/- 3.5 angstrom between the farthest atoms fitting into Pockets 1 to 9 of HLA-DR beta 1* structures. They displayed a polyproline II-like (PPIIL) structure with their backbone O and N atoms orientated to establish H-bonds with specific residues from HLA-DR beta 1*- peptide binding regions (PBR). Residues having specific charge and gauche(+) orientation regarding p3x1, p5x2, and p7x1 angles determined appropriate rotamer orientation for perfectly fitting into the TCR to induce an appropriate immune response. Immunological assays in Aotus monkeys involving IMPIPS mixtures led to promising results; taken together with the aforementioned physicochemical principles, non-interfering, long-lasting, protection-inducing, multi-epitope, multistage, minimal subunit-based chemically-synthesised peptides can be designed against diseases scourging humankind.	[Elkin Patarroyo, Manuel; Bermudez, Adriana; Patricia Alba, Martha; Vanegas, Magnolia; Moreno-Vranich, Armando; Antonio Poloche, Luis; Alfonso Patarroyo, Manuel] FIDIC, Bogota, Colombia; [Elkin Patarroyo, Manuel] Univ Nacl Colombia, Bogota, Colombia; [Bermudez, Adriana; Patricia Alba, Martha; Vanegas, Magnolia; Alfonso Patarroyo, Manuel] Univ Rosario, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario	Patarroyo, ME (corresponding author), FIDIC, Bogota, Colombia.	mepatarr@gmail.com	Vanegas, Magnolia/I-7968-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Bermudez, Adriana/I-7935-2016; Patarroyo, Manuel A/I-8046-2016	Vanegas, Magnolia/0000-0001-7722-4115; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Bermudez, Adriana/0000-0003-2669-7259; Patarroyo, Manuel A/0000-0002-4751-2500; Alba, Martha patricia/0000-0003-0641-5162	The Colombian Science, Technology and Innovation Department (Colciencias) [709-2013]	The Colombian Science, Technology and Innovation Department (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was financed by the "The Colombian Science, Technology and Innovation Department (Colciencias)" (Grant 709-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Balbin A, 2006, BIOCHIMIE, V88, P1307, DOI 10.1016/j.biochi.2006.05.009; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; Bermudez A, 2014, VACCINE, V32, P2117, DOI 10.1016/j.vaccine.2014.02.003; Bermudez A, 2008, VACCINE, V26, P6908, DOI 10.1016/j.vaccine.2008.09.071; Best RB, 2004, J AM CHEM SOC, V126, P7734, DOI 10.1021/ja049078w; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Cardenas C, 2005, J STRUCT BIOL, V149, P38, DOI 10.1016/j.jsb.2004.08.003; Cardenas C, 2004, BIOCHEM BIOPH RES CO, V323, P1265, DOI 10.1016/j.bbrc.2004.08.225; Cardenas C, 2002, COMPUT CHEM, V26, P667, DOI 10.1016/S0097-8485(02)00052-9; Cardenas C, 2007, J MOL GRAPH MODEL, V25, P605, DOI 10.1016/j.jmgm.2006.04.005; Chellgren BW, 2004, BIOCHEMISTRY-US, V43, P5864, DOI 10.1021/bi049922v; Chen K, 2005, J AM CHEM SOC, V127, P10146, DOI 10.1021/ja052094o; Choudhary A, 2009, J AM CHEM SOC, V131, P7244, DOI 10.1021/ja901188y; Creamer TP, 2002, ADV PROTEIN CHEM, V62, P263; Creamer TP, 1998, PROTEINS, V33, P218, DOI 10.1002/(SICI)1097-0134(19981101)33:2<218::AID-PROT6>3.0.CO;2-E; Curtidor H, 2011, CURR MED CHEM, V18, P4470, DOI 10.2174/092986711797287575; Daeffler KNM, 2012, J AM CHEM SOC, V134, P14890, DOI 10.1021/ja304560x; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; Deng L, 2012, P NATL ACAD SCI USA, V109, P14960, DOI 10.1073/pnas.1207186109; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Diaz D, 2000, IMMUNOGENETICS, V51, P528, DOI 10.1007/s002510000189; Diaz OL, 2000, IMMUNOGENETICS, V51, P212, DOI 10.1007/s002510050034; Donermeyer DL, 2006, J IMMUNOL, V177, P6911, DOI 10.4049/jimmunol.177.10.6911; Drobnak I, 2013, J AM CHEM SOC, V135, P1288, DOI 10.1021/ja305081b; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Patarroyo ME, 2011, CHEM REV, V111, P3459, DOI 10.1021/cr100223m; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Fattom A, 1999, VACCINE, V17, P126, DOI 10.1016/S0264-410X(98)00162-5; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806; HUNT JD, 1994, VACCINE, V12, P457, DOI 10.1016/0264-410X(94)90125-2; Jakobsche CE, 2010, J AM CHEM SOC, V132, P6651, DOI 10.1021/ja100931y; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Koch O, 2009, PROTEINS, V74, P353, DOI 10.1002/prot.22185; Kuemin M, 2009, J AM CHEM SOC, V131, P15474, DOI 10.1021/ja906466q; Lee MCS, 2008, NAT CHEM BIOL, V4, P161, DOI 10.1038/nchembio0308-161; Lopez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096973; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MORENO A, 1993, J IMMUNOL, V151, P489; Mota MM, 2002, BIOESSAYS, V24, P149, DOI 10.1002/bies.10050; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nino-Vasquez JJ, 2000, IMMUNOGENETICS, V51, P219, DOI 10.1007/s002510050035; Nosten F, 1996, LANCET, V348, P701, DOI 10.1016/S0140-6736(96)04465-0; NOYA O, 1994, J INFECT DIS, V170, P396, DOI 10.1093/infdis/170.2.396; Pappu RV, 2002, PROTEIN SCI, V11, P2437, DOI 10.1110/ps.0217402; Parra-Lopez C, 2006, J BIOL CHEM, V281, P14907, DOI 10.1074/jbc.M511571200; Patarroyo MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009771; Patarroyo ME, 2008, INT J BIOCHEM CELL B, V40, P543, DOI 10.1016/j.biocel.2007.09.005; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Patarroyo ME, 2012, BIOCHEM BIOPH RES CO, V429, P75, DOI 10.1016/j.bbrc.2012.10.089; Patarroyo ME, 2012, BIOCHEM BIOPH RES CO, V429, P81, DOI 10.1016/j.bbrc.2012.10.088; PATARROYO ME, 1987, NATURE, V328, P629, DOI 10.1038/328629a0; PATARROYO ME, 1988, NATURE, V332, P158, DOI 10.1038/332158a0; Pico de Coana Y, 2004, CYTOKINE, V27, P129, DOI 10.1016/j.cyto.2004.04.004; Pizzanelli S, 2010, J PHYS CHEM B, V114, P3965, DOI 10.1021/jp907502n; Porter LL, 2011, P NATL ACAD SCI USA, V108, P109, DOI 10.1073/pnas.1014674107; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Rodriguez LE, 2008, CHEM REV, V108, P3656, DOI 10.1021/cr068407v; Rossmeisl J, 2003, J AM CHEM SOC, V125, P16383, DOI 10.1021/ja0359658; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Salazar LM, 2004, BIOCHEM BIOPH RES CO, V322, P119, DOI 10.1016/j.bbrc.2004.07.086; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schuldt NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024147; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Sedegah M, 2004, GENE THER, V11, P448, DOI 10.1038/sj.gt.3302139; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; SEMPERTEGUI F, 1994, VACCINE, V12, P337, DOI 10.1016/0264-410X(94)90098-1; Shapovalov MV, 2007, PROTEINS, V66, P279, DOI 10.1002/prot.21150; Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Stapley BJ, 1999, PROTEIN SCI, V8, P587; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; VALERO MV, 1993, LANCET, V341, P705, DOI 10.1016/0140-6736(93)90483-W; Valero MV, 1996, VACCINE, V14, P1466, DOI 10.1016/S0264-410X(96)00070-9; Vogel G, 2012, SCIENCE, V338, P871, DOI 10.1126/science.338.6109.871; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; Wilson-Davis K, 1999, PHARMACOEPIDEM DR S, V8, P58, DOI 10.1002/(SICI)1099-1557(199901/02)8:1<58::AID-PDS390>3.0.CO;2-5; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039	102	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123249	10.1371/journal.pone.0123249	http://dx.doi.org/10.1371/journal.pone.0123249			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879751	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500043
J	Huang, H; Li, S; Sun, LZ; Zhou, GH				Huang, Huan; Li, Shuo; Sun, Lizhou; Zhou, Guohua			Digital Detection of Multiple Minority Mutants and Expression Levels of Multiple Colorectal Cancer-Related Genes Using Digital-PCR Coupled with Bead-Array	PLOS ONE			English	Article							DNA; MUTATIONS; TISSUE; STOOL; KRAS; RAS	To simultaneously analyze mutations and expression levels of multiple genes on one detection platform, we proposed a method termed "multiplex ligation-dependent probe amplification-digital amplification coupled with hydrogel bead-array" (MLPA-DABA) and applied it to diagnose colorectal cancer (CRC). CRC cells and tissues were sampled to extract nucleic acid, perform MLPA with sequence-tagged probes, perform digital emulsion polymerase chain reaction (PCR), and produce a hydrogel bead-array to immobilize beads and form a single bead layer on the array. After hybridization with fluorescent probes, the number of colored beads, which reflects the abundance of expressed genes and the mutation rate, was counted for diagnosis. Only red or green beads occurred on the chips in the mixed samples, indicating the success of single-molecule PCR. When a one-source sample was analyzed using mixed MLPA probes, beads of only one color occurred, suggesting the high specificity of the method in analyzing CRC mutation and gene expression. In gene expression analysis of a CRC tissue from one CRC patient, the mutant percentage was 3.1%, and the expression levels of CRC-related genes were much higher than those of normal tissue. The highly sensitive MLPA-DABA succeeds in the relative quantification of mutations and gene expressions of exfoliated cells in stool samples of CRC patients on the same chip platform. MLPA-DABA coupled with hydrogel bead-array is a promising method in the non-invasive diagnosis of CRC.	[Huang, Huan; Sun, Lizhou] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Li, Shuo] Nanjing Xiaozhuang Univ, Nanjing, Jiangsu, Peoples R China; [Zhou, Guohua] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Xiaozhuang University; Nanjing University	Huang, H (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	huanghuan@njmu.edu.cn		Zhou, Guohua/0000-0001-6675-4452	National Science Foundation of China [21305069, 21275161]; Training project of Young talents in Jiangsu Province Maternal and Child Health Hospital [FRC201302]; Jiangsu Province's Clinical Science & Technology Special Project [SBL2012061]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Training project of Young talents in Jiangsu Province Maternal and Child Health Hospital; Jiangsu Province's Clinical Science & Technology Special Project	The National Science Foundation of China (Grant No. 21305069 and 21275161) provided funding for the decision to publish and preparation of the manuscript. The Training project of Young talents in Jiangsu Province Maternal and Child Health Hospital (FRC201302) provided funding for data collection and analysis. Jiangsu Province's Clinical Science & Technology Special Project (SBL2012061) provided funding for study design.	Armaghany T, 2012, GASTROINTEST CANC RE, V5, P19; BARELI M, 1989, BLOOD, V73, P281; Church TR, 2005, J NATL CANCER I, V97, P328, DOI 10.1093/jnci/dji078; Deng LL, 2012, ANAL CHEM, V84, P5645, DOI 10.1021/ac3008016; Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Hsieh JS, 2005, AM SURGEON, V71, P336; Huang H, 2009, CHEM COMMUN, P4094, DOI 10.1039/b902196e; Huang JM, 2002, ONCOGENE, V21, P1909, DOI 10.1038/sj.onc.1205109; Kalmar A, 2013, METHODS, V59, pS16, DOI 10.1016/j.ymeth.2012.09.011; Kheirelseid EAH, 2013, J GASTROINTEST ONCOL, V4, P144, DOI 10.3978/j.issn.2078-6891.2013.010; Lee RDW, 2013, GENE, V512, P16, DOI 10.1016/j.gene.2012.10.001; Mao C, 2013, CANCER-AM CANCER SOC, V119, P714, DOI 10.1002/cncr.27804; Mouliere F, 2013, TRANSL ONCOL, V6, P319, DOI 10.1593/tlo.12445; Pincas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh150; Qi ZT, 2011, ANALYST, V136, P2252, DOI 10.1039/c0an00976h; Sinha R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060142; Xiao PF, 2007, ELECTROPHORESIS, V28, P1903, DOI 10.1002/elps.200600794	18	2	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123420	10.1371/journal.pone.0123420	http://dx.doi.org/10.1371/journal.pone.0123420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880764	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500052
J	Tsai, J; Grant, AM; Beckman, MG; Grosse, SD; Yusuf, HR; Richardson, LC				Tsai, James; Grant, Althea M.; Beckman, Michele G.; Grosse, Scott D.; Yusuf, Hussain R.; Richardson, Lisa C.			Determinants of Venous Thromboembolism among Hospitalizations of US Adults: A Multilevel Analysis	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; QUALITY-OF-CARE; RISK-FACTORS; PULMONARY-EMBOLISM; AMERICAN-COLLEGE; MEDICAL PATIENTS; HEALTH; PROPHYLAXIS; THROMBOPROPHYLAXIS; PREVENTION	Background Venous thromboembolism (VTE) is a significant clinical and public health concern. We evaluated a variety of multilevel factors-demographics, clinical and insurance status, preexisting comorbid conditions, and hospital characteristics-for VTE diagnosis among hospitalizations of US adults. Methods We generated adjusted odds ratios with 95% confidence intervals (CIs) and determined sources of outcome variation by conducting multilevel logistic regression analysis of data from the 2011 Nationwide Inpatient Sample that included 6,710,066 hospitalizations of US adults nested within 1,039 hospitals. Results Among hospitalizations of adults, age, sex, race or ethnicity, total days of hospital stay, status of health insurance, and operating room procedure were important determinants of VTE diagnosis; each of the following preexisting comorbid conditions-acquired immune deficiency syndrome, anemia, arthritis, congestive heart failure, coagulopathy, hypertension, lymphoma, metastatic cancer, other neurological disorders, obesity, paralysis, pulmonary circulation disorders, renal failure, solid tumor without metastasis, and weight loss-was associated independently with 1.04 (95% CI: 1.02-1.06) to 2.91 (95% CI: 2.81-3.00) times increased likelihood of VTE diagnosis than among hospitalizations of adults without any of these corresponding conditions. The presence of 2 or more of such conditions was associated a 180%-450% increased likelihood of a VTE diagnosis. Hospitalizations of adults who were treated in urban hospitals were associated with a 14%-15% increased likelihood of having a VTE diagnosis than those treated in rural hospitals. Approximately 7.4% of the total variation in VTE diagnosis occurred between hospitals. Conclusion The presence of certain comorbidities and hospital contextual factors is associated with significantly elevated likelihood of VTE diagnosis among hospitalizations of adults. The findings of this study underscore the importance of clinical risk assessment and adherence to evidence-based clinical practice guidelines in preventing VTE, as well as the need to evaluate potential contextual factors that might modify the risk of VTE among hospitalized patients.	[Tsai, James; Grant, Althea M.; Beckman, Michele G.; Grosse, Scott D.; Yusuf, Hussain R.; Richardson, Lisa C.] Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Tsai, J (corresponding author), Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.	jxt9@cdc.gov		Tsai, James/0000-0002-3114-124X; Grosse, Scott/0000-0003-1078-6855; Richardson, Lisa/0000-0002-9555-7674				Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; AHRQ, 2013, OV NAT INP SAMPL NIS; AHRQ, 2012, COM SOFTW VERS 3 7; AHRQ, 2012, PROC CLASS 2012; AHRQ, 2012, MAJ OP ROOM PROC IND; Bibas M, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.030; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Chandra D, 2009, ANN INTERN MED, V151, P180, DOI 10.7326/0003-4819-151-3-200908040-00129; Cohen AT, 2005, THROMB HAEMOSTASIS, V94, P750, DOI 10.1160/TH05-06-0385; Dabbagh O, 2010, CHEST, V137, P1145, DOI 10.1378/chest.09-2177; Dean Steven M, 2010, Congest Heart Fail, V16, P164, DOI 10.1111/j.1751-7133.2010.00148.x; DHHS, 2008, SURG GEN CALL ACT PR; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Folsom AR, 2007, J GERONTOL A-BIOL, V62, P79, DOI 10.1093/gerona/62.1.79; Franchini M, 2008, ANN HEMATOL, V87, P167, DOI 10.1007/s00277-007-0416-1; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2001, MAYO CLIN PROC, V76, P1102, DOI 10.4065/76.11.1102; Houchens R, 2007, HCUP METHODS SERIES, V2007-01; Huseynova K, 2009, J AM COLL SURGEONS, V208, P547, DOI 10.1016/j.jamcollsurg.2009.01.002; Introduction to the HCUP nationwide inpatient sample (NIS), 2011, HEALTHC COST UT PROJ; Kaboli Peter J, 2005, Cleve Clin J Med, V72 Suppl 1, pS7; Keenan CR, 2007, CURR OPIN PULM MED, V13, P377, DOI 10.1097/MCP.0b013e3281eb8ef0; Kim SC, 2013, ARTHRIT CARE RES, V65, P1600, DOI 10.1002/acr.22039; Lopes Antonio Augusto, 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P53, DOI 10.2174/187152506775268794; Lyman GH, 2011, CANCER-AM CANCER SOC, V117, P1334, DOI 10.1002/cncr.25714; Maynard GA, 2010, AHRQ PUBLICATION, V08-0075; Papanikolaou PN, 2006, PLOS MED, V3, P1603, DOI 10.1371/journal.pmed.0030341; Piazza G, 2007, CHEST, V132, P554, DOI 10.1378/chest.07-0430; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Ruppert Andras, 2011, J Med Econ, V14, P65, DOI 10.3111/13696998.2010.546465; Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P1433, DOI 10.1001/jama.2012.404; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Spencer FA, 2007, ARCH INTERN MED, V167, P1471, DOI 10.1001/archinte.167.14.1471; Streiff MB, 2012, HEMATOL-AM SOC HEMAT, P631, DOI 10.1182/asheducation-2012.1.631; Sundstrom A, 2009, BJOG-INT J OBSTET GY, V116, P91, DOI 10.1111/j.1471-0528.2008.01926.x; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; Thornlow DK, 2006, MED CARE, V44, P265, DOI 10.1097/01.mlr.0000199668.42261.a3; Tsai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070061; Tsai J, 2013, INT J MED SCI, V10, P1352, DOI 10.7150/ijms.6714; Tveit DP, 2002, AM J KIDNEY DIS, V39, P1011, DOI 10.1053/ajkd.2002.32774; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Vogeli C, 2009, MED CARE, V47, P591, DOI 10.1097/MLR.0b013e31819432cd; Wattanakit K, 2008, J AM SOC NEPHROL, V19, P135, DOI 10.1681/ASN.2007030308; White RH, 2012, CIRCULATION, V125, P2051, DOI 10.1161/CIRCULATIONAHA.112.102814; Wolberg AS, 2012, ANESTH ANALG, V114, P275, DOI 10.1213/ANE.0b013e31823a088c; Yusuf HR, 2013, CLIN APPL THROM 0627	49	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123842	10.1371/journal.pone.0123842	http://dx.doi.org/10.1371/journal.pone.0123842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879844	gold, Green Published			2022-12-26	WOS:000353016500064
J	Vultaggio, A; Virgili, G; Gaeta, F; Romano, A; Maggi, E; Matucci, A				Vultaggio, Alessandra; Virgili, Gianni; Gaeta, Francesco; Romano, Antonino; Maggi, Enrico; Matucci, Andrea			High Serum beta-Lactams Specific/Total IgE Ratio Is Associated with Immediate Reactions to beta-Lactams Antibiotics	PLOS ONE			English	Article							IMMUNOGLOBULIN-E; DIAGNOSIS; MARKERS; DISEASE	Total serum IgE result from the combination of specific and non-specific pools. High specific/total IgE ratio may reflect high level of allergen-specific IgE on mast cells. No data regarding its applications to drug allergies is available. One hundred seventy-one patients with a history of immediate reactions to beta-lactams, confirmed by positive skin testing, and 122 control subjects tolerant to beta-lactams, were studied. CAP System was used for the detection of serum total and specific IgE antibodies. The specific/total IgE ratio was tested for diagnostic accuracy compared with conventional criteria. We finally performed a simulation study to expand our investigation of the performance of the specific/total IgE ratio index in a scenario in which the new CAP detection threshold is lowered further. Specific/total IgE ratio values >= 0.002 were observed more frequently in reactive than in controls. Seventy-four of 80 subjects with values >= 0.002 were allergic to beta-lactams, yielding a positive predictive value of 92.5%. The application of specific/total IgE ratio significantly improves the positive likelihood ratio and the overall diagnostic performance. In addition, we showed the capability of this new criterion to identify true reactive patients even among subjects with high levels of total IgE (>200 kU/L). Significant increase in both receiver operator characteristic (ROC) curve and sensitivity were observed in imputed case of the simulation study. The beta-lactams-specific/total IgE ratio may be an additional index compared to the common criterion of positivity to a single hapten in the allergological work-up of patients with beta-lactams immediate adverse reactions.	[Vultaggio, Alessandra; Matucci, Andrea] Policlin Careggi, Immunoallergol Unit, Dept Biomed, Florence, Italy; [Virgili, Gianni] Univ Florence, Dept Specialised Surg Sci, Florence, Italy; [Gaeta, Francesco; Romano, Antonino] Complesso Integrato Columbus, Allergy Unit, Rome, Italy; [Maggi, Enrico] Univ Florence, Ctr Res Transfer & High Educ DENOTHE, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; University of Florence	Matucci, A (corresponding author), Policlin Careggi, Immunoallergol Unit, Dept Biomed, Florence, Italy.	andrea.matucci@unifi.it	Maggi, Enrico/AAA-8045-2019; Gaeta, Francesco/AAC-7107-2020; Romano, Antonino/D-3102-2017; Alessandra, Vultaggio/K-3201-2014; Virgili, Gianni/P-6607-2014	Maggi, Enrico/0000-0002-1824-3583; Gaeta, Francesco/0000-0003-2942-7633; Romano, Antonino/0000-0001-9742-9898; Virgili, Gianni/0000-0002-9960-2989	EU [FP6-LSBH-CT-2006-018861]	EU(European Commission)	This study was supported by the EU Project SENS-IT-IV (FP6-LSBH-CT-2006-018861).	Di Lorenzo G, 2009, J ALLERGY CLIN IMMUN, V123, P1103, DOI 10.1016/j.jaci.2009.02.012; Federly TJ, 2013, ANN ALLERG ASTHMA IM, V111, P20, DOI 10.1016/j.anai.2013.05.012; Hayen A, 2010, J CLIN EPIDEMIOL, V63, P883, DOI 10.1016/j.jclinepi.2009.08.024; ISHIZAKA T, 1984, FED PROC, V43, P2840; Jackola DR, 2004, HUM IMMUNOL, V65, P20, DOI 10.1016/j.humimm.2003.10.012; Janes H, 2008, AM J EPIDEMIOL, V168, P89, DOI 10.1093/aje/kwn099; Johansson SGO, 2013, J ALLERGY CLIN IMMUN, V132, P235, DOI 10.1016/j.jaci.2012.11.017; Johansson SGO, 2009, ALLERGY, V64, P1472, DOI 10.1111/j.1398-9995.2009.02051.x; Kerkhof M, 2003, ALLERGY, V58, P905, DOI 10.1034/j.1398-9995.2003.00230.x; Khan DA, 2010, J ALLERGY CLIN IMMUN, V125, pS126, DOI 10.1016/j.jaci.2009.10.028; Matricardi PM, 2009, ALLERGY, V64, P1093, DOI 10.1111/j.1398-9995.2009.02055.x; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Rutjes AWS, 2005, CLIN CHEM, V51, P1335, DOI 10.1373/clinchem.2005.048595; Torres MJ, 2003, ALLERGY, V58, P961, DOI 10.1034/j.1398-9995.2003.00280.x; Vultaggio A, 2009, CLIN EXP ALLERGY, V39, P838, DOI 10.1111/j.1365-2222.2009.03219.x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	16	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121857	10.1371/journal.pone.0121857	http://dx.doi.org/10.1371/journal.pone.0121857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880869	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500013
J	Wang, RY; Ng, CN				Wang, Raymond Yu; Ng, Cho Nam			Can Centralized Sanctioning Promote Trust in Social Dilemmas? A Two-Level Trust Game with Incomplete Information	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; POLITICAL TRUST; COOPERATION; RECIPROCITY; GOVERNANCE	The problem of trust is a paradigmatic social dilemma. Previous literature has paid much academic attention on effects of peer punishment and altruistic third-party punishment on trust and human cooperation in dyadic interactions. However, the effects of centralized sanctioning institutions on decentralized reciprocity in hierarchical interactions remain to be further explored. This paper presents a formal two-level trust game with incomplete information which adds an authority as a strategic purposive actor into the traditional trust game. This model allows scholars to examine the problem of trust in more complex game theoretic configurations. The analysis demonstrates how the centralized institutions might change the dynamics of reciprocity between the trustor and the trustee. Findings suggest that the sequential equilibria of the newly proposed two-level model simultaneously include the risk of placing trust for the trustor and the temptation of short-term defection for the trustee. Moreover, they have shown that even a slight uncertainty about the type of the newly introduced authority might facilitate the establishment of trust and reciprocity in social dilemmas.	[Wang, Raymond Yu] Univ Hong Kong, Fac Social Sci, Hong Kong, Hong Kong, Peoples R China; [Ng, Cho Nam] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wang, RY (corresponding author), Univ Hong Kong, Fac Social Sci, Hong Kong, Hong Kong, Peoples R China.	wangyuray@connect.hku.hk	Wang, Raymond Yu/AAL-2328-2020; Wang, Raymond Yu/AAV-8653-2021	Wang, Raymond Yu/0000-0003-0634-9492; 				Anderhub V, 2002, J ECON BEHAV ORGAN, V48, P197, DOI 10.1016/S0167-2681(01)00216-5; Arrow K., 1970, ANAL PUBLIC OUTPUT; Arrow K. J., 1974, LIMITS ORG; Bachmann R, 2001, ORGAN STUD, V22, P337, DOI 10.1177/0170840601222007; Baldassarri D, 2011, P NATL ACAD SCI USA, V108, P11023, DOI 10.1073/pnas.1105456108; Berg L, 2004, APPETITE, V42, P21, DOI 10.1016/S0195-6663(03)00112-0; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Bower AG, 1997, INT J IND ORGAN, V15, P165, DOI 10.1016/0167-7187(95)00495-5; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Buskens V, 1998, SOC NETWORKS, V20, P265, DOI 10.1016/S0378-8733(98)00005-7; Buskens V, 2000, RATION SOC, V12, P227, DOI 10.1177/104346300012002004; Buskens V, 2003, GAME ECON BEHAV, V42, P235, DOI 10.1016/S0899-8256(02)00563-8; Buskens V., 2002, SOCIAL NETWORKS TRUS, V30; Buskens V., 2002, GROUP COHESION TRUST, V19, P167, DOI [DOI 10.1016/S0882-6145(02)19007-2, 10.1016/S0882-6145(02)19007-2]; Buskens V, 2013, HDB RATIONAL CHOICE; Buskens V, 2010, SOC NETWORKS, V32, P301, DOI 10.1016/j.socnet.2010.05.001; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Coleman J., 1990, FDN SOCIAL THEORY; Cook KS, 2003, RUSSELL SAGE TRUST, V6, P209; Dasgupta P., 1988, TRUST MAKING BREAKIN, P49; Edelenbos J, 2012, ADMIN SOC, V44, P647, DOI 10.1177/0095399711413876; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Janssen MA, 2014, ECOLOGY SOC, P19; KREPS DM, 1982, ECONOMETRICA, V50, P863, DOI 10.2307/1912767; Kreps DM, 1990, PERSPECTIVES POSITIV, P90, DOI [DOI 10.1017/CBO9780511571657.006, 10.1017/CBO9780511571657.006]; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Lane C., 1998, TRUST ORG CONCEPTUAL; Levi M, 2000, ANNU REV POLIT SCI, V3, P475, DOI 10.1146/annurev.polisci.3.1.475; Li LJ, 2013, MOD CHINA, V39, P3, DOI 10.1177/0097700412450661; Lindgreen A., 2003, British Food Journal, V105, P310, DOI 10.1108/00070700310481694; Lorenz EH, 1988, TRUST MAKING BREAKIN, P194; Mishler W, 2001, COMP POLIT STUD, V34, P30, DOI 10.1177/0010414001034001002; Ng CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073793; Nooteboom B, 1997, ACAD MANAGE J, V40, P308, DOI 10.2307/256885; Norris P., 2002, DEMOCRATIC PHOENIX R; O'Gorman R, 2009, P ROY SOC B-BIOL SCI, V276, P323, DOI 10.1098/rspb.2008.1082; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; OUCHI WG, 1980, ADMIN SCI QUART, V25, P129, DOI 10.2307/2392231; Pedersen E. J., 2013, P ROYAL SOC B, V280; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Ratnasingam P, 2003, INTERORGANIZATIONAL; RING PS, 1992, STRATEGIC MANAGE J, V13, P483, DOI 10.1002/smj.4250130702; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Rothstein Bo, 2005, SOCIAL TRAPS PROBLEM; Sethi R, 2003, J ECON BEHAV ORGAN, V50, P1, DOI 10.1016/S0167-2681(02)00032-X; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Snijders C, 1996, TRUST COMMITMENTS; Traulsen A, 2012, P ROY SOC B-BIOL SCI, V279, P3716, DOI 10.1098/rspb.2012.0937; Uslaner E., 2002, MORAL FDN TRUST; Woolthuis RK, 1999, SLEEPING ENEMY TRUST; Zucker L., 1986, RES ORGAN BEHAV, V8, P1840, DOI DOI 10.1023/A	63	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124513	10.1371/journal.pone.0124513	http://dx.doi.org/10.1371/journal.pone.0124513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25879752	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500103
J	Bai, PY; Wittert, GA; Taylor, AW; Martin, SA; Milne, RW; Shi, ZM				Bai, Peter Y.; Wittert, Gary A.; Taylor, Anne W.; Martin, Sean A.; Milne, Robert W.; Shi, Zumin			The Association of Socio-Demographic Status, Lifestyle Factors and Dietary Patterns with Total Urinary Phthalates in Australian Men	PLOS ONE			English	Article							BISPHENOL-A; METABOLITE CONCENTRATIONS; PREGNANT-WOMEN; US POPULATION; UNITED-STATES; ACID ESTERS; EXPOSURE; MEDICATIONS; DIESTERS; OUTCOMES	Objective To investigate the associations between socio-demographic status, lifestyle factors, dietary patterns and urinary total phthalate concentration in a cohort of South Australian men. Method We randomly selected 1527 males aged 39 to 84 from wave two of the Men Androgen Inflammation Lifestyle Environment and Stress (MAILES) study. Total phthalate concentration was examined in fasting morning urine samples. Socio-demographic and lifestyle factors were assessed by questionnaire. Food intake was assessed by food frequency questionnaire (FFQ). Dietary patterns were constructed using factor analysis. Results Total phthalates were detected in 99.6% of the urine samples. The overall geometric mean (95% CI) of total phthalate concentration was 112.4 (107.5-117.5) ng/mL. The least square geometric means (LSGMs) of total phthalate concentration were significantly higher among people who were obese (127.8 ng/mL), consuming less than two serves fruit per day (125.7 ng/mL) and drinking more than one can (375mL) of carbonated soft drink per day (131.9 ng/mL). Two dietary patterns were identified: a prudent dietary pattern and a western dietary pattern. Both the western dietary pattern (p = 0.002) and multiple lifestyle risk factors including smoking, obesity, insufficient physical activity and the highest quartile of the western dietary pattern (p<0.001), were positively associated with total phthalate levels. There was no significant relationship between total phthalate concentration and sociodemographic status. Conclusion Phthalate exposure is ubiquitous and positively associated with lifestyle risk factors in urban dwelling Australian men.	[Bai, Peter Y.; Wittert, Gary A.; Taylor, Anne W.; Martin, Sean A.; Shi, Zumin] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Milne, Robert W.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	University of Adelaide; University of South Australia	Bai, PY (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA, Australia.	peter.bai@adelaide.edu.au	Shi, Zumin/A-1093-2009; Milne, Robert/C-6890-2009; wittert, gary/AAE-2398-2019; Taylor, Anne w/F-5708-2010	Shi, Zumin/0000-0002-3099-3299; Milne, Robert/0000-0002-4554-8366; Taylor, Anne w/0000-0002-4422-7974; Wittert, Gary/0000-0001-6818-6065	National Health and Medical Research Council (NHMRC) [627227]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by National Health and Medical Research Council (NHMRC), grant number #627227, to the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001; AIHW, 2012, 15613 AIHW AUS; Australian Institute of Health and Wellfare (AIHW), 2003, ACT AUSTR SURV GUID; Bradley EL, 2013, FOOD ADDIT CONTAM A, V30, P735, DOI 10.1080/19440049.2013.781684; Bradley EL, 2013, FOOD ADDIT CONTAM A, V30, P722, DOI 10.1080/19440049.2013.781683; Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012; Chen L, 2012, SCI TOTAL ENVIRON, V427, P60, DOI 10.1016/j.scitotenv.2012.03.090; Feng XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072643; Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005; Genuis SJ, 2012, SCI WORLD J, V2012, DOI [DOI 10.1100/2012/615068, 10.1100/2012/615068]; Goodman M, 2014, CRIT REV TOXICOL, V44, P151, DOI 10.3109/10408444.2013.860076; Grant JF, 2013, INT J EPIDEMIOL; Guo Y, 2012, J AGR FOOD CHEM; Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m; Guo ZY, 2010, J CHROMATOGR SCI, V48, P760, DOI 10.1093/chromsci/48.9.760; Heinemeyer G, 2013, INT J HYGIENE ENV HL; Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Kappenstein Oliver, 2012, Exp Suppl, V101, P87, DOI 10.1007/978-3-7643-8340-4_4; Kelley KE, 2012, ENVIRON HEALTH PERSP, V120, P379, DOI 10.1289/ehp.1103998; Khedr A, 2013, J CHROMATOGR B, V930, P98, DOI 10.1016/j.jchromb.2013.04.040; Kobrosly RW, 2012, ENVIRON RES, V115, P11, DOI 10.1016/j.envres.2012.03.008; Koch HM, 2013, INT J HYGIENE ENV HL; Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405, DOI 10.1289/ehp.02110405; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268; Mohr P, 2007, PUBLIC HEALTH NUTR, V10, P1456, DOI 10.1017/S1368980007000109; National Industrial Chemicals Notification and Assessment Scheme (NICNAS), 2008, EX CHEM HAZ ASS REP, DOI [10.1002/etc.2672, DOI 10.1002/ETC.2672]; Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X; Olsen L, 2012, ECOTOX ENVIRON SAFE, V75, P242, DOI 10.1016/j.ecoenv.2011.09.004; Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4; PETERSEN SB, 2012, PUBLIC HLTH NUT 0912; Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Saravanabhavan G, 2013, INT J HYGIENE ENV HL; Schecter A, 2013, ENVIRON HEALTH PERSP, V121, P473, DOI 10.1289/ehp.1206367; Schoenaker DAJM, 2013, J NUTR, V143, P392, DOI 10.3945/jn.112.169011; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; StataCorp, 2013, STAT REF MAN; Toxicity and Exposure Assessment for Children's Health (TEACH), 2006, TEACH CHEM SUMM PHTH; Tranfo G, 2012, INT J HYGIENE ENV HL; U.S. CDC, 2013, CHEM FACT SHEET PHTH; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014; Zeng Q, 2013, FOOD CHEM TOXICOL, V56, P18, DOI 10.1016/j.fct.2013.01.045; Zota A. R., 2014, ENV HLTH PERSPECT	49	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122140	10.1371/journal.pone.0122140	http://dx.doi.org/10.1371/journal.pone.0122140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875472	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000353015800042
J	Coles, CA; Wadeson, J; Leyton, CP; Siddell, JP; Greenwood, PL; White, JD; McDonagh, MB				Coles, Chantal A.; Wadeson, Jenny; Leyton, Carolina P.; Siddell, Jason P.; Greenwood, Paul L.; White, Jason D.; McDonagh, Matthew B.			Proliferation Rates of Bovine Primary Muscle Cells Relate to Liveweight and Carcase Weight in Cattle	PLOS ONE			English	Article							ADULT SKELETAL-MUSCLE; SATELLITE CELLS; GENE MYF-5; MYOD; MICE; DIFFERENTIATION; INACTIVATION; MYOGENESIS	Muscling in cattle is largely influenced by genetic background, ultimately affecting beef yield and is of major interest to the beef industry. This investigation aimed to determine whether primary skeletal muscle cells isolated from different breeds of cattle with a varying genetic potential for muscling differ in their myogenic proliferative capacity. Primary skeletal muscle cells were isolated and cultured from the Longissimus muscle (LM) of 6 month old Angus, Hereford and Wagyu X Angus cattle. Cells were assessed for rate of proliferation and gene expression of PAX7, MYOD, MYF5, and MYOG. Proliferation rates were found to differ between breeds of cattle whereby myoblasts from Angus cattle were found to proliferate at a greater rate than those of Hereford and Wagyu X Angus during early stages of growth (5-20 hours in culture) in vitro (P < 0.05). The proliferation rates of myoblasts during early stages of culture in vitro were also found to be positively related to the liveweight and carcase weight of cattle (P < 0.05). Gene expression of MYF5 was also found to be significantly down-regulated in WagyuX compared with Angus cattle (P < 0.05). These findings suggest that early events during myogenesis are important for determining liveweight and caracase weights in cattle.	[Coles, Chantal A.; Wadeson, Jenny; Leyton, Carolina P.; McDonagh, Matthew B.] Discovery Technol, Biosci Res Div, Dept Primary Ind Victoria, Melbourne, Vic 3083, Australia; [Coles, Chantal A.; White, Jason D.] Univ Melbourne, Dept Vet Sci, Melbourne, Vic 3010, Australia; [Siddell, Jason P.; Greenwood, Paul L.; McDonagh, Matthew B.] Univ New England, Cooperat Res Ctr Cattle & Beef Qual, Armidale, NSW 2351, Australia; [Siddell, Jason P.; Greenwood, Paul L.; McDonagh, Matthew B.] Beef Ind Ctr Excellence, New South Wales Dept Primary Ind, Armidale, NSW 2351, Australia	Victorian Department of Environment & Primary Industries; University of Melbourne; University of New England; NSW Department of Primary Industries	Coles, CA (corresponding author), Discovery Technol, Biosci Res Div, Dept Primary Ind Victoria, Melbourne, Vic 3083, Australia.	chantal.coles@mcri.edu.au	Greenwood, Paul L/G-9747-2013; White, Jason/AAF-8712-2020	Greenwood, Paul L/0000-0002-7719-8233; White, Jason/0000-0002-0557-392X	Cooperative Research Centre for Beef Technologies Australia [1.1.3]; Victorian Government's Operational Infrastructure Support Program	Cooperative Research Centre for Beef Technologies Australia; Victorian Government's Operational Infrastructure Support Program	This work was supported by Cooperative Research Centre for Beef Technologies Australia Project Number: 1.1.3, Project Name: Biological validation and gene expression underpinning gene discovery (Proof of concept), Project Leader: Dr. Paul Greenwood; and Sub-Program 1.1 Full utilisation of genetic markers for improved beef quality, Start Date: 01/07/2005, End Date: 30/06/2012. Sponsors were involved in large scale coordination of cattle including management and finances in housing cattle up to slaughter date and coordination of cattle into abbattoirs for sample collection. The funders also financed laboratory reagents and labour for data analysis and preparation of the manuscript. This work was also supported in part by the Victorian Government's Operational Infrastructure Support Program.	Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kook SH, 2006, MOL CELLS, V22, P239; Lavulo LT, 2008, CELLS TISSUES ORGANS, V187, P141, DOI 10.1159/000110080; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x	15	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124468	10.1371/journal.pone.0124468	http://dx.doi.org/10.1371/journal.pone.0124468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875203	Green Published, gold			2022-12-26	WOS:000353015800142
J	Crawford, GL; Boldison, J; Copland, DA; Adamson, P; Gale, D; Brandt, M; Nicholson, LB; Dick, AD				Crawford, G. L.; Boldison, J.; Copland, D. A.; Adamson, P.; Gale, D.; Brandt, M.; Nicholson, L. B.; Dick, A. D.			The Role of Lipoprotein-Associated Phospholipase A(2) in a Murine Model of Experimental Autoimmune Uveoretinitis	PLOS ONE			English	Article							CELLULAR INFILTRATE; UVEITIS; OXLDL; CLASSIFICATION; INFLAMMATION; MACROPHAGES; INHIBITION; ACTIVATION; DARAPLADIB; RESPONSES	Macrophage activation is, in part, regulated via hydrolysis of oxidised low density lipoproteins by Lipoprotein-Associated phospholipase A(2) (Lp-PLA(2)), resulting in increased macrophage migration, pro-inflammatory cytokine release and chemokine expression. In uveitis, tissue damage is mediated as a result of macrophage activation; hence inhibition of LpPLA(2) may limit macrophage activation and protect the tissue. Utilising Lp-PLA(2) gene-deficient (KO) mice and a pharmacological inhibitor of Lp-PLA(2) (SB-435495) we aimed to determine the effect of Lp-PLA(2) suppression in mediating retinal protection in a model of autoimmune retinal inflammation, experimental autoimmune uveoretinitis (EAU). Following immunisation with RBP-3 (IRBP) 1-20 or 161-180 peptides, clinical disease was monitored and severity assessed, infiltrating leukocytes were enumerated by flow cytometry and tissue destruction quantified by histology. Despite ablation of Lp-PLA(2) enzyme activity in LpPLA(2) KO mice or wild-type mice treated with SB-435495, the number of infiltrating CD45(+) cells in the retina was equivalent to control EAU animals, and there was no reduction in disease severity. Thus, despite the reported beneficial effects of therapeutic Lp-PLA(2) depletion in a variety of vascular inflammatory conditions, we were unable to attenuate disease, show delayed disease onset or prevent progression of EAU in Lp-PLA(2) KO mice. Although EAU exhibits inflammatory vasculopathy there is no overt defect in lipid metabolism and given the lack of effect following Lp-PLA(2) suppression, these data support the hypothesis that sub-acute autoimmune inflammatory disease progresses independently of Lp-PLA(2) activity.	[Crawford, G. L.; Copland, D. A.; Nicholson, L. B.; Dick, A. D.] Univ Bristol, Sch Clin Sci, Acad Unit Ophthalmol, Bristol, Avon, England; [Boldison, J.; Nicholson, L. B.; Dick, A. D.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Adamson, P.] GlaxoSmithKline, Ophthiris Discovery Performance Unit, Stevenage, Herts, England; [Gale, D.] GlaxoSmithKline, Ophthiris Discovery Performance Unit, King Of Prussia, PA USA; [Brandt, M.] Platform Technol Sci, King Of Prussia, PA USA	University of Bristol; University of Bristol; GlaxoSmithKline; GlaxoSmithKline	Dick, AD (corresponding author), Univ Bristol, Sch Clin Sci, Acad Unit Ophthalmol, Bristol, Avon, England.	a.dick@bristol.ac.uk	Copland, David/AAE-5334-2020; Copland, David/AAG-2368-2019	Copland, David/0000-0002-2257-4270; Dick, Andrew/0000-0002-0742-3159	Biotechnology and biological sciences research council [BB/J500197/1]; GlaxoSmithKline [STU100020289]; GlaxoSmithKline; Biotechnology and Biological Sciences Research Council [1135012] Funding Source: researchfish	Biotechnology and biological sciences research council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	http://www.bbsrc.ac.uk/home/home.aspx, Biotechnology and biological sciences research council: BB/J500197/1, received by GLC (nee Gemma Beers) and http://www.gsk.com/ GlaxoSmithKline: STU100020289, received by GLC (nee Gemma Beers). The funder GlaxoSmithKline provided support in the form of salaries for authors PA, DG & MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamson P, 2013, US Patent, Patent No. [20,130,267,544, 20130267544]; Arai H, 2002, PROSTAG OTH LIPID M, V68-9, P83, DOI 10.1016/S0090-6980(02)00023-0; Blackie JA, 2003, BIOORG MED CHEM LETT, V13, P1067, DOI 10.1016/S0960-894X(03)00058-1; Brilakis ES, 2005, EUR HEART J, V26, P137, DOI 10.1093/eurheartj/ehi010; Calder CJ, 2005, J IMMUNOL, V175, P6286, DOI 10.4049/jimmunol.175.10.6286; Chung Y, 2013, J IMMUNOL, V190; Copland DA, 2007, AM J PATHOL, V171, P580, DOI 10.2353/ajpath.2007.070272; Copland DA, 2008, INVEST OPHTH VIS SCI, V49, P5458, DOI 10.1167/iovs.08-2348; Dick AD, 1996, EUR J IMMUNOL, V26, P1018, DOI 10.1002/eji.1830260510; Forrester JV, 2013, INT REV IMMUNOL, V32, P76, DOI 10.3109/08830185.2012.747524; Forrester JV, 1997, EYE, V11, P162, DOI 10.1038/eye.1997.45; Forrester JV, 1998, CURR EYE RES, V17, P426, DOI 10.1080/02713689808951224; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Jiang ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-100; Kerr EC, 2008, PROG RETIN EYE RES, V27, P527, DOI 10.1016/j.preteyeres.2008.07.001; Kerr EC, 2008, J AUTOIMMUN, V31, P354, DOI 10.1016/j.jaut.2008.08.006; Kotosai M, 2013, LIPIDS, V48, P569, DOI 10.1007/s11745-013-3779-1; Lee RWJ, 2012, EYE, V26, P17, DOI 10.1038/eye.2011.255; Lee RW, 2014, AUTOIMMUNE AND AUTOI; Lee RH, 2011, ARCHIT DIGEST, V68, P26; Lim H, 2014, IMMUNITY, V40, P153, DOI 10.1016/j.immuni.2013.11.021; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Sanchez-Quesada JL, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-112; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Raveney BJE, 2010, IMMUNOLOGY, V131, P340, DOI 10.1111/j.1365-2567.2010.03305.x; Raveney BJE, 2009, J IMMUNOL, V183, P2321, DOI 10.4049/jimmunol.0901340; Schewitz-Bowers LP, 2010, EXPERT REV OPHTHALMO, V5, P43, DOI 10.1586/EOP.09.68; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Selmi C, 2014, AUTOIMMUN REV, V13, P591, DOI 10.1016/j.autrev.2014.01.006; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Shoji T, 2000, ATHEROSCLEROSIS, V148, P171, DOI 10.1016/S0021-9150(99)00218-X; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Wang WD, 2011, J INEQUAL APPL, DOI 10.1186/1029-242X-2011-6; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; White HD, 2014, NEW ENGL J MED, V370, P1702, DOI 10.1056/NEJMoa1315878; (WHO) WHO, GLOB DAT VIS IMP; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Xu HP, 2003, INVEST OPHTH VIS SCI, V44, P226, DOI 10.1167/iovs.01-1202; Yeo TK, 2013, OCUL IMMUNOL INFLAMM, V21, P264, DOI 10.3109/09273948.2013.774424; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122093	10.1371/journal.pone.0122093	http://dx.doi.org/10.1371/journal.pone.0122093			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874928	gold, Green Submitted, Green Published			2022-12-26	WOS:000353015800038
J	Cardoso, CW; Ribeiro, GS; Reis, MG; Flannery, B; Reis, JN				Cardoso, Cristiane Wanderley; Ribeiro, Guilherme Sousa; Reis, Mitermayer Galvao; Flannery, Brendan; Reis, Joice Neves			Effectiveness of Meningococcal C Conjugate Vaccine in Salvador, Brazil: A Case-Control Study	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; DISEASE; EPIDEMIC; IMPACT; TEENAGERS; RISK; AGE	Background During a citywide epidemic of serogroup C meningococcal disease in Salvador in 2010, Brazil, the state government initiated mass vaccination targeting two age groups with high attack rates: individuals aged < 5 years and 10-24 years. More than 600,000 doses of meningococcal serogroup C conjugate vaccines were administered. We performed a casecontrol study to evaluate vaccine uptake, document vaccine effectiveness and identify reasons for non-vaccination. Methods and Findings Population-based surveillance identified patients with laboratory-confirmed invasive meningococcal C MenC) disease during 2010. Information on MenC vaccination was obtained from case patients and age-matched individuals from the same neighborhoods. MenC vaccine effectiveness was estimated based on the exact odds ratios obtained by conditional logistic regression analysis. Of 51 laboratory-confirmed cases of serogroup C meningococcal disease among patients < 5 and 10-24 years of age 50 were included in the study and matched with 240 controls. Overall case-fatality was 25%. MenC vaccine coverage among controls increased from 7.1% to 70.2% after initiation of the vaccination campaign. None of the 50 case patients but 70 (29.2%) of the 240 control individuals, including 59 (70.2%) of 84 matched with cases from the period afterMenC vaccination, had received at least one MenC vaccine dose. Overall effectiveness of MenC was 98% with a lower 95% exact confidence limit of 89%. Conclusions MenC vaccines administered during the meningococcal epidemic were highly effective, suggesting that rapid vaccine uptake through campaigns contributed to control of meningococcal disease.	[Cardoso, Cristiane Wanderley; Ribeiro, Guilherme Sousa; Reis, Mitermayer Galvao; Reis, Joice Neves] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil; [Ribeiro, Guilherme Sousa] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Flannery, Brendan] Pan Amer Hlth Org, Brasilia, DF, Brazil; [Reis, Joice Neves] Univ Fed Bahia, Sch Pharm, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Pan American Health Organization; Universidade Federal da Bahia	Reis, JN (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.	joice@ufba.br	Reis, Mitermayer/AAO-9742-2020; Ribeiro, Guilherme/B-6624-2008; Reis, Joice N/H-9227-2013; Cardoso, Cristiane W/U-3350-2019; Pedreira, Joice Neves Reis/AAO-3536-2021; Cardoso, Cristiane W/Y-8510-2018	Reis, Mitermayer/0000-0002-3051-9060; Ribeiro, Guilherme/0000-0002-6798-2059; Pedreira, Joice Neves Reis/0000-0001-5273-2658; Cardoso, Cristiane/0000-0001-5432-1174	Bahia State Foundation [PP-SUS0001/2009]; Secretary of Health Surveillance [SVS/MS - 284/2013]	Bahia State Foundation; Secretary of Health Surveillance	This work was supported by the grants from the Bahia State Foundation (PP-SUS0001/2009) and Secretary of Health Surveillance (SVS/MS - 284/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P521; [Anonymous], 2013, NATL IMMUNIZATION PR; Baker M, 2000, PEDIATR INFECT DIS J, V19, P983, DOI 10.1097/00006454-200010000-00009; Bose A, 2003, LANCET, V361, P675, DOI 10.1016/S0140-6736(03)12563-9; Cano R, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.07.00474-en; Cardoso CW, 2012, VACCINE, V30, P5541, DOI 10.1016/j.vaccine.2012.06.044; Center for Disease Control and Prevention, 2013, MEN DIS SIGNS SYMPT; Coen PG, 2006, INT J EPIDEMIOL, V35, P330, DOI 10.1093/ije/dyi295; Cordeiro SM, 2007, T ROY SOC TROP MED H, V101, P1147, DOI 10.1016/j.trstmh.2007.06.012; Teixeira AMD, 2011, REV PANAM SALUD PUBL, V30, P7; de Greeff SC, 2006, PEDIATR INFECT DIS J, V25, P79, DOI 10.1097/01.inf.0000195594.41449.c6; Moraes José Cássio de, 2005, Cad. Saúde Pública, V21, P1458, DOI 10.1590/S0102-311X2005000500019; Larrauri A, 2005, VACCINE, V23, P4097, DOI 10.1016/j.vaccine.2005.03.045; Lee CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000374; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Murray RL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1062; PELTOLA H, 1982, LANCET, V2, P595; Azevedo LCP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064524; Safadi MAP, 2013, EPIDEMIOL INFECT, V141, P447, DOI 10.1017/S0950268812001689; Secretaria de Saude do Estado de Sao Paulo, IM ESP SUAS IND 2013; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7; WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195	24	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123734	10.1371/journal.pone.0123734	http://dx.doi.org/10.1371/journal.pone.0123734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874777	Green Published, gold			2022-12-26	WOS:000352845100206
J	Jia, XY; Cui, Z; Li, JN; Hu, SY; Zhao, MH				Jia, Xiao-yu; Cui, Zhao; Li, Jian-nan; Hu, Shui-yi; Zhao, Ming-hui			Identification of Critical Residues of Linear B Cell Epitope on Goodpasture Autoantigen	PLOS ONE			English	Article							BASEMENT-MEMBRANE ANTIBODY; CD4(+) T-CELLS; ANTIGEN; MODULATION; DISEASE; COMPLEX; GLOMERULONEPHRITIS; SUSCEPTIBILITY; IMMUNITY; COLLAGEN	Background The autoantigen of anti-glomerular basement membrane (GBM) disease has been identified as the non-collagenous domain 1 of alpha 3 chain of type IV collagen, alpha 3(IV)NC1. Our previous study revealed a peptide on alpha 3(IV) NC1 as a major linear epitope for B cells and potentially nephrogenic, designated as P14 (alpha 3129-150). This peptide has also been proven to be the epitope of auto-reactive T cells in anti-GBM patients. This study was aimed to further characterize the critical motif of P14. Methods 16 patients with anti-GBMdisease and positive anti-P14 antibodies were enrolled. A set of truncated and alanine substituted peptides derived from P14 were synthesized. Circulating antibodies against the peptides were detected by enzyme linked immunosorbent assay (ELISA). Results We found that all sera with anti-P14 antibodies reacted with the 13-mer sequence in the C-terminus of P14 (P14c) exclusively. The level of antibodies against P14 was highly correlated with the level of antibodies against P14c (r=0.970, P<0.001). P14c was the core immunogenic region and the amino acid sequence (ISLWKGFSFIMFT) was highly hydrophobic. Each amino acid residue in P14c was sequentially replaced by alanine. Three residues of glycine142, phenylalanine143, and phenylalanine145 were identified crucial for antibody binding based on the remarkable decline (P<0.001) of antibody reaction after each residue replacement. Conclusions We defined GFxF (alpha 3142, 143,145) as the critical motif of P14. It may provide some clues for understanding the etiology of anti-GBM disease.	[Jia, Xiao-yu; Cui, Zhao; Li, Jian-nan; Hu, Shui-yi; Zhao, Ming-hui] Peking Univ, Div Renal, Dept Med,Key Lab CKD Prevent & Treatment,Minist E, Hosp 1,Inst Nephrol,Key Lab Renal Dis,Minist Hlth, Beijing, Peoples R China; [Zhao, Ming-hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University	Cui, Z (corresponding author), Peking Univ, Div Renal, Dept Med,Key Lab CKD Prevent & Treatment,Minist E, Hosp 1,Inst Nephrol,Key Lab Renal Dis,Minist Hlth, Beijing, Peoples R China.	cuizhao@bjmu.edu.cn	Li, Jiannan/AAD-2792-2022; Cui, Zhao/ABZ-9262-2022	Cui, Zhao/0000-0002-5837-1926; Hu, Shui-Yi/0000-0003-2036-0866; Li, Jiannan/0000-0003-4023-690X	Chinese 973 project [2012CB517702]; Natural Science Fund of China to the Innovation Research Group [81321064]; National Natural Science Fund of China [81170645, 81370801, 81330020, 81400703]	Chinese 973 project(National Basic Research Program of China); Natural Science Fund of China to the Innovation Research Group; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant of Chinese 973 project (No. 2012CB517702), a grant from Natural Science Fund of China to the Innovation Research Group (81321064) and grants of National Natural Science Fund of China (81170645, 81370801, 81330020, 81400703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AN, 2002, EUR J IMMUNOL, V32, P530, DOI 10.1002/1521-4141(200202)32:2<530::AID-IMMU530>3.0.CO;2-X; Arends J, 2006, J IMMUNOL, V176, P1252, DOI 10.4049/jimmunol.176.2.1252; Berg M, 1997, EUR J IMMUNOL, V27, P1022, DOI 10.1002/eji.1830270432; BOLTON WK, 1984, J CLIN INVEST, V73, P1263, DOI 10.1172/JCI111328; Bolton WK, 2005, J AM SOC NEPHROL, V16, P2657, DOI 10.1681/ASN.2004100823; Cairns LS, 2003, J AM SOC NEPHROL, V14, P2801, DOI 10.1097/01.ASN.0000091588.80007.0E; Chen JL, 2013, CLIN J AM SOC NEPHRO, V8, P51, DOI 10.2215/CJN.05140512; David M, 2001, J BIOL CHEM, V276, P6370, DOI 10.1074/jbc.M008956200; Goodpasture EW, 2009, AM J MED SCI, V338, P148, DOI 10.1097/MAJ.0b013e31818fff94; Gozalbo-Rovira R, 2013, KIDNEY INT, V83, P438, DOI 10.1038/ki.2012.399; Jia XY, 2012, CLIN J AM SOC NEPHRO, V7, P926, DOI 10.2215/CJN.09930911; Kalluri R, 1997, J CLIN INVEST, V100, P2263, DOI 10.1172/JCI119764; Kitagawa W, 2008, NEPHROL DIAL TRANSPL, V23, P3126, DOI 10.1093/ndt/gfn179; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; Macaulay AE, 1997, J IMMUNOL, V158, P4171; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Ooi JD, 2013, J AM SOC NEPHROL, V24, P419, DOI 10.1681/ASN.2012070705; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; Quaratino S, 2005, J IMMUNOL, V174, P557, DOI 10.4049/jimmunol.174.1.557; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reynolds J, 2000, J CLIN INVEST, V105, P643, DOI 10.1172/JCI6710; Robertson J, 2005, KIDNEY INT, V68, P1061, DOI 10.1111/j.1523-1755.2005.00498.x; Salama AD, 2001, J AM SOC NEPHROL, V12, P1908, DOI 10.1681/ASN.V1291908; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; STOCKINGER B, 1992, EUR J IMMUNOL, V22, P1271, DOI 10.1002/eji.1830220523; VOGT AB, 1994, J IMMUNOL, V153, P1665; Watts C, 1998, IMMUNOL REV, V164, P11, DOI 10.1111/j.1600-065X.1998.tb01203.x; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14; Wu J, 2004, J IMMUNOL, V172, P4567, DOI 10.4049/jimmunol.172.7.4567; Wu J, 2002, J CLIN INVEST, V109, P517, DOI 10.1172/JCI200213876; Yang R, 2009, CLIN IMMUNOL, V133, P245, DOI 10.1016/j.clim.2009.07.005; Zou J, 2007, J AM SOC NEPHROL, V18, P771, DOI 10.1681/ASN.2006091056	34	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123277	10.1371/journal.pone.0123277	http://dx.doi.org/10.1371/journal.pone.0123277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874890	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100158
J	Lanzi, S; Codecasa, F; Cornacchia, M; Maestrini, S; Capodaglio, P; Brunani, A; Fanari, P; Salvadori, A; Malatesta, D				Lanzi, Stefano; Codecasa, Franco; Cornacchia, Mauro; Maestrini, Sabrina; Capodaglio, Paolo; Brunani, Amelia; Fanari, Paolo; Salvadori, Alberto; Malatesta, Davide			Long Maximal Incremental Tests Accurately Assess Aerobic Fitness in Class II and III Obese Men	PLOS ONE			English	Article							OXYGEN-UPTAKE KINETICS; ANAEROBIC THRESHOLD; LIPID OXIDATION; EXERCISE; METABOLISM; OVERWEIGHT; VO(2)PEAK; CAPACITY; DURATION; PROTOCOL	This study aimed to compare two different maximal incremental tests with different time durations [a maximal incremental ramp test with a short time duration (8-12 min) (S-Test) and a maximal incremental test with a longer time duration (20-25 min) (L-Test)] to investigate whether an L-Test accurately assesses aerobic fitness in class II and III obese men. Twenty obese men (BMI >= 35 kg.m-2) without secondary pathologies (mean +/- SE; 36.7 +/- 1.9 yr; 41.8 +/- 0.7 kg*m(-2)) completed an STest (warm-up: 40 W; increment: 20W*min(-1)) and an LTest [warm-up: 20% of the peak power output (PPO) reached during the STest; increment: 10% PPO every 5 min until 70% PPO was reached or until the respiratory exchange ratio reached 1.0, followed by 15 W.min(-1) until exhaustion] on a cycle-ergometer to assess the peak oxygen uptake <(V)over dot>O-2peak and peak heart rate (HRpeak) of each test. There were no significant differences in <(V)over dot>O-2peak (S-Test: 3.1 +/- 0.1 L*min(-1); L-Test: 3.0 +/- 0.1 L*min(-1)) and HRpeak (S-Test: 174 +/- 4 bpm; L-Test: 173 +/- 4 bpm) between the two tests. Bland-Altman plot analyses showed good agreement and Pearson product-moment and intra-class correlation coefficients showed a strong correlation between <(V)over dot>O-2peak (r=0.81 for both; p <= 0.001) and HRpeak (r=0.95 for both; p <= 0.001) during both tests. <(V)over dot>O-2peak and HRpeak assessments were not compromised by test duration in class II and III obese men. Therefore, we suggest that the L-Test is a feasible test that accurately assesses aerobic fitness and may allow for the exercise intensity prescription and individualization that will lead to improved therapeutic approaches in treating obesity and severe obesity.	[Lanzi, Stefano; Malatesta, Davide] Univ Lausanne, Inst Sport Sci Univ Lausanne, Lausanne, Switzerland; [Lanzi, Stefano; Malatesta, Davide] Univ Lausanne, Fac Biol & Med, Dept Physiol, Lausanne, Switzerland; [Codecasa, Franco; Cornacchia, Mauro; Fanari, Paolo; Salvadori, Alberto] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Pulm Rehabil Dept, Verbania, Italy; [Maestrini, Sabrina] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Mol Biol Lab, Verbania, Italy; [Capodaglio, Paolo] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Orthopaed Rehabil Unit, Verbania, Italy; [Capodaglio, Paolo] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Clin Lab Gait & Posture Anal, Verbania, Italy; [Brunani, Amelia] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Dept Rehabil Med, Verbania, Italy	University of Lausanne; University of Lausanne; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Lanzi, S (corresponding author), Univ Lausanne, Inst Sport Sci Univ Lausanne, Lausanne, Switzerland.	lanziste@bluwein.ch	Fanari, Paolo/AAA-2489-2020; Paolo, Capodaglio/AAB-7795-2019; Malatesta, Davide/G-5812-2012	Fanari, Paolo/0000-0001-6544-8509; Paolo, Capodaglio/0000-0003-3719-8789; Malatesta, Davide/0000-0003-3905-5642; Amelia, Brunani/0000-0003-3059-544X; Lanzi, Stefano/0000-0003-1089-6309				Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Ara I, 2011, INT J OBESITY, V35, P99, DOI 10.1038/ijo.2010.123; Astorino T.A., 2004, J EXERC PHYSL, V7, P1; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Aucouturier J, 2009, EUR J APPL PHYSIOL, V105, P325, DOI 10.1007/s00421-008-0907-3; Baillot A, 2014, OBES REV, V15, P721, DOI 10.1111/obr.12171; BARSTOW TJ, 1991, J APPL PHYSIOL, V71, P2099, DOI 10.1152/jappl.1991.71.6.2099; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bentley DJ, 2003, J SCI MED SPORT, V6, P422, DOI 10.1016/S1440-2440(03)80268-2; Bishop D, 1998, J Sci Med Sport, V1, P171; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bordenave S, 2008, DIABETES METAB, V34, P162, DOI 10.1016/j.diabet.2007.11.006; Brun JF, 2012, J ENDOCRINOL INVEST, V35, P686, DOI 10.3275/8466; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Castres I, 2011, J SPORT MED PHYS FIT, V51, P283; Cheneviere X, 2009, MED SCI SPORT EXER, V41, P1615, DOI 10.1249/MSS.0b013e31819e2f91; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; De Glisezinski I, 1998, AM J PHYSIOL-ENDOC M, V275, pE951, DOI 10.1152/ajpendo.1998.275.6.E951; Deriaz O, 2001, INT J OBESITY, V25, P1579, DOI 10.1038/sj.ijo.0801809; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1998, DIABETES CARE S1, V21, pS5; FROELICHER VF, 1974, J APPL PHYSIOL, V36, P720, DOI 10.1152/jappl.1974.36.6.720; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Houmard JA, 2012, EXERC SPORT SCI REV, V40, P204, DOI 10.1097/JES.0b013e31825d53fc; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Kang J, 2001, EUR J APPL PHYSIOL, V84, P291, DOI 10.1007/s004210000366; Kuipers H, 2003, INT J SPORTS MED, V24, P486; Lanzi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088707; Larsen S, 2009, DIABETOLOGIA, V52, P1400, DOI 10.1007/s00125-009-1353-4; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; McCole SD, 2001, MED SCI SPORT EXER, V33, P1265, DOI 10.1097/00005768-200108000-00004; McConnell T R, 1988, Br J Sports Med, V22, P3; Midgley AW, 2008, SPORTS MED, V38, P441, DOI 10.2165/00007256-200838060-00001; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Nordby P, 2006, SCAND J MED SCI SPOR, V16, P209, DOI 10.1111/j.1600-0838.2005.00480.x; Ozyener F, 2011, J SPORT SCI MED, V10, P584; Pierce S J, 1999, J Sci Med Sport, V2, P356, DOI 10.1016/S1440-2440(99)80008-5; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Venables MC, 2008, MED SCI SPORT EXER, V40, P495, DOI 10.1249/MSS.0b013e31815f256f; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Weston SB, 2002, INT J SPORTS MED, V23, P22, DOI 10.1055/s-2002-19267; Wood RE, 2010, MED SCI SPORT EXER, V42, P470, DOI 10.1249/MSS.0b013e3181b666ad; Yoon BK, 2007, MED SCI SPORT EXER, V39, P1186, DOI 10.1249/mss.0b13e318054e304; ZOLADZ JA, 1995, J PHYSIOL-LONDON, V488, P211, DOI 10.1113/jphysiol.1995.sp020959	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124180	10.1371/journal.pone.0124180	http://dx.doi.org/10.1371/journal.pone.0124180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875746	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100243
J	Madeo, A; Piras, P; Re, F; Gabriele, S; Nardinocchi, P; Teresi, L; Torromeo, C; Chialastri, C; Schiariti, M; Giura, G; Evangelista, A; Dominici, T; Varano, V; Zachara, E; Puddu, PE				Madeo, Andrea; Piras, Paolo; Re, Federica; Gabriele, Stefano; Nardinocchi, Paola; Teresi, Luciano; Torromeo, Concetta; Chialastri, Claudia; Schiariti, Michele; Giura, Geltrude; Evangelista, Antonietta; Dominici, Tania; Varano, Valerio; Zachara, Elisabetta; Puddu, Paolo Emilio			A New 4D Trajectory-Based Approach Unveils Abnormal LV Revolution Dynamics in Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							VENTRICULAR ROTATIONAL MECHANICS; EUROPEAN-SOCIETY; ECHOCARDIOGRAPHY; GENOTYPE; STRAIN; QUANTIFICATION; ASSOCIATION; GUIDELINES	The assessment of left ventricular shape changes during cardiac revolution may be a new step in clinical cardiology to ease early diagnosis and treatment. To quantify these changes, only point registration was adopted and neither Generalized Procrustes Analysis nor Principal Component Analysis were applied as we did previously to study a group of healthy subjects. Here, we extend to patients affected by hypertrophic cardiomyopathy the original approach and preliminarily include genotype positive/phenotype negative individuals to explore the potential that incumbent pathology might also be detected. Using 3D Speckle Tracking Echocardiography, we recorded left ventricular shape of 48 healthy subjects, 24 patients affected by hypertrophic cardiomyopathy and 3 genotype positive/phenotype negative individuals. We then applied Generalized Procrustes Analysis and Principal Component Analysis and inter-individual differences were cleaned by Parallel Transport performed on the tangent space, along the horizontal geodesic, between the per- subject consensuses and the grand mean. Endocardial and epicardial layers were evaluated separately, different from many ecocardiographic applications. Under a common Principal Component Analysis, we then evaluated left ventricle morphological changes (at both layers) explained by first Principal Component scores. Trajectories' shape and orientation were investigated and contrasted. Logistic regression and Receiver Operating Characteristic curves were used to compare these morphometric indicators with traditional 3D Speckle Tracking Echocardiography global parameters. Geometric morphometrics indicators performed better than 3D Speckle Tracking Echocardiography global parameters in recognizing pathology both in systole and diastole. Genotype positive/phenotype negative individuals clustered with patients affected by hypertrophic cardiomyopathy during diastole, suggesting that incumbent pathology may indeed be foreseen by these methods. Left ventricle deformation in patients affected by hypertrophic cardiomyopathy compared to healthy subjects may be assessed by modern shape analysis better than by traditional 3D Speckle Tracking Echocardiography global parameters. Hypertrophic cardiomyopathy pathophysiology was unveiled in a new manner whereby also diastolic phase abnormalities are evident which is more difficult to investigate by traditional ecocardiographic techniques.	[Madeo, Andrea; Piras, Paolo; Torromeo, Concetta; Schiariti, Michele; Giura, Geltrude; Dominici, Tania; Puddu, Paolo Emilio] Univ Roma La Sapienza, Dipartimento Sci Cardiovasc Resp Nefrol Anestesio, I-00185 Rome, Italy; [Madeo, Andrea; Re, Federica; Chialastri, Claudia; Zachara, Elisabetta] Osped S Camillo Forlanini, Ctr Cardiomiopatie, Rome, Italy; [Piras, Paolo] Univ Rome Tre, Dipartimento Sci, I-00146 Rome, Italy; [Piras, Paolo] Ctr Evolut Ecol, Rome, Italy; [Piras, Paolo; Nardinocchi, Paola] Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, I-00100 Rome, Italy; [Gabriele, Stefano] Univ Rome Tre, LaMS Modeling & Simulat Lab, Dipartimento Architettura, I-00146 Rome, Italy; [Teresi, Luciano; Varano, Valerio] Univ Rome Tre, LaMS Modeling & Simulat Lab, Dipartimento Matemat & Fis, I-00146 Rome, Italy; [Evangelista, Antonietta] Osped San Giovanni Calibita Fatebenefratelli Isol, Rome, Italy	Sapienza University Rome; Azienda Ospedaliera San Camillo-Forlanini; Roma Tre University; Sapienza University Rome; Roma Tre University; Roma Tre University	Piras, P (corresponding author), Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, Via Eudossiana 18, I-00100 Rome, Italy.	ppiras@uniroma3.it	schiariti, michele/W-4393-2018; Puddu, Paolo Emilio/G-6180-2012; Madeo, Andrea/AIC-5118-2022; Gabriele, Stefano/J-1091-2019; Gabriele, Stefano/G-5280-2010; nardinocchi, paola/C-9454-2009	schiariti, michele/0000-0001-5077-8134; Puddu, Paolo Emilio/0000-0002-6191-7838; Madeo, Andrea/0000-0002-5320-6796; Gabriele, Stefano/0000-0001-8264-2792; Gabriele, Stefano/0000-0001-8264-2792; TORROMEO, Concetta/0000-0003-0936-2780; Teresi, Luciano/0000-0002-5178-8120; Piras, Paolo/0000-0001-9832-2742; Nardinocchi, Paola/0000-0002-9972-1662; Varano, Valerio/0000-0003-0298-6398				Abate E, 2014, J AM SOC ECHOCARDIOG, V27, P239, DOI 10.1016/j.echo.2013.12.009; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bertini M, 2010, HEART, V96, P1737, DOI 10.1136/hrt.2010.197533; Campbell SG, 2011, J R SOC INTERFACE, V8, P1550, DOI 10.1098/rsif.2011.0184; Collyer ML, 2015, HEREDITY, V115, P357, DOI 10.1038/hdy.2014.75; Collyer ML, 2013, HYSTRIX, V24, P75, DOI 10.4404/hystrix-24.1-6298; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Evangelista A, 2015, J BIOMECH, V48, P465, DOI 10.1016/j.jbiomech.2014.12.028; Evangelista A, 2011, PROG BIOPHYS MOL BIO, V107, P112, DOI 10.1016/j.pbiomolbio.2011.07.008; Goffinet C, 2009, EUR HEART J, V30, P608, DOI 10.1093/eurheartj/ehn511; Gruner C, 2013, CIRC-CARDIOVASC GENE, V6, P19, DOI 10.1161/CIRCGENETICS.112.963363; Hillis DM, 1994, HOMOLOGY HIERARCHICA; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Kuhl HP, 2004, J AM COLL CARDIOL, V43, P2083, DOI 10.1016/j.jacc.2004.01.037; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leitman M, 2010, J AM SOC ECHOCARDIOG, V23, P64, DOI 10.1016/j.echo.2009.10.004; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron BJ, 2011, AM J CARDIOL, V107, P604, DOI 10.1016/j.amjcard.2010.10.022; Maron BJ, 2014, GUIDE HYPERTROPHIC C, V3rd; Martinez-Legazpi P, 2014, J AM COLL CARDIOL, V64, P1711, DOI 10.1016/j.jacc.2014.06.1205; Piras P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086896; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Seo Y, 2009, CIRC-CARDIOVASC IMAG, V2, P451, DOI 10.1161/CIRCIMAGING.109.858480; Serri K, 2006, J AM COLL CARDIOL, V47, P1175, DOI 10.1016/j.jacc.2005.10.061; Sugeng L, 2003, HEART, V89, P29; van Dalen BM, 2013, LEFT VENTRICULAR TWI; Yang Y, 2008, INT J AP MAT COM-POL, V18, P399, DOI 10.2478/v10006-008-0036-5; Zheng Y, 2007, P 11 IEEE INT C COMP	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122376	10.1371/journal.pone.0122376	http://dx.doi.org/10.1371/journal.pone.0122376			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875818	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100069
J	Stein, JD; Talwar, N; Kang, JH; Okereke, OI; Wiggs, JL; Pasquale, LR				Stein, Joshua D.; Talwar, Nidhi; Kang, Jae H.; Okereke, Olivia I.; Wiggs, Janey L.; Pasquale, Louis R.			Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large US Managed Care Network	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MOUSE MODEL; GENE-EXPRESSION; TNF-ALPHA; PREVENTS; DISEASES; SMOKING; CELLS	Objective Tumor Necrosis Factor (TNF) mediates retinal ganglion cell death in glaucoma. Anti-TNF drugs are neuroprotective in an animal model of glaucoma. It is unclear whether medications with anti-TNF properties such as bupropion have an impact on the risk of developing open-angle glaucoma (OAG) in humans. The purpose of this study is to determine whether bupropion use alters the risk of developing OAG. Methods Claims data for beneficiaries age >= 35 years with no pre-existing OAG enrolled in a large nationwide U.S. managed care network continuously for >= 4 years between 2001-2011 was analyzed to identify patients who had been newly-diagnosed with OAG. The amount of bupropion use as captured from outpatient pharmacy claims over a four-year period was also quantified for each beneficiary. Multivariable Cox regression modeling assessed the impact of bupropion and other antidepressant medications on the risk of developing OAG with adjustment for sociodemographic characteristics of the enrollees along with medical and ocular comorbidities. Results Of 638,481 eligible enrollees, 15,292 (2.4%) developed OAG. After adjustment for confounding factors including use of other antidepressant medication classes, each additional month of bupropion use was associated with a 0.6% reduced risk of OAG (HR = 0.994, (95% CI: 0.989-0.998), p = 0.007). Compared to nonusers, those with 24-48 months of bupropion use had a 21% reduced hazard (HR=0.79, (CI: 0.65-0.94), p = 0.0099) of OAG. This association did not differ among persons taking bupropion for depression or for other reasons (p-interaction = 0.82). There was no significant association between use of tricyclic antidepressants (HR = 1.000, (CI: 0.997-1.004), p = 0.95) or selective serotonin reuptake in-hibitors (HR = 0.999, (CI: 0.997-1.001), p = 0.39) and development of OAG. Conclusion These findings suggest bupropion use may be beneficial in reducing the risk of OAG. If prospective studies confirm the findings of this analysis, this may identify a novel therapeutic target for OAG.	[Stein, Joshua D.; Talwar, Nidhi] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Kang, Jae H.; Okereke, Olivia I.; Pasquale, Louis R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Div Network Med, Boston, MA 02115 USA; [Okereke, Olivia I.] Harvard Univ, Sch Publ Hlth, Sch Med, Boston, MA 02115 USA; [Okereke, Olivia I.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Okereke, Olivia I.] Harvard Univ, Sch Med, Boston, MA USA; [Wiggs, Janey L.; Pasquale, Louis R.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Stein, JD (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	jdstein@med.umich.edu	Okereke, Olivia I/R-9934-2016; Okereke, Olivia/AAF-7031-2021	Stein, Joshua/0000-0003-2937-6987	National Eye Institute [1K23EY019511, EY00703, RO1 EY015473]; American Glaucoma Society; Research to Prevent Blindness; Harvard Glaucoma Center of Excellence; Margolis Fund; Arthur Ashley Foundation; NATIONAL EYE INSTITUTE [K23EY019511, R01EY015473] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Glaucoma Society; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Harvard Glaucoma Center of Excellence; Margolis Fund; Arthur Ashley Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by National Eye Institute K23 Mentored Clinician Scientist Award (JDS:1K23EY019511); American Glaucoma Society Young Clinician Scientist Grant (JDS), Research to Prevent Blindness "Physician Scientist Award" (JDS); National Eye Institute Core Grant EY00703; National Eye Institute RO1 EY015473 (LRP); Harvard Glaucoma Center of Excellence (LRP, JLW); the Margolis Fund (LRP); and the Arthur Ashley Foundation (LRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Byrne AM, 2012, CLIN EXP ALLERGY, V42, P550, DOI 10.1111/j.1365-2222.2012.03956.x; Camara-Lemarroy CR, 2013, TRANSPL P, V45, P2502, DOI 10.1016/j.transproceed.2013.04.010; Edwards R, 2008, J GLAUCOMA, V17, P558, DOI 10.1097/IJG.0b013e31815f530c; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Howell GR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-76; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Jain R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/278392; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kast RE, 2001, GASTROENTEROLOGY, V121, P1260; Manosso LM, 2013, PROG NEURO-PSYCHOPH, V46, P48, DOI 10.1016/j.pnpbp.2013.06.012; Modell JG, 2002, PSYCHOSOM MED, V64, P835, DOI 10.1097/01.PSY.0000021954.59258.9B; Muir KW, 2013, JAMA OPHTHALMOL, V131, P119, DOI 10.1001/jamaophthalmol.2013.577; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Newman-Casey PA, 2014, JAMA OPHTHALMOL, V132, P298, DOI 10.1001/jamaophthalmol.2013.7618; Peake STC, 2013, INFLAMM BOWEL DIS, V19, P1546, DOI 10.1097/MIB.0b013e318281333b; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; RUDORFER MV, 1994, DRUG SAFETY, V10, P18, DOI 10.2165/00002018-199410010-00003; Stein JD, 2013, AM J OPHTHALMOL, V156, P1169, DOI 10.1016/j.ajo.2013.06.035; Stein JD, 2012, OPHTHALMOLOGY, V119, P2074, DOI 10.1016/j.ophtha.2012.04.029; Stein JD, 2011, ARCH OPHTHALMOL-CHIC, V129, P1053, DOI 10.1001/archophthalmol.2011.191; Takusagawa HL, 2012, ARCH OPHTHALMOL-CHIC, V130, P120, DOI 10.1001/archopht.130.1.120; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Wang DY, 2010, INVEST OPHTH VIS SCI, V51, P4084, DOI 10.1167/iovs.09-4864; Wise LA, 2011, ANN EPIDEMIOL, V21, P430, DOI 10.1016/j.annepidem.2011.03.006; Wu J, 2012, INVEST OPHTH VIS SCI, V53, P7142, DOI 10.1167/iovs.12-9968; Xin XY, 2013, MOL VIS, V19, P526; Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666, DOI 10.1001/archopht.118.5.666; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123682	10.1371/journal.pone.0123682	http://dx.doi.org/10.1371/journal.pone.0123682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875446	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100198
J	Tietze, A; Mouridsen, K; Lassen-Ramshad, Y; Ostergaard, L				Tietze, Anna; Mouridsen, Kim; Lassen-Ramshad, Yasmin; Ostergaard, Leif			Perfusion MRI Derived Indices of Microvascular Shunting and Flow Control Correlate with Tumor Grade and Outcome in Patients with Cerebral Glioma	PLOS ONE			English	Article							BLOOD-VOLUME MEASUREMENTS; STEM-CELLS; BRAIN-TUMORS; ENHANCED MR; DSC-MRI; HYPOXIA; GLIOBLASTOMA; ANGIOGENESIS; VASCULATURE; CANCER	Objectives Deficient microvascular blood flow control is thought to cause tumor hypoxia and increase resistance to therapy. In glioma patients, we tested whether perfusion-weighted MRI (PWI) based indices of microvascular flow control provide more information on tumor grade and patient outcome than does the established PWI angiogenesis marker, cerebral blood volume (CBV). Material and Methods Seventy-two glioma patients (sixty high-grade, twelve low-grade gliomas) were included. Capillary transit time heterogeneity (CTH) and the coefficient of variation (COV), its ratio to blood mean transit time, provide indices of microvascular flow control and the extent to which oxygen can be extracted by tumor tissue. The ability of these parameters and CBV to differentiate tumor grade were assessed by receiver operating characteristic curves and logistic regression. Their ability to predict time to progression and overall survival was examined by the Cox proportional-hazards regression model, and by survival curves using log-rank tests. Results The best prediction of grade (AUC = 0.876; p < 0.05) was achieved by combining knowledge of CBV and CTH in the enhancing tumor and peri-focal edema, and patients with glioblastoma multiforme were identified best by CTH (AUC = 0.763; p<0.001). CTH outperformed CBV and COV in predicting time to progression and survival in all gliomas and in a subgroup consisting of only high-grade gliomas. Conclusion Our study confirms the importance of microvascular flow control in tumor growth by demonstrating that determining CTH improves tumor grading and outcome prediction in glioma patients compared to CBV alone.	[Tietze, Anna; Mouridsen, Kim; Ostergaard, Leif] Aarhus Univ Hosp, Dept Neuroradiol, DK-8000 Aarhus, Denmark; [Tietze, Anna; Ostergaard, Leif] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Lassen-Ramshad, Yasmin] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Tietze, A (corresponding author), Aarhus Univ Hosp, Dept Neuroradiol, DK-8000 Aarhus, Denmark.	annatietze@gmail.com	Østergaard, Leif/A-9281-2008; Ostergaard, Lars/AAA-3020-2020; Tietze, Anna/H-3333-2018	Østergaard, Leif/0000-0003-2930-6997; Ostergaard, Lars/0000-0003-2459-0511; Tietze, Anna/0000-0002-2601-9055; Ostergaard, Lars/0000-0002-7619-605X	Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab) [902063]; Savvaerksejer Jeppe Juhls og Hustru Ovita Juhls Mindelegat; Harboefonden	Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab); Savvaerksejer Jeppe Juhls og Hustru Ovita Juhls Mindelegat; Harboefonden	Support was provided by the Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab; AT, LO, KM; http://ufm.dk/en; grant number: 902063), "Savvaerksejer Jeppe Juhls og Hustru Ovita Juhls Mindelegat" (AT, LO; http://www.jeppe-juhls-legater.dk/), and "Harboefonden" (AT; http://www.harboefonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Asgari S, 2003, ACTA NEUROCHIR, V145, P453, DOI 10.1007/s00701-003-0035-0; Bar EE, 2011, BRAIN PATHOL, V21, P119, DOI 10.1111/j.1750-3639.2010.00460.x; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bisdas S, 2009, AM J NEURORADIOL, V30, P681, DOI 10.3174/ajnr.A1465; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Caseiras GB, 2010, EUR J RADIOL, V73, P215, DOI 10.1016/j.ejrad.2008.11.005; Cher LM, 2006, J NUCL MED, V47, P410; Danchaivijitr N, 2008, RADIOLOGY, V247, P170, DOI 10.1148/radiol.2471062089; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jensen RL, 2014, NEURO-ONCOLOGY, V16, P280, DOI 10.1093/neuonc/not148; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Kawai N, 2014, EUR J NUCL MED MOL I, V41, P1870, DOI 10.1007/s00259-014-2776-9; Law M, 2006, NEUROSURGERY, V58, P1099, DOI 10.1227/01.NEU.0000215944.81730.18; Lemasson B, 2012, RADIOLOGY, V265, P743, DOI 10.1148/radiol.12112621; Lev MH, 2004, AM J NEURORADIOL, V25, P214; Mouridsen K, 2006, MAGN RESON MED, V55, P524, DOI 10.1002/mrm.20759; Mouridsen K, 2006, NEUROIMAGE, V33, P570, DOI 10.1016/j.neuroimage.2006.06.015; Mouridsen K, 2014, J CEREBR BLOOD F MET, V34, P1511, DOI 10.1038/jcbfm.2014.111; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Ostergaard L, 2013, CANCER RES, V73, P5618, DOI 10.1158/0008-5472.CAN-13-0964; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Quarles CC, 2007, MAGN RESON MED, V57, P680, DOI 10.1002/mrm.21193; Quarles CC, 2009, PHYS MED BIOL, V54, P5749, DOI 10.1088/0031-9155/54/19/006; RENKIN EM, 1985, MICROVASC RES, V30, P251, DOI 10.1016/0026-2862(85)90057-3; Schabel MC, 2012, MAGN RESON MED, V68, P1632, DOI 10.1002/mrm.24162; Secomb TW, 2012, BASIC CLIN PHARMACOL, V110, P63, DOI 10.1111/j.1742-7843.2011.00815.x; Spence AM, 2008, CLIN CANCER RES, V14, P2623, DOI 10.1158/1078-0432.CCR-07-4995; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Toth V, 2013, J NEURO-ONCOL, V115, P197, DOI 10.1007/s11060-013-1210-7; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014	42	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123044	10.1371/journal.pone.0123044	http://dx.doi.org/10.1371/journal.pone.0123044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875182	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100128
J	Zha, C; Jiang, XH; Peng, SF				Zha, Cong; Jiang, Xue Hua; Peng, Shi Fang			iTRAQ-Based Quantitative Proteomic Analysis on S100 Calcium Binding Protein A2 in Metastasis of Laryngeal Cancer	PLOS ONE			English	Article							BASAL CYTOKERATIN EXPRESSION; PUTATIVE TUMOR-SUPPRESSOR; NECK-CANCER; IN-VITRO; TRANSCRIPTIONAL ACTIVATION; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; MESSENGER-RNA; CELL; GROWTH	Laryngeal cancer is the most frequent neoplasm in the head and neck region, with the vast majority of tumors originating from squamous cells. The survival rate of patients with laryngeal cancer has not improved substantially over the past 25 years. To acquire further knowledge regarding the molecules responsible for laryngeal cancer oncogenesis and, in turn, to improve target therapy iTRAQ and mass spectrometry analysis were utilized to detect differences in protein expression from 15 paired laryngeal cancer and adjacent non-cancerous tissue samples. Using mass spectrometry analysis, the expression levels of 100 proteins in laryngeal cancer samples were distinct from the non-tumor, non-cancerous samples. Further validation of the differentially expressed proteins S100A2, KRT16, FGB and HSPB1 were carried out using quantitative real-time RT-PCR, immunoblot and immunohistochemistry. Functional analysis of one of the highly expressed proteins, S100 calcium binding protein A2 (S100A2), was performed using RNA interference. As a consequence, attenuated S100A2 expression enhanced the ability of HEp-2 cell lines to migrate and invade in vitro. Our investigation complements the current understanding of laryngeal cancer progression. Furthermore, this study supports the concept that enhanced expression of S100A2 may be a promising strategy in developing novel cancer therapeutic drugs.	[Zha, Cong; Jiang, Xue Hua] Sichuan Univ, West China Sch Pharm, Chengdu 610064, Sichuan, Peoples R China; [Peng, Shi Fang] Cent South Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Peng, Shi Fang] Cent South Univ, Dept Hlth Management Ctr, Changsha, Hunan, Peoples R China	Sichuan University; Central South University; Central South University	Jiang, XH (corresponding author), Sichuan Univ, West China Sch Pharm, Chengdu 610064, Sichuan, Peoples R China.	jxh1013@vip.163.com; sfp1988@gmail.com			Startup Fund of WestChina School of Pharmacy, Sichuan University, Sichuan, China; Startup Fund of Xiangya Hospital, Central South University, Hunan, China	Startup Fund of WestChina School of Pharmacy, Sichuan University, Sichuan, China; Startup Fund of Xiangya Hospital, Central South University, Hunan, China	This research was supported by the Startup Fund of WestChina School of Pharmacy, Sichuan University, Sichuan, China; the Startup Fund of Xiangya Hospital, Central South University, Hunan, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Chang T, 2011, EXP DERMATOL, V20, P555, DOI 10.1111/j.1600-0625.2010.01235.x; Chatterji B, 2009, PROTEOMICS, V9, P1044, DOI 10.1002/pmic.200701135; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chong PK, 2010, J PROTEOMICS, V73, P1632, DOI 10.1016/j.jprot.2010.04.005; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Feng G, 2001, CANCER RES, V61, P7999; Franz C, 1998, J BIOL CHEM, V273, P18826, DOI 10.1074/jbc.273.30.18826; Fujii K, 2005, PROTEOMICS, V5, P1411, DOI 10.1002/pmic.200401004; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jagadeeshan S, 2015, ONCOGENE, V34, P455, DOI 10.1038/onc.2013.576; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Lauriola L, 2000, INT J CANCER, V89, P345, DOI 10.1002/1097-0215(20000720)89:4<345::AID-IJC5>3.0.CO;2-T; Lefebvre JL, 2006, LANCET ONCOL, V7, P747, DOI 10.1016/S1470-2045(06)70860-9; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090181; Liu JS, 2010, CANCER BIOTHER RADIO, V25, P29, DOI 10.1089/cbr.2009.0706; Liu ZB, 2009, TUMORI J, V95, P53; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2011, DIAGN CYTOPATHOL, V39, P752, DOI 10.1002/dc.21461; Ma YL, 2009, MOL CELL PROTEOMICS, V8, P1878, DOI 10.1074/mcp.M800541-MCP200; Martens JE, 2004, ANTICANCER RES, V24, P771; Medina JE, 2011, HEAD NECK-J SCI SPEC, V33, P746, DOI 10.1002/hed.21453; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Nagy N, 2002, HISTOL HISTOPATHOL, V17, P123, DOI 10.14670/HH-17.123; Nagy N, 2001, LAB INVEST, V81, P599, DOI 10.1038/labinvest.3780269; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Potemski P, 2005, ONCOLOGY-BASEL, V69, P478, DOI 10.1159/000090986; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sengupta S, 2010, NEOPLASIA, V12, P837, DOI 10.1593/neo.10662; Sewell DA, 2007, ORL-J OTO-RHIN-LARYN, V69, P77, DOI 10.1159/000097406; Shibata K, 1998, CANCER RES, V58, P900; Shibata K, 1997, CLIN EXP METASTAS, V15, P612, DOI 10.1023/A:1018495414975; Solassol J, 2010, BRIT J CANCER, V102, P181, DOI 10.1038/sj.bjc.6605470; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Sun Y, 1999, MOL CARCINOGEN, V24, P25, DOI 10.1002/(SICI)1098-2744(199901)24:1<25::AID-MC4>3.3.CO;2-J; Tan MJ, 1999, FEBS LETT, V445, P265, DOI 10.1016/S0014-5793(99)00135-0; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Torbenson M, 2002, MODERN PATHOL, V15, P826, DOI 10.1097/01.MP.0000024257.83046.7C; Toyoshima T, 2009, J ORAL PATHOL MED, V38, P530, DOI 10.1111/j.1600-0714.2009.00748.x; Tsai WC, 2006, MOL CANCER RES, V4, P539, DOI 10.1158/1541-7786.MCR-05-0266; Waalkes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-503; Warawdekar UM, 2006, CLIN CHIM ACTA, V372, P83, DOI 10.1016/j.cca.2006.03.023; Wei KJ, 2009, ORAL DIS, V15, P111, DOI 10.1111/j.1601-0825.2008.01501.x; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yang YX, 2012, J PROTEOME RES, V11, P5736, DOI 10.1021/pr300555y; Zvrko E, 2012, COLLEGIUM ANTROPOL, V36, P119	53	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122322	10.1371/journal.pone.0122322	http://dx.doi.org/10.1371/journal.pone.0122322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874882	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100062
J	Nakajima, H; Kubo, T; Ihara, H; Hikida, T; Danjo, T; Nakatsuji, M; Shahani, N; Itakura, M; Ono, Y; Azuma, YT; Inui, T; Kamiya, A; Sawa, A; Takeuchi, T				Nakajima, Hidemitsu; Kubo, Takeya; Ihara, Hideshi; Hikida, Takatoshi; Danjo, Teruko; Nakatsuji, Masatoshi; Shahani, Neelam; Itakura, Masanori; Ono, Yoko; Azuma, Yasu-Taka; Inui, Takashi; Kamiya, Atsushi; Sawa, Akira; Takeuchi, Tadayoshi			Nuclear-translocated Glyceraldehyde-3-phosphate Dehydrogenase Promotes Poly(ADP-ribose) Polymerase-1 Activation during Oxidative/Nitrosative Stress in Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ARTERY OCCLUSION; CELL-DEATH; RAT-BRAIN; GAPDH; NEURODEGENERATION; PATHWAYS; ISCHEMIA; MODEL; APOPTOSIS; DELIVERY	In addition to its role in DNA repair, nuclear poly(ADP-ribose) polymerase-1 (PARP-1) mediates brain damage when it is over-activated by oxidative/nitrosative stress. Nonetheless, it remains unclear how PARP-1 is activated in neuropathological contexts. Here we report that PARP-1 interacts with a pool of glyceradehyde-3-phosphate dehydrogenase (GAPDH) that translocates into the nucleus under oxidative/nitrosative stress both in vitro and in vivo. A well conserved amino acid at the N terminus of GAPDH determines its protein binding with PARP-1. Wild-type (WT) but not mutant GAPDH, that lacks the ability to bind PARP-1, can promote PARP-1 activation. Importantly, disrupting this interaction significantly diminishes PARP-1 overactivation and protects against both brain damage and neurological deficits induced by middle cerebral artery occlusion/reperfusion in a rat stroke model. Together, these findings suggest that nuclear GAPDH is a key regulator of PARP-1 activity, and its signaling underlies the pathology of oxidative/nitrosative stress-induced brain damage including stroke.	[Nakajima, Hidemitsu; Kubo, Takeya; Itakura, Masanori; Ono, Yoko; Azuma, Yasu-Taka; Takeuchi, Tadayoshi] Osaka Prefecture Univ, Lab Vet Pharmacol, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988531, Japan; [Ihara, Hideshi] Osaka Prefecture Univ, Dept Sci, Izumisano, Osaka 5988531, Japan; [Hikida, Takatoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto 6068501, Japan; [Hikida, Takatoshi] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; [Danjo, Teruko] Osaka Biosci Inst, Dept Syst Biol, Osaka 5650874, Japan; [Nakatsuji, Masatoshi; Inui, Takashi] Osaka Prefecture Univ, Lab Biol Macromol, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988531, Japan; [Nakajima, Hidemitsu; Shahani, Neelam; Kamiya, Atsushi; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA	Osaka Metropolitan University; Osaka Metropolitan University; Kyoto University; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Johns Hopkins University	Takeuchi, T (corresponding author), Osaka Prefecture Univ, Lab Vet Pharmacol, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988531, Japan.	takeuchi@vet.osakafu-u.ac.jp	Hikida, Takatoshi/J-5561-2017; kamiya, atsushi/L-8550-2016; Inui, Takashi/G-1069-2011	Hikida, Takatoshi/0000-0002-8653-311X; kamiya, atsushi/0000-0002-4274-5567; Nakajima, Hidemitsu/0000-0002-0441-1929; Azuma, Yasu-Taka/0000-0002-3515-171X	Japan Society for the Promotion of Science KAKENHI [15605666, 22580339, 25450428, 23120011, 23680034]; Grants-in-Aid for Scientific Research [15H04275] Funding Source: KAKEN; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091230, P50MH094268] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 15605666 (to T. T.), 22580339 and 25450428 (to H. N.), and 23120011 and 23680034 (to T. H.).	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Nakajima H, 2005, J PHARMACOL EXP THER, V312, P472, DOI 10.1124/jpet.104.075465; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2012, J BIOTECHNOL, V157, P326, DOI 10.1016/j.jbiotec.2011.10.003; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Nakamura T, 2013, ANTIOXID REDOX SIGN, V18, P239, DOI 10.1089/ars.2012.4703; OGATA N, 1981, J BIOL CHEM, V256, P4135; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Sun Y, 2003, GENE THER, V10, P115, DOI 10.1038/sj.gt.3301868; Tanaka R, 2002, J CEREBR BLOOD F MET, V22, P280, DOI 10.1097/00004647-200203000-00005; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Wang L, 2002, GENE THER, V9, P381, DOI 10.1038/sj.gt.3301682	33	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14493	14503		10.1074/jbc.M114.635607	http://dx.doi.org/10.1074/jbc.M114.635607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25882840	Green Published, hybrid			2022-12-26	WOS:000355754600021
J	Pisano, A; Ceglia, S; Palmieri, C; Vecchio, E; Fiume, G; de Laurentiis, A; Mimmi, S; Falcone, C; Iaccino, E; Scialdone, A; Pontoriero, M; Masci, FF; Valea, R; Krishnan, S; Gaspari, M; Cuda, G; Scala, G; Quinto, I				Pisano, Antonio; Ceglia, Simona; Palmieri, Camillo; Vecchio, Eleonora; Fiume, Giuseppe; de Laurentiis, Annamaria; Mimmi, Selena; Falcone, Cristina; Iaccino, Enrico; Scialdone, Annarita; Pontoriero, Marilena; Masci, Francesca Fasanella; Valea, Rosanna; Krishnan, Shibu; Gaspari, Marco; Cuda, Giovanni; Scala, Giuseppe; Quinto, Ileana			CRL3(IBTK) Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CUL3-BASED E3 LIGASE; INITIATION-FACTOR 4A; UBIQUITIN LIGASES; EUKARYOTIC TRANSLATION; DOMAIN PROTEINS; TYROSINE KINASE; BINDING-PROTEIN; BTB DOMAIN; CYCLIN-E	The human inhibitor of Bruton's tyrosine kinase isoform alpha (IBtk alpha) is a BTB protein encoded by the IBTK gene, which maps to chromosomal locus 6q14.1, a mutational hot spot in lymphoproliferative disorders. Here, we demonstrate that IBtk alpha forms a CRL3IBTK complex promoting its self-ubiquitylation. We identified the tumor suppressor Pdcd4 as IBtk alpha interactor and ubiquitylation substrate of CRL3(IBTK) for proteasomal degradation. Serum-induced degradation of Pdcd4 required both IBtk alpha and Cul3, indicating that CRL3(IBTK) regulated the Pdcd4 stability in serum signaling. By promoting Pdcd4 degradation, IBtk alpha counteracted the suppressive effect of Pdcd4 on translation of reporter luciferase mRNAs with stem-loop structured or unstructured 5'-UTR. IBtk alpha depletion by RNAi caused Pdcd4 accumulation and decreased the translation of Bcl-xL mRNA, a well known target of Pdcd4 repression. By characterizing CRL3(IBTK) as a novel ubiquitin ligase, this study provides new insights into regulatory mechanisms of cellular pathways, such as the Pdcd4-dependent translation of mRNAs.	[Pisano, Antonio; Ceglia, Simona; Palmieri, Camillo; Vecchio, Eleonora; Fiume, Giuseppe; de Laurentiis, Annamaria; Mimmi, Selena; Falcone, Cristina; Iaccino, Enrico; Scialdone, Annarita; Pontoriero, Marilena; Masci, Francesca Fasanella; Valea, Rosanna; Krishnan, Shibu; Gaspari, Marco; Cuda, Giovanni; Scala, Giuseppe; Quinto, Ileana] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy	Magna Graecia University of Catanzaro	Scala, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy.	scala@unicz.it; quinto@unicz.it	Cuda, Giovanni/AAC-2821-2019; Cuda, Giovanni/F-5359-2012; Falcone, Cristina/AAP-9529-2020; Gaspari, Marco/ABE-1539-2020; Gaspari, Marco/C-2756-2009; Mimmi, Selena/J-7860-2016; Iaccino, Enrico/I-7333-2015; Mimmi, Selena/AAB-9585-2019; Gaspari, Marco/HGB-2399-2022; vecchio, eleonora/AAT-4287-2020; Palmieri, Camillo/A-3195-2009	Cuda, Giovanni/0000-0001-6313-1866; Cuda, Giovanni/0000-0001-6313-1866; Gaspari, Marco/0000-0002-5411-8800; Gaspari, Marco/0000-0002-5411-8800; Mimmi, Selena/0000-0003-2187-9176; Iaccino, Enrico/0000-0002-3565-7817; Mimmi, Selena/0000-0003-2187-9176; QUINTO, Ileana/0000-0001-8212-8515; krishnan, shibu/0000-0002-5727-6046; Palmieri, Camillo/0000-0001-6707-4723; FIUME, Giuseppe/0000-0002-5414-6190	Ministero della Salute [GR-2009-1606801, RF-2010-2306943]; Ministero dell'Istruzione, dell'Universita e della Ricerca; International Agency for Research on Cancer (AIRC) [IG-2009-9411]; COFIN-MIUR; Fondazione Italiana per la Ricerca sul Cancro (FIRC)	Ministero della Salute(Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); International Agency for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); COFIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Ministero della Salute Grants GR-2009-1606801 (to C. P.) and RF-2010-2306943 (to G. S.) and Ministero dell'Istruzione, dell'Universita e della Ricerca Grant POR CALABRIA FSE 2007/2013 (to G. S.), International Agency for Research on Cancer (AIRC) Grant IG-2009-9411 (to G. S.), and COFIN-MIUR (to G. S. and I. Q.).; Supported by Fondazione Italiana per la Ricerca sul Cancro (FIRC) fellowships.	Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Biyanee A, 2015, ONCOGENE, V34, P1384, DOI 10.1038/onc.2014.83; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; de Laurentiis A, 2006, INT J BIOL MACROMOL, V39, P122, DOI 10.1016/j.ijbiomac.2006.02.020; De Laurentiis A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007898; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fiume G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066087; Fiume G, 2009, COMPUT BIOL CHEM, V33, P434, DOI 10.1016/j.compbiolchem.2009.08.001; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Guardavaccaro D, 2004, ONCOGENE, V23, P2037, DOI 10.1038/sj.onc.1207413; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Janda E, 2011, BLOOD, V117, P6520, DOI 10.1182/blood-2010-09-308080; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumar N, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2012.37; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Liwak U, 2012, MOL CELL BIOL, V32, P1818, DOI 10.1128/MCB.06317-11; Lu A, 2013, J CELL BIOL, V203, P233, DOI 10.1083/jcb.201305158; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Spatuzza C, 2008, NUCLEIC ACIDS RES, V36, P4402, DOI 10.1093/nar/gkn413; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	50	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13958	13971		10.1074/jbc.M114.634535	http://dx.doi.org/10.1074/jbc.M114.634535			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882842	Green Published, hybrid			2022-12-26	WOS:000355313000027
J	Dhanjal, S; Kajitani, N; Glahder, J; Mossberg, AK; Johansson, C; Schwartz, S				Dhanjal, Soniya; Kajitani, Naoko; Glahder, Jacob; Mossberg, Ann-Kristin; Johansson, Cecilia; Schwartz, Stefan			Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3 '-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATE GENE-EXPRESSION; HNRNP C; POLYADENYLATION ELEMENT; BINDING PROTEINS; POLYMERASE-II; CODING REGION; HPV-16 L1; TRANSCRIPTS; INHIBITION; IDENTIFICATION	In order to identify cellular factors that regulate human papillomavirus type 16 (HPV16) gene expression, cervical cancer cells permissive for HPV16 late gene expression were identified and characterized. These cells either contained a novel spliced variant of the L1 mRNAs that bypassed the suppressed HPV16 late, 5'-splice site SD3632; produced elevated levels of RNA-binding proteins SRSF1 (ASF/SF2), SRSF9 (SRp30c), and HuR that are known to regulate HPV16 late gene expression; or were shown by a gene expression array analysis to overexpress the RALYLRNA-binding protein of the heterogeneous nuclear ribonucleoprotein C (hnRNP C) family. Overexpression of RALYL or hnRNP C1 induced HPV16 late gene expression from HPV16 subgenomic plasmids and from episomal forms of the full-length HPV16 genome. This induction was dependent on the HPV16 early untranslated region. Binding of hnRNP C1 to the HPV16 early, untranslated region activated HPV16 late 5'-splice site SD3632 and resulted in production of HPV16 L1 mRNAs. Our results suggested that hnRNP C1 controls HPV16 late gene expression.	[Dhanjal, Soniya; Kajitani, Naoko; Glahder, Jacob; Mossberg, Ann-Kristin; Johansson, Cecilia; Schwartz, Stefan] Lund Univ, Dept Lab Med, S-22184 Lund, Sweden	Lund University	Schwartz, S (corresponding author), Lund Univ, Dept Lab Med, BMC-B13,Rm B1314c, S-22362 Lund, Sweden.	Stefan.Schwartz@med.lu.se	Johansson, Cecilia/O-9433-2019; Johansson, Cecilia/B-4751-2019	Johansson, Cecilia/0000-0001-5965-2853; 	Swedish Research Council-Medicine Grant [2012-1933]; Swedish Cancer Society [CAN 2012/542]; Gunnar Nilsson Cancer Research Trust Fund; Hedda and John Forssmans Foundation through the Royal Physiographic Society in Lund; Crafoord Foundation	Swedish Research Council-Medicine Grant; Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Cancer Research Trust Fund; Hedda and John Forssmans Foundation through the Royal Physiographic Society in Lund; Crafoord Foundation	This work was supported by Swedish Research Council-Medicine Grant 2012-1933, Swedish Cancer Society Grant CAN 2012/542, the Gunnar Nilsson Cancer Research Trust Fund, the Hedda and John Forssmans Foundation through the Royal Physiographic Society in Lund, and the Crafoord Foundation (to S. S.).	Baker C., 1997, HUMAN PAPILLOMAVIRUS; Bernard HU, 2013, VIROLOGY, V445, P197, DOI 10.1016/j.virol.2013.04.035; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Brunner JE, 2010, VIROLOGY, V400, P240, DOI 10.1016/j.virol.2010.01.031; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; Casaca A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-358; Cheunim T, 2008, VIRUS RES, V131, P189, DOI 10.1016/j.virusres.2007.09.006; Chow LT, 2010, APMIS, V118, P422, DOI 10.1111/j.1600-0463.2010.02625.x; Collier B, 2002, J VIROL, V76, P2739, DOI 10.1128/JVI.76.6.2739-2752.2002; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fay J, 2009, J MED VIROL, V81, P897, DOI 10.1002/jmv.21406; Graham SV, 2008, FRONT BIOSCI-LANDMRK, V13, P5646; Howley P. M., 2006, VIROLOGY, P2299; Irimura Sanae, 2009, Kobe J Med Sci, V54, pE227; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izquierdo JM, 2010, NUCLEIC ACIDS RES, V38, P8001, DOI 10.1093/nar/gkq698; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Jia R, 2010, INT J BIOL SCI, V6, P806; Jia R, 2009, FRONT BIOSCI-LANDMRK, V14, P1270, DOI 10.2741/3307; Jia R, 2009, J VIROL, V83, P167, DOI 10.1128/JVI.01719-08; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Johansson C, 2012, EMBO J, V31, P3212, DOI 10.1038/emboj.2012.147; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Lee HH, 2004, J CELL SCI, V117, P5579, DOI 10.1242/jcs.01482; Li XZ, 2013, NUCLEIC ACIDS RES, V41, P10488, DOI 10.1093/nar/gkt803; Li XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072776; McBride AA, 2013, VIROLOGY, V445, P57, DOI 10.1016/j.virol.2013.06.006; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Oberg D, 2005, J VIROL, V79, P9254, DOI 10.1128/JVI.79.14.9254-9269.2005; Orru B, 2012, J VIROL METHODS, V183, P106, DOI 10.1016/j.jviromet.2012.03.023; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; PINOLROMA S, 1993, MOL CELL BIOL, V13, P5762, DOI 10.1128/MCB.13.9.5762; Rosenberger S, 2010, P NATL ACAD SCI USA, V107, P7006, DOI 10.1073/pnas.1002620107; Rush M, 2005, J VIROL, V79, P12002, DOI 10.1128/JVI.79.18.12002-12015.2005; Schwartz S, 2013, VIROLOGY, V445, P187, DOI 10.1016/j.virol.2013.04.034; Shabman RS, 2011, J INFECT DIS, V204, pS904, DOI 10.1093/infdis/jir323; Sokolowski M, 1997, ONCOGENE, V15, P2303, DOI 10.1038/sj.onc.1201415; Sokolowski M, 2001, VIRUS RES, V73, P163, DOI 10.1016/S0168-1702(00)00238-0; Somberg M, 2008, J VIROL, V82, P3665, DOI 10.1128/JVI.02140-07; Somberg M, 2011, J GEN VIROL, V92, P2411, DOI 10.1099/vir.0.033183-0; Somberg M, 2010, J VIROL, V84, P8219, DOI 10.1128/JVI.00462-10; Spangberg K, 2000, VIROLOGY, V274, P378, DOI 10.1006/viro.2000.0461; Tenzer S, 2013, J PROTEOME RES, V12, P2869, DOI 10.1021/pr400193j; Terhune SS, 2001, J VIROL, V75, P8147, DOI 10.1128/JVI.75.17.8147-8157.2001; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; TOMITA Y, 1993, GENE, V133, P223; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhao X, 2008, VIRUS GENES, V36, P45, DOI 10.1007/s11262-007-0174-0; Zhao XM, 2007, VIROLOGY, V369, P351, DOI 10.1016/j.virol.2007.08.002; Zhao XM, 2005, J VIROL, V79, P4270, DOI 10.1128/JVI.79.7.4270-4288.2005; Zhao XM, 2004, J VIROL, V78, P10888, DOI 10.1128/JVI.78.20.10888-10905.2004; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	62	17	17	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13354	13371		10.1074/jbc.M115.638098	http://dx.doi.org/10.1074/jbc.M115.638098			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25878250	hybrid, Green Published			2022-12-26	WOS:000354975700033
J	Tavares, R; Pathak, SK				Tavares, Raquel; Pathak, Sushil Kumar			Helicobacter pylori Protein JHP0290 Exhibits Proliferative and Anti-Apoptotic Effects in Gastric Epithelial Cells	PLOS ONE			English	Article							CANCER; MUCOSA; CYCLE; PHOSPHORYLATION; PROGRESSION; ACTIVATION; EXPRESSION; INFECTION; TURNOVER; KINETICS	The influence of Helicobacter pylori infection on gastric epithelial cell proliferation, apoptosis and signaling pathways contributes to the development of infection-associated diseases. Here we report that JHP0290, which is a poorly functionally characterized protein from H. pylori, regulates multiple responses in human gastric epithelial cells. The differential expression and release of JHP0290 homologues was observed among H. pylori strains. JHP0290 existed in monomeric and dimeric forms in H. pylori cell extracts and culture broth. Recombinant purified JHP0290 (rJHP0290) also showed monomeric and dimeric forms, whereas the rJHP0290 C162A mutant exhibited only a monomeric form. The dimeric form of the protein was found to bind more efficiently to gastric epithelial cells than the monomeric form. The exposure of gastric epithelial cells to rJHP0290 induced proliferation in a dose-dependent manner. Faster progression into the cell cycle was observed in rJHP0290-challenged gastric epithelial cells. Furthermore, we detected an anti-apoptotic effect of rJHP0290 in gastric epithelial cells when the cells were treated with rJHP0290 in combination with Camptothecin (CPT), which is an inducer of apoptosis. CPT-induced caspase 3 activation was significantly reduced in the presence of rJHP0290. In addition, the activation of ERK MAPK and the transcription factor NF kappa B was observed in rJHP0290-challenged gastric epithelial cells lines. Our results suggest that JHP0290 may affect H. pylori-induced gastric diseases via the regulation of gastric epithelial cell proliferation and anti-apoptotic pathways.	[Tavares, Raquel; Pathak, Sushil Kumar] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden	Stockholm University	Pathak, SK (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden.	sushil.pathak@su.se			Swedish Research Council; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg Foundation	This work was supported by the Swedish Research Council (www.vr.se) and the Ake Wiberg Foundation (http://www.ake-wiberg.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2000, MICROBES INFECT, V2, P1159, DOI 10.1016/S1286-4579(00)01270-3; Anti M, 1998, GUT, V43, pS27, DOI 10.1136/gut.43.2008.S27; Basak C, 2005, J IMMUNOL, V174, P5672, DOI 10.4049/jimmunol.174.9.5672; Basmarke-Wehelie R, 2011, GASTROENTEROLOGY, V141, P918, DOI 10.1053/j.gastro.2011.05.009; Cahill RJ, 1996, GUT, V38, P177, DOI 10.1136/gut.38.2.177; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen YC, 2006, WORLD J GASTROENTERO, V12, P5972, DOI 10.3748/wjg.v12.i37.5972; Correa P, 1997, J NATL CANCER I, V89, P836, DOI 10.1093/jnci/89.12.836; Correa P, 1998, BRIT MED BULL, V54, P151; De Luca A, 2003, CANCER RES, V63, P6350; Devi S, 2014, HELICOBACTER, V19, P26, DOI 10.1111/hel.12100; Ding SZ, 2008, J GASTROEN HEPATOL, V23, pE67, DOI 10.1111/j.1440-1746.2007.04912.x; Epplein M, 2013, CANCER EPIDEM BIOMAR, V22, P1964, DOI 10.1158/1055-9965.EPI-13-0702; Epplein M, 2012, CANCER EPIDEM BIOMAR, V21, P2185, DOI 10.1158/1055-9965.EPI-12-0792-T; Fan XG, 1996, GUT, V38, P19, DOI 10.1136/gut.38.1.19; Haas G, 2002, PROTEOMICS, V2, P313, DOI 10.1002/1615-9861(200203)2:3<313::AID-PROT313>3.0.CO;2-7; Hennig EE, 2004, INFECT IMMUN, V72, P3429, DOI 10.1128/IAI.72.6.3429-3435.2004; Hirata Y, 2001, INFECT IMMUN, V69, P3965, DOI 10.1128/IAI.69.6.3965-3971.2001; Holck S, 2007, FEMS IMMUNOL MED MIC, V50, P206, DOI 10.1111/j.1574-695X.2007.00254.x; Jang TJ, 2000, J GASTROENTEROL, V35, P265, DOI 10.1007/s005350050344; Jones NL, 1997, AM J PATHOL, V151, P1695; Kalali B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/426309; Kang D, 2013, HELICOBACTER, V18, P347, DOI 10.1111/hel.12057; Kim N, 2002, J BACTERIOL, V184, P6155, DOI 10.1128/JB.184.22.6155-6162.2002; Lamb A, 2013, J CELL BIOCHEM, V114, P491, DOI 10.1002/jcb.24389; Lamb A, 2010, GUT MICROBES, V1, P109, DOI 10.4161/gmic.1.2.11587; LYNCH DAF, 1995, GUT, V36, P346, DOI 10.1136/gut.36.3.346; Maeda S, 2002, J CLIN PATHOL-MOL PA, V55, P286, DOI 10.1136/mp.55.5.286; Maeda S, 2002, GUT, V50, P771, DOI 10.1136/gut.50.6.771; Masato S, 2009, CELL HOST MICROBE; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; Nozawa Y, 2002, BIOCHEM PHARMACOL, V64, P21, DOI 10.1016/S0006-2952(02)01030-4; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Pathak SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077872; Peek RM, 1999, CANCER RES, V59, P6124; Peek RM, 1997, JNCI-J NATL CANCER I, V89, P863, DOI 10.1093/jnci/89.12.863; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Shiotani A, 2005, J GASTROENTEROL, V40, P337, DOI 10.1007/s00535-004-1549-9; Shirin H, 1999, CANCER RES, V59, P2277; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sommi P, 2002, EXP CELL RES, V281, P128, DOI 10.1006/excr.2002.5629; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suganuma M, 2005, J CANCER RES CLIN, V131, P305, DOI 10.1007/s00432-004-0652-x; Sugiyama Toshiro, 2004, Medical Electron Microscopy, V37, P149; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yanai A, 2003, J INFECT DIS, V188, P1741, DOI 10.1086/379629; Yokota S, 2010, INFECT IMMUN, V78, P468, DOI 10.1128/IAI.00903-09	50	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124407	10.1371/journal.pone.0124407	http://dx.doi.org/10.1371/journal.pone.0124407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879227	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500099
J	Rodriguez-Ramilo, ST; Fernandez, J; Toro, MA; Hernandez, D; Villanueva, B				Teresa Rodriguez-Ramilo, Silvia; Fernandez, Jesus; Angel Toro, Miguel; Hernandez, Delfino; Villanueva, Beatriz			Genome-Wide Estimates of Coancestry, Inbreeding and Effective Population Size in the Spanish Holstein Population	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; SELECTION; PEDIGREE; CATTLE; PREDICTION; INFORMATION; DEFICIENCY; DEPRESSION; STRATEGIES; DIVERSITY	Estimates of effective population size in the Holstein cattle breed have usually been low despite the large number of animals that constitute this breed. Effective population size is inversely related to the rates at which coancestry and inbreeding increase and these rates have been high as a consequence of intense and accurate selection. Traditionally, coancestry and inbreeding coefficients have been calculated from pedigree data. However, the development of genome-wide single nucleotide polymorphisms has increased the interest of calculating these coefficients from molecular data in order to improve their accuracy. In this study, genomic estimates of coancestry, inbreeding and effective population size were obtained in the Spanish Holstein population and then compared with pedigree-based estimates. A total of 11,135 animals genotyped with the Illumina BovineSNP50 BeadChip were available for the study. After applying filtering criteria, the final genomic dataset included 36,693 autosomal SNPs and 10,569 animals. Pedigree data from those genotyped animals included 31,203 animals. These individuals represented only the last five generations in order to homogenise the amount of pedigree information across animals. Genomic estimates of coancestry and inbreeding were obtained from identity by descent segments (coancestry) or runs of homozygosity (inbreeding). The results indicate that the percentage of variance of pedigree-based coancestry estimates explained by genomic coancestry estimates was higher than that for inbreeding. Estimates of effective population size obtained from genome-wide and pedigree information were consistent and ranged from about 66 to 79. These low values emphasize the need of controlling the rate of increase of coancestry and inbreeding in Holstein selection programmes.	[Teresa Rodriguez-Ramilo, Silvia; Fernandez, Jesus; Villanueva, Beatriz] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Angel Toro, Miguel] Escuela Tecn Super Ingenieros Agonomos, Dept Anim Prod, Madrid, Spain; [Hernandez, Delfino] Dept Tecnico Conafe, Madrid, Spain		Rodriguez-Ramilo, ST (corresponding author), INIA, Dept Mejora Genet Anim, Madrid, Spain.	rodriguez.silvia@inia.es	Ramilo, Silvia Teresa Rodriguez/AAC-2843-2021; Toro, Miguel Angel Angel/H-9370-2015; Toro, Miguel Angel/AAA-1309-2019; Fernandez, Jesus/H-4894-2015	Ramilo, Silvia Teresa Rodriguez/0000-0001-7150-0692; Toro, Miguel Angel Angel/0000-0001-7460-2483; Toro, Miguel Angel/0000-0001-7460-2483; Fernandez, Jesus/0000-0001-8269-1893	Ministerio de Economia y Competitividad, Spain [CGL2012-39861-C02-02]	Ministerio de Economia y Competitividad, Spain	This study was supported by the Ministerio de Economia y Competitividad, Spain (grant CGL2012-39861-C02-02).	Avendano S, 2003, J ANIM SCI, V81, P2964; Bjelland DW, 2013, J DAIRY SCI, V96, P4697, DOI 10.3168/jds.2012-6435; Boichard D, 2002, P 7 WORLD C GEN APPL; Brotherstone S, 2005, PHILOS T R SOC B, V360, P1479, DOI 10.1098/rstb.2005.1668; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; Daetwyler HD, 2007, J ANIM BREED GENET, V124, P369, DOI 10.1111/j.1439-0388.2007.00693.x; de Roos APW, 2011, J DAIRY SCI, V94, P1559, DOI 10.3168/jds.2010-3354; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ferencakovic M, 2013, J ANIM BREED GENET, V130, P286, DOI 10.1111/jbg.12012; Ferencakovic M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-42; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Gomez-Romano F, 2014, P 10 WORLD C GEN APP; Gomez-Romano F, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-38; Gonzalez-Recio O, 2007, J DAIRY SCI, V90, P5744, DOI 10.3168/jds.2007-0203; Grundy B, 1998, GENET RES, V72, P159, DOI 10.1017/S0016672398003474; Gutierrez JP, 2005, J ANIM BREED GENET, V122, P172, DOI 10.1111/j.1439-0388.2005.00512.x; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Hill WG, 2010, PHILOS T R SOC B, V365, P73, DOI 10.1098/rstb.2009.0203; Kearney JF, 2004, J DAIRY SCI, V87, P3503, DOI 10.3168/jds.S0022-0302(04)73485-2; KEHRLI ME, 1990, AM J VET RES, V51, P1826; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Li MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026256; Luan T, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0064-6; Lund MS, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-43; MacLeod I. M., 2013, Proceedings of the Twentieth Conference of the Association for the Advancement of Animal Breeding and Genetics, Translating Science into Action, Napier, New Zealand, 20th-23rd October 2013, P215; Malecot G., 1948, MATH HEREDITE; Meuwissen THE, 2011, J ANIM BREED GENET, V128, P429, DOI 10.1111/j.1439-0388.2011.00966.x; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Meuwissen THE, 1997, J ANIM SCI, V75, P934; Meuwissen THE, 2001, GENETICS, V157, P1819; Miglior F., 2008, PHENOTYPIC ANAL INBR; Pryce JE, 2012, J DAIRY SCI, V95, P377, DOI 10.3168/jds.2011-4254; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; de Cara MAR, 2013, MOL ECOL, V22, P6091, DOI 10.1111/mec.12560; Rodriguez-Ramilo ST, 2007, AQUACULTURE, V273, P434, DOI 10.1016/j.aquaculture.2007.10.036; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Saura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078314; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Schutz E, 2008, J DAIRY SCI, V91, P4854, DOI 10.3168/jds.2008-1154; SHANKS RD, 1984, J HERED, V75, P337, DOI 10.1093/oxfordjournals.jhered.a109951; Silio L, 2013, J ANIM BREED GENET, V130, P349, DOI 10.1111/jbg.12031; Sonesson AK, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-27; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Su G, 2012, J DAIRY SCI, V95, P4657, DOI 10.3168/jds.2012-5379; Sun C, 2013, J DAIRY SCI, V96, P8014, DOI 10.3168/jds.2013-6969; Rodriguez-Ramilo ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093424; Toro M, 2002, CONSERV GENET, V3, P309, DOI 10.1023/A:1019921131171; Toro MA, 2014, LIVEST SCI, V166, P48, DOI 10.1016/j.livsci.2014.04.020; Toro MA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-27; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; VanRaden PM., 2007, INTERBULL B, V37, P33; Weigel K. A., 2001, Journal of Dairy Science, V84, pE177, DOI 10.3168/jds.S0022-0302(01)70213-5; Weigel KA, 2002, J DAIRY SCI, V85, P2376, DOI 10.3168/jds.S0022-0302(02)74318-X; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	58	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124157	10.1371/journal.pone.0124157	http://dx.doi.org/10.1371/journal.pone.0124157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880228	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000353016500087
J	Wakasa, K; Kawabata, R; Nakao, S; Hattori, H; Taguchi, K; Uchida, J; Yamanaka, T; Maehara, Y; Fukushima, M; Oda, S				Wakasa, Kentaro; Kawabata, Rumi; Nakao, Seiki; Hattori, Hiroyoshi; Taguchi, Kenichi; Uchida, Junji; Yamanaka, Takeharu; Maehara, Yoshihiko; Fukushima, Masakazu; Oda, Shinya			Dynamic Modulation of Thymidylate Synthase Gene Expression and Fluorouracil Sensitivity in Human Colorectal Cancer Cells	PLOS ONE			English	Article							DIHYDROPYRIMIDINE DEHYDROGENASE; MAMMALIAN-CELLS; 5-FLUOROURACIL; LINES; INHIBITION; SYNTHETASE; MECHANISM; RESISTANT	Biomarkers have revolutionized cancer chemotherapy. However, many biomarker candidates are still in debate. In addition to clinical studies, a priori experimental approaches are needed. Thymidylate synthase (TS) expression is a long-standing candidate as a biomarker for 5-fluorouracil (5-FU) treatment of cancer patients. Using the Tet-OFF system and a human colorectal cancer cell line, DLD-1, we first constructed an in vitro system in which TS expression is dynamically controllable. Quantitative assays have elucidated that TS expression in the transformant was widely modulated, and that the dynamic range covered 15-fold of the basal level. 5-FU sensitivity of the transformant cells significantly increased in response to downregulated TS expression, although being not examined in the full dynamic range because of the doxycycline toxicity. Intriguingly, our in vitro data suggest that there is a linear relationship between TS expression and the 5-FU sensitivity in cells. Data obtained in a mouse model using transformant xenografts were highly parallel to those obtained in vitro. Thus, our in vitro and in vivo observations suggest that TS expression is a determinant of 5-FU sensitivity in cells, at least in this specific genetic background, and, therefore, support the possibility of TS expression as a biomarker for 5-FU-based cancer chemotherapy.	[Wakasa, Kentaro; Nakao, Seiki; Taguchi, Kenichi; Fukushima, Masakazu; Oda, Shinya] Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan; [Kawabata, Rumi; Uchida, Junji] Taiho Pharmaceut Co Ltd, Tokushima Res Ctr, Tokushima, Japan; [Hattori, Hiroyoshi] Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Yamanaka, Takeharu] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa 232, Japan; [Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Taiho Pharmaceutical; Nagoya Medical Center; Yokohama City University; Kyushu University	Wakasa, K (corresponding author), Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan.	soda@nk-cc.go.jp			Ministry of Health, Labour and Welfare; Ministry of Education, Science, Sports and Culture of Japan; Taiho Pharmaceutical Co., Ltd.	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Taiho Pharmaceutical Co., Ltd.	This study was funded by grants from the Ministry of Health, Labour and Welfare and the Ministry of Education, Science, Sports and Culture of Japan and also partly supported by the Taiho Pharmaceutical Co., Ltd. (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that the in vivo experiments were done in the laboratories of the Taiho Pharmaceutical Co., Ltd. Co-authors RK and JU are employed by Taiho Pharmaceutical Co., Ltd. Taiho Pharmaceutical Co., Ltd. provided support in the form of salaries for authors RK and JU and in vivo experiments were done in the laboratories of the Taiho Pharmaceutical Co., Ltd., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AYUSAWA D, 1984, J BIOL CHEM, V259, P4361; Bissoon-Haqqani S, 2006, J HISTOCHEM CYTOCHEM, V54, P19, DOI 10.1369/jhc.5A6642.2005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burcin Mark M., 1998, Frontiers in Bioscience, V3, pC1; Ciaparrone M, 2006, ONCOLOGY-BASEL, V70, P366, DOI 10.1159/000098110; DUNLAP RB, 1971, BIOCHEMISTRY-US, V10, P88, DOI 10.1021/bi00777a014; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Grem JL, 2001, CLIN CANCER RES, V7, P999; Koci L, 2012, ONCOL LETT, V3, P913, DOI 10.3892/ol.2012.593; Koopman M, 2009, EUR J CANCER, V45, P1935, DOI 10.1016/j.ejca.2009.04.023; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Longley DB, 2001, CLIN CANCER RES, V7, P3533; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; NEWMAN EM, 1988, BIOCHEM PHARMACOL, V37, P443, DOI 10.1016/0006-2952(88)90212-2; Okabe H, 2000, INT J MOL MED, V5, P133; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; SPEARS CP, 1982, CANCER RES, V42, P450; Sprowl JA, 2012, DRUG RESIST UPDATE, V15, P5, DOI 10.1016/j.drup.2012.01.009; Tokunaga E, 2000, EUR J CANCER, V36, P1998, DOI 10.1016/S0959-8049(00)00200-8; YOSHIOKA A, 1987, J BIOL CHEM, V262, P8235	23	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123076	10.1371/journal.pone.0123076	http://dx.doi.org/10.1371/journal.pone.0123076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881233	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500037
J	Chen, JN; Li, SH; Sun, WS; Li, JR				Chen, Jinan; Li, Shenghua; Sun, Wenshan; Li, Junrong			Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; ACTIN POLYMERIZATION; S-NITROSYLATION; TAU PATHOLOGY; LONG-TERM; CDK5; PHOSPHORYLATION; PEPTIDE; ACTIVATOR	Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine kinase that is activated by the neuron specific activators p35/p39 and plays many important roles in neuronal development. However, aberrant activation of Cdk5 is believed to be associated with the pathogenesis of several neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD). Here in the present study, enhanced Cdk5 activity was observed in mouse models of AD; whereas soluble amyloid-beta oligomers (A beta), which contribute to synaptic failures during AD pathogenesis, induced Cdk5 hyperactivation in cultured hippocampal neurons. Inhibition of Cdk5 activity by pharmacological or genetic approaches reversed dendritic spine loss caused by soluble amyloid-beta oligomers (A beta) treatment. Interestingly, we found that the anti-diabetes drug pioglitazone could inhibit Cdk5 activity by decreasing p35 protein level. More importantly, pioglitazone treatment corrected long-term potentiation (LTP) deficit caused by A beta exposure in cultured slices and pioglitazone administration rescued impaired LTP and spatial memory in AD mouse models. Taken together, our study describes an unanticipated role of pioglitazone in alleviating AD and reveals a potential therapeutic drug for AD curing.	[Chen, Jinan; Li, Shenghua; Sun, Wenshan; Li, Junrong] Nanjing Med Univ, Jiangning Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Chen, JN (corresponding author), Nanjing Med Univ, Jiangning Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	cjn1523@yahoo.com; Ljry612@163.com						Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Cancino GI, 2011, NEUROBIOL AGING, V32, P1249, DOI 10.1016/j.neurobiolaging.2009.07.007; Ceglia I, 2010, J NEUROCHEM, V114, P182, DOI 10.1111/j.1471-4159.2010.06743.x; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Cho DH, 2013, J NEUROCHEM, V126, P685, DOI 10.1111/jnc.12264; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Derosa Giuseppe, 2012, Curr Mol Pharmacol, V5, P272; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gupta R, 2012, PHARMACOL BIOCHEM BE, V102, P184, DOI 10.1016/j.pbb.2012.03.028; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lalioti V, 2009, P NATL ACAD SCI USA, V106, P4249, DOI 10.1073/pnas.0900218106; Lavelle L, 2010, NEW ENGL J MED, V363, P1772, DOI 10.1056/NEJMc1008660; Masciopinto F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.189; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; Miller BW, 2011, ANN PHARMACOTHER, V45, P1416, DOI 10.1345/aph.1Q238; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Qu J, 2012, PRION, V6, P364, DOI 10.4161/pri.21250; Qu J, 2011, P NATL ACAD SCI USA, V108, P14330, DOI 10.1073/pnas.1105172108; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Searcy JL, 2012, J ALZHEIMERS DIS, V30, P943, DOI 10.3233/JAD-2012-111661; Shukla V, 2013, FASEB J, V27, P174, DOI 10.1096/fj.12-217497; Stevens J, 2009, FASEB J, V23; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Xiang GQ, 2012, J PHARM PHARMACOL, V64, P589, DOI 10.1111/j.2042-7158.2011.01432.x; Zhao WQ, 2009, BBA-MOL BASIS DIS, V1792, P482, DOI 10.1016/j.bbadis.2008.10.014; Zheng YL, 2010, J BIOL CHEM, V285, P34202, DOI 10.1074/jbc.M110.134643	32	32	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123864	10.1371/journal.pone.0123864	http://dx.doi.org/10.1371/journal.pone.0123864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875370	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700048
J	Lagenaur, LA; Swedek, I; Lee, PP; Parks, TP				Lagenaur, Laurel A.; Swedek, Iwona; Lee, Peter P.; Parks, Thomas P.			Robust Vaginal Colonization of Macaques with a Novel Vaginally Disintegrating Tablet Containing a Live Biotherapeutic Product to Prevent HIV Infection in Women	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYANOVIRIN-N; BACTERIAL VAGINOSIS; PREEXPOSURE PROPHYLAXIS; MICROBICIDE DEVELOPMENT; MACACA-MULATTA; TENOFOVIR GEL; AFRICAN WOMEN; LACTOBACILLUS; ACQUISITION	MucoCept is a biotherapeutic for prevention of HIV-1 infection in women and contains a human, vaginal Lactobacillus jensenii that has been genetically enhanced to express the HIV-1 entry inhibitor, modified cyanovirin-N (mCV-N). The objective of this study was to develop a solid vaginal dosage form that supports sustained vaginal colonization of the MucoCept Lactobacillus at levels previously shown, with freshly prepared cultures, to protect macaques from SHIV infection and to test this formulation in a macaque vaginal colonization model. Vaginally disintegrating tablets were prepared by lyophilizing the formulated bacteria in tablet-shaped molds, then packaging in foil pouches with desiccant. Disintegration time, potency and stability of the tablets were assessed. For colonization, non-synchronized macaques were dosed vaginally with either one tablet or five tablets delivered over five days. Vaginal samples were obtained at three, 14, and 21 days post-dosing and cultured to determine Lactobacillus colonization levels. To confirm identity of the MucoCept Lactobacillus strain, genomic DNA was extracted from samples on days 14 and 21 and a strain-specific PCR was performed. Supernatants from bacteria were tested for the presence of the mCV-N protein by Western blot. The tablets were easy to handle, disintegrated within two minutes, potent (5.7x10(11) CFU/g), and stable at 4 degrees C and 25 degrees C. Vaginal administration of the tablets to macaques resulted in colonization of the MucoCept Lactobacillus in 66% of macaques at 14 days post-dosing and 83% after 21 days. There was no significant difference in colonization levels for the one or five tablet dosing regimens (p=0.88 Day 14, p=0.99 Day 21). Strain-specific PCR confirmed the presence of the bacteria even in culture-negative macaques. Finally, the presence of mCV-N protein was confirmed by Western blot analysis using a specific anti-mCV-N antibody.	[Lagenaur, Laurel A.; Swedek, Iwona; Lee, Peter P.; Parks, Thomas P.] Osel Inc, Mountain View, CA 94043 USA; [Lagenaur, Laurel A.] NCI, Vaccine Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lagenaur, LA (corresponding author), Osel Inc, Mountain View, CA 94043 USA.	llagenaur@mail.nih.gov		Lee, Peter P./0000-0002-2660-4377	National Institutes of Health (NIH) research grant [5R33AI071978]; Bill and Melinda Gates Foundation; Osel Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI071978, R44AI100753] Funding Source: NIH RePORTER	National Institutes of Health (NIH) research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Osel Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) research grant 5R33AI071978 and Phase 1 and Phase 2 Grand Challenges Explorations grants through the Bill and Melinda Gates Foundation (www.grandchallenges.org/). Osel Inc. played an indirect role through the participation of the co-authors and provided support in the form of salaries for authors LAL, TPP and IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Alexandre KB, 2010, VIROLOGY, V402, P187, DOI 10.1016/j.virol.2010.03.021; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Badgujar BP, 2011, ACTA PHARMACEUT, V61, P117, DOI 10.2478/v10007-011-0020-8; Basu B, 2011, J ADV PHARM TECHNOL, V2, P266, DOI 10.4103/2231-4040.90885; Benning L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096844; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Brichacek B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078817; Brotman RM, 2014, MENOPAUSE, V21, P450, DOI 10.1097/GME.0b013e3182a4690b; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Damelin LH, 2011, J MED MICROBIOL, V60, P180, DOI 10.1099/jmm.0.024463-0; Dey B, 2000, J VIROL, V74, P4562, DOI 10.1128/JVI.74.10.4562-4569.2000; Fiereck K, 2013, DEV WORLD BIOETHICS; Friend DR, 2013, ANTIVIR RES, V99, P391, DOI 10.1016/j.antiviral.2013.06.021; Gengiah TN, 2014, INT J CLIN PHARM-NET, V36, P70, DOI 10.1007/s11096-013-9861-1; GIORGI A, 1987, MICROBIOLOGICA, V10, P377; Gravett MG, 2012, J MED PRIMATOL, V41, P183, DOI 10.1111/j.1600-0684.2012.00537.x; Hemalatha R, 2012, EUR J CLIN MICROBIOL, V31, P3097, DOI 10.1007/s10096-012-1671-1; Hemmerling A, 2010, SEXUALLY TRANSMITTED; Hu QX, 2007, VIROLOGY, V368, P145, DOI 10.1016/j.virol.2007.06.029; Kilic AO, 2001, CLIN DIAGN LAB IMMUN, V8, P31, DOI 10.1128/CDLI.8.1.31-39.2001; Lagenaur L, 2011, MUCOSAL IMMUNOL; Liegler T, 2014, J INFECT DIS; Liu XW, 2006, ANTIMICROB AGENTS CH, V50, P3250, DOI 10.1128/AAC.00493-06; MacQueen KM, 2014, AIDS BEHAV, V18, P826, DOI 10.1007/s10461-014-0753-8; Maggi L, 2000, EUR J PHARM BIOPHARM, V50, P389, DOI 10.1016/S0939-6411(00)00121-1; Mansoor LE, 2014, AIDS BEHAV, V18, P841, DOI 10.1007/s10461-014-0752-9; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Mastromarino P, 2009, CLIN MICROBIOL INFEC, V15, P67, DOI 10.1111/j.1469-0691.2008.02112.x; Mirmonsef P, 2012, AIDS RES HUM RETROV, V28, P76, DOI [10.1089/AID.2011.0071, 10.1089/aid.2011.0071]; Ngugi BM, 2011, SEX TRANSM DIS, V38, P1020, DOI 10.1097/OLQ.0b013e3182267ac4; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pendharkar S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-43; RAVEL J, 2010, P NATL ACAD SCI US; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schellenberg JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041217; Stapleton AE, 2011, CLIN INFECT DIS, V52, P1212, DOI 10.1093/cid/cir183; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Vallor AC, 2001, J INFECT DIS, V184, P1431, DOI 10.1086/324445; Van der Elst EM, 2013, AIDS BEHAV, V17, P2162, DOI 10.1007/s10461-012-0317-8; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Vasquez A, 2002, J CLIN MICROBIOL, V40, P2746, DOI 10.1128/JCM.40.8.2746-2749.2002; Yu RR, 2009, J MED PRIMATOL, V38, P125, DOI 10.1111/j.1600-0684.2008.00316.x	48	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122730	10.1371/journal.pone.0122730	http://dx.doi.org/10.1371/journal.pone.0122730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875100	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700023
J	Maity, J; Honcharenko, D; Stromberg, R				Maity, Jyotirmoy; Honcharenko, Dmytro; Stromberg, Roger			Synthesis of Triamino Acid Building Blocks with Different Lipophilicities	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; ALPHA-AMINO ALDEHYDES; CYSTEINE; INHIBITORS; REDUCTION; BEARING; DESIGN	To obtain different amino acids with varying lipophilicity and that can carry up to three positive charges we have developed a number of new triamino acid building blocks. One set of building blocks was achieved by aminoethyl extension, via reductive amination, of the side chain of ortnithine, diaminopropanoic and diaminobutanoic acid. A second set of triamino acids with the aminoethyl extension having hydrocarbon side chains was synthesized from diaminobutanoic acid. The aldehydes needed for the extension by reductive amination were synthesized from the corresponding Fmoc-L-2-amino fatty acids in two steps. Reductive amination of these compounds with Boc-L-Dab-OH gave the C4-C8 alkyl-branched triamino acids. All triamino acids were subsequently Boc-protected at the formed secondary amine to make the monomers appropriate for the N-terminus position when performing Fmoc-based solid-phase peptide synthesis.	[Maity, Jyotirmoy; Honcharenko, Dmytro; Stromberg, Roger] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden	Karolinska Institutet	Stromberg, R (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	Roger.Stromberg@ki.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	We gratefully acknowledge financial support from the Swedish Research Council. We also thank Prof. Goran Widmalm and Wangchuk Rabten at Stockholm University for assistance with the polarimeter.	Bandyopadhyay A, 2010, ORG BIOMOL CHEM, V8, P4855, DOI 10.1039/c0ob00199f; Bhattacharya S, 2009, CHEM COMMUN, P4632, DOI 10.1039/b900666b; Bondebjerg J, 2002, J AM CHEM SOC, V124, P11046, DOI 10.1021/ja0123913; Brown ZZ, 2010, ORG LETT, V12, P1436, DOI 10.1021/ol100048g; Chhabra SR, 2002, J ORG CHEM, V67, P4017, DOI 10.1021/jo010456e; Chhabra SR, 1999, TETRAHEDRON LETT, V40, P4905, DOI 10.1016/S0040-4039(99)00909-0; Clausen JD, 2012, AMINO ACIDS, V43, P1633, DOI 10.1007/s00726-012-1239-5; Cochrane SA, 2014, J MED CHEM, V57, P1127, DOI 10.1021/jm401779d; Debaene F, 2004, TETRAHEDRON, V60, P8677, DOI 10.1016/j.tet.2004.05.107; Debaene F, 2007, TETRAHEDRON, V63, P6577, DOI 10.1016/j.tet.2007.03.033; FEHRENTZ JA, 1994, TETRAHEDRON LETT, V35, P9031, DOI 10.1016/0040-4039(94)88419-6; Flodin NW, 1997, J AM COLL NUTR, V16, P7, DOI 10.1080/07315724.1997.10718644; FUKUYAMA T, 1990, J AM CHEM SOC, V112, P7050, DOI 10.1021/ja00175a043; GRIFFITH RS, 1978, DERMATOLOGICA, V156, P257, DOI 10.1159/000250926; Gros L, 2006, J MED CHEM, V49, P6094, DOI 10.1021/jm060290f; HO PT, 1993, J ORG CHEM, V58, P2313, DOI 10.1021/jo00060a056; Honcharenko D, 2014, ORG BIOMOL CHEM, V12, P6684, DOI 10.1039/c4ob00959b; Lawton GR, 2004, J AM CHEM SOC, V126, P12762, DOI 10.1021/ja046436m; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Lehmann TJ, 2001, BIOORGAN MED CHEM, V9, P1827, DOI 10.1016/S0968-0896(01)00079-7; Liberska A, 2011, CHEM COMMUN, V47, P12774, DOI 10.1039/c1cc15805h; Liu XL, 2011, PHARM RES-DORDR, V28, P962, DOI 10.1007/s11095-010-0303-7; MACKELLAR C, 1992, NUCLEIC ACIDS RES, V20, P3411, DOI 10.1093/nar/20.13.3411; Maity J, 2014, MOLBANK, DOI 10.3390/M833; Mandal PK, 2009, J MED CHEM, V52, P6126, DOI 10.1021/jm901105k; MAREK M, 1970, COMP BIOCHEM PHYSIOL, V35, P737, DOI 10.1016/0010-406X(70)90992-8; Mariani R, 2005, BIOORG MED CHEM LETT, V15, P3748, DOI 10.1016/j.bmcl.2005.05.060; Matsumori N, 2004, CHEM BIODIVERS, V1, P346, DOI 10.1002/cbdv.200490030; MCCORD TJ, 1964, ARCH BIOCHEM BIOPHYS, V105, P349, DOI 10.1016/0003-9861(64)90018-9; NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221; Smriga M, 2003, P NATL ACAD SCI USA, V100, P15370, DOI 10.1073/pnas.2436556100; Tedeschi T, 2008, TETRAHEDRON LETT, V49, P4958, DOI 10.1016/j.tetlet.2008.05.114; Tokuyama H, 2002, SYNTHESIS-STUTTGART, P1121; Tripathi RP, 2008, CURR ORG CHEM, V12, P1093, DOI 10.2174/138527208785740283; Wang G, 2003, ORG LETT, V5, P737, DOI 10.1021/ol0275567; Wen JJ, 1998, TETRAHEDRON-ASYMMETR, V9, P1855, DOI 10.1016/S0957-4166(98)00183-9; Xu XD, 2012, POLYM CHEM-UK, V3, P2479, DOI 10.1039/c2py20299a; Zhang L, WO 2013/142088 A1, Patent No. 2013142088	38	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124046	10.1371/journal.pone.0124046	http://dx.doi.org/10.1371/journal.pone.0124046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25876040	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700054
J	Eberson, LS; Sanchez, PA; Majeed, BA; Tawinwung, S; Secomb, TW; Larson, DF				Eberson, Lance S.; Sanchez, Pablo A.; Majeed, Beenish A.; Tawinwung, Supannikar; Secomb, Timothy W.; Larson, Douglas F.			Effect of Lysyl Oxidase Inhibition on Angiotensin II-Induced Arterial Hypertension, Remodeling, and Stiffness	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ABDOMINAL AORTIC-ANEURYSMS; GROWTH-FACTOR-BETA; CROSS-LINKING; COLLAGEN-SYNTHESIS; BLOOD-PRESSURE; ELASTIN; MICE; CELLS; DYSFUNCTION	It is well accepted that angiotensin II (Ang II) induces altered vascular stiffness through responses including both structural and material remodeling. Concurrent with remodeling is the induction of the enzyme lysyl oxidase (LOX) through which ECM proteins are crosslinked. The study objective was to determine the effect of LOX mediated cross-linking on vascular mechanical properties. Three-month old mice were chronically treated with Ang II with or without the LOX blocker, beta-aminopropionitrile (BAPN), for 14 days. Pulse wave velocity (PWV) from Doppler measurements of the aortic flow wave was used to quantify in vivo vascular stiffness in terms of an effective Young's modulus. The increase in effective Young's modulus with Ang II administration was abolished with the addition of BAPN, suggesting that the material properties are a major controlling element in vascular stiffness. BAPN inhibited the Ang II induced collagen cross-link formation by 2-fold and PWV by 44% (P<0.05). Consistent with this observation, morphometric analysis showed that BAPN did not affect the Ang II mediated increase in medial thickness but significantly reduced the adventitial thickness. Since the hypertensive state contributes to the measured in vivo PWV stiffness, we removed the Ang II infusion pumps on Day 14 and achieved normal arterial blood pressures. With pump removal we observed a decrease of the PWV in the Ang II group to 25% above that of the control values (P=0.002), with a complete return to control values in the Ang II plus BAPN group. In conclusion, we have shown that the increase in vascular stiffness with 14 day Ang II administration results from a combination of hypertension- induced wall strain, adventitial wall thickening and Ang II mediated LOX ECM cross-linking, which is a major material source of vascular stiffening, and that the increased PWV was significantly inhibited with co-administration of BAPN.	[Eberson, Lance S.; Sanchez, Pablo A.; Secomb, Timothy W.; Larson, Douglas F.] Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA; [Majeed, Beenish A.; Tawinwung, Supannikar; Larson, Douglas F.] Univ Arizona, Dept Pharmacol, Tucson, AZ USA; [Eberson, Lance S.; Sanchez, Pablo A.; Majeed, Beenish A.; Tawinwung, Supannikar; Larson, Douglas F.] Univ Arizona, Coll Med, Sarver Heart Ctr, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona	Larson, DF (corresponding author), Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA.	dflarson@u.arizona.edu		Tawinwung, Supannikar/0000-0003-2151-4580; Secomb, Timothy/0000-0002-0176-5502	NIH [R01HL105280]; Steinbronn Heart Failure Research Award through the Sarver Heart Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105280] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Steinbronn Heart Failure Research Award through the Sarver Heart Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH R01HL105280, Steinbronn Heart Failure Research Award to DFL through the Sarver Heart Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2004, BRIT J PHARMACOL, V142, P1055, DOI 10.1038/sj.bjp.0705832; Behmoaras J, 2008, REJUV RES, V11, P883, DOI 10.1089/rej.2008.0760; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Bruel A, 1998, ATHEROSCLEROSIS, V140, P135, DOI 10.1016/S0021-9150(98)00130-0; Che ZQ, 2008, HYPERTENS RES, V31, P1233, DOI 10.1291/hypres.31.1233; Chow MJ, 2014, BIOPHYS J, V106, P2684, DOI 10.1016/j.bpj.2014.05.014; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dernellis J, 2005, HYPERTENSION, V45, P426, DOI 10.1161/01.HYP.0000157818.58878.93; Fitch RM, 2006, AM J PHYSIOL-HEART C, V290, pH1190, DOI 10.1152/ajpheart.00327.2005; Ford CM, 1999, ARTERIOSCL THROM VAS, V19, P1843, DOI 10.1161/01.ATV.19.8.1843; Greenwald SE, 1997, J BIOMECH ENG-T ASME, V119, P438, DOI 10.1115/1.2798291; Gulan U, 2014, IEEE J BIOMED HEALTH; Guo XM, 2003, AM J PHYSIOL-HEART C, V285, pH2614, DOI 10.1152/ajpheart.00567.2003; Haidet GC, 1996, AM HEART J, V132, P319, DOI 10.1016/S0002-8703(96)90428-7; Hametner B, 2014, INT J CARDIOL, V171, P31, DOI 10.1016/j.ijcard.2013.11.039; Humphrey JD, 2008, CELL BIOCHEM BIOPHYS, V50, P53, DOI 10.1007/s12013-007-9002-3; Humphrey JD, 2008, HYPERTENSION, V52, P195, DOI 10.1161/HYPERTENSIONAHA.107.103440; IWATSUKI K, 1977, P NATL ACAD SCI USA, V74, P360, DOI 10.1073/pnas.74.1.360; Jiang B, 2008, ULTRASOUND MED BIOL, V34, P509, DOI 10.1016/j.ultrasmedbio.2007.09.008; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Kanematsu Y, 2010, HYPERTENSION, V55, P1267, DOI 10.1161/HYPERTENSIONAHA.109.140558; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Majeed B, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/126365; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; Mitchell GF, 2003, CIRCULATION, V108, P1592, DOI 10.1161/01.CIR.0000093435.04334.1F; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Remus EW, 2012, AM J PHYSIOL-HEART C, V303, pH1067, DOI 10.1152/ajpheart.00217.2012; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Saphirstein RJ, 2014, MICROCIRCULATION, V21, P201, DOI 10.1111/micc.12101; Sehgel NL, 2013, AM J PHYSIOL-HEART C, V305, pH1281, DOI 10.1152/ajpheart.00232.2013; van der Slot-Verhoeven AJ, 2005, BBA-MOL BASIS DIS, V1740, P60, DOI 10.1016/j.bbadis.2005.02.007; Weber T, 2012, HYPERTENSION, V60, P534, DOI 10.1161/HYPERTENSIONAHA.112.194571; Woodiwiss AJ, 2001, CIRCULATION, V103, P155; Yu QL, 2010, MATRIX BIOL, V29, P511, DOI 10.1016/j.matbio.2010.06.003; Zhang L, 2012, ANN VASC SURG, V26, P996, DOI 10.1016/j.avsg.2012.02.004	39	31	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124013	10.1371/journal.pone.0124013	http://dx.doi.org/10.1371/journal.pone.0124013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875748	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100233
J	Grantham, NS; Reich, BJ; Pacifici, K; Laber, EB; Menninger, HL; Henley, JB; Barberan, A; Leff, JW; Fierer, N; Dunn, RR				Grantham, Neal S.; Reich, Brian J.; Pacifici, Krishna; Laber, Eric B.; Menninger, Holly L.; Henley, Jessica B.; Barberan, Albert; Leff, Jonathan W.; Fierer, Noah; Dunn, Robert R.			Fungi Identify the Geographic Origin of Dust Samples	PLOS ONE			English	Article							POLLEN ANALYSIS; BOOTSTRAP; BACTERIAL; SEQUENCES	There is a long history of archaeologists and forensic scientists using pollen found in a dust sample to identify its geographic origin or history. Such palynological approaches have important limitations as they require time-consuming identification of pollen grains, a priori knowledge of plant species distributions, and a sufficient diversity of pollen types to permit spatial or temporal identification. We demonstrate an alternative approach based on DNA sequencing analyses of the fungal diversity found in dust samples. Using nearly 1,000 dust samples collected from across the continental U.S., our analyses identify up to 40,000 fungal taxa from these samples, many of which exhibit a high degree of geographic endemism. We develop a statistical learning algorithm via discriminant analysis that exploits this geographic endemicity in the fungal diversity to correctly identify samples to within a few hundred kilometers of their geographic origin with high probability. In addition, our statistical approach provides a measure of certainty for each prediction, in contrast with current palynology methods that are almost always based on expert opinion and devoid of statistical inference. Fungal taxa found in dust samples can therefore be used to identify the origin of that dust and, more importantly, we can quantify our degree of certainty that a sample originated in a particular place. This work opens up a new approach to forensic biology that could be used by scientists to identify the origin of dust or soil samples found on objects, clothing, or archaeological artifacts.	[Grantham, Neal S.; Reich, Brian J.; Laber, Eric B.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Pacifici, Krishna] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Menninger, Holly L.; Dunn, Robert R.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Henley, Jessica B.; Barberan, Albert; Leff, Jonathan W.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Leff, Jonathan W.; Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Dunn, RR (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	Rob_Dunn@ncsu.edu	Barberan, Albert/A-5319-2013; Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020; Pacifici, Krishna/AAF-5171-2020	Dunn, Robert/0000-0002-6030-4837; Pacifici, Krishna/0000-0002-7518-7186; BARBERAN, ALBERT/0000-0002-3066-7530; FIERER, NOAH/0000-0002-6432-4261; Reich, Brian/0000-0002-5473-120X	A. P. Sloan Microbiology of the Built Environment Program	A. P. Sloan Microbiology of the Built Environment Program	Funding for this work was provided by a grant from the A. P. Sloan Microbiology of the Built Environment Program (http://www.sloan.org/major-program-areas/basic-research/microbiology-of-thebuilt-environment/) to NF and RRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; [Anonymous], 1992, HDB PALYNOLOGY MORPH; Araujo R, 2009, FORENS SCI INT-GEN S, V2, P297, DOI 10.1016/j.fsigss.2009.08.145; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Blanco-Ulate B, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00228-13; Bock JH, 1997, J FORENSIC SCI, V42, P364; Bowers RM, 2013, ENVIRON SCI TECHNOL, V47, P12097, DOI 10.1021/es402970s; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; BRYANT V M JR, 1990, Palynology, V14, P193; Bryant VA, 2006, FORENSIC SCI INT, V163, P183, DOI 10.1016/j.forsciint.2005.11.021; Coyle HM, 2001, CROAT MED J, V42, P340; DICICCIO TJ, 1992, BIOMETRIKA, V79, P285, DOI 10.2307/2336840; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Flores GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044563; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Giampaoli S, 2014, FORENSIC SCI INT, V240, P41, DOI 10.1016/j.forsciint.2014.02.028; HALL P, 1986, ANN STAT, V14, P1431, DOI 10.1214/aos/1176350168; Hastie T., 2009, UNSUPERVISED LEARNIN; Hawksworth DL, 2011, FORENSIC SCI INT, V206, P1, DOI 10.1016/j.forsciint.2010.06.012; Hwang GM, 2013, AASP PALYNOLOGICAL S; Locard, 1930, AM J POLICE SCI, P276, DOI [10.2307/1147154, DOI 10.2307/1147154]; MARTIN MA, 1990, J AM STAT ASSOC, V85, P1105, DOI 10.2307/2289608; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058020; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; Montali E, 2006, FORENSIC SCI INT, V163, P211, DOI 10.1016/j.forsciint.2005.11.020; Morgan RM, 2013, SCI JUSTICE, V53, P375, DOI 10.1016/j.scijus.2013.03.004; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; PYE K., 2004, FORENSIC GEOSCIENCE, V232, P1, DOI [10.1144/gsl.sp.2004.232.01.01, DOI 10.1144/GSL.SP.2004.232.01.01, 10.1144/GSL.SP.2004.232.01.01]; Pye K, 2007, FORENSIC SCI INT, V165, P52, DOI 10.1016/j.forsciint.2006.03.001; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; STONEY D. A., 2011, J AM SOC TRACE EVIDE, V2, P13; Szibor R, 1998, NATURE, V395, P449, DOI 10.1038/26646; Talbot JM, 2014, P NATL ACAD SCI; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warny S, 2013, AASP PALYNOLOGICAL S, V46; Warny S, 2013, SCIENCE, V339, P1149, DOI 10.1126/science.339.6124.1149-a	37	42	42	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122605	10.1371/journal.pone.0122605	http://dx.doi.org/10.1371/journal.pone.0122605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875229	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100087
J	Liu, CC; Hsieh, HM; Wu, CF; Hsieh, TJ; Huang, SP; Chou, YH; Huang, CN; Wu, WJ; Wu, MT				Liu, Chia-Chu; Hsieh, Hui-Min; Wu, Chia-Fang; Hsieh, Tusty-Jiuan; Huang, Shu-Pin; Chou, Yii-Her; Huang, Chun-Nung; Wu, Wen-Jeng; Wu, Ming-Tsang			Long-Term Prescription of a-Blockers Decrease the Risk of Recurrent Urolithiasis Needed for Surgical Intervention-A Nationwide Population-Based Study	PLOS ONE			English	Article							SHOCK-WAVE LITHOTRIPSY; STONE CLEARANCE; RENAL STONES; SUBTYPES; NEPHROLITHIASIS; TAMSULOSIN; UPDATE	Purpose a1 receptors and subtypes have been confirmed to distribute in human pelvis and calyces recently. As used in ureteral stones, a-blocker treatment may facilitate kidney stone passage and long-term prescription of a-blocker may decrease the risk of recurrent urolithiasis. The aim of this study is to determine if use of a-blockers 180 days or more can decrease the risk of recurrent urolithiasis needed for surgical intervention. Materials and Methods A representative database of 1,000,000 patients from Taiwan's National Health Insurance was analyzed. Eligible patients were those who had received the first-time procedure for upper urinary stone removal, including extracorporeal shock-wave lithotripsy, ureterorenoscopic lithotripsy, or both, between 2000 and 2010. After completing a 180-day treatment for first event, patients were prospectively followed-up until a second set of stone procedures was performed (proxy of stone recurrence), loss to follow-up, or end of study. The effect of percentage of total number of days of a-blocker use on need for second set of stone procedures within a post treatment 180-day follow-up period was analyzed by quartile. A nested case-control study was also performed. Results 1,259 patients were eligible for final analyses. During 3,980 person-years follow-up, 167 patients had recurrent urolithiasis needed for surgical intervention. From first to fourth quartile of drug exposure, recurrence rates were 45.64, 47.19, 43.11, and 18.52 per 1,000 person-years. The adjusted hazard ratio was 0.46 (95% CI = 0.24 to 0.89) for the fourth quartile (vs. quartile 1). In the nested case-control study, adjusted ORs was 0.23 (95% CI = 0.10 to 0.53) in the fourth quartile (vs. quartile 1). The results remained similar even in patients categorized by cumulative defined daily dose (cDDD) quartiles and average cDDD per day quartiles. Conclusion Use of a-blockers for 180 days or more decrease the risk of recurrent urolithiasis needed for surgical intervention. In patients at higher risk of recurrent urolithiasis, long term prescription of a-blockers might help them prevent further surgical intervention.	[Liu, Chia-Chu; Huang, Shu-Pin; Chou, Yii-Her; Huang, Chun-Nung; Wu, Wen-Jeng] Kaohsiung Med Univ, Coll Med, Dept Urol, Kaohsiung, Taiwan; [Liu, Chia-Chu; Huang, Shu-Pin; Chou, Yii-Her; Huang, Chun-Nung; Wu, Wen-Jeng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Liu, Chia-Chu] Pingtung Hosp, Dept Urol, Minist Hlth & Welf, Execut Yuan, Pingtung, Taiwan; [Hsieh, Hui-Min; Wu, Chia-Fang; Wu, Ming-Tsang] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Hsieh, Tusty-Jiuan] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Ctr Environm & Occupat Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Wu, MT (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan.	960021@ms.kmuh.org.tw	LIU, CHIA CHU/T-2880-2019; Wu, Ming-Tsang/G-5637-2012	Wu, Ming-Tsang/0000-0001-7307-7816; wu, wen jeng/0000-0002-9691-7416; Hsieh, Tusty-Jiuan/0000-0001-5387-6522	Kaohsiung Medical University [KMU-DT103004]; Kaohsiung Medical University Hospital [KMUH101-1I04, KMUH102-2R58, KMUH102-2M40, KMUH103-3R44]; National Science Council [NSC 101-2314-B-037-037-MY3]; Ministry of Science and Technology [MOST 103-2314-B-037-066-MY2]; Taiwan's National Health Research Institutes [NHRI-EX102-10209PI]	Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taiwan's National Health Research Institutes	This work was supported by Kaohsiung Medical University (KMU-DT103004), Kaohsiung Medical University Hospital (KMUH101-1I04; KMUH102-2R58; KMUH102-2M40; KMUH103-3R44), the National Science Council (NSC 101-2314-B-037-037-MY3), Ministry of Science and Technology (MOST 103-2314-B-037-066-MY2), and Taiwan's National Health Research Institutes (NHRI-EX102-10209PI), none of which had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, THE INTERNATIONAL CL; Brown J, 2006, INT UROL NEPHROL, V38, P87, DOI 10.1007/s11255-005-3622-6; Cupisti A, 2011, J NEPHROL, V24, pS25, DOI 10.5301/JN.2011.7766; Heran BS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004643.pub3; Huang CY, 2009, UROL INT, V83, P410, DOI 10.1159/000251180; Hussein MM, 2010, SCAND J UROL NEPHROL, V44, P27, DOI 10.3109/00365590903359916; John TT, 2010, UROLOGY, V75, P1040, DOI 10.1016/j.urology.2009.07.1257; Karabacak OR, 2013, UROLITHIASIS, V41, P385, DOI 10.1007/s00240-013-0592-5; Lee YH, 2006, UROLOGY, V67, P480, DOI 10.1016/j.urology.2005.09.067; Lee YH, 2002, UROL INT, V68, P172, DOI 10.1159/000048445; Liu CC, 2009, ANN EPIDEMIOL, V19, P539, DOI 10.1016/j.annepidem.2009.02.006; Milani S, 2005, BJU INT, V95, P29, DOI 10.1111/j.1464-410X.2005.05485.x; Moe OW, 2011, KIDNEY INT, V79, P385, DOI 10.1038/ki.2010.389; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; MORITA T, 1987, TOHOKU J EXP MED, V152, P111, DOI 10.1620/tjem.152.111; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; Romero Victoriano, 2010, Rev Urol, V12, pe86; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Seitz C, 2009, EUR UROL, V56, P455, DOI 10.1016/j.eururo.2009.06.012; Sigala S, 2005, NEUROUROL URODYNAM, V24, P142, DOI 10.1002/nau.20097; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Tomiyama Y, 2007, EUR J PHARMACOL, V573, P201, DOI 10.1016/j.ejphar.2007.06.056; Vicentini FC, 2011, UROLOGY, V78, P1016, DOI 10.1016/j.urology.2011.04.062; WHO, 2003, WHO COLLABORATING CE; Worcester EM, 2010, NEW ENGL J MED, V363, P954, DOI 10.1056/NEJMcp1001011; Zhu YF, 2010, BJU INT, V106, P256, DOI 10.1111/j.1464-410X.2009.09014.x	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122494	10.1371/journal.pone.0122494	http://dx.doi.org/10.1371/journal.pone.0122494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875226	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100077
J	de Paz, AM; Sanchez-Mut, JV; Samitier-Marti, M; Petazzi, P; Saez, M; Szczesna, K; Huertas, D; Esteller, M; Ausio, J				Martinez de Paz, Alexia; Vicente Sanchez-Mut, Jose; Samitier-Marti, Mireia; Petazzi, Paolo; Saez, Mauricio; Szczesna, Karolina; Huertas, Dori; Esteller, Manel; Ausio, Juan			Circadian Cycle-Dependent MeCP2 and Brain Chromatin Changes	PLOS ONE			English	Article							BINDING-PROTEIN 2; BDNF TRANSCRIPTION; MOUSE-BRAIN; CLOCK; EXPRESSION; SLEEP; PHOSPHORYLATION; DISEASE; ACETYLATION; PATTERNS	Methyl CpG binding protein 2 (MeCP2) is a chromosomal protein of the brain, very abundant especially in neurons, where it plays an important role in the regulation of gene expression. Hence it has the potential to be affected by the mammalian circadian cycle. We performed expression analyses of mice brain frontal cortices obtained at different time points and we found that the levels of MeCP2 are altered circadianly, affecting overall organization of brain chromatin and resulting in a circadian-dependent regulation of well-stablished MeCP2 target genes. Furthermore, this data suggests that alterations of MeCP2 can be responsible for the sleeping disorders arising from pathological stages, such as in autism and Rett syndrome.	[Martinez de Paz, Alexia; Vicente Sanchez-Mut, Jose; Samitier-Marti, Mireia; Petazzi, Paolo; Saez, Mauricio; Szczesna, Karolina; Huertas, Dori; Esteller, Manel; Ausio, Juan] Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain; [Esteller, Manel] ICREA, Barcelona, Catalonia, Spain; [Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA; University of Victoria	Esteller, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain.	emesteller@idibell.cat; jausio@uvic.ca	Petazzi, Paolo/H-7707-2013; Esteller, Manel/L-5956-2014; Saez, Mauricio/AAN-6750-2021; Sanchez-Mut, Jose V./A-8651-2019	Esteller, Manel/0000-0003-4490-6093; Sanchez-Mut, Jose V./0000-0002-9292-8521; Martinez de Paz, Alexia/0000-0003-0808-1389; Saez Venegas, Mauricio Alejandro/0000-0002-3355-7628; Petazzi, Paolo/0000-0002-1036-2895; Samitier Marti, Mireia/0000-0002-3771-7991	European Community [PITN-GA2009-238242]; European Research Council [268626]; E-RARE EuroRETT network (Carlos III Health Institute) [PI071327]; Foundation Lejeune; MINECO [SAF2011 22803]; Catalan Association of Rett Syndrome; Health and Science Department of the Catalan Government (Generalitat de Catalunya); Canadian Institutes of Health Research (CIHR) [MOP-97878]; Catalan Institution for Research and Advanced Studies; ICREA Funding Source: Custom	European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); E-RARE EuroRETT network (Carlos III Health Institute); Foundation Lejeune; MINECO(Spanish Government); Catalan Association of Rett Syndrome; Health and Science Department of the Catalan Government (Generalitat de Catalunya); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Catalan Institution for Research and Advanced Studies(ICREA); ICREA(ICREA)	Funding was provided by the European Community's Seven Framework Programme (FP7/2007-2013) under grant agreement no PITN-GA2009-238242 DISCHROM project and by the European Research Council under grant agreement no. 268626 EPINORC project, E-RARE EuroRETT network (Carlos III Health Institute Project no PI071327), the Foundation Lejeune, MINECO Project no SAF2011 22803, the Catalan Association of Rett Syndrome, and the Health and Science Department of the Catalan Government (Generalitat de Catalunya) (M.E.). Canadian Institutes of Health Research (CIHR) [MOP-97878] grant (J.A.). M.E. is supported as a Catalan Institution for Research and Advanced Studies Research Professor.	Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Albrecht A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084668; Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Alvarez-Saavedra M, 2011, HUM MOL GENET, V20, P731, DOI 10.1093/hmg/ddq519; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Ausio J, 2014, TRENDS MOL MED; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bohland JW, 2010, METHODS, V50, P105, DOI 10.1016/j.ymeth.2009.09.001; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; de Leon-Guerrero SD, 2011, EUR J NEUROSCI, V33, P1563, DOI 10.1111/j.1460-9568.2011.07658.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duong HA, 2014, NAT STRUCT MOL BIOL, V21, P126, DOI 10.1038/nsmb.2746; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Hardin PE, 2013, CURR OPIN NEUROBIOL, V23, P724, DOI 10.1016/j.conb.2013.02.018; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Ko Y, 2013, P NATL ACAD SCI USA, V110, P3095, DOI 10.1073/pnas.1222897110; Lim ASP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004792; Malow BA, 2012, PEDIATRICS, V130, pS106, DOI 10.1542/peds.2012-0900I; Martin-Fairey CA, 2014, BRAIN RES; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Muller D, 2014, SCIENCE, V343, P1264, DOI 10.1126/science.1246448; Nakahata Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-1; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Nomura Y, 2005, BRAIN DEV-JPN, V27, pS35, DOI 10.1016/j.braindev.2005.03.017; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharma VK, 2003, CHRONOBIOL INT, V20, P901, DOI 10.1081/CBI-120026099; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Stengel A, 2013, PEPTIDES, V42, P70, DOI 10.1016/j.peptides.2012.12.022; Thambirajah AA, 2012, NUCLEIC ACIDS RES, V40, P2884, DOI 10.1093/nar/gkr1066; Urdinguio RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003669; Wither RG, 2013, EXP NEUROL, V239, P49, DOI 10.1016/j.expneurol.2012.09.005; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Young D, 2007, BRAIN DEV-JPN, V29, P609, DOI 10.1016/j.braindev.2007.04.001; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123693	10.1371/journal.pone.0123693	http://dx.doi.org/10.1371/journal.pone.0123693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875630	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100199
J	Munoz-Rodriguez, JL; Vrba, L; Futscher, BW; Hu, CC; Komenaka, IK; Meza-Montenegro, MM; Gutierrez-Millan, LE; Daneri-Navarro, A; Thompson, PA; Martinez, ME				Munoz-Rodriguez, Jose L.; Vrba, Lukas; Futscher, Bernard W.; Hu, Chengcheng; Komenaka, Ian K.; Mercedes Meza-Montenegro, Maria; Enrique Gutierrez-Millan, Luis; Daneri-Navarro, Adrian; Thompson, Patricia A.; Martinez, Maria Elena			Differentially Expressed MicroRNAs in Postpartum Breast Cancer in Hispanic Women	PLOS ONE			English	Article							DNA METHYLATION; TRANSIENT INCREASE; PREGNANCY; RISK; GENE; AGE; INACTIVATION; PROGRESSION; METASTASIS; SIGNATURE	The risk of breast cancer transiently increases immediately following pregnancy; peaking between 3-7 years. The biology that underlies this risk window and the effect on the natural history of the disease is unknown. MicroRNAs (miRNAs) are small non-coding RNAs that have been shown to be dysregulated in breast cancer. We conducted miRNA profiling of 56 tumors from a case series of multiparous Hispanic women and assessed the pattern of expression by time since last full-term pregnancy. A data-driven splitting analysis on the pattern of 355 miRNAs separated the case series into two groups: a) an early group representing women diagnosed with breast cancer <= 5.2 years postpartum (n = 12), and b) a late group representing women diagnosed with breast cancer >= 5.3 years postpartum (n = 44). We identified 15 miRNAs with significant differential expression between the early and late postpartum groups; 60% of these miRNAs are encoded on the X chromosome. Ten miRNAs had a two-fold or higher difference in expression with miR-138, miR-660, miR-31, miR-135b, miR-17, miR-454, and miR-934 overexpressed in the early versus the late group; while miR-892a, miR-199a-5p, and miR-542-5p were underexpressed in the early versus the late postpartum group. The DNA methylation of three out of five tested miRNAs (miR-31, miR-135b, and miR-138) was lower in the early versus late postpartum group, and negatively correlated with miRNA expression. Here we show that miRNAs are differentially expressed and differentially methylated between tumors of the early versus late postpartum, suggesting that potential differences in epigenetic dysfunction may be operative in postpartum breast cancers.	[Munoz-Rodriguez, Jose L.; Vrba, Lukas; Futscher, Bernard W.] Univ Arizona, Ctr Canc, Tucson, AZ 85721 USA; [Munoz-Rodriguez, Jose L.; Futscher, Bernard W.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Hu, Chengcheng] Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Komenaka, Ian K.] Maricopa Cty Gen Hosp, Dept Surg, Phoenix, AZ USA; [Mercedes Meza-Montenegro, Maria] Inst Tecnol Sonora, Obregon, Mexico; [Enrique Gutierrez-Millan, Luis] Univ Sonora, Dept Invest Cient & Tecnol, Hermosillo 83000, Sonora, Mexico; [Daneri-Navarro, Adrian] Univ Guadalajara, Dept Fisiol, Ctr Univ Ciencias Salud, Guadalajara 44430, Jalisco, Mexico; [Thompson, Patricia A.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Martinez, Maria Elena] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA	University of Arizona; University of Arizona; University of Arizona; Maricopa County General Hospital; Universidad de Sonora; Universidad de Guadalajara; University of Arizona; University of California System; University of California San Diego	Futscher, BW (corresponding author), Univ Arizona, Ctr Canc, Tucson, AZ 85721 USA.	bfutscher@uacc.arizona.edu	Komenaka, Ian/ABC-5161-2021; Daneri-Navarro, Adrian/C-1935-2013; Rodríguez, Jose Manuel JMMR Muñoz/A-7323-2016; Vrba, Lukas/J-9268-2015; Hu, Chengcheng/A-8391-2017	Daneri-Navarro, Adrian/0000-0002-8206-749X; Rodríguez, Jose Manuel JMMR Muñoz/0000-0002-4688-6420; Vrba, Lukas/0000-0003-3042-6275; Hu, Chengcheng/0000-0001-8525-0356; Meza-Montenegro, Maria Mercedes/0000-0002-1199-9310	National Cancer Institute [3U01CA153086-01, 3U01CA153086-02S1]; NATIONAL CANCER INSTITUTE [U01CA153086] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project described was supported by Grant Number 3U01CA153086-01 from the National Cancer Institute. JLMR also received support under the Research Supplements to Promote Diversity in Health-Related Research Program, Grant Number 3U01CA153086-02S1 from the National Cancer Institute. The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsen G, 2005, BRIT J CANCER, V92, P167, DOI 10.1038/sj.bjc.6602302; ALBREKTSEN G, 1995, BRIT J CANCER, V72, P480, DOI 10.1038/bjc.1995.359; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; American Cancer Society, 2012, CANC FACTS FIG HISP; American Cancer Society, 2014, BREAST CANC FACTS; [Anonymous], 2014, R LANG ENV STAT COMP; Arigoni M, 2013, AM J PATHOL, V182, P2058, DOI 10.1016/j.ajpath.2013.02.046; Aure MR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r126; Ben Gacem R, 2014, TUMOR BIOL, V35, P4047, DOI 10.1007/s13277-013-1530-4; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Callihan EB, 2013, BREAST CANCER RES TR, V138, P549, DOI 10.1007/s10549-013-2437-x; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chaligne R, 2014, FEBS LETT, V588, P2514, DOI 10.1016/j.febslet.2014.06.023; Chie WC, 2000, AM J EPIDEMIOL, V151, P715, DOI 10.1093/oxfordjournals.aje.a010266; Demicheli R, 2007, CANCER-AM CANCER SOC, V110, P1880, DOI 10.1002/cncr.22998; Ferlay J, 2013, IARC CANC BASE; Friend KE, 2012, AM SURGEON, V78, P819; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/782490; Jinda S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3633; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; Laurila EM, 2013, GENE CHROMOSOME CANC, V52, P1103, DOI 10.1002/gcc.22107; Lee YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052979; Liu Q, 2002, CANCER CAUSE CONTROL, V13, P299, DOI 10.1023/A:1015287208222; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Lyons TR, 2009, J MAMMARY GLAND BIOL, V14, P87, DOI 10.1007/s10911-009-9119-7; Martinez ME, 2010, HEALTH, V2, P1040, DOI DOI 10.4236/HEALTH.2010.29153; Morita S, 2012, INT J MOL SCI, V13, P8259, DOI 10.3390/ijms13078259; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Novak P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052299; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Risendal B, 2008, CANCER CAUSE CONTROL, V19, P1349, DOI 10.1007/s10552-008-9206-x; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vrba L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054398; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Yuan JH, 2003, CANCER RES, V63, P4174	55	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124340	10.1371/journal.pone.0124340	http://dx.doi.org/10.1371/journal.pone.0124340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875827	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100251
J	Nathan, G; Kredo-Russo, S; Geiger, T; Lenz, A; Kaspi, H; Hornstein, E; Efrat, S				Nathan, Gili; Kredo-Russo, Sharon; Geiger, Tamar; Lenz, Ayelet; Kaspi, Haggai; Hornstein, Eran; Efrat, Shimon			MiR-375 Promotes Redifferentiation of Adult Human beta Cells Expanded In Vitro	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; MESENCHYMAL TRANSITION; MICRORNA EXPRESSION; INSULIN; PROTEIN; PHOSPHORYLATION; GLUCOSE; PROLIFERATION; STABILITY; ABLATION	In-vitro expansion of beta cells from adult human pancreatic islets could provide abundant cells for cell replacement therapy of diabetes. However, proliferation of beta-cell-derived (BCD) cells is associated with dedifferentiation. Here we analyzed changes inmicroRNAs (miRNAs) during BCD cell dedifferentiation and identified miR-375 as one of the miRNAs greatly downregulated. We hypothesized that restoration of miR-375 expression in expanded BCD cells may contribute to their redifferentiation. Our findings demonstrate that overexpression of miR-375 alone leads to activation of beta-cell gene expression, reduced cell proliferation, and a switch from N-cadherin to E-cadherin expression, which characterizes mesenchymal-epithelial transition. These effects, which are reproducible in cells derived from multiple human donors, are likely mediated by repression of PDPK1 transcripts and indirect downregulation of GSK3 activity. These findings support an important role of miR-375 in regulation of human beta-cell phenotype, and suggest that miR-375 upregulation may facilitate the generation of functional insulin-producing cells following ex-vivo expansion of human islet cells.	[Nathan, Gili; Geiger, Tamar; Lenz, Ayelet; Efrat, Shimon] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Kredo-Russo, Sharon; Kaspi, Haggai; Hornstein, Eran] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Efrat, S (corresponding author), Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il		Efrat, Shimon/0000-0001-5987-232X; Geiger, Tamar/0000-0002-9526-197X	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was funded by a grant from the Israel Science Foundation to SE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Elghazi L, 2009, GASTROENTEROLOGY, V136, P1091, DOI 10.1053/j.gastro.2008.11.043; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hong S, 2014, NEOPLASIA, V16, P279, DOI 10.1016/j.neo.2014.03.010; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Kredo-Russo S, 2012, DEVELOPMENT, V139, P3021, DOI 10.1242/dev.080127; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; Liu Y, 2010, DIABETOLOGIA, V53, P2600, DOI 10.1007/s00125-010-1882-x; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Ougolkov Andrei V, 2006, Future Oncol, V2, P91, DOI 10.2217/14796694.2.1.91; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Patel S, 2008, CANCER CELL, V14, P351, DOI 10.1016/j.ccr.2008.10.013; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519	38	46	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122108	10.1371/journal.pone.0122108	http://dx.doi.org/10.1371/journal.pone.0122108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875172	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100058
J	Wang, L; Zhang, Y; Asakawa, T; Li, W; Han, S; Li, QY; Xiao, BG; Namba, H; Lu, CZ; Dong, Q				Wang, Liang; Zhang, Yang; Asakawa, Tetsuya; Li, Wei; Han, Sha; Li, Qinying; Xiao, Baoguo; Namba, Hiroki; Lu, Chuanzhen; Dong, Qiang			Neuroprotective Effect of Neuroserpin in Oxygen-Glucose Deprivation- and Reoxygenation-Treated Rat Astrocytes In Vitro	PLOS ONE			English	Article							NF-KAPPA-B; TISSUE-PLASMINOGEN ACTIVATOR; PROTECTS NEURONS; INHIBITOR NEUROSERPIN; DUAL ROLE; APOPTOSIS; INFLAMMATION; EXPRESSION; PATHWAY; DYSFUNCTION	Neuroserpin (NSP) reportedly exerts neuroprotective effects in cerebral ischemic animal models and patients; however, the mechanism of protection is poorly understood. We thus attempted to confirm neuroprotective effects of NSP on astrocytes in the ischemic state and then explored the relative mechanisms. Astrocytes from neonatal rats were treated with oxygen-glucose deprivation (OGD) followed by reoxygenation (OGD/R). To confirm the neuroprotective effects of NSP, we measured the cell survival rate, relative lactate dehydrogenase (LDH) release; we also performed morphological methods, namely Hoechst 33342 staining and Annexin V assay. To explore the potential mechanisms of NSP, the release of nitric oxide (NO) and TNF-alpha related to NSP administration were measured by enzymelinked immunosorbent assay. The proteins related to the NF-kappa B, ERK1/2, and PI3K/Akt pathways were investigated by Western blotting. To verify the cause-and-effect relationship between neuroprotection and the NF-kappa B pathway, a NF-kappa B pathway inhibitor sc3060 was employed to observe the effects of NSP-induced neuroprotection. We found that NSP significantly increased the cell survival rate and reduced LDH release in OGD/R-treated astrocytes. It also reduced NO/TNF-alpha release. Western blotting showed that the protein levels of p-IKKB alpha/beta and P65 were upregulated by the OGD/R treatment and such effects were significantly inhibited by NSP administration. The NSP-induced inhibition could be significantly reversed by administration of the NF-kappa B pathway inhibitor sc3060, whereas, expressions of p-ERK1, p-ERK2, and p-AKT were upregulated by the OGD/R treatment; however, their levels were unchanged by NSP administration. Our results thus verified the neuroprotective effects of NSP in ischemic astrocytes. The potential mechanisms include inhibition of the release of NO/TNF-alpha and repression of the NF-kappa B signaling pathways. Our data also indicated that NSP has little influence on the MAPK and PI3K/Akt pathways.	[Wang, Liang; Zhang, Yang; Han, Sha; Lu, Chuanzhen; Dong, Qiang] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Wang, Liang; Li, Qinying; Xiao, Baoguo; Lu, Chuanzhen; Dong, Qiang] Fudan Univ, Inst Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Zhang, Yang] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China; [Asakawa, Tetsuya; Namba, Hiroki] Hamamatsu Univ, Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka 4312102, Japan; [Asakawa, Tetsuya] Hamamatsu Univ, Sch Med, Dept Psychiat, Hamamatsu, Shizuoka 4312102, Japan; [Li, Wei] Fudan Univ, Dept Neurol, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Nanjing University; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Fudan University	Wang, L (corresponding author), Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China.	ianliangwang@yahoo.com; asakawat1971@gmail.com	Asakawa, Tetsuya/ABE-5307-2020	Asakawa, Tetsuya/0000-0002-2300-3509	Science and Technology Commission of Shanghai Municipality [13441902600]; Clinical Medical Research Grant of Chinese medical Association [09010180173]; Japan Society for the Promotion of Science [20791025, 24592157]; Grants-in-Aid for Scientific Research [24592157] Funding Source: KAKEN	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Clinical Medical Research Grant of Chinese medical Association; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	LW was supported by the Grant from Science and Technology Commission of Shanghai Municipality (No. 13441902600) and Clinical Medical Research Grant of Chinese medical Association (No. 09010180173). TA was supported by grants from the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists, Type B, No. 20791025 and Grant-in-Aid for Scientific Research C, General, No. 24592157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Chavez-Valdez R, 2012, NEUROSCIENCE, V219, P192, DOI 10.1016/j.neuroscience.2012.05.002; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Davies MJ, 2009, J BIOL CHEM, V284, P18202, DOI 10.1074/jbc.M109.010744; Docagne F, 1999, FASEB J, V13, P1315, DOI 10.1096/fasebj.13.11.1315; Gabryel B, 2002, NEUROTOXICOLOGY, V23, P385, DOI 10.1016/S0161-813X(02)00084-0; Gelderblom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063118; Gouix E, 2014, PHARMACOL RES, V87, P8, DOI 10.1016/j.phrs.2014.06.002; Graham LS, 2009, CLIN IMMUNOL, V133, P265, DOI 10.1016/j.clim.2009.07.011; Hanzel CE, 2014, J ALZHEIMERS DIS, V40, P667, DOI 10.3233/JAD-132282; Jiang ZJ, 2003, NEUROCHEM RES, V28, P831, DOI 10.1023/A:1023206906164; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lasierra-Cirujeda J, 2013, J BLOOD MED, V4, P31, DOI 10.2147/JBM.S35496; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lebeurrier N, 2005, MOL CELL NEUROSCI, V30, P552, DOI 10.1016/j.mcn.2005.09.005; Lebeurrier N, 2008, J CELL SCI, V121, P3357, DOI 10.1242/jcs.031872; Lee TW, 2012, J NEUROCHEM, V121, P561, DOI 10.1111/j.1471-4159.2011.07639.x; Ma J, 2012, BIOL RES, V45, P357, DOI 10.4067/S0716-97602012000400005; Man HY, 2012, J NEUROCHEM, V121, P495, DOI 10.1111/j.1471-4159.2012.07655.x; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Navarrete M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00033; Nijboer CH, 2008, STROKE, V39, P2578, DOI 10.1161/STROKEAHA.108.516401; Noto R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032444; O'Riordan JM, 2005, AM J GASTROENTEROL, V100, P1257, DOI 10.1111/j.1572-0241.2005.41338.x; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Rodriguez-Gonzalez R, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-58; Rodriguez-Gonzalez R, 2011, THROMB HAEMOSTASIS, V105, P421, DOI 10.1160/TH10-09-0621; Rodriguez-Gonzalez R, 2011, NEUROCHEM INT, V58, P337, DOI 10.1016/j.neuint.2010.12.006; Rogove AD, 1999, J CELL SCI, V112, P4007; Tung WH, 2010, J CELL PHYSIOL, V224, P376, DOI 10.1002/jcp.22133; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wan SC, 2012, CLIN LAB, V58, P891, DOI 10.7754/Clin.Lab.2011.110527; Wang CF, 2014, REV NEUROSCIENCE, V25, P255, DOI 10.1515/revneuro-2013-0055; Wang L, 2004, BRAIN RES, V1015, P175, DOI 10.1016/j.brainres.2004.04.053; Wu JL, 2010, AM J PATHOL, V177, P2576, DOI 10.2353/ajpath.2010.100466; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yepes M, 2000, BLOOD, V96, P569; Zhang AL, 2010, NEUROSCI LETT, V478, P32, DOI 10.1016/j.neulet.2010.04.062; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41; Zhang ZH, 2014, BRAIN RES, V1563, P72, DOI 10.1016/j.brainres.2014.03.036	40	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123932	10.1371/journal.pone.0123932	http://dx.doi.org/10.1371/journal.pone.0123932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874935	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100225
J	Welinder, C; Pawlowski, K; Sugihara, Y; Yakovleva, M; Jonsson, G; Ingvar, C; Lundgren, L; Baldetorp, B; Olsson, H; Rezeli, M; Jansson, B; Laurell, T; Fehniger, T; Dome, B; Malm, J; Wieslander, E; Nishimura, T; Marko-Varga, G				Welinder, Charlotte; Pawlowski, Krzysztof; Sugihara, Yutaka; Yakovleva, Maria; Jonsson, Goran; Ingvar, Christian; Lundgren, Lotta; Baldetorp, Bo; Olsson, Hakan; Rezeli, Melinda; Jansson, Bo; Laurell, Thomas; Fehniger, Thomas; Dome, Balazs; Malm, Johan; Wieslander, Elisabet; Nishimura, Toshihide; Marko-Varga, Gyorgy			A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues	PLOS ONE			English	Article							MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; EXPRESSION; IDENTIFICATION; CLASSIFICATION; RESISTANCE; PROTEOMICS; PEPTIDES; DEPTH	Malignant melanoma has the highest increase of incidence of malignancies in the western world. In early stages, front line therapy is surgical excision of the primary tumor. Metastatic disease has very limited possibilities for cure. Recently, several protein kinase inhibitors and immune modifiers have shown promising clinical results but drug resistance in metastasized melanoma remains a major problem. The need for routine clinical biomarkers to follow disease progression and treatment efficacy is high. The aim of the present study was to build a protein sequence database in metastatic melanoma, searching for novel, relevant biomarkers. Ten lymph node metastases (South-Swedish Malignant Melanoma Biobank) were subjected to global protein expression analysis using two proteomics approaches (with/without orthogonal fractionation). Fractionation produced higher numbers of protein identifications (4284). Combining both methods, 5326 unique proteins were identified (2641 proteins overlapping). Deep mining proteomics may contribute to the discovery of novel biomarkers for metastatic melanoma, for example dividing the samples into two metastatic melanoma "genomic subtypes", ("pigmentation" and "high immune") revealed several proteins showing differential levels of expression. In conclusion, the present study provides an initial version of a metastatic melanoma protein sequence database producing a total of more than 5000 unique protein identifications. The raw data have been deposited to the ProteomeXchange with identifiers PXD001724 and PXD001725.	[Welinder, Charlotte; Sugihara, Yutaka; Jonsson, Goran; Lundgren, Lotta; Baldetorp, Bo; Olsson, Hakan; Jansson, Bo; Fehniger, Thomas; Wieslander, Elisabet; Nishimura, Toshihide; Marko-Varga, Gyorgy] Lund Univ, Dept Clin Sci, Oncol & Pathol, Lund, Sweden; [Welinder, Charlotte; Laurell, Thomas; Fehniger, Thomas; Nishimura, Toshihide; Marko-Varga, Gyorgy] Lund Univ, CEBMMS, Biomed Ctr D13, Lund, Sweden; [Pawlowski, Krzysztof] Warsaw Univ Life Sci, Warsaw, Poland; [Yakovleva, Maria; Dome, Balazs] Natl Koranyi Inst Pulmonol, Budapest, Hungary; [Yakovleva, Maria; Rezeli, Melinda; Laurell, Thomas; Marko-Varga, Gyorgy] Lund Univ, Biomed Ctr, Dept Biomed Engn, Clin Prot Sci & Imaging, Lund, Sweden; [Ingvar, Christian] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Surg, Lund, Sweden; [Lundgren, Lotta; Olsson, Hakan] Skane Univ Hosp, Lund, Sweden; [Olsson, Hakan] Lund Univ, Dept Clin Sci, Canc Epidemiol, Lund, Sweden; [Dome, Balazs] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Malm, Johan] Lund Univ, Skane Univ Hosp Malmo, Dept Lab Med, Sect Clin Chem, Malmo, Sweden; [Nishimura, Toshihide; Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Tokyo 1608402, Japan	Lund University; Lund University; Warsaw University of Life Sciences; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Medical University of Vienna; Lund University; Skane University Hospital; Tokyo Medical University	Marko-Varga, G (corresponding author), Lund Univ, CEBMMS, Biomed Ctr D13, Lund, Sweden.	Gyorgy.Marko-Varga@bme.lth.se	Baldetorp, Bo/HDM-9924-2022; Laurell, Thomas/B-5524-2013; Ingvar, Christian/AAE-9841-2019; Welinder, Charlotte/G-1144-2014; Pawłowski, Krzysztof/C-2949-2013	Laurell, Thomas/0000-0002-2486-3607; Welinder, Charlotte/0000-0001-9626-0576; Pawłowski, Krzysztof/0000-0002-5367-0935; Olsson, Hakan/0000-0002-8794-9635; Dome, Balazs/0000-0001-8799-8624	Mrs. Berta Kamprad Foundation; Swedish Academy of Pharmaceutical Sciences; Swedish Research Council; Swedish Foundation for Strategic Research; Vinnova; Crafoord Foundation; European Research Council [ERC-2011-294576]; Ingabritt & Arne Lundbergs forskningsstiftelse	Mrs. Berta Kamprad Foundation; Swedish Academy of Pharmaceutical Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Vinnova(Vinnova); Crafoord Foundation; European Research Council(European Research Council (ERC)European Commission); Ingabritt & Arne Lundbergs forskningsstiftelse	This work was supported by grants from Mrs. Berta Kamprad Foundation, Swedish Academy of Pharmaceutical Sciences, Swedish Research Council, the Swedish Foundation for Strategic Research, Vinnova, Ingabritt & Arne Lundbergs forskningsstiftelse, the Crafoord Foundation and European Research Council Advanced Grant ERC-2011-294576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Avwioro G, 2011, J PHARMACY AND CLINI, V1; Azimi A, 2014, BRIT J CANCER, V110, P2489, DOI 10.1038/bjc.2014.169; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Baldetorp B., 2013, PUBLIC SERVICE REVIE; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Byrum Stephanie D, 2013, J Proteomics Bioinform, V6, P43; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cirenajwis H, 2015, MOLECULAR STRATIFICA; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Harbst K, 2014, J PATHOL, V233, P39, DOI 10.1002/path.4318; Harbst K, 2012, CLIN CANCER RES, V18, P4026, DOI 10.1158/1078-0432.CCR-12-0343; Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Levine D, 2014, METHODS MOL BIOL, V1102, P177, DOI 10.1007/978-1-62703-727-3_11; Lillie RD, 1965, HISTOPATHOLOGIC TECH; Machtejevas E, 2004, J CHROMATOGR B, V803, P121, DOI 10.1016/j.jchromb.2003.07.015; Machtejevas E, 2009, J SEP SCI, V32, P2223, DOI 10.1002/jssc.200900058; Mactier S, 2014, PIGMENT MELANOMA RES; Matsuo Y, 2010, PMID, V5, DOI [10.1371/journal.pone.0010481, DOI 10.1371/J0URNAL.P0NE.0010481]; Nading MA, 2010, SEMIN CUTAN MED SURG, V29, P142, DOI 10.1016/j.sder.2010.06.004; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Sabel Michael S, 2011, Int J Proteomics, V2011, P181890, DOI 10.1155/2011/181890; Srinivas PR, 2001, CLIN CHEM, V47, P1901; Sugihara Y, 2014, PROTEOMICS, V14, P1963, DOI 10.1002/pmic.201300476; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Tas F, 2012, J ONCOL, V2012, DOI 10.1155/2012/647684; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wagner K, 2002, ANAL CHEM, V74, P809, DOI 10.1021/ac010627f; Welinder C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110804; Welinder C, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-7; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Zarei M, 2012, J PROTEOME RES, V11, P4269, DOI 10.1021/pr300375d	41	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123661	10.1371/journal.pone.0123661	http://dx.doi.org/10.1371/journal.pone.0123661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874936	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100196
J	Yan, HF; Liu, YJ; Xie, XF; Zhang, CY; Hu, CM; Hao, G; Ge, XJ				Yan, Hai-Fei; Liu, Yun-Jiao; Xie, Xiu-Feng; Zhang, Cai-Yun; Hu, Chi-Ming; Hao, Gang; Ge, Xue-Jun			DNA Barcoding Evaluation and Its Taxonomic Implications in the Species-Rich Genus Primula L. in China	PLOS ONE			English	Article							HYBRID ORIGIN; IDENTIFICATION; YUNNAN; HYBRIDIZATION; FAILURE; SPACER; PLANTS; LOCI	The genus Primula is extremely diverse in the east Himalaya-Hengduan Mountains (HHM) in China as a result of rapid radiation. In order to overcome the difficulty of morphological classification of this genus, we surveyed three plastid regions (rbcL, matK, and trnH-psbA) and two nuclear markers (ITS and ITS2) from 227 accessions representing 66 Primula species across 18 sections, to assess their discriminatory power as barcodes. We found that ITS alone or combined with plastid regions showed the best discrimination across different infrageneric ranks and at species level. We suggest rbcL + matK + ITS as the first choice at present to barcode Primula plants. Although the present barcoding combination performed poorly in many closely related species of Primula, it still provided many new insights into current Primula taxonomy, such as the underlying presence of cryptic species, and several potential improper taxonomic treatments. DNA barcoding is one useful technique in the integrative taxonomy of the genus Primula, but it still requires further efforts to improve its effectiveness in some taxonomically challenging groups.	[Yan, Hai-Fei; Hu, Chi-Ming; Ge, Xue-Jun] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Liu, Yun-Jiao; Zhang, Cai-Yun; Hao, Gang] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Xie, Xiu-Feng] Guangdong Agr Ind Business Polytech Coll, Trop Agr Dept, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; South China Agricultural University	Hao, G (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	haogang@scau.edu.cn; xjge@scbg.ac.cn	Ge, Xue-Jun/AAP-5967-2020	Ge, Xue-Jun/0000-0002-5008-9475	National Natural Science Foundation of China [31270009, 31170205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (grant nos. 31270009, 31170205) [http://www.nsfc.gov.cn/].	Alves TLS, 2014, MOL ECOL RESOUR, V14, P324, DOI 10.1111/1755-0998.12182; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Cianchi R, 2015, PLANT BIOSYST, V149, P229, DOI 10.1080/11263504.2013.826745; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Vos JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0075; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Elliott TL, 2014, MOL ECOL RESOUR, V14, P883, DOI 10.1111/1755-0998.12277; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Feng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071710; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gong X, 2003, NOVON, V13, P193, DOI 10.2307/3393517; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hu C. M., 2011, Edinburgh Journal of Botany, V68, P297, DOI 10.1017/S096042861100014X; HU CM, 1990, NORD J BOT, V10, P399, DOI 10.1111/j.1756-1051.1990.tb01779.x; Hu CM, 1996, PRIMULACEAE; Hu CM, 1994, J TROPICAL SUBTROPIC, V2, P1; Hu CM, 1990, PRIMULACEAE; Huang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082400, 10.1371/journal.pone.0068688]; Janzen DH, 2012, INVERTEBR SYST, V26, P478, DOI 10.1071/IS12038; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019874; Kane NC, 2008, MOL ECOL, V17, P5175, DOI 10.1111/j.1365-294X.2008.03972.x; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Li R, 2009, ANN BOT FENN, V46, P130, DOI 10.5735/085.046.0208; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Liu BB, 2014, MOL ECOL, V23, P3013, DOI 10.1111/mec.12783; Ma YP, 2014, ANN BOT-LONDON, V113, P763, DOI 10.1093/aob/mct312; Mast AR, 2001, INT J PLANT SCI, V162, P1381, DOI 10.1086/323444; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Ming HC, 2003, NOVON, V13, P196, DOI 10.2307/3393518; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Percy DM, 2014, MOL ECOL, V23, P4737, DOI 10.1111/mec.12837; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Rambaut A, 2002, SE AL VERSION2 0A11; Richards J, 2003, PRIMULA; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Saitoh T, 2015, MOL ECOL RESOUR, V15, P177, DOI 10.1111/1755-0998.12282; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Smith WW, 1977, PLANT MONOGRAPH REPR; Smith WW, 1942, GENUS PRIMULA SECTIO, P227; Smith WW, 1941, GENUS PRIMULA SECTIO, P122; Sun YS, 2014, MOL ECOL, V23, P343, DOI 10.1111/mec.12599; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JA, 2003, SYST BOT, V28, P723; Trift I, 2002, SYST BOT, V27, P396; Twyford AD, 2014, MOL ECOL, V23, P4674, DOI 10.1111/mec.12892; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wu X, 2013, PHYTOTAXA, V131, P49, DOI 10.11646/phytotaxa.131.1.9; Xie XF, 2012, J SYST EVOL, V50, P284, DOI 10.1111/j.1759-6831.2012.00204.x; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Yan HF, 2010, J SYST EVOL, V48, P123, DOI 10.1111/j.1759-6831.2010.00068.x; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zhu XF, 2009, ACTA BIOL CRACOV BOT, V51, P29	75	30	33	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122903	10.1371/journal.pone.0122903	http://dx.doi.org/10.1371/journal.pone.0122903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875620	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100116
J	Rispal, D; Eltschinger, S; Stahl, M; Vaga, S; Bodenmiller, B; Abraham, Y; Filipuzzi, I; Movva, NR; Aebersold, R; Helliwell, SB; Loewith, R				Rispal, Delphine; Eltschinger, Sandra; Stahl, Michael; Vaga, Stefania; Bodenmiller, Bernd; Abraham, Yann; Filipuzzi, Ireos; Movva, N. Rao; Aebersold, Ruedi; Helliwell, Stephen B.; Loewith, Robbie			Target of Rapamycin Complex 2 Regulates Actin Polarization and Endocytosis via Multiple Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; CELL INTEGRITY PATHWAY; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; SPHINGOLIPID HOMEOSTASIS; SIGNALING PATHWAY; PLASMA-MEMBRANE; SERINE PALMITOYLTRANSFERASE; MEDIATED ENDOCYTOSIS; GROWTH-CONTROL	Target of rapamycin is a Ser/Thr kinase that operates in two conserved multiprotein complexes, TORC1 and TORC2. Unlike TORC1, TORC2 is insensitive to rapamycin, and its functional characterization is less advanced. Previous genetic studies demonstrated that TORC2 depletion leads to loss of actin polarization and loss of endocytosis. To determine how TORC2 regulates these readouts, we engineered a yeast strain in which TORC2 can be specifically and acutely inhibited by the imidazoquinoline NVP-BHS345. Kinetic analyses following inhibition of TORC2, supported with quantitative phosphoproteomics, revealed that TORC2 regulates these readouts via distinct pathways as follows: rapidly through direct protein phosphorylation cascades and slowly through indirect changes in the tensile properties of the plasma membrane. The rapid signaling events are mediated in large part through the phospholipid flippase kinases Fpk1 and Fpk2, whereas the slow signaling pathway involves increased plasma membrane tension resulting from a gradual depletion of sphingolipids. Additional hits in our phosphoproteomic screens highlight the intricate control TORC2 exerts over diverse aspects of eukaryote cell physiology.	[Rispal, Delphine; Eltschinger, Sandra; Stahl, Michael; Loewith, Robbie] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Rispal, Delphine; Eltschinger, Sandra; Stahl, Michael; Loewith, Robbie] Univ Geneva, Inst Genet & Genom Geneva iGE3, CH-1211 Geneva, Switzerland; [Vaga, Stefania; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Bodenmiller, Bernd] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Abraham, Yann; Filipuzzi, Ireos; Movva, N. Rao; Helliwell, Stephen B.] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Loewith, Robbie] Natl Ctr Competence Res Chem Biol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Novartis; University of Zurich	Helliwell, SB (corresponding author), Novartis Inst Biomed Res, Novartis Campus, CH-4056 Basel, Switzerland.	stephen.helliwell@novartis.com; robbie.loewith@unige.ch	Loewith, Robbie J/S-6289-2016	Loewith, Robbie J/0000-0002-2482-603X; Vaga, Stefania/0000-0002-8912-7715; Abraham, Yann/0000-0001-5600-5896; Stahl, Michael/0000-0002-7171-9691	Swiss National Science Foundation; National Centre for Competence in Research in Chemical Biology; Canton of Geneva; European Research Council; European Molecular Biology Organization; Marie Curie International Outgoing Fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre for Competence in Research in Chemical Biology; Canton of Geneva; European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie International Outgoing Fellowship(European Commission)	This work was supported in part by the Swiss National Science Foundation, the National Centre for Competence in Research in Chemical Biology, the Canton of Geneva, and the European Research Council (to R. L.). The collection of protein phosphorylation data was supported in part by the PhosphoNetX project of SystemsX.; Supported by Fellowships from the Swiss National Science Foundation, the European Molecular Biology Organization, and the Marie Curie International Outgoing Fellowship.	Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Bodenmiller B, 2010, METHOD ENZYMOL, V470, P317, DOI 10.1016/S0076-6879(10)70013-6; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012; Clough T, 2009, J PROTEOME RES, V8, P5275, DOI 10.1021/pr900610q; deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helliwell SB, 1998, GENETICS, V148, P99; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kliegman JI, 2013, CELL REP, V5, P1725, DOI 10.1016/j.celrep.2013.11.040; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lundgren Deborah H, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1303s28; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Niles BJ, 2014, MOL BIOL CELL, V25, P3962, DOI 10.1091/mbc.E14-06-1122; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; Nussio MR, 2009, LANGMUIR, V25, P1086, DOI 10.1021/la803288s; Robertson AS, 2009, CELL MOL LIFE SCI, V66, P2049, DOI 10.1007/s00018-009-0001-y; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Smythe E, 2003, EMBO REP, V4, P246, DOI 10.1038/sj.embor.embor776; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Takeda M, 2014, EUKARYOT CELL, V13, P363, DOI 10.1128/EC.00279-13; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	68	56	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14963	14978		10.1074/jbc.M114.627794	http://dx.doi.org/10.1074/jbc.M114.627794			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25882841	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000356177300014
J	Oh, YT; Lee, KM; Bari, W; Raskin, DM; Yoon, SS				Oh, Young Taek; Lee, Kang-Mu; Bari, Wasimul; Raskin, David M.; Yoon, Sang Sun			(p) ppGpp, a Small Nucleotide Regulator, Directs the Metabolic Fate of Glucose in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EL-TOR BIOTYPE; VIRULENCE ACTIVATOR APHA; TOXIN-COREGULATED PILUS; TRIMETHYLAMINE N-OXIDE; ESCHERICHIA-COLI; STRINGENT RESPONSE; PSEUDOMONAS-AERUGINOSA; MYCOBACTERIUM-TUBERCULOSIS; KLEBSIELLA-TERRIGENA; NUTRIENT LIMITATION	When V. cholerae encounters nutritional stress, it activates (p) ppGpp-mediated stringent response. The genes relA and relV are involved in the production of (p) ppGpp, whereas the spoT gene encodes an enzyme that hydrolyzes it. Herein, we show that the bacterial capability to produce (p) ppGpp plays an essential role in glucose metabolism. The V. cholerae mutants defective in (p) ppGpp production (i.e. Delta relA Delta relV and Delta relA Delta relV Delta spoT mutants) lost their viability because of uncontrolled production of organic acids, when grown with extra glucose. In contrast, the Delta relA Delta spoT mutant, a (p) ppGpp overproducer strain, exhibited better growth in the presence of the same glucose concentration. An RNA sequencing analysis demonstrated that transcriptions of genes consisting of an operon for acetoin biosynthesis were markedly elevated in N16961, a seventh pandemic O1 strain, but not in its (p) ppGpp(0) mutant during glucose-stimulated growth. Transposon insertion in acetoin biosynthesis gene cluster resulted in glucose-induced loss of viability of the Delta relA Delta spoT mutant, further suggesting the crucial role of acetoin production in balanced growth under glucose-rich environments. Additional deletion of the aphA gene, encoding a negative regulator for acetoin production, failed to rescue the (p) ppGpp(0) mutant from the defective glucose-mediated growth, suggesting that (p) ppGpp-mediated acetoin production occurs independent of the presence of AphA. Overall, our results reveal that (p) ppGpp, in addition to its well known role as a stringent response mediator, positively regulates acetoin production that contributes to the successful glucose metabolism and consequently the proliferation of V. cholerae cells under a glucose-rich environment, a condition that may mimic the human intestine.	[Oh, Young Taek; Lee, Kang-Mu; Bari, Wasimul; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 120752, South Korea; [Raskin, David M.] Marian Univ, Coll Osteopath Med, Indianapolis, IN 46222 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, 250 Seongsanno, Seoul 120752, South Korea.	sangsun_yoon@yuhs.ac	Raskin, David/AAZ-5973-2021	Raskin, David/0000-0001-7421-7809; Yoon, Sang Sun/0000-0003-2979-365X; LEE, Kang-Mu/0000-0001-7414-5921	National Research Foundation of Korea - Korean Government (the Ministry of Science, ICT and Future Planning) [2014R1A2A2A01002861, 2014R1A4A1008625, 2014R1A1A2056139]; Yonsei University College of Medicine, Dongwha Holdings Faculty Research Grant [6-2014-0057]	National Research Foundation of Korea - Korean Government (the Ministry of Science, ICT and Future Planning); Yonsei University College of Medicine, Dongwha Holdings Faculty Research Grant	This work was supported by grants from National Research Foundation of Korea Grants 2014R1A2A2A01002861, 2014R1A4A1008625, and 2014R1A1A2056139 funded by the Korean Government (the Ministry of Science, ICT and Future Planning). This work was also supported by Yonsei University College of Medicine, Dongwha Holdings Faculty Research Grant 6-2014-0057.	Agirrezabala X, 2013, EMBO REP, V14, P811, DOI 10.1038/embor.2013.106; Amato SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093110; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Barbier T, 2011, FEBS LETT, V585, P2929, DOI 10.1016/j.febslet.2011.08.011; Bari W, 2012, J MICROBIOL, V50, P631, DOI 10.1007/s12275-012-2116-3; Bari W, 2011, INFECT IMMUN, V79, P3149, DOI 10.1128/IAI.01237-10; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Blankschien MD, 2010, METAB ENG, V12, P409, DOI 10.1016/j.ymben.2010.06.002; BLOMQVIST K, 1993, J BACTERIOL, V175, P1392, DOI 10.1128/JB.175.5.1392-1404.1993; Carneiro S, 2012, METABOLITES, V2, P717, DOI 10.3390/metabo2040717; Celinska E, 2009, BIOTECHNOL ADV, V27, P715, DOI 10.1016/j.biotechadv.2009.05.002; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; CLARK DP, 1988, APPL BIOCHEM BIOTECH, V17, P163, DOI 10.1007/BF02779155; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Gaca AO, 2013, MBIO, V4, DOI 10.1128/mBio.00646-13; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Hahn S, 2001, BMJ-BRIT MED J, V323, P81, DOI 10.1136/bmj.323.7304.81; Hardiman T, 2007, J BIOTECHNOL, V132, P359, DOI 10.1016/j.jbiotec.2007.08.029; HARSHMAN RB, 1971, BIOCHEMISTRY-US, V10, P3980, DOI 10.1021/bi00797a027; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; He HJ, 2012, J BACTERIOL, V194, P2962, DOI 10.1128/JB.00014-12; Henard CA, 2014, MOL MICROBIOL, V91, P790, DOI 10.1111/mmi.12498; Heroven AK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00146; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x; Kovacikova G, 2003, J BACTERIOL, V185, P4825, DOI 10.1128/JB.185.16.4825-4836.2003; Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11; Le Bouguenec C, 2011, INT J MED MICROBIOL, V301, P1, DOI 10.1016/j.ijmm.2010.04.021; Lee KM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394932; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Manske C, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00125; MAYER D, 1995, J BACTERIOL, V177, P5261, DOI 10.1128/jb.177.18.5261-5269.1995; McKenney D, 1997, J ANTIMICROB CHEMOTH, V40, P415, DOI 10.1093/jac/40.3.415; Merrell DS, 1999, MOL MICROBIOL, V34, P836, DOI 10.1046/j.1365-2958.1999.01650.x; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Min KB, 2014, FEMS MICROBIOL LETT, V360, P157, DOI 10.1111/1574-6968.12600; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakagawa A, 2006, GENES GENET SYST, V81, P299, DOI 10.1266/ggs.81.299; Oh YT, 2014, J BIOL CHEM, V289, P13232, DOI 10.1074/jbc.M113.540088; Okada Y, 2002, APPL ENVIRON MICROB, V68, P1541, DOI 10.1128/AEM.68.4.1541-1547.2002; OMBAKA EA, 1983, REV INFECT DIS, V5, pS880; PATRA FC, 1989, BMJ-BRIT MED J, V298, P1353, DOI 10.1136/bmj.298.6684.1353; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Sircar B K, 1990, Indian J Public Health, V34, P68; Solopova A, 2014, P NATL ACAD SCI USA, V111, P7427, DOI 10.1073/pnas.1320063111; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; Spira B, 1998, MOL GEN GENET, V257, P469, DOI 10.1007/s004380050671; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Tojo S, 2010, J BACTERIOL, V192, P1573, DOI 10.1128/JB.01394-09; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Yoon MY, 2014, J MICROBIOL, V52, P983, DOI 10.1007/s12275-014-4655-2; Yoon SS, 2008, INFECT IMMUN, V76, P1282, DOI 10.1128/IAI.00736-07; Yoon SS, 2006, INFECT IMMUN, V74, P6547, DOI 10.1128/IAI.00695-06; Zaborin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034883	72	12	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13178	13190		10.1074/jbc.M115.640466	http://dx.doi.org/10.1074/jbc.M115.640466			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25882848	Green Published, hybrid			2022-12-26	WOS:000354975700020
J	Houston, DR; Yen, LH; Pettit, S; Walkinshaw, MD				Houston, Douglas R.; Yen, Li-Hsuan; Pettit, Simon; Walkinshaw, Malcolm D.			Structure- and Ligand-Based Virtual Screening Identifies New Scaffolds for Inhibitors of the Oncoprotein MDM2	PLOS ONE			English	Article							SMALL-MOLECULE RITA; PROTEIN-PROTEIN INTERACTIONS; SCORING FUNCTIONS; P53 FUNCTION; TARGETING MDM2; DOCKING; DISCOVERY; RESTORATION; PREDICTION; WEIGHT	A major challenge in the field of ligand discovery is to identify chemically useful fragments that can be developed into inhibitors of specific protein-protein interactions. Low molecular weight fragments (with molecular weight less than 250 Da) are likely to bind weakly to a protein's surface. Here we use a new virtual screening procedure which uses a combination of similarity searching and docking to identify chemically tractable scaffolds that bind to the p53-interaction site of MDM2. The binding has been verified using capillary electrophoresis which has proven to be an excellent screening method for such small, weakly binding ligands.	[Houston, Douglas R.; Yen, Li-Hsuan; Walkinshaw, Malcolm D.] Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh, Midlothian, Scotland; [Pettit, Simon] Selcia Ltd, Ongar, Essex, England	University of Edinburgh	Houston, DR (corresponding author), Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh, Midlothian, Scotland.	DouglasR.Houston@ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019	walkinshaw, malcolm/0000-0001-5955-9325; Houston, Douglas/0000-0002-3469-1546	BBSRC-Biotechnology and Biological Sciences Research Council (Industrial CASE Award)	BBSRC-Biotechnology and Biological Sciences Research Council (Industrial CASE Award)	BBSRC-Biotechnology and Biological Sciences Research Council (Industrial CASE Award). MDW and LHY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Benaliouche H, 2014, SCI WORLD J, DOI 10.1155/2014/829369; Bixby D, 2008, CELL CYCLE, V7, P971, DOI 10.4161/cc.7.8.5754; Blackburn TJ, 2013, MEDCHEMCOMM, V4, P1297, DOI 10.1039/c3md00161j; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; de Winter H., SILICOS IT CHEMOINFO; Ding QJ, 2013, J MED CHEM, V56, P5979, DOI 10.1021/jm400487c; Domling A, 2008, CURR OPIN CHEM BIOL, V12, P281, DOI 10.1016/j.cbpa.2008.04.603; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Espinoza-Fonseca LM, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-38; Genheden S, 2010, J COMPUT CHEM, V31, P837, DOI 10.1002/jcc.21366; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Hann MM, 2004, CURR OPIN CHEM BIOL, V8, P255, DOI 10.1016/j.cbpa.2004.04.003; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Hardcastle IR, 2011, J MED CHEM, V54, P1233, DOI 10.1021/jm1011929; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hipp Jason, 2011, J Pathol Inform, V2, P25, DOI 10.4103/2153-3539.82050; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w; Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kasparov G., CHESS METAPHORS ARTI, P232; Krajewski M, 2005, NAT MED, V11, P1135, DOI 10.1038/nm1105-1135; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuenemann MA, 2014, J CHEM INF MODEL; Kukol A, 2011, EUR J MED CHEM, V46, P4661, DOI 10.1016/j.ejmech.2011.05.026; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Labbe CM, 2013, DRUG DISCOV TODAY, V18, P958, DOI 10.1016/j.drudis.2013.05.003; Laura R., 2014, 19 INT COMM CONTR RE; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li Y, 2014, J CHEM INF MODEL, V54, P1717, DOI 10.1021/ci500081m; Little James N., 1999, American Biotechnology Laboratory, V17, P36; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Marx J, 2007, SCIENCE, V315, P1211, DOI 10.1126/science.315.5816.1211; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mpamhanga CP, 2009, J MED CHEM, V52, P4454, DOI 10.1021/jm900414x; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pan YP, 2003, J CHEM INF COMP SCI, V43, P267, DOI 10.1021/ci020055f; Patil S.P., 2014, NUCLEIC ACIDS RES, V28, P89, DOI DOI 10.1093/NAR/GKQ786; PEARLMAN RS, CONCORD; Pierceall William E, 2004, Methods Mol Biol, V261, P187; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Rella M, 2006, J CHEM INF MODEL, V46, P708, DOI 10.1021/ci0503614; Renner S, 2005, CHEMBIOCHEM, V6, P1119, DOI 10.1002/cbic.200400376; Rew Y, 2014, J MED CHEM, V57, P6332, DOI 10.1021/jm500627s; Roh JL, 2012, CANCER LETT, V325, P35, DOI 10.1016/j.canlet.2012.05.020; Rouvray D., 2002, TOPOLOGY CHEM, V2002, P16, DOI [10.1533/9780857099617.16, DOI 10.1533/9780857099617.16]; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Santana L, 2006, J MED CHEM, V49, P1149, DOI 10.1021/jm0509849; Sauton N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-184; Schuster D, 2006, J MED CHEM, V49, P3454, DOI 10.1021/jm0600794; Seifert MHJ, 2008, MINI-REV MED CHEM, V8, P63, DOI 10.2174/138955708783331540; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shave S.R., 2010, DEV HIGH PERFORMANCE; Taylor P, 2008, BRIT J PHARMACOL, V153, pS55, DOI 10.1038/sj.bjp.0707532; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tuccinardi T, 2014, J CHEM INF MODEL, V54, P2980, DOI 10.1021/ci500424n; Tuccinardi T, 2009, COMB CHEM HIGH T SCR, V12, P303, DOI 10.2174/138620709787581666; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Villoutreix BO, 2009, COMB CHEM HIGH T SCR, V12, P1000, DOI 10.2174/138620709789824682; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vu B, 2013, ACS MED CHEM LETT, V4, P466, DOI 10.1021/ml4000657; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Wang RX, 2001, J CHEM INF COMP SCI, V41, P1422, DOI 10.1021/ci010025x; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; Willett P, 2013, COMPUT STRUCT BIOTEC, V5, DOI 10.5936/csbj.201302002; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhong SJ, 2010, CURR OPIN DRUG DISC, V13, P326	82	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121424	10.1371/journal.pone.0121424	http://dx.doi.org/10.1371/journal.pone.0121424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884407	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000017
J	Liu, L; Li, XS; Yuan, R; Zhang, HH; Qiang, LX; Shen, JL; Jin, SD				Liu, Li; Li, Xiangshun; Yuan, Rui; Zhang, Honghong; Qiang, Lixia; Shen, Jingling; Jin, Shoude			Associations of ABHD2 Genetic Variations with Risks for Chronic Obstructive Pulmonary Disease in a Chinese Han Population	PLOS ONE			English	Article							MICE LACKING; COPD; BURDEN; EPIDEMIOLOGY; EXPRESSION; MANAGEMENT; SMOKING	The human alpha/beta hydrolase domain-containing protein 2 gene (ABHD2) plays a critical role in pulmonary emphysema, a major subset of the clinical entity known as chronic obstructive pulmonary disease (COPD). Here, we evaluated genetic variation in the ABHD2 gene in a Chinese Han population of 286 COPD patients and 326 control subjects. The rs12442260 CT/CC genotype was associated with COPD (P < 0.001) under a dominant model. In the former-smoker group, the rs12442260 TT genotype was associated with a decreased risk of developing COPD after adjusting for age, gender and pack-years (P = 0.012). Rs12442260 was also associated with pre-FEV1 (the predicted bronchodilator forced expiratory volume in the first second) in controls (P = 0.027), but with FEV1/forced vital capacity (FVC) ratios only in COPD patients (P = 0.012) under a dominant model. Results from the current study suggest that ABHD2 gene polymorphisms contribute to COPD susceptibility in the Chinese Han population.	[Liu, Li; Yuan, Rui; Zhang, Honghong; Shen, Jingling] Harbin Med Univ, Dept Histol & Embryol, Harbin 150001, Heilongjiang Pr, Peoples R China; [Li, Xiangshun; Qiang, Lixia; Jin, Shoude] Harbin Med Univ, Hosp 4, Div Resp Dis, Harbin 150001, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Liu, L (corresponding author), Harbin Med Univ, Dept Histol & Embryol, Harbin 150001, Heilongjiang Pr, Peoples R China.	shenjingling@rocketmail.com; jinshoude@163.com			National Natural Science Foundation of China [30900413]; Science Foundation of Heilongjiang Province of China [LC201024]; National Basic Science Research Program of China (973 Program) [2012CBA01303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Heilongjiang Province of China; National Basic Science Research Program of China (973 Program)(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (30900413), Science Foundation of Heilongjiang Province of China (LC201024), the National Basic Science Research Program of China (973 Program) (grant no. 2012CBA01303).	Anto JM, 2001, EUR RESPIR J, V17, P982, DOI 10.1183/09031936.01.17509820; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; Castaldi PJ, 2010, HUM MOL GENET, V19, P526, DOI 10.1093/hmg/ddp519; Celli BR, 2008, CHEST, V133, P1451, DOI 10.1378/chest.07-2061; Chen YX, 2006, BIOCHEM BIOPH RES CO, V340, P758, DOI 10.1016/j.bbrc.2005.12.068; Edgar AJ, 2002, BIOCHEM BIOPH RES CO, V292, P617, DOI 10.1006/bbrc.2002.6692; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Jin S, 2009, BIOCHEM BIOPH RES CO, V380, P419, DOI 10.1016/j.bbrc.2009.01.098; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Mannino David M, 2002, MMWR Surveill Summ, V51, P1; Miyata K, 2005, BIOCHEM BIOPH RES CO, V329, P296, DOI 10.1016/j.bbrc.2005.01.127; Miyata K, 2008, BIOCHEM BIOPH RES CO, V365, P207, DOI 10.1016/j.bbrc.2007.10.127; Nakamura Hidetoshi, 2011, Allergology International, V60, P253, DOI 10.2332/allergolint.11-RAI-0326; Parikh I, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-32; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rennard SI, 2004, LANCET, V364, P791, DOI 10.1016/S0140-6736(04)16941-9; Sandford AJ, 2002, THORAX, V57, P736, DOI 10.1136/thorax.57.8.736; Sethi JM, 2000, CLIN CHEST MED, V21, P67, DOI 10.1016/S0272-5231(05)70008-3; Shahdoust M, 2013, ASIAN PAC J CANCER P, V14, P111, DOI 10.7314/APJCP.2013.14.1.111; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Silverman EK, 2002, CHEST, V121, p1S, DOI 10.1378/chest.121.3_suppl.1S-a; Trajkov D, 2009, IRAN J ALLERGY ASTHM, V8, P31, DOI 08.01/ijaai.3142; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang XJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-275; Yoshida T, 2010, CANCER INFORM, V9, P147	34	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123929	10.1371/journal.pone.0123929	http://dx.doi.org/10.1371/journal.pone.0123929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880496	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500069
J	Macianskiene, R; Martisiene, I; Navalinskas, A; Vosyliute, R; Treinys, R; Vaidelyte, B; Benetis, R; Jurevicius, J				Macianskiene, Regina; Martisiene, Irma; Navalinskas, Antanas; Vosyliute, Ruta; Treinys, Rimantas; Vaidelyte, Birute; Benetis, Rimantas; Jurevicius, Jonas			Evaluation of Excitation Propagation in the Rabbit Heart: Optical Mapping and Transmural Microelectrode Recordings	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; PHOTON SCATTERING; CARDIAC-MUSCLE; SIGNALS; LIGHT	Background Because of the optical features of heart tissue, optical and electrical action potentials are only moderately associated, especially when near-infrared dyes are used in optical mapping (OM) studies. Objective By simultaneously recording transmural electrical action potentials (APs) and optical action potentials (OAPs), we aimed to evaluate the contributions of both electrical and optical influences to the shape of the OAP upstroke. Methods and Results A standard glass microelectrode and OM, using an near-infrared fluorescent dye (di-4-ANBDQBS), were used to simultaneously record transmural APs and OAPs in a Langendorff-perfused rabbit heart during atrial, endocardial, and epicardial pacing. The actual profile of the transmural AP upstroke across the LV wall, together with the OAP upstroke, allowed for calculations of the probing-depth constant (k similar to 2.1 mm, n = 24) of the fluorescence measurements. In addition, the transmural AP recordings aided the quantitative evaluation of the influences of depth-weighted and lateral-scattering components on the OAP upstroke. These components correspond to the components of the propagating electrical wave that are transmural and parallel to the epicardium. The calculated mean values for the depth-weighted and lateral-scattering components, whose sum comprises the OAP upstroke, were (in ms) 10.18 +/- 0.62 and 0.0 +/- 0.56 for atrial stimulation, 9.37 +/- 1.12 and 3.01 +/- 1.30 for endocardial stimulation, and 6.09 +/- 0.79 and 8.16 +/- 0.98 for epicardial stimulation; (n = 8 for each). For this dye, 90% of the collected fluorescence originated up to 4.83 +/- 0.18 mm (n = 24) from the epicardium. Conclusions The co-registration of OM and transmural microelectrode APs enabled the probing depth of fluorescence measurements to be calculated and the OAP upstroke to be divided into two components (depth-weighted and lateral-scattering), and it also allowed the relative strengths of their effects on the shape of the OAP upstroke to be evaluated.	[Macianskiene, Regina; Martisiene, Irma; Navalinskas, Antanas; Vosyliute, Ruta; Treinys, Rimantas; Vaidelyte, Birute; Benetis, Rimantas; Jurevicius, Jonas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania	Lithuanian University of Health Sciences	Macianskiene, R (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.	jonas.jurevicius@lsmuni.lt		Treinys, Rimantas/0000-0002-7590-7606	European Social Fund under the Global Grant measure	European Social Fund under the Global Grant measure	This research was funded by the European Social Fund under the Global Grant measure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter WT, 2001, BIOPHYS J, V80, P516, DOI 10.1016/S0006-3495(01)76034-1; Bishop MJ, 2007, BIOPHYS J, V93, P3714, DOI 10.1529/biophysj.107.110981; Bishop MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00338; Bishop MJ, 2006, BIOPHYS J, V90, P2938, DOI 10.1529/biophysj.105.076505; Ding L, 2001, IEEE T BIO-MED ENG, V48, P1098, DOI 10.1109/10.951512; Efimov IR, 1998, CIRCULATION, V98, P54, DOI 10.1161/01.CIR.98.1.54; EFIMOV IR, 1994, CIRCULATION, V90, P1469, DOI 10.1161/01.CIR.90.3.1469; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Gardner CM, 1996, LASER SURG MED, V18, P129; GILMOUR RF, 1984, AM J PHYSIOL, V247, pH303, DOI 10.1152/ajpheart.1984.247.2.H303; Girouard SD, 1996, J CARDIOVASC ELECTR, V7, P1024, DOI 10.1111/j.1540-8167.1996.tb00478.x; Hyatt CJ, 2005, CIRC RES, V97, P277, DOI 10.1161/01.RES.0000176022.74579.47; Hyatt CJ, 2003, BIOPHYS J, V85, P2673, DOI 10.1016/S0006-3495(03)74690-6; Kanaporis G, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.096007; Kelly A, 2013, CIRC-ARRHYTHMIA ELEC, V6, P809, DOI 10.1161/CIRCEP.113.000334; KNISLEY SB, 1995, CIRC RES, V77, P1229, DOI 10.1161/01.RES.77.6.1229; Knisley SB, 2003, ANN BIOMED ENG, V31, P32, DOI 10.1114/1.1535413; Kong W, 2012, AM J PHYSIOL-HEART C, V302, pH1294, DOI 10.1152/ajpheart.00426.2011; Masse S, 2007, AM J PHYSIOL-HEART C, V292, pH2589, DOI 10.1152/ajpheart.01336.2006; Mitrea BG, 2009, IEEE ENG MED BIO, P4194, DOI 10.1109/IEMBS.2009.5334048; Nanthakumar K, 2007, AM J PHYSIOL-HEART C, V293, pH875, DOI 10.1152/ajpheart.01415.2006; Spach MS, 1998, CIRC RES, V83, P1144, DOI 10.1161/01.RES.83.11.1144; Svaasand L O, 1984, Prog Clin Biol Res, V170, P91; Walton RD, 2012, BIOPHYS J, V102, P30, DOI 10.1016/j.bpj.2011.10.036; Walton RD, 2009, IEEE ENG MED BIO, P4523, DOI 10.1109/IEMBS.2009.5334106; Warren M, 2010, AM J PHYSIOL-HEART C, V299, pH1271, DOI 10.1152/ajpheart.00248.2010; Welch AJ, 1997, LASER SURG MED, V21, P166, DOI 10.1002/(SICI)1096-9101(1997)21:2<166::AID-LSM8>3.3.CO;2-Q	28	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123050	10.1371/journal.pone.0123050	http://dx.doi.org/10.1371/journal.pone.0123050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881157	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500036
J	Wu, Q; Jiang, D; Huang, CJ; van Dyk, LF; Li, LW; Chu, HW				Wu, Qun; Jiang, Di; Huang, Chunjian; van Dyk, Linda F.; Li, Liwu; Chu, Hong Wei			Trehalose-Mediated Autophagy Impairs the Anti-Viral Function of Human Primary Airway Epithelial Cells	PLOS ONE			English	Article							C VIRUS-INFECTION; RHINOVIRUS INFECTION; VIRAL-INFECTIONS; DENDRITIC CELLS; INNATE IMMUNITY; KINASE M; INDUCTION; ASTHMA; MECHANISM; ALPHA	Human rhinovirus (HRV) is the most common cause of acute exacerbations of chronic lung diseases including asthma. Impaired anti-viral IFN-.1 production and increased HRV replication in human asthmatic airway epithelial cells may be one of the underlying mechanisms leading to asthma exacerbations. Increased autophagy has been shown in asthmatic airway epithelium, but the role of autophagy in anti-HRV response remains uncertain. Trehalose, a natural glucose disaccharide, has been recognized as an effective autophagy inducer in mammalian cells. In the current study, we used trehalose to induce autophagy in normal human primary airway epithelial cells in order to determine if autophagy directly regulates the anti-viral response against HRV. We found that trehalose-induced autophagy significantly impaired IFN-lambda 1 expression and increased HRV-16 load. Inhibition of autophagy via knockdown of autophagy-related gene 5 (ATG5) effectively rescued the impaired IFN-lambda 1 expression by trehalose and subsequently reduced HRV-16 load. Mechanistically, ATG5 protein interacted with retinoic acid-inducible gene I (RIG-I) and IFN-beta promoter stimulator 1 (IPS-1), two critical molecules involved in the expression of anti-viral interferons. Our results suggest that induction of autophagy in human primary airway epithelial cells inhibits the anti-viral IFN-lambda 1 expression and facilitates HRV infection. Intervention of excessive autophagy in chronic lung diseases may provide a novel approach to attenuate viral infections and associated disease exacerbations.	[Wu, Qun; Jiang, Di; Huang, Chunjian; Chu, Hong Wei] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [van Dyk, Linda F.] Univ Colorado Denver, Denver Sch Med, Dept Immunol & Microbiol, Aurora, CO USA; [Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Virginia Polytechnic Institute & State University	Chu, HW (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	chuhw@njhealth.org		Li, Liwu/0000-0001-8870-5299; van Dyk, Linda/0000-0003-2662-5554	National Institutes of Health [R01AI106287, R01HL122321]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01AI106287 and R01HL122321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12; Contoli M, 2009, MINERVA MED, V100, P467; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Hao WD, 2012, J VIROL, V86, P13524, DOI 10.1128/JVI.02094-12; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Hermant P, 2014, J INNATE IMMUN, V6, P563, DOI 10.1159/000360084; Horikawa I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5706; Ioannidis I, 2013, J VIROL, V87, P3261, DOI 10.1128/JVI.01956-12; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Martin LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033454; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Minutoli L, 2007, SHOCK, V27, P91, DOI 10.1097/01.shk.0000235092.76292.bc; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mo RH, 2012, MOL BIOTECHNOL, V51, P1, DOI 10.1007/s12033-011-9422-6; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Nobre A, 2014, MICROBIOL-SGM, V160, P1547, DOI 10.1099/mic.0.075895-0; Okamoto M, 2014, J IMMUNOL, V192, P2770, DOI 10.4049/jimmunol.1301459; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Poon AH, 2012, J ALLERGY CLIN IMMUN, V129, P569, DOI 10.1016/j.jaci.2011.09.035; Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Stock Ingo, 2014, Med Monatsschr Pharm, V37, P44; Suarez AL, 2011, J VIROL, V85, P6293, DOI 10.1128/JVI.00001-11; Sykes A, 2014, THORAX, V69, P240, DOI 10.1136/thoraxjnl-2012-202909; Takeshita F, 2008, AUTOPHAGY, V4, P67, DOI 10.4161/auto.5055; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Wu Q, 2013, VIROLOGY, V446, P199, DOI 10.1016/j.virol.2013.08.005; Wu Q, 2012, J ALLERGY CLIN IMMUN, V129, P825, DOI 10.1016/j.jaci.2011.10.043; Yordy B, 2013, INT IMMUNOL, V25, P1, DOI 10.1093/intimm/dxs101; Zaru M, 2007, EUR J PHARM BIOPHARM, V67, P655, DOI 10.1016/j.ejpb.2007.04.005; Zhang XJ, 2014, AUTOPHAGY, V10, P588, DOI 10.4161/auto.27710; Zhou DJ, 2012, J INFECT DIS, V205, P1258, DOI 10.1093/infdis/jis187	40	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124524	10.1371/journal.pone.0124524	http://dx.doi.org/10.1371/journal.pone.0124524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879848	Green Submitted, gold, Green Published			2022-12-26	WOS:000353016500104
J	Long, NM; Rule, DC; Tuersunjiang, N; Nathanielsz, PW; Ford, SP				Long, Nathan M.; Rule, Daniel C.; Tuersunjiang, Nuermaimaiti; Nathanielsz, Peter W.; Ford, Stephen P.			Maternal Obesity in Sheep Increases Fatty Acid Synthesis, Upregulates Nutrient Transporters, and Increases Adiposity in Adult Male Offspring after a Feeding Challenge	PLOS ONE			English	Article							DIET-INDUCED OBESITY; NERVOUS-SYSTEM CONTROL; INSULIN-RESISTANCE; LEPTIN RESISTANCE; METABOLIC SYNDROME; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; GENE-EXPRESSION; ALTERED GROWTH; ADIPOCYTE SIZE	Maternal obesity in women is increasing worldwide. The objective of this study was to evaluate differences in adipose tissue metabolism and function in adult male offspring from obese and control fed mothers subjected to an ad libitum feeding challenge. We developed a model in which obese ewes were fed 150% of feed provided for controls from 60 days before mating to term. All ewes were fed to requirements during lactation. After weaning, F1 male offspring were fed only to maintenance requirements until adulthood (control = 7, obese = 6), when they were fed ad libitum for 12 weeks with intake monitored. At the end of the feeding challenge offspring were given an intravenous glucose tolerance test (IVGTT), necropsied, and adipose tissue collected. During the feeding trial F1obese males consumed more (P < 0.01), gained more weight (P < 0.01) and became heavier (P < 0.05) than F1control males. During IVGTT, Obese F1 offspring were hyperglycemic and hypoinsulinemic (P < 0.01) compared to F1 control F1. At necropsy perirenal and omental adipose depots weights were 47% and 58% greater respectively and subcutaneous fat thickness 41% greater in F1obese vs F1control males (P < 0.05). Adipocyte diameters were greater (P <= 0.04) in perirenal, omental and subcutaneous adipose depots in F1obese males (11, 8 and 7% increase vs. control, respectively). When adipose tissue was incubated for 2 hrs with C-14 labeled acetate, subcutaneous, perirenal, and omental adipose tissue of F1 obese males exhibited greater incorporation (290, 83, and 90% increase vs. control, respectively P < 0.05) of acetate into lipids. Expression of fatty acid transporting, binding, and syntheses mRNA and protein was increased (P < 0.05) compared to F1 control offspring. Maternal obesity increased appetite and adiposity associated with increased adipocyte diameters and increased fatty acid synthesis in over-nourished adult male offspring.	[Long, Nathan M.; Tuersunjiang, Nuermaimaiti; Nathanielsz, Peter W.; Ford, Stephen P.] Univ Wyoming, Ctr Study Fetal Programming, Laramie, WY 82071 USA; [Long, Nathan M.] Clemson Univ, Dept Anim & Vet Sci, Clemson, SC USA; [Rule, Daniel C.; Tuersunjiang, Nuermaimaiti; Ford, Stephen P.] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Nathanielsz, Peter W.] Univ Texas San Antonio, Hlth Sci Ctr, Dept Obstet & Gynecol, Ctr Pregnancy & Newborn Res, San Antonio, TX 78284 USA	University of Wyoming; Clemson University; University of Wyoming; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio	Ford, SP (corresponding author), Univ Wyoming, Ctr Study Fetal Programming, Laramie, WY 82071 USA.	spford@uwyo.edu		Nathanielsz, Peter/0000-0001-8410-6280	University of Wyoming National Institute of Health [INBRE P20-RR-16474-04, HD 21350]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021350] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	University of Wyoming National Institute of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the University of Wyoming National Institute of Health Grant INBRE P20-RR-16474-04 and HD 21350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P671; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Budge H, 2003, PEDIATR RES, V53, P302, DOI [10.1203/00006450-200302000-00016, 10.1203/01.PDR.0000047653.73271.C4]; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Caluwaerts S, 2007, METABOLISM, V56, P1431, DOI 10.1016/j.metabol.2007.06.007; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; Duckett SK, 2009, J ANIM SCI, V87, P1120, DOI 10.2527/jas.2008-1420; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; FASS, 2010, GUID CAR US AGR AN A; Ford SP, 2007, J ANIM SCI, V85, P1285, DOI 10.2527/jas.2005-624; Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Lomax MA, 2007, ENDOCRINOLOGY, V148, P461, DOI 10.1210/en.2006-0918; Long NM, 2012, J ANIM SCI, V90, P2201, DOI 10.2527/jas.2011-4343; Long NM, 2012, J ANIM SCI, V90, P197, DOI 10.2527/jas.2011-4237; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Long NM, 2010, J ANIM SCI, V88, P3251, DOI 10.2527/jas.2009-2512; Long NM, 2011, J PHYSIOL-LONDON, V589, P1455, DOI 10.1113/jphysiol.2010.201681; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Murrieta CM, 2003, MEAT SCI, V65, P523, DOI 10.1016/S0309-1740(02)00244-9; National Research Council, 1985, NUTR REQ SHEEP; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Proulx K, 2001, ENDOCRINOLOGY, V142, P4607, DOI 10.1210/en.142.11.4607; RULE DC, 1987, ANIM PROD, V44, P454, DOI 10.1017/S0003356100012411; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; SANSON DW, 1993, J ANIM SCI, V71, P1112, DOI 10.2527/1993.7151112x; Schaefer-Graf UM, 2005, DIABETES CARE, V28, P1745, DOI 10.2337/diacare.28.7.1745; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Yan X, 2011, BIOL REPROD, V85, P172, DOI 10.1095/biolreprod.110.089649; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhang L, 2011, DOMEST ANIM ENDOCRIN, V40, P30, DOI 10.1016/j.domaniend.2010.08.004; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhu MJ, 2010, AM J PHYSIOL-REG I, V299, pR1224, DOI 10.1152/ajpregu.00309.2010	49	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122152	10.1371/journal.pone.0122152	http://dx.doi.org/10.1371/journal.pone.0122152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875659	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800043
J	Davis, JA; Burgoon, LD				Davis, J. Allen; Burgoon, Lyle D.			Can Data Science Inform Environmental Justice and Community Risk Screening for Type 2 Diabetes?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; SLC30A8 RS13266634; COMMON VARIANTS; POLYMORPHISMS; IGF2BP2; CDKAL1; CHINESE; SUSCEPTIBILITY; LOCI	Background Having the ability to scan the entire country for potential "hotspots" with increased risk of developing chronic diseases due to various environmental, demographic, and genetic susceptibility factors may inform risk management decisions and enable better environmental public health policies. Objectives Develop an approach for community-level risk screening focused on identifying potential genetic susceptibility hotpots. Methods Our approach combines analyses of phenotype-genotype data, genetic prevalence of single nucleotide polymorphisms, and census/geographic information to estimate census tract-level population attributable risks among various ethnicities and total population for the state of California. Results We estimate that the rs13266634 single nucleotide polymorphism, a type 2 diabetes susceptibility genotype, has a genetic prevalence of 56.3%, 47.4% and 37.0% in Mexican Mestizo, Caucasian, and Asian populations. Looking at the top quintile for total population attributable risk, 16 California counties have greater than 25% of their population living in hotspots of genetic susceptibility for developing type 2 diabetes due to this single genotypic susceptibility factor. Conclusions This study identified counties in California where large portions of the population may bear additional type 2 diabetes risk due to increased genetic prevalence of a susceptibility genotype. This type of screening can easily be extended to include information on environmental contaminants of interest and other related diseases, and potentially enables the rapid identification of potential environmental justice communities. Other potential uses of this approach include problem formulation in support of risk assessments, land use planning, and prioritization of site cleanup and remediation actions.	[Davis, J. Allen; Burgoon, Lyle D.] US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency	Davis, JA (corresponding author), US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	davis.allen@epa.gov	Burgoon, Lyle D./I-2894-2019	Burgoon, Lyle D./0000-0003-4977-5352				Gamboa-Melendez MA, 2012, DIABETES, V61, P3314, DOI 10.2337/db11-0550; [Anonymous], UNITED STATES CENSUS; [Anonymous], CENTERS FOR DISEASE; [Anonymous], 2013, DATABASE OF SINGLE N; Astell-Burt T., 2013, DIABETES CARE; Bronstein M, 2008, HUM GENET, V124, P101, DOI 10.1007/s00439-008-0520-x; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cauchi S, 2010, MOL GENET METAB, V100, P77, DOI 10.1016/j.ymgme.2010.01.001; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; Gaskin DJ, 2013, AM J PUBLIC HEALTH; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hertel JK, 2008, DIABETOLOGIA, V51, P971, DOI 10.1007/s00125-008-0982-3; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Huang QO, 2010, EUR J CLIN PHARMACOL, V66, P1207, DOI 10.1007/s00228-010-0882-6; Kuo CC, 2013, CURR DIABETES REP, V13, P831, DOI 10.1007/s11892-013-0432-6; Lee YH, 2008, J HUM GENET, V53, P991, DOI 10.1007/s10038-008-0341-8; Lewis JP, 2008, DIABETES, V57, P2220, DOI 10.2337/db07-1319; Lin Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-97; Luna MTT, 2005, ARCH MED RES, V36, P210, DOI 10.1016/j.arcmed.2005.03.004; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Miao X, 2013, FRONT MED-PRC, V7, P31, DOI 10.1007/s11684-013-0251-9; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000312; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabara Y, 2009, DIABETES, V58, P493, DOI 10.2337/db07-1785; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; United States Environmental Protection Agency, 2013, NEXT GENERATION RISK, DOI [10.1016/j.yrtph.2013.12.002, DOI 10.1016/J.YRTPH.2013.12.002]; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Xiang J, 2008, J CLIN ENDOCR METAB, V93, P4107, DOI 10.1210/jc.2008-0161; Xu KF, 2011, DIABETES RES CLIN PR, V91, P195, DOI 10.1016/j.diabres.2010.11.012; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	49	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0121855	10.1371/journal.pone.0121855	http://dx.doi.org/10.1371/journal.pone.0121855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875676	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700011
J	Felsmann, K; Baudis, M; Gimbel, K; Kayler, ZE; Ellerbrock, R; Bruehlheide, H; Bruckhoff, J; Welk, E; Puhlmann, H; Weiler, M; Gessler, A; Ulrich, A				Felsmann, Katja; Baudis, Mathias; Gimbel, Katharina; Kayler, Zachary E.; Ellerbrock, Ruth; Bruehlheide, Helge; Bruckhoff, Johannes; Welk, Erik; Puhlmann, Heike; Weiler, Markus; Gessler, Arthur; Ulrich, Andreas			Soil Bacterial Community Structure Responses to Precipitation Reduction and Forest Management in Forest Ecosystems across Germany	PLOS ONE			English	Article							INDUCED TREE MORTALITY; MICROBIAL COMMUNITY; RIBOSOMAL-RNA; HERBACEOUS-LAYER; CLIMATE-CHANGE; DROUGHT; CARBON; DIVERSITY; GROWTH; WATER	Soil microbial communities play an important role in forest ecosystem functioning, but how climate change will affect the community composition and consequently bacterial functions is poorly understood. We assessed the effects of reduced precipitation with the aim of simulating realistic future drought conditions for one growing season on the bacterial community and its relation to soil properties and forest management. We manipulated precipitation in beech and conifer forest plots managed at different levels of intensity in three different regions across Germany. The precipitation reduction decreased soil water content across the growing season by between 2 to 8% depending on plot and region. T-RFLP analysis and pyrosequencing of the 16S rRNA gene were used to study the total soil bacterial community and its active members after six months of precipitation reduction. The effect of reduced precipitation on the total bacterial community structure was negligible while significant effects could be observed for the active bacteria. However, the effect was secondary to the stronger influence of specific soil characteristics across the three regions and management selection of overstorey tree species and their respective understorey vegetation. The impact of reduced precipitation differed between the studied plots; however, we could not determine the particular parameters being able to modify the response of the active bacterial community among plots. We conclude that the moderate drought induced by the precipitation manipulation treatment started to affect the active but not the total bacterial community, which points to an adequate resistance of the soil microbial system over one growing season.	[Felsmann, Katja; Kayler, Zachary E.; Ellerbrock, Ruth; Bruckhoff, Johannes; Gessler, Arthur; Ulrich, Andreas] Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany; [Baudis, Mathias; Bruehlheide, Helge; Welk, Erik] Univ Halle Wittenberg, Inst Biology Geobot & Bot Garden, D-06108 Halle, Germany; [Gimbel, Katharina; Puhlmann, Heike; Weiler, Markus] Univ Freiburg, Fac Environm & Nat Resources, D-79106 Freiburg, Germany; [Puhlmann, Heike] Forest Res Inst Baden Wurttemberg, Dept Soils & Environm, Freiburg, Germany; [Gessler, Arthur] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Gessler, Arthur] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland	Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); Martin Luther University Halle Wittenberg; University of Freiburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Ulrich, A (corresponding author), Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany.	aulrich@zalf.de	Weiler, Markus/F-5584-2011; Gessler, Arthur/C-7121-2008; Gimbel, Katharina/M-6279-2015; Ulrich, Andreas/G-3956-2012; WELK, Erik/AGL-4971-2022	Weiler, Markus/0000-0001-6245-6917; Gessler, Arthur/0000-0002-1910-9589; Gimbel, Katharina/0000-0003-4555-1773; Ulrich, Andreas/0000-0003-3854-9608; Kayler, Zachary/0000-0003-0090-7537	DFG [GE1090/11-1, BR1698/16-1, WE4598/3-1]	DFG(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (DFG-Refno.WE4598/3-1, GE1090/11-1, and BR1698/16-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; [Anonymous], 1994, 10694 DIN ISO; Bachmair S, 2009, J HYDROL, V369, P241, DOI 10.1016/j.jhydrol.2009.02.031; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Barnard RL, 2013, ISME J, V7, P2229, DOI 10.1038/ismej.2013.104; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baudis M, 2014, FOREST ECOL MANAG, V330, P283, DOI 10.1016/j.foreco.2014.07.012; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Bouskill NJ, 2013, ISME J, V7, P384, DOI 10.1038/ismej.2012.113; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Cregger MA, 2012, APPL ENVIRON MICROB, V78, P8587, DOI 10.1128/AEM.02050-12; Crowther TW, 2014, GLOBAL CHANGE BIOL, V20, P2983, DOI 10.1111/gcb.12565; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans SE, 2014, ECOLOGY, V95, P110, DOI 10.1890/13-0500.1; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Fuchslueger L, 2014, NEW PHYTOL, V201, P916, DOI 10.1111/nph.12569; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; GILLIAM FS, 1995, ECOL APPL, V5, P947, DOI 10.2307/2269345; Goransson H, 2013, SOIL BIOL BIOCHEM, V57, P477, DOI [10.1016/j.soilbio2012.08.031, 10.1016/j.soilbio.2012.08.031]; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Hammel K., 2001, CHARAKTERISIERUNG AN, P185; Holden SR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00163; Hommel R, 2014, PHYSIOL PLANTARUM, V152, P98, DOI 10.1111/ppl.12160; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Iovieno P, 2008, FEMS MICROBIOL ECOL, V65, P400, DOI 10.1111/j.1574-6941.2008.00524.x; Kandeler E, 2000, BIOL FERT SOILS, V32, P390, DOI 10.1007/s003740000268; Keitel C, 2003, PLANT CELL ENVIRON, V26, P1157, DOI 10.1046/j.1365-3040.2003.01040.x; Krebs CJ., 1999, ECOLOGICAL METHODOLO; Kreuzwieser J, 2010, TREE PHYSIOL, V30, P1221, DOI 10.1093/treephys/tpq055; Landesman WJ, 2010, SOIL BIOL BIOCHEM, V42, P1751, DOI 10.1016/j.soilbio.2010.06.012; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lorenz K, 2001, J PLANT NUTR SOIL SC, V164, P9, DOI 10.1002/1522-2624(200102)164:1<9::AID-JPLN9>3.0.CO;2-Q; Manzoni S, 2014, SOIL BIOL BIOCHEM, V73, P69, DOI 10.1016/j.soilbio.2014.02.008; McCune B., 2011, PC ORD MULTIVARIATE; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mielke P. W., 2001, PERMUTATION METHODS; Molin S, 1999, ENVIRON MICROBIOL, V1, P383, DOI 10.1046/j.1462-2920.1999.00056.x; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; Morales VL, 2010, J HYDROL, V393, P29, DOI 10.1016/j.jhydrol.2009.12.048; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nicotra AB, 1999, ECOLOGY, V80, P1908, DOI 10.1890/0012-9658(1999)080[1908:SHOLAW]2.0.CO;2; OLSEN RA, 1987, MICROB ECOL, V13, P59, DOI 10.1007/BF02014963; Pailler A, 2014, SOIL BIOL BIOCHEM, V70, P1, DOI 10.1016/j.soilbio.2013.12.003; Pinheiro J, 2020, R PACKAGE VERSION 31; Prescott CE, 2002, TREE PHYSIOL, V22, P1193, DOI 10.1093/treephys/22.15-16.1193; Prescott CE, 2013, FOREST ECOL MANAG, V309, P19, DOI 10.1016/j.foreco.2013.02.034; Puhlmann H, WALDOKOL LANDSCHAFTS, V12, P61; Royer-Tardif S, 2010, SOIL BIOL BIOCHEM, V42, P813, DOI 10.1016/j.soilbio.2010.01.018; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; Sala A, 2012, TREE PHYSIOL, V32, P764, DOI 10.1093/treephys/tpr143; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Scheller RM, 2002, ECOL APPL, V12, P1329, DOI 10.1890/1051-0761(2002)012[1329:USPADI]2.0.CO;2; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt M., 2007, Forstarchiv, V78, P205; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoning I, 2013, PLANT SOIL, V370, P625, DOI 10.1007/s11104-013-1654-8; SHUTTLEWORTH WJ, 1985, Q J ROY METEOR SOC, V111, P839, DOI 10.1256/smsqj.46909; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Sukenik A, 2012, ISME J, V6, P670, DOI 10.1038/ismej.2011.128; Sun H, 2014, APPL SOIL ECOL, V74, P37, DOI 10.1016/j.apsoil.2013.09.010; Thoms C, 2013, SOIL BIOL BIOCHEM, V66, P239, DOI 10.1016/j.soilbio.2013.05.018; Tian J, 2012, EUR J SOIL BIOL, V52, P67, DOI 10.1016/j.ejsobi.2012.07.002; Towe S, 2011, J MICROBIOL METH, V84, P406, DOI 10.1016/j.mimet.2010.12.028; Ulrich A, 2006, FEMS MICROBIOL ECOL, V56, P430, DOI 10.1111/j.1574-6941.2006.00085.x; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wang Y, 2012, MICROBES ENVIRON, V27, P111, DOI 10.1264/jsme2.ME11304; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Willerslev E, 2004, CURR BIOL, V14, pR9, DOI 10.1016/j.cub.2003.12.012; Wolf AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083661; World Reference Base for Soil Resources (WRB), 2006, FRAM INT CLASS CORR; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Zumsteg A, 2013, SOIL BIOL BIOCHEM, V61, P121, DOI 10.1016/j.soilbio.2013.02.017	83	38	39	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122539	10.1371/journal.pone.0122539	http://dx.doi.org/10.1371/journal.pone.0122539			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875835	Green Published, gold			2022-12-26	WOS:000353014700019
J	Solis, MY; Cooper, S; Hobson, RM; Artioli, GG; Otaduy, MC; Roschel, H; Robertson, J; Martin, D; Painelli, VS; Harris, RC; Gualano, B; Sale, C				Solis, Marina Yazigi; Cooper, Simon; Hobson, Ruth M.; Artioli, Guilherme G.; Otaduy, Maria C.; Roschel, Hamilton; Robertson, Jacques; Martin, Daniel; Painelli, Vitor S.; Harris, Roger C.; Gualano, Bruno; Sale, Craig			Effects of Beta-Alanine Supplementation on Brain Homocarnosine/Carnosine Signal and Cognitive Function: An Exploratory Study	PLOS ONE			English	Article							PEPT2 NULL MICE; CARNOSINE SYNTHETASE; EXERCISE PERFORMANCE; AMINO ACIDS; MUSCLE; HISTIDINE; ABSORPTION; TRANSPORT; PROTECTS; CULTURES	Objectives Two independent studies were conducted to examine the effects of 28 d of beta-alanine supplementation at 6.4 g d(-1) on brain homocarnosine/carnosine signal in omnivores and vegetarians (Study 1) and on cognitive function before and after exercise in trained cyclists (Study 2). Methods In Study 1, seven healthy vegetarians (3 women and 4 men) and seven age-and sex-matched omnivores undertook a brain 1H-MRS exam at baseline and after beta-alanine supplementation. In study 2, nineteen trained male cyclists completed four 20-Km cycling time trials (two pre supplementation and two post supplementation), with a battery of cognitive function tests (Stroop test, Sternberg paradigm, Rapid Visual Information Processing task) being performed before and after exercise on each occasion. Results In Study 1, there were no within-group effects of beta-alanine supplementation on brain homocarnosine/carnosine signal in either vegetarians (p = 0.99) or omnivores (p = 0.27); nor was there any effect when data from both groups were pooled (p = 0.19). Similarly, there was no group by time interaction for brain homocarnosine/ carnosine signal (p = 0.27). In study 2, exercise improved cognitive function across all tests (P<0.05), although there was no effect (P>0.05) of beta-alanine supplementation on response times or accuracy for the Stroop test, Sternberg paradigm or RVIP task at rest or after exercise. Conclusion 28 d of beta-alanine supplementation at 6.4g d(-1) appeared not to influence brain homocarnosine/carnosine signal in either omnivores or vegetarians; nor did it influence cognitive function before or after exercise in trained cyclists.	[Solis, Marina Yazigi; Artioli, Guilherme G.; Roschel, Hamilton; Painelli, Vitor S.; Gualano, Bruno] Univ Sao Paulo, Sch Phys Educ & Sport, BR-05508030 Sao Paulo, SP, Brazil; [Cooper, Simon; Hobson, Ruth M.; Robertson, Jacques; Martin, Daniel; Sale, Craig] Nottingham Trent Univ, Biomed Life & Hlth Sci Res Ctr, Nottingham NG11 8NS, England; [Otaduy, Maria C.] Univ Sao Paulo, Fac Med, LIM44, BR-05403900 Sao Paulo, SP, Brazil; [Harris, Roger C.] Junipa Ltd, Newmarket, Suffolk, England	Universidade de Sao Paulo; Nottingham Trent University; Universidade de Sao Paulo	Sale, C (corresponding author), Nottingham Trent Univ, Biomed Life & Hlth Sci Res Ctr, Nottingham NG11 8NS, England.	craig.sale@ntu.ac.uk	Gualano, Bruno/ABA-9571-2020; Otaduy, Maria/AAV-6070-2020; Painelli, Vitor/AAB-6925-2020; Roschel, Hamilton/D-4353-2012; Otaduy, Maria/C-1316-2012; Gualano, Bruno/C-7190-2012; Artioli, Guilherme Giannini/K-5925-2013	Gualano, Bruno/0000-0001-7100-8681; Otaduy, Maria/0000-0003-2515-1131; Painelli, Vitor/0000-0001-5828-9669; Roschel, Hamilton/0000-0002-9513-6132; Otaduy, Maria/0000-0003-2515-1131; Gualano, Bruno/0000-0001-7100-8681; Artioli, Guilherme Giannini/0000-0001-8463-2213; Cooper, Simon/0000-0001-5219-5020; Sale, Craig/0000-0002-5816-4169	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/11221-0, 2011/17059/2, 2013/04806-0]	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful to Fundacao do Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants #2010/11221-0, #2011/17059/2 and #2013/04806-0). In addition, the authors are thankful to Natural Alternatives International (NAI) for providing the supplements for Study 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; Aldini G, 2004, J MASS SPECTROM, V39, P1417, DOI 10.1002/jms.696; Altman DG, 1996, BRIT MED J, V313, P570; ASATOOR AM, 1970, GUT, V11, P250, DOI 10.1136/gut.11.3.250; Baraniuk James Nicholas, 2013, Glob J Health Sci, V5, P69, DOI 10.5539/gjhs.v5n3p69; BAUER K, 1994, EUR J BIOCHEM, V219, P43, DOI 10.1111/j.1432-1033.1994.tb19912.x; BOLDYREV AA, 1993, INT J BIOCHEM, V25, P1101, DOI 10.1016/0020-711X(93)90587-5; Boldyrev AA, 2008, REJUV RES, V13, P156; Boldyrev A, 2008, REJUV RES, V11, P821, DOI 10.1089/rej.2008.0716; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; BRUUN A, 1974, EXP EYE RES, V19, P435, DOI 10.1016/0014-4835(74)90052-9; Chengappa KNR, 2012, SCHIZOPHR RES, V142, P145, DOI 10.1016/j.schres.2012.10.001; Cooper SB, 2012, BRIT J NUTR, V107, P1823, DOI 10.1017/S0007114511005022; Dobrota D, 2005, NEUROCHEM RES, V30, P1283, DOI 10.1007/s11064-005-8799-7; Dunnett M, 1999, Equine Vet J Suppl, P499; Everaert I, 2011, AMINO ACIDS, V40, P1221, DOI 10.1007/s00726-010-0749-2; Fedorova TN, 2009, BIOCHEM MOSC SUPPL S, V3, P62, DOI 10.1134/S1990747809010085; Gross M, 2014, EUR J APPL PHYSIOL, V114, P221, DOI 10.1007/s00421-013-2767-8; HARDING JW, 1979, BRAIN RES, V173, P99, DOI 10.1016/0006-8993(79)91099-0; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Herculano B, 2013, J ALZHEIMERS DIS, V33, P983, DOI 10.3233/JAD-2012-121324; Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4; Hipkiss AR, 2009, EXP GERONTOL, V44, P237, DOI 10.1016/j.exger.2008.11.001; Hobson R, J SPOR IN PRESS 0717, P1; Hoffman JR, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-15; Hoffmann AM, 1996, NEUROSCI LETT, V215, P29, DOI 10.1016/S0304-3940(96)12937-2; Hogervorst E, 2008, MED SCI SPORT EXER, V40, P1841, DOI 10.1249/MSS.0b013e31817bb8b7; Horning MS, 2000, BRAIN RES, V852, P56, DOI 10.1016/S0006-8993(99)02215-5; Kamal MA, 2009, AM J PHYSIOL-REG I, V296, pR986, DOI 10.1152/ajpregu.90744.2008; KISH SJ, 1979, J NEUROCHEM, V32, P1629, DOI 10.1111/j.1471-4159.1979.tb02272.x; Komura J, 1997, FEBS LETT, V400, P131, DOI 10.1016/S0014-5793(96)01366-X; Leech R, BRAIN IN PRESS  0718; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x; Ozdemir MSR, 2007, PHYS MED BIOL, V52, P6781, DOI 10.1088/0031-9155/52/23/001; PARROTT AC, 1991, HUM PSYCHOPHARM CLIN, V6, P1, DOI 10.1002/hup.470060102; PERRY TL, 1971, J NEUROCHEM, V18, P521, DOI 10.1111/j.1471-4159.1971.tb11980.x; Petroff OAC, 1998, ANN NEUROL, V44, P948, DOI 10.1002/ana.410440614; Preston JE, 1998, NEUROSCI LETT, V242, P105, DOI 10.1016/S0304-3940(98)00058-5; Rothman DL, 1997, MAGN RESON MED, V38, P924, DOI 10.1002/mrm.1910380611; Rothman DL, 2001, NMR BIOMED, V14, P149, DOI 10.1002/nbm.692; Sale C, 2013, AMINO ACIDS, V44, P1477, DOI 10.1007/s00726-013-1476-2; Solis MY, 2014, BRIT J NUTR, V111, P1272, DOI 10.1017/S0007114513003802; Stellingwerff T, 2012, AMINO ACIDS, V42, P2461, DOI 10.1007/s00726-011-1054-4; STERNBERG S, 1969, AM SCI, V57, P421; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stvolinsky S, 2000, BRAIN RES BULL, V53, P445, DOI 10.1016/S0361-9230(00)00366-X; Teuscher NS, 2004, J NEUROCHEM, V89, P375, DOI 10.1111/j.1471-4159.2004.02333.x; Vermathen P, 2000, MAGN RESON MED, V43, P665, DOI 10.1002/(SICI)1522-2594(200005)43:5<665::AID-MRM8>3.0.CO;2-3; Weinsier R, 2000, AM J CLIN NUTR, V71, P1211	50	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123857	10.1371/journal.pone.0123857	http://dx.doi.org/10.1371/journal.pone.0123857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875297	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000353014700047
J	Chen, XB; Di, PP; Wang, HM; Li, BL; Pan, YJ; Yan, SL; Wang, YJ				Chen, Xiaobing; Di, Panpan; Wang, Hongming; Li, Bailin; Pan, Yingjie; Yan, Shuling; Wang, Yongjie			Bacterial Community Associated with the Intestinal Tract of Chinese Mitten Crab (Eriocheir sinensis) Farmed in Lake Tai, China	PLOS ONE			English	Article							STALK-FORMING LINEAGE; MICROBIAL DIVERSITY; GUT MICROBIOTA; MIDGUT GLANDS; SP NOV.; MOLLICUTES; MORPHOLOGY; GENES	Chinese mitten crab (CMC, Eriocheir sinensis) is an economically valuable species in South-East Asia that has been widely farmed in China. Characterization of the intestinal bacterial diversity of CMC will provide insights into the aquaculturing of CMCs. Based on the analysis of cloned 16S rRNA genes from culture-independent CMC gut bacteria, 124 out of 128 different clones reveal > 95% nucleotide similarity to the species belonging to the four phyla of Tenericutes, Bacteroidetes, Firmicutes and Proteobacteria; one clone shows 91% sequence similarity to themember of TM7 (a candidate phylum without cultured representatives). Fluorescent in situ hybridization also reveals the abundance of Bacteroidetes in crab intestine. Electron micrographs show that spherical and filamentous bacteria are closely associated with themicrovillus brush border of the midgut epithelium and are often inserted into the space between the microvilli using a stalk-like cell appendage. In contrast, the predominant rod-shaped bacteria in the hindgut are tightly attached to the epithelium surface by an unusual pili-like structure. Both 16S rRNA gene denaturing gel gradient electrophoresis and metagenome library indicate that the CMC Mollicutes group 2 appears to be present in both the midgut and hindgut with no significant difference in abundance. The CMC Mollicutes group 1, however, was found mostly in the midgut of CMCs. The CMC gut Mollicutes phylotypes appear to be most closely related to Mollicutes symbionts detected in the gut of isopods (Crustacea: Isopoda). Overall, the results suggest that CMCs harbor diverse, novel and specific gut bacteria, which are likely to live in close relationships with the CMC host.	[Chen, Xiaobing; Di, Panpan; Wang, Hongming; Pan, Yingjie; Wang, Yongjie] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China; [Pan, Yingjie; Wang, Yongjie] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai, Peoples R China; [Chen, Xiaobing; Di, Panpan; Wang, Hongming; Li, Bailin; Pan, Yingjie; Wang, Yongjie] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Yan, Shuling] Univ Goettingen, Inst Biochem & Mol Cell Biol, Gottingen, Germany	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Gottingen	Wang, YJ (corresponding author), Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China.	yjwang@shou.edu.cn	li, bai/GRJ-4913-2022; li, bz/GVR-7133-2022	Wang, Yongjie/0000-0002-7209-585X	National Natural Science Foundation of China [41376135]; Doctoral Fund of Ministry of Education of China [20133104110006]; Innovation Program of Shanghai Municipal Education Commission, China [14ZZ144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Innovation Program of Shanghai Municipal Education Commission, China(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by the National Natural Science Foundation of China (No. 41376135), Doctoral Fund of Ministry of Education of China (20133104110006), Innovation Program of Shanghai Municipal Education Commission (14ZZ144), China, to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; Chinese Fishery Bureau, 2013, CHIN FISH YB, P23; Cho JC, 2004, APPL ENVIRON MICROB, V70, P432, DOI 10.1128/AEM.70.1.432-440.2004; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Collado L, 2009, INT J SYST EVOL MICR, V59, P1391, DOI 10.1099/ijs.0.003749-0; DAVIS CP, 1974, INFECT IMMUN, V10, P948, DOI 10.1128/IAI.10.4.948-956.1974; Foster HA, 2010, METHODS MOL BIOL, V659, P427, DOI 10.1007/978-1-60761-789-1_33; Fraune S, 2008, ENVIRON MICROBIOL, V10, P2497, DOI 10.1111/j.1462-2920.2008.01672.x; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Han SF, 2010, AQUAC RES, V42, P47, DOI 10.1111/j.1365-2109.2010.02543.x; Ke Li, 2007, Weishengwu Xuebao, V47, P649; Kostanjsek R, 2007, APPL ENVIRON MICROB, V73, P5566, DOI 10.1128/AEM.02468-06; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larsen AM, 2014, J APPL MICROBIOL, V116, P1396, DOI 10.1111/jam.12475; Li K, 2007, J APPL MICROBIOL, V103, P675, DOI 10.1111/j.1365-2672.2007.03295.x; Liu HD, 2011, AQUACULTURE, V317, P32, DOI 10.1016/j.aquaculture.2011.04.008; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Na H, 2009, INT J SYST EVOL MICR, V59, P2241, DOI 10.1099/ijs.0.009027-0; Nechitaylo TY, 2009, ENVIRON MICROBIOL, V11, P1016, DOI 10.1111/j.1462-2920.2008.01837.x; NELSON ET, 1976, INFECT IMMUN, V14, P527, DOI 10.1128/IAI.14.2.527-547.1976; Olmos J, 2011, MAR DRUGS, V9, P1119, DOI 10.3390/md9061119; Ravi AV, 2007, LETT APPL MICROBIOL, V45, P219, DOI 10.1111/j.1472-765X.2007.02180.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; SANFORD SE, 1991, J VET DIAGN INVEST, V3, P328, DOI 10.1177/104063879100300410; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Verna C, 2010, ENVIRON MICROBIOL, V12, P2355, DOI 10.1111/j.1462-2920.2010.02299.x; Wang W, 2004, RES MICROBIOL, V155, P630, DOI 10.1016/j.resmic.2004.04.010; Wang YJ, 2004, APPL ENVIRON MICROB, V70, P6166, DOI 10.1128/AEM.70.10.6166-6172.2004; Wang YJ, 2004, ARCH MICROBIOL, V181, P299, DOI 10.1007/s00203-004-0655-7; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wu SG, 2012, WORLD J MICROB BIOT, V28, P2165, DOI 10.1007/s11274-012-1022-5; Wu SG, 2010, AQUACULTURE, V303, P1, DOI 10.1016/j.aquaculture.2009.12.025; Yan QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030603; Yu Z, 2014, J EUKARYOT MICROBIOL, V61, P126, DOI 10.1111/jeu.12090	36	51	57	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123990	10.1371/journal.pone.0123990	http://dx.doi.org/10.1371/journal.pone.0123990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875449	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100230
J	Kuo, CH; Hsieh, TC; Wang, CH; Chou, CL; Lai, YH; Chen, YY; Lin, YL; Wu, ST; Fang, TC				Kuo, Chiu-Huang; Hsieh, Tsung-Cheng; Wang, Chih-Hsien; Chou, Chu-Lin; Lai, Yu-Hsien; Chen, Yi-Ya; Lin, Yu-Li; Wu, Sheng-Teng; Fang, Te-Chao			Increased Risks of Mortality and Atherosclerotic Complications in Incident Hemodialysis Patients Subsequently with Bone Fractures: A Nationwide Case-Matched Cohort Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; CHRONIC KIDNEY-DISEASE; HIP FRACTURE; DIALYSIS PATIENTS; TEMPORAL TRENDS; OUTCOMES; ASSOCIATION; CHOLESTEROL; IMPACT; RATES	Background Hemodialysis (HD) patients with bone fractures have an increased risk for death. However, the risks for mortality and atherosclerotic complications in incident HD patients subsequently with bone fractures are unknown. Methods Data derived from the Taiwan National Health Institute Research Database between January 1997 and December 2008 was analyzed. The enrolled patients included 3,008 incident HD patients subsequently with a single long bone fracture (LB Fx) and 2,070 incident HD patients subsequently with a single non-long bone fracture (NLB Fx). These patients were matched (1:5 ratio) for age, sex, and same duration of HD with incident HD patients who had no fractures and outcomes were measured over a 3-year follow-up. Results After demographic and co-morbidity adjustment, LB Fx increased the risk for overall mortality (HR = 1.59, p < 0.001) and stroke (HR = 1.09, p = 0.028) in incident HD patients. NLB Fx increased the risk for overall mortality (HR = 1.52, p < 0.001), stroke (HR = 1.19, p < 0.001), coronary artery disease (CAD), (HR = 1.13, p = 0.003), and peripheral arterial occlusive disease (PAOD), (HR = 1.41, p < 0.001) in incident HD patients. Moreover, incident patients subsequently with NLB Fx had significantly higher risks of CAD and PAOD than those subsequently with LB Fx. Conclusions The rates of mortality and stroke were significantly higher in incident HD patients subsequently with bone fractures than in matched patients without bone fractures. Incident HD patients subsequently with NLB Fx had significantly higher risks of CAD and PAOD than those subsequently with LB Fx and without bone fractures. Thus, incident HD patients subsequently with bone fractures should be closely followed for a higher mortality and possible development of atherosclerotic complications.	[Kuo, Chiu-Huang; Wang, Chih-Hsien; Lai, Yu-Hsien; Chen, Yi-Ya; Lin, Yu-Li; Wu, Sheng-Teng] Buddhist Tzu Chi Gen Hosp, Div Nephrol, Dept Internal Med, Hualien, Taiwan; [Hsieh, Tsung-Cheng; Chou, Chu-Lin] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Fang, Te-Chao] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Fang, Te-Chao] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Fang, TC (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	fangtechao@yahoo.com.tw		Chou, Chu-Lin/0000-0002-9695-1067; Lai, Yu-Hsien/0000-0002-6687-1058; Hsieh, Tsung-Cheng/0000-0003-3024-8675	Tzu Chi General Hospital (Hualien, Taiwan) [TCRD 100-56]	Tzu Chi General Hospital (Hualien, Taiwan)	This study was supported by a grant (TCRD 100-56) from Tzu Chi General Hospital (Hualien, Taiwan). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Beaubrun AC, 2013, J AM SOC NEPHROL, V24, P1461, DOI 10.1681/ASN.2012090916; Berry SD, 2007, ARCH INTERN MED, V167, P1971, DOI 10.1001/archinte.167.18.1971; Cauley JA, 2007, JAMA-J AM MED ASSOC, V298, P2761, DOI 10.1001/jama.298.23.2761; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P2264, DOI 10.2215/CJN.09711010; Chen LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065077; Chou CL, 2014, ARCH MED RES, V45, P188, DOI 10.1016/j.arcmed.2014.01.009; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fusaro M, 2014, KIDNEY INT, V85, P20, DOI 10.1038/ki.2013.302; Hung HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054304; Hung TH, 2014, HEPATOL RES, V44, P863, DOI 10.1111/hepr.12190; Ioannidis G, 2009, CAN MED ASSOC J, V181, P265, DOI 10.1503/cmaj.081720; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kilpatrick RD, 2007, J AM SOC NEPHROL, V18, P293, DOI 10.1681/ASN.2006070795; Li WH, 2012, NEPHROL DIAL TRANSPL, V27, P833, DOI 10.1093/ndt/gfr277; Lin HF, 2012, NEPHROL DIAL TRANSPL, V27, P1585, DOI 10.1093/ndt/gfr464; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Mittalhenkle A, 2004, AM J KIDNEY DIS, V44, P672, DOI 10.1053/j.ajkd.2004.07.001; Nair SS, 2013, CLIN J AM SOC NEPHRO, V8, P1336, DOI 10.2215/CJN.10901012; Robbins JA, 2006, J AM GERIATR SOC, V54, P1885, DOI 10.1111/j.1532-5415.2006.00985.x; Rodriguez-Garcia M, 2009, NEPHROL DIAL TRANSPL, V24, P239, DOI 10.1093/ndt/gfn466; Tentori F, 2014, KIDNEY INT, V85, P166, DOI 10.1038/ki.2013.279; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	24	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121705	10.1371/journal.pone.0121705	http://dx.doi.org/10.1371/journal.pone.0121705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874794	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100045
J	Nielsen, MH; Irvine, H; Vedel, S; Raungaard, B; Beck-Nielsen, H; Handberg, A				Nielsen, Morten Hjuler; Irvine, Helle; Vedel, Simon; Raungaard, Bent; Beck-Nielsen, Henning; Handberg, Aase			Elevated Atherosclerosis-Related Gene Expression, Monocyte Activation and Microparticle-Release Are Related to Increased Lipoprotein-Associated Oxidative Stress in Familial Hypercholesterolemia	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ACHILLES-TENDON THICKNESS; C-REACTIVE PROTEIN; OXIDIZED LDL; DENDRITIC CELLS; MACROPHAGES; PATHOGENESIS; CHOLESTEROL; GAMMA; CD36	Objective Animal and in vitro studies have suggested that hypercholesterolemia and increased oxidative stress predisposes to monocyte activation and enhanced accumulation of oxidized LDL cholesterol (oxLDL-C) through a CD36-dependent mechanism. The aim of this study was to investigate the hypothesis that elevated oxLDL-C induce proinflammatory monocytes and increased release of monocyte-derived microparticles (MMPs), as well as up-regulation of CD36, chemokine receptors and proinflammatory factors through CD36-dependent pathways and that this is associated with accelerated atherosclerosis in subjects with heterozygous familial hypercholesterolemia (FH), in particular in the presence of Achilles tendon xanthomas (ATX). Approach and Results We studied thirty FH subjects with and without ATX and twenty-three healthy control subjects. Intima-media thickness (IMT) and Achilles tendon (AT) thickness were measured by ultrasonography. Monocyte classification and MMP analysis were performed by flow cytometry. Monocyte expression of genes involved in atherosclerosis was determined by quantitative PCR. IMT and oxLDL-C were increased in FH subjects, especially in the presence of ATX. In addition, FH subjects had elevated proportions of intermediate CD14++CD16+monocytes and higher circulating MMP levels. Stepwise linear regression identified oxLDLC, gender and intermediate monocytes as predictors of MMPs. Monocyte expression of pro-atherogenic and pro-inflammatory genes regulated by oxLDL-C-CD36 interaction was increased in FH, especially in ATX+ subjects. Monocyte chemokine receptor CX(3)CR1 was identified as an independent contributor to IMT. Conclusions Our data support that lipoprotein-associated oxidative stress is involved in accelerated atherosclerosis in FH, particularly in the presence of ATX, by inducing pro-inflammatory monocytes and increased release of MMPs along with elevated monocyte expression of oxLDLC-induced atherosclerosis-related genes.	[Nielsen, Morten Hjuler] Univ Southern Denmark, Danish PhD Sch Mol Metab, Odense, Denmark; [Irvine, Helle] Aarhus Univ Hosp, Dept Med & Cardiol A, DK-8000 Aarhus, Denmark; [Vedel, Simon] Aarhus Univ Hosp, Dept Radiol, DK-8000 Aarhus, Denmark; [Raungaard, Bent] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Beck-Nielsen, Henning] Odense Univ Hosp, Dept Endocrinol M, DK-5000 Odense, Denmark; [Nielsen, Morten Hjuler; Handberg, Aase] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark	University of Southern Denmark; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital	Nielsen, MH (corresponding author), Univ Southern Denmark, Danish PhD Sch Mol Metab, Odense, Denmark.	mohn@rn.dk		Handberg, Aase/0000-0001-5719-203X	Danish Heart Association; Novo Nordisk Foundation via Danish PhD School of Molecular Metabolism	Danish Heart Association; Novo Nordisk Foundation via Danish PhD School of Molecular Metabolism	This work was supported by The Danish Heart Association and the Novo Nordisk Foundation via Danish PhD School of Molecular Metabolism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artieda M, 2005, FEBS LETT, V579, P4503, DOI 10.1016/j.febslet.2005.06.087; Barlic J, 2006, CIRCULATION, V114, P807, DOI 10.1161/CIRCULATIONAHA.105.602359; Caparevic Z, 2009, SRP ARK CELOK LEK, V137, P140, DOI 10.2298/SARH0904140C; Chapman CML, 2004, STROKE, V35, P1619, DOI 10.1161/01.STR.0000130857.19423.ad; Civeira F, 2005, ARTERIOSCL THROM VAS, V25, P1960, DOI 10.1161/01.ATV.0000177811.14176.2b; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; de Groot E, 2008, NAT CLIN PRACT CARD, V5, P280, DOI 10.1038/ncpcardio1163; Descamps OS, 2001, ATHEROSCLEROSIS, V157, P514, DOI 10.1016/S0021-9150(01)00533-0; Dzik WH, 2010, CYTOM PART B-CLIN CY, V78B, P81, DOI 10.1002/cyto.b.20504; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Frankenberger M, 1996, BLOOD, V87, P373; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gurnell M, 2003, CLIN ENDOCRINOL, V59, P267, DOI 10.1046/j.1365-2265.2003.01767.x; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Huh HY, 1996, BLOOD, V87, P2020; Jarauta E, 2008, ATHEROSCLEROSIS; Kiortsis DN, 2006, ATHEROSCLEROSIS, V186, P228, DOI 10.1016/j.atherosclerosis.2006.02.002; Leroyer AS, 2008, J INTERN MED, V263, P528, DOI 10.1111/j.1365-2796.2008.01957.x; Libby P, 2007, NUTR REV, V65, pS140, DOI [10.1111/j.1753-4887.2007.tb00352.x, 10.1301/nr.2007.dec.S140-S146]; Liu ML, 2007, ARTERIOSCL THROM VAS, V27, P430, DOI 10.1161/01.ATV.0000254674.47693.e8; Matsumoto N, 2004, THROMB HAEMOSTASIS, V91, P146, DOI 10.1160/TH03-04-0247; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mosig S, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-60; Mosig S, 2009, FASEB J, V23, P866, DOI 10.1096/fj.08-118240; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Le NA, 2015, INT J MOL SCI, V16, P401, DOI 10.3390/ijms16010401; Nielsen MH, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.20795; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rothe G, 1996, ARTERIOSCL THROM VAS, V16, P1437, DOI 10.1161/01.ATV.16.12.1437; Shi J, 2006, CYTOM PART A, V69A, P1193, DOI 10.1002/cyto.a.20345; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Stein Evan A, 2002, Curr Atheroscler Rep, V4, P14, DOI 10.1007/s11883-002-0057-8; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Tsouli SG, 2005, EUR J CLIN INVEST, V35, P236, DOI 10.1111/j.1365-2362.2005.01484.x; Tsouli SG, 2006, J LIPID RES, V47, P2208, DOI 10.1194/jlr.M600109-JLR200; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wegner M, 2012, CLIN BIOCHEM, V45, P1620, DOI 10.1016/j.clinbiochem.2012.08.019; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZieglerHeitbrock HWL, 1996, IMMUNOL TODAY, V17, P424, DOI 10.1016/0167-5699(96)10029-3	49	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121516	10.1371/journal.pone.0121516	http://dx.doi.org/10.1371/journal.pone.0121516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875611	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100042
J	Garcia-Fernandez, R; Perbandt, M; Rehders, D; Ziegelmuller, P; Piganeau, N; Hahn, U; Betzel, C; Chavez, MD; Redecke, L				Garcia-Fernandez, Rossana; Perbandt, Markus; Rehders, Dirk; Ziegelmueller, Patrick; Piganeau, Nicolas; Hahn, Ulrich; Betzel, Christian; de los Angeles Chavez, Maria; Redecke, Lars			Three-dimensional Structure of a Kunitz-type Inhibitor in Complex with an Elastase-like Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE PANCREATIC ELASTASE; HUMAN-LEUKOCYTE ELASTASE; NEUTROPHIL ELASTASE; TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; CATHEPSIN-G; CHYMOTRYPSIN ELASTASE; PROTEINASE-INHIBITOR; ACTIVE-SITE; SUBSTRATE	Elastase-like enzymes are involved in important diseases such as acute pancreatitis, chronic inflammatory lung diseases, and cancer. Structural insights into their interaction with specific inhibitors will contribute to the development of novel anti-elastase compounds that resist rapid oxidation and proteolysis. Proteinaceous Kunitz-type inhibitors homologous to the bovine pancreatic trypsin inhibitor (BPTI) provide a suitable scaffold, but the structural aspects of their interaction with elastase-like enzymes have not been elucidated. Here, we increased the selectivity of ShPI-1, a versatile serine protease inhibitor from the sea anemone Stichodactyla helianthus with high biomedical and biotechnological potential, toward elastase-like enzymes by substitution of the P1 residue (Lys(13)) with leucine. The variant (rShPI-1/K13L) exhibits a novel anti-porcine pancreatic elastase (PPE) activity together with a significantly improved inhibition of human neuthrophil elastase and chymotrypsin. The crystal structure of the PPE.rShPI-1/K13L complex determined at 2.0 angstrom resolution provided the first details of the canonical interaction between a BPTI-Kunitz-type domain and elastase-like enzymes. In addition to the essential impact of the variant P1 residue for complex stability, the interface is improved by increased contributions of the primary and secondary binding loop as compared with similar trypsin and chymotrypsin complexes. A comparison of the interaction network with elastase complexes of canonical inhibitors from the chelonian in family supports a key role of the P3 site in ShPI-1 in directing its selectivity against pancreatic and neutrophil elastases. Our results provide the structural basis for site-specific mutagenesis to further improve the binding affinity and/or direct the selectivity of BPTI-Kunitz-type inhibitors toward elastase-like enzymes.	[Garcia-Fernandez, Rossana; de los Angeles Chavez, Maria] Univ La Habana, Ctr Estudio Prot, Fac Biol, Havana 20146, Cuba; [Perbandt, Markus; Ziegelmueller, Patrick; Piganeau, Nicolas; Hahn, Ulrich; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Dept Chem, D-22761 Hamburg, Germany; [Perbandt, Markus] Hamburg Ctr Ultrafast Imaging, D-22761 Hamburg, Germany; [Rehders, Dirk; Redecke, Lars] Univ Hamburg, Inst Biochem & Mol Biol, Joint Lab Struct Biol Infect & Inflammat, D-20146 Hamburg, Germany; [Rehders, Dirk; Redecke, Lars] Med Univ Lubeck, Inst Biochem, Deutsch Elektronen Synchrotron DESY, D-22603 Hamburg, Germany	Universidad de la Habana; University of Hamburg; University of Hamburg; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Lubeck	Redecke, L (corresponding author), Univ Hamburg, Joint Lab Struct Biol Infect & Inflammat, Inst Biochem & Mol Biol, Bldg 22a,Notkestr 85, D-22603 Hamburg, Germany.	redecke@biochem.uni-luebeck.de	Betzel, Christian/G-8105-2018; García-Fernández, Rossana/A-8920-2011; Hahn, Ulrich/E-8069-2010; Perbandt, Markus/K-7603-2018	Betzel, Christian/0000-0002-3879-5019; Hahn, Ulrich/0000-0002-6526-0693; 	International Foundation for Science, Sweden [F4086-1, F4086-2]; German Academic Exchange Service (DAAD); excellence cluster (The Hamburg Centre for Ultrafast Imaging-Structure, Dynamics, and Control of Matter at the Atomic Scale) of the Deutsche Forschungsgemeinschaft; German Federal Ministry of Education and Research [01DN13028]	International Foundation for Science, Sweden(International Foundation for Science); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); excellence cluster (The Hamburg Centre for Ultrafast Imaging-Structure, Dynamics, and Control of Matter at the Atomic Scale) of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by Grants F4086-1 and F4086-2 from the International Foundation for Science, Sweden; the German Academic Exchange Service (DAAD); the excellence cluster (The Hamburg Centre for Ultrafast Imaging-Structure, Dynamics, and Control of Matter at the Atomic Scale) of the Deutsche Forschungsgemeinschaft; and Grant 01DN13028 from the German Federal Ministry of Education and Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANTUCH W, 1993, EUR J BIOCHEM, V212, P675, DOI 10.1111/j.1432-1033.1993.tb17705.x; Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Ay J, 2003, ACTA CRYSTALLOGR D, V59, P247, DOI 10.1107/S0907444902020887; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Buchler M., 1987, ELASTASE ACUTE PANCR, P110; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chughtai B, 2004, J AEROSOL MED, V17, P289, DOI 10.1089/jam.2004.17.289; COPELAND RA, 1995, BIOORG MED CHEM LETT, V5, P1947, DOI 10.1016/0960-894X(95)00330-V; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; ESTELL DA, 1986, SCIENCE, V233, P659, DOI 10.1126/science.233.4764.659; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; Garcia-Fernandez R, 2012, ACTA CRYSTALLOGR F, V68, P1289, DOI 10.1107/S1744309112039085; Garcia-Fernandez R, 2012, J STRUCT BIOL, V180, P271, DOI 10.1016/j.jsb.2012.08.009; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gil DF, 2011, FEMS YEAST RES, V11, P575, DOI 10.1111/j.1567-1364.2011.00749.x; Gonzalez Y, 2007, BIOL CHEM, V388, P1183, DOI 10.1515/BC.2007.129; Helland R, 1998, EUR J BIOCHEM, V256, P317, DOI 10.1046/j.1432-1327.1998.2560317.x; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; Kiczak L, 2001, BBA-PROTEIN STRUCT M, V1550, P153, DOI 10.1016/S0167-4838(01)00282-5; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; Koizumi M, 2008, J SYNCHROTRON RADIAT, V15, P308, DOI 10.1107/S0909049507060670; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kraunsoe JAE, 1996, BIOCHEMISTRY-US, V35, P9090, DOI 10.1021/bi953013b; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Krowarsch D, 1999, J MOL BIOL, V289, P175, DOI 10.1006/jmbi.1999.2757; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Ley AC, 2003, US patent, Patent No. [003/0175919 A1, 0030175919]; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; McBride JD, 1999, EUR J BIOCHEM, V266, P403, DOI 10.1046/j.1432-1327.1999.00867.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCWHERTER CA, 1989, BIOCHEMISTRY-US, V28, P5708, DOI 10.1021/bi00440a002; Moroy G, 2012, ANTI-CANCER AGENT ME, V12, P565, DOI 10.2174/187152012800617696; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; Ooyama T, 1995, CIBA F SYMP, V192, P307; PEANASKY RJ, 1984, ARCH BIOCHEM BIOPHYS, V232, P127, DOI 10.1016/0003-9861(84)90528-9; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; Schmidt AE, 2005, J BIOL CHEM, V280, P27832, DOI 10.1074/jbc.M504105200; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; SINHA S, 1987, P NATL ACAD SCI USA, V84, P2228, DOI 10.1073/pnas.84.8.2228; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; TSCHESCHE H, 1987, BIOCHIM BIOPHYS ACTA, V913, P97, DOI 10.1016/0167-4838(87)90238-X; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; VEDVICK T, 1991, J IND MICROBIOL, V7, P197, DOI 10.1007/BF01575883; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wurtele M, 2000, ACTA CRYSTALLOGR D, V56, P520, DOI 10.1107/S0907444900000299; Yanes O, 2007, NAT PROTOC, V2, P119, DOI 10.1038/nprot.2006.487; Zani ML, 2004, EUR J BIOCHEM, V271, P2370, DOI 10.1111/j.1432-1033.2004.04156.x	65	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14154	14165		10.1074/jbc.M115.647586	http://dx.doi.org/10.1074/jbc.M115.647586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25878249	hybrid, Green Published			2022-12-26	WOS:000355313000043
J	D'Ambrosio, A; Agricola, E; Russo, L; Gesualdo, F; Pandolfi, E; Bortolus, R; Castellani, C; Lalatta, F; Mastroiacovo, P; Tozzi, AE				D'Ambrosio, Angelo; Agricola, Eleonora; Russo, Luisa; Gesualdo, Francesco; Pandolfi, Elisabetta; Bortolus, Renata; Castellani, Carlo; Lalatta, Faustina; Mastroiacovo, Pierpaolo; Tozzi, Alberto Eugenio			Web-Based Surveillance of Public Information Needs for Informing Preconception Interventions	PLOS ONE			English	Article							HEALTH-PROMOTION; FOLIC-ACID; INTERNET; CARE; RECOMMENDATIONS; MOTHERS; WOMEN	Background The risk of adverse pregnancy outcomes can be minimized through the adoption of healthy lifestyles before pregnancy by women of childbearing age. Initiatives for promotion of preconception health may be difficult to implement. Internet can be used to build tailored health interventions through identification of the public's information needs. To this aim, we developed a semi-automatic web-based system for monitoring Google searches, web pages and activity on social networks, regarding preconception health. Methods Based on the American College of Obstetricians and Gynecologists guidelines and on the actual search behaviors of Italian Internet users, we defined a set of keywords targeting preconception care topics. Using these keywords, we analyzed the usage of Google search engine and identified web pages containing preconception care recommendations. We also monitored how the selected web pages were shared on social networks. We analyzed discrepancies between searched and published information and the sharing pattern of the topics. Results We identified 1,807 Google search queries which generated a total of 1,995,030 searches during the study period. Less than 10% of the reviewed pages contained preconception care information and in 42.8% information was consistent with ACOG guidelines. Facebook was the most used social network for sharing. Nutrition, Chronic Diseases and Infectious Diseases were the most published and searched topics. Regarding Genetic Risk and Folic Acid, a high search volume was not associated to a high web page production, while Medication pages were more frequently published than searched. Vaccinations elicited high sharing although web page production was low; this effect was quite variable in time. Conclusion Our study represent a resource to prioritize communication on specific topics on the web, to address misconceptions, and to tailor interventions to specific populations.	[D'Ambrosio, Angelo; Agricola, Eleonora; Russo, Luisa; Gesualdo, Francesco; Pandolfi, Elisabetta; Tozzi, Alberto Eugenio] Bambino Gesu Pediat Hosp, IRCCS, Multifactorial Dis & Complex Phenotype Res Area, Rome, Italy; [Bortolus, Renata] Verona Univ Hosp, Dept Hosp Management & Pharm, Off Res Promot, Verona, Italy; [Castellani, Carlo] Verona Univ Hosp, Cyst Fibrosis Ctr, Verona, Italy; [Lalatta, Faustina] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Clin Genet Unit, Milan, Italy; [Mastroiacovo, Pierpaolo] Alessandra Lisi Int Ctr Birth Defects & Prematur, Rome, Italy	IRCCS Bambino Gesu; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico	D'Ambrosio, A (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Multifactorial Dis & Complex Phenotype Res Area, Rome, Italy.	bakaburg1@gmail.com	D'Ambrosio, Angelo/Y-1798-2018; Castellani, Carlo/AAB-3847-2019; Bortolus, Renata/K-6396-2016; Gesualdo, Francesco/H-9221-2012; Tozzi, Alberto Eugenio/F-9494-2012; Pandolfi, Elisabetta/K-5173-2016	D'Ambrosio, Angelo/0000-0002-2045-5155; Bortolus, Renata/0000-0003-3857-4133; Gesualdo, Francesco/0000-0002-9087-4398; Tozzi, Alberto Eugenio/0000-0002-6884-984X; Pandolfi, Elisabetta/0000-0003-2424-2736	Centro nazionale per la prevenzione e il controllo delle malattie (CCM)-Italian Ministry of Health [201301X003129]	Centro nazionale per la prevenzione e il controllo delle malattie (CCM)-Italian Ministry of Health	Centro nazionale per la prevenzione e il controllo delle malattie (CCM)-Italian Ministry of Health. (Grant n. 201301X003129) (http://www.ccmnetwork.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricola E, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-14; American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P665; Amitai Y, 2004, PREV MED, V39, P731, DOI 10.1016/j.ypmed.2004.02.042; [Anonymous], 2011, Obstet Gynecol, V117, P747, DOI 10.1097/AOG.0b013e318214780e; Atrash H, 2008, AM J OBSTET GYNECOL, V199, pS259, DOI 10.1016/j.ajog.2008.08.059; Ayers JW, 2013, AM J PREV MED, V44, P520, DOI 10.1016/j.amepre.2013.01.012; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bock BC, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.989; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Brigo F, 2014, EPILEPSY BEHAV, V31, P67, DOI 10.1016/j.yebeh.2013.11.020; Chunara R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061373; Chung M, 2012, J PEDIATR-US, V161, P1080, DOI 10.1016/j.jpeds.2012.06.004; Committee on Obstetric Practice, 2012, Obstet Gynecol, V120, P416, DOI 10.1097/AOG.0b013e31826804e8; Corchia C, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-68; Cugelman B, 2011, J MED INTERNET RES, V13, P84, DOI 10.2196/jmir.1367; Dehkordy SF, 2014, ACAD RADIOL, V21, P1172, DOI 10.1016/j.acra.2014.05.005; Delvoye P, 2009, EUR J CONTRACEP REPR, V14, P307, DOI 10.1080/13625180903056123; Gesualdo F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-561; Gosselin P, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1127; Helander E, 2014, J MED INTERNET RES, V16, P52, DOI 10.2196/jmir.3084; Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067; Larsson M, 2009, MIDWIFERY, V25, P14, DOI 10.1016/j.midw.2007.01.010; Linkov F, 2014, SURG OBES RELAT DIS, V10, P533, DOI 10.1016/j.soard.2013.10.007; Merchant Gina, 2014, J Med Internet Res, V16, pe158, DOI 10.2196/jmir.3267; National Institute of Statistics (ISTAT), 2010, CITT NUOV TECN; Neuhauser L, 2003, J HEALTH PSYCHOL, V8, P7, DOI 10.1177/1359105303008001426; Nicholson L, 2014, BR J OPHTHALMOL, V98; Patton LL, 2014, OR SURG OR MED OR PA, V118, P78, DOI 10.1016/j.oooo.2014.03.019; Plunkett KS, 2002, OBSTET GYN CLIN N AM, V29, P265, DOI 10.1016/S0889-8545(02)00003-7; Shannon GD, 2014, MATERN CHILD HLTH J, V18, P1354, DOI 10.1007/s10995-013-1370-2; Simmering JE, 2014, RES SOC ADMIN PHARM, V10, P896, DOI 10.1016/j.sapharm.2014.01.003; Squiers L, 2013, AM J HEALTH PROMOT, V27, pS10, DOI 10.4278/ajhp.120217-QUAL-95; Stephenson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103085; Tafuri S, 2014, HUM VACCIN IMMUNOTHE, V10; Tian H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1278; van der Pal-de Bruin KM, 2000, PAEDIATR PERINAT EP, V14, P111; Vance K, 2009, DERMATOL CLIN, V27, P133, DOI 10.1016/j.det.2008.11.010; Weymann N, 2014, HLTH PROMOT INT	38	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122551	10.1371/journal.pone.0122551	http://dx.doi.org/10.1371/journal.pone.0122551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879682	Green Submitted, gold, Green Published			2022-12-26	WOS:000353016500022
J	Faber, BW; Kadir, KA; Rodriguez-Garcia, R; Remarque, EJ; Saul, FA; Vulliez-Le Normand, B; Bentley, GA; Kocken, CHM; Singh, B				Faber, Bart W.; Kadir, Khamisah Abdul; Rodriguez-Garcia, Roberto; Remarque, Edmond J.; Saul, Frederick A.; Vulliez-Le Normand, Brigitte; Bentley, Graham A.; Kocken, Clemens H. M.; Singh, Balbir			Low Levels of Polymorphisms and No Evidence for Diversifying Selection on the Plasmodium knowlesi Apical Membrane Antigen 1 Gene	PLOS ONE			English	Article							MALARIA VACCINE CANDIDATE; FALCIPARUM; TRANSMISSION; IMMUNIZATION; SPECIFICITY; FREQUENCY; VIVAX; AMA1	Infection with Plasmodium knowlesi, a zoonotic primate malaria, is a growing human health problem in Southeast Asia. P. knowlesi is being used in malaria vaccine studies, and a number of proteins are being considered as candidate malaria vaccine antigens, including the Apical Membrane Antigen 1 (AMA1). In order to determine genetic diversity of the ama1 gene and to identify epitopes of AMA1 under strongest immune selection, the ama1 gene of 52 P. knowlesi isolates derived from human infections was sequenced. Sequence analysis of isolates from two geographically isolated regions in Sarawak showed that polymorphism in the protein is low compared to that of AMA1 of the major human malaria parasites, P. falciparum and P. vivax. Although the number of haplotypes was 27, the frequency of mutations at the majority of the polymorphic positions was low, and only six positions had a variance frequency higher than 10%. Only two positions had more than one alternative amino acid. Interestingly, three of the high-frequency polymorphic sites correspond to invariant sites in PfAMA1 or PvAMA1. Statistically significant differences in the quantity of three of the six high frequency mutations were observed between the two regions. These analyses suggest that the pkama1 gene is not under balancing selection, as observed for pfama1 and pvama1, and that the PkAMA1 protein is not a primary target for protective humoral immune responses in their reservoir macaque hosts, unlike PfAMA1 and PvAMA1 in humans. The low level of polymorphism justifies the development of a single allele PkAMA1-based vaccine.	[Faber, Bart W.; Rodriguez-Garcia, Roberto; Remarque, Edmond J.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Kadir, Khamisah Abdul; Singh, Balbir] Univ Malaysia Sarawak, Fac Med & Hlth Sci, Malaria Res Ctr, Kuching, Sarawak, Malaysia; [Saul, Frederick A.; Vulliez-Le Normand, Brigitte; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, Dept Biol Struct & Chim, Paris, France; [Saul, Frederick A.; Vulliez-Le Normand, Brigitte; Bentley, Graham A.] CNRS, URA 2185, Paris, France	University of Malaysia Sarawak; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Faber, BW (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	faber@bprc.nl; bskhaira55@gmail.com	Remarque, Ed/AAE-8643-2020; Singh, Balbir/A-3610-2009	Kocken, Clemens/0000-0002-4784-1734; Singh, Balbir/0000-0002-9143-3965; Faber, Bart/0000-0001-6808-1204	European Commission EUROMALVAC2 [QLK2-CT-2002-01197]; Centre National de la Recherche Scientifique; Universiti Malaysia Sarawak [01(TD03)/1003/2013(01)]; European Commission EMVDA [LSHP-CT-2007-037506]; E(M)VI, European (Malaria) Vaccine Initiative; Universiti of Sarawak [E14054/F05/54/PKI/09/2012(01)]	European Commission EUROMALVAC2; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universiti Malaysia Sarawak; European Commission EMVDA; E(M)VI, European (Malaria) Vaccine Initiative; Universiti of Sarawak	This work was supported by: European Commission EUROMALVAC2 (contract QLK2-CT-2002-01197), The Centre National de la Recherche Scientifique, The Universiti Malaysia Sarawak (grant number 01(TD03)/1003/2013(01)), European Commission EMVDA grant LSHP-CT-2007-037506, E(M)VI, The European (Malaria) Vaccine Initiative, and Universiti of Sarawak: Grant E14054/F05/54/PKI/09/2012(01); www.emvda.org; www.euvaccine.eu; www.evimalar.org; ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/71_en.htm. The external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002506; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; COLLINS WE, 1967, J PARASITOL, V53, P841, DOI 10.2307/3276783; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; EDESON JFB, 1953, T ROY SOC TROP MED H, V47, P399, DOI 10.1016/S0035-9203(53)80020-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FU YX, 1993, GENETICS, V133, P693; Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-182; Kusi KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015391; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-40; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Lee KS, 2009, INT J PARASITOL, V39, P1125, DOI 10.1016/j.ijpara.2009.03.003; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; Miura K, 2013, INFECT IMMUN, V81, P1491, DOI 10.1128/IAI.01414-12; Ord RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003366; Pacheco MA, 2012, INFECT GENET EVOL, V12, P978, DOI 10.1016/j.meegid.2012.02.009; Pacheco MA, 2010, INFECT GENET EVOL, V10, P655, DOI 10.1016/j.meegid.2010.03.013; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2001, GENETICS, V158, P1505; Putaporntip C, 2013, INFECT GENET EVOL, V18, P213, DOI 10.1016/j.meegid.2013.05.019; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; TAJIMA F, 1989, GENETICS, V123, P597; Vulliez-Le Normand B, 2015, PLOS ONE IN PRESS; WHARTON RH, 1961, SCIENCE, V134, P279, DOI 10.1126/science.134.3474.279; William T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-390	36	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124400	10.1371/journal.pone.0124400	http://dx.doi.org/10.1371/journal.pone.0124400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881166	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000353016500096
J	Han, M; Kim, K; Jang, SJ; Cho, HS; Bouma, BE; Oh, WY; Ryu, S				Han, Myounghee; Kim, Kyunghun; Jang, Sun-Joo; Cho, Han Saem; Bouma, Brett E.; Oh, Wang-Yuhl; Ryu, Sukyoung			GPU-Accelerated Framework for Intracoronary Optical Coherence Tomography Imaging at the Push of a Button	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INCOMPLETE STENT APPOSITION; DRUG-ELUTING STENTS; MYOCARDIAL-INFARCTION; INSIGHTS; OCT; CPU	Frequency domain optical coherence tomography (FD-OCT) has become one of the important clinical tools for intracoronary imaging to diagnose and monitor coronary artery disease, which has been one of the leading causes of death. To help more accurate diagnosis and monitoring of the disease, many researchers have recently worked on visualization of various coronary microscopic features including stent struts by constructing three-dimensional (3D) volumetric rendering from series of cross-sectional intracoronary FD-OCT images. In this paper, we present the first, to our knowledge, "push-of-a-button" graphics processing unit (GPU)-accelerated framework for intracoronary OCT imaging. Our framework visualizes 3D microstructures of the vessel wall with stent struts from raw binary OCT data acquired by the system digitizer as one seamless process. The framework reports the state-of-the-art performance; from raw OCT data, it takes 4.7 seconds to provide 3D visualization of a 5-cm-long coronary artery (of size 1600 samples x 1024 A-lines x 260 frames) with stent struts and detection of malapposition automatically at the single push of a button.	[Han, Myounghee; Kim, Kyunghun; Ryu, Sukyoung] Korea Adv Inst Sci & Technol, Dept Comp Sci, Taejon 305701, South Korea; [Jang, Sun-Joo; Cho, Han Saem; Oh, Wang-Yuhl] Korea Adv Inst Sci & Technol, Dept Mech Engn, Taejon 305701, South Korea; [Jang, Sun-Joo] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Bouma, Brett E.] Harvard Univ, Sch Med, Boston, MA USA; [Bouma, Brett E.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ryu, S (corresponding author), Korea Adv Inst Sci & Technol, Dept Comp Sci, Taejon 305701, South Korea.	sryu.cs@kaist.ac.kr	Ryu, Sukyoung/C-2080-2011; Ryu, Sukyoung/A-8543-2015; Jang, Sun-Joo/AAI-9828-2021	Ryu, Sukyoung/0000-0002-0019-9772; Jang, Sun-Joo/0000-0002-4311-4855; Kim, Kyunghun/0000-0002-2902-8811	National Research Foundation of Korea [NRF-2010-0017465, NRF-2014R1A2A2A01003235, NRF-2008-0062609]; Ministry of Science, ICT and Future Planning of Korea [GFP/CISS-2012M3A6A6054200, NIPA-2013-H0401-13-1007]; National Institute of Health [P41 EB015903]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded in part by the National Research Foundation of Korea to WO (NRF-2010-0017465) and SR (NRF-2014R1A2A2A01003235, NRF-2008-0062609), by the Ministry of Science, ICT and Future Planning of Korea (GFP/CISS-2012M3A6A6054200, NIPA-2013-H0401-13-1007) to WO, and by the National Institute of Health (P41 EB015903) to BEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnema GT, 2008, PHYS MED BIOL, V53, P3083, DOI 10.1088/0031-9155/53/12/001; Bradski G., 2000, DOBBS J SOFTWARE TOO; Brezinski ME, 1996, AM J CARDIOL, V77, P92, DOI 10.1016/S0002-9149(97)89143-6; Chieffo A, 2014, EUROINTERVENTION, V10, P916, DOI 10.4244/EIJY14M06_10; Cho HS, 2014, BIOMED OPT EXPRESS, V5, P223, DOI 10.1364/BOE.5.000223; CUDA N, 2011, CUDA C PROGR GUID V4; CUDA N, 2011, NVIDIA CUDA CUFFT LI; de Boer JF, 2001, APPL OPTICS, V40, P5787, DOI 10.1364/AO.40.005787; Farooq V, 2013, EUR HEART J, V34, P875, DOI 10.1093/eurheartj/ehr409; Farooq V, 2011, JACC-CARDIOVASC INTE, V4, P921, DOI 10.1016/j.jcin.2011.06.004; Gonzalez R.C., 2008, DIGITAL IMAGE PROCES, V3, P627; Gonzalo N, 2008, Minerva Cardioangiol, V56, P511; Gonzalo N, 2009, JACC-CARDIOVASC INTE, V2, P445, DOI 10.1016/j.jcin.2009.01.012; Grundeken MJ, 2014, EUROINTERVENTION; Han M, 2013, PROC SPIE, V8565, DOI 10.1117/12.2004335; Hoyert DL, 2012, NATL VITAL STAT REPO, P61; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jablin TB, 2011, ACM SIGPLAN NOTICES, V46, P142, DOI 10.1145/1993316.1993516; Jian Y, FDOCT GPU OPEN SOURC; Jian YF, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026002; Kauffmann C, 2010, IEEE T MED IMAGING, V29, P807, DOI 10.1109/TMI.2009.2037755; Kubo T, 2012, CIRC J, V76, P2076, DOI 10.1253/circj.CJ-12-0828; Lee KKC, 2012, BIOMED OPT EXPRESS, V3, P1557, DOI 10.1364/BOE.3.001557; Lee VW, 2010, CONF PROC INT SYMP C, P451, DOI 10.1145/1816038.1816021; Li J, 2011, APPL OPTICS, V50, P1832, DOI 10.1364/AO.50.001832; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lu H, 2012, BIOMED OPT EXPRESS, V3, P2809, DOI 10.1364/BOE.3.002809; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozaki Y, 2010, EUR HEART J, V31, P1470, DOI 10.1093/eurheartj/ehq066; Rasakanthan J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548153; Reiber JHC, 2011, CARDIOVASC DIAGN THE, V1, P57, DOI 10.3978/j.issn.2223-3652.2011.09.03; ROSENFEL.A, 1966, J ACM, V13, P471; Tearney GJ, 1996, CIRCULATION, V94, P3013, DOI 10.1161/01.CIR.94.11.3013; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tearney GJ, 2008, JACC-CARDIOVASC IMAG, V1, P752, DOI 10.1016/j.jcmg.2008.06.007; Ughi Giovanni J, 2012, Biomed Opt Express, V3, P3291, DOI 10.1364/BOE.3.003291; Watanabe Y, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275463; Yang PS, 2015, J CARDIOL, V65, P305, DOI 10.1016/j.jjcc.2014.12.004; Yun SH, 2004, OPT EXPRESS, V12, P4822, DOI 10.1364/OPEX.12.004822; Zhang K, 2012, IEEE J SEL TOP QUANT, V18, P1270, DOI 10.1109/JSTQE.2011.2164517	41	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124192	10.1371/journal.pone.0124192	http://dx.doi.org/10.1371/journal.pone.0124192			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880375	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500088
J	Jiang, TS; Mandal, RK; Wideman, RF; Khatiwara, A; Pevzner, I; Kwon, YM				Jiang, Tieshan; Mandal, Rabindra K.; Wideman, Robert F., Jr.; Khatiwara, Anita; Pevzner, Igal; Kwon, Young Min			Molecular Survey of Bacterial Communities Associated with Bacterial Chondronecrosis with Osteomyelitis (BCO) in Broilers	PLOS ONE			English	Article							FEMORAL-HEAD NECROSIS; STAPHYLOCOCCUS-AUREUS; LEG WEAKNESS; PAIRED-END; CHICKENS; LAMENESS; IDENTIFICATION; GENERATION; INFECTION; REVEALS	Bacterial chondronecrosis with osteomyelitis (BCO) is recognized as an important cause of lameness in commercial broiler chickens (meat-type chickens). Relatively little is known about the microbial communities associated with BCO. This study was conducted to increase our understanding of the microbial factors associated with BCO using a culture-independent approach. Using Illumina sequencing of the hyper-variable region V6 in the 16S rRNA gene, we characterized the bacterial communities in 97 femoral or tibial heads from normal and lame broilers carefully selected to represent diverse variations in age, line, lesion type, floor type, clinical status and bone type. Our in-depth survey based on 14 million assembled sequence reads revealed that complex bacterial communities exist in all samples, including macroscopically normal bones from clinically healthy birds. Overall, Proteobacteria (mean 90.9%) comprised the most common phylum, followed by Firmicutes (6.1%) and Actinobacteria (2.6%), accounting for more than 99% of all reads. Statistical analyses demonstrated that there are differences in bacterial communities in different types of bones (femur vs. tibia), lesion types (macroscopically normal femora or tibiae vs. those with pathognomonic BCO lesions), and among individual birds. This analysis also showed that BCO samples overrepresented genera Staphylococcus, whose species have been frequently isolated in BCO samples in previous studies. Rarefaction analysis demonstrated the general tendency that increased severities of BCO lesions were associated with reduced species diversity in both femoral and tibial samples when compared to macroscopically normal samples. These observations suggest that certain bacterial subgroups are preferentially selected in association with the development of BCO lesions. Understanding the microbial species associated with BCO will identify opportunities for understanding and modulating the pathogenesis of this form of lameness in broilers.	[Jiang, Tieshan; Mandal, Rabindra K.; Wideman, Robert F., Jr.; Kwon, Young Min] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA; [Wideman, Robert F., Jr.; Khatiwara, Anita; Kwon, Young Min] Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA; [Pevzner, Igal] Cobb Vantress Inc, Siloam Springs, AR USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Jiang, TS (corresponding author), Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA.	txj001@uark.edu			Cobb-Vantress Inc., Siloam Springs, Arkansas, USA	Cobb-Vantress Inc., Siloam Springs, Arkansas, USA	Funding for this project was provided by Cobb-Vantress Inc., Siloam Springs, Arkansas, USA. The funder provided support in the form of a salary for author IP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDREASEN JR, 1993, AVIAN DIS, V37, P284, DOI 10.2307/1591650; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bradshaw RH, 2002, AVIAN POULT BIOL REV, V13, P45, DOI 10.3184/147020602783698421; Butterworth A, 1999, WORLD POULTRY SCI J, V55, P327, DOI 10.1079/WPS19990024; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Cai H, 2003, J VET DIAGN INVEST, V15, P465, DOI 10.1177/104063870301500511; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CARRERO P, 1995, J CLIN MICROBIOL, V33, P275, DOI 10.1128/JCM.33.2.275-276.1995; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dimitriu PA, 2005, INT J SYST EVOL MICR, V55, P2273, DOI 10.1099/ijs.0.63647-0; Dinev I, 2009, BRIT POULTRY SCI, V50, P284, DOI 10.1080/00071660902942783; DUFF SRI, 1987, RES VET SCI, V42, P17, DOI 10.1016/S0034-5288(18)30650-7; Dumas MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024785; Durairaj V, 2009, AVIAN DIS, V53, P21, DOI 10.1637/8367-051908-Reg.1; El-Lethey H, 2003, VET IMMUNOL IMMUNOP, V95, P91, DOI 10.1016/S0165-2427(02)00308-2; Ernebjerg M, 2012, APPL ENVIRON MICROB, V78, P1345, DOI 10.1128/AEM.06585-11; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Grohskopf LA, 2001, NEW ENGL J MED, V344, P1491, DOI 10.1056/NEJM200105173442001; Harris L. G., 2002, European Cells & Materials, V4, P39; Hong PY, 2010, APPL ENVIRON MICROB, V76, P5631, DOI 10.1128/AEM.00281-10; Hume E, 2004, Arch Soc Esp Oftalmol, V79, P475; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Joiner KS, 2005, VET PATHOL, V42, P275, DOI 10.1354/vp.42-3-275; Julie G, 2009, KNEE, V16, P512, DOI 10.1016/j.knee.2009.02.008; Kip N, 2011, ENV MICROBIOL REP, V3, P667, DOI 10.1111/j.1758-2229.2011.00260.x; Lang KS, 2010, APPL ENVIRON MICROB, V76, P5321, DOI 10.1128/AEM.00323-10; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; McNamee PT, 1998, VET REC, V143, P131, DOI 10.1136/vr.143.5.131; McNamee PT, 1999, AVIAN PATHOL, V28, P26, DOI 10.1080/03079459995019; McNamee PT, 2000, AVIAN PATHOL, V29, P253, DOI 10.1080/03079450050118386; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NRC, 1994, NUTR REQ POULTR; Pattison M, 1992, BONE BIOL SKELETAL D, P329; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smeltzer MS, 2000, POULTRY SCI, V79, P1042, DOI 10.1093/ps/79.7.1042; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; SPEERS DJ, 1985, INFECT IMMUN, V49, P443, DOI 10.1128/IAI.49.2.443-446.1985; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; THORP BH, 1993, AVIAN PATHOL, V22, P325, DOI 10.1080/03079459308418924; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ursua PR, 1996, J CLIN MICROBIOL, V34, P216, DOI 10.1128/JCM.34.1.216-217.1996; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Whiteford N, 2009, BIOINFORMATICS, V25, P2194, DOI 10.1093/bioinformatics/btp383; Wideman RF, 2012, POULTRY SCI, V91, P2464, DOI 10.3382/ps.2012-02386; Wideman RF, 2012, POULTRY SCI, V91, P870, DOI 10.3382/ps.2011-01907; Wideman Robert F, 2012, Front Endocrinol (Lausanne), V3, P183, DOI 10.3389/fendo.2012.00183; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	59	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124403	10.1371/journal.pone.0124403	http://dx.doi.org/10.1371/journal.pone.0124403			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881241	gold, Green Submitted, Green Published			2022-12-26	WOS:000353016500097
J	Rudenick, PA; Bijnens, BH; Segers, P; Garcia-Dorado, D; Evangelista, A				Rudenick, Paula A.; Bijnens, Bart H.; Segers, Patrick; Garcia-Dorado, David; Evangelista, Arturo			Assessment of Wall Elasticity Variations on Intraluminal Haemodynamics in Descending Aortic Dissections Using a Lumped-Parameter Model	PLOS ONE			English	Article							IN-VITRO PHANTOM; BLOOD-FLOW; TRUE-LUMEN; TEAR SIZE; MANAGEMENT; SIMULATIONS; DIAGNOSIS; IMPEDANCE; PATTERNS; ANALOG	Descending aortic dissection (DAD) is associated with high morbidity and mortality rates. Aortic wall stiffness is a variable often altered in DAD patients and potentially involved in long-term outcome. However, its relevance is still mostly unknown. To gain more detailed knowledge of how wall elasticity (compliance) might influence intraluminal haemodynamics in DAD, a lumped-parameter model was developed based on experimental data from a pulsatile hydraulic circuit and validated for 8 clinical scenarios. Next, the variations of intraluminal pressures and flows were assessed as a function of wall elasticity. In comparison with the most rigid-wall case, an increase in elasticity to physiological values was associated with a decrease in systolic and increase in diastolic pressures of up to 33% and 63% respectively, with a subsequent decrease in the pressure wave amplitude of up to 86%. Moreover, it was related to an increase in multidirectional intraluminal flows and transition of behaviour as 2 parallel vessels towards a vessel with a side-chamber. The model supports the extremely important role of wall elasticity as determinant of intraluminal pressures and flow patterns for DAD, and thus, the relevance of considering it during clinical assessment and computational modelling of the disease.	[Rudenick, Paula A.; Garcia-Dorado, David; Evangelista, Arturo] Univ Autonoma Barcelona, Univ Hosp, E-08193 Barcelona, Spain; [Rudenick, Paula A.; Garcia-Dorado, David; Evangelista, Arturo] Univ Autonoma Barcelona, Res Inst Vall dHebron, E-08193 Barcelona, Spain; [Rudenick, Paula A.; Bijnens, Bart H.] Univ Pompeu Fabra, DTIC, Physense, Barcelona, Spain; [Bijnens, Bart H.] ICREA, Barcelona, Spain; [Segers, Patrick] Univ Ghent, Inst Biomed Technol, Biofluid Tissue & Solid Mech Med Applicat, B-9000 Ghent, Belgium	Autonomous University of Barcelona; Autonomous University of Barcelona; Pompeu Fabra University; ICREA; Ghent University	Rudenick, PA (corresponding author), Univ Autonoma Barcelona, Univ Hosp, E-08193 Barcelona, Spain.	paula.rudenick@upf.edu	Bijnens, Bart H/C-2955-2008; Bijnens, Bart/AAE-7186-2021; Segers, Patrick/AAA-7844-2020	Bijnens, Bart H/0000-0003-3130-6937; Bijnens, Bart/0000-0003-3130-6937; Segers, Patrick/0000-0003-3870-3409	Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain [PI108/0608, PI11/01709]; Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR), Spain; EU [611823]; ICREA Funding Source: Custom	Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain; Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR), Spain; EU(European Commission); ICREA(ICREA)	This study was partially supported by the Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain (ref. PI108/0608, PI11/01709); the Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR 2011), Spain; and the EU FP7 for research, technological development and demonstration under grant agreement VP2HF (no 611823).	Cheng Z, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000964; Cheng Z, 2013, J VASC SURG, V57, p35S, DOI 10.1016/j.jvs.2012.07.061; Chung JW, 2000, RADIOLOGY, V214, P87, DOI 10.1148/radiology.214.1.r00ja3287; Erbel R, 2001, EUR HEART J, V22, P1642, DOI 10.1053/euhj.2001.2782; Evangelista A, 2006, THORACIC AORTIC DIS, P33; Evangelista A, 2012, CIRCULATION, V125, P3133, DOI 10.1161/CIRCULATIONAHA.111.090266; Francois CJ, 2013, J THORAC CARDIOV SUR, V145, P1359, DOI 10.1016/j.jtcvs.2012.07.019; JAGER GN, 1965, CIRC RES, V16, P121, DOI 10.1161/01.RES.16.2.121; Karmonik C, 2013, MAGN RESON MED, V69, P1438, DOI 10.1002/mrm.24376; Khan IA, 2002, CHEST, V122, P311, DOI 10.1378/chest.122.1.311; LePage MA, 2001, AM J ROENTGENOL, V177, P207, DOI 10.2214/ajr.177.1.1770207; Milisic V, 2004, ESAIM-MATH MODEL NUM, V38, P613, DOI 10.1051/m2an:2004036; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Nienaber CA, 2003, CIRCULATION, V108, P772, DOI 10.1161/01.CIR.0000087400.48663.19; Nienaber CA, 2006, ESC TXB CARDIOVASCUL, P993; Quint LE, 2003, J ENDOVASC THER, V10, P505, DOI 10.1583/1545-1550(2003)010<0505:AITDWS>2.0.CO;2; Reymond P, 2013, MED ENG PHYS, V35, P784, DOI 10.1016/j.medengphy.2012.08.009; Roccabianca S, 2014, J MECH BEHAV BIOMED, V29, P618, DOI 10.1016/j.jmbbm.2013.01.026; Rubin Sylvain, 2006, Interact Cardiovasc Thorac Surg, V5, P746, DOI 10.1510/icvts.2006.134957; Rudenick PA, 2013, LECT NOTES COMPUTER, V7746, P375; Rudenick PA, 2013, J VASC SURG, V57, P464, DOI 10.1016/j.jvs.2012.07.008; Rudenick PA, 2010, LECT NOTES COMPUT SC, V6364, P114, DOI 10.1007/978-3-642-15835-3_12; Shi YB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-33; Soudah E, 2015, COMPUT METHOD BIOMEC, V18, P805, DOI 10.1080/10255842.2013.847095; Tan FPP, 2009, INT J APPL MECH, V1, P179, DOI 10.1142/S1758825109000095; Taylor M, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P77; Trimarchi S, 2014, ANN CARDIOTHORAC SUR, V3, P285, DOI 10.3978/j.issn.2225-319X.2014.05.01; Tsai TT, 2006, CIRCULATION, V114, P2226, DOI 10.1161/CIRCULATIONAHA.106.622340; Tse KM, 2011, J BIOMECH, V44, P827, DOI 10.1016/j.jbiomech.2010.12.014; WESTERHOF N, 1969, J BIOMECH, V2, P121, DOI 10.1016/0021-9290(69)90024-4; Williams D M, 1993, J Vasc Interv Radiol, V4, P75, DOI 10.1016/S1051-0443(93)71824-2; Williams DM, 1997, RADIOLOGY, V203, P23, DOI 10.1148/radiology.203.1.9122399; Wu D, 2013, J SURG RES, V184, P907, DOI 10.1016/j.jss.2013.06.007	33	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124011	10.1371/journal.pone.0124011	http://dx.doi.org/10.1371/journal.pone.0124011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881158	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500076
J	Zitzmann-Roth, EM; von Sonnenburg, F; de la Motte, S; Arndtz-Wiedemann, N; von Krempelhuber, A; Uebler, N; Vollmar, J; Virgin, G; Chaplin, P				Zitzmann-Roth, Eva-Maria; von Sonnenburg, Frank; de la Motte, Stephan; Arndtz-Wiedemann, Nathaly; von Krempelhuber, Alfred; Uebler, Nadine; Vollmar, Jens; Virgin, Garth; Chaplin, Paul			Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young, Healthy Study Population	PLOS ONE			English	Article							UNITED-STATES; TROPONIN-I; FOLLOW-UP; COMPLICATIONS; MYOPERICARDITIS; IMMUNOGENICITY; ELECTROCARDIOGRAPHY; ABNORMALITIES; MYOCARDITIS; CIVILIANS	Background Conventional smallpox vaccines based on replicating vaccinia virus (VV) strains (e.g. Lister Elstree, NYCBOH) are associated with a high incidence of myo-/pericarditis, a severe inflammatory cardiac complication. A new smallpox vaccine candidate based on a nonreplicating Modified Vaccinia Ankara (MVA) poxvirus has been assessed for cardiac safety in a large placebo-controlled clinical trial. Methods Cardiac safety of one and two doses of MVA compared to placebo was assessed in 745 healthy subjects. Vaccinia-naive subjects received either one dose of MVA and one dose of placebo, two doses of MVA, or two doses of placebo by subcutaneous injection four weeks apart; vaccinia-experienced subjects received a single dose of MVA. Solicited and unsolicited adverse events (AE) and cardiac safety parameters (recorded as Adverse Events of Special Interest, AESI) were monitored after each injection. Results A total of 5 possibly related AESI (3 cases of palpitations, 2 of tachycardia) were reported during the study. No case of myo- or pericarditis occurred. One possibly related serious AE (SAE) was reported during the 6-month follow-up period (sarcoidosis). The most frequently observed AEs were injection site reactions. Conclusions Vaccination with MVA was safe and well tolerated and did not increase the risk for development of myo-/pericarditis.	[Zitzmann-Roth, Eva-Maria] Praxis Zitzmann Roth, Munich, Germany; [von Sonnenburg, Frank] Univ Munich, Dept Trop Med & Infect Dis, Sect Int Med & Publ Hlth, Munich, Germany; [de la Motte, Stephan] Harrison Clin Res GmbH, Munich, Germany; [Arndtz-Wiedemann, Nathaly; von Krempelhuber, Alfred; Uebler, Nadine; Vollmar, Jens; Virgin, Garth; Chaplin, Paul] Bavarian Nord GmbH, Martinsried, Germany	University of Munich; Bavarian Nordic	Arndtz-Wiedemann, N (corresponding author), Bavarian Nord GmbH, Martinsried, Germany.	nathaly.arndtz@bavarian-nordic.com			NIAID [N01-Al-40072]; Bavarian Nordic	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bavarian Nordic	The study was funded by NIAID contract # N01-Al-40072. The study sponsor was Bavarian Nordic. All authors except for those employed by Bavarian Nordic received research grants from Bavarian Nordic to support the conduct of this trial. AK, JV, NU and GV were employees of Bavarian Nordic at the time of the study conduct. NA and PC are employees of Bavarian Nordic, at the time of study conduct and still currently. The funder provided support in the form of salaries for authors AK, JV, NU, GV, NA and PC, but did not have and additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acambis, 2007, ACAM2000 SMALLP VACC; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Cassimatis DC, 2004, J AM COLL CARDIOL, V43, P1503, DOI 10.1016/j.jacc.2003.11.053; Eckart RE, 2005, AM J CARDIOL, V95, P1252, DOI 10.1016/j.amjcard.2005.01.061; Eckart RE, 2004, J AM COLL CARDIOL, V44, P201, DOI 10.1016/j.jacc.2004.05.004; Eijsvogels T, 2010, AM J CARDIOL, V105, P267, DOI 10.1016/j.amjcard.2009.08.679; Elizaga ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054407; Food and Drug Administration HHS, 2005, Fed Regist, V70, P61134; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; Frey SE, 2013, VACCINE, V31, P3025, DOI 10.1016/j.vaccine.2013.04.050; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; Greenberg RN, 2013, J INFECT DIS, V207, P749, DOI 10.1093/infdis/jis753; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hingorani P, 2012, INDIAN J MED RES, V135, P322; Hiss RG, 1962, CIRCULATION, V25; Kennedy JS, 2009, EXPERT REV VACCINES, V8, P13, DOI 10.1586/14760584.8.1.13; Kobza R, 2012, HEART RHYTHM, V9, P2018, DOI 10.1016/j.hrthm.2012.08.034; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; MAYR A, 1964, ZENTBL BAKTERIOLOG P, V195, P24; Mayr A., 1975, INFECTION, V3, P6, DOI [10.1007/BF01641272, DOI 10.1007/BF01641272]; MMWR, 2003, MMWR MORB MORTAL WKL, V52, P444; Mora LF, 2009, SOUTH MED J, V102, P615, DOI 10.1097/SMJ.0b013e31819fe55b; Morgan J, 2008, CLIN INFECT DIS, V46, pS242, DOI 10.1086/524747; Neff J, 2008, CLIN INFECT DIS, V46, pS258, DOI 10.1086/524749; Neumayr G, 2001, AM J CARDIOL, V87, P369, DOI 10.1016/S0002-9149(00)01382-5; Nosanchuk JS, 1999, CLIN CHEM, V45, P714; Sano J, 2009, AM J MED, V122, P79, DOI 10.1016/j.amjmed.2008.07.025; Sharma Umesh, 2011, WMJ, V110, P291; Sniadack MM, 2008, CLIN INFECT DIS, V46, pS251, DOI 10.1086/524741; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Suter M, VACCINE; Vollmar J, 2006, VACCINE, V24, P2065, DOI 10.1016/j.vaccine.2005.11.022; von Krempelhuber A, 2010, VACCINE, V28, P1209, DOI 10.1016/j.vaccine.2009.11.030; Wu AHB, 1999, CLIN CHEM, V45, P1104	35	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122653	10.1371/journal.pone.0122653	http://dx.doi.org/10.1371/journal.pone.0122653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879867	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500024
J	Gaibelet, G; Allart, S; Terce, F; Azalbert, V; Bertrand-Michel, J; Hamdi, S; Collet, X; Orlowski, S				Gaibelet, Gerald; Allart, Sophie; Terce, Francois; Azalbert, Vincent; Bertrand-Michel, Justine; Hamdi, Safouane; Collet, Xavier; Orlowski, Stephane			Specific Cellular Incorporation of a Pyrene-Labelled Cholesterol: Lipoprotein-Mediated Delivery toward Ordered Intracellular Membranes	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; PROSTATE-CANCER CELLS; I SR-BI; LIPID DROPLETS; PLASMA-LIPOPROTEINS; MIXED MICELLES; LIVING CELLS; LDL RECEPTOR; HDL RECEPTOR	In the aim of testing tools for tracing cell trafficking of exogenous cholesterol, two fluorescent derivatives of cholesterol, 22-nitrobenzoxadiazole-cholesterol (NBD-Chol) and 21-methylpyrenyl-cholesterol (Pyr-met-Chol), with distinctive chemico-physical characteristics, have been compared for their cell incorporation properties, using two cell models differently handling cholesterol, with two incorporation routes. In the Caco-2 cell model, the cholesterol probes were delivered in bile salt micelles, as a model of intestinal absorption. The two probes displayed contrasting behaviors for cell uptake characteristics, cell staining, and efflux kinetics. In particular, Pyr-met-Chol cell incorporation involved SR-BI, while that of NBD-Chol appeared purely passive. In the PC-3 cell model, which overexpresses lipoprotein receptors, the cholesterol probes were delivered via the serum components, as a model of systemic delivery. We showed that Pyr-met-Chol-labelled purified LDL or HDL were able to specifically deliver Pyr-met-Chol to the PC-3 cells, while NBD-Chol incorporation was independent of lipoproteins. Observations by fluorescence microscopy evidenced that, while NBD-Chol readily stained the cytosolic lipid droplets, Pyr-met-Chol labelling led to the intense staining of intracellular structures of membranous nature, in agreement with the absence of detectable esterification of Pyr-met-Chol. A 48 h incubation of PC-3 cells with either Pyr-met-Chol-labelled LDL or HDL gave same staining patterns, mainly colocalizing with Lamp1, caveolin-1 and CD63. These data indicated convergent trafficking downwards their respective receptors, LDL-R and SR-BI, toward the cholesterolrich internal membrane compartments, late endosomes and multivesicular bodies. Interestingly, Pyr-met-Chol staining of these structures exhibited a high excimer fluorescence emission, revealing their ordered membrane environment, and indicating that Pyr-met-Chol behaves as a fair cholesterol tracer regarding its preferential incorporation into cholesterolrich domains. We conclude that, while NBD-Chol is a valuable marker of cholesterol esterification, Pyr-met-Chol is a reliable new lipoprotein fluorescent marker which allows to probe specific intracellular trafficking of cholesterol-rich membranes.	[Gaibelet, Gerald; Hamdi, Safouane; Orlowski, Stephane] CHU Purpan, INSERM U563 1048, F-31024 Toulouse 3, France; [Gaibelet, Gerald; Orlowski, Stephane] IBiTec Saclay, I2BC, SB2SM, CEA, F-91191 Gif Sur Yvette, France; [Gaibelet, Gerald; Orlowski, Stephane] IBiTec Saclay, I2BC, CNRS UMR8221 UMR9198, F-91191 Gif Sur Yvette, France; [Gaibelet, Gerald; Allart, Sophie; Terce, Francois; Azalbert, Vincent; Bertrand-Michel, Justine; Collet, Xavier] Univ Toulouse 3, UMR 1048, F-31000 Toulouse, France; [Allart, Sophie] INSERM U1043, Plateau Tech Imagerie Cellulaire, F-31300 Toulouse, France; [Terce, Francois; Azalbert, Vincent; Collet, Xavier] INSERM U1048, F-31400 Toulouse, France; [Bertrand-Michel, Justine] INSERM U1048, Lipid Platform Metatoul, F-31400 Toulouse, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Orlowski, S (corresponding author), CHU Purpan, INSERM U563 1048, F-31024 Toulouse 3, France.	stephane.orlowski@cea.fr	HAMDI, Safouane/AAC-4205-2019; Blasco Baque, Vincent/AHA-9524-2022; Collet, Xavier/M-6938-2017; Tercé, François/M-5863-2018	Tercé, François/0000-0003-4488-2167; /0000-0002-2434-3441; Sophie, Allart/0000-0001-7447-2471	Institut National de la Sante Et de la Recherche Medicale; Agence Nationale de la Recherche [06-PNRA 5.34]; Vaincre La Mucoviscidose [FC0906]; "Contrat d'Interface" from Centre Hospitalo-Universitaire de Toulouse; Societe Francaise de Nutrition	Institut National de la Sante Et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Vaincre La Mucoviscidose; "Contrat d'Interface" from Centre Hospitalo-Universitaire de Toulouse; Societe Francaise de Nutrition	This work was supported by grants from Institut National de la Sante Et de la Recherche Medicale, from Agence Nationale de la Recherche (06-PNRA 5.34 "Absinte"), and from Vaincre La Mucoviscidose (FC0906). XC was a recipient of a "Contrat d'Interface" from Centre Hospitalo-Universitaire de Toulouse; GG was a recipient of a "Prix de Recherche 2008" from Societe Francaise de Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2002, BBA-MOL CELL BIOL L, V1580, P77, DOI 10.1016/S1388-1981(01)00190-1; Amara A, 2003, J VIROL, V77, P2550, DOI 10.1128/JVI.77.4.2550-2558.2003; Andrieux K, 2004, PHARM RES-DORDR, V21, P1505, DOI 10.1023/B:PHAM.0000036927.37888.93; Aumuller G, 1999, ANN ANAT, V181, P437, DOI 10.1016/S0940-9602(99)80020-X; BAUCHART D, 1985, REPROD NUTR DEV, V25, P243, DOI 10.1051/rnd:19850214; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cai XH, 1997, J PHARM SCI, V86, P372, DOI 10.1021/js9602148; CHAPMAN MJ, 1986, METHOD ENZYMOL, V128, P70; Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2; CHIJIIWA K, 1989, BIOCHIM BIOPHYS ACTA, V1001, P111; Dagher G, 2003, J LIPID RES, V44, P1811, DOI 10.1194/jlr.M300267-JLR200; Frolov A, 2000, J BIOL CHEM, V275, P12769, DOI 10.1074/jbc.275.17.12769; Gaibelet G, 2013, BIOCHEM BIOPH RES CO, V440, P533, DOI 10.1016/j.bbrc.2013.09.101; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hager MH, 2006, CURR OPIN CLIN NUTR, V9, P379, DOI 10.1097/01.mco.0000232896.66791.62; Haikal Z, 2008, LIPIDS, V43, P401, DOI 10.1007/s11745-008-3172-7; Harwood HJ, 1997, BIOCHEM J, V323, P649, DOI 10.1042/bj3230649; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; Hofnagel O, 2007, BBA-MOL CELL BIOL L, V1771, P1117, DOI 10.1016/j.bbalip.2007.06.003; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; KAO YJ, 1986, J LIPID RES, V27, P781; KASURINEN J, 1995, BIOCHEMISTRY-US, V34, P2049, DOI 10.1021/bi00006a027; Koivusalo M, 2004, BIOPHYS J, V86, P923, DOI 10.1016/S0006-3495(04)74168-5; Kravets FG, 2000, PROSTATE, V43, P169, DOI 10.1002/(SICI)1097-0045(20000515)43:3<169::AID-PROS2>3.0.CO;2-D; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496; Lagane B, 2002, BIOPHYS CHEM, V95, P7, DOI 10.1016/S0301-4622(01)00235-6; Le Guyader L, 2007, BIOPHYS J, V93, P4462, DOI 10.1529/biophysj.107.112821; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Li H, 2004, ACAD RADIOL, V11, P669, DOI 10.1016/j.acra.2004.01.016; Lin DS, 2010, ATHEROSCLEROSIS, V208, P155, DOI 10.1016/j.atherosclerosis.2009.07.031; Llorente A, 2007, EUR J CELL BIOL, V86, P405, DOI 10.1016/j.ejcb.2007.05.001; Lougheed M, 1999, ARTERIOSCL THROM VAS, V19, P1881, DOI 10.1161/01.ATV.19.8.1881; Loura LMS, 2001, BBA-BIOMEMBRANES, V1511, P236, DOI 10.1016/S0005-2736(01)00269-3; Lusa S, 1998, BIOCHEM J, V332, P451, DOI 10.1042/bj3320451; Maier O, 2002, CHEM PHYS LIPIDS, V116, P3, DOI 10.1016/S0009-3084(02)00017-8; MANDERS EMM, 1992, J CELL SCI, V103, P857; Marks DL, 2008, HISTOCHEM CELL BIOL, V130, P819, DOI 10.1007/s00418-008-0509-5; Marrink SJ, 2002, BIOCHEMISTRY-US, V41, P5375, DOI 10.1021/bi015613i; Matsuoka K, 2006, CHEM PHYS LIPIDS, V139, P1, DOI 10.1016/j.chemphyslip.2005.08.006; Mazeres S, 2001, SPECTROCHIM ACTA A, V57, P2297, DOI 10.1016/S1386-1425(01)00486-3; Mobius W, 2003, TRAFFIC, V4, P222; Morel E, 2004, MOL BIOL CELL, V15, P132, DOI 10.1091/mbc.E03-04-0215; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Peng Y, 2004, MOL BIOL CELL, V15, P384, DOI 10.1091/mbc.e03-06-0445; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Rohrl C, 2012, CURR PHARM BIOTECHNO, V13, P331, DOI 10.2174/138920112799095338; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; SATO Y, 1995, BBA-LIPID LIPID MET, V1257, P38, DOI 10.1016/0005-2760(95)00053-F; Scheidt HA, 2003, J BIOL CHEM, V278, P45563, DOI 10.1074/jbc.M303567200; SCHUBERT R, 1988, BIOCHEMISTRY-US, V27, P8787, DOI 10.1021/bi00424a015; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Sparrow CP, 1999, J LIPID RES, V40, P1747; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; STEPHAN ZF, 1993, J LIPID RES, V34, P325; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; Tesseromatis C, 2008, EUR J DRUG METAB PH, V33, P225, DOI 10.1007/BF03190876; Webber MM, 1997, PROSTATE, V30, P58; Wiedmann TS, 2002, PHARMACEUT RES, V19, P1203, DOI 10.1023/A:1019858428449; Wustner D, 2004, J LIPID RES, V45, P427, DOI 10.1194/jlr.M300440-JLR200; Wustner D, 2007, CHEM PHYS LIPIDS, V146, P1, DOI 10.1016/j.chemphyslip.2006.12.004	70	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121563	10.1371/journal.pone.0121563	http://dx.doi.org/10.1371/journal.pone.0121563			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875769	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800023
J	Hirota, Y; Nakagawa, K; Sawada, N; Okuda, N; Suhara, Y; Uchino, Y; Kimoto, T; Funahashi, N; Kamao, M; Tsugawa, N; Okano, T				Hirota, Yoshihisa; Nakagawa, Kimie; Sawada, Natsumi; Okuda, Naoko; Suhara, Yoshitomo; Uchino, Yuri; Kimoto, Takashi; Funahashi, Nobuaki; Kamao, Maya; Tsugawa, Naoko; Okano, Toshio			Functional Characterization of the Vitamin K-2 Biosynthetic Enzyme UBIAD1	PLOS ONE			English	Article							SYNECHOCYSTIS SP PCC-6803; MENAQUINONE-4 VITAMIN-K-2; PHYLLOQUINONE VITAMIN-K-1; CRYSTAL-STRUCTURE; TARGET GENES; PRENYLTRANSFERASE; TERE1; CHOLESTEROL; EXPRESSION; PHYTYLTRANSFERASE	UbiA prenyltransferase domain-containing protein 1 (UBIAD1) plays a significant role in vitamin K-2 (MK-4) synthesis. We investigated the enzymological properties of UBIAD1 using microsomal fractions from Sf9 cells expressing UBIAD1 by analysing MK-4 biosynthetic activity. With regard to UBIAD1 enzyme reaction conditions, highest MK-4 synthetic activity was demonstrated under basic conditions at a pH between 8.5 and 9.0, with a DTT >= 0.1 mM. In addition, we found that geranyl pyrophosphate and farnesyl pyrophosphate were also recognized as a side-chain source and served as a substrate for prenylation. Furthermore, lipophilic statins were found to directly inhibit the enzymatic activity of UBIAD1. We analysed the aminoacid sequences homologies across the menA and UbiA families to identify conserved structural features of UBIAD1 proteins and focused on four highly conserved domains. We prepared protein mutants deficient in the four conserved domains to evaluate enzyme activity. Because no enzyme activity was detected in the mutants deficient in the UBIAD1 conserved domains, these four domains were considered to play an essential role in enzymatic activity. We also measured enzyme activities using point mutants of the highly conserved aminoacids in these domains to elucidate their respective functions. We found that the conserved domain I is a substrate recognition site that undergoes a structural change after substrate binding. The conserved domain II is a redox domain site containing a CxxC motif. The conserved domain III is a hinge region important as a catalytic site for the UBIAD1 enzyme. The conserved domain IV is a binding site for Mg2+/isoprenyl side-chain. In this study, we provide a molecular mapping of the enzymological properties of UBIAD1.	[Hirota, Yoshihisa; Nakagawa, Kimie; Sawada, Natsumi; Okuda, Naoko; Uchino, Yuri; Kimoto, Takashi; Funahashi, Nobuaki; Kamao, Maya; Tsugawa, Naoko; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Kobe, Hyogo 658, Japan; [Hirota, Yoshihisa] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Japan; [Suhara, Yoshitomo] Shibaura Inst Technol, Dept Biosci & Engn, Saitama, Japan	Kobe Pharmaceutical University; Shibaura Institute of Technology	Hirota, Y (corresponding author), Kobe Pharmaceut Univ, Dept Hyg Sci, Kobe, Hyogo 658, Japan.	hirota@suzuka-u.ac.jp; t-okano@kobepharma-u.ac.jp	Funahashi, Nobuaki/ABF-1529-2021; Hirota, Yoshihisa/R-6741-2019	Funahashi, Nobuaki/0000-0003-0888-1060; Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	JSPS [23390022, 2379110, 26860047, 24-7941]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-aid for Scientific Research (B) (grant number 23390022 to TO: https://kaken.nii.ac.jp/d/r/20131542.en.html) from JSPS, a Grant-in-aid for Scientific Research (Young Scientists-B) (grant number 2379110 to KN: https://kaken.nii.ac.jp/d/r/90309435.en.html and 26860047 to YH: https://kaken.nii.ac.jp/d/r/70724277.en.html) from JSPS, and a Grant-in-aid for JSPS Fellows (grant number 24-7941 to YH: https://kaken.nii.ac.jp/d/p/12J07941.ja.html) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2001, MED HYPOTHESES, V57, P151, DOI 10.1054/mehy.2001.1307; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; Brandt W, 2009, PHYTOCHEMISTRY, V70, P1758, DOI 10.1016/j.phytochem.2009.09.001; Cheng W, 2014, SCIENCE, V343, P878, DOI 10.1126/science.1246774; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; Danziger J, 2008, CLIN J AM SOC NEPHRO, V3, P1504, DOI 10.2215/CJN.00770208; Fredericks WJ, 2013, ONCOTARGET, V4, P1075, DOI 10.18632/oncotarget.1103; Fredericks WJ, 2013, J CELL BIOCHEM, V114, P2170, DOI 10.1002/jcb.24567; Fredericks WJ, 2013, INT J ONCOL, V43, P638, DOI 10.3892/ijo.2013.1985; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hegarty JM, 2013, DEVELOPMENT, V140, P1713, DOI 10.1242/dev.093112; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Hemmi H, 2004, J BIOL CHEM, V279, P50197, DOI 10.1074/jbc.M409207200; Hirota Y, 2013, J BIOL CHEM, V288, P33071, DOI 10.1074/jbc.M113.477356; Huang H, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001911; Ichikawa T, 2007, J MOL ENDOCRINOL, V39, P239, DOI 10.1677/JME-07-0048; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kurosu M, 2010, MOLECULES, V15, P1531, DOI 10.3390/molecules15031531; McGarvey TW, 2003, PROSTATE, V54, P144, DOI 10.1002/pros.10174; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Mugoni V, 2013, NAT PROTOC, V8, P2337, DOI 10.1038/nprot.2013.139; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Nakagawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104078; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nickerson ML, 2013, HUM MUTAT, V34, P317, DOI 10.1002/humu.22230; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Ohara K, 2009, BIOCHEM J, V421, P231, DOI 10.1042/BJ20081968; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; SAIKI K, 1993, J BIOL CHEM, V268, P26041; Schledz M, 2001, FEBS LETT, V499, P15, DOI 10.1016/S0014-5793(01)02508-X; Stafford DW, 2005, J THROMB HAEMOST, V3, P1873, DOI 10.1111/j.1538-7836.2005.01419.x; Suhara Y, 2012, YAKUGAKU ZASSHI, V132, P881, DOI 10.1248/yakushi.132.881; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Xia Y, 2015, DEV BIOL, V398, P218, DOI 10.1016/j.ydbio.2014.12.001; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Zu YG, 2006, J SEP SCI, V29, P1607, DOI 10.1002/jssc.200600047	48	34	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0125737	10.1371/journal.pone.0125737	http://dx.doi.org/10.1371/journal.pone.0125737			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874989	Green Submitted, gold, Green Published			2022-12-26	WOS:000353015800159
J	Lee, A; Ratnarajah, N; Tuan, TA; Chen, SHA; Qiu, AQ				Lee, Annie; Ratnarajah, Nagulan; Tuan, Ta Anh; Chen, Shen-Hsing Annabel; Qiu, Anqi			Adaptation of Brain Functional and Structural Networks in Aging	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DEFAULT MODE NETWORK; WORKING-MEMORY; SPONTANEOUS FLUCTUATIONS; NEURAL SPECIALIZATION; CEREBRAL-CORTEX; TEMPORAL-LOBE; CONNECTIVITY; OLDER; FMRI	The human brain, especially the prefrontal cortex (PFC), is functionally and anatomically reorganized in order to adapt to neuronal challenges in aging. This study employed structural MRI, resting-state fMRI (rs-fMRI), and high angular resolution diffusion imaging (HARDI), and examined the functional and structural reorganization of the PFC in aging using a Chinese sample of 173 subjects aged from 21 years and above. We found age-related increases in the structural connectivity between the PFC and posterior brain regions. Such findings were partially mediated by age-related increases in the structural connectivity of the occipital lobe within the posterior brain. Based on our findings, it is thought that the PFC reorganization in aging could be partly due to the adaptation to age-related changes in the structural reorganization of the posterior brain. This thus supports the idea derived from task-based fMRI that the PFC reorganization in aging may be adapted to the need of compensation for resolving less distinctive stimulus information from the posterior brain regions. In addition, we found that the structural connectivity of the PFC with the temporal lobe was fully mediated by the temporal cortical thickness, suggesting that the brain morphology plays an important role in the functional and structural reorganization with aging.	[Lee, Annie; Ratnarajah, Nagulan; Tuan, Ta Anh; Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore 117576, Singapore; [Chen, Shen-Hsing Annabel] Nanyang Technol Univ, Div Psychol, Singapore 637332, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117456, Singapore; [Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore 117609, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore 117576, Singapore.	bieqa@nus.edu.sg	Chen, SH Annabel/F-3742-2011; Qiu, Anqi/H-2267-2011	Chen, SH Annabel/0000-0002-1540-5516; Qiu, Anqi/0000-0002-0215-6338; Ratnarajah, Nagulan/0000-0003-1758-9969	Young Investigator Award at the National University of Singapore [NUSYIA FY10 P07]; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2012-T2-2-130]	Young Investigator Award at the National University of Singapore(National University of Singapore); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore)	The work was supported by grants from the Young Investigator Award at the National University of Singapore (NUSYIA FY10 P07) and the Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2012-T2-2-130).	Batouli AH, 2009, IRAN J RADIOL, V6, P153; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Bookheimer S, 2007, NEUROPSYCHOL REV, V17, P145, DOI 10.1007/s11065-007-9026-x; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; CONVIT A, 1995, PSYCHIAT QUART, V66, P343, DOI 10.1007/BF02238754; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Daselaar SM, 2006, CEREB CORTEX, V16, P1771, DOI 10.1093/cercor/bhj112; Daselaar SM, 2003, BRAIN, V126, P43, DOI 10.1093/brain/awg005; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Dennis NA, 2008, J EXP PSYCHOL LEARN, V34, P791, DOI 10.1037/0278-7393.34.4.791; Du J, 2011, NEUROIMAGE, V56, P162, DOI 10.1016/j.neuroimage.2011.01.067; Duverne S, 2009, CEREB CORTEX, V19, P733, DOI 10.1093/cercor/bhn122; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Fischer FU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086258; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Ford JH, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00307; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frey S, 2000, P NATL ACAD SCI USA, V97, P8723, DOI 10.1073/pnas.140543497; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; Goh JO, 2010, NEUROIMAGE, V51, P336, DOI 10.1016/j.neuroimage.2010.01.107; Goh JOS, 2011, AGING DIS, V2, P30; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Grady CL, 2008, CEREB CORTEX, V18, P189, DOI 10.1093/cercor/bhm045; Grady CL, 2000, BIOL PSYCHOL, V54, P259, DOI 10.1016/S0301-0511(00)00059-4; Grady CL, 2002, PSYCHOL AGING, V17, P7, DOI 10.1037//0882-7974.17.1.7; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hugenschmidt CE, 2009, BRAIN TOPOGR, V21, P241, DOI 10.1007/s10548-009-0098-1; Iidaka T, 2001, COGNITIVE BRAIN RES, V11, P1, DOI 10.1016/S0926-6410(00)00058-6; Johnson SC, 2000, NEUROIMAGE, V11, P179, DOI 10.1006/nimg.1999.0530; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Lee Y, 2011, J COGNITIVE NEUROSCI, V23, P3433, DOI 10.1162/jocn_a_00026; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Levine BK, 2000, NEUROBIOL AGING, V21, P577, DOI 10.1016/S0197-4580(00)00144-5; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mevel K, 2013, NEUROBIOL AGING, V34, P1292, DOI 10.1016/j.neurobiolaging.2012.08.018; Ng TP, 2007, AM J GERIAT PSYCHIAT, V15, P130, DOI 10.1097/01.JGP.0000235710.17450.9a; Nyberg L, 2003, P NATL ACAD SCI USA, V100, P13728, DOI 10.1073/pnas.1735487100; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Payer D, 2006, NEUROREPORT, V17, P487, DOI 10.1097/01.wnr.0000209005.40481.31; Persson J, 2004, NEUROIMAGE, V23, P1382, DOI 10.1016/j.neuroimage.2004.08.004; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rajah MN, 2010, CORTEX, V46, P535, DOI 10.1016/j.cortex.2009.07.006; Raz N, 2004, NEUROLOGY, V62, P433, DOI 10.1212/01.WNL.0000106466.09835.46; Razlighi QR, 2014, BRAIN BEHAV, V4, P143, DOI 10.1002/brb3.202; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; St Jacques PL, 2009, PSYCHOL SCI, V20, P74, DOI 10.1111/j.1467-9280.2008.02258.x; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Takeuchi H, 2012, HUMAN BRAIN MAPPING; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2013, TRENDS COGN SCI, V17, P600, DOI 10.1016/j.tics.2013.09.011; Voss MW, 2008, BRAIN RES, V1244, P121, DOI 10.1016/j.brainres.2008.09.051; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Weissman-Fogel I, 2010, HUM BRAIN MAPP, V31, P1713, DOI 10.1002/hbm.20968; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Ziegler G, 2012, HUM BRAIN MAPP, V33, P2377, DOI 10.1002/hbm.21374	75	14	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123462	10.1371/journal.pone.0123462	http://dx.doi.org/10.1371/journal.pone.0123462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875816	Green Published, gold			2022-12-26	WOS:000353015800100
J	Parsons, WL; Parsons, KM				Parsons, William L.; Parsons, Kristen M.			Morphological Variations within the Ontogeny of Deinonychus antirrhopus (Theropoda, Dromaeosauridae)	PLOS ONE			English	Article							ASSESSING GROWTH; PERIOSTEAL BONE; BODY-SIZE; DINOSAUR; EVOLUTION; TYRANNOSAURIDAE; HETEROCHRONY; LOCOMOTION; OSTEOLOGY; HISTOLOGY	This research resulted from the determination that MCZ 8791 is a specimen of Deinonychus antirrhopus between one and two years of age and that the morphological variations within particular growth stages of this taxon have yet to be described. The primary goal of the research is to identify ontogenetic variations in this taxon. Histological analyses determined that the Deinonychus specimens AMNH 3015 and MOR 1178 were adults. Comparisons are made between MCZ 8791 and these adult specimens. The holotype, YPM 5205, and the other associated specimens of this taxon within the YPM collection are similar in size and morphology to AMNH 3015. Further comparisons were made with the three partial specimens OMNH 50268, MCZ 4371, and MOR 1182. Although these specimens represent only a partial ontogenetic series, a number of morphological variations can be described. One secondary goal of this research is to compare the known pattern of variable, informative, ontogenetic characters in MCZ 8791 to a similar pattern of morphological characters in the sub-adult dromaeosaurid specimen Bambiraptor feinbergorum, AMNH FR: 30556. If the characters that have been determined to represent variable juvenile morphology in the ontogeny of Deinonychus are exhibited in Bambiraptor, this study will begin the process of determining whether a similar, conservative, ontogenetic pattern exists throughout the rest of Dromaeosauridae. If defensible, it may reduce the number of sympatric taxa within this clade. The other secondary goal relates to the forelimb function. The approximate body size, forelimb length, wrist development, and the presence of a more prominent olecranon on the ulna of MCZ 8791 support the hypothesis that juveniles of this taxon possessed some form of flight capability.	[Parsons, William L.; Parsons, Kristen M.] Buffalo Museum Sci, Dept Geol, Buffalo, NY 14211 USA		Parsons, WL (corresponding author), Buffalo Museum Sci, Dept Geol, 1020 Humboldt Pkwy, Buffalo, NY 14211 USA.	bparsons@gow.org						[Anonymous], 1998, RAILS GUIDE RAILS CR; [Anonymous], 1980, COLD LOOK WARM BLOOD; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; Brinkman Daniel L., 1998, Oklahoma Geological Survey Bulletin, V146, P1; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; BROCHU CA, 1995, J HERPETOL, V29, P464, DOI 10.2307/1565002; Burnham DA, 2004, LIFE O PAST, P67; Burnham David A., 2000, University of Kansas Paleontological Contributions New Series, V13, P1; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; CAMPBELL KE, 1983, AUK, V100, P390, DOI 10.1093/auk/100.2.390; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P12398, DOI 10.1073/pnas.0702040104; Chiappe LM, 1996, MUNCHER GEOWEISS, V30, ps203; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; Currie Philip J., 2000, Gaia (Lisboa), V15, P271; de Ricqles A, 2001, CR ACAD SCI II A, V332, P647, DOI 10.1016/S1251-8050(01)01580-4; Dial KP, 2003, AUK, V120, P941, DOI 10.1642/0004-8038(2003)120[0941:EOALCO]2.0.CO;2; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Goloboff PJ, 2013, TREE ANAL USING NEW; Guenther MF, 2009, ANAT REC, V292, P1427, DOI 10.1002/ar.20988; Han G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5382; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Kirkland JI, 1993, HUNTERIA, V2, P116; Lee AH, 2013, J VERTEBR PALEONTOL, V33, P865, DOI 10.1080/02724634.2013.743898; Longrich NR, 2009, P NATL ACAD SCI USA, V106, P5002, DOI 10.1073/pnas.0811664106; Matthew WD, 1922, B AM MUS NAT HIST, V56, P367; Mayr G, 2010, J VERTEBR PALEONTOL, V30, P1313, DOI 10.1080/02724634.2010.501465; Myhrvold NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081917; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Novas FE, 2005, NATURE, V433, P858, DOI 10.1038/nature03285; Osborne T., 1998, ECOLOGY KORI BUSTARD; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Ostrom J.H., 1974, Postilla, VNo. 165, P1; Ostrom J.H., 1976, BREVIORA, V439, P1; Parsons William L., 2009, Bulletin of the Buffalo Society of Natural Sciences, V38, P43; Paul G.S., 2010, PRINCETON FIELD GUID; Reid R.E.H., 1990, Modern Geology, V15, P19; Rozhdestvensky AK, 1965, PALEONTOL ZH, V3, P95; Sampson SD, 1993, THESIS U TORONTO TOR; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; SUES HD, 1978, ZOOL J LINN SOC-LOND, V62, P381, DOI 10.1111/j.1096-3642.1978.tb01049.x; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Turner AH, 2012, B AM MUS NAT HIST, P5; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Woodward HN, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P195; Woolley JD, 2000, J EXP BIOL, V203, P1767; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056	61	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121476	10.1371/journal.pone.0121476	http://dx.doi.org/10.1371/journal.pone.0121476			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875499	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800021
J	Phan, MD; Forde, BM; Peters, KM; Sarkar, S; Hancock, S; Stanton-Cook, M; Ben Zakour, NL; Upton, M; Beatson, SA; Schembri, MA				Phan, Minh Duy; Forde, Brian M.; Peters, Kate M.; Sarkar, Sohinee; Hancock, Steven; Stanton-Cook, Mitchell; Ben Zakour, Nouri L.; Upton, Mathew; Beatson, Scott A.; Schembri, Mark A.			Molecular Characterization of a Multidrug Resistance IncF Plasmid from the Globally Disseminated Escherichia coli ST131 Clone	PLOS ONE			English	Article							SEQUENCE TYPE 131; F-PLASMID; BETA-LACTAMASE; NUCLEOTIDE-SEQUENCE; STABLE MAINTENANCE; DNA GYRASE; REPA1 GENE; REPLICATION; NR1; CTX-M-15	Escherichia coli sequence type 131 (E. coli ST131) is a recently emerged and globally disseminated multidrug resistant clone associated with urinary tract and bloodstream infections. Plasmids represent a major vehicle for the carriage of antibiotic resistance genes in E. coli ST131. In this study, we determined the complete sequence and performed a comprehensive annotation of pEC958, an IncF plasmid from the E. coli ST131 reference strain EC958. Plasmid pEC958 is 135.6 kb in size, harbours two replicons (RepFIA and RepFII) and contains 12 antibiotic resistance genes (including the bla(CTX-M-15) gene). We also carried out hyper-saturated transposon mutagenesis and multiplexed transposon directed insertion- site sequencing (TraDIS) to investigate the biology of pEC958. TraDIS data showed that while only the RepFII replicon was required for pEC958 replication, the RepFIA replicon contains genes essential for its partitioning. Thus, our data provides direct evidence that the RepFIA and RepFII replicons in pEC958 cooperate to ensure their stable inheritance. The gene encoding the antitoxin component (ccdA) of the post-segregational killing system CcdAB was also protected from mutagenesis, demonstrating this system is active. Sequence comparison with a global collection of ST131 strains suggest that IncF represents the most common type of plasmid in this clone, and underscores the need to understand its evolution and contribution to the spread of antibiotic resistance genes in E. coli ST131.	[Phan, Minh Duy; Forde, Brian M.; Peters, Kate M.; Sarkar, Sohinee; Hancock, Steven; Stanton-Cook, Mitchell; Ben Zakour, Nouri L.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Upton, Mathew] Univ Plymouth, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England; [Upton, Mathew] Univ Plymouth, Peninsula Sch Dent, Plymouth PL4 8AA, Devon, England	University of Queensland; University of Plymouth; University of Plymouth	Schembri, MA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.	m.schembri@uq.edu.au	Upton, Mathew/J-7514-2019; ZAKOUR, Nouri L BEN/B-9338-2011; Beatson, Scott/B-6985-2013; Forde, Brian/GLQ-9491-2022; Hancock, Steven/AAJ-5231-2021; Phan, Minh-Duy/I-9147-2012; Schembri, Mark A/C-7262-2009	Upton, Mathew/0000-0003-4287-6396; ZAKOUR, Nouri L BEN/0000-0002-6949-1755; Beatson, Scott/0000-0002-1806-3283; Forde, Brian/0000-0002-2264-4785; Hancock, Steven/0000-0001-7203-2640; Phan, Minh-Duy/0000-0002-3426-1044; Schembri, Mark A/0000-0003-4863-9260; Sarkar, Sohinee/0000-0001-9364-1920	Australian National Health and Medical Research Council (NHMRC) [APP1012076, APP1067455]; Australian Research Council [FT100100662]; NHMRC [APP1090456]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC) (http://www.nhmrc.gov.au/) to MAS and SAB (APP1012076 and APP1067455). MAS is supported by an Australian Research Council (http://www.arc.gov.au/) Future Fellowship (FT100100662). SAB is supported by an NHMRC Career Development Fellowship (APP1090456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Andersen PS, 2013, GENOME ANNOUNCEMENTS, V1; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; AUSTIN S, 1983, PLASMID, V10, P73, DOI 10.1016/0147-619X(83)90059-8; Bonnin RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034752; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chen L, 2014, ANTIMICROB AGENTS CH, V58, P2422, DOI 10.1128/AAC.02587-13; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P1005, DOI 10.1093/jac/dkr041; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Fiett J, 2014, ANTIMICROB AGENTS CH, V58, P1203, DOI 10.1128/AAC.01197-13; Floyd RV, 2012, J INFECT DIS, V206, P1589, DOI 10.1093/infdis/jis554; Forde BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104400; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gibreel TM, 2012, J ANTIMICROB CHEMOTH, V67, P346, DOI 10.1093/jac/dkr451; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; JIANG T, 1993, J BACTERIOL, V175, P5350, DOI 10.1128/JB.175.17.5350-5358.1993; Johnson JR, 2010, ANTIMICROB AGENTS CH, V54, P546, DOI 10.1128/AAC.01089-09; KLINE BC, 1985, PLASMID, V14, P1, DOI 10.1016/0147-619X(85)90027-7; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LANE D, 1986, NUCLEIC ACIDS RES, V14, P9713; LANE HED, 1981, PLASMID, V5, P100, DOI 10.1016/0147-619X(81)90079-2; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lanza VF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004766; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lou ZQ, 2014, CHINESE MED J-PEKING, V127, P528, DOI 10.3760/cma.j.issn.0366-6999.20130253; MAAS R, 1989, MOL GEN GENET, V218, P190, DOI 10.1007/BF00331268; MANEEWANNAKUL S, 1992, J BACTERIOL, V174, P5567, DOI 10.1128/JB.174.17.5567-5574.1992; MASAI H, 1983, P NATL ACAD SCI-BIOL, V80, P6814, DOI 10.1073/pnas.80.22.6814; MIKI T, 1992, J MOL BIOL, V225, P39, DOI 10.1016/0022-2836(92)91024-J; MIKI T, 1980, J BACTERIOL, V141, P87, DOI 10.1128/JB.141.1.87-99.1980; Phan MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003834; Montesinos I, 2010, J ANTIMICROB CHEMOTH, V65, P1828, DOI 10.1093/jac/dkq208; MOORE D, 1990, J BACTERIOL, V172, P4263, DOI 10.1128/jb.172.8.4263-4270.1990; MORI H, 1986, J MOL BIOL, V192, P1, DOI 10.1016/0022-2836(86)90459-6; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; O'Hara JA, 2014, ANTIMICROB AGENTS CH, V58, P4234, DOI 10.1128/AAC.02182-13; OHTSUBO E, 1977, PLASMID, V1, P8, DOI 10.1016/0147-619X(77)90004-X; Ohtsubo H, 1986, Adv Biophys, V21, P115, DOI 10.1016/0065-227X(86)90018-3; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P5933, DOI 10.1128/AAC.00639-11; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Price LB, 2013, MBIO, V4, DOI 10.1128/mBio.00377-13; PULLINGER GD, 1992, MOL MICROBIOL, V6, P1631, DOI 10.1111/j.1365-2958.1992.tb00888.x; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; SILVER L, 1977, J BACTERIOL, V131, P929, DOI 10.1128/JB.131.3.929-942.1977; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; SYKORA P, 1992, J THEOR BIOL, V159, P53, DOI 10.1016/S0022-5193(05)80767-2; TABUCHI A, 1988, J MOL BIOL, V202, P511, DOI 10.1016/0022-2836(88)90282-3; TANIMOTO K, 1985, MOL GEN GENET, V198, P356, DOI 10.1007/BF00383019; Totsika M, 2013, J INFECT DIS; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Tripathi A, 2012, P NATL ACAD SCI USA, V109, P12497, DOI 10.1073/pnas.1121217109; TSUCHIMOTO S, 1992, J BACTERIOL, V174, P4205, DOI 10.1128/JB.174.13.4205-4211.1992; TSUCHIMOTO S, 1988, J BACTERIOL, V170, P1461, DOI 10.1128/jb.170.4.1461-1466.1988; Uchida Y, 2010, INT J ANTIMICROB AG, V35, P444, DOI 10.1016/j.ijantimicag.2009.12.012; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; WOMBLE DD, 1988, MICROBIOL REV, V52, P433, DOI 10.1128/MMBR.52.4.433-451.1988; WOMBLE DD, 1986, J MOL BIOL, V192, P529, DOI 10.1016/0022-2836(86)90274-3; Woodford N, 2004, J ANTIMICROB CHEMOTH, V54, P735, DOI 10.1093/jac/dkh424; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; WU RP, 1992, J BACTERIOL, V174, P7620, DOI 10.1128/JB.174.23.7620-7628.1992; WU RP, 1993, J BACTERIOL, V175, P3161, DOI 10.1128/JB.175.10.3161-3173.1993; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zong ZY, 2013, ANTIMICROB AGENTS CH, V57, P597, DOI 10.1128/AAC.01081-12	86	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122369	10.1371/journal.pone.0122369	http://dx.doi.org/10.1371/journal.pone.0122369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875675	gold, Green Submitted, Green Published			2022-12-26	WOS:000353015800055
J	Sarveswaran, S; Ghosh, R; Morisetty, S; Ghosh, J				Sarveswaran, Sivalokanathan; Ghosh, Ritisha; Morisetty, Shravan; Ghosh, Jagadananda			MK591, a Second Generation Leukotriene Biosynthesis Inhibitor, Prevents Invasion and Induces Apoptosis in the Bone-Invading C4-2B Human Prostate Cancer Cells: Implications for the Treatment of Castration-Resistant, Bone-Metastatic Prostate Cancer	PLOS ONE			English	Article							ARACHIDONATE 5-LIPOXYGENASE; SIGNALING PATHWAY; FATTY-ACIDS; DIETARY-FAT; MYC; GROWTH; ACTIVATION; PROMOTER; BINDING; STRESS	Castration-resistant prostate cancer (CRPC) is a major clinical challenge for which no cure is currently available primarily because of the lack of proper understanding about appropriate molecular target(s). Previously we observed that inhibition of 5-lipoxygenase (5-Lox) activity induces apoptosis in some types of prostate cancer cells, suggesting an important role of 5-Lox in the viability of prostate cancer cells. However, nothing is known about the role of 5-Lox in the survival of castration-resistant, metastatic prostate cancer cells. Thus, we tested the effects of MK591, a second-generation, specific inhibitor of 5-Lox activity, on the viability and metastatic characteristics of CRPC cells. We observed that MK591 effectively kills the bone-invading C4-2B human prostate cancer cells (which bear characteristics of CRPC), but does not affect normal, non-cancer fibroblasts (which do not express 5-Lox) in the same experimental conditions. We also observed that MK591 dramatically inhibits the in vitro invasion and soft-agar colony formation of C4-2B cells. Interestingly, we found that treatment with MK591 dramatically down-regulates the expression of c-Myc and its targets at sub-lethal doses. In light of frequent over-activation of c-Myc in a spectrum of aggressive cancers (including CRPC), and the challenges associated with inhibition of c-Myc (because of its non-enzymatic nature), our novel findings of selective killing, and blockade of invasive and soft-agar colony-forming abilities of the castration-resistant, bone-metastatic C4-2B prostate cancer cells by MK591, open up a new avenue to attack CRPC cells for better management of advanced prostate cancer while sparing normal, non-cancer body cells.	[Sarveswaran, Sivalokanathan; Ghosh, Ritisha; Morisetty, Shravan; Ghosh, Jagadananda] Henry Ford Hlth Syst, Dept Urol, Detroit, MI 48202 USA; [Ghosh, Jagadananda] Henry Ford Hlth Syst, Josephine Ford Canc Ctr, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Ghosh, J (corresponding author), Henry Ford Hlth Syst, Dept Urol, Detroit, MI 48202 USA.	jghosh1@hfhs.org			National Cancer Institute of the National Institutes of Health [RO1 CA152334]; United States Department of Defense Prostate Cancer Research Program [W81-XWH-05-1-0022]; Henry Ford Health System internal research grant [A10203]; NATIONAL CANCER INSTITUTE [R01CA152334] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense Prostate Cancer Research Program(United States Department of Defense); Henry Ford Health System internal research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award number RO1 CA152334, the United States Department of Defense Prostate Cancer Research Program W81-XWH-05-1-0022, and the Henry Ford Health System internal research grant A10203 to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Anderson KM, 1998, PROSTATE, V37, P161, DOI 10.1002/(SICI)1097-0045(19981101)37:3<161::AID-PROS5>3.0.CO;2-D; Attard G, 2006, BRIT J CANCER, V95, P767, DOI 10.1038/sj.bjc.6603223; Carson JP, 1999, CANCER RES, V59, P1449; Civenni G, 2013, CANCER RES, V73, P6816, DOI 10.1158/0008-5472.CAN-13-0615; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; DEPRE M, 1994, CLIN PHARMACOL THER, V56, P22, DOI 10.1038/clpt.1994.96; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fleshner Neil, 2004, Journal of Urology, V171, pS19, DOI 10.1097/01.ju.0000107838.33623.19; GANN PH, 1994, J NATL CANCER I, V86, P281, DOI 10.1093/jnci/86.4.281; Ghosh J, 1998, P NATL ACAD SCI USA, V95, P13182, DOI 10.1073/pnas.95.22.13182; Ghosh J, 2003, BIOCHEM BIOPH RES CO, V307, P342, DOI 10.1016/S0006-291X(03)01201-4; Ghosh J, 1997, BIOCHEM BIOPH RES CO, V235, P418, DOI 10.1006/bbrc.1997.6799; Ghosh J, 1999, ADV EXP MED BIOL, V469, P577; Ghosh J., 2008, CURR ENZYME INHIB, V4, P18, DOI DOI 10.2174/157340808783502540; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; HOSHIKO S, 1990, P NATL ACAD SCI USA, V87, P9073, DOI 10.1073/pnas.87.23.9073; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Klan N, 2003, BIOL CHEM, V384, P777, DOI 10.1515/BC.2003.086; Koh CM, 2011, AM J PATHOL, V178, P1824, DOI 10.1016/j.ajpath.2010.12.040; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Kolonel LN, 1999, JNCI-J NATL CANCER I, V91, P414, DOI 10.1093/jnci/91.5.414; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lin DL, 2001, PROSTATE, V47, P212, DOI 10.1002/pros.1065; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013500; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; Nadeau PJ, 2009, MOL BIOL CELL, V20, P3628, DOI 10.1091/mbc.E09-03-0211; PRASIT P, 1993, J LIPID MEDIATOR, V6, P239; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Roberts WG, 1997, GASTROENTEROLOGY, V112, P725, DOI 10.1053/gast.1997.v112.pm9041233; Rose DP, 1997, AM J CLIN NUTR, V66, P1513; Ryan CJ, 2005, J CLIN ONCOL, V23, P8242, DOI 10.1200/JCO.2005.03.3092; Sarveswaran S, 2013, CANCER LETT, V336, P185, DOI 10.1016/j.canlet.2013.04.027; Sarveswaran S, 2011, BBA-MOL CELL RES, V1813, P2108, DOI 10.1016/j.bbamcr.2011.07.015; Sarveswaran S, 2010, CANCER LETT, V291, P167, DOI 10.1016/j.canlet.2009.10.008; Shaw GL, 2007, BJU INT, V99, P1056, DOI 10.1111/j.1464-410X.2007.06770.x; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sorg BL, 2006, BBA-MOL CELL BIOL L, V1761, P686, DOI 10.1016/j.bbalip.2006.04.005; Tanaka A, 2003, BIOORG MED CHEM LETT, V13, P1037, DOI 10.1016/S0960-894X(03)00089-1; THALMANN GN, 1994, CANCER RES, V54, P2577; Uhl J, 2002, J BIOL CHEM, V277, P4374, DOI 10.1074/jbc.M107665200; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; WANG Y, 1995, J NATL CANCER I, V87, P1456, DOI 10.1093/jnci/87.19.1456; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; WEST DW, 1991, CANCER CAUSE CONTROL, V2, P85, DOI 10.1007/BF00053126; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Wolfer A, 2010, CELL CYCLE, V9, P3639, DOI 10.4161/cc.9.18.13220; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; WYNDER EL, 1994, NUTR CANCER, V22, P1, DOI 10.1080/01635589409514327; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722	65	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122805	10.1371/journal.pone.0122805	http://dx.doi.org/10.1371/journal.pone.0122805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875826	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800076
J	Sur, A; Pradhan, B; Banerjee, A; Aich, P				Sur, Abhinav; Pradhan, Biswaranjan; Banerjee, Arka; Aich, Palok			Immune Activation Efficacy of Indolicidin Is Enhanced upon Conjugation with Carbon Nanotubes and Gold Nanoparticles	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; HOST-DEFENSE PEPTIDES; MODULATION; RESISTANCE; DELIVERY; BINDING; PROTEIN; MICE	Antibiotic resistance is concern of today's world. Search for alternative molecules, for treatment and immune stimulation, remains at the forefront. One such group of biomolecules with promise, along the line of immune stimulation or therapy, is host defense peptide ( HDP). These molecules, however, are required at a higher dose to be effective which leads to high cost. To alleviate such problems, an aid can be used to achieve similar efficacy but at a smaller effective dose of the immune stimulant. We hypothesised that by conjugating HDPs with carbon nanotubes and/or gold nanoparticles, it would be possible to stimulate a protective immune response in host system at a lower dosage of HDP. In this report, we characterized, using biophysical methodologies, conjugation of Indolicidin, as a representative of HDP. We further established efficacy of peptide-nanomaterial conjugates in activating innate immunity and protecting against pathogen infection in vitro at a significantly small dose.	[Sur, Abhinav; Pradhan, Biswaranjan; Banerjee, Arka; Aich, Palok] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Orissa, India	National Institute of Science Education & Research (NISER)	Aich, P (corresponding author), Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Orissa, India.	palok.aich@niser.ac.in	Sur, Abhinav/GXZ-4996-2022; Aich, Palok/A-3605-2010; Pradhan, Biswaranjan/AAW-5511-2020	Aich, Palok/0000-0003-4927-7812; Pradhan, Biswaranjan/0000-0002-8337-7748; Sur, Abhinav/0000-0003-2236-1459	Department of Science & Technology, India [SR/NM/NS-58/2010]	Department of Science & Technology, India(Department of Science & Technology (India))	Funding is through Nanomission project of Department of Science & Technology, India with DST # SR/NM/NS-58/2010. Funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AJ, 2013, ACS NANO, V7, P1108, DOI 10.1021/nn3055175; Andres E, 2004, REV MED INTERNE, V25, P629, DOI 10.1016/j.revmed.2004.02.025; Bianco Alberto, 2005, Current Drug Delivery, V2, P253, DOI 10.2174/1567201054367959; Boehr DD, 2003, CHEM BIOL, V10, P189, DOI 10.1016/S1074-5521(03)00026-7; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Chakravarthy KV, 2010, P NATL ACAD SCI USA, V107, P10172, DOI 10.1073/pnas.0914561107; Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b; Davies SA, 2009, GEN COMP ENDOCR, V162, P113, DOI 10.1016/j.ygcen.2008.09.012; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Harrison C J, 2009, Minerva Pediatr, V61, P503; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Kotagiri N, 2014, INT J NANOMED, V9, P85, DOI 10.2147/IJN.S51854; Kovacs-Nolan J, 2009, VACCINE, V27, P2055, DOI 10.1016/j.vaccine.2009.01.118; Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Minati L, 2012, LANGMUIR, V28, P15900, DOI 10.1021/la303298u; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nijnik A, 2009, J IMMUNOL, V183, P5788, DOI 10.4049/jimmunol.0901491; Okuyama-Nishida Y, 2009, ANTIMICROB AGENTS CH, V53, P2510, DOI 10.1128/AAC.00863-08; Pompilio A, 2011, PEPTIDES, V32, P1807, DOI 10.1016/j.peptides.2011.08.002; Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Watari F, 2009, J R SOC INTERFACE, V6, pS371, DOI 10.1098/rsif.2008.0488.focus; Wheeler DS, 2009, RECENT PATENTS INFLA, V3, P96, DOI 10.2174/187221309788489779; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983	29	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123905	10.1371/journal.pone.0123905	http://dx.doi.org/10.1371/journal.pone.0123905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876153	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800122
J	Yang, WH; Heine, O; Pauly, S; Kim, P; Bloch, W; Mester, J; Grau, M				Yang, Woo Hwi; Heine, Oliver; Pauly, Sebastian; Kim, Pilsang; Bloch, Wilhelm; Mester, Joachim; Grau, Marijke			Rapid Rather than Gradual Weight Reduction Impairs Hemorheological Parameters of Taekwondo Athletes through Reduction in RBC-NOS Activation	PLOS ONE			English	Article							RED-BLOOD-CELLS; NITRIC-OXIDE; PLASMA NITRITE; EXERCISE; DEFORMABILITY; ERYTHROCYTES; RHEOLOGY; AGGREGATION; REHYDRATION; DEHYDRATION	Purpose Rapid weight reduction is part of the pre-competition routine and has been shown to negatively affect psychological and physiological performance of Taekwondo (TKD) athletes. This is caused by a reduction of the body water and an electrolyte imbalance. So far, it is unknown whether weight reduction also affects hemorheological properties and hemorheology- influencing nitric oxide (NO) signaling, important for oxygen supply to the muscles and organs. Methods For this purpose, ten male TKD athletes reduced their body weight by 5% within four days (rapid weight reduction, RWR). After a recovery phase, athletes reduced body weight by 5% within four weeks (gradual weight reduction, GWR). Each intervention was preceded by two baseline measurements and followed by a simulated competition. Basal blood parameters (red blood cell (RBC) count, hemoglobin concentration, hematocrit, mean corpuscular volume, mean cellular hemoglobin and mean cellular hemoglobin concentration), RBC-NO synthase activation, RBC nitrite as marker for NO synthesis, RBC deformability and aggregation parameters were determined on a total of eight investigation days. Results Basal blood parameters were not affected by the two interventions. In contrast to GWR, RWR decreased activation of RBC-NO synthase, RBC nitrite, respective NO concentration and RBC deformability. Additionally, RWR increased RBC aggregation and disaggregation threshold. Conclusion The results point out that a rapid weight reduction negatively affects hemorheological parameters and NO signaling in RBC which might limit performance capacity. Thus, GWR should be preferred to achieve the desired weight prior to a competition to avoid these negative effects.	[Pauly, Sebastian; Kim, Pilsang; Bloch, Wilhelm; Grau, Marijke] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Inst Cardiovasc Res & Sport Med, Cologne, Germany; [Yang, Woo Hwi; Mester, Joachim] German Sport Univ Cologne, Inst Training Sci & Sport Informat, Cologne, Germany; [Bloch, Wilhelm; Mester, Joachim; Grau, Marijke] German Sport Univ Cologne, German Res Ctr Elite Sports, Cologne, Germany; [Yang, Woo Hwi; Heine, Oliver] Olymp Training Ctr Rhineland, Cologne, Germany	German Sport University Cologne; German Sport University Cologne; German Sport University Cologne	Grau, M (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Inst Cardiovasc Res & Sport Med, Cologne, Germany.	m.grau@dshs-koeln.de	Yang, Woo-Hwi/O-6393-2016; Grau, Marijke/AAM-7025-2020; Yang, Woo-Hwi/ABF-6255-2020	Yang, Woo-Hwi/0000-0001-6618-1834; Yang, Woo-Hwi/0000-0001-6618-1834; Grau, Dr. Marijke/0000-0003-1980-9195	German Sport University Cologne	German Sport University Cologne	This study was supported by the grant funding of the German Sport University Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadizad S, 2006, CLIN HEMORHEOL MICRO, V35, P317; ALESSIO HM, 1993, MED SCI SPORT EXER, V25, P218, DOI 10.1249/00005768-199302000-00010; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265; Baskurt O, 2012, RED BLOOD CELL AGGRE, P1; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt OK, 1998, FREE RADICAL BIO MED, V24, P102, DOI 10.1016/S0891-5849(97)00169-X; BEUTLER E, 1988, TRANSFUSION, V28, P353, DOI 10.1046/j.1537-2995.1988.28488265266.x; BEUTLER E, 1969, TRANSFUSION, V9, P109, DOI 10.1111/j.1537-2995.1969.tb05527.x; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Brito CJ, 2012, INT J SPORT NUTR EXE, V22, P89, DOI 10.1123/ijsnem.22.2.89; Brun JF, 2012, CLIN HEMORHEOL MICRO, V51, P29, DOI 10.3233/CH-2011-1426; Brun JF, 2010, BIORHEOLOGY, V47, P95, DOI 10.3233/BIR-2010-0563; Brun JF, 2000, CLIN HEMORHEOL MICRO, V22, P287; Brun JF, 1998, CLIN HEMORHEOL MICRO, V19, P89; Bull BS, 1996, 26TH WORLD CONGRESS; CARD RT, 1982, TRANSFUSION, V22, P96, DOI 10.1046/j.1537-2995.1982.22282177134.x; Connes P, 2013, CLIN HEMORHEOL MICRO, V53, P187, DOI 10.3233/CH-2012-1643; DERN RJ, 1967, J LAB CLIN MED, V69, P968; El-Sayed MS, 2005, SPORTS MED, V35, P649, DOI 10.2165/00007256-200535080-00001; ERNST E, 1991, CLIN HEMORHEOL, V11, P429; FRANCESCONI RP, 1987, J APPL PHYSIOL, V62, P1271, DOI 10.1152/jappl.1987.62.3.1271; Gaudard A, 2004, CLIN HEMORHEOL MICRO, V30, P1; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Grau M, 2007, J CHROMATOGR B, V851, P106, DOI 10.1016/j.jchromb.2007.02.002; Grau M, 2015, CLIN HEMORHEOL MICRO, V60, P215, DOI 10.3233/CH-141850; Grau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056759; HARADIN AR, 1969, TRANSFUSION, V9, P229; HARDEMAN MR, 1987, CLIN CHIM ACTA, V165, P227, DOI 10.1016/0009-8981(87)90166-5; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Henkelman S, 2010, TRANSFUSION, V50, P941, DOI 10.1111/j.1537-2995.2009.02521.x; Kelm M, 1999, CARDIOVASC RES, V41, P765, DOI 10.1016/S0008-6363(98)00259-4; Kilic-Toprak E, 2012, MED SCI MONITOR, V18, pCR351, DOI 10.12659/MSM.882878; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Koral J, 2009, J SPORT SCI, V27, P115, DOI 10.1080/02640410802413214; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; LIPOWSKY HH, 1993, MICROVASC RES, V46, P43, DOI 10.1006/mvre.1993.1034; Lundberg JO, 2010, BIOCHEM BIOPH RES CO, V396, P39, DOI 10.1016/j.bbrc.2010.02.136; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P40, DOI 10.1111/j.1600-0838.2010.01207.x; McArdle W, 1986, EXERCISE PHYSIOLOGY; MCMURRAY RG, 1991, INT J SPORTS MED, V12, P167, DOI 10.1055/s-2007-1024662; Michalska-Malecka K, 2012, CLIN HEMORHEOL MICRO, V51, P277, DOI 10.3233/CH-2012-1533; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Oppliger RA, 1996, MED SCI SPORT EXER, V28, pR9; Pelletier MM, 2006, FREE RADICAL BIO MED, V41, P541, DOI 10.1016/j.freeradbiomed.2006.05.001; Rampling MW, 2004, BIORHEOLOGY, V41, P91; RIBISL PM, 1970, RES QUART, V41, P536, DOI 10.1080/10671188.1970.10615013; ROBINSON S, 1954, PHYSIOL REV, V34, P202, DOI 10.1152/physrev.1954.34.2.202; Roemmich JN, 1996, INT J SPORTS MED, V17, P92, DOI 10.1055/s-2007-972814; SALTIN B, 1964, J APPL PHYSIOL, V19, P1125, DOI 10.1152/jappl.1964.19.6.1125; SMITH JA, 1995, SPORTS MED, V19, P9, DOI 10.2165/00007256-199519010-00002; SOMER T, 1993, ANN MED, V25, P31, DOI 10.3109/07853899309147854; SOPKO G, 1985, METABOLISM, V34, P227, DOI 10.1016/0026-0495(85)90005-8; Suhr F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045982; Tikhomirova IA, 2002, CLIN HEMORHEOL MICRO, V26, P85; Tripette J, 2010, AM J PHYSIOL-HEART C, V299, pH908, DOI 10.1152/ajpheart.00298.2010; Ulker P, 2009, BIORHEOLOGY, V46, P121, DOI 10.3233/BIR-2009-0532; VICAUT E, 1995, J CARDIOVASC SURG, V36, P361; WEBSTER S, 1990, MED SCI SPORT EXER, V22, P229; Yalcin O, 2003, J APPL PHYSIOL, V94, P997, DOI 10.1152/japplphysiol.00368.2002; Yang WH, 2014, ARCH BUDO, V10, P169	63	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123767	10.1371/journal.pone.0123767	http://dx.doi.org/10.1371/journal.pone.0123767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875585	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700042
J	Baiamonte, M; Brennan, CH; Vinson, GP				Baiamonte, Matteo; Brennan, Caroline H.; Vinson, Gavin P.			Sustained Action of Developmental Ethanol Exposure on the Cortisol Response to Stress in Zebrafish Larvae and Adults	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-INTERRENAL AXIS; PRENATAL EXPOSURE; BETA-ENDORPHIN; ALCOHOL DEPENDENCE; ADRENAL RESPONSES; CORTICOSTERONE; BRAIN; MODEL; RAT	Background Ethanol exposure during pregnancy is one of the leading causes of preventable birth defects, leading to a range of symptoms collectively known as fetal alcohol spectrum disorder. More moderate levels of prenatal ethanol exposure lead to a range of behavioural deficits including aggression, poor social interaction, poor cognitive performance and increased likelihood of addiction in later life. Current theories suggest that adaptation in the hypothalamo-pituitary-adrenal (HPA) axis and neuroendocrine systems contributes to mood alterations underlying behavioural deficits and vulnerability to addiction. In using zebrafish (Danio rerio), the aim is to determine whether developmental ethanol exposure provokes changes in the hypothalamo-pituitary-interrenal (HPI) axis (the teleost equivalent of the HPA), as it does in mammalian models, therefore opening the possibilities of using zebrafish to elucidate the mechanisms involved, and to test novel therapeutics to alleviate deleterious symptoms. Results and Conclusions The results showed that developmental exposure to ambient ethanol, 20mM-50mM 1-9 days post fertilisation, had immediate effects on the HPI, markedly reducing the cortisol response to air exposure stress, as measured by whole body cortisol content. This effect was sustained in adults 6 months later. Morphology, growth and locomotor activity of the animals were unaffected, suggesting a specific action of ethanol on the HPI. In this respect the data are consistent with mammalian results, although they contrast with the higher corticosteroid stress response reported in rats after developmental ethanol exposure. The mechanisms that underlie the specific sensitivity of the HPI to ethanol require elucidation.	[Baiamonte, Matteo; Brennan, Caroline H.; Vinson, Gavin P.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Vinson, GP (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	G.P.Vinson@qmul.ac.uk			National Centre for the replacement, refinement and reduction of animals in research; Biotechnology and Biological Sciences Research Council [976807] Funding Source: researchfish; National Centre for the Replacement [G1000053/1] Funding Source: researchfish	National Centre for the replacement, refinement and reduction of animals in research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement	This study was supported by the National Centre for the replacement, refinement and reduction of animals in research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinoff B, 2003, ALCOHOL CLIN EXP RES, V27, P1420, DOI 10.1097/01.ALC.0000087581.13912.64; Alderman SL, 2012, J ENDOCRINOL, V215, P393, DOI 10.1530/JOE-12-0379; Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; ANGELOGIANNI P, 1989, ALCOHOL CLIN EXP RES, V13, P564, DOI 10.1111/j.1530-0277.1989.tb00379.x; Bailey JM, 2015, NEUROTOXICOL TERATOL, V48, P1, DOI 10.1016/j.ntt.2015.01.005; Boyd KN, 2010, J NEUROCHEM, V112, P784, DOI 10.1111/j.1471-4159.2009.06509.x; Brennan CH, 2011, NEUROMETHODS, V52, P163, DOI 10.1007/978.1.60761.922.2_7; Collier AD, 2014, PROG NEURO-PSYCHOPH, V55, P16, DOI 10.1016/j.pnpbp.2014.05.014; de Jong IEM, 2009, PSYCHOPHARMACOLOGY, V204, P693, DOI 10.1007/s00213-009-1498-3; Dedovic K, 2009, NEUROIMAGE, V47, P864, DOI 10.1016/j.neuroimage.2009.05.074; ELLIS FW, 1966, J PHARMACOL EXP THER, V153, P121; Fernandes Y, 2009, ALCOHOL CLIN EXP RES, V33, P601, DOI 10.1111/j.1530-0277.2008.00874.x; Fuzzen MLM, 2010, ZEBRAFISH, V7, P349, DOI 10.1089/zeb.2010.0662; Kammerer BD, 2010, COMP BIOCHEM PHYS A, V157, P260, DOI 10.1016/j.cbpa.2010.07.009; Keedwell PA, 2001, ADDICT BIOL, V6, P247, DOI 10.1080/13556210120056580; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; Kim CK, 1999, ALCOHOL CLIN EXP RES, V23, P301, DOI 10.1097/00000374-199902000-00016; Kim CK, 1999, ALCOHOL CLIN EXP RES, V23, P52; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lopez-Olmeda JF, 2013, CHRONOBIOL INT, V30, P530, DOI 10.3109/07420528.2012.754448; Marchesi C, 1997, PSYCHIAT RES, V72, P187, DOI 10.1016/S0165-1781(97)00101-7; NELSON LR, 1986, ALCOHOL CLIN EXP RES, V10, P397, DOI 10.1111/j.1530-0277.1986.tb05112.x; Osborn JA, 1996, PSYCHONEUROENDOCRINO, V21, P127, DOI 10.1016/0306-4530(95)00037-2; Paintner A, 2012, J CHILD NEUROL, V27, P258, DOI 10.1177/0883073811428376; Park E, 2004, NEUROSCI LETT, V368, P345, DOI 10.1016/j.neulet.2004.08.001; Parker MO, 2014, PROG NEURO-PSYCHOPH, V55, P94, DOI 10.1016/j.pnpbp.2014.03.011; PIAZZA PV, 1994, BRAIN RES, V658, P259, DOI 10.1016/S0006-8993(09)90034-8; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026647; Reimers MJ, 2004, NEUROTOXICOL TERATOL, V26, P769, DOI 10.1016/j.ntt.2004.06.012; Richardson HN, 2008, EUR J NEUROSCI, V28, P1641, DOI 10.1111/j.1460-9568.2008.06455.x; Rivier C, 1996, ALCOHOL CLIN EXP RES, V20, P240, DOI 10.1111/j.1530-0277.1996.tb01636.x; RIVIER C, 1984, J PHARMACOL EXP THER, V229, P127; Rivier C, 1996, BRAIN RES, V726, P1, DOI 10.1016/0006-8993(96)00301-0; ROBERTS AJ, 1995, J PHARMACOL EXP THER, V275, P790; Rose AK, 2010, ALCOHOL CLIN EXP RES, V34, P2011, DOI 10.1111/j.1530-0277.2010.01298.x; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Spanagel R, 2014, TRENDS NEUROSCI, V37, P219, DOI 10.1016/j.tins.2014.02.006; Taves MD, 2015, ENDOCRINOLOGY, V156, P511, DOI 10.1210/en.2013-1606; Tran S, 2014, PROG NEURO-PSYCHOPH, V55, P87, DOI 10.1016/j.pnpbp.2014.02.008; Vinson GP, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0028; Vinson GP, 1992, THE ADRENAL CORTEX; WEINBERG J, 1992, ALCOHOL, V9, P219, DOI 10.1016/0741-8329(92)90057-H; Weinberg J, 1996, ALCOHOL CLIN EXP RES, V20, P122, DOI 10.1111/j.1530-0277.1996.tb01054.x; Xia LP, 2014, TOXICOL LETT, V226, P98, DOI 10.1016/j.toxlet.2014.01.023	44	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124488	10.1371/journal.pone.0124488	http://dx.doi.org/10.1371/journal.pone.0124488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875496	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100263
J	Chiba, H; Nishide, H; Uchiyama, I				Chiba, Hirokazu; Nishide, Hiroyo; Uchiyama, Ikuo			Construction of an Ortholog Database Using the Semantic Web Technology for Integrative Analysis of Genomic Data	PLOS ONE			English	Article							ONTOLOGY; GENE; INFORMATION; UNIFICATION; ANNOTATION; DIVERSITY; RESOURCE; SEQUENCE; UNIPROT; BIOLOGY	Recently, various types of biological data, including genomic sequences, have been rapidly accumulating. To discover biological knowledge from such growing heterogeneous data, a flexible framework for data integration is necessary. Ortholog information is a central resource for interlinking corresponding genes among different organisms, and the Semantic Web provides a key technology for the flexible integration of heterogeneous data. We have constructed an ortholog database using the Semantic Web technology, aiming at the integration of numerous genomic data and various types of biological information. To formalize the structure of the ortholog information in the Semantic Web, we have constructed the Ortholog Ontology (OrthO). While the OrthO is a compact ontology for general use, it is designed to be extended to the description of database-specific concepts. On the basis of OrthO, we described the ortholog information from our Microbial Genome Database for Comparative Analysis (MBGD) in the form of Resource Description Framework (RDF) and made it available through the SPARQL endpoint, which accepts arbitrary queries specified by users. In this framework based on the OrthO, the biological data of different organisms can be integrated using the ortholog information as a hub. Besides, the ortholog information from different data sources can be compared with each other using the OrthO as a shared ontology. Here we show some examples demonstrating that the ortholog information described in RDF can be used to link various biological data such as taxonomy information and Gene Ontology. Thus, the ortholog database using the Semantic Web technology can contribute to biological knowledge discovery through integrative data analysis.	[Chiba, Hirokazu; Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, Okazaki, Aichi 4448585, Japan; [Nishide, Hiroyo; Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Data Integrat & Anal Facil, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Uchiyama, I (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	uchiyama@nibb.ac.jp		Uchiyama, Ikuo/0000-0002-9197-5000	National Bioscience Database Center, Japan Science Technology Agency	National Bioscience Database Center, Japan Science Technology Agency	This work was supported by the National Bioscience Database Center, Japan Science Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Minarro-Gimenez JA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S10-S13; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berners-Lee T, 2001, NATURE, V410, P1023, DOI 10.1038/35074206; Chen HJ, 2013, BRIEF BIOINFORM, V14, P109, DOI 10.1093/bib/bbs014; Chiba H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-148; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dumontier M, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-14; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Erling Orri, 2007, CSSW, V113, P59; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gennari JH, 2003, INT J HUM-COMPUT ST, V58, P89, DOI 10.1016/S1071-5819(02)00127-1; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Katayama T, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-5; Katayama T, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-6; Kim JF, 2001, TRENDS GENET, V17, P65, DOI 10.1016/S0168-9525(00)02175-2; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Schmitt T, 2011, BRIEF BIOINFORM, V12, P485, DOI 10.1093/bib/bbr025; Sonnhammer ELL, 2014, BIOINFORMATICS, V30, P2993, DOI 10.1093/bioinformatics/btu492; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; Uchiyama I, 2013, NUCLEIC ACIDS RES, V41, pD631, DOI 10.1093/nar/gks1006; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83	29	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122802	10.1371/journal.pone.0122802	http://dx.doi.org/10.1371/journal.pone.0122802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875762	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100103
J	Huang, C; Liu, W; Hu, Y; Zou, ZJ; Zhao, ZH; Shen, L; Weschler, LB; Sundell, J				Huang, Chen; Liu, Wei; Hu, Yu; Zou, Zhijun; Zhao, Zhuohui; Shen, Li; Weschler, Louise B.; Sundell, Jan			Updated Prevalences of Asthma, Allergy, and Airway Symptoms, and a Systematic Review of Trends over Time for Childhood Asthma in Shanghai, China	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; BUILDING CHARACTERISTICS; ENVIRONMENTAL-FACTORS; RESPIRATORY SYMPTOMS; HOME DAMPNESS; RISK-FACTORS; PHASE-III; HEALTH; ASSOCIATIONS; RHINITIS	Background The prevalence of asthma among Shanghai children has increased over time. This increase might be associated with changes in environmental exposures. Investigation of the timetrend of asthma and current prevalences is essential to understanding the causes. Objective To estimate the current prevalences of asthma, allergies and other respiratory symptoms among Shanghai preschool children, and to investigate the time-trend of childhood asthma prevalence of from 1990 to 2011. Methods From April 2011 to April 2012, the CCHH (China, Children, Homes, Health) cross-sectional study was conducted in Shanghai. Questionnaires were distributed to 17,898 parents or guardians of preschool children from 72 kindergartens in 5 districts. Previous similar studies were also summarized by a systematic literature review. Results From a total of 14,884 questionnaires for 3-7 year old children, prevalences of the following diseases and symptoms were calculated: asthma 10.2%, wheeze (ever) 28.1%, pneumonia (ever) 33.5%, otitis media 11.0%, rhinitis (ever) 54.1%, hay fever 12.2%, eczema (ever) 22.7%, and food allergy 15.7%. Urban children had higher prevalences of most symptoms than suburban children. The prevalence of asthma has increased significantly, almost five-fold, from 2.1% in 1990 to 10.2% in the present study. The prevalence of asthma in boys was higher than in girls in the present study and in all reviewed studies. Conclusions Asthma, allergy and airway symptoms are common among preschool children in Shanghai. The prevalence of childhood asthma in Shanghai has increased rapidly from 1990 to 2011.	[Huang, Chen; Liu, Wei; Zou, Zhijun; Shen, Li] Univ Shanghai Sci & Technol, Dept Bldg Environm & Energy Engn, Sch Environm & Architecture, Shanghai, Peoples R China; [Hu, Yu] Tongji Architectural Design Grp Co Ltd TJAD, Shanghai, Peoples R China; [Zhao, Zhuohui] Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China; [Sundell, Jan] Tsinghua Univ, Sch Architecture, Dept Bldg Sci, Beijing 100084, Peoples R China	University of Shanghai for Science & Technology; Fudan University; Tsinghua University	Huang, C (corresponding author), Univ Shanghai Sci & Technol, Dept Bldg Environm & Energy Engn, Sch Environm & Architecture, Shanghai, Peoples R China.	hcyhyywj@163.com	Liu, Wei/E-3097-2015	Liu, Wei/0000-0001-9863-4332	National Natural Science Foundation of China [51278302]; Innovation Program of Shanghai Municipal Education Commission [14ZZ132]; Hujiang Foundation of China [D14003]; Innovation Fund Project for Graduate Student of Shanghai [JWCXSL1401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Hujiang Foundation of China; Innovation Fund Project for Graduate Student of Shanghai	This study is financially supported by National Natural Science Foundation of China (51278302), Innovation Program of Shanghai Municipal Education Commission (14ZZ132), Hujiang Foundation of China (D14003), and The Innovation Fund Project for Graduate Student of Shanghai (JWCXSL1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, ALLERGY, V64, P123, DOI 10.1111/j.1398-9995.2008.01884.x; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bjerg A, 2010, ALLERGY, V65, P48, DOI 10.1111/j.1398-9995.2009.02105.x; Bjorksten B, 2008, PEDIAT ALLERG IMM-UK, V19, P110, DOI 10.1111/j.1399-3038.2007.00601.x; Bornehag CG, 2004, INDOOR AIR, V14, P59, DOI 10.1111/j.1600-0668.2004.00274.x; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Castro-Rodriguez JA, 2011, CURR OPIN ALLERGY CL, V11, P157, DOI 10.1097/ACI.0b013e3283464c4a; CEPSY China electricity council, 2013, CHIN EL POW STAT YB; Chen Yu-zhi, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P112; Chen YZ., 1998, CHIN J PEDIAT, V36, P352; Choi J, 2014, BUILD ENVIRON, V75, P176, DOI 10.1016/j.buildenv.2014.01.019; de Marco R, 2000, AM J RESP CRIT CARE, V162, P68, DOI 10.1164/ajrccm.162.1.9907008; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Dong GH, 2008, RESPIRATION, V76, P82, DOI 10.1159/000121370; [董蔚 Dong Wei], 2012, [临床儿科杂志, Journal of Chinical Pediatrics], V30, P1139; Duggan EM, 2012, PEDIAT ALLERG IMM-UK, V23, P464, DOI 10.1111/j.1399-3038.2012.01291.x; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Grize L, 2006, ALLERGY, V61, P556, DOI 10.1111/j.1398-9995.2006.01030.x; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; Hong Soyoung, 2012, Environ Health Toxicol, V27, pe2012006, DOI 10.5620/eht.2012.27.e2012006; Hu Y, 2014, INDOOR AIR, V24, P450, DOI 10.1111/ina.12104; Huang C, 2013, CHINESE SCI BULL, V58, P4203, DOI 10.1007/s11434-013-5679-4; Li F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-437; Liu W, 2014, INDOOR BUILT ENVIRON, V23, P270, DOI 10.1177/1420326X13516970; Liu W, 2013, CHINESE SCI BULL, V58, P4211, DOI 10.1007/s11434-013-5728-z; Mallol J, 2013, ALLERGOL IMMUNOPATH, V41, P73, DOI 10.1016/j.aller.2012.03.001; Mi YH, 2006, INDOOR AIR, V16, P454, DOI 10.1111/j.1600-0668.2006.00439.x; Naydenov K, 2008, BUILD ENVIRON, V43, P1840, DOI 10.1016/j.buildenv.2007.10.020; Niu C., 2010, CHIN J SCH HEAL, V31, P708; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; Poulos Leanne M, 2005, Paediatr Respir Rev, V6, P20, DOI 10.1016/j.prrv.2004.11.004; Qian JJ, 2011, J INTER MED CON PRAC, V6, P121; Qu F, 2013, CHINESE SCI BULL, V58, P4190, DOI 10.1007/s11434-013-5790-6; Shanghai Municipal Bureau of Statistics, 2012, SHANGH STAT YB 2012; Shi YM., 2010, CHIN J GEN PRACTICE, V11, P1436; Song DP, 2008, CHIN J PRI MED PHAR, V15, P1421; The Cooperation Group on Childhood Asthma of Shanghai Medical Association, 1994, J CLIN PEDIAT, V12, P107; The Cooperation Group on Childhood Asthma of Shanghai Medical Association, 2002, J CLIN PEDIAT, V12, P144; Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WILSON NM, 1995, EUR RESPIR J, V8, P364, DOI 10.1183/09031936.95.08030364; Wu JinGai, 2010, Journal of Environment and Health, V27, P127; Yangzong YZ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-860; Yuan Dong, 2007, Journal of Environmental & Occupational Medicine, V24, P573; Zhang YP, 2013, CHINESE SCI BULL, V58, P4182, DOI 10.1007/s11434-013-5914-z; Zhang YP, 2013, ENVIRON HEALTH PERSP, V121, P751, DOI 10.1289/ehp.1205983; [张玉娥 Zhang Yue], 2012, [临床儿科杂志, Journal of Chinical Pediatrics], V30, P339; [张玉娥 ZHANG Yue], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P149; Zhao J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-551; Zollner IK, 2005, THORAX, V60, P545, DOI 10.1136/thx.2004.029561; 杭晶卿, 2002, [中国实用内科杂志, Chinese Journal of Practical Internal Medicine], V22, P616	58	74	79	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121577	10.1371/journal.pone.0121577	http://dx.doi.org/10.1371/journal.pone.0121577			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875829	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100043
J	Ji, C; Miao, Z; He, XL				Ji, Cong; Miao, Zong; He, Xionglei			A Simple Strategy for Reducing False Negatives in Calling Variants from Single-Cell Sequencing Data	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; GENETIC-VARIATION; SOMATIC MUTATION; GENOME; CANCER; NUCLEOTIDE; EVOLUTION; EMBRYO; TUMOR	Due to the growth of interest in single-cell genomics, computational methods for distinguishing true variants from artifacts are highly desirable. While special attention has been paid to false positives in variant or mutation calling from single-cell sequencing data, an equally important but often neglected issue is that of false negatives derived from allele dropout during the amplification of single cell genomes. In this paper, we propose a simple strategy to reduce the false negatives in single-cell sequencing data analysis. Simulation results show that this method is highly reliable, with an error rate of 4.94x10(-5), which is orders of magnitude lower than the expected false negative rate (similar to 34%) estimated from a single-cell exome dataset, though the method is limited by the low SNP density in the human genome. We applied this method to analyze the exome data of a few dozen single tumor cells generated in previous studies, and extracted cell specific mutation information for a small set of sites. Interestingly, we found that there are difficulties in using the classical clonal model of tumor cell growth to explain the mutation patterns observed in some tumor cells.	[Ji, Cong; Miao, Zong; He, Xionglei] Sun Yat Sen Univ, Coll Ecol & Evolut, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Ji, C (corresponding author), Sun Yat Sen Univ, Coll Ecol & Evolut, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	jicong2015@outlook.com			Marine Fisheries Science and Technology Promotion Project of Guangdong Province [A201301C09]; Science and Technology Planning Project of Guangdong Province [2012A080202006]	Marine Fisheries Science and Technology Promotion Project of Guangdong Province; Science and Technology Planning Project of Guangdong Province	This work is supported by the Marine Fisheries Science and Technology Promotion Project of Guangdong Province (no. A201301C09) and the Science and Technology Planning Project of Guangdong Province (no. 2012A080202006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Burlet P, 2006, MOL HUM REPROD, V12, P647, DOI 10.1093/molehr/gal069; Caldas C, 2012, NAT BIOTECHNOL, V30, P408, DOI 10.1038/nbt.2213; Davis EE, 2014, CLIN GENET, V85, P359, DOI 10.1111/cge.12189; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Guo Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-194; Heinmoller E, 2002, LAB INVEST, V82, P443, DOI 10.1038/labinvest.3780437; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Renwick P, 2006, REPROD BIOMED ONLINE, V13, P110, DOI 10.1016/S1472-6483(10)62024-X; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shibata D, 2012, SCIENCE, V336, P304, DOI 10.1126/science.1222361; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; STRACHAN T, 2010, HUMAN MOL GENETICS; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	24	0	0	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123789	10.1371/journal.pone.0123789	http://dx.doi.org/10.1371/journal.pone.0123789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876174	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100214
J	Larmarange, J; Mossong, J; Barnighausen, T; Newell, ML				Larmarange, Joseph; Mossong, Joel; Barnighausen, Till; Newell, Marie Louise			Participation Dynamics in Population-Based Longitudinal HIV Surveillance in Rural South Africa	PLOS ONE			English	Article							OPTIMAL MATCHING METHODS; ANTIRETROVIRAL TREATMENT; SEQUENCE-ANALYSIS; LIFE EXPECTANCY; HIGH-PREVALENCE; SCALE-UP; INFECTION; SEROPREVALENCE; MORTALITY; COMMUNITY	Population-based HIV surveillance is crucial to inform understanding of the HIV pandemic and evaluate HIV interventions, but little is known about longitudinal participation patterns in such settings. We investigated the dynamics of longitudinal participation patterns in a high HIV prevalence surveillance setting in rural South Africa between 2003 and 2012, taking into account demographic dynamics. At any given survey round, 22,708 to 30,495 persons were eligible. Although the yearly participation rates were relatively modest (26% to 46%), cumulative rates increased substantially with multiple recruitment opportunities: 68% of eligible persons participated at least once, 48% at least twice and 31% at least three times after five survey rounds. We identified two types of study fatigue: at the individual level, contact and consent rates decreased with multiple recruitment opportunities and, at the population level, these rates also decreased over calendar time, independently of multiple recruitment opportunities. Using sequence analysis and hierarchical clustering, we identified three broad individual participation profiles: consenters (20%), switchers (43%) and refusers (37%). Men were over represented among refusers, women among consenters, and temporary non-residents among switchers. The specific subgroup of persons who were systemically not contacted or refusers constitutes a challenge for population-based surveillance and interventions.	[Larmarange, Joseph] Ctr Populat & Dev, Inst Rech Dev, UMR Paris Descartes Ined IRD 196, Paris, France; [Larmarange, Joseph; Mossong, Joel; Barnighausen, Till; Newell, Marie Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Mossong, Joel] Lab Natl St, Surveillance & Epidemiol Infect Dis, Luxembourg, Luxembourg; [Barnighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Newell, Marie Louise] Univ Southampton, Fac Med, Fac Social & Human Sci, Southampton SO9 5NH, Hants, England	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of Southampton	Larmarange, J (corresponding author), Ctr Populat & Dev, Inst Rech Dev, UMR Paris Descartes Ined IRD 196, Paris, France.	joseph.larmarange@ceped.org	Mossong, Joël/D-4998-2009; Larmarange, Joseph/I-5889-2015; Bärnighausen, Till/Y-2388-2019; Newell, Marie-Louise/AAE-8222-2019	Mossong, Joël/0000-0003-0717-9835; Larmarange, Joseph/0000-0001-7097-700X; Newell, Marie-Louise/0000-0002-1074-7699	Wellcome Trust, UK [065377/2/01/B, 082384/Z/07/Z]; Institut de Recherche pour le Developpement (IRD); German government through the Centre for International Migration and Development (CIM); Wellcome Trust; NIH; National Institute of Child Health and Human Development [1R01-HD058482-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482, R01HD084233] Funding Source: NIH RePORTER	Wellcome Trust, UK(Wellcome Trust); Institut de Recherche pour le Developpement (IRD); German government through the Centre for International Migration and Development (CIM); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for the Africa Centre's Demographic Surveillance Information System and Population-based HIV Survey was received from the Wellcome Trust, UK (grants 065377/2/01/B and 082384/Z/07/Z). JL was supported by the Institut de Recherche pour le Developpement (IRD) and JM received partial financial support from the German government through the Centre for International Migration and Development (CIM). TB has been supported by the Wellcome Trust and by NIH and by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development.	ABBOTT A, 1986, J INTERDISCIPL HIST, V16, P471, DOI 10.2307/204500; Abbott A, 2000, SOCIOL METHOD RES, V29, P3, DOI 10.1177/0049124100029001001; Aisenbrey S, 2010, SOCIOL METHOD RES, V38, P420, DOI 10.1177/0049124109357532; Asiki G, 2013, INT J EPIDEMIOL; Barnighausen T, 2012, TROP MED INT HEALTH, V17, pe103, DOI 10.1111/j.1365-3156.2012.02928.x; Barnighausen T, 2011, EPIDEMIOLOGY, V22, P27, DOI 10.1097/EDE.0b013e3181ffa201; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Boerma JT, 1999, AIDS, V13, P1233, DOI 10.1097/00002030-199907090-00013; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Camlin CS, 2013, POPUL SPACE PLACE; Elzinga CH, 2014, SOCIOL METHOD RES; French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS), 2011, IMP IMM VERS WHO REC; Gabadinho A, 2011, ANAL VISUALIZING STA; Giordano K, 2012, JHASE, V4, P1; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Granich R, 2010, CURR OPIN HIV AIDS, V5, P298, DOI 10.1097/COH.0b013e32833a6c32; Helleringer S, 2012, AIDS BEHAV; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; HIV Prevention Trials Network, 2013, POP EFF ANT THER RED; HULL HF, 1988, JAMA-J AM MED ASSOC, V260, P935, DOI 10.1001/jama.260.7.935; Husson F., 2010, EXPLORATORY MULTIVAR, DOI DOI 10.1201/B10345; Iwuji C, 2014, 20 INT AIDS C; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; JENUM P, 1988, NIPH (National Institute of Public Health) Annals (Oslo), V11, P53; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Maher D, 2013, B WORLD HEALTH ORGAN, V91, P950, DOI 10.2471/BLT.13.117309; Marston M, 2008, SEX TRANSM INFECT, V84, pI71, DOI 10.1136/sti.2008.030353; Michael D, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.21783; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mossong J, 2013, AIDS, V27, P2471, DOI 10.1097/01.aids.0000432475.14992.da; Muhwava W, 2010, AFRICAN POPULATION S, V24, P259; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reniers G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-163; Reniers G, 2009, AIDS, V23, P621, DOI 10.1097/QAD.0b013e3283269e13; Reynolds L, 2012, SOC SCI MED; Robette N., 2012, B DE LELO TT ME THOD, V116, P5, DOI [DOI 10.1177/0759106312454635, 10.1177/0759106312454635]; Sakarovitch C, 2007, STAT MED, V26, P320, DOI 10.1002/sim.2540; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; University of California San Francisco, 2013, SUST E AFR RES COMM; Welaga P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-193; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Zuch M, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-3	49	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123345	10.1371/journal.pone.0123345	http://dx.doi.org/10.1371/journal.pone.0123345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875851	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100165
J	Pierre, PV; Johnson, AC; Fridberger, A				Pierre, Pernilla Videhult; Johnson, Ann-Christin; Fridberger, Anders			Subjective and Clinically Assessed Hearing Loss; A Cross-Sectional Register-Based Study on a Swedish Population Aged 18 through 50 Years	PLOS ONE			English	Article							GENERATIONAL-DIFFERENCES; OTOACOUSTIC EMISSIONS; PREVALENCE; IMPAIRMENT; AUDIOMETRY; HEALTH; NOISE; ACCURACY; EXPOSURE; EAR	Objectives Questionnaire studies suggest that hearing is declining among young adults. However, few studies have examined the reliability of hearing questionnaires among young adult subjects. This study examined the associations between pure tone audiometrically assessed (PTA) hearing loss and questionnaire responses in young to middle aged adults. Materials and Methods A cross-sectional study using questionnaire and screening PTA (500 through 6000 Hz) data from 15322 Swedish subjects (62% women) aged 18 through 50 years. PTA hearing loss was defined as a hearing threshold above 20 dB in both ears at one or more frequencies. Data were analysed with chi-square tests, nonlinear regression, binary logistic regression, and the generalized estimating equation (GEE) approach. Results The prevalence of PTA hearing loss was 6.0% in men and 2.9% in women (p < 0.001). Slight hearing impairment was reported by 18.5% of the men and 14.8% of the women (p < 0.001), whereas 0.5% of men and women reported very impaired hearing. Using multivariate GEE modelling, the odds ratio of PTA hearing loss was 30.4 (95% CI, 12.7-72.9) in men and 36.5 (17.2-77.3) in women reporting very impaired hearing. The corresponding figures in those reporting slightly impaired hearing were 7.06 (5.25-9.49) in men and 8.99 (6.38-12.7) in women. These values depended on the sound stimulus frequency (p = 0.001). The area under the ROC curve was 0.904 (0.892-0.915) in men and 0.886 (0.872-0.900) in women. Conclusions Subjective hearing impairment predicted clinically assessed hearing loss, suggesting that there is cause for concern as regards the future development of hearing in young to middle-aged people.	[Pierre, Pernilla Videhult; Johnson, Ann-Christin] Karolinska Inst, Div Audiol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Pierre, Pernilla Videhult] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Fridberger, Anders] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden	Karolinska Institutet; Uppsala University; Linkoping University	Pierre, PV (corresponding author), Karolinska Inst, Div Audiol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	pernilla.videhult-pierre@ki.se	Fridberger, Anders/E-8977-2010	Fridberger, Anders/0000-0002-7960-1559; Videhult Pierre, Pernilla/0000-0002-2623-4660	Swedish Research Council for Health, Working Life, and Welfare [2006-1526]	Swedish Research Council for Health, Working Life, and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	Swedish Research Council for Health, Working Life, and Welfare (http://www.forte.se) financially supported the study (2006-1526; PVP, A-CJ, AF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Almqvist C, 2011, EUR J EPIDEMIOL, V26, P67, DOI 10.1007/s10654-010-9521-x; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baker M, 2004, J HUM RESOUR, V39, P1067, DOI 10.2307/3559039; Bardel A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-37; Bhagat SP, 2008, INT J AUDIOL, V47, P751, DOI 10.1080/14992020802310879; Borchgrevink H M, 2005, Noise Health, V7, P1; Chang HP, 2009, EAR HEARING, V30, P576, DOI 10.1097/AUD.0b013e3181ac127a; Engdahl B, 2013, INT J AUDIOL, V52, P74, DOI 10.3109/14992027.2012.733423; Hoffman HJ, 2010, EAR HEARING, V31, P725, DOI 10.1097/AUD.0b013e3181e9770e; Johansson MSK, 2003, INT J AUDIOL, V42, P18, DOI 10.3109/14992020309056081; Jylha M, 1998, J GERONTOL B-PSYCHOL, V53, pS144, DOI 10.1093/geronb/53B.3.S144; Kiely KM, 2012, J AGING HEALTH, V24, P439, DOI 10.1177/0898264311425088; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; Middendorf PJ, 2004, AM J IND MED, V46, P492, DOI 10.1002/ajim.20092; Muhr P, 2007, SCAND J PUBLIC HEALT, V35, P524, DOI 10.1080/14034940701281477; Muhr P, 2010, INT J AUDIOL, V49, P317, DOI 10.3109/14992020903431280; Nondahl DM, 2012, EAR HEARING, V33, P640, DOI 10.1097/AUD.0b013e31825069e8; Nondahl DM, 1998, AUDIOLOGY, V37, P295; Okamoto M, 2005, CLIN OTOLARYNGOL, V30, P16, DOI 10.1111/j.1365-2273.2004.00904.x; PERSSON BO, 1993, SCAND AUDIOL, V22, P141, DOI 10.3109/01050399309046030; Picavet HSJ, 1996, J EPIDEMIOL COMMUN H, V50, P86, DOI 10.1136/jech.50.1.86; Pierre PV, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-874; Ramkissoon Ishara, 2011, J Clin Med Res, V3, P183, DOI 10.4021/jocmr611w; Salonen J, 2011, INT J AUDIOL, V50, P297, DOI 10.3109/14992027.2010.549517; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; Statistics Sweden, 2011, MIS 2011 1; Sulaiman AH, 2014, EUR ARCH OTO-RHINO-L, V271, P1463, DOI 10.1007/s00405-013-2612-z; Swanepoel D, 2013, J AM ACAD AUDIOL, V24, P514, DOI 10.3766/jaaa.24.6.7; Torre P, 2006, INT J AUDIOL, V45, P559, DOI 10.1080/14992020600860935; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Widen SE, 2009, INT J AUDIOL, V48, P537, DOI 10.1080/14992020902894541; Wilson DH, 1999, INT J EPIDEMIOL, V28, P247, DOI 10.1093/ije/28.2.247; Zhan WH, 2010, AM J EPIDEMIOL, V171, P260, DOI 10.1093/aje/kwp370	36	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123290	10.1371/journal.pone.0123290	http://dx.doi.org/10.1371/journal.pone.0123290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875116	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100160
J	Rubinstein, M; Katzenellenbogen, M; Eshed, R; Rozen, A; Katzir, N; Colle, M; Yang, LM; Grumet, R; Weng, YQ; Sherman, A; Ophir, R				Rubinstein, Mor; Katzenellenbogen, Mark; Eshed, Ravit; Rozen, Ada; Katzir, Nurit; Colle, Marivi; Yang, Luming; Grumet, Rebecca; Weng, Yiqun; Sherman, Amir; Ophir, Ron			Ultrahigh-Density Linkage Map for Cultivated Cucumber (Cucumis sativus L.) Using a Single-Nucleotide Polymorphism Genotyping Array	PLOS ONE			English	Article							SEGREGATION DISTORTION; GENE CONVERSION; QTL ANALYSIS; GENOME; RECOMBINATION; TRAITS; EVOLUTION; FRUIT; DOMESTICATION; CONSTRUCTION	Genotyping arrays are tools for high-throughput genotyping, which is beneficial in constructing saturated genetic maps and therefore high-resolution mapping of complex traits. Since the report of the first cucumber genome draft, genetic maps have been constructed mainly based on simple-sequence repeats (SSRs) or on combinations of SSRs and sequence-related amplified polymorphism (SRAP). In this study, we developed the first cucumber genotyping array consisting of 32,864 single-nucleotide polymorphisms (SNPs). These markers cover the cucumber genome with a median interval of similar to 2 Kb and have expected genotype calls in parents/F-1 hybridizations as a training set. The training set was validated with Fluidigm technology and showed 96% concordance with the genotype calls in the parents/F-1 hybridizations. Application of the genotyping array was illustrated by constructing a 598.7 cM genetic map based on a '9930' x 'Gy14' recombinant inbred line (RIL) population comprised of 11,156 SNPs. Marker collinearity between the genetic map and reference genomes of the two parents was estimated at R-2 = 0.97. We also used the array-derived genetic map to investigate chromosomal rearrangements, regional recombination rate, and specific regions with segregation distortions. Finally, 82% of the linkage-map bins were polymorphic in other cucumber variants, suggesting that the array can be applied for genotyping in other lines. The genotyping array presented here, together with the genotype calls of the parents/F-1 hybridizations as a training set, should be a powerful tool in future studies with high-throughput cucumber genotyping. An ultrahigh-density linkage map constructed	[Rubinstein, Mor; Katzenellenbogen, Mark; Eshed, Ravit; Rozen, Ada; Sherman, Amir; Ophir, Ron] Agr Res Org, Dept Fruit Trees Sci, Inst Plant Sci, Volcani Ctr, Rishon Leziyyon, Israel; [Katzir, Nurit] Agr Res Org, Dept Fruit Trees Sci, Inst Plant Sci, Newe Yaar Ctr, Ramat Yishai, Israel; [Katzenellenbogen, Mark] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Colle, Marivi; Grumet, Rebecca] Michigan State Univ, Dept Hort, Plant Breeding Genet Genom & Biotechnol, E Lansing, MI 48824 USA; [Yang, Luming; Weng, Yiqun] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Weng, Yiqun] USDA ARS, Vegetable Crops Res Unit, Madison, WI USA	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Ophir, R (corresponding author), Agr Res Org, Dept Fruit Trees Sci, Inst Plant Sci, Volcani Ctr, Rishon Leziyyon, Israel.	ron@agri.gov.il	Yang, Luming/K-3222-2019	Ophir, Ron/0000-0002-7951-6661	U.S.-Israel Binational Agricultural Research and Development (BARD) fund [IS-4341-10]; U.S. Department of Agriculture Specialty Crop Research Initiative grant [2011-51181-30661]; ARS [ARS-0425034] Funding Source: Federal RePORTER	U.S.-Israel Binational Agricultural Research and Development (BARD) fund(US-Israel Binational Science Foundation); U.S. Department of Agriculture Specialty Crop Research Initiative grant; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was jointly funded by a U.S.-Israel Binational Agricultural Research and Development (BARD) fund (grant no. IS-4341-10). Work in Yiqun Weng's lab was partially supported by a U.S. Department of Agriculture Specialty Crop Research Initiative grant (project no. 2011-51181-30661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Beissinger TM, 2013, GENETICS, V193, P1073, DOI 10.1534/genetics.112.147710; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carvalho BS, 2010, BIOINFORMATICS, V26, P242, DOI 10.1093/bioinformatics/btp624; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chai HS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-356; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Dijkhuizen A, 1996, EUPHYTICA, V90, P79; Drouaud J, 2006, GENOME RES, V16, P106, DOI 10.1101/gr.4319006; Farkhari M, 2011, PLANT BREEDING, V130, P533, DOI 10.1111/j.1439-0523.2011.01866.x; Fazio G, 2003, THEOR APPL GENET, V107, P864, DOI 10.1007/s00122-003-1277-1; Galtier N, 2001, GENETICS, V159, P907; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; Gresham D, 2010, P NATL ACAD SCI USA, V107, P1482, DOI 10.1073/pnas.0913883107; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Han YH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-18; He XM, 2013, THEOR APPL GENET, V126, P2149, DOI 10.1007/s00122-013-2125-6; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; Khan MA, 2012, J EXP BOT, V63, P4045, DOI 10.1093/jxb/ers105; KNERR LD, 1989, THEOR APPL GENET, V78, P119, DOI 10.1007/BF00299764; Kumar S, 2007, MOL GENET GENOMICS, V278, P187, DOI 10.1007/s00438-007-0248-7; Li DW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-396; Li YH, 2011, THEOR APPL GENET, V123, P973, DOI 10.1007/s00122-011-1640-6; Lin, 2008, VALIDATION AND EXTEN; Lin S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r63; Liu X, 2010, RES J AGRON, V4, P78, DOI [10.3923/rjagr.2010.78.83, DOI 10.3923/RJAGR.2010.78.83]; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; McCouch SR, 2010, BREEDING SCI, V60, P524, DOI 10.1270/jsbbs.60.524; Miller AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078680; Mondragon-Palomino M, 2005, MOL BIOL EVOL, V22, P2444, DOI 10.1093/molbev/msi241; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Pavy N, 2013, MOL ECOL RESOUR, V13, P324, DOI 10.1111/1755-0998.12062; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Woycicki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022728; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Xu YB, 2012, MOL BREEDING, V29, P833, DOI 10.1007/s11032-012-9699-6; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yang LM, 2014, PLANT J, V77, P16, DOI 10.1111/tpj.12355; Yang LM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-53; Yang LM, 2012, PLANT J, V71, P895, DOI 10.1111/j.1365-313X.2012.05017.x; Yuan XJ, 2008, EUPHYTICA, V164, P473, DOI 10.1007/s10681-008-9722-5; Yuan XJ, 2008, PLANT BREEDING, V127, P180, DOI 10.1111/j.1439-0523.2007.01426.x; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z; Zhang WW, 2012, THEOR APPL GENET, V124, P249, DOI 10.1007/s00122-011-1701-x; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhu CS, 2007, THEOR APPL GENET, V114, P295, DOI 10.1007/s00122-006-0432-x	62	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124101	10.1371/journal.pone.0124101	http://dx.doi.org/10.1371/journal.pone.0124101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874931	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100239
J	Stonko, DP; Manning, L; Starz-Gaiano, M; Peercy, BE				Stonko, David P.; Manning, Lathiena; Starz-Gaiano, Michelle; Peercy, Bradford E.			A Mathematical Model of Collective Cell Migration in a Three-Dimensional, Heterogeneous Environment	PLOS ONE			English	Article							COMPUTATIONAL-MODEL; MOTILITY; ADHESION; CADHERIN; GUIDANCE; MECHANISMS; COOPERATE; FEEDBACK	Cell migration is essential in animal development, homeostasis, and disease progression, but many questions remain unanswered about how this process is controlled. While many kinds of individual cell movements have been characterized, less effort has been directed towards understanding how clusters of cells migrate collectively through heterogeneous, cellular environments. To explore this, we have focused on the migration of the border cells during Drosophila egg development. In this case, a cluster of different cell types coalesce and traverse as a group between large cells, called nurse cells, in the center of the egg chamber. We have developed a new model for this collective cell migration based on the forces of adhesion, repulsion, migration and stochastic fluctuation to generate the movement of discrete cells. We implement the model using Identical Math Cells, or IMCs. IMCs can each represent one biological cell of the system, or can be aggregated using increased adhesion forces to model the dynamics of larger biological cells. The domain of interest is filled with IMCs, each assigned specific biophysical properties to mimic a diversity of cell types. Using this system, we have successfully simulated the migration of the border cell cluster through an environment filled with larger cells, which represent nurse cells. Interestingly, our simulations suggest that the forces utilized in this model are sufficient to produce behaviors of the cluster that are observed in vivo, such as rotation. Our framework was developed to capture a heterogeneous cell population, and our implementation strategy allows for diverse, but precise, initial position specification over a three-dimensional domain. Therefore, we believe that this model will be useful for not only examining aspects of Drosophila oogenesis, but also for modeling other two or three-dimensional systems that have multiple cell types and where investigating the forces between cells is of interest.	[Stonko, David P.; Peercy, Bradford E.] Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA; [Manning, Lathiena; Starz-Gaiano, Michelle] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Peercy, BE (corresponding author), Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA.	bpeercy@umbc.edu	Starz-Gaiano, Michelle/AAJ-1810-2021	Stonko, David/0000-0002-2804-2857	National Science Foundation (NSF) [CNS-0821258, CNS-1228778, DMS-0821311]; NSF-UBM Training program [DBI-1031420]; NSF [IOS-1054422]; University of Maryland Baltimore/Baltimore County Seed Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [1228778] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1031420] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF-UBM Training program; NSF(National Science Foundation (NSF)); University of Maryland Baltimore/Baltimore County Seed Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded in part by grants CNS-0821258, CNS-1228778, DMS-0821311 from the National Science Foundation (NSF) for the UMBC High Performance Computing Facility. DPS, MSG, and BEP were funded in part by a NSF-UBM Training program grant: DBI-1031420, LM and MSG were funded in part by NSF grant IOS-1054422; DS and BEP were funded in part by a University of Maryland Baltimore/Baltimore County Seed Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Arciero J, 2013, COMPLEX SYSTEMS COMP, P185; Ashburner M., 1989, DROSOPHILA LAB HDB; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Danuser G, 2013, ANNU REV CELL DEV BI, V29, P501, DOI 10.1146/annurev-cellbio-101512-122308; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Etienne-Manneville S, 2014, CURR OPIN CELL BIOL, V30, P51, DOI 10.1016/j.ceb.2014.06.004; Fletcher AG, 2014, BIOPHYS J, V106, P2291, DOI 10.1016/j.bpj.2013.11.4498; Frascoli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059249; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Groen CM, 2012, MOL BIOL CELL, V23, P4567, DOI 10.1091/mbc.E12-05-0417; Hudson AM, 2014, METHODS, V68, P207, DOI 10.1016/j.ymeth.2014.01.005; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Kraning-Rush CM, 2012, METHOD CELL BIOL, V110, P139, DOI 10.1016/B978-0-12-388403-9.00006-0; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Monahan AJ, 2013, DEV BIOL, V379, P152, DOI 10.1016/j.ydbio.2013.03.022; Montell DJ, 2012, NAT REV MOL CELL BIO, V13, P631, DOI 10.1038/nrm3433; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Nogare DD, 2014, DEVELOPMENT, V141, P3188, DOI 10.1242/dev.106690; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Rangarajan R, 2008, CELL ADHES MIGR, V2, P106, DOI 10.4161/cam.2.2.6211; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Starz-Gaiano M, 2008, DEV CELL, V14, P726, DOI 10.1016/j.devcel.2008.03.005; Stonko D, 2014, TECHNICAL REPORT; Stonko DP, 2013, THESIS; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Thompson RN, 2012, B MATH BIOL, V74, P2793, DOI 10.1007/s11538-012-9779-0; Van de Bor V, 2011, DEVELOPMENT, V138, P1383, DOI 10.1242/dev.056184; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vargas DA, 2011, ANN BIOMED ENG, V39, P2068, DOI 10.1007/s10439-011-0290-9; Vedel S, 2013, P NATL ACAD SCI USA, V110, P129, DOI 10.1073/pnas.1204291110; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wright NA, 1997, FEBS LETT, V408, P121, DOI 10.1016/S0014-5793(97)00424-9; Yamao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027950; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	51	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122799	10.1371/journal.pone.0122799	http://dx.doi.org/10.1371/journal.pone.0122799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875645	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100102
J	Wang, Q; Zhao, DY; Xu, H; Zhou, H; Yang, QY; Liu, F; Zhou, GP				Wang, Quan; Zhao, De-Yu; Xu, Hong; Zhou, Hui; Yang, Qian-Yuan; Liu, Feng; Zhou, Guo-Ping			Down-Regulation of MicroRNA-223 Promotes Degranulation via the PI3K/Akt Pathway by Targeting IGF-1R in Mast Cells	PLOS ONE			English	Article							IGE; INFLAMMATION; ACTIVATION; APOPTOSIS; MIR-223	Background Mast cells play a central role in allergic and inflammatory disorders by inducing degranulation and inflammatory mediator release. Recent reports have shown that miRNAs play an important role in inflammatory response regulation. Therefore, the role of miR-223 in mast cells was investigated. Methods The expression of miR-223 was quantified by quantitative real-time polymerase chain reaction (qRT-PCR) in immunoglobulin E (IgE)-mediated mast cells. After successful miR-223 inhibition by transfection, degranulation was detected in IgE-mediated mast cells. The phosphorylation of I kappa B-alpha and Akt were examined using western blotting. NF-kappa B was tested using electrophoretic mobility shift assay. PI3K-inhibitor (LY294002) was used to investigate whether the PI3K/Akt pathway was essential for mast cell activation. The TargetScan database and a luciferase reporter system were used to identify whether insulin-like growth factor 1 receptor (IGF-1R) is a direct target of miR-223. Results MiR-223 expression was up-regulated in IgE-mediated mast cells, whereas its down-regulation promoted mast cell degranulation. Levels of I kappa B-alpha and Akt phosphorylation as well as NF-kappa B were increased in miR-223 inhibitor cells. LY294002 could block the PI3K/Akt signaling pathway and rescue the promotion caused by suppressing miR-223 in mast cells. IGF-1R was identified as a direct target of miR-223. Conclusions These findings suggest that down-regulation of miR-223 promotes degranulation via the PI3K/Akt pathway by targeting IGF-1R in mast cells.	[Wang, Quan; Zhao, De-Yu; Xu, Hong; Yang, Qian-Yuan; Liu, Feng] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Hui] Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Dept Pediat, Nanjing, Jiangsu, Peoples R China; [Zhou, Guo-Ping] Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liu, F (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	axsliu@163.com; gpzhou@aliyun.com			National Natural Science Foundation of China [81200012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this work was supported by the National Natural Science Foundation of China (81200012; Feng Liu).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biethahn K, 2014, ALLERGY, V69, P752, DOI 10.1111/all.12407; Estan MC, 2012, BIOCHEM PHARMACOL, V84, P1604, DOI 10.1016/j.bcp.2012.09.022; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Nigrovic PA, 2007, IMMUNOL REV, V217, P19, DOI 10.1111/j.1600-065X.2007.00506.x; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Pan Y, 2014, J IMMUNOL, V192, P437, DOI 10.4049/jimmunol.1301790; Perry MM, 2014, AM J RESP CELL MOL, V50, P7, DOI 10.1165/rcmb.2013-0067OC; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Peschke K, 2014, CELL REP, V8, P1300, DOI 10.1016/j.celrep.2014.07.046; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Yu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078769; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	19	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123575	10.1371/journal.pone.0123575	http://dx.doi.org/10.1371/journal.pone.0123575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875646	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100189
J	Yoshida, K; Hara, S; Hisabori, T				Yoshida, Keisuke; Hara, Satoshi; Hisabori, Toru			Thioredoxin Selectivity for Thiol-based Redox Regulation of Target Proteins in Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADP-MALATE-DEHYDROGENASE; LIGHT ACTIVATION; ATP SYNTHASE; PLASTIDIAL THIOREDOXINS; ARABIDOPSIS-THALIANA; MAGNESIUM CHELATASE; INVERSE REGULATION; STRUCTURAL BASIS; GAMMA-SUBUNIT; REDUCTION	Redox regulation based on the thioredoxin (Trx) system is believed to ensure light-responsive control of various functions in chloroplasts. Five Trx subtypes have been reported to reside in chloroplasts, but their functional diversity in the redox regulation of Trx target proteins remains poorly clarified. To directly address this issue, we studied the Trx-dependent redox shifts of several chloroplast thiol-modulated enzymes in vitro and in vivo. In vitro assays using a series of Arabidopsis recombinant proteins provided new insights into Trx selectivity for the redox regulation as well as the underpinning for previous suggestions. Most notably, by combining the discrimination of thiol status with mass spectrometry and activity measurement, we identified an uncharacterized aspect of the reductive activation of NADP-malate dehydrogenase; two redox-active Cys pairs harbored in this enzyme were reduced via distinct utilization of Trxs even within a single polypeptide. In our in vitro assays, Trx-f was effective in reducing all thiol-modulated enzymes analyzed here. We then investigated the in vivo physiological relevance of these in vitro findings, using Arabidopsis wild-type and Trx-f-deficient plants. Photoreduction of fructose-1,6-bis-phosphatase was partially impaired in Trx-f-deficient plants, but the global impact of Trx-f deficiency on the redox behaviors of thiol-modulated enzymes was not as striking as expected from the in vitro data. Our results provide support for the in vivo functionality of the Trx system and also highlight the complexity and plasticity of the chloroplast redox network.	[Yoshida, Keisuke; Hara, Satoshi; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan; [Yoshida, Keisuke; Hisabori, Toru] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014; Yoshida, Keisuke/E-5231-2014; Hara, Satoshi/C-1341-2015	Hisabori, Toru/0000-0003-2046-0277; Yoshida, Keisuke/0000-0001-6542-6254; Hara, Satoshi/0000-0001-6275-6469	Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science [26840090]; Grants-in-Aid for Scientific Research [15H04384] Funding Source: KAKEN	Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST) and Grant-in-aid for Scientific Research 26840090 (to K. Y.) from the Japan Society for the Promotion of Science.	Arsova B, 2010, PLANT CELL, V22, P1498, DOI 10.1105/tpc.109.071001; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Carr PD, 1999, STRUCTURE, V7, P461, DOI 10.1016/S0969-2126(99)80058-6; Chiadmi M, 1999, EMBO J, V18, P6809, DOI 10.1093/emboj/18.23.6809; Chibani K, 2011, FEBS LETT, V585, P1077, DOI 10.1016/j.febslet.2011.03.006; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Dietz KJ, 2006, J EXP BOT, V57, P1697, DOI 10.1093/jxb/erj160; Dunford RP, 1998, PHOTOSYNTH RES, V58, P221, DOI 10.1023/A:1006178826976; Geck RK, 1996, J BIOL CHEM, V271, P24736, DOI 10.1074/jbc.271.40.24736; Goyer A, 2001, FEBS LETT, V505, P405, DOI 10.1016/S0014-5793(01)02860-5; Hara S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00508; Hara S, 2013, BBA-GEN SUBJECTS, V1830, P3077, DOI 10.1016/j.bbagen.2013.01.012; Hirasawa M, 2000, BIOCHEMISTRY-US, V39, P3344, DOI 10.1021/bi9916731; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; HODGES M, 1994, PLANT MOL BIOL, V26, P225, DOI 10.1007/BF00039534; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hutchison RS, 2000, BIOCHEMISTRY-US, V39, P6679, DOI 10.1021/bi0001978; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; ISSAKIDIS E, 1994, J BIOL CHEM, V269, P3511; Issakidis E, 1996, FEBS LETT, V392, P121, DOI 10.1016/0014-5793(96)00801-0; ISSAKIDIS E, 1992, J BIOL CHEM, V267, P21577; Jacquot JP, 1997, FEBS LETT, V401, P143, DOI 10.1016/S0014-5793(96)01459-7; Johansson K, 1999, BIOCHEMISTRY-US, V38, P4319, DOI 10.1021/bi982876c; Kohzuma K, 2013, J BIOL CHEM, V288, P13156, DOI 10.1074/jbc.M113.453225; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; Laugier E, 2013, PLANT CELL ENVIRON, V36, P670, DOI 10.1111/pce.12005; Luo T, 2012, PLANT PHYSIOL, V159, P118, DOI 10.1104/pp.112.195446; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Michelet L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00470; Miginiac-Maslow M, 2002, PHOTOSYNTH RES, V72, P1, DOI 10.1023/A:1016099228450; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Motohashi K, 2006, J BIOL CHEM, V281, P35039, DOI 10.1074/jbc.M605938200; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Richter AS, 2013, PLANT PHYSIOL, V162, P63, DOI 10.1104/pp.113.217141; Rouhier N, 2005, ANTIOXID REDOX SIGN, V7, P919, DOI 10.1089/ars.2005.7.919; Ruelland E, 1998, J BIOL CHEM, V273, P33482, DOI 10.1074/jbc.273.50.33482; Ruelland E, 1997, J BIOL CHEM, V272, P19851, DOI 10.1074/jbc.272.32.19851; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; SCHURMANN P, 1981, EUR J BIOCHEM, V116, P37, DOI 10.1111/j.1432-1033.1981.tb05297.x; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Serrato AJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00463; Thormahlen I, 2013, PLANT CELL ENVIRON, V36, P16, DOI 10.1111/j.1365-3040.2012.02549.x; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; WOLOSIUK RA, 1979, J BIOL CHEM, V254, P1627; Yano H, 2001, P NATL ACAD SCI USA, V98, P4794, DOI 10.1073/pnas.071041998; Yoshida K, 2014, PLANT CELL PHYSIOL, V55, P1415, DOI 10.1093/pcp/pcu066; Yoshida K, 2013, PLANT CELL PHYSIOL, V54, P875, DOI 10.1093/pcp/pct037; Yoshida K, 2009, PLANT CELL PHYSIOL, V50, P1449, DOI 10.1093/pcp/pcp090	52	63	65	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14278	14288		10.1074/jbc.M115.647545	http://dx.doi.org/10.1074/jbc.M115.647545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25878252	hybrid, Green Published			2022-12-26	WOS:000355754600002
J	Abuya, T; Warren, CE; Miller, N; Njuki, R; Ndwiga, C; Maranga, A; Mbehero, F; Njeru, A; Bellows, B				Abuya, Timothy; Warren, Charlotte E.; Miller, Nora; Njuki, Rebecca; Ndwiga, Charity; Maranga, Alice; Mbehero, Faith; Njeru, Anne; Bellows, Ben			Exploring the Prevalence of Disrespect and Abuse during Childbirth in Kenya	PLOS ONE			English	Article							DOMESTIC VIOLENCE; MATERNITY SERVICES; RISK-FACTORS; HEALTH; CARE; TANZANIA; WOMEN; EXPERIENCES; DELIVERY; ACCOUNTS	Background Poor quality of care including fear of disrespect and abuse (D&A) perpetuated by health workers influences women's decisions to seek maternity care. Key manifestations of D&A include: physical abuse, non-consented care, non-confidential care, non-dignified care, discrimination, abandonment, and detention in facilities. This paper describes manifestations of D&A experienced in Kenya and measures their prevalence. Methods This paper is based on baseline data collected during a before-and-after study designed to measure the effect of a package of interventions to reduce the prevalence of D&A experienced by women during labor and delivery in thirteen Kenyan health facilities. Data were collected through an exit survey of 641 women discharged from postnatal wards. We present percentages of D&A manifestations and odds ratios of its relationship with demographic characteristics using a multivariate fixed effects logistic regression model. Results Twenty percent of women reported any form of D&A. Manifestations of D&A includes: non-confidential care (8.5%), non-dignified care (18%), neglect or abandonment (14.3%), Non-consensual care (4.3%) physical abuse (4.2%) and, detainment for non-payment of fees (8.1). Women aged 20-29 years were less likely to experience non-confidential care compared to those under 19; OR: [0.6 95% CI (0.36, 0.90); p= 0.017]. Clients with no companion during delivery were less likely to experience inappropriate demands for payment; OR: [0.49 (0.26, 0.95); p= 0.037]; while women with higher parities were three times more likely to be detained for lack of payment and five times more likely to be bribed compared to those experiencing there first birth. Conclusion One out of five women experienced feeling humiliated during labor and delivery. Six categories of D&A during childbirth in Kenya were reported. Understanding the prevalence of D&A is critical in developing interventions at national, health facility and community levels to address the factors and drivers that influence D&A in facilities and to encourage clients' future facility utilization.	[Abuya, Timothy; Ndwiga, Charity; Bellows, Ben] Populat Council, Nairobi, Kenya; [Warren, Charlotte E.] Populat Council, Washington, DC 20008 USA; [Miller, Nora] Woman Care Global, San Diego, CA 92130 USA; [Njuki, Rebecca] Ctr Populat Hlth Res & Management, Nairobi, Kenya; [Maranga, Alice] Federat Women Lawyers, Nairobi, Kenya; [Mbehero, Faith] Natl Nurses Assoc Kenya, Nairobi 4942200100, Kenya; [Njeru, Anne] Minist Hlth, Div Reprod Hlth, Nairobi, Kenya	Population Council	Abuya, T (corresponding author), Populat Council, POB 17643-00500, Nairobi, Kenya.	tabuya@popcouncil.org	Abuya, Timothy/AAH-5479-2020	Bellows, Ben/0000-0001-9205-6623	United States Agency for International Development under USAID [GHS-A-00-09-00015-00]	United States Agency for International Development under USAID(United States Agency for International Development (USAID))	The project is funded by the United States Agency for International Development under USAID Cooperative Agreement No. GHS-A-00-09-00015-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MILL DEV GOALS REP; Audo M O, 2005, East Afr Med J, V82, P547; Bowser D, 2010, ECPLORING EVIDENCE D; Bryce J, 2010, TRACKING PROGR MATER; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; FCI, 2005, FCI 2005 SKILL CAR I; FIDA Kenya and Centre for Reproductive Rights, 2007, FAILURE DELIVER VIOL; FINKELHOR D, 1994, CHILD ABUSE NEGLECT, V18, P409, DOI 10.1016/0145-2134(94)90026-4; Freedman LP, 2014, B WORLD HEALTH ORGAN, V92, P915, DOI 10.2471/BLT.14.137869; Garcia-Moreno CH, 2011, WHO MULTCOUNTRY STUD; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Goverment of Kenya, 2002, STAND MAT CAR KENY; Hindin Michelle J., 2008, INTIMATE PARTNER VIO; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Koenig MA, 2003, B WORLD HEALTH ORGAN, V81, P53; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; McMahon SA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-268; Mselle LT, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-174; Muhajarine N, 1999, CAN MED ASSOC J, V160, P1007; National Cordinating Agency for Population and Development (NCAPD) [Kenya] [Kenya] MoMSM [Kenya] MoPHaSM Kenya National Bureau of Statistics (KNBS) [Kenya] IM, 2011, KEN NAT BUR STAT KNS; Schroll AM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-74; Sunita K, 2004, PROFILING DOMESTIC V; Warren C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-177; Warren CE, 2013, BMC PREGNANCY CHILDB, V13, DOI [10.1186/1471-2393-13-21, 10.1186/1471-2393-13-150]; WHO UNICEF, 2010, COUNTD 2015 DEC REP	28	170	171	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123606	10.1371/journal.pone.0123606	http://dx.doi.org/10.1371/journal.pone.0123606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884566	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000078
J	Lee, JS; Chiou, MJ; Teng, FL; See, LC				Lee, Jiahn-Shing; Chiou, Meng-Jiun; Teng, Feng-Ling; See, Lai-Chu			The Role of Principal and Secondary Diagnoses of Hospitalized Eye Trauma: A Nationwide Cohort in Taiwan, 1996-2010	PLOS ONE			English	Article							OCULAR TRAUMA; INJURY; POPULATION	Purpose To estimate the rate of hospitalized eye trauma in Taiwan and investigate the role between principal and secondary diagnoses of such trauma. Methods Nationwide fixed cohort study of 1,000,000 beneficiaries from the Taiwan Longitudinal Health Database was used and 4819 patients who were hospitalized for eye trauma during 1996-2010 were analyzed. Results During 1996-2010, the incidence rates of hospitalized eye trauma (per 100 000 person-years) were 35.0 (95% confidence interval (CI), 34.0 to 36.0) for total diagnosis, 9.8 (95% CI, 9.3 to 10.3) for a principal diagnosis, and 25.3 (95% CI, 24.4 to 26.1) for a secondary diagnosis. The sex risk ratio was 3.1 for a principal diagnosis and 2.1 for a secondary diagnosis. The main causes of eye trauma were traffic accident, work accident, assault (among males < 60 years of age), and falls (among elderly men and women). The proportion admitted to an ophthalmic department among those with a principal diagnosis of eye trauma (64.8%) was significantly higher than among those with a secondary diagnosis (2.3%) (p<. 0001). Patients with a principal diagnosis of eye trauma had shorter hospital stays (7.1 +/- 10.2 days) and lower fatality (0.07%) than those with a secondary diagnosis of eye trauma (10.0 +/- 31.6 days and 0.3%, respectively). Conclusion Data only from ophthalmic admissions tends to underestimate the true incidence rate of hospitalized eye trauma. Patients with a principal diagnosis of eye trauma had less severe injuries than did those with a secondary diagnosis.	[Lee, Jiahn-Shing] Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan; [Lee, Jiahn-Shing] Chang Gung Univ, Taoyuan, Taiwan; [Chiou, Meng-Jiun; See, Lai-Chu] Chang Gung Univ, Dept Publ Hlth, Coll Med, Taoyuan, Taiwan; [Teng, Feng-Ling] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [See, Lai-Chu] Chang Gung Univ, Biostat Core Lab, Mol Med Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University	See, LC (corresponding author), Chang Gung Univ, Dept Publ Hlth, Coll Med, Taoyuan, Taiwan.	lichu@mail.cgu.edu.tw		Lee, Jiahn-Shing/0000-0001-7007-939X; See, Lai-Chu/0000-0002-1379-8969				Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Baker R S, 1999, Ophthalmic Epidemiol, V6, P159, DOI 10.1076/opep.6.3.159.1505; Cao HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049884; Chang CH, 2008, GRAEF ARCH CLIN EXP, V246, P223, DOI 10.1007/s00417-007-0733-z; Cillino S, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-6; Desai P, 1996, BRIT J OPHTHALMOL, V80, P592, DOI 10.1136/bjo.80.7.592; Huang SK, 2014, J FORMOS MED ASSOC, V113, P1, DOI 10.1016/j.jfma.2013.08.010; KLOPFER J, 1992, ARCH OPHTHALMOL-CHIC, V110, P838, DOI 10.1001/archopht.1992.01080180110037; Lai MS, 2012, J FORMOS MED ASSOC, V111, P587, DOI 10.1016/j.jfma.2012.08.016; Mela EK, 2005, OPHTHAL EPIDEMIOL, V12, P185, DOI 10.1080/09286580590964801; *NAT HLTH RES I, INTR NAT HLTH INS RE; National Health Research Institutes Taiwan, 2012, UN HLTH COV TAIW UPD; Negrel A D, 1998, Ophthalmic Epidemiol, V5, P143, DOI 10.1076/opep.5.3.143.8364; Rothman K, 1986, MODERN EPIDEMIOLOGY; Saeed A, 2010, INJURY, V41, P86, DOI 10.1016/j.injury.2009.01.118; SNIEZEK JE, 1989, JAMA-J AM MED ASSOC, V262, P2270, DOI 10.1001/jama.262.16.2270; TIELSCH JM, 1989, ARCH OPHTHALMOL-CHIC, V107, P519, DOI 10.1001/archopht.1989.01070010533025; Wong TY, 1999, AM J OPHTHALMOL, V128, P345, DOI 10.1016/S0002-9394(99)00167-1	18	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123348	10.1371/journal.pone.0123348	http://dx.doi.org/10.1371/journal.pone.0123348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884507	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000058
J	Charron, L; Geffard, O; Chaumot, A; Coulaud, R; Jaffal, A; Gaillet, V; Dedourge-Geffard, O; Geffard, A				Charron, Laetitia; Geffard, Olivier; Chaumot, Arnaud; Coulaud, Romain; Jaffal, Ali; Gaillet, Veronique; Dedourge-Geffard, Odile; Geffard, Alain			Consequences of Lower Food Intake on the Digestive Enzymes Activities, the Energy Reserves and the Reproductive Outcome in Gammarus fossarum	PLOS ONE			English	Article							SITU FEEDING ASSAY; DAPHNIA-MAGNA; WATER-QUALITY; ENVIRONMENTAL ASSESSMENT; CONFOUNDING FACTORS; RAPID-DETERMINATION; SPP. CRUSTACEA; GROWTH ASSAY; PULEX; BIOMARKERS	Digestive enzyme activity is often used as a sensitive response to environmental pollution. However, only little is known about the negative effects of stress on digestive capacities and their consequences on energy reserves and reproduction, although these parameters are important for the maintenance of populations. To highlight if changes in biochemical responses (digestive enzymes and reserves) led to impairments at an individual level (fertility), Gammarus fossarum were submitted to a lower food intake throughout a complete female reproductive cycle (i.e. from ovogenesis to offspring production). For both males and females, amylase activity was inhibited by the diet stress, whereas trypsin activity was not influenced. These results underline similar sensitivity of males and females concerning their digestive capacity. Energy reserves decreased with food starvation in females, and remained stable in males. The number of embryos per female decreased with food starvation. Lower digestive activity in males and females therefore appears as an early response. These results underline the ecological relevance of digestive markers, as they make it possible to anticipate upcoming consequences on reproduction in females, a key biological variable for population dynamics.	[Charron, Laetitia; Jaffal, Ali; Gaillet, Veronique; Dedourge-Geffard, Odile; Geffard, Alain] Univ Reims, Unite Format & Rech Sci Exactes & Nat, Unite Mixte Rech Ineris UMR Stress Environm & Bio, Reims 2, France; [Geffard, Olivier; Chaumot, Arnaud; Coulaud, Romain] Inst Natl Rech Sci & Technol Environm & Agr, Unite Rech Milieux Aquat Ecol & Pollut, Villeurbanne, France	Universite de Reims Champagne-Ardenne; INRAE	Geffard, A (corresponding author), Univ Reims, Unite Format & Rech Sci Exactes & Nat, Unite Mixte Rech Ineris UMR Stress Environm & Bio, Moulin Housse, Reims 2, France.	alain.geffard@univ-reims.fr		Geffard, Alain/0000-0001-9236-2890; Olsen, Jennifer/0000-0001-6547-8791; chaumot, arnaud/0000-0001-9132-3419; Geffard, olivier/0000-0001-7760-4644; Dedourge-Geffard, Odile/0000-0001-6308-2080	National Research Agency; CESA program [GAMMA 021 02]; PIREN-Seine Program	National Research Agency(French National Research Agency (ANR)); CESA program; PIREN-Seine Program	This research program was financially supported by the National Research Agency, CESA program GAMMA 021 02 "Variability-adaptation-diversity and Ecotoxicology in gammarids" (2012-2015), and the PIREN-Seine Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard-Triquet C., 2013, ECOLOGICAL BIOMARKER; [Anonymous], STATISTICA; Baillieul M, 2005, COMP BIOCHEM PHYS C, V140, P364, DOI 10.1016/j.cca.2005.03.007; Baillieul M, 1996, FUNCT ECOL, V10, P227, DOI 10.2307/2389847; BARLOCHE.F, 1973, OIKOS, V24, P295, DOI 10.2307/3543888; Besse JP, 2013, WATER RES, V47, P650, DOI 10.1016/j.watres.2012.10.024; Boldina-Cosqueric I, 2010, ECOTOX ENVIRON SAFE, V73, P1733, DOI 10.1016/j.ecoenv.2010.08.008; Bourgeault A, 2010, ENVIRON TOXICOL, V25, P468, DOI 10.1002/tox.20591; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charron L, 2013, ENVIRON SCI POLLUT R, V20, P9044, DOI 10.1007/s11356-013-1921-5; Charron L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096393; Coulaud R, 2011, WATER RES, V45, P6417, DOI 10.1016/j.watres.2011.09.035; De Coen W. M., 1997, Journal of Aquatic Ecosystem Stress and Recovery, V6, P43, DOI 10.1023/A:1008228517955; De Coen WM, 2003, ENVIRON TOXICOL CHEM, V22, P1632, DOI [10.1897/1551-5028(2003)22&lt;1632:TMBLRB&gt;2.0.CO;2, 10.1002/etc.5620220727]; De Coen WM, 1998, HYDROBIOLOGIA, V367, P199, DOI 10.1023/A:1003240502946; Dedourge-Geffard O, 2013, ECOTOX ENVIRON SAFE, V97, P139, DOI 10.1016/j.ecoenv.2013.07.016; DEPLEDGE MH, 1994, ECOTOXICOLOGY, V3, P161, DOI 10.1007/BF00117081; Dick JTA, 2005, MAR ECOL PROG SER, V291, P151, DOI 10.3354/meps291151; Duquesne S, 2006, ECOTOX ENVIRON SAFE, V65, P145, DOI 10.1016/j.ecoenv.2006.01.008; Dutra BK, 2009, COMP BIOCHEM PHYS C, V149, P640, DOI 10.1016/j.cbpc.2009.01.005; Felten V, 2008, FUND APPL LIMNOL, V170, P303, DOI 10.1127/1863-9135/2008/0170-0303; Forbes VE, 2006, ENVIRON TOXICOL CHEM, V25, P272, DOI 10.1897/05-257R.1; Foucreau N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077242; Garcia-Esquivel Z, 2002, COMP BIOCHEM PHYS A, V133, P63, DOI 10.1016/S1095-6433(02)00112-5; GARCIACARRENO FL, 1993, J FOOD BIOCHEM, V17, P97, DOI 10.1111/j.1745-4514.1993.tb00864.x; Geffard O, 2010, ENVIRON TOXICOL CHEM, V29, P2249, DOI 10.1002/etc.268; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Handy RD, 1999, ECOTOXICOLOGY, V8, P329, DOI 10.1023/A:1008930404461; Hervant F, 1997, COMP BIOCHEM PHYS A, V118, P1277, DOI 10.1016/S0300-9629(97)00047-9; Kalman J, 2009, MAR ECOL PROG SER, V393, P55, DOI 10.3354/meps08239; Kelly DW, 2002, HYDROBIOLOGIA, V485, P199, DOI 10.1023/A:1021370405349; Koop JHE, 2008, LIMNOLOGICA, V38, P378, DOI 10.1016/j.limno.2008.05.004; Lacaze E, 2011, ENVIRON RES, V111, P626, DOI 10.1016/j.envres.2011.03.012; Maazouzi C, 2009, FUND APPL LIMNOL, V175, P327, DOI 10.1127/1863-9135/2009/0175-0327; MacNeil C, 1997, BIOL REV, V72, P349, DOI 10.1017/S0006323196005038; Macneil C, 1999, BIOL REV, V74, P375, DOI 10.1017/S0006323199005368; MALTBY L, 1990, FUNCT ECOL, V4, P393, DOI 10.2307/2389601; MALTBY L, 1990, ECOTOX ENVIRON SAFE, V19, P292, DOI 10.1016/0147-6513(90)90031-Y; Maltby L, 2002, ENVIRON TOXICOL CHEM, V21, P361, DOI 10.1897/1551-5028(2002)021<0361:EOTGPI>2.0.CO;2; Maltby L, 1994, WATER QUALITY STRESS, V4, P98; Meier GM, 2000, ARCH HYDROBIOL, V147, P447; Mezek T, 2010, AQUAT ECOL, V44, P397, DOI 10.1007/s10452-009-9299-7; Muyssen BTA, 2002, AQUAT TOXICOL, V56, P69, DOI 10.1016/S0166-445X(01)00206-5; NAYLOR C, 1990, WATER RES, V24, P757, DOI 10.1016/0043-1354(90)90032-2; NAYLOR C, 1989, HYDROBIOLOGIA, V188, P517, DOI 10.1007/BF00027819; Olsen GH, 2008, MAR ENVIRON RES, V66, P215, DOI 10.1016/j.marenvres.2008.02.063; Palais F, 2010, MOLLUSCAN RES, V30, P29; Plaistow SJ, 2003, ANIM BEHAV, V65, P683, DOI 10.1006/anbe.2003.2116; POCKL M, 1992, FRESHWATER BIOL, V27, P211, DOI 10.1111/j.1365-2427.1992.tb00534.x; Sroda S, 2011, CHEMOSPHERE, V83, P538, DOI 10.1016/j.chemosphere.2010.12.023; Sutcliffe D.W., 1992, Freshwater Forum, V2, P102; Tankoua OF, 2012, AQUAT TOXICOL, V114, P96, DOI 10.1016/j.aquatox.2012.02.016; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P302; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; WILLOUGHBY LG, 1976, FRESHWATER BIOL, V6, P577, DOI 10.1111/j.1365-2427.1976.tb01647.x; Xuereb B, 2009, AQUAT TOXICOL, V94, P114, DOI 10.1016/j.aquatox.2009.06.010	57	82	82	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0125154	10.1371/journal.pone.0125154	http://dx.doi.org/10.1371/journal.pone.0125154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880985	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500114
J	Gerxhani, K; Bruggeman, J				Gerxhani, Klarita; Bruggeman, Jeroen			Time Lag and Communication in Changing Unpopular Norms	PLOS ONE			English	Article							SPACES; MODEL	Humans often coordinate their social lives through norms. When a large majority of people are dissatisfied with an existing norm, it seems obvious that they will change it. Often, however, this does not occur. We investigate how a time lag between individual support of a norm change and the change itself hinders such change, related to the critical mass of supporters needed to effectuate the change, and the (im)possibility of communicating about it. To isolate these factors, we utilize a laboratory experiment. As predicted, we find unambiguous effects of time lag on precluding norm change; a higher threshold for a critical mass does so as well. Communication facilitates choosing superior norms but it does not necessarily lead to norm change when the uncertainty on whether there will be a norm change in the future is high. Communication seems to help coordination on actions at the present but not the future. Hence, the uncertainty driven by time lag makes individuals choose the status quo, here the unpopular norm.	[Gerxhani, Klarita; Bruggeman, Jeroen] Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands	University of Amsterdam	Gerxhani, K (corresponding author), Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands.	k.gerxhani@uva.nl	Gerxhani, Klarita/K-2446-2018	Gerxhani, Klarita/0000-0002-9056-4920				BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Bicchieri C., 1999, BUS ETHICS Q, V9, P127, DOI DOI 10.2307/3857639; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Boyd R, 2010, PHILOS T R SOC B, V365, P3787, DOI 10.1098/rstb.2010.0046; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Easley D, 2010, NETWORKS CROWDS MARK; Elster Jon, 2007, EXPLAINING SOCIAL BE; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Grantham J, 2012, NATURE, V491, P303, DOI 10.1038/491303a; Hannan H, 2007, LOGICS ORG THEORY AU; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Horne C., 2001, SOCIAL NORMS, P3; Janis IL, 1982, GROUPTHINK PSYCHOL S; Kellogg KC, 2009, AM J SOCIOL, V115, P657, DOI 10.1086/603535; Knight J, 1998, NEW I SOCIOLOGY, P105; Ledyard JO, 1996, HDB EXPT EC, P111; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mackie G, 1996, AM SOCIOL REV, V61, P999, DOI 10.2307/2096305; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641; Polletta F, 1999, THEOR SOC, V28, P1, DOI 10.1023/A:1006941408302; Richerson P. J, 2005, NOT GENES ALONE; ROGERS AR, 1990, AM NAT, V135, P398, DOI 10.1086/285053; Schelling T.C., 1960, STRATEGY CONFLICT; Willer R, 2009, AM J SOCIOL, V115, P451, DOI 10.1086/599250; Wills T.A., 1991, SOCIAL COMP CONT THE, P287; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124715	10.1371/journal.pone.0124715	http://dx.doi.org/10.1371/journal.pone.0124715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25880200	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500107
J	Naganathan, A; Wood, MP; Moore, SD				Naganathan, Anusha; Wood, Matthew P.; Moore, Sean D.			The Large Ribosomal Subunit Protein L9 Enables the Growth of EF-P Deficient Cells and Enhances Small Subunit Maturation	PLOS ONE			English	Article							ELONGATION-FACTOR-P; ESCHERICHIA-COLI; TRANSLATION ELONGATION; QUALITY-CONTROL; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; INITIATION-FACTOR; ESSENTIAL GTPASE; MESSENGER-RNAS; PEPTIDE-BOND	The loss of the large ribosomal protein L9 causes a reduction in translation fidelity by an unknown mechanism. To identify pathways affected by L9, we identified mutants of E. coli that require L9 for fitness. In a prior study, we characterized L9-dependent mutations in the essential GTPase Der (EngA). Here, we describe a second class of L9-dependent mutations that either compromise or inactivate elongation factor P (EF-P, eIF5A in eukaryotes). Without L9, Delta efp cells are practically inviable. Cell fractionation studies revealed that, in both the Der and EF-P mutant cases, L9's activity reduces immature 16S rRNA in 30S particles and partially restores the abundance of monosomes. Inspired by these findings, we discovered that L9 also enhances 16S maturation in wild-type cells. Surprisingly, although the amount of immature 16S in 30S particles was found to be elevated in Delta rplI cells, the amount in polysomes was low and inversely correlated with the immature 16S abundance. These findings provide an explanation for the observed fitness increases afforded by L9 in these mutants and reveal particular physiological conditions in which L9 becomes critical. Additionally, L9 may affect the partitioning of small subunits containing immature 16S rRNA.	[Naganathan, Anusha; Moore, Sean D.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Wood, Matthew P.] Seattle Biomed, Seattle, WA 98109 USA; [Wood, Matthew P.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	State University System of Florida; University of Central Florida; Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Moore, SD (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	sean.moore@ucf.edu		Wood, Matthew/0000-0001-6741-0088	National Institutes of Health [R15 GM102714-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R15 GM102714-01 from the National Institutes of Health: http://www.nigms.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski FM, 1996, J MOL BIOL, V261, P357, DOI 10.1006/jmbi.1996.0469; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; Belotserkovsky JM, 2011, FEBS J, V278, P3508, DOI 10.1111/j.1742-4658.2011.08272.x; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bharat A, 2006, J BACTERIOL, V188, P7992, DOI 10.1128/JB.00959-06; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Carr AC, 2012, J BACTERIOL, V194, P5932, DOI 10.1128/JB.00913-12; Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Connolly K, 2013, MOL MICROBIOL, V87, P968, DOI 10.1111/mmi.12145; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; Cougot N, 2013, J MOL BIOL; Demirci H, 2010, RNA, V16, P2319, DOI 10.1261/rna.2357210; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; Frazier AD, 2012, ARCH MICROBIOL, V194, P1033, DOI 10.1007/s00203-012-0839-5; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gupta N, 2014, NAT STRUCT MOL BIOL; HERBST KL, 1994, P NATL ACAD SCI USA, V91, P12525, DOI 10.1073/pnas.91.26.12525; HEROLD M, 1987, J BIOL CHEM, V262, P8826; Herr AJ, 2000, EMBO J, V19, P2671, DOI 10.1093/emboj/19.11.2671; Hersch SJ, 2014, J BIOL CHEM, V289, P28160, DOI 10.1074/jbc.M114.593277; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; HOFFMAN DW, 1994, EMBO J, V13, P205, DOI 10.1002/j.1460-2075.1994.tb06250.x; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; Hwang J, 2006, MOL MICROBIOL, V61, P1660, DOI 10.1111/j.1365-2958.2006.05348.x; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Jomaa A, 2011, RNA, V17, P697, DOI 10.1261/rna.2509811; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Korepanov AP, 2012, NUCLEIC ACIDS RES, V40, P9153, DOI 10.1093/nar/gks676; Kurata T, 2015, J MOL BIOL, V427, P955, DOI 10.1016/j.jmb.2014.12.013; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Leipuviene R, 2007, J BACTERIOL, V189, P7024, DOI 10.1128/JB.00710-07; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lieberman KR, 2000, J MOL BIOL, V297, P1129, DOI 10.1006/jmbi.2000.3621; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; MANGIAROTTI G, 1974, NATURE, V247, P147, DOI 10.1038/247147a0; MODOLELL J, 1969, NATURE, V224, P345, DOI 10.1038/224345a0; Moore SD, 2008, P NATL ACAD SCI USA, V105, P11685, DOI 10.1073/pnas.0805633105; Naganathan A, 2013, J BACTERIOL, V195, P3682, DOI 10.1128/JB.00464-13; Nakatogawa H, 2004, CURR OPIN MICROBIOL, V7, P145, DOI 10.1016/j.mib.2004.01.001; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Peil L, 2012, NAT CHEM BIOL; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Roy-Chaudhuri B, 2008, MOL MICROBIOL, V68, P1547, DOI 10.1111/j.1365-2958.2008.06252.x; Roy-Chaudhuri B, 2010, P NATL ACAD SCI USA, V107, P4567, DOI 10.1073/pnas.0912305107; Samatova E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5459; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Schifano JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4538; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Seidman JS, 2011, J BIOL CHEM, V286, P31105, DOI 10.1074/jbc.M111.268201; Selmer M, 2012, ACTA CRYSTALLOGR D, V68, P578, DOI 10.1107/S0907444912006348; Shimizu Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00170; Song W, 2014, NUCLEIC ACIDS RES, V42, P4669, DOI 10.1093/nar/gku093; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yang ZX, 2014, PROTEIN CELL, V5, P394, DOI 10.1007/s13238-014-0044-1; Zaher HS, 2011, CELL, V147, P396, DOI 10.1016/j.cell.2011.08.045; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhang X, 2014, NUCL ACIDS RES; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	74	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120060	10.1371/journal.pone.0120060	http://dx.doi.org/10.1371/journal.pone.0120060			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879934	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500005
J	Vondrackova, S; Szakova, J; Drabek, O; Tejnecky, V; Hejcman, M; Mullerova, V; Tlustos, P				Vondrackova, Stanislava; Szakova, Jirina; Drabek, Ondrej; Tejnecky, Vaclav; Hejcman, Michal; Muellerova, Vladimira; Tlustos, Pavel			Aluminium Uptake and Translocation in Al Hyperaccumulator Rumex obtusifolius Is Affected by Low-Molecular-Weight Organic Acids Content and Soil pH	PLOS ONE			English	Article							ENVIRONMENTAL-SAMPLES; EXTRACTION PROCEDURES; FAGOPYRUM-ESCULENTUM; CONTAMINATED SOILS; ALKALINE SOILS; FOREST SOILS; HEAVY-METALS; OXALIC-ACID; PLANT; RESISTANCE	Background and Aims High Al resistance of Rumex obtusifolius together with its ability to accumulate Al has never been studied in weakly acidic conditions (pH > 5.8) and is not sufficiently described in real soil conditions. The potential elucidation of the role of organic acids in plant can explain the Al tolerance mechanism. Methods We established a pot experiment with R. obtusifolius planted in slightly acidic and alkaline soils. For the manipulation of Al availability, both soils were untreated and treated by lime and superphosphate. We determined mobile Al concentrations in soils and concentrations of Al and organic acids in organs. Results Al availability correlated positively to the extraction of organic acids (citric acid < oxalic acid) in soils. Monovalent Al cations were the most abundant mobile Al forms with positive charge in soils. Liming and superphosphate application were ambiguous measures for changing Al mobility in soils. Elevated transport of total Al from belowground organs into leaves was recorded in both lime-treated soils and in superphosphate-treated alkaline soil as a result of sufficient amount of Ca available from soil solution as well as from superphosphate that can probably modify distribution of total Al in R. obtusifolius as a representative of "oxalate plants." The highest concentrations of Al and organic acids were recorded in the leaves, followed by the stem and belowground organ infusions. Conclusions In alkaline soil, R. obtusifolius is an Al-hyperaccumulator with the highest concentrations of oxalate in leaves, of malate in stems, and of citrate in belowground organs. These organic acids form strong complexes with Al that can play a key role in internal Al tolerance but the used methods did not allow us to distinguish the proportion of total Al-organic complexes to the free organic acids.	[Vondrackova, Stanislava; Szakova, Jirina; Tlustos, Pavel] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Agroenvironm Chem & Plant Nutr, Prague 16521 6, Suchdol, Czech Republic; [Drabek, Ondrej; Tejnecky, Vaclav] Czech Univ Life Sci, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Prague 16521 6, Suchdol, Czech Republic; [Hejcman, Michal; Muellerova, Vladimira] Czech Univ Life Sci, Fac Environm Sci, Dept Ecol, Prague 16521 6, Suchdol, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Vondrackova, S (corresponding author), Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Agroenvironm Chem & Plant Nutr, Kamycka 129, Prague 16521 6, Suchdol, Czech Republic.	vondrackovas@af.czu.cz	Kroulikova, Stanislava/GRF-3434-2022; Tejnecký, Václav/K-9043-2013; Tlustos, Pavel/L-5312-2019; Drábek, Ondřej/AAU-3496-2021; MÃllerovÃ, VladimÃra/ABI-6294-2020; Száková, Jiřina/K-6296-2019	Kroulikova, Stanislava/0000-0003-4721-1158; Tejnecký, Václav/0000-0003-0296-4981; Tlustos, Pavel/0000-0003-1274-0658; Száková, Jiřina/0000-0002-3390-6365; Hejcman, Michal/0000-0002-3513-2017; Jurasova, Vladimira/0000-0003-2293-6566	Czech University of Life Sciences in Prague [CIGA 20124205, CIGA 20142027]	Czech University of Life Sciences in Prague	This study was supported by the Czech University of Life Sciences in Prague (CIGA 20124205, CIGA 20142027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2005, FOREST ECOL MANAG, V211, P227, DOI 10.1016/j.foreco.2005.02.044; Arunakumara KKIU, 2013, J KOREAN SOC APPL BI, V56, P1, DOI 10.1007/s13765-012-2314-z; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Brautigan DJ, 2012, PLANT SOIL, V360, P187, DOI 10.1007/s11104-012-1232-5; Drabek O, 2005, J INORG BIOCHEM, V99, P1788, DOI 10.1016/j.jinorgbio.2005.06.024; Ettler V, 2009, J HAZARD MATER, V170, P1264, DOI 10.1016/j.jhazmat.2009.05.068; Gleyzes C, 2002, TRAC-TREND ANAL CHEM, V21, P451, DOI 10.1016/S0165-9936(02)00603-9; HARRISON WJ, 1992, GEOCHIM COSMOCHIM AC, V56, P565, DOI 10.1016/0016-7037(92)90082-T; Hejcman M, 2014, PLANT SOIL ENVIRON, V60, P489, DOI 10.17221/414/2014-PSE; Hejcman M, 2012, PLANT SOIL ENVIRON, V58, P561, DOI 10.17221/612/2012-PSE; Huang J, 2009, WASTE MANAGE RES, V27, P668, DOI 10.1177/0734242X09103835; HUE NV, 1986, SOIL SCI SOC AM J, V50, P28, DOI 10.2136/sssaj1986.03615995005000010006x; Inostroza-Blancheteau C, 2012, MOL BIOL REP, V39, P2069, DOI 10.1007/s11033-011-0954-4; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kassaye YA, 2013, ACTA PHYSIOL PLANT, V35, P1749, DOI 10.1007/s11738-012-1212-7; KINRAIDE TB, 1990, PLANT PHYSIOL, V93, P1620, DOI 10.1104/pp.93.4.1620; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Koopmans GF, 2005, J ENVIRON QUAL, V34, P1446, DOI 10.2134/jeq2005.0028; Kubova J, 2005, ANAL CHIM ACTA, V547, P119, DOI 10.1016/j.aca.2004.12.014; Li JY, 2006, APPL GEOCHEM, V21, P1750, DOI 10.1016/j.apgeochem.2006.06.013; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2005, CRIT REV PLANT SCI, V24, P267, DOI 10.1080/07352680500196017; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; Malik J, 2008, FOOD CHEM, V111, P520, DOI 10.1016/j.foodchem.2008.04.009; Malik J, 2013, FOOD CHEM, V139, P728, DOI 10.1016/j.foodchem.2013.02.013; MARSCHNER H, 1991, PLANT SOIL, V134, P1, DOI 10.1007/BF00010712; Matus P, 2009, J INORG BIOCHEM, V103, P1473, DOI 10.1016/j.jinorgbio.2009.08.004; MCCOLL JG, 1986, WATER AIR SOIL POLL, V31, P917, DOI 10.1007/BF00284237; Miyagi A, 2013, WEED RES, V53, P30, DOI 10.1111/j.1365-3180.2012.00949.x; Miyagi A, 2010, METABOLOMICS, V6, P146, DOI 10.1007/s11306-009-0186-y; Mucha AP, 2005, ESTUAR COAST SHELF S, V65, P191, DOI 10.1016/j.ecss.2005.06.007; Namiesnik J, 2010, CRIT REV ANAL CHEM, V40, P68, DOI 10.1080/10408340903153234; Peters RW, 1999, J HAZARD MATER, V66, P151, DOI 10.1016/S0304-3894(99)00010-2; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; Quevauviller P, 1998, TRAC-TREND ANAL CHEM, V17, P289, DOI 10.1016/S0165-9936(97)00119-2; Reyna-Llorens I, 2015, ENVIRON EXP BOT, V111, P74, DOI 10.1016/j.envexpbot.2014.11.005; Scancar J, 2006, ANAL BIOANAL CHEM, V386, P999, DOI 10.1007/s00216-006-0422-5; Schottelndreier M, 2001, ANN BOT-LONDON, V87, P769, DOI 10.1006/anbo.2001.1405; Schwertfeger DM, 2009, SOIL SCI SOC AM J, V73, P737, DOI 10.2136/sssaj2008.0009; Shen RF, 2001, J EXP BOT, V52, P1683, DOI 10.1093/jexbot/52.361.1683; SIMS JR, 1971, SOIL SCI, V112, P137, DOI 10.1097/00010694-197108000-00007; Singh D, 2011, CURR SCI INDIA, V100, P1509; Strobel BW, 2001, GEODERMA, V99, P169, DOI 10.1016/S0016-7061(00)00102-6; Strom L, 2005, SOIL BIOL BIOCHEM, V37, P2046, DOI 10.1016/j.soilbio.2005.03.009; Tejnecky V, 2010, BIOGEOCHEMISTRY, V101, P151, DOI 10.1007/s10533-010-9450-5; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; TLUSTOS P, 1994, ROST VYROBA, V40, P1107; Tolra R, 2011, J PLANT RES, V124, P165, DOI 10.1007/s10265-010-0344-3; Tolra RP, 2005, ENVIRON EXP BOT, V54, P231, DOI 10.1016/j.envexpbot.2004.07.006; Trichopoulou A, 2000, FOOD CHEM, V70, P319, DOI 10.1016/S0308-8146(00)00091-1; TYLER G, 1994, EXPERIENTIA, V50, P701, DOI 10.1007/BF01952878; van Hees PAW, 2000, GEODERMA, V94, P201, DOI 10.1016/S0016-7061(98)00139-6; Vardavas CI, 2006, FOOD CHEM, V99, P813, DOI 10.1016/j.foodchem.2005.08.057; Vondrackova S, 2014, PLANT SOIL, V379, P231, DOI 10.1007/s11104-014-2058-0; Watanabe T, 2002, COMMUN SOIL SCI PLAN, V33, P1247, DOI 10.1081/CSS-120003885; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Wuana RA, 2010, INT J ENVIRON SCI TE, V7, P485, DOI 10.1007/BF03326158; Zheng SJ, 1998, PLANT PHYSIOL, V117, P745, DOI 10.1104/pp.117.3.745	58	10	12	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123351	10.1371/journal.pone.0123351	http://dx.doi.org/10.1371/journal.pone.0123351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880431	gold, Green Submitted, Green Published			2022-12-26	WOS:000353016500049
J	Wen, ZZT; Bitoun, JP; Liao, SM				Wen, Zezhang T.; Bitoun, Jacob P.; Liao, Sumei			PBP1a-Deficiency Causes Major Defects in Cell Division, Growth and Biofilm Formation by Streptococcus mutans	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; STRESS RESPONSES; PNEUMONIAE; RESISTANCE; GENES; ACID; GLUCOSYLTRANSFERASES; HYDROXYAPATITE; TRANSFORMATION; TOLERANCE	Streptococcus mutans, a key etiological agent of human dental caries, lives almost exclusively on the tooth surface in plaque biofilms and is known for its ability to survive and respond to various environmental insults, including low pH, and antimicrobial agents from other microbes and oral care products. In this study, a penicillin-binding protein (PBP1a)-deficient mutant, strain JB467, was generated by allelic replacement mutagenesis and analyzed for the effects of such a deficiency on S. mutans' stress tolerance response and biofilm formation. Our results so far have shown that PBP1a-deficiency in S. mutans affects growth of the deficient mutant, especially at acidic and alkaline pHs. As compared to the wild-type, UA159, the PBP1a-deficient mutant, JB467, had a reduced growth rate at pH 6.2 and did not grow at all at pH 8.2. Unlike the wild-type, the inclusion of paraquat in growth medium, especially at 2 mM or above, significantly reduced the growth rate of the mutant. Acid killing assays showed that the mutant was 15-fold more sensitive to pH 2.8 than the wild-type after 30 minutes. In a hydrogen peroxide killing assay, the mutant was 16-fold more susceptible to hydrogen peroxide (0.2%, w/v) after 90 minutes than the wild-type. Relative to the wild-type, the mutant also had an aberrant autolysis rate, indicative of compromises in cell envelope integrity. As analyzed using on 96-well plate model and spectrophotometry, biofilm formation by the mutant was decreased significantly, as compared to the wild-type. Consistently, Field Emission-SEM analysis also showed that the PBP1a-deficient mutant had limited capacity to form biofilms. TEM analysis showed that PBP1a mutant existed primarily in long rod-like cells and cells with multiple septa, as compared to the coccal wild-type. The results presented here highlight the importance of pbp1a in cell morphology, stress tolerance, and biofilm formation in S. mutans.	[Wen, Zezhang T.; Bitoun, Jacob P.; Liao, Sumei] Louisiana State Univ, Hlth Sci Ctr, Dept Comprehens Dent & Biomat, New Orleans, LA 70112 USA; [Wen, Zezhang T.; Bitoun, Jacob P.; Liao, Sumei] Louisiana State Univ, Hlth Sci Ctr, Ctr Oral & Craniofacial Biol, New Orleans, LA 70112 USA; [Wen, Zezhang T.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wen, ZZT (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Comprehens Dent & Biomat, New Orleans, LA 70112 USA.	zwen@lsuhsc.edu	Liao, Sumei/E-6589-2015		National Institute for Dental and Craniofacial Research, United States of America [DE19452]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019452] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research, United States of America; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by R01 grant DE19452 from the National Institute for Dental and Craniofacial Research, United States of America (http://www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Banzhaf M, 2012, MOL MICROBIOL, V85, P179, DOI 10.1111/j.1365-2958.2012.08103.x; BELLI WA, 1991, APPL ENVIRON MICROB, V57, P1134, DOI 10.1128/AEM.57.4.1134-1138.1991; Berg KH, 2013, J BACTERIOL, V195, P4342, DOI 10.1128/JB.00184-13; Bitoun JP, 2012, APPL ENVIRON MICROB, V78, P2914, DOI 10.1128/AEM.07823-11; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Evans KL, 2013, J BACTERIOL, V195, P4415, DOI 10.1128/JB.00596-13; Fani F, 2014, ANTIMICROB AGENTS CH, V58, P1397, DOI 10.1128/AAC.01311-13; Grebe T, 1996, ANTIMICROB AGENTS CH, V40, P829, DOI 10.1128/AAC.40.4.829; Gregoire S, 2011, APPL ENVIRON MICROB, V77, P6357, DOI 10.1128/AEM.05203-11; Hamilton A, 2006, INFECT IMMUN, V74, P6179, DOI 10.1128/IAI.00895-06; Hu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051905; Hughes HV, 2013, MOL MICROBIOL, V90, P1162, DOI 10.1111/mmi.12422; Job V, 2008, J BIOL CHEM, V283, P4886, DOI 10.1074/jbc.M706181200; Koksharova OA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P963, DOI 10.1134/S0006297913090010; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LeBanc D., 1991, GENETICS MOL BIOL ST, P235; Lemos JAC, 2001, J BACTERIOL, V183, P6074, DOI 10.1128/JB.183.20.6074-6084.2001; Li YH, 2002, J BACTERIOL, V184, P6333, DOI 10.1128/JB.184.22.6333-6342.2002; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Liao SM, 2014, J BACTERIOL, V196, P2355, DOI 10.1128/JB.01493-14; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; MARTIN C, 1992, EMBO J, V11, P3831, DOI 10.1002/j.1460-2075.1992.tb05475.x; MARTIN C, 1992, J BACTERIOL, V174, P4517, DOI 10.1128/JB.174.13.4517-4523.1992; Massidda O, 2013, ENVIRON MICROBIOL, V15, P3133, DOI 10.1111/1462-2920.12189; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nguyen UT, 2014, ANTIMICROB AGENTS CH, V58, P6508, DOI 10.1128/AAC.03671-14; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Otero LH, 2013, P NATL ACAD SCI USA, V110, P16808, DOI 10.1073/pnas.1300118110; Perry JA, 2009, FEMS MICROBIOL LETT, V299, P261, DOI 10.1111/j.1574-6968.2009.01758.x; Priyadarshini R, 2006, J BACTERIOL, V188, P5345, DOI 10.1128/JB.00476-06; Reichmann P, 1997, J INFECT DIS, V176, P1001, DOI 10.1086/516532; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; TAO L, 1988, J BACTERIOL, V170, P3752, DOI 10.1128/jb.170.8.3752-3755.1988; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; Vijayan S, 2014, CURR MICROBIOL, V68, P174, DOI 10.1007/s00284-013-0453-z; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Wen ZZT, 2006, J BACTERIOL, V188, P2983, DOI 10.1128/JB.188.8.2983-2992.2006; Zeng L, 2006, MOL MICROBIOL, V62, P187, DOI 10.1111/j.1365-2958.2006.05359.x	48	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124319	10.1371/journal.pone.0124319	http://dx.doi.org/10.1371/journal.pone.0124319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880908	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500093
J	Stout, D; Hecht, E; Khreisheh, N; Bradley, B; Chaminade, T				Stout, Dietrich; Hecht, Erin; Khreisheh, Nada; Bradley, Bruce; Chaminade, Thierry			Cognitive Demands of Lower Paleolithic Toolmaking	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; SUPERIOR FRONTAL GYRUS; STONE TOOL TECHNOLOGY; HUMAN-EVOLUTION; WORKING-MEMORY; HUMAN BRAIN; CORTEX; ORGANIZATION; ATTENTION; NETWORKS	Stone tools provide some of the most abundant, continuous, and high resolution evidence of behavioral change over human evolution, but their implications for cognitive evolution have remained unclear. We investigated the neurophysiological demands of stone toolmaking by training modern subjects in known Paleolithic methods ("Oldowan", "Acheulean") and collecting structural and functional brain imaging data as they made technical judgments (outcome prediction, strategic appropriateness) about planned actions on partially completed tools. Results show that this task affected neural activity and functional connectivity in dorsal prefrontal cortex, that effect magnitude correlated with the frequency of correct strategic judgments, and that the frequency of correct strategic judgments was predictive of success in Acheulean, but not Oldowan, toolmaking. This corroborates hypothesized cognitive control demands of Acheulean toolmaking, specifically including information monitoring and manipulation functions attributed to the "central executive" of working memory. More broadly, it develops empirical methods for assessing the differential cognitive demands of Paleolithic technologies, and expands the scope of evolutionary hypotheses that can be tested using the available archaeological record.	[Stout, Dietrich; Khreisheh, Nada] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Hecht, Erin] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Bradley, Bruce] Univ Exeter, Dept Archaeol, Exeter, Devon, England; [Chaminade, Thierry] Aix Marseille Univ, Inst Neurosci Timone, Marseille, France	Emory University; University System of Georgia; Georgia State University; University of Exeter; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Stout, D (corresponding author), Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA.	dwstout@emory.edu	Chaminade, Thierry/F-8367-2010; Chaminade, Thierry/AAF-6072-2020	Chaminade, Thierry/0000-0003-4952-1467; Chaminade, Thierry/0000-0003-4952-1467; Hecht, Erin/0000-0003-1247-0432; Khreisheh, Nada/0000-0002-3002-4228; Stout, Dietrich/0000-0003-3555-7637	Leverhulme Trust [F/00144/BP]	Leverhulme Trust(Leverhulme Trust)	This research was funded by a grant from the Leverhulme Trust (http://www.leverhulme.ac.uk/), "Learning to Be Human: Skill Acquisition and the Development of the Human Brain," F/00144/BP to BB and DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati D, 2007, COGNITION, V103, P358, DOI 10.1016/j.cognition.2006.04.002; Ambrose SH, 2010, CURR ANTHROPOL, V51, pS135, DOI 10.1086/650296; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bledowski C, 2010, BEHAV BRAIN RES, V214, P172, DOI 10.1016/j.bbr.2010.05.041; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Carmel D, 2008, NEURON, V57, P799, DOI 10.1016/j.neuron.2008.03.009; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Coolidge FL, 2005, CAMB ARCHAEOL J, V15, P5, DOI 10.1017/S0959774305000016; Deacon T., 1997, SYMBOLIC SPECIES COE; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Engels F., 1873, PHILOS TECHNOLOGY, P71; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Faisal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013718; Falquez R, 2014, FRONT BEHAV NEUROSCI, P8, DOI [10. 3389/ fnbeh. 2014. 00008, DOI 10.3389/FNBEH.2014.00008]; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gerlach C, 2007, J COGNITIVE NEUROSCI, V19, P296, DOI 10.1162/jocn.2007.19.2.296; Gerlach KD, 2014, SOCIAL COGNITIVE AFF; Gowlett J, 2012, CURR ANTHROPOL, V53, P693, DOI 10.1086/667994; Hecht E. E., 2014, BRAIN STRUCTURE FUNC, P1, DOI [10.1007/s00429-013-0527-5, DOI 10.1007/S00429-013-0527-5]; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kelly R.L., 2013, ARCHAEOLOGY, V6th Edn; Khreisheh N., 2013, THESIS EXETER U; Khreisheh NN, 2013, ADV ARCHAEOL PRACT, V1, P37, DOI 10.7183/2326-3768.1.1.37; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Li W, 2013, NEUROIMAGE, V78, P46, DOI 10.1016/j.neuroimage.2013.04.011; Magnani M, 2014, J ARCHAEOL SCI, V46, P37, DOI 10.1016/j.jas.2014.02.029; Mithen S, 1996, PREHISTORY MIND COGN; Moore MW, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P13; Mruczek REB, 2013, J NEUROPHYSIOL, V109, P2883, DOI 10.1152/jn.00658.2012; Nonaka T, 2010, J HUM EVOL, V59, P155, DOI 10.1016/j.jhevol.2010.04.006; Oakley KP, 1954, HIST TECHNOLOGY, P1; Pelegrin J, 1990, ARCHAEOLOGICAL REV C, V9, P116; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Schiffer M., 2013, MANUALS ARCHAEOLOGIC, V9, P43; Shea JJ, 2013, J ARCHAEOL METHOD TH, V20, P151, DOI 10.1007/s10816-012-9128-5; Shea JJ, 2011, EVOL ANTHROPOL, V20, P48, DOI 10.1002/evan.20290; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shultz S, 2012, PHILOS T R SOC B, V367, P2130, DOI 10.1098/rstb.2012.0115; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Stout D, 2014, J ARCHAEOL SCI, V41, P576, DOI 10.1016/j.jas.2013.10.001; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Stout D, 2011, EUR J NEUROSCI, V33, P1328, DOI 10.1111/j.1460-9568.2011.07619.x; Stout D, 2011, PHILOS T R SOC B, V366, P1050, DOI 10.1098/rstb.2010.0369; Stout D, 2010, TOP COGN SCI, V2, P614, DOI 10.1111/j.1756-8765.2009.01078.x; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VanLehn K, 1996, ANNU REV PSYCHOL, V47, P513, DOI 10.1146/annurev.psych.47.1.513; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Whittaker J.C., 1994, FLINTKNAPPING MAKING; Williams E, 2014, J HUMAN EVOLUTION; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Wynn T, 2011, EVOL ANTHROPOL, V20, P181, DOI 10.1002/evan.20323; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034	70	91	95	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121804	10.1371/journal.pone.0121804	http://dx.doi.org/10.1371/journal.pone.0121804			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CG1EL	25875283	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800032
J	Vedder, A; Smigielski, L; Gutyrchik, E; Bao, Y; Blautzik, J; Poppel, E; Zaytseva, Y; Russell, E				Vedder, Aline; Smigielski, Lukasz; Gutyrchik, Evgeny; Bao, Yan; Blautzik, Janusch; Poeppel, Ernst; Zaytseva, Yuliya; Russell, Edmund			Neurofunctional Correlates of Environmental Cognition: An fMRI Study with Images from Episodic Memory	PLOS ONE			English	Article							MENTAL-IMAGERY; CORTEX; REPRESENTATIONS; PERCEPTION; MECHANISMS; EXPOSURE; RECOVERY	This study capitalizes on individual episodic memories to investigate the question, how different environments affect us on a neural level. Instead of using predefined environmental stimuli, this study relied on individual representations of beauty and pleasure. Drawing upon episodic memories we conducted two experiments. Healthy subjects imagined pleasant and non-pleasant environments, as well as beautiful and non-beautiful environments while neural activity was measured by using functional Magnetic Resonance Imaging. Although subjects found the different conditions equally simple to visualize, our results revealed more distribut-ed brain activations for non-pleasant and non-beautiful environments than for pleasant and beautiful environments. The additional regions activated in non-pleasant (left lateral prefrontal cortex) and non-beautiful environments (supplementary motor area, anterior cortical midline structures) are involved in self-regulation and top-down cognitive control. Taken together, the results show that perceptual experiences and emotional evaluations of environments within a positive and a negative frame of reference are based on distinct patterns of neural activity. We interpret the data in terms of a different cognitive and processing load placed by exposure to different environments. The results hint at the efficiency of subject-generated representations as stimulus material.	[Vedder, Aline; Smigielski, Lukasz; Gutyrchik, Evgeny; Poeppel, Ernst; Zaytseva, Yuliya; Russell, Edmund] LMU, Human Sci Ctr, Munich, Germany; [Vedder, Aline] LMU, Inst Sociol, Munich, Germany; [Vedder, Aline; Gutyrchik, Evgeny; Poeppel, Ernst; Zaytseva, Yuliya] LMU, Inst Med Psychol, Munich, Germany; [Vedder, Aline; Gutyrchik, Evgeny; Bao, Yan; Poeppel, Ernst; Zaytseva, Yuliya] Parmenides Ctr Art & Sci, Pullach, Germany; [Blautzik, Janusch] LMU, Inst Clin Radiol, Munich, Germany; [Bao, Yan; Poeppel, Ernst] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Bao, Yan] Peking Univ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [Zaytseva, Yuliya] Moscow Res Inst Psychiat, Moscow, Russia; [Zaytseva, Yuliya] Univ Kansas, Dept Hist, Lawrence, KS USA	University of Munich; University of Munich; University of Munich; University of Munich; Peking University; Peking University; University of Kansas	Gutyrchik, E (corresponding author), LMU, Human Sci Ctr, Munich, Germany.	evgeny.gutyrchik@med.uni-muenchen.de		Zaytseva, Yuliya/0000-0002-6560-8127; Gutyrchik, Evgeny/0000-0003-0550-2547; Smigielski, Lukasz/0000-0002-7428-7644	Munich Center for Neuroscience; Bavarian State Ministry of Education, Science and the Arts; Hanns-Seidel-Foundation; Parmenides Center for Art and Science; Andrea von Braun Foundation; Bavarian Research Foundation; National Natural Science Foundation of China	Munich Center for Neuroscience; Bavarian State Ministry of Education, Science and the Arts; Hanns-Seidel-Foundation; Parmenides Center for Art and Science; Andrea von Braun Foundation; Bavarian Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from the Munich Center for Neuroscience (www.mcn.uni-muenchen.de) to the Rachel Carson Center, the Bavarian State Ministry of Education, Science and the Arts (www.stmwfk.bayern.de), the Hanns-Seidel-Foundation (www.hss.de), the Parmenides Center for Art and Science (www.parmenides-foundation.org), the Andrea von Braun Foundation (www.avbstiftung.de), the Bavarian Research Foundation (www.forschungsstiftung.de), and the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avram M, 2013, NEUROSCI LETT, V534, P128, DOI 10.1016/j.neulet.2012.11.053; Bao Y, 2012, NEUROSCI BIOBEHAV R, V36, P2143, DOI 10.1016/j.neubiorev.2012.06.008; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Belardinelli MO, 2009, ACTA PSYCHOL, V132, P190, DOI 10.1016/j.actpsy.2009.06.009; Borst G, 2008, MEM COGNITION, V36, P849, DOI 10.3758/MC.36.4.849; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Buijs AE, 2009, LANDSCAPE URBAN PLAN, V91, P113, DOI 10.1016/j.landurbplan.2008.12.003; Cichy RM, 2012, CEREB CORTEX, V22, P372, DOI 10.1093/cercor/bhr106; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; FINKE RA, 1985, PSYCHOL BULL, V98, P236, DOI 10.1037/0033-2909.98.2.236; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kellert SR, 2013, THE BIOPHILIA HYPOTH; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kosslyn SM, 1999, MEM COGNITION, V27, P276, DOI 10.3758/BF03211412; Laumann K, 2001, J ENVIRON PSYCHOL, V21, P31, DOI 10.1006/jevp.2000.0179; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lutz A, 2013, NEUROIMAGE, V66, P288, DOI 10.1016/j.neuroimage.2012.10.067; Martinez-Soto J, 2013, INTELL BUILD INT, V5, P10, DOI 10.1080/17508975.2013.807765; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Park M, 2013, BRAIN RES, V1523, P68, DOI 10.1016/j.brainres.2013.05.042; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Poppel E., 2014, SUBJECTIVE TIME PHIL, P241, DOI DOI 10.7551/MITPRESS/8516.003.0020; Poppel E., 2011, CULTURE NEURAL FRAME, P215, DOI DOI 10.1007/978-3-642-15423-2_14; Sapolsky RM, 2004, THE ACCLAIMED GUIDE; Schweitzer M, 2004, J ALTERN COMPLEM MED, V10, pS71, DOI 10.1089/acm.2004.10.S-71; SHEEHAN PW, 1967, J CLIN PSYCHOL, V23, P386, DOI 10.1002/1097-4679(196707)23:3<386::AID-JCLP2270230328>3.0.CO;2-S; Silveira S, 2012, PERCEPTION, V41, P569, DOI 10.1068/p7191; Staricoff RL, 2003, HEALING ENV, P63; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ulrich R.S., 1993, 33 M SOC PSYCH RES R; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Weidner R, 2002, CEREB CORTEX, V12, P318, DOI 10.1093/cercor/12.3.318; Wells NM, 2010, J ARCHIT PLAN RES, V27, P124	47	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122470	10.1371/journal.pone.0122470	http://dx.doi.org/10.1371/journal.pone.0122470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875000	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700015
J	Bien, CH; Muessig, KE; Lee, R; Lo, EJ; Yang, LG; Yang, B; Peeling, RW; Tucker, JD				Bien, Cedric H.; Muessig, Kathryn E.; Lee, Ramon; Lo, Elaine J.; Yang, Li Gang; Yang, Bin; Peeling, Rosanna W.; Tucker, Joseph D.			HIV and Syphilis Testing Preferences among Men Who Have Sex with Men in South China: A Qualitative Analysis to Inform Sexual Health Services	PLOS ONE			English	Article							RISK; MSM; INFECTION; HIV/AIDS; CARE; INTERVENTION; EPIDEMIOLOGY; METAANALYSIS; POPULATIONS; PREVALENCE	Background Health services for men who have sex with men (MSM) are inadequate in many areas around the world. HIV and syphilis test uptake remain suboptimal among MSM in China and many other regions. To inform the development of more comprehensive sexually transmitted disease (STD) testing programs among MSM, we collected descriptive data on MSM testing practices and preferences. Methods MSM in two large urban Chinese cities were recruited through community-based organizations and clinics to participate in semi-structured interviews. We purposively sampled MSM across a range of sociodemographic characteristics and testing history, and assessed preferences for HIV and syphilis testing in the context of facilitators and barriers to testing and previous testing experiences. Each interview transcript was coded and thematically analyzed using Atlas.ti 7.0. Results 35 MSM were interviewed. Confidentiality and privacy were the most important factors influencing participants' decisions about whether and where to get tested. Men preferred rapid testing (results available within 30 minutes) compared to conventional tests where results take several hours or days to return. Participants described concerns about quality and accuracy of rapid tests offered in non-clinical settings such as community-based organizations. Men preferred testing service providers who were MSM-friendly, non-discriminatory, and medically trained. Preferred service center environments included: convenient but discrete location, MSM-friendly atmosphere, and clean/standard medical facilities. Conclusion Our data highlight the need for HIV/syphilis testing services that are confidential and inclusive of MSM. Rapid testing in decentralized (i.e. peripheral health facilities and community-level, non-clinical venues) settings provides an opportunity to reach individuals who have not been tested before, but must be accompanied by quality assurance systems and technical competence. Implementation research could further evaluate HIV/syphilis testing programs responsive to MSM preferences. Short Summary A qualitative study of MSM in South China found thatmen preferred rapid STD testing at MSM-focused test centers, but were concerned about test quality assurance and confidentiality.	[Bien, Cedric H.; Muessig, Kathryn E.; Tucker, Joseph D.] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Bien, Cedric H.] Mt Sinai Sch Med, New York, NY USA; [Muessig, Kathryn E.; Lo, Elaine J.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Lee, Ramon] Harvard Univ, Sch Med, Boston, MA USA; [Yang, Li Gang; Yang, Bin] Guangdong Prov STD Control Ctr, Guangzhou, Guangdong, Peoples R China; [Peeling, Rosanna W.; Tucker, Joseph D.] London Sch Hyg & Trop Med, London WC1, England; [Tucker, Joseph D.] Univ N Carolina, Sch Med, Chapel Hill, NC USA	Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tucker, JD (corresponding author), Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China.	jdtucker@med.unc.edu	Muessig, Kate/P-1242-2018	Tucker, Joseph/0000-0003-2804-1181	NIAID [1R01AI114310-01]; NIH Fogarty Career Development Award (US NIH) [1K01TW008200-01A1]; NIH institutional training grant [5T32AI007001-35]; UNC Center for AIDS Research [NIAID 5P30AI050410-13]; Partnership for Social Science Research on HIV/AIDS in China [NICHD 1R24 HD056670-04]; American Society of Tropical Medicine and Hygiene/Burroughs Welcome Fund; Columbia University College of Physicians and Surgeons Dean's International Grant; Harvard Medical School; IDSA Medical Scholars Program; Doris Duke Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD056670] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW008200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001, R01AI114310, P30AI050410] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Fogarty Career Development Award (US NIH); NIH institutional training grant; UNC Center for AIDS Research; Partnership for Social Science Research on HIV/AIDS in China; American Society of Tropical Medicine and Hygiene/Burroughs Welcome Fund; Columbia University College of Physicians and Surgeons Dean's International Grant; Harvard Medical School; IDSA Medical Scholars Program; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the NIAID (1R01AI114310-01), an NIH Fogarty Career Development Award (US NIH 1K01TW008200-01A1), an NIH institutional training grant (5T32AI007001-35), the UNC Center for AIDS Research (NIAID 5P30AI050410-13), the Partnership for Social Science Research on HIV/AIDS in China (NICHD 1R24 HD056670-04), a junior faculty award from the American Society of Tropical Medicine and Hygiene/Burroughs Welcome Fund, Columbia University College of Physicians and Surgeons Dean's International Grant, Harvard Medical School, IDSA Medical Scholars Program, and a grant from the Doris Duke Charitable Foundation to UNC-Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrinopoulos K, 2015, AIDS BEHAV, V19, P60, DOI 10.1007/s10461-014-0813-0; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Chai J, 2012, AIDS CARE, V24, P424, DOI 10.1080/09540121.2011.613907; Chiu YHC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018294; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Cochran SD, 2011, AM J PUBLIC HEALTH, V101, P1133, DOI 10.2105/AJPH.2010.300013; Cohall A, 2010, AM J PUBLIC HEALTH, V100, P1961, DOI 10.2105/AJPH.2008.140632; Dixon-Woods M, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-39; Fan EL, 2014, GLOB PUBLIC HEALTH, V9, P85, DOI 10.1080/17441692.2014.881520; Han L, 2014, JAIDS-J ACQ IMM DEF, V67, P216, DOI 10.1097/QAI.0000000000000278; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huang ZJ, 2012, AIDS BEHAV, V16, P858, DOI 10.1007/s10461-011-0119-4; Huang ZH, 2013, AIDS RES HUM RETROV, V29, P441, DOI [10.1089/aid.2012.0151, 10.1089/AID.2012.0151]; Institute of Medicine, 2011, HLTH LESB GAY BIS TR; Lambdin B, 2012, 19 INT AIDS C WASH D; Learmonth KM, 2008, J CLIN MICROBIOL, V46, P1692, DOI 10.1128/JCM.01761-07; Lee D, 2010, SEX TRANSM DIS, V37, P557, DOI 10.1097/OLQ.0b013e3181d707de; Li XF, 2012, AIDS BEHAV, V16, P499, DOI 10.1007/s10461-012-0161-x; Lorente N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061225; Marley G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-422; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Prost A, 2007, SEX TRANSM INFECT, V83, P547, DOI 10.1136/sti.2007.027110; Prost A, 2007, SEX TRANSM INFECT, V83, P185, DOI 10.1136/sti.2006.023341; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Tao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102812; Tucker JD, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0601-5; Tucker JD, 2013, CURR OPIN INFECT DIS, V26, P73, DOI 10.1097/QCO.0b013e32835c21b0; Tucker JD, 2011, SEX TRANSM INFECT, V87, pII16, DOI 10.1136/sti.2010.048314; Wei CY, 2014, SEX TRANSM INFECT, V90, P469, DOI 10.1136/sextrans-2013-051460; Wei CY, 2014, AIDS CARE, V26, P372, DOI 10.1080/09540121.2013.824538; Wei S, 2013, AIDS BEHAV, V17, P1151, DOI 10.1007/s10461-011-0110-0; Wu ZY, 2011, B WORLD HEALTH ORGAN, V89, P227, DOI 10.2471/BLT.10.082552; Xu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064652; Yan HJ, 2014, SEX TRANSM INFECT, V90, P388, DOI 10.1136/sextrans-2013-051397; Yang L, 2012, INT UN SEX TRANSM IN; Yin YP, 2012, SEX TRANSM DIS, V39, P354, DOI 10.1097/OLQ.0b013e318244aef0; Zeng Gang, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P977; Zhang D, 2011, INT J STD AIDS; Zhang Da-peng, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P431; Zhang DP, 2014, AIDS CARE, V26, P1118, DOI 10.1080/09540121.2014.902420; Zhang L, 2013, SEX TRANSM DIS, V40, P235, DOI 10.1097/OLQ.0b013e31827ca6b9; Zhong F, 2011, AIDS BEHAV, V15, P1058, DOI 10.1007/s10461-009-9619-x; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	47	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124161	10.1371/journal.pone.0124161	http://dx.doi.org/10.1371/journal.pone.0124161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875336	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100242
J	Favero, M; Cangiano, A; Busetto, G				Favero, Morgana; Cangiano, Alberto; Busetto, Giuseppe			Adult Rat Motor Neurons Do Not Re-Establish Electrical Coupling during Axonal Regeneration and Muscle Reinnervation	PLOS ONE			English	Article							MAMMALIAN SPINAL-CORD; SYNAPSE ELIMINATION; GAP-JUNCTIONS; NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE; IN-VIVO; NEONATAL-RAT; NEWBORN RAT; MOTONEURONS; TRANSMISSION	Gap junctions (GJs) between neurons are present in both the newborn and the adult nervous system, and although important roles have been suggested or demonstrated in a number of instances, in many other cases a full understanding of their physiological role is still missing. GJs are expressed in the rodent lumbar cord at birth and mediate both dye and electrical coupling between motor neurons. This expression has been proposed to mediate: (i) fast synchronization of motoneuronal spike activity, in turn linked to the process of refinement of neuromuscular connections, and (ii) slow synchronization of locomotor-like oscillatory activity. Soon after birth this coupling disappears. Since in the adult rat regeneration of motor fibers after peripheral nerve injury leads to a recapitulation of synaptic refinement at the target muscles, we tested whether GJs between motor neurons are transiently re-expressed. We found that in conditions of maximal responsiveness of lumbar motor neurons (such as no depression by anesthetics, decerebrate release of activity of subsets of motor neurons, use of temporal and spatial summation by antidromic and orthodromic stimulations, testing of large ensembles of motor neurons) no firing is observed in ventral root axons in response to antidromic spike invasion of nearby counterparts. We conclude that junctional coupling between motor neurons is not required for the refinement of neuromuscular innervation in the adult.	[Favero, Morgana; Cangiano, Alberto; Busetto, Giuseppe] Univ Verona, Dept Neurol & Movement Sci, Sect Physiol & Psychol, I-37134 Verona, Italy; [Favero, Morgana; Cangiano, Alberto; Busetto, Giuseppe] Natl Inst Neurosci, I-37134 Verona, Italy	University of Verona	Busetto, G (corresponding author), Univ Verona, Dept Neurol & Movement Sci, Sect Physiol & Psychol, I-37134 Verona, Italy.	giuseppe.busetto@univr.it			Italian Ministry of Education, Universities and Research; Research Projects of National Interest, Italy [2006055835]	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); Research Projects of National Interest, Italy	This work was supported by Italian Ministry of Education, Universities and Research (to A.C.), Research Projects of National Interest 2006 Grant 2006055835, Italy (to G.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belousov AB, 2013, TRENDS NEUROSCI, V36, P227, DOI 10.1016/j.tins.2012.11.001; Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Brunton L., 2011, GOODMAN GILMANS PHAR; Buffelli M, 2002, P NATL ACAD SCI USA, V99, P13200, DOI 10.1073/pnas.202471199; Buffelli M, 1997, J MUSCLE RES CELL M, V18, P683, DOI 10.1023/A:1018687923929; Burke RE, 1994, MYOLOGY, P464; Busetto G, 2000, J NEUROSCI, V20, P685, DOI 10.1523/JNEUROSCI.20-02-00685.2000; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; CZEH G, 1990, BRAIN RES, V527, P224, DOI 10.1016/0006-8993(90)91141-3; Favero M, 2010, NEUROSCIENCE, V167, P343, DOI 10.1016/j.neuroscience.2010.01.055; Favero M, 2014, NEUROSCIENTIST, V20, P8, DOI 10.1177/1073858413491148; Favero M, 2012, P NATL ACAD SCI USA, V109, pE1667, DOI 10.1073/pnas.1201147109; FULTON BP, 1980, PROC R SOC SER B-BIO, V208, P115, DOI 10.1098/rspb.1980.0045; Gonzalez-Nieto D, 2008, P NATL ACAD SCI USA, V105, P17169, DOI 10.1073/pnas.0804189105; Hansen NL, 2001, J NEUROPHYSIOL, V86, P1266, DOI 10.1152/jn.2001.86.3.1266; Hedo G, 1999, NEUROSCIENCE, V92, P309, DOI 10.1016/S0306-4522(98)00734-9; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Kiehn O, 2002, TRENDS NEUROSCI, V25, P108, DOI 10.1016/S0166-2236(02)02038-6; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; KUNO M, 1970, J PHYSIOL-LONDON, V210, P807, DOI 10.1113/jphysiol.1970.sp009243; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; MAGLADERY JW, 1950, B JOHNS HOPKINS HOSP, V86, P265; MATSUMOTO A, 1988, J NEUROSCI, V8, P4177; Matsumura M, 1996, J NEUROSCI, V16, P7757; Mazo I, 2015, EUR J PAIN, V19, P1012, DOI 10.1002/ejp.629; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; NICHOLSON GM, 1988, NEUROPHARMACOLOGY, V27, P459, DOI 10.1016/0028-3908(88)90127-X; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; NORDSTROM MA, 1992, J PHYSIOL-LONDON, V453, P547, DOI 10.1113/jphysiol.1992.sp019244; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; Personius KE, 2008, J NEUROSCI, V28, P8983, DOI 10.1523/JNEUROSCI.5226-07.2008; Personius KE, 2007, P NATL ACAD SCI USA, V104, P11808, DOI 10.1073/pnas.0703357104; PIERAU FK, 1969, FED PROC, V28, P1006; REDFERN PA, 1970, J PHYSIOL-LONDON, V209, P701, DOI 10.1113/jphysiol.1970.sp009187; REES D, 1978, J PHYSIOL-LONDON, V278, pP8; RIBCHESTER RR, 1993, J PHYSIOL-LONDON, V466, P421; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; Rothwell J., 1994, CONTROL HUMAN VOLUNT, V2nd ed.; SALA C, 1995, J NEUROSCI, V15, P520; Sherrington C S, 1898, J Physiol, V22, P319; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Tapia J.C., 2012, FUNDAMENTAL NEUROSCI, P437; Tresch MC, 2002, J NEUROSCI, V22, P9997; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; van der Want JJL, 1998, BRAIN RES, V779, P342, DOI 10.1016/S0006-8993(97)01238-9; WALTON KD, 1991, J PHYSIOL-LONDON, V433, P283, DOI 10.1113/jphysiol.1991.sp018426	49	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123576	10.1371/journal.pone.0123576	http://dx.doi.org/10.1371/journal.pone.0123576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875765	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100190
J	Ku, HY; Su, PH; Wen, HJ; Sun, HL; Wang, CJ; Chen, HY; Jaakkola, JJK; Wang, SL				Ku, Hsiu Ying; Su, Pen Hua; Wen, Hui Ju; Sun, Hai Lun; Wang, Chien Jen; Chen, Hsiao Yen; Jaakkola, Jouni J. K.; Wang, Shu-Li		TMICS Grp	Prenatal and Postnatal Exposure to Phthalate Esters and Asthma: A 9-Year Follow-Up Study of a Taiwanese Birth Cohort	PLOS ONE			English	Article							CHILDREN; ASSOCIATION; SYMPTOMS; HEALTH; YOUNG; METABOLITES; PREVALENCE; BIPHENYLS; ALLERGIES; DIOXINS	Previous studies have shown that phthalate exposure in childhood is associated with the development of respiratory problems. However, few studies have assessed the relative impact of prenatal and postnatal exposure to phthalates on the development of asthma later in childhood. Therefore, we assessed the impact of prenatal and postnatal phthalate exposure on the development of asthma and wheezing using a Taiwanese birth cohort. A total of 430 pregnant women were recruited, and 171 (39.8%) of them had their children followed when they were aged 2, 5, and 8 years. The International Study of Asthma and Allergies in Childhood questionnaire was used to assess asthma and wheezing symptoms and serumtotal immunoglobulin E levels were measured at 8 years of age. Urine samples were obtained from 136 women during their third trimester of pregnancy, 99 children at 2 years of age, and 110 children at 5 years. Four common phthalate monoester metabolites inmaternal and children's urine were measured using liquid chromatography-electrospray ionization-tandem mass spectrometry. Maternal urinary mono-benzyl phthalate [MBzP] concentrations were associated with an increased occurrence of wheezing in boys at 8 years of age (odds ratio [OR] = 4.95 (95% CI 1.08-22.63)), for upper quintile compared to the others) after controlling for parental allergies and family members' smoking status. Urinary mono-2-ethylhexyl phthalate [MEHP] levels over the quintile at 2-year-old were associated with increased asthma occurrence (adjusted OR = 6.14 (1.17-32.13)) in boys. Similarly, the sum of di-2-ethyl-hexyl phthalate [DEHP] metabolites at 5 years was associated with asthma in boys (adjusted OR = 4.36 (1.01-18.86)). Urinary MEHP inmaternal and 5-year-old children urine were significantly associated with increased IgE in allergic children at 8 years. Prenatal and postnatal exposure to phthalate was associated with the occurrence of asthma in children, particularly for boys.	[Ku, Hsiu Ying; Wang, Shu-Li] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Ku, Hsiu Ying; Wen, Hui Ju; Wang, Chien Jen; Chen, Hsiao Yen; Wang, Shu-Li] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Miaoli, Taiwan; [Su, Pen Hua] Chung Shan Med Univ Hosp, Dept Pediat, Div Genet, Taichung 40201, Taiwan; [Sun, Hai Lun] Chung Shan Med Univ Hosp, Dept Pediat, Taichung 40201, Taiwan; [Jaakkola, Jouni J. K.] Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Jaakkola, Jouni J. K.] Med Res Ctr, Oulu, Finland; [Wang, Shu-Li] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Wang, Shu-Li] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; National Health Research Institutes - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; University of Oulu; China Medical University Taiwan; National Defense Medical Center	Wang, SL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	slwang@nhri.org.tw	Jaakkola, Jouni J.K./G-4314-2012	Wang, Shu-Li/0000-0002-0686-4729; Wen, Hui-Ju/0000-0003-1268-3120; Jaakkola, Jouni/0000-0003-4168-4683	Department of National Health Research Institutes, Taiwan [EH-102-SP-02, EO-103-PP-05, EH-103-SP-02, EO-104-PP-05, EO-090-PP-03]; Ministry of Science and Technology (MOST) [103-2314-B-400006]	Department of National Health Research Institutes, Taiwan; Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	Financial support received from the Department of National Health Research Institutes, Taiwan, is gratefully acknowledged: EH-102-SP-02, EO-103-PP-05, EH-103-SP-02, EO-104-PP-05, EO-090-PP-03 and also Ministry of Science and Technology (MOST 103-2314-B-400006). The funding agents had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bertelsen RJ, 2013, ENVIRON HEALTH PERSP, V121, P251, DOI 10.1289/ehp.1205256; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Bolling AK, 2012, TOXICOL LETT, V209, P43, DOI 10.1016/j.toxlet.2011.11.016; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Carlstedt F, 2013, INDOOR AIR, V23, P32, DOI 10.1111/j.1600-0668.2012.00788.x; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Chen YC, 2014, AM J RESP CRIT CARE, V189, P1194, DOI 10.1164/rccm.201401-0097OC; Chiang LC, 2007, ASIAN PAC J ALLERGY, V25, P1; Delacourt C, 2002, REV FR ALLERGOL, V42, P267, DOI 10.1016/S0335-7457(02)00148-X; Dietert RR, 2008, BIRTH DEFECTS RES B, V83, P547, DOI 10.1002/bdrb.20170; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039008; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797; Just AC, 2012, AM J RESP CRIT CARE, V186, P830, DOI 10.1164/rccm.201203-0398OC; Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7; Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498; Krawiec ME, 2001, AM J RESP CRIT CARE, V163, P1338, DOI 10.1164/ajrccm.163.6.2005116; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Kuo CH, 2013, ALLERGY, V68, P870, DOI 10.1111/all.12162; Larsson M, 2010, INDOOR AIR, V20, P494, DOI 10.1111/j.1600-0668.2010.00671.x; Li LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062526; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663; Moral R, 2011, ENV HLTH, V10, pe5; Osman MF, 2009, PAEDIATR PERINAT EP, V23, P567, DOI 10.1111/j.1365-3016.2009.01064.x; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Rosenwasser LJ, 2011, CURR ALLERGY ASTHM R, V11, P178, DOI 10.1007/s11882-011-0179-6; Su PH, 2012, ENVIRON INT, V39, P181, DOI 10.1016/j.envint.2011.09.009; Wang IJ, 2013, ENV INT C, V62C, P48; Wang SL, 2004, CHEMOSPHERE, V54, P1459, DOI 10.1016/j.chemosphere.2003.08.012; Whyatt RM, 2014, ENVIRON HEALTH PERSP, V122, P1141, DOI 10.1289/ehp.1307670; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Wu MT, 2012, ENVIRON INT, V44, P75, DOI 10.1016/j.envint.2012.01.014	38	66	67	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123309	10.1371/journal.pone.0123309	http://dx.doi.org/10.1371/journal.pone.0123309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875379	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100162
J	Nunez, J; Rabinovich, GA; Sandino, J; Mainar, L; Palau, P; Santas, E; Villanueva, MP; Nunez, E; Bodi, V; Chorro, FJ; Minana, G; Sanchis, J				Nunez, Julio; Rabinovich, Gabriel A.; Sandino, Justo; Mainar, Luis; Palau, Patricia; Santas, Enrique; Pilar Villanueva, Maria; Nunez, Eduardo; Bodi, Vicent; Chorro, Francisco J.; Minana, Gema; Sanchis, Juan			Prognostic Value of the Interaction between Galectin-3 and Antigen Carbohydrate 125 in Acute Heart Failure	PLOS ONE			English	Article							STATIN THERAPY; ASSOCIATION; SURFACE; CA125; CELLS; INFLAMMATION; CONTRIBUTES	Aims Galectin-3 (Gal-3) and carbohydrate antigen 125 (CA125) have emerged as robust prognostic biomarkers in heart failure. Experimental data have also suggested a potential molecular interaction between CA125 and Gal-3; however, the biological and clinical relevance of this interaction is still uncertain. We sought to evaluate, in patients admitted for acute heart failure, the association between plasma Gal-3 with all-cause mortality and the risk for rehospitalizations among high and low levels of CA125. Methods and Results We included 264 consecutive patients admitted for acute heart failure to the Cardiology Department in a third-level center. Both biomarkers were measured on admission. Negative binomial and Cox regression models were used to evaluate the prognostic effect of the interaction between Gal-3 and CA125 (dichotomized by its median) with hospital readmission and all-cause mortality, respectively. During a median follow-up of 2 years (IQR = 1-2.8), 108 (40.9%) patients deaths and 365 rehospitalizations in 171 (69.5%) patients were registered. In a multivariable setting, the effect of Gal-3 on mortality and rehospitalization was differentially mediated by CA125 (p = 0.007 and p< 0.001, respectively). Indeed, in patients with CA125 above median (> 67 U/ml), values across the continuum of Gal-3 showed a positive and almost linear relationship with either the risk of death or rehospitalization. Conversely, when CA125 was below median (<= 67 U/ml), Gal-3 lacked any prognostic effect on both endpoints. Conclusion In patients with acute heart failure, Gal-3 was strongly associated with higher risk of longterm mortality and repeated rehospitalizations, but only in those patients exhibiting higher values of CA125 (above 67 U/ml).	[Nunez, Julio; Sandino, Justo; Mainar, Luis; Santas, Enrique; Nunez, Eduardo; Bodi, Vicent; Chorro, Francisco J.; Sanchis, Juan] Univ Valencia, Hosp Clin, Serv Cardiol, Valencia, Spain; [Rabinovich, Gabriel A.] Univ Buenos Aires, CONICET, Inst Biol & Med Expt IBYME, Lab Inmunopatol, Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Palau, Patricia] Hosp Plana, Serv Cardiol, Villa Real, Spain; [Pilar Villanueva, Maria] Univ Valencia, Hosp Clin, Serv Bioquim Clin, Valencia, Spain; [Minana, Gema] Hosp Manises, Serv Cardiol, Manises, Spain	University of Valencia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; University of Buenos Aires; University of Valencia	Nunez, J (corresponding author), Univ Valencia, Hosp Clin, Serv Cardiol, Valencia, Spain.	yulnunez@gmail.com	Palau, Patricia/AGR-8555-2022; Palau, Patricia/T-1027-2017; Chorro, Francisco J/AAB-6766-2020	Palau, Patricia/0000-0001-5040-0924; Palau, Patricia/0000-0001-5040-0924; Nunez, Julio/0000-0003-1672-7119	Convocatoria Investigacion Clinica Independiente Ministerio de Economica y Competitividad (Cofinanciado FEDER) Referencia [EC10-108]	Convocatoria Investigacion Clinica Independiente Ministerio de Economica y Competitividad (Cofinanciado FEDER) Referencia	This work was supported in part by grants from Convocatoria Investigacion Clinica Independiente Ministerio de Economica y Competitividad (Cofinanciado FEDER) Referencia EC10-108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; D'Aloia A, 2003, J AM COLL CARDIOL, V41, P1805, DOI 10.1016/S0735-1097(03)00311-5; de Boer RA, 2014, CARDIOVASC DRUG THER, V28, P237, DOI 10.1007/s10557-014-6520-2; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Felder M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-129; Forsman H, 2011, ARTHRITIS RHEUM-US, V63, P445, DOI 10.1002/art.30118; Funasaka T, 2014, GLYCOBIOLOGY, V24, P886, DOI 10.1093/glycob/cwu086; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Gonzalez GE, 2014, INT J CARDIOL, V176, P1423, DOI 10.1016/j.ijcard.2014.08.011; Gullestad L, 2012, EUR HEART J, V33, P2290, DOI 10.1093/eurheartj/ehs077; Jiang WW, 2009, J IMMUNOL, V182; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Meijers WC, 2014, AM HEART J, V167, P853, DOI 10.1016/j.ahj.2014.02.011; Minana G, 2010, INT J CARDIOL, V145, P547, DOI 10.1016/j.ijcard.2010.04.081; Mitic N, 2010, ARCH BIOL SCI, V62, P271, DOI 10.2298/ABS1002271M; Motiwala SR, 2013, EUR J HEART FAIL, V15, P1157, DOI 10.1093/eurjhf/hft075; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nunez J, 2014, HEART FAIL REV, V19, P575, DOI 10.1007/s10741-013-9402-y; Nunez J, 2012, EUR J HEART FAIL, V14, P974, DOI 10.1093/eurjhf/hfs090; Nunez J, 2011, REV ESP CARDIOL, V64, P1100, DOI [10.1016/j.rec.2011.05.033, 10.1016/j.recesp.2011.05.029]; Nunez J, 2012, INT J CARDIOL, V159, P21, DOI 10.1016/j.ijcard.2011.02.001; Nunez J, 2011, INT J CARDIOL, V146, P473, DOI 10.1016/j.ijcard.2010.12.027; Nunez J, 2010, EUR HEART J, V31, P1752, DOI 10.1093/eurheartj/ehq142; Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331; Rogers JK, 2014, EUR J HEART FAIL, V16, P33, DOI 10.1002/ejhf.29; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; Seropian IM, 2013, AM J PATHOL, V182, P29, DOI 10.1016/j.ajpath.2012.09.022; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Wong NK, 2003, J BIOL CHEM, V278, P28619, DOI 10.1074/jbc.M302741200; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168; ZEILLEMAKER AM, 1994, J CLIN PATHOL, V47, P263, DOI 10.1136/jcp.47.3.263	33	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122360	10.1371/journal.pone.0122360	http://dx.doi.org/10.1371/journal.pone.0122360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875367	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100067
J	Ramadas, GCV; Rocha, AMAC; Fernandes, EMGP				Ramadas, Gisela C. V.; Rocha, Ana Maria A. C.; Fernandes, Edite M. G. P.			Testing Nelder-Mead Based Repulsion Algorithms for Multiple Roots of Nonlinear Systems via a Two-Level Factorial Design of Experiments	PLOS ONE			English	Article							SIMPLEX-METHOD; SOLVING SYSTEMS; EQUATIONS; CONVERGENCE; VARIANT	This paper addresses the challenging task of computing multiple roots of a system of nonlinear equations. A repulsion algorithm that invokes the Nelder-Mead (N-M) local search method and uses a penalty-type merit function based on the error function, known as 'erf', is presented. In the N-M algorithm context, different strategies are proposed to enhance the quality of the solutions and improve the overall efficiency. The main goal of this paper is to use a two-level factorial design of experiments to analyze the statistical significance of the observed differences in selected performance criteria produced when testing different strategies in the N-M based repulsion algorithm. The main goal of this paper is to use a two-level factorial design of experiments to analyze the statistical significance of the observed differences in selected performance criteria produced when testing different strategies in the N-M based repulsion algorithm.	[Ramadas, Gisela C. V.] Polytech Porto, Sch Engn, Dept Math, P-4200072 Porto, Portugal; [Rocha, Ana Maria A. C.; Fernandes, Edite M. G. P.] Univ Minho, ALGORITMI Res Ctr, P-4710057 Braga, Portugal	Polytechnic Institute of Porto; Universidade do Minho	Ramadas, GCV (corresponding author), Polytech Porto, Sch Engn, Dept Math, P-4200072 Porto, Portugal.	gcv@isep.ipp.pt	Fernandes, Edite/B-7116-2008; Rocha, Ana Maria A. C./N-2995-2013	Fernandes, Edite/0000-0003-0722-9361; Rocha, Ana Maria A. C./0000-0001-8679-2886; Goncalves Vieira Ramadas, Gisela Cristina/0000-0003-3883-2964	CIDEM (Centre for Research & Development in Mechanical Engineering, Portugal); FCT (Fundacao para a Ciencia e Tecnologia) [PEst-OE/EME/UI0615/2014, PEst-OE/EEI/UI0319/2014]	CIDEM (Centre for Research & Development in Mechanical Engineering, Portugal); FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology)	This work has been supported by CIDEM (Centre for Research & Development in Mechanical Engineering, Portugal) and FCT (Fundacao para a Ciencia e Tecnologia) within the Projects Scope: PEst-OE/EME/UI0615/2014 and PEst-OE/EEI/UI0319/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2007, DOE SIMPLIFIED PRACT; Gao FC, 2012, COMPUT OPTIM APPL, V51, P259, DOI 10.1007/s10589-010-9329-3; Grosan C, 2008, IEEE T SYST MAN CY A, V38, P698, DOI 10.1109/TSMCA.2008.918599; Hirsch MJ, 2009, NONLINEAR ANAL-REAL, V10, P2000, DOI 10.1016/j.nonrwa.2008.03.006; Jaberipour M, 2011, COMPUT MATH APPL, V62, P566, DOI 10.1016/j.camwa.2011.05.031; Kelley CT, 1999, SIAM J OPTIMIZ, V10, P43, DOI 10.1137/S1052623497315203; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; MARANAS CD, 1995, J GLOBAL OPTIM, V7, P143, DOI 10.1007/BF01097059; Mckinnon KIM, 1998, SIAM J OPTIMIZ, V9, P148, DOI 10.1137/S1052623496303482; Montgomery D.C., 2012, DESIGN ANAL EXPT; MORGAN AP, 1983, ACM T MATH SOFTWARE, V9, P1, DOI 10.1145/356022.356023; Nazareth L, 2002, COMPUT OPTIM APPL, V22, P133, DOI 10.1023/A:1014842520519; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nie JW, 2008, SIAM J OPTIMIZ, V19, P1534, DOI 10.1137/060668791; Parsopoulos KE, 2004, IEEE T EVOLUT COMPUT, V8, P211, DOI 10.1109/tevc.2004.826076; Pourjafari E, 2012, SWARM EVOL COMPUT, V4, P33, DOI 10.1016/j.swevo.2011.12.001; Price CJ, 2002, J OPTIMIZ THEORY APP, V113, P5, DOI 10.1023/A:1014849028575; Ramadas GCV, 2014, LECT NOTES COMPUT SC, V8580, P126, DOI 10.1007/978-3-319-09129-7_10; Silva RMA, 2014, J GLOBAL OPTIM, V60, P289, DOI 10.1007/s10898-013-0105-7; SPENDLEY W, 1962, TECHNOMETRICS, V4, P441, DOI 10.2307/1266283; Tsoulos IG, 2010, NONLINEAR ANAL-REAL, V11, P2465, DOI 10.1016/j.nonrwa.2009.08.003; VanHentenryck P, 1997, SIAM J NUMER ANAL, V34, P797, DOI 10.1137/S0036142995281504; Voglis C, 2009, APPL MATH COMPUT, V213, P216, DOI 10.1016/j.amc.2009.03.012; Yamamura K, 2003, J COMPUT APPL MATH, V152, P587, DOI 10.1016/S0377-0427(02)00731-8; Yamamura K, 2009, APPL MATH COMPUT, V215, P405, DOI 10.1016/j.amc.2009.05.017	25	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121844	10.1371/journal.pone.0121844	http://dx.doi.org/10.1371/journal.pone.0121844			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875591	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100049
J	Hemmasi, S; Czulkies, BA; Schorch, B; Veit, A; Aktories, K; Papatheodorou, P				Hemmasi, Sarah; Czulkies, Bernd A.; Schorch, Bjoern; Veit, Antonia; Aktories, Klaus; Papatheodorou, Panagiotis			Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS IOTA-TOXIN; BOTULINUM C2 TOXIN; ANTHRAX TOXIN; BINDING; IDENTIFICATION; EPIDEMIOLOGY; MECHANISM; INFECTION; PROTEIN; STRAIN	CDT(Clostridium difficile transferase) is a binary, actin ADP-ribosylating toxin frequently associated with hypervirulent strains of the human enteric pathogen C. difficile, the most serious cause of antibiotic-associated diarrhea and pseudomembranous colitis. CDT leads to the collapse of the actin cytoskeleton and, eventually, to cell death. Low doses of CDT result in the formation of microtubule-based protrusions on the cell surface that increase the adherence and colonization of C. difficile. The lipolysis-stimulated lipoprotein receptor (LSR) is the host cell receptor for CDT, and our aim was to gain a deeper insight into the interplay between both proteins. We show that CDT interacts with the extracellular, Ig-like domain of LSR with an affinity in the nanomolar range. We identified LSR splice variants in the colon carcinoma cell line HCT116 and disrupted the LSR gene in these cells by applying the CRISPR-Cas9 technology. LSR truncations ectopically expressed in LSR knock-out cells indicated that intracellular parts of LSR are not essential for plasma membrane targeting of the receptor and cellular uptake of CDT. By generating a series of N-and C-terminal truncations of the binding component of CDT (CDTb), we found that amino acids 757-866 of CDTb are sufficient for binding to LSR. With a transposon-based, random mutagenesis approach, we identified potential LSR-interacting epitopes in CDTb. This study increases our understanding about the interaction between CDT and its receptor LSR, which is key to the development of anti-toxin strategies for preventing cell entry of the toxin.	[Hemmasi, Sarah; Czulkies, Bernd A.; Schorch, Bjoern; Veit, Antonia; Aktories, Klaus; Papatheodorou, Panagiotis] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Hemmasi, Sarah; Schorch, Bjoern] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Czulkies, Bernd A.] Univ Freiburg, Hermann Staudinger Grad Sch, D-79104 Freiburg, Germany; [Schorch, Bjoern] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Aktories, Klaus] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Papatheodorou, P (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25, D-79104 Freiburg, Germany.	panagiotis.papatheodorou@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022; Papatheodorou, Panagiotis/N-7509-2015	Aktories, Klaus/0000-0002-5397-0436; Papatheodorou, Panagiotis/0000-0003-3571-695X; Schorch, Bjorn/0000-0001-8311-0210	Deutsche Forschungsgemeinschaft [AK6/23-1]; Centre for Biological Signalling Studies (Freiburg, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre for Biological Signalling Studies (Freiburg, Germany)	This work was supported by Deutsche Forschungsgemeinschaft Grant AK6/23-1 and the Centre for Biological Signalling Studies (Freiburg, Germany).	Aktories K, 2004, INT J MED MICROBIOL, V293, P557, DOI 10.1078/1438-4221-00305; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Barth H, 2005, REV PHYSIOL BIOCH P, V152, P165, DOI 10.1007/s10254-004-0029-1; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bihain BE, 1998, CURR OPIN LIPIDOL, V9, P221, DOI 10.1097/00041433-199806000-00006; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Furuse M, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28960; Furuse M, 2012, ANN NY ACAD SCI, V1257, P54, DOI 10.1111/j.1749-6632.2012.06486.x; Gerding DN, 2014, GUT MICROBES, V5, P15, DOI 10.4161/gmic.26854; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Kaiser E, 2011, INFECT IMMUN, V79, P3913, DOI 10.1128/IAI.05372-11; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kelly CP, 1998, ANNU REV MED, V49, P375; Kyne L, 2010, NEW ENGL J MED, V362, P264, DOI 10.1056/NEJMe0910055; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marvaud JC, 2001, INFECT IMMUN, V69, P2435, DOI 10.1128/IAI.69.4.2435-2441.2001; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Mesli S, 2004, EUR J BIOCHEM, V271, P3103, DOI 10.1111/j.1432-1033.2004.04223.x; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Papatheodorou P, 2013, MBIO, V4, DOI 10.1128/mBio.00244-13; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; Pilpa RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002354; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Schmidt G, 2015, CURR OPIN MICROBIOL, V23, P55, DOI 10.1016/j.mib.2014.11.003; Schwan C, 2011, J BIOL CHEM, V286, P29356, DOI 10.1074/jbc.M111.261925; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sterthoff C, 2010, INFECT IMMUN, V78, P1468, DOI 10.1128/IAI.01351-09; Stiles BG, 2002, BIOCHEM J, V367, P801, DOI 10.1042/BJ20020566; Stiles BG, 2014, TOXINS, V6, P2626, DOI 10.3390/toxins6092626; Stiles BG, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00011; Sun JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010553; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wigelsworth DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051356; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390; YEN FT, 1994, BIOCHEMISTRY-US, V33, P1172, DOI 10.1021/bi00171a017; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	44	24	24	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14031	14044		10.1074/jbc.M115.650523	http://dx.doi.org/10.1074/jbc.M115.650523			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882847	hybrid, Green Published			2022-12-26	WOS:000355313000033
J	Ma, TT; Wang, H; Wang, C; Chang, DY; Zhao, MH; Chen, M				Ma, Tian-Tian; Wang, Huan; Wang, Chen; Chang, Dong-Yuan; Zhao, Ming-Hui; Chen, Min			Urinary Levels of High Mobility Group Box-1 Are Associated with Disease Activity in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis	PLOS ONE			English	Article							CHROMATIN PROTEIN; HMGB1; INFLAMMATION; CLASSIFICATION; RECEPTOR; MARKER	Background High mobility group box-1 (HMGB1), a kind of pro-inflammatory mediator, is associated with inflammatory conditions and tissue damage. Our previous study demonstrated that the circulating levels of HMGB1 correlated with disease activity of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). In the current study, we aimed to measure urinary levels of HMGB1 in AAV patients, correlated them to clinical activity index and analysed the immunohistochemical HMGB1 staining in kidney specimens. Methods 50 patients with AAV in active stage and 56 patients with AAV in remission were recruited. The urinary levels of HMGB1 were determined by enzyme-linked immunosorbent assay. Moreover, renal biopsy specimens from 27 patients with active AAV were randomly collected to evaluate the deposition of HMGB1. Results Urinary HMGB1 levels in AAV patients in active stage were significantly higher than those in AAV patients in remission and healthy controls (1.46 [0.56-3.43] versus 0.38 [0.10-1.35] mg/mu molCr, P= 0.001; 1.46 [0.56-3.43] versus 0.48 [0.40-0.60] mg/mu molCr, P= 0.000, respectively). Further analysis found that urinary levels of HMGB1 correlated with erythrocyte sedimentation rate (r=0.354, p=0.012), C-reactive protein (r=0.289, p=0.042), and Birmingham Vasculitis Activity Score (r=0.350, p=0.013). Renal tissue of active AAV patients showed HMGB1 was mainly expressed in the cytoplasm and the extracellular space. The percentage of HMGB1-negative nuclei in renal tissue of patients with active AAV was significantly higher than that in normal controls (60.6 +/- 20.2 % versus 2.7 +/- 0.6 %, p<0.01). Conclusion Urinary levels of HMGB1 may be associated with the disease activity in AAV patients.	[Ma, Tian-Tian; Wang, Huan; Wang, Chen; Chang, Dong-Yuan; Zhao, Ming-Hui; Chen, Min] Peking Univ, Div Renal, Dept Med, Hosp 1, Beijing 100871, Peoples R China	Peking University	Chen, M (corresponding author), Peking Univ, Div Renal, Dept Med, Hosp 1, Beijing 100871, Peoples R China.	chenmin74@sina.com			Chinese 973 project [2012CB517702]; Research Fund for the Doctoral Program of Higher Education of China [20120001110018]; National Natural Science Fund [81425008, 81321064, 81300599]; "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China [2011BAI10B04]	Chinese 973 project(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China	This study is supported by a grant of Chinese 973 project (No. 2012CB517702), the Research Fund for the Doctoral Program of Higher Education of China (No. 20120001110018), three grants of the National Natural Science Fund (No. 81425008, No. 81321064 and No. 81300599), and the "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China (No. 2011BAI10B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulahad DA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4015; Bajema IM, 1999, KIDNEY INT, V56, P1751, DOI 10.1046/j.1523-1755.1999.00758.x; Berden AE, 2010, J AM SOC NEPHROL, V21, P1628, DOI 10.1681/ASN.2010050477; Bruchfeld A, 2011, MOL MED, V17, P29, DOI 10.2119/molmed.2010.00132; Chen Y, 2013, RHEUMATOLOGY, V52, P1739, DOI 10.1093/rheumatology/ket134; de Souza AWS, 2014, CLIN EXP IMMUNOL, V178, P270, DOI 10.1111/cei.12422; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Hauer HA, 2002, KIDNEY INT, V61, P80, DOI 10.1046/j.1523-1755.2002.00089.x; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Henes FO, 2011, ANN RHEUM DIS, V70, P1926, DOI 10.1136/ard.2010.146456; Hirata Y, 2013, ATHEROSCLEROSIS, V231, P227, DOI 10.1016/j.atherosclerosis.2013.09.010; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jayne D, 2009, NEPHROLOGY, V14, P42, DOI 10.1111/j.1440-1797.2009.01101.x; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; LUQMANI RA, 1994, Q J MED, V87, P671; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; de Souza AWS, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4284; Urbonaviciute V, 2011, J INTERN MED, V270, P309, DOI 10.1111/j.1365-2796.2011.02432.x; Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231; Wang C, 2013, ARTHRIT CARE RES, V65, P1828, DOI 10.1002/acr.22187	24	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123586	10.1371/journal.pone.0123586	http://dx.doi.org/10.1371/journal.pone.0123586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884225	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000076
J	Ruiz, MA; Feng, B; Chakrabarti, S				Ruiz, Michael Anthony; Feng, Biao; Chakrabarti, Subrata			Polycomb Repressive Complex 2 Regulates MiR-200b in Retinal Endothelial Cells: Potential Relevance in Diabetic Retinopathy	PLOS ONE			English	Article							ZESTE HOMOLOG 2; OXIDATIVE STRESS; VASCULAR COMPLICATIONS; EPIGENETIC REGULATION; SUPPRESSOR MICRORNAS; HISTONE METHYLATION; EZH2; GLUCOSE; GENES; EXPRESSION	Glucose-induced augmented vascular endothelial growth factor (VEGF) production is a key event in diabetic retinopathy. We have previously demonstrated that downregulation of miR-200b increases VEGF, mediating structural and functional changes in the retina in diabetes. However, mechanisms regulating miR-200b in diabetes are not known. Histone methyltransferase complex, Polycomb Repressive Complex 2 (PRC2), has been shown to repress miRNAs in neoplastic process. We hypothesized that, in diabetes, PRC2 represses miR-200b through its histone H3 lysine-27 trimethylation mark. We show that human retinal microvascular endothelial cells exposed to high levels of glucose regulate miR-200b repression through histone methylation and that inhibition of PRC2 increases miR-200b while reducing VEGF. Furthermore, retinal tissue from animal models of diabetes showed increased expression of major PRC2 components, demonstrating in vivo relevance. This research established a repressive relationship between PRC2 and miR-200b, providing evidence of a novel mechanism of miRNA regulation through histone methylation.	[Ruiz, Michael Anthony; Feng, Biao; Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada	Western University (University of Western Ontario)	Chakrabarti, S (corresponding author), Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada.	subrata.chakrabarti@lhsc.on.ca		Chakrabarti, Subrata/0000-0002-0208-1401	Canadian Diabetes Association; Heart and Stroke Foundation of Ontario	Canadian Diabetes Association; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This research was supported in parts by grants from the Canadian Diabetes Association (Operating Grant 2010-2013) and the Heart and Stroke Foundation of Ontario (Grant-in-Aid competition 2013/2014). Specifically, these grants were received by SC to carry out the experiments in this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aiello LP, 2014, DIABETES CARE, V37, P17, DOI 10.2337/dc13-2251; American Diabetes Association, 2002, DIABETES CARE, V25, pS28, DOI [10.2337/diacare.25.2007.S28, DOI 10.2337/DIACARE.25.2007.S28]; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043726; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chadwick BP, 2003, DEV CELL, V4, P445, DOI 10.1016/S1534-5807(03)00097-2; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Chistiakov DA, 2011, DIABETES METAB SYND, V5, P165, DOI 10.1016/j.dsx.2012.02.025; Chronopoulos A, 2011, CURR EYE RES, V36, P747, DOI 10.3109/02713683.2011.585735; Davidson JA, 2007, ENDOCRINE, V32, P107, DOI 10.1007/s12020-007-0040-9; Deb G, 2013, EPIGENETICS-US, V8, P464, DOI 10.4161/epi.24532; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dreger H, 2012, HYPERTENSION, V60, P1176, DOI 10.1161/HYPERTENSIONAHA.112.191098; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Feng B, 2012, BIOMED PHARMACOTHER, V66, P397, DOI 10.1016/j.biopha.2012.06.002; Schoof CRG, 2012, AM J CANCER RES, V2, P414; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Ho L, 2008, CELL STEM CELL, V3, P577, DOI 10.1016/j.stem.2008.11.007; Huang A, 2012, DIABETES, V61, P3181, DOI 10.2337/db12-0559; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kumar M, 2012, PROTEIN CELL, V3, P726, DOI 10.1007/s13238-012-2055-0; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Okabe J, 2012, CIRC RES, V110, P1067, DOI 10.1161/CIRCRESAHA.112.266171; RUDNEY HARRY, 1940, SCIENCE, V92, P112, DOI 10.1126/science.92.2379.112; Ruiz MA, 2013, CAN J DIABETES, V37, P339, DOI 10.1016/j.jcjd.2013.07.003; Son SM, 2012, DIABETES METAB J, V36, P190, DOI 10.4093/dmj.2012.36.3.190; Syreeni A, 2011, DIABETES, V60, P3073, DOI 10.2337/db11-0073; Tan JZ, 2014, ACTA PHARMACOL SIN, V35, P161, DOI 10.1038/aps.2013.161; Tousoulis Dimitris, 2011, Recent Pat Cardiovasc Drug Discov, V6, P103; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Yamagishi S, 2009, THER APHER DIAL, V13, P534, DOI 10.1111/j.1744-9987.2009.00775.x; Yan JQ, 2012, CELL MOL LIFE SCI, V69, P115, DOI 10.1007/s00018-011-0731-5; Zourek M, 2008, PHYSIOL RES, V57, P531, DOI 10.33549/physiolres.931255	48	58	60	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123987	10.1371/journal.pone.0123987	http://dx.doi.org/10.1371/journal.pone.0123987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884496	Green Submitted, gold, Green Published			2022-12-26	WOS:000353017000098
J	Sato, H; Tanabe, AS; Toju, H				Sato, Hirotoshi; Tanabe, Akifumi S.; Toju, Hirokazu			Contrasting Diversity and Host Association of Ectomycorrhizal Basidiomycetes versus Root-Associated Ascomycetes in a Dipterocarp Rainforest	PLOS ONE			English	Article							DARK SEPTATE ENDOPHYTES; FUNGAL DIVERSITY; COMMUNITY COMPOSITION; GENUS STROBILOMYCES; MYCORRHIZAL FUNGI; SEEDLING SURVIVAL; PLANT; BIODIVERSITY; NETWORKS; EVOLUTION	Root-associated fungi, including ectomycorrhizal and root-endophytic fungi, are among the most diverse and important belowground plant symbionts in dipterocarp rainforests. Our study aimed to reveal the biodiversity, host association, and community structure of ectomycorrhizal Basidiomycota and root-associated Ascomycota (including root-endophytic Ascomycota) in a lowland dipterocarp rainforest in Southeast Asia. The host plant chloroplast ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit (rbcL) region and fungal internal transcribed spacer 2 (ITS2) region were sequenced using tag-encoded, massively parallel 454 pyrosequencing to identify host plant and root-associated fungal taxa in root samples. In total, 1245 ascomycetous and 127 putative ectomycorrhizal basidiomycetous taxa were detected from 442 root samples. The putative ectomycorrhizal Basidiomycota were likely to be associated with closely related dipterocarp taxa to greater or lesser extents, whereas host association patterns of the root-associated Ascomycota were much less distinct. The community structure of the putative ectomycorrhizal Basidiomycota was possibly more influenced by host genetic distances than was that of the root-associated Ascomycota. This study also indicated that in dipterocarp rainforests, root-associated Ascomycota were characterized by high biodiversity and indistinct host association patterns, whereas ectomycorrhizal Basidiomycota showed less biodiversity and a strong host phylogenetic preference for dipterocarp trees. Our findings lead to the working hypothesis that root-associated Ascomycota, which might be mainly represented by root-endophytic fungi, have biodiversity hotspots in the tropics, whereas biodiversity of ectomycorrhizal Basidiomycota increases with host genetic diversity.	[Sato, Hirotoshi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Tanabe, Akifumi S.] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; [Tanabe, Akifumi S.] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Toju, Hirokazu] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Japan Fisheries Research & Education Agency (FRA); Kyoto University; Kyoto University	Sato, H (corresponding author), Kyoto Univ, Ctr Ecol Res, 509-3,2 Chome, Otsu, Shiga 5202113, Japan.	h-sato@sys.bot.kyoto-u.ac.jp	Toju, Hirokazu/T-7355-2019; Toju, Hirokazu/S-7307-2017; Tanabe, Akifumi/P-9381-2015	Toju, Hirokazu/0000-0002-3362-3285; Tanabe, Akifumi/0000-0003-1017-6504	Funding Program for Next Generation World-Leading Researchers of Cabinet Office; Japanese Government [GS014];  [24870017];  [26711026]; Grants-in-Aid for Scientific Research [26840128] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers of Cabinet Office; Japanese Government; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in Aid for Scientific Research (24870017) to H.S.; and by the Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese Government (GS014) and the Grant-in Aid for Scientific Research (26711026) to H.T.	Addy HD, 2005, CAN J BOT, V83, P1, DOI [10.1139/B04-171, 10.1139/b04-171]; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dickie IA, 2008, NEW PHYTOL, V180, P263, DOI 10.1111/j.1469-8137.2008.02635.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gao C, 2013, MOL ECOL, V22, P3403, DOI 10.1111/mec.12297; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Halling RE., 2005, COMMON MUSHROOMS TAL; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Henkel TW, 2005, NEW PHYTOL, V167, P543, DOI 10.1111/j.1469-8137.2005.01431.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kernaghan G, 2011, MICROB ECOL, V62, P460, DOI 10.1007/s00248-011-9851-6; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Lee H. S., 2002, Journal of Tropical Forest Science, V14, P379; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mandyam K, 2005, STUD MYCOL, P173; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McGuire KL, 2007, ECOLOGY, V88, P567, DOI 10.1890/05-1173; Moyersoen B, 2006, NEW PHYTOL, V172, P753, DOI 10.1111/j.1469-8137.2006.01860.x; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Oksanen J, R PACKAGE VERSION; Onguene NA, 2002, MYCORRHIZA, V12, P13, DOI 10.1007/s00572-001-0140-y; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Peterson R. L., 2004, Mycorrhizas: anatomy and cell biology; Phosri C, 2012, BIODIVERS CONSERV, V21, P2287, DOI 10.1007/s10531-012-0250-1; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Read D, 1997, NATURE, V388, P517, DOI 10.1038/41426; Read DJ, 2004, CAN J BOT, V82, P1243, DOI [10.1139/b04-123, 10.1139/B04-123]; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Sato H, 2008, MOL PHYLOGENET EVOL, V48, P326, DOI 10.1016/j.ympev.2008.01.033; Sato H, 2007, AM J BOT, V94, P1630, DOI 10.3732/ajb.94.10.1630; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; Smith ME, 2011, NEW PHYTOL, V192, P699, DOI 10.1111/j.1469-8137.2011.03844.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stone JK, 2000, BOOK SOIL P, P3; Swofford DL, 2002, PHYLOGENETIC ANAL US; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; Tanabe AS, 2013, ASSAMS V0 1 2013 01; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Tedersoo L, 2013, NEW PHYTOL, V199, P822, DOI 10.1111/nph.12328; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tedersoo L, 2010, NEW PHYTOL, V185, P351, DOI 10.1111/j.1469-8137.2009.03134.x; Tedersoo L, 2009, ENVIRON MICROBIOL, V11, P3166, DOI 10.1111/j.1462-2920.2009.02020.x; Toju H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078248; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Tsumura Y, 1996, THEOR APPL GENET, V93, P22, DOI 10.1007/BF00225722; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919	70	19	20	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125550	10.1371/journal.pone.0125550	http://dx.doi.org/10.1371/journal.pone.0125550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884708	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000160
J	van Hees, NJM; Giltay, EJ; Tielemans, SMAJ; Geleijnse, JM; Puvill, T; Janssen, N; van der Does, W				van Hees, Nathalie J. M.; Giltay, Erik J.; Tielemans, Susanne M. A. J.; Geleijnse, Johanna M.; Puvill, Thomas; Janssen, Nadine; van der Does, Willem			Essential Amino Acids in the Gluten-Free Diet and Serum in Relation to Depression in Patients with Celiac Disease	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; BRANCHED-CHAIN AMINO; TRYPTOPHAN-METABOLISM; FIBER; MOOD; ASSOCIATION; ADOLESCENTS; DISORDERS; DEPLETION; SYMPTOMS	Introduction Celiac disease (CD) is associated with an increased risk of major depressive disorder, possibly due to deficiencies in micronutrients in the gluten-free diet. We aimed to investigate whether essential amino acids (i.e., the precursors of serotonin, dopamine and other neurotransmitters) are depleted in the diet and serum of CD patients with major depressive disorder. Methods In a cross-sectional study we assessed dietary intake of amino acids and serum levels of amino acids, in 77 CD patients on a gluten-free diet and in 33 healthy controls. Major depressive disorder was assessed with structured interviews (using the Mini International Neuropsychiatric Interview Plus). Dietary intake was assessed using a 203-item food frequency questionnaire. Results Participants had a mean age of 55 years and 74% were women. The intake of vegetable protein was significantly lower in CD patients than in healthy controls (mean difference of 7.8 g/d; 95% CI: 4.7-10.8), as were serum concentrations of tyrosine, phenylalanine and tryptophan (all p < 0.005). However, within the CD patient group, the presence of major depressive disorder (n = 42) was not associated with intake or serum levels of essential amino acids. Conclusions Patients with CD on a long-term gluten-free diet, with good adherence, consume significantly less vegetable protein than controls, and their serum levels of several essential amino acids were also lower. Despite its potential adverse effect, intake and serum levels of essential amino acids were not related to major depression.	[van Hees, Nathalie J. M.; Janssen, Nadine; van der Does, Willem] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Giltay, Erik J.; van der Does, Willem] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Tielemans, Susanne M. A. J.; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Puvill, Thomas] Leyden Acad Vital & Ageing, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research	van Hees, NJM (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.	heesnjmvan@fsw.ledenuniv.nl	Giltay, Erik J./AAL-9948-2021; Van der Does, Willem/B-1465-2008; Geleijnse, Johanna Marianna M/B-5749-2012	Van der Does, Willem/0000-0002-9753-2454; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; /0000-0001-6716-0023; Giltay, Erik/0000-0001-8874-2292	Netherlands Science Foundation (N.W.OMaGW Vici grant) [453-06-005]; Leiden University Fund (LUF); Gratama foundation [08.10]	Netherlands Science Foundation (N.W.OMaGW Vici grant); Leiden University Fund (LUF); Gratama foundation	This project was funded by a grant from the Netherlands Science Foundation (N.W.OMaGW Vici grant # 453-06-005 to WVdD), http://www.nwo.nl/en, and grants from the Leiden University Fund (LUF) and Gratama foundation # 08.10, http://www.luf.nl/subsidies/information-in-english. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 2008, INT J CLIN PRACT, V62, P1063, DOI 10.1111/j.1742-1241.2008.01763.x; Addolorato G, 1996, HEPATO-GASTROENTEROL, V43, P1513; Addolorato G, 2008, DIGEST DIS, V26, P140, DOI 10.1159/000116772; American Psychiatric Association APATFoDSMIV, 2000, DIAGN STAT MAN MENT; [Anonymous], 2006, DUTCH FOOD COMP TABL; Beirao EM, BRAZILIAN J INFECT D; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; Carta MG, 2002, J PSYCHOSOM RES, V53, P789, DOI 10.1016/S0022-3999(02)00328-8; [FAO] FaAO, 1993, MAIZ HUM NUTR; FAO/WHO/UNU (Expert Consultation), 2007, WHO TECHN REP SER, V935; Fernstrom JD, 2013, AMINO ACIDS, V45, P419, DOI 10.1007/s00726-012-1330-y; Fernstrom JD, 2012, J NUTR, V142, p2236S, DOI 10.3945/jn.111.157065; FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489; Geleijnse JM, 2010, AM HEART J, V159, P539, DOI 10.1016/j.ahj.2009.12.033; HALLERT C, 1983, PSYCHOL MED, V13, P267, DOI 10.1017/S003329170005087X; HALLERT C, 1982, SCAND J GASTROENTERO, V17, P17, DOI 10.3109/00365528209181037; HALLERT C, 1982, SCAND J GASTROENTERO, V17, P87, DOI 10.3109/00365528209181049; HERNANZ A, 1991, GUT, V32, P1478, DOI 10.1136/gut.32.12.1478; HUTSON SM, 1981, AM J CLIN NUTR, V34, P173, DOI 10.1093/ajcn/34.2.173; Kalia M, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2005.01.009; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Leffler DA, 2009, CLIN GASTROENTEROL H, V7, P530, DOI 10.1016/j.cgh.2008.12.032; Matthews DE, 2005, J NUTR, V135, p1580S, DOI 10.1093/jn/135.6.1580S; Merens W, 2005, BRIT J NUTR, V94, P415, DOI 10.1079/BJN20051492; Nutt DJ, 2007, J CLIN PSYCHIAT, V68, P42; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Pynnonen PA, 2002, PSYCHOSOMATICS, V43, P331, DOI 10.1176/appi.psy.43.4.331; Pynnonen PA, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-14; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Sainio EL, 1996, AMINO ACIDS, V10, P21, DOI 10.1007/BF00806091; Schulte-van Maaren YWM, 2013, J EVAL CLIN PRACT, V19, P342, DOI 10.1111/j.1365-2753.2012.01830.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Thompson T, 2000, J AM DIET ASSOC, V100, P1389, DOI 10.1016/S0002-8223(00)00386-2; Thompson T, 2005, J HUM NUTR DIET, V18, P163, DOI 10.1111/j.1365-277X.2005.00607.x; Tommasini A, 2004, ARCH DIS CHILD, V89, P512, DOI 10.1136/adc.2003.029603; Torres MI, 2007, CLIN EXP IMMUNOL, V148, P419, DOI 10.1111/j.1365-2249.2007.03365.x; van Hees NJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097778; van Hees NJM, 2013, J PSYCHOSOM RES, V74, P155, DOI 10.1016/j.jpsychores.2012.11.007; van Vliet I M, 2007, Tijdschr Psychiatr, V49, P393; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Wild D, 2010, ALIMENT PHARM THER, V32, P573, DOI 10.1111/j.1365-2036.2010.04386.x; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803	46	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122619	10.1371/journal.pone.0122619	http://dx.doi.org/10.1371/journal.pone.0122619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884227	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000036
J	Benevento, E; Djebbari, A; Keshavarz-Motamed, Z; Cecere, R; Kadem, L				Benevento, Emilia; Djebbari, Abdelghani; Keshavarz-Motamed, Zahra; Cecere, Renzo; Kadem, Lyes			Hemodynamic Changes following Aortic Valve Bypass: A Mathematical Approach	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; APICOAORTIC CONDUIT; MAGNETIC-RESONANCE; STENOSIS; SURGERY; OUTCOMES; ECHOCARDIOGRAPHY; IMPLANTATION; REPLACEMENT; CARDIOLOGY	Aortic valve bypass (AVB) has been shown to be a viable solution for patients with severe aortic stenosis (AS). Under this circumstance, the left ventricle (LV) has a double outlet. The objective was to develop a mathematical model capable of evaluating the hemodynamic performance following the AVB surgery. A mathematical model that captures the interaction between LV, AS, arterial system, and AVB was developed. This model uses a limited number of parameters that all can be non-invasively measured using patient data. The model was validated using in vivo data from the literature. The model was used to determine the effect of different AVB and AS configurations on flow proportion and pressure of the aortic valve and the AVB. Results showed that the AVB leads to a significant reduction in transvalvular pressure gradient. The percentage of flow through the AVB can range from 55.47% to 69.43% following AVB with a severe AS. LV stroke work was also significantly reduced following the AVB surgery and reached a value of around 1.2 J for several AS severities. Findings of this study suggest: 1) the AVB leads to a significant reduction in transvalvular pressure gradients; 2) flow distribution between the AS and the AVB is significantly affected by the conduit valve size; 3) the AVB leads to a significant reduction in LV stroke work; and 4) hemodynamic performance variations can be estimated using the model.	[Benevento, Emilia; Keshavarz-Motamed, Zahra; Kadem, Lyes] Concordia Univ, Dept Mech & Ind Engn, Montreal, PQ, Canada; [Djebbari, Abdelghani] Univ Abou Bekr Belkaid Tlemcen, Tilimsen, Algeria; [Keshavarz-Motamed, Zahra] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Keshavarz-Motamed, Zahra] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Keshavarz-Motamed, Zahra] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Cecere, Renzo] McGill Univ, Dept Surg, Div Cardiac Surg, Montreal, PQ H3A 2T5, Canada	Concordia University - Canada; Universite Abou Bekr Belkaid; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Laval University; McGill University	Keshavarz-Motamed, Z (corresponding author), Concordia Univ, Dept Mech & Ind Engn, Montreal, PQ, Canada.	lcfd@encs.concordia.ca	Djebbari, Abdelghani/H-5717-2011	Djebbari, Abdelghani/0000-0001-7330-5188	Fonds de recherche du Quebec - Nature et technologies [176048]	Fonds de recherche du Quebec - Nature et technologies	The work was supported by Fonds de recherche du Quebec - Nature et technologies, 176048 (ZKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulos G, 1997, CIRCULATION, V96, P3403; Balaras E, 2009, J THORAC CARDIOV SUR, V137, P680, DOI 10.1016/j.jtcvs.2008.08.032; Carrel A, 1910, ANN SURG, V52, P83, DOI 10.1097/00000658-191007000-00009; Charlson E, 2006, J HEART VALVE DIS, V15, P312; Cooley DA, 2000, ANN THORAC SURG, V69, P1511, DOI 10.1016/S0003-4975(00)01242-X; Elmistekawy E, 2010, J SAUDI HEART ASSOC, V22, P187, DOI 10.1016/j.jsha.2010.06.003; Gammie JS, 2008, CIRCULATION, V118, P1460, DOI 10.1161/CIRCULATIONAHA.108.790030; Garcia D, 2005, J BIOMECH, V38, P1303, DOI 10.1016/j.jbiomech.2004.06.018; Garcia J, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-25; Keshavarz-Motamed Z, 2011, J BIOMECH, V44, P2817, DOI 10.1016/j.jbiomech.2011.08.001; Keshavarz-Motamed Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086793; Kotani S, 2010, INTERACT CARDIOV TH, V10, P486, DOI 10.1510/icvts.2009.220707; Lund JT, 2013, INTERACT CARDIOV TH, V17, P79, DOI 10.1093/icvts/ivt087; Palacios IF, 2012, CIRCULATION, V125, P3233, DOI 10.1161/CIRCULATIONAHA.112.093104; Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886; Reuthebuch O, 2013, INTERACT CARDIOV TH, V16, P482, DOI 10.1093/icvts/ivs513; Rosengart TK, 2008, CIRCULATION, V117, P1750, DOI 10.1161/CIRCULATIONAHA.107.188525; SARNOFF SJ, 1955, CIRCULATION, V11, P564, DOI 10.1161/01.CIR.11.4.564; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; SHANEBROOK JR, 1979, CARDIOVASC DIS, V6, P425; Stauffer CE, 2011, ANN THORAC SURG, V92, P1332, DOI 10.1016/j.athoracsur.2011.04.069; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; To A, 2011, J AM COLL CARDIOL, V58, P0735; Varadarajan P, 2006, EUR J CARDIO-THORAC, V30, P722, DOI 10.1016/j.ejcts.2006.07.028; Vliek CJ, 2010, ANN THORAC SURG, V90, P136, DOI 10.1016/j.athoracsur.2010.03.046; Wijesinghe N, 2010, JACC-CARDIOVASC INTE, V3, P1122, DOI 10.1016/j.jcin.2010.08.016; Zoghbi WA, 2009, J AM SOC ECHOCARDIOG, V22, P975, DOI 10.1016/j.echo.2009.07.013	27	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123000	10.1371/journal.pone.0123000	http://dx.doi.org/10.1371/journal.pone.0123000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881082	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500035
J	Hagopian, K; Tomilov, AA; Kim, K; Cortopassi, GA; Ramsey, JJ				Hagopian, Kevork; Tomilov, Alexey A.; Kim, Kyoungmi; Cortopassi, Gino A.; Ramsey, Jon J.			Key Glycolytic Enzyme Activities of Skeletal Muscle Are Decreased under Fed and Fasted States in Mice with Knocked Down Levels of Shc Proteins	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE; CALORIC RESTRICTION; GENE-EXPRESSION; KINASE; INSULIN; METABOLISM; PHOSPHOFRUCTOKINASE; HEXOKINASE; INCREASES; PHOSPHORYLATION	Shc proteins interact with the insulin receptor, indicating a role in regulating glycolysis. To investigate this idea, the activities of key glycolytic regulatory enzymes and metabolites levels were measured in skeletal muscle from mice with low levels of Shc proteins (ShcKO) and wild-type (WT) controls. The activities of hexokinase, phosphofructokinase-1 and pyruvate kinase were decreased in ShcKO versusWT mice under both fed and fasted conditions. Increased alanine transaminase and branched-chain amino acid transaminase activities were also observed in ShcKO mice under both fed and fasting conditions. Protein expression of glycolytic enzymes was unchanged in the ShcKO and WT mice, indicating that decreased activities were not due to changes in their transcription. Changes in metabolite levels were consistent with the observed changes in enzyme activities. In particular, the levels of fructose-2,6-bisphosphate, a potent activator of phosphofructokinase-1, were consistently decreased in the ShcKO mice. Furthermore, the levels of lactate (inhibitor of hexokinase and phosphofructokinase-1) and citrate (inhibitor of phosphofructokinase-1 and pyruvate kinase) were increased in fed and fasted ShcKO versus WT mice. Pyruvate dehydrogenase activity was lower in ShcKO versusWT mice under fed conditions, and showed inhibition under fasting conditions in both ShcKO and WT mice, with ShcKO mice showing less inhibition than the WT mice. Pyruvate dehydrogenase kinase 4 levels were unchanged under fed conditions but were lower in the ShcKO mice under fasting conditions. These studies indicate that decreased levels of Shc proteins in skeletal muscle lead to a decreased glycolytic capacity in both fed and fasted states.	[Hagopian, Kevork; Tomilov, Alexey A.; Cortopassi, Gino A.; Ramsey, Jon J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Kim, Kyoungmi] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hagopian, K (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	khagopian@ucdavis.edu			National Institutes of Health [P01 AG025532]; UC Davis MMPC [NIH DKO92993]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK092993, U2CDK092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis MMPC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grant P01 AG025532 (GAC, JJR). The authors also thank UC Davis MMPC (Grant NIH DKO92993) for performing the triglyceride analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIBI SA, 1976, METABOLISM, V25, P1287, DOI 10.1016/S0026-0495(76)80012-1; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; Cai GZ, 1997, BIOPHYS CHEM, V64, P199, DOI 10.1016/S0301-4622(96)02232-6; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; COORE HG, 1971, BIOCHEM J, V125, P115, DOI 10.1042/bj1250115; Depre C, 1998, EUR J BIOCHEM, V258, P277, DOI 10.1046/j.1432-1327.1998.2580277.x; Dieni CA, 2011, COMP BIOCHEM PHYS B, V159, P236, DOI 10.1016/j.cbpb.2011.05.003; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; FOE LG, 1982, J BIOL CHEM, V257, P6368; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hagopian K, 2012, METABOLISM, V61, P1703, DOI 10.1016/j.metabol.2012.05.007; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; JACOBSON K, 1961, J BIOL CHEM, V236, P343; Keppler D., 1984, METHOD ENZYMAT AN, V6, P11; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Mollering H, 1985, METHOD ENZYMAT AN, P2; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Natalicchio A, 2009, AM J PHYSIOL-ENDOC M, V296, pE228, DOI 10.1152/ajpendo.90347.2008; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; ODESSEY R, 1979, BIOCHEM J, V178, P475, DOI 10.1042/bj1780475; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; RANDLE PJ, 1986, BIOCHEM SOC T, V14, P799, DOI 10.1042/bst0140799; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Roberts DJ, 2013, J BIOL CHEM, V288, P23798, DOI 10.1074/jbc.M113.482026; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; ROUSSEAU GG, 1993, PROG NUCLEIC ACID RE, V45, P99, DOI 10.1016/S0079-6603(08)60868-5; Sasaoka T, 2000, ENDOCR J, V47, P373, DOI 10.1507/endocrj.47.373; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; SOLING HD, 1981, CURR TOP CELL REGUL, V20, P107; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; SUGDEN MC, 1993, ADV ENZYME REGUL, V33, P71; Thompson AL, 2000, DIABETES, V49, P1761, DOI 10.2337/diabetes.49.11.1761; Thomson DM, 2009, ACTA PHYSIOL, V196, P147, DOI 10.1111/j.1748-1716.2009.01973.x; Tomilov AA, 2011, AGING CELL, V10, P55, DOI 10.1111/j.1474-9726.2010.00641.x; Usenik A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015447; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315; Ventura A, 2002, J BIOL CHEM, V277, P22370, DOI 10.1074/jbc.M200280200; VILLARPA.C, 1970, ANNU REV BIOCHEM, V39, P639, DOI 10.1146/annurev.bi.39.070170.003231; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Xiong Y, 2011, COLD SH Q B, V76, P285, DOI 10.1101/sqb.2011.76.010942	58	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124204	10.1371/journal.pone.0124204	http://dx.doi.org/10.1371/journal.pone.0124204			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880638	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500090
J	Huang, YF; Chang, CT; Muo, CH; Tsai, CH; Shen, YF; Wu, CZ				Huang, Yi Fang; Chang, Chung Ta; Muo, Chih Hsin; Tsai, Chun Hao; Shen, Yu Fu; Wu, Ching Zong			Impact of Bisphosphonate-related Osteonecrosis of the Jaw on Osteoporotic Patients after Dental Extraction: A Population-Based Cohort Study	PLOS ONE			English	Article							CLINICAL-FEATURES; RISK; EPIDEMIOLOGY; PREVENTION	Background and Aims Little is currently known about the risk of developing bisphosphonate-related osteonecrosis of the jaw (BRONJ). This study sought to determine the incidence of BRONJ in osteoporotic patients. We also sought to identify the nature and types of risk factors of osteonecrosis of jaw (ONJ) related to the use of oral bisphosphonates (BPs). Materials and Methods Data from the National Health Insurance system of Taiwan. This cohort study included 19,399 adult osteoporosis patients received dental extraction in 2000-2010 (osteoporosis cohort) and 38,669 age and gender matched comparisons selected from dental extraction people without osteoporosis and osteonecrosis history (comparison cohort). All study subjects were followed from the date of their dental extraction (index date) to the development of ONJ and were included in the study up to 2011 or were lost to the study, whichever occurred first. Cox proportional hazard regression was used to estimate the hazard ratio and 95% confidence intervals for the two cohorts. Results Patients with osteoporosis had a significantly higher risk to develop ONJ than healthy persons (adjusted HR, 2.05; 95% confidence interval, 1.58-2.65). The risk of ONJ increased with the severity of osteoporosis, no matter whether patient with cancer or not. A cumulative effect of dental extraction frequency may increase the risk of ONJ. Conclusions We concluded that ONJ is caused by a number of factors. Osteoporosis and past dental history play the very important roles, while BPs play the synergistic effect.	[Huang, Yi Fang; Shen, Yu Fu] Chang Gung Mem Hosp, Dept Gen Dent, Linkou, Taiwan; [Huang, Yi Fang; Chang, Chung Ta; Wu, Ching Zong] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Chang, Chung Ta] Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Muo, Chih Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Tsai, Chun Hao] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan; [Tsai, Chun Hao] China Med Univ, Grad Inst Clin Med, Taichung, Taiwan; [Wu, Ching Zong] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan; [Wu, Ching Zong] Lotung PohAi Hosp, Dept Dent, Yilan, Taiwan	Chang Gung Memorial Hospital; Taipei Medical University; Far Eastern Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital	Wu, CZ (corresponding author), Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan.	chinaowu@tmu.edu.tw	Huang, Yi-Fang/ABB-5777-2021; Chang, Chung-Ta/ABB-5600-2021; Tsai, Chun-Hao/H-3140-2013	Chang, Chung-Ta/0000-0002-9211-1407; Tsai, Chun-Hao/0000-0002-4428-3132; Huang, Yi-Fang/0000-0003-2569-999X	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; China Medical University Hospital [1MS1]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002) and China Medical University Hospital (1MS1). The funders had no role in study design, data collection and analysis, decision to publication, or preparation of the manuscript.	AAOMS, 2007, J ORAL MAXIL SURG, V65, P369, DOI 10.1016/j.joms.2006.11.003; American Dental Association Council on Scientific Affairs, 2006, J Am Dent Assoc, V137, P1144; Assael LA, 2009, J ORAL MAXIL SURG, V67, P35, DOI 10.1016/j.joms.2009.01.003; Badros A, 2006, J CLIN ONCOL, V24, P945, DOI 10.1200/JCO.2005.04.2465; Bedogni A, 2012, ORAL DIS, V18, P621, DOI 10.1111/j.1601-0825.2012.01903.x; Bilezikian JP, 2006, NEW ENGL J MED, V355, P2278, DOI 10.1056/NEJMp068157; Durie BGM, 2005, NEW ENGL J MED, V353, P99; Edwards BJ, 2008, J AM DENT ASSOC, V139, P545, DOI 10.14219/jada.archive.2008.0214; Font RG, 2008, MED ORAL PATOL ORAL, V13, pE318; Khan AA, 2011, J RHEUMATOL, V38, P1396, DOI 10.3899/jrheum.100221; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; King AE, 2008, PHARMACOTHERAPY, V28, P667, DOI 10.1592/phco.28.5.667; Kotecha RS, 2010, PEDIATR BLOOD CANCER, V54, P934, DOI 10.1002/pbc.22428; Krueger CD, 2007, ANN PHARMACOTHER, V41, P276, DOI 10.1345/aph.1H521; Kruger TB, 2013, ACTA ODONTOL SCAND, V71, P1386, DOI 10.3109/00016357.2013.764007; Kuehn BM, 2005, JAMA-J AM MED ASSOC, V293, P2458, DOI 10.1001/jama.293.20.2458; Lin TC, 2014, OSTEOPOROSIS INT, V25, P1503, DOI 10.1007/s00198-014-2624-6; Lin TC, 2011, CLIN PHARMACOL THER, V90, P109, DOI 10.1038/clpt.2011.62; Loukota RA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5988; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Migliorati CA, 2005, J AM DENT ASSOC, V136, P1658, DOI 10.14219/jada.archive.2005.0108; Migliorati Cesar Augusto, 2007, J Evid Based Dent Pract, V7, P77, DOI 10.1016/j.jebdp.2007.03.015; Miksad RA, 2011, ONCOLOGIST, V16, P121, DOI 10.1634/theoncologist.2010-0183; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Scully Crispian, 2006, Implant Dent, V15, P212, DOI 10.1097/01.id.0000236120.22719.02; Solomon DH, 2013, OSTEOPOROSIS INT, V24, P237, DOI 10.1007/s00198-012-2042-6; Van den Wyngaert T, 2006, ANN ONCOL, V17, P1197, DOI 10.1093/annonc/mdl294; Weitzman R, 2007, CRIT REV ONCOL HEMAT, V62, P148, DOI 10.1016/j.critrevonc.2006.12.005; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yarom N, 2007, OSTEOPOROSIS INT, V18, P1363, DOI 10.1007/s00198-007-0384-2; Yuh DY, 2014, J DENT, V42, P1343, DOI 10.1016/j.jdent.2014.05.001	32	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120756	10.1371/journal.pone.0120756	http://dx.doi.org/10.1371/journal.pone.0120756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880208	Green Submitted, gold, Green Published			2022-12-26	WOS:000353016500007
J	Maeda, M; Hayashi, T; Mizuno, N; Hattori, Y; Kuzuya, M				Maeda, Morihiko; Hayashi, Toshio; Mizuno, Natsumi; Hattori, Yuichi; Kuzuya, Masafumi			Intermittent High Glucose Implements Stress-Induced Senescence in Human Vascular Endothelial Cells: Role of Superoxide Production by NADPH Oxidase	PLOS ONE			English	Article							PROTEIN-KINASE-C; NITRIC-OXIDE; OXIDATIVE STRESS; CELLULAR SENESCENCE; ENHANCES APOPTOSIS; EXPRESSION; ACTIVATION; SYNTHASE; HYPERGLYCEMIA; FLUCTUATIONS	Impaired glucose tolerance characterized by postprandial hyperglycemia, which occurs frequently in elderly persons and represents an important preliminary step in diabetes mellitus, poses an independent risk factor for the development of atherosclerosis. Endothelial cellular senescence is reported to precede atherosclerosis. We reported that continuous high glucose stimulus causes endothelial senescence more markedly than hypertension or dyslipidemia stimulus. In the present study, we evaluated the effect of fluctuating glucose levels on human endothelial senescence. Constant high glucose increased senescence-associated-beta-galactosidase(SA-beta-gal) activity, a widely used marker for cellular senescence. Interestingly, in intermittent high glucose, this effect was more pronounced as well as increase of p21 and p 16(INK4a), senescence related proteins with DNA damage. However, telomerase was not activated and telomere length was not shortened, thus stress-induced senescence was shown. However, constant high glucose activated telomerase and shortened telomere length, which suggested replicative senescence. Intermittent but not constant high glucose strikingly up-regulated the expression of p22(phox), an NADPH oxidase component, increasing superoxide. The small interfering RNA of p22(pho)x undermined the increase in SA-beta-gal activity induced by intermittent high glucose. Conclusively, intermittent high glucose can promote vascular endothelial senescence more than constant high glucose, which is in partially dependent on superoxide overproduction.	[Maeda, Morihiko; Hayashi, Toshio; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4668550, Japan; [Mizuno, Natsumi; Hattori, Yuichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 9300194, Japan	Nagoya University; University of Toyama	Maeda, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4668550, Japan.	hayashi@med.nagoya-u.ac.jp	Kuzuya, Masafumi/I-1583-2012; Hayashi, Toshio/I-7346-2014	Hayashi, Toshio/0000-0002-7711-2700; Mizuno, Natsumi/0000-0001-7161-266X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590881]; Grants-in-Aid for Scientific Research [24590881] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan No. 24590881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Wanschel ACBA, 2014, NITRIC OXIDE-BIOL CH, V36, P58, DOI 10.1016/j.niox.2013.12.003; Ceriello A, 1998, DIABETIC MED, V15, P188; Chait A, 2009, J LIPID RES, V50, pS335, DOI 10.1194/jlr.R800059-JLR200; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Christ M, 2002, DIABETES, V51, P2648, DOI 10.2337/diabetes.51.8.2648; Erusalimsky JD, 2008, EXP PHYSIOL, V94.3, P299; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Esaki T, 1997, ATHEROSCLEROSIS, V128, P39, DOI 10.1016/S0021-9150(96)05976-X; Guo X, 2000, ACTA PHARMACOL SIN, V21, P325; Han J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086539; Hayashi T, 2007, BBA-MOL BASIS DIS, V1772, P364, DOI 10.1016/j.bbadis.2006.11.011; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; Hayashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088391; Hayashi T, 2014, P NATL ACAD SCI USA, V111, P1168, DOI 10.1073/pnas.1322153111; Hayashi T, 2008, PHARMACOL THERAPEUT, V120, P333, DOI 10.1016/j.pharmthera.2008.09.002; Herrera M, 2009, J BIOL CHEM, V284, P1454, DOI 10.1074/jbc.M804322200; Hunt Michelle A, 2010, J Biomol Tech, V21, P66; Liu XJ, 2013, EXP THER MED, V6, P361, DOI 10.3892/etm.2013.1166; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nabzdyk CS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-48; Nolly MB, 2014, J MOL CELL CARDIOL, V67, P60, DOI 10.1016/j.yjmcc.2013.12.004; Park MH, 2014, APPL BIOCHEM BIOTECH, V174, P632, DOI 10.1007/s12010-014-1099-4; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Sun JZ, 2009, MOL CELL ENDOCRINOL, V313, P64, DOI 10.1016/j.mce.2009.08.019; Taguchi K, 2014, J PHARMACOL EXP THER, V349, P199, DOI 10.1124/jpet.113.211854; TAKEUCHI A, 1995, AM J PHYSIOL-RENAL, V268, pF13, DOI 10.1152/ajprenal.1995.268.1.F13; Torimoto K, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-1; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; Zalli A, 2014, P NATL ACAD SCI USA, V111, P4519, DOI 10.1073/pnas.1322145111; Zhang X, 2014, NITRIC OXIDE-BIOL CH, V40, P10, DOI 10.1016/j.niox.2014.05.001	38	56	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123169	10.1371/journal.pone.0123169	http://dx.doi.org/10.1371/journal.pone.0123169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879533	gold, Green Submitted, Green Published			2022-12-26	WOS:000353016500041
J	Stemig, M; Astelford, K; Emery, A; Cho, JJ; Allen, B; Huang, TH; Gopalakrishnan, R; Mansky, KC; Jensen, ED				Stemig, Melissa; Astelford, Kristina; Emery, Ann; Cho, Jangyeun J.; Allen, Ben; Huang, Tsang-hai; Gopalakrishnan, Rajaram; Mansky, Kim C.; Jensen, Eric D.			Deletion of Histone Deacetylase 7 in Osteoclasts Decreases Bone Mass in Mice by Interactions with MITF	PLOS ONE			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; ACID-PHOSPHATASE GENE; RECEPTOR ACTIVATOR; MINERAL DENSITY; NUCLEAR DOMAIN; P38 MAPK; EXPRESSION; DIFFERENTIATION; PU.1; IDENTIFICATION	Molecular regulators of osteoclast formation and function are an important area of research due to the central role of osteoclasts in bone resorption. Transcription factors such as MITF are essential for osteoclast generation by regulating expression of the genes required for cellular differentiation and resorptive function. We recently reported that histone deacetylase 7 (HDAC7) binds to and represses the transcriptional activity of MITF in osteoclasts, and that loss of HDAC7 in vitro accelerated osteoclastogenesis. In the current study, we extend this initial observation by showing that conditional deletion of HDAC7 in osteoclasts of mice leads to an in vivo enhancement in osteoclast formation, associated with increased bone resorption and lower bone mass. Expression of multiple MITF target genes is increased in bone marrow derived osteoclast cultures from the HDAC7 knockout mice. Interestingly, multiple regions of the HDAC7 amino-terminus can bind to MITF or exert repressive activity. Moreover, mutation or deletion of the HDAC7 conserved deacetylase catalytic domain had little effect on repressive function. These observations identify HDAC7 in osteoclasts as an important molecular regulator of MITF activity and bone homeostasis, but also highlight a gap in our understanding of exactly how HDAC7 functions as a corepressor.	[Stemig, Melissa; Emery, Ann; Gopalakrishnan, Rajaram; Jensen, Eric D.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN USA; [Astelford, Kristina; Cho, Jangyeun J.; Allen, Ben; Mansky, Kim C.] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA; [Huang, Tsang-hai] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 701, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Cheng Kung University	Mansky, KC (corresponding author), Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA.	kmansky@umn.edu; jens0709@umn.edu		Mansky, Kim/0000-0002-2826-5030	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR061352, R01AR056642]; University of Minnesota Office of the Vice-President for Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061352, R01AR056642] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Minnesota Office of the Vice-President for Research(University of Minnesota System); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grant number R01AR061352 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to EDJ and KCM, http://www.niams.nih.gov; grant number R01AR056642 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to RG, http://www.niams.nih.gov; Grant-in-Aid of Research, Artistry, and Scholarship from the University of Minnesota Office of the Vice-President for Research to EDJ, http://www.research.umn.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boluk A, 2004, PHARMACOL RES, V50, P93, DOI 10.1016/j.phrs.2003.11.011; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Cantley MD, 2012, J PHARM PHARMACOL, V64, P763, DOI 10.1111/j.2042-7158.2011.01421.x; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Ecevit CG, 2004, PEDIATR NEUROL, V31, P279, DOI 10.1016/j.pediatrneurol.2004.03.021; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jensen ED, 2007, CRIT REV EUKAR GENE, V17, P187; Jin ZX, 2013, MOL ENDOCRINOL, V27, P325, DOI 10.1210/me.2012-1302; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kao HY, 2000, GENE DEV, V14, P55; Karvonen U, 2006, EXP CELL RES, V312, P3165, DOI 10.1016/j.yexcr.2006.06.018; Kim HN, 2012, EUR J PHARMACOL, V691, P69, DOI 10.1016/j.ejphar.2012.07.034; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Ma C, 2011, J BIOL CHEM, V286, P4819, DOI 10.1074/jbc.M110.146860; Malik S, 2010, MOL CELL BIOL, V30, P399, DOI 10.1128/MCB.00907-09; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Mansky KC, 2002, J LEUKOCYTE BIOL, V71, P304; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vestergaard P, 2004, EPILEPSIA, V45, P1330, DOI 10.1111/j.0013-9580.2004.18804.x; Wang AH, 2005, J BIOL CHEM, V280, P29117, DOI 10.1074/jbc.M500295200; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Williams PJ, 2011, ANN NY ACAD SCI, V1240, P18, DOI 10.1111/j.1749-6632.2011.06286.x	37	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123843	10.1371/journal.pone.0123843	http://dx.doi.org/10.1371/journal.pone.0123843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875108	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800120
J	Warren, CR; Kassir, E; Spurlin, J; Martinez, J; Putnam, NH; Farach-Carson, MC				Warren, Curtis R.; Kassir, Elias; Spurlin, James; Martinez, Jerahme; Putnam, Nicholas H.; Farach-Carson, Mary C.			Evolution of the Perlecan/HSPG2 Gene and Its Activation in Regenerating Nematostella vectensis	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; GENOME REVEALS; CELL; PROTEIN; EXPRESSION; FEATURES; ORIGIN; SYSTEM; GROWTH	The heparan sulfate proteoglycan 2 (HSPG2)/perlecan gene is ancient and conserved in all triploblastic species. Its presence maintains critical cell boundaries in tissue and its large (up to similar to 900 kDa) modular structure has prompted speculation about the evolutionary origin of the gene. The gene's conservation amongst basal metazoans is unclear. After the recent sequencing of their genomes, the cnidarian Nematostella vectensis and the placozoan Trichoplax adhaerens have become favorite models for studying tissue regeneration and the evolution of multicellularity. More ancient basal metazoan phyla include the poriferan and ctenophore, whose evolutionary relationship has been clarified recently. Our in silico and PCR-based methods indicate that the HSPG2 gene is conserved in both the placozoan and cnidarian genomes, but not in those of the ctenophores and only partly in poriferan genomes. HSPG2 also is absent from published ctenophore and Capsaspora owczarzaki genomes. The gene in T. adhaerens is encoded as two separate but genetically juxtaposed genes that house all of the constituent pieces of the mammalian HSPG2 gene in tandem. These genetic constituents are found in isolated genes of various poriferan species, indicating a possible intronic recombinatory mechanism for assembly of the HSPG2 gene. Perlecan's expression during wound healing and boundary formation is conserved, as expression of the gene was activated during tissue regeneration and reformation of the basement membrane of N. vectensis. These data indicate that the complex HSPG2 gene evolved concurrently in a common ancestor of placozoans, cnidarians and bilaterians, likely along with the development of differentiated cell types separated by acellular matrices, and is activated to reestablish these tissue borders during wound healing.	[Warren, Curtis R.; Kassir, Elias; Spurlin, James; Martinez, Jerahme; Putnam, Nicholas H.; Farach-Carson, Mary C.] Rice Univ, Dept Biosci, Houston, TX 77005 USA; [Farach-Carson, Mary C.] Rice Univ, Dept Bioengn, Houston, TX USA	Rice University; Rice University	Farach-Carson, MC (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.	farachca@rice.edu	; Putnam, Nicholas/B-9968-2008	Farach-Carson, Mary/0000-0002-4526-3088; Putnam, Nicholas/0000-0002-1315-782X	National Institutes of Health/National Cancer Institute Program Project - MCFC Project 2 PI [P01CA098912]; National Science Foundation Research Experiences for Undergraduates program - EMK [DBI1004853]; NATIONAL CANCER INSTITUTE [P01CA098912] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute Program Project - MCFC Project 2 PI; National Science Foundation Research Experiences for Undergraduates program - EMK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by P01CA098912 National Institutes of Health/National Cancer Institute Program Project - MCFC Project 2 PI (http://www.cancer.gov/) and DBI1004853 National Science Foundation Research Experiences for Undergraduates program - EMK (http://www.nsf.gov/div/index.jsp?div=DBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Bossert PE, 2013, DEV DYNAM, V242, P1320, DOI 10.1002/dvdy.24021; Carr M, 2008, P NATL ACAD SCI USA, V105, P16641, DOI 10.1073/pnas.0801667105; DATTA S, 1992, GENETICS, V130, P523; Dohrmann M, 2013, INTEGR COMP BIOL, V53, P503, DOI 10.1093/icb/ict008; Dubuc TQ, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-24; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Feta A, 2009, BIOCHEM J, V419, P585, DOI 10.1042/BJ20082081; Govindasamy N, 2014, BIOL OPEN; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Ojeda AF, 2013, GENE EXPR PATTERNS, V13, P303, DOI 10.1016/j.gep.2013.05.006; Passamaneck YJ, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-34; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel A, 2006, INVERTEBRATE BIOLOGY, V126, P99; Riesgo A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-376; Ringrose JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2424; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stefanik DJ, 2013, NAT PROTOC, V8, P892, DOI 10.1038/nprot.2012.151; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tucker RP, 2011, INVERTEBR BIOL, V130, P11, DOI 10.1111/j.1744-7410.2010.00219.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yamazaki M, 2004, J ORAL PATHOL MED, V33, P177, DOI 10.1111/j.0904-2512.2004.00087.x; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	34	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124578	10.1371/journal.pone.0124578	http://dx.doi.org/10.1371/journal.pone.0124578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876075	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800145
J	Weng, TC; Chan, TC; Lin, HT; Chang, CKJ; Wang, WW; Li, ZRT; Cheng, HY; Chu, YR; Chiu, AWH; Yen, MY; King, CC				Weng, Ting Chia; Chan, Ta Chien; Lin, Hsien Tang; Chang, Chia Kun Jasper; Wang, Wen Wen; Li, Zheng Rong Tiger; Cheng, Hao-Yuan; Chu, Yu-Roo; Chiu, Allen Wen-Hsiang; Yen, Muh-Yong; King, Chwan-Chuen			Early Detection for Cases of Enterovirus- and Influenza-Like Illness through a Newly Established School-Based Syndromic Surveillance System in Taipei, January 2010 similar to August 2011	PLOS ONE			English	Article							ASTHMA SURVEILLANCE; EPIDEMIC; CHILDREN; DISEASE; TAIWAN; HOUSEHOLD; INFECTION; VIRUS; FRANCE; NUMBER	School children may transmit pathogens with cluster cases occurring on campuses and in families. In response to the 2009 influenza A (H1N1) pandemic, Taipei City Government officials developed a School-based Infectious Disease Syndromic Surveillance System (SIDSSS). Teachers and nurses from preschools to universities in all 12 districts within Taipei are required to daily report cases of symptomatic children or sick leave requests through the SID-SSS. The pre-diagnosis at schools is submitted firstly as common pediatric disease syndrome-groups and re-submitted after confirmation by physicians. We retrieved these data from January 2010 to August 2011 for spatio-temporal analysis and evaluated the temporal trends with cases obtained from both the Emergency Department-based Syndromic Surveillance System (ED-SSS) and the Longitudinal Health Insurance Database 2005 (LHID2005). Through the SID-SSS, enterovirus-like illness (EVI) and influenza-like illness (ILI) were the two most reported syndrome groups (77.6% and 15.8% among a total of 19,334 cases, respectively). The pre-diagnosis judgments made by school teachers and nurses showed high consistency with physicians' clinical diagnoses for EVI (97.8%) and ILI (98.9%). Most importantly, the SID-SSS had better timeliness with earlier peaks of EVI and ILI than those in the ED-SSS. Furthermore, both of the syndrome groups in these two surveillance systems had the best correlation reaching 0.98 and 0.95, respectively (p<0.01). Spatio-temporal analysis observed the patterns of EVI and ILI both diffuse from the northern suburban districts to central Taipei, with ILI spreading faster. This novel system can identify early suspected cases of two important pediatric infections occurring at schools, and clusters from schools/families. It was also cost-effective (95.5% of the operation cost reduced and 59.7% processing time saved). The timely surveillance of mild EVI and ILI cases integrated with spatial analysis may help public health decision-makers with where to target for enhancing surveillance and prevention measures to minimize severe cases.	[Weng, Ting Chia] NTU, Coll Med, Dept Med, Taipei, Taiwan; [Chan, Ta Chien] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Lin, Hsien Tang; Chu, Yu-Roo] Taipei City Govt, Dept Hlth, Taipei, Taiwan; [Chang, Chia Kun Jasper; Wang, Wen Wen; Li, Zheng Rong Tiger; King, Chwan-Chuen] NTU, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Cheng, Hao-Yuan] NTU Hosp, Dept Pediat, Taipei, Taiwan; [Chiu, Allen Wen-Hsiang; Yen, Muh-Yong] Taipei City Govt, Dept Hlth, Taipei City Hosp, Taipei, Taiwan; [Chiu, Allen Wen-Hsiang; Yen, Muh-Yong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Taipei City Hospital; National Yang Ming Chiao Tung University	Yen, MY (corresponding author), Taipei City Govt, Dept Hlth, Taipei City Hosp, Taipei, Taiwan.	myyen1121@gmail.com; chwanchuen@gmail.com		King, Chwan-Chuen/0000-0002-6078-2601	National Science Council, Executive Yuan of Taiwan [NSC 102-2815-C-002 -182-B, NSC 102-2621-M-002-002]; Medical Foundation in Memory of Dr. Deh-Lin Cheng; Foundation of Health Sciences; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Science Council, Executive Yuan of Taiwan(Ministry of Science and Technology, Taiwan); Medical Foundation in Memory of Dr. Deh-Lin Cheng; Foundation of Health Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was financially supported by a grant from the National Science Council, Executive Yuan of Taiwan [NSC 102-2815-C-002 -182-B] and [NSC 102-2621-M-002-002] and the student scholarships from the Medical Foundation in Memory of Dr. Deh-Lin Cheng and the Foundation of Health Sciences to cultivate young infectious disease researchers. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Bailey-Davis L, 2012, PEDIATRICS, V130, P1102, DOI 10.1542/peds.2012-0192; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; CARRAT F, 1992, AM J EPIDEMIOL, V135, P1293, DOI 10.1093/oxfordjournals.aje.a116236; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chao A, 1996, STAT SINICA, V6, P403; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; COUCH RB, 1986, J INFECT DIS, V153, P431, DOI 10.1093/infdis/153.3.431; Crawford GB, 2011, PUBLIC HEALTH REP, V126, P591; Department of Budget TaipeiCityGovernment, 2019, REP FAM INC EXP SURV; EFRON B, 1976, BIOMETRIKA, V63, P435, DOI 10.1093/biomet/63.3.435; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Fujii H, 2002, JPN J INFECT DIS, V55, P97; Glatman-Freedman A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050228, DOI 10.1371/JOURNAL.PONE.0050228]; Huang YC, 2013, BMC INFECT DIS, P13; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Lawson AB, 2005, SPATIAL AND SYNDROMIC SURVEILLANCE FOR PUBLIC HEALTH, P1, DOI 10.1002/0470092505.ch1; LENAWAY DD, 1995, PUBLIC HEALTH REP, V110, P333; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Magzamen S, 2005, PEDIAT ALLERG IMM-UK, V16, P669, DOI 10.1111/j.1399-3038.2005.00304.x; Medaglia F, 2013, J SCHOOL HEALTH, V83, P907, DOI 10.1111/josh.12109; Minor PD, 2004, NAT REV MICROBIOL, V2, P473, DOI 10.1038/nrmicro906; Nihiser AJ, 2009, PEDIATRICS, V124, pS89, DOI 10.1542/peds.2008-3586L; Ohta A, 2007, J EPIDEMIOL, V17, pS14, DOI 10.2188/jea.17.S14; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Schmidt WP, 2010, EURO SURVEILL, V15; Short VL, 2011, AM J PUBLIC HEALTH, V101, P2178, DOI 10.2105/AJPH.2011.300132; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Thibaut HJ, 2012, BIOCHEM PHARMACOL, V83, P185, DOI 10.1016/j.bcp.2011.08.016; Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2; Witt CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S10; World Health Organization, 2014, CUM NUMB CONF HUM CA; Wu HS, 2014, EMERG INFECT DIS, V20, P857, DOI 10.3201/eid2005.131393; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Yen MY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007962; Zhang DM, 2010, INT J INFECT DIS, V14, pE739, DOI 10.1016/j.ijid.2009.12.002	44	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122865	10.1371/journal.pone.0122865	http://dx.doi.org/10.1371/journal.pone.0122865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875080	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800079
J	Williams, PA; Stilhano, RS; To, VP; Tran, L; Wong, K; Silva, EA				Williams, Priscilla A.; Stilhano, Roberta S.; To, Vivian P.; Tran, Lyndon; Wong, Kevin; Silva, Eduardo A.			Hypoxia Augments Outgrowth Endothelial Cell (OEC) Sprouting and Directed Migration in Response to Sphingosine-1-Phosphate (S1P)	PLOS ONE			English	Article							COLONY-FORMING CELLS; PLURIPOTENT STEM-CELLS; PROGENITOR CELLS; SPHINGOSINE 1-PHOSPHATE; GROWTH-FACTORS; CORD-BLOOD; IN-VITRO; THERAPEUTIC ANGIOGENESIS; CROSS-TALK; DELIVERY	Therapeutic angiogenesis provides a promising approach to treat ischemic cardiovascular diseases through the delivery of proangiogenic cells and/or molecules. Outgrowth endothelial cells (OECs) are vascular progenitor cells that are especially suited for therapeutic strategies given their ease of noninvasive isolation from umbilical cord or adult peripheral blood and their potent ability to enhance tissue neovascularization. These cells are recruited to sites of vascular injury or tissue ischemia and directly incorporate within native vascular endothelium to participate in neovessel formation. A better understanding of how OEC activity may be boosted under hypoxia with external stimulation by proangiogenic molecules remains a challenge to improving their therapeutic potential. While vascular endothelial growth factor (VEGF) is widely established as a critical factor for initiating angiogenesis, sphingosine-1-phosphate (S1P), a bioactive lysophospholipid, has recently gained great enthusiasm as a potential mediator in neovascularization strategies. This study tests the hypothesis that hypoxia and the presence of VEGF impact the angiogenic response of OECs to S1P stimulation in vitro. We found that hypoxia altered the dynamically regulated S1P receptor 1 (S1PR1) expression on OECs in the presence of S1P (1.0 mu M) and/or VEGF (1.3 nM). The combined stimuli of S1P and VEGF together promoted OEC angiogenic activity as assessed by proliferation, wound healing, 3D sprouting, and directed migration under both normoxia and hypoxia. Hypoxia substantially augmented the response to S1P alone, resulting in similar to 6.5-fold and similar to 25-fold increases in sprouting and directed migration, respectively. Overall, this report highlights the importance of establishing hypoxic conditions in vitro when studying ischemia-related angiogenic strategies employing vascular progenitor cells.	[Williams, Priscilla A.; To, Vivian P.; Wong, Kevin; Silva, Eduardo A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Stilhano, Roberta S.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Tran, Lyndon] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; Universidade Federal de Sao Paulo (UNIFESP); University of California System; University of California Davis	Silva, EA (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	esilva@ucdavis.edu	Silva, Eduardo A./M-2711-2015; STILHANO, roberta/F-6923-2015	Silva, Eduardo A./0000-0003-3173-7622; STILHANO, roberta/0000-0002-0653-5968	University of California, Davis; American Heart Association (AHA) [15PRE22930044]	University of California, Davis(University of California System); American Heart Association (AHA)(American Heart Association)	This work was supported by start-up funds provided by the University of California, Davis. PAW was supported by the American Heart Association Western States Affiliate 2014 Predoctoral Fellowship (AHA Award Number 15PRE22930044; (http://my.americanheart.org/)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Anderson EM, 2014, TISSUE EN A IN PRESS; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763; Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70; Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110; Cao Y, 2010, EXP CELL RES, V316, P1304, DOI 10.1016/j.yexcr.2010.02.031; Capitani N, 2012, BLOOD, V120, P4391, DOI 10.1182/blood-2012-04-425959; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779; Decaris ML, 2009, ANGIOGENESIS, V12, P303, DOI 10.1007/s10456-009-9152-6; Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0; Fuchs S, 2001, J AM COLL CARDIOL, V37, P1726, DOI 10.1016/S0735-1097(01)01200-1; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Ikeda T, 2011, BIOCHEM J, V436, P399, DOI 10.1042/BJ20101490; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kawamoto A, 2007, CATHETER CARDIO INTE, V70, P477, DOI 10.1002/ccd.21292; Kuiper C, 2014, FREE RADICAL BIO MED, V69, P308, DOI 10.1016/j.freeradbiomed.2014.01.033; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Liu Jingjing, 2011, World J Biol Chem, V2, P1, DOI 10.4331/wjbc.v2.i1.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HW, 2012, MOL CELL BIOCHEM, V363, P217, DOI 10.1007/s11010-011-1173-y; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Mier-y-Teran-Romero L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000726; Mikhaylova M, 2008, NEOPLASIA, V10, P380, DOI 10.1593/neo.07854; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061; Ogle ME, 2014, ACTA BIOMATER, V10, P4704, DOI 10.1016/j.actbio.2014.08.007; Ouma GO, 2012, VASC MED, V17, P174, DOI 10.1177/1358863X12438270; Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Poitevin S, 2014, CARDIOVASC RES, V103, P121, DOI 10.1093/cvr/cvu104; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Prasain N, 2014, NAT BIOTECHNOL, V32, P1151, DOI 10.1038/nbt.3048; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qi X, 2010, EUR J PHARMACOL, V634, P121, DOI 10.1016/j.ejphar.2010.02.038; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; Sefcik LS, 2011, TISSUE ENG PT A, V17, P617, DOI [10.1089/ten.tea.2010.0404, 10.1089/ten.TEA.2010.0404]; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; Silva EA, 2014, ANGIOGENESIS; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Sun RC, 2014, CELL METAB, V19, P285, DOI 10.1016/j.cmet.2013.11.022; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Takuwa Yoh, 2010, World J Biol Chem, V1, P298, DOI 10.4331/wjbc.v1.i10.298; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70; Williamson KA, 2013, AGING CELL, V12, P139, DOI 10.1111/acel.12031; Yoon CM, 2008, BLOOD, V112, P1129, DOI 10.1182/blood-2007-11-125203	59	57	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123437	10.1371/journal.pone.0123437	http://dx.doi.org/10.1371/journal.pone.0123437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875493	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800098
J	Xia, Y; Lian, S; Khoi, PN; Yoon, HJ; Joo, YE; Chay, KO; Kim, KK; Do Jung, Y				Xia, Yong; Lian, Sen; Khoi, Pham Ngoc; Yoon, Hyun Joong; Joo, Young Eun; Chay, Kee Oh; Kim, Kyung Keun; Do Jung, Young			Chrysin Inhibits Tumor Promoter-Induced MMP-9 Expression by Blocking AP-1 via Suppression of ERK and JNK Pathways in Gastric Cancer Cells	PLOS ONE			English	Article							INDUCED MATRIX-METALLOPROTEINASE-9 EXPRESSION; NF-KAPPA-B; MATRIX METALLOPROTEINASES; C-JUN; CYCLOOXYGENASE-2 EXPRESSION; NUCLEAR-FACTOR; PHOSPHORYLATION; ANGIOGENESIS; FOS; PROLIFERATION	Cell invasion is a crucial mechanism of cancer metastasis and malignancy. Matrix metallo-proteinase-9 (MMP-9) is an important proteolytic enzyme involved in the cancer cell invasion process. High expression levels of MMP-9 in gastric cancer positively correlate with tumor aggressiveness and have a significant negative correlation with patients' survival times. Recently, mechanisms suppressing MMP-9 by phytochemicals have become increasingly investigated. Chrysin, a naturally occurring chemical in plants, has been reported to suppress tumor metastasis. However, the effects of chrysin on MMP-9 expression in gastric cancer have not been well studied. In the present study, we tested the effects of chrysin on MMP-9 expression in gastric cancer cells, and determined its underlying mechanism. We examined the effects of chrysin on MMP-9 expression and activity via RT-PCR, zymography, promoter study, and western blotting in human gastric cancer AGS cells. Chrysin inhibited phorbol-12-myristate 13-acetate (PMA)-induced MMP-9 expression in a dose-dependent manner. Using AP-1 decoy oligodeoxynucleotides, we confirmed that AP-1 was the crucial transcriptional factor for MMP-9 expression. Chrysin blocked AP-1 via suppression of the phosphorylation of c-Jun and c-Fos through blocking the JNK1/2 and ERK1/2 pathways. Furthermore, AGS cells pretreated with PMA showed markedly enhanced invasiveness, which was partially abrogated by chrysin and MMP-9 antibody. Our results suggest that chrysin may exert at least part of its anticancer effect by controlling MMP-9 expression through suppression of AP-1 activity via a block of the JNK1/2 and ERK1/2 signaling pathways in gastric cancer AGS cells.	[Xia, Yong; Lian, Sen; Khoi, Pham Ngoc; Yoon, Hyun Joong; Joo, Young Eun; Chay, Kee Oh; Kim, Kyung Keun; Do Jung, Young] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Gwangju, South Korea	Chonnam National University	Do Jung, Y (corresponding author), Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Gwangju, South Korea.	ydjung@chonnam.ac.kr	Xia, Yong/AAX-2206-2021; Xia, Yong/L-1618-2019		National Cancer Center [0720570]; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2010-0009910]; Medical Research Center from the Korean Science and Engineering Foundation [2012-000-9442]	National Cancer Center; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Medical Research Center from the Korean Science and Engineering Foundation	This work was supported by a Research grant (0720570) from the National Cancer Center (www.ncc.re.kr), Basic Science Research Program grant through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2010-0009910, www.moe.go.kr), and a Medical Research Center (2012-000-9442) grant from the Korean Science and Engineering Foundation (www.nrf.re.kr). All above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Chen CC, 2004, MOL PHARMACOL, V66, P683; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; Chen RH, 1996, ONCOGENE, V12, P1493; Davies C, 2012, BIOCHEM SOC T, V40, P85, DOI 10.1042/BST20110641; Harris GK, 2006, J NUTR, V136, P1517, DOI 10.1093/jn/136.6.1517; Hwang YP, 2010, BIOCHEM PHARMACOL, V79, P1714, DOI 10.1016/j.bcp.2010.02.003; Ishikawa Y, 2000, KIDNEY INT, V58, P1078, DOI 10.1046/j.1523-1755.2000.00265.x; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jin XH, 2014, B CANCER, V101, pE1, DOI 10.1684/bdc.2013.1882; Kim S, 2009, PHYTOMEDICINE, V16, P573, DOI 10.1016/j.phymed.2008.11.006; Li X, 2011, TOXICOL IN VITRO, V25, P630, DOI 10.1016/j.tiv.2010.12.013; Lin CM, 2010, J AGR FOOD CHEM, V58, P7082, DOI 10.1021/jf100421w; Lin CM, 2006, PLANTA MED, V72, P708, DOI 10.1055/s-2006-931602; Lirdprapamongkol K, 2013, ONCOL REP, V30, P2357, DOI 10.3892/or.2013.2667; Liu QX, 2011, BIOCELL, V35, P71; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Oh SJ, 2010, FOOD CHEM TOXICOL, V48, P3227, DOI 10.1016/j.fct.2010.08.028; Orditura M, 2014, WORLD J GASTROENTERO, V20, P1635, DOI 10.3748/wjg.v20.i7.1635; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pan MH, 2008, CHEM SOC REV, V37, P2558, DOI 10.1039/b801558a; Khoi PN, 2013, INT J ONCOL, V43, P868, DOI 10.3892/ijo.2013.2006; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Song Dong Up, 2014, Chonnam Med J, V50, P6, DOI 10.4068/cmj.2014.50.1.6; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; Velinov N, 2010, Khirurgiia (Sofiia), P44; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Woo KJ, 2005, FEBS LETT, V579, P705, DOI 10.1016/j.febslet.2004.12.048; Yang B, 2014, J APPL TOXICOL, V34, P105, DOI 10.1002/jat.2941; Zhang T, 2004, BIOORGAN MED CHEM, V12, P6097, DOI 10.1016/j.bmc.2004.09.013	38	47	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124007	10.1371/journal.pone.0124007	http://dx.doi.org/10.1371/journal.pone.0124007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875631	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800127
J	Gonzalez, M; Rojas, S; Avila, P; Cabrera, L; Villalobos, R; Palma, C; Aguayo, C; Pena, E; Gallardo, V; Guzman-Gutierrez, E; Saaz, T; Salsoso, R; Sanhueza, C; Pardo, F; Leiva, A; Sobrevia, L				Gonzalez, Marcelo; Rojas, Susana; Avila, Pia; Cabrera, Lissette; Villalobos, Roberto; Palma, Carlos; Aguayo, Claudio; Pena, Eduardo; Gallardo, Victoria; Guzman-Gutierrez, Enrique; Saez, Tamara; Salsoso, Rocio; Sanhueza, Carlos; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis			Insulin Reverses D-Glucose-Increased Nitric Oxide and Reactive Oxygen Species Generation in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							L-ARGININE TRANSPORT; SLC29A1 PROMOTER ACTIVITY; ADENOSINE TRANSPORT; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; DIABETES-MELLITUS; EXPRESSION; DYSFUNCTION; SYNTHASE; CAT-1	Vascular tone is controlled by the L-arginine/nitric oxide (NO) pathway, and NO bioavailability is strongly affected by hyperglycaemia-induced oxidative stress. Insulin leads to high expression and activity of human cationic amino acid transporter 1 (hCAT-1), NO synthesis and vasodilation; thus, a protective role of insulin on high D-glucose-alterations in endothelial function is likely. Vascular reactivity to U46619 (thromboxane A(2) mimetic) and calcitonin gene related peptide (CGRP) was measured in KCl preconstricted human umbilical vein rings (wire myography) incubated in normal (5 mmol/L) or high (25 mmol/L) D-glucose. hCAT-1, endothelial NO synthase (eNOS), 42 and 44 kDa mitogen-activated protein kinases (p42/44(mapk)), protein kinase B/Akt (Akt) expression and activity were determined by western blotting and qRT-PCR, tetrahydrobiopterin (BH4) level was determined by HPLC, and L-arginine transport (0-1000 mu mol/L) was measured in response to 5-25 mmol/L D-glucose (0-36 hours) in passage 2 human umbilical vein endothelial cells (HUVECs). Assays were in the absence or presence of insulin and/or apocynin (nicotinamide adenine dinucleotide phosphate-oxidase [NADPH oxidase] inhibitor), tempol or Mn(III) TMPyP (SOD mimetics). High D-glucose increased hCAT-1 expression and activity, which was biphasic (peaks: 6 and 24 hours of incubation). High D-glucose-increased maximal transport velocity was blocked by insulin and correlated with lower hCAT-1 expression and SLC7A1 gene promoter activity. High D-glucose-increased transport parallels higher reactive oxygen species (ROS) and superoxide anion (O-2(center dot-)) generation, and increased U46619-contraction and reduced CGRP-dilation of vein rings. Insulin and apocynin attenuate ROS and O-2(center dot-) generation, and restored vascular reactivity to U46619 and CGRP. Insulin, but not apocynin or tempol reversed high D-glucose-increased NO synthesis; however, tempol and Mn(III) TMPyP reversed the high D- glucose-reduced BH4 level. Insulin and tempol blocked the high D-glucose-increased p42/44(mapk) phosphorylation. Vascular dysfunction caused by high D- glucose is likely attenuated by insulin through the L-arginine/NO and O-2(center dot-)/NADPH oxidase pathways. These findings are of interest for better understanding vascular dysfunction in states of foetal insulin resistance and hyperglycaemia.	[Gonzalez, Marcelo; Rojas, Susana; Avila, Pia; Cabrera, Lissette; Palma, Carlos] Univ Concepcion, Fac Biol Sci, Dept Physiol, Vasc Physiol Lab, Concepcion 4070386, Chile; [Pena, Eduardo; Gallardo, Victoria] Univ Concepcion, Fac Biol Sci, Dept Physiopathol, Concepcion 4070386, Chile; [Aguayo, Claudio] Univ Concepcion, Fac Pharm, Dept Clin Biochem & Immunol, Concepcion 4070386, Chile; [Cabrera, Lissette] Univ Diego Port, Fac Med, Dept Morphophysiol, Santiago 8370076, Chile; [Aguayo, Claudio; Guzman-Gutierrez, Enrique] Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Chillan 3800708, Chile; [Guzman-Gutierrez, Enrique] Univ San Sebastian, Fac Hlth Sci, Concepcion 4080871, Chile; [Sobrevia, Luis] Univ Queensland, Fac Med & Biomed Sci, UQCCR, Herston, Qld 4029, Australia; [Sobrevia, Luis] Univ Seville, Fac Pharm, Dept Physiol, E-41012 Seville, Spain; [Saez, Tamara; Salsoso, Rocio; Sanhueza, Carlos; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis] Pontificia Univ Catolica Chile, CMPL, Div Obstet & Gynaecol, Sch Med,Fac Med, Santiago 8330024, Chile	Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; University Diego Portales; Universidad San Sebastian; University of Queensland; University of Sevilla; Pontificia Universidad Catolica de Chile	Gonzalez, M (corresponding author), Univ Concepcion, Fac Biol Sci, Dept Physiol, Vasc Physiol Lab, POB 160-C, Concepcion 4070386, Chile.	mgonzalezo@udec.cl; sobrevia@med.puc.cl; aaleiva@uc.cl	Sobrevia, Luis/H-9608-2016; Palma, Carlos/ABB-6084-2020; Rodriguez, Maria/AAB-1401-2021; Aguayo, Claudio/AAX-7364-2020; Gonzalez, Marcelo/O-4416-2016; Guzman-Gutierrez, Enrique/H-3536-2016	Palma, Carlos/0000-0001-6182-7501; Gonzalez, Marcelo/0000-0002-0521-3633; Guzman-Gutierrez, Enrique/0000-0001-6589-5667	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile [1110977, 11100192, 11110059, 3130583, 3140516]; International NETWORK program (CONICYT), Chile [130102]; Direccion de Investigacion, Universidad de Concepcion (DIUC), Chile [210.033.103-1.0]; Faculty of Medicine, Pontificia Universidad Catolica de Chile-PhD fellowship; Universidad de Concepcion-MSc (Chile) fellowships	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); International NETWORK program (CONICYT), Chile; Direccion de Investigacion, Universidad de Concepcion (DIUC), Chile; Faculty of Medicine, Pontificia Universidad Catolica de Chile-PhD fellowship; Universidad de Concepcion-MSc (Chile) fellowships	The work was supported by the following: Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) (grant numbers 1110977, 11100192, 11110059, 3130583, 3140516), Chile; International NETWORK program (CONICYT) (grant number 130102), Chile; and Direccion de Investigacion, Universidad de Concepcion (DIUC) (grant number 210.033.103-1.0), Chile. RS is recipient of a Faculty of Medicine, Pontificia Universidad Catolica de Chile-PhD fellowship; TS and RS hold CONICYT-PhD (Chile) fellowships; PA and LC held Universidad de Concepcion-MSc (Chile) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine EH, 2006, J VASC RES, V43, P309, DOI 10.1159/000093196; Banerjee M, 2006, NAT CLIN PRACT CARD, V3, P596, DOI 10.1038/ncpcardio0683; Brewster S, 2013, J AM COLL CARDIOL, V62, P677, DOI 10.1016/j.jacc.2013.01.080; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Damm P, 2009, INT J GYNECOL OBSTET, V104, pS25, DOI 10.1016/j.ijgo.2008.11.025; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Farias M, 2010, CARDIOVASC RES, V86, P45, DOI 10.1093/cvr/cvp410; Felice F, 2010, MICROVASC RES, V80, P332, DOI 10.1016/j.mvr.2010.05.004; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; Fukushima T, 1980, Methods Enzymol, V66, P429; Gonzalez M, 2004, PFLUG ARCH EUR J PHY, V448, P383; Gonzalez M, 2011, J CELL PHYSIOL, V226, P2916, DOI 10.1002/jcp.22635; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Guzman-Gutierrez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041705; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Hayward CE, 2013, PLACENTA, V34, P281, DOI 10.1016/j.placenta.2013.01.001; Huang CC, 2009, J BIOL CHEM, V284, P32312, DOI 10.1074/jbc.M109.024471; Jayakumar T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/403703; Kaneto H, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/453892; Karbach S, 2012, J DIABETES COMPLICAT, V26, P155, DOI 10.1016/j.jdiacomp.2012.03.011; Kohlhaas CF, 2011, BIOCHEM BIOPH RES CO, V412, P747, DOI 10.1016/j.bbrc.2011.08.048; Lindsay RS, 2007, CLIN ENDOCRINOL, V66, P322, DOI 10.1111/j.1365-2265.2006.02719.x; Liu J, 1998, AMINO ACIDS, V15, P321, DOI 10.1007/BF01320897; Pepine CJ, 2009, AM J MED, V122, P10, DOI 10.1016/j.amjmed.2009.03.003; Potdar S, 2009, MICROVASC RES, V78, P191, DOI 10.1016/j.mvr.2009.04.001; Puebla C, 2008, J CELL PHYSIOL, V215, P645, DOI 10.1002/jcp.21347; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Roe ND, 2011, DIABETES OBES METAB, V13, P465, DOI 10.1111/j.1463-1326.2011.01369.x; Roe ND, 2012, VASC PHARMACOL, V57, P168, DOI 10.1016/j.vph.2012.02.004; Salomon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040578; Salsoso R, 2015, PLACENTA, V36, P287, DOI 10.1016/j.placenta.2014.12.007; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schneider S, 2012, J PERINAT MED, V40, P511, DOI 10.1515/jpm-2012-0015; Shin S, 2011, BIOCHEM BIOPH RES CO, V414, P660, DOI 10.1016/j.bbrc.2011.09.112; Sobrevia L, 1996, J PHYSIOL-LONDON, V490, P775, DOI 10.1113/jphysiol.1996.sp021185; Sobrevia L, 2015, EXP PHYSIOL, V100, P231, DOI 10.1113/expphysiol.2014.082743; Sobrevia L, 2009, CURR VASC PHARMACOL, V7, P467, DOI 10.2174/157016109789043919; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Taye A, 2010, EUR J PHARMACOL, V627, P42, DOI 10.1016/j.ejphar.2009.10.045; Westermeier F, 2015, FASEB J, V29, P37, DOI 10.1096/fj.14-254219; Westgate JA, 2006, DIABETES CARE, V29, P1345, DOI 10.2337/dc05-1677; Yano M, 2004, REDOX REP, V9, P111, DOI 10.1179/135100004225004779; Zhou ZW, 2012, EUR J PHARMACOL, V697, P97, DOI 10.1016/j.ejphar.2012.09.051	44	37	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122398	10.1371/journal.pone.0122398	http://dx.doi.org/10.1371/journal.pone.0122398			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875935	Green Submitted, gold, Green Published			2022-12-26	WOS:000353014700014
J	Ponsuksili, S; Siengdee, P; Du, Y; Trakooljul, N; Murani, E; Schwerin, M; Wimmers, K				Ponsuksili, Siriluck; Siengdee, Puntita; Du, Yang; Trakooljul, Nares; Murani, Eduard; Schwerin, Manfred; Wimmers, Klaus			Identification of Common Regulators of Genes in Co-Expression Networks Affecting Muscle and Meat Properties	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOBLAST DIFFERENTIATION; THIAMINE-DEFICIENCY; GLUCOSE-UPTAKE; EXPRESSION; MOUSE; PIGS; QUALITY; CXCR7; DEGENERATION	Understanding the genetic contributions behind skeletal muscle composition and metabolism is of great interest in medicine and agriculture. Attempts to dissect these complex traits combine genome-wide genotyping, expression data analyses and network analyses. Weighted gene co-expression network analysis (WGCNA) groups genes into modules based on patterns of co-expression, which can be linked to phenotypes by correlation analysis of trait values and the module eigengenes, i.e. the first principal component of a given module. Network hub genes and regulators of the genes in the modules are likely to play an important role in the emergence of respective traits. In order to detect common regulators of genes in modules showing association with meat quality traits, we identified eQTL for each of these genes, including the highly connected hub genes. Additionally, the module eigengene values were used for association analyses in order to derive a joint eQTL for the respective module. Thereby major sites of orchestrated regulation of genes within trait-associated modules were detected as hotspots of eQTL of many genes of a module and of its eigengene. These sites harbor likely common regulators of genes in the modules. We exemplarily showed the consistent impact of candidate common regulators on the expression of members of respective modules by RNAI knockdown experiments. In fact, Cxcr7 was identified and validated as a regulator of genes in a module, which is involved in the function of defense response in muscle cells. Zfp3612 was confirmed as a regulator of genes of a module related to cell death or apoptosis pathways. The integration of eQTL in module networks enabled to interpret the differentially-regulated genes from a systems perspective. By integrating genome-wide genomic and transcriptomic data, employing co-expression and eQTL analyses, the study revealed likely regulators that are involved in the fine-tuning and synchronization of genes with trait-associated expression.	[Ponsuksili, Siriluck; Siengdee, Puntita; Du, Yang; Trakooljul, Nares; Murani, Eduard; Schwerin, Manfred; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, D-18196 Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Wilhelm Stahl Allee 2, D-18196 Dummerstorf, Germany.	wimmers@fbn-dummertorf.de	Siengdee, Puntita/AAF-4813-2019; Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790; Trakooljul, Nares/0000-0002-3214-2498; Du, Yang/0000-0002-5707-513X; Siengdee, Puntita/0000-0003-0665-0912	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [PO753/6-1, WI1754/14-1]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; PO753/6-1 and WI1754/14-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2013, BBA-MOL BASIS DIS, V1832, P1294, DOI 10.1016/j.bbadis.2013.03.021; Andersson L, 2003, BIOCHEM SOC T, V31, P232, DOI 10.1042/BST0310232; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berdanier CD, 1997, ADVANCED NUTRITION M; Bernard C, 2007, J AGR FOOD CHEM, V55, P5229, DOI 10.1021/jf063372l; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; Calingasan NY, 1996, AM J PATHOL, V149, P1063; Davis RC, 2012, PHYSIOL GENOMICS, V44, P1, DOI 10.1152/physiolgenomics.00003.2011; ESTRADE M, 1993, COMP BIOCHEM PHYS B, V104, P321, DOI 10.1016/0305-0491(93)90375-F; Evangelisti C, 2009, CELL SIGNAL, V21, P801, DOI 10.1016/j.cellsig.2009.01.027; Fan YY, 2013, J MOL HISTOL, V44, P75, DOI 10.1007/s10735-012-9445-8; Farber CR, 2010, J BONE MINER RES, V25, P2359, DOI 10.1002/jbmr.138; Farber CR, 2009, J BONE MINER RES, V24, P1937, DOI [10.1359/jbmr.091101, 10.1359/JBMR.091101]; Farber CR, 2009, PHYSIOL GENOMICS, V37, P294, DOI 10.1152/physiolgenomics.90245.2008; Feng Z, 2007, GENE, V403, P170, DOI 10.1016/j.gene.2007.08.009; Filteau M, 2013, MOL BIOL EVOL, V30, P1384, DOI 10.1093/molbev/mst053; Frederikse PH, 1999, BIOCHEM BIOPH RES CO, V258, P703, DOI 10.1006/bbrc.1999.0560; Ge YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068068; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; GUNTERT M, 1993, PROGRESS IN FLAVOUR PRECURSOR STUDIES, P361; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hara M, 2011, J EXP MED, V208, P715, DOI 10.1084/jem.20101059; Henningsen J, 2011, MOL BIOSYST, V7, P311, DOI 10.1039/c0mb00209g; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hunger C, 2012, EXP CELL RES, V318, P2178, DOI 10.1016/j.yexcr.2012.06.020; Kim MY, 2010, CARDIOVASC RES, V87, P119, DOI 10.1093/cvr/cvq048; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; MA JT, 1994, BIOCHEM BIOPH RES CO, V200, P1742, DOI 10.1006/bbrc.1994.1654; Meinert L, 2009, MEAT SCI, V81, P255, DOI 10.1016/j.meatsci.2008.07.031; Melchonna R, 2010, MUSCLE NERVE, V41, P828, DOI 10.1002/mus.21611; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Mo XY, 2011, MOL BIOL REP, V38, P4389, DOI 10.1007/s11033-010-0566-4; Moreno-Sanchez N, 2010, FUNCT INTEGR GENOMIC, V10, P609, DOI 10.1007/s10142-010-0175-2; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nilsson EC, 2006, J BIOL CHEM, V281, P7244, DOI 10.1074/jbc.M510461200; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Ponsuksili S, 2009, FUNCT INTEGR GENOMIC, V9, P455, DOI 10.1007/s10142-009-0131-1; Ponsuksili S, 2014, INT J BIOL SCI, V10, P327, DOI 10.7150/ijbs.8134; Ponsuksili S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-533; Ponsuksili S, 2012, GENETICS, V192, P1109, DOI 10.1534/genetics.112.143081; Ponsuksili S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-572; Rajan S, 2012, PHYSIOL GENOMICS, V44, P183, DOI 10.1152/physiolgenomics.00093.2011; Ramos SBV, 2012, J BIOL CHEM, V287, P13116, DOI 10.1074/jbc.M111.330837; Reiner G, 2002, ANIM GENET, V33, P49, DOI 10.1046/j.1365-2052.2002.00805.x; Rosenvold K, 2003, MEAT SCI, V64, P219, DOI 10.1016/S0309-1740(02)00186-9; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schott J, 2010, WIRES RNA, V1, P432, DOI 10.1002/wrna.13; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stratz P, 2014, ANIM GENET, V45, P350, DOI 10.1111/age.12133; Stumpo DJ, 2010, WIRES RNA, V1, P60, DOI 10.1002/wrna.1; Tao G, 2012, J MOL CELL CARDIOL, V53, P626, DOI 10.1016/j.yjmcc.2012.08.002; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; TonoOka S, 1996, J HISTOCHEM CYTOCHEM, V44, P907, DOI 10.1177/44.8.8756762; TROUCHE D, 1995, FEBS LETT, V361, P140, DOI 10.1016/0014-5793(95)00140-5; Yu SH, 2011, DEV DYNAM, V240, P384, DOI 10.1002/dvdy.22549; Zhang LB, 2013, NATURE, V499, P92, DOI 10.1038/nature12215; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	63	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123678	10.1371/journal.pone.0123678	http://dx.doi.org/10.1371/journal.pone.0123678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875247	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700037
J	Beziau, DM; Toussaint, F; Blanchette, A; Dayeh, NR; Charbel, C; Tardif, JC; Dupuis, J; Ledoux, J				Beziau, Delphine M.; Toussaint, Fanny; Blanchette, Alexandre; Dayeh, Nour R.; Charbel, Chimene; Tardif, Jean-Claude; Dupuis, Jocelyn; Ledoux, Jonathan			Expression of Phosphoinositide-Specific Phospholipase C Isoforms in Native Endothelial Cells	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; CA2+ SIGNALS; CALCIUM; ACTIVATION; CHANNELS; ROLES; PHOSPHORYLATION; GROWTH	Phospholipase C (PLC) comprises a superfamily of enzymes that play a key role in a wide array of intracellular signalling pathways, including protein kinase C and intracellular calcium. Thirteen different mammalian PLC isoforms have been identified and classified into 6 families (PLC-beta, gamma, delta, epsilon, zeta and eta) based on their biochemical properties. Although the expression of PLC isoforms is tissue-specific, concomitant expression of different PLC has been reported, suggesting that PLC family is involved in multiple cellular functions. Despite their critical role, the PLC isoforms expressed in native endothelial cells (ECs) remains undetermined. A conventional PCR approach was initially used to elucidate the mRNA expression pattern of PLC isoforms in 3 distinct murine vascular beds: mesenteric (MA), pulmonary (PA) and middle cerebral arteries (MCA). mRNA encoding for most PLC isoforms was detected in MA, MCA and PA with the exception of eta 2 and beta 2 (only expressed in PA), delta 4 (only expressed in MCA), eta 1 (expressed in all but MA) and zeta (not detected in any vascular beds tested). The endothelial-specific PLC expression was then sought in freshly isolated ECs. Interestingly, the PLC expression profile appears to differ across the investigated arterial beds. While mRNA for 8 of the 13 PLC isoforms was detected in ECs from MA, two additional PLC isoforms were detected in ECs from PA and MCA. Co-expression of multiple PLC isoforms in ECs suggests an elaborate network of signalling pathways: PLC isoforms may contribute to the complexity or diversity of signalling by their selective localization in cellular microdomains. However in situ immunofluorescence revealed a homogeneous distribution for all PLC isoforms probed (beta 3, gamma 2 and delta 1) in intact endothelium. Although PLC isoforms play a crucial role in endothelial signal transduction, subcellular localization alone does not appear to be sufficient to determine the role of PLC in the signalling microdomains found in the native endothelium.	[Beziau, Delphine M.; Toussaint, Fanny; Blanchette, Alexandre; Dayeh, Nour R.; Charbel, Chimene; Tardif, Jean-Claude; Dupuis, Jocelyn; Ledoux, Jonathan] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Beziau, Delphine M.; Toussaint, Fanny; Ledoux, Jonathan] Univ Montreal, Dept Mol & Integrat Physiol, Montreal, PQ, Canada; [Charbel, Chimene; Ledoux, Jonathan] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Dayeh, Nour R.; Tardif, Jean-Claude; Dupuis, Jocelyn; Ledoux, Jonathan] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Ledoux, J (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	jonathan.ledoux@umontreal.ca	Dupuis, Jocelyn/C-6613-2013; Ledoux, Jonathan/D-2945-2012	Dupuis, Jocelyn/0000-0002-3193-1014; Ledoux, Jonathan/0000-0001-8540-7763	Universite de Montreal; Societe Quebecois d'Hypertension Arterielle (SQHA); Fonds de Recherche du Quebec - Sante (FRQS); Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation (CFI); Heart and Stroke Foundation of Canada (HSFC)	Universite de Montreal; Societe Quebecois d'Hypertension Arterielle (SQHA); Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada)	This study was support through studentship and salary grants: Universite de Montreal - Fanny Toussaint, Nour R. Dayeh; Societe Quebecois d'Hypertension Arterielle (SQHA) - Delphine M. Beziau and Fanny Toussaint; Fonds de Recherche du Quebec - Sante (FRQS) - Jonathan Ledoux; Canadian Institutes of Health Research (CIHR) - Jonathan Ledoux; The Canada Foundation for Innovation (CFI) - Jonathan Ledoux; Heart and Stroke Foundation of Canada (HSFC) - Jonathan Ledoux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bhattacharya R, 2009, J CELL SCI, V122, P1025, DOI 10.1242/jcs.041913; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Cines DB, 1998, BLOOD, V91, P3527; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Crljen V, 2004, FEBS LETT, V571, P35, DOI 10.1016/j.febslet.2004.06.051; De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; FU YG, 1994, THROMB RES, V73, P405, DOI 10.1016/0049-3848(94)90042-6; Fujii M, 2009, J CELL BIOCHEM, V108, P638, DOI 10.1002/jcb.22297; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110; Gonzales AL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004732; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Hoeppner LH, 2012, BLOOD, V120, P2167, DOI 10.1182/blood-2012-03-417824; HOMMA Y, 1989, BIOCHEM BIOPH RES CO, V164, P406, DOI 10.1016/0006-291X(89)91734-8; Ishida S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086410; Jang Hyun-Jun, 2013, Advances in Biological Regulation, V53, P51, DOI 10.1016/j.jbior.2012.09.008; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Johnson RP, 2009, J PHYSIOL-LONDON, V587, P2537, DOI 10.1113/jphysiol.2008.168252; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; KIBRIA G, 1980, THORAX, V35, P186, DOI 10.1136/thx.35.3.186; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Kim YH, 1999, J BIOL CHEM, V274, P26127, DOI 10.1074/jbc.274.37.26127; Kirby BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054849; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Ledoux J, 2008, J GEN PHYSIOL, V131, P125, DOI 10.1085/jgp.200709875; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Lo Vasco VR, 2011, J CLIN PATHOL, V64, P911, DOI 10.1136/jclinpath-2011-200096; Mao GF, 2000, BRIT J HAEMATOL, V110, P402, DOI 10.1046/j.1365-2141.2000.02201.x; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Saunders CM, 2002, DEVELOPMENT, V129, P3533; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Socha MJ, 2011, AM J PHYSIOL-HEART C, V301, pH773, DOI 10.1152/ajpheart.00214.2011; Sonkusare SK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005052; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Sullivan MN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005659; Sun LS, 2007, PLATELETS, V18, P217, DOI 10.1080/09537100601016133; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tran CHT, 2012, AM J PHYSIOL-CELL PH, V302, pC1226, DOI 10.1152/ajpcell.00418.2011; Vines CM, 2012, ADV EXP MED BIOL, V740, P235, DOI 10.1007/978-94-007-2888-2_10; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003	56	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123769	10.1371/journal.pone.0123769	http://dx.doi.org/10.1371/journal.pone.0123769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875657	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100211
J	Chen, HY; Cui, SH; Zhao, YA; Zhang, CM; Zhang, SB; Peng, XJ				Chen, Huiying; Cui, Shaohui; Zhao, Yinan; Zhang, Chuanmin; Zhang, Shubiao; Peng, Xiaojun			Grafting Chitosan with Polyethylenimine in an Ionic Liquid for Efficient Gene Delivery	PLOS ONE			English	Article							MOLECULAR-WEIGHT POLYETHYLENIMINE; TRANSFECTION EFFICIENCY; IN-VITRO; NONVIRAL VECTOR; SIRNA DELIVERY; NANOPARTICLES; COPOLYMER; TOXICITY; CARRIERS; POLYMER	Modifying chitosan (CS) with polyethylenimine (PEI) grafts is an effective way to improve its gene transfection performance. However, it is still a challenge to conduct the grafting with fine control and high efficiency, particularly for the modification of water-insoluble CS. Herein, a novel method to graft CS with PEI (1.8 kDa, PEI-1.8) was developed by using ionic liquid 1-butyl-3-methyl imidazolium acetate ([ BMIM] Ac) as a reaction solvent, water-insoluble CS as a reaction substrate and 1,1-carbonyldiimidazole (CDI) as a linking agent. The grafting reaction was greatly accelerated and the reaction time was largely shortened to 4 h by taking advantages of the good solubility of CS, the enhanced nucleophilicity of amino groups and the preferential stability of the activated complexes in the ionic liquid. The chitosan-graft-polyethylenimine (CS-g-PEI) products were characterized by H-1 NMR, FTIR and GPC. PEI1.8 was quantitatively grafted to CS through urea linkages, and the grafting degree (GD) was conveniently tuned by varying the molar ratios of PEI-1.8 to D-glucosamine units of CS in the range of 9.0 x 10(-3) to 9.0 x 10(-2). Compared with CS, the synthesized CS-g-PEI copolymers showed higher pDNA-binding affinity, which increased with the GD as shown in Agarose gel electrophoresis. The dynamic light scattering (DLS) experiment demonstrated that the CS-g-PEI/pDNA polyplexes had suitable particle sizes and proper zeta-potentials for cell transfection. The CS-g-PEI copolymer with a medium GD of 4.5% conferred the best gene transfection, with the efficiency 44 times of CS and 38 times of PEI-1.8 in HEp-2 cells. The cytotoxicity of CS-g-PEI was tested and found nearly as low as that of CS and much lower than that of PEI.	[Chen, Huiying; Zhao, Yinan; Zhang, Chuanmin; Peng, Xiaojun] Dalian Univ Technol, State Key Lab Fine Chem, Fac Chem Environm & Biol Sci & Technol, Dalian, Liaoning, Peoples R China; [Chen, Huiying; Cui, Shaohui; Zhao, Yinan; Zhang, Shubiao] Dalian Nationalities Univ, Coll Life Sci, Key Lab Biotechnol & Bioresources Utilizat, State Ethn Affairs Commiss,Minist Educ, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian Minzu University	Zhang, SB (corresponding author), Dalian Nationalities Univ, Coll Life Sci, Key Lab Biotechnol & Bioresources Utilizat, State Ethn Affairs Commiss,Minist Educ, Dalian, Liaoning, Peoples R China.	zsb@dlnu.edu.cn	zhang, chuanmin/AAV-9453-2020		National High Technology Research and Development Program of China (863 Program) [2014AA020707]; Natural Science Foundation of China [21176046]; Fundamental Research Funds for the Dalian Nationalities University	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Dalian Nationalities University	This work was supported by National High Technology Research and Development Program of China (863 Program, 2014AA020707) http://www.863.gov.cn/, National Natural Science Foundation of China (21176046) http://www.nsfc.gov.cn/, and Fundamental Research Funds for the Dalian Nationalities University, http://kjc.dlnu.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre M, 2014, POLYMERS-BASEL, V6, P1727, DOI 10.3390/polym6061727; Benns JM, 2000, BIOCONJUGATE CHEM, V11, P637, DOI 10.1021/bc0000177; Benns JM, 2002, J CONTROL RELEASE, V79, P255, DOI 10.1016/S0168-3659(01)00513-2; BOTTEGA R, 1992, BIOCHEMISTRY-US, V31, P9025, DOI 10.1021/bi00152a045; Chang KL, 2011, J CONTROL RELEASE, V156, P195, DOI 10.1016/j.jconrel.2011.07.021; Chen HY, 2014, ACTA POLYM SIN, P1089; Crowhurst L, 2004, J AM CHEM SOC, V126, P11549, DOI 10.1021/ja046757y; Ding FY, 2014, NANOSCALE, V6, P9477, DOI 10.1039/c4nr02814g; El Seoud OA, 2007, BIOMACROMOLECULES, V8, P2629, DOI 10.1021/bm070062i; Gao JQ, 2010, INT J PHARMACEUT, V387, P286, DOI 10.1016/j.ijpharm.2009.12.033; Hiemenz P. C., 1997, PRINCIPLES COLLOID S, V3rd; Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.jconrel.2005.05.004; Jain A, 2013, CRIT REV THER DRUG, V30, P91; Jere D, 2009, INT J PHARMACEUT, V378, P194, DOI 10.1016/j.ijpharm.2009.05.046; Jia LJ, 2013, POLYM CHEM-UK, V4, P156, DOI 10.1039/c2py20781h; Jiang HL, 2008, J CONTROL RELEASE, V131, P150, DOI 10.1016/j.jconrel.2008.07.029; Jiang HL, 2007, J CONTROL RELEASE, V117, P273, DOI 10.1016/j.jconrel.2006.10.025; Jiang HL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025013; Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004; Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Li ZT, 2010, CARBOHYD POLYM, V80, P254, DOI 10.1016/j.carbpol.2009.11.021; Liu CC, 2012, INT J NANOMED, V7, P5339, DOI 10.2147/IJN.S36179; Liu WG, 2002, J CONTROL RELEASE, V83, P1; Lu B, 2008, BIOMACROMOLECULES, V9, P2594, DOI 10.1021/bm8004676; Lu B, 2009, MOL BIOSYST, V5, P629, DOI 10.1039/b822505b; Lu HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084703; Lu HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069950, 10.1371/journal.pone.0072410]; MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2; Malmo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054182; Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8; Murata J, 1996, CARBOHYD POLYM, V29, P69, DOI 10.1016/0144-8617(95)00144-1; Pei LJ, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40052; Pezzoli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034711; Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947; Ragelle H, 2013, J CONTROL RELEASE, V172, P207, DOI 10.1016/j.jconrel.2013.08.005; Rajesh R, 2012, PROCESS BIOCHEM, V47, P1079, DOI 10.1016/j.procbio.2012.03.014; Ranieri G, 2008, IND ENG CHEM RES, V47, P638, DOI 10.1021/ie070632v; Sarkar K, 2013, CARBOHYD POLYM, V92, P2048, DOI 10.1016/j.carbpol.2012.11.067; Sezer AD, 2012, EXPERT OPIN DRUG DEL, V9, P1129, DOI 10.1517/17425247.2012.702752; Shi BY, 2013, POLYM CHEM-UK, V4, P840, DOI 10.1039/c2py20494k; Singh B, 2014, J NANOSCI NANOTECHNO, V14, P564, DOI 10.1166/jnn.2014.9079; Stefanescu C, 2012, CARBOHYD POLYM, V87, P435, DOI 10.1016/j.carbpol.2011.08.003; SUH J, 1994, BIOORG CHEM, V22, P318, DOI 10.1006/bioo.1994.1025; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Tran CD, 2013, J BIOMED MATER RES A, V101, P2248, DOI 10.1002/jbm.a.34520; Tripathi SK, 2012, NANOMED-NANOTECHNOL, V8, P337, DOI 10.1016/j.nano.2011.06.022; Wang B, 2012, BIOTECHNOL LETT, V34, P19, DOI 10.1007/s10529-011-0748-8; Wong K, 2006, BIOCONJUGATE CHEM, V17, P152, DOI 10.1021/bc0501597; Zhao H, 2006, TETRAHEDRON-ASYMMETR, V17, P377, DOI 10.1016/j.tetasy.2006.01.015	50	18	20	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121817	10.1371/journal.pone.0121817	http://dx.doi.org/10.1371/journal.pone.0121817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875475	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100048
J	Li, XM; Zhong, L; Xue, FZ; Zhang, AG				Li, Xiumin; Zhong, Ling; Xue, Fangzheng; Zhang, Anguo			A Priori Data-Driven Multi-Clustered Reservoir Generation Algorithm for Echo State Network	PLOS ONE			English	Article							PSEUDOPERIODIC TIME-SERIES; COMPLEX NETWORK; SPATIAL GROWTH; WORLD NETWORKS; BEHAVIOR; SYSTEMS; WINDOWS	Echo state networks (ESNs) with multi-clustered reservoir topology perform better in reservoir computing and robustness than those with random reservoir topology. However, these ESNs have a complex reservoir topology, which leads to difficulties in reservoir generation. This study focuses on the reservoir generation problem when ESN is used in environments with sufficient priori data available. Accordingly, a priori data-driven multi-cluster reservoir generation algorithm is proposed. The priori data in the proposed algorithm are used to evaluate reservoirs by calculating the precision and standard deviation of ESNs. The reservoirs are produced using the clustering method; only the reservoir with a better evaluation performance takes the place of a previous one. The final reservoir is obtained when its evaluation score reaches the preset requirement. The prediction experiment results obtained using the Mackey-Glass chaotic time series show that the proposed reservoir generation algorithm provides ESNs with extra prediction precision and increases the structure complexity of the network. Further experiments also reveal the appropriate values of the number of clusters and time window size to obtain optimal performance. The information entropy of the reservoir reaches the maximum when ESN gains the greatest precision.	[Li, Xiumin; Zhong, Ling; Xue, Fangzheng; Zhang, Anguo] Chongqing Univ, Key Lab Dependable Serv Comp Cyber Phys Soc, Minist Educ, Chongqing 400044, Peoples R China; [Li, Xiumin; Zhong, Ling; Xue, Fangzheng; Zhang, Anguo] Chongqing Univ, Coll Automat, Chongqing 400044, Peoples R China	Chongqing University; Chongqing University	Xue, FZ (corresponding author), Chongqing Univ, Key Lab Dependable Serv Comp Cyber Phys Soc, Minist Educ, Chongqing 400044, Peoples R China.	xuefangzheng@cqu.edu.cn	Li, Xiumin/ABA-5948-2020; Zhang, Anguo/K-3723-2019; Zhang, Anguo/AAF-4985-2019	Li, Xiumin/0000-0002-2398-4757; Zhang, Anguo/0000-0002-4825-7054	National Natural Science Foundation of China [61473051, 61304165]; Fundamental Research Funds for the Central Universities [CDJZR11170006, CDJZR12170008, CDJZR12170018]; Chongqing Natural Science Foundation [2011BB0081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work is supported by the National Natural Science Foundation of China (Nos. 61473051 and 61304165), the Fundamental Research Funds for the Central Universities (Nos. CDJZR11170006, CDJZR12170008 and CDJZR12170018) and Chongqing Natural Science Foundation (No. 2011BB0081).	Boccato L, 2014, NEUROCOMPUTING, V138, P297, DOI 10.1016/j.neucom.2014.01.036; Cui Hong-yan, 2013, Journal of China Universities of Posts and Telecommunications, V20, P59, DOI 10.1016/S1005-8885(13)60070-9; Deng ZD, 2007, IEEE T NEURAL NETWOR, V18, P1364, DOI 10.1109/TNN.2007.894082; Ding HY, 2005, IEEE INT WORKSH VLSI; Gallicchio C, 2013, NEUROCOMPUTING, V101, P319, DOI 10.1016/j.neucom.2012.08.017; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032910; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Ihara S, 1993, INFORM THEORY CONTIN, V2; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H., 2001, 148 GMD; Jaeger H., 2002, 159 GMD; Kaiser M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036103; Kaiser M, 2007, NEUROCOMPUTING, V70, P1829, DOI 10.1016/j.neucom.2006.10.060; Li DC, 2012, IEEE T NEUR NET LEAR, V23, P787, DOI 10.1109/TNNLS.2012.2188414; Ma QL, 2013, NEUROCOMPUTING, V122, P406, DOI 10.1016/j.neucom.2013.06.012; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nisbach F, 2007, EUR PHYS J B, V58, P185, DOI 10.1140/epjb/e2007-00214-4; Skowronski MD, 2007, NEURAL NETWORKS, V20, P414, DOI 10.1016/j.neunet.2007.04.006; Song QS, 2010, NEUROCOMPUTING, V73, P2177, DOI 10.1016/j.neucom.2010.01.015; Venayagamoorthy GK, 2009, NEURAL NETWORKS, V22, P861, DOI 10.1016/j.neunet.2009.03.021; Wiener N, 1965, 2 EDITION CONTROL CO; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhang J, 2008, PHYSICA D, V237, P2856, DOI 10.1016/j.physd.2008.05.008	27	7	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120750	10.1371/journal.pone.0120750	http://dx.doi.org/10.1371/journal.pone.0120750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875296	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100026
J	Ren, J; Huang, SC; Zhang, JC; Zhu, Q; Wilson, AD; Snapp-Childs, W; Bingham, GP				Ren, Jie; Huang, Shaochen; Zhang, Jiancheng; Zhu, Qin; Wilson, Andrew D.; Snapp-Childs, Winona; Bingham, Geoffrey P.			The 50s Cliff: A Decline in Perceptuo-Motor Learning, Not a Deficit in Visual Motion Perception	PLOS ONE			English	Article							RHYTHMIC MOVEMENT COORDINATION; PHASE-TRANSITIONS; 3-D SHAPE; AGE; STABILITY; FEEDBACK; SYSTEM; SPEED; DEPTH	Previously, we measured perceptuo-motor learning rates across the lifespan and found a sudden drop in learning rates between ages 50 and 60, called the "50s cliff." The task was a unimanual visual rhythmic coordination task in which participants used a joystick to oscillate one dot in a display in coordination with another dot oscillated by a computer. Participants learned to produce a coordination with a 90 degrees relative phase relation between the dots. Learning rates for participants over 60 were half those of younger participants. Given existing evidence for visual motion perception deficits in people over 60 and the role of visual motion perception in the coordination task, it remained unclear whether the 50s cliff reflected onset of this deficit or a genuine decline in perceptuo-motor learning. The current work addressed this question. Two groups of 12 participants in each of four age ranges (20s, 50s, 60s, 70s) learned to perform a bimanual coordination of 90 degrees relative phase. One group trained with only haptic information and the other group with both haptic and visual information about relative phase. Both groups were tested in both information conditions at baseline and post-test. If the 50s cliff was caused by an age dependent deficit in visual motion perception, then older participants in the visual group should have exhibited less learning than those in the haptic group, which should not exhibit the 50s cliff, and older participants in both groups should have performed less well when tested with visual information. Neither of these expectations was confirmed by the results, so we concluded that the 50s cliff reflects a genuine decline in perceptuo-motor learning with aging, not the onset of a deficit in visual motion perception.	[Ren, Jie; Huang, Shaochen; Zhang, Jiancheng; Zhu, Qin; Bingham, Geoffrey P.] Shanghai Univ Sport, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China; [Zhu, Qin] Univ Wyoming, Kinesiol & Hlth, Laramie, WY 82071 USA; [Wilson, Andrew D.] Leeds Metropolitan Univ, Social Psychol & Commun Sci, Leeds LS1 3HE, W Yorkshire, England; [Snapp-Childs, Winona; Bingham, Geoffrey P.] Indiana Univ, Psychol & Brain Sci, Bloomington, IN USA	Shanghai University of Sport; University of Wyoming; Leeds Beckett University; Indiana University System; Indiana University Bloomington	Bingham, GP (corresponding author), Shanghai Univ Sport, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China.	gbingham@indiana.edu	; Zhu, Qin "Arthur"/C-8732-2009; Wilson, Andrew/A-7891-2008	Snapp-Childs, Winona/0000-0003-4354-7092; Zhu, Qin "Arthur"/0000-0002-2088-6043; Wilson, Andrew/0000-0002-0459-0728	First-class Disciplines of Shanghai Colleges and Universities (Psychology)	First-class Disciplines of Shanghai Colleges and Universities (Psychology)	This study was supported by the First-class Disciplines of Shanghai Colleges and Universities (Psychology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Andersen GJ, 2012, WIRES COGN SCI, V3, P403, DOI 10.1002/wcs.1167; Betts LR, 2005, NEURON, V45, P361, DOI 10.1016/j.neuron.2004.12.041; Bingham GP, 1999, PERCEPT PSYCHOPHYS, V61, P246, DOI 10.3758/BF03206886; Bingham GP, 2004, THEORIES TIME TO CON; Coats RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085758; Coats RO, 2013, EXP BRAIN RES, V225, P75, DOI 10.1007/s00221-012-3349-4; Ghisletta P, 2010, J GERONTOL B-PSYCHOL, V65, P163, DOI 10.1093/geronb/gbp126; KELSO JAS, 1981, B PSYCHONOMIC SOC, V18, P63; Kelso S., 1995, DYNAMIC PATTERNS SEL; Liang Z, 2010, NEUROBIOL AGING, V31, P863, DOI 10.1016/j.neurobiolaging.2008.06.013; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; Norman JF, 2004, PSYCHOL AGING, V19, P506, DOI 10.1037/0882-7974.19.3.506; Norman JF, 2003, PERCEPTION, V32, P85, DOI 10.1068/p3478; Norman JF, 2000, PERCEPTION, V29, P1335, DOI 10.1068/p3111; Panzer S, 2011, HUM MOVEMENT SCI, V30, P459, DOI 10.1016/j.humov.2010.11.003; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Serrien DJ, 2000, J GERONTOL B-PSYCHOL, V55, pP295, DOI 10.1093/geronb/55.5.P295; Snapp-Childs W, 2011, EXP BRAIN RES, V215, P89, DOI 10.1007/s00221-011-2874-x; Snowden RJ, 2006, PERCEPTION, V35, P9, DOI 10.1068/p5399; Stratford, 2001, PHYSIOTHER CAN, V53, P259; Swinnen SP, 1998, COGN NEUROPSYCHOL, V15, P439, DOI 10.1080/026432998381104; Temprado JJ, 2003, HUM MOVEMENT SCI, V22, P339, DOI 10.1016/S0167-9457(03)00049-6; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Wilson AD, 2005, EXP BRAIN RES, V164, P517, DOI 10.1007/s00221-005-2272-3; Wilson AD, 2003, J EXP PSYCHOL HUMAN, V29, P1179, DOI 10.1037/0096-1523.29.6.1179; Wilson AD, 2011, BEHAV RES METHODS, V43, P210, DOI 10.3758/s13428-010-0034-z; Wilson AD, 2010, J EXP PSYCHOL HUMAN, V36, P1508, DOI 10.1037/a0020412; Wilson AD, 2010, EXP BRAIN RES, V205, P513, DOI 10.1007/s00221-010-2388-y; WIMMERS RH, 1992, HUM MOVEMENT SCI, V11, P217, DOI 10.1016/0167-9457(92)90062-G; Wishart LR, 2002, ACTA PSYCHOL, V110, P247, DOI 10.1016/S0001-6918(02)00036-7; Zaal FTJM, 2000, J EXP PSYCHOL HUMAN, V26, P1209, DOI 10.1037//0096-1523.26.3.1209; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	35	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121708	10.1371/journal.pone.0121708	http://dx.doi.org/10.1371/journal.pone.0121708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874880	Green Published, gold			2022-12-26	WOS:000352845100046
J	Tao, GY; Hua, J; Chen, JL				Tao, Guoyu; Hua, Jennifer; Chen, Jessica L.			Understanding Sexual Activity and Chlamydia Testing Rate Based on Linked National Survey and Medicaid Claims Data	PLOS ONE			English	Article							CARE-EFFECTIVENESS-DATA; UNITED-STATES; COVERAGE; WOMEN; CHILDREN	Background Monitoring adherence to national recommendations for annual chlamydia screening of female adolescents and young adult women is important for targeting quality improvement interventions to improve low screening rates. However, accurate measurement of rates may vary depending on the data source used to determine eligible sexually-active women. Methods The 2001-2004 NHANES data linked with Medicaid administrative data by respondent's unique identifier, the 2011-2012 NHANES data, and the 2004 and 2010 Medicaid data were used in this cross-sectional analysis. We defined self-reported sexual activity by self-reported sexual behaviors, claim-identified sexual activity by reproductive-related claims among women who had >= one healthcare claim, HEDIS-defined sexual activity by reproductive-related claims among women who were enrolled in Medicaid for >= 330 days and had >= one healthcare claim, and chlamydia tests by claims submitted in the 12 months prior to the survey interview. Results Of Medicaid women aged 18-25 years, 91.5% self-reported to be sexually-active. Of self-reported sexually-active women aged 18-25 years, 92.0% had >= one healthcare claim in the 12 months prior to the survey interview; of this subpopulation, only 58.8% were enrolled in Medicaid for >= 330 days in the 12 months prior to the survey interview; of this further subpopulation, 74.1% had healthcare claims identifying them as sexually-active in the 12 months prior to the survey interview. Of HEDIS-defined sexually-active women, 42.4% had chlamydia testing. Conclusion Our study suggests that the number of sexually-active women aged 18-25 years used as the denominator in the chlamydia testing measure could be significantly different, depending upon the definition applied and the data used. Our data highlight the limited representativeness of Medicaid population in the current HEDIS measure on chlamydia testing when a high proportion of women who were enrolled in Medicaid for <330 days had been excluded from the measure. The interventions that can improve the proportion of women who were enrolled in Medicaid for >= 330 days among all young Medicaid women are needed not only for improving health care services, but also for measuring quality of healthcare.	[Tao, Guoyu; Hua, Jennifer; Chen, Jessica L.] Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Tao, GY (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	gat3@cdc.gov	Tao, Guoyu/AAV-9345-2021					[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P362; [Anonymous], 2011, NATL HLTH STAT REPOR; Berlan ED, 2014, PEDIATRICS; Broad JM, 2013, SEX TRANSM DIS, V40, P292, DOI 10.1097/OLQ.0b013e3182809776; Centers forDisease Control and Prevention (CDC), 2012, SEX TRANSM DIS SURV; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; Fairbrother G, 2011, ACAD PEDIATR, V11, P318, DOI 10.1016/j.acap.2011.05.004; Khosropour CM, 2014, SEX TRANSM DIS, V41, P665, DOI 10.1097/OLQ.0000000000000186; Ku L, 2013, HEALTH AFFAIR, V32, P1576, DOI 10.1377/hlthaff.2013.0362; Lefevre ML, 2014, ANN INTERN MED; Mangione-Smith R, 2000, ARCH PEDIAT ADOL MED, V154, P1108, DOI 10.1001/archpedi.154.11.1108; Medicine CoAaSfAHa, 2014, PEDIATRICS, V134, pe302; Mirel Lisa B, 2014, Natl Health Stat Report, P1; NCQA, 2013, HEDIS 2013 TECHNICAL; Physicians. AAoF, 2014, PHYSICIANS; Tao GY, 2007, SEX TRANSM DIS, V34, P180, DOI 10.1097/01.olq.0000230437.79119.31; Tao Guoyu, 2002, Jt Comm J Qual Improv, V28, P435; Tao GY, 2012, SEX TRANSM DIS, V39, P605, DOI 10.1097/OLQ.0b013e318254c837; Wei F, 2003, AM J MANAG CARE, V9, P585; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122927	10.1371/journal.pone.0122927	http://dx.doi.org/10.1371/journal.pone.0122927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875858	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100119
J	Reddycherla, AV; Meinert, I; Reinhold, A; Reinhold, D; Schraven, B; Simeonil, L				Reddycherla, Amarendra V.; Meinert, Ines; Reinhold, Annegret; Reinhold, Dirk; Schraven, Burkhart; Simeonil, Luca			miR-20a Inhibits TCR-Mediated Signaling and Cytokine Production in Human Naive CD4(+) T Cells	PLOS ONE			English	Article							MIR-17-92 CLUSTER; MIR-17-SIMILAR-TO-92 FAMILY; ACTIVATION KINETICS; REGULATES EFFECTOR; MAP KINASE; RESPONSES; MICRORNAS; DIFFERENTIATION; INTERLEUKIN-6; EXPRESSION	Upon TCR stimulation by peptide-MHC complexes, CD4(+) T cells undergo activation and proliferation. This process will ultimately culminate in T-cell differentiation and the acquisition of effector functions. The production of specific cytokines by differentiated CD4(+) T cells is crucial for the generation of the appropriate immune response. Altered CD4(+) T-cell activation and cytokine production result in chronic inflammatory conditions and autoimmune disorders. miRNAs have been shown to be important regulators of T-cell biology. In this study, we have focused our investigation on miR-20a, a member of the miR-17-92 cluster, whose expression is decreased in patients suffering from multiple sclerosis. We have found that miR-20a is rapidly induced upon TCR-triggering in primary human naive CD4(+) T cells and that its transcription is regulated in a Erk-, NF-kappa B-, and Ca++-dependent manner. We have further shown that overexpression of miR-20a inhibits TCR-mediated signaling but not the proliferation of primary human naive CD4(+) T cells. However, miR-20a overexpression strongly suppresses IL-10 secretion and moderately decreases IL-2, IL-6 and IL8 production, which are crucial regulators of inflammatory responses. Our study suggests that miR-20a is a new player in the regulation of TCR signaling strength and cytokine production.	[Reddycherla, Amarendra V.; Meinert, Ines; Reinhold, Annegret; Reinhold, Dirk; Schraven, Burkhart; Simeonil, Luca] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Schraven, Burkhart] Helmholtz Ctr Infect Res, Dept Immune Control, Braunschweig, Germany	Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research	Simeonil, L (corresponding author), Otto Von Guericke Univ, Inst Mol & Clin Immunol, Leipziger Str 44, Magdeburg, Germany.	Iuca.simeoni@med.ovgu.de	Simeoni, Luca/G-2121-2013		Deutsche Forschung Gemeinschaft (DFG) [GRK1167/TP12, SFB854/TP19]	Deutsche Forschung Gemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschung Gemeinschaft (DFG) to LS and BS (GRK1167/TP12), and to LS (SFB854/TP19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arndt B, 2013, J IMMUNOL METHODS, V387, P276, DOI 10.1016/j.jim.2012.11.006; Assier E, 2010, JOINT BONE SPINE, V77, P532, DOI 10.1016/j.jbspin.2010.07.007; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Buckler JL, 2008, IMMUNOL REV, V224, P239, DOI 10.1111/j.1600-065X.2008.00650.x; Cebrian M, 1998, J EXP MED, V28, P1621; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; Dodeller F, 2005, EUR J IMMUNOL, V35, P3631, DOI 10.1002/eji.200535029; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Graves Paul, 2012, Genomics Proteomics & Bioinformatics, V10, P239, DOI 10.1016/j.gpb.2012.06.004; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liston A, 2012, CELL MOL LIFE SCI, V69, P3533, DOI 10.1007/s00018-012-1124-0; Liu SQ, 2014, J BIOL CHEM, V289, P12446, DOI 10.1074/jbc.M114.550723; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Milner JD, 2010, J IMMUNOL, V184, P6569, DOI 10.4049/jimmunol.1000674; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; NUNES J, 1991, MOL IMMUNOL, V28, P427, DOI 10.1016/0161-5890(91)90156-E; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Poltorak M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-4; Psathas JN, 2013, BLOOD, V122, P4220, DOI 10.1182/blood-2012-12-473090; Rincon M, 2012, TRENDS IMMUNOL, V33, P571, DOI 10.1016/j.it.2012.07.003; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Skinner JPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088997; Sloan DD, 2007, J VIROL, V81, P12504, DOI 10.1128/JVI.01111-07; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tanaka T, 2014, SEMIN IMMUNOL, V26, P88, DOI 10.1016/j.smim.2014.01.009; Taub DD, 1996, J CLIN INVEST, V97, P1931, DOI 10.1172/JCI118625; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; van Haaften G, 2010, GENE DEV, V24, P1, DOI 10.1101/gad.1887110; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wu TQ, 2012, P NATL ACAD SCI USA, V109, P9965, DOI 10.1073/pnas.1207327109; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xue F, 2013, GENES IMMUN, V14, P1, DOI [10.1038/gene.2012.54, DOI 10.1038/GENE.2012.54]; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhang MM, 2011, J IMMUNOL, V186, P4716, DOI 10.4049/jimmunol.1002989; Zhu DH, 2013, J ALLERGY CLIN IMMUN, V132, P426, DOI 10.1016/j.jaci.2013.02.005	55	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125311	10.1371/journal.pone.0125311	http://dx.doi.org/10.1371/journal.pone.0125311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884400	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000157
J	Shen, M; Zhao, DK; Qiao, Q; Liu, L; Wang, JL; Cao, GH; Li, T; Zhao, ZW				Shen, Mi; Zhao, Da-Ke; Qiao, Qin; Liu, Lei; Wang, Jun-Ling; Cao, Guan-Hua; Li, Tao; Zhao, Zhi-Wei			Identification of Glutathione S-Transferase (GST) Genes from a Dark Septate Endophytic Fungus (Exophiala pisciphila) and Their Expression Patterns under Varied Metals Stress	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HEAVY-METAL; PHANEROCHAETE-CHRYSOSPORIUM; SUPERGENE FAMILY; IN-VITRO; TOLERANCE; EVOLUTION; DSE; SUPERFAMILY; TOXICITY	Glutathione S-transferases (GSTs) compose a family of multifunctional enzymes that play important roles in the detoxification of xenobiotics and the oxidative stress response. In the present study, twenty four GST genes from the transcriptome of ametal-tolerant dark septate endophyte (DSE), Exophiala pisciphila, were identified based on sequence homology, and their responses to various heavy metal exposures were also analyzed. Phylogenetic analysis showed that the 24 GST genes from E. pisciphila (EpGSTs) were divided into eight distinct classes, including seven cytosolic classes and one mitochondrial metaxin 1-like class. Moreover, the variable expression patterns of these EpGSTs were observed under different heavy metal stresses at their effective concentrations for inhibiting growth by 50%(EC50). Lead (Pb) exposure caused the up-regulation of all EpGSTs, while cadmium (Cd), copper (Cu) and zinc (Zn) treatments led to the significant up-regulation of most of the EpGSTs (p < 0.05 to p < 0.001). Furthermore, although heavy metal-specific differences in performance were observed under various heavy metals in Escherichia coli BL21 (DE3) transformed with EpGSTN-31, the overexpression of this gene was able to enhance the heavy metal tolerance of the host cells. These results indicate that E. Pisciphilaharbored a diverse of GST genes and the up-regulated EpGSTs are closely related to the heavy metal tolerance of E. pisciphila. The study represents the first investigation of the GST family in E. pisciphila and provides a primary interpretation of heavymetal detoxification for E. pisciphila.	[Shen, Mi; Zhao, Da-Ke; Wang, Jun-Ling; Cao, Guan-Hua; Li, Tao; Zhao, Zhi-Wei] Yunnan Univ, Key Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; [Shen, Mi; Zhao, Da-Ke; Wang, Jun-Ling; Cao, Guan-Hua; Li, Tao; Zhao, Zhi-Wei] Yunnan Univ, Key Lab Microbial Divers Southwest China, Minist Educ, Kunming, Yunnan, Peoples R China; [Zhao, Da-Ke; Qiao, Qin; Zhao, Zhi-Wei] Yunnan Univ, Sch Agr, Kunming, Yunnan, Peoples R China; [Liu, Lei] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University; Yunnan University; Yunnan University	Zhao, ZW (corresponding author), Yunnan Univ, Key Lab Conservat & Utilizat Bioresources, Cuihu North Rd 2, Kunming, Yunnan, Peoples R China.	zhaozhw@ynu.edu.cn		Jun-Ling, Wang/0000-0002-1067-3300	National Natural Science Foundation of China [31160009, 31460114, 41161083, 41461073]; Key Project of Applied Basic Research of Yunnan [2013FA001]; Postdoctoral Sustentation Fund through Yunnan University; Young Academic and Technical Leader Raising Foundation of Yunnan Province [2012HB006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Applied Basic Research of Yunnan; Postdoctoral Sustentation Fund through Yunnan University; Young Academic and Technical Leader Raising Foundation of Yunnan Province	This work was supported by the National Natural Science Foundation of China (31160009, ZWZ; 31460114, ZWZ; 41161083, TL; 41461073, TL, http://npd.nsfc.gov.cn/fundingProjectSearchAction.action!search.action). The funders had the role in study design, data collection and analysis, and decision to publish. This work was also supported by the Key Project of Applied Basic Research of Yunnan (2013FA001, ZWZ) the Postdoctoral Sustentation Fund supported through Yunnan University and the Young Academic and Technical Leader Raising Foundation of Yunnan Province (2012HB006, D KZ), who had the role in preparation of the manuscript.	Armstrong LC, 1997, J BIOL CHEM, V272, P6510, DOI 10.1074/jbc.272.10.6510; Basantani M, 2007, CAN J BOT, V85, P443, DOI 10.1139/B07-033; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.e03-01-0007; Dixit P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016360; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Foley V, 1998, BIOCHEM J, V333, P839, DOI 10.1042/bj3330839; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Garcera A, 2010, FEMS YEAST RES, V10, P422, DOI 10.1111/j.1567-1364.2010.00613.x; Gonzalez-Guerrero Manuel, 2009, P107, DOI 10.1007/978-3-540-87978-7_8; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; Kumar S, 2013, PLANT MOL BIOL REP, V31, P569, DOI 10.1007/s11105-012-0524-5; Kumar S, 2013, J HAZARD MATER, V248, P228, DOI 10.1016/j.jhazmat.2013.01.004; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Lee KW, 2008, AQUAT TOXICOL, V89, P158, DOI 10.1016/j.aquatox.2008.06.011; Li T, 2011, SCI TOTAL ENVIRON, V409, P1069, DOI 10.1016/j.scitotenv.2010.12.012; Liu D, 2013, MOL BIOL+, V47, P515, DOI 10.1134/S0026893313040109; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Mannervik B, 2012, J BIOL CHEM, V287, P6072, DOI 10.1074/jbc.X112.342675; Mariani D, 2008, REDOX REP, V13, P246, DOI 10.1179/135100008X309028; Mathieu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080298; McGoldrick S, 2005, FEMS MICROBIOL LETT, V242, P1, DOI 10.1016/j.femsle.2004.10.033; Morel M, 2013, MICROB BIOTECHNOL, V6, P248, DOI 10.1111/1751-7915.12015; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Nair PMG, 2011, AQUAT TOXICOL, V101, P550, DOI 10.1016/j.aquatox.2010.12.006; Ovecka M, 2014, BIOTECHNOL ADV, V32, P73, DOI 10.1016/j.biotechadv.2013.11.011; Rai R, 2003, J BIOL CHEM, V278, P12826, DOI 10.1074/jbc.M212186200; Regvar M, 2010, PLANT SOIL, V330, P345, DOI 10.1007/s11104-009-0207-7; Rojas-Loria CC, 2014, ACTA PHYSIOL PLANT, V36, P2501, DOI 10.1007/s11738-014-1623-8; Sato I, 2009, J BIOL CHEM, V284, P8042, DOI 10.1074/jbc.M807771200; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Thuillier A, 2013, FEBS LETT, V587, P2125, DOI 10.1016/j.febslet.2013.05.031; Thuillier Anne, 2011, Int J Evol Biol, V2011, P938308, DOI 10.4061/2011/938308; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Yu XL, 2012, COMP BIOCHEM PHYS B, V161, P356, DOI 10.1016/j.cbpb.2011.12.009; Zhang LB, 2012, COMP BIOCHEM PHYS C, V155, P517, DOI 10.1016/j.cbpc.2012.01.002; Zhang WW, 2013, J HAZARD MATER, V261, P646, DOI 10.1016/j.jhazmat.2013.08.023; Zhang Y, 2013, SOIL SEDIMENT CONTAM, V22, P532, DOI 10.1080/15320383.2013.750267; Zhang YJ, 2008, J MICROBIOL, V46, P624, DOI 10.1007/s12275-008-0163-6; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhao D, 2015, MICROBIOL RES, V170, P27, DOI 10.1016/j.micres.2014.09.005; Zhou WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056604	48	38	41	5	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123418	10.1371/journal.pone.0123418	http://dx.doi.org/10.1371/journal.pone.0123418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884726	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000060
J	Li, LR; Wang, DJ; Zhou, J; Cheng, Y; Liang, T; Zhang, GM				Li, Liru; Wang, Dejun; Zhou, Jun; Cheng, Yan; Liang, Tian; Zhang, Guangmei			Characteristics of Human Amniotic Fluid Mesenchymal Stem Cells and Their Tropism to Human Ovarian Cancer	PLOS ONE			English	Article							DELIVERY VEHICLES; GENE-THERAPY; BRAIN; BLADDER	The mesenchymal stem cells (MSCs) derived from amniotic fluid (AF) have become an attractive stem cells source for cell-based therapy because they can be harvested at low cost and avoid ethical disputes. In human research, stem cells derived from AF gradually became a hot research direction for disease treatment, specifically for their plasticity, their reduced immunogenicity and their tumor tropism regardless of the tumor size, location and source. Our work aimed to obtain and characterize human amniotic fluid mesenchymal stem cells (AFMSCs) and detect their ovarian cancer tropsim in nude mice model. Ten milliliters of twenty independent amniotic fluid samples were collected from 16-20 week pregnant women who underwent amniocentesis for fetal genetic determination in routine prenatal diagnosis in the first affiliated hospital of Harbin medical university. We successfully isolated the AFMSCs from thirteen of twenty amniotic fluid samples. AFMSCs presented a fibroblastic-like morphology during the culture. Flow cytometry analyses showed that the cells were positive for specific stem cell markers CD73, CD90, CD105, CD166 and HLA-ABC (MHC class I), but negative for CD 45, CD40, CD34, CD14 and HLA-DR (MHC class II). RT-PCR results showed that the AFMSCs expressed stem cell marker OCT4. AFMSCs could differentiate into bone cells, fat cells and chondrocytes under certain conditions. AFMSCs had the high motility to migrate to ovarian cancer site but didn't have the tumorigenicity. This study enhances the possibility of AFMSCs as drug carrier in human cell-based therapy. Meanwhile, the research emphasis in the future can also put in targeting therapy of ovarian cancer.	[Li, Liru; Wang, Dejun; Zhou, Jun; Cheng, Yan; Liang, Tian; Zhang, Guangmei] Harbin Med Univ, Dept Genecol & Obstet, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Li, LR (corresponding author), Harbin Med Univ, Dept Genecol & Obstet, Harbin, Heilongjiang, Peoples R China.	guangmeizhang@126.com			National Natural Science Foundation [81242092]; Heilongjiang innovation experiment program [201310226045]; State Key Basic Research and Development Project of China [2012CB526700]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Heilongjiang innovation experiment program; State Key Basic Research and Development Project of China(State Key Development Program for Basic Research of China)	This work was supported by the National Natural Science Foundation (NO. 81242092) URL: http://www.nsfc.gov.cn/, Heilongjiang innovation experiment program (NO.201310226045) URL:http://125.223.1.200/hljgj/, and State Key Basic Research and Development Project of China (2012CB526700) URL: http://www.most.gov.cn/.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021; Bexell D, 2010, MOL THER, V18, P1067, DOI 10.1038/mt.2010.58; Bitsika V, 2012, STEM CELLS DEV, V21, P1097, DOI 10.1089/scd.2011.0151; Cananz iM, 2009, ETHICS BIOSCI LIFE, V4, P17; Chen X, 2008, MOL THER, V16, P749, DOI 10.1038/mt.2008.3; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; De Coppi P, 2007, J UROLOGY, V177, P369, DOI 10.1016/j.juro.2006.09.103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Lee DH, 2009, CLIN CANCER RES, V15, P4925, DOI 10.1158/1078-0432.CCR-08-3076; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Pappa KI, 2009, REGEN MED, V4, P423, DOI 10.2217/RME.09.12; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rachakatla RS, 2007, CANCER GENE THER, V14, P828, DOI 10.1038/sj.cgt.7701077; Rennie K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/721538; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Roubelakis MG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/107836; Serakinci N, 2011, CANCER BIOTHER RADIO, V26, P767, DOI 10.1089/cbr.2011.1024; Sessarego N, 2008, HAEMATOLOGICA, V93, P339, DOI 10.3324/haematol.11869; Siegel N, 2007, STEM CELL REV, V3, P256, DOI 10.1007/s12015-007-9003-z; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279	25	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123350	10.1371/journal.pone.0123350	http://dx.doi.org/10.1371/journal.pone.0123350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880317	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500048
J	Wei, T; Zhang, P; Wang, K; Ding, RX; Yang, BP; Nie, JF; Jia, ZK; Han, QF				Wei, Ting; Zhang, Peng; Wang, Ke; Ding, Ruixia; Yang, Baoping; Nie, Junfeng; Jia, Zhikuan; Han, Qingfang			Effects of Wheat Straw Incorporation on the Availability of Soil Nutrients and Enzyme Activities in Semiarid Areas	PLOS ONE			English	Article							CROP RESIDUE MANAGEMENT; ORGANIC-MATTER; CARBON SEQUESTRATION; NITROGEN MANAGEMENT; AGGREGATE STABILITY; TILLAGE PRACTICES; RED SOIL; RICE; CHINA; FERTILITY	Soil infertility is the main barrier to dryland agricultural production in China. To provide a basis for the establishment of a soil amelioration technical system for rainfed fields in the semiarid area of northwest China, we conducted a four-year (2007-2011) field experiment to determine the effects of wheat straw incorporation on the arid soil nutrient levels of crop-land cultivated with winter wheat after different straw incorporation levels. Three wheat straw incorporation levels were tested (H: 9000 kg hm(-2), M: 6000 kg hm(-2), and L: 3000 kg hm(-2)) and no straw incorporation was used as the control (CK). The levels of soil nutrients, soil organic carbon (SOC), soil labile organic carbon (LOC), and enzyme activities were analyzed each year after the wheat harvest. After straw incorporation for four years, the results showed that variable straw amounts had different effects on the soil fertility indices, where treatment H had the greatest effect. Compared with CK, the average soil available N, available P, available K, SOC, and LOC levels were higher in the 0-40 cm soil layers after straw incorporation treatments, i.e., 9.1-30.5%, 9.8-69.5%, 10.3-27.3%, 0.7-23.4%, and 44.4-49.4% higher, respectively. On average, the urease, phosphatase, and invertase levels in the 0-40 cm soil layers were 24.4-31.3%, 9.9-36.4%, and 42.9-65.3% higher, respectively. Higher yields coupled with higher nutrient contents were achieved with H, M and L compared with CK, where these treatments increased the crop yields by 26.75%, 21.51%, and 7.15%, respectively.	[Wei, Ting; Zhang, Peng; Wang, Ke; Ding, Ruixia; Nie, Junfeng; Jia, Zhikuan; Han, Qingfang] Northwest A&F Univ, Chinese Inst Water Saving Agr, Yangling 712100, Shaanxi, Peoples R China; [Wei, Ting; Zhang, Peng; Wang, Ke; Ding, Ruixia; Yang, Baoping; Nie, Junfeng; Jia, Zhikuan; Han, Qingfang] Northwest A&F Univ, Minist Agr, Key Lab Crop Physiecol & Tillage Sci Northwest Lo, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Jia, ZK (corresponding author), Northwest A&F Univ, Chinese Inst Water Saving Agr, Yangling 712100, Shaanxi, Peoples R China.	jiazhk@126.com; hanqf88@nwsuaf.edu.cn			China Support Program for Dryland Farming in the 11th 5-year plan period [2006BAD29B03]; National High Technology Research and Development Program of China [2013AA102902-5]; China Support Program for Dryland Farming in the 12th 5-year plan period [2012BAD09B03, 2011AA100504, 2011BAD29B09]; Program of Introducing Talents of Discipline to Universities [B12007]; Youth Project of National Natural Science Fund [31201156]; Basic Science Research Fund in Northwest AF University [QN2013005]	China Support Program for Dryland Farming in the 11th 5-year plan period; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); China Support Program for Dryland Farming in the 12th 5-year plan period; Program of Introducing Talents of Discipline to Universities; Youth Project of National Natural Science Fund; Basic Science Research Fund in Northwest AF University	This study was sponsored by the China Support Program (2006BAD29B03) for Dryland Farming in the 11th 5-year plan period, by the National High Technology Research and Development Program of China (Project No. 2013AA102902-5), by the China Support Program (2012BAD09B03, 2011AA100504, and 2011BAD29B09) for Dryland Farming in the 12th 5-year plan period, by the Program of Introducing Talents of Discipline to Universities (No. B12007), by the Youth Project of National Natural Science Fund (31201156), and by the Basic Science Research Fund in Northwest A&F University (QN2013005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulakh MS, 2001, SOIL SCI SOC AM J, V65, P820, DOI 10.2136/sssaj2001.653820x; Bakht J, 2009, SOIL TILL RES, V104, P233, DOI 10.1016/j.still.2009.02.006; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; BHATNAGAR VK, 1983, SOIL TILL RES, V3, P27, DOI 10.1016/0167-1987(83)90014-4; Chen CR, 2005, FOREST ECOL MANAG, V206, P237, DOI 10.1016/j.foreco.2004.11.005; DICK RP, 1996, SSSA SPECIAL PUBLICA, V49, P247, DOI DOI 10.2136/SS-SASPECPUB49.C15.IN:D0RAN; Dick RP, 1988, SOIL BIOL BIOCHEM, V6, pl59, DOI DOI 10.1007/BF00257667; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Dong WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044504; DORICH RA, 1984, SOIL SCI SOC AM J, V48, P72, DOI 10.2136/sssaj1984.03615995004800010013x; Frankenberger Jr Johanson J, 1983, PLANT SOIL, V74, P301; Fuentes M, 2009, EUR J AGRON, V30, P228, DOI 10.1016/j.eja.2008.10.005; Gangwar KS, 2006, SOIL TILL RES, V88, P242, DOI 10.1016/j.still.2005.06.015; Garg S, 2008, BIORESOURCE TECHNOL, V99, P5773, DOI 10.1016/j.biortech.2007.10.063; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; Haynes RJ, 1997, SOIL BIOL BIOCHEM, V29, P1647, DOI 10.1016/S0038-0717(97)00078-3; Hu KeLin, 1999, Transactions of the Chinese Society of Agricultural Engineering, V15, P33; Jin K, 2009, SOIL TILL RES, V104, P115, DOI 10.1016/j.still.2009.02.004; Jin XC, 2005, SCI CHINA SER C, V48, P948, DOI 10.1360/062005-286; Karami A, 2012, AGR ECOSYST ENVIRON, V148, P22, DOI 10.1016/j.agee.2011.10.021; Knudsen D, 1982, MONOGR, V2, P225, DOI DOI 10.2134/AGR0NM0N0GR9.2.2ED.C13; Lao XiuRong, 2002, Transactions of the Chinese Society of Agricultural Engineering, V18, P49; Lee J, 2010, SCI HORTIC-AMSTERDAM, V124, P299, DOI 10.1016/j.scienta.2010.01.004; LI LM, 2006, SOILS, V38, P422; Li ZP, 2010, SOIL TILL RES, V106, P268, DOI 10.1016/j.still.2009.12.008; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Loginow W, 1987, POL J SOIL SCI, P20; Lou YL, 2011, SOIL TILL RES, V113, P70, DOI 10.1016/j.still.2011.01.007; Mandal KG, 2004, J FOOD AGRIC ENVIRON, V2, P224; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; MARTENS DA, 1992, SOIL SCI, V153, P53, DOI 10.1097/00010694-199201000-00008; MAURYA PR, 1981, FIELD CROP RES, V4, P33, DOI 10.1016/0378-4290(81)90052-6; Mulumba LN, 2008, SOIL TILL RES, V98, P106, DOI 10.1016/j.still.2007.10.011; Mupangwa W, 2008, PHYS CHEM EARTH, V33, P762, DOI 10.1016/j.pce.2008.06.049; Olsen S.R., 1982, PHOSPHORUS METHODS S; Pinheiro EFM, 2004, SOIL TILL RES, V77, P79, DOI 10.1016/j.still.2003.11.005; Plaza C, 2004, SOIL BIOL BIOCHEM, V36, P1577, DOI 10.1016/j.soilbio.2004.07.017; Power JF, 1998, SOIL SCI SOC AM J, V62, P1393, DOI 10.2136/sssaj1998.03615995006200050035x; Roldan A, 2005, APPL SOIL ECOL, V30, P11, DOI 10.1016/j.apsoil.2005.01.004; Roldan A, 2003, SOIL TILL RES, V72, P65, DOI 10.1016/S0167-1987(03)00051-5; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Saroa GS, 2003, LAND DEGRAD DEV, V14, P481, DOI 10.1002/ldr.569; Shah Z, 2003, FIELD CROP RES, V83, P1, DOI 10.1016/S0378-4290(03)00005-4; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Smith J. L., 1992, Soil microbial ecology: applications in agricultural and environmental management., P65; Surekha K, 2003, NUTR CYCL AGROECOSYS, V67, P145, DOI 10.1023/A:1025543810663; Tabatabai M.A., 1994, METHODS SOIL ANAL 2, V5, P775; Tan DeShui, 2007, Scientia Agricultura Sinica, V40, P133, DOI 10.1016/S1671-2927(07)60035-2; Tong XG, 2014, CATENA, V113, P251, DOI 10.1016/j.catena.2013.08.005; Tripathy R, 2004, J PLANT NUTR SOIL SC, V167, P216, DOI 10.1002/jpln.200321175; Uhlen G, 1996, NORW J AGR SCI, P9; UTOMO M, 1990, AGRON J, V82, P979, DOI 10.2134/agronj1990.00021962008200050028x; Wagner S, 2007, J PLANT NUTR SOIL SC, V170, P173, DOI 10.1002/jpln.200521732; [王灿 Wang Can], 2008, [生态环境, Ecology and Environment], V17, P688; Wang SQ, 2003, TELLUS B, V55, P416, DOI 10.1034/j.1600-0889.2003.00039.x; Yang YS, 2009, PLANT SOIL, V323, P153, DOI 10.1007/s11104-009-9921-4; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092839; Zhang WJ, 2009, NUTR CYCL AGROECOSYS, V84, P59, DOI 10.1007/s10705-008-9226-7; Zhao YC, 2009, EUR J AGRON, V31, P36, DOI 10.1016/j.eja.2009.03.001; Zhou J., 2002, CHINESE AGR SCI B, V4; Zhu HH, 2010, PLANT SOIL, V331, P427, DOI 10.1007/s11104-009-0263-z	61	97	107	8	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120994	10.1371/journal.pone.0120994	http://dx.doi.org/10.1371/journal.pone.0120994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880452	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500009
J	Nikolopoulos, GK; Fotiou, A; Kanavou, E; Richardson, C; Detsis, M; Pharris, A; Suk, JE; Semenza, JC; Costa-Storti, C; Paraskevis, D; Sypsa, V; Malliori, MM; Friedman, SR; Hatzakis, A				Nikolopoulos, Georgios K.; Fotiou, Anastasios; Kanavou, Eleftheria; Richardson, Clive; Detsis, Marios; Pharris, Anastasia; Suk, Jonathan E.; Semenza, Jan C.; Costa-Storti, Claudia; Paraskevis, Dimitrios; Sypsa, Vana; Malliori, Melpomeni-Minerva; Friedman, Samuel R.; Hatzakis, Angelos			National Income Inequality and Declining GDP Growth Rates Are Associated with Increases in HIV Diagnoses among People Who Inject Drugs in Europe: A Panel Data Analysis	PLOS ONE			English	Article							POPULATION HEALTH; POVERTY	Background There is sparse evidence that demonstrates the association between macro-environmental processes and drug-related HIV epidemics. The present study explores the relationship between economic, socio-economic, policy and structural indicators, and increases in reported HIV infections among people who inject drugs (PWID) in the European Economic Area (EEA). Methods We used panel data (2003-2012) for 30 EEA countries. Statistical analyses included logistic regression models. The dependent variable was taking value 1 if there was an outbreak (significant increase in the national rate of HIV diagnoses in PWID) and 0 otherwise. Explanatory variables included the growth rate of Gross Domestic Product (GDP), the share of the population that is at risk for poverty, the unemployment rate, the Eurostat S80/S20 ratio, the Gini coefficient, the per capita government expenditure on health and social protection, and variables on drug control policy and drug-using population sizes. Lags of one to three years were investigated. Findings In multivariable analyses, using two-year lagged values, we found that a 1% increase of GDP was associated with approximately 30% reduction in the odds of an HIV outbreak. In GDP-adjusted analyses with three-year lagged values, the effect of the national income inequality on the likelihood of an HIV outbreak was significant [ S80/S20 Odds Ratio (OR) = 3.89; 95% Confidence Interval (CI): 1.15 to 13.13]. Generally, the multivariable analyses produced similar results across three time lags tested. Interpretation Given the limitations of ecological research, we found that declining economic growth and increasing national income inequality were associated with an elevated probability of a large increase in the number of HIV diagnoses among PWID in EEA countries during the last decade. HIV prevention may be more effective if developed within national and European-level policy contexts that promote income equality, especially among vulnerable groups.	[Nikolopoulos, Georgios K.; Detsis, Marios; Paraskevis, Dimitrios; Sypsa, Vana; Hatzakis, Angelos] Athens Univ Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Nikolopoulos, Georgios K.] Hellen Ctr Dis Control & Prevent, Amarousio, Greece; [Fotiou, Anastasios; Kanavou, Eleftheria; Richardson, Clive] Univ Mental Hlth Res Inst, Greek Reitox Focal Point EMCDDA, Athens, Greece; [Fotiou, Anastasios; Malliori, Melpomeni-Minerva] Athens Univ Med Sch, Dept Psychiat, Athens, Greece; [Richardson, Clive] Pante Univ Social & Polit Sci, Athens, Greece; [Pharris, Anastasia; Suk, Jonathan E.; Semenza, Jan C.] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden; [Costa-Storti, Claudia] EMCDDA, Lisbon, Portugal; [Friedman, Samuel R.] Natl Dev & Res Inst, New York, NY USA	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; Panteion University; European Centre for Disease Prevention & Control; National Development & Research Institutes, Inc	Nikolopoulos, GK (corresponding author), Athens Univ Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece.	gknikolopoulos@gmail.com	Suk, Jonathan/L-2300-2017; Nikolopoulos, Georgios/H-5698-2011; Paraskevis, Dimitrios/H-5835-2019; Fotiou, Anastasios/X-2091-2019	Suk, Jonathan/0000-0003-4689-4583; Nikolopoulos, Georgios/0000-0002-3307-0246; Paraskevis, Dimitrios/0000-0001-6167-7152; Fotiou, Anastasios/0000-0001-7905-3241; Detsis, Marios/0000-0003-1907-845X; Friedman, Sam/0000-0003-2083-1226; SYPSA, VANA/0000-0002-9430-7614	European Centre for Disease Prevention and Control (ECDC) [ECD.4167]; Hellenic Scientific Society [ECD.4167]; International AIDS Society; US National Institute on Drug Abuse; National Institute on Drug Abuse (NIDA) (Center for Drug Use and HIV Research) [P30 DA11041]; National Institute on Drug Abuse (NIDA) (Preventing HIV Transmission by Recently-Infected Drug Users) [DP1 DA034989];  [T32 DA007233]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041, T32DA007233, DP1DA034989] Funding Source: NIH RePORTER	European Centre for Disease Prevention and Control (ECDC); Hellenic Scientific Society; International AIDS Society; US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Drug Abuse (NIDA) (Center for Drug Use and HIV Research); National Institute on Drug Abuse (NIDA) (Preventing HIV Transmission by Recently-Infected Drug Users); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was undertaken under service contract ECD.4167 with funding provided by the European Centre for Disease Prevention and Control (ECDC). AF, EK and CR report personal fees from the Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases related to the ECDC grant ECD.4167. GKN and SF also declare that: (1) the International AIDS Society and the US National Institute on Drug Abuse have supported the post-doc fellowship of GKN; (2) SF and GKN are involved in the Transmission Reduction Intervention Project (TRIP) and they acknowledge support from National Institute on Drug Abuse (NIDA) (grants P30 DA11041-Center for Drug Use and HIV Research, DP1 DA034989-Preventing HIV Transmission by Recently-Infected Drug Users, and T32 DA007233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs B, 2010, SOC SCI MED, V71, P266, DOI 10.1016/j.socscimed.2010.04.002; Bonovas S, 2012, J Prev Med Hyg, V53, P169; Botescu A, 2012, HIV AIDS INJECTING D; Costanza R, 2014, NATURE, V505, P283, DOI 10.1038/505283a; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; European Centre for Disease Prevention and Control, 2011, PEOPL WHO INJ DRUGS; European Centre for Disease Prevention and Control/World Health Organization Regional Office for Europe, 2013, HIV AIDS SURV EUR 20; European Monitoring Centre for Drugs and Drug Addiction, 2013, EUR DRUG REP 2013 TR; Fotiou A., 2012, HIV OUTBREAK INJECTI; Friedman SR, 2014, ANN EPIDEMIOL, V24, P304, DOI 10.1016/j.annepidem.2014.01.008; Friedman SR, 2009, INT J DRUG POLICY, V20, P283, DOI 10.1016/j.drugpo.2008.10.006; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Friedman SR, 2001, 2000 GLOB RES NETW M, P147; Holmqvist G., 2009, WORKING PAPER; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Lin CC, 2003, ETHNIC DIS, V13, P240; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; MacArthur GJ, 2014, INT J DRUG POLICY, V25, P34, DOI 10.1016/j.drugpo.2013.07.001; Paraskevis D, 2011, EUROSURVEILLANCE, V16, P2; Paraskevis D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078941; Pharris A, 2011, EURO SURVEILL, V16; Pickett KE, 2010, BRIT J PSYCHIAT, V197, P426, DOI 10.1192/bjp.bp.109.072066; Platt L., 2013, HIV EPIDEMICS EUROPE; Rabe-Hesketh S, 2012, MULTILEVEL LONGITUDI, VII; Ram R, 2005, SOC SCI MED, V61, P2568, DOI 10.1016/j.socscimed.2005.04.038; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Suhrcke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020724; Suk JE, 2009, EMERG INFECT DIS, V15, P1812, DOI 10.3201/eid1511.090916; Sypsa V, 2015, AM J PUBLIC HEALTH, V105, P196, DOI 10.2105/AJPH.2013.301656; Tsafack-Temah C, 2008, THESIS U AUVERGNE CL; Wiessing L, 2011, EURO SURVEILL, V16	33	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122367	10.1371/journal.pone.0122367	http://dx.doi.org/10.1371/journal.pone.0122367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875598	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800054
J	Pan, H; Chen, J; Shen, KZ; Wang, XP; Wang, P; Fu, GH; Meng, HZ; Wang, YM; Jin, BY				Pan, Hao; Chen, Jun; Shen, Kezhen; Wang, Xueping; Wang, Ping; Fu, Guanghou; Meng, Hongzhou; Wang, Yimin; Jin, Baiye			Mitochondrial Modulation by Epigallocatechin 3-Gallate Ameliorates Cisplatin Induced Renal Injury through Decreasing Oxidative/Nitrative Stress, Inflammation and NF-kB in Mice	PLOS ONE			English	Article							GREEN TEA CATECHINS; RAT-KIDNEY MITOCHONDRIA; REDOX STATE UNBALANCE; INDUCED NEPHROTOXICITY; OXIDATIVE STRESS; CANCER CHEMOPREVENTION; SUPEROXIDE-PRODUCTION; ENERGETIC METABOLISM; CELL-PROLIFERATION; PROSTATE-CANCER	Cancer chemotherapy drug cisplatin is known for its nephrotoxicity. The aim of this study is to investigate whether Epigallocatechin 3-Gallate (EGCG) can reduce cisplatin mediated side effect in kidney and to understand its mechanism of protection against tissue injury. We used a well-established 3-day cisplatin induced nephrotoxicity mice model where EGCG were administered. EGCG is a major active compound in Green Tea and have strong anti-oxidant and anti-inflammatory properties. EGCG protected against cisplatin induced renal dysfunction as measured by serum creatinine and blood urea nitrogen (BUN). EGCG improved cisplatin induced kidney structural damages such as tubular dilatation, cast formation, granulovaculoar degeneration and tubular cell necrosis as evident by PAS staining. Cisplatin induced kidney specific mitochondrial oxidative stress, impaired activities of mitochondrial electron transport chain enzyme complexes, impaired anti-oxidant defense enzyme activities such as glutathione peroxidase (GPX) and manganese superoxide dismutase (MnSOD) in mitochondria, inflammation (tumor necrosis factor a and interleukin 1 beta), increased accumulation of NF-kappa B in nuclear fraction, p53 induction, and apoptotic cell death (caspase 3 activity and DNA fragmentation). Treatment of mice with EGCG markedly attenuated cisplatin induced mitochondrial oxidative/nitrative stress, mitochondrial damages to electron transport chain activities and antioxidant defense enzyme activities in mitochondria. These mitochondrial modulations by EGCG led to protection mechanism against cisplatin induced inflammation and apoptotic cell death in mice kidney. As a result, EGCG improved renal function in cisplatin mediated kidney damage. In addition to that, EGCG attenuated cisplatin induced apoptotic cell death and mitochondrial reactive oxygen species (ROS) generation in human kidney tubular cell line HK-2. Thus, our data suggest that EGCG may represent new promising adjunct candidate for cisplatin.	[Pan, Hao; Chen, Jun; Wang, Xueping; Wang, Ping; Fu, Guanghou; Meng, Hongzhou; Wang, Yimin; Jin, Baiye] Zhejiang Univ, Coll Med, Dept Urol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Jun] First Peoples Hosp Wenling City, Dept Urol, Wenling, Zhejiang, Peoples R China; [Shen, Kezhen] Zhejiang Univ, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth, Affiliated Hosp 1,Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Jin, BY (corresponding author), Zhejiang Univ, Coll Med, Dept Urol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	jinbaiye1964@aliyun.com		Pan, Hao/0000-0001-9925-0752	National Natural Science Foundation of China [81000302]; Science and Technology Department of Zhejiang Province [2013C37053, 2014C33200]; Natural Science Foundation of Zhejiang Province [LY14H050001]; Zhejiang medical and health science and technology plan project [201461868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang medical and health science and technology plan project	This work was supported by grants from National Natural Science Foundation of China (no. 81000302), Science and Technology Department of Zhejiang Province (no. 2013C37053, 2014C33200), Natural Science Foundation of Zhejiang Province (no. LY14H050001), Zhejiang medical and health science and technology plan project (201461868). The funding agency has no role in study design or conclusion.	Ahn WS, 2003, DNA CELL BIOL, V22, P217, DOI 10.1089/104454903321655846; Al-Majed AA, 2003, J BIOCHEM MOL TOXIC, V17, P146, DOI 10.1002/jbt.10072; Albrecht DS, 2008, CHEM-BIOL INTERACT, V171, P89, DOI 10.1016/j.cbi.2007.09.001; Ali BH, 2006, FOOD CHEM TOXICOL, V44, P1173, DOI 10.1016/j.fct.2006.01.013; Braicu C, 2013, J NANOSCI NANOTECHNO, V13, P632, DOI 10.1166/jnn.2013.6882; Cavet ME, 2011, MOL VIS, V17, P533; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Chen D, 2011, ADV CLIN CHEM, V53, P155, DOI 10.1016/S0065-2423(11)53007-0; Connors SK, 2012, NUTR CANCER, V64, P4, DOI 10.1080/01635581.2012.630158; DAUGAARD G, 1987, INT J ANDROL, V10, P347, DOI 10.1111/j.1365-2605.1987.tb00201.x; DAUGAARD G, 1989, CANCER CHEMOTH PHARM, V25, P1, DOI 10.1007/BF00694330; Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683; Guerrero-Beltran CE, 2012, J NUTR BIOCHEM, V23, P494, DOI 10.1016/j.jnutbio.2011.02.004; Guerrero-Beltran CE, 2010, TOXICOL LETT, V199, P80, DOI 10.1016/j.toxlet.2010.08.009; Gaona-Gaona L, 2011, TOXICOLOGY, V286, P20, DOI 10.1016/j.tox.2011.04.014; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Jung SH, 2014, MOL CELLS, V37, P234, DOI 10.14348/molcells.2014.2322; Kang KP, 2011, NEPHROL DIAL TRANSPL, V26, P814, DOI 10.1093/ndt/gfq528; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Kursunluoglu G, 2014, CELL BIOCH BIOPHYS; Lambert JD, 2006, DRUG METAB DISPOS, V34, P8, DOI 10.1124/dmd.104.003434; Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030; Lecumberri E, 2013, CLIN NUTR, V32, P894, DOI 10.1016/j.clnu.2013.03.008; Meng QY, 2008, FREE RADICAL BIO MED, V44, P1032, DOI 10.1016/j.freeradbiomed.2007.11.023; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V51, P1774, DOI 10.1016/j.freeradbiomed.2011.08.006; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nasri H, 2014, J RENAL INJ PREV, V3, P47, DOI 10.12861/jrip.2014.16; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086057; Pan H, 2009, J PHARMACOL EXP THER, V328, P708, DOI 10.1124/jpet.108.147181; Peairs A, 2010, CELL MOL IMMUNOL, V7, P123, DOI 10.1038/cmi.2010.1; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Sahu BD, 2011, FOOD CHEM TOXICOL, V49, P3090, DOI 10.1016/j.fct.2011.08.018; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL, V41, P803, DOI 10.3109/10408444.2011.602662; Santos NAG, 2008, CANCER CHEMOTH PHARM, V61, P145, DOI 10.1007/s00280-007-0459-y; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Schroeder EK, 2009, ANTIOXID REDOX SIGN, V11, P469, DOI [10.1089/ars.2008.2215, 10.1089/ARS.2008.2215]; Shimizu M, 2011, MOL NUTR FOOD RES, V55, P832, DOI 10.1002/mnfr.201000622; Shirakami Y, 2012, CURR DRUG TARGETS, V13, P1842, DOI 10.2174/138945012804545506; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Suzuki D, 1999, J AM SOC NEPHROL, V10, P822; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Trujillo J, 2013, REDOX BIOL, V1, P448, DOI 10.1016/j.redox.2013.09.003; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Wang Y, 2015, BASIC CLIN PHARM TOX; Waseem M, 2013, CELL BIOCHEM FUNCT, V31, P678, DOI 10.1002/cbf.2955; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242; Zhong Y, 2012, FOOD CHEM, V134, P742, DOI 10.1016/j.foodchem.2012.02.172; Zhou H, 2004, TOXICOL APPL PHARM, V200, P111, DOI 10.1016/j.taap.2004.04.003; Zhou P, 2013, MOL MED REP, V7, P1096, DOI 10.3892/mmr.2013.1296; Zou PM, 2014, INT J CLIN EXP PATHO, V7, P4607	64	62	63	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124775	10.1371/journal.pone.0124775	http://dx.doi.org/10.1371/journal.pone.0124775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875356	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800152
J	Jardine, CB; Bond, AL; Davidson, PJA; Butler, RW; Kuwae, T				Jardine, Catherine B.; Bond, Alexander L.; Davidson, Peter J. A.; Butler, Robert W.; Kuwae, Tomohiro			Biofilm Consumption and Variable Diet Composition of Western Sandpipers (Calidris mauri) during Migratory Stopover	PLOS ONE			English	Article							FRASER-RIVER ESTUARY; SEMIPALMATED SANDPIPERS; BILL LENGTH; DIFFERENTIAL MIGRATION; INTERTIDAL MUDFLAT; LATITUDINAL CLINES; DISTANCE MEASURES; BRITISH-COLUMBIA; SITE SELECTION; PREY ABUNDANCE	Many shorebird species undertake long-distance migrations punctuated by brief stays at food-rich, estuarine stopover locations. Understanding use of these food resources helps guide conservation and responsible development decisions. We determined the extent and degree to which Western Sandpiper (Calidris mauri) utilized biofilm as a food resource across a large and variable stopover location during northward (spring) migration. We investigated the spatial heterogeneity in diet composition, to determine whether shorebirds were consistently feeding on biofilm or whether diet varied between naturally and anthropogenically delineated sites. We used stable isotope analysis to estimate that biofilm conservatively comprised 22% to 53% of Western Sandpiper droppings across all sampling sites and that prey composition differed significantly between areas within the stopover location. Widespread biofilm consumption demonstrates the importance of biofilm as a dietary component. Variable diet composition suggests that habitat heterogeneity may be an important component of high quality stopover locations in the context of "state-dependant trade-offs" of Western Sandpiper population sub-groups. Future management decisions must consider and address potential impacts on the biofilm community throughout a stopover location, as single site studies of diet composition may not be adequate to develop effective management strategies for entire stopover sites.	[Jardine, Catherine B.; Davidson, Peter J. A.; Butler, Robert W.] Pacific Wildlife Res Ctr, Bird Studies Canada, Delta, BC, Canada; [Bond, Alexander L.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Kuwae, Tomohiro] Port & Airport Res Inst, Coastal & Estuarine Environm Res Grp, Yokosuka, Kanagawa, Japan	Environment & Climate Change Canada; Canadian Wildlife Service; Pacific Wildlife Research Centre; University of Saskatchewan; Port & Airport Research Institute	Jardine, CB (corresponding author), Pacific Wildlife Res Ctr, Bird Studies Canada, Delta, BC, Canada.	cjardine@bsc-eoc.org		Bond, Alexander/0000-0003-2125-7238	Vancouver Airport Fuel Facilities Corporation	Vancouver Airport Fuel Facilities Corporation	Bird Studies Canada was commissioned to conduct this work by Coastal and Ocean Resources Inc., as part of a wider study of biofilm in the Fraser Estuary funded by Vancouver Airport Fuel Facilities Corporation, which contributed to the environmental review process for the facility development proposal. The funders provided direction on the research question that was pursued but did not participate in study design, data collection and analysis, or preparation of the manuscript. The funders have granted permission for the results of the study to be submitted for publication.	Beninger PG, 2011, MAR ECOL PROG SER, V428, P259, DOI 10.3354/meps09050; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Bond AL, 2012, J ORNITHOL, V153, P115, DOI 10.1007/s10336-011-0704-3; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Boundary Bay Wildlife Management Area, 2014, BOUND BAY WILDL MAN; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Butler RW, 2002, WILSON BULL, V114, P485, DOI 10.1676/0043-5643(2002)114[0485:SFALMO]2.0.CO;2; Butler RW, 1994, 83 CAN WILDL SERV; CARTAR RV, 1984, WILSON BULL, V96, P277; Catry T, 2009, MAR ECOL PROG SER, V374, P259, DOI 10.3354/meps07713; Characklis W. G., 1990, BIOFILMS; Clark CW, 1999, EVOL ECOL RES, V1, P443; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; COLWELL MA, 1993, CONDOR, V95, P94, DOI 10.2307/1369390; de Brouwer JFC, 2001, MAR ECOL PROG SER, V218, P33, DOI 10.3354/meps218033; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Delany S, 2006, WATERBIRD POPULATION; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Drever MC, 2014, J FIELD ORNITHOL, V85, P10, DOI 10.1111/jofo.12045; Elner Robert W., 2003, Wader Study Group Bulletin, V100, P30; Elner RW, 2005, MAR BIOL, V146, P1223, DOI 10.1007/s00227-004-1521-5; Fernandez G, 2012, J FIELD ORNITHOL, V83, P272, DOI 10.1111/j.1557-9263.2012.00375.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Guglielmo CG, 2003, PHYSIOL BIOCHEM ZOOL, V76, P84, DOI 10.1086/367942; Herlory O, 2004, MAR ECOL PROG SER, V282, P33, DOI 10.3354/meps282033; HICKLIN PW, 1984, CAN J ZOOL, V62, P2201, DOI 10.1139/z84-321; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hoskins DL, 2003, MAR ECOL PROG SER, V247, P93, DOI 10.3354/meps247093; Iverson GC, 1996, CONDOR, V98, P10, DOI 10.2307/1369502; Jimenez Reyes A., 2013, THESIS S FRASER U; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; Kuwae T, 2008, ECOLOGY, V89, P599, DOI 10.1890/07-1442.1; Kuwae T, 2012, ECOL LETT, V15, P347, DOI 10.1111/j.1461-0248.2012.01744.x; Kuwae T, 2010, MAR ECOL PROG SER, V406, P281, DOI 10.3354/meps08519; MacDonald EC, 2012, CONDOR, V114, P135, DOI 10.1525/cond.2012.100246; Mathot KJ, 2007, ECOLOGY, V88, P781, DOI 10.1890/06-1225; Mathot KJ, 2010, WATERBIRDS, V33, P300, DOI 10.1675/063.033.0305; Mathot KJ, 2004, CAN J ZOOL, V82, P1035, DOI 10.1139/Z04-080; Mehlman DW, 2005, AUK, V122, P1281, DOI 10.1642/0004-8038(2005)122[1281:CSSFFM]2.0.CO;2; Morisita M., 1959, MEM FS KYUSHU U    E, V3, P65, DOI DOI 10.18960/SEITAI.11.6_252_4; Myers J.P., 1987, American Scientist, V75, P18; Nebel S, 2005, ACTA OECOL, V28, P33, DOI 10.1016/j.actao.2005.02.002; Nebel S, 2002, AUK, V119, P922, DOI 10.1642/0004-8038(2002)119[0922:WSCMDT]2.0.CO;2; Nebel Silke, 2003, Wader Study Group Bulletin, V100, P118; O'Hara PD, 2006, CONDOR, V108, P225, DOI 10.1650/0010-5422(2006)108[0225:DMIWSW]2.0.CO;2; O'Hara PD, 2005, J AVIAN BIOL, V36, P191, DOI 10.1111/j.0908-8857.2005.03368.x; OREILLY KM, 1995, AM ZOOL, V35, P222; PAGE G, 1971, BIRD BANDING, V42, P297, DOI 10.2307/4511799; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Placyk JS, 2004, J FIELD ORNITHOL, V75, P223, DOI 10.1648/0273-8570-75.3.223; Pomeroy AC, 2006, OIKOS, V112, P629, DOI 10.1111/j.0030-1299.2006.14403.x; Pomeroy AC, 2008, AVIAN CONSERV ECOL, V3; Quinn JT, 2012, CAN J ZOOL, V90, P1181, DOI 10.1139/Z2012-086; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauber TW, 2008, PATTERN RECOGN, V41, P637, DOI 10.1016/j.patcog.2007.06.023; Roberts Bank Wildlife Management Area, 2014, ROB BANK WILDL MAN A; Seaman DAA, 2006, AUK, V123, P563, DOI 10.1642/0004-8038(2006)123[563:LPSDIR]2.0.CO;2; Sewell MA, 1996, MAR ECOL PROG SER, V144, P23, DOI 10.3354/meps144023; Skagen SK, 1996, CAN FIELD NAT, V110, P419; Stein RW, 2008, CAN J ZOOL, V86, P601, DOI 10.1139/Z08-033; Stein RW, 2006, FUNCT ECOL, V20, P142, DOI 10.1111/j.1365-2435.2006.01065.x; Stein RW, 2005, PHYSIOL BIOCHEM ZOOL, V78, P434, DOI 10.1086/430038; Sturgeon Bank Wildlife Management Area, 2014, STURG BANK WILDL MAN; Sutherland TF, 2000, MAR BIOL, V137, P983, DOI 10.1007/s002270000406; Taylor IS, 1999, BIOGEOCHEMISTRY, V45, P303, DOI 10.1023/A:1026433702118; Underwood GJC, 2005, LIMNOL OCEANOGR, V50, P755, DOI 10.4319/lo.2005.50.3.0755; Warnock N, 1998, CONDOR, V100, P456, DOI 10.2307/1369711; Warnock N. D., 1996, BIRDS N AM ONLINE; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713; Ydenberg RC, 2002, J AVIAN BIOL, V33, P47, DOI 10.1034/j.1600-048X.2002.330108.x	71	23	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124164	10.1371/journal.pone.0124164	http://dx.doi.org/10.1371/journal.pone.0124164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875528	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700057
J	Mattenberger, Y; Silva, F; Belin, D				Mattenberger, Yves; Silva, Filo; Belin, Dominique			55.2, a Phage T4 ORFan Gene, Encodes an Inhibitor of Escherichia coli Topoisomerase I and Increases Phage Fitness	PLOS ONE			English	Article							R-LOOP FORMATION; DNA TOPOISOMERASES; BACTERIOPHAGE-T4 DNA; TN5 TRANSPOSASE; REPLICATION; BACTERIAL; MUTANTS; GYRASE; ROLES; PROTEIN	Topoisomerases are enzymes that alter the topological properties of DNA. Phage T4 encodes its own topoisomerase but it can also utilize host-encoded topoisomerases. Here we characterized 55.2, a phage T4 predicted ORF of unknown function. High levels of expression of the cloned 55.2 gene are toxic in E. coli. This toxicity is suppressed either by increased topoisomerase I expression or by partial inactivation of the ATPase subunit of the DNA gyrase. Interestingly, very low-level expression of 55.2, which is non-lethal to wild type E. coli, prevents the growth of a deletion mutant of the topoisomerase I (topA) gene. In vitro, gp55.2 binds DNA and blocks specifically the relaxation of negatively supercoiled DNA by topoisomerase I. In vivo, expression of gp55.2 at low non-toxic levels alters the steady state DNA supercoiling of a reporter plasmid. Although 55.2 is not an essential gene, competition experiments indicate that it is required for optimal phage growth. We propose that the role of gp55.2 is to subtly modulate host topoisomerase I activity during infection to insure optimal T4 phage yield.	[Mattenberger, Yves; Silva, Filo; Belin, Dominique] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland	University of Geneva	Mattenberger, Y (corresponding author), Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland.	yves.mattenberger@unige.ch		Mattenberger, Yves/0000-0002-1651-7691	Fondation Schmidheiny DB Geneva Department of Education	Fondation Schmidheiny DB Geneva Department of Education	Fondation Schmidheiny DB Geneva Department of Education The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ang D, 2012, GENETICS, V190, P989, DOI 10.1534/genetics.111.135640; ARMSTRONG KA, 1984, J MOL BIOL, V175, P331, DOI 10.1016/0022-2836(84)90352-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; Bieler S, 2006, J BACTERIOL, V188, P7049, DOI 10.1128/JB.00688-06; Bost S, 1999, J BACTERIOL, V181, P2185, DOI 10.1128/JB.181.7.2185-2191.1999; BOYD D, 1987, P NATL ACAD SCI USA, V84, P8525, DOI 10.1073/pnas.84.23.8525; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHURCHWARD G, 1983, NUCLEIC ACIDS RES, V11, P5645, DOI 10.1093/nar/11.16.5645; Clark DJ, 2009, METHODS MOL BIOL, V543, P523, DOI 10.1007/978-1-60327-015-1_30; Comeau AM, 2005, CURR OPIN MICROBIOL, V8, P488, DOI 10.1016/j.mib.2005.06.004; Comeau AM, 2008, RES MICROBIOL, V159, P306, DOI 10.1016/j.resmic.2008.05.001; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; DIGATE RJ, 1988, J BIOL CHEM, V263, P13366; DINARDO S, 1982, CELL, V31, P43, DOI 10.1016/0092-8674(82)90403-2; Drlica K, 1999, CURR OPIN MICROBIOL, V2, P504, DOI 10.1016/S1369-5274(99)00008-9; DRLICA K, 1992, MOL MICROBIOL, V6, P425, DOI 10.1111/j.1365-2958.1992.tb01486.x; DRLICA K, 1978, J MOL BIOL, V120, P145, DOI 10.1016/0022-2836(78)90061-X; DROLET M, 1995, P NATL ACAD SCI USA, V92, P3526, DOI 10.1073/pnas.92.8.3526; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; EPSTEIN RH, 1963, COLD SPRING HARB SYM, V28, P375, DOI 10.1101/SQB.1963.028.01.053; Epstein RH, 2012, GENETICS, V190, P833, DOI 10.1534/genetics.112.138438; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Ghosh S, 2014, NUCLEIC ACIDS RES, V42, P11156, DOI 10.1093/nar/gku804; Gormley NA, 1996, BIOCHEMISTRY-US, V35, P5083, DOI 10.1021/bi952888n; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hardy CD, 2003, ANTIMICROB AGENTS CH, V47, P941, DOI 10.1128/AAC.47.3.941-947.2003; Higgins N. Patrick, 2005, P133; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Jeong KS, 2006, PLOS GENET, V2, P1464, DOI 10.1371/journal.pgen.0020152; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Kreuzer KN, 1998, BBA-GENE STRUCT EXPR, V1400, P339, DOI 10.1016/S0167-4781(98)00145-6; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LIU LF, 1979, NATURE, V281, P456, DOI 10.1038/281456a0; Luke K, 2002, VIROLOGY, V299, P182, DOI 10.1006/viro.2002.1409; Masse E, 1999, J BIOL CHEM, V274, P16654, DOI 10.1074/jbc.274.23.16654; Mattenberger Y, 2011, MOL MICROBIOL, V82, P1406, DOI 10.1111/j.1365-2958.2011.07897.x; MCCARTHY D, 1976, J MOL BIOL, V106, P963, DOI 10.1016/0022-2836(76)90346-6; MCCARTHY D, 1979, J MOL BIOL, V127, P265, DOI 10.1016/0022-2836(79)90329-2; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mosig G, 2001, P NATL ACAD SCI USA, V98, P8306, DOI 10.1073/pnas.131007398; Mosig G, 1983, MECHANISMS DNA REPLI, P173; Mosig Gisela, 1994, P54; MUFTI S, 1974, J VIROL, V14, P860, DOI 10.1128/JVI.14.4.860-871.1974; Otsuka Y, 2012, MOL MICROBIOL, V83, P669, DOI 10.1111/j.1365-2958.2012.07975.x; Perez-Cheeks BA, 2012, MOL MICROBIOL, V86, P1007, DOI 10.1111/mmi.12039; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; Phoenix P, 1997, J BIOL CHEM, V272, P1473, DOI 10.1074/jbc.272.3.1473; PRUSS GJ, 1982, CELL, V31, P35, DOI 10.1016/0092-8674(82)90402-0; Reckinger AR, 2007, NUCLEIC ACIDS RES, V35, P79, DOI 10.1093/nar/gkl981; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Schvartzman JB, 2004, EMBO REP, V5, P256, DOI 10.1038/sj.embor.7400101; SELICK HE, 1988, J BIOL CHEM, V263, P11336; SELZER G, 1983, CELL, V32, P119, DOI 10.1016/0092-8674(83)90502-0; SHURE M, 1977, NUCLEIC ACIDS RES, V4, P1183, DOI 10.1093/nar/4.5.1183; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; SINDEN RR, 1982, J MOL BIOL, V162, P659, DOI 10.1016/0022-2836(82)90394-1; Stavans J, 2006, PHYS BIOL, V3, pR1, DOI 10.1088/1478-3975/3/4/R01; STETLER GL, 1979, P NATL ACAD SCI USA, V76, P3737, DOI 10.1073/pnas.76.8.3737; Stockum A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-26; Stupina VA, 2005, J BIOL CHEM, V280, P355, DOI 10.1074/jbc.M411924200; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; TSEDINH YC, 1988, J MOL BIOL, V202, P735, DOI 10.1016/0022-2836(88)90554-2; Vetcher AA, 2010, BIOPHYS CHEM, V148, P104, DOI 10.1016/j.bpc.2010.02.016; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yigit H, 1998, J BACTERIOL, V180, P5866, DOI 10.1128/JB.180.22.5866-5874.1998; Yigit H, 1999, J BACTERIOL, V181, P3185, DOI 10.1128/JB.181.10.3185-3192.1999; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103; ZHU CX, 1995, J MOL BIOL, V250, P609, DOI 10.1006/jmbi.1995.0402; Zhu Q, 2001, P NATL ACAD SCI USA, V98, P9766, DOI 10.1073/pnas.171579898	84	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124309	10.1371/journal.pone.0124309	http://dx.doi.org/10.1371/journal.pone.0124309			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875362	Green Submitted, Green Published, gold			2022-12-26	WOS:000353014700066
J	Yoda, K; Inaba, M; Hamamoto, K; Yoda, M; Tsuda, A; Mori, K; Imanishi, Y; Emoto, M; Yamada, S				Yoda, Koichiro; Inaba, Masaaki; Hamamoto, Kae; Yoda, Maki; Tsuda, Akihiro; Mori, Katsuhito; Imanishi, Yasuo; Emoto, Masanori; Yamada, Shinsuke			Association between Poor Glycemic Control, Impaired Sleep Quality, and Increased Arterial Thickening in Type 2 Diabetic Patients	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTOR; INSOMNIA; EEG; DISEASE; JAPAN; ATHEROSCLEROSIS; DEPRIVATION; HEMOGLOBIN; COMPLAINTS	Objective Poor sleep quality is an independent predictor of cardiovascular events. However, little is known about the association between glycemic control and objective sleep architecture and its influence on arteriosclerosis in patients with type-2 diabetes mellitus (DM). The present study examined the association of objective sleep architecture with both glycemic control and arteriosclerosis in type-2 DM patients. Design Cross-sectional study in vascular laboratory. Methods The subjects were 63 type-2 DM inpatients (M/F, 32/31; age, 57.5 +/- 13.1) without taking any sleeping promoting drug and chronic kidney disease. We examined objective sleep architecture by single-channel electroencephalography and arteriosclerosis by carotid-artery intima-media thickness (CA-IMT). Results HbA1c was associated significantly in a negative manner with REM sleep latency (interval between sleep-onset and the first REM period) (beta=-0.280, p=0.033), but not with other measurements of sleep quality. REM sleep latency associated significantly in a positive manner with log delta power (the marker of deep sleep) during that period (beta=0.544, p=0.001). In the model including variables univariately correlated with CA-IMT (REM sleep latency, age, DM duration, systolic blood pressure, and HbA1c) as independent variables, REM sleep latency (beta=-0.232, p=0.038), but not HbA1c were significantly associated with CA-IMT. When log delta power was included in place of REM sleep latency, log delta power (beta=-0.257, p=0.023) emerged as a significant factor associated with CA-IMT. Conclusions In type-2 DM patients, poor glycemic control was independently associated with poor quality of sleep as represented by decrease of REM sleep latency which might be responsible for increased CA-IMT, a relevant marker for arterial wall thickening.	[Yoda, Koichiro; Inaba, Masaaki; Hamamoto, Kae; Yoda, Maki; Tsuda, Akihiro; Mori, Katsuhito; Imanishi, Yasuo; Emoto, Masanori; Yamada, Shinsuke] Osaka City Univ, Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 545, Japan	Osaka Metropolitan University	Yoda, K (corresponding author), Osaka City Univ, Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 545, Japan.	y45162001@yahoo.co.jp						AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Armitage R, 2013, SLEEP MED, V14, P257, DOI 10.1016/j.sleep.2012.11.012; Bruehl H, 2007, J CLIN ENDOCR METAB, V92, P2439, DOI 10.1210/jc.2006-2540; DEMENT W, 1957, J EXP PSYCHOL, V53, P339, DOI 10.1037/h0048189; Flexer A, 2005, ARTIF INTELL MED, V33, P199, DOI 10.1016/j.artmed.2004.04.004; Fujishima M, 1996, DIABETES, V45, pS14, DOI 10.2337/diab.45.3.S14; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Geyer J. D., 2009, CLIN SLEEP DISORDERS, P265; Iber C., 2007, AASM MANUAL SCORING; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Javaheri S, 2012, CURR HYPERTENS REP, V14, P442, DOI 10.1007/s11906-012-0289-0; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; KOSTIC VS, 1989, J NEUROL, V236, P421, DOI 10.1007/BF00314903; Krystal AD, 2002, SLEEP, V25, P630; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nakazaki C, 2012, AM J HYPERTENS, V25, P1149, DOI 10.1038/ajh.2012.107; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Pallayova Maria, 2010, J Diabetes Sci Technol, V4, P344; Phillips B, 2007, J CLIN SLEEP MED, V3, P489; Poland, 1992, J Sleep Res, V1, P54; Redwine L, 2000, J CLIN ENDOCR METAB, V85, P3597, DOI 10.1210/jc.85.10.3597; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI [10.1111/jsr.12102, 10.1111/jsr.12254]; Skomro RP, 2001, SLEEP MED, V2, P417, DOI 10.1016/S1389-9457(01)00110-1; Takahashi H, 2013, J ORAL REHABIL, V40, P892, DOI 10.1111/joor.12110; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; Tribl GG, 2013, SLEEP MED REV, V17, P133, DOI 10.1016/j.smrv.2012.05.001; Unosawa S, 2012, J CARDIOL, V60, P61, DOI 10.1016/j.jjcc.2012.01.012; Yanase T, 2006, AM J HYPERTENS, V19, P1206, DOI 10.1016/j.amjhyper.2006.05.010; Yoda K, 2014, DIABETES CARE, V37, P644, DOI 10.2337/dc13-1102	32	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122521	10.1371/journal.pone.0122521	http://dx.doi.org/10.1371/journal.pone.0122521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875738	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700018
J	Chen, LQ; Wu, SJ; Lu, HF; Huang, K; Zhao, LJ				Chen, Liqiong; Wu, Shijuan; Lu, Hongfang; Huang, Kun; Zhao, Lijie			Numerical Simulation and Structural Optimization of the Inclined Oil/Water Separator	PLOS ONE			English	Article								Improving the separation efficiency of the inclined oil/water separator, a new type of gravity separation equipment, is of great importance. In order to obtain a comprehensive understanding of the internal flow field of the separation process of oil and water within this separator, a numerical simulation based on Euler multiphase flow analysis and the realizable k-epsilon two equation turbulence model was executed using Fluent software. The optimal value ranges of the separator's various structural parameters used in the numerical simulation were selected through orthogonal array experiments. A field experiment on the separator was conducted with optimized structural parameters in order to validate the reliability of the numerical simulation results. The research results indicated that the horizontal position of the dispenser, the hole number, and the diameter had significant effects on the oil/water separation efficiency, and that the longitudinal position of the dispenser and the position of the weir plate had insignificant effects on the oil/water separation efficiency. The optimal structural parameters obtained through the orthogonal array experiments resulted in an oil/water separation efficiency of up to 95%, which was 4.996% greater than that realized by the original structural parameters.	[Chen, Liqiong; Wu, Shijuan; Lu, Hongfang; Huang, Kun] Southwest Petr Univ, Sch Petr Engn, Chengdu, Sichuan, Peoples R China; [Zhao, Lijie] China Univ Petr, Coll Geosci, State Key Lab Petr Resources & Prospecting, Beijing, Peoples R China	Southwest Petroleum University; China University of Petroleum	Lu, HF (corresponding author), Southwest Petr Univ, Sch Petr Engn, Chengdu, Sichuan, Peoples R China.	luhongfang_sci@126.com	Lu, Hongfang/T-1016-2019	Lu, Hongfang/0000-0002-5172-9008	Science and Technology Innovation Foundation of CNPC [2012D-5006-0602]; Graduate Innovation Foundation of SouthWest Petroleum University (SGIFSWPU)	Science and Technology Innovation Foundation of CNPC; Graduate Innovation Foundation of SouthWest Petroleum University (SGIFSWPU)	This research is supported by Science and Technology Innovation Foundation of CNPC (2012D-5006-0602) and Graduate Innovation Foundation of SouthWest Petroleum University (SGIFSWPU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen PAK, 2000, COLLOID SURFACE A, V170, P33, DOI 10.1016/S0927-7757(99)00518-X; Deng ZA, 2006, CHINA PETROL MACH, V34, P18; Frising T, 2006, J DISPER SCI TECHNOL, V27, P1035, DOI 10.1080/01932690600767098; [高雄发 Gao Xiongfa], 2014, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V45, P101; Hou XR, 2011, THESIS DALIAN MARITI; [黄坤 Huang Kun], 2014, [石油与天然气化工, Chemical Engineering of Oil and Gas], V43, P241; Jia C, 2014, ROCK SOIL MECH, V35, P1718; Klasson KT, 2005, SEP SCI TECHNOL, V40, P453, DOI 10.1081/SS-200042503; [刘苏 Liu Su], 2012, [西南石油大学学报．自然科学版, Journal of Southwest Petroleum University], V34, P147; [刘晓敏 LIU Xiaomin], 2006, [流体机械, Fluid Machinery], V34, P13; Liu Y.H, 2009, THESIS TIANJIN U; Lu YJ, 1999, ACTA PETROLEI SINICA, P34; Lv YL, 2008, CHINA PETROL MACH, V36, P12; Wang GD, ACTA PETROLEI SINICA, V27, P112; Wang HM, CHEM ENG MACH, V36, P13; Zhang L., 2005, THESIS TIANJIN U	16	11	11	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124095	10.1371/journal.pone.0124095	http://dx.doi.org/10.1371/journal.pone.0124095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874861	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100238
J	Ferre, ER; Walther, LE; Haggard, P				Ferre, Elisa Raffaella; Walther, Leif Erik; Haggard, Patrick			Multisensory Interactions between Vestibular, Visual and Somatosensory Signals	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; SELF-MOTION; SUPERIOR COLLICULUS; EQUILIBRIUM ORGAN; STIMULATION; INTEGRATION; CORTEX; RESPONSES; INFORMATION; MODULATION	Vestibular inputs are constantly processed and integrated with signals from other sensory modalities, such as vision and touch. The multiply-connected nature of vestibular cortical anatomy led us to investigate whether vestibular signals could participate in a multi-way interaction with visual and somatosensory perception. We used signal detection methods to identify whether vestibular stimulation might interact with both visual and somatosensory events in a detection task. Participants were instructed to detect near-threshold somatosensory stimuli that were delivered to the left index finger in one half of experimental trials. A visual signal occurred close to the finger in half of the trials, independent of somatosensory stimuli. A novel Near infrared caloric vestibular stimulus (NirCVS) was used to artificially activate the vestibular organs. Sham stimulations were used to control for non-specific effects of NirCVS. We found that both visual and vestibular events increased somatosensory sensitivity. Critically, we found no evidence for supra-additive multisensory enhancement when both visual and vestibular signals were administered together: in fact, we found a trend towards sub-additive interaction. The results are compatible with a vestibular role in somatosensory gain regulation.	[Ferre, Elisa Raffaella; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Walther, Leif Erik] Heidelberg Univ, Univ Med Mannheim, Dept Otorhinolaryngol & Head & Neck Surg, Mannheim, Germany	University of London; University College London; Ruprecht Karls University Heidelberg	Ferre, ER (corresponding author), UCL, Inst Cognit Neurosci, London, England.	e.ferre@ucl.ac.uk		Ferre, Elisa Raffaella/0000-0002-0643-848X; Haggard, Patrick/0000-0001-7798-793X	EU Project VERE Workpackage 1; ESRC; ERC Advanced Grant HUMVOL; ESRC [ES/J023140/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023140/1] Funding Source: researchfish	EU Project VERE Workpackage 1; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ERC Advanced Grant HUMVOL; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	ERF and PH were supported by EU Project VERE Workpackage 1. PH was additionally supported by a Professorial Fellowship from ESRC and by ERC Advanced Grant HUMVOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; BOTTINI G, 1995, NATURE, V376, P778, DOI 10.1038/376778a0; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Brown RJ, 2010, J PSYCHOSOM RES, V69, P241, DOI 10.1016/j.jpsychores.2009.11.010; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; BUTTNER U, 1978, BRAIN RES, V153, P392, DOI 10.1016/0006-8993(78)90421-3; Chen AH, 2010, J NEUROSCI, V30, P3022, DOI 10.1523/JNEUROSCI.4029-09.2010; Deutschlander A, 2002, HUM BRAIN MAPP, V16, P92, DOI 10.1002/hbm.10030; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Ferre ER, 2013, NEUROSCI LETT, V550, P35, DOI 10.1016/j.neulet.2013.06.046; Ferre ER, 2011, EUR J NEUROSCI, V34, P1337, DOI 10.1111/j.1460-9568.2011.07859.x; Ferre ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086379; Fetsch CR, 2013, NAT REV NEUROSCI, V14, P429, DOI 10.1038/nrn3503; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gallistel CR, 2009, PSYCHOL REV, V116, P439, DOI 10.1037/a0015251; Garcia-Marques L, 2003, PSYCHON B REV, P1; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Haggard P, 2013, CURR BIOL, V23, pR164, DOI 10.1016/j.cub.2013.01.047; Helbig HB, 2007, EXP BRAIN RES, V179, P595, DOI 10.1007/s00221-006-0814-y; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Johnson RM, 2006, BRAIN RES, V1073, P398, DOI 10.1016/j.brainres.2005.12.025; Klam F, 2003, EUR J NEUROSCI, V18, P995, DOI 10.1046/j.1460-9568.2003.02813.x; Klam F, 2006, J PHYSIOL-LONDON, V574, P367, DOI 10.1113/jphysiol.2005.103697; Konen CS, 2014, CEREB CORTEX, V24, P501, DOI 10.1093/cercor/bhs331; Kruschke JK, 2011, PERSPECT PSYCHOL SCI, V6, P299, DOI 10.1177/1745691611406925; LOFTUS GR, 1978, MEM COGNITION, V6, P312, DOI 10.3758/BF03197461; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Macmillan N. A., 2004, DETECTION THEORY USE; McKenzie KJ, 2010, PERCEPTION, V39, P839, DOI 10.1068/p6401; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Mirams L, 2010, EXP BRAIN RES, V202, P787, DOI 10.1007/s00221-010-2185-7; Naito Y, 2003, BRAIN, V126, P1562, DOI 10.1093/brain/awg165; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prsa M, 2012, J NEUROPHYSIOL, V108, P2282, DOI 10.1152/jn.00439.2012; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Sripati AP, 2006, J NEUROSCI, V26, P2101, DOI 10.1523/JNEUROSCI.3720-05.2006; Stanford TR, 2007, NEUROREPORT, V18, P787, DOI 10.1097/WNR.0b013e3280c1e315; Stein BE, 2011, PROG BRAIN RES, V191, P145, DOI 10.1016/B978-0-444-53752-2.00007-2; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; VALLAR G, 1993, BRAIN, V116, P71, DOI 10.1093/brain/116.1.71; VALLAR G, 1990, CORTEX, V26, P123, DOI 10.1016/S0010-9452(13)80078-0; Vega-Bermudez F, 1999, J NEUROPHYSIOL, V81, P2711, DOI 10.1152/jn.1999.81.6.2711; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Walther LE, 2011, ACTA OTORHINOLARYNGO, V31, P90; Walther LE, 2004, HNO, V52, P525, DOI 10.1007/s00106-003-0935-6; Walther LE, 2004, LARYNGO RHINO OTOL, V83, P88, DOI 10.1055/s-2004-814238; Walther LE, 2003, LARYNGO RHINO OTOL, V82, P687; Wenzel R, 1996, BRAIN, V119, P101, DOI 10.1093/brain/119.1.101; Zhou YD, 2014, PNAS, V97, P9777	59	24	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124573	10.1371/journal.pone.0124573	http://dx.doi.org/10.1371/journal.pone.0124573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875819	Green Published, gold, Green Accepted			2022-12-26	WOS:000352845100266
J	Jensen, TB; Cheema, MU; Szymiczek, A; Damkier, HH; Praetorius, J				Jensen, Thomas Buus; Cheema, Muhammad Umar; Szymiczek, Agata; Damkier, Helle Hasager; Praetorius, Jeppe			Renal Type A Intercalated Cells Contain Albumin in Organelles with Aldosterone-Regulated Abundance	PLOS ONE			English	Article							ALPHA-FETOPROTEIN; KIDNEY; RAT; EXPRESSION; TRANSPORT; SUBTYPES; SUBUNIT; BINDING; MODEL; WATER	Albumin has been identified in preparations of renal distal tubules and collecting ducts by mass spectrometry. This study aimed to establish whether albumin was a contaminant in those studies or actually present in the tubular cells, and if so, identify the albumin containing cells and commence exploration of the origin of the intracellular albumin. In addition to the expected proximal tubular albumin immunoreactivity, albumin was localized to mouse renal type-A intercalated cells and cells in the interstitium by three anti-albumin antibodies. Albumin did not colocalize with markers for early endosomes (EEA1), late endosomes/lysosomes (cathepsin D) or recycling endosomes (Rab11). Immuno-gold electron microscopy confirmed the presence of albumin-containing large spherical membrane associated bodies in the basal parts of intercalated cells. Message for albumin was detected in mouse renal cortex as well as in a wide variety of other tissues by RT-PCR, but was absent from isolated connecting tubules and cortical collecting ducts. Wild type I MDCK cells showed robust uptake of fluorescein-albumin from the basolateral side but not from the apical side when grown on permeable support. Only a subset of cells with low peanut agglutinin binding took up albumin. Albumin-aldosterone conjugates were also internalized from the basolateral side by MDCK cells. Aldosterone administration for 24 and 48 hours decreased albumin abundance in connecting tubules and cortical collecting ducts from mouse kidneys. We suggest that albumin is produced within the renal interstitium and taken up from the basolateral side by type-A intercalated cells by clathrin and dynamin independent pathways and speculate that the protein might act as a carrier of less water-soluble substances across the renal interstitium from the capillaries to the tubular cells.	[Jensen, Thomas Buus; Cheema, Muhammad Umar; Szymiczek, Agata; Damkier, Helle Hasager; Praetorius, Jeppe] Aarhus Univ, Dept Biomed, Hlth, Aarhus, Denmark	Aarhus University	Praetorius, J (corresponding author), Aarhus Univ, Dept Biomed, Hlth, Aarhus, Denmark.	jp@ana.au.dk	Praetorius, Jeppe/AAU-7893-2020; Buus, Thomas Winther/AAE-2028-2019	Praetorius, Jeppe/0000-0001-6109-247X; Buus, Thomas Winther/0000-0003-4801-6389; Damkier, Helle/0000-0001-7518-4017	Danish Council for Independent Research | Medical Sciences; Lundbeck Foundation; Danish Heart Association	Danish Council for Independent Research | Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Danish Heart Association	Thomas B Jensen was supported by a scholar stipend from The Danish Council for Independent Research | Medical Sciences. Running expences were covered by the Lundbeck Foundation and the Danish Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biner HL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134836; Birn H, 2000, J CLIN INVEST, V105, P1353, DOI 10.1172/JCI8862; Boron W, 2009, MED PHYSL; BRENNER BM, 1976, PHYSIOL REV, V56, P502, DOI 10.1152/physrev.1976.56.3.502; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; CHRISTENSEN EI, 1991, SEMIN NEPHROL, V11, P414; CLAPP WL, 1988, LAB INVEST, V58, P549; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; Da Silva N, 2010, AM J PHYSIOL-CELL PH, V298, pC1326, DOI 10.1152/ajpcell.00552.2009; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; Hofmeister MV, 2009, AM J PHYSIOL-RENAL, V296, pF194, DOI 10.1152/ajprenal.90495.2008; Jensen TB, 2012, NEPHRON PHYSIOL, V121, P9; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; MAUNSBAC.AB, 1966, NATURE, V212, P546, DOI 10.1038/212546a0; MOORMAN AFM, 1990, HISTOCHEM J, V22, P653, DOI 10.1007/BF01047449; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; POLIARD A, 1988, DIFFERENTIATION, V39, P59, DOI 10.1111/j.1432-0436.1988.tb00081.x; Rosenbaek LL, 2014, J BIOL CHEM, V289, P13347, DOI 10.1074/jbc.M113.543710; SCHWEGLER JS, 1991, PFLUG ARCH EUR J PHY, V418, P383, DOI 10.1007/BF00550876; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; van der Lubbe N, 2012, PFLUG ARCH EUR J PHY, V463, P853, DOI 10.1007/s00424-012-1104-0; Ware LB, 2011, AM J PHYSIOL-RENAL, V300, pF628, DOI 10.1152/ajprenal.00654.2010; WEISBERG HF, 1978, ANN CLIN LAB SCI, V8, P155; Winter C, 2011, AM J PHYSIOL-CELL PH, V301, pC1251, DOI 10.1152/ajpcell.00076.2011; WUNSCH S, 1995, J CELL PHYSIOL, V164, P164, DOI 10.1002/jcp.1041640121	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124902	10.1371/journal.pone.0124902	http://dx.doi.org/10.1371/journal.pone.0124902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874770	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100283
J	Lin, MY; Kuo, MC; Hung, CC; Wu, WJ; Chen, LT; Yu, ML; Hsu, CC; Lee, CH; Chen, HC; Hwang, SJ				Lin, Ming Yen; Kuo, Mei Chuan; Hung, Chi Chih; Wu, Wen Jeng; Chen, Li Tzong; Yu, Ming Lung; Hsu, Chih Cheng; Lee, Chien Hung; Chen, Hung Chun; Hwang, Shang Jyh			Association of Dialysis with the Risks of Cancers	PLOS ONE			English	Article							STAGE RENAL-DISEASE; TRANSITIONAL-CELL CARCINOMA; ARISTOLOCHIC ACID; URINARY-TRACT; POPULATION; KIDNEY; NEPHROPATHY; DIAGNOSIS; TAIWAN	Background To increase the survival span after dialysis in patients with end-stage renal disease (ESRD), identifying specific cancer risks is crucial in the cancer screening of these patients. The aim of this study was to investigate the risks of various cancers in an incident dialysis group in comparison with a non-dialysis group. Method We conducted a nationwide cohort study by using data from the Taiwan National Health Insurance Research Database. Patients who initially received long-term dialysis between January 1997 and December 2004, were selected and defined as the dialysis group and were matched with the non-dialysis patients (control group) according to age, sex, and index year. Competing risk analysis was used to estimate cumulative incidence and subdistribution hazard ratios (SHRs) of the first cancer occurrence. Results After consideration for the competing risk of mortality, the dialysis group showed a significantly higher 7-year cancer incidence rate than did the control group (6.4%; 95% confidence interval [CI], 6.0%-6.7% vs 1.7%; 95% CI, 1.4%-2.1%; P <0.001). The modified Cox proportional hazard model revealed that the dialysis group had significantly association with increased risks for all cancers (SHR, 3.43; 95% CI, 3.02-3.88). The risk of cancers was dominated in younger and female patients. Specific cancer risks were significantly higher in the dialysis group particularly in the development of oral, colorectal, liver, blood, breast, renal, upper urinary tract, and bladder cancer than in the control group. Multivariable stratified analyses confirmed the association between long-term dialysis and cancer in all subgroups of patients. Conclusions Dialysis is associated with a higher risk of cancer in patients with ESRD. However, cancer screening in ESRD population should be a selective approach, based on individual patient health condition and life expectancy.	[Lin, Ming Yen; Kuo, Mei Chuan; Hung, Chi Chih; Chen, Hung Chun; Hwang, Shang Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Lin, Ming Yen; Kuo, Mei Chuan; Hung, Chi Chih; Chen, Hung Chun; Hwang, Shang Jyh] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Lin, Ming Yen] Natl Appl Res Labs, Instrument Technol Res Ctr, Hsinchu, Taiwan; [Wu, Wen Jeng] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wu, Wen Jeng; Yu, Ming Lung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Wu, Wen Jeng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Wu, Wen Jeng] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Kaohsiung, Taiwan; [Chen, Li Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Li Tzong] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Yu, Ming Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Hepatobiliary, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Chih Cheng; Hwang, Shang Jyh] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Lee, Chien Hung] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Applied Research Laboratories - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University	Hwang, SJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	sjhwang@kmu.edu.tw	Yu, Ming-Lung/AAZ-4306-2020; Lee, Chien-Hung/D-4437-2009; Lin, Ming Yen/A-8637-2010	Yu, Ming-Lung/0000-0001-8145-1900; Lee, Chien-Hung/0000-0002-0988-264X; Lin, Ming Yen/0000-0002-8194-4833; wu, wen jeng/0000-0002-9691-7416	National Science Council, Taiwan [NSC 102-3114-Y-492-076-023]; Ministry of Health and Welfare [MOHW103-TD-B-111-05]; Kaohsiung Medical University [QP094005]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Kaohsiung Medical University	The authors would like to thank the National Science Council, Taiwan (NSC 102-3114-Y-492-076-023), the Ministry of Health and Welfare (MOHW103-TD-B-111-05), and Kaohsiung Medical University (QP094005) for supporting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CH, 2001, AM J NEPHROL, V21, P441, DOI 10.1159/000046647; Chang CH, 2007, CANCER-AM CANCER SOC, V109, P1487, DOI 10.1002/cncr.22557; Chen CH, 2013, INT J CANCER, V133, P14, DOI 10.1002/ijc.28013; Chen CH, 2012, P NATL ACAD SCI USA, V109, P8241, DOI 10.1073/pnas.1119920109; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien IC, 2009, SCHIZOPHR RES, V111, P17, DOI 10.1016/j.schres.2009.04.003; Chung CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044675; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eggers PW, 2011, CURR OPIN NEPHROL HY, V20, P241, DOI 10.1097/MNH.0b013e3283454319; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Grandits G, 2018, USING SAS PERFORM IN, V2010; Gray B., CMPRSK SUBDISTRIBUTI; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hsieh CY, 2013, J FORMOSAN MED ASS; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Lee JJ, 2010, AM J KIDNEY DIS, V56, P23, DOI 10.1053/j.ajkd.2010.01.015; Liang JA, 2011, JPN J CLIN ONCOL, V41, P752, DOI 10.1093/jjco/hyr051; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin HF, 2012, NEPHROL DIAL TRANSPL, V27, P1585, DOI 10.1093/ndt/gfr464; Lin MY, 2012, SCI C ANN M 2012 TAI, P308; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Satoh S, 2005, J UROLOGY, V174, P1749, DOI 10.1097/01.ju.0000177489.98031.54; Shebl FM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-65; Skov Dalgaard L, 2013, BMC NEPHROL, V14, P137, DOI [10.1186/1471-2369-14-137, DOI 10.1186/1471-2369-14-137]; Stefanovic V, 2008, NAT CLIN PRACT UROL, V5, P105, DOI 10.1038/ncpuro1019; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; Stewart JH, 2009, NEPHROL DIAL TRANSPL, V24, P3225, DOI 10.1093/ndt/gfp331; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Wang SM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/149750; Yang CS, 2000, AM J KIDNEY DIS, V35, P313, DOI 10.1016/S0272-6386(00)70343-X; Yang HY, 2009, J EPIDEMIOL, V19, P17, DOI 10.2188/jea.JE20080035	33	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122856	10.1371/journal.pone.0122856	http://dx.doi.org/10.1371/journal.pone.0122856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874862	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100110
J	Liu, QH; Wu, X; Ma, JQ; Chen, BC; Xin, CY				Liu, Qihua; Wu, Xiu; Ma, Jiaqing; Chen, Bocong; Xin, Caiyun			Effects of Delaying Transplanting on Agronomic Traits and Grain Yield of Rice under Mechanical Transplantation Pattern	PLOS ONE			English	Article							SEEDLING AGE; WATER PRODUCTIVITY; DRY-MATTER; ACCUMULATION; ATTRIBUTES; NITROGEN	A delay in the mechanical transplantation (MT) of rice seedlings frequently occurs in Huanghuai wheat-rice rotation cropping districts of China, due to the late harvest of wheat, the poor weather conditions and the insufficiency of transplanters, missing the optimum transplanting time and causing seedlings to age. To identify how delaying transplanting rice affects the agronomic characteristics including the growth duration, photosynthetic productivity and dry matter remobilization efficiency and the grain yield under mechanical transplanting pattern, an experiment with a split-plot design was conducted over two consecutive years. The main plot includes two types of cultivation: mechanical transplanting and artificial transplanting (AT). The subplot comprises four japonica rice cultivars. The results indicate that the rice jointing, booting, heading and maturity stages were postponed under MT when using AT as a control. The tiller occurrence number, dry matter weight per tiller, accumulative dry matter for the population, leaf area index, crop growth rate, photosynthetic potential, and dry matter remobilization efficiency of the leaf under MT significantly decreased compared to those under AT. In contrast, the reduction rate of the leaf area during the heading-maturity stage was markedly enhanced under MT. The numbers of effective panicles and filled grains per panicle and the grain yield significantly decreased under MT. A significant correlation was observed between the dry matter production, remobilization and distribution characteristics and the grain yield. We infer that, as with rice from old seedlings, the decrease in the tiller occurrence, the photosynthetic productivity and the assimilate remobilization efficiency may be important agronomic traits that are responsible for the reduced grain yield under MT.	[Liu, Qihua; Wu, Xiu; Ma, Jiaqing; Chen, Bocong; Xin, Caiyun] Shandong Acad Agr Sci, Rice Res Inst, Jinan 250100, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences	Liu, QH (corresponding author), Shandong Acad Agr Sci, Rice Res Inst, Jinan 250100, Shandong, Peoples R China.	zxbsds@163.com; mjq1961sd@163.com						Adhikari B. B., 2013, American Journal of Plant Sciences, V4, P146; Brar SK, 2012, AGR WATER MANAGE, V115, P217, DOI 10.1016/j.agwat.2012.09.001; Chahal GBS, 2007, AGR WATER MANAGE, V88, P14, DOI 10.1016/j.agwat.2006.08.007; Cheng SH, 2012, REPORT RICE IND DEV, P149; Choi WeonYoung, 2006, Korean Journal of Crop Science, V51, P379; Cock J. H., 1972, Proceedings of the Crop Science Society of Japan, V41, P226; Han X, 2011, NO EC TRADE, V3, P38; Hemmat A, 2003, SOIL TILL RES, V70, P65, DOI 10.1016/S0167-1987(02)00119-8; Huo ZhongYang, 2012, Acta Agronomica Sinica, V38, P1908; Ito T, 2009, J DEV ECON, V88, P292, DOI 10.1016/j.jdeveco.2008.06.002; Katsura K, 2007, FIELD CROP RES, V103, P170, DOI 10.1016/j.fcr.2007.06.001; Knight J, 2011, CHINA ECON REV, V22, P585, DOI 10.1016/j.chieco.2011.01.006; Kobayashi K., 2009, Japanese Journal of Crop Science, V78, P17, DOI 10.1626/jcs.78.17; Laszlo S, 2008, WORLD DEV, V36, P2421, DOI 10.1016/j.worlddev.2008.04.001; Li Jie, 2011, Acta Agronomica Sinica, V37, P1235; Li Jie, 2011, Acta Agronomica Sinica, V37, P309, DOI 10.3724/SP.J.1006.2011.00309; Mobasser Hamid Reza, 2007, Asian Journal of Plant Sciences, V6, P438; Ntanos DA, 2002, FIELD CROP RES, V74, P93, DOI 10.1016/S0378-4290(01)00203-9; Park HK, 2002, KOREAN J CROP SCI, V47, P167; Ranamukhaarachchi S., 2011, RECENT RES SCI TECHN, V3, P76; Sarwa N, 2011, CHIL J AGR RES, V71, P343, DOI 10.4067/S0718-58392011000300001; Shafiq MN, 2007, J ASIAN ECON, V18, P946, DOI 10.1016/j.asieco.2007.07.003; Takahashi Y., 2007, Japanese Journal of Crop Science, V76, P355, DOI 10.1626/jcs.76.355; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Thanunathan K., 2002, CROP RES, V24, P421; Thomas EV, 2002, MECH MACH THEORY, V37, P395; Wang XB, 2007, CHINA ECON REV, V18, P287, DOI 10.1016/j.chieco.2007.02.004; Xiong J, 2013, AGRON J, V105, P1142, DOI 10.2134/agronj2012.0297; Yu LY, 2006, SCANNING, V28, P73; Zhang ZuJian, 2008, Acta Agronomica Sinica, V34, P297, DOI 10.3724/SP.J.1006.2008.00297	30	26	28	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123330	10.1371/journal.pone.0123330	http://dx.doi.org/10.1371/journal.pone.0123330			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875607	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100164
J	Petzold, K; Poster, D; Krauer, F; Spanaus, K; Andreisek, G; Nguyen-Kim, TDL; Pavik, I; Ho, TA; Serra, AL; Rotar, L				Petzold, Katja; Poster, Diane; Krauer, Fabienne; Spanaus, Katharina; Andreisek, Gustav; Thi Dan Linh Nguyen-Kim; Pavik, Ivana; Thien Anh Ho; Serra, Andreas L.; Rotar, Laura			Urinary Biomarkers at Early ADPKD Disease Stage	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; TAMM-HORSFALL PROTEIN; GELATINASE-ASSOCIATED LIPOCALIN; INJURY; UROMODULIN; EXPRESSION; FAILURE; GROWTH; DAMAGE	Background Autosomal dominant polycystic kidney disease ( ADPKD) is characterized by a decline in renal function at late disease stage when the majority of functional renal parenchyma is replaced by cystic tissue. Thus, kidney function, assessed by estimated glomerular filtration rate (eGFR) does not well represent disease burden in early disease. Here, we investigated various urinary markers for tubular injury and their association with disease burden in ADPKD patients at early disease course. Methods ADPKD patients between 18 and 40 years with an eGFR greater or equal to 70 ml per min per 1.73m(2) were eligible for this cross-sectional study. Urinary Neutrophil Gelatinase- Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), and Uromodulin (UMOD) were investigated by Enzyme-Linked Immunosorbent Assay. Clara Cell Protein 16 (CC16) was investigated by Latex Immuno Assay. Cryoscopy was performed to assess urine osmolality and Urinary Albumin-to-Creatinine Ratio (UACR) was calculated. The association and the predictive properties of the markers on eGFR and height adjusted total kidney volume (htTKV) was evaluated using multiple regression analysis, incorporating different control variables for adjustment. Internal bootstrapping validated the obtained results. Results In 139 ADPKD patients (age 31 +/- 7 years, mean eGFR of 93 +/- 19 ml per min per 1.73m(2)) the total kidney volume was negatively correlated with eGFR and UMOD and positive associated with age, UACR, KIM-1 and urine osmolality after adjustment for possible confounders. Urine osmolality and htTKV were also associated with eGFR, whereas no association of CC16, NGAL and UMOD with eGFR or htTKV was found. Conclusion UACR and urinary KIM-1 are independently associated with kidney size but not with renal function in our study population. Urine osmolality was associated with eGFR and kidney volume following adjustment for multiple confounders. Despite statistical significance, the clinical value of our results is not yet conceivable. Further studies are needed to evaluate the property of the aforementioned biomarkers to assess disease state at early ADPKD stage.	[Petzold, Katja; Serra, Andreas L.; Rotar, Laura] Inst Physiol, Zurich, Switzerland; [Petzold, Katja; Serra, Andreas L.; Rotar, Laura] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Poster, Diane; Krauer, Fabienne; Serra, Andreas L.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Spanaus, Katharina] Univ & Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland; [Andreisek, Gustav; Thi Dan Linh Nguyen-Kim] Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Serra, Andreas L.; Rotar, Laura] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Petzold, Katja; Serra, Andreas L.; Rotar, Laura] Univ Zurich, Coordinat Ctr, EuroCYST Initiat, Zurich, Switzerland; [Thien Anh Ho] Catholic Univ Louvain, Clin Univ St Luc, Sch Med, Div Nephrol, B-1200 Brussels, Belgium; [Serra, Andreas L.; Rotar, Laura] Univ Zurich, Trancyst PEOPLE MCA ITN FP7, Zurich, Switzerland	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Zurich	Serra, AL (corresponding author), Inst Physiol, Zurich, Switzerland.	andreas.serra@uzh.ch	Nguyen-Kim, PD Dr. Thi Dan Linh/AAD-7478-2019	Nguyen-Kim, Thi Dan Linh/0000-0001-9888-0453; Krauer, Fabienne/0000-0001-8341-4011	EuroCYST Initiative (ERA EDTA); TransCYST (FP7-PEOPLE-MCA-ITN) [317246]; European Community's 7th Framework Program (FP7) (EURenOmics) [305608]; Action de Recherche Concertee (Communaute Francaise de Belgique) [ARC10/15-029]; Inter-University Attraction Pole (IUAP, Belgium Federal Government); NCCR Kidney. CH program (Swiss National Science Foundation); Swiss National Science Foundation [310030-146490]	EuroCYST Initiative (ERA EDTA); TransCYST (FP7-PEOPLE-MCA-ITN); European Community's 7th Framework Program (FP7) (EURenOmics); Action de Recherche Concertee (Communaute Francaise de Belgique); Inter-University Attraction Pole (IUAP, Belgium Federal Government); NCCR Kidney. CH program (Swiss National Science Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the EuroCYST Initiative (ERA EDTA), TransCYST (FP7-PEOPLE-MCA-ITN no. 317246), European Community's 7th Framework Program (FP7/2007-2013) under grant n degrees 305608 (EURenOmics); Action de Recherche Concertee (ARC10/15-029, Communaute Francaise de Belgique); Inter-University Attraction Pole (IUAP, Belgium Federal Government); the NCCR Kidney. CH program (Swiss National Science Foundation); and the Swiss National Science Foundation 310030-146490.	Aberg F, 2014, CLIN TRANSPLANT, V28, P869, DOI 10.1111/ctr.12394; Arthur JM, 2014, KIDNEY INT, V85, P431, DOI 10.1038/ki.2013.333; Bachhaus K, 2000, BACHHAUS MULTIVARIAT; BERNARD A, 1991, CLIN CHIM ACTA, V201, P231, DOI 10.1016/0009-8981(91)90374-L; BERNARD A, 1995, TOXICOL LETT, V77, P145, DOI 10.1016/0378-4274(95)03284-3; BERNARD AM, 1994, KIDNEY INT, pS34; Blanco G, 2013, AM J PHYSIOL-RENAL, V305, pF797, DOI 10.1152/ajprenal.00248.2013; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Briggs JP, 2008, KIDNEY INT, V74, P987, DOI 10.1038/ki.2008.426; CARONE FA, 1988, KIDNEY INT, V33, P8, DOI 10.1038/ki.1988.2; Chakraborty J, 2004, UROL RES, V32, P79, DOI 10.1007/s00240-003-0374-6; Chao YCE, 2008, J OCCUP ENVIRON HYG, V5, P519, DOI 10.1080/15459620802225481; CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1349; Damman K, 2010, HEART, V96, P1297, DOI 10.1136/hrt.2010.194878; Devuyst O, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-28; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Gattone VH, 1999, DEV GENET, V24, P309, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<309::AID-DVG14>3.0.CO;2-5; Haase-Fielitz A, 2014, ANN CLIN BIOCHEM, V51, P335, DOI 10.1177/0004563214521795; Jouret F, 2007, J AM SOC NEPHROL, V18, P707, DOI 10.1681/ASN.2006030269; Kistler AD, 2009, KIDNEY INT, V75, P235, DOI 10.1038/ki.2008.558; Kuehn EW, 2007, BIOCHEM BIOPH RES CO, V364, P861, DOI 10.1016/j.bbrc.2007.10.103; Kuehn EW, 2002, AM J PHYSIOL-RENAL, V283, pF1326, DOI 10.1152/ajprenal.00166.2002; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lohninger H., 2007, LOHNINGER GRUNDLAGEN; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; Meijer E, 2010, AM J KIDNEY DIS, V56, P883, DOI 10.1053/j.ajkd.2010.06.023; Meijer E, 2010, CLIN J AM SOC NEPHRO, V5, P1091, DOI 10.2215/CJN.00360110; Mollsten A, 2010, SCAND J UROL NEPHROL, V44, P438, DOI 10.3109/00365599.2010.504190; Nisula S, 2014, ANESTH ANALG, V119, P95, DOI 10.1213/ANE.0000000000000243; Olden M, 2014, J AM SOC NEPHROL, V25, P1869, DOI 10.1681/ASN.2013070781; Parikh CR, 2012, KIDNEY INT, V81, P784, DOI 10.1038/ki.2011.465; Pavik I, 2011, KIDNEY INT, V79, P234, DOI 10.1038/ki.2010.375; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Prajczer S, 2010, NEPHROL DIAL TRANSPL, V25, P1896, DOI 10.1093/ndt/gfp748; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Roscioni SS, 2013, DIABETOLOGIA, V56, P259, DOI 10.1007/s00125-012-2755-2; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Singer E, 2011, KIDNEY INT, V80, P405, DOI 10.1038/ki.2011.41; Tesch GH, 2010, NEPHROLOGY, V15, P609, DOI 10.1111/j.1440-1797.2010.01361.x; Ho TA, 2012, KIDNEY INT, V82, P1121, DOI 10.1038/ki.2012.225; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2012, KIDNEY INT, V81, P577, DOI 10.1038/ki.2011.411; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Youhanna S, 2014, NEPHROL DIAL TRANSPL, V29, P136, DOI 10.1093/ndt/gft345; Zhou JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071023	45	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123555	10.1371/journal.pone.0123555	http://dx.doi.org/10.1371/journal.pone.0123555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875363	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000352845100187
J	Zago, CE; Silva, S; Sanita, PV; Barbugli, PA; Dias, CMI; Lordello, VB; Vergani, CE				Zago, Chaiene Evelin; Silva, Sonia; Sanita, Paula Volpato; Barbugli, Paula Aboud; Improta Dias, Carla Maria; Lordello, Virginia Barreto; Vergani, Carlos Eduardo			Dynamics of Biofilm Formation and the Interaction between Candida albicans and Methicillin-Susceptible (MSSA) and -Resistant Staphylococcus aureus (MRSA)	PLOS ONE			English	Article							ENZYMATIC-ACTIVITY PROFILE; IN-VITRO EVALUATION; VIRULENCE; QUANTIFICATION; SPP.; PHOSPHOLIPASES; FLUCONAZOLE; PREVALENCE; DAPTOMYCIN; EXPRESSION	Polymicrobial biofilms are an understudied and a clinically relevant problem. This study evaluates the interaction between C. albicans, and methicillin-susceptible (MSSA) and resistant (MRSA) S. aureus growing in single-and dual-species biofilms. Single and dual species adhesion (90 min) and biofilms (12, 24, and 48 h) were evaluated by complementary methods: counting colony-forming units (CFU mL(-1)), XTT-reduction, and crystal violet staining (CV). The secretion of hydrolytic enzymes by the 48 h biofilms was also evaluated using fluorimetric kits. Scanning electron microscopy (SEM) was used to assess biofilm structure. The results from quantification assays were compared using two-way ANOVAs with Tukey post-hoc tests, while data from enzymatic activities were analyzed by one-way Welch-ANOVA followed by Games-Howell post hoc test (alpha = 0.05). C. albicans, MSSA and MRSA were able to adhere and to form biofilm in both single or mixed cultures. In general, all microorganisms in both growth conditions showed a gradual increase in the number of cells and metabolic activity over time, reaching peak values between 12 h and 48 h (rho<0.05). C. albicans single-and dual-biofilms had significantly higher total biomass values (rho<0.05) than single biofilms of bacteria. Except for single MRSA biofilms, all microorganisms in both growth conditions secreted proteinase and phospholipase-C. SEM images revealed extensive adherence of bacteria to hyphal elements of C. albicans. C. albicans, MSSA, and MRSA can co-exist in biofilms without antagonism and in an apparent synergistic effect, with bacteria cells preferentially associated to C. albicans hyphal forms.	[Zago, Chaiene Evelin; Sanita, Paula Volpato; Barbugli, Paula Aboud; Improta Dias, Carla Maria; Lordello, Virginia Barreto; Vergani, Carlos Eduardo] Univ Estadual Paulista, UNESP, Dept Dent Mat & Prosthodont, Araraquara Dent Sch, Sao Paulo, Brazil; [Silva, Sonia] Univ Minho, IBB, Ctr Biol Engn, Braga, Portugal	Universidade Estadual Paulista; Universidade do Minho	Vergani, CE (corresponding author), Univ Estadual Paulista, UNESP, Dept Dent Mat & Prosthodont, Araraquara Dent Sch, Sao Paulo, Brazil.	vergani@foar.unesp.br	Barbugli, Paula/AAK-8605-2021; Sanitá, Paula/A-7777-2015; Barbugli, Paula/D-7148-2013; Zago, Chaiene Evelin/D-9530-2013; Vergani, Carlos E/A-3043-2008; Silva, Sónia/F-1190-2013; FAPESP, CDMF/J-3591-2015	Vergani, Carlos E/0000-0002-7375-4714; Silva, Sónia/0000-0003-0000-7387; FAPESP, CDMF/0000-0002-4464-0937; Barbugli, Paula/0000-0002-0078-1172; Barreto Lordello, Virginia/0000-0002-8199-0151	CAPES (Coordination for the Improvement of Higher Level Personnel); CNPq (Council for Technical and Scientific Development) [400658/2012-7]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BPD/71076/2010]	CAPES (Coordination for the Improvement of Higher Level Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Council for Technical and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This work was supported by CAPES (Coordination for the Improvement of Higher Level Personnel), CNPq (Council for Technical and Scientific Development) (Grant 400658/2012-7) and Fundacao para a Ciencia e Tecnologia (FCT), Portugal (SFRH/BPD/71076/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2001, ARCH GERONTOL GERIAT, V32, P45, DOI 10.1016/S0167-4943(00)00091-1; Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Altieri KT, 2012, J AM DENT ASSOC, V143, P270, DOI 10.14219/jada.archive.2012.0152; Baena-Morroy T, 2004, ORAL MED PATHOLOGY, V10, P27; Bamford CV, 2009, INFECT IMMUN, V77, P3696, DOI 10.1128/IAI.00438-09; Bosco Vera Lucia, 2003, Pesqui Odontol Bras, V17, P217, DOI 10.1590/S1517-74912003000300004; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; CARLSON E, 1983, INFECT IMMUN, V42, P285, DOI 10.1128/IAI.42.1.285-292.1983; CARLSON E, 1985, INFECT IMMUN, V50, P655, DOI 10.1128/IAI.50.3.655-659.1985; Chadwick PR, 1999, INT J ANTIMICROB AG, V11, P89, DOI 10.1016/S0924-8579(98)00103-4; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Colombo AL, 1999, DIAGN MICR INFEC DIS, V34, P281; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; D'Eca A, 2011, REV SOC BRAS MED TRO, V44, P334, DOI 10.1590/S0037-86822011005000036; El-Azizi MA, 2004, J APPL MICROBIOL, V96, P1067, DOI 10.1111/j.1365-2672.2004.02213.x; Faix R G, 1989, J Perinatol, V9, P131; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Harriott MM, 2010, ANTIMICROB AGENTS CH, V54, P3746, DOI 10.1128/AAC.00573-10; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Hua X, 2009, MOL VIS, V15, P1476; Hube B, 1996, Curr Top Med Mycol, V7, P55; Ibarra-Trujillo C, 2012, REV IBEROAM MICOL, V29, P214, DOI 10.1016/j.riam.2012.02.003; KAMINISHI H, 1995, INFECT IMMUN, V63, P984, DOI 10.1128/IAI.63.3.984-988.1995; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lyon JP, 2006, ORAL SURG ORAL MED O, V102, P632, DOI 10.1016/j.tripleo.2005.12.015; Manfredi M, 2006, ORAL MICROBIOL IMMUN, V21, P183, DOI 10.1111/j.1399-302X.2006.00275.x; Mylotte JM, 2002, CLIN INFECT DIS, V35, P1205, DOI 10.1086/344281; Naglik JR, 1999, INFECT IMMUN, V67, P2482, DOI 10.1128/IAI.67.5.2482-2490.1999; Negri M, 2010, MYCOPATHOLOGIA, V169, P175, DOI 10.1007/s11046-009-9246-0; O'Day DM, 2000, INVEST OPHTH VIS SCI, V41, P1116; Palavecino E, 2004, CLIN LAB MED, V24, P403, DOI 10.1016/j.cll.2004.03.007; Pande M, 2006, J AGR FOOD CHEM, V54, P10141, DOI 10.1021/jf062206a; Pereira CA, 2011, LASER MED SCI, V26, P341, DOI 10.1007/s10103-010-0852-3; Peters BM, 2013, INFECT IMMUN, V81, P2178, DOI 10.1128/IAI.00265-13; Peters BM, 2012, MICROBIOL-SGM, V158, P2975, DOI 10.1099/mic.0.062109-0; Peters BM, 2010, FEMS IMMUNOL MED MIC, V59, P493, DOI 10.1111/j.1574-695X.2010.00710.x; Pinto E, 2008, J ORAL PATHOL MED, V37, P587, DOI 10.1111/j.1600-0714.2008.00687.x; Rajendran R, 2010, MYCOPATHOLOGIA, V170, P229, DOI 10.1007/s11046-010-9319-0; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Roveta S, 2008, INT J ANTIMICROB AG, V31, P321, DOI 10.1016/j.ijantimicag.2007.11.012; SALYERS AA, 1994, BACTERIAL PATHOGENES; Sanita PV, 2014, OR SURG OR MED OR PA, V118, P84, DOI 10.1016/j.oooo.2014.03.020; Sanita PV, 2014, MYCOSES, V57, P351, DOI 10.1111/myc.12162; Sanita PV, 2011, ORAL SURG ORAL MED O, V111, P726, DOI 10.1016/j.tripleo.2011.02.033; Schlecht LM, 2015, MICROBIOL-SGM, V161, P168, DOI 10.1099/mic.0.083485-0; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Silva S, 2010, CURR MICROBIOL, V61, P534, DOI 10.1007/s00284-010-9649-7; Silva S, 2009, MED MYCOL, V47, P681, DOI 10.3109/13693780802549594; Smith AJ, 2003, J HOSP INFECT, V55, P184, DOI 10.1016/j.jhin.2003.08.004; Smith K, 2009, INT J ANTIMICROB AG, V33, P374, DOI 10.1016/j.ijantimicag.2008.08.029; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Taniguchi L, 2009, J MICROBIOL METH, V78, P171, DOI 10.1016/j.mimet.2009.05.012; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Thein ZM, 2006, ARCH ORAL BIOL, V51, P672, DOI 10.1016/j.archoralbio.2006.02.005	57	94	97	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123206	10.1371/journal.pone.0123206	http://dx.doi.org/10.1371/journal.pone.0123206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875834	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100152
J	Makino, K; Takeichi, O; Hatori, K; Imai, K; Ochiai, K; Ogiso, B				Makino, Kosuke; Takeichi, Osamu; Hatori, Keisuke; Imai, Kenichi; Ochiai, Kuniyasu; Ogiso, Bunnai			Epstein-Barr Virus Infection in Chronically Inflamed Periapical Granulomas	PLOS ONE			English	Article							CYTOKINE EXPRESSION; APICAL PERIODONTITIS; GASTRIC-CARCINOMA; T-LYMPHOCYTE; CELLS; CYTOMEGALOVIRUS; THERAPY; LESIONS; GROWTH; IL-10	Periapical granulomas are lesions around the apex of a tooth caused by a polymicrobial infection. Treatment with antibacterial agents is normally performed to eliminate bacteria from root canals; however, loss of the supporting alveolar bone is typically observed, and tooth extraction is often selected if root canal treatment does not work well. Therefore, bacteria and other microorganisms could be involved in this disease. To understand the pathogenesis of periapical granulomas more precisely, we focused on the association with Epstein-Barr virus (EBV) using surgically removed periapical granulomas (n = 32). EBV DNA was detected in 25 of 32 periapical granulomas (78.1%) by real-time PCR, and the median number of EBV DNA copies was approximately 8,688.01/mu g total DNA. In contrast, EBV DNA was not detected in healthy gingival tissues (n = 10); the difference was statistically significant according to the Mann-Whitney U test (p = 0.0001). Paraffin sections were also analyzed by in situ hybridization to detect EBV-encoded small RNA (EBER)-expressing cells. EBER was detected in the cytoplasm and nuclei of B cells and plasma cells in six of nine periapical granulomas, but not in healthy gingival tissues. In addition, immunohistochemical analysis for latent membrane protein 1 (LMP-1) of EBV using serial tissue sections showed that LMP-1-expressing cells were localized to the same areas as EBER-expressing cells. These data suggest that B cells and plasma cells in inflamed granulomas are a major source of EBV infection, and that EBV could play a pivotal role in controlling immune cell responses in periapical granulomas.	[Makino, Kosuke; Takeichi, Osamu; Hatori, Keisuke; Ogiso, Bunnai] Nihon Univ, Sch Dent, Dept Endodont, Chiyoda Ku, Tokyo 101, Japan; [Imai, Kenichi; Ochiai, Kuniyasu] Nihon Univ, Sch Dent, Dept Microbiol, Chiyoda Ku, Tokyo 101, Japan	Nihon University; Nihon University	Takeichi, O (corresponding author), Nihon Univ, Sch Dent, Dept Endodont, Chiyoda Ku, Tokyo 101, Japan.	takeichi.osamu@nihon-u.ac.jp			 [23592811];  [26462897]	; 	OT: Grant-in-AId for Scientific Research (http://www.jsps.go.jp/j-grantsinaid/index.html) for 2013 (23592811) and 2014 (26462897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Chang K L, 1992, Diagn Mol Pathol, V1, P246, DOI 10.1097/00019606-199203000-00037; Chen V, 2009, J ENDODONT, V35, P182, DOI 10.1016/j.joen.2008.11.018; Chong JM, 2002, J VIROL, V76, P6825, DOI 10.1128/JVI.76.13.6825-6831.2002; Endo LH, 2001, INT J PEDIATR OTORHI, V58, P9, DOI 10.1016/S0165-5876(00)00446-8; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FURNARI FB, 1992, J VIROL, V66, P2837, DOI 10.1128/JVI.66.5.2837-2845.1992; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; Guilherme BPS, 2011, ORAL SURG ORAL MED O, V112, P678, DOI 10.1016/j.tripleo.2011.05.003; Hren NI, 2009, ARCH ORAL BIOL, V54, P156, DOI 10.1016/j.archoralbio.2008.09.014; Iwakiri D, 2005, ONCOGENE, V24, P1767, DOI 10.1038/sj.onc.1208357; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Jungermann GB, 2011, J ENDODONT, V37, P1337, DOI 10.1016/j.joen.2011.06.028; Kivity S, 2014, J AUTOIMMUN, V51, P17, DOI 10.1016/j.jaut.2014.02.008; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Nair PNR, 2004, CRIT REV ORAL BIOL M, V15, P348, DOI 10.1177/154411130401500604; Nakai H, 2012, MICROBIOL IMMUNOL, V56, P93, DOI 10.1111/j.1348-0421.2011.00410.x; de Brito LCN, 2012, J ENDODONT, V38, P481, DOI 10.1016/j.joen.2011.12.010; Sabeti M, 2003, ORAL MICROBIOL IMMUN, V18, P327, DOI 10.1034/j.1399-302X.2003.00079.x; Sabeti M, 2012, J ENDODONT, V38, P47, DOI 10.1016/j.joen.2011.09.026; Samanta M, 2008, ONCOGENE, V27, P4150, DOI 10.1038/onc.2008.75; Sawada S, 2007, AUTOIMMUN REV, V6, P126, DOI 10.1016/j.autrev.2006.08.014; SCHWEMMLE M, 1992, P NATL ACAD SCI USA, V89, P10292, DOI 10.1073/pnas.89.21.10292; Sin SH, 2012, J INTERF CYTOK RES, V32, P53, DOI 10.1089/jir.2011.0083; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Siqueira Jose F Jr, 2009, J Oral Microbiol, V1, DOI 10.3402/jom.v1i0.2009; Sunde PT, 2008, J CLIN VIROL, V42, P176, DOI 10.1016/j.jcv.2008.01.007; Szkaradkiewicz A, 2006, VIRUS RES, V118, P115, DOI 10.1016/j.virusres.2005.12.001; Takeichi O, 1998, IMMUNOLOGY, V93, P275; Windley W, 2005, J ENDODONT, V31, P439, DOI 10.1097/01.don.0000148143.80283.ea; Yang LX, 2004, CANCER RES, V64, P5332, DOI 10.1158/0008-5472.CAN-04-0733	31	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121548	10.1371/journal.pone.0121548	http://dx.doi.org/10.1371/journal.pone.0121548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884725	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000020
J	Schumak, B; Klocke, K; Kuepper, JM; Biswas, A; Djie-Maletz, A; Limmer, A; van Rooijen, N; Mack, M; Hoerauf, A; Dunay, IR				Schumak, Beatrix; Klocke, Katrin; Kuepper, Janina M.; Biswas, Aindrila; Djie-Maletz, Andrea; Limmer, Andreas; van Rooijen, Nico; Mack, Matthias; Hoerauf, Achim; Dunay, Ildiko Rita			Specific Depletion of Ly6C(hi) Inflammatory Monocytes Prevents Immunopathology in Experimental Cerebral Malaria	PLOS ONE			English	Article							T-CELL RESPONSES; CHEMOKINE RECEPTOR CCR2; BLOOD-BRAIN-BARRIER; CD8(+) T; PLASMODIUM-BERGHEI; TOXOPLASMA-GONDII; DENDRITIC CELLS; INBRED STRAINS; BONE-MARROW; INFECTION	Plasmodium berghei ANKA (PbA) infection of C57BL/6 mice leads to experimental cerebral malaria (ECM) that is commonly associated with serious T cell mediated damage. In other parasitic infection models, inflammatory monocytes have been shown to regulate Th1 responses but their role in ECM remains poorly defined, whereas neutrophils are reported to contribute to ECM immune pathology. Making use of the recent development of specific monoclonal antibodies (mAb), we depleted in vivo Ly6C(hi) inflammatory monocytes (by anti-CCR2), Ly6G(+) neutrophils (by anti-Ly6G) or both cell types (by anti-Gr1) during infection with Ovalbumin-transgenic PbA parasites (PbTg). Notably, the application of anti-Gr1 or anti-CCR2 but not anti-Ly6G antibodies into PbTg-infected mice prevented ECM development. In addition, depletion of Ly6Chi inflammatory monocytes but not neutrophils led to decreased IFN gamma levels and IFN gamma(+)CD8(+) T effector cells in the brain. Importantly, anti-CCR2 mAb injection did not prevent the generation of PbTg-specific T cell responses in the periphery, whereas anti-Gr1 mAb injection strongly diminished T cell frequencies and CTL responses. In conclusion, the specific depletion of Ly6Chi inflammatory monocytes attenuated brain inflammation and immune cell recruitment to the CNS, which prevented ECM following Plasmodium infection, pointing out a substantial role of Ly6C(+) monocytes in ECM inflammatory processes.	[Schumak, Beatrix; Klocke, Katrin; Kuepper, Janina M.; Hoerauf, Achim] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Biswas, Aindrila; Dunay, Ildiko Rita] Univ Magdeburg, Inst Med Microbiol, D-39106 Magdeburg, Germany; [Djie-Maletz, Andrea] Univ Freiburg, Dept Neurosurg, D-79106 Freiburg, Germany; [Limmer, Andreas] Univ Bonn, Inst Mol Med, Bonn, Germany; [Limmer, Andreas] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [van Rooijen, Nico] Vrije Univ, Fac Med, VUMC Dept Mol Cell Biol, Amsterdam, Netherlands; [Mack, Matthias] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany	University of Bonn; Otto von Guericke University; University of Freiburg; University of Bonn; University of Bonn; Vrije Universiteit Amsterdam; University of Regensburg	Schumak, B (corresponding author), Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany.	bschumak@uni-bonn.de; ildikodunay@gmail.com	Van Rooijen, Nico/Z-1578-2019	Kuehlwein, Janina M./0000-0003-3648-2649	German Research Foundation Excellence Cluster Immunosensation (DFG) [EXC 1023]; BONFOR intramural funding scheme of the Medical Faculty at Bonn University [2012-1-22, 2013-1-29]; German Research Foundation [DU1112/3-1]	German Research Foundation Excellence Cluster Immunosensation (DFG); BONFOR intramural funding scheme of the Medical Faculty at Bonn University; German Research Foundation(German Research Foundation (DFG))	This study received financial support from the German Research Foundation Excellence Cluster Immunosensation (DFG, EXC 1023), through an award to BS to establish a research group (http://www.immunosensation.de). AH is a steering committee member of the EXC 1023 and also of the German Center for Infection Research, DZIF (www.dzif.de). BS and JMK are supported by the BONFOR intramural funding scheme of the Medical Faculty at Bonn University (grants 2012-1-22, 2013-1-29) (www.ukb.unibonn.de/bonfor/). IRD is supported by the German Research Foundation (DU1112/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Belnoue E, 2003, INFECT IMMUN, V71, P3648, DOI 10.1128/IAI.71.6.3648-3651.2003; Biswas A, 2015, J IMMUNOL, V194, P3223, DOI 10.4049/jimmunol.1402037; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Chen L, 2000, CLIN EXP IMMUNOL, V120, P125, DOI 10.1046/j.1365-2249.2000.01196.x; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Dunay IR, 2010, CURR OPIN IMMUNOL, V22, P461, DOI 10.1016/j.coi.2010.04.008; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; GREENBERG J, 1957, J PARASITOL, V43, P413, DOI 10.2307/3274665; GREENBERG J, 1957, J PARASITOL, V43, P420, DOI 10.2307/3274666; Helk E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003096; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Hucke S, 2012, BRAIN, V135, P1586, DOI 10.1093/brain/aws058; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Johnson HL, 2012, J IMMUNOL, V189, P1937, DOI 10.4049/jimmunol.1200658; Karlmark KR, 2012, EUR J MICROBIOL IMMU, V2, P97, DOI 10.1556/EuJMI.2.2012.2.1; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Maffei M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-87; Mohle L, 2014, EUR J MICROBIOL IMMU, V4, P65, DOI 10.1556/EuJMI.4.2014.1.6; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Naert G, 2013, J MOL CELL BIOL, V5, P284, DOI 10.1093/jmcb/mjt028; Naert G, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00051; Ribes S, 2013, INFECT IMMUN, V81, P1810, DOI 10.1128/IAI.01349-12; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Schmidt KE, 2011, MICROBES INFECT, V13, P828, DOI 10.1016/j.micinf.2011.04.006; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sheel M, 2012, TRENDS PARASITOL, V28, P408, DOI 10.1016/j.pt.2012.07.008; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang BM, 2012, CELL IMMUNOL, V278, P103, DOI 10.1016/j.cellimm.2012.07.005; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wojtasiak M, 2010, J GEN VIROL, V91, P2158, DOI 10.1099/vir.0.021915-0; Yanez DM, 1996, J IMMUNOL, V157, P1620	43	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124080	10.1371/journal.pone.0124080	http://dx.doi.org/10.1371/journal.pone.0124080			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884830	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000101
J	Ornellas, F; Souza-Mello, V; Mandarim-de-Lacerda, CA; Aguila, MB				Ornellas, Fernanda; Souza-Mello, Vanessa; Mandarim-de-Lacerda, Carlos Alberto; Aguila, Marcia Barbosa			Programming of Obesity and Comorbidities in the Progeny: Lessons from a Model of Diet-Induced Obese Parents	PLOS ONE			English	Article							HIGH-FAT DIET; ANTHROPOMETRIC RELATIONSHIPS; INSULIN; GLUCOSE; MICE; DYSFUNCTION; MECHANISMS; EXPRESSION; OXIDATION; C57BL/6J	Aim To determine the impact of paternal obesity, maternal obesity or the combination of two obese parents on markers of adult offspring metabolism, with a focus on body mass (BM), lipid and carbohydrate, components of lipogenesis and beta-oxidation in the liver, sex dimorphism in the offspring that received a SC diet during the postnatal period. Materials and Methods Male and female C57BL/6 mice were fed a high-fat diet (HF; 49% lipids) or standard chow (SC; 17% lipids) for 8 weeks before mating until lactation. The offspring were labeled according to sex, maternal diet (first letters), paternal diet (second letters), and received a SCdiet until 12-weeks of age when they were sacrificed. BM, eating behavior, glucose tolerance, plasma analysis, gene and protein expression of the components of lipogenesis and beta-oxidation in the liver of offspring were evaluated. Results HF diet-fed mothers and fathers were overweight, hyperglycemic and glucose intolerant and had a deteriorating lipid profile. The adult male and female offspring of HF-mothers were overweight, with an increased adiposity index, hyperphagic, had an impaired glucose metabolism, increased total cholesterol and triacylglycerol levels, increased lipogenesis concomitant with decreased beta-oxidation resulting in liver steatosis. The male and female offspring of HF-father had impaired glucose metabolism, exacerbated lipogenesis without influencing beta-oxidation and enhanced hepatic steatosis. These findings are independent of BM. Male and female offspring of a mother and father that received a HF diet demonstrated these effects most prominently in adult life. Conclusion Paternal obesity leads to alterations in glucose metabolism, increase in components of lipogenesis and liver steatosis. In contrast, maternal obesity leads to overweight and changes in the metabolic profile and liver resulting from activation of hepatic lipogenesis with impaired beta-oxidation. When both parents are obese, the effects observed in the male and female offspring are exacerbated.	[Ornellas, Fernanda; Souza-Mello, Vanessa; Mandarim-de-Lacerda, Carlos Alberto; Aguila, Marcia Barbosa] State Univ Rio Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Aguila, MB (corresponding author), State Univ Rio Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	marciaguila@gmail.com	Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Aguila, Marcia/P-2349-2019; Souza-Mello, Vanessa/D-5092-2013; Souza-Mello, Vanessa/E-3463-2014; Aguila, Marcia Barbosa/ABF-6505-2020; Mandarim-de-Lacerda, Carlos A/F-7125-2012	Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Souza-Mello, Vanessa/0000-0002-2510-9569; Aguila, Marcia Barbosa/0000-0003-3994-4589; 	Conselho Nacional de Ciencia e Tecnologia from Brazil [302.154/2011-6]; Fundacao do Amparo a Pesquisa do Rio de Janeiro from Rio de Janeiro State [E-26/102.944/2011]	Conselho Nacional de Ciencia e Tecnologia from Brazil; Fundacao do Amparo a Pesquisa do Rio de Janeiro from Rio de Janeiro State	This research was supported by grants from the Conselho Nacional de Ciencia e Tecnologia from Brazil (grant # 302.154/2011-6, to CML), and Fundacao do Amparo a Pesquisa do Rio de Janeiro from Rio de Janeiro State (grant # E-26/102.944/2011, to CML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2011, J INTERN MED, V270, P388, DOI 10.1111/j.1365-2796.2011.02347.x; Aguila M, 2003, LIVER INT, V23, P363, DOI 10.1034/j.1478-3231.2003.00858.x; Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Barbosa-da-Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039837; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Berge JM, 2014, HEALTH PLACE, V26, P69, DOI 10.1016/j.healthplace.2013.11.007; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Botton J, 2010, EARLY HUM DEV, V86, P445, DOI 10.1016/j.earlhumdev.2010.06.001; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Dake BL, 2015, OBESITY, V23, P623, DOI 10.1002/oby.21009; de Onis M, 2000, AM J CLIN NUTR, V72, P1032; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Entringer S, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/632548; Fields DA, 2012, PEDIATR OBES, V7, P304, DOI 10.1111/j.2047-6310.2012.00059.x; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goodman ZD, 2014, CLIN LIVER DIS, V18, P33, DOI 10.1016/j.cld.2013.09.010; Gregorio BM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.042; Guan HP, 2014, PROG MOL BIOL TRANSL, V121, P165, DOI 10.1016/B978-0-12-800101-1.00006-5; Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI [10.2147/DMSOTT.S7384, 10.2147/DMSO.S7384]; Heude B, 2005, INT J OBESITY, V29, P1222, DOI 10.1038/sj.ijo.0802920; Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210; Lionetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092753; Long NM, 2012, J ANIM SCI, V90, P2201, DOI 10.2527/jas.2011-4343; Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Muoio DM, 2008, DIABETES, V57, P1455, DOI 10.2337/db08-0281; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ornellas F, 2013, LIFE SCI, V93, P454, DOI 10.1016/j.lfs.2013.08.005; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Penesova A, 2010, DIABETES CARE, V33, P1823, DOI 10.2337/dc10-0664; Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Robinson K, 2011, CRIT CARE, V15, DOI 10.1186/cc10021; Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110; Safer DL, 2001, INT J OBESITY, V25, P1532, DOI 10.1038/sj.ijo.0801786; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Watkins AJ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00981.2013	48	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124737	10.1371/journal.pone.0124737	http://dx.doi.org/10.1371/journal.pone.0124737			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880318	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500108
J	Villeponteau, B; Matsagas, K; Nobles, AC; Rizza, C; Horwitz, M; Benford, G; Mockett, RJ				Villeponteau, Bryant; Matsagas, Kennedy; Nobles, Amber C.; Rizza, Cristina; Horwitz, Marc; Benford, Gregory; Mockett, Robin J.			Herbal Supplement Extends Life Span Under Some Environmental Conditions and Boosts Stress Resistance	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; DROSOPHILA-MELANOGASTER; C. ELEGANS; CAENORHABDITIS-ELEGANS; PTEROCARPUS-MARSUPIUM; ALZHEIMERS-DISEASE; VEGF LEVELS; LONGEVITY; RESVERATROL; MORTALITY	Genetic studies indicate that aging is modulated by a great number of genetic pathways. We have used Drosophila longevity and stress assays to test a multipath intervention strategy. To carry out this strategy, we supplemented the flies with herbal extracts (SC100) that are predicted to modulate the expression of many genes involved in aging and stress resistance, such as mTOR, NOS, NF-KappaB, and VEGF. When flies were housed in large cages with SC100 added, daily mortality rates of both male and female flies were greatly diminished in mid to late life. Surprisingly, SC100 also stabilized midlife mortality rate increases so as to extend the maximum life span substantially beyond the limits previously reported for D. melanogaster. Under these conditions, SC100 also promoted robust resistance to partial starvation stress and to heat stress. Fertility was the same initially in both treated and control flies, but it became significantly higher in treated flies at older ages as the fertility of control flies declined. Mean and maximum life spans of flies in vials at the same test site were also extended by SC100, but the life spans were short in absolute terms. In contrast, at an independent test site where stress was minimized, the flies exhibited much longer mean life spans, but the survival curves became highly rectangular and the effects of SC100 on both mean and maximum life spans declined greatly or were abolished. The data indicate that SC100 is a novel herbal mix with striking effects on enhancing Drosophila stress resistance and life span in some environments, while minimizing mid to late life mortality rates. They also show that the environment and other factors can have transformative effects on both the length and distribution of survivorship, and on the ability of SC100 to extend the life span.	[Villeponteau, Bryant; Matsagas, Kennedy; Rizza, Cristina; Horwitz, Marc; Benford, Gregory] Genescient Inc, Fountain Valley, CA 92708 USA; [Benford, Gregory] Univ Calif Irvine, Irvine, CA USA; [Nobles, Amber C.; Mockett, Robin J.] Univ S Alabama, Mobile, AL 36688 USA	University of California System; University of California Irvine; University of South Alabama	Villeponteau, B (corresponding author), Genescient Inc, Fountain Valley, CA 92708 USA.	bvillepo@san.rr.com			Genescient Corporation	Genescient Corporation	The California part of this study was funded by Genescient Corporation. The authors recommended and received approval for publication from the Genescient Board of Directors. Gregory Benford is on the Board. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. Studies conducted at the University of South Alabama were funded by donations from Mr. Douglas R. Arends and an anonymous donor. The authors are not aware of any competing interests with the anonymous donor. The specific roles of these authors are articulated in the 'author contributions' section.	Austad S, 2010, AGING CELL, V9, P297, DOI 10.1111/j.1474-9726.2010.00565.x; Auyeung KKW, 2010, INT J MOL MED, V26, P341, DOI 10.3892/ijmm_00000471; Ayyadevara S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00211; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Borroni B, 2008, REJUV RES, V11, P773, DOI 10.1089/rej.2008.0711; Borroni B, 2010, J ALZHEIMERS DIS, V21, P87, DOI 10.3233/JAD-2010-091615; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Cesarone MR, 2010, PHYTOMEDICINE, V17, P835, DOI 10.1016/j.phymed.2010.04.009; Chang J, 2012, NEUROBIOL AGING, V33, P2062, DOI 10.1016/j.neurobiolaging.2011.08.015; Cho HS, 2008, NEUROTOXICOLOGY, V29, P656, DOI 10.1016/j.neuro.2008.03.004; Cho WCS, 2009, CANCER INVEST, V27, P334, DOI 10.1080/07357900802392683; Di X, 2010, NEUROSCIENCE, V168, P778, DOI 10.1016/j.neuroscience.2010.04.019; Dong Li-hua, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P417; Easton DM, 2008, AGE, V30, P311, DOI 10.1007/s11357-008-9073-0; Egashira N, 2007, J PHARMACOL SCI, V105, P211, DOI 10.1254/jphs.SCZ070901; Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Grimm Tanja, 2006, J Inflamm (Lond), V3, P1, DOI 10.1186/1476-9255-3-1; Iemitsu M, 2006, AM J PHYSIOL-HEART C, V291, pH1290, DOI 10.1152/ajpheart.00820.2005; JAHROMI MAF, 1993, J NAT PROD, V56, P989, DOI 10.1021/np50097a001; Joseph JA, 2008, J AGR FOOD CHEM, V56, P10544, DOI 10.1021/jf802279h; Joshi A, 1996, EXP GERONTOL, V31, P533, DOI 10.1016/0531-5565(96)00003-4; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kumar S, 2005, CHRONOBIOL INT, V22, P641, DOI 10.1080/07420520500179423; Kumsta C, 2014, AGING CELL, V13, P419, DOI 10.1111/acel.12189; Kwak CJ, 2009, J HYPERTENS, V27, P92, DOI 10.1097/HJH.0b013e3283186994; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060338; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Manickam M, 1997, J NAT PROD, V60, P609, DOI 10.1021/np9607013; Mateo I, 2007, ACTA NEUROL SCAND, V116, P56, DOI 10.1111/j.1600-0404.2006.00775.x; Matsagas K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006578; Mockett RJ, 2006, BIOGERONTOLOGY, V7, P157, DOI 10.1007/s10522-006-9004-3; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Mockett RJ, 2013, J GERONTOL A-BIOL, V68, P1157, DOI 10.1093/gerona/glt031; Moskalev AA, 2014, CELL CYCLE, V13, P1063, DOI 10.4161/cc.28433; Mueller LD, 1995, EXP GERONTOL, V30, P553, DOI 10.1016/0531-5565(95)00029-1; Mueller LD, 1996, P NATL ACAD SCI USA, V93, P15249, DOI 10.1073/pnas.93.26.15249; Nusbaum TJ, 1996, EXP GERONTOL, V31, P507, DOI 10.1016/0531-5565(96)00002-2; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; Paul S, 2010, CARCINOGENESIS, V31, P1272, DOI 10.1093/carcin/bgq004; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prowse N, 1997, J INSECT PHYSIOL, V43, P501, DOI 10.1016/S0022-1910(97)00014-0; Robine JM, 2001, EXP GERONTOL, V36, P915, DOI 10.1016/S0531-5565(00)00250-3; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; Rose MR, 2002, EVOLUTION, V56, P1982; Savory FR, 2014, ECOL EVOL, V4, P1176, DOI 10.1002/ece3.1013; Shahrestani Parvin, 2009, Curr Aging Sci, V2, P3; Shen Bin, 2011, Zhongguo Gu Shang, V24, P652; Takeda A, 2011, CELL MOL NEUROBIOL, V31, P1079, DOI 10.1007/s10571-011-9707-0; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; Tomada N, 2010, J SEX MED, V7, P1410, DOI 10.1111/j.1743-6109.2009.01648.x; Unno K, 2011, FREE RADICAL RES, V45, P966, DOI 10.3109/10715762.2011.566869; Villar-Cheda B, 2009, J CEREBR BLOOD F MET, V29, P230, DOI 10.1038/jcbfm.2008.127; Wang YY, 2014, COMPLEMENT THER MED, V22, P826, DOI 10.1016/j.ctim.2014.06.004; Wang ZD, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/268963; WILSON DL, 1994, MECH AGEING DEV, V74, P15, DOI 10.1016/0047-6374(94)90095-7; Xu Chun-jiao, 2007, Hua Xi Kou Qiang Yi Xue Za Zhi, V25, P432; Xu Chun-jiao, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P512; Xu J, 2014, AGING CELL, V13, P19, DOI 10.1111/acel.12145; Yaguchi Y, 2014, EUR J NUTR; Yu Qin, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P393; Zhang L, 2011, PHARMAZIE, V66, P144, DOI 10.1691/ph.2011.0738; Zhang MM, 2004, WORLD J GASTROENTERO, V10, P3500; Zimmerman SM, 2014, AGING CELL, V13, P329, DOI 10.1111/acel.12179	65	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0119068	10.1371/journal.pone.0119068	http://dx.doi.org/10.1371/journal.pone.0119068			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879540	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500001
J	Wardle, SL; Bailey, MES; Kilikevicius, A; Malkova, D; Wilson, RH; Venckunas, T; Moran, CN				Wardle, Sophie L.; Bailey, Mark E. S.; Kilikevicius, Audrius; Malkova, Dalia; Wilson, Richard H.; Venckunas, Tomas; Moran, Colin N.			Plasma MicroRNA Levels Differ between Endurance and Strength Athletes	PLOS ONE			English	Article							SKELETAL-MUSCLE; CIRCULATING MICRORNAS; EXERCISE; CANCER; CELLS; BIOMARKERS; MARKERS; MIRNAS; SERUM; YOUNG	Aim MicroRNAs (miRNAs) are stable in the circulation and are likely to function in inter-organ communication during a variety of metabolic responses that involve changes in gene expression, including exercise training. However, it is unknown whether differences in circulating-miRNA (c-miRNA) levels are characteristic of training modality. Methods We investigated whether levels of candidate c-miRNAs differ between elite male athletes of two different training modalities (n = 10 per group) -endurance (END) and strength (STR) - and between these groups and untrained controls (CON; n = 10). Fasted, non-exercised, morning plasma samples were analysed for 14 c-miRNAs (miR-1, miR-16-2, miR-20a-1, miR-21, miR-93, miR-103a, miR-133a, miR-146a, miR-192, miR-206, miR-221, miR-222, miR-451, miR-499). Moreover, we investigated whether c-miRNA levels were associated with quantitative performance-related phenotypes within and between groups. Results miR-222 was present at different levels in the three participant groups (p = 0.028) with the highest levels being observed in END and the lowest in STR. A number of other c-miRNAs were present at higher levels in END than in STR (relative to STR, +/- 1 SEM; miR-222: 1.94 fold (1.73-2.18), p = 0.011; miR-21: 1.56 fold (1.39-1.74), p = 0.013; miR-146a: 1.50 fold (1.38-1.64), p = 0.019; miR-221: 1.51 fold (1.34-1.70), p = 0.026). Regression analyses revealed several associations between candidate c-miRNA levels and strength-related performance measures before and after adjustment for muscle or fat mass, but not following adjustment for group. Conclusion Certain c-miRNAs (miR-222, miR-21, miR-146a and miR-221) differ between endurance- and resistance-trained athletes and thus have potential as useful biomarkers of exercise training and / or play a role in exercise mode-specific training adaptations. However, levels of these c-miRNAs are probably unrelated to muscle bulk or fat reserves.	[Wardle, Sophie L.; Moran, Colin N.] Univ Stirling, Hlth & Exercise Sci Res Grp, Stirling FK9 4LA, Scotland; [Bailey, Mark E. S.; Wilson, Richard H.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland; [Kilikevicius, Audrius; Venckunas, Tomas] Lithuanian Sports Univ, Kaunas, Lithuania; [Malkova, Dalia] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland	University of Stirling; University of Glasgow; Lithuanian Sports University; University of Glasgow	Venckunas, T (corresponding author), Lithuanian Sports Univ, Kaunas, Lithuania.	tomas.venckunas@lsu.lt	Moran, Colin/F-5416-2011	Moran, Colin/0000-0001-6226-8131; Bailey, Mark E. S./0000-0002-9788-2278				Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Baggish AL, 2014, J APPL PHYSIOL, V116, P522, DOI 10.1152/japplphysiol.01141.2013; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Banzet S, 2013, J APPL PHYSIOL, V115, P1237, DOI 10.1152/japplphysiol.00075.2013; Beneke R, 2002, EUR J APPL PHYSIOL, V87, P388, DOI 10.1007/s00421-002-0622-4; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Clark DA, 1998, INT J BIOCHEM CELL B, V30, P293, DOI 10.1016/S1357-2725(97)00128-3; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Kraemer W J, 1996, Exerc Sport Sci Rev, V24, P363; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; MARTIN AD, 1990, MED SCI SPORT EXER, V22, P729, DOI 10.1249/00005768-199010000-00027; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Roberts MD, 2011, APPL PHYSIOL NUTR ME, V36, P96, DOI 10.1139/H10-090; Russell AP, 2013, J PHYSIOL-LONDON, V591, P4637, DOI 10.1113/jphysiol.2013.255695; Sawada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070823; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Wolfarth B, 2014, MED SCI SPORT EXER, V46, P851, DOI 10.1249/MSS.0000000000000300; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zhu K, 2013, CARCINOGENESIS, V34, P2071, DOI 10.1093/carcin/bgt160	40	57	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122107	10.1371/journal.pone.0122107	http://dx.doi.org/10.1371/journal.pone.0122107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881132	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353016500016
J	Gonzalez-Ortega, I; Alberich, S; Echeburua, E; Aizpuru, F; Millan, E; Vieta, E; Matute, C; Gonzalez-Pinto, A				Gonzalez-Ortega, Itxaso; Alberich, Susana; Echeburua, Enrique; Aizpuru, Felipe; Millan, Eduardo; Vieta, Eduard; Matute, Carlos; Gonzalez-Pinto, Ana			Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; PSYCHIATRIC-DISORDERS; SELF-MEDICATION; AXIS I; SCHIZOPHRENIA; ASSOCIATION; DEPENDENCE; SEVERITY; TRIAL; SCALE	Background Although depressive symptoms in first episode psychosis have been associated with cannabis abuse, their influence on the long-term functional course of FEP patients who abuse cannabis is unknown. The aims of the study were to examine the influence of subclinical depressive symptoms on the long-term outcome in first episode-psychosis patients who were cannabis users and to assess the influence of these subclinical depressive symptoms on the ability to quit cannabis use. Methods 64 FEP patients who were cannabis users at baseline were followed-up for 5 years. Two groups were defined: (a) patients with subclinical depressive symptoms at least once during follow-up (DPG), and (b) patients without subclinical depressive symptoms during follow-up (NDPG). Psychotic symptoms were measured using the Positive and Negative Syndrome Scale (PANSS), depressive symptoms using the Hamilton Depression Rating Scale (HDRS)-17, and psychosocial functioning was assessed using the Global Assessment of Functioning (GAF). A linear mixed-effects model was used to analyze the combined influence of cannabis use and subclinical depressive symptomatology on the clinical outcome. Results Subclinical depressive symptoms were associated with continued abuse of cannabis during follow-up (beta=4.45; 95% confidence interval [CI]: 1.78 to 11.17; P=.001) and with worse functioning (beta=-5.50; 95% CI: -9.02 to -0.33; P=.009). Conclusions Subclinical depressive symptoms and continued cannabis abuse during follow-up could be predictors of negative outcomes in FEP patients.	[Gonzalez-Ortega, Itxaso; Alberich, Susana; Echeburua, Enrique; Gonzalez-Pinto, Ana] Univ Basque Country, Univ Hosp Alava Santiago, CIBERSAM, Dept Psychiat, Vitoria, Spain; [Aizpuru, Felipe] Osakidetza, Araba Res Unit, Vitoria, Spain; [Millan, Eduardo] Osakidetza, Direcc Asistencia Sanit, Vitoria, Spain; [Vieta, Eduard] Univ Barcelona, Hosp Clin, IDIBAPS, CIBERSAM,Inst Biosci,Bipolar Disorders Program, Barcelona, Spain; [Matute, Carlos] Univ Basque Country, Achucarro Basque Ctr Neurosci, CIBERNED, Leioa, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; University of Basque Country	Gonzalez-Ortega, I (corresponding author), Univ Basque Country, Univ Hosp Alava Santiago, CIBERSAM, Dept Psychiat, Vitoria, Spain.	itxaso.gonzalezortega@osakidetza.net	Echeburua, Enrique/F-9033-2010; Vieta, Eduard/Y-2919-2019; Matute, Carlos/N-5559-2014	Echeburua, Enrique/0000-0001-7654-0781; Vieta, Eduard/0000-0002-0548-0053; Matute, Carlos/0000-0001-8672-711X; Gonzalez-Pinto, Ana Maria/0000-0002-2568-5179; Alberich, Susana/0000-0002-4945-3428; Gonzalez-Ortega, Itxaso/0000-0001-7074-4353	Spanish Government [PS09/02002, EC10-333, PI10/01430, PI10/01746, PI11/01977, PI11/02708, 2011/1064, 11-BI-01, 1677-DJ-030, EC10-220]; European Regional Development Funds; Basque Country Government [2008111010, 2009111047, 2010111170, 2010112009, 2011111110, 2011111113, SAIO10-PC10BF01, SAIO11-PE11BF006, SAIO11-PE11BF007, SAIO10-PR10BF01, GIC 10/80, KRONIK 11/010]; Basque Foundation for Health Innovation and Research (BIOEF) [BIO09/EM/010]; Spanish Clinical Research Network (CAIBER) [1392-D-079]; University of the Basque Country [GIC10/80, US10/08, EHU08/54]; Stanley Research Foundation [03-RC-003]	Spanish Government(Spanish GovernmentEuropean Commission); European Regional Development Funds(European Commission); Basque Country Government(Basque Government); Basque Foundation for Health Innovation and Research (BIOEF); Spanish Clinical Research Network (CAIBER); University of the Basque Country; Stanley Research Foundation	This work was supported by health research funds from the Spanish Government (PS09/02002 CIBER Network; EC10-333, PI10/01430, PI10/01746, PI11/01977, PI11/02708, 2011/1064, 11-BI-01, 1677-DJ-030, and EC10-220); European Regional Development Funds, and local grants from the Basque Country Government (2008111010, 2009111047, 2010111170, 2010112009, 2011111110, 2011111113, SAIO10-PC10BF01, SAIO11-PE11BF006, SAIO11-PE11BF007, SAIO10-PR10BF01, GIC 10/80, and KRONIK 11/010); the Basque Foundation for Health Innovation and Research (BIOEF; BIO09/EM/010); the Spanish Clinical Research Network (CAIBER; 1392-D-079) and the University of the Basque Country (GIC10/80, US10/08, and EHU08/54). The psychiatric research department in University Hospital of Alava-Santiago is supported by the Stanley Research Foundation (03-RC-003). These institutions had no further role in the study design, data collection, analysis or interpretation, writing of the report, or in the decision to submit the paper for publication.	Allsop DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044864; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arendt M, 2007, PSYCHOL MED, V37, P935, DOI 10.1017/S0033291706009688; Barrigon ML, 2010, J PSYCHIATR RES, V44, P413, DOI 10.1016/j.jpsychires.2009.10.004; Barrowclough C, 2013, SCHIZOPHRENIA BULL, V39, P339, DOI 10.1093/schbul/sbr152; Birchwood M, 2005, EUR ARCH PSY CLIN N, V255, P202, DOI 10.1007/s00406-005-0588-4; Bobes J. G, 2002, BANCO INSTRUMENTOS B; Bossong MG, 2013, EUR NEUROPSYCHOPHARM, V23, P1687, DOI 10.1016/j.euroneuro.2013.06.009; Campos AC, 2012, PHILOS T R SOC B, V367, P3364, DOI 10.1098/rstb.2011.0389; Chen RQ, 2013, CELL, V155, P1154, DOI 10.1016/j.cell.2013.10.042; Clausen L, 2014, PSYCHOL MED, V44, P117, DOI 10.1017/S0033291713000433; Cotton SM, 2012, SCHIZOPHR RES, V134, P20, DOI 10.1016/j.schres.2011.08.018; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; Degenhardt L, 2003, ADDICTION, V98, P1493, DOI 10.1046/j.1360-0443.2003.00437.x; Degenhardt L, 2007, ADDICTION, V102, P1076, DOI 10.1111/j.1360-0443.2007.01839.x; Denson TF, 2006, ADDICT BEHAV, V31, P738, DOI 10.1016/j.addbeh.2005.05.052; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; First M. B., 1997, STRUCTURED CLIN INTE; Gonzalez-Pinto A, 2008, J CLIN PSYCHIAT, V69, P1210, DOI 10.4088/JCP.v69n0802; Gonzalez-Pinto A, 2011, SCHIZOPHRENIA BULL, V37, P631, DOI 10.1093/schbul/sbp126; Gregg L, 2014, PSYCHOL ADDICT BEHAV, V28, P247, DOI 10.1037/a0034761; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hartley S, 2013, ACTA PSYCHIAT SCAND, V128, P327, DOI 10.1111/acps.12080; Hjorthoj CR, 2013, SCHIZOPHR RES, V151, P191, DOI 10.1016/j.schres.2013.10.014; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kokkevi A., 1995, EUR ADDICT RES, V1, P208, DOI [10.1159/000259089, DOI 10.1159/000259089]; Kuepper R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070378; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; Lynskey MT, 2004, ARCH GEN PSYCHIAT, V61, P1026, DOI 10.1001/archpsyc.61.10.1026; Madigan K, 2013, SCHIZOPHR RES, V143, P138, DOI 10.1016/j.schres.2012.10.018; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; National Institute for Health and Clinical Excellence, 2009, DEPR AD CHRON PHYS H; Otten R, 2013, ADDICT BIOL, V18, P826, DOI 10.1111/j.1369-1600.2011.00380.x; Peralta MV, 1994, ACTAS LUSO-ESP NEUR, V22, P171; R Development Core Team, R LANG ENV STAT COMP; Ramos-Brieva J A, 1986, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V14, P324; Riedel M, 2012, WORLD J BIOL PSYCHIA, V13, P30, DOI 10.3109/15622975.2011.552633; Romm KL, 2010, J NERV MENT DIS, V198, P67, DOI 10.1097/NMD.0b013e3181c81fc0; Ruiz-Veguilla M, 2013, J PSYCHIATR RES, V47, P1036, DOI 10.1016/j.jpsychires.2013.03.003; Schofield D, 2006, AUST NZ J PSYCHIAT, V40, P570, DOI 10.1111/j.1440-1614.2006.01840.x; Secora AM, 2010, J ADDICT DIS, V29, P325, DOI 10.1080/10550887.2010.489444; Sonmez N, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-106; Stone JM, 2014, PSYCHOL MED, V44, P499, DOI 10.1017/S0033291713000883; Tomlinson KL, 2006, ADDICT BEHAV, V31, P461, DOI 10.1016/j.addbeh.2005.05.028; Tosato S, 2013, J PSYCHIATR RES, V47, P438, DOI 10.1016/j.jpsychires.2012.11.009; Upthegrove R, 2010, ACTA PSYCHIAT SCAND, V122, P211, DOI 10.1111/j.1600-0447.2009.01506.x; van Gastel WA, 2013, PSYCHOL MED, V43, P1849, DOI 10.1017/S0033291712002723; Wu LT, 2013, J PSYCHIATR RES, V47, P1940, DOI 10.1016/j.jpsychires.2013.08.022; Wu LT, 2011, J PSYCHIATR RES, V45, P1453, DOI 10.1016/j.jpsychires.2011.06.012; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028	52	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123707	10.1371/journal.pone.0123707	http://dx.doi.org/10.1371/journal.pone.0123707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875862	Green Published, gold			2022-12-26	WOS:000353015800111
J	Hsu, JF; Chu, SM; Lee, CW; Yang, PH; Lien, RY; Chiang, MC; Fu, RH; Huang, HR; Tsai, MH				Hsu, Jen-Fu; Chu, Shih-Ming; Lee, Chiang-Wen; Yang, Pong-Hong; Lien, Reyin; Chiang, Ming-Chou; Fu, Ren-Huei; Huang, Hsuan-Rong; Tsai, Ming-Horng			Incidence, Clinical Characteristics and Attributable Mortality of Persistent Bloodstream Infection in the Neonatal Intensive Care Unit	PLOS ONE			English	Article							LATE-ONSET SEPSIS; COAGULASE-NEGATIVE STAPHYLOCOCCI; RISK-FACTORS; BACTEREMIA; THERAPY; EPIDEMIOLOGY; CANDIDIASIS; CANDIDEMIA; INFANTS	Background An atypical pattern of neonatal sepsis, characterized by persistent positive blood culture despite effective antimicrobial therapy, has been correlated with adverse outcomes. However, previous studies focused only on coagulate-negative staphylococcus infection. Methods All episodes of persistent bloodstream infection (BSI), defined as 3 or more consecutive positive blood cultures with the same bacterial species, at least two of them 48 hours apart, during a single sepsis episode, were enrolled over an 8-year period in a tertiary level neonatal intensive care unit. These cases were compared with all non-persistent BSI during the same period. Results We identified 81 episodes of persistent BSI (8.5% of all neonatal late-onset sepsis) in 74 infants, caused by gram-positive pathogens (n=38, 46.9%), gram-negative pathogens (n=21, 25.9%), fungus (n=20, 24.7%) and polymicrobial bacteremia (n=2, 2.5%). Persistent BSI does not differ from non-persistent BSI in most clinical characteristics and patient demo-graphics, but tends to have a prolonged septic course, longer duration of feeding intolerance and more frequent requirement of blood transfusions. No difference was observed for death attributable to infection (9.8% vs. 6.5%), but neonates with persistent BSI had significantly higher rates of infectious complications (29.6% vs. 9.2%, P<0.001), death from all causes (21.6% vs. 11.7%, P=0.025), and duration of hospitalization among survivors [median (interquartile range): 80.0 (52.5-117.5) vs. 64.0 (40.0-96.0) days, P = 0.005] than those without persistent BSI. Conclusions Although persistent BSI does not contribute directly to increased mortality, the associated morbidities, infectious complications and prolonged septic courses highlight the importance of aggressive treatment to optimize outcomes.	[Hsu, Jen-Fu; Chu, Shih-Ming; Yang, Pong-Hong; Lien, Reyin; Chiang, Ming-Chou; Fu, Ren-Huei; Huang, Hsuan-Rong] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Neonatol, Taoyuan, Taiwan; [Tsai, Ming-Horng] Chang Gung Mem Hosp, Div Neonatol & Pediat Hematol Oncol, Dept Pediat, Yunlin, Taiwan; [Hsu, Jen-Fu; Chu, Shih-Ming; Yang, Pong-Hong; Lien, Reyin; Chiang, Ming-Chou; Fu, Ren-Huei; Huang, Hsuan-Rong; Tsai, Ming-Horng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Chiang-Wen; Tsai, Ming-Horng] Chang Gung Univ Sci & Technol, Div Basic Med Sci, Dept Nursing, Chiayi, Taiwan; [Lee, Chiang-Wen; Tsai, Ming-Horng] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan; [Lee, Chiang-Wen] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology	Tsai, MH (corresponding author), Chang Gung Mem Hosp, Div Neonatol & Pediat Hematol Oncol, Dept Pediat, Yunlin, Taiwan.	mingmin.tw@yahoo.com.tw			Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital [CLRPG340599]	Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital	All authors thank Mrs. Chiao-Ching Chiang for keeping the database of our NICU, and all nursing staff working in our NICUs for keeping extremely detailed patient records, which contributed greatly to the completion of this research. We want to thank Miss Chun-Chun Cheng and Mr. Yu-Jr Lin for statistical consultation, who was supported by grants from Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital (CLRPG340599).	Anderson-Berry A, 2011, NEONATOLOGY, V99, P23, DOI 10.1159/000292567; Apisarnthanarak A, 2003, PEDIATRICS, V112, P1283, DOI 10.1542/peds.112.6.1283; Benjamin DK, 2010, PEDIATRICS, V126, pE865, DOI 10.1542/peds.2009-3412; Benjamin DK, 2000, PEDIATRICS, V106, P712, DOI 10.1542/peds.106.4.712; Bizzarro MJ, 2008, INFECT CONT HOSP EP, V29, P914, DOI 10.1086/591323; Chapman RL, 2000, PEDIATR INFECT DIS J, V19, P822, DOI 10.1097/00006454-200009000-00003; Chapman RL, 2003, PEDIATR INFECT DIS J, V22, P17, DOI 10.1097/00006454-200301000-00008; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI S; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; Dimitriou G, 2011, CLIN MICROBIOL INFEC, V17, P1684, DOI 10.1111/j.1469-0691.2011.03489.x; DOBSON SRM, 1990, PEDIATRICS, V85, P165; Gleason CA, 2011, AVERYS DIS NEWBORN; Gordon A, 2006, PEDIATR INFECT DIS J, V25, P25, DOI 10.1097/01.inf.0000195628.35980.2e; GRAY JE, 1992, PEDIATRICS, V90, P561; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Karlowicz MG, 2002, PEDIATR INFECT DIS J, V21, P22, DOI 10.1097/00006454-200201000-00005; Karlowicz MG, 2000, PEDIATRICS, V106, P1387, DOI 10.1542/peds.106.6.1387; Khashu M, 2006, PEDIATRICS, V117, P340, DOI 10.1542/peds.2005-0333; Klingenberg C, 2007, CLIN MICROBIOL INFEC, V13, P1100, DOI 10.1111/j.1469-0691.2007.01818.x; Lemonovich TL, 2011, INFECTION, V39, P549, DOI 10.1007/s15010-011-0189-2; Linder N, 2011, EUR J PEDIATR, V170, P989, DOI 10.1007/s00431-010-1387-0; Makhoul IR, 2002, PEDIATRICS, V109, P34, DOI 10.1542/peds.109.1.34; Odio CM, 2004, PEDIATR INFECT DIS J, V23, P1093, DOI 10.1097/01.inf.0000145408.51526.0a; Oeser C, 2013, PEDIATR INFECT DIS J, V32, P23, DOI 10.1097/INF.0b013e318275612e; PATRICK CC, 1989, PEDIATRICS, V84, P977; Robinson JA, 2012, J PERINATOL, V32, P621, DOI 10.1038/jp.2011.162; Sutter D, 2008, PEDIATR INFECT DIS J, V27, P400, DOI 10.1097/INF.0b013e31816591be; Tsai MH, 2014, CLIN MICROBIOL INFEC, V20, pO928, DOI 10.1111/1469-0691.12661; Tsai MH, 2014, PEDIATRICS, V133, pE322, DOI 10.1542/peds.2013-1248; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; Tsai MH, 2012, AM J INFECT CONTROL, V40, P59, DOI 10.1016/j.ajic.2011.04.051; Tsai MH, 2009, PEDIATR INFECT DIS J, V28, P966, DOI 10.1097/INF.0b013e3181aa3a29; Uckay I, 2012, ANTIMICROB AGENTS CH, V56, P1258, DOI 10.1128/AAC.05808-11; van der Lugt NM, 2010, BMC PEDIATR, V19, P10; Xia HP, 2014, PEDIATR INFECT DIS J, V33, P106, DOI 10.1097/INF.0000000000000009	35	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124567	10.1371/journal.pone.0124567	http://dx.doi.org/10.1371/journal.pone.0124567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875677	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800143
J	Starha, P; Travnicek, Z; Dvorak, Z; Radosova-Muchova, T; Pracharova, J; Vanco, J; Kasparkova, J				Starha, Pavel; Travnicek, Zdenek; Dvorak, Zdenek; Radosova-Muchova, Tereza; Pracharova, Jitka; Vanco, Jan; Kasparkova, Jan			Potentiating Effect of UVA Irradiation on Anticancer Activity of Carboplatin Derivatives Involving 7-Azaindoles	PLOS ONE			English	Article							INTERSTRAND CROSS-LINKS; PLATINUM(II) COMPLEXES; DNA; CISPLATIN; ADDUCTS; CIS-DIAMMINEDICHLOROPLATINUM(II); CYTOTOXICITY; RECOGNITION; HYDROLYSIS; RESISTANCE	The moderate-to-high in vitro cytotoxicity against ovarian A2780 (IC50 = 4.7-14.4 mu M), prostate LNCaP (IC50 = 18.7-30.8 mu M) and prostate PC-3 (IC50 = 17.6-42.3 mu M) human cancer cell lines of the platinum(II) cyclobutane-1,1'-dicarboxylato complexes [Pt(cbdc)(naza)2] (1-6; cbdc = cyclobutane-1,1'-dicarboxylate(2-); naza = halogeno-substituted 7-azaindoles), derived from the anticancer metallodrug carboplatin, are reported. The complexes containing the chloro-and bromo-substituted 7-azaindoles (1, 2, and 4-6) showed a significantly higher (p < 0.05) cytotoxicity against A2780 cell line as compared to cisplatin used as a reference drug. Addition of the non-toxic concentration (5.0 mu M) of L-buthionine sulfoximine (L-BSO, an effective inhibitor of.-glutamylcysteine synthase) markedly increases the in vitro cytotoxicity of the selected complex 3 against A2780 cancer cell line by a factor of about 4.4. The cytotoxicity against A2780 and LNCaP cells, as well as the DNA platination, were effectively enhanced by UVA light irradiation (lambda(max) = 365 nm) of the complexes, with the highest phototoxicity determined for compound 3, resulting in a 4-fold decline in the A2780 cells viability from 25.1% to 6.1%. The H-1 NMR and ESI-MS experiments suggested that the complexes did not interact with glutathione as well as their ability to interact with guanosine monophosphate. The studies also confirmed UVA light induced the formation of the cis [Pt(H2O)(2)(cbdc')(naza)] intermediate, where cbdc' represents monodentate-coordinated cbdc ligand, which is thought to be responsible for the enhanced cytotoxicity. This is further supported by the results of transcription mapping experiments showing that the studied complexes preferentially form the bifunctional adducts with DNA under UVA irradiation, in contrast to the formation of the less effective monofunctional adducts in dark.	[Starha, Pavel; Travnicek, Zdenek; Dvorak, Zdenek; Vanco, Jan] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Starha, Pavel; Travnicek, Zdenek; Vanco, Jan] Palacky Univ, Fac Sci, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic; [Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic; [Radosova-Muchova, Tereza] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Radosova-Muchova, Tereza; Pracharova, Jitka; Kasparkova, Jan] Palacky Univ, Fac Sci, Dept Biophys, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Travnicek, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Starha, Pavel/H-3902-2016; Vanco, Jan/H-2705-2013	Vanco, Jan/0000-0003-3351-1192; Travnicek, Zdenek/0000-0002-5890-7874; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Foundation [GACR P207/11/0841]; National Program of Sustainability I of the Ministry of Education, Youth and Sports of the Czech Republic [LO1204, LO1305]; Palacky University in Olomouc [IGA_PrF_2014009, IGA_PrF_2014029]	Czech Science Foundation(Grant Agency of the Czech Republic); National Program of Sustainability I of the Ministry of Education, Youth and Sports of the Czech Republic; Palacky University in Olomouc	Support was provided by the Czech Science Foundation (GACR P207/11/0841), [www.gacr.cz] to ZT and PS; the National Program of Sustainability I (LO1204 and LO1305) of the Ministry of Education, Youth and Sports of the Czech Republic, [www.msmt.cz] to ZT, PS, JV, ZD, TR, JP and JK; Palacky University in Olomouc (IGA_PrF_2014009 and IGA_PrF_2014029), [www.upol.cz] to ZT, PS, TR, JP and JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry NPE, 2013, CHEM COMMUN, V49, P5106, DOI 10.1039/c3cc41143e; BRABEC V, 1993, P NATL ACAD SCI USA, V90, P5345, DOI 10.1073/pnas.90.11.5345; BRABEC V, 1994, BIOCHEMISTRY-US, V33, P1316, DOI 10.1021/bi00172a005; Brabec V, 2002, PROG NUCLEIC ACID RE, V71, P1, DOI 10.1016/S0079-6603(02)71040-4; BUTOUR JL, 1977, EUR J BIOCHEM, V78, P455, DOI 10.1111/j.1432-1033.1977.tb11758.x; BUTOUR JL, 1991, EUR J BIOCHEM, V202, P975, DOI 10.1111/j.1432-1033.1991.tb16458.x; Dhara S. C., 1970, IND J CHEM, P193; Dvorak L, 2010, EUR J INORG CHEM, P3441, DOI 10.1002/ejic.201000322; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; FARRELL N, 1990, BIOCHEMISTRY-US, V29, P9522, DOI 10.1021/bi00493a005; FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025; FREY U, 1993, INORG CHEM, V32, P1333, DOI 10.1021/ic00060a005; Hay RW, 1998, POLYHEDRON, V17, P2337, DOI 10.1016/S0277-5387(97)00477-4; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jansen BAJ, 2002, J INORG BIOCHEM, V89, P197, DOI 10.1016/S0162-0134(02)00381-1; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelland LR, 2000, PLATINUM BASED DRUGS; LEMAIRE MA, 1991, P NATL ACAD SCI USA, V88, P1982, DOI 10.1073/pnas.88.5.1982; Mackay FS, 2007, P NATL ACAD SCI USA, V104, P20743, DOI 10.1073/pnas.0707742105; Mlcouskova J, 2012, J BIOL INORG CHEM, V17, P891, DOI 10.1007/s00775-012-0906-z; Muchova T, 2013, J BIOL INORG CHEM, V18, P579, DOI 10.1007/s00775-013-1003-7; New EJ, 2009, J INORG BIOCHEM, V103, P1120, DOI 10.1016/j.jinorgbio.2009.05.005; Pavelka M, 2007, CHEM-EUR J, V13, P10108, DOI 10.1002/chem.200700887; Ramos-Lima FJ, 2006, J MED CHEM, V49, P2640, DOI 10.1021/jm0602514; Romero-Canelon I, 2013, J MED CHEM, V56, P1291, DOI 10.1021/jm3017442; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Smith NA, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0519; Starha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090341; Starha P, 2012, J INORG BIOCHEM, V115, P57, DOI 10.1016/j.jinorgbio.2012.05.006; Starha P, 2012, POLYHEDRON, V33, P404, DOI 10.1016/j.poly.2011.11.059; Zamora A, 2013, J INORG BIOCHEM, V128, P48, DOI 10.1016/j.jinorgbio.2013.07.010; Zhao J, 2012, INORG CHEM, V51, P10317, DOI 10.1021/ic301374z; Zhao Y, 2013, CHEM-EUR J, V19, P9578, DOI 10.1002/chem.201300374	34	14	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123595	10.1371/journal.pone.0123595	http://dx.doi.org/10.1371/journal.pone.0123595			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875850	gold, Green Submitted, Green Published			2022-12-26	WOS:000353015800106
J	Avanzi, MP; Izak, M; Oluwadara, OE; Mitchell, WB				Avanzi, Mauro P.; Izak, Marina; Oluwadara, Oluwasijibomi E.; Mitchell, William Beau			Actin Inhibition Increases Megakaryocyte Proplatelet Formation through an Apoptosis Dependent Mechanism	PLOS ONE			English	Article							CELL-DEATH; CASPASE ACTIVATION; PLATELET FORMATION; BCL-X; DIFFERENTIATION; MITOCHONDRIA; SENESCENCE; EXPRESSION; MATURATION; PROTEINS	Background Megakaryocytes assemble and release platelets through the extension of proplatelet processes, which are cytoplasmic extensions that extrude from the megakaryocyte and form platelets at their tips. Proplatelet formation and platelet release are complex processes that require a combination of structural rearrangements. While the signals that trigger the initiation of proplatelet formation process are not completely understood, it has been shown that inhibition of cytoskeletal signaling in mature megakaryocytes induces proplatelet formation. Megakaryocyte apoptosis may also be involved in initiation of proplatelet extension, although this is controversial. This study inquires whether the proplatelet production induced by cytoskeletal signaling inhibition is dependent on activation of apoptosis. Methods Megakaryocytes derived from human umbilical cord blood CD34+ cells were treated with the actin polymerization inhibitor latrunculin and their ploidy and proplatelet formation were quantitated. Apoptosis activation was analyzed by flow cytometry and luminescence assays. Caspase activity was inhibited by two compounds, ZVAD and QVD. Expression levels of pro-survival and pro-apoptosis genes were measured by quantitative RT-PCR. Protein levels of Bcl-XL, Bax and Bak were measured by western blot. Cell ultrastructure was analyzed by electron microscopy. Results Actin inhibition resulted in increased ploidy and increased proplatelet formation in cultured umbilical cord blood-derived megakaryocytes. Actin inhibition activated apoptosis in the cultured cells. The effects of actin inhibition on proplatelet formation were blocked by caspase inhibition. Increased expression of both pro-apoptotic and pro-survival genes was observed. Pro-survival protein (Bcl-xL) levels were increased compared to levels of proapoptotic proteins Bak and Bax. Despite apoptosis being activated, the megakaryocytes underwent minimal ultrastructural changes during actin inhibition.	[Avanzi, Mauro P.; Izak, Marina; Oluwadara, Oluwasijibomi E.; Mitchell, William Beau] New York Blood Ctr, Platelet Biol Lab, New York, NY 10021 USA	New York Blood Center	Mitchell, WB (corresponding author), New York Blood Ctr, Platelet Biol Lab, New York, NY 10021 USA.	bmitchell@nybloodcenter.org						Avanzi MP, 2014, BRIT J HAEMATOL, V164, P867, DOI 10.1111/bjh.12709; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Battinelli E, 2000, BLOOD, V95, P3451, DOI 10.1182/blood.V95.11.3451.011k34_3451_3459; Battinelli E, 2001, P NATL ACAD SCI USA, V98, P14458, DOI 10.1073/pnas.241427398; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Dunois-Larde C, 2009, BLOOD, V114, P1875, DOI 10.1182/blood-2009-03-209205; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Falcieri E, 2000, ANAT RECORD, V258, P90, DOI 10.1002/(SICI)1097-0185(20000101)258:1<90::AID-AR10>3.0.CO;2-G; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Josefsson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4455; Josefsson EC, 2011, J EXP MED, V208, P2017, DOI 10.1084/jem.20110750; Kaluzhny Y, 2003, ACTA HAEMATOL-BASEL, V111, P67, DOI 10.1159/000074487; Kaluzhny Y, 2002, BLOOD, V100, P1670, DOI 10.1182/blood-2001-12-0263; Konishi H, 2009, ANTICANCER RES, V29, P2091; Kozuma Y, 2007, J THROMB HAEMOST, V5, P1274, DOI 10.1111/j.1538-7836.2007.02546.x; Kozuma Y, 2009, LEUKEMIA, V23, P1080, DOI 10.1038/leu.2009.7; Kren BT, 1996, CELL GROWTH DIFFER, V7, P1633; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Martin S, 2001, TELECONNECT, V19, P10; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; RADLEY JM, 1983, BRIT J HAEMATOL, V53, P277, DOI 10.1111/j.1365-2141.1983.tb02022.x; Sanz C, 2001, EXP HEMATOL, V29, P728, DOI 10.1016/S0301-472X(01)00635-X; Suzuki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069315; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tenedini E, 2004, BLOOD, V104, P3126, DOI 10.1182/blood-2003-07-2597; Terui Y, 1998, EXP HEMATOL, V26, P236; Thon Jonathan N, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-29423-5_1; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; White MJ, 2012, BLOOD, V119, P4283, DOI 10.1182/blood-2011-11-394858; White MJ, 2010, SEMIN HEMATOL, V47, P227, DOI 10.1053/j.seminhematol.2010.03.006; Yang L, 2010, BLOOD, V116, P4307, DOI 10.1182/blood-2010-02-267435; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Zauli G, 1997, BLOOD, V90, P2234	39	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0125057	10.1371/journal.pone.0125057	http://dx.doi.org/10.1371/journal.pone.0125057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875470	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700074
J	Witowski, N; Lusczek, E; Determan, C; Lexcen, D; Mulier, K; Ostrowski, B; Beilman, G				Witowski, Nancy; Lusczek, Elizabeth; Determan, Charles, Jr.; Lexcen, Daniel; Mulier, Kristine; Ostrowski, Beverly; Beilman, Greg			A Four-Compartment Metabolomics Analysis of the Liver, Muscle, Serum, and Urine Response to Polytrauma with Hemorrhagic Shock following Carbohydrate Prefeed	PLOS ONE			English	Article							SKELETAL-MUSCLE; MITOCHONDRIAL MEGACHANNEL; NETWORK ANALYSIS; ACID CYCLE; RESUSCITATION; METABOLISM; MODULATION; GLUCOSE; TRAUMA; PLASMA	Objective Hemorrhagic shock accompanied by injury represents a major physiologic stress. Fasted animals are often used to study hemorrhagic shock (with injury). A fasted state is not guaranteed in the general human population. The objective of this study was to determine if fed animals would exhibit a different metabolic profile in response to hemorrhagic shock with trauma when compared to fasted animals. Methods Proton (1H) NMR spectroscopy was used to determine concentrations of metabolites from four different compartments (liver, muscle, serum, urine) taken at defined time points throughout shock/injury and resuscitation. PLS-DA was performed and VIP lists established for baseline, shock and resuscitation (10 metabolites for each compartment at each time interval) on metabolomics data from surviving animals. Results Fed status prior to the occurrence of hemorrhagic shock with injury alters the metabolic course of this trauma and potentially affects mortality. The death rate for CPF animals is higher than FS animals (47 vs 28%). The majority of deaths occur post-resuscitation suggesting reperfusion injury. The metabolomics response to shock reflects priorities evident at baseline. FS animals raise the baseline degree of proteolysis to provide additional amino acids for energy production while CPF animals rely on both glucose and, to a lesser extent, amino acids. During early resuscitation levels of metabolites associated with energy production drop, suggesting diminished demand. Conclusions Feeding status prior to the occurrence of hemorrhagic shock with injury alters the metabolic course of this trauma and potentially affects mortality. The response to shock reflects metabolic priorities at baseline.	[Witowski, Nancy; Lusczek, Elizabeth; Determan, Charles, Jr.; Lexcen, Daniel; Mulier, Kristine; Beilman, Greg] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Ostrowski, Beverly] Univ Minnesota, Minnesota NMR Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Witowski, N (corresponding author), Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.	witow001@umn.edu		Beilman, Gregory/0000-0001-5036-3027; Lusczek, Elizabeth/0000-0003-4680-965X	Office of Naval Research [N00014-09-0323]; University of Minnesota; North Memorial Center; Office of the Vice President for Research; Medical School; College of Biological Science; National Institutes of Health; NSF; Minnesota Medical Foundation	Office of Naval Research(Office of Naval Research); University of Minnesota(University of Minnesota System); North Memorial Center; Office of the Vice President for Research; Medical School; College of Biological Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Minnesota Medical Foundation	Funding was provided by Office of Naval Research - N00014-09-0323, University of Minnesota, and North Memorial Center. Funding for NMR instrumentation was provided by the Office of the Vice President for Research, the Medical School, the College of Biological Science, National Institutes of Health, NSF, and the Minnesota Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Argiles JM, 2001, LIFE SCI, V69, P1345, DOI 10.1016/S0024-3205(01)01238-3; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Colling KP, 2015, SHOCK, V44, P103, DOI 10.1097/SHK.0000000000000324; de Lange P, 2006, FASEB J, V20, DOI 10.1096/fj.06-6025fje; Determan CE, 2014, METABOLOMICS, V10, P950, DOI 10.1007/s11306-014-0621-6; Deussen A, 2012, J MOL CELL CARDIOL, V52, P794, DOI 10.1016/j.yjmcc.2011.10.001; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; FRIEDMAN SG, 1982, J TRAUMA, V22, P86, DOI 10.1097/00005373-198202000-00002; Frizzell N, 2012, BIOCHEM J, V445, P247, DOI 10.1042/BJ20112142; GRANGER DN, 1986, GASTROENTEROLOGY, V90, P80, DOI 10.1016/0016-5085(86)90078-8; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Heininger K, 2002, INT REV NEUROBIOL, V51, P103, DOI 10.1016/S0074-7742(02)51004-7; Holcomb JB, 1999, J TRAUMA, V47, P233, DOI 10.1097/00005373-199908000-00002; Lexcen DR, 2012, J TRAUMA ACUTE CARE, V73, pS147, DOI 10.1097/TA.0b013e3182609821; Liland KH, 2011, TRAC-TREND ANAL CHEM, V30, P827, DOI 10.1016/j.trac.2011.02.007; LJUNGQVIST O, 1990, AM J PHYSIOL, V259, pE692, DOI 10.1152/ajpendo.1990.259.5.E692; LJUNGQVIST O, 1987, CIRC SHOCK, V22, P251; Lusczek E. R., 2011, J BIOANAL BIOMED, V3, P38, DOI DOI 10.4172/1948-593X.1000041; Lusczek ER, 2013, METABOLOMICS, V9, P223, DOI 10.1007/s11306-012-0441-5; MATEOS FA, 1987, J CLIN INVEST, V79, P847, DOI 10.1172/JCI112893; Mortishire-Smith RJ, 2004, CHEM RES TOXICOL, V17, P165, DOI 10.1021/tx034123j; Mulier KE, 2005, SHOCK, V23, P248, DOI 10.1097/01.shk.0000153353.58341.ff; Mulier KE, 2012, J SURG RES, V174, pE31, DOI 10.1016/j.jss.2011.10.005; Naimi M, 2010, TRENDS ENDOCRIN MET, V21, P75, DOI 10.1016/j.tem.2009.09.003; Orman MA, 2012, J THEOR BIOL, V293, P101, DOI 10.1016/j.jtbi.2011.10.019; R Core Team, 2013, R LANG ENV STAT COMP; Ruilope L M, 2001, Curr Hypertens Rep, V3, P197, DOI 10.1007/s11906-001-0038-2; Sanchez G, 2013, DISCRIMINER TOOLS TR; Simpson GL, 2014, PERMUTE FUNCTIONS GE; Sonanez-Organis JG, 2012, J EXP BIOL, V215, P1448, DOI 10.1242/jeb.067173; SZABO I, 1992, J BIOL CHEM, V267, P2940; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; VIANT MA, 2007, METHOD MOL BIOL, P229; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wishart DS, 2006, CURR OPIN NEPHROL HY, V15, P637, DOI 10.1097/01.mnh.0000247499.64291.52	40	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124467	10.1371/journal.pone.0124467	http://dx.doi.org/10.1371/journal.pone.0124467			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875111	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700069
J	Ahmadiafshar, A; Mohsenifard, MR; Mazloomzadeh, S				Ahmadiafshar, Akefeh; Mohsenifard, Mahmood Reza; Mazloomzadeh, Saeideh			Evaluation of Serum & Salivary IgA in Patients with Type 1 Diabetes	PLOS ONE			English	Article							IMMUNOGLOBULIN-A DEFICIENCY; BLOOD-DONORS; PREVALENCE; CHILDREN	Background Diabetes mellitus is a common immune mediated disorder. The aim of the present study is to evaluate the level of serum and salivary IgA levels in patients with Type 1 diabetes. Material and Method In this case control study, serum and salivary IgA levels of patients with diabetes type 1 and similar non diabetes subjects were measured. Age, gender, duration of diabetes and the last HbA1c level of diabetic patients were also studied. Data was analyzed by SPSS software. Results Two hundred and fifty subjects (126 diabetics and 124 non diabetics) were enrolled in the study. The mean value of serum IgA in patients with Type 1 Diabetes and controls was 1.77 +/- 1.55 g/lit and 2.39 +/- 1.52 g/lit, respectively. The mean salivary IgA level in diabetics and controls was 276 +/- 162.5 40 mu g/ml and 129 +/- 112.2 40 mu g/ml, respectively. Selective IgA deficiency was detected in two (1.6%) and three(2.4%) cases of diabetic and control group; respectively (p=0.68). We found low salivary IgA level in 44.4% diabetic and 33.9% control (p=0.08). There was no significant correlation between serum and salivary IgA level. There was also significant association between serum IgA levels with age. Salivary IgA was significantly correlated with HbA1c level. But considering gender, duration of diabetes we didn't find any association. Conclusion We didn't find any significant difference in serum and salivary IgA level among diabetic and non diabetics and also, no association between serum and salivary IgA levels.	[Ahmadiafshar, Akefeh; Mohsenifard, Mahmood Reza] Zanjan Univ Med Sci, Metab Dis Res Ctr, Zanjan, Iran; [Ahmadiafshar, Akefeh; Mazloomzadeh, Saeideh] Zanjan Univ Med Sci, Social Determinants Hlth Res Ctr, Zanjan, Iran; [Mohsenifard, Mahmood Reza] Zanjan Univ Med Sci, Mousavi Hosp, Zanjan, Iran		Ahmadiafshar, A (corresponding author), Zanjan Univ Med Sci, Metab Dis Res Ctr, Zanjan, Iran.	akefeh45@zums.ac.ir	Ahmadiafshar, Akefeh/M-8150-2019; Ahmadiafshar, a/L-1879-2016; Mazloomzadeh, Saeideh/H-4062-2016; Vazirinejad, Reza/Q-9333-2017	Ahmadiafshar, a/0000-0002-9202-6915; Mazloomzadeh, Saeideh/0000-0001-6325-0662; Vazirinejad, Reza/0000-0002-1967-7631	Zanjan University of Medical Sciences	Zanjan University of Medical Sciences	This study was supported by (Zanjan University of Medical Sciences) after being approved by the research council of ZUMS and permission of the ethic committee of ZUMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bakianian Vaziri P, 2010, J Dent (Tehran), V7, P13; Basturk B, 2011, TURKISH J PEDIATR, V53, P364; Belazi M A, 1998, Int J Paediatr Dent, V8, P29, DOI 10.1046/j.1365-263X.1998.00057.x; Bhuyan SK, 2011, J INDIAN ACAD ORAL M, V23, P548, DOI DOI 10.5005/jp-journals-10011-1220; Bokor-Bratic M, MED PREGL, V53, P164; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Branco-de-Almeida LS, 2011, BRAZ ORAL RES, V25, P550, DOI 10.1590/S1806-83242011000600013; Chandran S, 2006, INDIAN J MED RES, V123, P653; Dunne JL, 2014, CLIN EXP IMMUNOL, V177, P30, DOI 10.1111/cei.12321; Fageras M, 2011, PEDIATR RES, V70, P572, DOI 10.1203/PDR.0b013e318232169e; Feng ML, 2011, TRANSFUSION MED, V21, P338, DOI 10.1111/j.1365-3148.2011.01082.x; Jafarzadeh Abdollah, 2010, Braz. oral res., V24, P21, DOI 10.1590/S1806-83242010000100004; Lamb MM, 2015, PEDIATR DIABETES, V16, P31, DOI 10.1111/pedi.12115; Moazezi Z, 2014, IRAN J ALLERGY ASTHM, V13, P110; Moise Ana, 2010, J Med Life, V3, P60; Moradinejad MH, 2011, IRAN J ALLERGY ASTHM, V10, P35, DOI 010.01/ijaai.3540; OHMURO H, 1993, NEPHRON, V63, P355, DOI 10.1159/000187224; Palmer DS, 2010, TRANSFUSION, V50, P1524, DOI 10.1111/j.1537-2995.2010.02588.x; Peng J, 2014, J AUTOIMMUN, V53, P85, DOI 10.1016/j.jaut.2014.03.005; Rashkova M, 2009, OHDMBSC, V8, P16; RodriguezSegade S, 1996, CLIN CHEM, V42, P1064; Saghafi S, 2008, IRAN J ALLERGY ASTHM, V7, P157, DOI 07.03/ijaai.157162; Sakowicz-Burkiewicz M, 2013, IMMUNOBIOLOGY, V218, P591, DOI 10.1016/j.imbio.2012.07.010; Sayarifard F, 2012, ACTA DIABETOL, V49, P131, DOI 10.1007/s00592-010-0183-7; Svensson J, 2012, HUM IMMUNOL, V73, P17, DOI 10.1016/j.humimm.2011.10.019; Teeuw W, 2004, BIOL CHEM, V385, P1137, DOI 10.1515/BC.2004.147; Wang N, 2012, CURR OPIN ALLERGY CL, V12, P602, DOI 10.1097/ACI.0b013e3283594219; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Zipris D, 2013, CURR OPIN ENDOCRINOL, V20, P265, DOI 10.1097/MED.0b013e3283628569	31	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122757	10.1371/journal.pone.0122757	http://dx.doi.org/10.1371/journal.pone.0122757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875365	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100098
J	Fujita, T; Yuno, M; Okuzaki, D; Ohki, R; Fujii, H				Fujita, Toshitsugu; Yuno, Miyuki; Okuzaki, Daisuke; Ohki, Rieko; Fujii, Hodaka			Identification of Non-Coding RNAs Associated with Telomeres Using a Combination of enChIP and RNA Sequencing	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; CHROMATIN IMMUNOPRECIPITATION; EFFICIENT ISOLATION; GENOMIC REGIONS; HUMAN-DISEASE; NUCLEAR; MUTATIONS; COMPONENT; UNVEILS	Accumulating evidence suggests that RNAs interacting with genomic regions play important roles in the regulation of genome functions, including X chromosome inactivation and gene expression. However, to our knowledge, no non-biased methods of identifying RNAs that interact with a specific genomic region have been reported. Here, we used enChIP-RNA-Seq, a combination of engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) and RNA sequencing (RNA-Seq), to perform a non-biased search for RNAs interacting with telomeres. In enChIP-RNA-Seq, the target genomic regions are captured using an engineered DNA-binding molecule such as a transcription activator-like protein. Subsequently, RNAs that interact with the target genomic regions are purified and sequenced. The RNAs detected by enChIP-RNA-Seq contained known telomere-binding RNAs, including the telomerase RNA component (Terc), the RNA component of mitochondrial RNA processing endoribonuclease (Rmrp), and Cajal body-specific RNAs. In addition, a number of novel telomere-binding non-coding RNAs were also identified. Binding of two candidate non-coding RNAs to telomeres was confirmed by immunofluorescence microscopy and RNA fluorescence in situ hybridization (RNA-FISH) analyses. The novel telomerebinding non-coding RNAs identified here may play important roles in telomere functions. To our knowledge, this study is the first non-biased identification of RNAs associated with specific genomic regions. The results presented here suggest that enChIP-RNA-Seq analyses are useful for the identification of RNAs interacting with specific genomic regions, and may help to contribute to current understanding of the regulation of genome functions.	[Fujita, Toshitsugu; Yuno, Miyuki; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Suita, Osaka 565, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 565, Japan; [Ohki, Rieko] Natl Canc Ctr, Res Inst, Div Rare Canc Res, Tokyo 104, Japan	Osaka University; Osaka University; National Cancer Center - Japan	Fujii, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Suita, Osaka 565, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/N-9792-2019; Fujita, Toshitsugu/AAB-4964-2022; FUJITA, Toshitsugu/ABH-5101-2020; Okuzaki, Daisuke/AAN-5641-2020; Fujii, Hodaka/A-2420-2008	Fujii, Hodaka/0000-0003-1296-4256; FUJITA, Toshitsugu/0000-0002-9536-9999; Okuzaki, Daisuke/0000-0002-4552-783X; Fujii, Hodaka/0000-0003-1296-4256	Takeda Science Foundation; Asahi Glass Foundation; Uehara Memorial Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [25830131, 26430133, 23118516, 25118512, 221S0002]; Ministry of Health, Labour and Welfare	Takeda Science Foundation(Takeda Science Foundation (TSF)); Asahi Glass Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Kurata Memorial Hitachi Science and Technology Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Takeda Science Foundation (T. F.), the Asahi Glass Foundation, the Uehara Memorial Foundation (H. F.), the Kurata Memorial Hitachi Science and Technology Foundation (T. F. and H. F.), Grant-in-Aid for Young Scientists (B) (#25830131) (T. F.), Grant-in-Aid for Scientific Research (C) (#26430133) (R. O.), Grant-in- Aid for Scientific Research on Innovative Areas "Cell Fate" (#23118516) (T. F.), "Transcription Cycle" (#25118512), "Genome Support" (#221S0002) (H. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare (R. O.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Fujita T, 2012, ADV BIOSCI BIOTECHNO, V3, P626, DOI [10.4236/abb.2012.35081., DOI 10.4236/ABB.2012.35081]; Fujita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116579; Fujita T, 2014, BMC MOL BIOL, V15, DOI 10.1186/s12867-014-0026-0; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fujita Toshitsugu, 2013, ISRN Biochem, V2013, P913273, DOI 10.1155/2013/913273; Fujita T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03171; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Fujita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026109; Gendrel AV, 2014, ANNU REV CELL DEV BI; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Kwon S, 2013, BMB REP, V46, P65, DOI 10.5483/BMBRep.2013.46.2.016; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; de Silanes IL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5723; de Silanes IL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1032; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Naganuma T, 2013, RNA BIOL, V10, P456, DOI 10.4161/rna.23547; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Uziel O, 2005, BRIT J CANCER, V92, P1881, DOI 10.1038/sj.bjc.6602592; Vance KW, 2014, TRENDS GENET, V30, P348, DOI 10.1016/j.tig.2014.06.001; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Yang L, 2014, TRENDS BIOCHEM SCI, V39, P35, DOI 10.1016/j.tibs.2013.10.002	39	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123387	10.1371/journal.pone.0123387	http://dx.doi.org/10.1371/journal.pone.0123387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874893	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100170
J	Xue, Y; Zhao, A; Cai, L; Yang, B; Szeto, IMY; Ma, DF; Zhang, YM; Wang, PY				Xue, Yong; Zhao, Ai; Cai, Li; Yang, Baoru; Szeto, Ignatius M. Y.; Ma, Defu; Zhang, Yumei; Wang, Peiyu			Growth and Development in Chinese Pre-Schoolers with Picky Eating Behaviour: A Cross-Sectional Study	PLOS ONE			English	Article							EARLY FEEDING PROBLEMS; COGNITIVE-DEVELOPMENT; AFFLUENT SOCIETY; SENSITIVE PERIOD; FOOD NEOPHOBIA; CHILDREN; PATTERNS; FRUIT; CHILDHOOD; GIRLS	Objective To explore the associations between picky eating behaviour and pre-schoolers' growth and development. Corresponding potential mechanisms, such as nutrient and food subgroup intake, as well as micronutrients in the blood, will be considered. Methods Picky eating behaviour was present if it was reported by parents. From various areas of China, 937 healthy children of 3-7 years old were recruited using a multi-stage stratified cluster sampling method. Children and their mothers' socio-demographic information and children's anthropometry, intelligence, blood samples, one 24-hour dietary intake record and food frequency questionnaire were collected. Z-scores and intelligence tests were used to evaluate growth and development (cognitive development). Multilevel models were employed to verify the associations between picky eating behaviour and growth and development. Results The prevalence of picky eating as reported by parents was 54% in pre-schoolers. Compared with the non-picky eaters, weight for age in picky eaters was 0.14 z-score (95% CI: -0.25, -0.02; p = 0.017) lower while no significant difference was found in intelligence (p > 0.05). Picky eating behaviour lasting over two years was associated with lower weight for age, as was nit-picking meat (the prevalence from parents' perception was 23% in picky eaters) (p < 0.05). Picky eaters consumed fewer cereals, vegetables, and fish (p < 0.05), and had a lower dietary intake of protein, dietary fibre, iron, and zinc (p < 0.05). There were no differences in the concentrations of essential minerals in whole blood (p > 0.05). Conclusions Picky eating behaviour is reported by parents in half of the Chinese pre-schoolers, which is negatively associated with growth (weight for age). Lower protein and dietary fibre as well as lower iron and zinc intakes were associated with picky eating as were lower intakes of vegetables, fish and cereals.	[Xue, Yong; Cai, Li; Yang, Baoru; Szeto, Ignatius M. Y.; Zhang, Yumei; Wang, Peiyu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China; [Zhao, Ai; Ma, Defu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, YM (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China.	zhangyumei@bjmu.edu.cn; wpeiyu@bjmu.edu.cn	Yang, Baoru/AAD-6221-2019	Yang, Baoru/0000-0001-5561-514X	China Mengniu Dairy Stock Company Ltd.	China Mengniu Dairy Stock Company Ltd.	The investigation was supported by China Mengniu Dairy Stock Company Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ARCH DIS CHILD, V99, DOI 10.1136/archdischild-2013-305833; Benton D, 2010, MOL NUTR FOOD RES, V54, P457, DOI 10.1002/mnfr.200900158; Bhutia Dechenla Tshering, 2014, J Family Med Prim Care, V3, P63, DOI 10.4103/2249-4863.130279; Birch LL, 2003, AM J CLIN NUTR, V78, P215, DOI 10.1093/ajcn/78.2.215; BIRCH LL, 1992, NUTR REV, V50, P249, DOI 10.1111/j.1753-4887.1992.tb01341.x; Birch LL, 1998, P NUTR SOC, V57, P617, DOI 10.1079/PNS19980090; Carruth BR, 1998, J AM COLL NUTR, V17, P180, DOI 10.1080/07315724.1998.10718744; Carruth BR, 2004, J AM DIET ASSOC, V104, pS57, DOI 10.1016/j.jada.2003.10.024; Carruth BR, 2000, J AM COLL NUTR, V19, P771, DOI 10.1080/07315724.2000.10718077; CASHDAN E, 1994, HUM NATURE-INT BIOS, V5, P279, DOI 10.1007/BF02692155; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527; DAHL M, 1987, ACTA PAEDIATR SCAND, V76, P881, DOI 10.1111/j.1651-2227.1987.tb17258.x; DAHL M, 1987, ACTA PAEDIATR SCAND, V76, P872, DOI 10.1111/j.1651-2227.1987.tb17257.x; de Moura JE, 2013, BIOL TRACE ELEM RES, V155, P23, DOI 10.1007/s12011-013-9766-9; Dennison BA, 1998, J AM COLL NUTR, V17, P371, DOI 10.1080/07315724.1998.10718778; Dovey TM, 2008, APPETITE, V50, P181, DOI 10.1016/j.appet.2007.09.009; Dubois L, 2007, EUR J CLIN NUTR, V61, P846, DOI 10.1038/sj.ejcn.1602586; Dubois L, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-9; Ekstein S, 2010, CLIN PEDIATR, V49, P217, DOI 10.1177/0009922809337331; Fisher JO, 2002, J AM DIET ASSOC, V102, P58, DOI 10.1016/S0002-8223(02)90017-9; Fortunato JE, 2008, CLIN PEDIATR, V47, P496, DOI 10.1177/0009922807310937; Galloway AT, 2003, J AM DIET ASSOC, V103, P692, DOI 10.1053/jada.2003.50134; Galloway AT, 2005, J AM DIET ASSOC, V105, P541, DOI 10.1016/j.jada.2005.01.029; Goh Daniel Yt, 2012, Asia Pac Fam Med, V11, P5, DOI 10.1186/1447-056X-11-5; Jacobi C, 2003, J AM ACAD CHILD PSY, V42, P76, DOI 10.1097/00004583-200301000-00013; Jacobi C, 2008, INT J EAT DISORDER, V41, P626, DOI 10.1002/eat.20545; Kotler LA, 2001, J AM ACAD CHILD PSY, V40, P1434, DOI 10.1097/00004583-200112000-00014; Lassen A, 2004, PUBLIC HEALTH NUTR, V7, P263, DOI 10.1079/PHN2003532; Lewinsohn PM, 2005, INT J EAT DISORDER, V38, P208, DOI 10.1002/eat.20175; LI D, 1990, PSYCHOL REP, V67, P531; Liu Yuxin, 2002, Zhonghua Yi Xue Za Zhi, V82, P389; MARCHI M, 1990, J AM ACAD CHILD PSY, V29, P112, DOI 10.1097/00004583-199001000-00017; Mascola AJ, 2010, EAT BEHAV, V11, P253, DOI 10.1016/j.eatbeh.2010.05.006; McAfee AJ, 2012, PUBLIC HEALTH NUTR, V15, P1670, DOI 10.1017/S136898001200016X; McDermott BM, 2010, ACTA PAEDIATR, V99, P68, DOI 10.1111/j.1651-2227.2009.01517.x; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Mennella JA, 2008, PHYSIOL BEHAV, V94, P29, DOI 10.1016/j.physbeh.2007.11.014; Mennella JA, 2012, CLIN NUTR, V31, P1022, DOI 10.1016/j.clnu.2012.05.005; Meshram II, 2013, ASIA PAC J PUBLIC HL; Micali N, 2011, J DEV BEHAV PEDIATR, V32, P572, DOI 10.1097/DBP.0b013e31822bc7b7; Morrison H, 2013, APPETITE, V63, P77, DOI 10.1016/j.appet.2012.12.017; Mukhopadhyay K, 2013, ACTA PAEDIATR, V102, P278, DOI 10.1111/apa.12113; Munoz KA, 1997, PEDIATRICS, V100, P323, DOI 10.1542/peds.100.3.323; Nicklaus S, 2005, APPETITE, V44, P289, DOI 10.1016/j.appet.2005.01.006; RYDELL AM, 1995, J GENET PSYCHOL, V156, P217, DOI 10.1080/00221325.1995.9914818; Scaglioni S, 2008, BRIT J NUTR, V99, pS22, DOI 10.1017/S0007114508892471; Schulze KJ, 2014, J NUTR, V144, P979, DOI 10.3945/jn.114.192336; Shim JE, 2011, J AM DIET ASSOC, V111, P1363, DOI 10.1016/j.jada.2011.06.410; STARK LJ, 1986, J APPL BEHAV ANAL, V19, P367, DOI 10.1901/jaba.1986.19-367; TODD KS, 1983, AM J CLIN NUTR, V37, P139, DOI 10.1093/ajcn/37.1.139; Wright CM, 2007, PEDIATRICS, V120, pe1069, DOI 10.1542/peds.2006-2961; Xing LF, 2014, J ZHEJIANG UNIV-SC B, V15, P51, DOI 10.1631/jzus.B1300229; Yang L L, 1994, Int J Neurosci, V74, P109; Yang Y.X., 2005, CHINA FOOD COMPOSITI	55	25	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123664	10.1371/journal.pone.0123664	http://dx.doi.org/10.1371/journal.pone.0123664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875004	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100197
J	Yadav, CB; Bhareti, P; Muthamilarasan, M; Mukherjee, M; Khan, Y; Rathi, P; Prasad, M				Yadav, Chandra Bhan; Bhareti, Priyanka; Muthamilarasan, Mehanathan; Mukherjee, Minakshi; Khan, Yusuf; Rathi, Pushpendra; Prasad, Manoj			Genome-Wide SNP Identification and Characterization in Two Soybean Cultivars with Contrasting Mungbean Yellow Mosaic India Virus Disease Resistance Traits	PLOS ONE			English	Article							SOFTWARE; TOOL; TM4	Mungbean yellow mosaic India virus (MYMIV) is a bipartite Geminivirus, which causes severe yield loss in soybean (Glycine max). Considering this, the present study was conducted to develop large-scale genome-wide single nucleotide polymorphism (SNP) markers and identify potential markers linked with known disease resistance loci for their effective use in genomics-assisted breeding to impart durable MYMIV tolerance. The whole-genome re-sequencing of MYMIV resistant cultivar 'UPSM-534' and susceptible Indian cultivar 'JS335' was performed to identify high-quality SNPs and InDels (insertion and deletions). Approximately 234 and 255 million of 100-bp paired-end reads were generated from 'UPSM-534 and JS-335, respectively, which provided similar to 98% coverage of reference soybean genome. A total of 3083987 SNPs (1559556 in UPSM-534 and 1524431 in JS-335) and 562858 InDels (281958 in UPSM-534 and 280900 in JS-335) were identified. Of these, 1514 SNPs were found to be present in 564 candidate disease resistance genes. Among these, 829 non-synonymous and 671 synonymous SNPs were detected in 266 and 286 defence-related genes, respectively. Noteworthy, a non-synonymous SNP (in chromosome 18, named 18-1861613) at the 149th base-pair of LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE gene responsible for a G/C transversion [ proline (CCC) to alanine (GCC)] was identified and validated in a set of 12 soybean cultivars. Taken together, the present study generated a large-scale genomic resource such as, SNPs and InDels at a genome-wide scale that will facilitate the dissection of various complex traits through construction of high-density linkage maps and fine mapping. In the present scenario, these markers can be effectively used to design high-density SNP arrays for their large-scale validation and high-throughput genotyping in diverse natural and mapping populations, which could accelerate genomics-assisted MYMIV disease resistance breeding in soybean.	[Yadav, Chandra Bhan; Muthamilarasan, Mehanathan; Mukherjee, Minakshi; Khan, Yusuf; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India; [Bhareti, Priyanka; Rathi, Pushpendra] Govind Ballabh Pant Univ Agr & Technol, Dept Genet & Plant Breeding, Pantnagar 263145, Uttarakhand, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Govind Ballabh Pant University of Agriculture Technology	Prasad, M (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	manoj_prasad@nipgr.ac.in	khan, yusuf/AAQ-9470-2021; Muthamilarasan, Mehanathan/H-9340-2017; Prasad, Manoj/AAE-8540-2019; Khan, Yusuf/E-6726-2015	Muthamilarasan, Mehanathan/0000-0001-7589-6372; Prasad, Manoj/0000-0003-0691-0163; Yadav, Chandra Bhan/0000-0001-9613-2232; Khan, Yusuf/0000-0001-6986-4657	Department of Biotechnology, Ministry of Science and Technology, Government of India, India [BT/PR14302/AGR/02/736/2010]; National Institute of Plant Genome Research, Government of India, India; University Grants Commission, New Delhi, India	Department of Biotechnology, Ministry of Science and Technology, Government of India, India; National Institute of Plant Genome Research, Government of India, India; University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was financially supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India, India (Grant no. BT/PR14302/AGR/02/736/2010) and core grant of National Institute of Plant Genome Research, Government of India, India. MuM is the recipient of research fellowship from University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya PK, 1999, EUPHYTICA, V108, P157, DOI 10.1023/A:1003620713110; Bhupender Kumar, 2014, Australian Journal of Crop Science, V8, P27; Chung WH, 2014, DNA RES, V21, P153, DOI 10.1093/dnares/dst047; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gutierrez C, 1999, CELL MOL LIFE SCI, V56, P313, DOI 10.1007/s000180050433; Hanley-Bowdoin L, 2000, CRIT REV BIOCHEM MOL, V35, P105; Jain M, 2014, PLANT BIOTECHNOL J, V12, P253, DOI 10.1111/pbi.12133; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Karangula UB, 2009, CURR ISSUES MOL BIOL, V11, pI73; KOBAYASHI M, 2014, PLANT CELL PHYSIOL, V55, P445, DOI DOI 10.1093/pcp/pct181; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lal SK, 2005, SOYBEAN GENET NEWS L, V1, P32; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; LI YJ, 2013, J INEQUAL APPL, DOI DOI 10.1186/1471-2164-14-579; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Muthamilarasan M, 2013, J BIOSCIENCES, V38, P433, DOI 10.1007/s12038-013-9302-2; Nene YL, 1972, INDIAN J RES B, V4, P191; Qiu LJ, 2013, PLANT MOL BIOL, V83, P41, DOI 10.1007/s11103-013-0076-6; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sahu PP, 2014, FUNCT INTEGR GENOMIC, V14, P47, DOI 10.1007/s10142-013-0346-z; Sahu PP, 2010, MOL PLANT PATHOL, V11, P531, DOI [10.1111/J.1364-3703.2010.00630.X, 10.1111/j.1364-3703.2010.00630.x]; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Xu XY, 2013, P NATL ACAD SCI USA, V110, P13469, DOI 10.1073/pnas.1222368110; Yadav RK, 2009, VIRUS RES, V144, P89, DOI 10.1016/j.virusres.2009.04.011; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuan J, 2002, CROP SCI, V42, P271, DOI 10.2135/cropsci2002.0271	29	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123897	10.1371/journal.pone.0123897	http://dx.doi.org/10.1371/journal.pone.0123897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875830	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100221
J	Jing, YP; Wu, KW; Liu, JS; Ai, Q; Ge, P; Dai, J; Jiang, R; Zhou, D; Che, Q; Wan, JY; Zhang, L				Jing, Yuping; Wu, Kunwei; Liu, Jiashuo; Ai, Qing; Ge, Pu; Dai, Jie; Jiang, Rong; Zhou, Dan; Che, Qian; Wan, Jingyuan; Zhang, Li			Aminotriazole Alleviates Acetaminophen Poisoning via Downregulating P450 2E1 and Suppressing Inflammation	PLOS ONE			English	Article							INDUCED LIVER-INJURY; CARBON-TETRACHLORIDE; OXIDANT STRESS; CELL-DEATH; INDUCED HEPATOTOXICITY; NEUTROPHIL ACTIVATION; ACATALASEMIC MICE; HYDROGEN-PEROXIDE; CATALASE ACTIVITY; TERMINAL KINASE	Aminotriazole (ATZ) is commonly used as a catalase (CAT) inhibitor. We previously found ATZ attenuated oxidative liver injury, but the underlying mechanisms remain unknown. Acetaminophen (APAP) overdose frequently induces life-threatening oxidative hepatitis. In the present study, the potential hepatoprotective effects of ATZ on oxidative liver injury and the underlying mechanisms were further investigated in a mouse model with APAP poisoning. The experimental data indicated that pretreatment with ATZ dose-and time-dependently suppressed the elevation of plasma aminotransferases in APAP exposed mice, these effects were accompanied with alleviated histological abnormality and improved survival rate of APAP-challenged mice. In mice exposed to APAP, ATZ pretreatment decreased the CAT activities, hydrogen peroxide (H2O2) levels, malondialdehyde (MDA) contents, myeloperoxidase (MPO) levels in liver and reduced TNF-a levels in plasma. Pretreatment with ATZ also downregulated APAP-induced cytochrome P450 2E1 (CYP2E1) expression and JNK phosphorylation. In addition, posttreatment with ATZ after APAP challenge decreased the levels of plasma aminotransferases and increased the survival rate of experimental animals. Posttreatment with ATZ had no effects on CYP2E1 expression or JNK phosphorylation, but it significantly decreased the levels of plasma TNF-alpha. Our data indicated that the LD50 of ATZ in mice was 5367.4 mg/kg body weight, which is much higher than the therapeutic dose of ATZ in the present study. These data suggested that ATZ might be effective and safe in protect mice against APAP-induced hepatotoxicity, the beneficial effects might resulted from downregulation of CYP2E1 and inhibiton of inflammation.	[Jing, Yuping; Wu, Kunwei; Liu, Jiashuo; Ge, Pu; Zhou, Dan; Che, Qian; Zhang, Li] Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China; [Ai, Qing] Chongqing Med Univ, Dept Physiol, Chongqing, Peoples R China; [Dai, Jie] Hosp Chongqing Univ Arts & Sci, Chongqing, Peoples R China; [Jiang, Rong] Chongqing Med Univ, Lab Stem Cell & Tissue Engn, Chongqing, Peoples R China; [Wan, Jingyuan] Chongqing Med Univ, Dept Pharmacol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Zhang, L (corresponding author), Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China.	zhangli@cqmu.edu.cn	Wu, Kunwei/AAY-8111-2021	Wu, Kunwei/0000-0003-4074-0567	National Nature Science Foundation of China [81370179]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Nature Science Foundation of China (No. 81370179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2010, BIOCHEM PHARMACOL, V79, P57, DOI 10.1016/j.bcp.2009.07.016; Antoniades CG, 2014, HEPATOLOGY, V59, P1564, DOI 10.1002/hep.26933; Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; Bajt ML, 2011, TOXICOL SCI, V122, P598, DOI 10.1093/toxsci/kfr116; Bateman DN, 2014, LANCET, V383, P697, DOI 10.1016/S0140-6736(13)62062-0; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Cesaratto Laura, 2004, Ann Hepatol, V3, P86; Chaudhuri S, 2012, TOXICOL APPL PHARM, V264, P192, DOI 10.1016/j.taap.2012.08.001; Chen X, 2009, WORLD J GASTROENTERO, V15, P1829, DOI 10.3748/wjg.15.1829; Chen XL, 2004, ARCH BIOCHEM BIOPHYS, V422, P197, DOI 10.1016/j.abb.2003.12.023; Cheung C, 2005, DRUG METAB DISPOS, V33, P449, DOI 10.1124/dmd.104.002402; Deng XY, 2012, FOOD CHEM TOXICOL, V50, P3073, DOI 10.1016/j.fct.2012.05.052; Fukuoka N, 2008, AM J NEPHROL, V28, P661, DOI 10.1159/000121357; Gandhi A, 2010, J TOXICOL SCI, V35, P163, DOI 10.2131/jts.35.163; Han D., 2010, HDB EXP PHARM, V196, P267, DOI DOI 10.1007/978-3-642-00663-0_10; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jaeschke H, 2003, TOXICOL LETT, V144, P279, DOI 10.1016/S0378-4274(03)00239-X; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Josephy PD, 2005, DRUG METAB REV, V37, P581, DOI 10.1080/03602530500205200; Jozwiak-Bebenista M, 2014, ACTA POL PHARM, V71, P11; Kim ND, 1997, BIOCHEM PHARMACOL, V53, P261, DOI 10.1016/S0006-2952(96)00647-8; Kim SN, 2007, DRUG METAB DISPOS, V35, P1754, DOI 10.1124/dmd.107.015545; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Li JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.241; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Maddrey WC, 2005, J CLIN GASTROENTEROL, V39, pS83, DOI 10.1097/01.mcg.0000155548.91524.6e; Miller L, 2013, TOXICOL SCI, V134, P400, DOI 10.1093/toxsci/kft122; Milton NGN, 2001, NEUROTOXICOLOGY, V22, P767, DOI 10.1016/S0161-813X(01)00064-X; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Sen P, 2003, MUTAT RES-FUND MOL M, V529, P87, DOI 10.1016/S0027-5107(03)00106-4; Sinclair J, 1998, BIOCHEM PHARMACOL, V55, P1557; Smith C, 2000, EXP MOL PATHOL, V69, P223, DOI 10.1006/exmp.2000.2328; Dao VTV, 2011, J CELL MOL MED, V15, P2326, DOI 10.1111/j.1582-4934.2010.01227.x; Wang DH, 1996, ARCH TOXICOL, V70, P189, DOI 10.1007/s002040050259; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Williams CD, 2014, TOXICOL APPL PHARM, V275, P122, DOI 10.1016/j.taap.2014.01.004; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC	43	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122781	10.1371/journal.pone.0122781	http://dx.doi.org/10.1371/journal.pone.0122781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884831	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000041
J	Kusch, A; Schmidt, M; Gurgen, D; Postpieszala, D; Catar, R; Hegner, B; Davidson, MM; Mahmoodzadeh, S; Dragun, D				Kusch, Angelika; Schmidt, Maria; Guergen, Dennis; Postpieszala, Daniel; Catar, Rusan; Hegner, Bjoern; Davidson, Merci M.; Mahmoodzadeh, Shokoufeh; Dragun, Duska			17 beta- Estradiol Regulates mTORC2 Sensitivity to Rapamycin in Adaptive Cardiac Remodeling	PLOS ONE			English	Article							COMPLEX INTEGRITY; INHIBITS MTORC2; PROTEIN-KINASE; UP-REGULATION; AKT; ESTROGEN; PHOSPHORYLATION; HYPERTROPHY; PATHWAY; ACTIVATION	Adaptive cardiac remodeling is characterized by enhanced signaling of mTORC2 downstream kinase Akt. In females, 17 beta-estradiol (E2), as well as Akt contribute essentially to sex-related premenopausal cardioprotection. Pharmacologic mTOR targeting with rapamycin is increasingly used for various clinical indications, yet burdened with clinical heterogeneity in therapy responses. The drug inhibits mTORC1 and less-so mTORC2. In male rodents, rapamycin decreases maladaptive cardiac hypertrophy whereas it leads to detrimental dilative cardiomyopathy in females. We hypothesized that mTOR inhibition could interfere with 17 beta-estradiol (E2)-mediated sexual dimorphism and adaptive cell growth and tested responses in murine female hearts and cultured female cardiomyocytes. Under physiological in vivo conditions, rapamycin compromised mTORC2 function only in female, but not in male murine hearts. In cultured female cardiomyocytes, rapamycin impaired simultaneously IGF-1 induced activation of both mTOR signaling branches, mTORC1 and mTORC2 only in presence of E2. Use of specific estrogen receptor (ER)alpha- and ER beta-ago-nists indicated involvement of both estrogen receptors (ER) in rapamycin effects on mTORC1 and mTORC2. Classical feedback mechanisms common in tumour cells with upregulation of PI3K signaling were not involved. E2 effect on Akt-pS473 downregulation by rapamycin was independent of ERK as shown by sequential mTOR and MEK-inhibition. Furthermore, regulatory mTORC2 complex defining component rictor phosphorylation at Ser1235, known to interfere with Akt-substrate binding to mTORC2, was not altered. Functionally, rapamycin significantly reduced trophic effect of E2 on cell size. In addition, cardiomyocytes with reduced Akt-pS473 under rapamycin treatment displayed decreased SERCA2A mRNA and protein expression suggesting negative functional consequences on cardiomyocyte contractility. Rictor silencing confirmed regulation of SERCA2A expression by mTORC2 in E2-cultured female cardiomyocytes. These data highlight a novel modulatory function of E2 on rapamycin effect on mTORC2 in female cardiomyocytes and regulation of SERCA2A expression by mTORC2. Conceivably, rapamycin abrogates the premenopausal "female advantage".	[Kusch, Angelika; Schmidt, Maria; Guergen, Dennis; Postpieszala, Daniel; Catar, Rusan; Hegner, Bjoern; Dragun, Duska] Charite, Charite Campus Virchow Klinikum, Dept Nephrol & Intens Care Med, D-13353 Berlin, Germany; [Kusch, Angelika; Guergen, Dennis; Catar, Rusan; Hegner, Bjoern; Mahmoodzadeh, Shokoufeh; Dragun, Duska] Charite, Ctr Cardiovasc Res, D-13353 Berlin, Germany; [Davidson, Merci M.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY USA; [Mahmoodzadeh, Shokoufeh] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Columbia University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kusch, A (corresponding author), Charite, Charite Campus Virchow Klinikum, Dept Nephrol & Intens Care Med, D-13353 Berlin, Germany.	angelika.kusch@charite.de	Schmidt, Maria/V-3196-2019; Catar, Rusan Ali/I-3948-2019; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria Inês/AGT-5691-2022	Catar, Rusan Ali/0000-0002-7000-7860; Schmidt, Maria Inês/0000-0002-3837-0731; Mahmoodzadeh, Shokoufeh/0000-0002-3094-7874; Hegner, Bjorn/0000-0003-3524-1165; Dragun, Duska/0000-0002-0310-9269	Deutsche Forschungsgemeinschaft DFG [DR 498/1-2 - FOR1054]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	Funding was provided by Deutsche Forschungsgemeinschaft DFG - DR 498/1-2 - FOR1054, http://www.dfg.de/en/, DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Arias-Loza PA, 2008, GENDER MED, V5, pS34, DOI 10.1016/j.genm.2008.03.005; Aryal B, 2014, P NATL ACAD SCI USA, V111, P2011, DOI 10.1073/pnas.1321783111; Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Buss SJ, 2012, AM J PHYSIOL-HEART C, V302, pH420, DOI 10.1152/ajpheart.00211.2011; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Chen SN, 2014, CIRC RES, V114, P454, DOI 10.1161/CIRCRESAHA.114.302810; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cong BH, 2014, MOL CELL ENDOCRINOL, V382, P17, DOI 10.1016/j.mce.2013.09.002; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Dworatzek E, 2014, CARDIOVASC RES, V102, P418, DOI 10.1093/cvr/cvu065; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Gabardi S, 2010, PHARMACOTHERAPY, V30, P1044, DOI 10.1592/phco.30.10.1044; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Garcia-Segura LM, 2006, NEUROENDOCRINOLOGY, V84, P275, DOI 10.1159/000097485; Gurgen D, 2013, HYPERTENSION, V61, P730, DOI 10.1161/HYPERTENSIONAHA.111.00276; Gurgen D, 2011, HYPERTENSION, V57, P648, DOI 10.1161/HYPERTENSIONAHA.110.166157; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jeanes HL, 2008, J ENDOCRINOL, V197, P493, DOI 10.1677/JOE-08-0071; Jesmin S, 2010, EUR J PHARMACOL, V641, P168, DOI 10.1016/j.ejphar.2010.05.020; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Kim SJ, 2008, AM J PHYSIOL-HEART C, V295, pH130, DOI 10.1152/ajpheart.00298.2008; Kushwaha SS, 2008, EUR HEART J, V29, P2742, DOI 10.1093/eurheartj/ehn407; Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462; Liu CG, 2007, CLIN EXP PHARMACOL P, V34, P998, DOI 10.1111/j.1440-1681.2007.04675.x; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Lorenz K, 2009, INT J BIOCHEM CELL B, V41, P2351, DOI 10.1016/j.biocel.2009.08.002; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Miyamoto S, 2009, CARDIOVASC RES, V82, P272, DOI 10.1093/cvr/cvp087; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; Prossnitz ER, 2014, MOL CELL ENDOCRINOL, V389, P71, DOI 10.1016/j.mce.2014.02.002; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Siedlecki AM, 2009, KIDNEY INT, V75, P800, DOI 10.1038/ki.2008.690; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Voelkers M, 2013, CIRCULATION, V128, P2132, DOI 10.1161/CIRCULATIONAHA.113.003638; Wallace EL, 2012, AM J CARDIOL, V109, P932, DOI 10.1016/j.amjcard.2011.11.021; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yano N, 2008, AM J PHYSIOL-HEART C, V295, pH1690, DOI 10.1152/ajpheart.00531.2008; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	70	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123385	10.1371/journal.pone.0123385	http://dx.doi.org/10.1371/journal.pone.0123385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880554	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000353016500050
J	Norambuena, F; Hermon, K; Skrzypczyk, V; Emery, JA; Sharon, Y; Beard, A; Turchini, GM				Norambuena, Fernando; Hermon, Karen; Skrzypczyk, Vanessa; Emery, James A.; Sharon, Yoni; Beard, Alastair; Turchini, Giovanni M.			Algae in Fish Feed: Performances and Fatty Acid Metabolism in Juvenile Atlantic Salmon	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; ULVA MEAL SUPPLEMENTATION; BODY-COMPOSITION; RAINBOW-TROUT; NILE TILAPIA; AMINO-ACID; GROWTH-PERFORMANCE; LIPID-METABOLISM; EDIBLE SEAWEED; DIETARY FIBER	Algae are at the base of the aquatic food chain, producing the food resources that fish are adapted to consume. Previous studies have proven that the inclusion of small amounts (<10% of the diet) of algae in fish feed (aquafeed) resulted in positive effects in growth performance and feed utilisation efficiency. Marine algae have also been shown to possess functional activities, helping in the mediation of lipid metabolism, and therefore are increasingly studied in human and animal nutrition. The aim of this study was to assess the potentials of two commercially available algae derived products (dry algae meal), Verdemin (derived from Ulva ohnoi) and Rosamin (derived from diatom Entomoneis spp.) for their possible inclusion into diet of Atlantic Salmon (Salmo salar). Fish performances, feed efficiency, lipid metabolism and final product quality were assessed to investigated the potential of the two algae products (in isolation at two inclusion levels, 2.5% and 5%, or in combination), in experimental diets specifically formulated with low fish meal and fish oil content. The results indicate that inclusion of algae product Verdemin and Rosamin at level of 2.5 and 5.0% did not cause any major positive, nor negative, effect in Atlantic Salmon growth and feed efficiency. An increase in the omega-3 long-chain polyunsaturated fatty acid (n-3 LC-PUFA) content in whole body of fish fed 5% Rosamin was observed.	[Norambuena, Fernando; Hermon, Karen; Skrzypczyk, Vanessa; Emery, James A.; Turchini, Giovanni M.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Sharon, Yoni; Beard, Alastair] MBD Energy Ltd, Melbourne, Vic, Australia	Deakin University	Norambuena, F (corresponding author), Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia.	f.norambuena@deakin.edu.au		Turchini, Giovanni/0000-0003-0694-4283	MBD energy; MBD Energy Ltd.	MBD energy; MBD Energy Ltd.	This project was funded by MBD energy, whose products are featured in this study; their support was greatly appreciated. Co-authors Yoni Sharon and Alastair Beard are employed by MBD Energy Ltd. MBD Energy Ltd. provided support in the form of salaries for authors YS and AB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Airanthi MKWA, 2011, J AGR FOOD CHEM, V59, P4156, DOI 10.1021/jf104643b; Aki T, 2014, LIPIDS, V49, P133, DOI 10.1007/s11745-013-3856-5; AOAC, 2005, AN FEED OFF METH AN, P52; ATKINSON JL, 1984, CAN J FISH AQUAT SCI, V41, P1384, DOI 10.1139/f84-170; Azaza MS, 2008, J APPL ICHTHYOL, V24, P202, DOI 10.1111/j.1439-0426.2007.01017.x; Cyrus MD, 2014, AQUAC NUTR, P1; D'Orazio N, 2012, MAR DRUGS, V10, P604, DOI 10.3390/md10030604; Dawczynski C, 2007, FOOD CHEM, V103, P891, DOI 10.1016/j.foodchem.2006.09.041; de Oliveira MN, 2009, FOOD CHEM, V115, P254, DOI 10.1016/j.foodchem.2008.12.004; Diler I., 2007, J BIOL SCI, V7, P305, DOI [10.3923/jbs.2007.305.308, DOI 10.3923/JBS.2007.305.308]; Ergun S, 2009, AQUACULT INT, V17, P355, DOI 10.1007/s10499-008-9207-5; Fleurence J, 1999, TRENDS FOOD SCI TECH, V10, P25, DOI 10.1016/S0924-2244(99)00015-1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis DS, 2007, J AGR FOOD CHEM, V55, P1582, DOI 10.1021/jf062153x; Francis DS, 2006, AQUACULTURE, V253, P547, DOI 10.1016/j.aquaculture.2005.08.008; Grammes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083213; Guroy B, 2012, AQUAC INT, P1; Guroy BK, 2007, TURK J VET ANIM SCI, V31, P91; Guroy D, 2011, J ANIM PHYSIOL AN N, V95, P320, DOI 10.1111/j.1439-0396.2010.01057.x; HASHIM R, 1992, AQUACULTURE, V108, P299, DOI 10.1016/0044-8486(92)90114-Z; Hidalgo MC, 1999, AQUACULTURE, V170, P267, DOI 10.1016/S0044-8486(98)00413-X; Jones AC, 2014, FISH FISH, P1; Kim SK, 2011, ADV FOOD NUTR RES, V64, P191, DOI 10.1016/B978-0-12-387669-0.00014-4; Li P, 2009, AMINO ACIDS, V37, P43, DOI 10.1007/s00726-008-0171-1; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; MONTGOMERY WL, 1980, ENVIRON BIOL FISH, V5, P143, DOI 10.1007/BF02391621; Mustafa MG, 1995, ISR J AQUACULT-BAMID, V47, P155; NAKAGAWA H, 1987, AQUACULTURE, V62, P109, DOI 10.1016/0044-8486(87)90315-2; Nakagawa H, 1997, BIOMED PHARMACOTHER, V51, P345, DOI 10.1016/S0753-3322(97)88053-5; Nakagawa Heisuke, 1993, Asian Fisheries Science, V6, P139; Norambuena F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081705; Ortiz J, 2006, FOOD CHEM, V99, P98, DOI 10.1016/j.foodchem.2005.07.027; Peng J, 2011, MAR DRUGS, V9, P1806, DOI 10.3390/md9101806; ROSELL KG, 1985, J PHYCOL, V21, P304, DOI 10.1111/j.0022-3646.1985.00304.x; SATOH K, 1987, NIPPON SUISAN GAKK, V53, P1115; Shpigel M, 1999, J SHELLFISH RES, V18, P227; STANLEY JG, 1976, AQUACULTURE, V7, P219, DOI 10.1016/0044-8486(76)90140-X; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tsukui T, 2007, J AGR FOOD CHEM, V55, P5025, DOI 10.1021/jf070110q; Turchini GM, 2007, LIPIDS, V42, P1065, DOI 10.1007/s11745-007-3105-x; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Valente LMP, 2006, AQUACULTURE, V252, P85, DOI 10.1016/j.aquaculture.2005.11.052; Wahbeh MI, 1997, AQUACULTURE, V159, P101, DOI 10.1016/S0044-8486(97)00183-X; Wassef E.A., 2005, EGYPT J AQUAT RES, V31, P321; Wilke T, 2014, EUR J LIPID SCI TECH, P1; Yildirim O, 2009, KAFKAS UNIV VET FAK, V15, P455; Yuan YV, 2006, FOOD CHEM TOXICOL, V44, P1144, DOI 10.1016/j.fct.2006.02.002	48	88	90	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124042	10.1371/journal.pone.0124042	http://dx.doi.org/10.1371/journal.pone.0124042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875839	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800129
J	Salillas, E; Barraza, P; Carreiras, M				Salillas, Elena; Barraza, Paulo; Carreiras, Manuel			Oscillatory Brain Activity Reveals Linguistic Prints in the Quantity Code	PLOS ONE			English	Article							NUMBER REPRESENTATIONS; SYNCHRONIZATION; NETWORKS; CHILDREN; DYSCALCULIA; PERCEPTION; MECHANISMS; DYNAMICS; ORIGINS; ADULTS	Number representations change through education, although it is currently unclear whether and how language could impact the magnitude representation that we share with other species. The most prominent view is that language does not play any role in modulating the core numeric representation involved in the contrast of quantities. Nevertheless, possible cultural hints on the numerical magnitude representation are currently on discussion focus. In fact, the acquisition of number words provides linguistic input that the quantity system may not ignore. Bilingualism offers a window to the study of this question, especially in bilinguals where the two number wording systems imply also two different numerical systems, such as in Basque-Spanish bilinguals. The present study evidences linguistic prints in the core number representational system through the analysis of EEG oscillatory activity during a simple number comparison task. Gamma band synchronization appears when Basque-Spanish bilinguals compare pairs of Arabic numbers linked through the Basque base-20 wording system, but it does not if the pairs are related through the base-10 system. Crucially, this gamma activity, originated in a left fronto-parietal network, only appears in bilinguals who learned math in Basque and not in equivalent proficiency bilinguals who learned math in Spanish. Thus, this neural index reflected in gamma band synchrony appears to be triggered by early learning experience with the base-20 numerical associations in Basque number words.	[Salillas, Elena; Carreiras, Manuel] BCBL, Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain; [Barraza, Paulo] Univ Chile, Ctr Invest Avanzada Educ, Santiago, Chile; [Carreiras, Manuel] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain	Universidad de Chile; Basque Foundation for Science	Salillas, E (corresponding author), BCBL, Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain.	e.salillas@bcbl.eu	Carreiras, Manuel/D-5267-2009; , CIAE/R-5423-2017; Salillas, Elena/E-1262-2015	Carreiras, Manuel/0000-0001-6726-7613; Salillas, Elena/0000-0002-0873-5357; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892	Marie Curie grant FP7-PEOPLE-IEF; Ministry of Science and Innovation [PSI2011-23995]; Basal Funds for Centers of Excellence; Associative Research Program of CONICYT [FB 0003]; Initial Teacher Training of MECESUP3 [UCH1201]; Spanish Ministry of Economy and Competitiveness [CSD2008-00048]; European Research Council [ERC-2011-ADG-295362]	Marie Curie grant FP7-PEOPLE-IEF; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basal Funds for Centers of Excellence(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Associative Research Program of CONICYT; Initial Teacher Training of MECESUP3; Spanish Ministry of Economy and Competitiveness(Spanish Government); European Research Council(European Research Council (ERC)European Commission)	This research was supported by the Marie Curie grant FP7-PEOPLE-2010-IEF and the Ministry of Science and Innovation grant PSI2011-23995 awarded to ES. PB was supported by the Basal Funds for Centers of Excellence, Project FB 0003 from the Associative Research Program of CONICYT and the Project UCH1201 from Initial Teacher Training of MECESUP3. This research was partially supported by the CONSOLIDER-INGENIO2010 CSD2008-00048 grant from the Spanish Ministry of Economy and Competitiveness, and the ERC-2011-ADG-295362 grant from the European Research Council awarded to MC.	Ansari D, 2005, NEUROREPORT, V16, P1769, DOI 10.1097/01.wnr.0000183905.23396.f1; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Barraza P, 2014, NEUROSCI LETT, V567, P40, DOI 10.1016/j.neulet.2014.03.021; BURGESS AP, 1999, HANDB EL CL, V6, P139; Butterworth B, 2010, TRENDS COGN SCI, V14, P534, DOI 10.1016/j.tics.2010.09.007; Campbell JID, 2009, EUR J COGN PSYCHOL, V21, P686, DOI 10.1080/09541440802214846; CAMPBELL JID, 1988, J EXP PSYCHOL GEN, V117, P204, DOI 10.1037/0096-3445.117.2.204; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Goodglass H., 1983, BOSTON NAMING TEST; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hsu YF, 2012, NEUROIMAGE, V59, P3103, DOI 10.1016/j.neuroimage.2011.11.017; Kaufmann L, 2006, NEUROREPORT, V17, P587, DOI 10.1097/00001756-200604240-00007; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Libertus ME, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-1; MCCLOSKEY M, 1992, COGNITION, V44, P107, DOI 10.1016/0010-0277(92)90052-J; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Micheloyannis S, 2005, NEUROSCI LETT, V373, P212, DOI 10.1016/j.neulet.2004.10.005; Miller KF, 2005, HDB MATH COGNITION; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Perez A, 2012, NEUROPSYCHOLOGIA, V50, P2584, DOI 10.1016/j.neuropsychologia.2012.07.009; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Salillas E, 2014, CORTEX, V52, P1, DOI 10.1016/j.cortex.2013.12.009; Salillas E, 2012, PSYCHOL SCI, V23, P745, DOI 10.1177/0956797612446347; Temple E, 1998, P NATL ACAD SCI USA, V95, P7836, DOI 10.1073/pnas.95.13.7836; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550	31	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121434	10.1371/journal.pone.0121434	http://dx.doi.org/10.1371/journal.pone.0121434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875210	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800020
J	Saxena, R; Gupta, S; Singh, K; Mitra, K; Tripathi, AK; Tripathi, RK				Saxena, Reshu; Gupta, Sudipti; Singh, Kavita; Mitra, Kalyan; Tripathi, Anil Kumar; Tripathi, Raj Kamal			Proteomic Profiling of SupT1 Cells Reveal Modulation of Host Proteins by HIV-1 Nef Variants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DOWN-REGULATION; REPLICATION; CYCLOPHILIN; MOLECULES; INFECTION; GENE; ENDOCYTOSIS; PROGRESSION; INTERFERES	Nef is an accessory viral protein that promotes HIV-1 replication, facilitating alterations in cellular pathways via multiple protein-protein interactions. The advent of proteomics has expanded the focus on better identification of novel molecular pathways regulating disease progression. In this study, nef was sequenced from randomly selected patients, however, sequence variability identified did not elicited any specific mutation that could have segregated HIV-1 patients in different stages of disease progression. To explore the difference in Nef functionality based on sequence variability we used proteomics approach. Proteomic profiling was done to compare the effect of Nef variants in host cell protein expression. 2DGE in control and Nef transfected SupT1 cells demonstrated several differentially expressed proteins. Fourteen protein spots were detected with more than 1.5 fold difference. Significant down regulation was seen in six unique protein spots in the Nef treated cells. Proteins were identified as Cyclophilin A, EIF5A-1 isoform B, Rho GDI 1 isoform a, VDAC1, OTUB1 and alpha-enolase isoform 1 (ENO1) through LC-MS/MS. The differential expression of the 6 proteins was analyzed by Real time PCR, Western blotting and Immunofluorescence studies with two Nef variants (RP14 and RP01) in SupT1 cells. There was contrasting difference between the effect of these Nef variants upon the expression of these six proteins. Downregulation of alpha-enolase (ENO1), VDAC1 and OTUB1 was more significant by Nef RP01 whereas Cyclophilin A and RhoGDI were found to be more downregulated by Nef RP14. This difference in Nef variants upon host protein expression was also studied through a site directed mutant of Nef RP01 ((55AAAAAAA61)) and the effect was found to be reversed. Deciphering the role of these proteins mediated by Nef variants will open a new avenue of research in understanding Nef mediated pathogenesis. Overall study determines modulation of cellular protein expression in T cells by HIV-1 Nef variants.	[Saxena, Reshu; Gupta, Sudipti; Tripathi, Raj Kamal] Cent Drug Res Inst, CSIR, Div Toxicol, Lucknow 226001, Uttar Pradesh, India; [Singh, Kavita; Mitra, Kalyan] Cent Drug Res Inst, CSIR, Sophisticated Analyt Instrument Facil, Elect Microscopy Lab, Lucknow 226001, Uttar Pradesh, India; [Tripathi, Anil Kumar] King Georges Med Univ, Dept Med, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University	Tripathi, RK (corresponding author), Cent Drug Res Inst, CSIR, Div Toxicol, Sect 10,Janakipuram Extens,Sitapur Rd, Lucknow 226001, Uttar Pradesh, India.	rajkamalcdri@gmail.com	Saxena, Reshu/AAU-3178-2021	Tripathi, Anil/0000-0001-9139-8701; Saxena, Reshu/0000-0001-7252-4688	Council of Scientific and Indistrial Research (CSIR)-Central Drug Research Institute (CDRI); CSIR [BSC0111]; ICMR	Council of Scientific and Indistrial Research (CSIR)-Central Drug Research Institute (CDRI); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICMR(Indian Council of Medical Research (ICMR))	The authors thank "Council of Scientific and Indistrial Research (CSIR)-Central Drug Research Institute (CDRI)" for providing the institutional Funding and CSIR Network Project-'Indepth' (BSC0111) for providing financial support. RS acknowledges fellowship support from ICMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDROVANDI GM, 1993, NATURE, V363, P732, DOI 10.1038/363732a0; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Audoly G, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-48; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bell I, 1998, J GEN VIROL, V79, P2717, DOI 10.1099/0022-1317-79-11-2717; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; BILLICH A, 1995, J VIROL, V69, P2451, DOI 10.1128/JVI.69.4.2451-2461.1995; Bregnard C, 2011, RETROVIROLOGY S2, V8, pP3; Bregnard C, 2013, J VIROL, V87, P3729, DOI 10.1128/JVI.02477-12; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Carl S, 2000, J INFECT DIS, V181, P132, DOI 10.1086/315187; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Catucci M, 2000, J MED VIROL, V60, P294, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;294::AID-JMV8&gt;3.0.CO;2-1; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; Chaudhry A, 2007, CELL HOST MICROBE, V1, P37, DOI 10.1016/j.chom.2007.01.001; Choe EY, 2002, J BIOL CHEM, V277, P46079, DOI 10.1074/jbc.M204698200; Choi HJ, 2004, J BIOL CHEM, V279, P51688, DOI 10.1074/jbc.M410068200; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Das SR, 2005, INDIAN J MED RES, V121, P315; Fackler OT, 2006, J VIROLOGY; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; FREUND J, 1994, EUR J BIOCHEM, V221, P811, DOI 10.1111/j.1432-1033.1994.tb18795.x; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002; HA HJ, 1993, J BIOL CHEM, V268, P12143; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Hanna Z, 2004, VIROLOGY, V327, P273, DOI 10.1016/j.virol.2004.06.028; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Joseph AM, 2005, CURR HIV RES, V3, P87, DOI 10.2174/1570162052773013; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 1999, J VIROL, V73, P5497, DOI 10.1128/JVI.73.7.5497-5508.1999; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kumar B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067586; LEFFERS H, 1993, EXP CELL RES, V209, P165, DOI 10.1006/excr.1993.1298; Lin YL, 2005, J VIROL, V79, P7938, DOI 10.1128/JVI.79.12.7938-7941.2005; Liu K.-J., 2007, J CANC MOL, V3, P45; Lu XB, 1996, CURR BIOL, V6, P1677, DOI 10.1016/S0960-9822(02)70792-6; Lutz NW, 1997, AIDS, V11, P147, DOI 10.1097/00002030-199702000-00003; Mukerji J, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-33; Nazir A, 2010, PLOS ONE, V13, P5; O'Neill E, 2006, J VIROL, V80, P1311, DOI 10.1128/JVI.80.3.1311-1320.2006; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Rasola A, 2001, J IMMUNOL, V166, P81, DOI 10.4049/jimmunol.166.1.81; Ratner L, 1996, VIROLOGY, V223, P245, DOI 10.1006/viro.1996.0474; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Saphire ACS, 2000, IMMUNOL RES, V21, P211, DOI 10.1385/IR:21:2-3:211; Saxena SK, 2012, FUTURE VIROL, V7, P609, DOI 10.2217/FVL.12.42; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shi XP, 1996, EXP CELL RES, V225, P348, DOI 10.1006/excr.1996.0185; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; SINGH P, 2011, PLOS ONE, V6; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; Stantchev TS, 2001, CYTOKINE GROWTH F R, V12, P219, DOI 10.1016/S1359-6101(00)00033-2; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Van Duyne R, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-21; Vignoli AL, 2000, MOL CELL BIOCHEM, V215, P73, DOI 10.1023/A:1026590916661; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Wang T, 2008, J NEUROIMMUNE PHARM, V3, P173, DOI 10.1007/s11481-008-9110-x; Welker R, 1996, VIROLOGY, V219, P228, DOI 10.1006/viro.1996.0240; Wiederin J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-8; Zheng J, 2011, ANAL CHIM ACTA, V702, P149, DOI 10.1016/j.aca.2011.06.045	77	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122994	10.1371/journal.pone.0122994	http://dx.doi.org/10.1371/journal.pone.0122994			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874870	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100124
J	Strandgren, C; Nasser, HA; McKenna, T; Koskela, A; Tuukkanen, J; Ohlsson, C; Rozell, B; Eriksson, M				Strandgren, Charlotte; Nasser, Hasina Abdul; McKenna, Tomas; Koskela, Antti; Tuukkanen, Juha; Ohlsson, Claes; Rozell, Bjorn; Eriksson, Maria			Transgene silencing of the Hutchinson-Gilford progeria syndrome mutation results in a reversible bone phenotype, whereas resveratrol treatment does not show overall beneficial effects	FASEB JOURNAL			English	Article						lamin A/C; nuclear lamina; osteoblasts; premature aging; osteocytes	MOUSE MODEL; FARNESYLTRANSFERASE INHIBITOR; LAMIN-A; NUCLEAR ABNORMALITIES; GENE-EXPRESSION; DISEASE; LEADS; FARNESYLATION; PROGRESSION; PREVENTS	Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature aging disorder that is most commonly caused by a de novo point mutation in exon 11 of the LMNA gene, c.1824C>T, which results in an increased production of a truncated form of lamin A known as progerin. In this study, we used a mouse model to study the possibility of recovering from HGPS bone disease upon silencing of the HGPS mutation, and the potential benefits from treatment with resveratrol. We show that complete silencing of the transgenic expression of progerin normalized bone morphology and mineralization already after 7 weeks. The improvements included lower frequencies of rib fractures and callus formation, an increased number of osteocytes in remodeled bone, and normalized dentinogenesis. The beneficial effects from resveratrol treatment were less significant and to a large extent similar to mice treated with sucrose alone. However, the reversal of the dental phenotype of overgrown and laterally displaced lower incisors in HGPS mice could be attributed to resveratrol. Our results indicate that the HGPS bone defects were reversible upon suppressed transgenic expression and suggest that treatments targeting aberrant progerin splicing give hope to patients who are affected by HGPS.	[Strandgren, Charlotte; Nasser, Hasina Abdul; McKenna, Tomas; Eriksson, Maria] Karolinska Inst, Ctr Innovat Med, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Rozell, Bjorn] Karolinska Inst, Dept Lab Med, S-14183 Huddinge, Sweden; [Koskela, Antti; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, Oulu, Finland; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Rozell, Bjorn] Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark	Karolinska Institutet; Karolinska Institutet; University of Oulu; University of Gothenburg; University of Copenhagen	Eriksson, M (corresponding author), Karolinska Inst, Ctr Innovat Med, Dept Biosci & Nutr, S-14183 Huddinge, Sweden.	maria.eriksson.2@ki.se	Ohlsson, Claes/AGP-3544-2022; Tuukkanen, Juha/R-3728-2018	Ohlsson, Claes/0000-0002-9633-2805; Tuukkanen, Juha/0000-0002-1723-6461; Koskela, Antti/0000-0001-7371-2488	Swedish Research Council; Progeria Research Foundation; Karolinska Institutet; Novo Nordisk Fonden [NNF14OC0010513, NNF13OC0005785] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Progeria Research Foundation; Karolinska Institutet(Karolinska Institutet); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Raoul Kuiper for pathology advisement, Asa-Lena Dackland for fluorescence-activated cell sorting analysis, Per Larshammar and Robin Chatterjee for technical consultation on droplet digital PCR, and Eva Schmidt for technical assistance. This study was supported by the Swedish Research Council, The Progeria Research Foundation, and Karolinska Institutet. This study was in part performed at the Live Cell Imaging Unit, Department of Biosciences and Nutrition, Karolinska Institutet.	Baek JH, 2015, HUM MOL GENET, V24, P1305, DOI 10.1093/hmg/ddu541; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; COADY JM, 1967, J DENT RES, V46, P384, DOI 10.1177/00220345670460021201; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Finley J, 2014, MED HYPOTHESES, V83, P580, DOI 10.1016/j.mehy.2014.08.016; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; GALL G A E, 1968, Theoretical and Applied Genetics, V38, P304, DOI 10.1007/BF01297571; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003; Gordon CM, 2011, J BONE MINER RES, V26, P1670, DOI 10.1002/jbmr.392; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Karimian E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067859; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mansour A, 2012, J EXP MED, V209, P537, DOI 10.1084/jem.20110994; McKenna T, 2014, AGING CELL, V13, P292, DOI 10.1111/acel.12173; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosengardten Y, 2011, AGING CELL, V10, P1011, DOI 10.1111/j.1474-9726.2011.00743.x; Sagelius H, 2008, J MED GENET, V45, P794, DOI 10.1136/jmg.2008.060772; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Schmidt E, 2012, J BIOL CHEM, V287, P33512, DOI 10.1074/jbc.M112.366450; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Zegarelli EV, 1944, AM J PATHOL, V20, P23; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820	39	19	19	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3193	3205		10.1096/fj.14-269217	http://dx.doi.org/10.1096/fj.14-269217			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25877214				2022-12-26	WOS:000358796900009
J	Ghouri, N; Purves, D; Deans, KA; Logan, G; McConnachie, A; Wilson, J; Gill, JMR; Sattar, N				Ghouri, Nazim; Purves, David; Deans, Kevin A.; Logan, Greig; McConnachie, Alex; Wilson, John; Gill, Jason M. R.; Sattar, Naveed			An Investigation of Two-Dimensional Ultrasound Carotid Plaque Presence and Intima Media Thickness in Middle-Aged South Asian and European Men Living in the United Kingdom	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INCREASED INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; VASCULAR-DISEASE; FOLLOW-UP; ATHEROSCLEROSIS; UK	Objectives Ultrasound studies of carotid intima media thickness (cIMT) and plaques are limited in South Asians, a group at elevated cardiovascular disease (CVD) risk. We determined whether South Asians have a difference in these ultrasound markers compared to Europeans living in the United Kingdom and whether measured risk factor(s) could account for any such differences. Methods One hundred South Asian men, aged 40 to 70 years and 100 European men of similar age and BMI, without diagnosed CVD or diabetes, underwent carotid ultrasound for measurement of cIMT and carotid plaque presence. Physical activity, cardiorespiratory fitness, anthropometry and blood pressure were assessed, fasted blood taken for measurement of cardiometabolic risk factors and demographic and lifestyle factors recorded. Results Age-adjusted mean (SD) cIMT was similar in South Asians and Europeans (0.64 (0.16) mm v 0.65 (0.12) mm, p = 0.64). Plaque was present in 48 South Asians and 37 Europeans and overall, there was no age-adjusted difference between South Asian and Europeans for plaque score(odds ratio 1.49, 95% CI, 0.86-2.80, p = 0.16), however, South Asians appeared to have more plaques at a younger age than Europeans; at age 40-50 years the odds of South Asians having plaques was 2.63 (95% CI, 1.16-5.93) times that for Europeans. Conclusions cIMT is similar between healthy South Asian and European men. Whilst there was no overall difference in plaque presence in South Asians, there is an indication of greater plaque prevalence at younger ages - an observation requiring further investigation. Prospective studies linking plaques to CVD outcomes in South Asians are needed to investigate whether these measures help improve CVD risk prediction.	[Ghouri, Nazim; Logan, Greig; Wilson, John; Gill, Jason M. R.; Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Purves, David; McConnachie, Alex] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Glasgow G12 8QA, Lanark, Scotland; [Deans, Kevin A.] Aberdeen Royal Infirm, Dept Clin Biochem, Aberdeen AB25 2ZN, Scotland; [Logan, Greig] AUT Univ, Human Potential Ctr, Auckland 1142, New Zealand	University of Glasgow; University of Glasgow; University of Aberdeen; Auckland University of Technology	Ghouri, N (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland.	nazim.ghouri@glasgow.ac.uk; jason.gill@glasgow.ac.uk; naveed.sattar@glasgow.ac.uk		Sattar, Naveed/0000-0002-1604-2593; Ghouri, Noushima/0000-0002-8202-3913	Chest, Heart and Stroke Scotland	Chest, Heart and Stroke Scotland	NG was supported by a Fellowship from Chest, Heart and Stroke Scotland.	ADAMS MR, 1995, CIRCULATION, V92, P2127, DOI 10.1161/01.CIR.92.8.2127; Agyemang C, 2002, J HUM HYPERTENS, V16, P739, DOI 10.1038/sj.jhh.1001488; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; [Anonymous], 2006, HLTH MIN ETHN GROUPS; BALARAJAN R, 1984, BRIT MED J, V289, P1185, DOI 10.1136/bmj.289.6453.1185; Baldassarre D, 2012, J AM COLL CARDIOL, V60, P1489, DOI 10.1016/j.jacc.2012.06.034; Barnett PA, 1997, J HYPERTENS, V15, P49, DOI 10.1097/00004872-199715010-00004; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Chaturvedi N, 2007, ATHEROSCLEROSIS, V193, P204, DOI 10.1016/j.atherosclerosis.2006.06.017; Deans KA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4170; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; Ghouri N, 2013, DIABETOLOGIA, V56, P2238, DOI 10.1007/s00125-013-2969-y; Gill JMR, 2011, DIABETES CARE, V34, P1214, DOI 10.2337/dc10-2313; Hall LML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014197; Hall LML, 2008, FUTURE LIPIDOL, V3, P411, DOI 10.2217/17460875.3.4.411; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hollander M, 2003, STROKE, V34, P2367, DOI 10.1161/01.STR.0000091393.32060.0E; Jose PO, 2014, J AM COLL CARDIOL, V64, P2486, DOI 10.1016/j.jacc.2014.08.048; Koulaouzidis G, 2013, INT J CARDIOL; Koulaouzidis G, 2012, INT J CARDIOL; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Makris GC, 2011, ATHEROSCLEROSIS, V219, P377, DOI 10.1016/j.atherosclerosis.2011.05.006; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; Mukhopadhyay B, 2006, DIABETIC MED, V23, P94, DOI 10.1111/j.1464-5491.2005.01735.x; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Ntuk UE, 2014, DIABETES CARE, V37, P2500, DOI 10.2337/dc13-2966; R Core Team RFfSCVA, 2014, R LANG ENV STAT COMP; ROMAN MJ, 1992, CIRCULATION, V86, P1909, DOI 10.1161/01.CIR.86.6.1909; Simon A, 2007, EUR HEART J, V28, P2967, DOI 10.1093/eurheartj/ehm487; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Stein JH, 2005, J AM SOC ECHOCARDIOG, V18, P244, DOI 10.1016/j.echo.2004.12.002; Tillin T, 2008, INT J CARDIOL, V129, P406, DOI 10.1016/j.ijcard.2007.07.129; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Wendelhag I, 1997, STROKE, V28, P2195, DOI 10.1161/01.STR.28.11.2195; Whincup PH, 2012, STROKE, V43, P1747, DOI 10.1161/STROKEAHA.111.644955; Wild SH, 2007, J PUBLIC HEALTH-UK, V29, P191, DOI 10.1093/pubmed/fdm010; Williams E.D., 2010, J EPIDEMIOL COMMUNIT; Yamada K, 2009, CEREBROVASC DIS, V28, P417, DOI 10.1159/000235746; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	42	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123317	10.1371/journal.pone.0123317	http://dx.doi.org/10.1371/journal.pone.0123317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884221	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000353017000056
J	Reinhold, AK; Batti, L; Bilbao, D; Buness, A; Rittner, HL; Heppenstall, PA				Reinhold, A. K.; Batti, L.; Bilbao, D.; Buness, A.; Rittner, H. L.; Heppenstall, P. A.			Differential Transcriptional Profiling of Damaged and Intact Adjacent Dorsal Root Ganglia Neurons in Neuropathic Pain	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; SENSORY NEURONS; SPINAL-CORD; RAT; EXPRESSION; RECEPTORS; INVOLVEMENT; INHIBITION; INJURY; ALPHA	Neuropathic pain, caused by a lesion in the somatosensory system, is a severely impairing mostly chronic disease. While its underlying molecular mechanisms are not thoroughly understood, neuroimmune interactions as well as changes in the pain pathway such as sensitization of nociceptors have been implicated. It has been shown that not only are different cell types involved in generation and maintenance of neuropathic pain, like neurons, immune and glial cells, but, also, intact adjacent neurons are relevant to the process. Here, we describe an experimental approach to discriminate damaged from intact adjacent neurons in the same dorsal root ganglion (DRG) using differential fluorescent neuronal labelling and fluorescence-activated cell sorting (FACS). Two fluorescent tracers, Fluoroemerald (FE) and 1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine perchlorate (DiI), were used, whose properties allow us to distinguish between damaged and intact neurons. Subsequent sorting permitted transcriptional analysis of both groups. Results and qPCR validation show a strong regulation in damaged neurons versus contralateral controls as well as a moderate regulation in adjacent neurons. Data for damaged neurons reveal an mRNA expression pattern consistent with established upregulated genes like galanin, which supports our approach. Moreover, novel genes were found strongly regulated such as corticotropinreleasing hormone (CRH), providing novel targets for further research. Differential fluorescent neuronal labelling and sorting allows for a clear distinction between primarily damaged neuropathic neurons and "bystanders," thereby facilitating a more detailed understanding of their respective roles in neuropathic processes in the DRG.	[Reinhold, A. K.; Batti, L.; Bilbao, D.; Buness, A.; Heppenstall, P. A.] European Mol Biol Lab, Monterotondo, Italy; [Reinhold, A. K.; Rittner, H. L.] Univ Hosp, Dept Anaesthesiol, Wurzburg, Germany	European Molecular Biology Laboratory (EMBL); University of Wurzburg	Reinhold, AK (corresponding author), European Mol Biol Lab, Monterotondo, Italy.	paul.heppenstall@embl.de	RIttner, Heike/AAC-6523-2019	RIttner, Heike/0000-0003-4867-0188; Reinhold, Ann Kristin/0000-0002-0269-462X; Bilbao Cortes, Daniel/0000-0003-1630-8811; Batti, Laura/0000-0003-3717-8470	project "ncRNAPain" under the European Union's 7th framework programme [602133]; EMBL Monterotondo Flow cytometry facility; EMBL Genomics Core Facility	project "ncRNAPain" under the European Union's 7th framework programme; EMBL Monterotondo Flow cytometry facility; EMBL Genomics Core Facility	This study was technically supported by EMBL Monterotondo Flow cytometry facility and EMBL Genomics Core Facility. The study has received funding from the project "ncRNAPain" under the European Union's 7th framework programme (Grant no. 602133).	Aguilera G, 2012, FRONT NEUROENDOCRIN, V33, P67, DOI 10.1016/j.yfrne.2011.08.002; Ali Z, 1999, J NEUROPHYSIOL, V81, P455, DOI 10.1152/jn.1999.81.2.455; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Choi D, 2002, J NEUROSCI METH, V117, P167, DOI 10.1016/S0165-0270(02)00098-5; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; FRITZSCH B, 1991, J NEUROSCI METH, V39, P9, DOI 10.1016/0165-0270(91)90088-H; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Hughes JP, 2012, ANN NY ACAD SCI, V1255, P30, DOI 10.1111/j.1749-6632.2012.06561.x; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kim EH, 2011, ANAT CELL BIOL, V44, P60, DOI 10.5115/acb.2011.44.1.60; Labuz D, 2009, J CLIN INVEST, V119, P278, DOI [10.1172/JCI36246, 10.1172/JCI36246C1]; Ma W, 1997, NEUROSCIENCE, V79, P1183, DOI 10.1016/S0306-4522(97)00088-2; Mechaly I, 2006, MOL CELL NEUROSCI, V32, P217, DOI 10.1016/j.mcn.2006.04.004; Mousa SA, 2003, PAIN, V106, P297, DOI 10.1016/S0304-3959(03)00302-6; Mousa SA, 2007, NEUROPSYCHOPHARMACOL, V32, P2530, DOI 10.1038/sj.npp.1301393; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Ng KY, 2010, NEURON GLIA BIOL, V6, P19, DOI 10.1017/S1740925X09990433; Parkitna JR, 2006, J PHYSIOL PHARMACOL, V57, P401; Pecorelli A, 2015, BBA-MOL BASIS DIS, V1852, P507, DOI 10.1016/j.bbadis.2014.11.016; Rountree RB, 2010, J INVEST DERMATOL, V130, P102, DOI 10.1038/jid.2009.223; Sarantopoulos C, 2002, REGION ANESTH PAIN M, V27, P47, DOI 10.1053/rapm.2002.29124; SATO J, 1991, SCIENCE, V251, P1608, DOI 10.1126/science.2011742; Schafers M, 2003, EUR J NEUROSCI, V17, P791, DOI 10.1046/j.1460-9568.2003.02504.x; SKOFITSCH G, 1985, PEPTIDES, V6, P307, DOI 10.1016/0196-9781(85)90057-9; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; VIDALSANZ M, 1988, EXP NEUROL, V102, P92, DOI 10.1016/0014-4886(88)90081-7; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yuan H, 2010, SPINAL CORD, V48, P850, DOI 10.1038/sc.2010.47	33	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123342	10.1371/journal.pone.0123342	http://dx.doi.org/10.1371/journal.pone.0123342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880204	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500047
J	Barbaro, D; Di Bari, L; Gandin, V; Evangelisti, C; Vitulli, G; Schiavi, E; Marzano, C; Ferretti, AM; Salvadori, P				Barbaro, Daniele; Di Bari, Lorenzo; Gandin, Valentina; Evangelisti, Claudio; Vitulli, Giovanni; Schiavi, Eleonora; Marzano, Cristina; Ferretti, Anna M.; Salvadori, Piero			Glucose-Coated Superparamagnetic Iron Oxide Nanoparticles Prepared by Metal Vapour Synthesis Are Electively Internalized in a Pancreatic Adenocarcinoma Cell Line Expressing GLUT1 Transporter	PLOS ONE			English	Article							MAGNETIC NANOPARTICLES; THERMOTHERAPY; FEASIBILITY; HYPERTHERMIA; PARTICLES	Iron oxide nanoparticles (IONP) can have a variety of biomedical applications due to their visualization properties through Magnetic Resonance Imaging (MRI) and heating with radio frequency or alternating magnetic fields. In the oncological field, coating IONP with organic compounds to provide specific features and to achieve the ability of binding specific molecular targets appears to be very promising. To take advantage of the high avidity of tumor cells for glucose, we report the development of very small glucose-coated IONP (glc-IONP) by employing an innovative technique, Metal Vapor Synthesis (MVS). Moreover, we tested the internalization of our gl-IONP on a tumor line, BxPC3, over-expressing GLUT 1 transporter. Both glc-IONP and polyvinylpyrrolidone-IONP (PVP-IONP), as control, were prepared with MVS and were tested on BxPC3 at various concentrations. To evaluate the role of GLUT-1 transporter, we also investigated the effect of adding a polyclonal anti-GLUT1 antibody. After proper treatment, the iron value was assessed by atomic absorption spectrometer, reported in mcg/L and expressed in mg of protein. Our IONP prepared with MVS were very small and homogeneously distributed in a narrow range (1.75-3.75 nm) with an average size of 2.7 nm and were super-paramagnetic. Glc-IONP were internalized by BxPC3 cells in a larger amount than PVP-IONP. After 6h of treatment with 50 mcg/mL of IONPs, the content of Fe was 1.5 times higher in glc-IONP-treated cells compared with PVP-IONP-treated cells. After 1h pre-treatment with anti-GLUT1, a reduction of 41% cellular accumulation of glc-IONP was observed. Conversely, the uptake of PVP-IONPs was reduced only by 14% with antibody pretreatment. In conclusion, MVS allowed us to prepare small, homogeneous, super-paramagnetic glc-IONP, which are electively internalized by a tumor line over-expressing GLUT1. Our glc-IONP appear to have many requisites for in vivo use.	[Barbaro, Daniele] Gen Hosp, Endocrinol Sect, I-57100 Livorno, Italy; [Di Bari, Lorenzo] Univ Pisa, Dept Chem & Ind Chem, I-56124 Pisa, Italy; [Gandin, Valentina; Marzano, Cristina] Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35100 Padua, Italy; [Evangelisti, Claudio; Ferretti, Anna M.] CNR, Inst Mol Sci & Technol, I-20138 Milan, Italy; [Vitulli, Giovanni; Schiavi, Eleonora; Salvadori, Piero] ErreDue SpA, I-57121 Livorno, Italy	University of Pisa; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR)	Barbaro, D (corresponding author), Gen Hosp, Endocrinol Sect, Viale Alfieri 36, I-57100 Livorno, Italy.	danielebarbaro@katamail.com; lorenzo.dibari@unipi.it; valentina.gandin@unipd.it	Evangelisti, Claudio/L-4815-2015; Salvadori, Piero A/B-2342-2012; Ferretti, Anna Maria/E-6861-2010; Di Bari, Lorenzo/H-4804-2015	Evangelisti, Claudio/0000-0002-8855-2592; Salvadori, Piero A/0000-0001-6114-1059; Ferretti, Anna Maria/0000-0002-7373-7965; Di Bari, Lorenzo/0000-0003-2347-2150; GANDIN, VALENTINA/0000-0003-0442-0670				Branca RT, 2010, P NATL ACAD SCI USA, V107, P3693, DOI 10.1073/pnas.1000386107; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Dudeck O, 2006, INVEST RADIOL, V41, P527, DOI 10.1097/01.rli.0000209601.15533.5a; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Gromnicova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081043; Gupta AK, 2007, NANOMEDICINE-UK, V2, P23, DOI 10.2217/17435889.2.1.23; Hassan S, 2014, J NANOSCI NANOTECHNO, V14, P402, DOI 10.1166/jnn.2014.8747; Hayashi K, 2013, THERANOSTICS, V3, P366, DOI 10.7150/thno.5860; Jin RR, 2014, CURR OPIN PHARMACOL, V18, P18, DOI 10.1016/j.coph.2014.08.002; Johannsen M, 2005, INT J HYPERTHER, V21, P637, DOI 10.1080/02656730500158360; Johannsen M, 2007, EUR UROL, V52, P1653, DOI 10.1016/j.eururo.2006.11.023; Jordan A, 2006, J NEURO-ONCOL, V78, P7, DOI 10.1007/s11060-005-9059-z; Jordan A, 1996, INT J HYPERTHER, V12, P705, DOI 10.3109/02656739609027678; Jordan A., 2006, HYPERTHERMIA CANC TR, P1; Kalambur VS, 2007, LANGMUIR, V23, P12329, DOI 10.1021/la701100r; Kim JW, 2006, CANCER RES, V99, P8027; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Klabunde K.J., 1994, FREE ATOMS CLUSTERS; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Laurent S, 2014, EXPERT OPIN DRUG DEL, V11, P1449, DOI 10.1517/17425247.2014.924501; Lin GG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/625095; Maier-Hauff K, 2007, J NEURO-ONCOL, V81, P53, DOI 10.1007/s11060-006-9195-0; Plotkin M, 2006, INT J HYPERTHER, V22, P319, DOI 10.1080/02656730600734128; Schmid G., 1994, CLUSTERS COLLOIDS TH, P459, DOI DOI 10.1002/9783527616077.CH6; Selvi RB, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-35; Shan XH, 2012, EUR J RADIOL, V81, P95, DOI 10.1016/j.ejrad.2011.03.013; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Urban C, 2013, TRANSL CANCER RES, V2, P292, DOI 10.3978/j.issn.2218-676X.2013.08.05; Vitulli G, 2008, METAL NANOCLUSTERS IN CATALYSIS AND MATERIALS SCIENCE: THE ISSUE OF SIZE CONTROL, P437, DOI 10.1016/B978-044453057-8.50034-9; Wust P, 2006, INT J HYPERTHER, V22, P673, DOI 10.1080/02656730601106037; Xiong F, 2012, PHARM RES-DORDR, V29, P1087, DOI 10.1007/s11095-011-0653-9	32	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123159	10.1371/journal.pone.0123159	http://dx.doi.org/10.1371/journal.pone.0123159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874906	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800087
J	Kim, Y; Bae, JM; Li, G; Cho, NY; Kang, GH				Kim, Younghoon; Bae, Jeong Mo; Li, Gang; Cho, Nam Yun; Kang, Gyeong Hoon			Image Analyzer-Based Assessment of Tumor-Infiltrating T Cell Subsets and Their Prognostic Values in Colorectal Carcinomas	PLOS ONE			English	Article							COLON-CANCER PATIENTS; GENETIC ALTERATIONS; CLINICAL IMPACT; INVASION FRONT; LYMPHOCYTES; SURVIVAL; CD8(+); IMMUNOLOGY; MARKERS	To find useful tools to evaluate the prognosis in colorectal carcinoma (CRC) patients, we investigated the prognostic values of tumor-infiltrating T lymphocyte subsets according to intratumoral subsites as well as clinical or molecular characteristics. Immunohistochemistry for CD8, CD45RO, and FOXP3 was performed, and densities of the T cell subsets in each tissue microarray core (cells/mm(2)) were measured by image analysis. In the training set (n = 218) of CRC, T cell subset densities in the invasion front were more strongly associated with patient outcome than those in the tumor center. In the validation set (n = 549), T cell subset densities in the invasion front were evaluated. Univariate analysis showed that all three T cell subset densities were significantly associated with longer progression free survival and overall survival time (p < 0.001). In multivariate analysis, a high CD45RO density correlated independently with longer progression free survival (p = 0.011) and overall survival time (p = 0.007) in CRC patients, regardless of tumor location or adjuvant chemotherapy status. Our results showed that CD45RO density in the invasion front was the only independent prognostic factor regarding CRC. However, CD8 and FOXP3 densities were also independent prognostic factors in certain clinical settings. Thus, image analysis of tissue microarray cores in the invasion front of CRC could be used as a valid method for evaluating the prognostic significance of T cell subset densities.	[Kim, Younghoon; Li, Gang; Kang, Gyeong Hoon] Seoul Natl Univ Coll Med, Dept Pathol, Seoul, South Korea; [Bae, Jeong Mo; Cho, Nam Yun; Kang, Gyeong Hoon] Seoul Natl Univ Coll Med, Lab Epigenet, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kang, GH (corresponding author), Seoul Natl Univ Coll Med, Dept Pathol, Seoul, South Korea.	ghkang@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010	Kang, Gyeong Hoon/0000-0003-2380-6675; Kim, Younghoon/0000-0003-4656-0188	National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2059080]; Ministry of Health Welfare [HI13C1804, HI14C1277]; NRF - Ministry of Science, ICT and Future Planning (MSIP) [2011-0030049]	National Research Foundation of Korea (NRF) - Ministry of Education; Ministry of Health Welfare; NRF - Ministry of Science, ICT and Future Planning (MSIP)	This study was supported by a grant from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2059080), a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI13C1804 & HI14C1277), and the NRF grant funded by the Ministry of Science, ICT and Future Planning (MSIP) (2011-0030049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2000, J SURG ONCOL, V74, P249, DOI 10.1002/1096-9098(200008)74:4<249::AID-JSO2>3.0.CO;2-S; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Dalerba P, 2003, CRIT REV ONCOL HEMAT, V46, P33, DOI 10.1016/S1040-8428(02)00159-2; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hojo S, 2007, CANCER RES, V67, P4725, DOI 10.1158/0008-5472.CAN-06-3424; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Kim JH, 2009, VIRCHOWS ARCH, V455, P485, DOI 10.1007/s00428-009-0857-0; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Lee DW, 2015, ANN SURG ONCOL, V22, P187, DOI 10.1245/s10434-014-3826-z; Lee WS, 2010, CANCER-AM CANCER SOC, V116, P5188, DOI 10.1002/cncr.25293; Ling A, 2014, BRIT J CANCER, V110, P2551, DOI 10.1038/bjc.2014.161; Mackay CR, 1999, NATURE, V401, P659, DOI 10.1038/44309; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mei Z, 2014, BRIT J CANCER, V110, P1595, DOI 10.1038/bjc.2014.46; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; OSTENSTAD B, 1994, GUT, V35, P382, DOI 10.1136/gut.35.3.382; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Suzuki H, 2010, CANCER IMMUNOL IMMUN, V59, P653, DOI 10.1007/s00262-009-0781-9; Titu LV, 2002, CANCER IMMUNOL IMMUN, V51, P235, DOI 10.1007/s00262-002-0276-4; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Xu W, 2013, J CANCER RES CLIN, V139, P1845, DOI 10.1007/s00432-013-1500-7; Yoon HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042274; Yuen ST, 2002, CANCER RES, V62, P6451	39	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122183	10.1371/journal.pone.0122183	http://dx.doi.org/10.1371/journal.pone.0122183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875774	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800044
J	Kopova, I; Lavrentiev, V; Vacik, J; Bacakova, L				Kopova, Ivana; Lavrentiev, Vasily; Vacik, Jiri; Bacakova, Lucie			Growth and Potential Damage of Human Bone-Derived Cells Cultured on Fresh and Aged C-60/Ti Films	PLOS ONE			English	Article							OSTEOBLAST-LIKE; FULLERENE C-60; SURFACE-TREATMENT; OXIDATIVE STRESS; ADHESION; C60; MECHANISMS; DIFFERENTIATION; DEXAMETHASONE; COMPOSITES	Thin films of binary C-60/Ti composites, with various concentrations of Ti ranging from similar to 25% to similar to 70%, were deposited on microscopic glass coverslips and were tested for their potential use in bone tissue engineering as substrates for the adhesion and growth of bone cells. The novelty of this approach lies in the combination of Ti atoms (i.e., widely used biocompatible material for the construction of stomatological and orthopedic implants) with atoms of fullerene C-60, which can act as very efficient radical scavengers. However, fullerenes and their derivatives are able to generate harmful reactive oxygen species and to have cytotoxic effects. In order to stabilize C-60 molecules and to prevent their possible cytotoxic effects, deposition in the compact form of Ti/C-60 composites (with various Ti concentrations) was chosen. The reactivity of C-60/Ti composites may change in time due to the physicochemical changes of molecules in an air atmosphere. In this study, we therefore tested the dependence between the age of C-60/Ti films (from one week to one year) and the adhesion, morphology, proliferation, viability, metabolic activity and potential DNA damage to human osteosarcoma cells (lines MG-63 and U-2 OS). After 7 days of cultivation, we did not observe any negative influence of fresh or aged C-60/Ti layers on cell behavior, including the DNA damage response. The presence of Ti atoms resulted in improved properties of the C-60 layers, which became more suitable for cell cultivation.	[Kopova, Ivana; Bacakova, Lucie] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague 4, Krc, Czech Republic; [Lavrentiev, Vasily; Vacik, Jiri] Acad Sci Czech Republ, Inst Nucl Phys, CZ-25068 Rez, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Nuclear Physics Institute of the Czech Academy of Sciences	Kopova, I (corresponding author), Acad Sci Czech Republ, Inst Physiol, Videnska 1083, CR-14220 Prague 4, Krc, Czech Republic.	ivana.kopova@biomed.cas.cz	Nemcakova, Ivana/R-2531-2016; Lavrentiev, Vasily/G-9510-2014; Vacik, Jiri/G-9263-2014; Bacakova, Lucie/C-2664-2012	Nemcakova, Ivana/0000-0001-9725-8048; Vacik, Jiri/0000-0002-1875-4914; Bacakova, Lucie/0000-0002-1818-9484; Lavrentiev, Vasily/0000-0001-8344-080X	Grant Agency of the Czech Republic [P107/11/1856, P108/12/1168]; CANAM infrastructure (NPI ASCR Rez)	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); CANAM infrastructure (NPI ASCR Rez)	This research was supported by the Grant Agency of the Czech Republic (grants No. P107/11/1856 and P108/12/1168) and CANAM infrastructure (NPI ASCR Rez).	Bacakova L, 2001, J BIOMED MATER RES, V54, P567; Bacakova L., 2008, NANOPARTICLES NEW RE, P39; Bacakova L, 2011, ADVANCES IN DIVERSE INDUSTRIAL APPLICATIONS OF NANOCOMPOSITES, P399; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Dwivedi N, 2011, ACS APPL MATER INTER, V3, P4268, DOI 10.1021/am200939j; Gao J, 2010, TOXICOL APPL PHARM, V244, P130, DOI 10.1016/j.taap.2009.12.025; Grausova L, 2008, J OPTOELECTRON ADV M, V10, P2071; Grinevich A, 2009, J BIOMED MATER RES A, V88A, P952, DOI 10.1002/jbm.a.31918; Harcuba P, 2012, J MECH BEHAV BIOMED, V7, P96, DOI 10.1016/j.jmbbm.2011.07.001; Honma M, 2012, MUTAT RES-GEN TOX EN, V749, P97, DOI 10.1016/j.mrgentox.2012.08.006; Jain S, 2013, J BIOMED MATER RES B, V101B, P520, DOI 10.1002/jbm.b.32852; Jirka I, 2013, MAT SCI ENG C-MATER, V33, P1636, DOI 10.1016/j.msec.2012.12.073; Johnston HJ, 2010, TOXICOL SCI, V114, P162, DOI 10.1093/toxsci/kfp265; Joska L., 2014, BIOMATTER, V4; Ko WB, 2006, ULTRASONICS, V44, pE363, DOI 10.1016/j.ultras.2006.05.003; Kopova I, 2013, INT J MOL SCI, V14, P9182, DOI 10.3390/ijms14059182; Liu HJ, 2012, J ORTHOP RES, V30, P1051, DOI 10.1002/jor.22054; Liu X, 2005, SOL ENERG MAT SOL C, V87, P5, DOI 10.1016/j.solmat.2004.09.011; Lucafo M, 2013, TOXICOLOGY, V314, P183, DOI 10.1016/j.tox.2013.10.001; Moller P, 2012, CURR MOL MED, V12, P732, DOI 10.2174/156652412800792624; Mrdanovic J, 2009, MUTAT RES-GEN TOX EN, V680, P25, DOI 10.1016/j.mrgentox.2009.08.008; Murakami M, 2013, PHOTODERMATOL PHOTO, V29, P196, DOI 10.1111/phpp.12050; Popa AC, 2013, J MATER SCI-MATER M, V24, P2695, DOI 10.1007/s10856-013-5026-y; Rebecca M, 2009, TOXICOL APPL PHARM, V234, P58, DOI 10.1016/j.taap.2008.08.021; Ferreira JLR, 2014, AQUAT TOXICOL, V147, P76, DOI 10.1016/j.aquatox.2013.12.007; Rouse JG, 2006, TOXICOL IN VITRO, V20, P1313, DOI 10.1016/j.tiv.2006.04.004; Shinohara N, 2009, TOXICOL LETT, V191, P289, DOI 10.1016/j.toxlet.2009.09.012; Strasky J, 2013, APPL SURF SCI, V281, P73, DOI 10.1016/j.apsusc.2013.02.053; Talyzin AV, 2003, THIN SOLID FILMS, V429, P96, DOI 10.1016/S0040-6090(03)00278-5; Trpkovic A, 2012, ARCH TOXICOL, V86, P1809, DOI 10.1007/s00204-012-0859-6; Tsai PC, 2008, J NANOSCI NANOTECHNO, V8, P2516, DOI 10.1166/jnn.2008.600; Vacik J, 2004, NUCL INSTRUM METH B, V219, P862, DOI 10.1016/j.nimb.2004.01.177; Vacik J, 2010, NUCL INSTRUM METH B, V268, P1976, DOI 10.1016/j.nimb.2010.02.112; Vacik J, 2010, DIAM RELAT MATER, V19, P242, DOI 10.1016/j.diamond.2009.10.016; Vacik J, 2009, J ALLOY COMPD, V483, P374, DOI 10.1016/j.jallcom.2008.08.112; Vacik J, 2011, J ALLOY COMPD, V509, pS380, DOI 10.1016/j.jallcom.2011.04.107; Vandrovcova M, 2011, PHYSIOL RES, V60, P403, DOI 10.33549/physiolres.932045; Vandrovcova M, 2008, PHYS STATUS SOLIDI A, V205, P2252, DOI 10.1002/pssa.200879730; Vandrovcova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100475; Vesterdal LK, 2014, TOXICOL APPL PHARM, V274, P350, DOI 10.1016/j.taap.2013.10.001; Xu X, 2012, NUCLEIC ACIDS RES, V40, P7622, DOI 10.1093/nar/gks517; Yudoh K, 2007, ARTHRITIS RHEUM-US, V56, P3307, DOI 10.1002/art.22917; Yudoh K, 2009, INT J NANOMED, V4, P233; Zhang Y, 2013, ACS APPL MATER INTER, V5, P5291, DOI 10.1021/am401153k; Zhao XC, 2005, BIOPHYS J, V89, P3856, DOI 10.1529/biophysj.105.064410	45	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123680	10.1371/journal.pone.0123680	http://dx.doi.org/10.1371/journal.pone.0123680			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875338	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800110
J	Obana-Koshino, A; Ono, H; Miura, J; Sakai, M; Uchida, H; Nakamura, W; Nohara, K; Maruyama, Y; Hattori, A; Sakai, T				Obana-Koshino, Aya; Ono, Hitomi; Miura, Jiro; Sakai, Manabu; Uchida, Hitoshi; Nakamura, Wataru; Nohara, Kanji; Maruyama, Yusuke; Hattori, Atsuhiko; Sakai, Takayoshi			Melatonin Inhibits Embryonic Salivary Gland Branching Morphogenesis by Regulating Both Epithelial Cell Adhesion and Morphology	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; IN-VITRO; IMMUNE-SYSTEM; MOUSE; CANCER; RHYTHM; EXPRESSION; MICE; PINEALECTOMY; ACTIVATION	Many organs, including salivary glands, lung, and kidney, are formed by epithelial branching during embryonic development. Branching morphogenesis occurs via either local outgrowths or the formation of clefts that subdivide epithelia into buds. This process is promoted by various factors, but the mechanism of branching morphogenesis is not fully understood. Here we have defined melatonin as a potential negative regulator or "brake" of branching morphogenesis, shown that the levels of it and its receptors decline when branching morphogenesis begins, and identified the process that it regulates. Melatonin has various physiological functions, including circadian rhythm regulation, free-radical scavenging, and gonadal development. Furthermore, melatonin is present in saliva and may have an important physiological role in the oral cavity. In this study, we found that the melatonin receptor is highly expressed on the acinar epithelium of the embryonic submandibular gland. We also found that exogenous melatonin reduces salivary gland size and inhibits branching morphogenesis. We suggest that this inhibition does not depend on changes in either proliferation or apoptosis, but rather relates to changes in epithelial cell adhesion and morphology. In summary, we have demonstrated a novel function of melatonin in organ formation during embryonic development.	[Obana-Koshino, Aya; Ono, Hitomi; Uchida, Hitoshi; Nohara, Kanji; Sakai, Takayoshi] Osaka Univ, Grad Sch Dent, Dept Oral Facial Disorders, Suita, Osaka, Japan; [Miura, Jiro] Osaka Univ, Grad Sch Dent, Div Interdisciplinary Dent, Suita, Osaka, Japan; [Sakai, Manabu] Osaka Univ, Dent Hosp, Clin Lab, Suita, Osaka, Japan; [Uchida, Hitoshi; Nakamura, Wataru] Osaka Univ, Grad Sch Dent, Lab Oral Chronobiol, Suita, Osaka, Japan; [Maruyama, Yusuke; Hattori, Atsuhiko] Tokyo Med & Dent Univ, Dept Biol, Ichikawa, Chiba, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Tokyo Medical & Dental University (TMDU)	Sakai, T (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral Facial Disorders, Suita, Osaka, Japan.	sakai@dent.osaka-u.ac.jp	Sakai, Takayoshi/L-1456-2019; 学, 酒井/GXF-6076-2022; Miura, Jiro/AAF-8083-2021	Sakai, Takayoshi/0000-0003-4348-4896; 学, 酒井/0000-0003-0403-6994; Miura, Jiro/0000-0002-0000-025X	JSPS [24390452, 24570068]; Grants-in-Aid for Scientific Research [24659890, 24390452] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors would like to thank Yuichi Kadoya for helpful discussion. This work was supported in part by grants to T.S. (Grant-in-Aid for Scientific Research [B] 24390452 by the JSPS) and to A.H. (Grant-in-Aid for Scientific Research [C] 24570068 by the JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batmanabane M, 1996, ANAT RECORD, V245, P519; Carrillo-Vico A, 2004, FASEB J, V18, P537, DOI 10.1096/fj.03-0694fje; Carrillo-Vico A, 2003, CELL MOL LIFE SCI, V60, P2272, DOI 10.1007/s00018-003-3207-4; Cos S, 1998, CANCER RES, V58, P4383; DOLLINS AB, 1994, P NATL ACAD SCI USA, V91, P1824, DOI 10.1073/pnas.91.5.1824; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Garcia-Maurino S, 2000, J PINEAL RES, V29, P129, DOI 10.1034/j.1600-079X.2000.290301.x; Gomez-Corvera A, 2009, J PINEAL RES, V47, P15, DOI 10.1111/j.1600-079X.2009.00683.x; Hieda Y, 1997, DEV GROWTH DIFFER, V39, P1; Hsu JCF, 2010, INT J ORAL SCI, V2, P117, DOI 10.4248/IJOS10042; ITOH MT, 1995, MOL CELL ENDOCRINOL, V115, P59, DOI 10.1016/0303-7207(95)03670-3; Jung-Hynes B, 2011, J PINEAL RES, V50, P140, DOI 10.1111/j.1600-079X.2010.00823.x; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; Kennaway DJ, 1998, J CLIN ENDOCR METAB, V83, P1013, DOI 10.1210/jc.83.3.1013; Koyama H, 2002, J BONE MINER RES, V17, P1219, DOI 10.1359/jbmr.2002.17.7.1219; Kumasaka S, 2010, HISTOCHEM CELL BIOL, V133, P577, DOI 10.1007/s00418-010-0698-6; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; Martinez-Campa C, 2006, J PINEAL RES, V40, P291, DOI 10.1111/j.1600-079X.2006.00315.x; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Mima J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061653; Miyajima H, 2011, BIOMATERIALS, V32, P6754, DOI 10.1016/j.biomaterials.2011.05.072; Naji L, 2004, LIFE SCI, V74, P2227, DOI 10.1016/j.lfs.2003.08.046; Nakahara D, 2003, P NATL ACAD SCI USA, V100, P9584, DOI 10.1073/pnas.1631069100; Onodera T, 2010, SCIENCE, V329, P562, DOI 10.1126/science.1191880; Picoli LC, 2011, MICROSC RES TECHNIQ, V74, P1154, DOI 10.1002/jemt.21008; Poirel VJ, 2003, NEUROENDOCRINOL LETT, V24, P33; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Sack RL, 2000, NEW ENGL J MED, V343, P1070, DOI 10.1056/NEJM200010123431503; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sakai T, 2009, J MED INVESTIG, V56, P234, DOI 10.2152/jmi.56.234; Sanchez-Barcelo EJ, 2003, ENDOCR-RELAT CANCER, V10, P153, DOI 10.1677/erc.0.0100153; Satomura K, 2007, J PINEAL RES, V42, P231, DOI 10.1111/j.1600-079X.2006.00410.x; Shimozuma M, 2011, HISTOCHEM CELL BIOL, V135, P389, DOI 10.1007/s00418-011-0800-8; Torres-Farfan C, 2006, J PINEAL RES, V41, P58, DOI 10.1111/j.1600-079X.2006.00331.x; UBEDA A, 1995, CANCER LETT, V91, P241, DOI 10.1016/0304-3835(95)03736-G; VAKKURI O, 1985, J ENDOCRINOL, V105, P263, DOI 10.1677/joe.0.1050263; VAKKURI O, 1985, ACTA PHYSIOL SCAND, V124, P409, DOI 10.1111/j.1748-1716.1985.tb07676.x; VAKKURI O, 1985, LIFE SCI, V37, P489, DOI 10.1016/0024-3205(85)90412-6; Vivien-Roels B, 1998, J BIOL RHYTHM, V13, P403, DOI 10.1177/074873098129000228; YELLON SM, 1988, BIOL REPROD, V39, P1093, DOI 10.1095/biolreprod39.5.1093; Yonei Y., 2010, ANTIAGEING MED, V7, P85	43	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0119960	10.1371/journal.pone.0119960	http://dx.doi.org/10.1371/journal.pone.0119960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876057	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800009
J	Lee, S; Jeong, SJ; Il Hwang, S; Hong, SK; Lee, HJ; Byun, SS; Choe, G; Lee, SE				Lee, Sangchul; Jeong, Seong Jin; Il Hwang, Sung; Hong, Sung Kyu; Lee, Hak Jong; Byun, Seok Soo; Choe, Gheeyoung; Lee, Sang Eun			Clinical Value of Core Length in Contemporary Multicore Prostate Biopsy	PLOS ONE			English	Article							CANCER-DETECTION RATE; RADICAL PROSTATECTOMY; SPECIMENS; QUALITY; SIZE; MEN	Objectives There is little data about the clinical value of core length for prostate biopsy (PBx). We investigated the clinical values of various clinicopathological biopsy-related parameters, including core length, in the contemporary multi-core PBx. Patients and Methods Medical records of 5,243 consecutive patients who received PBx at our institution were reviewed. Among them, 3,479 patients with prostate-specific antigen (PSA) <= 10ng/ml level who received transrectal ultrasound (TRUS)-guided multi (>= 12)-core PBx at our institution were analyzed for prostate cancer (PCa). Gleason score upgrading (GSU) was analyzed in 339 patients who were diagnosed with low-risk PCa and received radical prostatectomy. Multivariate logistic regression analyses for PCa detection and prediction of GSU were performed. Results The mean age and PSA of the entire cohort were 63.5 years and 5.4ng/ml, respectively. The overall cancer detection rate was 28.5%. There was no statistical difference in core length between patients diagnosed with PCa and those without PCa (16.1 +/- 1.8 vs 16.1 +/- 1.9mm, P = 0.945). The core length was also not significantly different (16.4 +/- 1.7 vs 16.4 +/- 1.6mm, P = 0.889) between the GSU group and non-GSU group. Multivariate logistic regression analyses demonstrated that the core length of PBx did not affect PCa detection in TRUS-guided multi-core PBx (P = 0.923) and was not prognostic for GSU in patients with low-risk PCa (P = 0.356). Conclusions In patients undergoing contemporary multi-core PBx, core length may not have significant impact on PCa detection and also GSU following radical prostatectomy among low-risk PCa group.	[Lee, Sangchul; Jeong, Seong Jin; Hong, Sung Kyu; Byun, Seok Soo; Lee, Sang Eun] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea; [Il Hwang, Sung; Lee, Hak Jong] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Choe, Gheeyoung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea.	skhong@snubh.org		Hwang, Sung Il/0000-0001-7516-5369				Beauval JB, 2012, UROLOGY, V80, P656, DOI 10.1016/j.urology.2012.04.051; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Boccon-Gibod L, 2004, EUR UROL, V46, P177, DOI 10.1016/j.eururo.2004.04.006; Chun FKH, 2010, EUR UROL, V58, P851, DOI 10.1016/j.eururo.2010.08.041; Cicione A, 2012, UROL INT, V89, P57, DOI 10.1159/000339250; Dogan HS, 2005, EUR UROL, V47, P297, DOI 10.1016/j.eururo.2004.09.004; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Eichler K, 2006, J UROLOGY, V175, P1605, DOI 10.1016/S0022-5347(05)00957-2; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Ficarra V, 2006, EUR UROL, V50, P266, DOI 10.1016/j.eururo.2005.12.057; Fiset PO, 2013, CAN J UROL, V20, P6848; Guichard G, 2007, EUR UROL, V52, P430, DOI 10.1016/j.eururo.2007.02.062; Iczkowski KA, 2002, UROLOGY, V59, P698, DOI 10.1016/S0090-4295(02)01515-7; Inal GH, 2008, PROSTATE CANCER P D, V11, P270, DOI 10.1038/pcan.2008.34; Iremashvili V, 2012, CANCER-AM CANCER SOC, V118, P378, DOI 10.1002/cncr.26306; Jiang XK, 2013, EUR UROL, V63, P1031, DOI 10.1016/j.eururo.2013.01.035; Miller DC, 2006, JNCI-J NATL CANCER I, V98, P1134, DOI 10.1093/jnci/djj308; Mullins JK, 2012, J UROLOGY, V187, P1620, DOI 10.1016/j.juro.2011.12.072; Obek C, 2012, J UROLOGY, V187, P2051, DOI 10.1016/j.juro.2012.01.075; Rogatsch H, 2000, HUM PATHOL, V31, P1102, DOI 10.1053/hupa.2000.9837; Shariat Shahrokh F, 2008, Rev Urol, V10, P262; van der Kwast TH, 2003, J CLIN PATHOL, V56, P336, DOI 10.1136/jcp.56.5.336; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123704	10.1371/journal.pone.0123704	http://dx.doi.org/10.1371/journal.pone.0123704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875823	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700039
J	Leitner, G; Blum, SE; Rivas, AL				Leitner, Gabriel; Blum, Shlomo E.; Rivas, Ariel L.			Visualizing the Indefinable: Three-Dimensional Complexity of 'Infectious Diseases'	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SYSTEMS BIOLOGY; SUBCLINICAL MASTITIS; MILK-COMPOSITION; TIME; IDENTIFICATION; CHALLENGES; CYTOKINES; MODELS; CELLS	Background The words 'infection' and 'inflammation' lack specific definitions. Here, such words are not defined. Instead, the ability to visualize host-microbial interactions was explored. Methods Leukocyte differential counts and four bacterial species (Staphylococcus aureus, Streptococcus dysgalactiae, Staphylococcus chromogenes, and Escherichia coli) were determined or isolated in a cross-sectional and randomized study conducted with 611 bovine milk samples. Two paradigms were evaluated: (i) the classic one, which measures nonstructured (count or percent) data; and (ii) a method that, using complex data structures, detects and differentiates three-dimensional (3D) interactions among lymphocytes (L), macrophages (M), and neutrophils (N). Results Classic analyses failed to differentiate bacterial-positive (B+) from -negative (B-) observations: B-and B+ data overlapped, even when statistical significance was achieved. In contrast, the alternative approach showed distinct patterns, such as perpendicular data inflections, which discriminated microbial-negative/mononuclear cell-predominating (MCP) from microbial-positive/ phagocyte-predominating (PP) subsets. Two PP subcategories were distinguished, as well as PP/culture-negative (false-negative) and MCP/culture-positive (false-positive) observations. In 3D space, MCP and PP subsets were perpendicular to one another, displaying >= 91% specificity or sensitivity. Findings supported five inferences: (i) disease is not always ruled out by negative bacterial tests; (ii) low total cell counts can coexist with high phagocyte percents; (iii) neither positive bacterial isolation nor high cell counts always coincide with PP profiles; (iv) statistical significance is not synonymous with discrimination; and (v) hidden relationships cannot be detected when simple (non-structured) data formats are used and statistical analyses are performed before data subsets are identified, but can be uncovered when complexity is investigated. Conclusions Pattern recognition-based assessments can detect host-microbial interactions usually unobserved. Such cutoff-free, confidence interval-free, gold standard-free approaches provide interpretable information on complex entities, such as 'infection' and 'inflammation', even without definitions. To investigate disease dynamics, combinations of observational and experimental longitudinal studies, on human and non-human infections, are recommended.	[Leitner, Gabriel; Blum, Shlomo E.] Kimron Vet Inst, Natl Mastitis Reference Ctr, IL-50250 Bet Dagan, Israel; [Rivas, Ariel L.] Univ New Mexico, Hlth Sci Ctr, Internal Med, Ctr Global Hlth, Albuquerque, NM 87131 USA; [Rivas, Ariel L.] N Carolina State Univ, Populat Hlth & Pathobiol, Raleigh, NC 27695 USA	Kimron Veterinary Institute; University of New Mexico; University of New Mexico's Health Sciences Center; University of North Carolina; North Carolina State University	Leitner, G (corresponding author), Kimron Vet Inst, Natl Mastitis Reference Ctr, IL-50250 Bet Dagan, Israel.	leitnerg@moag.gov.il						Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Becker JM, 2013, MIS QUART, V37, P665, DOI 10.25300/MISQ/2013/37.3.01; Blum S, 2010, J VET DIAGN INVEST, V22, P995, DOI 10.1177/104063871002200627; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Bose B, 2013, PROG BIOPHYS MOL BIO, V113, P358, DOI 10.1016/j.pbiomolbio.2013.07.001; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cook NR, 2007, CIRCULATION, V116, pE134, DOI 10.1161/CIRCULATIONAHA.107.715359; Crofts AR, 2007, COMPLEXITY, V13, P14, DOI 10.1002/cplx.20180; Deirmengian C, 2005, CLIN ORTHOP RELAT R, P38, DOI 10.1097/01.blo.0000185756.17401.32; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Evans MR, 2013, TRENDS ECOL EVOL, V28, P578, DOI 10.1016/j.tree.2013.05.022; Fair JM, 2015, TRANSBOUND EMERG DIS, V62, P437, DOI 10.1111/tbed.12162; French GL, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2009.03092.x; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Gurdasani D, 2014, AIDS, V28, P149, DOI 10.1097/QAD.0000000000000049; Hespel C, 2012, EUR J IMMUNOL, V42, P2535, DOI 10.1002/eji.201242480; Huneman P, 2012, SYNTHESE, V185, P195, DOI 10.1007/s11229-010-9721-7; Klinke DJ, 2009, ANN BIOMED ENG, V37, P1886, DOI 10.1007/s10439-009-9733-y; Koskinen MT, 2010, J DAIRY SCI, V93, P5707, DOI 10.3168/jds.2010-3167; Koskinen MT, 2009, J DAIRY SCI, V92, P952, DOI 10.3168/jds.2008-1549; Kurakin A, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-6; Leitner G, 2006, INT DAIRY J, V16, P648, DOI 10.1016/j.idairyj.2005.10.020; Leitner G, 2004, J DAIRY SCI, V87, P1719, DOI 10.3168/jds.S0022-0302(04)73325-1; Leitner G, 2003, J VET MED B, V50, P45, DOI 10.1046/j.1439-0450.2003.00602.x; Leitner G, 2007, J DAIRY RES, V74, P186, DOI 10.1017/S0022029906002299; Ludewig B, 2012, EUR J IMMUNOL, V42, P3116, DOI 10.1002/eji.201242508; Merin U, 2008, DAIRY SCI TECHNOL, V88, P407, DOI 10.1051/dst:2008022; Nadell CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2770; Noble D, 2012, INTERFACE FOCUS, V2, P55, DOI 10.1098/rsfs.2011.0067; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; Owens, 2004, MICROBIOLOGICAL PROC, V4th ed.; Pinsky MR, 2010, CRIT CARE MED, V38, pS649, DOI 10.1097/CCM.0b013e3181f24484; Pitkala A, 2005, J DAIRY SCI, V88, P553, DOI 10.3168/jds.S0022-0302(05)72717-X; Rivas AL, 2001, J VET DIAGN INVEST, V13, P399, DOI 10.1177/104063870101300506; Rivas AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053984; San Miguel M, 2012, EUR PHYS J-SPEC TOP, V214, P245, DOI 10.1140/epjst/e2012-01694-y; Schuetz P, 2007, CURR OPIN CRIT CARE, V13, P578, DOI 10.1097/MCC.0b013e3282c9ac2a; Segre JA, 2013, J INVEST DERMATOL, V133, P2141, DOI 10.1038/jid.2013.260; Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134; Stephan A, 2006, SYNTHESE, V151, P485, DOI 10.1007/s11229-006-9019-y; Villarino AV, 2004, ARTHRITIS RES THER, V6, P225, DOI 10.1186/ar1227; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181; Wynn JL, 2014, PEDIATR CRIT CARE ME, V15, P523, DOI 10.1097/PCC.0000000000000157; Yip D, 2013, BIOCHEM BIOPH RES CO, V433, P327, DOI 10.1016/j.bbrc.2013.03.008	51	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123674	10.1371/journal.pone.0123674	http://dx.doi.org/10.1371/journal.pone.0123674			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875169	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700036
J	Okuda, H; Kiuchi, H; Takao, T; Miyagawa, Y; Tsujimura, A; Nonomura, N; Miyata, H; Okabe, M; Ikawa, M; Kawakami, Y; Goshima, N; Wada, M; Tanaka, H				Okuda, Hidenobu; Kiuchi, Hiroshi; Takao, Tetsuya; Miyagawa, Yasushi; Tsujimura, Akira; Nonomura, Norio; Miyata, Haruhiko; Okabe, Masaru; Ikawa, Masahito; Kawakami, Yoshitaka; Goshima, Naoki; Wada, Morimasa; Tanaka, Hiromitsu			A Novel Transcriptional Factor Nkapl Is a Germ Cell-Specific Suppressor of Notch Signaling and Is Indispensable for Spermatogenesis	PLOS ONE			English	Article							CHROMOSOME SYNAPSIS; SELF-RENEWAL; STEM-CELLS; MOUSE; GENE; EXPRESSION; ACTIVATION; DEFECTS; COMPLEX; DIFFERENTIATION	Spermatogenesis is an elaborately regulated system dedicated to the continuous production of spermatozoa via the genesis of spermatogonia. In this process, a variety of genes are expressed that are relevant to the differentiation of germ cells at each stage. Although Notch signaling plays a critical role in germ cell development in Drosophila and Caenorhabditis elegans, its function and importance for spermatogenesis in mammals is controversial. We report that Nkapl is a novel germ cell-specific transcriptional suppressor in Notch signaling. It is also associated with several molecules of the Notch corepressor complex such as CIR, HDAC3, and CSL. It was expressed robustly in spermatogonia and early spermatocytes after the age of 3 weeks. Nkapl-deleted mice showed complete arrest at the level of pachytene spermatocytes. In addition, apoptosis was observed in this cell type. Overexpression of NKAPL in germline stem cells demonstrated that Nkapl induced changes in spermatogonial stem cell (SSC) markers and the reduction of differentiation factors through the Notch signaling pathway, whereas testes with Nkapl deleted showed inverse changes in those markers and factors. Therefore, Nkapl is indispensable because aberrantly elevated Notch signaling has negative effects on spermatogenesis, affecting SSC maintenance and differentiation factors. Notch signaling should be properly regulated through the transcriptional factor Nkapl.	[Okuda, Hidenobu; Kiuchi, Hiroshi; Takao, Tetsuya; Miyagawa, Yasushi; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Osaka, Japan; [Tsujimura, Akira] Juntendo Univ Hosp, Dept Urol, Tokyo, Japan; [Miyata, Haruhiko; Okabe, Masaru; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Anim Resource Ctr Infect Dis, Osaka, Japan; [Kawakami, Yoshitaka; Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Wada, Morimasa; Tanaka, Hiromitsu] Nagasaki Int Univ, Fac Pharmaceut Sci, Div Mol Biol, Nagasaki, Japan	Osaka University; Juntendo University; Osaka University; National Institute of Advanced Industrial Science & Technology (AIST); Nagasaki International University	Tanaka, H (corresponding author), Nagasaki Int Univ, Fac Pharmaceut Sci, Div Mol Biol, Nagasaki, Japan.	h-tanaka@niu.ac.jp	ikawa, masahito/A-5315-2009	ikawa, masahito/0000-0001-9859-6217; Miyata, Haruhiko/0000-0003-4758-5803	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24659713]; Japan Society for the Promotion of Science (JSPS) [11021]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan 24659713, (http://www.mext.go.jp/english/), the Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (JSPS), 11021 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Barrios F, 2012, J CELL SCI, V125, P1455, DOI 10.1242/jcs.092593; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Chen DY, 2003, BIOCHEM BIOPH RES CO, V310, P720, DOI 10.1016/j.bbrc.2003.09.074; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2003, CYTOGENET GENOME RES, V103, P267, DOI 10.1159/000076812; Garcia TX, 2013, DEV BIOL, V377, P188, DOI 10.1016/j.ydbio.2013.01.031; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Huang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071213; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2013, ANNU REV CELL DEV BI, V29, P163, DOI 10.1146/annurev-cellbio-101512-122353; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kitadate Y, 2010, P NATL ACAD SCI USA, V107, P14241, DOI 10.1073/pnas.1003462107; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; McCright B, 2001, DEVELOPMENT, V128, P491; Michie AM, 2007, INT IMMUNOL, V19, P1421, DOI 10.1093/intimm/dxm113; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Morichika K, 2010, DEV GROWTH DIFFER, V52, P235, DOI 10.1111/j.1440-169X.2009.01164.x; Murta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072767; Nishimune Y, 2006, J ANDROL, V27, P326, DOI 10.2164/jandrol.05162; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Okuda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035195; Pajerowski AG, 2009, IMMUNITY, V30, P696, DOI 10.1016/j.immuni.2009.02.011; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Pereira LAVD, 1998, INT J ANDROL, V21, P34; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; SEARLE AG, 1983, CYTOGENET CELL GENET, V36, P617, DOI 10.1159/000131985; Song HW, 2014, SEMIN CELL DEV BIOL, V30, P14, DOI 10.1016/j.semcdb.2014.02.005; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanaka H, 1997, INT J ANDROL, V20, P361; Tanaka H, 2003, INT J ANDROL, V26, P52, DOI 10.1046/j.1365-2605.2003.00389.x; Tang H, 2008, DEVELOPMENT, V135, P3745, DOI 10.1242/dev.024786; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tsuchida J, 1998, DEV BIOL, V197, P67, DOI 10.1006/dbio.1998.8885; Vemuganti SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-285; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yomogida K, 2003, BIOL REPROD, V69, P1303, DOI 10.1095/biolreprod.103.015958; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	60	20	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124293	10.1371/journal.pone.0124293	http://dx.doi.org/10.1371/journal.pone.0124293			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875095	Green Published, gold			2022-12-26	WOS:000353014700064
J	Adegbija, O; Hoy, W; Wang, ZQ				Adegbija, Odewumi; Hoy, Wendy; Wang, Zhiqiang			Predicting Absolute Risk of Type 2 Diabetes Using Age and Waist Circumference Values in an Aboriginal Australian Community	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; POPULATION; OBESITY; PEOPLE; TOOL	Objectives To predict in an Australian Aboriginal community, the 10-year absolute risk of type 2 diabetes associated with waist circumference and age on baseline examination. Method A sample of 803 diabetes-free adults (82.3% of the age-eligible population) from baseline data of participants collected from 1992 to 1998 were followed-up for up to 20 years till 2012. The Cox-proportional hazard model was used to estimate the effects of waist circumference and other risk factors, including age, smoking and alcohol consumption status, of males and females on prediction of type 2 diabetes, identified through subsequent hospitalisation data during the follow-up period. The Weibull regression model was used to calculate the absolute risk estimates of type 2 diabetes with waist circumference and age as predictors. Results Of 803 participants, 110 were recorded as having developed type 2 diabetes, in subsequent hospitalizations over a follow-up of 12633.4 person-years. Waist circumference was strongly associated with subsequent diagnosis of type 2 diabetes with P<0.0001 for both genders and remained statistically significant after adjusting for confounding factors. Hazard ratios of type 2 diabetes associated with 1 standard deviation increase in waist circumference were 1.7 (95%CI 1.3 to 2.2) for males and 2.1 (95%CI 1.7 to 2.6) for females. At 45 years of age with baseline waist circumference of 100 cm, a male had an absolute diabetic risk of 10.9%, while a female had a 14.3% risk of the disease. Conclusions The constructed model predicts the 10-year absolute diabetes risk in an Aboriginal Australian community. It is simple and easily understood and will help identify individuals at risk of diabetes in relation to waist circumference values. Our findings on the relationship between waist circumference and diabetes on gender will be useful for clinical consultation, public health education and establishing WC cut-off points for Aboriginal Australians.	[Adegbija, Odewumi; Hoy, Wendy; Wang, Zhiqiang] Univ Queensland, Sch Med, Ctr Chron Dis, Brisbane, Qld, Australia	University of Queensland	Adegbija, O (corresponding author), Univ Queensland, Sch Med, Ctr Chron Dis, Brisbane, Qld, Australia.	o.adegbija@uq.edu.au	Adegbija, Odewumi/N-1434-2019; Wang, Zhiqiang/A-5835-2010; Hoy, Wendy E/A-7325-2010	Wang, Zhiqiang/0000-0002-5839-743X; Hoy, Wendy E/0000-0002-8405-1539; Adegbija, Odewumi/0000-0001-6517-3795	National Health and Medical Research Council of Australia [APP1025350]; National Health and Medical Research Council of Australia grant [320860]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia grant(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by National Health and Medical Research Council of Australia APP1025350). The baseline screening was supported by National Health and Medical Research Council of Australia grant (320860). Dr Wendy Hoy's National Health and Medical Research Council of Australia Australia Research Fellowship (#511081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Government, 2013, AB TORR STRAIT ISL D; Australian Government Department of Health, 2010, AUSTR TYP 2 DAIB RIS; Baker IDI Heart & Biabetes Institure Diabetes Australia, 2012, DIAB AUSTR DIAB SIL; Bambrick HJ, 2005, AUSTR INDIGENOUS HLT, V5, P1; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; Burke V, 2007, DIABETES RES CLIN PR, V78, P360, DOI 10.1016/j.diabres.2007.04.007; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Chittleborough CR, 2007, PUBLIC HEALTH, V121, P92, DOI 10.1016/j.puhe.2006.09.017; Daniel M, 1999, DIABETES CARE, V22, P1993, DOI 10.2337/diacare.22.12.1993; Diabetes Australia Guideline Development Consortium, 2009, NAT EV BAS GUID CAW, V2009, P1; Hearst News Service, 1908, HEARST NEWS SER 0507, P1; Hoy WE, 2000, MED J AUSTRALIA, V172, P473, DOI 10.5694/j.1326-5377.2000.tb124070.x; Janiszewski PM, 2007, DIABETES CARE, V30, P3105, DOI 10.2337/dc07-0945; Kondalsamy-Chennakesavan S, 2008, AM J HUM BIOL, V20, P317, DOI 10.1002/ajhb.20729; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; McDermott RA, 2010, MED J AUSTRALIA, V192, P562, DOI 10.5694/j.1326-5377.2010.tb03636.x; O'Dea K., 1987, P NUTR SOC AUST, V12, P56; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; StataCorp, 2011, STAT STAT SOFTW REL, P173; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wang Z, 2004, INT J OBESITY, V28, P1580, DOI 10.1038/sj.ijo.0802771; Wang Z, 2004, EUR J CLIN NUTR, V58, P888, DOI 10.1038/sj.ejcn.1601891; Wang Z, 2010, BMC EMERG MED, V10, DOI [10.1186/1471-227X-10-1, 10.1186/1471-2458-10-487]; Wang ZQ, 2003, ETHNIC DIS, V13, P324	26	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123788	10.1371/journal.pone.0123788	http://dx.doi.org/10.1371/journal.pone.0123788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876058	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100213
J	Chen, CC; Chang, MW; Chang, CP; Chang, WY; Chang, SC; Lin, MT; Yang, CL				Chen, Chi-Chun; Chang, Ming-Wen; Chang, Ching-Ping; Chang, Wen-Ying; Chang, Shin-Chieh; Lin, Mao-Tsun; Yang, Chin-Lung			Improved Infrared-Sensing Running Wheel Systems with an Effective Exercise Activity Indicator	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; REGIONAL ANGIOGENESIS; PHYSICAL-ACTIVITY; FORCED EXERCISE; ISCHEMIA; BRAIN; MODEL; RATS; VOLUNTARY; NEUROGENESIS	This paper describes an infrared-sensing running wheel (ISRW) system for the quantitative measurement of effective exercise activity in rats. The ISRW system provides superior exercise training compared with commercially available traditional animal running platforms. Four infrared (IR) light-emitting diode/detector pairs embedded around the rim of the wheel detect the rat's real-time position; the acrylic wheel has a diameter of 55 cm and a thickness of 15 cm, that is, it is larger and thicker than traditional exercise wheels, and it is equipped with a rubber track. The acrylic wheel hangs virtually frictionless, and a DC motor with an axially mounted rubber wheel, which has a diameter of 10 cm, drives the acrylic wheel from the outer edge. The system can automatically train rats to run persistently. The proposed system can determine effective exercise activity (EEA), with the IR sensors (which are connected to a conventional PC) recording the rat exercise behavior. A prototype of the system was verified by a hospital research group performing ischemic stroke experiments on rats by considering middle cerebral artery occlusion. The experimental data demonstrated that the proposed system provides greater neuroprotection in an animal stroke model compared with a conventional treadmill and a motorized running wheel for a given exercise intensity. The quantitative exercise effectiveness indicator showed a 92% correlation between an increase in the EEA and a decrease in the infarct volume. This indicator can be used as a noninvasive and objective reference in clinical animal exercise experiments.	[Chen, Chi-Chun; Chang, Shin-Chieh] Natl Chin Yi Univ Technol, Dept Elect Engn, Taichung, Taiwan; [Chang, Ming-Wen] South Taiwan Univ Sci & Technol, Dept Elect Engn, Tainan, Taiwan; [Chang, Ching-Ping] South Taiwan Univ Sci & Technol, Tainan, Taiwan; [Chang, Wen-Ying; Yang, Chin-Lung] Natl Cheng Kung Univ, Dept Elect Engn, Tainan 70101, Taiwan; [Lin, Mao-Tsun] ChiMei Med Ctr, Dept Med Res, Tainan, Taiwan	National Chin-Yi University of Technology; National Cheng Kung University	Yang, CL (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, 1 Univ Rd, Tainan 70101, Taiwan.	cyang@mail.ncku.edu.tw	Yang, Chin-Lung/D-4008-2015	Yang, Chin-Lung/0000-0002-5542-7576; Chang, Ching-Ping/0000-0003-0890-9414				Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Arida RM, 2004, NEUROSCI LETT, V364, P135, DOI 10.1016/j.neulet.2004.03.086; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Brown DA, 2007, J APPL PHYSIOL, V103, P1979, DOI 10.1152/japplphysiol.00706.2007; Buchheit M, 2013, SPORTS MED, V43, P927, DOI 10.1007/s40279-013-0066-5; Caton SJ, 2012, PHYSIOL BEHAV, V106, P185, DOI 10.1016/j.physbeh.2012.02.003; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Dalleck LC, 2013, PREV MED, V57, P392, DOI 10.1016/j.ypmed.2013.06.002; Demirel HA, 1998, MED SCI SPORT EXER, V30, P1211, DOI 10.1097/00005768-199808000-00005; Ding Y, 2004, NEUROSCIENCE, V124, P583, DOI 10.1016/j.neuroscience.2003.12.029; Ding YC, 2003, STROKE, V34, P240; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fantegrossi WE, 2013, J NEUROSCI METH, V212, P338, DOI 10.1016/j.jneumeth.2012.10.020; FORDYCE DE, 1991, BEHAV BRAIN RES, V46, P123, DOI 10.1016/S0166-4328(05)80105-6; Frasier CR, 2011, J APPL PHYSIOL, V111, P905, DOI 10.1152/japplphysiol.00004.2011; Gartshore G, 1997, EXP NEUROL, V147, P353, DOI 10.1006/exnr.1997.6635; Greenwood BN, 2013, EUR J NEUROSCI, V37, P469, DOI 10.1111/ejn.12044; Hayes K, 2008, ACTA NEUROPATHOL, V115, P289, DOI 10.1007/s00401-008-0340-z; Hillman CH, 2008, BE SMART EXERCISE YO; Jin J, 2010, BRAIN INJURY, V24, P533, DOI 10.3109/02699051003610458; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kennard JA, 2012, PHYSIOL BEHAV, V106, P423, DOI 10.1016/j.physbeh.2012.02.023; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Li J, 2004, NEUROL RES, V26, P404, DOI 10.1179/016164104225016038; Liebetanz D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-168; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Peng CW, 2011, J MED BIOL ENG, V31, P1, DOI 10.5405/jmbe.718; Raichlen DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020601; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; Schmidt-Kassow M, 2012, NEUROREPORT, V23, P889, DOI 10.1097/WNR.0b013e32835946ca; Smith AD, 2003, EXP NEUROL, V184, P31, DOI 10.1016/j.expneurol.2003.08.017; Symons JD, 2003, J APPL PHYSIOL, V95, P1638, DOI 10.1152/japplphysiol.01168.2002; Todoroki K, 2004, JPN J PHYS FIT SPORT, V53, P537, DOI 10.7600/jspfsm1949.53.537; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Vancini RL, 2013, EPILEPSY BEHAV, V29, P431, DOI 10.1016/j.yebeh.2013.08.023; Wang RY, 2001, BRAIN RES, V922, P140, DOI 10.1016/S0006-8993(01)03154-7; Waters RP, 2008, PHYSIOL BEHAV, V93, P1044, DOI 10.1016/j.physbeh.2008.01.013; Yanagita S, 2007, LIFE SCI, V80, P356, DOI 10.1016/j.lfs.2006.09.027; Zhang F, 2011, NEUROSCIENCE, V177, P170, DOI 10.1016/j.neuroscience.2011.01.018	49	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122394	10.1371/journal.pone.0122394	http://dx.doi.org/10.1371/journal.pone.0122394			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875841	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100070
J	Kim, M; McKinnon, D; MacCarthy, T; Rosati, B; McKinnon, D				Kim, Min; McKinnon, Don; MacCarthy, Thomas; Rosati, Barbara; McKinnon, David			Regulatory Evolution and Voltage-Gated Ion Channel Expression in Squid Axon: Selection-Mutation Balance and Fitness Cliffs	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; ACTION-POTENTIALS; GENE-EXPRESSION; CONDUCTION-VELOCITY; LOLIGO-OPALESCENS; SODIUM-CHANNELS; METABOLIC COST; GIANT; EXCITABILITY; ESCAPE	It has been suggested that optimization of either axonal conduction velocity or the energy efficiency of action potential conduction predominates in the selection of voltage-gated sodium conductance levels in the squid axon. A population genetics model of channel gene regulatory function was used to examine the role of these and other evolutionary forces on the selection of both sodium and potassium channel expression levels. In this model, the accumulating effects ofmutations result in degradation of gene regulatory function, causing channel gene expression to fall to near-zero in the absence of positive selection. In the presence of positive selection, channel expression levels fall to the lowest values consistent with the selection criteria, thereby establishing a selection-mutation balance. Within the parameter space of sodium and potassium conductance values, the physiological performance of the squid axon model showed marked discontinuities associated with conduction failure and excitability. These discontinuities in physiological functionmay produce fitness cliffs. A fitness cliff associated with conduction failure, combined with the effects of phenotypic noise, can account for the selection of sodium conductance levels, without considering either conduction velocity or metabolic cost. A fitness cliff associated with a transition in axonal excitability, combined with phenotypic noise, can explain the selection of potassium channel expression levels. The results suggest that voltage-gated ion channel expression will fall to low levels, consistent with key functional constraints, even in the absence of positive selection for energy efficiency. Channel expression levels and individual variation in channel expression within the population can be explained by regulatory evolution in combination with genetic variation in regulatory function and phenotypic noise, without resorting to more complexmechanisms, such as activity-dependent homeostasis. Only a relatively small region of the large, nominally isofunctional parameter space for channel expression will normally be occupied, because of the effects of mutation.	[Kim, Min; McKinnon, David] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [McKinnon, Don; Rosati, Barbara; McKinnon, David] SUNY Stony Brook, Inst Mol Cardiol, Stony Brook, NY 11794 USA; [MacCarthy, Thomas] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Rosati, Barbara] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [McKinnon, David] Vet Affairs Med Ctr, Dept Res, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	McKinnon, D (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	dmckinnon@notes.cc.sunysb.edu			VA Merit Review Grant	VA Merit Review Grant(US Department of Veterans Affairs)	The project was supported by a VA Merit Review Grant to D.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; ADRIAN RH, 1975, PROC R SOC SER B-BIO, V189, P81, DOI 10.1098/rspb.1975.0043; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; Bezzina CR, 2006, CIRCULATION, V113, P338, DOI 10.1161/CIRCULATIONAHA.105.580811; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Clay JR, 2008, J R SOC INTERFACE, V5, P1421, DOI 10.1098/rsif.2008.0166; Clay JR, 1998, J NEUROPHYSIOL, V80, P903, DOI 10.1152/jn.1998.80.2.903; Crotty P, 2006, J NEUROPHYSIOL, V96, P1237, DOI 10.1152/jn.01204.2005; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; DIAMOND JM, 1992, NATURE, V355, P204, DOI 10.1038/355204a0; Dong M, 2006, AM J PHYSIOL-HEART C, V291, pH631, DOI 10.1152/ajpheart.00084.2006; DUDLEY R, 1991, PHYSIOL ZOOL, V64, P627, DOI 10.1086/physzool.64.3.30158197; Ewens W. J, 2004, MATHEMATICAL POPULAT, VI; Feder ME, 2000, ANNU REV ECOL SYST, V31, P315, DOI 10.1146/annurev.ecolsys.31.1.315; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Gilly WF, 1996, BIOL BULL, V191, P337, DOI 10.2307/1543006; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hartl DL, 2007, PRINCIPLES OF POPULA; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; HINES M, 1984, INT J BIOMED COMPUT, V15, P69, DOI 10.1016/0020-7101(84)90008-4; HODGKIN A, 1975, PHILOS T ROY SOC B, V270, P297, DOI 10.1098/rstb.1975.0010; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kim June-Bum, 2014, Korean J Pediatr, V57, P1, DOI 10.3345/kjp.2014.57.1.1; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu Z, 1998, J NEUROSCI, V18, P2309; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Meng XY, 2012, DISCRETE CONT DYN-A, V32, P2729, DOI 10.3934/dcds.2012.32.2729; Neumeister H, 2000, J EXP BIOL, V203, P547; O'Leary T, 2013, P NATL ACAD SCI USA, V110, pE2645, DOI 10.1073/pnas.1309966110; OTIS TS, 1990, P NATL ACAD SCI USA, V87, P2911, DOI 10.1073/pnas.87.8.2911; PACKARD A, 1969, NATURE, V221, P875, DOI 10.1038/221875a0; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Preuss T, 2000, J EXP BIOL, V203, P559; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Rosati B, 2004, CIRC RES, V94, P874, DOI 10.1161/01.RES.0000124921.81025.1F; Rosati B, 2009, EVOL DEV, V11, P610, DOI 10.1111/j.1525-142X.2009.00367.x; Rosati B, 2008, PHYSIOL GENOMICS, V35, P262, DOI 10.1152/physiolgenomics.00159.2007; Rosenthal JJC, 2000, BIOL BULL, V199, P135, DOI 10.2307/1542873; Rosenthal JJC, 2002, J EXP BIOL, V205, P1819; Sanchez P, 2008, HYDROBIOLOGIA, V612, P91, DOI 10.1007/s10750-008-9487-9; Sangrey TD, 2004, J NEUROPHYSIOL, V91, P2541, DOI 10.1152/jn.00646.2003; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Sengupta B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000840; Skelly DA, 2009, ANNU REV GENOM HUM G, V10, P313, DOI 10.1146/annurev-genom-082908-150121; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Valavanis VD, 2002, B MAR SCI, V71, P867; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yan QH, 2012, P NATL ACAD SCI USA, V109, P1601, DOI 10.1073/pnas.1114516109	62	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120785	10.1371/journal.pone.0120785	http://dx.doi.org/10.1371/journal.pone.0120785			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875483	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100027
J	Maricato, JT; Furtado, MN; Takenaka, MC; Nunes, ERM; Fincatti, P; Meliso, FM; da Silva, IDCG; Jasiulionis, MG; Sucupira, MCD; Diaz, RS; Janini, LMR				Maricato, Juliana T.; Furtado, Maria N.; Takenaka, Maisa C.; Nunes, Edsel R. M.; Fincatti, Patricia; Meliso, Fabiana M.; da Silva, Ismael D. C. G.; Jasiulionis, Miriam G.; de Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie; Janini, Luiz M. R.			Epigenetic Modulations in Activated Cells Early after HIV-1 Infection and Their Possible Functional Consequences	PLOS ONE			English	Article							COFFIN-LOWRY-SYNDROME; IMMUNODEFICIENCY-VIRUS-INFECTION; TYPE-1 REVERSE TRANSCRIPTION; RSK2 GENE RPS6KA3; CD4(+) T-CELLS; OXIDATIVE STRESS; DNA METHYLATION; EXPRESSION; REACTIVATION; REPLICATION	Epigenetic modifications refer to a number of biological processes which alter the structure of chromatin and its transcriptional activity such as DNA methylation and histone post-translational processing. Studies have tried to elucidate how the viral genome and its products are affected by epigenetic modifications imposed by cell machinery and how it affects the ability of the virus to either, replicate and produce a viable progeny or be driven to latency. The purpose of this study was to evaluate epigenetic modifications in PBMCs and CD4(+) cells after HIV-1 infection analyzing three approaches: (i) global DNA-methylation; (ii) qPCR array and (iii) western blot. HIV-1 infection led to methylation increases in the cellular DNA regardless the activation status of PBMCs. The analysis of H3K9me3 and H3K27me3 suggested a trend towards transcriptional repression in activated cells after HIV-1 infection. Using a qPCR array, we detected genes related to epigenetic processes highly modulated in activated HIV-1 infected cells. SETDB2 and RSK2 transcripts showed highest up-regulation levels. SETDB2 signaling is related to transcriptional silencing while RSK2 is related to either silencing or activation of gene expression depending on the signaling pathway triggered down-stream. In addition, activated cells infected by HIV-1 showed lower CD69 expression and a decrease of IL-2, IFN-gamma and metabolism-related factors transcripts indicating a possible functional consequence towards global transcriptional repression found in HIV-1 infected cells. Conversely, based on epigenetic markers studied here, non-stimulated cells infected by HIV-1, showed signs of global transcriptional activation. Our results suggest that HIV-1 infection exerts epigenetic modulations in activated cells that may lead these cells to transcriptional repression with important functional consequences. Moreover, non-stimulated cells seem to increase gene transcription after HIV-1 infection. Based on these observations, it is possible to speculate that the outcome of viral infections may be influenced by the cellular activation status at the moment of infection.	[Maricato, Juliana T.; Takenaka, Maisa C.; Janini, Luiz M. R.] Univ Fed Sao Paulo, Paulista Med Sch, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Meliso, Fabiana M.; Jasiulionis, Miriam G.] Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Furtado, Maria N.; Nunes, Edsel R. M.; Fincatti, Patricia; da Silva, Ismael D. C. G.; de Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie; Janini, Luiz M. R.] Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Maricato, JT (corresponding author), Univ Fed Sao Paulo, Paulista Med Sch, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	julianamaricato@hotmail.com	Furtado, Maria/GLR-6287-2022; Jasiulionis, Miriam/G-2207-2012; Maricato, Juliana/F-1608-2012	Jasiulionis, Miriam/0000-0002-4135-0440; Janini, Luiz Mario/0000-0002-6186-6284	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed EA, 2014, JAIDS-J ACQ IMM DEF, V65, P19, DOI 10.1097/QAI.0b013e3182a1bca4; [Anonymous], 2010, PROFILER PCR ARRAY S, P5; Arikawa E, 2010, RT2 PROFILER PCR ARR; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Delaunoy JP, 2006, CLIN GENET, V70, P161, DOI 10.1111/j.1399-0004.2006.00660.x; Delaunoy JP, 2001, HUM MUTAT, V17, P103, DOI 10.1002/1098-1004(200102)17:2<103::AID-HUMU2>3.0.CO;2-N; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Desplats P, 2013, NEUROLOGY, V80, P1415, DOI 10.1212/WNL.0b013e31828c2e9e; Grant PA, 2001, GENOME BIOL, V2; Guimiot F, 2004, GENE EXPR PATTERNS, V4, P111, DOI 10.1016/j.modgep.2003.06.001; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Iafrate AJ, 1997, EMBO J, V16, P673, DOI 10.1093/emboj/16.4.673; Ishida T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-69; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jost S, 2014, J VIROL, V88, P8349, DOI 10.1128/JVI.00924-14; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Levy Y, 2014, EUR J IMMUNOL, V44, P2802, DOI 10.1002/eji.201344433; Liu XF, 2013, VIRUSES-BASEL, V5, P1325, DOI 10.3390/v5051325; Loisel-Meyer S, 2012, P NATL ACAD SCI USA, V109, P2549, DOI 10.1073/pnas.1121427109; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Molognoni F, 2011, EPIGENETICS-US, V6, P451, DOI 10.4161/epi.6.4.14917; Niller HH, 2009, SEMIN CANCER BIOL, V19, P158, DOI 10.1016/j.semcancer.2009.02.012; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; PARKER MI, 1986, J BIOL CHEM, V261, P2786; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001286; Su PF, 2007, INT J CANCER, V121, P1257, DOI 10.1002/ijc.22849; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Vatakis DN, 2009, J VIROL, V83, P3374, DOI 10.1128/JVI.02161-08; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Westby M, 1998, CLIN EXP IMMUNOL, V111, P257; Willemsen NM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-92; Woellmer A, 2013, CURR OPIN VIROL, V3, P260, DOI 10.1016/j.coviro.2013.03.005; Wu YL, 2013, FREE RADICAL BIO MED, V65, P632, DOI 10.1016/j.freeradbiomed.2013.07.037; Yedavalli VRK, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-9; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Youngblood B, 2013, J IMMUNOL, V191, P540, DOI 10.4049/jimmunol.1203161; Zack JA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-37; Zeniou M, 2004, NUCLEIC ACIDS RES, V32, P1214, DOI 10.1093/nar/gkh272; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	44	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0119234	10.1371/journal.pone.0119234	http://dx.doi.org/10.1371/journal.pone.0119234			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875202	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100012
J	Noble, C; Nilsson, AN; Freitag, C; Beech, JP; Tegenfeldt, JO; Ambjornsson, T				Noble, Charleston; Nilsson, Adam N.; Freitag, Camilla; Beech, Jason P.; Tegenfeldt, Jonas O.; Ambjornsson, Tobias			A Fast and Scalable Kymograph Alignment Algorithm for Nanochannel-Based Optical DNA Mappings	PLOS ONE			English	Article							ORDERED RESTRICTION MAPS; SINGLE-MOLECULE APPROACH; AXONAL-TRANSPORT; DYNAMICS; SEQUENCE	Optical mapping by direct visualization of individual DNA molecules, stretched in nanochannels with sequence-specific fluorescent labeling, represents a promising tool for disease diagnostics and genomics. An important challenge for this technique is thermal motion of the DNA as it undergoes imaging; this blurs fluorescent patterns along the DNA and results in information loss. Correcting for this effect (a process referred to as kymograph alignment) is a common preprocessing step in nanochannel-based optical mapping workflows, and we present here a highly efficient algorithm to accomplish this via pattern recognition. We compare our method with the one previous approach, and we find that our method is orders of magnitude faster while producing data of similar quality. We demonstrate proof of principle of our approach on experimental data consisting of melt mapped bacteriophage DNA.	[Noble, Charleston; Nilsson, Adam N.; Ambjornsson, Tobias] Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden; [Noble, Charleston; Freitag, Camilla; Beech, Jason P.; Tegenfeldt, Jonas O.] Lund Univ, Dept Phys, Div Solid State Phys, S-22362 Lund, Sweden; [Freitag, Camilla] Gothenburg Univ, Dept Phys, Gothenburg, Sweden	Lund University; Lund University; University of Gothenburg	Ambjornsson, T (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden.	tobias.ambjornsson@thep.lu.se	beech, jason/A-5831-2010; Tegenfeldt, Jonas/B-9506-2008	beech, jason/0000-0002-1347-4657; Tegenfeldt, Jonas/0000-0002-3695-6886; Ambjornsson, Tobias/0000-0002-6439-8842; Kinos, Adam/0000-0002-1472-0100	Swedish Research Council [2009-2924, 2007-584]; VINNOVA [P35735-1]; Carl Tryggers Foundation [12: 13]; Hasselblad Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); Carl Tryggers Foundation; Hasselblad Foundation	TA, Swedish Research Council, grant no. 2009-2924, http://www.vr.se/ Funding provided to JOT, 2007-584, Swedish Research Council, grant no. 2007-584, http://www.vr.se/, JOT, VINNOVA, grant number P35735-1, http://www.vinnova.se/en/, TA, The Carl Tryggers Foundation grant no. 12: 13 http://www.carltryggersstiftelse.se/, and JOT, The Hasselblad Foundation http://www.hasselbladfoundation.org/news. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiev GE, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-68; Aston C, 1999, TRENDS BIOTECHNOL, V17, P297, DOI 10.1016/S0167-7799(99)01326-8; Baday M, 2012, NANO LETT, V12, P3861, DOI 10.1021/nl302069q; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; CAI WW, 1995, P NATL ACAD SCI USA, V92, P5164, DOI 10.1073/pnas.92.11.5164; Cai WW, 1998, P NATL ACAD SCI USA, V95, P3390, DOI 10.1073/pnas.95.7.3390; Chetta J, 2011, J NEUROSCI METH, V199, P230, DOI 10.1016/j.jneumeth.2011.05.013; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cormen Thomas H., 2009, INTRO ALGORITHMS; Cover TM, 1991, ELEMENTS INFORM THEO, P12, DOI [10.1002/0471200611.ch2, DOI 10.1002/0471200611.CH2]; Das SK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq673; de Gennes P. G., 1979, SCALING CONCEPTS POL; Douville N, 2008, ANAL BIOANAL CHEM, V391, P2395, DOI 10.1007/s00216-008-1995-y; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huang KM, 2008, 2008 IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS & INTERPRETATION, P29, DOI 10.1109/SSIAI.2008.4512277; Jing JP, 1998, P NATL ACAD SCI USA, V95, P8046, DOI 10.1073/pnas.95.14.8046; Jo K, 2007, P NATL ACAD SCI USA, V104, P2673, DOI 10.1073/pnas.0611151104; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Lim SF, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3613671; Marie R, 2013, P NATL ACAD SCI USA, V110, P4893, DOI 10.1073/pnas.1214570110; MENG X, 1995, NAT GENET, V9, P432, DOI 10.1038/ng0495-432; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; Neely RK, 2010, CHEM SCI, V1, P453, DOI 10.1039/c0sc00277a; Nilsson AN, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku556; Nyberg LK, 2012, BIOCHEM BIOPH RES CO, V417, P404, DOI 10.1016/j.bbrc.2011.11.128; Obashi K, 2013, EUR J NEUROSCI, V38, P2350, DOI 10.1111/ejn.12263; Persson F, 2010, CHEM SOC REV, V39, P985, DOI 10.1039/b912918a; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reisner W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196101; Reisner W, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/106601; Reisner W, 2010, P NATL ACAD SCI USA, V107, P13294, DOI 10.1073/pnas.1007081107; SAMAD A, 1995, GENOME RES, V5, P1, DOI 10.1101/gr.5.1.1; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Tegenfeldt JO, 2004, P NATL ACAD SCI USA, V101, P10979, DOI 10.1073/pnas.0403849101; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Valouev A, 2006, J COMPUT BIOL, V13, P442, DOI 10.1089/cmb.2006.13.442; Valouev A, 2006, P NATL ACAD SCI USA, V103, P15770, DOI 10.1073/pnas.0604040103; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Xiao M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1044; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001; Zhou S, 2004, J BACTERIOL, V186, P7773, DOI 10.1128/JB.186.22.7773-7782.2004; Zhou SG, 2002, APPL ENVIRON MICROB, V68, P6321, DOI 10.1128/AEM.68.12.6321-6331.2002	46	6	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121905	10.1371/journal.pone.0121905	http://dx.doi.org/10.1371/journal.pone.0121905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875920	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100052
J	Schrimpf, C; Gillmann, HJ; Sahlmann, B; Meinders, A; Larmann, J; Wilhelmi, M; Aper, T; Rustum, S; Lichtinghagen, R; Theilmeier, G; Teebken, OE				Schrimpf, Claudia; Gillmann, Hans-Joerg; Sahlmann, Bianca; Meinders, Antje; Larmann, Jan; Wilhelmi, Mathias; Aper, Thomas; Rustum, Saad; Lichtinghagen, Ralf; Theilmeier, Gregor; Teebken, Omke E.			Renal Function Interferes with Copeptin in Prediction of Major Adverse Cardiac Events in Patients Undergoing Vascular Surgery	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; VASOPRESSIN; TROPONIN; RULE; BIOMARKERS; ISCHEMIA; SYSTEM; RISK	Objective Precise perioperative risk stratification is important in vascular surgery patients who are at high risk for major adverse cardiovascular events (MACE) peri- and postoperatively. In clinical practice, the patient's perioperative risk is predicted by various indicators, e.g. revised cardiac index (RCRI) or modifications thereof. Patients suffering from chronic kidney disease (CKD) are stratified into a higher risk category. We hypothesized that Copeptin as a novel biomarker for hemodynamic stress could help to improve the prediction of perioperative cardiovascular events in patients undergoing vascular surgery including patients with chronic kidney disease. Methods 477 consecutive patients undergoing abdominal aortic, peripheral arterial or carotid surgery from June 2007 to October 2012 were prospectively enrolled. Primary endpoint was 30-day postoperative major adverse cardiovascular events (MACE). Results 41 patients reached the primary endpoint, including 63.4% aortic, 26.8% carotid, and 9.8% peripheral surgeries. Linear regression analysis showed that RCRI (P<.001), pre(P<.001), postoperative Copeptin (P<.001) and Copeptin level change (P=.001) were associated with perioperative MACE, but CKD remained independently associated with MACE and Copeptin levels. Multivariate regression showed that increased Copeptin levels added risk predictive information to the RCRI (P=.003). Especially in the intermediate RCRI categories was Copeptin significantly associated with the occurrence of MACE. (P<.05 Kruskal Wallis test). Subdivision of the study cohort into CKD stages revealed that preoperative Copeptin was significantly associated with CKD stages (P<.0001) and preoperative Copeptin measurements could not predict MACE in patients with more severe CKD stages. Conclusion Preoperative Copeptin loses its risk predictive potential for perioperative MACE in patients with chronic kidney disease undergoing vascular surgery.	[Schrimpf, Claudia; Wilhelmi, Mathias; Aper, Thomas; Rustum, Saad; Teebken, Omke E.] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Div Vasc & Endovasc Surg, Hannover, Germany; [Gillmann, Hans-Joerg; Sahlmann, Bianca; Meinders, Antje; Larmann, Jan; Theilmeier, Gregor] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Dept Clin Chem, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Teebken, OE (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Div Vasc & Endovasc Surg, Hannover, Germany.	teebken.omke@mh-hannover.de	; Larmann, Jan/B-4034-2011	Aper, Thomas/0000-0001-9549-0249; Larmann, Jan/0000-0003-3365-4572				Abbasi A, 2012, DIABETOLOGIA, V55, P1963, DOI 10.1007/s00125-012-2545-x; Bertges DJ, 2010, J VASC SURG, V52, P674, DOI 10.1016/j.jvs.2010.03.031; Bottiger BW, 2004, ANAESTHESIA, V59, P1083, DOI 10.1111/j.1365-2044.2004.03960.x; Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113; Charpentier S, 2012, ACAD EMERG MED, V19, P517, DOI 10.1111/j.1553-2712.2012.01350.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fenske W, 2011, J AM SOC NEPHROL, V22, P782, DOI 10.1681/ASN.2010070691; Gillmann HJ, 2014, CRIT CARE MED, V42, P1498, DOI 10.1097/CCM.0000000000000249; Hoeks SE, 2009, AM J MED, V122, P559, DOI 10.1016/j.amjmed.2008.10.041; Holmes CL, 2004, CRIT CARE, V8, P15, DOI 10.1186/cc2338; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Jarai R, 2011, AM J CARDIOL, V108, P1188, DOI 10.1016/j.amjcard.2011.06.024; Jochberger S, 2009, CRIT CARE MED, V37, P476, DOI 10.1097/CCM.0b013e3181957532; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lin S, 2012, RESUSCITATION, V83, P684, DOI 10.1016/j.resuscitation.2011.12.015; Luyt CE, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.009; Maravic-Stojkovic V, 2014, ANGIOLOGY, V65, P122, DOI 10.1177/0003319712473637; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Ray P, 2012, AM J EMERG MED, V30, P440, DOI 10.1016/j.ajem.2011.12.008; Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.076; Sutton R, 2002, BRIT J SURG, V89, P763, DOI 10.1046/j.1365-2168.2002.02080.x; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Vondrakova D, 2011, INT J CARDIOL, V150, P343, DOI 10.1016/j.ijcard.2011.05.029	23	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123093	10.1371/journal.pone.0123093	http://dx.doi.org/10.1371/journal.pone.0123093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VK4RY	25875814	gold, Green Published, Green Submitted			2022-12-26	WOS:000703335300001
J	Sreedhar, RV; Kumari, P; Rupwate, SD; Rajasekharan, R; Srinivasan, M				Sreedhar, R. V.; Kumari, Priya; Rupwate, Sunny D.; Rajasekharan, Ram; Srinivasan, Malathi			Exploring Triacylglycerol Biosynthetic Pathway in Developing Seeds of Chia (Salvia hispanica L.): A Transcriptomic Approach	PLOS ONE			English	Article							MONOACYLGLYCEROL ACYLTRANSFERASE; DIACYLGLYCEROL ACYLTRANSFERASE; BIFUNCTIONAL ENZYME; RNA-SEQ; EXPRESSION; ALIGNMENT; GENOME; LIPIDS; GENES	Chia (Salvia hispanica L.), a member of the mint family (Lamiaceae), is a rediscovered crop with great importance in health and nutrition and is also the highest known terrestrial plant source of heart-healthy omega-3 fatty acid, alpha linolenic acid (ALA). At present, there is no public genomic information or database available for this crop, hindering research on its genetic improvement through genomics-assisted breeding programs. The first comprehensive analysis of the global transcriptome profile of developing Salvia hispanica L. seeds, with special reference to lipid biosynthesis is presented in this study. RNA from five different stages of seed development was extracted and sequenced separately using the Illumina GAIIx platform. De novo assembly of processed reads in the pooled transcriptome using Trinity yielded 76,014 transcripts. The total transcript length was 66,944,462 bases (66.9 Mb), with an average length of approximately 880 bases. In the molecular functions category of Gene Ontology (GO) terms, ATP binding and nucleotide binding were found to be the most abundant and in the biological processes category, the metabolic process and the regulation of transcription-DNA-dependent and oxidation-reduction process were abundant. From the EuKaryotic Orthologous Groups of proteins (KOG) classification, the major category was "Metabolism" (31.97%), of which the most prominent class was 'carbohydrate metabolism and transport' (5.81% of total KOG classifications) followed by 'secondary metabolite biosynthesis transport and catabolism' (5.34%) and 'lipid metabolism' (4.57%). A majority of the candidate genes involved in lipid biosynthesis and oil accumulation were identified. Furthermore, 5596 simple sequence repeats (SSRs) were identified. The transcriptome data was further validated through confirmative PCR and qRT-PCR for select lipid genes. Our study provides insight into the complex transcriptome and will contribute to further genome-wide research and understanding of chia. The identified novel UniGenes will facilitate gene discovery and creation of genomic resource for this crop.	[Sreedhar, R. V.; Kumari, Priya; Srinivasan, Malathi] CSIR, CFTRI, LIPIC, Resource Ctr,Lipidomic Ctr, Bangalore 560065, Karnataka, India; [Rupwate, Sunny D.; Rajasekharan, Ram] CSIR, CFTRI, LIPIC, Lipid Ctr, Mysore 570020, Karnataka, India; [Srinivasan, Malathi] CSIR, Acad Sci & Innovat Res, New Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Srinivasan, M (corresponding author), CSIR, CFTRI, LIPIC, Resource Ctr,Lipidomic Ctr, Bangalore 560065, Karnataka, India.	m.srinivasan@cftri.res.in	Rajasekharan, Ram/R-2257-2019	Ram, Rajasekharan/0000-0002-4114-0654	Council of Scientific and Industrial Research (CSIR), INDIA through 12th Five year plan project LIPIC [BSC0401]	Council of Scientific and Industrial Research (CSIR), INDIA through 12th Five year plan project LIPIC	This work was financially supported by Council of Scientific and Industrial Research (CSIR), INDIA through 12th Five year plan project LIPIC (BSC0401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, OFFICIAL J EUROPEA L, V21; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ayerza(h) Ricardo, 2008, P377, DOI 10.1007/978-1-59745-330-1_26; Ayerza R, 2011, IND CROP PROD, V34, P1366, DOI 10.1016/j.indcrop.2010.12.007; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Bourre J M, 2004, J Nutr Health Aging, V8, P163; Bozhko M, 2003, MOL ECOL, V12, P3147, DOI 10.1046/j.1365-294X.2003.01983.x; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Ge XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087693; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haslam RP, 2013, PLANT BIOTECHNOL J, V11, P157, DOI 10.1111/pbi.12012; Huima, 2013, BMC PLANT BIOL, V13, P152, DOI [10.1186/1471-2229-13-152, DOI 10.1186/1471-2229-13-152]; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; KENNEDY EP, 1961, FED PROC, V20, P934; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Legrand S, 2010, GENE, V450, P55, DOI 10.1016/j.gene.2009.10.004; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; Monsanto Company, 2009, STEAR SDA OM 3 SOYB; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz LA, 2013, FOOD REV INT, V29, P394, DOI 10.1080/87559129.2013.818014; Nykiforuk CL, 2012, TRANSGENIC RES, V21, P367, DOI 10.1007/s11248-011-9543-5; OHLROGGE JB, 1991, BIOCHIM BIOPHYS ACTA, V1082, P1, DOI 10.1016/0005-2760(91)90294-R; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Reyes-Caudillo E, 2008, FOOD CHEM, V107, P656, DOI 10.1016/j.foodchem.2007.08.062; Rupwate SD, 2012, FEBS LETT, V586, P1555, DOI 10.1016/j.febslet.2012.04.022; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Small Ernest, 2011, Biodiversity (Ottawa), V12, P49, DOI 10.1080/14888386.2011.575104; USDA, 2011, MILK NAT NUTR DAT ST; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vijayaraj P, 2012, PLANT PHYSIOL, V160, P667, DOI 10.1104/pp.112.202135; Wang HW, 2007, PLANT J, V52, P716, DOI 10.1111/j.1365-313X.2007.03268.x; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084105; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Zhang J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-228	40	28	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123580	10.1371/journal.pone.0123580	http://dx.doi.org/10.1371/journal.pone.0123580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875809	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100191
J	Stroo, I; Claessen, N; Teske, GJD; Butter, LM; Florquin, S; Leemans, JC				Stroo, Ingrid; Claessen, Nike; Teske, Gwendoline J. D.; Butter, Loes M.; Florquin, Sandrine; Leemans, Jaklien C.			Deficiency for the Chemokine Monocyte Chemoattractant Protein-1 Aggravates Tubular Damage after Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; EPITHELIAL-CELLS; ISCHAEMIA/REPERFUSION INJURY; INDUCED APOPTOSIS; OXIDATIVE STRESS; KAPPA-B; EXPRESSION; KIDNEY; REPAIR; GROWTH	Temporal expression of chemokines is a crucial factor in the regulation of renal ischemia/reperfusion (I/R) injury and repair. Beside their role in the migration and activation of inflammatory cells to sites of injury, chemokines are also involved in other processes such as angiogenesis, development and migration of stem cells. In the present study we investigated the role of the chemokine MCP-1 (monocyte chemoattractant protein-1 or CCL2), the main chemoattractant for monocytes, during renal I/R injury. MCP-1 expression peaks several days after inducing renal I/R injury coinciding with macrophage accumulation. However, MCP-1 deficient mice had a significant decreased survival and increased renal damage within the first two days, i.e. the acute inflammatory response, after renal I/R injury with no evidence of altered macrophage accumulation. Kidneys and primary tubular epithelial cells from MCP-1 deficient mice showed increased apoptosis after ischemia. Taken together, MCP-1 protects the kidney during the acute inflammatory response following renal I/R injury.	[Stroo, Ingrid; Claessen, Nike; Teske, Gwendoline J. D.; Butter, Loes M.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Stroo, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	I.Stroo@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020		Dutch Kidney Foundation (NSN) [2059]	Dutch Kidney Foundation (NSN)	This work was supported by a grant from the Dutch Kidney Foundation (NSN#2059) (IS/JCL) (http://www.nierstichting.nl/asset/voor-professionals/biomedisch-onderzoek/report-bwo-proj-groups-20feb12.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Buckley S, 2008, AM J PHYSIOL-LUNG C, V294, pL739, DOI 10.1152/ajplung.00294.2007; Dessing MC, 2014, KIDNEY INT; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Diaz-Guerra E, 2007, J IMMUNOL, V179, P7352, DOI 10.4049/jimmunol.179.11.7352; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Furuichi K, 2003, J AM SOC NEPHROL, V14, P1066, DOI 10.1097/01.ASN.0000059339.14780.E4; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Guan QN, 2010, TRANSPLANTATION, V89, P1320, DOI 10.1097/TP.0b013e3181d8e9dc; JIANG YL, 1992, J IMMUNOL, V148, P2423; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Miura M, 2001, AM J PATHOL, V159, P2137, DOI 10.1016/S0002-9440(10)63065-9; Morimoto H, 2008, CARDIOVASC RES, V78, P554, DOI 10.1093/cvr/cvn035; Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; PRODJOSUDJADI W, 1995, KIDNEY INT, V48, P1477, DOI 10.1038/ki.1995.437; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Rice JC, 2002, RENAL FAILURE, V24, P703, DOI 10.1081/JDI-120015673; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rozen S, 2000, Methods Mol Biol, V132, P365; SAFIRSTEIN R, 1991, AM J PHYSIOL, V261, pF1095, DOI 10.1152/ajprenal.1991.261.6.F1095; Schecter AD, 2004, J LEUKOCYTE BIOL, V75, P1079, DOI 10.1189/jlb.0903421; SCHMOUDER RL, 1993, KIDNEY INT, V44, P43, DOI 10.1038/ki.1993.211; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Stokman G, 2010, NEPHROL DIAL TRANSPL, V25, P3852, DOI 10.1093/ndt/gfq311; Stroo I, 2010, INT IMMUNOL, V22, P433, DOI 10.1093/intimm/dxq025; Sung FL, 2002, KIDNEY INT, V62, P1160, DOI 10.1111/j.1523-1755.2002.kid577.x; Tarzami ST, 2005, BIOCHEM BIOPH RES CO, V335, P1008, DOI 10.1016/j.bbrc.2005.07.168; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Voskuil M, 2004, VASC MED, V9, P287, DOI 10.1191/1358863x04vm571oa; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Zamara E, 2007, J HEPATOL, V46, P230, DOI 10.1016/j.jhep.2006.09.007	43	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123203	10.1371/journal.pone.0123203	http://dx.doi.org/10.1371/journal.pone.0123203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875776	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100150
J	Tolea, MI; Morris, JC; Galvin, JE				Tolea, Magdalena I.; Morris, John C.; Galvin, James E.			Longitudinal Associations between Physical and Cognitive Performance among Community-Dwelling Older Adults	PLOS ONE			English	Article							FUNCTIONAL LIMITATIONS; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; DECLINE; IMPAIRMENT; DEMENTIA; HEALTH; RISK; DISABILITY; DIAGNOSIS	To assess the directionality of the association between physical and cognitive decline in later life, we compared patterns of decline in performance across groups defined by baseline presence of cognitive and/or physical impairment [none (n = 217); physical only (n = 169); cognitive only (n = 158), or both (n = 220)] in a large sample of participants in a cognitive aging study at the Knight Alzheimer's Disease Research Center at Washington University in St. Louis who were followed for up to 8 years (3,079 observations). Rates of decline reached 20% for physical performance and varied across cognitive tests (global, memory, speed, executive function, and visuospatial skills). We found that physical decline was better predicted by baseline cognitive impairment (slope = -1.22, p<0.001), with baseline physical impairment not contributing to further decline in physical performance (slope = -0.25, p = 0.294). In turn, baseline physical impairment was only marginally associated with rate of cognitive decline across various cognitive domains. The cognitive-functional association is likely to operate in the direction of cognitive impairment to physical decline although physical impairment may also play a role in cognitive decline/dementia. Interventions to prevent further functional decline and development of disability and complete dependence may benefit if targeted to individuals with cognitive impairment who are at increased risk.	[Tolea, Magdalena I.; Galvin, James E.] NYU, Sch Med, Alzheimers Dis Res Ctr, Dept Neurol, New York, NY 10012 USA; [Tolea, Magdalena I.; Galvin, James E.] NYU, Sch Med, Dept Psychiat, Alzheimers Dis Res Ctr, New York, NY USA; [Tolea, Magdalena I.; Galvin, James E.] NYU, Sch Med, Dept Populat Hlth, Alzheimers Dis Res Ctr, New York, NY USA; [Morris, John C.] Washington Univ, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO USA	New York University; New York University; New York University; Washington University (WUSTL)	Tolea, MI (corresponding author), NYU, Sch Med, Alzheimers Dis Res Ctr, Dept Neurol, New York, NY 10012 USA.	Magdalena.Tolea@nyumc.org	Galvin, James/AAM-7492-2021		NIH [P01 AG03991, P50 AG05681, R01 AG040211, P30 AG008051]; Morris and Alma Schapiro Fund; New York State Department of Health [DOH-2011-1004010353]; NATIONAL INSTITUTE ON AGING [P50AG005681, P01AG003991, R01AG040211, P30AG008051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morris and Alma Schapiro Fund; New York State Department of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection was supported by grants from NIH (P01 AG03991 and P50 AG05681) to JCM. Data Analysis was supported by grants from the NIH (R01 AG040211 and P30 AG008051), Morris and Alma Schapiro Fund, and the New York State Department of Health (DOH-2011-1004010353) to JEG. The authors take responsibility for the integrity of the data and accuracy of the data analysis and have the right to publish any and all data, separate and apart from the guidance of any sponsor.	Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; Alzheimer's Association, 2013, ALZH DEM FACTS FIG; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Bherer L., 2013, J AGING RES, V2013, DOI [10.1155/2013/657508., 10.1155/2013/657508]; Binder EF, 1999, J GERONTOL A-BIOL, V54, pM428, DOI 10.1093/gerona/54.8.M428; Blankevoort CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070799; Boelens C, 2013, TECHNOL HEALTH CARE, V21, P521, DOI 10.3233/THC-130748; Chodosh J, 2010, J AM GERIATR SOC, V58, P2350, DOI 10.1111/j.1532-5415.2010.03171.x; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; De Buyser SL, 2013, EUR J CLIN INVEST, V43, P379, DOI 10.1111/eci.12056; Elovainio M, 2009, J EPIDEMIOL COMMUN H, V63, P468, DOI 10.1136/jech.2008.081505; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Fillenbaum GG, 2008, ALZHEIMERS DEMENT, V4, P96, DOI 10.1016/j.jalz.2007.08.005; Ford K, 2008, COGNITIVE FUNCTIONIN, DOI [10.1159/000247132, DOI 10.1159/000247132]; Giuliani CA, 2008, GERONTOLOGIST, V48, P203, DOI 10.1093/geront/48.2.203; Greiner PA, 1996, AM J PUBLIC HEALTH, V86, P62, DOI 10.2105/AJPH.86.1.62; Gure TR, 2013, J GERIATR PSYCH NEUR, V26, P78, DOI 10.1177/0891988713481264; Heaney JLJ, 2012, PSYCHONEUROENDOCRINO, V37, P341, DOI 10.1016/j.psyneuen.2011.07.001; Ishizaki T, 2006, ARCH GERONTOL GERIAT, V42, P47, DOI 10.1016/j.archger.2005.06.001; Iwasa H, 2008, ARCH GERONTOL GERIAT, V47, P139, DOI 10.1016/j.archger.2007.07.008; Kanne SM, 1998, NEUROLOGY, V50, P979, DOI 10.1212/WNL.50.4.979; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; KELLYHAYES M, 1992, AM J PUBLIC HEALTH, V82, P841, DOI 10.2105/AJPH.82.6.841; Magouirk-Bettcher B, 2011, AGING HLTH, V7, P505; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nagi SZ, 1965, SOCIOLOGY REHABILITA, P100; National Center for Health Statistics, 2013, HLTH US 2012 SPEC FE; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Penninx BWJH, 2009, J GERONTOL A-BIOL, V64, P96, DOI 10.1093/gerona/gln005; Rajan KB, 2012, J GERONTOL A-BIOL, V67, P1419, DOI 10.1093/gerona/gls098; REUBEN DB, 1990, J AM GERIATR SOC, V38, P1105, DOI 10.1111/j.1532-5415.1990.tb01373.x; Roman GC, 2004, J NEUROL SCI, V226, P81, DOI 10.1016/j.jns.2004.09.016; Stark SL, 2013, NEUROLOGY, V81, P437, DOI 10.1212/WNL.0b013e31829d8599; Wilkins CH, 2013, J AM GERIATR SOC, V61, P1055, DOI 10.1111/jgs.12255; Wilkins CH, 2010, ARCH GERONTOL GERIAT, V50, P96, DOI 10.1016/j.archger.2009.02.006; Yaffe K, 2009, ARCH NEUROL-CHICAGO, V66, P324, DOI 10.1001/archneurol.2008.566; Zahodne LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073645	40	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122878	10.1371/journal.pone.0122878	http://dx.doi.org/10.1371/journal.pone.0122878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875165	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100114
J	Walseng, E; Walchli, S; Fallang, LE; Yang, WW; Vefferstad, A; Areffard, A; Olweus, J				Walseng, Even; Walchli, Sebastien; Fallang, Lars-Egil; Yang, Weiwen; Vefferstad, Anette; Areffard, Ali; Olweus, Johanna			Soluble T-Cell Receptors Produced in Human Cells for Targeted Delivery	PLOS ONE			English	Article							IN-VITRO; DIRECTED EVOLUTION; HIGH-AFFINITY; PEPTIDE-MHC; SINGLE; RECOGNITION; SPECIFICITY; MOLECULES; PROTEINS; DISPLAY	Recently, technology has become available to generate soluble T-cell receptors (sTCRs) that contain the antigen recognition part. In contrast to antibodies, sTCRs recognize intracellular in addition to extracellular epitopes, potentially increasing the number of applications as reagents for target detection and immunotherapy. Moreover, recent data show that they can be used for identification of their natural peptide ligands in disease. Here we describe a new and simplified expression method for sTCRs in human cells and show that these sTCRs can be used for antigen-specific labeling and elimination of human target cells. Four different TCRs were solubilized by expression of constructs encoding the TCR alpha (alpha) and beta (beta) chains lacking the transmembrane and intracellular domains, linked by a ribosomal skipping 2A sequence that facilitates equimolar production of the chains. Cell supernatants containing sTCRs labeled target cells directly in a peptide (p)-human leukocyte antigen (HLA)-specific manner. We demonstrated that a MART-1p/HLA-A*02:01-specific sTCR fused to a fluorescent protein, or multimerized onto magnetic nanoparticles, could be internalized. Moreover, we showed that this sTCR and two sTCRs recognizing CD20p/HLA-A*02:01 could mediate selective elimination of target cells expressing the relevant pHLA complex when tetramerized to streptavidin-conjugated toxin, demonstrating the potential for specific delivery of cargo. This simple and efficient method can be utilized to generate a wide range of minimally modified sTCRs from the naturally occurring TCR repertoire for antigen-specific detection and targeting.	[Walseng, Even; Walchli, Sebastien; Fallang, Lars-Egil; Yang, Weiwen; Vefferstad, Anette; Areffard, Ali; Olweus, Johanna] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Immunol, Oslo, Norway; [Walchli, Sebastien] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Cell Therapy, Oslo, Norway; [Yang, Weiwen; Vefferstad, Anette; Olweus, Johanna] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Canc Immunotherapy, Oslo, Norway; [Yang, Weiwen; Vefferstad, Anette; Olweus, Johanna] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Inflammat Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Walchli, S (corresponding author), Oslo Univ Hosp, Radiumhosp, Dept Cell Therapy, Oslo, Norway.	sebastien.walchli@rr-research.no; johanna.olweus@medisin.uio.no	Olweus, Johanna/G-8008-2015	Olweus, Johanna/0000-0002-1898-3100; Walchli, Sebastien/0000-0001-5869-1746	Research Council of Norway; Regional Health Authorities South-Eastern Norway; Oslo University Hospital Radiumhospitalet; Norwegian Cancer Association; K. G. Jebsen Foundation	Research Council of Norway(Research Council of Norway); Regional Health Authorities South-Eastern Norway; Oslo University Hospital Radiumhospitalet; Norwegian Cancer Association; K. G. Jebsen Foundation	This study was financed by the Research Council of Norway (EW, LEF), the Regional Health Authorities South-Eastern Norway (AA), Oslo University Hospital Radiumhospitalet (SW, AV, WY), the Norwegian Cancer Association and the K. G. Jebsen Foundation (JO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen IW, 2010, LEUKEMIA, V24, P1901, DOI 10.1038/leu.2010.186; Adler MJ, 2012, HEMATOL ONCOL CLIN N, V26, P447, DOI 10.1016/j.hoc.2012.02.013; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Card KF, 2004, CANCER IMMUNOL IMMUN, V53, P345, DOI 10.1007/s00262-003-0450-3; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Chlewicki LK, 2005, J MOL BIOL, V346, P223, DOI 10.1016/j.jmb.2004.11.057; CHUNG S, 1994, P NATL ACAD SCI USA, V91, P12654, DOI 10.1073/pnas.91.26.12654; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Epel M, 2002, CANCER IMMUNOL IMMUN, V51, P565, DOI 10.1007/s00262-002-0312-4; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GREGOIRE C, 1991, P NATL ACAD SCI USA, V88, P8077, DOI 10.1073/pnas.88.18.8077; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Irving M, 2012, J BIOL CHEM; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Laugel B, 2005, J BIOL CHEM, V280, P1882, DOI 10.1074/jbc.M409427200; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Moll R, 2001, Nurse Educ, V26, P122, DOI 10.1097/00006223-200105000-00012; Molloy PE, 2005, CURR OPIN PHARMACOL, V5, P438, DOI 10.1016/j.coph.2005.02.004; Mosquera LA, 2005, J IMMUNOL, V174, P4381, DOI 10.4049/jimmunol.174.7.4381; Ng TB, 2010, CURR PROTEIN PEPT SC, V11, P37, DOI 10.2174/138920310790274662; Pecorari F, 1999, J MOL BIOL, V285, P1831, DOI 10.1006/jmbi.1998.2422; Richman SA, 2007, BIOMOL ENG, V24, P361, DOI 10.1016/j.bioeng.2007.02.009; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Stone JD, 2012, METHOD ENZYMOL, V503, P189, DOI 10.1016/B978-0-12-396962-0.00008-2; Stronen E, 2009, SCAND J IMMUNOL, V69, P319, DOI 10.1111/j.1365-3083.2008.02223.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; Valmori D, 1998, J IMMUNOL, V160, P1750; van Boxel GI, 2009, J IMMUNOL METHODS, V350, P14, DOI 10.1016/j.jim.2009.08.008; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Walchli B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027930; Willcox BE, 1999, PROTEIN SCI, V8, P2418; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145	48	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0119559	10.1371/journal.pone.0119559	http://dx.doi.org/10.1371/journal.pone.0119559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875651	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100016
J	Zhang, T; Guo, R; Gao, S; Guo, JX; Sun, W				Zhang, Tao; Guo, Rui; Gao, Song; Guo, Jixun; Sun, Wei			Responses of Plant Community Composition and Biomass Production to Warming and Nitrogen Deposition in a Temperate Meadow Ecosystem	PLOS ONE			English	Article							SPECIES RICHNESS; TALLGRASS PRAIRIE; ELEVATED CO2; TERRESTRIAL ECOSYSTEMS; BIODIVERSITY LOSS; CLIMATE-CHANGE; N-DEPOSITION; DIVERSITY; STEPPE; CHINA	Climate change has profound influences on plant community composition and ecosystem functions. However, its effects on plant community composition and biomass production are not well understood. A four-year field experiment was conducted to examine the effects of warming, nitrogen (N) addition, and their interactions on plant community composition and biomass production in a temperate meadow ecosystem in northeast China. Experimental warming had no significant effect on plant species richness, evenness, and diversity, while N addition highly reduced the species richness and diversity. Warming tended to reduce the importance value of graminoid species but increased the value of forbs, while N addition had the opposite effect. Warming tended to increase the belowground biomass, but had an opposite tendency to decrease the aboveground biomass. The influences of warming on aboveground production were dependent upon precipitation. Experimental warming had little effect on aboveground biomass in the years with higher precipitation, but significantly suppressed aboveground biomass in dry years. Our results suggest that warming had indirect effects on plant production via its effect on the water availability. Nitrogen addition significantly increased above-and below-ground production, suggesting that N is one of the most important limiting factors determining plant productivity in the studied meadow steppe. Significant interactive effects of warming plus N addition on belowground biomass were also detected. Our observations revealed that environmental changes (warming and N deposition) play significant roles in regulating plant community composition and biomass production in temperate meadow steppe ecosystem in northeast China.	[Zhang, Tao; Gao, Song; Guo, Jixun; Sun, Wei] NE Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China; [Guo, Rui] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Key Lab Dryland Agr, Minist Agr, Beijing 100193, Peoples R China; [Zhang, Tao] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China	Northeast Normal University - China; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Guo, JX (corresponding author), NE Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China.	gjixun@nenu.edu.cn; sunwei@nenu.edu.cn			National Natural Science Foundation of China [31170303, 31300097, 31100322, 31270445]; Program for New Century Excellent Talents in University [NCET-12-0814]; State Key Laboratory of Desert and Oasis Ecology; Xinjiang Institute of Ecology and Geography; Chinese Academy of Sciences; Fundamental Research Funds for the Central Universities [12QNJJ017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Desert and Oasis Ecology; Xinjiang Institute of Ecology and Geography; Chinese Academy of Sciences(Chinese Academy of Sciences); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the National Natural Science Foundation of China (31170303, 31300097, 31100322 and 31270445), Program for New Century Excellent Talents in University (NCET-12-0814), State Key Laboratory of Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences and Fundamental Research Funds for the Central Universities (No. 12QNJJ017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2001, BIOGEOCHEMISTRY, V54, P1, DOI 10.1023/A:1010653913530; Baer SG, 2004, OECOLOGIA, V139, P617, DOI 10.1007/s00442-004-1541-3; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bowman WD, 2006, ECOL APPL, V16, P1183, DOI 10.1890/1051-0761(2006)016[1183:NCLFAV]2.0.CO;2; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Cook C.W., 1986, RANGE RES BASIC PROB; De Boeck HJ, 2008, BIOGEOSCIENCES, V5, P585, DOI 10.5194/bg-5-585-2008; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Engel EC, 2009, J PLANT ECOL, V2, P1, DOI 10.1093/jpe/rtn026; Fay PA, 2011, BIOGEOSCIENCES, V8, P3053, DOI 10.5194/bg-8-3053-2011; Fonty E, 2009, GLOBAL CHANGE BIOL, V15, P2360, DOI 10.1111/j.1365-2486.2009.01923.x; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Gedan KB, 2009, ECOL LETT, V12, P842, DOI 10.1111/j.1461-0248.2009.01337.x; Gill RA, 2014, PLANT SOIL, V374, P197, DOI 10.1007/s11104-013-1868-9; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Harmens H, 2004, GRASS FORAGE SCI, V59, P144, DOI 10.1111/j.1365-2494.2004.00414.x; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; Huberty LE, 1998, J ECOL, V86, P794, DOI 10.1046/j.1365-2745.1998.8650794.x; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchison JS, 2010, ECOSYSTEMS, V13, P661, DOI 10.1007/s10021-010-9344-3; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060441; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Ma LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027645; Magill AH, 2000, ECOSYSTEMS, V3, P238, DOI 10.1007/s100210000023; Natali SM, 2012, J ECOL, V100, P488, DOI 10.1111/j.1365-2745.2011.01925.x; Niu SL, 2008, J PLANT ECOL-UK, V1, P103, DOI 10.1093/jpe/rtn003; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Payne RJ, 2013, P NATL ACAD SCI USA, V110, P984, DOI 10.1073/pnas.1214299109; Pennings SC, 2005, OIKOS, V110, P547, DOI 10.1111/j.0030-1299.2005.13792.x; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; Rull V, 2006, GLOBAL CHANGE BIOL, V12, P1, DOI 10.1111/j.1365-2486.2005.001080.x; Sardans J, 2008, APPL SOIL ECOL, V39, P223, DOI 10.1016/j.apsoil.2007.12.011; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Song L, 2011, BIOGEOSCIENCES, V8, P2341, DOI 10.5194/bg-8-2341-2011; Song L, 2012, J ARID LAND, V4, P3, DOI 10.3724/SP.J.1227.2012.00003; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; van den Berg LJL, 2011, GLOBAL CHANGE BIOL, V17, P1871, DOI 10.1111/j.1365-2486.2010.02345.x; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zhang NY, 2013, SOIL BIOL BIOCHEM, V65, P96, DOI 10.1016/j.soilbio.2013.05.015; Zhang Y, 2008, ATMOS ENVIRON, V42, P1035, DOI 10.1016/j.atmosenv.2007.12.015	58	33	34	19	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123160	10.1371/journal.pone.0123160	http://dx.doi.org/10.1371/journal.pone.0123160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874975	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100142
J	Ohno, T; Shimizu, M; Shirakami, Y; Baba, A; Kochi, T; Kubota, M; Tsurumi, H; Tanaka, T; Moriwaki, H				Ohno, Tomohiko; Shimizu, Masahito; Shirakami, Yohei; Baba, Atsushi; Kochi, Takahiro; Kubota, Masaya; Tsurumi, Hisashi; Tanaka, Takuji; Moriwaki, Hisataka			Metformin Suppresses Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-+Lepr(db)/+Lepr(db) Mice	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HOMEOSTASIS MODEL ASSESSMENT; ACTIVATED PROTEIN-KINASE; SENSITIVITY CHECK INDEX; PROMOTES GLUCOSE-UPTAKE; HEPATOCELLULAR-CARCINOMA; INSULIN SENSITIVITY; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; NONALCOHOLIC STEATOHEPATITIS; INDUCED HEPATOCARCINOGENESIS	Obesity and related metabolic disorders, such as diabetes mellitus, raise the risk of liver carcinogenesis. Metformin, which is widely used in the treatment of diabetes, ameliorates insulin sensitivity. Metformin is also thought to have antineoplastic activities and to reduce cancer risk. The present study examined the preventive effect ofmetformin on the development of diethylnitrosamine (DEN)-induced liver tumorigenesis in C57BL/KsJ-+Lepr(db)/+Lepr(db) (db/db) obese and diabetic mice. The mice were given a single injection of DEN at 2 weeks of age and subsequently received drinking water containing metformin for 20 weeks. Metformin administration significantly reduced the multiplicity of hepatic premalignant lesions and inhibited liver cell neoplasms. Metformin also markedly decreased serum levels of insulin and reduced insulin resistance, and inhibited phosphorylation of Akt, mammalian target of rapamycin (mTOR), and p70S6 in the liver. Furthermore, serum levels of leptin were decreased, while those of adiponectin were increased by metformin. These findings suggest that metformin prevents liver tumorigenesis by ameliorating insulin sensitivity, inhibiting the activation of Akt/mTOR/p70S6 signaling, and improving adipokine imbalance. Therefore, metformin may be a potent candidate for chemoprevention of liver tumorigenesis in patients with obesity or diabetes.	[Ohno, Tomohiko; Shimizu, Masahito; Shirakami, Yohei; Baba, Atsushi; Kochi, Takahiro; Kubota, Masaya; Tsurumi, Hisashi; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, Gifu, Japan; [Tanaka, Takuji] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan	Gifu University; Gifu University	Shirakami, Y (corresponding author), Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, Gifu, Japan.	ys2443@gifu-u.ac.jp						Akasaka Y, 2010, BBA-MOL CELL BIOL L, V1801, P1115, DOI 10.1016/j.bbalip.2010.06.009; [Anonymous], 2008, LANCET, V371, P1723, DOI [10.1056/NEJMOA0707193, 10.1016/S0140-6736(08)60733-3]; Asensio-Lopez MC, 2011, FREE RADICAL BIO MED, V51, P1861, DOI 10.1016/j.freeradbiomed.2011.08.015; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Bolukbas FF, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-23; Cai XB, 2013, ONCOL REP, V30, P2449, DOI 10.3892/or.2013.2718; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Cheng JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093256; Cheong SH, 2014, J NUTR BIOCHEM, V25, P136, DOI 10.1016/j.jnutbio.2013.09.012; Cua IHY, 2007, HEPATOLOGY, V46, P66, DOI 10.1002/hep.21703; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818; Eskens BJM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-175; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Evert M, 2012, HEPATOLOGY, V55, P1473, DOI 10.1002/hep.25600; Frith C H, 1994, IARC Sci Publ, P223; Fujita H, 2005, ENDOCR J, V52, P427, DOI 10.1507/endocrj.52.427; Hagiwara A, 2012, J CELL PHYSIOL, V227, P2097, DOI 10.1002/jcp.22941; Imai K, 2010, HEPATOL RES, V40, P376, DOI 10.1111/j.1872-034X.2009.00616.x; Iwasa J, 2010, CANCER SCI, V101, P460, DOI 10.1111/j.1349-7006.2009.01402.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Kang S, 2003, EUR J ENDOCRINOL, V148, P147, DOI 10.1530/eje.0.1480147; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Kitade M, 2006, HEPATOLOGY, V44, P983, DOI 10.1002/hep.21338; Klein J, 2004, J ENDOCRINOL, V183, P299, DOI 10.1677/joe.1.05646; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koketsu Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE719, DOI 10.1152/ajpendo.00253.2007; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Liu ZJ, 2007, HORM METAB RES, V39, P489, DOI 10.1055/s-2007-981680; Minakawa M, 2012, BIOCHEM BIOPH RES CO, V422, P469, DOI 10.1016/j.bbrc.2012.05.017; Minakawa M, 2011, J CLIN BIOCHEM NUTR, V48, P237, DOI 10.3164/jcbn.10-119; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Ohno T, 2012, CANCER LETT, V323, P215, DOI 10.1016/j.canlet.2012.04.015; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; POPP J A, 1989, Toxicologic Pathology, V17, P561; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Saito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070010; Sarafidis PA, 2007, J HUM HYPERTENS, V21, P709, DOI 10.1038/sj.jhh.1002201; Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892; Shimizu M, 2013, SEMIN IMMUNOPATHOL, V35, P191, DOI 10.1007/s00281-012-0336-6; Shimizu M, 2012, INT J MOL SCI, V13, P579, DOI 10.3390/ijms13010579; Shimizu M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-281; Shimizu M, 2011, CANCER PREV RES, V4, P396, DOI 10.1158/1940-6207.CAPR-10-0331; Shimizu M, 2011, CANCER PREV RES, V4, P128, DOI 10.1158/1940-6207.CAPR-10-0163; Shirakami Y, 2012, CARCINOGENESIS, V33, P268, DOI 10.1093/carcin/bgr275; Singh S, 2013, AM J GASTROENTEROL, V108, P881, DOI 10.1038/ajg.2013.5; Stumvoll M, 2007, ENDOCR RES, V32, P39, DOI 10.1080/07435800701743828; Tajima K, 2013, AM J PHYSIOL-ENDOC M, V305, pE987, DOI 10.1152/ajpendo.00133.2013; TORNKVIST A, 1994, J BIOL CHEM, V269, P13919; Toyama K, 2011, BIOCHEM BIOPH RES CO, V410, P508, DOI 10.1016/j.bbrc.2011.06.012; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Yan SQ, 2001, CANCER RES, V61, P5016; Yokoyama H, 2003, DIABETES CARE, V26, P2426, DOI 10.2337/diacare.26.8.2426; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	64	18	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124081	10.1371/journal.pone.0124081	http://dx.doi.org/10.1371/journal.pone.0124081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879666	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500082
J	Fischer, MJM; Soller, KJ; Sauer, SK; Kalucka, J; Veglia, G; Reeh, PW				Fischer, Michael J. M.; Soller, Kailey J.; Sauer, Susanne K.; Kalucka, Joanna; Veglia, Gianluigi; Reeh, Peter W.			Formalin Evokes Calcium Transients from the Endoplasmatic Reticulum	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; TRPA1; ACTIVATION; RECEPTOR; EXCITABILITY; CONTRIBUTES; NEURONS; COLD	The formalin test is the most widely used behavioral screening test for analgesic compounds. The cellular mechanism of action of formaldehyde, inducing a typically biphasic pain-related behavior in rodents is addressed in this study. The chemoreceptor channel TRPA1 was suggested as primary transducer, but the high concentrations used in the formalin test elicit a similar response in TRPA1 wildtype and knockout animals. Here we show that formaldehyde evokes a dose-dependent calcium release from intracellular stores in mouse sensory neurons and primary keratinocytes as well as in non-neuronal cell lines, and independent of TRPA1. The source of calcium is the endoplasmatic reticulum and inhibition of the sarco/endoplasmic reticulum calcium-ATPase has a major contribution. This TRPA1-independent mechanism may underlie formaldehyde-induced pan-neuronal excitation and subsequent inflammation.	[Fischer, Michael J. M.; Sauer, Susanne K.; Reeh, Peter W.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Soller, Kailey J.; Veglia, Gianluigi] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Kalucka, Joanna] Katholieke Univ Leuven, VIB Vesalius Res Ctr, Leuven, Belgium; [Veglia, Gianluigi] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	University of Erlangen Nuremberg; University of Minnesota System; University of Minnesota Twin Cities; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Minnesota System; University of Minnesota Twin Cities	Fischer, MJM (corresponding author), Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany.	fischer@physiologie1.uni-erlangen.de	Reeh, Peter W./J-8981-2012; Fischer, Michael J.M./P-8715-2014	Reeh, Peter W./0000-0002-4367-094X; Fischer, Michael J.M./0000-0002-3811-7066; Sauer, Susanne Katharina/0000-0002-9734-885X; Kalucka, Joanna/0000-0003-4887-7672	Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing; National Institutes of Health [GM 64742]; AHA [13PRE16950023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064742] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. GV is supported by National Institutes of Health GM 64742 and KS is supported by AHA 13PRE16950023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang S, 2007, EUR J NEUROSCI, V26, P2516, DOI 10.1111/j.1460-9568.2007.05882.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Dittert I, 1998, J NEUROSCI METH, V82, P195, DOI 10.1016/S0165-0270(98)00051-X; Drion G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041806; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Fischer M, 2014, PAIN, V155, P511, DOI 10.1016/j.pain.2013.11.015; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; Gover T D, 2009, Handb Exp Pharmacol, P563, DOI 10.1007/978-3-540-79090-7_16; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jain A, 2011, PAIN, V152, P2765, DOI 10.1016/j.pain.2011.08.025; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kalucka J, 2013, MOL CELL BIOL, V33, P3426, DOI 10.1128/MCB.00609-13; Kosugi M, 2007, J NEUROSCI, V27, P4443, DOI 10.1523/JNEUROSCI.0557-07.2007; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee B, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-5; Lirk P, 2008, ANESTH ANALG, V107, P673, DOI 10.1213/ane.0b013e31817b7a73; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; MADDEN TD, 1979, NATURE, V279, P538, DOI 10.1038/279538a0; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mizumoto N, 2003, J INVEST DERMATOL, V121, P1066, DOI 10.1046/j.1523-1747.2003.12558.x; Qin FZ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00084.2014; Radtke C, 2010, PAIN, V148, P94, DOI 10.1016/j.pain.2009.10.014; Raoux M, 2013, TOXICOL IN VITRO, V27, P402, DOI 10.1016/j.tiv.2012.08.010; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Roussel C, 2006, CELL CALCIUM, V39, P455, DOI 10.1016/j.ceca.2006.01.004; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748	34	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123762	10.1371/journal.pone.0123762	http://dx.doi.org/10.1371/journal.pone.0123762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875358	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800115
J	Kim, SJ; Kim, K; Park, SB; Hong, DJ; Jhun, BW				Kim, Se Jin; Kim, Kang; Park, Sung Bum; Hong, Duck Jin; Jhun, Byung Woo			Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; COMMUNITY-ACQUIRED PNEUMONIA; REAL-TIME PCR; IMMUNOCOMPETENT ADULTS; COMPUTATIONAL ANALYSIS; INFECTIONS	The benefits of treatment with antiviral therapy for severe adenovirus (AdV) pneumonia are not well established. We described the clinical characteristics and treatment outcomes of early cidofovir treatment of severe AdV pneumonia in non-immunocompromised patients. We retrospectively reviewed the medical records of all patients diagnosed with severe AdV pneumonia between 2012 and 2014. A total of seven non-immunocompromised patients with severe AdV pneumonia were identified, and all isolates typed (n = 6) were human AdV-B55. All patients had progressive respiratory failure with lobar consolidation with or without patchy ground glass opacity. Three patients required vasopressors and mechanical ventilation. All patients had abnormal laboratory findings including: leukopenia, thrombocytopenia, or elevated liver enzymes. After admission, all patients received antiviral therapy with cidofovir, and the median time from admission to cidofovir administration was 48 h and median the time from onset of symptoms to cidofovir administration was 7.1 days. After cidofovir administration, complete symptomatic improvement occurred after a median of 12 days and radiographic resolution occurred after a median of 21 days. Consequently, all patients completely improved without complications. Our data suggest that early administration of cidofovir in the course of treatment for respiratory failure as a result of AdV pneumonia in non-immunocompromised patients could be a treatment strategy worth considering, especially in cases of HAdV-55 infection.	[Kim, Se Jin; Kim, Kang; Park, Sung Bum; Jhun, Byung Woo] Armed Forces Capital Hosp, Dept Med, Div Pulm & Crit Care Med, Songnam, Gyeonggi Provin, South Korea; [Hong, Duck Jin] Armed Forces Capital Hosp, Dept Lab Med, Songnam, Gyeonggi Provin, South Korea		Jhun, BW (corresponding author), Armed Forces Capital Hosp, Dept Med, Div Pulm & Crit Care Med, Songnam, Gyeonggi Provin, South Korea.	byungwoo.jhun@gmail.com						Barker JH, 2003, CLIN INFECT DIS, V37, pE142, DOI 10.1086/379127; Brosch L, 2009, MIL MED, V174, P1295, DOI 10.7205/MILMED-D-03-0208; Cao B, 2014, CHEST, V145, P79, DOI 10.1378/chest.13-1186; Carballal Guadalupe, 2002, BMC Pediatr, V2, P6, DOI 10.1186/1471-2431-2-6; Claas ECJ, 2005, J CLIN MICROBIOL, V43, P1738, DOI 10.1128/JCM.43.4.1738-1744.2005; Clark Tristan W, 2011, J Med Case Rep, V5, P259, DOI 10.1186/1752-1947-5-259; Damen M, 2008, J CLIN MICROBIOL, V46, P3997, DOI 10.1128/JCM.00563-08; Doan ML, 2007, J HEART LUNG TRANSPL, V26, P883, DOI 10.1016/j.healun.2007.06.009; DUDDING BA, 1972, NEW ENGL J MED, V286, P1289, DOI 10.1056/NEJM197206152862403; Gregory SM, 2011, FUTURE VIROL, V6, P357, DOI 10.2217/FVL.11.6; Gu L, 2012, J CLIN VIROL, V54, P295, DOI 10.1016/j.jcv.2012.04.018; Hakim FA, 2008, EUR J CLIN MICROBIOL, V27, P153, DOI 10.1007/s10096-007-0416-z; Heo JY, 2014, EMERG INFECT DIS, V20, P875, DOI 10.3201/eid2005.131692; Hijikata N, 2012, J INFECT CHEMOTHER; Hindiyeh M, 2000, Semin Respir Infect, V15, P101; Jeon K, 2007, EUR J CLIN MICROBIOL, V26, P481, DOI 10.1007/s10096-007-0312-6; Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09; Klinger JR, 1998, AM J RESP CRIT CARE, V157, P645, DOI 10.1164/ajrccm.157.2.9608057; LEVIN S, 1967, J AMER MED ASSOC, V201, P975; Liu EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024491; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Matsushima Y, 2012, EMERG INFECT DIS, V18, P846, DOI 10.3201/eid1805.111584; Mayeur N, 2012, HEART LUNG, V41, P401, DOI 10.1016/j.hrtlng.2011.09.006; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Robinson CM, 2009, J VIROL, V83, P8980, DOI 10.1128/JVI.00786-09; Ryu JS, 2003, YONSEI MED J, V44, P732, DOI 10.3349/ymj.2003.44.4.732; Shiley KT, 2010, J THORAC IMAG, V25, P68, DOI 10.1097/RTI.0b013e3181b0ba8b; Simsir A, 1998, TRANSPLANTATION, V65, P592, DOI 10.1097/00007890-199802270-00027; Sun B, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0456-6; Trei JS, 2010, EMERG INFECT DIS, V16, P769, DOI 10.3201/eid1605.091633; Vento TJ, 2011, J INFECT DIS, V203, P1388, DOI 10.1093/infdis/jir040; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Yang ZH, 2009, J CLIN MICROBIOL, V47, P3082, DOI 10.1128/JCM.00282-09	35	33	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122642	10.1371/journal.pone.0122642	http://dx.doi.org/10.1371/journal.pone.0122642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875735	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800069
J	Sankaranarayanan, P; Schomay, TE; Aiello, KA; Alter, O				Sankaranarayanan, Preethi; Schomay, Theodore E.; Aiello, Katherine A.; Alter, Orly			Tensor GSVD of Patient- and Platform-Matched Tumor and Normal DNA Copy-Number Profiles Uncovers Chromosome Arm-Wide Patterns of Tumor-Exclusive Platform-Consistent Alterations Encoding for Cell Transformation and Predicting Ovarian Cancer Survival	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; PROGNOSTIC-FACTOR; EXPRESSION; APOPTOSIS; IDENTIFICATION; GLIOBLASTOMA; CHEMOTHERAPY; PROTEINS; SUBTYPE; TOOL	The number of large-scale high-dimensional datasets recording different aspects of a single disease is growing, accompanied by a need for frameworks that can create one coherent model from multiple tensors of matched columns, e.g., patients and platforms, but independent rows, e.g., probes. We define and prove the mathematical properties of a novel tensor generalized singular value decomposition (GSVD), which can simultaneously find the similarities and dissimilarities, i.e., patterns of varying relative significance, between any two such tensors. We demonstrate the tensor GSVD in comparative modeling of patient-and platform-matched but probe-independent ovarian serous cystadenocarcinoma (OV) tumor, mostly high-grade, and normal DNA copy-number profiles, across each chromosome arm, and combination of two arms, separately. The modeling uncovers previously unrecognized patterns of tumor-exclusive platform-consistent co-occurring copy-number alterations (CNAs). We find, first, and validate that each of the patterns across only 7p and Xq, and the combination of 6p+12p, is correlated with a patient's prognosis, is independent of the tumor's stage, the best predictor of OV survival to date, and together with stage makes a better predictor than stage alone. Second, these patterns include most known OV-associated CNAs that map to these chromosome arms, as well as several previously unreported, yet frequent focal CNAs. Third, differential mRNA, microRNA, and protein expression consistently map to the DNA CNAs. A coherent picture emerges for each pattern, suggesting roles for the CNAs in OV pathogenesis and personalized therapy. In 6p+12p, deletion of the p21-encoding CDKN1A and p38-encoding MAPK14 and amplification of RAD51AP1 and KRAS encode for human cell transformation, and are correlated with a cell's immortality, and a patient's shorter survival time. In 7p, RPA3 deletion and POLD2 amplification are correlated with DNA stability, and a longer survival. In Xq, PABPC5 deletion and BCAP31 amplification are correlated with a cellular immune response, and a longer survival.	[Sankaranarayanan, Preethi; Schomay, Theodore E.; Aiello, Katherine A.; Alter, Orly] Univ Utah, Sci Comp & Imaging SCI Inst, Salt Lake City, UT 84112 USA; [Sankaranarayanan, Preethi; Schomay, Theodore E.; Aiello, Katherine A.; Alter, Orly] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Alter, Orly] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Alter, O (corresponding author), Univ Utah, Sci Comp & Imaging SCI Inst, Salt Lake City, UT 84112 USA.	orly@sci.utah.edu		Alter, Orly/0000-0002-0418-1078	Utah Science, Technology, and Research (USTAR) Initiative; National Human Genome Research Institute (NHGRI) [HG-004302]; National Science Foundation (NSF) CAREER [DMS-0847173]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004302] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0847173] Funding Source: National Science Foundation	Utah Science, Technology, and Research (USTAR) Initiative; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the Utah Science, Technology, and Research (USTAR) Initiative, National Human Genome Research Institute (NHGRI) R01 Grant HG-004302 and National Science Foundation (NSF) CAREER Award DMS-0847173 (to OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed J, 2011, NUCLEIC ACIDS RES, V39, pD960, DOI 10.1093/nar/gkq910; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Anglesio MS, 2008, MOL CANCER RES, V6, P1678, DOI 10.1158/1541-7786.MCR-08-0193; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayhan A, 2009, AM J SURG PATHOL, V33, P1220, DOI 10.1097/PAS.0b013e3181a24354; BAI ZJ, 1993, SIAM J SCI COMPUT, V14, P1464, DOI 10.1137/0914085; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blanco P, 2001, GENOMICS, V74, P1, DOI 10.1006/geno.2001.6530; Bourdon V, 2002, CANCER RES, V62, P6218; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; COX DR, 1972, J R STAT SOC B, V34, P187; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; Duncan TJ, 2010, INT J GYNECOL PATHOL, V29, P8, DOI 10.1097/PGP.0b013e3181b64ec3; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Engler DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030996; Friedland S, 2005, SIAM J MATRIX ANAL A, V27, P434, DOI 10.1137/S0895479804439791; Golub G. H., 2012, MATRIX COMPUTATIONS; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harries M, 2002, LANCET ONCOL, V3, P529, DOI 10.1016/S1470-2045(02)00846-X; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horn R. A., 2012, MATRIX ANAL; Ikeda T, 2002, GENE, V298, P59, DOI 10.1016/S0378-1119(02)00927-7; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Kumar GR, 2011, MOL CELL BIOL, V31, P3113, DOI 10.1128/MCB.05402-11; Kwon YH, 2003, J BIOL CHEM, V278, P30348, DOI 10.1074/jbc.M300996200; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030098; Lee LA, 2005, DEV CELL, V8, P435, DOI 10.1016/j.devcel.2004.12.008; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; PAIGE CC, 1981, SIAM J NUMER ANAL, V18, P398, DOI 10.1137/0718026; Pellegrini Matteo, 2008, BMC Cancer, V8, P264, DOI 10.1186/1471-2407-8-264; Ponnapalli SP, 2006, RES WORKSH ALG MOD M; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Prisco MG, 2012, HUM PATHOL, V43, P282, DOI 10.1016/j.humpath.2011.05.002; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Sibley CR, 2012, NUCLEIC ACIDS RES, V40, P438, DOI 10.1093/nar/gkr722; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Vandewalle J., 2003, P ECCTD 03 EUR C CIR, P389; VANLOAN C, 1985, NUMER MATH, V46, P479, DOI 10.1007/BF01389653; VANLOAN CF, 1976, SIAM J NUMER ANAL, V13, P76, DOI 10.1137/0713009; WALDMAN T, 1995, CANCER RES, V55, P5187; Wiltshire RN, 2000, NEURO-ONCOLOGY, V2, P164, DOI 10.1093/neuonc/2.3.164; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020	61	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121396	10.1371/journal.pone.0121396	http://dx.doi.org/10.1371/journal.pone.0121396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875127	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800019
J	Saygin, ZM; Osher, DE; Koldewyn, K; Martin, RE; Finn, A; Saxe, R; Gabrieli, JDE; Sheridan, M				Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Martin, Rebecca E.; Finn, Amy; Saxe, Rebecca; Gabrieli, John D. E.; Sheridan, Margaret			Structural Connectivity of the Developing Human Amygdala	PLOS ONE			English	Article							PROBABILISTIC DIFFUSION TRACTOGRAPHY; STATE FUNCTIONAL CONNECTIVITY; INFANT RHESUS-MONKEYS; HUMAN CEREBRAL-CORTEX; HUMAN BRAIN; IN-VIVO; BASOLATERAL AMYGDALA; NEONATAL DEVELOPMENT; THALAMIC STRUCTURES; FACIAL EXPRESSIONS	A large corpus of research suggests that there are changes in the manner and degree to which the amygdala supports cognitive and emotional function across development. One possible basis for these developmental differences could be the maturation of amygdalar connections with the rest of the brain. Recent functional connectivity studies support this conclusion, but the structural connectivity of the developing amygdala and its different nuclei remains largely unstudied. We examined age related changes in the DWI connectivity fingerprints of the amygdala to the rest of the brain in 166 individuals of ages 5-30. We also developed a model to predict age based on individual-subject amygdala connectivity, and identified the connections that were most predictive of age. Finally, we segmented the amygdala into its four main nucleus groups, and examined the developmental changes in connectivity for each nucleus. We observed that with age, amygdalar connectivity becomes increasingly sparse and localized. Age related changes were largely localized to the subregions of the amygdala that are implicated in social inference and contextual memory (the basal and lateral nuclei). The central nucleus' connectivity also showed differences with age but these differences affected fewer target regions than the basal and lateral nuclei. The medial nucleus did not exhibit any age related changes. These findings demonstrate increasing specificity in the connectivity patterns of amygdalar nuclei across age.	[Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Martin, Rebecca E.; Finn, Amy; Saxe, Rebecca; Gabrieli, John D. E.; Sheridan, Margaret] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Osher, David E.] Boston Univ, Psychol & Brain Sci, Boston, MA 02215 USA; [Martin, Rebecca E.; Sheridan, Margaret] Boston Childrens Hosp, Labs Cognit Neurosci, Boston, MA USA; [Koldewyn, Kami] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	Massachusetts Institute of Technology (MIT); Boston University; Harvard University; Boston Children's Hospital; Bangor University	Saygin, ZM (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zsaygin@mit.edu	Saygin, Zeynep M./AAV-4951-2020; Koldewyn, Kami/Q-6108-2019; Gabrieli, John/AAJ-2869-2020	Koldewyn, Kami/0000-0003-3588-6449; Sheridan, Margaret/0000-0002-8909-7501	Robert Wood Johnson Health and Society Scholars Program; Ellison Medical Foundation; Simons Foundation; Simons Center for the Social Brain at MIT; Poitras Center for Affective Disorders Research	Robert Wood Johnson Health and Society Scholars Program(Robert Wood Johnson Foundation (RWJF)); Ellison Medical Foundation(Lawrence Ellison Foundation); Simons Foundation; Simons Center for the Social Brain at MIT; Poitras Center for Affective Disorders Research	This work was supported by funds from the Robert Wood Johnson Health and Society Scholars Program, the Ellison Medical Foundation, Simons Foundation and Simons Center for the Social Brain at MIT, and the Poitras Center for Affective Disorders Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Bach DR, 2011, J NEUROSCI, V31, P618, DOI 10.1523/JNEUROSCI.2744-10.2011; BACHEVALIER J, 1994, NEUROPSYCHOLOGIA, V32, P627, DOI 10.1016/0028-3932(94)90025-6; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bian XL, 2008, J NEUROPHYSIOL, V99, P77, DOI 10.1152/jn.00902.2007; Bouwmeester H, 2002, J COMP NEUROL, V450, P241, DOI 10.1002/cne.10321; Bouwmeester H, 2002, J COMP NEUROL, V442, P239, DOI 10.1002/cne.10084; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Chareyron LJ, 2012, J COMP NEUROL, V520, P3745, DOI 10.1002/cne.23132; Colby JB, 2011, NEUROIMAGE, V54, P25, DOI 10.1016/j.neuroimage.2010.08.014; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Freese J. L., 2009, HUMAN AMYGDALA, P3; Gee DG, 2013, P NATL ACAD SCI USA, V110, P15638, DOI 10.1073/pnas.1307893110; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gloor P, 1997, THE TEMPORAL LOBE AN; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Jbabdi S, 2014, IMAGING STRUCTURE FU, P585; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kalin NH, 2001, J NEUROSCI, V21, P2067, DOI 10.1523/JNEUROSCI.21-06-02067.2001; KALIN NH, 1991, CHILD DEV, V62, P1175, DOI 10.1111/j.1467-8624.1991.tb01598.x; Killgore WDS, 2006, NEUROREPORT, V17, P167, DOI 10.1097/01.wnr.0000198951.30939.73; Kirby E, 2012, MOL PSYCHIAT; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; LeDoux J, 1996, PROG BRAIN RES, V107, P437; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LEHMAN MN, 1980, SCIENCE, V210, P557, DOI 10.1126/science.7423209; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lonigan CJ, 2001, TEMPERAMENTAL INFLUE; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Malkova L, 2010, BEHAV NEUROSCI, V124, P742, DOI 10.1037/a0021622; Monk CS, 2003, NEUROIMAGE, V20, P420, DOI 10.1016/S1053-8119(03)00355-0; O'Leary D D, 1992, Curr Opin Neurobiol, V2, P70, DOI 10.1016/0959-4388(92)90165-H; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Pine DS, 2007, J CHILD PSYCHOL PSYC, V48, P631, DOI 10.1111/j.1469-7610.2007.01751.x; Prather MD, 2001, NEUROSCIENCE, V106, P653, DOI 10.1016/S0306-4522(01)00445-6; Qin S, 2012, PNAS; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; RODMAN HR, 1994, CEREB CORTEX, V4, P484, DOI 10.1093/cercor/4.5.484; Saygin ZM, 2011, NEUROIMAGE, V56, P1353, DOI 10.1016/j.neuroimage.2011.03.006; Scherf KS, 2013, HORM BEHAV, V64, P298, DOI 10.1016/j.yhbeh.2013.05.011; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shen K, 2012, J NEUROSCI, V32, P17465, DOI 10.1523/JNEUROSCI.2709-12.2012; Solano-Castiella E, 2010, NEUROIMAGE, V49, P2958, DOI 10.1016/j.neuroimage.2009.11.027; Sporns O, 2014, HUMAN CONNECTOME LIN, VSecond, P401; Swartz JR, 2014, NEUROIMAGE, V86, P212, DOI 10.1016/j.neuroimage.2013.08.018; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; THOMPSON CI, 1969, PHYSIOL BEHAV, V4, P249, DOI 10.1016/0031-9384(69)90088-2; Tomassini V, 2007, J NEUROSCI, V27, P10259, DOI 10.1523/JNEUROSCI.2144-07.2007; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Van Essen D. C., 2014, DIFFUSION MRI, P337, DOI DOI 10.1016/B978-0-12-396460-1.00016-0; Vapnik V.N., 1995, NATURE STAT LEARNING; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; WEBSTER MJ, 1991, J NEUROSCI, V11, P1095; Webster MJ, 1991, NEUROREPORT INT J RA; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	73	26	26	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0125170	10.1371/journal.pone.0125170	http://dx.doi.org/10.1371/journal.pone.0125170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875758	Green Published, gold			2022-12-26	WOS:000353015800156
J	Widmann, P; Reverter, A; Weikard, R; Suhre, K; Hammon, HM; Albrecht, E; Kuehn, C				Widmann, Philipp; Reverter, Antonio; Weikard, Rosemarie; Suhre, Karsten; Hammon, Harald M.; Albrecht, Elke; Kuehn, Christa			Systems Biology Analysis Merging Phenotype, Metabolomic and Genomic Data Identifies Non-SMC Condensin I Complex, Subunit G (NCAPG) and Cellular Maintenance Processes as Major Contributors to Genetic Variability in Bovine Feed Efficiency	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SINGLE NUCLEOTIDE POLYMORPHISMS; MILK-PRODUCTION TRAITS; BEEF-CATTLE; WIDE ASSOCIATION; GROWTH-RATE; POSITIONAL CANDIDATE; SEQUENCE VARIANTS; CHAROLAIS BULLS; REVEALS GENES	Feed efficiency is a paramount factor for livestock economy. Previous studies had indicated a substantial heritability of several feed efficiency traits. In our study, we investigated the genetic background of residual feed intake, a commonly used parameter of feed efficiency, in a cattle resource population generated from crossing dairy and beef cattle. Starting from a whole genome association analysis, we subsequently performed combined phenotype-metabolome-genome analysis taking a systems biology approach by inferring gene networks based on partial correlation and information theory approaches. Our data about biological processes enriched with genes from the feed efficiency network suggest that genetic variation in feed efficiency is driven by genetic modulation of basic processes relevant to general cellular functions. When looking at the predicted upstream regulators from the feed efficiency network, the Tumor Protein P53 (TP53) and Transforming Growth Factor beta 1 (TGFB1) genes stood out regarding significance of overlap and number of target molecules in the data set. These results further support the hypothesis that TP53 is a major upstream regulator for genetic variation of feed efficiency. Furthermore, our data revealed a significant effect of both, the Non-SMC Condensin I Complex, Subunit G (NCAPG) I442M (rs109570900) and the Growth /differentiation factor 8 (GDF8) Q204X (rs110344317) loci, on residual feed intake and feed conversion. For both loci, the growth promoting allele at the onset of puberty was associated with a negative, but favorable effect on residual feed intake. The elevated energy demand for increased growth triggered by the NCAPG 442M allele is obviously not fully compensated for by an increased efficiency in converting feed into body tissue. As a consequence, the individuals carrying the NCAPG 442M allele had an additional demand for energy uptake that is reflected by the association of the allele with increased daily energy intake as observed in our study.	[Widmann, Philipp; Weikard, Rosemarie; Kuehn, Christa] Leibniz Inst Farm Anim Biol, Inst Genome Biol, Genome Physiol Unit, Dummerstorf, Germany; [Hammon, Harald M.] Leibniz Inst Farm Anim Biol, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Albrecht, Elke] Leibniz Inst Farm Anim Biol, Inst Muscle Biol & Growth, Dummerstorf, Germany; [Reverter, Antonio] CSIRO Agr Flagship, Brisbane, Qld, Australia; [Suhre, Karsten] Weill Cornell Med Coll Qatar, Doha, Qatar; [Suhre, Karsten] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Kuehn, Christa] Univ Rostock, Fac Agr & Environm Sci, D-18055 Rostock, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Qatar Foundation (QF); Weill Cornell Medical College Qatar; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Rostock	Kuehn, C (corresponding author), Leibniz Inst Farm Anim Biol, Inst Genome Biol, Genome Physiol Unit, Dummerstorf, Germany.	kuehn@fbn-dummerstorf.de	Albrecht, Elke/ABB-6155-2021; Suhre, Karsten/AAF-1778-2020; Hammon, Harald/AAD-9990-2020; Reverter, Antonio/C-9699-2013	Albrecht, Elke/0000-0001-5974-1514; Suhre, Karsten/0000-0001-9638-3912; Reverter, Antonio/0000-0002-4681-9404; Kuehn, Christa/0000-0002-0216-424X	German Federal Ministry of Education and Research (BMBF) [FKZ 0313391C]; International Leibniz Graduate School on Functional Diversity in Farm Animals (ILGS DivA); 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar - Qatar Foundation	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); International Leibniz Graduate School on Functional Diversity in Farm Animals (ILGS DivA); 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar - Qatar Foundation	The work was supported by the German Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) within the scope of the FUGATO QUALIPID project (FKZ 0313391C). PW was supported by the International Leibniz Graduate School on Functional Diversity in Farm Animals (ILGS DivA, http://www.leibniz-gemeinschaft.de/). KS is supported by 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation (http://www.qf.org.qa/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer JA, 1997, J ANIM SCI, V75, P2024; Arthur PF, 2001, J ANIM SCI, V79, P2805; Arthur PF, 2001, LIVEST PROD SCI, V68, P131, DOI 10.1016/S0301-6226(00)00243-8; BARBER KA, 1975, J ANIM SCI, V40, P288, DOI 10.2527/jas1975.402288x; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Bottje W, 2013, J ANIM SCI, V91, P1582, DOI 10.2527/jas.2012-5787; Brody S, 1945, BIOENERGETICS AND GR; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Crews DH, 2005, GENET MOL RES, V4, P152; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Durunna ON, 2011, J ANIM SCI, V89, P158, DOI 10.2527/jas.2009-2514; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Ferrell RE, 1999, GENOMICS, V62, P203, DOI 10.1006/geno.1999.5984; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Herd RM, 2000, LIVEST PROD SCI, V63, P111, DOI 10.1016/S0301-6226(99)00122-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Karisa BK, 2013, J ANIM SCI, V91, P3502, DOI 10.2527/jas.2012-6170; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Kuhn C, 2002, ARCH TIERZUCHT, V45, P317; Lindholm-Perry AK, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-103; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009; Lu D, 2013, J ANIM SCI, V91, P3612, DOI 10.2527/jas.2012-5716; Moore SS, 2009, J ANIM SCI, V87, pE41, DOI 10.2527/jas.2008-1418; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Nkrumah JD, 2007, J ANIM SCI, V85, P2147, DOI 10.2527/jas.2006-764; Paternoster L, 2011, HUM MOL GENET, V20, P4069, DOI 10.1093/hmg/ddr309; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Raven LA, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-29; Reverter A, 2013, J ANIM SCI, V91, P530, DOI 10.2527/jas.2012-5780; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter Antonio, 2013, Methods Mol Biol, V1019, P437, DOI 10.1007/978-1-62703-447-0_20; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Serao NVL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078530; Serao NVL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-94; Setoguchi K, 2011, ANIM GENET, V42, P650, DOI 10.1111/j.1365-2052.2011.02196.x; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman EL, 2009, J ANIM SCI, V87, P37, DOI 10.2527/jas.2008-0876; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Suhre K, 2012, NAT REV GENET, V13, P759, DOI 10.1038/nrg3314; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Szabo G, 1998, MAMM GENOME, V9, P671, DOI 10.1007/s003359900843; Tetens J, 2013, ANIM GENET, V44, P467, DOI 10.1111/age.12031; Thaller G, 2003, J ANIM SCI, V81, P1911; Tozaki T, 2011, J VET MED SCI, V73, P1617, DOI 10.1292/jvms.11-0295; Turner S., QQMAN Q Q MANHATTAN; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weikard R, 2012, ANIM GENET, V43, P318, DOI 10.1111/j.1365-2052.2011.02258.x; Weikard R, 2010, PHYSIOL GENOMICS, V42A, P79, DOI 10.1152/physiolgenomics.00120.2010; Widmann P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-798; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799	66	28	30	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124574	10.1371/journal.pone.0124574	http://dx.doi.org/10.1371/journal.pone.0124574			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875852	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800144
J	Xu, CY; Zhu, SL; Xing, C; Li, DG; Zhu, NF; Zhou, HD				Xu, Changyan; Zhu, Sailing; Xing, Cheng; Li, Dagang; Zhu, Nanfeng; Zhou, Handong			Isolation and Properties of Cellulose Nanofibrils from Coconut Palm Petioles by Different Mechanical Process	PLOS ONE			English	Article							WHEAT-STRAW; EXTRACTION; FIBERS; NANOCRYSTALS; REINFORCEMENT; BEHAVIOR; RESIDUE	In this study, cellulose nanofibrils (CNFs) were successfully isolated from coconut palm petiole residues falling off naturally with chemical pretreatments and mechanical treatments by a grinder and a homogenizor. FTIR spectra analysis showed that most of hemicellulose and lignin were removed from the fiber after chemical pretreatments. The compositions of CNFS indicated that high purity of nanofibrils with cellulose contain more than 95% was obtained. X-ray diffractogram demonstrated that chemical pretreatments significantly increased the crystallinity of CNFs from 38.00% to 70.36%; however, 10-15 times of grinding operation followed by homogenizing treatment after the chemical pretreatments did not significantly improve the crystallinity of CNFs. On the contrary, further grinding operation could destroy crystalline regions of the cellulose. SEM image indicated that high quality of CNFs could be isolated from coconut palm petiole residues with chemical treatments in combination of 15 times of grinding followed by 10 times of homogenization and the aspect ratio of the obtained CNFs ranged from 320 to 640. The result of TGA-DTG revealed that the chemical-mechanical treatments improved thermal stability of fiber samples, and the CNFs with 15 grinding passing times had the best thermal stability. This work suggests that the CNFs can be successfully extracted from coconut palm petiole residues and it may be a potential feed-stock for nanofiber reinforced composites due to its high aspect ratio and crystallinity.	[Xu, Changyan; Zhu, Sailing; Li, Dagang; Zhu, Nanfeng; Zhou, Handong] Nanjing Forestry Univ, Packaging Engn Dept, Nanjing, Jiangsu, Peoples R China; [Xing, Cheng] Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA	Nanjing Forestry University; Michigan State University	Zhou, HD (corresponding author), Nanjing Forestry Univ, Packaging Engn Dept, Nanjing, Jiangsu, Peoples R China.	changyanxu1999@163.com		Zhu, Sailing/0000-0002-9197-5641; Xu, Changyan/0000-0003-4370-9784	Education Department of Jiangsu Province; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents; National Natural Science Foundation of China [31300483]; Natural Science Foundation of Jiangsu Province of China [BK20130971]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD);  [2013102980182]	Education Department of Jiangsu Province; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 	The project name is Fabrication of Functional packaging nano materials from Coconut Palm Petioles, and the Project No. is 2013102980182 (http://www.ec.js.edu.cn/art/2013/9/25/art-4266-131624.html). CYX received funding from the Education Department of Jiangsu Province. This work was also financially supported by "Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents", "National Natural Science Foundation of China (Grant No. 31300483)", "Natural Science Foundation of Jiangsu Province of China (Grant No. BK20130971)" and "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2009, CELLULOSE, V16, P1017, DOI 10.1007/s10570-009-9334-9; Abraham E, 2013, CARBOHYD POLYM, V92, P1477, DOI 10.1016/j.carbpol.2012.10.056; Alemdar A, 2008, BIORESOURCE TECHNOL, V99, P1664, DOI 10.1016/j.biortech.2007.04.029; Ashori A, 2006, POLYM-PLAST TECHNOL, V45, P131, DOI 10.1080/03602550500373782; Bhatnagar A, 2005, J REINF PLAST COMP, V24, P1259, DOI 10.1177/0731684405049864; Bledzki AK, 2010, COMPOS SCI TECHNOL, V70, P840, DOI 10.1016/j.compscitech.2010.01.022; Chirayil CJ, 2014, IND CROP PROD, V59, P27, DOI 10.1016/j.indcrop.2014.04.020; Dai DS, 2013, IND CROP PROD, V44, P192, DOI 10.1016/j.indcrop.2012.11.010; Fan YM, 2009, CARBOHYD POLYM, V77, P832, DOI 10.1016/j.carbpol.2009.03.008; Fengel D, 1984, WOOD CHEM ULTRASTRUC, V42, P314; Neto WPF, 2013, IND CROP PROD, V42, P480, DOI 10.1016/j.indcrop.2012.06.041; Hult EL, 2000, CELLULOSE, V7, P35, DOI 10.1023/A:1009236932134; Hult EL, 2001, POLYMER, V42, P3309, DOI 10.1016/S0032-3861(00)00774-6; Iwamoto S, 2007, APPL PHYS A-MATER, V89, P461, DOI 10.1007/s00339-007-4175-6; Johar N, 2012, IND CROP PROD, V37, P93, DOI 10.1016/j.indcrop.2011.12.016; Jonoobi M, 2012, IND CROP PROD, V40, P232, DOI 10.1016/j.indcrop.2012.03.018; Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078; Li Y, 2009, IND CROP PROD, V29, P420, DOI 10.1016/j.indcrop.2008.08.005; Lima MMD, 2004, MACROMOL RAPID COMM, V25, P771, DOI 10.1002/marc.200300268; Maheswari CU, 2012, BIOMASS BIOENERG, V46, P555, DOI 10.1016/j.biombioe.2012.06.039; Manfredi LB, 2006, POLYM DEGRAD STABIL, V91, P255, DOI 10.1016/j.polymdegradstab.2005.05.003; Costa LMM, 2013, IND CROP PROD, V41, P198, DOI 10.1016/j.indcrop.2012.04.025; Monteiro SN, 2008, POLYM TEST, V27, P591, DOI 10.1016/j.polymertesting.2008.03.003; Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9; Mwaikambo LY, 2006, J MATER SCI, V41, P2483, DOI 10.1007/s10853-006-5098-x; NGUYEN T, 1981, J MACROMOL SCI R M C, VC20, P1; Pasquini D, 2010, IND CROP PROD, V32, P486, DOI 10.1016/j.indcrop.2010.06.022; Ray D, 2002, J APPL POLYM SCI, V85, P2594, DOI 10.1002/app.10934; Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059; Sabri M, 2013, ADV MATER RES-SWITZ, V795, P313, DOI 10.4028/www.scientific.net/AMR.795.313; Sain M, 2006, IND CROP PROD, V23, P1, DOI 10.1016/j.indcrop.2005.01.006; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Silva GG, 2000, J APPL POLYM SCI, V76, P1197, DOI 10.1002/(SICI)1097-4628(20000516)76:7<1197::AID-APP23>3.0.CO;2-G; Silverio HA, 2013, IND CROP PROD, V44, P427, DOI 10.1016/j.indcrop.2012.10.014; Sun XF, 2005, CARBOHYD RES, V340, P97, DOI 10.1016/j.carres.2004.10.022; Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X; Zhu SL, 2014, PACKAGING ENG, V35, P10; Zobel B, 1996, TAPPI J, V49, P383	39	47	49	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122123	10.1371/journal.pone.0122123	http://dx.doi.org/10.1371/journal.pone.0122123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875280	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700012
J	Bussotti, S; Di Franco, A; Francour, P; Guidetti, P				Bussotti, Simona; Di Franco, Antonio; Francour, Patrice; Guidetti, Paolo			Fish Assemblages of Mediterranean Marine Caves	PLOS ONE			English	Article							DIDOGOBIUS-SPLECHTNAI; SOUTHERN APULIA; SUBMARINE CAVES; VISUAL CENSUS; ADRIATIC SEA; 1ST RECORDS; GOBIIDAE; PATTERNS; ECOLOGY	Fish assemblages associated with 14 marine caves and adjacent external rocky reefs were investigated at four Marine Protected Areas (MPAs) along the coasts of Italy. Within the caves sampling was carried out in different sub-habitats: walls, ceilings, bottoms and ends of caves. On the whole, 38 species were recorded inside the 14 caves investigated. Eighteen species were exclusively found inside the caves: they were mainly represented by speleophilic (i.e. species preferentially or exclusively inhabiting caves) gobids (e.g. Didogobius splechtnai) and nocturnal species (e.g. Conger conger). Forty-one species were censused outside, 20 of which were shared with cave habitats. Apogon imberbis was the most common fish found in all 14 caves investigated, followed by Thorogobius ephippiatus (recorded in 13 caves), and Diplodus vulgaris and Scorpaena notata (both censused in 12 caves). Distinct fish assemblages were found between external rocky reefs and the different cave subhabitats. New data on the distribution of some speleophilic gobids were collected, showing the existence of a pool of species shared by marine caves on a large scale (i.e. hundreds of km). Considering the uniqueness of cave fishes (18 exclusive species and different assemblage structures), the inclusion of marine caves among the habitats routinely investigated for fish biodiversity monitoring could facilitate the achievement of more comprehensive inventories. Due to their contribution to local species diversity and the shelter they provide to species valuable for conservation, marine caves should be prioritized for their inclusion not only within future MPAs through the Mediterranean Sea, but also into larger management spatial planning.	[Bussotti, Simona; Di Franco, Antonio; Francour, Patrice; Guidetti, Paolo] Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France; [Bussotti, Simona; Di Franco, Antonio; Guidetti, Paolo] CoNISMa Natl Interuniv Consortium Marine Sci, Rome, Italy	UDICE-French Research Universities; Universite Cote d'Azur; CoNISMa	Bussotti, S (corresponding author), Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France.	simonabussotti@libero.it	Di Franco, Antonio/A-8796-2010	Di Franco, Antonio/0000-0003-3411-7015; Guidetti, Paolo/0000-0002-7983-8775	'Ministero dell'Ambiente e della Tutela del Territorio e del Mare' (Italy) [codice Habitat 8330]; TOTAL Foundation (France)	'Ministero dell'Ambiente e della Tutela del Territorio e del Mare' (Italy); TOTAL Foundation (France)	The study was funded by the 'Ministero dell'Ambiente e della Tutela del Territorio e del Mare' (Italy) in the framework of the project 'Studio degli ambienti di grotte marine sommerse (codice Habitat 8330) nelle Aree Marine Protette di Pelagie, Plemmirio e Capo Caccia' and by TOTAL Foundation (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Malak D., 2011, OVERVIEW CONSERVATIO; Abdulla A., 2008, STATUS MARINE PROTEC; Abel E. F., 1959, Pubblicazioni della Stazione Zoologica di Napoli Suppl, V30, P519; Ahnelt H., 2004, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V105B, P5; Ahnelt H, 1998, CYBIUM, V22, P183; Ahnelt H., 1996, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V98, P529; Ahnelt Harald, 1994, Cybium, V18, P169; Anderson M.J., 2008, GUIDE SOFTWARE STAT; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arko-Pijevac Milvana, 2001, Natura Croatica, V10, P163; Azzurro E, 2007, MAR BIOL, V151, P2245, DOI 10.1007/s00227-007-0661-9; Azzurro E, 2015, BIOL INVASIONS, V17, P815, DOI 10.1007/s10530-014-0836-5; Ballesteros E, 2007, PARQUE NACL ARCHIPIE, P140; BIANCHI CN, 1996, B MUS I BIOL U GEN, V60, P41; Bilecenoglu Murat, 1999, Zoology in the Middle East, V17, P67; BORI C, 1985, Miscellania Zoologica (Barcelona), V9, P401; Bussotti S, 2003, ITAL J ZOOL, V70, P153, DOI 10.1080/11250000309356509; Bussotti S, 2009, ESTUAR COAST SHELF S, V81, P65, DOI 10.1016/j.ecss.2008.09.023; Bussotti S, 2002, MAR ECOL-P S Z N I, V23, P11, DOI 10.1111/j.1439-0485.2002.tb00004.x; Bussotti S, 2006, MAR ECOL PROG SER, V325, P109, DOI 10.3354/meps325109; Cicogna F., 2003, GROTTE MARINE CINQUA; Connell JH, 1961, ECOLOGY, V42, P315; CONNELL SD, 1991, J EXP MAR BIOL ECOL, V151, P271, DOI 10.1016/0022-0981(91)90129-K; Di Franco A, 2010, ICES J MAR SCI, V67, P871, DOI 10.1093/icesjms/fsq007; Ferrari G, 2005, THAL SAL S, V29, P117; Francour Patrice, 2007, Rapport du Congress de la CIESM, V38, P478; Francour P, 2008, ACTA ICHTHYOL PISCAT, V38, P139, DOI 10.3750/AIP2008.38.2.09; Gerovasileiou V, 2013, MAR ECOL PROG SER, V486, P13, DOI 10.3354/meps10374; Gerovasileiou V., 2014, P 1 MED S CONS DARK, P45; Gerovasileiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039873; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Giangrande A, 2004, BIODIVERS CONSERV, V13, P1633, DOI 10.1023/B:BIOC.0000029327.63397.6b; Gorley C.K., 2006, GETTING STARTED PRIM; Guarnieri G, 2012, MAR BIOL, V159, P1155, DOI 10.1007/s00227-012-1895-8; Guidetti P, 2000, ESTUAR COAST SHELF S, V50, P515, DOI 10.1006/ecss.1999.0584; Guidetti P, 2014, VIE MILIEU, V64, P1; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti Paolo, 2006, Thalassia Salentina, V29, P41; HARMELIN JG, 1985, TETHYS, V11, P214; Harmelin JG, 2003, SCI REP PORT CROS NA, V19, P117; HARMELIN-VIVIEN M L, 1985, Revue d'Ecologie la Terre et la Vie, V40, P467; Herler J, 1999, MAR ECOL-P S Z N I, V20, P49, DOI 10.1046/j.1439-0485.1999.00062.x; Herler J, 2002, CYBIUM, V26, P153; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; KOTRSCHAL K, 1983, PUBBLICAZIONI STAZIO, V4, P275; Kovacic M, 1999, NAT CROAT, V6, P1; Kovacic Marcelo, 1997, Natura Croatica, V6, P423; La Mesa G, 2013, ITAL J ZOOL, V80, P90, DOI 10.1080/11250003.2012.686523; Leonardi R., 1994, B SEDUTE ACCADEMIA G, V27, P599; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Muths D, 2015, J SEA RES, V95, P70, DOI 10.1016/j.seares.2014.10.009; Oertel A, 2007, MAR ECOL-EVOL PERSP, V28, P60, DOI 10.1111/j.1439-0485.2007.00169.x; Otero M., 2013, MONITORING MARINE IN; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Patzner RA, 1999, ENVIRON BIOL FISH, V55, P207, DOI 10.1023/A:1007535808710; RIEDL R, 1966, BIOL MEERESHOHLEN; Scsepka Sonja, 1999, Senckenbergiana Biologica, V79, P71; Stefanni S, 1999, CYBIUM, V23, P105; Suric M, 2010, ENVIRON EARTH SCI, V61, P1473, DOI 10.1007/s12665-010-0463-0; Todaro MA, 2006, MAR BIOL, V149, P1079, DOI 10.1007/s00227-006-0299-z; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, P524; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721; Zander C.D., 1990, MEMORIES BIOSPEOLOGI, V17, P17	64	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122632	10.1371/journal.pone.0122632	http://dx.doi.org/10.1371/journal.pone.0122632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875504	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100089
J	Gao, Y; Su, QD; Yi, Y; Jia, ZY; Wang, H; Lu, XX; Qiu, F; Bi, SL				Gao, Yan; Su, Qiudong; Yi, Yao; Jia, Zhiyuan; Wang, Hao; Lu, Xuexin; Qiu, Feng; Bi, Shengli			Enhanced Mucosal Immune Responses Induced by a Combined Candidate Mucosal Vaccine Based on Hepatitis A Virus and Hepatitis E Virus Structural Proteins Linked to Tuftsin	PLOS ONE			English	Article							B VACCINE; IMMUNOGENICITY; EXPRESSION; OLIGODEOXYNUCLEOTIDE	Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are the most common causes of infectious hepatitis. These viruses are spread largely by the fecal-oral route and lead to clinically important disease in developing countries. To evaluate the potential of targeting hepatitis A and E infection simultaneously, a combined mucosal candidate vaccine was developed with the partial open reading frame 2 (ORF2) sequence (aa 368-607) of HEV (HE-ORF2) and partial virus protein 1 (VP1) sequence (aa 1-198) of HAV (HA-VP1), which included the viral neutralization epitopes. Tuftsin is an immunostimulatory peptide which can enhance the immunogenicity of a protein by targeting it to macrophages and dendritic cells. Here, we developed a novel combined protein vaccine by conjugating tuftsin to HE-ORF2 and HA-VP1 and used synthetic CpG oligodeoxynucleotides (ODNs) as the adjuvant. Subsequent experiments in BALB/c mice demonstrated that tuftsin enhanced the serum-specific IgG and IgA antibodies against HEV and HAV at the intestinal, vaginal and pulmonary interface when delivered intranasally. Moreover, mice from the intranasally immunized tuftsin group (HE-ORF2-tuftsin + HA-VP1-tuftsin + CpG) showed higher levels of IFN-gamma-secreting splenocytes (Th1 response) and ratio of CD4(+)/CD8(+) T cells than those of the no-tuftsin group (HE-ORF2 + HA-VP1 + CpG). Thus, the tuftsin group generated stronger humoral and cellular immune responses compared with the no-tuftsin group. Moreover, enhanced responses to the combined protein vaccine were obtained by intranasal immunization compared with intramuscular injection. By integrating HE-ORF2, HA-VP1 and tuftsin in a vaccine, this study validated an important concept for further development of a combined mucosal vaccine against hepatitis A and E infection.	[Gao, Yan; Su, Qiudong; Yi, Yao; Jia, Zhiyuan; Wang, Hao; Lu, Xuexin; Qiu, Feng; Bi, Shengli] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Bi, SL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	shengli_bi@163.com		Wang, Hao/0000-0001-9425-4666; Bi, Shengli/0000-0002-0380-5790	Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention [2012ZX10002-001]	Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention	This study was supported by a grant from the Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention (2012ZX10002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2008, HEPATOL INT, V2, P308, DOI 10.1007/s12072-008-9071-4; Beloeil L, 2003, J IMMUNOL, V171, P2995, DOI 10.4049/jimmunol.171.6.2995; CANTOR H, 1976, COLD SPRING HARB SYM, V41, P23; Demicheli V, 2003, VACCINE, V21, P2242, DOI 10.1016/S0264-410X(03)00135-X; Du L N, 1998, Sheng Li Xue Bao, V50, P636; Fujihashi K, 2004, MECH AGEING DEV, V125, P889, DOI 10.1016/j.mad.2004.05.009; Gokulan K, 1999, DNA CELL BIOL, V18, P623, DOI 10.1089/104454999315033; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Kim Sae-Hae, 2012, Immune Netw, V12, P165, DOI 10.4110/in.2012.12.5.165; Kolomin T, 2014, MOL IMMUNOL, V58, P50, DOI 10.1016/j.molimm.2013.11.002; Kui X, 2009, VIRAL IMMUNOL, V22, P49, DOI 10.1089/vim.2008.0068; Lee JM, 2009, BIOTECHNOL APPL BIOC, V53, P101, DOI 10.1042/BA20080019; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Liu XY, 2012, VACCINE, V30, P6527, DOI 10.1016/j.vaccine.2012.08.054; Mezo G, 2004, BIOPOLYMERS, V73, P645, DOI 10.1002/bip.20024; MILLER MJ, 1993, CLIN INFECT DIS, V16, P612, DOI 10.1093/clind/16.5.612; Mitchell LA, 2006, VACCINE, V24, P5300, DOI 10.1016/j.vaccine.2006.04.015; NISHIOKA K, 1973, BIOCHIM BIOPHYS ACTA, V310, P230, DOI 10.1016/0005-2795(73)90025-1; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; PING LH, 1992, J VIROL, V66, P2208, DOI 10.1128/JVI.66.4.2208-2216.1992; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Roberton D, 2005, VACCINE, V23, P5099, DOI 10.1016/j.vaccine.2005.06.003; Lay LDLAR, 2008, J MED VIROL, V80, P798, DOI 10.1002/jmv.21147; Siemion IZ, 1999, PEPTIDES, V20, P645, DOI 10.1016/S0196-9781(99)00019-4; STAPLETON JT, 1991, J INFECT DIS, V163, P7, DOI 10.1093/infdis/163.1.7; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Torrieri-Dramard L, 2011, MOL THER, V19, P602, DOI 10.1038/mt.2010.222; Warren TL, 2000, J IMMUNOL, V165, P6244, DOI 10.4049/jimmunol.165.11.6244; Wolters B, 2003, VACCINE, V21, P3623, DOI 10.1016/S0264-410X(03)00399-2; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	30	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123400	10.1371/journal.pone.0123400	http://dx.doi.org/10.1371/journal.pone.0123400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875115	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100174
J	Goonesekera, SD; Fang, SC; Piccolo, RS; Florez, JC; McKinlay, JB				Goonesekera, Sunali D.; Fang, Shona C.; Piccolo, Rebecca S.; Florez, Jose C.; McKinlay, John B.			Biogeographic Ancestry Is Associated with Higher Total Body Adiposity among African-American Females: The Boston Area Community Health Survey	PLOS ONE			English	Article							GENETIC ADMIXTURE; BACH SURVEY; SOCIOECONOMIC-STATUS; DIABETES-MELLITUS; OBESITY; WOMEN; RISK; DISPARITIES; BMI	Objectives The prevalence of obesity is disproportionately higher among African-Americans and Hispanics as compared to whites. We investigated the role of biogeographic ancestry (BGA) on adiposity and changes in adiposity in the Boston Area Community Health Survey. Methods We evaluated associations between BGA, assessed via Ancestry Informative Markers, and adiposity (body mass index (BMI), percent body fat (PBF), and waist-to-hip ratio (WHR)) and changes in adiposity over 7 years for BMI and WHR and 2.5 years for PBF, per 10% greater proportion of BGA using multivariable linear regression. We also examined effect-modification by demographic and socio-behavioral variables. Results We observed positive associations between West-African ancestry and cross-sectional BMI (percent difference=0.62%; 95% CI: 0.04%, 1.20%), and PBF (beta=0.35; 95% CI: 0.11, 0.58). We also observed significant effect-modification of the association between West-African ancestry and BMI by gender (p-interaction: <0.002) with a substantially greater association in women. We observed no main associations between Native-American ancestry and adiposity but observed significant effect-modification of the association with BMI by diet (p-interaction: <0.003) with inverse associations among participants with higher Healthy Eating Scores. No associations were observed between BGA and changes in adiposity over time. Conclusion Findings support that West-African ancestry may contribute to high prevalence of total body adiposity among African-Americans, particularly African-American women.	[Goonesekera, Sunali D.; Fang, Shona C.; Piccolo, Rebecca S.; McKinlay, John B.] New England Res Inst, Dept Epidemiol & Biostat, Watertown, MA 02472 USA; [Fang, Shona C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Diabet Unit, Boston, MA 02114 USA	HealthCore, Inc; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Goonesekera, SD (corresponding author), New England Res Inst, Dept Epidemiol & Biostat, 480 Pleasant St, Watertown, MA 02472 USA.	sgoonesekera@neriscience.com			National Institute of Diabetes and Digestive and Kidney Diseases [DK056842, DK080786]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080786, R01DK056842, U01DK056842] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by awards DK056842 and DK080786 from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, AM HEART ASS DIET LI; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; BUUREN S, 2011, J STAT SOFTW, V45, P1, DOI DOI 10.18637/JSS.V045.I03; Cardel M, 2011, INT J OBESITY, V35, P60, DOI 10.1038/ijo.2010.203; Centers for Disease Control and Prevention, HLTH EFF OV OB; Cheng CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032840; Cheng CY, 2010, OBESITY, V18, P563, DOI 10.1038/oby.2009.282; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Fernandez JR, 2013, HUM HERED, V75, P98, DOI 10.1159/000353180; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Flegal KM, 2010, AM J CLIN NUTR, V91, P1020, DOI 10.3945/ajcn.2009.28589; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; Lins TC, 2012, GENET MOL BIOL, V35, P575, DOI 10.1590/S1415-47572012005000047; McDermott R, 1998, SOC SCI MED, V47, P1189, DOI 10.1016/S0277-9536(98)00191-9; McKinlay JB, 2007, EUR UROL, V52, P389, DOI 10.1016/j.eururo.2007.03.013; Nassir R, 2012, INT J OBESITY, V36, P304, DOI 10.1038/ijo.2011.84; NEEL JV, 1962, AM J HUM GENET, V14, P353; Norden-Krichmar TM, 2014, AM J HUM BIOL, V26, P347, DOI 10.1002/ajhb.22521; Oka M, 2011, PUBLIC HEALTH REP, V126, P700, DOI 10.1177/003335491112600512; Piccolo RS, 2014, ANN EPIDEMIOL, V24, P648, DOI 10.1016/j.annepidem.2014.06.098; Piccolo RS, 2014, INT J EPIDEMIOL, V43, P42, DOI 10.1093/ije/dys198; Qi L, 2012, DIABETOLOGIA, V55, P1329, DOI 10.1007/s00125-012-2486-4; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Speakman JR, 2008, INT J OBESITY, V32, P1611, DOI 10.1038/ijo.2008.161; Stanfield KM, 2012, INT J EPIDEMIOL, V41, P1409, DOI 10.1093/ije/dys139; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; U.S. Department of Agriculture & U.S. Department of Health and Human Services, DIET GUID AM 2010; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130; Ziv E, 2006, CANCER EPIDEM BIOMAR, V15, P1878, DOI 10.1158/1055-9965.EPI-06-0092	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122808	10.1371/journal.pone.0122808	http://dx.doi.org/10.1371/journal.pone.0122808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875902	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100104
J	Guaraldi, G; Zona, S; Brothers, TD; Carli, F; Stentarelli, C; Dolci, G; Santoro, A; Beghetto, B; Menozzi, M; Mussini, C; Falutz, J				Guaraldi, Giovanni; Zona, Stefano; Brothers, Thomas D.; Carli, Federica; Stentarelli, Chiara; Dolci, Giovanni; Santoro, Antonella; Beghetto, Barbara; Menozzi, Marianna; Mussini, Cristina; Falutz, Julian			Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles	PLOS ONE			English	Article							IMPROVEMENT GROUP INTERVENTION; INFECTED PERSONS; LIFE EXPECTANCY; ADULTS; PREVALENCE; PEOPLE; RISK; MEN; ERA	Objective People aging with HIV might have different health conditions compared with people who seroconverted at older ages. The study objective was to assess the prevalence of, and risk factors for, individual co-morbidities and multimorbidity (MM) between HIV-positive patients with a longer duration of HIV infection, and patients who seroconverted at an older age. We compared estimates across both groups to a matched community-based cohort sampled from the general population. Methods We performed a case-control study including antiretroviral therapy (ART)-experienced patients who were HIV seropositive for >= 20.6 years ("HIV-Aging"), or who were seropositive for < 11.3 years ("HIV-Aged") having access in 2013 at the Modena HIV Metabolic Clinic. Patients were matched in a 1:3 ratio with controls from the CINECA ARNO database. MM was defined as the concurrent presence of >2 NICM. Logistic regression models were constructed to evaluate associated predictors of NICM and MM. Results We analysed 404 HIV-Aging and 404 HIV-Aged participants in comparison to 2424 controls. The mean age was 46.7 +/- 6.2 years, 28.9% were women. Prevalence of HIV co-morbidities and MM were significantly higher in the HIV-positive groups compared to the general population (p<0.001) and a trend towards higher rates of MM was found in aging vs aged group. This difference turned to be significant in patients above the age of 45 years old (p<0.001). Conclusions People aging with HIV display heterogeneous health conditions. Host factors and duration of HIV infection are associated with increased risk of MM compared to the general population.	[Guaraldi, Giovanni; Zona, Stefano; Carli, Federica; Stentarelli, Chiara; Dolci, Giovanni; Santoro, Antonella; Beghetto, Barbara; Menozzi, Marianna; Mussini, Cristina] Univ Modena & Reggio Emilia, Modena, Italy; [Brothers, Thomas D.] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Falutz, Julian] McGill Univ, Ctr Hlth, Montreal, PQ, Canada	Universita di Modena e Reggio Emilia; Dalhousie University; McGill University	Guaraldi, G (corresponding author), Univ Modena & Reggio Emilia, Modena, Italy.	g.guaraldi@unimo.it	Guaraldi, Giovanni/J-9467-2018; Mussini, Cristina/K-8672-2016; Brothers, Thomas/ABH-5700-2020	Mussini, Cristina/0000-0002-6615-4198; Brothers, Thomas/0000-0002-5570-5556; Guaraldi, Giovanni/0000-0002-5724-3914; Dolci, Giovanni/0000-0001-9948-652X; Zona, Stefano/0000-0003-3451-2744; Santoro, Antonella/0000-0002-2345-9135	Canadian Institutes of Health Research Summer Research Studentship; European Union [305522]	Canadian Institutes of Health Research Summer Research Studentship(Canadian Institutes of Health Research (CIHR)); European Union(European Commission)	Thomas Brothers was supported by Canadian Institutes of Health Research Summer Research Studentship. Giovanni Guaraldi was partially supported by 'Co-morbidity in relation to AIDS' grant agreement (305522), European Union Seventh Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2014, J GERONTOL A-BIOL, V69, P189, DOI 10.1093/gerona/glt148; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Centers for Disease Control and Prevention (CDC), 2008, HIV AIDS PERS AG 50; Chambers LA, 2014, AIDS BEHAV, V18, P661, DOI 10.1007/s10461-013-0627-5; Cooperman NA, 2007, AIDS EDUC PREV, V19, P321, DOI 10.1521/aeap.2007.19.4.321; Greene M, 2013, JAMA-J AM MED ASSOC, V309, P1397, DOI 10.1001/jama.2013.2963; Guaraldi G, 2006, HIV CLIN TRIALS, V7, P97, DOI 10.1310/EYWJ-8B5K-X7VQ-9CPE; Guaraldi G, 2013, CLINICOECONOMIC OUTC, V5, P481, DOI 10.2147/CEOR.S40607; Guaraldi G, 2014, JAIDS-J ACQ IMM DEF, V65, P175, DOI 10.1097/QAI.0000000000000018; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Heckman TG, 2001, AIDS CARE, V13, P129, DOI 10.1080/09540120020018233; Heckman TG, 2006, ANN BEHAV MED, V32, P27, DOI 10.1207/s15324796abm3201_4; Heckman TG, 2011, J BEHAV MED, V34, P102, DOI 10.1007/s10865-010-9292-6; Krentz HB, 2015, HIV MED, V16, P38, DOI 10.1111/hiv.12176; Lazarus JV, 2010, HIV MED, V11, P479, DOI 10.1111/j.1468-1293.2009.00810.x; Levett T, 2014, REV CLIN GERONTOL, V24, P10, DOI 10.1017/S0959259813000208; Mahy M, 2014, AIDS, V28, pS453, DOI 10.1097/QAD.0000000000000479; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mutevedzi PC, 2011, FUTURE VIROL, V6, P755, DOI 10.2217/FVL.11.43; Neundorfer M. M., 2004, Journal of HIV/AIDS & Social Services, V3, P79, DOI 10.1300/J187v03n01_07; Onen NF, 2010, HIV CLIN TRIALS, V11, P100, DOI 10.1310/hct1102-100; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701	24	67	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118531	10.1371/journal.pone.0118531	http://dx.doi.org/10.1371/journal.pone.0118531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874806	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100008
J	Lee, MJ; Chen, CJ; Lee, KT; Shi, HY				Lee, Ming-Jang; Chen, Chao-Ju; Lee, King-Teh; Shi, Hon-Yi			Trend Analysis and Outcome Prediction in Mechanically Ventilated Patients: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE	Objective To investigate the relationship between changes in patient attributes and hospital attributes over time and to explore predictors of medical utilization and mortality rates in mechanical ventilation (MV) patients in Taiwan. Background Providing effective medical care for MV patients is challenging and requires good planning and effective clinical decision making policies. Most studies of MV, however, have only analyzed a single regional ventilator weaning center or respiratory care unit, high-quality population-based studies of MV trends and outcomes are scarce. Methods This population-based cohort study retrospectively analyzed 213,945 MV patients treated during 2004-2009. Results During the study period, the percentages of MV patients with the following characteristics significantly increased: age. 65 years, treatment at a medical center, and treatment by a high-volume physician. In contrast, the percentages of MV patients treated at local hospitals and by low-volume physicians significantly decreased (P<0.001). Age, gender, Deyo-Charlson co-morbidity index, teaching hospital, hospital level, hospital volume, and physician volume were significantly associated with MV outcome (P<0.001). Over the 6-year period analyzed in this study, the estimated mean hospital treatment cost increased 48.8% whereas mean length of stay decreased 13.9%. The estimated mean overall survival time for MV patients was 16.4 months (SD 0.4 months), and the overall in-hospital 1-, 3-, and 5year survival rates were 61.0%, 36.7%, 17.3%, and 9.6%, respectively. Conclusions These population-based data revealed increases in the percentages of MV patients treated at medical centers and by high-volume physicians, especially in younger patients. Notably, although LOS for MV patients decreased, hospital treatment costs increased. Healthcare providers and patients should recognize that attributes of both the patient and the hospital may affect outcomes.	[Lee, Ming-Jang] Madou Sin Lau Hosp, Dept Internal Med, Tainan, Taiwan; [Chen, Chao-Ju] Madou Sin Lau Hosp, Dept Resp Therepy, Tainan, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Div Hepatobiliary Pancreat Surg, Kaohsiung, Taiwan; [Lee, King-Teh; Shi, Hon-Yi] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Shi, HY (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	hshi@kmu.edu.tw						Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Batzlaff CM, 2014, MAYO CLIN PROC, V89, P638, DOI 10.1016/j.mayocp.2013.12.004; Brown J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053622; Chao CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050675; Chen CJ, 2013, AM J CRIT CARE, V22, P506, DOI 10.4037/ajcc2013950; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Fieselmann JF, 1999, CRIT CARE, V3, P23, DOI 10.1186/cc303; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hung TC, 2013, RESP CARE, V58, P669, DOI 10.4187/respcare.01519; Ko HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083298; Lai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073743; Leyenaar JK, 2014, JAMA PEDIATR, V168, P829, DOI 10.1001/jamapediatrics.2014.339; Limsuwat C, 2014, QUAL MANAG HEALTH CA, V23, P86, DOI 10.1097/QMH.0000000000000024; Livingston EH, 2010, JAMA-J AM MED ASSOC, V304, P95, DOI 10.1001/jama.2010.905; McMullen SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040190; O'Connor H, 2014, J INTENSIVE CARE MED, V29, P218, DOI 10.1177/0885066613486738; Reineck LA, 2014, CRIT CARE MED, V42, P1055, DOI 10.1097/CCM.0000000000000132; Rolston JD, 2014, J NEUROSURG, V120, P736, DOI 10.3171/2013.10.JNS122419; Wunsch H, 2010, CRIT CARE MED, V38, P1947, DOI 10.1097/CCM.0b013e3181ef4460	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122618	10.1371/journal.pone.0122618	http://dx.doi.org/10.1371/journal.pone.0122618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875442	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100088
J	Vukic, M; Neme, A; Seuter, S; Saksa, N; de Mello, VDF; Nurmi, T; Uusitupa, M; Tuomainen, TP; Virtanen, JK; Carlberg, C				Vukic, Maja; Neme, Antonio; Seuter, Sabine; Saksa, Noora; de Mello, Vanessa D. F.; Nurmi, Tarja; Uusitupa, Matti; Tuomainen, Tomi-Pekka; Virtanen, Jyrki K.; Carlberg, Carsten			Relevance of Vitamin D Receptor Target Genes for Monitoring the Vitamin D Responsiveness of Primary Human Cells	PLOS ONE			English	Article							25-HYDROXYVITAMIN-D; D-3	Vitamin D-3 has transcriptome- and genome-wide effects and activates, via the binding of its metabolite 1 alpha, 25-dihydroxyvitamin D-3 to the transcription factor vitamin D receptor (VDR), several hundred target genes. Using samples from a 5-month vitamin D-3 intervention study (VitDmet), we recently reported that the expression of 12 VDR target genes in peripheral blood mononuclear cells (PBMCs) as well as 12 biochemical and clinical parameters of the study participants are significantly triggered by vitamin D-3. In this study, we performed a more focused selection of further 12 VDR target genes and demonstrated that changes of their mRNA expression in PBMCs of VitDmet subjects significantly correlate with alterations of 25-hydroxyvitamin D-3 serum levels. Network and self-organizing map analysis of these datasets together with that of the other 24 parameters was followed by relevance calculations and identified changes in parathyroid hormone serum levels and the expression of the newly selected genes STS, BCL6, ITGAM, LRRC25, LPGAT1 and TREM1 as well as of the previously reported genes DUSP10 and CD14 as the most relevant parameters for describing vitamin D responsiveness in vivo. Moreover, parameter relevance ranking allowed the segregation of study subjects into high and low responders. Due to the long intervention period the vitamin D response was not too prominent on the level of transcriptional activation. Therefore, we performed in the separate VitDbol trial a short-term but high dose stimulation with a vitamin D-3 bolus. In PBMCs of VitDbol subjects we observed direct transcriptional effects on the selected VDR target genes, such as an up to 2.1-fold increase already one day after supplementation onset. In conclusion, both long-term and short-term vitamin D-3 supplementation studies allow monitoring the vitamin D responsiveness of human individuals and represent new types of human in vivo vitamin D-3 investigations.	[Vukic, Maja; Neme, Antonio; Seuter, Sabine; Saksa, Noora; Carlberg, Carsten] Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland; [de Mello, Vanessa D. F.; Nurmi, Tarja; Uusitupa, Matti; Tuomainen, Tomi-Pekka; Virtanen, Jyrki K.] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Carlberg, C (corresponding author), Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland.	carsten.carlberg@uef.fi	Carlberg, Carsten/C-9075-2011; Virtanen, Jyrki/G-5149-2013; Virtanen, Jyrki/AAC-8945-2020; Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Neme, Antonio/A-8999-2018	Carlberg, Carsten/0000-0003-2633-0684; Virtanen, Jyrki/0000-0002-0648-999X; Virtanen, Jyrki/0000-0002-0648-999X; Neme, Antonio/0000-0002-9952-1943; de Mello, Vanessa/0000-0003-3414-6983	Academy of Finland [267067, 137826]; Juselius Foundation; Diabetes Research Foundation	Academy of Finland(Academy of Finland); Juselius Foundation; Diabetes Research Foundation	This work was supported by the Academy of Finland (grant No. 267067 to C.C. and 137826 for the VitDmet study), the Juselius Foundation, and the Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia JF, 2006, AM J CLIN NUTR, V84, P602, DOI 10.1093/ajcn/84.3.602; Bendik I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00248; Campbell MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00181; Carlberg C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00167; Carlberg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071042; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Carlberg C, 2012, CURR TOP MED CHEM, V12, P528, DOI 10.2174/156802612799436623; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; HOLICK MF, 1977, BIOCHEM BIOPH RES CO, V76, P107, DOI 10.1016/0006-291X(77)91674-6; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Hossein-nezhad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058725; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Kovalenko PL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-26; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nurmi T, 2013, ANAL BIOCHEM, V435, P1, DOI 10.1016/j.ab.2012.12.010; Nurminen V, 2014, BIOCH BIOPHYS ACTA; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Saksa N, 2014, J STEROID BIOCH MOL; Seuter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096184; Seuter S, 2013, BBA-GENE REGUL MECH, V1829, P1266, DOI 10.1016/j.bbagrm.2013.10.003; Snellman G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007747; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TUOMAINEN TP, 2014, GLUCOSE METABO UNPUB; Tuoresmaki P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096105; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wilfinger J, 2014, J NUTR BIOCHEM, V25, P875, DOI 10.1016/j.jnutbio.2014.04.002	36	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124339	10.1371/journal.pone.0124339	http://dx.doi.org/10.1371/journal.pone.0124339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875760	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100250
J	Siegemund, S; Shepherd, J; Xiao, CC; Sauer, K				Siegemund, Sabine; Shepherd, Jovan; Xiao, Changchun; Sauer, Karsten			hCD2-iCre and Vav-iCre Mediated Gene Recombination Patterns in Murine Hematopoietic Cells	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; STEM-CELLS; BONE-MARROW; IN-VIVO; TRANSGENIC MICE; SELF-RENEWAL; T-CELL; EXPRESSION; IDENTIFICATION; PROGENITORS	Cre-recombinase mediated conditional deletion of Lox-P site flanked ("floxed") genes is widely used for functional gene annotation in mice. Many different Cre-transgenic mouse lines have been developed for cell-type specific gene disruption. But often, the precise tissue-patterns of Cre activity remain incompletely characterized. Two widely used transgenes for conditional gene recombination in hematopoietic cells are Vav-iCre driven from the murine Vav1 promotor, and hCD2-iCre driven from the human CD2 promotor. Vav-iCre expresses active Cre in fetal and adult hematopoietic stem cells and all descendants, hCD2-iCre in immature and mature B and T lymphocytes. To better characterize which hematopoietic cells contain hCD2-iCre activity, we compared EYFP fluorescence in hCD2-iCre(+/-)R26-stop-EYFP+/- and Vav-iCre(+/-)R26-stop-EYFP+/- mice. R26-stop-EYFPubiquitously encodes EYFPpreceded by a floxed stop cassette. By removing it, Cre activity induces measurable EYFP expression. Our results confirm the known activity patterns for both Cre transgenes and unveil additional hCD2-iCre mediated reporter gene recombination in common lymphoid progenitors, in natural killer cells and their progenitors, and in plasmacytoid and conventional dendritic cells. This supports previously proposed common lymphoid origins for natural killer cells and subsets of dendritic cells, and indicates the need to consider pleiotropic effects when studying hCD2-iCre mediated conditional knockout mice. Vav-iCre(+/-)R26-stop-EYFP+/- mice did not show the non-hematopoietic recombination in vascular endothelial cells seen in other Vav-Cre mouse lines, but displayed an unexpected Vav-iCre mediated recombination in a bone cell subset lacking hematopoietic markers. This pinpoints the need to consider stromal cell contributions to phenotypes of Vav-iCre mediated conditional knockout mice. Altogether, our data provide the first detailed assessment of hCD2-iCre and Vav-iCre mediated deletion of floxed genes during lymphocyte development from hematopoietic stem cells and open up novel applications for either Cre-transgenic mouse line.	[Siegemund, Sabine; Shepherd, Jovan; Xiao, Changchun; Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sauer, Karsten] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Sauer, K (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	ksauer@scripps.edu		Shepherd, Jovan/0000-0003-2067-550X	National Institutes of Health (NIH) [AI070845, GM100785]; NIH/NCATS [UL1 TR000109]; Leukemia and Lymphoma Society Scholar Award [1440-11]; Deutsche Forschungsgemeinschaft fellowship [SI 1547/1-1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100785] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Deutsche Forschungsgemeinschaft fellowship(German Research Foundation (DFG)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grants AI070845 and GM100785, NIH/NCATS grant UL1 TR000109, The Leukemia and Lymphoma Society Scholar Award 1440-11 to K.S., and Deutsche Forschungsgemeinschaft fellowship SI 1547/1-1 to S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Arcangeli ML, 2011, BLOOD, V118, P4609, DOI 10.1182/blood-2010-12-323972; Barouch-Bentov R, 2009, MOL CELL, V33, P43, DOI 10.1016/j.molcel.2008.12.024; Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23; Carotta S, 2011, BLOOD; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Ceredig R, 2012, NAT IMMUNOL, V13, P309, DOI 10.1038/ni.2265; Cichocki F, 2014, SEMIN IMMUNOL, V26, P114, DOI 10.1016/j.smim.2014.02.003; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Grzywacz B, 2011, BLOOD, V117, P3548, DOI 10.1182/blood-2010-04-281394; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Jia YH, 2008, P NATL ACAD SCI USA, V105, P4739, DOI 10.1073/pnas.0800218105; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LANG G, 1988, EMBO J, V7, P1675, DOI 10.1002/j.1460-2075.1988.tb02995.x; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Moore Amanda J, 2013, Adv Hematol, V2013, P949513, DOI 10.1155/2013/949513; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Ogilvy S, 1999, BLOOD, V94, P1855; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Sauer K, 2013, BLOOD, V121, P286, DOI 10.1182/blood-2012-05-429241; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Segura E, 2009, J IMMUNOL, V183, P1514, DOI 10.4049/jimmunol.0901524; Serwold T, 2009, BLOOD, V113, P807, DOI 10.1182/blood-2008-08-173682; Shi JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046590; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shortman K, 2013, ADV IMMUNOL, V120, P105, DOI 10.1016/B978-0-12-417028-5.00004-1; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sullivan RP, 2012, J IMMUNOL, V188, P3019, DOI 10.4049/jimmunol.1102294; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Vogt TK, 2009, BLOOD, V113, P3961, DOI 10.1182/blood-2008-08-176321; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson TJ, 2002, GENESIS, V33, P181, DOI 10.1002/gene.10107; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiong JA, 2011, INT IMMUNOL, V23, P55, DOI 10.1093/intimm/dxq457	56	33	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124661	10.1371/journal.pone.0124661	http://dx.doi.org/10.1371/journal.pone.0124661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884630	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000139
J	Altman, D; Minozzo, FC; Rassier, DE				Altman, David; Minozzo, Fabio C.; Rassier, Dilson E.			Thixotropy and Rheopexy of Muscle Fibers Probed Using Sinusoidal Oscillations	PLOS ONE			English	Article							SKELETAL-MUSCLE; CROSS-BRIDGES; BLEBBISTATIN INHIBITION; MECHANICAL-PROPERTIES; SINGLE MOLECULES; FORCE; TENSION; BEHAVIOR; STRETCH; ACTIN	Length changes of muscle fibers have previously been shown to result in a temporary reduction in fiber stiffness that is referred to as thixotropy. Understanding the mechanism of this thixotropy is important to our understanding of muscle function since there are many instances in which muscle is subjected to repeated patterns of lengthening and shortening. By applying sinusoidal length changes to one end of single permeabilized muscle fibers and measuring the force response at the opposite end, we studied the history-dependent stiffness of both relaxed and activated muscle fibers. For length change oscillations greater than 1 Hz, we observed thixotropic behavior of activated fibers. Treatment of these fibers with EDTA and blebbistatin, which inhibits myosin-actin interactions, quashed this effect, suggesting that the mechanism of muscle fiber thixotropy is cross-bridge dependent. We modeled a half-sarcomere experiencing sinusoidal length changes, and our simulations suggest that thixotropy could arise from force-dependent cross-bridge kinetics. Surprisingly, we also observed that, for length change oscillations less than 1 Hz, the muscle fiber exhibited rheopexy. In other words, the stiffness of the fiber increased in response to the length changes. Blebbistatin and EDTA did not disrupt the rheopectic behavior, suggesting that a non-cross-bridge mechanism contributes to this phenomenon.	[Altman, David] Willamette Univ, Dept Phys, Salem, OR 97301 USA; [Minozzo, Fabio C.; Rassier, Dilson E.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Rassier, Dilson E.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Rassier, Dilson E.] McGill Univ, Dept Phys, Montreal, PQ, Canada	Willamette University; McGill University; McGill University; McGill University	Altman, D (corresponding author), Willamette Univ, Dept Phys, Salem, OR 97301 USA.	daltman@gmail.com			Burroughs Wellcome Collaborative Research Travel Grant, BWF [1011279]; Natural Sciences and Engineering Research Council of Canada, NSERC [RGPIN 327310-11]	Burroughs Wellcome Collaborative Research Travel Grant, BWF; Natural Sciences and Engineering Research Council of Canada, NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the following: DA, Burroughs Wellcome Collaborative Research Travel Grant, BWF ID# 1011279, http://www.bwfund.org/; and DR, Natural Sciences and Engineering Research Council of Canada, NSERC RGPIN 327310-11, http://www.nserc-crsng.gc.ca/index_eng. asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger MSM, 1997, POLYM SCI DICT, V2nd; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Bianco P, 2007, BIOPHYS J, V93, P2102, DOI [10.1529/biophysj.107.106153, 10.1529/biophysj.l07.106153]; Buchthal F., 1951, DAN VIDENS SELS BIOL, V21, P1; Campbell KS, 2008, BIOPHYS J, V94, P327, DOI 10.1529/biophysj.107.114322; Campbell KS, 2000, J PHYSIOL-LONDON, V525, P531, DOI 10.1111/j.1469-7793.2000.00531.x; Campbell KS, 1998, J PHYSIOL-LONDON, V510, P941, DOI 10.1111/j.1469-7793.1998.941bj.x; Campbell KS, 2002, BIOPHYS J, V82, P929, DOI 10.1016/S0006-3495(02)75454-4; Cornachione AS, 2012, AM J PHYSIOL-CELL PH, V302, pC566, DOI 10.1152/ajpcell.00355.2011; Gordon AM, 1997, J MUSCLE RES CELL M, V18, P643, DOI 10.1023/A:1018631806182; HERBST M, 1976, PFLUG ARCH EUR J PHY, V364, P71, DOI 10.1007/BF01062914; HILL DK, 1968, J PHYSIOL-LONDON, V199, P637, DOI 10.1113/jphysiol.1968.sp008672; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; Kellermayer MSZ, 2008, BIOPHYS J, V94, P329, DOI 10.1529/biophysj.107.122309; Kellermayer MSZ, 2001, BIOPHYS J, V80, P852, DOI 10.1016/S0006-3495(01)76064-X; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LAKIE M, 1984, J PHYSIOL-LONDON, V353, P265, DOI 10.1113/jphysiol.1984.sp015335; LAKIE M, 1990, EXP PHYSIOL, V75, P123, DOI 10.1113/expphysiol.1990.sp003380; LANNERGREN J, 1971, J GEN PHYSIOL, V58, P145, DOI 10.1085/jgp.58.2.145; Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4; Minozzo FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068866; Minozzo FC, 2010, AM J PHYSIOL-CELL PH, V299, pC1127, DOI 10.1152/ajpcell.00073.2010; Mutungi G, 2000, J MUSCLE RES CELL M, V21, P301, DOI 10.1023/A:1005633931146; Pavlov I, 2009, AM J PHYSIOL-CELL PH, V297, pC1211, DOI 10.1152/ajpcell.00233.2009; Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045; PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N; Rassier DE, 2014, J MUSCLE RES CELL MO; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902	30	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121726	10.1371/journal.pone.0121726	http://dx.doi.org/10.1371/journal.pone.0121726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880774	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500012
J	Aminde, LN; Takah, NF; Dzudie, A; Bonko, NM; Awungafac, G; Teno, D; Mbuagbaw, L; Sliwa, K				Aminde, Leopold Ndemnge; Takah, Noah Fongwen; Dzudie, Anastase; Bonko, Neville Mengnjo; Awungafac, George; Teno, Divine; Mbuagbaw, Lawrence; Sliwa, Karen			Occupational Post-Exposure Prophylaxis (PEP) against Human Immunodeficiency Virus (HIV) Infection in a Health District in Cameroon: Assessment of the Knowledge and Practices of Nurses	PLOS ONE			English	Article							CARE WORKERS; EXPOSURE; RISK; GUIDELINES; AWARENESS	Background Health care providers are at risk of acquiring human immunodeficiency virus (HIV) infection from occupational exposure, with nurses being the most vulnerable. There is no data on the awareness of post-exposure prophylaxis (PEP) among nurses in Cameroon. This study aimed to assess the knowledge, practices of nurses regarding PEP for HIV and their determinants in Cameroon. Methods A cross-sectional study was conducted between April and July 2013, and involved 80 nurses in a rural health district in the North West Region of Cameroon. Data was collected using a structured questionnaire and analysed using the SPSS software version 20. Results In all, 73.7% of the participants had poor knowledge about PEP for HIV. Though many (83.8%) had heard about PEP, just 10 (12.5%) had received formal training on PEP for HIV. Only 24 (30%) and 20 (25%) knew the correct drug regimen and duration of treatment respectively. The majority (85%) considered themselves to be at risk of acquiring HIV at work, with 54 (67.5%) having experienced an exposure in the past, mainly while setting up intravenous lines (57.4%), recapping needles (37.0%) and during delivery (24.1%). Of those exposed, ten (18.9%) received PEP, which was started after 24 hours in 50%. In multivariable regression analyses, awareness of hospital policy [OR: 0.043 (0.005-0.404), p-value = 0.006] was associated with Good knowledge on PEP for HIV. Conclusions The knowledge and practice of nurses on PEP for HIV in Cameroon is low. There is urgent need for training programmes and workshops to increase awareness, improve practice, and reduce the risk of HIV acquisition from work related activities among health care providers.	[Aminde, Leopold Ndemnge; Dzudie, Anastase; Bonko, Neville Mengnjo] Univ Buea, Fac Hlth Sci, Dept Med, Buea, Cameroon; [Takah, Noah Fongwen; Awungafac, George] Global Hlth Syst Solut, Limbe, Cameroon; [Dzudie, Anastase] Gen Hosp Douala, Dept Internal Med, Douala, Cameroon; [Dzudie, Anastase] Univ Cape Town, Dept Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Bonko, Neville Mengnjo] Baptist Hosp, Mutengene, Cameroon; [Teno, Divine] Tubah Dist Hosp, Bambui, Cameroon; [Mbuagbaw, Lawrence] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa	University of Cape Town; McMaster University; University of Cape Town	Aminde, LN (corresponding author), Univ Buea, Fac Hlth Sci, Dept Med, Buea, Cameroon.	amindeln@gmail.com	Mbuagbaw, Lawrence/D-9381-2015; AMINDE, Leopold/K-5684-2019; Awungafac, George/Y-4075-2019; Awungafac, George/AAV-8385-2020	Mbuagbaw, Lawrence/0000-0001-5855-5461; AMINDE, Leopold/0000-0003-2787-7518; Awungafac, George/0000-0002-5859-0336; Awungafac, George/0000-0002-5859-0336; DZUDIE, Anastase/0000-0003-4038-4128				Agaba Patricia A, 2012, Niger Med J, V53, P155, DOI 10.4103/0300-1652.104386; Alenyo R., 2009, East and Central African Journal of Surgery, V14, P99; Bandolier E., 2003, OCCUPATIONAL EXPOSUR; CDC, 2007, UPD US PUBL HLTH SER; Chacko Joffi, 2007, Indian J Public Health, V51, P127; Chogle NL, 2002, NATL MED J INDIA, V15, P69; Diprose P, 2000, BRIT J ANAESTH, V84, P767, DOI 10.1093/oxfordjournals.bja.a013591; District C., 2012, INT J PHARM BIOL ARC, V3, P1394; Endalew GS, 2014, J HIV CLIN SCI RES, V1, P101; Esin IA, 2011, NIGER J CLIN PRACT, V14, P464, DOI 10.4103/1119-3077.91757; Foster TM, 2010, W INDIAN MED J, V59; Gupta A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-142; Krakower DS, 2015, CURR HIV AIDS REP; Mathewos B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-508; Ministry of Health and Family Welfare: Government of India National AIDS Control Organisation, 2009, MAN OCC EXP INCL POS; Monera T, 2012, J INT AIDS SOC, V15, DOI [10.1186/1758-2652-15-4, DOI 10.1186/1758-2652-15-4]; Nwankwo TO, 2011, NIGER J CLIN PRACT, V14, P34, DOI 10.4103/1119-3077.79237; Owino SO, 2013, J PUBLIC HLTH DEV, V11, P19; Owolabi Rotimi S, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P179, DOI 10.1177/1545109711401409; Sagoe-Moses C, 2001, NEW ENGL J MED, V345, P538, DOI 10.1056/NEJM200108163450711; Sarah AO AA, 2014, OCCUP MED HLTH AFF, V02; Sharma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105283; Taegtmeyer M, 2008, AIDS CARE, V20, P304, DOI 10.1080/09540120701583787; Takow Stephen Ekure, 2015, J Int Assoc Provid AIDS Care, V14, P77, DOI 10.1177/2325957413510607; Tebeje B, 2010, ETHIOP J HEALTH SCI, V20, P55; Tetali S., 2006, Indian Journal of Occupational and Environmental Medicine, V10, P35	26	20	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124416	10.1371/journal.pone.0124416	http://dx.doi.org/10.1371/journal.pone.0124416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879442	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500100
J	Ande, A; McArthur, C; Ayuk, L; Awasom, C; Achu, PN; Njinda, A; Sinha, N; Rao, PSS; Agudelo, M; Nookala, AR; Simon, S; Kumar, A; Kumar, S				Ande, Anusha; McArthur, Carole; Ayuk, Leo; Awasom, Charles; Achu, Paul Ngang; Njinda, Annette; Sinha, Namita; Rao, P. S. S.; Agudelo, Marisela; Nookala, Anantha Ram; Simon, Stephen; Kumar, Anil; Kumar, Santosh			Effect of Mild-to-Moderate Smoking on Viral Load, Cytokines, Oxidative Stress, and Cytochrome P450 Enzymes in HIV-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LC-MS/MS METHOD; CONCURRENT DETERMINATION; ALVEOLAR MACROPHAGES; NICOTINE METABOLITES; ENHANCED PRODUCTION; CIGARETTE-SMOKING; ALCOHOL; DISEASE; TOBACCO	Mild-to-moderate tobacco smoking is highly prevalent in HIV-infected individuals, and is known to exacerbate HIV pathogenesis. The objective of this study was to determine the specific effects of mild-to-moderate smoking on viral load, cytokine production, and oxidative stress and cytochrome P450 (CYP) pathways in HIV-infected individuals who have not yet received antiretroviral therapy (ART). Thirty-two human subjects were recruited and assigned to four different cohorts as follows: a) HIV negative non-smokers, b) HIV positive non-smokers, c) HIV negative mild-to-moderate smokers, and d) HIV positive mild-to-moderate smokers. Patients were recruited in Cameroon, Africa using strict selection criteria to exclude patients not yet eligible for ART and not receiving conventional or traditional medications. Those with active tuberculosis, hepatitis B or with a history of substance abuse were also excluded. Our results showed an increase in the viral load in the plasma of HIV positive patients who were mild-to-moderate smokers compared to individuals who did not smoke. Furthermore, although we did not observe significant changes in the levels of most pro-inflammatory cytokines, the cytokine IL-8 and MCP-1 showed a significant decrease in the plasma of HIV-infected patients and smokers compared with HIV negative non-smokers. Importantly, HIV-infected individuals and smokers showed a significant increase in oxidative stress compared with HIV negative non-smoker subjects in both plasma and monocytes. To examine the possible pathways involved in increased oxidative stress and viral load, we determined the mRNA levels of several antioxidant and cytochrome P450 enzymes in monocytes. The results showed that the levels of most antioxidants are unaltered, suggesting their inability to counter oxidative stress. While CYP2A6 was induced in smokers, CYP3A4 was induced in HIV and HIV positive smokers compared with HIV negative non-smokers. Overall, the findings suggest a possible association of oxidative stress and perhaps CYP pathway with smoking-mediated increased viral load in HIV positive individuals.	[Ande, Anusha; Nookala, Anantha Ram; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA; [McArthur, Carole] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO USA; [Ayuk, Leo; Awasom, Charles] Reg Hosp, Bamenda, North West Prov, Cameroon; [Achu, Paul Ngang; Njinda, Annette] Mezam Polyclin HIV AIDS Treatment Ctr, Bamenda, Cameroon; [Sinha, Namita; Rao, P. S. S.; Kumar, Santosh] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Agudelo, Marisela] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA; [Simon, Stephen] Univ Missouri, Sch Med, Dept Med Informat, Kansas City, MO 64108 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Tennessee System; University of Tennessee Health Science Center; State University System of Florida; Florida International University; University of Missouri System; University of Missouri Kansas City	Kumar, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	ksantosh@uthsc.edu	KUMAR, ANIL/ACD-8340-2022; Nookala, Anantha Ram/ABV-0636-2022; Boothapati, Anil Kumar/HHS-1813-2022; Nookala, Anantha Ram/ABT-0475-2022	McArthur, Carole/0000-0002-9286-8362	National Institute of Health [DA031616, AA022063, AA020806]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020806, R01AA022063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031616] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health (www.nih.gov) grants DA031616 (SK), AA022063 (SK), and AA020806 (AK).	ABBUD RA, 1995, J INFECT DIS, V172, P859, DOI 10.1093/infdis/172.3.859; Allam E, 2013, ORAL DIS, V19, P660, DOI 10.1111/odi.12050; Ande A, 2013, TOBACCO SMOKING EFFE; Ande A, 2012, DRUG ALCOHOL DEPEN, V125, P49, DOI 10.1016/j.drugalcdep.2012.03.015; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Aquaro S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-76; Atluri VSR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061399; Barbieri SS, 2011, CARDIOVASC RES, V90, P475, DOI 10.1093/cvr/cvr032; Benowitz NL, 2009, ANNU REV PHARMACOL, V49, P57, DOI 10.1146/annurev.pharmtox.48.113006.094742; Boelaert JR, 1996, J INFECT DIS, V173, P1045, DOI 10.1093/infdis/173.4.1045a; Buch S, 2012, CURR HIV RES, V10, P425, DOI 10.2174/157016212802138823; Burnham EL, 2013, AM J PHYSIOL-LUNG C, V304, pL873, DOI 10.1152/ajplung.00385.2012; Catalfamo M, 2012, CYTOKINE GROWTH F R, V23, P207, DOI 10.1016/j.cytogfr.2012.05.007; CHOCHOLA J, 1995, FREE RADICAL RES, V23, P197, DOI 10.3109/10715769509064034; Cioe PA, 2013, ADDICT BEHAV, V2; de-Torres JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060260; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594; Earla R, 2014, DRUG METAB DISPOS, V42, P282, DOI 10.1124/dmd.113.055186; Elbim C, 2001, J CLIN VIROL, V20, P99, DOI 10.1016/S1386-6532(00)00133-5; Hecht SS, 2000, P NATL ACAD SCI USA, V97, P12493, DOI 10.1073/pnas.220207697; HUGHES DA, 1985, CLIN EXP IMMUNOL, V61, P459; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035505; Jin MY, 2012, J NEUROIMMUNE PHARM, V7, P289, DOI 10.1007/s11481-011-9283-6; Jin MY, 2011, ALCOHOL CLIN EXP RES, V35, P132, DOI 10.1111/j.1530-0277.2010.01330.x; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kumar S, 2012, EXPERT OPIN DRUG MET, V8, P1363, DOI 10.1517/17425255.2012.714366; Levitzky YS, 2008, ATHEROSCLEROSIS, V201, P217, DOI 10.1016/j.atherosclerosis.2007.12.058; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; MALVY DJM, 1994, CLIN CHIM ACTA, V224, P89, DOI 10.1016/0009-8981(94)90124-4; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nelson M, 2006, INT J CLIN PRACT, V60, P976, DOI 10.1111/j.1742-1241.2006.01058.x; Pal D, 2006, J NEUROIMMUNE PHARM, V1, P323, DOI 10.1007/s11481-006-9034-2; Raza H, 2013, CELL PHYSIOL BIOCHEM, V31, P683, DOI 10.1159/000350087; Rock RB, 2008, J NEUROIMMUNE PHARM, V3, P143, DOI 10.1007/s11481-007-9098-7; Rowinski R, 2013, EXP GERONTOL, V48, P1141, DOI 10.1016/j.exger.2013.07.010; Silverstein PS, 2011, J NEUROVIROL, V17, P401, DOI 10.1007/s13365-011-0043-4; Stehbens WE, 2004, EXP MOL PATHOL, V77, P121, DOI 10.1016/j.yexmp.2004.04.007; Suzuki K, 2003, J EPIDEMIOL, V13, P29, DOI 10.2188/jea.13.29; Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009; TOLLERUD DJ, 1989, AM REV RESPIR DIS, V139, P1446, DOI 10.1164/ajrccm/139.6.1446; Torimoto N, 2003, BIOCHEMISTRY-US, V42, P15068, DOI 10.1021/bi034409n; Torre D, 2002, LANCET INFECT DIS, V2, P273, DOI 10.1016/S1473-3099(02)00262-1; Vallari A, 2010, AIDS RES HUM RETROV, V26, P109, DOI 10.1089/aid.2009.0178; Vandergeeten C, 2012, CYTOKINE GROWTH F R, V23, P143, DOI 10.1016/j.cytogfr.2012.05.001; VanderMeide PH, 1996, BIOTHERAPY, V8, P243, DOI 10.1007/BF01877210; Walubo A, 2007, EXPERT OPIN DRUG MET, V3, P583, DOI 10.1517/17425225.3.4.583; Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981; Wojna V, 2007, J NEUROVIROL, V13, P561, DOI 10.1080/13550280701620747; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhao LJ, 2010, TOXICOLOGY, V278, P242, DOI 10.1016/j.tox.2010.09.010	54	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122402	10.1371/journal.pone.0122402	http://dx.doi.org/10.1371/journal.pone.0122402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879453	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500020
J	Andersen, MB; Croy, CH; Dencker, D; Werge, T; Bymaster, FP; Felder, CC; Fink-Jensen, A				Andersen, Maibritt B.; Croy, Carrie Hughes; Dencker, Ditte; Werge, Thomas; Bymaster, Frank P.; Felder, Christian C.; Fink-Jensen, Anders			Antipsychotic-Like Effect of the Muscarinic Acetylcholine Receptor Agonist BuTAC in Non-Human Primates	PLOS ONE			English	Article							XANOMELINE; INHIBITION	Cholinergic, muscarinic receptor agonists exhibit functional dopamine antagonism and muscarinic receptors have been suggested as possible future targets for the treatment of schizophrenia and drug abuse. The muscarinic ligand (5R, 6R)-6-(3-butylthio-1,2,5-thiadiazol-4-yl)- 1-azabicyclo[3.2.1]octane (BuTAC) exhibits high affinity for muscarinic receptors with no or substantially less affinity for a large number of other receptors and binding sites, including the dopamine receptors and the dopamine transporter. In the present study, we wanted to examine the possible antipsychotic-like effects of BuTAC in primates. To this end, we investigated the effects of BuTAC on d-amphetamine-induced behaviour in antipsychotic-naive Cebus paella monkeys. Possible adverse events of BuTAC, were evaluated in the same monkeys as well as in monkeys sensitized to antipsychotic-induced extrapyramidal side effects. The present data suggests that, the muscarinic receptor ligand BuTAC exhibits antipsychotic-like behaviour in primates. The behavioural data of BuTAC as well as the new biochemical data further substantiate the rationale for the use of muscarinic M-1/M-2/M-4-preferring receptor agonists as novel pharmacological tools in the treatment of schizophrenia.	[Andersen, Maibritt B.; Werge, Thomas] SCT Hans Mental Hosp, Res Inst Biol Psychiat, iPSYCH, Roskilde, Denmark; [Croy, Carrie Hughes; Felder, Christian C.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Dencker, Ditte; Fink-Jensen, Anders] Univ Copenhagen, Lab Neuropsychiat, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Dencker, Ditte; Fink-Jensen, Anders] Univ Copenhagen, Psychiat Ctr Copenhagen, Copenhagen, Denmark; [Bymaster, Frank P.] Euthymics Biosci Inc, Cambridge, MA USA	Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Eli Lilly; University of Copenhagen; University of Copenhagen	Fink-Jensen, A (corresponding author), Univ Copenhagen, Lab Neuropsychiat, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	a.fink-jensen@dadlnet.dk		Fink-Jensen, Anders/0000-0001-7143-1236; Felder, Christian/0000-0003-1134-8881	Eli Lilly; Euthymics Bioscience Inc.; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Eli Lilly(Eli Lilly); Euthymics Bioscience Inc.; Lundbeck Foundation(Lundbeckfonden)	Eli Lilly provided funding for this study. The funder provided support in the form of salaries for authors CHC and CF, and Euthymics Bioscience Inc., provided support in the form of salaries for author FB, but neither company any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen MB, 2003, NEUROPSYCHOPHARMACOL, V28, P1168, DOI 10.1038/sj.npp.1300151; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; Brady AE, 2008, J PHARMACOL EXP THER, V327, P941, DOI 10.1124/jpet.108.140350; Bymaster FP, 1999, LIFE SCI, V64, P527, DOI 10.1016/S0024-3205(98)00597-9; Byun NE, 2014, NEUROPSYCHOPHARMACOL, V39, P1578, DOI 10.1038/npp.2014.2; CHALMERS RK, 1964, PSYCHOPHARMACOLOGIA, V6, P31, DOI 10.1007/BF00710912; DeLapp NW, 1999, J PHARMACOL EXP THER, V289, P946; Dencker D, 2012, PSYCHOPHARMACOLOGY, V224, P277, DOI 10.1007/s00213-012-2751-8; Dencker D, 2011, J NEUROSCI, V31, P5905, DOI 10.1523/JNEUROSCI.0370-11.2011; Jones CK, 2005, J PHARMACOL EXP THER, V312, P1055, DOI 10.1124/jpet.104.075887; Peacock L, 1999, NEUROPSYCHOPHARMACOL, V20, P35, DOI 10.1016/S0893-133X(98)00049-9; Peacock L, 1999, PSYCHOPHARMACOLOGY, V144, P189, DOI 10.1007/s002130050993; PFEIFFER CC, 1957, ANN NY ACAD SCI, V66, P753, DOI 10.1111/j.1749-6632.1957.tb40764.x; Rasmussen T, 2001, SCHIZOPHR RES, V49, P193, DOI 10.1016/S0920-9964(00)00129-8; Reddymasu SC, 2007, AM J GASTROENTEROL, V102, P2036, DOI 10.1111/j.1572-0241.2007.01255.x; Shannon HE, 2000, SCHIZOPHR RES, V42, P249, DOI 10.1016/S0920-9964(99)00138-3; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Thomsen M, 2010, PSYCHOPHARMACOLOGY, V208, P401, DOI 10.1007/s00213-009-1740-z; Watt ML, 2013, NEUROPSYCHOPHARMACOL, V38, P2717, DOI 10.1038/npp.2013.186	19	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122722	10.1371/journal.pone.0122722	http://dx.doi.org/10.1371/journal.pone.0122722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880220	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500027
J	Buckingham, S; Murphy, N; Gibb, H				Buckingham, Sebastian; Murphy, Nick; Gibb, Heloise			The Effects of Fire Severity on Macroinvertebrate Detritivores and Leaf Litter Decomposition	PLOS ONE			English	Article							DRY EUCALYPT FOREST; PINE FORESTS; BODY-SIZE; ARTHROPOD COMMUNITY; SOIL INVERTEBRATES; FLIGHT PERFORMANCE; TROPICAL SAVANNAS; GROUND BEETLES; DOMINANT ANTS; BOREAL FOREST	High severity wildfire events are a feature of forests globally and are likely to be more prevalent with climate change. As a disturbance process, fire has the potential to change important ecological functions, such as decomposition, through its impact on biodiversity. Despite the recognised importance of decomposition in terms of fuel loads and energy flow, little is known about the post-fire effects of fire severity on decomposition by litter-dwelling macroinvertebrate detritivores. We tested the hypotheses that: 1) increasing fire severity is associated with decreased rates of leaf litter decomposition by macroinvertebrate detritivores; and 2) the abundance and biomass of macroinvertebrate detritivores decreases with increasing fire severity, while body size increases. We used a litterbag experiment at long-unburnt, ground-burnt and crown-burnt sites (n = 7 for all treatments) to test the effect of fire severity on: a) macroinvertebrate-driven break-down of litter fuel loads; and b) the size and abundance of macroinvertebrate detritivores three years after fire. Microhabitat conditions differed among fire severity classes. Macroinvertebrate exclusion reduced litter decomposition by 34.7%. Macroinvertebrate detritivores were larger and less abundant following higher severity fires, possibly as a result of fire-induced changes in habitat structure. Opposing effects of fire severity on macroinvertebrate abundance and body size resulted in both similar detritivore biomass and, most interestingly, no differences in leaf litter decomposition under different fire severities. This suggests that the diversity of macroinvertebrates enhances functional resilience of litter decomposition to fire and that litter-breakdown is not inhibited within three years following a high severity fire in this forest type and where recolonisation sources are readily available. We found no support for the hypothesis that high severity fires reduce litter decomposition and therefore increase the likelihood of future fires.	[Buckingham, Sebastian; Gibb, Heloise] La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia; [Murphy, Nick] La Trobe Univ, Dept Genet, Melbourne, Vic 3086, Australia	La Trobe University; La Trobe University	Buckingham, S (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia.	jsbuckingham@students.latrobe.edu.au	Gibb, Heloise/B-8338-2013	Gibb, Heloise/0000-0001-7194-0620; Murphy, Nick/0000-0002-0907-4642	La Trobe University	La Trobe University	This study was supported by La Trobe University (PhD Scholarship; http://www.latrobe.edu.au/) and the Department of Sustainability and Environment Fieldwork expenses (www.dse.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AN, 2007, DIVERS DISTRIB, V13, P438, DOI 10.1111/j.1472-4642.2007.00353.x; Andersen AN, 2012, AUSTRAL ECOL, V37, P658, DOI 10.1111/j.1442-9993.2011.02334.x; ASHTON DH, 1975, AUST J BOT, V23, P413, DOI 10.1071/BT9750413; ATTIWILL PM, 1979, AUST J BOT, V27, P439, DOI 10.1071/BT9790439; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Bogorodskaya AV, 2010, CONTEMP PROBL ECOL+, V3, P653, DOI 10.1134/S199542551006007X; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Booth RG, 1990, COLEOPTERA CAB INT; Bradford MA, 2002, OIKOS, V99, P317, DOI 10.1034/j.1600-0706.2002.990212.x; Bradstock RA, 2010, GLOBAL ECOL BIOGEOGR, V19, P145, DOI 10.1111/j.1466-8238.2009.00512.x; Brennan KEC, 2009, GLOBAL CHANGE BIOL, V15, P2958, DOI 10.1111/j.1365-2486.2009.02011.x; Canhoto C, 1999, MICROBIAL ECOL, V37, P163, DOI 10.1007/s002489900140; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Clarke HG, 2011, INT J WILDLAND FIRE, V20, P550, DOI 10.1071/WF10070; Coleman D.C., 2004, FUNDAMENTALS SOIL EC; Coleman TW, 2006, FOREST ECOL MANAG, V233, P52, DOI 10.1016/j.foreco.2006.06.001; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; Crockford RH, 2002, HYDROL PROCESS, V16, P3317, DOI 10.1002/hyp.1001; Cruz MG, 2012, FOREST ECOL MANAG, V284, P269, DOI 10.1016/j.foreco.2012.02.035; CSIRO, 1991, INS AUSTR TXB STUD R; Dahlberg A, 2001, BIOL CONSERV, V100, P151, DOI 10.1016/S0006-3207(00)00230-5; Davies KF, 2000, ECOLOGY, V81, P1450, DOI 10.2307/177221; den Boer PJ, 1990, BIOL CONSERV, V54, P175; Dias ATC, 2013, OECOLOGIA, V172, P667, DOI 10.1007/s00442-012-2541-3; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; DINGLE H, 1980, EVOLUTION, V34, P371, DOI 10.1111/j.1558-5646.1980.tb04825.x; Driscoll DA, 2005, CONSERV BIOL, V19, P182, DOI 10.1111/j.1523-1739.2005.00586.x; DSE, 2005, NV2005 EVCBCS EC VEG; Farji-Brener AG, 2004, OIKOS, V104, P165, DOI 10.1111/j.0030-1299.2004.12740.x; Fattorini S, 2010, BIODIVERS CONSERV, V19, P1237, DOI 10.1007/s10531-009-9749-5; Fauria MM, 2008, PHILOS T R SOC B, V363, P2317, DOI 10.1098/rstb.2007.2202; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gibb H, 2010, OECOLOGIA, V164, P1061, DOI 10.1007/s00442-010-1703-4; Gill A. M., 1975, Australian Forestry, V38, P4; Gould JS, 2011, FOREST ECOL MANAG, V262, P531, DOI 10.1016/j.foreco.2011.04.022; Gruner Daniel S., 2003, Pacific Science, V57, P325, DOI 10.1353/psc.2003.0021; Hodar JA, 1996, ACTA OECOL, V17, P421; Holloway JD, 1987, LEPIDOPTERA CAB INT; Kampichler C, 2009, BIOL REV, V84, P375, DOI 10.1111/j.1469-185X.2009.00078.x; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Kim Ji Won, 2008, Journal of Asia-Pacific Entomology, V11, P77, DOI 10.1016/j.aspen.2008.05.003; Kiss L, 2006, BIODIVERS CONSERV, V15, P2925, DOI 10.1007/s10531-005-3430-4; Langlands PR, 2011, J ANIM ECOL, V80, P558, DOI 10.1111/j.1365-2656.2010.01795.x; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Malmstrom A, 2010, FOREST ECOL MANAG, V260, P62, DOI 10.1016/j.foreco.2010.04.001; Mccaw WL, 2012, FOREST ECOL MANAG, V271, P170, DOI 10.1016/j.foreco.2012.02.003; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Moretti M, 2006, OECOLOGIA, V149, P312, DOI 10.1007/s00442-006-0450-z; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Parr CL, 2007, OECOLOGIA, V151, P33, DOI 10.1007/s00442-006-0570-5; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Pryke JS, 2012, AUSTRAL ECOL, V37, P460, DOI 10.1111/j.1442-9993.2011.02307.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Radea C, 2000, EUR J SOIL BIOL, V36, P57, DOI 10.1016/S1164-5563(00)01045-1; Raison R. J., 1983, Australian Forestry, V46, P294; RAISON RJ, 1986, AUST J SOIL RES, V24, P33, DOI 10.1071/SR9860033; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Robinson NM, 2013, J APPL ECOL, V50, P1321, DOI 10.1111/1365-2664.12153; Rodrigo A, 2008, ECOSCIENCE, V15, P442, DOI 10.2980/15-4-3117; ROFF DA, 1991, AM ZOOL, V31, P205; Saint-Germain M, 2005, FOREST ECOL MANAG, V212, P118, DOI 10.1016/j.foreco.2005.03.001; Saint-Germain M, 2007, J APPL ECOL, V44, P330, DOI 10.1111/j.1365-2664.2006.01269.x; Schimmel J, 1996, ECOLOGY, V77, P1436, DOI 10.2307/2265541; Schowalter TD, 2012, ANNU REV ENTOMOL, V57, P1, DOI 10.1146/annurev-ento-120710-100610; Smucker KM, 2005, ECOL APPL, V15, P1535, DOI 10.1890/04-1353; Steffan-Dewenter I, 1997, OECOLOGIA, V109, P294, DOI 10.1007/s004420050087; Swift, 1983, DECOMPOSITION TROPIC; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Teague B., 2010, 2009 VICTORIAN BUSHF; TU CM, 1980, MICROB ECOL, V5, P321, DOI 10.1007/BF02020339; Vasconcelos HL, 2008, AUSTRAL ECOL, V33, P221, DOI 10.1111/j.1442-9993.2007.01811.x; Venables WN., 2002, MODERN APPL STAT S 4; Verdasca MJ, 2012, BIOL CONSERV, V146, P14, DOI 10.1016/j.biocon.2011.10.031; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Wardle D., 2002, COMMUNITIES ECOSYSTE; Watson PJ, 2012, INT J WILDLAND FIRE, V21, P755, DOI 10.1071/WF11034; Wikars LO, 2001, FOREST ECOL MANAG, V141, P189, DOI 10.1016/S0378-1127(00)00328-5; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Yanoviak SP, 2000, OIKOS, V89, P259, DOI 10.1034/j.1600-0706.2000.890206.x	83	19	19	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124556	10.1371/journal.pone.0124556	http://dx.doi.org/10.1371/journal.pone.0124556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880062	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500106
J	Shah, S; Sanchez, J; Stewart, A; Piperakis, MM; Cosstick, R; Nichols, C; Park, CK; Ma, X; Wysocki, V; Bitinaite, J; Horton, NC				Shah, Santosh; Sanchez, Jonathan; Stewart, Andrew; Piperakis, Michael M.; Cosstick, Richard; Nichols, Claire; Park, Chad K.; Ma, Xin; Wysocki, Vicki; Bitinaite, Jurate; Horton, Nancy C.			Probing the Run-On Oligomer of Activated SgrAI Bound to DNA	PLOS ONE			English	Article							MOBILITY-MASS-SPECTROMETRY; RESTRICTION-ENDONUCLEASE; ION MOBILITY; 3'-S-PHOSPHOROTHIOLATE LINKAGE; SEQUENCE-SPECIFICITY; AUTOMATED SYNTHESIS; METABOLIC ENZYMES; PROTEIN COMPLEXES; CLEAVAGE; OLIGODEOXYNUCLEOTIDES	SgrAI is a type II restriction endonuclease with an unusual mechanism of activation involving run-on oligomerization. The run-on oligomer is formed from complexes of SgrAI bound to DNA containing its 8 bp primary recognition sequence (uncleaved or cleaved), and also binds (and thereby activates for DNA cleavage) complexes of SgrAI bound to secondary site DNA sequences which contain a single base substitution in either the 1st/8th or the 2nd/7th position of the primary recognition sequence. This modulation of enzyme activity via runon oligomerization is a newly appreciated phenomenon that has been shown for a small but increasing number of enzymes. One outstanding question regarding the mechanistic model for SgrAI is whether or not the activating primary site DNA must be cleaved by SgrAI prior to inducing activation. Herein we show that an uncleavable primary site DNA containing a 3'S-phosphorothiolate is in fact able to induce activation. In addition, we now show that cleavage of secondary site DNA can be activated to nearly the same degree as primary, provided a sufficient number of flanking base pairs are present. We also show differences in activation and cleavage of the two types of secondary site, and that effects of selected single site substitutions in SgrAI, as well as measured collisional cross-sections from previous work, are consistent with the cryo-electron microscopy model for the run-on activated oligomer of SgrAI bound to DNA.	[Shah, Santosh; Sanchez, Jonathan; Stewart, Andrew; Nichols, Claire; Park, Chad K.; Ma, Xin; Wysocki, Vicki; Horton, Nancy C.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Stewart, Andrew] Univ Arizona, Grad Program Genet, Tucson, AZ 85721 USA; [Piperakis, Michael M.; Cosstick, Richard] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Ma, Xin; Wysocki, Vicki] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Bitinaite, Jurate] New England Biolabs Inc, Ipswich, MA 01938 USA	University of Arizona; University of Arizona; University of Liverpool; University System of Ohio; Ohio State University; New England Biolabs	Horton, NC (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	nhorton@u.arizona.edu	Horton, Nancy C/E-7881-2011	Horton, Nancy C/0000-0003-2710-8284; Bitinaite, Jurate/0000-0002-9190-6355; Wysocki, Vicki/0000-0003-0495-2538; Sanchez, Jonathan/0000-0003-0097-465X; Ma, Xin/0000-0002-2917-179X; Stewart, Andrew M/0000-0002-1645-3392	NSF [MCB-1410355]; NIH [T32GM008659, S10OD013237]; New England Biolabs, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD013237] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1410355] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Biolabs, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by NSF MCB-1410355 (www.nsf.gov)(to NCH), NIH T32GM008659 (www.nih.gov) (to JS), and NIH S10OD013237 (www.nih.gov)(to CKP). New England Biolabs, Inc provided support in the form of salaries for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AGGARWAL A K, 1990, Methods (Orlando), V1, P83, DOI 10.1016/S1046-2023(05)80150-1; Babic AC, 2008, J MOL BIOL, V383, P186, DOI 10.1016/j.jmb.2008.08.032; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Barry RM, 2011, CURR OPIN MICROBIOL, V14, P704, DOI 10.1016/j.mib.2011.09.015; Bitinaite J, 2002, P NATL ACAD SCI USA, V99, P1164, DOI 10.1073/pnas.022346799; CAREY J, 1991, METHOD ENZYMOL, V208, P103; Daniels LE, 2003, J MOL BIOL, V327, P579, DOI 10.1016/S0022-2836(03)00143-8; Dunten PW, 2008, NUCLEIC ACIDS RES, V36, P5405, DOI 10.1093/nar/gkn510; Fasman GD, HDB BIOCH MOL BIOL; Gaynor JW, 2007, NAT PROTOC, V2, P3122, DOI 10.1038/nprot.2007.451; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Hall Z, 2012, J AM CHEM SOC, V134, P3429, DOI 10.1021/ja2096859; Hingorani-Varma K, 2003, J BIOL CHEM, V278, P40392, DOI 10.1074/jbc.M304603200; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Joshi HK, 2006, J BIOL CHEM, V281, P23852, DOI 10.1074/jbc.M512339200; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Little EJ, 2011, ACTA CRYSTALLOGR D, V67, P67, DOI 10.1107/S0907444910047785; Lyumkis D, 2013, STRUCTURE, V21, P1848, DOI 10.1016/j.str.2013.08.012; Ma X, 2013, BIOCHEMISTRY-US, V52, P4373, DOI 10.1021/bi3013214; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2014, MOL BIOL CELL, V25, P2282, DOI 10.1091/mbc.E14-04-0912; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; O'Connell JD, 2014, MOL BIOSYST, V10, P851, DOI 10.1039/c3mb70508k; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Park CK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000554; Park CK, 2010, BIOCHEMISTRY-US, V49, P8818, DOI 10.1021/bi100557v; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Piperakis MM, 2013, ORG BIOMOL CHEM, V11, P966, DOI 10.1039/c2ob26940f; Reid SL, 2001, BIOCHEMISTRY-US, V40, P2484, DOI 10.1021/bi001956p; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Sabbagh G, 2004, NUCLEIC ACIDS RES, V32, P495, DOI 10.1093/nar/gkh189	34	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124783	10.1371/journal.pone.0124783	http://dx.doi.org/10.1371/journal.pone.0124783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880668	gold, Green Submitted, Green Published			2022-12-26	WOS:000353016500111
J	Taghizadeh, N; Boezen, HM; Schouten, JP; Schroder, CP; de Vries, EGE; Vonk, JM				Taghizadeh, Niloofar; Boezen, H. Marike; Schouten, Jan P.; Schroder, Carolien P.; de Vries, E. G. Elisabeth; Vonk, Judith M.			BMI and Lifetime Changes in BMI and Cancer Mortality Risk	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; PROSTATE-CANCER; LUNG-CANCER; GENERAL-POPULATION; PHYSICAL-ACTIVITY; FOLLOW-UP; OBESITY; ASSOCIATION; OVERWEIGHT	Body Mass Index (BMI) is known to be associated with cancer mortality, but little is known about the link between lifetime changes in BMI and cancer mortality in both males and females. We studied the association of BMI measurements (at baseline, highest and lowest BMI during the study-period) and lifetime changes in BMI (calculated over different time periods (i. e. short time period: annual change in BMI between successive surveys, long time period: annual change in BMI over the entire study period) with mortality from any cancer, and lung, colorectal, prostate and breast cancer in a large cohort study (n= 8,645. Vlagt-wedde-Vlaardingen, 1965-1990) with a follow-up on mortality status on December 31st 2008. We used multivariate Cox regression models with adjustments for age, smoking, sex, and place of residence. Being overweight at baseline was associated with a higher risk of prostate cancer mortality (hazard ratio (HR) = 2.22; 95% CI 1.19-4.17). Obesity at baseline was associated with a higher risk of any cancer mortality[ all subjects (1.23 (1.01-1.50)), and females (1.40 (1.07-1.84))]. Chronically obese females (females who were obese during the entire study-period) had a higher risk of mortality from any cancer (2.16 (1.47-3.18), lung (3.22 (1.06-9.76)), colorectal (4.32 (1.53-12.20)), and breast cancer (2.52 (1.15-5.54)). We found no significant association between long-term annual change in BMI and cancer mortality risk. Both short-term annual increase and decrease in BMI were associated with a lower mortality risk from any cancer[ all subjects: (0.67 (0.47-0.94)) and (0.73 (0.55-0.97)), respectively]. In conclusion, a higher BMI is associated with a higher cancer mortality risk. This study is the first to show that short-term annual changes in BMI were associated with lower mortality from any type of cancer.	[Taghizadeh, Niloofar; Boezen, H. Marike; Schouten, Jan P.; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Boezen, H. Marike; Schouten, Jan P.; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Schroder, Carolien P.; de Vries, E. G. Elisabeth] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	H.M.Boezen@umcg.nl	Vonk, Judith M/ABA-3009-2020; Vonk, Judith/K-8477-2019; Taghizadeh, Niloofar/AAF-2008-2020	Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547; de Vries, Elisabeth/0000-0002-8949-7425	Netherlands Asthma Found [187, 32.96.69]; Stichting Astma Bestrijding [2005/020]; Groningen University Institute for Drug Exploration	Netherlands Asthma Found; Stichting Astma Bestrijding; Groningen University Institute for Drug Exploration	This study was supported by the Netherlands Asthma Found (grant numbers 187 and 32.96.69), the Stichting Astma Bestrijding (grant number 2005/020) and Groningen University Institute for Drug Exploration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aleksandrova Krasimira, 2013, Front Biosci (Elite Ed), V5, P61; Lima GAB, 2009, ARQ BRAS ENDOCRINOL, V53, P969, DOI 10.1590/S0004-27302009000800010; Bennette C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-21; Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cao Y, 2011, CANCER PREV RES, P4486; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Derby CA, 2006, CLIN ENDOCRINOL, V65, P125, DOI 10.1111/j.1365-2265.2006.02560.x; El-Bastawissi AY, 2005, CANCER CAUSE CONTROL, V16, P407, DOI 10.1007/s10552-004-5027-8; Engeland A, 2003, BRIT J CANCER, V89, P1237, DOI 10.1038/sj.bjc.6601206; Fernandez E, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4544; Figarska SM, 2012, EUR J EPIDEMIOL, V27, P867, DOI 10.1007/s10654-012-9736-0; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Guilera M, 2005, NUTR CANCER, V51, P140, DOI 10.1207/s15327914nc5102_3; Haggstrom C, 2012, CANCER-AM CANCER SOC, V118, P6199, DOI 10.1002/cncr.27677; Hoffman MA, 2000, J UROLOGY, V163, P824, DOI 10.1016/S0022-5347(05)67812-3; Hospers JJ, 2000, EPIDEMIOLOGY, V11, P261, DOI 10.1097/00001648-200005000-00006; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Kitahara CM, 2013, J CLIN ONCOL, V31, P2450, DOI 10.1200/JCO.2012.48.4691; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Leung CC, 2011, INT J EPIDEMIOL, V40, P174, DOI 10.1093/ije/dyq134; Ma J, 2008, LANCET ONCOL, V9, P1039, DOI 10.1016/S1470-2045(08)70235-3; Michels KB, 2012, INT J CANCER, V130, P902, DOI 10.1002/ijc.26069; Nakada T, 2012, J TOXICOL SCI, V37, P555; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Petekkaya I, 2013, TUMORI J, V99, P129, DOI 10.1700/1283.14180; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Roddam AW, 2008, J NATL CANCER I, V100, P170, DOI 10.1093/jnci/djm323; Smith L, 2012, JNCI-J NATL CANCER I, V104, P778, DOI 10.1093/jnci/djs179; Tee MC, 2013, SURG ENDOSC, V27, P4449, DOI 10.1007/s00464-013-3127-9; VANDERLENDE R, 1981, CLIN RES PROC, V17, P775; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yang Y, 2013, INT J CANCER, V132, P1162, DOI 10.1002/ijc.27719; Zajacova A, 2013, GERONTOLOGIST; Zhao J, 2012, BMC PUBLIC HEALTH, V12, P12, DOI [10.1186/1471-2458-12-12, DOI 10.1186/1471-2458-12-12]; Zheng H, 2013, AM J EPIDEMIOL, DOI 10.1093	38	63	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0125261	10.1371/journal.pone.0125261	http://dx.doi.org/10.1371/journal.pone.0125261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881129	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500116
J	Wu, GY; Suo, ST; Lu, Q; Zhang, J; Zhu, WQ; Xu, JR				Wu, Guang-yu; Suo, Shi-teng; Lu, Qing; Zhang, Jin; Zhu, Wan-qiu; Xu, Jian-rong			The Value of Blood Oxygenation Level-Dependent (BOLD) MR Imaging in Differentiation of Renal Solid Mass and Grading of Renal Cell Carcinoma (RCC): Analysis Based on the Largest Cross-Sectional Area versus the Entire Whole Tumour	PLOS ONE			English	Article							SUBTYPE DIFFERENTIATION; RADIOFREQUENCY ABLATION; EXPERIENCE; NEPHRECTOMY; ANGIOGENESIS; MANAGEMENT; SURGERY; LESIONS; STAGE	Objectives To study the value of assessing renal masses using different methods in parameter approaches and to determine whether BOLD MRI is helpful in differentiating RCC from benign renal masses, differentiating clear-cell RCC from renal masses other than clear-cell RCC and determining the tumour grade. Methods Ninety-five patients with 139 renal masses (93 malignant and 46 benign) who underwent abdominal BOLD MRI were enrolled. R2* values were derived from the largest cross-section (R2* largest) and from the whole tumour (R2*(whole)). Intra-observer and inter-observer agreements were analysed based on two measurements by the same observer and the first measurement from each observer, respectively, and these agreements are reported with intraclass correlation coefficients and 95% confidence intervals. The diagnostic value of the R2* value in the evaluation was assessed with receiver-operating characteristic analysis. Results The intra-observer agreement was very good for R2*(largest) and R2*(whole) (all > 0.8). The inter-observer agreement of R2*(whole) (0.75, 95% confidence interval: 0.69 similar to 0.79) was good and was significantly improved compared with the R2*(largest) (0.61, 95% confidence interval: 0.52 similar to 0.68), as there was no overlap in the 95% confidence interval of the intra-class correlation coefficients. The diagnostic value in differentiating renal cell carcinoma from benign lesions with R2*(whole) (AUC=0.79/0.78[observer1/observer2]) and R2*(largest) (AUC=0.75[observer1]) was good and significantly higher (p= 0.01 for R2*(largest)[observer2] vs R2*(whole)[observer2], p < 0.01 for R2* (whole)[observer1] vs R2*(largest)[observer2]) than R2*(largest) for observer2 (AUC=0.64). For the grading of clear-cell RCC, both R2*(whole) and R2*(largest) were good (all > 0.7) and were not significantly different (p=0.89/0.93 for R2*largest vs R2*whole[observer1/observer2], 0.96 for R2*whole[observer1] vs R2*largest[observer2] and 0.96 for R2* whole [observer2] vs R2* largest[observer1]). Conclusions BOLD MRI could provide a feasible parameter for differentiating renal cell carcinoma from benign renal masses and for predicting clear-cell renal cell carcinoma grading. Compared with the largest cross-section, assessing the whole tumour provides better inter-observer agreement in parameter measurement for differentiating renal cell carcinoma from benign renal masses.	[Wu, Guang-yu; Suo, Shi-teng; Lu, Qing; Zhu, Wan-qiu; Xu, Jian-rong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Zhang, Jin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, JR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	renjixujr@163.com			National Natural Science Foundation of China [81371622]; National Basic Research Program of China/973 Program [2012CB932600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China/973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (81371622) and National Basic Research Program of China/973 Program (2012CB932600).	Abdellaoui A, 2008, FUTURE ONCOL, V4, P103, DOI 10.2217/14796694.4.1.103; Beck SDW, 2004, ANN SURG ONCOL, V11, P71, DOI 10.1007/BF02524349; Breen DJ, 2007, CARDIOVASC INTER RAD, V30, P936, DOI 10.1007/s00270-007-9090-x; Chen DYT, 2009, J NATL COMPR CANC NE, V7, P635, DOI 10.6004/jnccn.2009.0044; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Choi YA, 2014, AM J ROENTGENOL, V203, pW78, DOI 10.2214/AJR.13.11551; Fenner Annette, 2013, Nat Rev Urol, V10, P310, DOI 10.1038/nrurol.2013.102; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1016/S0022-5347(05)64153-5; Hankins JS, 2009, BLOOD, V113, P4853, DOI 10.1182/blood-2008-12-191643; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kinouchi T, 2003, UROLOGY, V62, P765, DOI 10.1016/S0090-4295(03)00512-0; Liu M, 2013, EUR RADIOL, V23, P3221, DOI 10.1007/s00330-013-2937-4; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Min JH, 2011, AM J ROENTGENOL, V197, pW489, DOI 10.2214/AJR.10.6319; Moczko Jerzya A, 2013, Przegl Lek, V70, P875; Nativ O, 1998, UROLOGY, V51, P693, DOI 10.1016/S0090-4295(98)00019-3; Padhani A, 2010, RADIOLOGY, V254, P1, DOI 10.1148/radiol.091669; Padhani AR, 2007, EUR RADIOL, V17, P861, DOI 10.1007/s00330-006-0431-y; Park HJ, 2014, ABDOM IMAGING, V39, P142, DOI 10.1007/s00261-013-0044-2; Patard JJ, 2004, J UROLOGY, V171, P2181, DOI 10.1097/01.ju.0000124846.37299.5e; Pedrosa I, 2008, RADIOGRAPHICS, V28, P985, DOI 10.1148/rg.284065018; Prasad PV, 2006, NEPHRON CLIN PRACT, V103, pC58, DOI 10.1159/000090610; Sadowski EA, 2005, RADIOLOGY, V236, P911, DOI 10.1148/radiol.2363041080; Snyder ME, 2006, J UROLOGY, V176, P2391, DOI 10.1016/j.juro.2006.08.013; Song TR, 2012, UROL ANNALS, V4, P24, DOI 10.4103/0974-7796.91617; Thomsen HS, 2006, EUR RADIOL, V16, P1835, DOI 10.1007/s00330-006-0223-4; Wang HY, 2010, RADIOLOGY, V257, P135, DOI 10.1148/radiol.10092396	27	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123431	10.1371/journal.pone.0123431	http://dx.doi.org/10.1371/journal.pone.0123431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875306	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800097
J	Yebyo, H; Alemayehu, M; Kahsay, A				Yebyo, Henock; Alemayehu, Mussie; Kahsay, Alemayehu			Why Do Women Deliver at Home? Multilevel Modeling of Ethiopian National Demographic and Health Survey Data	PLOS ONE			English	Article							INSTITUTIONAL DELIVERY; BIRTH ATTENDANTS; CHILDBIRTH; FACILITIES; SERVICES; PRADESH; STATE	Background Despite of the existing intensive efforts to improve maternal health in Ethiopia, the proportion of birth delivered at home remains high and is still the top priority among the national health threats. Objective The study aimed to examine effects of individual women and community-level factors of women's decision on place of delivery in Ethiopia. Methods Data were obtained from the nationally representative 2011 Ethiopian Demographic and Health Survey (EDHS) which used a two-stage cluster sampling design with rural-urban and regions as strata. The EDHS collected data from a big sample size but our study focused on a sample of 7,908 women whose most recent birth was within five years preceding 2011 and 576 communities in which the women were living in. The data were analyzed using a two-level mixed-effects logistic regression to determine fixed-effects of individual- and community-level factors and random-intercept of between-cluster characteristics. Results In the current study, 6980 out of 7908 deliveries (88.3%) took place at home. Lower educational levels (OR=2.74, 95%CI:1.84,4.70; p<0.0001), making no or only a limited number of ANC visits (OR=3.72,95% CI:2.85, 4.83; p<0.0001), non-exposure to media (OR=1.51, 95% CI 1.13, 2.01; p=0.004), higher parity (OR=2.68, 95%CI:1.96,3.68; p<0.0001), and perceived distance problem to reach health facilities (OR=1.29, 95%CI:1.03,1.62; p=0.022) were positively associated with home delivery. About 75% of the total variance in the odds of giving birth at home was accounted for the between-community differences of characteristics (ICC=0.75, p<0.0001). With regard to community-level characteristics, rural communities (OR=4.67, 95%CI:3.06,7.11; p<0.0001), pastoralist communities (OR=4.53, 95%CI:2.81,7.28; p<0.0001), communities with higher poverty levels (OR=1.49 95%CI:1.08,2.22; p=0.048), with lower levels of ANC utilization (OR=2.01, 95%CI:1.42,2.85; p<0.0001) and problem of distance to a health facility (OR=1.29, 95%CI:1.03,1.62; p=0.004) had a positive influence on women to give birth at home. Conclusions Not only individual characteristics of women, but also community-level factors determine women's decision to deliver at home.	[Yebyo, Henock; Alemayehu, Mussie; Kahsay, Alemayehu] Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Yebyo, H (corresponding author), Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.	henok.yebyo@mu.edu.et	Alemayehu, Mussie/AAH-3016-2019; PAN, ZEQIANG/X-6341-2018	Alemayehu, Mussie/0000-0002-0035-631X; Yebyo, Henock/0000-0001-5400-2448	United States Agency for International Development (USAID); ICF International	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); ICF International	The authors would like to thank United States Agency for International Development (USAID) and ICF International for their technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu S, 2012, BMC PREGNANCY CHILDB, V12, P47, DOI [10.1186/1471-2393-12-47, DOI 10.1186/1471-2393-12-47]; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; [Anonymous], J FAM WELFARE; Aremu O, 2012, INT J PREVENTIVE MED, V3, P278; Asmeret M., 2013, LEVELS DETERMINANTS, P83; Begum H. A., 2012, Journal of Family and Reproductive Health, V6, P49; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; CSA ICF, 2012, ETH DEM HLTH SURV 20; Faye A, 2011, ACTA OBSTET GYNECOLO, V4; Fikre AA, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-33; FMoH, 2015, DIS PREV CONTR; FMOH, 2010, HLTH SECT DEV PROGR; Friberg I, 2010, PLOS MED, V21, P7; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gebrehiwot T, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-137; Gedefaw A., 2013, ETHIOPIA SCI J PUBLI, V1, P18; Idris S. H., 2006, Annals of African Medicine, V5, P68; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Johnson FA, 2009, J COMMUN HEALTH, V34, P64, DOI 10.1007/s10900-008-9120-x; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kamal SMM, 2013, J HEALTH POPUL NUTR, V31, P96; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Koblinsky M, 2010, ETHIOP J HEALTH DEV, V24, P105; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; Lwelamira J, 2012, ASIAN J MED SCI, V4, P105; Mekonnen Medhanit Getachew, 2012, Pan Afr Med J, V13 Suppl 1, P17; Moore B., 2011, J MED MED SCI, V2, P864; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Mulumebet A, 2011, J HEALTH SCI, V21, P95; Nair M, 2012, RURAL REMOTE HEALTH, V12; Paul BK, 2002, SOC SCI MED, V54, P1755, DOI 10.1016/S0277-9536(01)00148-4; Rockers PC, 2009, MATERN CHILD HLTH J, V13, P879, DOI 10.1007/s10995-008-0412-7; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Tsegay Y, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-30; Tura G, 2008, ETHIOP J HLTH SCI, V17, P213; Utomo B, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-47; Wahed T, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-50; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990	38	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124718	10.1371/journal.pone.0124718	http://dx.doi.org/10.1371/journal.pone.0124718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874886	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800149
J	Mutai, H; Miya, F; Fujii, M; Tsunoda, T; Matsunaga, T				Mutai, Hideki; Miya, Fuyuki; Fujii, Masato; Tsunoda, Tatsuhiko; Matsunaga, Tatsuo			Attenuation of Progressive Hearing Loss in DBA/2J Mice by Reagents that Affect Epigenetic Modifications Is Associated with Up-Regulation of the Zinc Importer Zip4	PLOS ONE			English	Article							GENE-EXPRESSION; INNER-EAR; CONTROLLED-TRIAL; C57BL/6J MICE; COCHLEA; TINNITUS; MODEL; TRANSPORTERS; MAINTENANCE; METHYLATION	Various factors that are important for proper hearing have been identified, including serum levels of zinc. Here we investigated whether epigenetic regulatory pathways, which can be modified by environmental factors, could modulate hearing. RT-PCR detected expression of genes encoding DNA methyltransferase and histone deacetylase (Hdac) in the postnatal as well as adult mouse auditory epithelium. DBA/2J mice, which are a model for progressive hearing loss, were injected subcutaneously with one or a combination of the following reagents: <smallcaps> L</smallcaps>-methionine as a methyl donor, valproic acid as a pan-Hdac inhibitor, and folic acid and vitamin B12 as putative factors involved in age-related hearing loss. The mice were treated from ages 4 to 12 weeks (N >= 5), and auditory brain-stem response (ABR) thresholds were measured at 8, 16, and 32 kHz. Treatment of the mice with a combination of <smallcaps> L</smallcaps>-methionine and valproic acid (M+V) significantly reduced the increase in the ABR threshold at 32 kHz. Treatment with any of these reagents individually produced no such effect. Microarray analyses detected 299 gene probes that were significantly up-or down-regulated in the cochleae of mice treated with M+V compared with the control vehicle-treated mice. Quantitative RT-PCR confirmed significant up-regulation of a zinc importer gene, Zip4, in the cochleae of mice treated with M+V. Immunohistochemistry demonstrated an intense Zip4 signal in cochlear tissues such as the lateral wall, organ of Corti, and spiral ganglion. Finally, mice treated with the Zip4 inducer (-)-epigallocatechin-3-O-gallate showed a significant reduction in the increase of the ABR threshold at 32 kHz and up-regulation of Zip4 expression in the cochlea. This study suggests that epigenetic regulatory pathways can modify auditory function and that zinc intake in the cochlea via Zip4 mediates maintenance of mammalian hearing.	[Mutai, Hideki; Matsunaga, Tatsuo] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Div Balance & Hearing Res, Lab Auditory Disorders,Meguro Ku, Tokyo, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Fujii, Masato] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Div Balance & Hearing Res, Meguro Ku, Tokyo, Japan	RIKEN	Mutai, H (corresponding author), Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Div Balance & Hearing Res, Lab Auditory Disorders,Meguro Ku, Tokyo, Japan.	mutaihideki@kankakuki.go.jp	Tsunoda, Tatsuhiko/K-2061-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Miya, Fuyuki/0000-0001-6758-2015; matsunaga, tatsuo/0000-0001-9647-1496	Japan Society for the Promotion of Science KAKENHI [21791659, 24592573, 24390391]; Grants-in-Aid for Scientific Research [24592573] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding for this work came from Japan Society for the Promotion of Science KAKENHI (http://www.jsps.go.jp/j-grantsinaid/) grant numbers 21791659 and 24592573 to HM and 24390391 to TM. Grant numbers 21791659 and 24592573 supported study design, data collection, analysis, and preparation of the manuscript. Grant 24390391 supported data analysis.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkiten G, 2015, AM J OTOLARYNG, V36, P230, DOI 10.1016/j.amjoto.2014.11.001; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen FQ, 2009, J NEUROCHEM, V108, P1226, DOI 10.1111/j.1471-4159.2009.05871.x; D'Souza M, 2008, J NEUROSCI METH, V171, P279, DOI 10.1016/j.jneumeth.2008.02.022; De Silva MG, 2006, ACTA OTO-LARYNGOL, V126, P1148, DOI 10.1080/00016480600702118; Drottar M, 2006, LARYNGOSCOPE, V116, P292, DOI 10.1097/01.mlg.0000197630.85208.36; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Durga J, 2007, ANN INTERN MED, V146, P1, DOI 10.7326/0003-4819-146-1-200701020-00003; Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/582849; Fujinami Y, 2012, J PHARMACOL SCI, V118, P363, DOI 10.1254/jphs.11227FP; GERSDORFF M, 1987, ARCH OTO-RHINO-LARYN, V244, P190, DOI 10.1007/BF00464266; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; HOEVE LJ, 1990, EUR ARCH OTO-RHINO-L, V247, P267, DOI 10.1007/BF00176533; Houston DK, 1999, AM J CLIN NUTR, V69, P564; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; ICHIMIYA I, 1994, ACTA OTO-LARYNGOL, V114, P167, DOI 10.3109/00016489409126037; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002; Kang WS, 2012, NEUROREPORT, V23, P201, DOI 10.1097/WNR.0b013e328350235f; King JC, 2011, AM J CLIN NUTR, V94, p679S, DOI 10.3945/ajcn.110.005744; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Lasisi AO, 2010, OTOLARYNG HEAD NECK, V143, P826, DOI 10.1016/j.otohns.2010.08.031; Marano RJ, 2012, AGING CLIN EXP RES, V24, P603, DOI 10.3275/8590; Mikaelian D, 1965, ACTA OTO-LARYNGOL, V59, P451, DOI DOI 10.3109/00016486509124579; Mikuriya T, 2008, BRAIN RES, V1212, P9, DOI 10.1016/j.brainres.2008.03.031; Morsli H, 1999, DEVELOPMENT, V126, P2335; Mutai H, 2009, NEUROSCIENCE, V163, P1255, DOI 10.1016/j.neuroscience.2009.07.059; Mutai H, 2009, DEV NEUROBIOL, V69, P913, DOI 10.1002/dneu.20746; Nicholas S, 1999, J Am Acad Audiol, V10, P436; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Ochi K, 1997, OTOLARYNGOL JPN, V100, P915; PAASKE PB, 1991, ANN OTO RHINOL LARYN, V100, P647, DOI 10.1177/000348949110000809; Pillion JP, 2000, AUDIOLOGY, V39, P80; Provenzano MJ, 2007, HEARING RES, V233, P1, DOI 10.1016/j.heares.2007.07.002; Quesada IM, 2011, J NUTR BIOCHEM, V22, P153, DOI 10.1016/j.jnutbio.2009.12.009; Rarey KE, 1996, ACTA OTO-LARYNGOL, V116, P833, DOI 10.3109/00016489609137935; Reser D, 1999, NEUROTOXICOLOGY, V20, P731; SHAMBAUGH GE, 1989, AM J OTOL, V10, P156; SHAMBAUGH GE, 1985, AM J OTOL, V6, P116; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Someya S, 2007, BRAIN RES, V1182, P26, DOI 10.1016/j.brainres.2007.08.090; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Srividhya R, 2008, INT J DEV NEUROSCI, V26, P217, DOI 10.1016/j.ijdevneu.2007.12.003; Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999; Tremolizzo L, 2005, BIOL PSYCHIAT, V57, P500, DOI 10.1016/j.biopsych.2004.11.046; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Waldhaus J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036066; Willott JF, 1998, HEARING RES, V119, P27, DOI 10.1016/S0378-5955(98)00029-X; Yang CH, 2011, LARYNGOSCOPE, V121, P617, DOI 10.1002/lary.21291; ZENG XR, 1994, J BIOL CHEM, V269, P13748; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	55	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124301	10.1371/journal.pone.0124301	http://dx.doi.org/10.1371/journal.pone.0124301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875282	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700065
J	Fattebert, J; Balme, G; Dickerson, T; Slotow, R; Hunter, L				Fattebert, Julien; Balme, Guy; Dickerson, Tristan; Slotow, Rob; Hunter, Luke			Density-Dependent Natal Dispersal Patterns in a Leopard Population Recovering from Over-Harvest	PLOS ONE			English	Article							SPATIAL STRUCTURE; IBERIAN LYNX; DYNAMICS; HABITAT; METAPOPULATION; SELECTION	Natal dispersal enables population connectivity, gene flow and metapopulation dynamics. In polygynous mammals, dispersal is typically male-biased. Classically, the 'mate competition', 'resource competition' and 'resident fitness' hypotheses predict density-dependent dispersal patterns, while the 'inbreeding avoidance' hypothesis posits density-independent dispersal. In a leopard (Panthera pardus) population recovering from over-harvest, we investigated the effect of sex, population density and prey biomass, on age of natal dispersal, distance dispersed, probability of emigration and dispersal success. Over an 11-year period, we tracked 35 subadult leopards using VHF and GPS telemetry. Subadult leopards initiated dispersal at 13.6 +/- 0.4 months. Age at commencement of dispersal was positively density-dependent. Although males (11.0 +/- 2.5 km) generally dispersed further than females (2.7 +/- 0.4 km), some males exhibited opportunistic philopatry when the population was below capacity. All 13 females were philopatric, while 12 of 22 males emigrated. Male dispersal distance and emigration probability followed a quadratic relationship with population density, whereas female dispersal distance was inversely density-dependent. Eight of 12 known-fate females and 5 of 12 known-fate male leopards were successful in settling. Dispersal success did not vary with population density, prey biomass, and for males, neither between dispersal strategies (philopatry vs. emigration). Females formed matrilineal kin clusters, supporting the resident fitness hypothesis. Conversely, mate competition appeared the main driver for male leopard dispersal. We demonstrate that dispersal patterns changed over time, i.e. as the leopard population density increased. We conclude that conservation interventions that facilitated local demographic recovery in the study area also restored dispersal patterns disrupted by unsustainable harvesting, and that this indirectly improved connectivity among leopard populations over a larger landscape.	[Fattebert, Julien; Balme, Guy; Dickerson, Tristan; Hunter, Luke] Panthera, New York, NY 10018 USA; [Fattebert, Julien; Slotow, Rob; Hunter, Luke] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Balme, Guy] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa; [Slotow, Rob] UCL, Dept Genet Evolut & Environm, London, England	University of Kwazulu Natal; University of Cape Town; University of London; University College London	Fattebert, J (corresponding author), Panthera, New York, NY 10018 USA.	julien.fattebert@gmail.com	Fattebert, Julien/I-8126-2019; Hunter, Luke T.B./H-3324-2019; Slotow, Rob/AAM-9053-2020	Fattebert, Julien/0000-0001-5510-6804; Hunter, Luke T.B./0000-0001-9653-6544; Slotow, Rob/0000-0001-9469-1508	Panthera; Albert and Didy Hartog; Stichting Timbo Foundation; National Research Foundation [FA 2004050400038]; University of KwaZulu-Natal Gay Langmuir Bursary	Panthera; Albert and Didy Hartog; Stichting Timbo Foundation; National Research Foundation; University of KwaZulu-Natal Gay Langmuir Bursary	The work was funded by Panthera (http://www.panthera.org), Albert and Didy Hartog, the Stichting Timbo Foundation (http://www.stichting-timbo.nl), the National Research Foundation (FA 2004050400038 to GB), and the University of KwaZulu-Natal Gay Langmuir Bursary (to JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P.K, 1989, DISPERSAL RODENTS RE; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2013, ANIM BEHAV, V86, P791, DOI 10.1016/j.anbehav.2013.07.019; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Barton K., 2013, MUMIN MULTIMODEL INF; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beyer H. L, 2012, GEOSPATIAL MODELLING; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; COCKBURN A, 1985, OIKOS, V44, P367, DOI 10.2307/3544715; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Elliot NB, 2014, OIKOS, V123, P1049, DOI 10.1111/oik.01266; Fattebert J., 2014, THESIS U KWAZULU NAT; Fattebert J, 2015, ECOL APPL, V25, P1911, DOI 10.1890/14-1631.1; Fattebert J, 2013, S AFR J WILDL RES, V43, P61, DOI 10.3957/056.043.0108; Fieberg J, 2008, J WILDLIFE MANAGE, V72, P837, DOI 10.2193/2007-329; Gandon Sylvain, 2001, P155; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Goodrich JM, 2010, J MAMMAL, V91, P737, DOI 10.1644/09-MAMM-A-293.1; Gour DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066956; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gundersen G, 2001, ECOL LETT, V4, P14, DOI 10.1046/j.1461-0248.2001.00182.x; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; HOWARD WALTER E., 1960, AMER MIDLAND NAT, V63, P152, DOI 10.2307/2422936; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Lambin Xavier, 2001, P110; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Long RA, 2008, J WILDLIFE MANAGE, V72, P1133, DOI 10.2193/2007-337; Maehr DS, 2002, BIOL CONSERV, V106, P187, DOI 10.1016/S0006-3207(01)00245-2; Newby JR, 2013, BIOL CONSERV, V159, P230, DOI 10.1016/j.biocon.2012.10.018; Onorato D, 2011, J WILDLIFE MANAGE, V75, P378, DOI 10.1002/jwmg.43; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; Perrin Nicolas, 2001, P123; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Skinner J.D., 2005, MAMMALS SO AFRICA SU, V3rd; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Sutherland LJ, 2002, DISPERSAL ECOLOGY, P134; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Trinkel M, 2010, ANIM CONSERV, V13, P374, DOI 10.1111/j.1469-1795.2009.00344.x; Waser PM, 2001, CONSERV BIOL SER, V5, P484; Whitlock Michael C., 2001, P273; Wiens John A., 2001, P96; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WOLFF JO, 1994, OIKOS, V71, P349, DOI 10.2307/3546284; Zimmermann F, 2005, J ZOOL, V267, P381, DOI 10.1017/S0952836905007545	55	43	43	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122355	10.1371/journal.pone.0122355	http://dx.doi.org/10.1371/journal.pone.0122355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875293	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100066
J	Gaouar, SBS; Da Silva, A; Ciani, E; Kdidi, S; Aouissat, M; Dhimi, L; Lafri, M; Maftah, A; Mehtar, N				Gaouar, Samir Bachir Souheil; Da Silva, Anne; Ciani, Elena; Kdidi, Samia; Aouissat, Miloud; Dhimi, Laziz; Lafri, Mohamed; Maftah, Abderrahman; Mehtar, Nadhira			Admixture and Local Breed Marginalization Threaten Algerian Sheep Diversity	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; COMPUTER-PROGRAM; MICROSATELLITE; INFERENCE; RAREFACTION; SOFTWARE; ALLELES	Due to its geo-climatic conditions, Algeria represents a biodiversity hotspot, with sheep breeds well adapted to a patchwork of extremely heterogeneous harsh habitats. The importance of this peculiar genetic reservoir increases as climate change drives the demand for new adaptations. However, the expansion of a single breed (Ouled-Djellal) which occurred in the last decades has generated a critical situation for the other breeds; some of them are being subjected to uncontrolled cross-breeding with the favored breed and/or to marginalization (effective size contraction). This study investigated genetic diversity within and among six of the nine Algerian breeds, by use of 30 microsatellite markers. Our results showed that, in spite of the census contraction experienced by most of the considered breeds, genetic diversity is still substantial (average gene diversity ranging 0.68 to 0.76) and inbreeding was not identified as a problem. However, two breeds (Rembi and Taadmit) appeared to have lost most of their genetic originality because of intensive cross-breeding with Ouled-Djellal. Based on the above evidence, we suggest Hamra, Sidaoun, and D'man as breeds deserving the highest priority for conservation in Algeria.	[Gaouar, Samir Bachir Souheil; Mehtar, Nadhira] Aboubakr Belkaid Tlemcen Univ, Dept Biol, Tilimsen, Algeria; [Gaouar, Samir Bachir Souheil] Univ Sci & Technol, Mol & Cellular Lab USTOM, Oran, Algeria; [Da Silva, Anne; Maftah, Abderrahman] INRA, Genet Mol Anim UMR1061, Limoges, France; [Da Silva, Anne; Maftah, Abderrahman] Univ Limoges, Genet Mol Anim UMR1061, Limoges, France; [Ciani, Elena] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Kdidi, Samia] Arid Lands Inst Medenine, Livestock & Wildlife Lab, Medenine, Tunisia; [Kdidi, Samia] Tunis El Manar Univ, Fac Sci, Lab Genet Immunol & Human Pathol, Tunis, Tunisia; [Aouissat, Miloud] Tech Inst Breeding ITElv Ain El Hadjar, Saida, Algeria; [Dhimi, Laziz] Tech Inst Breeding ITElv Ain Mlila, Constantine, Algeria; [Lafri, Mohamed] Univ Blida, Lab Biotechnol Liees Reprod Anim LBRA, Blida, Algeria	INRAE; Universite de Limoges; Universita degli Studi di Bari Aldo Moro; Institut des Regions Arides; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite Saad Dahlab de Blida	Da Silva, A (corresponding author), INRA, Genet Mol Anim UMR1061, Limoges, France.	anne.blondeau@unilim.fr	Gaouar, Semir Bechir Suheil/J-1055-2019	ciani, elena/0000-0001-5673-0975; Gaouar, Semir Bechir Suheil/0000-0001-8691-7116	Italian Ministry of Agricultural, Food and Forestry Policies/University of Limoges (France)/University of Mohamed Boudiaf (Algeria)	Italian Ministry of Agricultural, Food and Forestry Policies/University of Limoges (France)/University of Mohamed Boudiaf (Algeria)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The partners of the project are "TROVIGEN", financed by the Italian Ministry of Agricultural, Food and Forestry Policies/University of Limoges (France)/University of Mohamed Boudiaf (Algeria).	BELKHIR K, 2000, 9060 CNRS UPR U MONT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calvo JH, 2006, SMALL RUMINANT RES, V64, P116, DOI 10.1016/j.smallrumres.2005.04.010; Chellig R, 1992, RACES OVINES ALGERIE, P1; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Ciani E, 2013, SMALL RUMINANT RES, V112, P21, DOI 10.1016/j.smallrumres.2012.12.013; Devendra C., 1982, GOAT SHEEP PRODUCTIO; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferrah A, 2013, ALGERIA ANAL FOOD AG; Food and Agricultural Organization of the United Nations, 1999, GLOB STRAT MAN FARM; Food and Agricultural Organization of the United Nations, 2011, MOL GEN CHAR AN GEN, V9, P65; Food and Agricultural Organization of the United Nations, 2014, CHAR VAL ADD LOC BRE; Gaouar S, 2005, Applications of Gene-Based Technologies for Improving Animal Production and Health in Developing Countries, P641, DOI 10.1007/1-4020-3312-5_48; Gaouar S, 2011, EAAP PUBLICATION, V129, P52; Gaouar S. B. S., 2014, Livestock Research for Rural Development, V26, P118; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gutierrez JP, 2005, J HERED, V96, P718, DOI 10.1093/jhered/esi118; Hedrick PW, 2013, J HERED, V104, P298, DOI 10.1093/jhered/ess139; Herold P, 2012, LIVEST PROD SCI, V129, P63; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lafri M, 2011, 4 JOURN VET; LAHLOU-KASSI A, 1989, Small Ruminant Research, V2, P225, DOI 10.1016/0921-4488(89)90003-5; Lewis P, 1999, GENETIC DATA ANAL CO; MADR, 2006, STAT AGR SYST INF; Miller SA, 1998, NUCLEIC ACIDS RES, V16, P12; National Report of the delinquency, 2009, CRIM FRANC; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Rege JEO, 2003, ECOL ECON, V45, P319, DOI 10.1016/S0921-8009(03)00087-9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santucci F, 2007, HEREDITY, V99, P340, DOI 10.1038/sj.hdy.6801006; Tapio I, 2005, HEREDITY, V94, P448, DOI 10.1038/sj.hdy.6800640; Tapio M, 2003, MOL ECOL, V12, P2045, DOI 10.1046/j.1365-294X.2003.01893.x; Trouette G., 1933, SELECTION OVINE TROU, P1; Upton M, 2004, 10 PPLPI FAO; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	47	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122667	10.1371/journal.pone.0122667	http://dx.doi.org/10.1371/journal.pone.0122667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875832	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100092
J	Ge, B; Tian, Y; Hu, XT; Chen, HB; Zhu, DJ; Zhang, T; Han, JW; Guo, L; Liu, TM				Ge, Bao; Tian, Yin; Hu, Xintao; Chen, Hanbo; Zhu, Dajiang; Zhang, Tuo; Han, Junwei; Guo, Lei; Liu, Tianming			Construction of Multi-Scale Consistent Brain Networks: Methods and Applications	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; WHITE-MATTER; SMALL-WORLD; ANATOMICAL NETWORKS; ARCHITECTURE; REGIONS; MRI; SEGMENTATION; ORGANIZATION; ATTENTION	Mapping human brain networks provides a basis for studying brain function and dysfunction, and thus has gained significant interest in recent years. However, modeling human brain networks still faces several challenges including constructing networks at multiple spatial scales and finding common corresponding networks across individuals. As a consequence, many previous methods were designed for a single resolution or scale of brain network, though the brain networks are multi-scale in nature. To address this problem, this paper presents a novel approach to constructing multi-scale common structural brain networks from DTI data via an improved multi-scale spectral clustering applied on our recently developed and validated DICCCOLs (Dense Individualized and Common Connectivity-based Cortical Landmarks). Since the DICCCOL landmarks possess intrinsic structural correspondences across individuals and populations, we employed the multi-scale spectral clustering algorithm to group the DICCCOL landmarks and their connections into sub-networks, meanwhile preserving the intrinsically-established correspondences across multiple scales. Experimental results demonstrated that the proposed method can generate multi-scale consistent and common structural brain networks across subjects, and its reproducibility has been verified by multiple independent datasets. As an application, these multi-scale networks were used to guide the clustering of multi-scale fiber bundles and to compare the fiber integrity in schizophrenia and healthy controls. In general, our methods offer a novel and effective framework for brain network modeling and tract-based analysis of DTI data.	[Ge, Bao] Minist Educ, Key Lab Modern Teaching Technol, Xian, Peoples R China; [Ge, Bao] Shaanxi Normal Univ, Sch Phys & Informat Technol, Xian, Peoples R China; [Tian, Yin] Xian Commun Inst, Dept Commun, Xian, Peoples R China; [Hu, Xintao; Zhang, Tuo; Han, Junwei; Guo, Lei] Northwestern Polytech Univ, Sch Automat, Xian 710072, Peoples R China; [Chen, Hanbo; Zhu, Dajiang; Liu, Tianming] Univ Georgia, Dept Comp Sci, Cort Architecture Imaging & Discovery Lab, Athens, GA 30602 USA; [Chen, Hanbo; Zhu, Dajiang; Liu, Tianming] Univ Georgia, Bioimaging Res Ctr, Athens, GA 30602 USA	Shaanxi Normal University; Northwestern Polytechnical University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Liu, TM (corresponding author), Univ Georgia, Dept Comp Sci, Cort Architecture Imaging & Discovery Lab, Athens, GA 30602 USA.	tliu@cs.uga.edu	Liu, Tianming/AAA-4602-2022		NIH [R01 DA-033393, R01 AG-042599]; NSF [CBET-1302089, IIS-1149260]; NATIONAL INSTITUTE ON AGING [R01AG042599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH R01 DA-033393, NIH R01 AG-042599, NSF CAREER Award IIS-1149260, and NSF CBET-1302089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anderson ML, 2013, NEUROIMAGE, V73, P50, DOI 10.1016/j.neuroimage.2013.01.071; Azran A, 2006, SPECTRAL METHODS FOR, V1, P190; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Camara E, 2007, FRONTIERS IN HUMAN N, V2, P19; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Foong J, 2002, NEUROREPORT, V13, P333, DOI 10.1097/00001756-200203040-00017; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; FOX NA, 1991, AM PSYCHOL, V46, P863, DOI 10.1037/0003-066X.46.8.863; Ge Bao, 2013, Inf Process Med Imaging, V23, P692, DOI 10.1007/978-3-642-38868-2_58; Ge B, 2013, NEUROINFORMATICS, V11, P119, DOI 10.1007/s12021-012-9169-7; Ge B, 2011, LECT NOTES COMPUT SC, V6892, P149, DOI 10.1007/978-3-642-23629-7_19; Gerig G, 2004, P ANN INT IEEE EMBS, V26, P4421; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jbabdi S, 2009, NEUROIMAGE, V44, P373, DOI 10.1016/j.neuroimage.2008.08.044; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Kennedy DN, 2010, NEUROINFORMATICS, V8, P61, DOI 10.1007/s12021-010-9070-1; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kyriakopoulos M, 2008, EUR PSYCHIAT, V23, P255, DOI 10.1016/j.eurpsy.2007.12.004; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Liu TM, 2008, NEUROIMAGE, V40, P991, DOI 10.1016/j.neuroimage.2007.12.027; Liu TM, 2007, NEUROIMAGE, V38, P114, DOI 10.1016/j.neuroimage.2007.07.002; Lv J, 2014, IEEE TRANS BIOMED EN; Maddah M, 2006, I S BIOMED IMAGING, P53; Meskaldji DE, 2013, NEUROIMAGE, V80, P416, DOI 10.1016/j.neuroimage.2013.04.084; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190; Nakic M, 2006, NEUROIMAGE, V31, P1752, DOI 10.1016/j.neuroimage.2006.02.022; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Rotarska-Jagiela A, 2008, NEUROIMAGE, V39, P1522, DOI 10.1016/j.neuroimage.2007.10.063; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seghier ML, 2011, CEREB CORTEX, V21, P1519, DOI 10.1093/cercor/bhq203; Shaywitz BA, 2001, NEUROIMAGE, V13, P601, DOI 10.1006/nimg.2000.0726; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Sporns O., 2010, NETWORKS OF THE BRAI; Surazhsky V, 2005, ACM T GRAPHIC, V24, P553, DOI 10.1145/1073204.1073228; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yuan YX, 2013, NEUROINFORMATICS, V11, P47, DOI 10.1007/s12021-012-9165-y; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103; Zhu DJ, 2013, CEREB CORTEX, V23, P786, DOI 10.1093/cercor/bhs072	60	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118175	10.1371/journal.pone.0118175	http://dx.doi.org/10.1371/journal.pone.0118175			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876038	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100003
J	Jones, HD; Yoo, J; Crother, TR; Kyme, P; Ben-Shlomo, A; Khalafi, R; Tseng, CW; Parks, WC; Arditi, M; Liu, GY; Shimada, K				Jones, Heather D.; Yoo, Jeena; Crother, Timothy R.; Kyme, Pierre; Ben-Shlomo, Anat; Khalafi, Ramtin; Tseng, Ching W.; Parks, William C.; Arditi, Moshe; Liu, George Y.; Shimada, Kenichi			Nicotinamide Exacerbates Hypoxemia in Ventilator-Induced Lung Injury Independent of Neutrophil Infiltration	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; HYPOXIC PULMONARY VASOCONSTRICTION; BINDING-PROTEIN-EPSILON; NITRIC-OXIDE SYNTHASE; ALVEOLAR MACROPHAGES; MECHANICAL VENTILATION; INFLAMMATION; RESVERATROL; LIPOPOLYSACCHARIDE; ACTIVATION	Background Ventilator-induced lung injury is a form of acute lung injury that develops in critically ill patients on mechanical ventilation and has a high degree of mortality. Nicotinamide phosphoribosyltransferase is an enzyme that is highly upregulated in ventilator-induced lung injury and exacerbates the injury when given exogenously. Nicotinamide (vitamin B3) directly inhibits downstream pathways activated by Nicotinamide phosphoribosyltransferase and is protective in other models of acute lung injury. Methods We administered nicotinamide i.p. to mice undergoing mechanical ventilation with high tidal volumes to study the effects of nicotinamide on ventilator-induced lung injury. Measures of injury included oxygen saturations and bronchoalveolar lavage neutrophil counts, protein, and cytokine levels. We also measured expression of nicotinamide phosophoribosyltransferase, and its downstream effectors Sirt1 and Cebpa, Cebpb, Cebpe. We assessed the effect of nicotinamide on the production of nitric oxide during ventilator-induced lung injury. We also studied the effects of ventilator-induced lung injury in mice deficient in C/EBP epsilon. Results Nicotinamide treatment significantly inhibited neutrophil infiltration into the lungs during ventilator-induced lung injury, but did not affect protein leakage or cytokine production. Surprisingly, mice treated with nicotinamide developed significantly worse hypoxemia during mechanical ventilation. This effect was not linked to increases in nitric oxide production or alterations in expression of Nicotinamide phosphoribosyl transferase, Sirt1, or Cebpa and Cebpb. Cebpe mRNA levels were decreased with either nicotinamide treatment or mechanical ventilation, but mice lacking C/EBP epsilon developed the same degree of hypoxemia and ventilator-induced lung injury as wild-type mice. Conclusions Nicotinamide treatment during VILI inhibits neutrophil infiltration of the lungs consistent with a strong anti-inflammatory effect, but paradoxically also leads to the development of significant hypoxemia. These findings suggest that pulmonary neutrophilia is not linked to hypoxemia in ventilator-induced lung injury, and that nicotinamide exacerbates hypoxemia during VILI.	[Jones, Heather D.; Yoo, Jeena; Parks, William C.] Cedars Sinai Med Ctr, Div Pulm & Crit Care Med, Los Angeles, CA 90048 USA; [Crother, Timothy R.; Kyme, Pierre; Tseng, Ching W.; Arditi, Moshe; Liu, George Y.; Shimada, Kenichi] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Jones, Heather D.; Crother, Timothy R.; Kyme, Pierre; Tseng, Ching W.; Arditi, Moshe; Liu, George Y.; Shimada, Kenichi] Cedars Sinai Med Ctr, Infect & Immunol Dis Res Ctr, Los Angeles, CA 90048 USA; [Ben-Shlomo, Anat; Khalafi, Ramtin] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Shimada, K (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA.	kenichi.shimada@cshs.org	Crother, Timothy R/E-2879-2010; Ben-Shlomo, Anat/AAH-6009-2021; Parks, William C./AAH-6786-2021	Crother, Timothy R/0000-0001-8465-6127; 	National Institutes of Health grant [UL1TR000124, AI067995]; Cedars-Sinai Research Institute Eigler-Mann-Whiting Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Research Institute Eigler-Mann-Whiting Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Institutes of Health grant UL1TR000124 (HJ), Cedars-Sinai Research Institute Eigler-Mann-Whiting Grant (HJ), National Institutes of Health grant AI067995 (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Adyshev DM, 2013, AM J RESP CELL MOL B; Ahmad SF, 2014, MOL IMMUNOL; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Bhatia M, 1998, INT J PANCREATOL, V24, P77; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Dhanireddy S, 2006, LAB INVEST, V86, P790, DOI 10.1038/labinvest.3700440; Eyal FG, 2007, INTENS CARE MED, V33, P1212, DOI 10.1007/s00134-007-0651-x; Fernandes CA, 2011, AM J PHYSIOL-LUNG C, V300, pL354, DOI 10.1152/ajplung.00198.2010; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Galli M, 2010, CANCER RES, V70, P8, DOI 10.1158/0008-5472.CAN-09-2465; Gill SE, 2010, AM J PATHOL, V176, P64, DOI 10.2353/ajpath.2010.090158; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Gurujeyalakshmi G, 2000, J PHARMACOL EXP THER, V293, P82; Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Jones HD, 2014, AM J RESP CELL MOL, V50, P270, DOI 10.1165/rcmb.2013-0087OC; Kapoor K, 2014, MOL CELL BIOCH; Kobayashi A, 1998, CHEST, V113, P1632, DOI 10.1378/chest.113.6.1632; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kuipers MT, 2012, ANESTHESIOLOGY, V116, P1104, DOI 10.1097/ALN.0b013e3182518bc0; Kwon WY, 2011, CRIT CARE MED, V39, P328, DOI 10.1097/CCM.0b013e3181feeae4; Kyme P, 2012, J CLIN INVEST, V122, P3316, DOI 10.1172/JCI62070; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Legutko A, 2009, OPEN IMMUNOL J, V2, P42; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; Li TX, 2013, MOL MED REP, V7, P1889, DOI 10.3892/mmr.2013.1444; Liaudet L, 2002, AM J RESP CRIT CARE, V165, P372, DOI 10.1164/ajrccm.165.3.2106050; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Matsuda A, 2013, ANN SURG; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Moreno-Vinasco L., 2014, AM J RESP CELL MOL B; NAGAI A, 1994, EUR RESPIR J, V7, P1125; PELLATDECEUNYNCK C, 1994, BIOCHEM J, V297, P53, DOI 10.1042/bj2970053; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Sittipunt C, 2001, AM J RESP CRIT CARE, V163, P503, DOI 10.1164/ajrccm.163.2.2004187; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Spohr F, 2005, AM J PHYSIOL-HEART C, V289, pH823, DOI 10.1152/ajpheart.00605.2004; Spragg RG, 2010, AM J RESP CRIT CARE, V181, P1121, DOI 10.1164/rccm.201001-0024WS; Su CF, 2007, EUR RESPIR J, V30, P199, DOI 10.1183/09031936.00025107; Suzuki E, 2010, LIFE SCI, V86, P676, DOI 10.1016/j.lfs.2010.02.019; Ullrich R, 1999, J CLIN INVEST, V104, P1421, DOI 10.1172/JCI6590; Ungerstedt JS, 2003, J THROMB HAEMOST, V1, P2554, DOI 10.1046/j.1538-7836.2003.00463.x; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Villar J, 2011, MINERVA ANESTESIOL, V77, P647; WANG QJ, 1991, BIOCHEM PHARMACOL, V42, P1115, DOI 10.1016/0006-2952(91)90296-H; WANG QJ, 1990, J BIOCHEM TOXICOL, V5, P13, DOI 10.1002/jbt.2570050104; Wosten-van Asperen RM, 2010, AM J PATHOL, V176, P2219, DOI 10.2353/ajpath.2010.090565; Wu CT, 2008, CHINESE J PHYSIOL, V51, P363; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Ye SQ, 2005, MICROVASC RES, V70, P142, DOI 10.1016/j.mvr.2005.08.003; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Yeh DYW, 2014, TRANSPL P, V46, P1131, DOI 10.1016/j.transproceed.2013.11.094; Yeh DYW, 2006, CHINESE J PHYSIOL, V49, P305; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR; Zhang HX, 2014, PULM PHARMACOL THER, V27, P150, DOI 10.1016/j.pupt.2013.07.007; Zhang LQ, 2008, FEBS LETT, V582, P1802, DOI 10.1016/j.febslet.2008.04.061; Zhang Z, 2014, MOL MED REP, V10, P101, DOI 10.3892/mmr.2014.2226	67	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123460	10.1371/journal.pone.0123460	http://dx.doi.org/10.1371/journal.pone.0123460			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875775	Green Published, gold			2022-12-26	WOS:000352845100178
J	Kumari, A; Kumar, J; Kumar, A; Chaudhury, A; Singh, SP				Kumari, Anita; Kumar, Jitendra; Kumar, Anil; Chaudhury, Ashok; Singh, Sudhir P.			Grafting Triggers Differential Responses between Scion and Rootstock	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FLORAL ORGAN; POSITIVE REGULATOR; WATER-DEFICIT; PROTEIN; STRESS; IDENTIFICATION; BIOSYNTHESIS	Grafting is a well-established practice to facilitate asexual propagation in horticultural and agricultural crops. It has become a method for studying molecular aspects of root-to-shoot and/or shoot-to-root signaling events. The objective of this study was to investigate differences in gene expression between the organs of the scion and rootstock of a homograft (Arabidopsis thaliana). MapMan and Gene Ontology enrichment analysis revealed differentially expressed genes from numerous functional categories related to stress responses in the developing flower buds and leaves of scion and rootstock. Meta-analysis suggested induction of drought-type responses in flower buds and leaves of the scion. The flower buds of scion showed over-representation of the transcription factor genes, such as Homeobox, NAC, MYB, bHLH, B3, C3HC4, PLATZ etc. The scion leaves exhibited higher accumulation of the regulatory genes for flower development, such as SEPALLATA 1-4, Jumonji C and AHL16. Differential transcription of genes related to ethylene, gibberellic acid and other stimuli was observed between scion and rootstock. The study is useful in understanding the molecular basis of grafting and acclimation of scion on rootstock.	[Kumari, Anita; Kumar, Jitendra; Kumar, Anil; Singh, Sudhir P.] Natl Agrifood Biotechnol Inst, Mohali, Punjab, India; [Kumari, Anita; Chaudhury, Ashok] Guru Jambheshwar Univ Sci & Technol, Hisar, Haryana, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Guru Jambheshwar University of Science & Technology	Singh, SP (corresponding author), Natl Agrifood Biotechnol Inst, Mohali, Punjab, India.	pratapsudhir17@gmail.com	Singh, Sudhir/AAE-5413-2019; Kumar, Jitendra/AAP-5018-2020	Kumar, Anil/0000-0002-3835-4280; chaudhury, ashok/0000-0002-0383-1497; Singh, Sudhir/0000-0001-5437-4292	Science and Engineering Research Board, Department of Science and Technology, Government of India [SR/FT/LS-88/2011]	Science and Engineering Research Board, Department of Science and Technology, Government of India	This work was supported by Science and Engineering Research Board (SR/FT/LS-88/2011), Department of Science and Technology, Government of India.	Aloni B, 2010, SCI HORTIC-AMSTERDAM, V127, P119, DOI 10.1016/j.scienta.2010.09.003; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Baxter CEL, 2007, PLANT J, V52, P105, DOI 10.1111/j.1365-313X.2007.03222.x; Bhaskara GB, 2012, PLANT PHYSIOL, V160, P379, DOI 10.1104/pp.112.202408; Binder BYK, 2009, BIOTECHNOL PROGR, V25, P861, DOI 10.1002/btpr.97; Bray EA, 2002, ANN BOT-LONDON, V89, P803, DOI 10.1093/aob/mcf104; Bricchi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046673; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Cookson SJ, 2014, J EXP BOT, V65, P2473, DOI 10.1093/jxb/eru145; Cookson SJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-147; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Ding Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-229; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ebel RC, 2000, J PLANT NUTR, V23, P1179, DOI 10.1080/01904160009382091; El-Sharkawy I, 2012, J EXP BOT, V63, P1225, DOI 10.1093/jxb/err345; Etehadnia M, 2008, J PLANT GROWTH REGUL, V27, P125, DOI 10.1007/s00344-008-9039-6; Flaishman MA, 2008, J PLANT GROWTH REGUL, V27, P231, DOI 10.1007/s00344-008-9050-y; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Groszmann M, 2011, PLANT J, V68, P816, DOI 10.1111/j.1365-313X.2011.04732.x; Ham BK, 2009, PLANT CELL, V21, P197, DOI 10.1105/tpc.108.061317; Harada T, 2010, SCI HORTIC-AMSTERDAM, V125, P545, DOI 10.1016/j.scienta.2010.05.013; Heyndrickx KS, 2012, PLANT PHYSIOL, V159, P884, DOI 10.1104/pp.112.196725; Howing T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00058; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Huang F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-89; Jain M, 2008, PLANT SIGNAL BEHAV, V3, P1024, DOI 10.4161/psb.6770; Jensen PJ, 2010, TREE GENET GENOMES, V6, P57, DOI 10.1007/s11295-009-0228-7; Jimenez S, 2007, SCI HORTIC-AMSTERDAM, V112, P73, DOI 10.1016/j.scienta.2006.12.010; Jones ML, 2005, J EXP BOT, V56, P2733, DOI 10.1093/jxb/eri266; Kasai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016895; Kato M, 2002, POSTHARVEST BIOL TEC, V24, P69, DOI 10.1016/S0925-5214(01)00111-9; Kirik V, 2005, DEVELOPMENT, V132, P1477, DOI 10.1242/dev.01708; Koprivova A, 2014, FEBS LETT, V588, P1116, DOI 10.1016/j.febslet.2014.02.031; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Lee JM, 2010, SCI HORTIC-AMSTERDAM, V127, P93, DOI 10.1016/j.scienta.2010.08.003; Lewandowska M, 2010, MOL PLANT, V3, P347, DOI 10.1093/mp/ssq007; Lu SX, 2011, PLANT PHYSIOL, V155, P906, DOI 10.1104/pp.110.167015; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mu RL, 2009, CELL RES, V19, P1291, DOI 10.1038/cr.2009.83; Mudge K., 2009, HIST GRAFTING; Nisar N, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-50; Poppenberger B, 2011, EMBO J, V30, P1149, DOI 10.1038/emboj.2011.35; Prassinos C, 2009, TREE PHYSIOL, V29, P927, DOI 10.1093/treephys/tpp027; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Shao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049861; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Singh AP, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt030; Singh SP, 2010, PLANT BIOTECHNOL J, V8, P1005, DOI 10.1111/j.1467-7652.2010.00527.x; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Son O, 2005, BIOCHEM BIOPH RES CO, V326, P203, DOI 10.1016/j.bbrc.2004.11.014; Song LH, 2013, PHYSIOL PLANTARUM, V148, P322, DOI 10.1111/ppl.12013; Sorce C., 2007, Advances in Horticultural Science, V21, P68; Stearns JC, 2003, BIOTECHNOL ADV, V21, P193, DOI 10.1016/S0734-9750(03)00024-7; Sun XL, 2012, J PLANT RES, V125, P429, DOI 10.1007/s10265-011-0448-4; Takahashi Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003760; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; TSUKAYA H, 1993, MOL GEN GENET, V237, P26, DOI 10.1007/BF00282780; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Wang L, 2012, PLANT BIOLOGY, V14, P745, DOI 10.1111/j.1438-8677.2011.00555.x; Wei B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084781; Xu YF, 2013, CURR BIOL, V23, P345, DOI 10.1016/j.cub.2013.01.030; Yang CJ, 2014, MOL PLANT, V7, P841, DOI 10.1093/mp/ssu013; Ying S, 2012, PLANTA, V235, P253, DOI 10.1007/s00425-011-1496-7; Zhang JH, 2013, MOL BIOL REP, V40, P2633, DOI 10.1007/s11033-012-2350-0; Zhang WN, 2014, PLANT J, V80, P106, DOI 10.1111/tpj.12622; Zhao PS, 2011, MOL BIOL+, V45, P785, DOI 10.1134/S0026893311050165; Zhu J, 2008, PLANT J, V55, P266, DOI 10.1111/j.1365-313X.2008.03500.x; Zhu Q, 2010, GENE, V457, P1, DOI 10.1016/j.gene.2010.02.011; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	81	22	24	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124438	10.1371/journal.pone.0124438	http://dx.doi.org/10.1371/journal.pone.0124438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874958	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100258
J	Teng, MS; Hsu, LA; Wu, SM; Sun, YC; Juan, SH; Ko, YL				Teng, Ming-Sheng; Hsu, Lung-An; Wu, Semon; Sun, Yu-Chen; Juan, Shu-Hui; Ko, Yu-Lin			Association of CDH13 Genotypes/Haplotypes with Circulating Adiponectin Levels, Metabolic Syndrome, and Related Metabolic Phenotypes: The Role of the Suppression Effect	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; T-CADHERIN; CARDIOVASCULAR-DISEASE; DEPENDENT PATHWAY; SENSITIVITY; PROTEIN; OBESITY; GENE; METAANALYSIS	Objective Previous genome-wide association studies have indicated an association between CDH13 genotypes and adiponectin levels. In this study, we used mediation analysis to assess the statistical association between CDH13 locus variants and adiponectin levels, metabolic syndrome, and related metabolic phenotypes. Methods and results A sample population of 530 Taiwanese participants was enrolled. Four CDH13 gene variants in the promoter and intron 1 regions were genotyped. After adjustment for clinical covariates, the CDH13 genotypes/haplotypes exhibited an association with the adiponectin levels (lowest P = 1.95 x 10(-11) for rs4783244 and lowest P = 3.78 x 10(-13) for haplotype ATTT). Significant correlations were observed between the adiponectin levels and the various metabolic syndrome- related phenotypes (all P <= 0.005). After further adjustment for the adiponectin levels, participants with a minor allele of rs12051272 revealed a considerable association with a more favorable metabolic profile, including higher insulin sensitivity, highdensity lipoprotein cholesterol levels, lower diastolic blood pressure, circulating levels of fasting plasma glucose, and triglycerides, and as a lower risk of metabolic syndrome (all P < 0.05). The mediation analysis further revealed a suppression effect of the adiponectin levels on the association between CDH13 genotypes and metabolic syndrome and its related phenotypes (Sobel test; all P < 0.001). Conclusion The genetic polymorphisms at the CDH13 locus independently affect the adiponectin levels, whereas the adiponectin levels exhibit a suppressive effect on the association between CDH13 locus variants and various metabolic phenotypes and metabolic syndrome. In addition, these results provide further evidence of the association between the CDH13 gene variants and the risks of metabolic syndrome and atherosclerotic cardiovascular disease.	[Teng, Ming-Sheng; Juan, Shu-Hui] Taipei Med Univ, Coll Med, Dept Physiol, Grad Inst Med Sci, Taipei, Taiwan; [Teng, Ming-Sheng; Wu, Semon] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Res, Taipei, Taiwan; [Hsu, Lung-An] Chang Gung Mem Hosp, Dept Internal Med, Cardiovasc Div 1, Taoyuan, Taiwan; [Hsu, Lung-An] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wu, Semon] Chinese Culture Univ, Dept Life Sci, Taipei, Taiwan; [Sun, Yu-Chen] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Cardiovasc Med Ctr, Taipei, Taiwan; [Ko, Yu-Lin] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; Chinese Culture University; Chang Gung Memorial Hospital; Tzu Chi University	Juan, SH (corresponding author), Taipei Med Univ, Coll Med, Dept Physiol, Grad Inst Med Sci, Taipei, Taiwan.	juansh@tmu.edu.tw; yulinkotw@yahoo.com.tw	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Hsu, Lung-An/0000-0002-0012-2804	National Science Council, Taiwan [NSC101-2314-B-303-023-MY3]; Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation [TCRD-TPE-NSC-102-01, TCRD-TPE-102-3, TCRD-TPE-103-22]; Tzu Chi University [TCIRP102001-02Y1]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Tzu Chi University	This study was supported by a grant from the National Science Council, Taiwan (No. NSC101-2314-B-303-023-MY3), grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (No. TCRD-TPE-NSC-102-01), grants from the Tzu Chi University (No. TCIRP102001-02Y1) to YLK, and grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-102-3, TCRD-TPE-103-22) to MST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, J INFECT DIS, V197, P34, DOI 10.1086/524144; Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauche IB, 2006, BIOCHEM BIOPH RES CO, V345, P1414, DOI 10.1016/j.bbrc.2006.05.033; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Cesari M, 2007, J CLIN ENDOCR METAB, V92, P3082, DOI 10.1210/jc.2007-0403; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gao H, 2013, DIABETES, V62, P4277, DOI 10.2337/db13-0129; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Henneman P, 2010, DIABETES CARE, V33, P908, DOI 10.2337/dc09-1385; Hsu LA, 2009, METABOLISM, V58, P983, DOI 10.1016/j.metabol.2009.02.021; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Liu PH, 2008, TWIN RES HUM GENET, V11, P495, DOI 10.1375/twin.11.5.495; MacKinnon D P, 1994, NIDA Res Monogr, V139, P127; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Menzaghi C, 2007, DIABETES, V56, P1198, DOI 10.2337/db06-0506; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Sobel ME, 1987, SOCIOL METHOD RES, V15, P151; Tan BK, 2006, DIABETOLOGIA, V49, P2723, DOI 10.1007/s00125-006-0419-9; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Teng MS, 2013, ATHEROSCLEROSIS, V228, P406, DOI 10.1016/j.atherosclerosis.2013.03.032; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wu Y, 2014, HUM MOL GENET, V23, P1108, DOI 10.1093/hmg/ddt488; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang WS, 2006, J MOL MED, V84, P112, DOI 10.1007/s00109-005-0011-7	38	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122664	10.1371/journal.pone.0122664	http://dx.doi.org/10.1371/journal.pone.0122664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875811	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100091
J	Yu, SF; Huang, HC; Deng, G; Xie, ZT; Ye, YC; Guo, RD; Cai, XJ; Hong, JY; Qian, DL; Zhou, XJ; Tao, ZH; Chen, BL; Li, Q				Yu, Shifang; Huang, Huicong; Deng, Gang; Xie, Zuoting; Ye, Yincai; Guo, Ruide; Cai, Xuejiao; Hong, Junying; Qian, Dingliang; Zhou, Xiangjing; Tao, Zhihua; Chen, Bile; Li, Qiang			miR-326 Targets Antiapoptotic Bcl-xL and Mediates Apoptosis in Human Platelets	PLOS ONE			English	Article							CYTOCHROME-C; CELL-DEATH; MICRORNA; MICROARRAY; EXPRESSION; MARKERS; STORAGE; FAMILY	Platelets play crucial roles in hemostasis, thrombosis, wound healing, inflammation, angiogenesis, and tumor metastases. Because they are anucleated blood cells, platelets lack nuclear DNA, but they do contain mitochondrial DNA, which plays a key role in regulating apoptosis. Recent evidence has suggested that miRNAs are also involved in regulating gene expression and apoptosis in platelets. Our previous study showed that the expression of miR-326 increased visibly when apheresis platelets were stored in vitro. The antiapoptotic Bcl-2 family regulator Bcl-xL has been identified as a putative target of miR-326. In the present study, dual reporter luciferase assays were used to characterize the function of miR-326 in the regulation of the apoptosis of platelet cells. These assays demonstrated that miR-326 bound to the 30-translated region of Bcl-xL. To directly assess the functional effects of miR-326 expression, levels of Bcl-xL and the apoptotic status of stored apheresis platelets were measured after transfection of miR-326 mimic or inhibitor. Results indicated that miR-326 inhibited Bcl-xL expression and induced apoptosis in stored platelets. Additionally, miR-326 inhibited Bcl-2 protein expression and enhanced Bak expression, possibly through an indirect mechanism, though there was no effect on the expression of Bax. The effect of miR-326 appeared to be limited to apoptosis, with no significant effect on platelet activation. These results provide new insight into the molecular mechanisms affecting differential platelet gene regulation, which may increase understanding of the role of platelet apoptosis in multiple diseases.	[Yu, Shifang; Tao, Zhihua] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Transfus Med, Hangzhou 310027, Zhejiang, Peoples R China; [Yu, Shifang; Xie, Zuoting; Ye, Yincai; Guo, Ruide; Cai, Xuejiao; Hong, Junying; Zhou, Xiangjing; Chen, Bile] Wenzhou Med Univ, Affiliated Hosp 1, Dept Transfus Med, Wenzhou, Peoples R China; [Huang, Huicong] Wenzhou Med Univ, Sch Basic Med Sci, Wenzhou, Peoples R China; [Deng, Gang] Ningbo Cent Blood Stn, Ningbo, Zhejiang, Peoples R China; [Qian, Dingliang; Li, Qiang] Wenzhou Med Univ, Affiliated Hosp 3, Dept Lab Med, Ruian, Peoples R China	Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Li, Q (corresponding author), Wenzhou Med Univ, Affiliated Hosp 3, Dept Lab Med, Ruian, Peoples R China.	zrtzh@zju.edu.cn; wswzyjs@126.com		li, qiang/0000-0003-0096-7679	Zhejiang Provincial Natural Science Foundation [LQ12H20001]; Social Development Research Project Foundation of Wenzhou Science and Technology Bureau [2011S0106, Y20110079]; Project of Ningbo Medical Science and Technology Plans [2013A25, 2011A01]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Social Development Research Project Foundation of Wenzhou Science and Technology Bureau; Project of Ningbo Medical Science and Technology Plans	This work was supported by grants from: Zhejiang Provincial Natural Science Foundation (NO. LQ12H20001); The Social Development Research Project Foundation of Wenzhou Science and Technology Bureau (NO. 2011S0106; Y20110079); The Project of Ningbo Medical Science and Technology Plans (No. 2013A25; 2011A01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x; Bugert P, 2003, THROMB HAEMOSTASIS, V90, P738; Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002; Gnatenko Dmitri V., 2009, V496, P245, DOI 10.1007/978-1-59745-553-4_16; Gyulkhandanyan AV, 2012, J THROMB THROMBOLYS, V33, P397, DOI 10.1007/s11239-012-0688-8; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Josefsson EC, 2012, METHODS MOL BIOL, V788, P59, DOI 10.1007/978-1-61779-307-3_5; Kannan M, 2009, TRANSFUSION, V49, P1443, DOI 10.1111/j.1537-2995.2009.02140.x; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kodama T, 2012, CELL DEATH DIFFER, V19, P1856, DOI 10.1038/cdd.2012.88; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Leytin V, 2006, J THROMB HAEMOST, V4, P2656, DOI 10.1111/j.1538-7836.2006.02200.x; Leytin V, 2009, LAB INVEST, V89, P374, DOI 10.1038/labinvest.2009.13; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; PACKHAM MA, 1994, CAN J PHYSIOL PHARM, V72, P278, DOI 10.1139/y94-043; Ple H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050746; Qi B, 2007, CELL, V128, P1035, DOI 10.1016/j.cell.2007.03.002; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shi R, 2013, THROMB RES, V131, P508, DOI 10.1016/j.thromres.2013.02.015; Shrivastava M, 2009, TRANSFUS APHER SCI, V41, P105, DOI 10.1016/j.transci.2009.07.002; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Vogler M, 2011, BLOOD, V117, P7145, DOI 10.1182/blood-2011-03-344812; Wang ZC, 2010, THROMB RES, V125, P340, DOI 10.1016/j.thromres.2010.02.001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu SF, 2014, BLOOD TRANSFUS-ITALY, V12, P541, DOI 10.2450/2014.0291-13; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081; Zhang WL, 2012, THROMB RES, V130, P81, DOI 10.1016/j.thromres.2012.02.013; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zimmerman GA, 2008, ARTERIOSCL THROM VAS, V28, pS17, DOI 10.1161/ATVBAHA.107.160218	34	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122784	10.1371/journal.pone.0122784	http://dx.doi.org/10.1371/journal.pone.0122784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875481	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100099
J	Zhang, Y; Wang, RX; Miao, LM; Zhu, LB; Jiang, HB; Yuan, H				Zhang, Yu; Wang, Ruixia; Miao, Limin; Zhu, Longbiao; Jiang, Hongbing; Yuan, Hua			Different Levels in Alcohol and Tobacco Consumption in Head and Neck Cancer Patients from 1957 to 2013	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; AERODIGESTIVE TRACT CANCERS; ORAL-CAVITY; HUMAN-PAPILLOMAVIRUS; RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; SMOKING; DRINKING; PHARYNGEAL; ETIOLOGY	Objective To provide a precise quantification of the association between alcohol and tobacco consumption trends in head and neck cancer patients over the past 45 years. Methods We combined findings from all studies published until March 2014 and evaluated the association between different levels in alcohol and tobacco consumption and head and neck cancers through a meta-analytic approach. Results We included 28 studies involving 13830 patients with head and neck cancer. In patients with alcohol consumption, the pooled odds ratio (OR) and 95% confidence interval (CI) were 1.29(1.06-1.57), 2.67(2.05-3.48) and 6.63(5.02-8.74) for light drinkers, moderate drinkers and heavy drinkers, respectively. In patients with tobacco consumption, the pooled OR and 95% CI were 2.33(1.84-2.95), 4.97(3.67-6.71) and 6.77(4.81-9.53) for light smokers, moderate smokers and heavy smokers, respectively. Conclusion The increased alcohol and tobacco consumption trends increased the risk of head and neck cancer over the past 45 years. Tobacco consumption was found to be a stronger risk factor for head and neck cancer than alcohol consumption. Thus, the control should be considered to limit the intake of alcohol and tobacco.	[Zhang, Yu; Wang, Ruixia; Miao, Limin; Zhu, Longbiao; Jiang, Hongbing; Yuan, Hua] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Yu; Jiang, Hongbing; Yuan, Hua] Stomatol Hosp Jiangsu Prov, Dept Oral & Maxillofacial Surg, Nanjing, Jiangsu, Peoples R China; [Miao, Limin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yuan, H (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.	rolener@gmail.com		Jiang, Hongbing/0000-0002-3748-0381	National Natural Science Foundation of China [81302361]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20133234120013]; China Postdoctoral Science Foundation [2013M540457]; Jiangsu Planned Projects for Postdoctoral Research Funds [1301018A]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [2014-37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Planned Projects for Postdoctoral Research Funds; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Funding was provided by National Natural Science Foundation of China (81302361), Specialized Research Fund for the Doctoral Program of Higher Education of China (20133234120013), China Postdoctoral Science Foundation (2013M540457), Jiangsu Planned Projects for Postdoctoral Research Funds (1301018A), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, 2014-37). The funders had no role in studydesign, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman D, 2011, ORAL ONCOL, V47, P725, DOI 10.1016/j.oraloncology.2011.05.004; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BLOT WJ, 1988, CANCER RES, V48, P3282; Boing AF, 2011, J EPIDEMIOL COMMUN H, V65, P709, DOI 10.1136/jech.2009.097691; Bouchardy C, 2000, INT J CANCER, V87, P734, DOI 10.1002/1097-0215(20000901)87:5<734::AID-IJC17>3.0.CO;2-E; Bradshaw PT, 2012, AM J EPIDEMIOL, V175, P1225, DOI 10.1093/aje/kwr468; Bravi F, 2013, BRIT J CANCER, V109, P2904, DOI 10.1038/bjc.2013.667; BRUGERE J, 1986, CANCER, V57, P391, DOI 10.1002/1097-0142(19860115)57:2<391::AID-CNCR2820570235>3.0.CO;2-Q; Castellsague X, 2004, INT J CANCER, V108, P741, DOI 10.1002/ijc.11627; CHOI SY, 1991, INT J EPIDEMIOL, V20, P878, DOI 10.1093/ije/20.4.878; Coronado GD, 2011, SALUD PUBLICA MEXICO, V53, P440; De Stefani E, 2007, CANCER LETT, V246, P282, DOI 10.1016/j.canlet.2006.03.008; Faggiano F, 1997, IARC Sci Publ, P65; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FRANCESCHI S, 1990, CANCER RES, V50, P6502; Freedman ND, 2008, INT J CANCER, V122, P2330, DOI 10.1002/ijc.23319; Garrote LF, 2001, BRIT J CANCER, V85, P46, DOI 10.1054/bjoc.2000.1825; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; GOEDDE HW, 1992, HUM GENET, V88, P344; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hansson BG, 2005, ACTA OTO-LARYNGOL, V125, P1337, DOI 10.1080/00016480510043945; Harris SL, 2010, HEAD NECK-J SCI SPEC, V32, P499, DOI 10.1002/hed.21220; Hayes RB, 1999, CANCER CAUSE CONTROL, V10, P27, DOI 10.1023/A:1008876115797; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; KELLER AZ, 1965, AM J PUBLIC HEALTH N, V55, P1578, DOI 10.2105/AJPH.55.10.1578; Macfarlane TV, 2010, CANCER CAUSE CONTROL, V21, P2213, DOI 10.1007/s10552-010-9641-3; MAIER H, 1992, CLIN INVESTIGATOR, V70, P320; MAIER H, 1994, OTOLARYNG HEAD NECK, V110, P168, DOI 10.1177/019459989411000205; Matsuo K, 2012, CANCER EPIDEM BIOMAR, V21, P1986, DOI 10.1158/1055-9965.EPI-12-0662; Menvielle G, 2004, EUR J CANCER PREV, V13, P165, DOI 10.1097/01.cej.0000130017.93310.76; Menvielle G, 2007, INT J CANCER, V121, P649, DOI 10.1002/ijc.22721; MERLETTI F, 1989, CANCER RES, V49, P4919; Montero PH, 2012, ARCH OTOLARYNGOL, V138, P817, DOI 10.1001/archoto.2012.1792; OREGGIA F, 1991, CANCER, V67, P180, DOI 10.1002/1097-0142(19910101)67:1<180::AID-CNCR2820670130>3.0.CO;2-R; Oze I, 2010, CANCER SCI, V101, P1875, DOI 10.1111/j.1349-7006.2010.01599.x; PAULY JL, 1995, CANCER RES, V55, P253; Peters ES, 2006, CANCER EPIDEM BIOMAR, V15, P2196, DOI 10.1158/1055-9965.EPI-06-0503; Radoi L, 2013, EUR J CANCER PREV, V22, P268, DOI 10.1097/CEJ.0b013e3283592cce; Rethman Michael P, 2012, Tex Dent J, V129, P491; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P991, DOI 10.1080/00016480510043440; Schlecht NF, 2001, CANCER CAUSE CONTROL, V12, P579, DOI 10.1023/A:1011226520220; Schwartz SM, 2001, CANCER EPIDEM BIOMAR, V10, P1137; Smith EM, 2012, J ONCOL, V2012, DOI 10.1155/2012/571862; Sobus SL, 2014, CANCER-AM CANCER SOC, V120, P3617, DOI 10.1002/cncr.28904; Subapriya R, 2007, EUR J CANCER PREV, V16, P251, DOI 10.1097/01.cej.0000228402.53106.9e; TUYNS AJ, 1988, INT J CANCER, V41, P483, DOI 10.1002/ijc.2910410403; Vlajinac HD, 2006, CANCER DETECT PREV, V30, P152, DOI 10.1016/j.cdp.2006.02.001; WYNDER EL, 1957, BRIT MED J, V1, P1137, DOI 10.1136/bmj.1.5028.1137; WYNDER EL, 1956, CANCER-AM CANCER SOC, V9, P86, DOI 10.1002/1097-0142(195601/02)9:1<86::AID-CNCR2820090108>3.0.CO;2-6; Yokoyama A, 2001, CARCINOGENESIS, V22, P433, DOI 10.1093/carcin/22.3.433; Zavras AI, 2001, ORAL ONCOL, V37, P28, DOI 10.1016/S1368-8375(00)00060-9; ZHENG TZ, 1990, CANCER CAUSE CONTROL, V1, P173, DOI 10.1007/BF00053170; Znaor A, 2003, INT J CANCER, V105, P681, DOI 10.1002/ijc.11114	58	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124045	10.1371/journal.pone.0124045	http://dx.doi.org/10.1371/journal.pone.0124045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875934	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100234
J	Moustakas, D; Mezzio, M; Rodriguez, BR; Constable, MA; Mulligan, ME; Voura, EB				Moustakas, Dimitrios; Mezzio, Michael; Rodriguez, Branden R.; Constable, Mic Andre; Mulligan, Margaret E.; Voura, Evelyn B.			Guarana Provides Additional Stimulation over Caffeine Alone in the Planarian Model	PLOS ONE			English	Article							IMPROVED COGNITIVE PERFORMANCE; PAULLINIA-CUPANA; ENERGY DRINKS; NERVOUS-SYSTEM; WITHDRAWAL; BEHAVIOR; COCAINE; FATIGUE; EXTRACT; ANTAGONIST	The stimulant effect of energy drinks is primarily attributed to the caffeine they contain. Many energy drinks also contain other ingredients that might enhance the tonic effects of these caffeinated beverages. One of these additives is guarana. Guarana is a climbing plant native to the Amazon whose seeds contain approximately four times the amount of caffeine found in coffee beans. The mix of other natural chemicals contained in guarana seeds is thought to heighten the stimulant effects of guarana over caffeine alone. Yet, despite the growing use of guarana as an additive in energy drinks, and a burgeoning market for it as a nutritional supplement, the science examining guarana and how it affects other dietary ingredients is lacking. To appreciate the stimulant effects of guarana and other natural products, a straightforward model to investigate their physiological properties is needed. The planarian provides such a system. The locomotor activity and convulsive response of planarians with substance exposure has been shown to provide an excellent system to measure the effects of drug stimulation, addiction and withdrawal. To gauge the stimulant effects of guarana we studied how it altered the locomotor activity of the planarian species Dugesia tigrina. We report evidence that guarana seeds provide additional stimulation over caffeine alone, and document the changes to this stimulation in the context of both caffeine and glucose.	[Voura, Evelyn B.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Moustakas, Dimitrios; Mezzio, Michael; Rodriguez, Branden R.; Constable, Mic Andre; Mulligan, Margaret E.; Voura, Evelyn B.] Dominican Coll, Dept Math & Sci, Orangeburg, NY 10962 USA; [Moustakas, Dimitrios] New York Coll Podiatr Med, New York, NY USA	Colgate University	Moustakas, D (corresponding author), Dominican Coll, Dept Math & Sci, Orangeburg, NY 10962 USA.	evelyn.voura@gmail.com			Dominican College; Colgate University	Dominican College; Colgate University	We would like to thank John G. Golfinos (Department of Neurosurgery, New York University Langone Medical Center) and Madeline Micceri Mignone (Department of Math and Science, Dominican College), for helpful discussions, support and encouragement. We also thank Adam F. Green and Mala Misra (Department of Biology, Colgate University), and Colleen A. Evans (Department of Math and Science, Dominican College) for comments on the manuscript. We greatly appreciate Siobhan O'Sullivan for her assistance. We are also grateful to Dominican College for their support of undergraduate research in the Department of Math and Science, and Colgate University for providing a publication grant to support this work.	Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021; Avci S, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2013.06.031; Babu KM, 2008, CLIN PEDIATR EMERG M, V9, P35, DOI 10.1016/j.cpem.2007.12.002; BEST JB, 1962, J COMP PHYSIOL PSYCH, V55, P560, DOI 10.1037/h0044394; Bittencourt LS, 2013, FOOD CHEM TOXICOL, V53, P119, DOI 10.1016/j.fct.2012.11.041; Breda JJ, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00134; Buttarelli FR, 2008, COMP BIOCHEM PHYS C, V147, P399, DOI 10.1016/j.cbpc.2008.01.009; Campos AR, 2005, PHYTOTHER RES, V19, P441, DOI 10.1002/ptr.1471; Childs E, 2006, PSYCHOPHARMACOLOGY, V185, P514, DOI 10.1007/s00213-006-0341-3; Campos MPD, 2011, J ALTERN COMPLEM MED, V17, P505, DOI 10.1089/acm.2010.0571; del Giglio Adriana Braz, 2013, Journal of Dietary Supplements, V10, P325, DOI 10.3109/19390211.2013.830676; DelCoso J, 2012, PLOS ONE, V7, P1; ERIKSSON KS, 1994, J COMP NEUROL, V345, P528, DOI 10.1002/cne.903450405; Espinola EB, 1997, J ETHNOPHARMACOL, V55, P223, DOI 10.1016/S0378-8741(96)01506-1; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; Gurley BJ, 2015, CLIN THER, V37, P275, DOI 10.1016/j.clinthera.2014.08.012; Haskell CF, 2007, J PSYCHOPHARMACOL, V21, P65, DOI 10.1177/0269881106063815; Haskell CF, 2013, NUTR RES REV, V26, P49, DOI 10.1017/S0954422413000036; Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3; Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381; Kennedy DO, 2008, APPETITE, V50, P506, DOI 10.1016/j.appet.2007.10.007; Kennedy DO, 2004, PHARMACOL BIOCHEM BE, V79, P401, DOI 10.1016/j.pbb.2004.07.014; Miranda VD, 2009, J ALTERN COMPLEM MED, V15, P431, DOI 10.1089/acm.2008.0324; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; Nishimura K, 2010, NEUROSCIENCE, V168, P18, DOI 10.1016/j.neuroscience.2010.03.038; Pagan OR, 2013, NEUROSCIENCE, V246, P265, DOI 10.1016/j.neuroscience.2013.05.010; Pagan OR, 2008, PHARMACOL BIOCHEM BE, V89, P160, DOI 10.1016/j.pbb.2007.12.008; Pagan OR, 2009, EUR J PHARMACOL, V615, P118, DOI 10.1016/j.ejphar.2009.05.022; Passarelli F, 1999, COMP BIOCHEM PHYS C, V124, P51, DOI 10.1016/S0742-8413(99)00048-1; Pesta DH, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-71; Prokai D, 2013, INT J MOL SCI, V14, P23289, DOI 10.3390/ijms141223289; Raffa R.B., 2008, MODEL DRUG ACTION AB; Raffa RB, 2001, J PHARMACOL TOXICOL, V45, P223, DOI 10.1016/S1056-8719(01)00152-6; Raffa RB, 2001, EUR J PHARMACOL, V430, P143, DOI 10.1016/S0014-2999(01)01358-9; Raffa RB, 2007, EUR J PHARMACOL, V564, P88, DOI 10.1016/j.ejphar.2007.02.006; Raffa RB, 2006, BRAIN RES, V1114, P31, DOI 10.1016/j.brainres.2006.07.037; Raffa RB, 2006, EUR J PHARMACOL, V540, P200, DOI 10.1016/j.ejphar.2006.04.027; Rawls SM, 2010, BEHAV PHARMACOL, V21, P301, DOI 10.1097/FBP.0b013e32833b0098; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Rodrigues M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/428560; Sacavage S, 2008, NEUROSCI LETT, V439, P84, DOI 10.1016/j.neulet.2008.04.086; Schimpl FC, 2014, PHYTOCHEMISTRY, V105, P25, DOI 10.1016/j.phytochem.2014.04.018; Schimpl FC, 2013, J ETHNOPHARMACOL, V150, P14, DOI 10.1016/j.jep.2013.08.023; Scholey AB, 2004, PSYCHOPHARMACOLOGY, V176, P320, DOI 10.1007/s00213-004-1935-2; Seifert SM, 2013, CLIN TOXICOL, V51, P566, DOI 10.3109/15563650.2013.820310; Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592; Smith N, 2010, EVID-BASED COMPL ALT, V7, P279, DOI 10.1093/ecam/nem162; Tallarida CS, 2014, NEUROPHARMACOLOGY, V79, P590, DOI 10.1016/j.neuropharm.2014.01.002; Tran Jason, 2014, J Public Health Epidemiol, V8, P202; Trunzo JJ, 2014, J PSYCHOACTIVE DRUGS, V46, P396, DOI 10.1080/02791072.2014.965291; Umeda S, 2004, BRAIN RES, V1018, P181, DOI 10.1016/j.brainres.2004.05.057; VENTURINI G, 1983, COMP BIOCHEM PHYS C, V74, P23, DOI 10.1016/0742-8413(83)90141-X; Vyas CA, 2011, J PHARMACOL TOX MET, V63, P119, DOI 10.1016/j.vascn.2010.08.002; Weckerle CS, 2003, PHYTOCHEMISTRY, V64, P735, DOI 10.1016/S0031-9422(03)00372-8; White D.J., 2014, NUTR NEUROSCI; Zeidan-Chulia F, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/791795; Zhang C, 2013, PHYSIOL BEHAV, V112, P8, DOI 10.1016/j.physbeh.2013.02.002	57	21	21	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123310	10.1371/journal.pone.0123310	http://dx.doi.org/10.1371/journal.pone.0123310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880065	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500046
J	Park, HYL; Jeong, HJ; Kim, YH; Park, CK				Park, Hae Young Lopilly; Jeong, Hyun Jin; Kim, Yoon Hee; Park, Chan Kee			Optic Disc Hemorrhage Is Related to Various Hemodynamic Findings by Disc Angiography	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OPEN-ANGLE GLAUCOMA; FLUORESCEIN FILLING DEFECTS; OCULAR PERFUSION-PRESSURE; NERVE HEAD; AUTONOMIC DYSFUNCTION; BLOOD-FLOW; PROGRESSION; RISK; FLUCTUATION	Background To investigate the hemodynamic characteristics of glaucoma eyes with disc hemorrhage (DH) by disc fluorescein angiography, and its relationship with glaucomatous changes of the optic disc and surrounding retinal nerve fiber layer (RNFL). Methods This study included 35 glaucoma eyes with DH who were followed up at least 5 years and had DH at presentation. Eyes were classified as eyes with DH at the border of localized RNFL defects and eyes with DH not related to localized RNFL defects. Prevalence of DH and location of the proximal border were recorded from disc photographs. Fluorescein angiography was performed 3 months after detecting the DH. Arm-retina time, arteriovenous transit time, disc filling time, choroidal filling time, and venous filling time were measured as retinal circulation parameters. The presence of disc filling defects and disc leaks were evaluated. Results There were 19 (54.3%) eyes with DH accompanying localized RNFL defects. The arm-retina time was prolonged in eyes with DH not related to RNFL defects (P = 0.044) and the arteriovenous transit time was prolonged in eyes with DH accompanying RNFL defects (P = 0.029). Among eyes with DH accompanying RNFL defects, 11 (57.9%) had vessel filling defects or delayed filling indicating blood flow stasis at the cup margin proximal to where DH occurred. Eyes with DH not related to RNFL defects did not show vessel filling defects or delayed filling. Conclusions and Relevance Eyes with DH related to RNFL defects showed prolonged arteriovenous transit time and had frequent vessel filling defects or delayed filling indicating blood flow stasis and thrombus formation at the site DH occurred. These findings suggest that vascular and hemodynamic changes due to glaucomatous structural changes cause DH in relation to localized RNFL defects.	[Park, Hae Young Lopilly; Jeong, Hyun Jin; Kim, Yoon Hee; Park, Chan Kee] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	ckpark@catholic.ac.kr			Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea	Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea	This study was supported by Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2002, AM J OPHTHALMOL, V134, P920, DOI 10.1016/S0002-9394(02)01791-9; Arend O, 2005, GRAEF ARCH CLIN EXP, V243, P659, DOI 10.1007/s00417-004-1092-7; Arend O, 2004, BRAIN RES BULL, V62, P517, DOI 10.1016/j.brainresbull.2003.07.008; ASHTON N, 1963, Br J Ophthalmol, V47, P521, DOI 10.1136/bjo.47.9.521; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Bennett PC, 2009, THROMB HAEMOSTASIS, V101, P1032, DOI 10.1160/TH08-08-0518; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P104, DOI 10.1167/iovs.06-0615; de Beaufort HC, 2010, GRAEF ARCH CLIN EXP, V248, P839, DOI 10.1007/s00417-010-1306-0; Delaney Y, 2006, OPTOMETRY VISION SCI, V83, P406, DOI 10.1097/01.opx.0000225877.13217.01; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; DRANCE SM, 1989, SURV OPHTHALMOL, V33, P331, DOI 10.1016/0039-6257(89)90010-6; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Graham SL, 1999, SURV OPHTHALMOL, V43, pS10, DOI 10.1016/S0039-6257(99)00016-8; Grieshaber MC, 2006, ACTA OPHTHALMOL SCAN, V84, P62, DOI 10.1111/j.1600-0420.2005.00590.x; Healey P, 2011, CLIN EXP OPHTHALMOL, V39, P485, DOI 10.1111/j.1442-9071.2011.02648.x; Ishida K, 2000, AM J OPHTHALMOL, V129, P707, DOI 10.1016/S0002-9394(00)00441-4; Jonas JB, 2002, INVEST OPHTH VIS SCI, V43, P2956; Kim SH, 2006, OPHTHALMOLOGY, V113, P598, DOI 10.1016/j.ophtha.2005.12.018; KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853; Michelson G, 1998, GRAEF ARCH CLIN EXP, V236, P80, DOI 10.1007/s004170050046; Na KS, 2010, J GLAUCOMA, V19, P377, DOI 10.1097/IJG.0b013e3181c4ae58; Nitta K, 2011, J GLAUCOMA, V20, P189, DOI 10.1097/IJG.0b013e3181e0799c; Park HYL, 2012, AM J OPHTHALMOL, V154, P466, DOI 10.1016/j.ajo.2012.03.028; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park HYL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1299, DOI 10.1001/archophthalmol.2011.249; Plange N, 2004, ARCH OPHTHALMOL-CHIC, V122, P195, DOI 10.1001/archopht.122.2.195; Plange N, 2003, BRIT J OPHTHALMOL, V87, P731, DOI 10.1136/bjo.87.6.731; Plange N, 2010, OPHTHAL PHYSL OPT, V30, P315, DOI 10.1111/j.1475-1313.2010.00717.x; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Schwartz B, 1994, Surv Ophthalmol, V38 Suppl, pS23, DOI 10.1016/0039-6257(94)90044-2; SCHWARTZ B, 1977, ARCH OPHTHALMOL-CHIC, V95, P1961; Sihota R, 2006, OPTOMETRY VISION SCI, V83, P520, DOI 10.1097/01.opx.0000225910.51370.02; Sonnsjo B, 2002, PROG RETIN EYE RES, V21, P35, DOI 10.1016/S1350-9462(01)00019-2; SONNSJO B, 1991, ACTA OPHTHALMOL, V69, P217; Spaeth G L, 1975, Trans Am Ophthalmol Soc, V73, P491; Sugiyama K, 1997, OPHTHALMOLOGY, V104, P1926, DOI 10.1016/S0161-6420(97)30005-0; Sugiyama T, 2006, AM J OPHTHALMOL, V141, P394, DOI 10.1016/j.ajo.2005.08.037; Sugiyama T, 2000, OPHTHALMIC RES, V32, P79, DOI 10.1159/000055594; Sung KR, 2009, INVEST OPHTH VIS SCI, V50, P5266, DOI 10.1167/iovs.09-3716; TALUSAN E, 1977, ARCH OPHTHALMOL-CHIC, V95, P2166; USUI T, 1991, BRIT J OPHTHALMOL, V75, P224, DOI 10.1136/bjo.75.4.224	42	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120000	10.1371/journal.pone.0120000	http://dx.doi.org/10.1371/journal.pone.0120000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879852	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500004
J	Rangel, J; Strauss, K; Seedorf, K; Hjelmen, CE; Johnston, JS				Rangel, Juliana; Strauss, Kim; Seedorf, Kaileah; Hjelmen, Carl E.; Johnston, J. Spencer			Endopolyploidy Changes with Age-Related Polyethism in the Honey Bee, Apis mellifera	PLOS ONE			English	Article							CELL-CYCLE; GENE-EXPRESSION; NUCLEAR-DNA; MUSCLE; ENDOREDUPLICATION; POLYPLOIDY; SIZE; PATTERNS; SKELETAL; GENOMES	Honey bees (Apis mellifera) exhibit age polyethism, whereby female workers assume increasingly complex colony tasks as they age. While changes in DNA methylation accompany age polyethism, other DNA modifications accompanying age polyethism are less known. Changes in endopolyploidy (DNA amplification in the absence of cell division) with increased larval age are typical in many insect cells and are essential in adults for creating larger cells, more copies of essential loci, or greater storage capacity in secretory cells. However, changes in endopolyploidy with increased adult worker age and polyethism are unstudied. In this study, we examined endopolyploidy in honey bee workers ranging in age from newly emerged up to 55 days old. We found a nonsignificant increase in ploidy levels with age (P < 0.1) in the most highly endopolyploid secretory cells, the Malpighian tubules. All other cell types decreased ploidy levels with age. Endopolyploidy decreased the least amount (nonsignificant) in neural (brain) cells and the stinger (P < 0.1). There was a significant reduction of endopolyploidy with age in leg (P < 0.05) and thoracic (P < 0.001) muscles. Ploidy in thoracic muscle dropped from an average of 0.5 rounds of replication in newly emerged workers to essentially no rounds of replication (0.125) in the oldest workers. Ploidy reduction in flight muscle cells is likely due to the production of G1 (2C) nuclei by amitotic division in the multinucleate striated flight muscles that are essential to foragers, the oldest workers. We suggest that ploidy is constrained by the shape, size and makeup of the multinucleate striated muscle cells. Furthermore, the presence of multiple 2C nuclei might be optimal for cell function, while higher ploidy levels might be a dead-end strategy of some aging adult tissues, likely used to increase cell size and storage capacity in secretory cells.	[Rangel, Juliana; Strauss, Kim; Seedorf, Kaileah; Hjelmen, Carl E.; Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Rangel, J (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	jrangel@tamu.edu	Hjelmen, Carl/AAO-8084-2020	Hjelmen, Carl/0000-0003-3061-6458	Texas AgriLife Research Hatch Project [TEX09557]; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund	Texas AgriLife Research Hatch Project; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund	This work was funded in part by Texas AgriLife Research Hatch Project TEX09557 awarded to JR. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anatskaya OV, 2010, FUNCT INTEGR GENOMIC, V10, P433, DOI 10.1007/s10142-010-0180-5; Aron S, 2005, CURR BIOL, V15, P824, DOI 10.1016/j.cub.2005.03.017; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; BARLOW PW, 1978, ACTA BIOTHEOR, V27, P1, DOI 10.1007/BF00048400; Barow M, 2003, PLANT CELL ENVIRON, V26, P571, DOI 10.1046/j.1365-3040.2003.00988.x; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Bennett MD, 1982, GENOME EVOLUTION; CIFUENTESDIAZ C, 1991, TISSUE CELL, V23, P801, DOI 10.1016/0040-8166(91)90032-O; Cortes F, 2003, MUTAGENESIS, V18, P105, DOI 10.1093/mutage/18.2.105; Crossley A.C., 1978, P499; D'Amato F., 1984, EMBRYOLOGY ANGIOSPER, P519, DOI DOI 10.1007/978-3-642-69302-1_11; Dade H.A., 1994, ANATOMY DISSECTION H; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Flemming AJ, 2000, P NATL ACAD SCI USA, V97, P5285, DOI 10.1073/pnas.97.10.5285; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; FRANCKE OF, 1979, J ARACHNOL, V7, P223; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099; Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219; Johnston JS, 2004, INSECT MOL BIOL, V13, P581, DOI 10.1111/j.0962-1075.2004.00514.x; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; KATO Y, 1987, DEVELOPMENT, V99, P137; Larkins BA, 2001, J EXP BOT, V52, P183, DOI 10.1093/jexbot/52.355.183; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; MASZEWSKI J, 1991, PLANT SYST EVOL, V177, P39, DOI 10.1007/BF00937825; MERRIAM RW, 1954, CHROMOSOMA, V6, P522; MITTWOCH U, 1966, NATURE, V210, P264, DOI 10.1038/210264a0; Mosieniak G, 2010, CURR PHARM DESIGN, V16, P734, DOI 10.2174/138161210790883714; NAGL W, 1976, NATURE, V261, P614, DOI 10.1038/261614a0; NAGL W, 1978, ENDOPOLYPLOIDY POLYT; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Peres LMC, 2014, APIDOLOGIE, V45, P601, DOI 10.1007/s13592-014-0277-2; PESSACQ TA, 1969, EXPERIENTIA, V25, P977, DOI 10.1007/BF01898100; RASCH EM, 1975, J HISTOCHEM CYTOCHEM, V23, P317; Riley BB, 2010, DEV DYNAM, V239, P828, DOI 10.1002/dvdy.22227; Schmidt-Ott U, 2009, DEV GENES EVOL, V219, P207, DOI 10.1007/s00427-009-0281-0; Scholes DR, 2014, J HYMENOPT RES, V37, P113, DOI 10.3897/JHR.37.6824; Scholes DR, 2013, ECOL EVOL, V3, P2128, DOI 10.1002/ece3.623; Seeley T.D., 2010, HONEYBEE DEMOCRACY; SHEN EYF, 1967, J CELL BIOL, V35, P377, DOI 10.1083/jcb.35.2.377; SOHAL RS, 1976, GERONTOLOGY, V22, P317, DOI 10.1159/000212146; TOSELLI PA, 1968, J CELL BIOL, V37, P462, DOI 10.1083/jcb.37.2.462; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Winston M.L., 1991, BIOL HONEY BEE; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523	49	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122208	10.1371/journal.pone.0122208	http://dx.doi.org/10.1371/journal.pone.0122208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881205	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500017
J	Bulbert, MW; Page, RA; Bernal, XE				Bulbert, Matthew W.; Page, Rachel A.; Bernal, Ximena E.			Danger Comes from All Fronts: Predator-Dependent Escape Tactics of Tungara Frogs	PLOS ONE			English	Article							FLIGHT INITIATION DISTANCE; ANTIPREDATOR BEHAVIOR; TURNING BEHAVIOR; EVASIVE BEHAVIOR; BAT PREDATION; PREY; STRATEGIES; ANURA; PERFORMANCE; RESPONSES	The escape response of an organism is generally its last line of defense against a predator. Because the effectiveness of an escape varies with the approach behaviour of the predator, it should be advantageous for prey to alter their escape trajectories depending on the mode of predator attack. To test this hypothesis we examined the escape responses of a single prey species, the ground-dwelling tungara frog (Engystomops pustulosus), to disparate predators approaching from different spatial planes: a terrestrial predator (snake) and an aerial predator (bat). Tungara frogs showed consistently distinct escape responses when attacked by terrestrial versus aerial predators. The frogs fled away from the snake models (Median: 131 degrees). In stark contrast, the frogs moved toward the bat models (Median: 27 degrees); effectively undercutting the bat's flight path. Our results reveal that prey escape trajectories reflect the specificity of their predators' attacks. This study emphasizes the flexibility of strategies performed by prey to outcompete predators with diverse modes of attack.	[Bulbert, Matthew W.] Macquarie Univ, Dept Biol, Behav Ecol Grp, N Ryde, NSW 2109, Australia; [Bulbert, Matthew W.; Page, Rachel A.; Bernal, Ximena E.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Bernal, Ximena E.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Macquarie University; Smithsonian Institution; Smithsonian Tropical Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Bulbert, MW (corresponding author), Macquarie Univ, Dept Biol, Behav Ecol Grp, N Ryde, NSW 2109, Australia.	matthew.bulbert@mq.edu.au	Page, Rachel/AAE-4816-2021; Page, Rachel A/GQQ-2818-2022	Page, Rachel A/0000-0001-7072-0669; Bulbert, Matthew/0000-0002-7313-2536	Texas Tech University	Texas Tech University	This work was partially supported by Texas Tech University funding to XEB. This research received no additional funding from any public, commercial or not-for-profit sectors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C, 2010, R PACKAGE CIRCULAR C; Batschelet E, 1981, CIRCULAR STAT BIOL; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; CAMHI JM, 1989, J COMP PHYSIOL A, V165, P83, DOI 10.1007/BF00613802; COMER CM, 1987, J COMP PHYSIOL A, V160, P571, DOI 10.1007/BF00611930; Cooper WE, 2005, CAN J ZOOL, V83, P1045, DOI 10.1139/Z05-104; Cooper WE, 2008, J HERPETOL, V42, P493, DOI 10.1670/07-066.1; Cooper WE, 2008, BEHAVIOUR, V145, P25, DOI 10.1163/156853908782687250; Cooper WE, 2007, ETHOLOGY, V113, P661, DOI 10.1111/j.1439-0310.2007.01363.x; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; William EC, 2006, ETHOLOGY, V112, P858, DOI 10.1111/j.1439-0310.2006.01240.x; Cooper WE, 2009, BEHAVIOUR, V146, P325, DOI 10.1163/156853909X410946; Dawkins R., 1982, pi; Domenici P, 2008, CURR BIOL, V18, P1792, DOI 10.1016/j.cub.2008.09.062; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Domenici P, 2011, J EXP BIOL, V214, P2474, DOI 10.1242/jeb.053801; Domenici Paolo, 2009, Communicative & Integrative Biology, V2, P497; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; ELLARD CG, 1988, EXP BRAIN RES, V71, P307; Endler JA, 2006, P R SOC B, V273, P2425, DOI 10.1098/rspb.2006.3650; ERLINGE S, 1974, Fauna och Flora Naturhistoriska Riksmuseet, V69, P203; Gomes FR, 2002, COPEIA, P994, DOI 10.1643/0045-8511(2002)002[0994:EAPFIA]2.0.CO;2; Gray HM, 1999, PREDATION HERPETOL R, V30, P93; HAYES F E, 1990, Bulletin of the Maryland Herpetological Society, V26, P81; HAYES FE, 1989, COPEIA, P1011, DOI 10.2307/1445987; Hedenstrom A, 2001, BEHAV ECOL, V12, P150, DOI 10.1093/beheco/12.2.150; Ilany A, 2008, BEHAV ECOL SOCIOBIOL, V62, P923, DOI 10.1007/s00265-007-0516-x; INGLE DJ, 1990, BIOSCIENCE, V40, P284, DOI 10.2307/1311265; JAEGER RG, 1976, COPEIA, P833; King C.M., 1985, Symposia of the Zoological Society of London, P219; King JR, 1996, J COMP PHYSIOL A, V178, P293; Kullberg C, 1998, P ROY SOC B-BIOL SCI, V265, P1659, DOI 10.1098/rspb.1998.0485; Kullberg C, 2007, BEHAV ECOL SOCIOBIOL, V61, P1555, DOI 10.1007/s00265-007-0387-1; Lagos PA, 2014, ANIM BEHAV, V97, P221, DOI 10.1016/j.anbehav.2014.09.019; Langerhans R. Brian, 2007, P177, DOI 10.1007/978-3-540-46046-6_10; Lind J, 2002, NATURWISSENSCHAFTEN, V89, P420, DOI 10.1007/s00114-002-0345-8; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; MARCHISIN A, 1978, J HERPETOL, V12, P151, DOI 10.2307/1563401; Martin J, 1996, J COMP PSYCHOL, V110, P187; Nakagawa H, 2010, STUD COMPUT INTELL, V266, P109; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; Page RA, 2008, ANIM BEHAV, V76, P761, DOI 10.1016/j.anbehav.2008.05.006; Pauly GB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P708, DOI 10.1086/504613; PENNYCUICK CJ, 1994, J AVIAN BIOL, V25, P39, DOI 10.2307/3677292; Pewsey A, 2013, CIRCULAR STAT R; Poulin B, 2001, J TROP ECOL, V17, P21, DOI 10.1017/S026646740100102X; Rao JS., 2001, TOPICS CIRCULAR STAT; Rose A.B., 1997, Australian Bird Watcher, V17, P25; Royan A, 2010, CAN J ZOOL, V88, P922, DOI 10.1139/Z10-059; Ryan M. J., 1985, TUNGARA FROG STUDY S; RYAN MJ, 1981, BEHAV ECOL SOCIOBIOL, V8, P273, DOI 10.1007/BF00299526; RYAN MJ, 1982, AM NAT, V119, P136, DOI 10.1086/283899; Schnitzler Hans-Ulrich, 1998, P183; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Shifferman E, 2004, J AVIAN BIOL, V35, P111, DOI 10.1111/j.0908-8857.2004.03257.x; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Tucker VA, 1998, J EXP BIOL, V201, P403; TUTTLE MD, 1982, ANIM BEHAV, V30, P393, DOI 10.1016/S0003-3472(82)80050-X; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; TUTTLE MD, 1981, BIOTROPICA, V13, P233, DOI 10.2307/2388132; Warrick DR, 1998, CAN J ZOOL, V76, P1063, DOI 10.1139/cjz-76-6-1063	62	21	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120546	10.1371/journal.pone.0120546	http://dx.doi.org/10.1371/journal.pone.0120546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874798	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800011
J	Cizauskas, CA; Turner, WC; Pitts, N; Getz, WM				Cizauskas, Carrie A.; Turner, Wendy C.; Pitts, Neville; Getz, Wayne M.			Seasonal Patterns of Hormones, Macroparasites, and Microparasites in Wild African Ungulates: The Interplay among Stress, Reproduction, and Disease	PLOS ONE			English	Article							ETOSHA-NATIONAL-PARK; TRICHOSTRONGYLUS-COLUBRIFORMIS; HAEMONCHUS-CONTORTUS; CORTISOL METABOLITES; PHYSIOLOGICAL STRESS; IMMUNE-RESPONSES; FOOD USE; PARASITES; SPRINGBOK; RESISTANCE	Sex hormones, reproductive status, and pathogen load all affect stress. Together with stress, these factors can modulate the immune system and affect disease incidence. Thus, it is important to concurrently measure these factors, along with their seasonal fluctuations, to better understand their complex interactions. Using steroid hormone metabolites from fecal samples, we examined seasonal correlations among zebra and springbok stress, reproduction, gastrointestinal (GI) parasite infections, and anthrax infection signatures in zebra and springbok in Etosha National Park (ENP), Namibia, and found strong seasonal effects. Infection intensities of all three GI macroparasites examined (strongyle helminths, Strongyloides helminths, and Eimeria coccidia) were highest in the wet season, concurrent with the timing of anthrax outbreaks. Parasites also declined with increased acquired immune responses. We found hormonal evidence that both mares and ewes are overwhelmingly seasonal breeders in ENP, and that reproductive hormones are correlated with immunosuppression and higher susceptibility to GI parasite infections. Stress hormones largely peak in the dry season, particularly in zebra, when parasite infection intensities are lowest, and are most strongly correlated with host mid-gestation rather than with parasite infection intensity. Given the evidence that GI parasites can cause host pathology, immunomodulation, and immunosuppression, their persistence in ENP hosts without inducing chronic stress responses supports the hypothesis that hosts are tolerant of their parasites. Such tolerance would help to explain the ubiquity of these organisms in ENP herbivores, even in the face of their potential immunomodulatory trade-offs with anti-anthrax immunity.	[Cizauskas, Carrie A.; Turner, Wendy C.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Cizauskas, Carrie A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Turner, Wendy C.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Pitts, Neville] Univ Witwatersrand, Sch Physiol, Johannesburg, South Africa; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	University of California System; University of California Berkeley; Princeton University; University of Oslo; University of Witwatersrand; University of Kwazulu Natal	Cizauskas, CA (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	cizauskas@gmail.com	; Getz, Wayne/I-4521-2013	Pitts, Neville/0000-0001-6432-6112; Getz, Wayne/0000-0001-8784-9354	National Institutes of Health Ecology and Evolution of Infectious Diseases [GM83863]; Andrew and Mary Thompson Rocca Scholarships; University of California, Berkeley, Department of Environmental Science, Policy, and Management; University of California, Berkeley, Graduate Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	National Institutes of Health Ecology and Evolution of Infectious Diseases; Andrew and Mary Thompson Rocca Scholarships; University of California, Berkeley, Department of Environmental Science, Policy, and Management(University of California System); University of California, Berkeley, Graduate Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health Ecology and Evolution of Infectious Diseases grant #GM83863 to WMG (http://www.fic.nih.gov/programs/Pages/ecology-infectiousdiseases.aspx); Andrew and Mary Thompson Rocca Scholarships to CAC (http://africa.berkeley.edu/fellowships/Rocca.php); University of California, Berkeley, Department of Environmental Science, Policy, and Management block grants and continuing fellowships to CAC (http://ourenvironment.berkeley.edu/current-graduate-students/funding/); and University of California, Berkeley, Graduate Division Summer Grants to CAC (http://grad.berkeley.edu/news/egrad/february-2013/summer-grant-2013/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Archie EA, 2012, P NATL ACAD SCI USA, V109, P9017, DOI 10.1073/pnas.1206391109; Asa CS, 2001, ZOO BIOL, V20, P185, DOI 10.1002/zoo.1019; Auer C., 1997, Madoqua, V20, P121; BANKS DJD, 1990, INT J PARASITOL, V20, P155, DOI 10.1016/0020-7519(90)90095-5; Barnier F, 2012, ACTA OECOL, V42, P11, DOI 10.1016/j.actao.2011.11.007; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Beasley AM, 2010, VET PARASITOL, V168, P60, DOI 10.1016/j.vetpar.2009.08.028; Bellan SE, 2013, METHODS ECOL EVOL, V4, P361, DOI 10.1111/2041-210x.12021; BIGGS HC, 1984, ONDERSTEPOORT J VET, V51, P175; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bowman DD, 2014, GEORGIS PARASITOLOGY, V10th; Cain JW, 2012, J ZOOL, V286, P58, DOI 10.1111/j.1469-7998.2011.00848.x; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Chapman CA, 2007, AM J PHYS ANTHROPOL, V134, P240, DOI 10.1002/ajpa.20664; Cizauskas CA, 2014, BMC ECOL, V14, DOI 10.1186/s12898-014-0027-3; Cizauskas CA, 2014, J ANIM ECOL, V83, P1078, DOI 10.1111/1365-2656.12207; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9; Cornell SJ, 2008, P ROY SOC B-BIOL SCI, V275, P511, DOI 10.1098/rspb.2007.1415; Daugschies A, 2005, J VET MED B, V52, P417, DOI 10.1111/j.1439-0450.2005.00894.x; DELGIUDICE GD, 1992, CAN J ZOOL, V70, P974, DOI 10.1139/z92-139; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dobson H, 2000, ANIM REPROD SCI, V60, P743, DOI 10.1016/S0378-4320(00)00080-4; Engert S., 1997, Madoqua, V20, P115; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Ezenwa VO, 2012, FUNCT ECOL, V26, P123, DOI 10.1111/j.1365-2435.2011.01919.x; Foerster S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050108; Fox J., 2019, R COMPANION APPL REG, V.; Gasaway WC, 1996, CAN J ZOOL, V74, P1556, DOI 10.1139/z96-170; Gibbons LM, 2005, MCMASTER EGG COUNTIN; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Grear DA, 2009, ECOL LETT, V12, P528, DOI 10.1111/j.1461-0248.2009.01306.x; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; HOLM S, 1979, SCAND J STAT, V6, P65; HORAK IG, 1992, ONDERSTEPOORT J VET, V59, P253; Kamath PL, 2014, P R SOC B, V281, P1; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Khansari D, 1999, IMMUNOL TODAY, V11, P170; Leggett HC, 2013, TRENDS ECOL EVOL, V28, P592, DOI 10.1016/j.tree.2013.07.002; Lello J, 2005, INT J PARASITOL, V35, P1509, DOI 10.1016/j.ijpara.2005.06.002; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINDEQUE PM, 1994, ONDERSTEPOORT J VET, V61, P71; Linklater WL, 2010, ANIM CONSERV, V13, P104, DOI 10.1111/j.1469-1795.2009.00308.x; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Little SF, 1997, INFECT IMMUN, V65, P5171, DOI 10.1128/IAI.65.12.5171-5175.1997; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marcus H, 2004, INFECT IMMUN, V72, P3471, DOI 10.1128/IAI.72.6.3471-3477.2004; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; Martinaud G, 2009, INT J PARASITOL, V39, P735, DOI 10.1016/j.ijpara.2008.11.006; Martinez-de la Puente J, 2011, NATURWISSENSCHAFTEN, V98, P99, DOI 10.1007/s00114-010-0746-z; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Monello RJ, 2010, J ZOOL, V282, P100, DOI 10.1111/j.1469-7998.2010.00717.x; Monfort SL, 1997, ZOO BIOL, V16, P533, DOI 10.1002/(SICI)1098-2361(1997)16:6<533::AID-ZOO6>3.0.CO;2-B; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Muehlenbein MP, 2006, AM J PHYS ANTHROPOL, V130, P546, DOI 10.1002/ajpa.20391; NAGY KA, 1994, J MAMMAL, V75, P860, DOI 10.2307/1382468; NAGY KA, 1994, AUST J ZOOL, V42, P55, DOI 10.1071/ZO9940055; Ncube H, 2011, GEN COMP ENDOCR, V172, P358, DOI 10.1016/j.ygcen.2011.03.027; Nielsen MK, 2007, VET J, V174, P23, DOI 10.1016/j.tvjl.2006.05.009; Nunn CL, 2003, P ROY SOC B-BIOL SCI, V270, P347, DOI 10.1098/rspb.2002.2249; Olleova M, 2012, J ZOOL, V288, P127, DOI 10.1111/j.1469-7998.2012.00930.x; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pickering AK, 2004, INFECT IMMUN, V72, P3069, DOI 10.1128/IAI.72.5.3069-3072.2004; Pilosof S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041487; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Rowe A, 2008, VET PARASITOL, V153, P285, DOI 10.1016/j.vetpar.2008.01.040; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin DB, 2004, MULTIPLE IMPUTATION; SALTZ D, 1991, J WILDLIFE MANAGE, V55, P1, DOI 10.2307/3809235; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Skinner DC, 2002, REPRODUCTION, V124, P509, DOI 10.1530/rep.0.1240509; Skinner DC, 2001, BIOL REPROD, V64, P1176, DOI 10.1095/biolreprod64.4.1176; SMUTS G L, 1974, Journal of the Southern African Wildlife Management Association, V4, P103; Team R, 2013, R LANG ENV STAT COMP; Turner WC, 2009, ECOLOGY ORALLY INGES; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; Turner WC, 2012, J ANIM ECOL, V81, P58, DOI 10.1111/j.1365-2656.2011.01892.x; Turner WC, 2010, J WILDLIFE DIS, V46, P1108, DOI 10.7589/0090-3558-46.4.1108; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Venables WN., 2002, MODERN APPL STAT S 4; Vera F, 2013, J ZOOL, V289, P111, DOI 10.1111/j.1469-7998.2012.00967.x; Vergouw D, 2012, J MANIP PHYSIOL THER, V35, P464, DOI 10.1016/j.jmpt.2012.07.002; Villanua D, 2006, PARASITOLOGY, V133, P251, DOI 10.1017/S003118200600031X; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Voyles J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035374; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Yun CH, 2000, DEV COMP IMMUNOL, V24, P303, DOI 10.1016/S0145-305X(99)00080-4; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	101	45	45	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120800	10.1371/journal.pone.0120800	http://dx.doi.org/10.1371/journal.pone.0120800			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875647	Green Published, gold			2022-12-26	WOS:000353015800015
J	Han, LM; Haron, Z; Yahya, K; Abu Bakar, S; Dimon, MN				Han, Lim Ming; Haron, Zaiton; Yahya, Khairulzan; Abu Bakar, Suhaimi; Dimon, Mohamad Ngasri			A Stochastic Simulation Framework for the Prediction of Strategic Noise Mapping and Occupational Noise Exposure Using the Random Walk Approach	PLOS ONE			English	Article							CONSTRUCTION EQUIPMENT; ENVIRONMENTAL NOISE; IMPACT ASSESSMENT; HEARING-LOSS; WORKERS; POLLUTION; METROPOLIS; MODELS; SITES; MAP	Strategic noise mapping provides important information for noise impact assessment and noise abatement. However, producing reliable strategic noise mapping in a dynamic, complex working environment is difficult. This study proposes the implementation of the random walk approach as a new stochastic technique to simulate noise mapping and to predict the noise exposure level in a workplace. A stochastic simulation framework and software, namely RW-eNMS, were developed to facilitate the random walk approach in noise mapping prediction. This framework considers the randomness and complexity of machinery operation and noise emission levels. Also, it assesses the impact of noise on the workers and the surrounding environment. For data validation, three case studies were conducted to check the accuracy of the prediction data and to determine the efficiency and effectiveness of this approach. The results showed high accuracy of prediction results together with a majority of absolute differences of less than 2 dBA; also, the predicted noise doses were mostly in the range of measurement. Therefore, the random walk approach was effective in dealing with environmental noises. It could predict strategic noise mapping to facilitate noise monitoring and noise control in the workplaces.	[Han, Lim Ming; Haron, Zaiton; Yahya, Khairulzan; Abu Bakar, Suhaimi] Univ Teknol Malaysia, Fac Civil Engn, Skudai, Malaysia; [Dimon, Mohamad Ngasri] Univ Teknol Malaysia, Fac Elect Engn, Skudai, Malaysia	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Haron, Z (corresponding author), Univ Teknol Malaysia, Fac Civil Engn, Skudai, Malaysia.	zaitonharon@utm.my	haron, zaiton/O-3067-2013; Abu Bakar, Suhaimi/N-1149-2017; Yahya, Khairulzan/K-6831-2012	haron, zaiton/0000-0002-3622-3375; Yahya, Khairulzan/0000-0002-4089-4438; MING HAN, LIM/0000-0003-4196-3201	Malaysian Ministry of Higher Education [GUP, QJ13000.2522.03H43]	Malaysian Ministry of Higher Education	The author ZH received the funding from the Malaysian Ministry of Higher Education (grant number: GUP Vot no. QJ13000.2522.03H43 [http://jpt.mohe.gov.my/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghonamy AI, 2010, J ENV SCI TECHNOLOGY, P1; [Anonymous], 2009, 52281 BSI; [Anonymous], 2008, 6393 BS ISO; [Anonymous], 2002, 616721 IEC; [Anonymous], 2010, 3744 EN ISO BSI; Arezes PM, 2006, INT J IND ERGONOM, V36, P1037, DOI 10.1016/j.ergon.2006.09.005; Armah FA, 2010, ENVIRON HAZARDS-UK, V9, P358, DOI 10.3763/ehaz.2010.0003; Asensio C, 2011, APPL ACOUST, V72, P599, DOI 10.1016/j.apacoust.2010.12.007; Barber M., 1970, RANDOM RESTRICTED WA; Barkokebas B, 2012, WORK, V41, P2982, DOI 10.3233/WOR-2012-0553-2982; BECHARA W, 1994, AIAA J, V32, P455, DOI 10.2514/3.12008; Bite P, 2005, BUDAPEST NOISE MAPPI, P981; BORG E, 1983, HEARING RES, V9, P247, DOI 10.1016/0378-5955(83)90029-1; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Cardoso Antonio Paes, 2006, Rev Port Pneumol, V12, P45; Chevalier S, 1999, J HYDROL, V222, P129, DOI 10.1016/S0022-1694(99)00108-0; Crocker MJ, 2007, HDB NOISE VIBRATION, P19; Cvetkovic V, 2012, ADV WATER RESOUR, V36, P98, DOI 10.1016/j.advwatres.2011.06.008; Daniel E, 2007, J SCHOOL HEALTH, V77, P225, DOI 10.1111/j.1746-1561.2007.00197.x; Dearden A, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P1440; Department of Environment, 2007, PLANN GUID ENV NOIS; Dowling JL, 2012, BEHAV ECOL, V23, P201, DOI 10.1093/beheco/arr176; Doygun H, 2008, ENVIRON MONIT ASSESS, V142, P65, DOI 10.1007/s10661-007-9908-7; Dshalalow JH, 2006, MATH COMPUT MODEL, V44, P931, DOI 10.1016/j.mcm.2006.02.022; Edwards CG, 2006, AM J EPIDEMIOL, V163, P327, DOI 10.1093/aje/kwj044; Eldien HH, 2009, CIE: 2009 INTERNATIONAL CONFERENCE ON COMPUTERS AND INDUSTRIAL ENGINEERING, VOLS 1-3, P1722, DOI 10.1109/ICCIE.2009.5223696; Eleftheriou PC, 2002, APPL ACOUST, V63, P35, DOI 10.1016/S0003-682X(01)00022-6; Erguler K, 2008, MATH BIOSCI, V216, P90, DOI 10.1016/j.mbs.2008.08.012; European Commission, 2016, EV DIR 2002 49 EC RE, DOI 10.2779/171432; Fernandez MD, 2009, APPL ACOUST, V70, P753, DOI 10.1016/j.apacoust.2008.07.014; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Hamoda MF, 2008, J CONSTR DEV CTRIES, V13, P79; Haron Z., 2008, MALAYSIAN J CIVIL EN, V20, P58; Haron Z, 2005, P I ACOUSTICS, V27, P4; Haron Z, 2004, J RECENT RES DEV SOU, V2, P213; Haron Z, 2012, ENER EDUC SCI TECH-A, V29, P989; Haron Z, 2009, J ASIAN ARCHIT BUILD, V8, P571, DOI 10.3130/jaabe.8.571; Hola B, 2010, AUTOMAT CONSTR, V19, P570, DOI 10.1016/j.autcon.2010.02.004; Hothersall DC, 2000, J SOUND VIB, V234, P207, DOI 10.1006/jsvi.1999.2886; Merchan CI, 2013, SCI TOTAL ENVIRON, V449, P115, DOI 10.1016/j.scitotenv.2013.01.063; Inoue M, 2010, ARCH ENV OCCUPATIONA, V60, P106; Ballesteros MJ, 2010, BUILD ENVIRON, V45, P711, DOI 10.1016/j.buildenv.2009.08.011; Karamalis A, 2012, MED IMAGE ANAL, V16, P1101, DOI 10.1016/j.media.2012.07.005; Kim Y, 2010, ASIAN NURS RES, V4, P10, DOI 10.1016/S1976-1317(10)60002-3; Knighton J, 2014, ECOL INFORM, V19, P1, DOI 10.1016/j.ecoinf.2013.11.001; Ko JH, 2011, APPL ACOUST, V72, P544, DOI 10.1016/j.apacoust.2010.09.002; Kock S, 2012, OCCUPATIONAL ENV MED, V61, P838; Kujala T, 2009, BIOL PSYCHOL, V81, P135, DOI 10.1016/j.biopsycho.2009.03.010; Kumicak J, 2004, NATO SCI SER II-MATH, V151, P61; Lee SW, 2008, APPL ACOUST, V69, P704, DOI 10.1016/j.apacoust.2007.02.009; Legris M, 1998, AM IND HYG ASSOC J, V59, P774, DOI 10.1202/0002-8894(1998)059<0774:NEPAHE>2.0.CO;2; Leonard ML, 2008, BEHAV ECOL, V19, P502, DOI 10.1093/beheco/arm161; LI H, 1995, BUILD RES INF, V23, P205, DOI 10.1080/09613219508727460; Lima EJA, 2004, APPL ECON LETT, V11, P255, DOI 10.1080/13504850410001674911; Manatakis E, 2002, APPL ACOUST, V63, P759, DOI 10.1016/S0003-682X(01)00073-1; Miyakita T, 1997, J SOUND VIB, V205, P441, DOI 10.1006/jsvi.1997.1010; Moudon AV, 2009, AM J PREV MED, V37, P167, DOI 10.1016/j.amepre.2009.03.019; Murphy E, 2011, APPL ACOUST, V72, P487, DOI 10.1016/j.apacoust.2010.10.006; Murphy E, 2006, 8 INT S TRANSP NOIS; Nanthavanij S, 1999, INT J IND ERGONOM, V23, P123; Nanthavanij S, 1999, INT J PROD ECON, V60-1, P319, DOI 10.1016/S0925-5273(98)00190-X; Neitzel R, 1999, AM IND HYG ASSOC J, V60, P807; Nelson J, 2004, COORDIN CHEM REV, V248, P1181, DOI 10.1016/j.ccr.2004.04.001; Oliver C, 2009, MARKOV PROCESSES STO; Oyedepo Sunday Olayinka, 2013, International Journal of Environmental Studies, V70, P503, DOI 10.1080/00207233.2013.813716; Paton D, 2012, LANDSCAPE URBAN PLAN, V104, P1, DOI 10.1016/j.landurbplan.2011.09.002; Pradhananga N, 2013, AUTOMAT CONSTR, V29, P107, DOI 10.1016/j.autcon.2012.09.004; Rachiotis G, 2006, AURIS NASUS LARYNX, V33, P381, DOI 10.1016/j.anl.2006.03.008; Ramirez A, 2012, APPLIED ACO IN PRESS; Rylander R, 2004, J SOUND VIB, V277, P471, DOI 10.1016/j.jsv.2004.03.008; Schreier AL, 2010, ANIM BEHAV, V80, P75, DOI 10.1016/j.anbehav.2010.04.002; Seixas NS, 2005, OCCUP ENVIRON MED, V62, P309, DOI 10.1136/oem.2004.018143; Seixas NS, 2001, AIHAJ, V62, P615; Smith SD, 1999, J CONSTR ENG M ASCE, V125, P133, DOI 10.1061/(ASCE)0733-9364(1999)125:3(133); Spitzer F, 1975, PRINCIPLES RANDOM WA; Tak S, 2009, AM J IND MED, V52, P358, DOI 10.1002/ajim.20690; Thurston FE, 2012, AM J IND MED, P1; Zannin PHT, 2011, APPL ACOUST, V72, P479, DOI 10.1016/j.apacoust.2010.09.014; Tsai KT, 2009, APPL ACOUST, V70, P964, DOI 10.1016/j.apacoust.2008.11.001; Verma A, 2014, COMPUTERS O IN PRESS; Vogiatzis K, 2014, SCI TOTAL ENVIRON, V482, P420, DOI 10.1016/j.scitotenv.2013.07.098; Yang JL, 2003, AUTOMAT CONSTR, V12, P725, DOI 10.1016/S0926-5805(03)00056-6; Zannin PHT, 2012, CITIES IN PRESS; Zhang H, 2014, J CLEAN PROD, V76, P85, DOI 10.1016/j.jclepro.2014.04.021; Zolfagharian Samaneh, 2012, Proceedings of the 2012 Construction Research Congress, P1750; [No title captured]	86	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120667	10.1371/journal.pone.0120667	http://dx.doi.org/10.1371/journal.pone.0120667			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875019	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800012
J	Nishimura, S; Bilguvar, K; Ishigame, K; Sestan, N; Gunel, M; Louvi, A				Nishimura, Sayoko; Bilguevar, Kaya; Ishigame, Keiko; Sestan, Nenad; Guenel, Murat; Louvi, Angeliki			Functional Synergy between Cholecystokinin Receptors CCKAR and CCKBR in Mammalian Brain Development	PLOS ONE			English	Article							DEVELOPING CEREBRAL-CORTEX; CINGULATE PIONEERING AXONS; GENE KNOCKOUT MICE; CORPUS-CALLOSUM; CORTICAL INTERNEURONS; GABAERGIC INTERNEURONS; NMDA RECEPTORS; FOOD-INTAKE; IN-VIVO; SPECIES-DIFFERENCES	Cholecystokinin (CCK), a peptide hormone and one of the most abundant neuropeptides in vertebrate brain, mediates its actions via two G-protein coupled receptors, CCKAR and CCKBR, respectively active in peripheral organs and the central nervous system. Here, we demonstrate that the CCK receptors have a dynamic and largely reciprocal expression in embryonic and postnatal brain. Using compound homozygous mutant mice lacking the activity of both CCK receptors, we uncover their additive, functionally synergistic effects in brain development and demonstrate that CCK receptor loss leads to abnormalities of cortical development, including defects in the formation of the midline and corpus callosum, and cortical interneuron migration. Using comparative transcriptome analysis of embryonic neocortex, we define the molecular mechanisms underlying these defects. Thus we demonstrate a developmental, hitherto unappreciated, role of the two CCK receptors in mammalian neocortical development.	[Nishimura, Sayoko; Ishigame, Keiko; Guenel, Murat; Louvi, Angeliki] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Bilguevar, Kaya; Guenel, Murat; Louvi, Angeliki] Yale Univ, Sch Med, Yale Program Neurogenet, New Haven, CT USA; [Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bilguevar, Kaya] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Sestan, Nenad; Guenel, Murat; Louvi, Angeliki] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Louvi, A (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	angeliki.louvi@yale.edu	Nishimura, Sayoko/F-4648-2015		Yale Program on Neurogenetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	Yale Program on Neurogenetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Yale Program on Neurogenetics.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alcantara S, 1998, J NEUROSCI, V18, P7779; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014; Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; BURGUNDER JM, 1990, J COMP NEUROL, V300, P26, DOI 10.1002/cne.903000104; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Campos CA, 2013, ENDOCRINOLOGY, V154, P2613, DOI 10.1210/en.2013-1062; Campos CA, 2012, ENDOCRINOLOGY, V153, P2633, DOI 10.1210/en.2012-1025; Cariboni A, 2007, J NEUROSCI, V27, P2387, DOI 10.1523/JNEUROSCI.5075-06.2007; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Caronia-Brown G, 2011, CEREB CORTEX, V21, P748, DOI 10.1093/cercor/bhq142; Chen Q, 2006, P NATL ACAD SCI USA, V103, P3881, DOI 10.1073/pnas.0505407103; Chen QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015999; Choe Y, 2012, NEURON, V73, P698, DOI 10.1016/j.neuron.2011.11.036; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Edwards TJ, 2014, BRAIN J NEUROLOGY; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Gallopin T, 2006, CEREB CORTEX, V16, P1440, DOI 10.1093/cercor/bhj081; GAUDREAU P, 1983, PEPTIDES, V4, P755, DOI 10.1016/0196-9781(83)90032-3; Giacobini P, 2004, J NEUROSCI, V24, P4737, DOI 10.1523/JNEUROSCI.0649-04.2004; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; HILL DR, 1987, J NEUROSCI, V7, P2967; HILL DR, 1987, NEUROSCI LETT, V79, P286, DOI 10.1016/0304-3940(87)90445-9; Hirota Y, 2007, J NEUROSCI, V27, P12829, DOI 10.1523/JNEUROSCI.1014-07.2007; Horinouchi Y, 2004, EUR NEUROPSYCHOPHARM, V14, P157, DOI 10.1016/S0924-977X(03)00103-2; Hu ZL, 2003, J NEUROSCI, V23, P10963; INGRAM SM, 1989, J COMP NEUROL, V287, P260, DOI 10.1002/cne.902870209; Ivy AC, 1928, AM J PHYSIOL, V86, P599, DOI 10.1152/ajplegacy.1928.86.3.599; Ji BA, 2000, J BIOL CHEM, V275, P19115, DOI 10.1074/jbc.M001685200; Jin GC, 2009, J CLIN INVEST, V119, P2691, DOI 10.1172/JCI38918; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KOESTER SE, 1994, J NEUROSCI, V14, P6608; KOESTER SE, 1993, DEV BIOL, V160, P1, DOI 10.1006/dbio.1993.1281; Kopin AS, 1999, J CLIN INVEST, V103, P383, DOI 10.1172/JCI4901; Kubota Y, 1997, BRAIN RES, V752, P175, DOI 10.1016/S0006-8993(96)01446-1; Lacourse KA, 1999, AM J PHYSIOL-GASTR L, V276, pG1302, DOI 10.1152/ajpgi.1999.276.5.G1302; Langhans N, 1997, GASTROENTEROLOGY, V112, P280, DOI 10.1016/S0016-5085(97)90000-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee SY, 2011, DEV NEUROBIOL, V71, P83, DOI 10.1002/dneu.20815; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Liapi A, 2008, DEV NEUROSCI-BASEL, V30, P117, DOI 10.1159/000109857; Lo CMC, 2012, ENDOCRINOLOGY, V153, P5857, DOI 10.1210/en.2012-1427; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; Lysko DE, 2011, J NEUROSCI, V31, P1739, DOI 10.1523/JNEUROSCI.3118-10.2011; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Marin O, 2013, EUR J NEUROSCI, V38, P2019, DOI 10.1111/ejn.12225; Matta JA, 2013, NAT NEUROSCI, V16, P1032, DOI 10.1038/nn.3459; Mendes SW, 2006, J NEUROSCI, V26, P882, DOI 10.1523/JNEUROSCI.3162-05.2006; MICELI MO, 1989, EUR J PHARMACOL, V169, P215, DOI 10.1016/0014-2999(89)90018-6; Miyasaka K, 1999, PANCREAS, V19, P114, DOI 10.1097/00006676-199908000-00002; Miyasaka K, 2004, J GASTROENTEROL, V39, P319, DOI 10.1007/s00535-003-1297-2; Miyasaka K, 2002, J NUTR, V132, P739, DOI 10.1093/jn/132.4.739; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Mohammad S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416214; MORAN TH, 1986, BRAIN RES, V362, P175, DOI 10.1016/0006-8993(86)91413-7; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Morozov YM, 2009, CEREB CORTEX, V19, pI78, DOI 10.1093/cercor/bhp028; Nagata A, 1996, P NATL ACAD SCI USA, V93, P11825, DOI 10.1073/pnas.93.21.11825; Niquille M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000230; Noble F, 2002, NEUROPEPTIDES, V36, P157, DOI 10.1054/npep.2002.0904; Noble F., 2006, HDB NEUROCHEMISTRY M, P545; NUNZI MG, 1985, J COMP NEUROL, V237, P485, DOI 10.1002/cne.902370406; OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Piper M, 2009, CEREB CORTEX, V19, pI11, DOI 10.1093/cercor/bhp027; Pletikos M, 2014, NEURON, V81, P321, DOI 10.1016/j.neuron.2013.11.018; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Rehfeld JF, 2007, CURR TOP MED CHEM, V7, P1154; Rehfeld JF, 2006, J MOL MED-JMM, V84, P544, DOI 10.1007/s00109-006-0055-3; Rindi G, 1998, YALE J BIOL MED, V71, P347; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Sanchez-Camacho C, 2011, DEV NEUROBIOL, V71, P337, DOI 10.1002/dneu.20865; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Schwarting GA, 2006, J NEUROSCI, V26, P6834, DOI 10.1523/JNEUROSCI.1728-06.2006; SEKIGUCHI R, 1986, BRAIN RES, V399, P271, DOI 10.1016/0006-8993(86)91517-9; Shu TZ, 2003, J NEUROBIOL, V57, P81, DOI 10.1002/neu.10252; Shu TZ, 2003, DEVELOPMENT, V130, P2929, DOI 10.1242/dev.00514; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; Silver J, 1993, Perspect Dev Neurobiol, V1, P227; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; Stanic D, 2008, P NATL ACAD SCI USA, V105, P3610, DOI 10.1073/pnas.0712303105; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Stumm RK, 2003, J NEUROSCI, V23, P5123; Sui Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00013; Sui Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031549; Tanriover G, 2008, NEUROSURGERY, V62, P930, DOI 10.1227/01.neu.0000318179.02912.ca; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; VANDERHAEGHEN JJ, 1975, NATURE, V257, P604, DOI 10.1038/257604a0; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wahlsten D, 2006, GENES BRAIN BEHAV, V5, P170, DOI 10.1111/j.1601-183X.2005.00153.x; WAHLSTEN D, 1982, BRAIN RES, V239, P329, DOI 10.1016/0006-8993(82)90513-3; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Watakabe A, 2012, J COMP NEUROL, V520, P3553, DOI 10.1002/cne.23160; WILLIAMS JA, 1986, PEPTIDES, V7, P293, DOI 10.1016/0196-9781(86)90228-7; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Xiao ZY, 2012, HIPPOCAMPUS, V22, P1438, DOI 10.1002/hipo.20984; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; YAMAMOTO M, 1986, J NEUROSCI, V6, P3576; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zwanzger P, 2012, DEPRESS ANXIETY, V29, P762, DOI 10.1002/da.21919	133	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124295	10.1371/journal.pone.0124295	http://dx.doi.org/10.1371/journal.pone.0124295			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875176	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800136
J	Omodaka, K; Horii, T; Takahashi, S; Kikawa, T; Matsumoto, A; Shiga, Y; Maruyama, K; Yuasa, T; Akiba, M; Nakazawa, T				Omodaka, Kazuko; Horii, Takaaki; Takahashi, Seri; Kikawa, Tsutomu; Matsumoto, Akiko; Shiga, Yukihiro; Maruyama, Kazuichi; Yuasa, Tetsuya; Akiba, Masahiro; Nakazawa, Toru			3D Evaluation of the Lamina Cribrosa with Swept-Source Optical Coherence Tomography in Normal Tension Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NERVE-FIBER LAYER; REGIONAL DIFFERENCES; THICKNESS; EYES; REPRODUCIBILITY; APOPTOSIS; HEALTHY; HEAD; OCT	Purpose Although the lamina cribrosa (LC) is the primary site of axonal damage in glaucoma, adequate methods to image and measure it are currently lacking. Here, we describe a noninvasive, in vivo method of evaluating the LC, based on swept-source optical coherence tomography (SS-OCT), and determine this method's ability to quantify LC thickness. Methods This study comprised 54 eyes, including normal (n = 18), preperimetric glaucoma (PPG; n = 18), and normal tension glaucoma (NTG; n = 18) eyes. We used SS-OCT to obtain 3 x 3 mm cube scans of an area centered on the optic disc, and then synchronized reconstructed Band en-face images from this data. We identified the LC in these B-scan images by marking the visible borders of the LC pores. We marked points on the anterior and posterior borders of the LC in 12 B-scan images in order to create a skeleton model of the LC. Finally, we used B-spline interpolation to form a 3D model of the LC, including only reliably measured scan areas. We calculated the average LC thickness (avgLCT) in this model and used Spearman's rank correlation coefficient to compare it with circumpapillary retinal nerve fiber layer thickness (cpRNFLT). Results We found that the correlation coefficient of avgLCT and cpRNFLT was 0.64 (p < 0.01). The coefficient of variation for avgLCT was 5.1%. AvgLCT differed significantly in the groups (normal: 282.6 +/- 20.6 mu m, PPG: 261.4 +/- 15.8 mu m, NTG: 232.6 +/- 33.3 mu m). The normal, PPG and NTG groups did not significantly differ in age, sex, refractive error or intraocular pressure (IOP), although the normal and NTG groups differed significantly in cpRNFLT and Humphrey field analyzer measurements of mean deviation. Conclusion Thus, our results indicate that the parameters of our newly developed method of measuring LC thickness with SS-OCT may provide useful and important data for glaucoma diagnosis and research.	[Omodaka, Kazuko; Takahashi, Seri; Shiga, Yukihiro; Maruyama, Kazuichi; Nakazawa, Toru] Tohoku Univ Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Horii, Takaaki; Yuasa, Tetsuya] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 990, Japan; [Kikawa, Tsutomu; Matsumoto, Akiko; Akiba, Masahiro] Topcon Corp, Tokyo, Japan; [Nakazawa, Toru] Tohoku Univ Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan	Tohoku University; Yamagata University; Topcon Corporation; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp	Maruyama, Kazuichi/GRX-8129-2022	Maruyama, Kazuichi/0000-0001-6283-5466	JST grant from JSPS KAKENHI [T.N. 26293372, T.N. 26670751]; JST Center for Revitalization Promotion	JST grant from JSPS KAKENHI; JST Center for Revitalization Promotion	This paper was supported in part by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (T.N. 26293372) and for Exploratory Research (T.N. 26670751), and by the JST Center for Revitalization Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; Anderson DR., 1999, AUTOMATED STATIC PER; Badala F, 2007, AM J OPHTHALMOL, V144, P724, DOI 10.1016/j.ajo.2007.07.010; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; EMERY JM, 1974, T AM ACAD OPHTHALMOL, V78, pO290; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P7576, DOI 10.1167/iovs.12-10305; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P198, DOI 10.1167/iovs.11-7848; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Mardin CY, 2001, CURR OPIN OPHTHALMOL, V12, P100, DOI 10.1097/00055735-200104000-00004; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Moore D, 2008, CLIN OPHTHALMOL, V2, P849; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Nadler Z, 2013, BIOMED OPT EXPRESS, V4, P2596, DOI 10.1364/BOE.4.002596; Naithani P, 2007, INVEST OPHTH VIS SCI, V48, P3138, DOI 10.1167/iovs.06-1407; Okisaka S, 1997, JPN J OPHTHALMOL, V41, P84, DOI 10.1016/S0021-5155(97)00013-0; Omodaka K, 2010, CLIN OPHTHALMOL, V4, P765; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park HY Lopilly, 2013, AM J OPHTHALMOL; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; Pollet-Villard F, 2014, INVEST OPHTH VIS SCI, V55, P2953, DOI 10.1167/iovs.13-13482; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tatton NA, 2001, SURV OPHTHALMOL, V45, pS268, DOI 10.1016/S0039-6257(01)00204-1; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099138	37	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122347	10.1371/journal.pone.0122347	http://dx.doi.org/10.1371/journal.pone.0122347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875096	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800052
J	Wang, CC; Su, KY; Chen, HY; Chang, SY; Shen, CF; Hsieh, CH; Hong, QS; Chiang, CC; Chang, GC; Yu, SL; Chen, JJW				Wang, Chi-Chung; Su, Kang-Yi; Chen, Hsuan-Yu; Chang, So-Yi; Shen, Chi-Fan; Hsieh, Chia-Hung; Hong, Qi-Sheng; Chiang, Ching-Cheng; Chang, Gee-Chen; Yu, Sung-Liang; Chen, Jeremy J. W.			HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma	PLOS ONE			English	Article							BREAST-CANCER CELLS; HOMEOBOX GENES; ARP2/3 COMPLEX; TUMOR-CELLS; EXPRESSION; MOTILITY; PAXILLIN; INVASION; PROTEIN; IDENTIFICATION	Homeobox genes comprise a family of regulatory genes that contain a common homeobox domain and act as transcription factors. Recent studies indicate that homeobox A5 (HOXA5) may serve as a tumour suppressor gene in breast cancers. However, the precise role and the underlying mechanism of HOXA5 in lung cancer remain unclear. Oligonucleotide microarrays and an invasion/metastasis lung adenocarcinoma cell line model were used to determine the correlation between HOXA5 expression and cancer cell invasion ability. We found that ectopic expression of HOXA5 in highly invasive cancer cells suppressed cell migration, invasion, and filopodia formation in vitro and inhibited metastatic potential in vivo. Knockdown of HOXA5 promoted the invasiveness of lung cancer cells. In addition, HOXA5 expression was associated with better clinical outcome in non-small cell lung cancer patients with wild-type EGFR. Furthermore, genome-wide transcriptomic and pathway analyses were performed to identify the potential molecular mechanisms. Our data showed that HOXA5 may bind to the promoters of the cytoskeleton-related genes and downregulate their mRNA and protein expression levels. Our studies provide new insights into how HOXA5 may contribute to the suppression of metastasis in lung cancer via cytoskeleton remodelling regulation. Therefore, targeted induction of HOXA5 may represent a promising approach for non-small-cell lung cancer therapy.	[Wang, Chi-Chung; Shen, Chi-Fan] Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan; [Su, Kang-Yi; Hong, Qi-Sheng; Chiang, Ching-Cheng; Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin & Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Su, Kang-Yi; Chen, Hsuan-Yu; Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10764, Taiwan; [Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Chang, So-Yi] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10764, Taiwan; [Hsieh, Chia-Hung] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	Fu Jen Catholic University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; China Medical University Taiwan; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Chung Hsing University; National Chung Hsing University	Chen, JJW (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.	jwchen@dragon.nchu.edu.tw	SU, KANG-YI/GNM-5753-2022; Chen, Hsuan-Yu/AAE-8428-2019	SU, KANG-YI/0000-0002-6538-9526; Chen, Jeremy J.W./0000-0003-1049-3825; YU, SUNG-LIANG/0000-0003-4535-9036	National Science Council (NSC), Taiwan [NSC97-2314-B-030-007-MY2, NSC99-2628-B-030-002-MY3]; Fu Jen Catholic University, Taiwan [9991A01-409931034019]; Ministry of Education, Taiwan	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); Fu Jen Catholic University, Taiwan; Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This study was supported by grants from the National Science Council (NSC), Taiwan, R.O.C. (NSC97-2314-B-030-007-MY2 and NSC99-2628-B-030-002-MY3 to CCW), as well as by grants from the Fu Jen Catholic University, Taiwan, R.O.C. (9991A01-409931034019 to CCW) and by the Ministry of Education, Taiwan, R.O.C. under the ATU plan (to JJWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2006, ONCOL REP, V15, P797; Apiou F, 1996, CYTOGENET CELL GENET, V73, P114, DOI 10.1159/000134320; Bailly M, 2002, NAT CELL BIOL, V4, pE292, DOI 10.1038/ncb1202-e292; Baljinnyam E, 2010, CANCER RES, V70, P5607, DOI 10.1158/0008-5472.CAN-10-0056; Chen CH, 2012, MOL CANCER RES, V10, P1319, DOI 10.1158/1541-7786.MCR-12-0189; Chen HX, 2005, J BIOL CHEM, V280, P19373, DOI 10.1074/jbc.M413528200; Chen HX, 2004, MOL CELL BIOL, V24, P924, DOI 10.1128/MCB.24.2.924-935.2004; Chen JJW, 2001, CANCER RES, V61, P5223; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; DEVITA G, 1993, EUR J CANCER, V29A, P887, DOI 10.1016/S0959-8049(05)80432-0; Ford HL, 1998, CELL BIOL INT, V22, P397, DOI 10.1006/cbir.1998.0329; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; Golpon HA, 2001, AM J PATHOL, V158, P955, DOI 10.1016/S0002-9440(10)64042-4; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hsiao KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069354; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Kerber ML, 2011, J CELL SCI, V124, P3733, DOI 10.1242/jcs.023549; Kim DS, 2009, MOL CARCINOGEN, V48, P1109, DOI 10.1002/mc.20561; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nunes Fabio Daumas, 2003, Pesqui Odontol Bras, V17, P94; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rettig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042012; Sakakura C, 2003, ANTICANCER RES, V23, P3691; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; Semba S, 2006, CLIN CANCER RES, V12, P2449, DOI 10.1158/1078-0432.CCR-05-2566; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shibao K, 2010, CELL CALCIUM, V48, P315, DOI 10.1016/j.ceca.2010.09.005; Shiraishi M, 2002, ONCOGENE, V21, P3804, DOI 10.1038/sj.onc.1205454; Stasinopoulos IA, 2005, J BIOL CHEM, V280, P2294, DOI 10.1074/jbc.M411018200; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Taylor HS, 2000, SEMIN REPROD MED, V18, P81, DOI 10.1055/s-2000-13478; TIBERIO C, 1994, INT J CANCER, V58, P608, DOI 10.1002/ijc.2910580426; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Uyeno LA, 2001, J SURG RES, V100, P46, DOI 10.1006/jsre.2001.6174; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vider BZ, 1997, BIOCHEM BIOPH RES CO, V232, P742, DOI 10.1006/bbrc.1997.6364; Wang L, 2003, J BIOL CHEM, V278, P44617, DOI 10.1074/jbc.M308929200; Yoo YD, 2007, J BIOL CHEM, V282, P7616, DOI 10.1074/jbc.M607596200; Zhang ML, 2014, TUMOR BIOL; Zheng HC, 2008, ANTICANCER RES, V28, P2225; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	49	31	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124191	10.1371/journal.pone.0124191	http://dx.doi.org/10.1371/journal.pone.0124191			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875824	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700059
J	Xisto, MIDS; Bittencourt, VCB; Liporagi-Lopes, LC; Haido, RMT; Mendonca, MSA; Sassaki, G; Figueiredo, RT; Romanos, MTV; Barreto-Bergter, E				Xisto, Mariana I. D. S.; Bittencourt, Vera C. B.; Liporagi-Lopes, Livia Cristina; Haido, Rosa M. T.; Mendonca, Morena S. A.; Sassaki, Guilherme; Figueiredo, Rodrigo T.; Romanos, Maria Teresa V.; Barreto-Bergter, Eliana			O-Glycosylation in Cell Wall Proteins in Scedosporium prolificans Is Critical for Phagocytosis and Inflammatory Cytokines Production by Macrophages	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PSEUDALLESCHERIA-BOYDII; CANDIDA-ALBICANS; ASPERGILLUS-FUMIGATUS; LINKED OLIGOSACCHARIDES; SPOROTHRIX-SCHENCKII; MURINE MACROPHAGES; RECOGNITION; POLYSACCHARIDES; DIFFERENTIATION	In this study, we analyze the importance of O-linked oligosaccharides present in peptidorhamnomannan ( PRM) from the cell wall of the fungus Scedosporium prolificans for recognition and phagocytosis of conidia by macrophages. Adding PRM led to a dose-dependent inhibition of conidia phagocytosis, whereas de-O-glycosylated PRM did not show any effect. PRM induced the release of macrophage-derived antimicrobial compounds. However, O-linked oligosaccharides do not appear to be required for such induction. The effect of PRM on conidia-induced macrophage killing was examined using latex beads coated with PRM or de-O-glycosylated PRM. A decrease in macrophage viability similar to that caused by conidia was detected. However, macrophage killing was unaffected when beads coated with de-O-glycosylated PRM were used, indicating the toxic effect of O-linked oligosaccharides on macrophages. In addition, PRM triggered TNF-alpha release by macrophages. Chemical removal of O-linked oligosaccharides from PRM abolished cytokine induction, suggesting that the O-linked oligosaccharidic chains are important moieties involved in inflammatory responses through the induction of TNF-alpha secretion. In summary, we show that O-glycosylation plays a role in the recognition and uptake of Scedosporium prolificans by macrophages, killing of macrophages and production of pro-inflammatory cytokines.	[Xisto, Mariana I. D. S.; Barreto-Bergter, Eliana] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Geral, Rio de Janeiro, Brazil; [Bittencourt, Vera C. B.; Haido, Rosa M. T.] Univ Fed Estado Rio de Janeiro, Inst Biomed, Dept Microbiol & Parasitol, Rio de Janeiro, Brazil; [Liporagi-Lopes, Livia Cristina] Univ Fed Rio de Janeiro, Fac Farm, Dept Anal Clin & Toxicol, Rio de Janeiro, Brazil; [Mendonca, Morena S. A.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio de Janeiro, Brazil; [Sassaki, Guilherme] UFRP, Dept Bioquim & Biol Mol, Curitiba, Parana, Brazil; [Figueiredo, Rodrigo T.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio de Janeiro, Brazil; [Romanos, Maria Teresa V.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Barreto-Bergter, E (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Geral, Rio de Janeiro, Brazil.	eliana.bergter@micro.ufrj.br	Bergter, Eliana Barreto/E-2664-2013; Sassaki, Guilherme/AAM-1112-2020; Bittencourt, Vera CB/A-7921-2019; Figueiredo, Rodrigo/F-5176-2016	Sassaki, Guilherme/0000-0001-7420-168X; Figueiredo, Rodrigo/0000-0002-7551-8782; bittencourt, vera/0000-0002-7403-9747; Xisto, Mariana Ingrid/0000-0002-1803-6381	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Conselho de Pesquisa da UFRJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Nucleos de Excelencia (PRONEX); FAPERJ; CNPq; CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho de Pesquisa da UFRJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Conselho de Pesquisa da UFRJ, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Programa de Nucleos de Excelencia (PRONEX). LCLL and EBB are supported by FAPERJ, CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffeto-Bergter E, 2008, INT J BIOL MACROMOL, V42, P93, DOI 10.1016/j.ijbiomac.2007.09.015; Bain JM, 2014, MBIO, V5, DOI 10.1128/mBio.01874-14; Barreto-Bergter E, 2011, CARBOHYD POLYM, V85, P349, DOI 10.1016/j.carbpol.2011.02.033; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Figueiredo RT, 2010, J BIOL CHEM, V285, P40714, DOI 10.1074/jbc.M110.181255; Figueiredo RT, 2012, CARBOHYD RES, V356, P260, DOI 10.1016/j.carres.2012.02.028; Gil-Lamaignere C, 2001, MED MYCOL, V39, P169, DOI 10.1080/714031013; Gorin PAJ, 2010, CARBOHYD POLYM, V79, P927, DOI 10.1016/j.carbpol.2009.10.015; Haido RMT, 1998, MED MYCOL, V36, P313, DOI 10.1080/02681219880000491; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; Hung CY, 2007, ANN NY ACAD SCI, V1111, P225, DOI 10.1196/annals.1406.020; Husain S, 2005, CLIN INFECT DIS, V40, P89, DOI 10.1086/426445; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Kudeken N, 1998, CLIN EXP IMMUNOL, V112, P287; Lackner M, 2014, ANTIMICROB AGENTS CH, V58, P5877, DOI 10.1128/AAC.03211-14; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; LLOYD KO, 1971, J IMMUNOL, V107, P663; Lopes LCL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000853; Lopes LCL, 2011, MYCOSES, V54, P28, DOI 10.1111/j.1439-0507.2011.02105.x; Mahmoud Yehia A-G, 2011, Mycobiology, V39, P40, DOI 10.4489/MYCO.2011.39.1.040; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; MENDONCA L, 1976, BIOCHEMISTRY-US, V15, P2423, DOI 10.1021/bi00656a028; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Nyberg K, 1996, J MED VET MYCOL, V34, P11; Peroval MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051243; Pinto MR, 2005, GLYCOBIOLOGY, V15, P895, DOI 10.1093/glycob/cwi084; Pinto MR, 2004, MICROBES INFECT, V6, P1259, DOI 10.1016/j.micinf.2004.07.006; Pinto MR, 2001, MICROBIOL-SGM, V147, P1499, DOI 10.1099/00221287-147-6-1499; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; Rocco NM, 2011, INFECT IMMUN, V79, P2385, DOI 10.1128/IAI.01249-10; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Roilides E, 2009, MED MYCOL, V47, P433, DOI 10.1080/13693780902738006; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Seider K, 2010, CURR OPIN MICROBIOL, V13, P392, DOI 10.1016/j.mib.2010.05.001; Sheth CC, 2011, MED MYCOL, V49, P513, DOI 10.3109/13693786.2010.551425; Smiderle FR, 2013, CARBOHYD POLYM, V97, P74, DOI 10.1016/j.carbpol.2013.04.049; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; VazquezTorres A, 1996, INFECT IMMUN, V64, P3127, DOI 10.1128/IAI.64.8.3127-3133.1996; WOLF JE, 1989, INFECT IMMUN, V57, P513, DOI 10.1128/IAI.57.2.513-519.1989; Zhu ZY, 2013, J PROTEOME RES, V12, P2375, DOI 10.1021/pr300447k	44	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123189	10.1371/journal.pone.0123189	http://dx.doi.org/10.1371/journal.pone.0123189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875427	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700027
J	Basu, S; Thorat, R; Dalal, SN				Basu, Srikanta; Thorat, Rahul; Dalal, Sorab N.			MMP7 Is Required to Mediate Cell Invasion and Tumor Formation upon Plakophilin3 Loss	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-7 EXPRESSION; HUMAN COLORECTAL-CANCER; MESSENGER-RNA; GENE-FUNCTION; HUMAN COLON; MATRILYSIN; LOCALIZATION; OVEREXPRESSION; PURIFICATION; METASTASIS	Plakophilin3 (PKP3) loss results in increased transformation in multiple cell lines in vitro and increased tumor formation in vivo. A microarray analysis performed in the PKP3 knockdown clones, identified an inflammation associated gene signature in cell lines derived from stratified epithelia as opposed to cell lines derived from simple epithelia. However, in contrast to the inflammation associated gene signature, the expression of MMP7 was increased upon PKP3 knockdown in all the cell lines tested. Using vector driven RNA interference, it was demonstrated that MMP7 was required for in-vitro cell migration and invasion and tumor formation in vivo. The increase in MMP7 levels was due to the increase in levels of the Phosphatase of Regenerating Liver3 (PRL3), which is observed upon PKP3 loss. The results suggest that MMP7 over-expression may be one of the mechanisms by which PKP3 loss leads to increased cell invasion and tumor formation.	[Basu, Srikanta; Thorat, Rahul; Dalal, Sorab N.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Dalal, SN (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India.	sdalal@actrec.gov.in	BASU, SRIKANTA/V-5586-2019	BASU, SRIKANTA/0000-0002-0461-3731	Department of Science and Technology (DST), Government of India [SR/SO/HS-011/2009]; ACTREC; Council for Scientific and Industrial Research (CSIR) Govt. of India [09/513(0074)/2009-EMR-I]	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); ACTREC; Council for Scientific and Industrial Research (CSIR) Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Science and Technology (DST), Government of India to SND. The grant number is SR/SO/HS-011/2009. The work was also supported by intra-mural funds from ACTREC. SB was supported by a fellowship from the Council for Scientific and Industrial Research (CSIR) Govt. of India. The fellowship number is 09/513(0074)/2009-EMR-I. The funders had no role in study design, data	Aigner K, 2007, FEBS LETT, V581, P1617, DOI 10.1016/j.febslet.2007.03.026; ALBINI A, 1987, CANCER RES, V47, P3239; Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Demirag GG, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-1; Desai BV, 2009, J CELL SCI, V122, P4401, DOI 10.1242/jcs.037457; Fingleton B, 2007, HYBRIDOMA, V26, P22, DOI 10.1089/hyb.2006.028; Fischer-Keso R., 2014, MOL CELL BIOL; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Guillen-Ahlers H, 2008, CARCINOGENESIS, V29, P1421, DOI 10.1093/carcin/bgn123; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Jheon AH, 2011, J CELL SCI, V124, P745, DOI 10.1242/jcs.078071; Jiang QH, 2014, SCI WORLD J, DOI 10.1155/2014/340271; Khapare N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038561; Kivisaari AK, 2008, BRIT J DERMATOL, V158, P778, DOI 10.1111/j.1365-2133.2008.08466.x; Kivisaari AK, 2010, BRIT J DERMATOL, V163, P726, DOI 10.1111/j.1365-2133.2010.09924.x; Kleinman H K, 2001, Curr Protoc Cell Biol, VChapter 12, DOI 10.1002/0471143030.cb1202s00; Kundu ST, 2008, INT J CANCER, V123, P2303, DOI 10.1002/ijc.23797; Lee SK, 2012, INT J CANCER, V131, pE190, DOI 10.1002/ijc.27381; Maurel J, 2007, INT J CANCER, V121, P1066, DOI 10.1002/ijc.22799; MCDONNELL S, 1991, MOL CARCINOGEN, V4, P527, DOI 10.1002/mc.2940040617; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; MIYAZAKI K, 1990, CANCER RES, V50, P7758; MORI M, 1995, CANCER, V75, P1516, DOI 10.1002/1097-0142(19950315)75:6+<1516::AID-CNCR2820751522>3.0.CO;2-7; Ohashi K, 2000, CANCER-AM CANCER SOC, V88, P2201, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2201::AID-CNCR2>3.3.CO;2-E; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Papagerakis S, 2003, HUM PATHOL, V34, P565, DOI 10.1016/S0046-8177(03)00174-6; Polistena A, 2014, IN VIVO, V28, P105; PORTE H, 1995, INT J CANCER, V64, P70, DOI 10.1002/ijc.2910640114; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1046/j.1432-0436.1999.6450291.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sehgal L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021975; Sklyarova T, 2008, J INVEST DERMATOL, V128, P1375, DOI 10.1038/sj.jid.5701189; Szarvas T, 2010, CANCER SCI, V101, P1300, DOI 10.1111/j.1349-7006.2010.01506.x; Takahashi H, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.08.049; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; WITTY JP, 1994, CANCER RES, V54, P4805; WOESSNER JF, 1988, J BIOL CHEM, V263, P16918; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Yamamoto H, 2001, J CLIN ONCOL, V19, P1118, DOI 10.1200/JCO.2001.19.4.1118; Yamashita K, 2000, CLIN CANCER RES, V6, P1169; Yamashita K, 1998, INT J CANCER, V79, P187; YOSHIMOTO M, 1993, INT J CANCER, V54, P614, DOI 10.1002/ijc.2910540415; ZENG ZS, 1995, BRIT J CANCER, V72, P575, DOI 10.1038/bjc.1995.376; Zeng ZS, 2002, CLIN CANCER RES, V8, P144	50	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123979	10.1371/journal.pone.0123979	http://dx.doi.org/10.1371/journal.pone.0123979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875355	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100229
J	Beck, IM; Van Crombruggen, K; Holtappels, G; Daubeuf, F; Frossard, N; Bachert, C; De Bosscher, K				Beck, Ilse M.; Van Crombruggen, Koen; Holtappels, Gabriele; Daubeuf, Francois; Frossard, Nelly; Bachert, Claus; De Bosscher, Karolien			Differential Cytokine Profiles upon Comparing Selective versus Classic Glucocorticoid Receptor Modulation in Human Peripheral Blood Mononuclear Cells and Inferior Turbinate Tissue	PLOS ONE			English	Article							NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; INFLAMMATORY MEDIATORS; ENTEROTOXIN-B; PLANT-ORIGIN; NASAL POLYPS; MOUSE MODEL; LIGAND; COMPOUND; DEXAMETHASONE	Background Glucocorticoid Receptor agonists, particularly classic glucocorticoids, are the mainstay among treatment protocols for various chronic inflammatory disorders, including nasal disease. To steer away from steroid-induced side effects, novel GR modulators exhibiting a more favorable therapeutic profile remain actively sought after. Currently, the impact of 2( 4-acetoxyphenyl)-2-chloro-N-methylethylammonium chloride a plant-derived selective glucocorticoid receptor modulator named compound A, on cytokine production in ex vivo human immune cells and tissue has scarcely been evaluated. Methods and Results The current study aimed to investigate the effect of a classic glucocorticoid versus compound A on cytokine and inflammatory mediator production after stimulation with Staphylococcus aureus-derived enterotoxin B protein in peripheral blood mononuclear cells (PBMCs) as well as in inferior nasal turbinate tissue. To this end, tissue fragments were stimulated with RPMI (negative control) or Staphylococcus aureus-derived enterotoxin B protein for 24 hours, in presence of solvent, or the glucocorticoid methylprednisolone or compound A at various concentrations. Supernatants were measured via multiplex for pro-inflammatory cytokines (IL-1 beta, TNF alpha) and T-cell-and subset-related cytokines (IFN-gamma, IL-2, IL-5, IL-6, IL-10, and IL-17). In concordance with the previously described stimulatory role of superantigens in the development of nasal polyposis, a 24h Staphylococcus aureus-derived enterotoxin B protein stimulation induced a significant increase of IL-2, IL-1 beta, TNF-alpha, and IL-17 in PBMCs and in inferior turbinates and of IL-5 and IFN-gamma in PBMCs. Conclusion Notwithstanding some differences in amplitude, the overall cytokine responses to methylprednisolone and compound A were relatively similar, pointing to a conserved and common mechanism in cytokine transrepression and anti-inflammatory actions of these GR modulators. Furthermore, these results provide evidence that selective glucocorticoid receptor modulator-mediated manipulation of the glucocorticoid receptor in human tissues, supports its anti-inflammatory potential.	[Beck, Ilse M.] Univ Ghent, Dept Radiat Oncol & Expt Canc Res, LECR, B-9000 Ghent, Belgium; [Van Crombruggen, Koen; Holtappels, Gabriele; Bachert, Claus] Ghent Univ Hosp, Upper Airway Res Lab URL, Ghent, Belgium; [Daubeuf, Francois; Frossard, Nelly] Univ Strasbourg, CNRS, Fac Pharm, Lab Innovat Therapeut,UMR 7200, Illkirch Graffenstaden, France; [Bachert, Claus] Karolinska Inst, Div ENT Dis, Stockholm, Sweden; [De Bosscher, Karolien] Univ Ghent, VIB Dept Med Prot Res, NRL, Receptor Res Labs, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Karolinska Institutet; Flanders Institute for Biotechnology (VIB); Ghent University	De Bosscher, K (corresponding author), Univ Ghent, VIB Dept Med Prot Res, NRL, Receptor Res Labs, B-9000 Ghent, Belgium.	Karolien.DeBosscher@vib-ugent.be	Bachert, Claus/J-8825-2012; Frossard, Nelly/F-8301-2013	De Bosscher, Karolien/0000-0001-5059-9718	Research Foundation-Flanders (FWO) [1.2.405.10.N.00]; FWO [1.2.546.07.N.01, 1.5.107.09.N.00]	Research Foundation-Flanders (FWO)(FWO); FWO(FWO)	IMB is a postdoctoral fellow of the Research Foundation-Flanders (FWO), grant number 1.2.405.10.N.00 (www.fwo.be). KDB was also supported as a postdoctoral fellow of the FWO (grant number 1.2.546.07.N.01) during the initial stages of this project. The work was funded by a Research Grant of the FWO to KDB (grant number 1.5.107.09.N.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2006, ALLERGY, V61, P693, DOI 10.1111/j.1398-9995.2006.01054.x; Bachert C, 2003, ALLERGY, V58, P176, DOI 10.1034/j.1398-9995.2003.02172.x; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Barnes PJ, 1998, PHARMACOL REV, V50, P515; Beck IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069115; Beck IM, 2013, EUR J PHARMACOL, V715, P1, DOI 10.1016/j.ejphar.2013.06.032; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bhatt D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00071; BIGSBY RM, 1993, J STEROID BIOCHEM, V46, P253, DOI 10.1016/0960-0760(93)90301-C; Bousquet J, 2008, ALLERGY, V63, P1, DOI 10.1111/j.1398-9995.2007.01594.x; Creed TJ, 2009, J IMMUNOL, V183, P164, DOI 10.4049/jimmunol.0801998; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2014, CELL MOL LIFE SCI, V71, P143, DOI 10.1007/s00018-013-1367-4; De Bosscher K, 2010, BRAIN BEHAV IMMUN, V24, P1035, DOI 10.1016/j.bbi.2010.06.010; Dejager L, 2014, CYTOKINE GROWTH F R, V25, P21, DOI 10.1016/j.cytogfr.2013.12.006; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; Drebert Z, 2015, J STEROID BIOCH MOL; Fokkens Wytske, 2007, Clin Allergy Immunol, V20, P241; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; GOMPEL A, 1986, J CLIN ENDOCR METAB, V63, P1174, DOI 10.1210/jcem-63-5-1174; Gossye V, 2009, ARTHRITIS RHEUM-US, V60, P3241, DOI 10.1002/art.24963; Hadley KE, 2011, STEROIDS, V76, P1176, DOI 10.1016/j.steroids.2011.05.007; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Islander U, 2010, INFECT IMMUN, V78, P381, DOI 10.1128/IAI.00724-09; KRAKAUER T, 1995, J LEUKOCYTE BIOL, V57, P450, DOI 10.1002/jlb.57.3.450; Lesovaya EA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1242, DOI 10.1134/S000629791111006X; Liberman AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035155; Liberman AC, 2009, ANN NY ACAD SCI, V1153, P6, DOI 10.1111/j.1749-6632.2008.03958.x; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; Moon IJ, 2012, ACTA OTO-LARYNGOL, V132, pS6, DOI 10.3109/00016489.2012.661074; Novo CAP, 2010, CLIN EXP ALLERGY, V40, P1323, DOI 10.1111/j.1365-2222.2010.03577.x; Passalacqua G, 2000, ALLERGY, V55, P16, DOI 10.1034/j.1398-9995.2000.00370.x; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Pedersen S, 1999, ALLERGY, V54, P42, DOI 10.1111/j.1398-9995.1999.tb04387.x; Pujols L, 2004, ALLERGY, V59, P1042, DOI 10.1111/j.1398-9995.2004.00635.x; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Rauner M, 2013, ENDOCRINOLOGY, V154, P3719, DOI 10.1210/en.2012-2221; Reber LL, 2012, J IMMUNOL, V188, P3478, DOI 10.4049/jimmunol.1004227; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Robertson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064831; Robertson S, 2010, J BIOL CHEM, V285, P8061, DOI 10.1074/jbc.M109.087866; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; Schulz M, 2002, J BIOL CHEM, V277, P26238, DOI 10.1074/jbc.M203268200; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Totino PRR, 2006, CELL BIOL INT, V30, P133, DOI 10.1016/j.cellbi.2005.09.002; van Loo G, 2010, MOL ENDOCRINOL, V24, P310, DOI 10.1210/me.2009-0236; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Villa E, 2011, EXPERT OPIN PHARMACO, V12, P2107, DOI 10.1517/14656566.2011.600688; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Yemelyanov A, 2008, CANCER RES, V68, P4763, DOI 10.1158/0008-5472.CAN-07-6104; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093754; Zhang N, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/673145; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088	60	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123068	10.1371/journal.pone.0123068	http://dx.doi.org/10.1371/journal.pone.0123068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875480	Green Published, gold			2022-12-26	WOS:000352845100131
J	Dillon, RT; Jacquemin, SJ				Dillon, Robert T., Jr.; Jacquemin, Stephen J.			The Heritability of Shell Morphometrics in the Freshwater Pulmonate Gastropod Physa	PLOS ONE			English	Article							CRYPTIC PHENOTYPIC PLASTICITY; PREDATOR-INDUCED DEFENSES; GENETIC-VARIATION; SHAPE VARIATION; LIFE-HISTORY; WILD-CAUGHT; SNAIL; HETEROSTROPHA; POPULATIONS; MORPHOLOGY	The cosmopolitan freshwater pulmonate snail Physa acuta hybridizes readily with Physa carolinae in the laboratory, although their F1 progeny are sterile. The two species differ qualitatively in shell shape, the former bearing a more globose shell and the latter more fusiform. We performed a hybridization experiment, measuring a set of 14 traditional (linear) and landmark-based shell morphological variables on even-aged parents and their offspring from both hybrids and purebred control lines. Parent-offspring regression yielded a strikingly high heritability estimate for score on the first relative warp axis, h(2) = 0.819 +/- 0.073, a result that would seem to confirm the value of geometric morphometrics as a tool for retrieving evolutionary relationships from gastropod shell form. Score on the second relative warp axis was also significantly heritable (h(2) = 0.312 +/- 0.123), although more moderate, as were scores on second principal components extracted from traditional measurements (correlation h(2) = 0.308 +/- 0.069, covariance h(2) = 0.314 +/- 0.050). Although score on the first relative warp axis was significantly correlated with centroid size (p < 0.001), scores on none of the three second axes were so correlated. This result suggests that second axis score might prove especially useful for estimating genetic divergence among mixed-age populations of gastropods sampled from the field.	[Dillon, Robert T., Jr.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Jacquemin, Stephen J.] Wright State Univ, Dept Biol, Celina, OH USA	College of Charleston; University System of Ohio; Wright State University Dayton	Dillon, RT (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	DillonR@cofc.edu						[Anonymous], 2015, PC ORD MULTIVARIATE; Auld JR, 2011, EVOL ECOL, V25, P189, DOI 10.1007/s10682-010-9394-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackith RE., 1971, MULTIVARIATE MORPHOM; BOULDING EG, 1993, EVOLUTION, V47, P576, DOI 10.1111/j.1558-5646.1993.tb02114.x; Britton DK, 2004, AM MALACOL BULL, V19, P93; Bronmark C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030467; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Bryant EH, 1998, EVOLUTION, V52, P626, DOI [10.2307/2411098, 10.1111/j.1558-5646.1998.tb01662.x]; Carballo M, 2001, J SHELLFISH RES, V20, P415; Chaves-Campos J, 2012, EVOL ECOL RES, V14, P743; Conde-Padin P, 2007, EVOL ECOL, V21, P635, DOI 10.1007/s10682-006-9142-8; DeWitt TJ, 1998, J EVOLUTION BIOL, V11, P465, DOI 10.1007/s000360050100; Dillon RT, 2013, HYDROBIOLOGIA, V709, P117, DOI 10.1007/s10750-012-1441-1; Dillon RT, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0031-5; Dillon RT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-144; Dillon RT, 2009, NAUTILUS, V123, P276; Dillon RT, 2009, J FRESHWATER ECOL, V24, P261, DOI 10.1080/02705060.2009.9664291; DILLON RT, 1994, BIOCHEM GENET, V32, P75, DOI 10.1007/BF00554416; DILLON RT, 1995, SYST BIOL, V44, P400, DOI 10.2307/2413600; DILLON RT, 1984, MALACOLOGIA, V25, P503; DILLON RT, 1992, J HERED, V83, P208, DOI 10.1093/oxfordjournals.jhered.a111194; DILLON RT, 1984, SYST ZOOL, V33, P69, DOI 10.2307/2413133; Dillon RT, 2002, INVERTEBR BIOL, V121, P226, DOI 10.1111/j.1744-7410.2002.tb00062.x; Dunithan A, 2012, AM MALACOL BULL, V30, P127; DupontNivet M, 1997, J ZOOL, V241, P757, DOI 10.1111/j.1469-7998.1997.tb05746.x; Falconer D. S., 1996, INTRO QUANTITATIVE G; GOULD SJ, 1974, SYST ZOOL, V23, P518, DOI 10.2307/2412470; Guerra-Varela J, 2009, EVOL ECOL, V23, P261, DOI 10.1007/s10682-007-9221-5; Gustafson KD, 2014, EVOL ECOL RES, V16, P77; Hoverman J, OIKOS, V121, P1219; Hoverman JT, 2009, FUNCT ECOL, V23, P1179, DOI 10.1111/j.1365-2435.2009.01586.x; HUMPHRIES JM, 1981, SYST ZOOL, V30, P291, DOI 10.2307/2413251; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jason K, 1983, MAR BIOL, V74, P49; JOHNSTON MR, 1991, PALEOBIOLOGY, V17, P19, DOI 10.1017/S0094837300010320; Krist AC, 2002, INVERTEBR BIOL, V121, P235; LAM PKS, 1988, J MOLLUS STUD, V54, P197, DOI 10.1093/mollus/54.2.197; Langerhans RB, 2002, EVOL ECOL RES, V4, P857; Lucas T, 2006, AQUACULTURE, V259, P146, DOI 10.1016/j.aquaculture.2006.05.039; Lynch M., 1998, GENETICS ANAL QUANTI; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; Reyment RA, 1984, MULTIVARIATE MORPHOM; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2007, TPSRELW VERSION 1 38; Rohlf FJ, 2008, TPSDIG VERSION 2 11; Rundle SD, 2004, P ROY SOC B-BIOL SCI, V271, pS67, DOI 10.1098/rsbl.2003.0106; Salice CJ, 2011, EVOL ECOL RES, V13, P373; Smith UE, 2013, SYST BIOL, V62, P366, DOI 10.1093/sysbio/syt002; Solas MR, 2013, AQUAT BIOL, V18, P253, DOI 10.3354/ab00508; Stone JR, 1998, SYST BIOL, V47, P254, DOI 10.1080/106351598260905; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Urabe M, 1998, J MOLLUS STUD, V64, P329, DOI 10.1093/mollus/64.3.329; van der Linde K, 2009, EVOL BIOL, V36, P311, DOI 10.1007/s11692-009-9061-z; Van Vleck L.D., 1987, GENETICS ANIMAL SCI; Wagner PJ, 1996, EVOLUTION, V50, P990, DOI 10.1111/j.1558-5646.1996.tb02341.x; WAGNER PJ, 1995, PALEOBIOLOGY, V21, P248, DOI 10.1017/S0094837300013294; Webster M, 2010, PALEONTOLOGICAL SOC, V,, P163, DOI DOI 10.1017/S1089332600001868; Weigensberg I, 1996, EVOLUTION, V50, P2149, DOI 10.1111/j.1558-5646.1996.tb03605.x; Wethington AR, 2009, NAUTILUS, V123, P282; Wethington AR, 1997, INVERTEBR BIOL, V116, P192, DOI 10.2307/3226896; WETHINGTON AR, 1993, P ROY SOC B-BIOL SCI, V252, P109, DOI 10.1098/rspb.1993.0053; Wethington AR, 1996, ANIM BEHAV, V51, P1107, DOI 10.1006/anbe.1996.0112; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	66	14	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121962	10.1371/journal.pone.0121962	http://dx.doi.org/10.1371/journal.pone.0121962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876155	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100053
J	Kamba, K; Nagata, T; Katahira, M				Kamba, Keisuke; Nagata, Takashi; Katahira, Masato			Catalytic Analysis of APOBEC3G Involving Real-Time NMR Spectroscopy Reveals Nucleic Acid Determinants for Deamination	PLOS ONE			English	Article							ACTIVE DNA DEMETHYLATION; CYTIDINE DEAMINASE; HIV-1 DNA; RESTRICTION; HYPERMUTATION; VIF; METHYLATION; SPECIFICITY; MECHANISM; DYNAMICS	APOBEC3G (A3G) is a single-stranded DNA-specific cytidine deaminase that preferentially converts cytidine to uridine at the third position of triplet cytosine (CCC) hotspots. A3G restricts the infectivity of viruses, such as HIV-1, by targeting CCC hotspots scattered through minus DNA strands, reverse-transcribed from genomic RNA. Previously, we developed a real-time NMR method and elucidated the origin of the 3'-> 5' polarity of deamination of DNA by the C-terminal domain of A3G (CD2), which is a phenomenon by which a hotspot located closer to the 5'-end is deaminated more effectively than one less close to the 5'-end, through quantitative analysis involving nonspecific binding to and sliding along DNA. In the present study we applied the real-time NMR method to analyze the catalytic activity of CD2 toward DNA oligonucleotides containing a nucleotide analog at a single or multiple positions. Analyses revealed the importance of the sugar and base moieties throughout the consecutive 5 nucleotides, the CCC hotspot being positioned at the center. It was also shown that the sugar or base moieties of the nucleotides outside this 5 nucleotide recognition sequence are also relevant as to CD2's activity. Analyses involving DNA oligonucleotides having two CCC hotspots linked by a long sequence of either deoxyribonucleotides, ribonucleotides or abasic deoxyribonucleotides suggested that the phosphate backbone is required for CD2 to slide along the DNA strand and to exert the 3'-> 5' polarity. Examination of the effects of different salt concentrations on the 3'-> 5' polarity indicated that the higher the salt concentration, the less prominent the 3'-> 5' polarity. This is most likely the result of alleviation of sliding due to a decrease in the affinity of CD2 with the phosphate backbone at high salt concentrations. We also investigated the reactivity of substrates containing 5-methylcytidine (5mC) or 5-hydroxymethylcytidine, and found that A3G exhibited low activity toward 5mC.	[Kamba, Keisuke; Nagata, Takashi; Katahira, Masato] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan; [Nagata, Takashi; Katahira, Masato] Kyoto Univ, Inst Adv Energy, Uji, Kyoto, Japan	Kyoto University; Kyoto University	Nagata, T (corresponding author), Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan.	nagata.takashi.6w@kyoto-u.ac.jp; katahira.masato.6u@kyoto-u.ac.jp	Nagata, Takashi/D-4547-2018	Nagata, Takashi/0000-0002-3733-2709	Ministry of Education, Science, Sports and Culture of Japan [23570146, 26440026, 25115507, 25291013, 26104520, 26650014]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Science, Sports and Culture of Japan with Grants-in-Aid for Scientific Research (23570146 and 26440026 to TN; 25115507, 25291013, 26104520, and 26650014 to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Cullen BR, 2003, MOL THER, V8, P525, DOI 10.1016/j.ymthe.2003.08.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Furukawa A, 2014, ANGEW CHEM INT EDIT, V53, P2349, DOI 10.1002/anie.201309940; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Goddard T. D., 2006, SPARKY 3; Goff SP, 2003, CELL, V114, P281, DOI 10.1016/S0092-8674(03)00602-0; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harjes S, 2013, J VIROL, V87, P7008, DOI 10.1128/JVI.03173-12; Harris RS, 2003, NAT IMMUNOL, V4, P641, DOI 10.1038/ni0703-641; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KewalRamani VN, 2003, SCIENCE, V301, P923, DOI 10.1126/science.1088965; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Nabel CS, 2013, P NATL ACAD SCI USA, V110, P14225, DOI 10.1073/pnas.1306345110; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Rausch JW, 2009, J BIOL CHEM, V284, P7047, DOI 10.1074/jbc.M807258200; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P6432, DOI 10.1021/bi300733d; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Teperek-Tkacz M, 2011, REPRODUCTION, V142, P621, DOI 10.1530/REP-11-0148; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	41	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124142	10.1371/journal.pone.0124142	http://dx.doi.org/10.1371/journal.pone.0124142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875164	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100241
J	Rouhi, J; Mamat, MH; Ooi, CHR; Mahmud, S; Mahmood, MR				Rouhi, Jalal; Mamat, Mohamad Hafiz; Ooi, C. H. Raymond; Mahmud, Shahrom; Mahmood, Mohamad Rusop			High-Performance Dye-Sensitized Solar Cells Based on Morphology-Controllable Synthesis of ZnO-ZnS Heterostructure Nanocone Photoanodes	PLOS ONE			English	Article							OPTICAL-PROPERTIES; NANOWIRE ARRAYS; AQUEOUS-SOLUTION; FIELD-EMISSION; NANOSTRUCTURES; GROWTH; FABRICATION; NANORODS; PHOTOVOLTAICS; DEPOSITION	High-density and well-aligned ZnO-ZnS core-shell nanocone arrays were synthesized on fluorine-doped tin oxide glass substrate using a facile and cost-effective two-step approach. In this synthetic process, the ZnO nanocones act as the template and provide Zn2+ ions for the ZnS shell formation. The photoluminescence spectrum indicates remarkably enhanced luminescence intensity and a small redshift in the UV region, which can be associated with the strain caused by the lattice mismatch between ZnO and ZnS. The obtained diffuse reflectance spectra show that the nanocone-based heterostructure reduces the light reflection in a broad spectral range and is much more effective than the bare ZnO nanocone and nanorod structures. Dye-sensitized solar cells based on the heterostructure ZnO-ZnS nanocones are assembled, and high conversion efficiency (eta) of approximately 4.07% is obtained. The. improvement can be attributed primarily to the morphology effect of ZnO nanocones on light-trapping and effectively passivating the interface surface recombination sites of ZnO nanocones by coating with a ZnS shell layer.	[Rouhi, Jalal; Mahmood, Mohamad Rusop] Univ Teknol MARA, Inst Sci, NANO SciTech Ctr, Ctr Nanosci & Nanotechnol, Shah Alam 40450, Selangor, Malaysia; [Rouhi, Jalal; Mamat, Mohamad Hafiz; Mahmood, Mohamad Rusop] Univ Teknol MARA, Fac Elect Engn, NANO ElectT Ctr, Shah Alam 40450, Selangor, Malaysia; [Ooi, C. H. Raymond] Univ Malaya, Dept Phys, Kuala Lumpur 50603, Malaysia; [Mahmud, Shahrom] Univ Sains Malaysia, Sch Phys, Nanooptoelect Res NOR Lab, George Town 11800, Pinang, Malaysia	Universiti Teknologi MARA; Universiti Teknologi MARA; Universiti Malaya; Universiti Sains Malaysia	Rouhi, J (corresponding author), Univ Teknol MARA, Inst Sci, NANO SciTech Ctr, Ctr Nanosci & Nanotechnol, Shah Alam 40450, Selangor, Malaysia.	jalal.rouhi@gmail.com	Rouhi, Jalal/AAJ-8076-2021; Mahmud, Shahrom/L-3316-2013; Mahmood, Mahmood/AAK-8215-2020; Mahmud, Shahrom/A-7754-2011; Bin Mahmood, Mohamad Rusop/N-4237-2017; Mamat, Mohamad Hafiz/P-9026-2015; Ooi, C. H. Raymond/B-9461-2010	Mahmud, Shahrom/0000-0002-1455-283X; Bin Mahmood, Mohamad Rusop/0000-0002-5842-627X; Mamat, Mohamad Hafiz/0000-0002-6640-2366; Ooi, C. H. Raymond/0000-0003-1084-5501	Long-Term Research Grant Scheme for Nanostructures, Nanomaterials and Devices for Fuel Cells and Hydrogen Production grant [600-RMI/LRGS 5/3]; NANO-SciTech Centre in Universiti Teknologi MARA; High Impact Research MoE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MoE/CHAN/04]	Long-Term Research Grant Scheme for Nanostructures, Nanomaterials and Devices for Fuel Cells and Hydrogen Production grant; NANO-SciTech Centre in Universiti Teknologi MARA; High Impact Research MoE Grant from the Ministry of Education Malaysia	The authors gratefully acknowledge that this work was supported by Long-Term Research Grant Scheme for Nanostructures, Nanomaterials and Devices for Fuel Cells and Hydrogen Production (600-RMI/LRGS 5/3 (3/2013)) grant, by the NANO-SciTech Centre in Universiti Teknologi MARA, and by the High Impact Research MoE Grant No. UM.C/625/1/HIR/MoE/CHAN/04 from the Ministry of Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anta JA, 2012, J PHYS CHEM C, V116, P11413, DOI 10.1021/jp3010025; Chang J, 2013, J PHYS CHEM C, V117, P13836, DOI 10.1021/jp402742n; Chao HY, 2010, SUPERLATTICE MICROST, V47, P160, DOI 10.1016/j.spmi.2009.07.005; Chaoui R, 2008, PHYS STATUS SOLIDI A, V205, P1724, DOI 10.1002/pssa.200723598; Datta A, 2007, J PHYS CHEM C, V111, P17260, DOI 10.1021/jp076093p; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Greene LE, 2003, ANGEW CHEM INT EDIT, V42, P3031, DOI 10.1002/anie.200351461; Han JB, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/40/405203; Hua GM, 2008, MATER LETT, V62, P4109, DOI 10.1016/j.matlet.2008.06.018; Jensen LL, 2008, J PHYS CHEM C, V112, P3439, DOI 10.1021/jp073554y; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Jiu JT, 2006, J PHYS CHEM B, V110, P2087, DOI 10.1021/jp055824n; Jothi NSN, 2013, MATER CHEM PHYS, V138, P186, DOI 10.1016/j.matchemphys.2012.11.042; Kao MC, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-260; Keis K, 2002, J PHOTOCH PHOTOBIO A, V148, P57, DOI 10.1016/S1010-6030(02)00039-4; Ku CH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2778454; Ku CH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/50/505706; Lan Z, 2007, J POWER SOURCES, V164, P921, DOI 10.1016/j.jpowsour.2006.11.011; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Law M, 2006, J PHYS CHEM B, V110, P22652, DOI 10.1021/jp0648644; Lee YJ, 2008, NANO LETT, V8, P1501, DOI 10.1021/nl080659j; Li JH, 2006, J PHYS CHEM B, V110, P14685, DOI [10.1021/jp061563l, 10.1021/jp0615631]; Liu W, 2010, APPL PHYS LETT, V97; Liu X, 2004, J APPL PHYS, V95, P3141, DOI 10.1063/1.1646440; Lo SS, 2011, ADV MATER, V23, P180, DOI 10.1002/adma.201002290; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2014, KONA POWDER PART J, P92; O'Brien PG, 2008, ADV MATER, V20, P1577, DOI 10.1002/adma.200702219; Pawar RC, 2011, MATER LETT, V65, P2235, DOI 10.1016/j.matlet.2011.04.045; Pawar RC, 2013, SENSOR ACTUAT B-CHEM, V187, P323, DOI 10.1016/j.snb.2012.11.100; Pawar RC, 2013, SCRIPTA MATER, V68, P142, DOI 10.1016/j.scriptamat.2012.10.003; Rouhi J, 2014, MATER LETT, V125, P147, DOI 10.1016/j.matlet.2014.03.183; Rouhi J, 2014, CERAM INT, V40, P11193, DOI 10.1016/j.ceramint.2014.03.157; Sagawa T, 2010, J PHYS CHEM LETT, V1, P1020, DOI 10.1021/jz100065u; Schrier J, 2007, NANO LETT, V7, P2377, DOI 10.1021/nl071027k; Sepulveda-Guzman S, 2009, MATER CHEM PHYS, V115, P172, DOI 10.1016/j.matchemphys.2008.11.030; Song J, 2007, J PHYS CHEM C, V111, P596, DOI 10.1021/jp0655017; Thavasi V, 2009, MAT SCI ENG R, V63, P81, DOI 10.1016/j.mser.2008.09.001; Wang HX, 2009, J PHYS CHEM C, V113, P18125, DOI 10.1021/jp906629t; Wang K, 2008, ADV MATER, V20, P3248, DOI 10.1002/adma.200800145; Wang XN, 2010, ACS NANO, V4, P3302, DOI 10.1021/nn1001547; Xu F, 2011, ENERG ENVIRON SCI, V4, P818, DOI 10.1039/c0ee00448k; Yan CL, 2006, J PHYS CHEM B, V110, P25850, DOI 10.1021/jp0659296; Yoo YZ, 2002, APPL PHYS LETT, V81, P3798, DOI 10.1063/1.1521577; Zhu J, 2009, NANO LETT, V9, P279, DOI 10.1021/nl802886y	46	39	39	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123433	10.1371/journal.pone.0123433	http://dx.doi.org/10.1371/journal.pone.0123433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875377	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100176
J	Harris, RMB; Carter, O; Gilfedder, L; Porfirio, LL; Lee, G; Bindoff, NL				Harris, Rebecca Mary Bernadette; Carter, Oberon; Gilfedder, Louise; Porfirio, Luciana Laura; Lee, Greg; Bindoff, Nathaniel Lee			Noah's Ark Conservation Will Not Preserve Threatened Ecological Communities under Climate Change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DISTRIBUTIONS; BIODIVERSITY; WOODLANDS; FUTURE; SHIFTS; PREDICTIONS; PROJECTIONS; MANAGEMENT; RESPONSES	Background Effective conservation of threatened ecological communities requires knowledge of where climatically suitable habitat is likely to persist into the future. We use the critically endangered Lowland Grassland community of Tasmania, Australia as a case study to identify options for management in cases where future climatic conditions become unsuitable for the current threatened community. Methods We model current and future climatic suitability for the Lowland Themeda and the Lowland Poa Grassland communities, which make up the listed ecological community. We also model climatic suitability for the structurally dominant grass species of these communities, and for closely related grassland and woodland communities. We use a dynamically down-scaled regional climate model derived from six CMIP3 global climate models, under the A2 SRES emissions scenario. Results All model projections showed a large reduction in climatically suitable area by mid-century. Outcomes are slightly better if closely related grassy communities are considered, but the extent of suitable area is still substantially reduced. Only small areas within the current distribution are projected to remain climatically suitable by the end of the century, and very little of that area is currently in good condition. Conclusions As the climate becomes less suitable, a gradual change in the species composition, structure and habitat quality of the grassland communities is likely. Conservation management will need to focus on maintaining diversity, structure and function, rather than attempting to preserve current species composition. Options for achieving this include managing related grassland types to maintain grassland species at the landscape-scale, and maximising the resilience of grasslands by reducing further fragmentation, weed invasion and stress from other land uses, while accepting that change is inevitable. Attempting to maintain the status quo by conserving the current structure and composition of Lowland Grassland communities is unlikely to be a viable management option in the long term.	[Harris, Rebecca Mary Bernadette; Lee, Greg; Bindoff, Nathaniel Lee] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr ACE, Hobart, Tas, Australia; [Carter, Oberon; Gilfedder, Louise] Dept Primary Ind Pk Water & Environm, Resource Management & Conservat Div, Hobart, Tas, Australia; [Porfirio, Luciana Laura] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Bindoff, Nathaniel Lee] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Bindoff, Nathaniel Lee] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW, Australia	Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian National University; University of Tasmania; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney	Harris, RMB (corresponding author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr ACE, Hobart, Tas, Australia.	rmharris@utas.edu.au	Bindoff, Nathaniel L/C-8050-2011; Harris, Rebecca/N-2790-2013	Bindoff, Nathaniel L/0000-0001-5662-9519; Harris, Rebecca/0000-0002-6426-2179	Australian Government's National Environmental Research Program [L0018856]	Australian Government's National Environmental Research Program(Australian Government)	This research is an output from the Landscapes and Policy Research Hub, which is supported through funding from the Australian Government's National Environmental Research Program (Grant number L0018856) (http://www.environment.gov.au/science/nerp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; [Anonymous], 2010, CLIMATE FUTURES TASM; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; Bucklin DN, 2015, DIVERS DISTRIB, V21, P23, DOI 10.1111/ddi.12247; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Corney S., 2010, CLIMATE FUTURES TASM; Corney S, 2013, J GEOPHYS RES-ATMOS, V118, P11936, DOI 10.1002/2013JD020087; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; DPIPWE, 2008, REV CONS STAT LOWL T; Dunlop M., 2012, IMPLICATIONS CLIMATE; Dunlop M, 2013, CLIMATE READY CONSER; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Grose MR, 2013, CLIM DYNAM, V40, P2035, DOI 10.1007/s00382-012-1405-1; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Gvozdik L, 2012, BIOL LETTERS, V8, P262, DOI 10.1098/rsbl.2011.0960; Harris Rebecca M. B., 2013, Ecological Management & Restoration, V14, P230, DOI 10.1111/emr.12055; Harris RMB, 2014, WIRES CLIM CHANGE, V5, P621, DOI 10.1002/wcc.291; Heller NE, 2014, CONSERV BIOL, V28, P696, DOI 10.1111/cobi.12269; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Heltberg R, 2009, GLOBAL ENVIRON CHANG, V19, P89, DOI 10.1016/j.gloenvcha.2008.11.003; Henwood William D., 2010, Great Plains Research, V20, P121; HilleRisLambers J, 2013, ANN NY ACAD SCI, V1297, P112, DOI 10.1111/nyas.12182; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Iftekhar MS, 2014, BIOL CONSERV, V169, P176, DOI 10.1016/j.biocon.2013.10.013; IPCC, 2007, CLIM CHANG 2007 PHYS; Irving DB, 2012, AUST METEOROL OCEAN, V62, P211; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kirkpatrick J. B., 2005, Ecological Management & Restoration, V6, P51, DOI 10.1111/j.1442-8903.2005.00219.x; Kirkpatrick J. B., 1995, AUSTR MOST THREATENE; Lee T, 2013, J CLIMATE, V26, P5810, DOI 10.1175/JCLI-D-12-00591.1; Lunt ID, 2013, BIOL CONSERV, V157, P172, DOI 10.1016/j.biocon.2012.08.034; LUNT ID, 1990, AUST J ECOL, V15, P155, DOI 10.1111/j.1442-9993.1990.tb01524.x; Macinnis-Ng C, 2011, ECOHYDROLOGY, V4, P379, DOI 10.1002/eco.138; Markovic M, 2013, CLIMATIC CHANGE, V120, P197, DOI 10.1007/s10584-013-0782-8; Martin TG, 2012, INVASIVE SPECIES AND; Matthews HD, 2013, SCIENCE, V340, P438, DOI 10.1126/science.1236372; McIntyre S., 2002, MANAGING CONSERVING; McShea WJ, 2014, ENVIRON CONSERV, V41, P93, DOI 10.1017/S0376892913000581; Murphy BP, 2014, J BIOGEOGR, V41, P133, DOI 10.1111/jbi.12204; Old K, 1990, EUCALYPT DIEBACK FOR; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pau S, 2013, GLOBAL CHANGE BIOL, V19, P184, DOI 10.1111/gcb.12037; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Porfirio LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113749; Prober SM, 2012, BIODIVERS CONSERV, V21, P1627, DOI 10.1007/s10531-012-0268-4; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ross RE, 2013, DIVERS DISTRIB, V19, P433, DOI 10.1111/ddi.12010; Sage RF, 2003, PHOTOSYNTH RES, V77, P209, DOI 10.1023/A:1025882003661; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Smith I, 2010, CLIMATIC CHANGE, V102, P377, DOI 10.1007/s10584-009-9757-1; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; TasVeg3, 2016, TASVEG VERS 3; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Vogel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036992; Volder A, 2013, GLOBAL CHANGE BIOL, V19, P843, DOI 10.1111/gcb.12068; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Witt GB, 2009, AUST J BOT, V57, P572, DOI 10.1071/BT08217; Xu T., 2011, ANUCLIM VERSION 6 1	73	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124014	10.1371/journal.pone.0124014	http://dx.doi.org/10.1371/journal.pone.0124014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881302	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500078
J	Lauron-Moreau, A; Pitre, FE; Argus, GW; Labrecque, M; Brouillet, L				Lauron-Moreau, Aurelien; Pitre, Frederic E.; Argus, George W.; Labrecque, Michel; Brouillet, Luc			Phylogenetic Relationships of American Willows (Salix L., Salicaceae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; SEQUENCE ALIGNMENT; CHLOROPLAST DNA; NORTH-AMERICA; RIBOSOMAL-RNA; DISPERSAL; INFERENCE; TERTIARY; BARCODE; GENES	Salix L. is the largest genus in the family Salicaceae (450 species). Several classifications have been published, but taxonomic subdivision has been under continuous revision. Our goal is to establish the phylogenetic structure of the genus using molecular data on all American willows, using three DNA markers. This complete phylogeny of American willows allows us to propose a biogeographic framework for the evolution of the genus. Material was obtained for the 122 native and introduced willow species of America. Sequences were obtained from the ITS (ribosomal nuclear DNA) and two plastid regions, matK and rbcL. Phylogenetic analyses (parsimony, maximum likelihood, Bayesian inference) were performed on the data. Geographic distribution was mapped onto the tree. The species tree provides strong support for a division of the genus into two subgenera, Salix and Vetrix. Subgenus Salix comprises temperate species from the Americas and Asia, and their disjunction may result from Tertiary events. Subgenus Vetrix is composed of boreo-arctic species of the Northern Hemisphere and their radiation may coincide with the Quaternary glaciations. Sixteen species have ambiguous positions; genetic diversity is lower in subg. Vetrix. A molecular phylogeny of all species of American willows has been inferred. It needs to be tested and further resolved using other molecular data. Nonetheless, the genus clearly has two clades that have distinct biogeographic patterns.	[Lauron-Moreau, Aurelien; Pitre, Frederic E.; Labrecque, Michel; Brouillet, Luc] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada; [Argus, George W.] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada	Universite de Montreal	Labrecque, M (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada.	michel.labrecque@umontreal.ca			Centre de recherche sur les grains (CEROM); Conseil pour le developpement de l'agriculture au Quebec (CDAQ)	Centre de recherche sur les grains (CEROM); Conseil pour le developpement de l'agriculture au Quebec (CDAQ)	This study was supported by the Centre de recherche sur les grains (CEROM) and the Conseil pour le developpement de l'agriculture au Quebec (CDAQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahzadeh A., 2011, Iranian Journal of Botany, V17, P244; Alford MH, 2009, WHAT ARE CLOSEST REL; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Argus, 1986, SYST BOT MONOGR, V9, P1, DOI [10.2307/25027618, DOI 10.2307/25027618]; Argus G.W., 2010, FLORA N AM N MEXICO, V7, P23; Argus G. W., 1997, SYST BOT MONOGR, V52, P1, DOI DOI 10.2307/25096638; Argus George W., 2007, Harvard Papers in Botany, V12, P335, DOI 10.3100/1043-4534(2007)12[335:SSDMAA]2.0.CO;2; Ausubel JH, 2009, P NATL ACAD SCI USA, V106, P12569, DOI 10.1073/pnas.0906757106; Azuma T, 2000, AM J BOT, V87, P67, DOI 10.2307/2656686; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; Ball CR, 1961, FLORA TEXAS, V3, P369; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Brunsfeld SJ, 2007, SYST BOT, V32, P129, DOI 10.1600/036364407780360094; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase Mark W., 2002, Kew Bulletin, V57, P141, DOI 10.2307/4110825; Chen JH, 2010, TAXON, V59, P29, DOI 10.1002/tax.591004; Chmelar J, 1978, FOLIA DENDROLOGICA, V4, P5; Condamine FL, 2013, J BIOGEOGR, V40, P9, DOI 10.1111/j.1365-2699.2012.02787.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis CC, 2010, AM J BOT, V97, P2031, DOI 10.3732/ajb.1000146; DORN RD, 1976, CAN J BOT, V54, P2769, DOI 10.1139/b76-297; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; Fang C.F., 1999, FLORA CHINA, P139; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guidi W., 2013, BIOMASS NOW SUSTAINA, DOI [10.5772/51111, DOI 10.5772/51111]; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo XY, 2008, FUNCT INTEGR GENOMIC, V8, P101, DOI 10.1007/s10142-007-0067-2; Hardig T. M., 2010, Journal of Botany, V2010, P197696, DOI 10.1155/2010/197696; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Holderegger R, 2002, MOL ECOL, V11, P1409, DOI 10.1046/j.1365-294X.2002.01548.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Karp A, 2011, J INTEGR PLANT BIOL, V53, P151, DOI 10.1111/j.1744-7909.2010.01015.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kimura A, 1928, BOT MAG TOKYO, V42, P287; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Kuzovkina YA, 2008, HORTICUL RE, V34, P447; Lauron-Moreau Aurelien, 2013, Plants-Basel, V2, P203, DOI 10.3390/plants2020203; Leskinen E, 1999, PLANT SYST EVOL, V215, P209, DOI 10.1007/BF00984656; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Lindegaard K. N., 1997, Aspects of Applied Biology, P155; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Manchester SR, 2001, INT J PLANT SCI, V162, pS19, DOI 10.1086/323657; McCauley DE, 1996, AM J BOT, V83, P727, DOI 10.2307/2445849; Milne RI, 2006, ANN BOT-LONDON, V98, P465, DOI 10.1093/aob/mcl148; Nakai T., 1920, BOT MAG TOKYO, V34, P66; Newsholme C, 1992, WILLOWS GENUS SALIX; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Oliver MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-143; Percy DM, 2014, MOL ECOL, V23, P4737, DOI 10.1111/mec.12837; Rambaut A., 2007, TRACER V1 4; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; REHDER A., 1949, BIBLIO CULTIVATED TR; RENZAGLIA KS, 1994, CAN J BOT, V72, P1436, DOI 10.1139/b94-177; ROGERS SO, 1987, PLANT MOL BIOL, V9, P509, DOI 10.1007/BF00015882; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy M, 2004, GEOL SOC AM BULL, V116, P30, DOI 10.1130/B25325.1; Schneider C, 1919, BOT GAZ, V67, P309, DOI 10.1086/332476; Skvortsov A.K., 1999, FACULTY MATH NATURAL; Skvortsov AK, 1968, WILLOWS OF THE URSS; Sneader W, 2000, BRIT MED J, V321, P1591, DOI 10.1136/bmj.321.7276.1591; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Stott KG, 1984, ECOLOGY MANAGEMENT F, P233; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; Takhtajan AL., 1986, FLORISTIC REGIONS WO; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tsai YHE, 2013, J BIOGEOGR, V40, P131, DOI 10.1111/j.1365-2699.2012.02775.x; Turgeon J, 2005, AM NAT, V165, pE78, DOI 10.1086/428682; Vijaykumar A, 2010, J HERED, V101, P177, DOI 10.1093/jhered/esp084; Volk TA, 2006, BIOMASS BIOENERG, V30, P715, DOI 10.1016/j.biombioe.2006.03.001; Wen J, 2001, INT J PLANT SCI, V162, pS117, DOI 10.1086/322940; Xiang QY, 2000, MOL PHYLOGENET EVOL, V15, P462, DOI 10.1006/mpev.2000.0766; Xiang QYJ, 2001, INT J PLANT SCI, V162, pS29, DOI 10.1086/323332	80	40	43	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121965	10.1371/journal.pone.0121965	http://dx.doi.org/10.1371/journal.pone.0121965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880993	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500014
J	Bertolini, G; Wicki, A; Baumann, CR; Straumann, D; Palla, A				Bertolini, Giovanni; Wicki, Andrea; Baumann, Christian R.; Straumann, Dominik; Palla, Antonella			Impaired Tilt Perception in Parkinson's Disease: A Central Vestibular Integration Failure	PLOS ONE			English	Article							PEDUNCULOPONTINE NUCLEUS; VESTIBULOOCULAR REFLEX; SYSTEM; STIMULATION; PROJECTIONS; DYSFUNCTION; DISTURBANCE; CEREBELLUM; DISORDERS; RESPONSES	Introduction Impaired balance control is a hallmark symptom in Parkinson's disease (PD). Altered sensory-motor integration contributes to the deficiency. We aimed to determine whether impaired vestibular signal processing added to the disorder. We exposed patients (N = 11; 68+/-6y) and age-matched healthy subjects (hS: N = 19; 65+/-11y) on a motion platform in complete darkness to two consecutive forward tilt movements (12 series; N = 24; overall 288 trials) and asked them to indicate which tilt was perceived larger. By combing tilt movements with translations we manipulated vestibular sensory input in order to investigate whether putative impairment resulted from a deficiency of the sensory organs (semicircular canals in 'single-SCC-cue-condition', otoliths in 'single-OT-cue-condition') themselves or to a sensory integration failure ('multi-cue-condition'). Results Tilt discrimination in the multi-cue-condition was inferior in patients compared to hS (p = 0.02). No significant differences between the two groups were found for both single-cueconditions. Comparison of multi-cue-condition with a prediction resulting from the combination of both single-cue-conditions by optimal observer theory revealed that patients (p = 0.04), in contrast to hS, failed to efficiently combine SCC and OT information to improve tilt perception. Conclusion We found that PD patients distinguished forward tilts less precise than hS, suggesting impaired vestibular perception. Tilt discrimination in patients, moreover, did not improve as much as in hS in conditions where both SCC and OT information was available compared to conditions where only SCC or OT cues were activated. The latter provides evidence that tilt misperception in PD most likely results from an integration failure of vestibular signals.	[Bertolini, Giovanni; Wicki, Andrea; Baumann, Christian R.; Straumann, Dominik; Palla, Antonella] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Bertolini, G (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	giovanni.bertolini@usz.ch	Bertolini, Giovanni/H-3510-2016; Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Bertolini, Giovanni/0000-0003-2428-9454; Baumann, Christian/0000-0003-3417-1978	Swiss National Science Foundation; Betty and David Koetser Foundation for Brain Research; Baasch Medicus Foundation; Zurich Center for Integrative Human Physiology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Betty and David Koetser Foundation for Brain Research; Baasch Medicus Foundation; Zurich Center for Integrative Human Physiology	Swiss National Science Foundation, Betty and David Koetser Foundation for Brain Research, Baasch Medicus Foundation, Zurich Center for Integrative Human Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Angelaki DE, 2009, ANN NY ACAD SCI, V1164, P19, DOI 10.1111/j.1749-6632.2009.03939.x; Aravamuthan BR, 2012, NEUROSCIENCE, V223, P183, DOI 10.1016/j.neuroscience.2012.07.054; Ballanger B, 2009, HUM BRAIN MAPP, V30, P3901, DOI 10.1002/hbm.20815; Benatru I, 2008, NEUROPHYSIOL CLIN, V38, P459, DOI 10.1016/j.neucli.2008.07.006; Boonstra TA, 2008, CURR OPIN NEUROL, V21, P461, DOI 10.1097/WCO.0b013e328305bdaf; Brock JW, 1996, PSYCHOPHARMACOLOGY, V123, P199, DOI 10.1007/BF02246178; BRONSTEIN AM, 1990, BRAIN, V113, P767, DOI 10.1093/brain/113.3.767; De Nunzio AM, 2005, EXP BRAIN RES, V165, P261, DOI 10.1007/s00221-005-2297-7; Delfini C, 2000, EXP BRAIN RES, V135, P285, DOI 10.1007/s002210000516; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Ehrenstein WH, 1999, MODERN TECHNIQUES NE, P1211, DOI DOI 10.1007/978-3-642-58552-4_43; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; FLAHERTY AW, 1991, J NEUROPHYSIOL, V66, P1249; Giardino L, 1996, BRAIN RES, V736, P111, DOI 10.1016/S0006-8993(96)00692-0; Hanakawa T, 1999, BRAIN, V122, P1271, DOI 10.1093/brain/122.7.1271; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Joyal CC, 2001, BEHAV BRAIN RES, V122, P131, DOI 10.1016/S0166-4328(00)00390-9; Meng H, 2014, J PHYSIOL-LONDON, V592, P171, DOI 10.1113/jphysiol.2013.259614; Mergner T, 1997, J VESTIBUL RES-EQUIL, V7, P347, DOI 10.1016/S0957-4271(96)00176-0; PASTOR MA, 1993, BRAIN, V116, P1177, DOI 10.1093/brain/116.5.1177; Pollak L, 2009, NEUROPHYSIOL CLIN, V39, P235, DOI 10.1016/j.neucli.2009.07.001; RASCOL O, 1995, MOVEMENT DISORD, V10, P163, DOI 10.1002/mds.870100206; REICHERT WH, 1982, NEUROLOGY, V32, P1133, DOI 10.1212/WNL.32.10.1133; Romanelli P, 2005, BRAIN RES REV, V48, P112, DOI 10.1016/j.brainresrev.2004.09.008; Soto E, 2010, CURR NEUROPHARMACOL, V8, P26, DOI 10.2174/157015910790909511; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/awl346; Stiles L, 2012, BEHAV BRAIN RES, V227, P150, DOI 10.1016/j.bbr.2011.11.006; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; Vitale C, 2011, MOVEMENT DISORD, V26, P1458, DOI 10.1002/mds.23657; von Saldern S, 2013, J NEUROSCI, V33, P8841, DOI 10.1523/JNEUROSCI.3020-12.2013; WEST M O, 1987, P27; WHITE OB, 1983, BRAIN, V106, P555, DOI 10.1093/brain/106.3.555; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wright WG, 2010, EXP NEUROL, V225, P202, DOI 10.1016/j.expneurol.2010.06.016; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Zanetti D, 2004, Acta Otorhinolaryngol Ital, V24, P49	39	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124253	10.1371/journal.pone.0124253	http://dx.doi.org/10.1371/journal.pone.0124253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874868	Green Published, gold, Green Accepted			2022-12-26	WOS:000353015800135
J	Halang, P; Vorburger, T; Steuber, J				Halang, Petra; Vorburger, Thomas; Steuber, Julia			Serine 26 in the PomB Subunit of the Flagellar Motor Is Essential for Hypermotility of Vibrio cholerae	PLOS ONE			English	Article							CONSERVED CHARGED RESIDUES; NADH-QUINONE OXIDOREDUCTASE; NA+-DRIVEN; ESCHERICHIA-COLI; TORQUE GENERATION; TRANSMEMBRANE SEGMENT; CONFORMATIONAL-CHANGE; PERIPLASMIC REGION; CYTOPLASMIC LOOP; POLAR FLAGELLUM	Vibrio cholerae is motile by means of its single polar flagellum which is driven by the sodium-motive force. In the motor driving rotation of the flagellar filament, a stator complex consisting of subunits PomA and PomB converts the electrochemical sodium ion gradient into torque. Charged or polar residues within the membrane part of PomB could act as ligands for Na+, or stabilize a hydrogen bond network by interacting with water within the putative channel between PomA and PomB. By analyzing a large data set of individual tracks of swimming cells, we show that S26 located within the transmembrane helix of PomB is required to promote very fast swimming of V. cholerae. Loss of hypermotility was observed with the S26T variant of PomB at pH 7.0, but fast swimming was restored by decreasing the H+ concentration of the external medium. Our study identifies S26 as a second important residue besides D23 in the PomB channel. It is proposed that S26, together with D23 located in close proximity, is important to perturb the hydration shell of Na+ before its passage through a constriction within the stator channel.	[Halang, Petra; Vorburger, Thomas; Steuber, Julia] Univ Hohenheim, Inst Microbiol, Stuttgart, Germany	University Hohenheim	Vorburger, T (corresponding author), Univ Hohenheim, Inst Microbiol, Stuttgart, Germany.	T.Vorburger@uni-hohenheim.de; julia.steuber@uni-hohenheim.de			Velux Foundation, Kirchgasse 42, "Zum Rothen Adler", Zurich, Switzerland	Velux Foundation, Kirchgasse 42, "Zum Rothen Adler", Zurich, Switzerland	This work was supported by a grant from the Velux Foundation, Kirchgasse 42, "Zum Rothen Adler", 8001 Zurich, Switzerland (to J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; Asai Y, 2003, J MOL BIOL, V327, P453, DOI 10.1016/S0022-2836(03)00096-2; Asai Y, 1997, J BACTERIOL, V179, P5104, DOI 10.1128/jb.179.16.5104-5110.1997; Asai Y, 1999, J BACTERIOL, V181, P6332, DOI 10.1128/JB.181.20.6332-6338.1999; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1974, NATURE, V249, P77, DOI 10.1038/249077a0; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Che YS, 2008, J BACTERIOL, V190, P6660, DOI 10.1128/JB.00503-08; Fukuoka H, 2009, MOL MICROBIOL, V71, P825, DOI 10.1111/j.1365-2958.2008.06569.x; GLAGOLEV AN, 1978, NATURE, V272, P280, DOI 10.1038/272280a0; Gosink KK, 2000, J BACTERIOL, V182, P4234, DOI 10.1128/JB.182.15.4234-4240.2000; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Griffitt KJ, 2013, MICROB ECOL, V65, P578, DOI 10.1007/s00248-013-0203-6; Halang P, 2013, J BACTERIOL, V195, P4888, DOI 10.1128/JB.00353-13; Hosking ER, 2006, J MOL BIOL, V364, P921, DOI 10.1016/j.jmb.2006.09.035; IMAE Y, 1989, J BIOENERG BIOMEMBR, V21, P705, DOI 10.1007/BF00762688; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kim EA, 2008, BIOCHEMISTRY-US, V47, P11332, DOI 10.1021/bi801347a; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; Kojima S, 1999, J BACTERIOL, V181, P1927, DOI 10.1128/JB.181.6.1927-1930.1999; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi035405l; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; LARSEN SH, 1974, P NATL ACAD SCI USA, V71, P1239, DOI 10.1073/pnas.71.4.1239; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Li N, 2011, J BACTERIOL, V193, P3773, DOI 10.1128/JB.00113-11; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Lloyd SA, 1999, NATURE, V400, P472, DOI 10.1038/22794; Lo CJ, 2013, P NATL ACAD SCI USA, V110, pE2544, DOI 10.1073/pnas.1301664110; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; MEKALANOS JJ, 1983, NATURE, V306, P551, DOI 10.1038/306551a0; Minato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097083; Morimoto YV, 2014, BIOMOLECULES, V4, P217, DOI 10.3390/biom4010217; Morimoto YV, 2013, J BACTERIOL, V195, P474, DOI 10.1128/JB.01971-12; Morimoto YV, 2010, MOL MICROBIOL, V78, P1117, DOI 10.1111/j.1365-2958.2010.07391.x; Morimoto YV, 2010, FEBS LETT, V584, P1268, DOI 10.1016/j.febslet.2010.02.051; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pogoryelov D, 2012, P NATL ACAD SCI USA, V109, pE1599, DOI 10.1073/pnas.1120027109; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Sato K, 2000, J BIOL CHEM, V275, P5718, DOI 10.1074/jbc.275.8.5718; Sato K, 2000, J BIOL CHEM, V275, P20223, DOI 10.1074/jbc.M002236200; SHARP LL, 1995, P NATL ACAD SCI USA, V92, P7946, DOI 10.1073/pnas.92.17.7946; Sowa Y, 2005, NATURE, V437, P916, DOI 10.1038/nature04003; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Steuber J, 2014, BIOL CHEM, V395, P1389, DOI 10.1515/hsz-2014-0204; STOLZ B, 1991, J BACTERIOL, V173, P7033, DOI 10.1128/jb.173.21.7033-7037.1991; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P11699, DOI 10.1021/bi901517n; Takekawa N, 2014, J BACTERIOL, V196, P1377, DOI 10.1128/JB.01392-13; Takekawa N, 2013, J BIOCHEM, V153, P441, DOI 10.1093/jb/mvt011; Tang H, 1996, J MOL BIOL, V261, P209, DOI 10.1006/jmbi.1996.0453; Terahara N, 2008, P NATL ACAD SCI USA, V105, P14359, DOI 10.1073/pnas.0802106105; Terahara N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046248; Terashima H, 2010, J MOL BIOL, V397, P689, DOI 10.1016/j.jmb.2010.01.050; Terauchi T, 2011, MICROBIOL-SGM, V157, P2422, DOI 10.1099/mic.0.048488-0; Thormann KM, 2010, MICROBIOL-SGM, V156, P1275, DOI 10.1099/mic.0.029595-0; Underwood SA, 2004, APPL ENVIRON MICROB, V70, P2734, DOI 10.1128/AEM.70.5.2734-2740.2004; Van Way SM, 2000, J MOL BIOL, V297, P7, DOI 10.1006/jmbi.2000.3548; Vorburger T, 2009, BBA-BIOENERGETICS, V1787, P1198, DOI 10.1016/j.bbabio.2009.05.015; WILSON ML, 1990, J BACTERIOL, V172, P3932, DOI 10.1128/jb.172.7.3932-3939.1990; Yakushi T, 2004, J BACTERIOL, V186, P5281, DOI 10.1128/JB.186.16.5281-5291.2004; Yorimitsu T, 2003, J MOL BIOL, V334, P567, DOI 10.1016/j.jmb.2003.09.052; Yorimitsu T, 1999, J BACTERIOL, V181, P5103, DOI 10.1128/JB.181.16.5103-5106.1999; Yorimitsu T, 2002, J MOL BIOL, V320, P403, DOI 10.1016/S0022-2836(02)00426-6; Zhou JD, 1997, J MOL BIOL, V273, P428, DOI 10.1006/jmbi.1997.1316; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Zhu SW, 2014, P NATL ACAD SCI USA, V111, P13523, DOI 10.1073/pnas.1324201111; Zhu SW, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00410	72	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123518	10.1371/journal.pone.0123518	http://dx.doi.org/10.1371/journal.pone.0123518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874792	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800102
J	Lu, HB; Zheng, C; Wang, ZW; Chen, C; Chen, HB; Hu, JZ				Lu, Hongbin; Zheng, Cheng; Wang, Zhanwen; Chen, Can; Chen, Huabin; Hu, Jianzhong			Effects of Low-Intensity Pulsed Ultrasound on New Trabecular Bone during Bone-Tendon Junction Healing in a Rabbit Model: A Synchrotron Radiation Micro-CT Study	PLOS ONE			English	Article							FEMUR FRACTURE MODEL; PARTIAL PATELLECTOMY; MICROCOMPUTED TOMOGRAPHY; DISTRACTION OSTEOGENESIS; COMPUTED-TOMOGRAPHY; PATELLAR TENDON; RAT MODEL; MU-CT; REPAIR; OSTEOPOROSIS	This study was designed to evaluate the effects of low-intensity pulsed ultrasound on bone regeneration during the bone-tendon junction healing process and to explore the application of synchrotron radiation micro computed tomography in three dimensional visualization of the bone-tendon junction to evaluate the microarchitecture of new trabecular bone. Twenty four mature New Zealand rabbits underwent partial patellectomy to establish a bone-tendon junction injury model at the patella-patellar tendon complex. Animals were then divided into low-intensity pulsed ultrasound treatment (20 min/day, 7 times/week) and placebo control groups, and were euthanized at week 8 and 16 postoperatively (n = 6 for each group and time point). The patella-patellar tendon specimens were harvested for radiographic, histological and synchrotron radiation micro computed tomography detection. The area of the newly formed bone in the ultrasound group was significantly greater than that of control group at postoperative week 8 and 16. The high resolution three dimensional visualization images of the bone-tendon junction were acquired by synchrotron radiation micro computed tomography. Low-intensity pulsed ultrasound treatment promoted dense and irregular woven bone formation at week 8 with greater bone volume fraction, number and thickness of new trabecular bone but with lower separation. At week 16, ultrasound group specimens contained mature lamellar bone with higher bone volume fraction and thicker trabeculae than that of control group; however, there was no significant difference in separation and number of the new trabecular bone. This study confirms that low-intensity pulsed ultrasound treatment is able to promot bone formation and remodeling of new trabecular bone during the bone-tendon junction healing process in a rabbit model, and the synchrotron radiation micro computed tomography could be applied for three dimensional visualization to quantitatively evaluate the microarchitecture of new bone in bone-tendon junction.	[Lu, Hongbin; Zheng, Cheng; Wang, Zhanwen; Chen, Can; Chen, Huabin] Cent S Univ, Xiangya Hosp, Dept Sports Med, Res Ctr Sports Med, Changsha, Hunan, Peoples R China; [Hu, Jianzhong] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Res Ctr Sports Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hu, JZ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Spine Surg, Res Ctr Sports Med, Changsha, Hunan, Peoples R China.	jianzhonghu@hotmail.com	Zheng, Cheng/AIA-7877-2022	Zheng, Cheng/0000-0003-1726-0258	National Natural Science Foundation of China [81171699, 84172072]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110162110068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No. 81171699 and No. 84172072) and Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20110162110068). HL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angle SR, 2011, ULTRASONICS, V51, P281, DOI 10.1016/j.ultras.2010.09.004; Bachl N, 2008, CLIN SPORT MED, V27, P87, DOI 10.1016/j.csm.2007.10.006; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Bonse U, 1996, PROG BIOPHYS MOL BIO, V65, P133, DOI 10.1016/S0079-6107(96)00011-9; Chappard C, 2006, OSTEOARTHR CARTILAGE, V14, P215, DOI 10.1016/j.joca.2005.09.008; Chappard C, 2006, MED PHYS, V33, P3568, DOI 10.1118/1.2256069; Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205; Chen RC, 2012, J SYNCHROTRON RADIAT, V19, P836, DOI 10.1107/S0909049512029731; Chen SH, 2014, J MED BIOL ENG, V34, P197, DOI 10.5405/jmbe.1346; Cheung EV, 2010, CLIN ORTHOP RELAT R, V468, P1476, DOI 10.1007/s11999-010-1323-7; Fazzalari NL, 2011, OSTEOPOROSIS INT, V22, P2003, DOI 10.1007/s00198-011-1611-4; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hess Gregory William, 2010, Foot Ankle Spec, V3, P29, DOI 10.1177/1938640009355191; Hung L K, 1993, J Orthop Trauma, V7, P252, DOI 10.1097/00005131-199306000-00010; Ito M, 2003, J BONE MINER METAB, V21, P287, DOI 10.1007/s00774-003-0422-x; Kalfas I H, 2001, Neurosurg Focus, V10, pE1; Katano M, 2011, EXP ANIM TOKYO, V60, P385, DOI 10.1538/expanim.60.385; Kinney JH, 2000, J BONE MINER RES, V15, P1981, DOI 10.1359/jbmr.2000.15.10.1981; Kuhn G, 2007, HOMO, V58, P97, DOI 10.1016/j.jchb.2006.11.002; Larrue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021297; Leung KS, 2002, CLIN BIOMECH, V17, P594, DOI 10.1016/S0268-0033(02)00075-X; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111939; Lu H, 2008, ULTRASOUND MED BIOL, V34, P1248, DOI 10.1016/j.ultrasmedbio.2008.01.009; Lu H, 2008, CLIN J SPORT MED, V18, P62, DOI 10.1097/JSM.0b013e31815c24ba; Lu HB, 2006, AM J SPORT MED, V34, P1287, DOI 10.1177/0363546506286788; Lu HB, 2011, J ORTHOP RES, V29, P672, DOI 10.1002/jor.21292; Lui PPY, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-59; MARDER RA, 1993, J BONE JOINT SURG AM, V75A, P35, DOI 10.2106/00004623-199301000-00006; Nogueira LP, 2010, MICRON, V41, P990, DOI 10.1016/j.micron.2010.06.013; Nolte PA, 2001, J TRAUMA, V51, P693, DOI 10.1097/00005373-200110000-00012; Okazaki N, 2014, BONE, V64, P82, DOI 10.1016/j.bone.2014.03.039; Qin L, 1999, MED SCI SPORT EXER, V31, P502, DOI 10.1097/00005768-199904000-00002; Qin L, 2006, ULTRASOUND MED BIOL, V32, P1905, DOI 10.1016/j.ultrasmedbio.2006.06.028; RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009; Salem KH, 2014, INT ORTHOP, V38, P1477, DOI 10.1007/s00264-013-2254-1; Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736; SALTZMAN CL, 1990, J BONE JOINT SURG AM, V72A, P1279, DOI 10.2106/00004623-199072090-00001; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schofer M. D., 2010, BIOMEDICAL CENTRAL M, V11, P229, DOI DOI 10.1186/1471-2474-11-229; Sone T, 2004, BONE, V35, P432, DOI 10.1016/j.bone.2004.05.011; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Waseem Z, 2010, PM&R, V2, P159, DOI 10.1016/j.pmrj.2009.11.008; Wu SL, 2009, PATHOBIOLOGY, V76, P99, DOI 10.1159/000209387; Xie LK, 2011, INT J ORAL MAX SURG, V40, P730, DOI 10.1016/j.ijom.2011.03.016; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; Zehbe R, 2012, MICRON, V43, P1060, DOI 10.1016/j.micron.2012.05.001; Zuluaga MA, 2014, PHYS MED BIOL, V59, P2155, DOI 10.1088/0031-9155/59/9/2155	48	19	20	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124724	10.1371/journal.pone.0124724	http://dx.doi.org/10.1371/journal.pone.0124724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874957	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800150
J	Morita, M; Mii, A; Shimizu, A; Yasuda, F; Shoji, J; Masuda, Y; Ohashi, R; Nagahama, K; Kaneko, T; Tsuruoka, S				Morita, Megumi; Mii, Akiko; Shimizu, Akira; Yasuda, Fumihiko; Shoji, Jun; Masuda, Yukinari; Ohashi, Ryuji; Nagahama, Kiyotaka; Kaneko, Tomohiro; Tsuruoka, Shuichi			Glomerular Endothelial Cell Injury and Focal Segmental Glomerulosclerosis Lesion in Idiopathic Membranous Nephropathy	PLOS ONE			English	Article							GROWTH-FACTOR; NEPHROTIC SYNDROME; PROGNOSTIC-FACTORS; VEGF INHIBITION; EXPRESSION; GLOMERULONEPHRITIS; HYPERTROPHY; PODOCYTES; URINE	Background Focal segmental glomerulosclerosis (FSGS) lesions have often been discussed as a negative predictor in idopathic membranous nephropathy (MN). The mechanism of the development of FSGS lesion in MN is still uncertain. Methods From 250 cases of MN, 26 cases contained FSGS lesion. We compared the clinicopathological characteristics between MN cases with FSGS lesion [MN-FSGS(+)] and MN without FSGS lesion [MN-FSGS(-)], matched for gender, age, stage of MN. Results The glomerular filtration rate (eGFR) was significantly lower in MN-FSGS(+) cases compared to MN-FSGS(-), although nephrotic syndrome, hematuria, and systolic blood pressure levels were not significantly different between the two groups. Pathologically, glomeruli in MN-FSGS(+) cases showed narrowing and loss of glomerular capillaries with separating from GBM or disappearance of CD34+ endothelial cells, and accumulation of extracellular matrix (ECM) in capillary walls, indicating the development of glomerular capillary injury. These findings of endothelial injury were seen even in MN-FSGS(-) cases, but they were more prominent in MN-FSGS(+) than MN-FSGS(-) by computer assessed morphometric analysis. In MN-FSGS(+) cases, 44 out of 534 glomeruli (8.2%) contained FSGS lesions (n = 31, NOS lesion; n = 13, perihilar lesion). Significant thickness of GBM with ECM accumulation was evident in MN-FSGS(+) cases. Podocyte injury with effacement of foot processes was also noted, but the expression of VEGF on podocytes was not different between the two groups, which suggests that the significant thickness of capillary walls may influence the function of VEGF from podocyte resulting in the glomerular capillary injury that contribute to the development of FSGS lesion in MN. Conclusion Glomerular capillary injury was seen in all MN cases. Furthermore, the prominent injuries of glomerular capillaries may be associated with the deterioration of eGFR and the formation of FSGS lesions in MN.	[Morita, Megumi; Mii, Akiko; Yasuda, Fumihiko; Kaneko, Tomohiro; Tsuruoka, Shuichi] Nippon Med Sch, Dept Nephrol, Tokyo 113, Japan; [Shimizu, Akira; Masuda, Yukinari; Nagahama, Kiyotaka] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo 113, Japan; [Shoji, Jun] George Washington Univ, Dept Neurol, Washington, DC 20037 USA; [Ohashi, Ryuji] Nippon Med Sch, Div Diagnost Pathol, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School; George Washington University; Nippon Medical School	Mii, A (corresponding author), Nippon Med Sch, Dept Nephrol, 1-1-5 Sendagi, Tokyo 113, Japan.	s3072@nms.ac.jp	Tsuruoka, Shuichi/ABF-8453-2020; Tsuruoka, Shuichi/W-3322-2019	Mii, Akiko/0000-0003-0326-8267	Japanese Society for the Promotion of Science [B23790963, C24591217]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Study funding was provided by Grants-in-Aid for Scientific Research (B23790963 to AM and C24591217 to AS) from the Japanese Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avihingsanon Y, 2009, KIDNEY INT, V75, P1340, DOI 10.1038/ki.2009.75; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Cattran DC, 2001, KIDNEY INT, V59, P1983, DOI 10.1046/j.1523-1755.2001.0590051983.x; CATTRAN DC, 1992, NEPHROL DIAL TRANSPL, V7, P48; Cattran DC, 1997, KIDNEY INT, V51, P901, DOI 10.1038/ki.1997.127; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; Dumoulin A, 2003, AM J KIDNEY DIS, V41, P38, DOI 10.1053/ajkd.2003.50015; Ehrenreich T, 1968, PATHOL ANNU, P145; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Fervenza FC, 2008, CLIN J AM SOC NEPHRO, V3, P905, DOI 10.2215/CJN.04321007; Gupta R, 2010, NEPHROL DIAL TRANSPL, V25, P444, DOI 10.1093/ndt/gfp521; Haas M, 1997, AM J KIDNEY DIS, V30, P621, DOI 10.1016/S0272-6386(97)90485-6; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Hara M, 2001, NEPHRON, V89, P342, DOI 10.1159/000046097; Hara M, 2010, HUM PATHOL, V41, P1265, DOI 10.1016/j.humpath.2010.02.004; Heeringa SF, 2007, NEPHROL DIAL TRANSPL, V22, P2201, DOI 10.1093/ndt/gfm188; Honkanen E, 2003, AM J KIDNEY DIS, V42, P1139, DOI 10.1053/j.ajkd.2003.08.014; Honkanen EO, 2000, KIDNEY INT, V57, P2343, DOI 10.1046/j.1523-1755.2000.00094.x; Hughson MD, 2002, AM J KIDNEY DIS, V39, P679, DOI 10.1053/ajkd.2002.31980; Katavetin P, 2008, NEW ENGL J MED, V359, P205, DOI 10.1056/NEJMc080770; LEE HS, 1993, CLIN NEPHROL, V39, P7; Machado JR, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/937623; Nishimoto K, 1999, CLIN NEPHROL, V51, P209; NOCHY D, 1994, CLIN NEPHROL, V42, P9; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; Reichert LJM, 1998, AM J KIDNEY DIS, V31, P1, DOI 10.1053/ajkd.1998.v31.pm9428445; SCHIEPPATI A, 1993, NEW ENGL J MED, V329, P85, DOI 10.1056/NEJM199307083290203; Schrijvers BF, 2004, KIDNEY INT, V65, P2003, DOI 10.1111/j.1523-1755.2004.00621.x; Shiiki H, 2004, KIDNEY INT, V65, P1400, DOI 10.1111/j.1523-1755.2004.00518.x; Shulman K, 1996, J AM SOC NEPHROL, V7, P661; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Troyanov S, 2006, KIDNEY INT, V69, P1641, DOI 10.1038/sj.ki.5000289; VANDAMME B, 1990, J PATHOL, V161, P47, DOI 10.1002/path.1711610109; WAKAI S, 1992, KIDNEY INT, V41, P428, DOI 10.1038/ki.1992.59; Yoshimoto K, 2004, KIDNEY INT, V65, P148, DOI 10.1111/j.1523-1755.2004.00403.x	35	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0116700	10.1371/journal.pone.0116700	http://dx.doi.org/10.1371/journal.pone.0116700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875837	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800001
J	Sinnott, M; Kinsley, BT; Jackson, AD; Walsh, C; O'Grady, T; Nolan, JJ; Gaffney, P; Boran, G; Kelleher, C; Carr, B				Sinnott, Margaret; Kinsley, Brendan T.; Jackson, Abaigeal D.; Walsh, Cathal; O'Grady, Tony; Nolan, John J.; Gaffney, Peter; Boran, Gerard; Kelleher, Cecily; Carr, Bernadette			Fasting Plasma Glucose as Initial Screening for Diabetes and Prediabetes in Irish Adults: The Diabetes Mellitus and Vascular Health Initiative (DMVhi)	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; PREVALENCE; POPULATION; BEHAVIORS; AUSTRALIA; OBESITY	Objective Type 2 diabetes has a long pre clinical asymptomatic phase. Early detection may delay or arrest disease progression. The Diabetes Mellitus and Vascular health initiative (DMVhi) was initiated as a prospective longitudinal cohort study on the prevalence of undiagnosed Type 2 diabetes and prediabetes, diabetes risk and cardiovascular risk in a cohort of Irish adults aged 45-75 years. Research Design and Methods Members of the largest Irish private health insurance provider aged 45 to 75 years were invited to participate in the study. Exclusion criteria: already diagnosed with diabetes or taking oral hypoglycaemic agents. Participants completed a detailed medical questionnaire, had weight, height, waist and hip circumference and blood pressure measured. Fasting blood samples were taken for fasting plasma glucose (FPG). Those with FPG in the impaired fasting glucose (IFG) range had a 75gm oral glucose tolerance test performed. Results 122,531 subjects were invited to participate. 29,144 (24%) completed the study. The prevalence of undiagnosed diabetes was 1.8%, of impaired fasting glucose (IFG) was 7.1% and of impaired glucose tolerance (IGT) was 2.9%. Dysglycaemia increased among those aged 45-54, 55-64 and 65-75 years in both males (10.6%, 18.5%, 21.7% respectively) and females (4.3%, 8.6%, 10.9% respectively). Undiagnosed T2D, IFG and IGT were all associated with gender, age, blood pressure, BMI, abdominal obesity, family history of diabetes and triglyceride levels. Using FPG as initial screening may underestimate the prevalence of T2D in the study population. Conclusions This study is the largest screening study for diabetes and prediabetes in the Irish population. Follow up of this cohort will provide data on progression to diabetes and on cardiovascular outcomes.	[Sinnott, Margaret; Jackson, Abaigeal D.; O'Grady, Tony; Carr, Bernadette] Vhi Healthcare Ltd, Dublin, Ireland; [Kinsley, Brendan T.] Mater Misericordiae Univ Hosp, Dublin, Ireland; [Walsh, Cathal] Univ Dublin Trinity Coll, Dept Stat, Dublin 2, Ireland; [Nolan, John J.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Gaffney, Peter; Boran, Gerard] Natl Childrens Hosp, Adelaide & Meath Hosp, Dublin, Ireland; [Kelleher, Cecily; Carr, Bernadette] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland	Mater Misericordiae University Hospital; University College Dublin; Trinity College Dublin; Steno Diabetes Center; Trinity College Dublin; University College Dublin	Carr, B (corresponding author), Vhi Healthcare Ltd, Dublin, Ireland.	bernadette.carr@vhi.ie	kelleher, cecily c/A-4233-2013	kelleher, cecily c/0000-0001-9548-4914; Jackson, Abaigeal/0000-0002-9030-0036; Walsh, Cathal/0000-0001-6599-9562	Vhi Healthcare; EU; Vhi Healthcare Ltd.	Vhi Healthcare; EU(European Commission); Vhi Healthcare Ltd.	The DMVhi research project was funded by Vhi Healthcare. Part funding was received for the project through the EU-funded DEXLIFE ressearch program. Vhi Healthcare Ltd., provided support in the form of salaries for authors MS, ADJ, TOG & BC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; Borch-Johnsen K, 1999, LANCET, V354, P617; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Creagh D, 2002, Ir Med J, V95, P298; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Genuth S, 2003, DIABETES CARE, V26, P3160; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Janssen PGH, 2007, FAM PRACT, V24, P555, DOI 10.1093/fampra/cmm052; Kavanagh A, 2010, SOC SCI MED, V71, P1150, DOI 10.1016/j.socscimed.2010.05.038; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Magliano DJ, 2008, DIABETES CARE, V31, P267, DOI 10.2337/dc07-0912; Simmons RK, 2010, DIABETES OBES METAB, V12, P838, DOI 10.1111/j.1463-1326.2010.01244.x; Smith SM, 2003, DIABETIC MED, V20, P717, DOI 10.1046/j.1464-5491.2003.00998.x; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vaccaro O, 2005, DIABETES CARE, V28, P1786, DOI 10.2337/diacare.28.7.1786; von Eckardstein A, 2013, JALA-J LAB AUTOM, V18, P306, DOI 10.1177/2211068212472183; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	26	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122704	10.1371/journal.pone.0122704	http://dx.doi.org/10.1371/journal.pone.0122704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874867	Green Published, gold			2022-12-26	WOS:000353015800072
J	Wilhelm-Buchstab, T; Buchstab, BM; Leitzen, C; Garbe, S; Mudder, T; Oberste-Beulmann, S; Sprinkart, AM; Simon, B; Nelles, M; Block, W; Schoroth, F; Schild, HH; Schuller, H				Wilhelm-Buchstab, Timo; Buchstab, Barbara Myrthe; Leitzen, Christina; Garbe, Stephan; Muedder, Thomas; Oberste-Beulmann, Susanne; Sprinkart, Alois Martin; Simon, Birgit; Nelles, Michael; Block, Wolfgang; Schoroth, Felix; Schild, Hans Heinz; Schueller, Heinrich			Extraretinal Induced Visual Sensations during IMRT of the Brain	PLOS ONE			English	Article							IONIZING-RADIATION; RAY; ASTRONAUTS; PHOSPHENE; ORBIT	Background We observed visual sensations (VSs) in patients undergoing intensity modulated radiotherapy (IMRT) of the brain without the beam passing through ocular structures. We analyzed this phenomenon especially with regards to reproducibility, and origin. Methods and Findings Analyzed were ten consecutive patients (aged 41-71 years) with glioblastoma multiforme who received pulsed IMRT (total dose 60Gy) with helical tomotherapy (TT). A megavolt-CT (MVCT) was performed daily before treatment. VSs were reported and recorded using a triggered event recorder. The frequency of VSs was calculated and VSs were correlated with beam direction and couch position. Subjective patient perception was plotted on an 8x8 visual field (VF) matrix. Distance to the orbital roof (OR) from the first beam causing a VS was calculated from the Dicom radiation therapy data and MVCT data. During 175 treatment sessions (average 17.5 per patient) 5959 VSs were recorded and analyzed. VSs occurred only during the treatment session not during the MVCTs. Plotting events over time revealed patient-specific patterns. The average cranio-caudad extension of VS-inducing area was 63.4mm (range 43.24-92.1mm). The maximum distance between the first VS and the OR was 56.1mm so that direct interaction with the retina is unlikely. Data on subjective visual perception showed that VSs occurred mainly in the upper right and left quadrants of the VF. Within the visual pathways the highest probability for origin of VSs was seen in the optic chiasm and the optic tract (22%). Conclusions There is clear evidence that interaction of photon irradiation with neuronal structures distant from the eye can lead to VSs.	[Wilhelm-Buchstab, Timo; Buchstab, Barbara Myrthe; Leitzen, Christina; Garbe, Stephan; Muedder, Thomas; Oberste-Beulmann, Susanne; Sprinkart, Alois Martin; Simon, Birgit; Nelles, Michael; Block, Wolfgang; Schoroth, Felix; Schild, Hans Heinz; Schueller, Heinrich] Univ Bonn, Dept Radiol, Radiooncol, D-53105 Bonn, Germany	University of Bonn	Wilhelm-Buchstab, T (corresponding author), Univ Bonn, Dept Radiol, Radiooncol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	Timo.Buchstab@ukb.uni-bonn.de	Wilhelm-Buchstab, Timo/AAE-3112-2020; Sprinkart, Alois Martin/T-5033-2019	Sprinkart, Alois Martin/0000-0002-1435-9562				BACHOFER CS, 1963, RADIAT RES, V18, P246, DOI 10.2307/3571445; Bokkon I, 2008, BIOSYSTEMS, V92, P168, DOI 10.1016/j.biosystems.2008.02.002; Brandes G, 1897, WIEDEMANNS ANN PHYS, V60, P478; Chapman P, 1972, P NAT S NAT MANM RAD, P1102; CHARMAN WN, 1971, NATURE, V232, P574, DOI 10.1038/232574a0; CHARMAN WN, 1971, NATURE, V230, P522, DOI 10.1038/230522a0; Cherenkov P, 1964, NOBEL LECT PHYS 1942, V3, P426; Chiang CS, 1991, BRAIN RES, V566, P256; Clatworthy AL, 1999, NEUROSCI LETT, V268, P45, DOI 10.1016/S0304-3940(99)00069-5; DARCY FJ, 1962, NATURE, V196, P1013, DOI 10.1038/1961013a0; De Vries KD, 2011, REV LETT, V2011; Edison TA, 1896, ELECTRON ENG, V22, P520; Fazzio GG, 1970, NATURE, V228, P260; Fuglesang C, 2006, AVIAT SPACE ENVIR MD, V77, P449; GANGLOFF H., 1965, ADVANCE BIOL MED PHYS, V10, P1; Jenrow KA, 2001, EXP NEUROL, V169, P96, DOI 10.1006/exnr.2000.7616; Jeraj R, 2004, MED PHYS, V31, P396, DOI 10.1118/1.1639148; Kramer M, 2012, GSI BIOPHYS; Lipetz J, 1955, BR J OPHTALMOL, V39, P577; MCNULTY PJ, 1972, SCIENCE, V178, P160, DOI 10.1126/science.178.4057.160; Newman F, 2008, MED PHYS, V35, P77, DOI 10.1118/1.2815358; PINSKY LS, 1974, SCIENCE, V183, P957, DOI 10.1126/science.183.4128.957; Sannita WG, 2006, VISION RES, V46, P2159, DOI 10.1016/j.visres.2005.12.002; Schardt D, 2013, BRAIN STIMUL, V6, P416, DOI 10.1016/j.brs.2012.08.003; SCHOBER H, 1964, VISION RES, V4, P251, DOI 10.1016/0042-6989(64)90007-0; STEIDLEY KD, 1990, VISION RES, V30, P1139, DOI 10.1016/0042-6989(90)90171-G; STEIDLEY KD, 1989, INT J RADIAT ONCOL, V17, P685, DOI 10.1016/0360-3016(89)90125-9; TOBIAS CA, 1971, NATURE, V230, P596, DOI 10.1038/230596a0; Tobias CA, 1970, OBSERVATIONS HUMAN S, P16; Wilhelm-Buchstab T, 2013, 30 JAHR OST GES RAD, V65	30	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123440	10.1371/journal.pone.0123440	http://dx.doi.org/10.1371/journal.pone.0123440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875609	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800099
J	Gokhale, PJ; Au-Young, JK; Dadi, S; Keys, DN; Harrison, NJ; Jones, M; Soneji, S; Enver, T; Sherlock, JK; Andrews, PW				Gokhale, Paul J.; Au-Young, Janice K.; Dadi, SriVidya; Keys, David N.; Harrison, Neil J.; Jones, Mark; Soneji, Shamit; Enver, Tariq; Sherlock, Jon K.; Andrews, Peter W.			Culture Adaptation Alters Transcriptional Hierarchies among Single Human Embryonic Stem Cells Reflecting Altered Patterns of Differentiation	PLOS ONE			English	Article							HUMAN TERATOCARCINOMA CELLS; MONOCLONAL-ANTIBODY; GLOBO-SERIES; PLURIPOTENT; STATES; LINES; NAIVE; HETEROGENEITY; EQUILIBRIUM; COMMITMENT	We have used single cell transcriptome analysis to re-examine the substates of early passage, karyotypically Normal, and late passage, karyotypically Abnormal ('Culture Adapted') human embryonic stem cells characterized by differential expression of the cell surface marker antigen, SSEA3. The results confirmed that culture adaptation is associated with alterations to the dynamics of the SSEA3(+) and SSEA3(-) substates of these cells, with SSEA3(-) Adapted cells remaining within the stem cell compartment whereas the SSEA3(-) Normal cells appear to have differentiated. However, the single cell data reveal that these substates are characterized by further heterogeneity that changes on culture adaptation. Notably the Adapted population includes cells with a transcriptome substate suggestive of a shift to a more naive-like phenotype in contrast to the cells of the Normal population. Further, a subset of the Normal SSEA3(+) cells expresses genes typical of endoderm differentiation, despite also expressing the undifferentiated stem cell genes, POU5F1 (OCT4) and NANOG, whereas such apparently lineage-primed cells are absent from the Adapted population. These results suggest that the selective growth advantage gained by genetically variant, culture adapted human embryonic stem cells may derive in part from a changed substate structure that influences their propensity for differentiation.	[Gokhale, Paul J.; Harrison, Neil J.; Jones, Mark; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Au-Young, Janice K.; Dadi, SriVidya; Keys, David N.; Sherlock, Jon K.] ThermoFisher, Foster City, CA USA; [Soneji, Shamit; Enver, Tariq] Univ Oxford, Weatherall Inst Mol Med, Oxford, England	University of Sheffield; University of Oxford	Andrews, PW (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.	p.w.andrews@sheffield.ac.uk		Andrews, Peter/0000-0001-7215-4410; Gokhale, Paul/0000-0001-7225-4403; Sherlock, Jon/0000-0001-5475-2361	Medical Research Council, UK [G0300268]; Human Frontiers Science Program [RGP0001/2012]; European Union's Seventh Framework Programme for research, technological development and demonstration [602423]; MRC [G0300268, G0700785] Funding Source: UKRI; Cancer Research UK [12796] Funding Source: researchfish; Medical Research Council [G0700785, G0300268] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontiers Science Program(Human Frontier Science Program); European Union's Seventh Framework Programme for research, technological development and demonstration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work described was funded by: Medical Research Council, UK (http://www.mrc.ac. uk), G0300268, PJG, NJH, MJ, PWA; Human Frontiers Science Program, RGP0001/2012, PJG, PWA; and European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602423, TE, PWA. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Work was a collaboration with Thermo Fisher (JKA-Y SVD DNK, JS) who provided reagents, helped design the study, performed experiments, collected and analysed data and helped prepare the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Avery S, 2013, STEM CELL REP, V1, P379, DOI 10.1016/j.stemcr.2013.10.005; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Fazeli A, 2011, INT J DEV BIOL, V55, P175, DOI 10.1387/ijdb.103177af; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Hough SR, 2014, STEM CELL REP, V2, P881, DOI 10.1016/j.stemcr.2014.04.014; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tonge PD, 2011, STEM CELL RES, V7, P145, DOI 10.1016/j.scr.2011.04.006; Tonge PD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010901; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Welling M, 2013, TRENDS CELL BIOL, V23, P442, DOI 10.1016/j.tcb.2013.04.004; Xu Y., 2010, P NATL ACAD SCI US	46	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123467	10.1371/journal.pone.0123467	http://dx.doi.org/10.1371/journal.pone.0123467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875838	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353014700032
J	Ovalle-Rivera, O; Laderach, P; Bunn, C; Obersteiner, M; Schroth, G				Ovalle-Rivera, Oriana; Laederach, Peter; Bunn, Christian; Obersteiner, Michael; Schroth, Gotz			Projected Shifts in Coffea arabica Suitability among Major Global Producing Regions Due to Climate Change	PLOS ONE			English	Article							IMPACT; TREE	Regional studies have shown that climate change will affect climatic suitability for Arabica coffee (Coffea arabica) within current regions of production. Increases in temperature and changes in precipitation patterns will decrease yield, reduce quality and increase pest and disease pressure. This is the first global study on the impact of climate change on suitability to grow Arabica coffee. We modeled the global distribution of Arabica coffee under changes in climatic suitability by 2050s as projected by 21 global circulation models. The results suggest decreased areas suitable for Arabica coffee in Mesoamerica at lower altitudes. In South America close to the equator higher elevations could benefit, but higher latitudes lose suitability. Coffee regions in Ethiopia and Kenya are projected to become more suitable but those in India and Vietnam to become less suitable. Globally, we predict decreases in climatic suitability at lower altitudes and high latitudes, which may shift production among the major regions that produce Arabica coffee.	[Ovalle-Rivera, Oriana; Laederach, Peter] Ctr Int Agr Trop, DAPA Program, Cali, Colombia; [Bunn, Christian] Humboldt Univ, Fac Agr & Hort, D-10099 Berlin, Germany; [Obersteiner, Michael] Int Inst Appl Syst Anal, ESM Program, A-2361 Laxenburg, Austria	Alliance; International Center for Tropical Agriculture - CIAT; Humboldt University of Berlin; International Institute for Applied Systems Analysis (IIASA)	Laderach, P (corresponding author), Ctr Int Agr Trop, DAPA Program, Apartado Aereo 6713, Cali, Colombia.	p.laderach@cgiar.org	Bunn, Christian/AAE-9504-2019	Bunn, Christian/0000-0003-2175-8745; Laderach, Peter/0000-0001-8708-6318	Climate Change, Agriculture and Food Security (CCAFS)	Climate Change, Agriculture and Food Security (CCAFS)	This study has been funded by the CGIAR program on Climate Change, Agriculture and Food Security (CCAFS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088463; Bunn C, 2012, INTEGRATED CLIMATE C, p611ff; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; ECOCROP (Food And Agriculture Organization of the United Nations US), COFF AR EC 2000; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fandohan B, 2013, BIOTECHNOL AGRON SOC, V17, P450; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fischlin A, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P211; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Haggar J, 2011, DESK STUDY IMPACTS C; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; ICO (International Coffee Organization England), HIST DAT COFF PROD 2; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Laderach P, 2009, MANAGEMENT INTRINSIC; Laderach P, 2010, PUBLICACION CATIE, V99, P54; Laderach P, 2010, MESOAMERICAN COFFEE; Laderach P, 2011, CLIM CHANG MANAG, P703, DOI 10.1007/978-3-642-14776-0_42; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Morales M, 2012, CATIE 2012; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rahn E, 2014, MITIG ADAPT STRAT GL, V19, P1119, DOI 10.1007/s11027-013-9467-x; Ramirez J, 2010, DECISION POLICY ANAL; Ramirez-Villegas J, 2012, AGR FOREST METEOROL, V161, P26, DOI 10.1016/j.agrformet.2012.03.015; Schroth G, 2014, REGIONAL ENV CHANGE, P1; Schroth G, 2014, AGRON SUSTAIN DEV, V34, P139, DOI 10.1007/s13593-013-0175-4; Schroth G, 2009, MITIG ADAPT STRAT GL, V14, P605, DOI 10.1007/s11027-009-9186-5; USDA (United States Departament of agriculture USA), 2011, COFF WORLD MARK TRAD; Villers L, 2009, INTERCIENCIA, V34, P322; WALLER J.M, 2007, COFFEE PESTS DIS THE; Waller JM, 2007, WORLD COFFEE PRODUCT, P17; Zullo J, 2011, CLIMATIC CHANGE, V109, P535, DOI 10.1007/s10584-011-0058-0	34	144	149	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124155	10.1371/journal.pone.0124155	http://dx.doi.org/10.1371/journal.pone.0124155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875230	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000353014700056
J	Chen, MZ; Hudson, CA; Vincent, EE; de Berker, DAR; May, MT; Hers, I; Dayan, CM; Andrews, RC; Tavare, JM				Chen, Mimi Z.; Hudson, Claire A.; Vincent, Emma E.; de Berker, David A. R.; May, Margaret T.; Hers, Ingeborg; Dayan, Colin M.; Andrews, Robert C.; Tavare, Jeremy M.			Bariatric Surgery in Morbidly Obese Insulin Resistant Humans Normalises Insulin Signalling but Not Insulin-Stimulated Glucose Disposal	PLOS ONE			English	Article							Y GASTRIC BYPASS; HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE B; WEIGHT-LOSS; FATTY-ACID; DIABETES-MELLITUS; DOSE-RESPONSE; AKT PHOSPHORYLATION; GLYCOGEN-SYNTHASE; IN-VIVO	Aims Weight-loss after bariatric surgery improves insulin sensitivity, but the underlying molecular mechanism is not clear. To ascertain the effect of bariatric surgery on insulin signalling, we examined glucose disposal and Akt activation in morbidly obese volunteers before and after Roux-en-Y gastric bypass surgery (RYGB), and compared this to lean volunteers. Materials and Methods The hyperinsulinaemic euglycaemic clamp, at five infusion rates, was used to determine glucose disposal rates (GDR) in eight morbidly obese (body mass index, BMI=47.3 +/- 2.2 kg/m(2)) patients, before and after RYGB, and in eight lean volunteers (BMI=20.7 +/- 0.7 kg/m(2)). Biopsies of brachioradialis muscle, taken at fasting and insulin concentrations that induced half-maximal (GDR(50)) and maximal (GDR(100)) GDR in each subject, were used to examine the phosphorylation of Akt-Thr308, Akt-473, and pras40, in vivo biomarkers for Akt activity. Results Pre-operatively, insulin-stimulated GDR was lower in the obese compared to the lean individuals (P<0.001). Weight-loss of 29.9 +/- 4 kg after surgery significantly improved GDR(50) (P=0.004) but not GDR(100) (P=0.3). These subjects still remained significantly more insulin resistant than the lean individuals (p<0.001). Weight loss increased insulin-stimulated skeletal muscle Akt-Thr308 and Akt-Ser473 phosphorylation, P=0.02 and P=0.03 respectively (MANCOVA), and Akt activity towards the substrate PRAS40 (P=0.003, MANCOVA), and in contrast to GDR, were fully normalised after the surgery (obese vs lean, P=0.6, P=0.35, P=0.46, respectively). Conclusions Our data show that although Akt activity substantially improved after surgery, it did not lead to a full restoration of insulin-stimulated glucose disposal. This suggests that a major defect downstream of, or parallel to, Akt signalling remains after significant weight-loss.	[Chen, Mimi Z.; Hudson, Claire A.; Andrews, Robert C.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Vincent, Emma E.; Tavare, Jeremy M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [de Berker, David A. R.] Bristol Royal Infirm & Gen Hosp, Bristol Dermatol Ctr, Bristol, Avon, England; [May, Margaret T.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hers, Ingeborg] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Dayan, Colin M.] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	University of Bristol; University of Bristol; Bristol Royal Infirmary; University of Bristol; University of Bristol; Cardiff University	Andrews, RC (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	Rob.Andrews@bristol.ac.uk	Dayan, Colin/AAH-6242-2019; Hers, Ingeborg/ABG-3357-2020	Dayan, Colin/0000-0002-6557-3462; Hudson, Claire/0000-0002-5588-8196; Hers, Ingeborg/0000-0002-6467-5715; andrews, robert/0000-0003-4939-1738; Vincent, Emma/0000-0002-8917-7384	Diabetes Research and Wellness Foundation; Medical Research Council; AstraZeneca	Diabetes Research and Wellness Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca)	This study was funded by a grant from Diabetes Research and Wellness Foundation, Medical Research Council and AstraZeneca. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bakker LEH, 2014, DIABETES, V63, P248, DOI 10.2337/db13-0696; Ballantyne GH, 2006, OBES SURG, V16, P1189, DOI 10.1381/096089206778392158; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Benedetti G, 2000, J AM COLL NUTR, V19, P270, DOI 10.1080/07315724.2000.10718926; BONADONNA RC, 1990, METABOLISM, V39, P452, DOI 10.1016/0026-0495(90)90002-T; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Chen MZ, 2014, DIABETIC MED, V31, P42; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Dar MS, 2012, OBES SURG, V22, P1077, DOI 10.1007/s11695-012-0624-1; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DiGiorgi M, 2010, SURG OBES RELAT DIS, V6, P249, DOI 10.1016/j.soard.2009.09.019; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; GARVEY WT, 1992, DIABETES, V41, P465, DOI 10.2337/diabetes.41.4.465; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Gonzalez N, 2005, REGUL PEPTIDES, V126, P203, DOI 10.1016/j.regpep.2004.10.002; Grimmsmann T, 2002, J ENDOCRINOL, V172, P645, DOI 10.1677/joe.0.1720645; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Kruszynska YT, 2002, J CLIN ENDOCR METAB, V87, P226, DOI 10.1210/jc.87.1.226; Leng Y, 2004, REV ENDOCR METAB DIS, V5, P111, DOI 10.1023/B:REMD.0000021432.84588.f6; Mari A, 2006, DIABETOLOGIA, V49, P2136, DOI 10.1007/s00125-006-0337-x; Meyer MM, 2002, DIABETOLOGIA, V45, P813, DOI 10.1007/s00125-002-0830-9; Middelbeek RJW, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.13; Miras AD, 2014, DIABETES OBES METAB, V16, P86, DOI 10.1111/dom.12177; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Pournaras DJ, 2011, BR J SURG; RANDLE PJ, 1963, LANCET, V1, P785; RIZZA RA, 1981, AM J PHYSIOL, V240, pE630, DOI 10.1152/ajpendo.1981.240.6.E630; Rosa G, 2007, INT J OBESITY, V31, P1429, DOI 10.1038/sj.ijo.0803630; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Storgaard H, 2004, J CLIN ENDOCR METAB, V89, P1301, DOI 10.1210/jc.2003-031243; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120084	10.1371/journal.pone.0120084	http://dx.doi.org/10.1371/journal.pone.0120084			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876175	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100019
J	Deleyrolle, L; Sabourin, JC; Rothhut, B; Fujita, H; Guichet, PO; Teigell, M; Ripoll, C; Chauvet, N; Perrin, F; Mamaeva, D; Noda, T; Mori, K; Yoshihara, Y; Hugnot, JP				Deleyrolle, Loic; Sabourin, Jean-Charles; Rothhut, Bernard; Fujita, Hiroko; Guichet, Pierre-Olivier; Teigell, Marisa; Ripoll, Chantal; Chauvet, Norbert; Perrin, Florence; Mamaeva, Daria; Noda, Tetsuo; Mori, Kensaku; Yoshihara, Yoshihiro; Hugnot, Jean-Philippe			OCAM Regulates Embryonic Spinal Cord Stem Cell Proliferation by Modulating ErbB2 Receptor	PLOS ONE			English	Article							ADHESION MOLECULE NCAM; OLFACTORY GLOMERULI; PROGENITOR CELLS; PRECURSOR CELLS; NEURAL STEM; DIFFERENTIATION; MOUSE; TRAFFICKING; BINDING; FAMILY	The proliferation and differentiation of neural stem cells are tightly controlled by intrinsic and extrinsic cues. Cell adhesion molecules are increasingly recognized as regulators of these processes. Here we report the expression of the olfactory cell adhesion molecule (OCAM/NCAM2/RNCAM) during mouse spinal cord development and in neural stem cells cultured as neurospheres. OCAM is also weakly expressed in the dormant adult stem cell niche around the central canal and is overexpressed after spinal cord injury. Both transmembrane (TM) and glycosylphosphatidylinositol (GPI)-linked isoforms are present in neurospheres. Electron microscopy and internalisation experiments revealed a dynamic trafficking of OCAM between the membrane and intracellular compartments. After differentiation, OCAM remains in neurons and oligodendrocytes whereas no expression is detected in astrocytes. Using OCAM knockout (KO) mice, we found that mutant spinal cord stem cells showed an increased proliferation and self-renewal rates although no effect on differentiation was observed. This effect was reversed by lentivirus-mediated re-introduction of OCAM. Mechanistically, we identified the ErbB2/Neu/HER2 protein as being implicated in the enhanced proliferation of mutant cells. ErbB2 protein expression and phosphorylation level were significantly increased in KO cells whereas no difference was observed at the mRNA level. Overexpression of ErbB2 in wild-type and mutant cells also increased their growth while reintroduction of OCAM in mutant cells reduced the level of phosphorylated ErbB2. These results indicate that OCAM exerts a posttranscriptional control on the ErbB2 signalling in spinal cord stem cells. This study adds further support for considering cell adhesion molecules as regulators of the ErbB signalling.	[Deleyrolle, Loic] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA; [Sabourin, Jean-Charles; Rothhut, Bernard; Guichet, Pierre-Olivier; Teigell, Marisa; Ripoll, Chantal; Perrin, Florence; Mamaeva, Daria; Hugnot, Jean-Philippe] Hop St Eloi, INSERM, Inst Neurosci, U1051, Montpellier, France; [Fujita, Hiroko] RIKEN, Brain Sci Inst, Saitama, Japan; [Chauvet, Norbert] INSERM, Inst Funct Gen, Dept Endocrinol, U661, Montpellier, France; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 170, Japan; [Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo, Japan; [Hugnot, Jean-Philippe] Univ Montpellier 2, Montpellier, France	State University System of Florida; University of Florida; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Japanese Foundation for Cancer Research; University of Tokyo; Universite de Montpellier	Rothhut, B (corresponding author), Hop St Eloi, INSERM, Inst Neurosci, U1051, Montpellier, France.	bernard.rothhut@inserm.fr	PERRIN, Florence/AAY-6815-2021; Chauvet, Norbert/D-7333-2016; Yoshihara, Yoshihiro/N-6481-2015; Noda, Tetsuo/B-1667-2016	Chauvet, Norbert/0000-0003-4388-6422; Yoshihara, Yoshihiro/0000-0002-0319-7166; Rothhut, Bernard/0000-0001-6467-8134; Mori, Kensaku/0000-0001-7853-9370; PERRIN, Florence/0000-0002-7630-0515; Guichet, Pierre-Olivier/0000-0003-0115-2199	AFM (French association against myopathy); ARSEP (association Francaise contre la sclerose en plaque); Grants-in-Aid for Scientific Research [25115005] Funding Source: KAKEN	AFM (French association against myopathy); ARSEP (association Francaise contre la sclerose en plaque); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the AFM (French association against myopathy). A scholarship was granted to LD by ARSEP (association Francaise contre la sclerose en plaque). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenius M, 2003, DEVELOPMENT, V130, P917, DOI 10.1242/dev.00317; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Bian S., 2013, NEURAL STEM CELLS NE; Borisovska M, 2011, J PHYSIOL-LONDON, V589, P1927, DOI 10.1113/jphysiol.2011.206276; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Carraway KL, 2009, FUTURE ONCOL, V5, P1631, DOI 10.2217/FON.09.125; Chan SA, 2005, J NEUROPHYSIOL, V94, P1037, DOI 10.1152/jn.01213.2004; Deleyrolle L, 2006, STEM CELLS, V24, P748, DOI 10.1634/stemcells.2005-0138; Dihne M, 2003, J NEUROSCI, V23, P6638; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Gibson NJ, 2011, CELL ADHES MIGR, V5, P48, DOI 10.4161/cam.5.1.13639; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hugnot JP, 2011, FRONT BIOSCI-LANDMRK, V16, P1044, DOI 10.2741/3734; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Klapper LN, 2000, CANCER RES, V60, P3384; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Mao YL, 2009, DEVELOPMENT, V136, P473, DOI 10.1242/dev.026054; Mich JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02669; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Noles SR, 2007, MOL CELL NEUROSCI, V35, P549, DOI 10.1016/j.mcn.2007.04.012; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Povlsen GK, 2008, J NEUROCHEM, V104, P624, DOI 10.1111/j.1471-4159.2007.05033.x; Sabelstrom H, 2014, EXP NEUROL, V260, P44, DOI 10.1016/j.expneurol.2013.01.026; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SALMON P, 2007, CURR PROTOC HUM GENE, pCH12, DOI DOI 10.1002/0471142905.HG0808S52; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Secher T, 2010, ADV EXP MED BIOL, V663, P227, DOI 10.1007/978-1-4419-1170-4_15; SHIN MH, 2002, EXP MOL MED, V34, P401; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Winther M, 2012, INT J BIOCHEM CELL B, V44, P441, DOI 10.1016/j.biocel.2011.11.020; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	41	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122337	10.1371/journal.pone.0122337	http://dx.doi.org/10.1371/journal.pone.0122337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875008	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100063
J	Levi, L; Toyooka, T; Patarroyo, M; Frisan, T				Levi, Laura; Toyooka, Tatsushi; Patarroyo, Manuel; Frisan, Teresa			Bacterial Genotoxins Promote Inside-Out Integrin beta 1 Activation, Formation of Focal Adhesion Complexes and Cell Spreading	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; DOUBLE-STRAND BREAKS; CYCLE ARREST; DNA-DAMAGE; GENOMIC INSTABILITY; ALPHA-5-BETA-1; CARCINOMA; MIGRATION; INVASION; EXPRESSION	Integrins are membrane bound receptors that regulate several cellular processes, such as cell adhesion, migration, survival and proliferation, and may contribute to tumor initiation/progression in cells exposed to genotoxic stress. The extent of integrin activation and its role in cell survival upon intoxication with bacterial genotoxins are still poorly characterized. These toxins induce DNA strand breaks in the target cells and activate the DNA damage response (DDR), coordinated by the Ataxia Telangectasia Mutated (ATM) kinase. In the present study, we demonstrate that induction of DNA damage by two bacterial genotoxins promotes activation of integrin beta 1, leading to enhanced assembly of focal adhesions and cell spreading on fibronectin, but not on vitronectin. This phenotype is mediated by an ATM-dependent inside-out integrin signaling, and requires the actin cytoskeleton remodeler NET1. The toxin-mediated cell spreading and anchorage-independent survival further relies on ALIX and TSG101, two components of the endosomal sorting complex required for transport (ESCRT), known to regulate integrin intracellular trafficking. These data reveal a novel aspect of the cellular response to bacterial genotoxins, and provide new tools to understand the carcinogenic potential of these effectors in the context of chronic intoxication and infection.	[Levi, Laura; Toyooka, Tatsushi; Frisan, Teresa] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Patarroyo, Manuel] Karolinska Inst, Dept Dent Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Frisan, T (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Teresa.Frisan@ki.se	Toyooka, Tatsushi/AFW-4023-2022; Frisan, Teresa/H-8444-2019; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017	Frisan, Teresa/0000-0002-1209-0942; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040	Swedish Research Council; Swedish Cancer Society; Karolinska Institutet doctoral funding (KID)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet doctoral funding (KID)	This work was supported by grants awarded by Swedish Research Council and the Swedish Cancer Society to TF and MP. LL is supported by the Karolinska Institutet doctoral funding (KID). TF is a fellow of the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Blazkova H, 2010, J CELL MOL MED, V14, P357, DOI 10.1111/j.1582-4934.2009.00862.x; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Eke I, 2014, SEMIN CANC BIOL; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Escalas N, 2000, EXP CELL RES, V257, P206, DOI 10.1006/excr.2000.4878; Fedor Y, 2013, CELL MICROBIOL, V15, P1, DOI 10.1111/cmi.12028; Feng MX, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-226; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Frisan T, 2012, FASEB J, V26, P5060, DOI 10.1096/fj.12-211946; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gelfanova V, 1999, INFECT IMMUN, V67, P6394; Guerra L, 2011, FEBS J, V278, P4577, DOI 10.1111/j.1742-4658.2011.08125.x; Guerra L, 2011, J CELL SCI, V124, P2735, DOI 10.1242/jcs.085845; Guerra L, 2011, TOXINS, V3, P172, DOI 10.3390/toxins3030172; Guerra L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002254; Guidi R, 2013, CELL MICROBIOL, V15, P2034, DOI 10.1111/cmi.12172; Guidi R, 2013, CELL MICROBIOL, V15, P98, DOI 10.1111/cmi.12034; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassane DC, 2003, INFECT IMMUN, V71, P541, DOI 10.1128/IAI.71.1.541-545.2003; Hassane DC, 2001, INFECT IMMUN, V69, P5752, DOI 10.1128/IAI.69.9.5752-5759.2001; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones J, 1997, J ORAL PATHOL MED, V26, P63, DOI 10.1111/j.1600-0714.1997.tb00023.x; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; Lobert VH, 2012, J CELL SCI, V125, P29, DOI 10.1242/jcs.088310; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Moncharmont C., 2014, CRIT REV ONCOL HEMAT; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Nam JM, 2009, INT J RADIAT BIOL, V85, P923, DOI 10.3109/09553000903232876; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Onodera Y, 2013, PHARMACOL THERAPEUT, V140, P1, DOI 10.1016/j.pharmthera.2013.05.007; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Sato T, 2002, INFECT IMMUN, V70, P528, DOI 10.1128/IAI.70.2.528-534.2002; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Stuffers S, 2009, EXP CELL RES, V315, P1619, DOI 10.1016/j.yexcr.2008.10.013; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; Yamamoto K, 2004, EUR J ORAL SCI, V112, P445, DOI 10.1111/j.1600-0722.2004.00157.x; Yang CQ, 2003, CANCER RES, V63, P8312	56	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124119	10.1371/journal.pone.0124119	http://dx.doi.org/10.1371/journal.pone.0124119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874996	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100240
J	Li, JL; Chen, X; Kang, B; Liu, M				Li, Jianlong; Chen, Xiao; Kang, Bin; Liu, Min			Mitochondrial DNA Genomes Organization and Phylogenetic Relationships Analysis of Eight Anemonefishes (Pomacentridae: Amphiprioninae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; DAMSELFISHES TELEOSTEI; EVOLUTION; REGION; MODEL; RADIATION; SEQUENCE; PROGRAM; ORIGIN; SERINE	Anemonefishes (Pomacentridae Amphiprioninae) are a group of 30 valid coral reef fish species with their phylogenetic relationships still under debate. The eight available mitogenomes of anemonefishes were used to reconstruct the molecular phylogenetic tree; six were obtained from this study (Amphiprion clarkii, A. frenatus, A. percula, A. perideraion, A. polymnus and Premnas biaculeatus) and two from GenBank (A. bicinctus and A. ocellaris). The seven Amphiprion species represent all four subgenera and P. biaculeatus is the only species from Premnas. The eight mitogenomes of anemonefishes encoded 13 protein-coding genes, two rRNA genes, 22 tRNA genes and two main non-coding regions, with the gene arrangement and translation direction basically identical to other typical vertebrate mitogenomes. Among the 13 protein-coding genes, A. ocellaris (AP006017) and A. percula (KJ174497) had the same length in ND5 with 1,866 bp, which were three nucleotides less than the other six anemonefishes. Both structures of ND5, however, could translate to amino acid successfully. Only four mitogenomes had the tandem repeats in D-loop; the tandem repeats were located in downstream after Conserved Sequence Block rather than the upstream and repeated in a simply way. The phylogenetic utility was tested with Bayesian and Maximum Likelihood methods using all 13 protein-coding genes. The results strongly supported that the subfamily Amphiprioninae was monophyletic and P. biaculeatus should be assigned to the genus Amphiprion. Premnas biaculeatus with the percula complex were revealed to be the ancient anemonefish species. The tree forms of ND1, COIII, ND4, Cytb, Cytb+ 12S rRNA, Cytb+ and Cytb+ COI+ 12S rRNA were similar to that 13 protein-coding genes, therefore, we suggested that the suitable single mitochondrial gene for phylogenetic analysis of anemonefishes maybe Cytb. Additional mitogenomes of anemonefishes with a combination of nuclear markers will be useful to substantiate these conclusions in future studies.	[Li, Jianlong; Liu, Min] Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Chen, Xiao] Guangxi Acad Sci, Guangxi Mangrove Res Ctr, Guangxi Key Lab Mangrove Conservat & Utilizat, Beihai, Guangxi, Peoples R China; [Kang, Bin] Jimei Univ, Coll Fisheries, Xiamen, Fujian, Peoples R China	Xiamen University; Jimei University	Liu, M (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	minliuxm@xmu.edu.cn		Li, Jianlong/0000-0002-0302-0061	Xiamen Southern Oceanographic Center of China;  [13GZY001NF12];  [14GZY019NF19]	Xiamen Southern Oceanographic Center of China; ; 	This research was supported by Xiamen Southern Oceanographic Center of China (www.hyj.xm.gov.cn/Ocean/WorkInfoList.aspx) to ML. The grant numbers are 13GZY001NF12 and 14GZY019NF19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G., 1975, DAMSELFISHES S SEAS; Allen G.R., 1972, P1; Allen Gerald R., 2010, Aqua, V16, P129; Allen Gerald R., 2008, Aqua (Miradolo Terme), V14, P105; Allen Gerald R., 1991, P1; Allen GR, 1975, ANEMONEFISHES THEIR; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; CHENG S, 1994, NATURE, V369, P684, DOI 10.1038/369684a0; Cooper WJ, 2009, MOL PHYLOGENET EVOL, V52, P1, DOI 10.1016/j.ympev.2008.12.010; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Elliott JK, 1999, P ROY SOC B-BIOL SCI, V266, P677, DOI 10.1098/rspb.1999.0689; FAUTIN DG, 1991, SYMBIOSIS, V10, P23; GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072; Guo XH, 2003, AQUACULTURE, V224, P25, DOI 10.1016/S0044-8486(03)00168-6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1995, SYST BIOL, V44, P3, DOI 10.2307/2413480; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Iwasaki W, 2013, MOL BIOL EVOL, V30, P2531, DOI 10.1093/molbev/mst141; Jang-Liaw NH, 2002, MOL PHYLOGENET EVOL, V25, P445, DOI 10.1016/S1055-7903(02)00278-6; Jin Xiao-Xiao, 2013, Yichuan, V35, P1391, DOI 10.3724/SP.J.1005.2013.01391; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; JOHANSEN S, 1990, NUCLEIC ACIDS RES, V18, P411, DOI 10.1093/nar/18.3.411; Kawahara R, 2008, MOL PHYLOGENET EVOL, V46, P224, DOI 10.1016/j.ympev.2007.07.009; Litsios G, 2014, P ROY SOC LOND B BIO, V281, P2013; Litsios G, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-212; Liu M, 2013, J FISH BIOL, V82, P1684, DOI 10.1111/jfb.12112; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MARISCAL RN, 1970, MAR BIOL, V6, P58, DOI 10.1007/BF00352608; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OSAWA S, 1989, J MOL EVOL, V29, P202, DOI 10.1007/BF02100203; Quenouille B, 2004, MOL PHYLOGENET EVOL, V31, P66, DOI 10.1016/s1055-7903(03)00278-1; SACCONE C, 1987, J MOL EVOL, V26, P205, DOI 10.1007/BF02099853; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Santini S, 2006, GENE, V385, P19, DOI 10.1016/j.gene.2006.03.028; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stepien Carol A., 1997, P1, DOI 10.1016/B978-012417540-2/50002-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang KL, 2001, COPEIA, P591, DOI 10.1643/0045-8511(2001)001[0591:PRADTP]2.0.CO;2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yamanoue Y, 2007, MOL PHYLOGENET EVOL, V45, P89, DOI 10.1016/j.ympev.2007.03.008; Zhuang X, 2007, THESIS XIAMEN U; Zhuang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073561	50	18	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123894	10.1371/journal.pone.0123894	http://dx.doi.org/10.1371/journal.pone.0123894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875768	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100220
J	Luo, LY; Jiang, SS; Huang, DQ; Lu, NH; Luo, ZJ				Luo, Lingyu; Jiang, Shanshan; Huang, Deqiang; Lu, Nonghua; Luo, Zhijun			MLK3 Phophorylates AMPK Independently of LKB1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER-CELLS; A TARGET; APOPTOSIS; INFLAMMATION; PATHWAYS; GROWTH; DRUGS; JNK	Emerging evidence has shown that cellular energy metabolism is regulated by the AMPK and MLK3-JNK signaling pathways, but the functional link between them remains to be determined. The present study aimed to explore the crosstalk between MLK3 and AMPK. We found that both JNK and AMPK were phosphorylated at their activation sites by TNF-alpha, Anisomycin, H2O2 and sorbitol. Interestingly, sorbitol stimulated phosphorylation of AMPK at T172 in LKB1-deficient cells. Following the screening of more than 100 kinases, we identified that MLK3 induced phosphorylation of AMPK at T172. Our in vitro analysis further revealed that MLK3-mediated phosphorylation of AMPK at T172 was independent of AMP, but addition of AMP caused a mobility shift of AMPK, an indication of autophosphorylation, suggesting that AMP binding and phosphorylation of T172 leads to maximal activation of AMPK. GST-pull down assays showed a direct interaction between AMPK alpha 1 subunit and MLK3. Altogether, our results indicate that MLK3 serves as a common upstream kinase of AMPK and JNK and functions as a direct upstream kinase for AMPK independent of LKB1.	[Luo, Lingyu; Huang, Deqiang; Lu, Nonghua] Nanchang Univ, Affiliated Hosp 1, Res Inst Digest Dis, Nanchang 330006, Jiangxi, Peoples R China; [Jiang, Shanshan] Nanchang Univ, Jiangxi Med Coll, Grad Program, Nanchang 330006, Jiangxi, Peoples R China; [Luo, Zhijun] Nanchang Univ, Inst Basic Med Sci, Nanchang 330006, Jiangxi, Peoples R China; [Luo, Zhijun] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Nanchang University; Nanchang University; Nanchang University; Boston University	Huang, DQ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Res Inst Digest Dis, Nanchang 330006, Jiangxi, Peoples R China.	hdq0515@163.com; zluo559914@gmail.com	Luo, Zhijun/AAE-9302-2019	Luo, Zhijun/0000-0001-8105-5289	National Science foundation of China [81171952, 81272926, 31460304, 81460374]; Jiangxi provincial Department Science and Technology [20133BBG70061]; NATIONAL EYE INSTITUTE [R21EY024388] Funding Source: NIH RePORTER	National Science foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi provincial Department Science and Technology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by grants from The National Science foundation of China (No. 81171952, No. 81272926, No. 31460304, and No. 81460374) and a grant from Jiangxi provincial Department Science and Technology (20133BBG70061).	Birch-Machin MA, 2006, CLIN EXP DERMATOL, V31, P548, DOI 10.1111/j.1365-2230.2006.02161.x; Chadee DN, 2013, CAN J PHYSIOL PHARM, V91, P268, DOI 10.1139/cjpp-2012-0258; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; Handley ME, 2007, INT J EXP PATHOL, V88, P111, DOI 10.1111/j.1365-2613.2007.00531.x; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Koul Hari K, 2013, Genes Cancer, V4, P342, DOI 10.1177/1947601913507951; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Luo LY, 2013, CANCER LETT, V328, P114, DOI 10.1016/j.canlet.2012.08.034; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Maki CG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038706, DOI 10.1371/JOURNAL.PONE.0038706]; Rana Ajay, 2013, Genes Cancer, V4, P334, DOI 10.1177/1947601913485415; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Sarvas Jessica L, 2013, J Diabetes Metab, VSuppl 13, DOI 10.4172/2155-6156.S13-003; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63	19	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123927	10.1371/journal.pone.0123927	http://dx.doi.org/10.1371/journal.pone.0123927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874865	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100224
J	Ostergren, C; Shim, J; Larsen, JV; Nielsen, LB; Bentzon, JF				Ostergren, Caroline; Shim, Jeong; Larsen, Jens Vinther; Nielsen, Lars Bo; Bentzon, Jacob F.			Genetic Analysis of Ligation-Induced Neointima Formation in an F2 Intercross of C57BL/6 and FVB/N Inbred Mouse Strains	PLOS ONE			English	Article							ATHEROSCLEROSIS SUSCEPTIBILITY; CAROTID-ARTERY; LOCI; HYPERPLASIA; MICE; MECHANISMS; EXPRESSION; CESSATION; FLOW; WALL	Objective Proliferation and migration of vascular smooth muscle cells (SMCs) are central for arterial diseases including atherosclerosis and restenosis. We hypothesized that the underlying mechanisms may be modeled by carotid ligation in mice. In FVB/N inbred mice, ligation leads to abundant neointima formation with proliferating media-derived SMCs, whereas in C57BL/6 mice hardly any neointima is formed. In the present study, we aimed to identify the chromosomal location of the causative gene variants in an F2 intercross between these two mouse strains. Methods and Results The neointimal cross-sectional area was significantly different between FVB/N, C57BL/6 and F1 female mice 4 weeks after ligation. Carotid artery ligation and a genome scan using 800 informative SNP markers were then performed in 157 female F2 mice. Using quantitative trait loci (QTL) analysis, we identified suggestive, but no genome-wide significant, QTLs on chromosomes 7 and 12 for neointimal cross-sectional area and on chromosome 14 for media area. Further analysis of the cross revealed 4 QTLs for plasma cholesterol, which combined explained 69% of the variation among F2 mice. Conclusions We identified suggestive QTLs for neointima and media area after carotid ligation in an intercross of FVB/N and C57BL/6 mice, but none that reached genome-wide significance indicating a complex genetic architecture of the traits. Genome-wide significant QTLs for total cholesterol levels were identified on chromosomes 1, 3, 9, and 12.	[Ostergren, Caroline; Shim, Jeong; Larsen, Jens Vinther; Bentzon, Jacob F.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Ostergren, Caroline; Shim, Jeong; Larsen, Jens Vinther; Bentzon, Jacob F.] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Bentzon, JF (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	jben@clin.au.dk	Bentzon, Jacob/B-5302-2016; Bentzon, Jacob Fog/ABC-4460-2021	Bentzon, Jacob/0000-0002-3020-5002; Bentzon, Jacob Fog/0000-0002-3020-5002	Danish Heart Foundation; Novo Nordic Foundation; Danish Medical Research Council	Danish Heart Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support was provided by the Danish Heart Foundation [www.hjerteforeningen.dk], Novo Nordic Foundation [http://www.novonordiskfonden.dk/], and the Danish Medical Research Council [www.http://ufm.dk/en/research-and-innovation/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Bonta PI, 2010, CIRCULATION, V121, P2023, DOI 10.1161/CIRCULATIONAHA.109.885673; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; da Cunha V, 2006, J LIPID RES, V47, P476, DOI 10.1194/jlr.M500341-JLR200; Dallinga-Thie GM, 2007, J LIPID RES, V48, P2788, DOI 10.1194/jlr.D700021-JLR200; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; Dansky HM, 2002, GENETICS, V160, P1599; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Godin D, 2000, CIRCULATION, V102, P2861; Harmon KJ, 2000, AM J PATHOL, V156, P1741, DOI 10.1016/S0002-9440(10)65045-6; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Holdt LM, 2008, ARTERIOSCL THROM VAS, V28, P1097, DOI 10.1161/ATVBAHA.108.165654; Inoue S, 2007, J VASC SURG, V46, P756, DOI 10.1016/j.jvs.2007.05.055; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Korshunov VA, 2009, ARTERIOSCL THROM VAS, V29, P47, DOI 10.1161/ATVBAHA.108.178111; Kuhel DG, 2002, ARTERIOSCL THROM VAS, V22, P955, DOI 10.1161/01.ATV.0000017994.77066.75; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Kuzuya M, 2003, CIRCULATION, V108, P1375, DOI 10.1161/01.CIR.0000086463.15540.3C; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Moore KJ, 2000, ANNU REV GENET, V34, P653, DOI 10.1146/annurev.genet.34.1.653; Moura R, 2007, ARTERIOSCL THROM VAS, V27, P2163, DOI 10.1161/ATVBAHA.107.151282; Nestor AL, 2006, PHYSIOL GENOMICS, V25, P286, DOI 10.1152/physiolgenomics.00135.2005; REUE K, 1991, J BIOL CHEM, V266, P12715; Shim J, 2011, ARTERIOSCL THROM VAS, V31, P1814, DOI 10.1161/ATVBAHA.111.229674; Silvestre-Roig C, 2014, CIRC-CARDIOVASC GENE, V7, P59, DOI 10.1161/CIRCGENETICS.113.000305; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Teupser D, 2006, P NATL ACAD SCI USA, V103, P123, DOI 10.1073/pnas.0509570102; Teupser D, 2009, ARTERIOSCL THROM VAS, V29, P678, DOI 10.1161/ATVBAHA.108.179408; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; Wang XS, 2002, ARTERIOSCL THROM VAS, V22, P884, DOI 10.1161/01.ATV.0000022201.18709.A1; Welch CL, 2001, P NATL ACAD SCI USA, V98, P7946, DOI 10.1073/pnas.141239098; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121899	10.1371/journal.pone.0121899	http://dx.doi.org/10.1371/journal.pone.0121899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875831	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100051
J	Passos, MT; Nishida, SK; Camara, NOS; Shimizu, MH; Mastroianni-Kirsztajn, G				Passos, Michelle T.; Nishida, Sonia K.; Camara, Niels O. S.; Shimizu, Maria Heloisa; Mastroianni-Kirsztajn, Gianna			Iohexol Clearance for Determination of Glomerular Filtration Rate in Rats Induced to Acute Renal Failure	PLOS ONE			English	Article							PLASMA-CLEARANCE; CREATININE CLEARANCE; SERUM; DOGS; KIDNEY; SAMPLE; INULIN; CATS	Introduction The glomerular filtration rate (GFR) is considered an especially important tool for the measurement of renal function. Inulin clearance (InCl) is the classic reference method for this purpose, although it is associated with a number of disadvantages; thus, other markers have been proposed, including iohexol. Determination of iohexol clearance (IoCl) has been established for clinical use; however, its application as a GFR marker in experimental rat models has not been reported. Objectives This study aims to standardize a methodology for the measurement of iohexol clearance and to evaluate its applicability as a marker of GFR in rats with induced toxic acute renal failure (ARF), using InCl as the gold standard. Materials and Methods Twenty-six Wistar male rats (200-300 g) were divided into the following two groups: a control group (n=7) and an ARF group (n=19). ARF was induced by the subcutaneous administration of cisplatin (5 mg/kg); IoCl and InCl were determined simultaneously, and plasma creatinine (pCreat) dosage was measured colorimetrically. Results The pCreat, InCl and IoCl levels were consistent with the expected values for the renal function ranges of the evaluated animals, and the IoCl and InCl levels were significantly correlated (r=0.792). An inverse moderate linear correlation between the IoCl and pCreat measurements (r=-0.587) and between the InCl and pCreat measurements (r=-0.722) were observed. Conclusion These results confirm a correlation between IoCl and the gold standard of GFR, InCl measurement. IoCl offers a relevant advantage over InCl because determination of the former allows the animal to live after the procedure.	[Passos, Michelle T.; Nishida, Sonia K.; Camara, Niels O. S.; Mastroianni-Kirsztajn, Gianna] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, SP, Brazil; [Camara, Niels O. S.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, SP, Brazil; [Shimizu, Maria Heloisa] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Mastroianni-Kirsztajn, G (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, SP, Brazil.	gm.kirsztajn@unifesp.br	Camara, Niels OS/G-8336-2011; Shimizu, Maria/B-7887-2013; Mastroianni Kirsztajn, Gianna/D-9596-2013; camara, niels olsen saraiva/AAX-3269-2020	Camara, Niels OS/0000-0001-5436-1248; Mastroianni Kirsztajn, Gianna/0000-0003-1317-4109; camara, niels olsen saraiva/0000-0001-5436-1248	CNPq (National Council for Research and Development), Brazil	CNPq (National Council for Research and Development), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M.T.P. and G.M.-K. are partially supported by CNPq (National Council for Research and Development), Brazil.	Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Bailey DB, 2009, AM J VET RES, V70, P1135, DOI 10.2460/ajvr.70.9.1135; BARBOUR GL, 1976, J NUCL MED, V17, P317; BROWN SCW, 1991, J UROLOGY, V146, P675, DOI 10.1016/S0022-5347(17)37891-6; Bussab W., 2006, ESTATISTICA BASICA; Caglar Y., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P443; Filler G, 2014, PEDIATR NEPHROL, V29, P183, DOI 10.1007/s00467-013-2426-7; Finco DR, 2001, J VET INTERN MED, V15, P368, DOI 10.1892/0891-6640(2001)015&lt;0368:RBPICA&gt;2.3.CO;2; Fischer PA, 2000, KIDNEY INT, V58, P1336, DOI 10.1046/j.1523-1755.2000.00290.x; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Frennby B, 1996, ACAD RADIOL, V3, P651, DOI 10.1016/S1076-6332(96)80191-7; Frennby B, 1996, ACAD RADIOL, V3, P145, DOI 10.1016/S1076-6332(05)80382-4; Friedman AN, 2014, AM J NEPHROL, V39, P8, DOI 10.1159/000357231; Gaspari F, 1996, J AM SOC NEPHROL, V7, P2689; Gleadhill A, 1996, RES VET SCI, V60, P117, DOI 10.1016/S0034-5288(96)90004-1; Heiene R, 2010, AM J VET RES, V71, P1100, DOI 10.2460/ajvr.71.9.1100; Margolick JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086311; Masereeuw R, 1996, BRIT J PHARMACOL, V119, P57, DOI 10.1111/j.1476-5381.1996.tb15677.x; Miyamoto K, 2001, J FELINE MED SURG, V3, P143, DOI 10.1053/jfms.2001.0125; Miyamoto K, 2001, AM J VET RES, V62, P572, DOI 10.2460/ajvr.2001.62.572; MOE L, 1995, RES VET SCI, V58, P138, DOI 10.1016/0034-5288(95)90067-5; Nesje M, 1997, VET RES COMMUN, V21, P29, DOI 10.1023/B:VERC.0000009698.28252.d1; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Schwartz GJ, 2007, PEDIATR NEPHROL, V22, P1839, DOI 10.1007/s00467-006-0358-1; SHIHABI ZK, 1992, CLIN CHEM, V38, P2117; Wilson KE, 2009, AM J VET RES, V70, P1545, DOI 10.2460/ajvr.70.12.1545; Zanocco JA, 2012, NEPHRON EXTRA, V2, P293, DOI 10.1159/000343899	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123753	10.1371/journal.pone.0123753	http://dx.doi.org/10.1371/journal.pone.0123753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875005	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100208
J	Song, JJ; Vanneste, S; De Ridder, D				Song, Jae Jin; Vanneste, Sven; De Ridder, Dirk			Dysfunctional Noise Cancelling of the Rostral Anterior Cingulate Cortex in Tinnitus Patients	PLOS ONE			English	Article							NEURAL MECHANISMS; AUDITORY-CORTEX; BRAIN ACTIVITY; ACTIVATION; HEARING; DISTRESS; PAIN; DISSOCIATION; OSCILLATIONS; METAANALYSIS	Background Peripheral auditory deafferentation and central compensation have been regarded as the main culprits of tinnitus generation. However, patient-to-patient discrepancy in the range of the percentage of daytime in which tinnitus is perceived (tinnitus awareness percentage, 0 - 100%), is not fully explicable only by peripheral deafferentation, considering that the deafferentation is a stable persisting phenomenon but tinnitus is intermittently perceived in most patients. Consequently, the involvement of a dysfunctional noise cancellation mechanism has recently been suggested with regard to the individual differences in reported tinnitus awareness. By correlating the tinnitus awareness percentage with resting-state source-localized electroencephalography findings, we may be able to retrieve the cortical area that is negatively correlated with tinnitus awareness percentage, and then the area may be regarded as the core of the noise cancelling system that is defective in patients with tinnitus. Methods and Findings Using resting-state cortical oscillation, we investigated 80 tinnitus patients by correlating the tinnitus awareness percentage with their source-localized cortical oscillatory activity and functional connectivity. The activity of bilateral rostral anterior cingulate cortices (ACCs), left dorsal-and pregenual ACCs for the delta band, bilateral rostral/pregenual/subgenual ACCs for the theta band, and left rostral/pregenual ACC for the beta 1 band displayed significantly negative correlations with tinnitus awareness percentage. Also, the connectivity between the left primary auditory cortex (A1) and the rostral ACC, as well as between the left A1 and the subgenual ACC for the beta 1 band, were negatively correlated with tinnitus awareness percentage. Conclusions These results may designate the role of the rostral ACC as the core of the descending noise cancellation system, and thus dysfunction of the rostral ACC may result in perception of tinnitus. The present study also opens a possibility of tinnitus modulation by neuromodulatory approaches targeting the rostral ACC.	[Song, Jae Jin] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea; [Vanneste, Sven] Univ Antwerp, Fac Med, Dept Translat Neurosci, Edegem, Belgium; [Vanneste, Sven] Univ Texas Dallas, Sch Behav & Brain Sci, Lab Auditory & Integrat Neurosci, Dallas, TX 75230 USA; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Unit Neurosurg, Dept Surg Sci, Dunedin, New Zealand; [De Ridder, Dirk] Sint Augustinus Hosp, BRAI2N, Antwerp, Belgium	Seoul National University (SNU); University of Antwerp; University of Texas System; University of Texas Dallas; University of Otago	Song, JJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.	jjsong96@gmail.com	Song, Jae-Jin/E-4633-2017	Song, Jae-Jin/0000-0002-6631-3232; Vanneste, Sven/0000-0003-1513-5752	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2014002619]; Seoul National University Bundang Hospital Research Fund [14-2014-019]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Seoul National University Bundang Hospital Research Fund	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014002619) (http://www.nrf.re.kr/nrf_eng_cms/) and the Seoul National University Bundang Hospital Research Fund 14-2014-019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Boyen K, 2014, HEARING RES, V312, P48, DOI 10.1016/j.heares.2014.03.001; Buchel C, 1999, J NEUROSCI, V19, P10869; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; De Ridder D, 2012, J NEUROSURG SCI, V56, P323; De Ridder D, 2012, NEUROSCI BIOBEHAV RE; De Ridder D, 2014, NEUROSCI BIOBEHAV R, V44, P16, DOI 10.1016/j.neubiorev.2013.03.021; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Del Bo L, 2008, OTOLARYNG HEAD NECK, V139, P391, DOI 10.1016/j.otohns.2008.06.019; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Feng YM, 2011, J LARYNGOL OTOL, V125, P741, DOI 10.1017/S0022215111000934; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Frot M, 2008, J NEUROSCI, V28, P944, DOI 10.1523/JNEUROSCI.2934-07.2008; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); HILLER W, 1994, BRIT J CLIN PSYCHOL, V33, P231, DOI 10.1111/j.2044-8260.1994.tb01117.x; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kong J, 2010, PAIN, V148, P257, DOI 10.1016/j.pain.2009.11.008; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2006, ACTA OTO-LARYNGOL, V126, P84, DOI 10.1080/03655230600895317; Leaver AM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00021; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Marshall AF, 2008, HEARING RES, V244, P35, DOI 10.1016/j.heares.2008.07.001; Meeus O, 2007, B-ENT, P11; Melcher JR, 2013, HEARING RES, V295, P79, DOI 10.1016/j.heares.2012.03.013; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Moller AR, 2006, PROG BRAIN RES, V157, P365, DOI 10.1016/S0079-6123(06)57022-0; Moller AR, 2009, NEUROL RES, V31, P1023, DOI 10.1179/174313209X383303; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Norena AJ, 2012, HEAR RES; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rajan R, 1998, NAT NEUROSCI, V1, P138, DOI 10.1038/388; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Saldana E, 2007, J NEUROSCI, V27, P13108, DOI 10.1523/JNEUROSCI.1892-07.2007; Schaette R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035238; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seydell-Greenwald A, 2012, BRAIN RES, V1485, P22, DOI 10.1016/j.brainres.2012.08.052; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Sherlin L, 2005, NEUROSCI LETT, V387, P72, DOI 10.1016/j.neulet.2005.06.069; Siepmann M, 2002, NEUROPSYCHOBIOLOGY, V45, P161, DOI 10.1159/000054958; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Song JJ, 2015, BRAIN STRUCT FUNCT, V220, P571, DOI 10.1007/s00429-013-0648-x; Song JJ, 2014, OTOL NEUROTOL, V35, P1780, DOI 10.1097/MAO.0000000000000560; Song JJ, 2014, BRAIN STRUCT FUNCT, V219, P1113, DOI 10.1007/s00429-013-0555-1; Song JJ, 2013, HEARING RES, V299, P1, DOI 10.1016/j.heares.2013.02.001; Song JJ, 2013, NEUROBIOL AGING, V34, P1853, DOI 10.1016/j.neurobiolaging.2013.01.014; Song JJ, 2012, J NUCL MED, V53, P1550, DOI 10.2967/jnumed.112.102939; Song JJ, 2012, OTOL NEUROTOL, V33, P137, DOI 10.1097/MAO.0b013e318241c27a; Tanibuchi I, 2003, J NEUROPHYSIOL, V89, P1067, DOI 10.1152/jn.00207.2002; Vanneste S, 2013, NEUROIMAGE, V82, P373, DOI 10.1016/j.neuroimage.2013.05.107; Vanneste S, 2011, EUR J NEUROSCI, V34, P605, DOI 10.1111/j.1460-9568.2011.07778.x; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Volkow ND, 2000, AM J PSYCHIAT, V157, P75, DOI 10.1176/ajp.157.1.75; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Zeng FG, 2012, HEAR RES	78	47	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123538	10.1371/journal.pone.0123538	http://dx.doi.org/10.1371/journal.pone.0123538			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875099	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100184
J	Berg, M; Nordgaard, O; Korner, H; Oltedal, S; Smaaland, R; Soreide, JA; Soreide, K				Berg, Marianne; Nordgaard, Oddmund; Korner, Hartwig; Oltedal, Satu; Smaaland, Rune; Soreide, Jon Arne; Soreide, Kjetil			Molecular Subtypes in Stage II-III Colon Cancer Defined by Genomic Instability: Early Recurrence-Risk Associated with a High Copy-Number Variation and Loss of RUNX3 and CDKN2A	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CPG ISLAND; CHROMOSOMAL INSTABILITY; BRAF MUTATION; CLASSIFICATION; GENE; CARCINOMAS; EXPRESSION	Objective We sought to investigate various molecular subtypes defined by genomic instability that may be related to early death and recurrence in colon cancer. Methods We sought to investigate various molecular subtypes defined by instability at microsatellites (MSI), changes in methylation patterns (CpG island methylator phenotype, CIMP) or copy number variation (CNV) in 8 genes. Stage II-III colon cancers (n = 64) were investigated by methylation-specific multiplex ligated probe amplification (MS-MLPA). Correlation of CNV, CIMP and MSI, with mutations in KRAS and BRAFV600E were assessed for overlap in molecular subtypes and early recurrence risk by uni-and multivariate regression. Results The CIMP phenotype occurred in 34% (22/64) and MSI in 27% (16/60) of the tumors, with noted CIMP/MSI overlap. Among the molecular subtypes, a high CNV phenotype had an associated odds ratio (OR) for recurrence of 3.2 (95% CI 1.1-9.3; P = 0.026). Losses of CACNA1G (OR of 2.9, 95% CI 1.4-6.0; P = 0.001), IGF2 (OR of 4.3, 95% CI 1.1-15.8; P = 0.007), CDKN2A (p16) (OR of 2.0, 95% CI 1.1-3.6; P = 0.024), and RUNX3 (OR of 3.4, 95% CI 1.3-8.7; P = 0.002) were associated with early recurrence, while MSI, CIMP, KRAS or BRAF V600E mutations were not. The CNV was significantly higher in deceased patients (CNV in 6 of 8) compared to survivors (CNV in 3 of 8). Only stage and loss of RUNX3 and CDKN2A were significant in the multivariable risk-model for early recurrence. Conclusions A high copy number variation phenotype is a strong predictor of early recurrence and death, and may indicate a dose-dependent relationship between genetic instability and outcome. Loss of tumor suppressors RUNX3 and CDKN2A were related to recurrence-risk and warrants further investigation.	[Berg, Marianne] Univ Stavanger, Ctr Organelle Res CORE, Stavanger, Norway; [Berg, Marianne; Korner, Hartwig; Soreide, Jon Arne; Soreide, Kjetil] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway; [Nordgaard, Oddmund; Oltedal, Satu; Smaaland, Rune] Stavanger Univ Hosp, Dept Hematol & Oncol, Stavanger, Norway; [Korner, Hartwig; Soreide, Jon Arne; Soreide, Kjetil] Univ Bergen, Dept Clin Med, Bergen, Norway	Universitetet i Stavanger; Stavanger University Hospital; Stavanger University Hospital; University of Bergen	Soreide, K (corresponding author), Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway.	kjetil.soreide@k1.uib.no	Søreide, Kjetil/A-9797-2010; Smaaland, Rune/AAH-2149-2021; Søreide, Jon Arne/H-7518-2019; Kørner, Hartwig/T-9372-2019	Søreide, Kjetil/0000-0001-7594-4354; Søreide, Jon Arne/0000-0001-7572-1089; 	Folke Hermansens Cancer Foundation [424508]; Mjaaland Cancer Research Fund [424506]	Folke Hermansens Cancer Foundation; Mjaaland Cancer Research Fund	This study was funded in part by grants from the Folke Hermansens Cancer Foundation (grant #424508 to KS for MB as a post-doctoral fellow, http://www.folke-fondet.org/Folke_Hermansen.html) and the Mjaaland Cancer Research Fund (grant #424506 to KS).	Ahlquist T, 2008, NEOPLASIA, V10, P680, DOI 10.1593/neo.08312; Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Bacolod MD, 2011, ANN SURG ONCOL, V18, P3694, DOI 10.1245/s10434-011-1615-5; Berg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086657; Berg M, 2013, MOL MED, V19, P286, DOI 10.2119/molmed.2013.00049; Berg M, 2011, INT J MOL SCI, V12, P9426, DOI 10.3390/ijms12129426; Berg M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-100; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brim H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082185; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Domingo E, 2013, J PATHOL, V229, P441, DOI 10.1002/path.4139; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gilje B, 2008, J MOL DIAGN, V10, P325, DOI 10.2353/jmoldx.2008.070183; Guastadisegni C, 2010, EUR J CANCER, V46, P2788, DOI 10.1016/j.ejca.2010.05.009; Hosmer DW, 1997, STAT MED, V16, P965; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; Kang GH, 2011, ARCH PATHOL LAB MED, V135, P698, DOI 10.1043/2010-0523-RA.1; Kloor M, 2014, LANGENBECK ARCH SURG, V399, P23, DOI 10.1007/s00423-013-1112-3; Kozlowski P, 2008, ELECTROPHORESIS, V29, P4627, DOI 10.1002/elps.200800126; Lea D, 2014, SCAND J GASTROENTERO, V49, P1153, DOI 10.3109/00365521.2014.950692; Lee CWL, 2010, CANCER RES, V70, P4243, DOI 10.1158/0008-5472.CAN-09-3805; Li XH, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1472-1; Livide G, 2012, PATHOL ONCOL RES, V18, P703, DOI 10.1007/s12253-012-9498-8; Lochhead P, 2013, JNCI-J NATL CANCER I, V105, P1151, DOI 10.1093/jnci/djt173; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nazemalhosseini Mojarad Ehsan, 2013, Gastroenterol Hepatol Bed Bench, V6, P120; Nordgard O, 2012, ANN SURG ONCOL, V19, P3719, DOI 10.1245/s10434-012-2454-8; Nordgard O, 2009, ANN SURG, V249, P602, DOI 10.1097/SLA.0b013e31819ec923; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Peltomaki P, 2012, EXP CELL RES, V318, P299, DOI 10.1016/j.yexcr.2011.12.001; Shima K, 2011, INT J CANCER, V128, P1080, DOI 10.1002/ijc.25432; Sideris M, 2014, ANTICANCER RES, V34, P2061; Simons CCJM, 2013, ANN ONCOL, V24, P2048, DOI 10.1093/annonc/mdt076; Simpkins SB, 1999, HUM MOL GENET, V8, P661, DOI 10.1093/hmg/8.4.661; Soong R, 2009, BRIT J CANCER, V100, P676, DOI 10.1038/sj.bjc.6604899; Soreide K, 2010, SCAND J GASTROENTERO, V45, P1255, DOI 10.3109/00365521.2010.496492; Soreide K, 2009, WORLD J SURG, V33, P2695, DOI 10.1007/s00268-009-0255-4; Soreide K, 2009, CANCER-AM CANCER SOC, V115, P271, DOI 10.1002/cncr.24024; Stuppia L, 2012, INT J MOL SCI, V13, P3245, DOI 10.3390/ijms13033245; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 1999, CANCER RES, V59, P4535; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Veen T, 2013, DIGEST SURG, V30, P1, DOI 10.1159/000349923; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Xing X, 2013, BRIT J CANCER, V108, P2542, DOI 10.1038/bjc.2013.251; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zoratto F, 2014, TUMOR BIOL, V35, P6195, DOI 10.1007/s13277-014-1845-9	56	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122391	10.1371/journal.pone.0122391	http://dx.doi.org/10.1371/journal.pone.0122391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879218	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353016500019
J	Muniz, LC; Menezes, AMB; Assuncao, MCF; Wehrmeister, FC; Martinez-Mesa, J; Goncalves, H; Domingues, MR; Gigante, DP; Horta, BL; Barros, FC				Muniz, Ludmila Correa; Baptista Menezes, Ana Maria; Formoso Assuncao, Maria Cecilia; Wehrmeister, Fernando Cesar; Martinez-Mesa, Jeovany; Goncalves, Helen; Domingues, Marlos Rodrigues; Gigante, Denise Petrucci; Horta, Bernardo Lessa; Barros, Fernando C.			Breastfeeding and Bone Mass at the Ages of 18 and 30: Prospective Analysis of Live Births from the Pelotas (Brazil) 1982 and 1993 Cohorts	PLOS ONE			English	Article							BODY-COMPOSITION; OSTEOPOROTIC FRACTURES; CHILDHOOD GROWTH; MATERNAL SMOKING; CALCIUM INTAKE; DENSITY; ADOLESCENCE; CHILDREN; WEIGHT; SIZE	Objective To evaluate the effect of total breastfeeding, breastfeeding duration and type of breastfeeding at 3 months of age on bone mass at 18 and 30 years. Study Design A prospective, longitudinal study was conducted with two birth cohorts (1982 and 1993) in Pelotas, Southern Brazil. Measurements of bone mineral content (BMC) and bone mineral density (BMD) at 18 and 30 years of age were obtained by dual-energy X-ray absorptiometry (DXA). Information on breastfeeding was collected during the first 4 years of life. Analyses were performed by linear regression and stratified by sex. Results A total of 1109 and 3226 participants provided complete information on breastfeeding in early life and bone mass at 18 and 30 years, respectively. No association between breastfeeding and bone mass was observed in women at both ages nor among men at age 30. Among men at the age of 18, BMC and BMD were higher among those breastfed regardless of duration (p= 0.032 and p= 0.043, respectively). Conclusions Despite a very weak positive effect of breastfeeding (yes/no) on BMC and BMD at age 18 in men, most findings pointed to a lack of association between breastfeeding and bone mass until young adulthood.	[Muniz, Ludmila Correa; Baptista Menezes, Ana Maria; Formoso Assuncao, Maria Cecilia; Wehrmeister, Fernando Cesar; Martinez-Mesa, Jeovany; Goncalves, Helen; Gigante, Denise Petrucci; Horta, Bernardo Lessa; Barros, Fernando C.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Domingues, Marlos Rodrigues] Univ Fed Pelotas, Postgrad Program Phys Educ, Pelotas, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas	Muniz, LC (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	ludmuniz@yahoo.com.br	Gigante, Denise/G-9285-2015; Gonçalves, Helen/P-2381-2018; MESA, JEOVANY MARTINEZ/AAE-9703-2020; Domingues, Marlos R/A-4758-2009; Wehrmeister, Fernando/A-3006-2014; Menezes, Ana MB/G-7266-2012; Gonçalves, Helen/M-1603-2017; Horta, Bernardo/A-7604-2008	Gigante, Denise/0000-0001-7309-5838; Domingues, Marlos R/0000-0002-2503-2944; Wehrmeister, Fernando/0000-0001-7137-1747; Menezes, Ana MB/0000-0002-2996-9427; Gonçalves, Helen/0000-0001-6470-3352; Horta, Bernardo/0000-0001-9843-412X	Wellcome Trust; International Development Research Center; World Health Organization; Overseas Development Administration; European Union; National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Brazilian Public Health Association (ABRASCO); Brazilian Ministry of Health	Wellcome Trust(Wellcome TrustEuropean Commission); International Development Research Center; World Health Organization(World Health Organization); Overseas Development Administration; European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Public Health Association (ABRASCO); Brazilian Ministry of Health	This article is based on data from the studies "Pelotas Birth Cohort, 1982 and 1993" conducted by the Postgraduate Program in Epidemiology at the Universidade Federal de Pelotas. The 1982 and 1993 birth cohort studies are currently supported by Wellcome Trust. The International Development Research Center, the World Health Organization, Overseas Development Administration, European Union, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq), the Brazilian Public Health Association (ABRASCO) and the Brazilian Ministry of Health supported previous phases of the studies. The aforementioned funders had no role in the design, analysis or writing of this article.	[Anonymous], 2004, LIFE COURSE APPROACH; Araujo CL, 2010, CAD SAUDE PUBLICA, V26, P1875, DOI 10.1590/S0102-311X2010001000003; BATES CJ, 1994, PHARMACOL THERAPEUT, V62, P193, DOI 10.1016/0163-7258(94)90011-6; Butte NF, 2000, PEDIATRICS, V106, P1355, DOI 10.1542/peds.106.6.1355; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; Cooper C, 1997, ANN RHEUM DIS, V56, P17, DOI 10.1136/ard.56.1.17; COOPER C, 1995, J BONE MINER RES, V10, P940; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Fewtrell M, 2011, CURR OPIN CLIN NUTR, V14, P297, DOI 10.1097/MCO.0b013e328345361b; Fewtrell MS, 2013, BR J NUTR, V110, P1; Foley S, 2009, BONE, V44, P752, DOI 10.1016/j.bone.2008.11.009; Goncalves H, 2014, INT J EPIDEMIOL, V43, P1082, DOI 10.1093/ije/dyu077; Gonzalez-Chica DA, 2012, INT J EPIDEMIOL, V41, P743, DOI 10.1093/ije/dys002; HANSEN MA, 1991, BMJ-BRIT MED J, V303, P961, DOI 10.1136/bmj.303.6808.961; Harvey NC, 2009, BRIT J NUTR, V102, P915, DOI 10.1017/S0007114509317420; Hasselstrom H, 2006, CALCIFIED TISSUE INT, V79, P7, DOI 10.1007/s00223-006-0012-8; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Jones G, 2013, OSTEOPOROSIS INT, V24, P1605, DOI 10.1007/s00198-012-2207-3; Jones G, 2000, OSTEOPOROSIS INT, V11, P146, DOI 10.1007/PL00004176; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Lewiecki EM, 2004, J CLIN ENDOCR METAB, V89, P3651, DOI 10.1210/jc.2004-0124; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Molgaard C, 2011, AM J CLIN NUTR, V94, p1865S, DOI 10.3945/ajcn.110.001214; MORLEY R, 1994, ACTA PAEDIATR, V83, P123, DOI 10.1111/j.1651-2227.1994.tb13410.x; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Pirila S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019068; Prentice A, 2003, J NUTR, V133, p1693S, DOI 10.1093/jn/133.5.1693S; Rea Marina Ferreira, 2003, Cad. Saúde Pública, V19, pS37, DOI 10.1590/S0102-311X2003000700005; Torgerson DJ, 2011, EFFECTIVE MANAGEMENT, P111, DOI [DOI 10.1093/BMB/LDU016, 10.1093/bmb/ldu016]; VALIMAKI MJ, 1994, BMJ-BRIT MED J, V309, P230, DOI 10.1136/bmj.309.6949.230; Victora CG, 2008, CAD SAUDE PUBLICA, V24, pS409, DOI 10.1590/S0102-311X2008001500006; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008; Victora CG, 1993, INT J EPIDEMIOL, V2008, P704, DOI DOI 10.1093/IJEIDYRN277; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; WELTEN DC, 1994, J BONE MINER RES, V9, P1089, DOI 10.1002/jbmr.5650090717; Young RJ, 2005, J PEDIATR GASTR NUTR, V41, P88, DOI 10.1097/01.MPG.0000162481.81900.E6	37	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122759	10.1371/journal.pone.0122759	http://dx.doi.org/10.1371/journal.pone.0122759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880483	gold, Green Published			2022-12-26	WOS:000353016500029
J	Neves, RC; Reichert, H				Neves, Ricardo Cardoso; Reichert, Heinrich			Microanatomy and Development of the Dwarf Male of Symbion pandora (Phylum Cycliophora): New Insights from Ultrastructural Investigation Based on Serial Section Electron Microscopy	PLOS ONE			English	Article							CRYPTIC SPECIATION; AMERICANUS; MORPHOLOGY; LARVA	Cycliophorans have a complex life cycle that involves several sexual and asexual stages. One of the sexual stages is the 40 mu m-long dwarf male, which is among the smallest free-living metazoans. Although the dwarf male has a highly complex body plan, this minute organism is composed of a very low number of somatic cells (similar to 50). The developmental processes that give rise to this unique phenotype are largely unknown. Here we use high resolution serial block face-scanning electron microscopy to analyze the anatomy and morphogenesis of three cycliophoran dwarf males at different developmental stages ranging from internal bud to mature male. The anatomical and morphological features of the mature dwarf male stage reported here largely correspond to those reported in earlier studies. Interestingly, the organs that typically characterize the anatomy of the mature dwarf male, e.g., muscles, brain, testis and glands, are already formed in the young male. However, there are striking differences between the mature male and young male stages at the level of cellular architecture. Thus, while the young male stage, like the internal bud stage, possesses approximately 200 nucleated cells, the mature male stage comprises only around 50 nucleated cells; muscle and epidermal cells of the mature male lack nuclei. Moreover, the total body volume of the mature male is only 63% of the body of the young male implying that the maturation of the young male into a mature male involves a marked reduction of internal body volume, mainly by massive nuclei loss. Our comparative analysis of these dwarf male specimens reveals unprecedented insight into the striking morphological and developmental differences that characterize these highly miniaturized male stages both at the level of body organization and at the level of cellular ultrastructure.	[Neves, Ricardo Cardoso; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Neves, RC (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.	ricardo.neves@unibas.ch	Neves, Ricardo Cardoso/J-9822-2014	Neves, Ricardo Cardoso/0000-0002-9219-9066	EU [227799]	EU(European Commission)	This study was partially funded by EU FP7 ASSEMBLE (grant agreement no. 227799; http://www.assemblemarine.org) for financial support for traveling and sampling in Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current funding sources for this study.	Baker JM, 2007, MAR BIOL, V151, P2183, DOI 10.1007/s00227-007-0654-8; Baker JM, 2007, ZOOL SCR, V36, P353, DOI 10.1111/j.1463-6409.2006.00288.x; Deerinck T. J., 2010, MICROSCOPY-JPN, V1, P6; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Franzen A, 2000, INVERTEBR REPROD DEV, V37, P129, DOI 10.1080/07924259.2000.9652411; Funch P, 1996, J MORPHOL, V230, P231, DOI 10.1002/(SICI)1097-4687(199612)230:3<231::AID-JMOR1>3.0.CO;2-H; FUNCH P, 1995, NATURE, V378, P711, DOI 10.1038/378711a0; Funch P., 1999, ENCY REPROD, V1, P800; Funch Peter, 1997, P409; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Kim HY, 2013, DEVELOPMENT, V140, P3146, DOI 10.1242/dev.093682; Neves RC, 2010, J MORPHOL, V271, P596, DOI 10.1002/jmor.10819; Neves RC, 2014, ORG DIVERS EVOL, V14, P363, DOI 10.1007/s13127-014-0179-1; Neves RC, 2012, J MORPHOL, V273, P850, DOI 10.1002/jmor.20025; Neves RC, 2010, HELGOLAND MAR RES, V64, P257, DOI 10.1007/s10152-010-0204-5; Neves RC, 2010, ZOOL ANZ, V249, P1, DOI 10.1016/j.jcz.2010.02.002; Neves RC, 2009, BIOL BULL-US, V217, P2, DOI 10.1086/BBLv217n1p2; Neves RC, 2009, J MORPHOL, V270, P257, DOI 10.1002/jmor.10681; Nielsen Claus, 1997, P13; Obst M, 2006, MAR BIOL, V148, P945, DOI 10.1007/s00227-005-0131-1; Obst M, 2005, MOL ECOL, V14, P4427, DOI 10.1111/j.1365-294X.2005.02752.x; Obst M, 2003, J MORPHOL, V255, P261, DOI 10.1002/jmor.10040; Obst M, 2006, ORG DIVERS EVOL, V6, P83, DOI 10.1016/j.ode.2005.05.001; Polilov AA, 2012, ARTHROPOD STRUCT DEV, V41, P29, DOI 10.1016/j.asd.2011.09.001	24	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122364	10.1371/journal.pone.0122364	http://dx.doi.org/10.1371/journal.pone.0122364			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875482	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800053
J	Pollom, RA; Rose, GA				Pollom, Riley A.; Rose, George A.			Size-Based Hydroacoustic Measures of Within-Season Fish Abundance in a Boreal Freshwater Ecosystem	PLOS ONE			English	Article							BODY-SIZE; SPECTRA; ASSEMBLAGES; INDICATORS; ACOUSTICS	Eleven sequential size-based hydroacoustic surveys conducted with a 200 kHz split-beam transducer during the summers of 2011 and 2012 were used to quantify seasonal declines in fish abundance in a boreal reservoir in Manitoba, Canada. Fish densities were sufficiently low to enable single target resolution and tracking. Target strengths converted to log(2)-based size-classes indicated that smaller fish were consistently more abundant than larger fish by a factor of approximately 3 for each halving of length. For all size classes, in both years, abundance (natural log) declined linearly over the summer at rates that varied from -0.067.day(-1) for the smallest fish to -0.016.day(-1) for the largest (R-2 = 0.24-0.97). Inter-annual comparisons of size-based abundance suggested that for larger fish (>16 cm), mean winter decline rates were an order of magnitude lower (-0.001. day(-1)) and overall survival higher (71%) than in the main summer fishing season (mean loss rate -0.038.day(-1); survival 33%). We conclude that size-based acoustic survey methods have the potential to assess within-season fish abundance dynamics, and may prove useful in long-term monitoring of productivity and hence management of boreal aquatic ecosystems.	[Pollom, Riley A.; Rose, George A.] Mem Univ Newfoundland, Fisheries & Marine Inst, Ctr Fisheries Ecosyst Res, St John, NF, Canada	Memorial University Newfoundland	Pollom, RA (corresponding author), Univ British Columbia, Fisheries Ctr, Project Seahorse, Vancouver, BC V5Z 1M9, Canada.	r.pollom@fisheries.ubc.ca		Pollom, Riley/0000-0001-8260-4614	National Sciences and Engineering Research Council HydroNet Research Network; Memorial University of Newfoundland Graduate Studentship	National Sciences and Engineering Research Council HydroNet Research Network; Memorial University of Newfoundland Graduate Studentship	This work was supported by the National Sciences and Engineering Research Council HydroNet Research Network to GR and Memorial University of Newfoundland Graduate Studentship to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CS, 1998, CAN J FISH AQUAT SCI, V55, P1854, DOI 10.1139/cjfas-55-8-1854; Beamesderfer R.C., 1988, North American Journal of Fisheries Management, V8, P505, DOI 10.1577/1548-8675(1988)008<0505:SSABIE>2.3.CO;2; Blanchard JL, 2009, J ANIM ECOL, V78, P270, DOI 10.1111/j.1365-2656.2008.01466.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; CHOPIN FS, 1995, FISH RES, V21, P315, DOI 10.1016/0165-7836(94)00301-C; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; DICKIE LM, 1987, ECOL MONOGR, V57, P233, DOI 10.2307/2937082; Elton C., 1927, ANIMAL ECOLOGY; Emmrich M, 2012, FRESHWATER BIOL, DOI 10.111/fwb.12022; Foote K, 1987, 144 ICES; Gislason H, 1998, ICES J MAR SCI, V55, P362, DOI 10.1006/jmsc.1997.0323; Graham NAJ, 2005, CORAL REEFS, V24, P118, DOI 10.1007/s00338-004-0466-y; Guillard J, 2007, INT REV HYDROBIOL, V92, P605, DOI 10.1002/iroh.200710948; Irwin BJ, 2008, ESTIMATING WALLEYE S; Jennings S, 2002, MAR ECOL PROG SER, V240, P11, DOI 10.3354/meps240011; Jennings S, 2001, J ANIM ECOL, V70, P934, DOI 10.1046/j.0021-8790.2001.00552.x; Kerr S. R., 2001, COM ECO SYS; Koslow JA, 2009, ICES J MAR SCI, V66, P966, DOI 10.1093/icesjms/fsp082; Lazarus P, 2012, PROFESSIONAL BOATBUI; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; LOVE RH, 1971, J ACOUST SOC AM, V49, P816, DOI 10.1121/1.1912422; Patel R, 2009, J ACOUST SOC AM, V125, P698, DOI 10.1121/1.3050325; Persaud AD, 2012, AQUAT SCI, V74, P203, DOI 10.1007/s00027-011-0212-9; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Romanuk TN, 2011, GLOBAL ECOL BIOGEOGR, V20, P231, DOI 10.1111/j.1466-8238.2010.00579.x; Sawada K., 1993, J MARINE ACOUSTICAL, V20, P73, DOI [DOI 10.3135/JMASJ.20.73, 10.3135/jmasj.20.73]; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Shin YJ, 2004, CAN J FISH AQUAT SCI, V61, P414, DOI 10.1139/F03-154; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; STEWART KW, 2004, FRESHWATER FISHES MA; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Trenkel VM, 2011, MAR ECOL PROG SER, V442, P285, DOI 10.3354/meps09425; Wheeland LJ, 2015, ECOL FRESHW FISH, V24, P67, DOI 10.1111/eff.12126	33	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124799	10.1371/journal.pone.0124799	http://dx.doi.org/10.1371/journal.pone.0124799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875467	gold, Green Published, Green Accepted			2022-12-26	WOS:000353015800153
J	Numasawa, Y; Kohsaka, S; Miyata, H; Kawamura, A; Noma, S; Suzuki, M; Nakagawa, S; Momiyama, Y; Naito, K; Fukuda, K				Numasawa, Yohei; Kohsaka, Shun; Miyata, Hiroaki; Kawamura, Akio; Noma, Shigetaka; Suzuki, Masahiro; Nakagawa, Susumu; Momiyama, Yukihiko; Naito, Kotaro; Fukuda, Keiichi			Impact of Body Mass Index on In-Hospital Complications in Patients Undergoing Percutaneous Coronary Intervention in a Japanese Real-World Multicenter Registry	PLOS ONE			English	Article							LONG-TERM OUTCOMES; OBESITY PARADOX; ARTERY-DISEASE; BLEEDING COMPLICATIONS; VASCULAR COMPLICATIONS; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; HEART-FAILURE; MORTALITY; RISK	Background Obesity is associated with advanced cardiovascular disease. However, some studies have reported the "obesity paradox" after percutaneous coronary intervention (PCI). The relationship between body mass index (BMI) and clinical outcomes after PCI has not been thoroughly investigated, especially in Asian populations. Methods We studied 10,142 patients who underwent PCI at 15 Japanese hospitals participating in the JCD-KICS registry from September 2008 to April 2013. Patients were divided into four groups according to BMI: underweight, BMI <18.5 (n=462); normal, BMI >= 18.5 and <25.0 (n= 5,945); overweight, BMI >= 25.0 and <30.0 (n=3,100); and obese, BMI >= 30.0 (n= 635). Results Patients with a high BMI were significantly younger (p<0.001) and had a higher incidence of coronary risk factors such as hypertension (p<0.001), hyperlipidemia (p<0.001), diabetes mellitus (p<0.001), and current smoking (p<0.001), than those with a low BMI. Importantly, patients in the underweight group had the worst in-hospital outcomes, including overall complications (underweight, normal, overweight, and obese groups: 20.4%, 11.5%, 8.4%, and 10.2%, p<0.001), in-hospital mortality (5.8%, 2.1%, 1.2%, and 2.7%, p<0.001), cardiogenic shock (3.5%, 2.0%, 1.5%, and 1.6%, p=0.018), bleeding complications (10.0%, 4.5%, 2.6%, and 2.8%, p<0.001), and receiving blood transfusion (7.6%, 2.7%, 1.6%, and 1.7%, p<0.001). BMI was inversely associated with bleeding complications after adjustment by multivariate logistic regression analysis (odds ratio, 0.95; 95% confidence interval, 0.92-0.98; p=0.002). In subgroup multivariate analysis of patients without cardiogenic shock, BMI was inversely associated with overall complications (OR, 0.98; 95% CI, 0.95-0.99; p=0.033) and bleeding complications (OR, 0.95; 95% CI, 0.91-0.98; p=0.006). Furthermore, there was a trend that BMI was moderately associated with in-hospital mortality (OR, 0.94; 95% CI, 0.88-1.01; p=0.091). Conclusions Lean patients, rather than obese patients are at greater risk for in-hospital complications during and after PCI, particularly for bleeding complications.	[Numasawa, Yohei] Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga, Tochigi, Japan; [Kohsaka, Shun; Kawamura, Akio; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Miyata, Hiroaki] Univ Tokyo, Healthcare Qual Assessment, Tokyo, Japan; [Noma, Shigetaka] Saiseikai Utsunomiya Hosp, Dept Cardiol, Utsunomiya, Tochigi, Japan; [Suzuki, Masahiro] Saitama Natl Hosp, Natl Hosp Org, Dept Cardiol, Saitama, Japan; [Nakagawa, Susumu] Saiseikai Cent Hosp, Dept Cardiol, Tokyo, Japan; [Momiyama, Yukihiko] Tokyo Med Ctr, Natl Hosp Org, Dept Cardiol, Tokyo, Japan; [Naito, Kotaro] Keiyu Hosp, Dept Cardiol, Kanagawa, Japan	Keio University; University of Tokyo; Tokyo Saiseikai Central Hospital	Numasawa, Y (corresponding author), Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga, Tochigi, Japan.	numasawa@cpnet.med.keio.ac.jp	MOMIYAMA, YUKIHIKO/GHR-6526-2022; Fukuda, Keiichi/L-3777-2013; Numasawa, Yohei/AAC-9604-2020	MOMIYAMA, YUKIHIKO/0000-0002-7710-1446; Numasawa, Yohei/0000-0002-1739-2800; Kohsaka, Shun/0000-0003-3779-2972	Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI) [21790751]	Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI No. 21790751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 2009, CIRC-CARDIOVASC INTE, V2, P423, DOI 10.1161/CIRCINTERVENTIONS.109.860494; Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Angeras O, 2013, EUR HEART J, V34, P345, DOI 10.1093/eurheartj/ehs217; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Benderly M, 2010, AM J CARDIOL, V106, P297, DOI 10.1016/j.amjcard.2010.03.078; Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016; Byrne J, 2009, AM J CARDIOL, V103, P507, DOI 10.1016/j.amjcard.2008.10.027; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Cox N, 2004, AM J CARDIOL, V94, P1174, DOI 10.1016/j.amjcard.2004.07.088; Das SR, 2011, J AM COLL CARDIOL, V58, P2642, DOI 10.1016/j.jacc.2011.09.030; Daugherty SL, 2013, J AM COLL CARDIOL, V61, P2070, DOI 10.1016/j.jacc.2013.02.030; Delhaye C, 2010, AM HEART J, V159, P1139, DOI 10.1016/j.ahj.2010.03.011; Diercks DB, 2006, AM HEART J, V152, P140, DOI 10.1016/j.ahj.2005.09.024; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Gurm HS, 2002, J AM COLL CARDIOL, V39, P834, DOI 10.1016/S0735-1097(02)01687-X; Gurm HS, 2002, AM J CARDIOL, V90, P42, DOI 10.1016/S0002-9149(02)02384-6; Herrmann J, 2014, AM J CARDIOL, V114, P9, DOI 10.1016/j.amjcard.2014.03.057; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kaneko H, 2013, J CARDIOL, V62, P18, DOI 10.1016/j.jjcc.2013.02.009; Kang SJ, 2015, CIRC-CARDIOVASC INTE, V8, DOI [10.1161/CIRCINTERVENTIONS.114.002079, DOI 10.1161/CIRCINTERVENTI0NS.114.002079]; Kohsaka S, 2010, AM J CARDIOL, V105, P1698, DOI 10.1016/j.amjcard.2010.01.349; Kosuge M, 2008, CIRC J, V72, P521; Kuno T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072672; Lancefield T, 2010, JACC-CARDIOVASC INTE, V3, P660, DOI 10.1016/j.jcin.2010.03.018; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Mak KH, 2009, EUR HEART J, V30, P857, DOI 10.1093/eurheartj/ehp037; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Mobeirek AF, 2014, ANN SAUDI MED, V34, P38, DOI 10.5144/0256-4947.2014.38; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Ndrepepa G, 2015, AM J CARDIOL, V115, P434, DOI 10.1016/j.amjcard.2014.11.022; Niraj A, 2007, CLIN CARDIOL, V30, P391, DOI 10.1002/clc.20113; Numasawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116496; Numasawa Y, 2013, CARDIOVASC INTERV TH, V28, P242, DOI 10.1007/s12928-013-0162-3; Numasawa Y, 2013, CARDIOVASC INTERV TH, V28, P148, DOI 10.1007/s12928-012-0138-8; Ohno Y, 2013, J AM COLL CARDIOL, V62, P1260, DOI 10.1016/j.jacc.2013.03.086; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Oreopoulos A, 2008, OBESITY, V16, P442, DOI 10.1038/oby.2007.36; Payvar S, 2013, J AM COLL CARDIOL, V62, P692, DOI 10.1016/j.jacc.2013.05.058; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Sarno G, 2011, AM J CARDIOL, V108, P195, DOI 10.1016/j.amjcard.2011.03.023; Sarno G, 2010, AM J CARDIOL, V105, P475, DOI 10.1016/j.amjcard.2009.09.055; Sasayama S, 2008, CIRCULATION, V118, P2669, DOI 10.1161/CIRCULATIONAHA.108.837054; Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019; Wang TY, 2007, AM J CARDIOL, V100, P391, DOI 10.1016/j.amjcard.2007.03.035; Wang ZJ, 2009, HEART, V95, P1587, DOI 10.1136/hrt.2009.172395; Witassek F, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13986	47	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124399	10.1371/journal.pone.0124399	http://dx.doi.org/10.1371/journal.pone.0124399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874887	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700068
J	Qanadli, SD; Jouannic, AM; Dehmeshki, J; Lu, TL				Qanadli, Salah D.; Jouannic, Anne-Marie; Dehmeshki, Jamshid; Lu, Tri-Linh			CT Attenuation Values of Blood and Myocardium: Rationale for Accurate Coronary Artery Calcifications Detection with Multi-Detector CT	PLOS ONE			English	Article							ELECTRON-BEAM CT; IMPROVED REPRODUCIBILITY; CALCIUM; QUANTIFICATION; SCANNER; DISEASE	Objectives To determine inter-session and intra/inter-individual variations of the attenuations of aortic blood/myocardium with MDCT in the context of calcium scoring. To evaluate whether these variations are dependent on patients' characteristics. Methods Fifty-four volunteers were evaluated with calcium scoring non-enhanced CT. We measured attenuations (inter-individual variation) and standard deviations (SD, intra-individual variation) of the blood in the ascending aorta and of the myocardium of left ventricle. Every volunteer was examined twice to study the inter-session variation. The fat pad thickness at the sternum and noise (SD of air) were measured too. These values were correlated with the measured aortic/ventricular attenuations and their SDs (Pearson). Historically fixed thresholds (90 and 130 HU) were tested against different models based on attenuations of blood/ventricle. Results The mean attenuation was 46HU (range, 17-84HU) with mean SD 23HU for the blood, and 39HU (10-82HU) with mean SD 18 HU for the myocardium. The attenuation/SD of the blood were significantly higher than those of the myocardium (p<0.01). The inter-session variation was not significant. There was a poor correlation between SD of aortic blood/ventricle with fat thickness/noise. Based on existing models, 90 HU threshold offers a confidence interval of approximately 95% and 130 HU more than 99%. Conclusions Historical thresholds offer high confidence intervals for exclusion of aortic blood/myocardium and by the way for detecting calcifications. Nevertheless, considering the large variations of blood/myocardium CT values and the influence of patient's characteristics, a better approach might be an adaptive threshold.	[Qanadli, Salah D.; Jouannic, Anne-Marie; Lu, Tri-Linh] Univ Lausanne Hosp, Dept Radiol, CH-1011 Lausanne, Switzerland; [Qanadli, Salah D.; Dehmeshki, Jamshid] Univ Kingston, Fac Comp Informat Syst & Math, Digital Imaging Res Ctr, Quantitat Med Imaging Int Inst, London, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kingston University	Qanadli, SD (corresponding author), Univ Lausanne Hosp, Dept Radiol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	salah.qanadli@chuv.ch	Dr. Tri-Linh Christian Lu, FMH EBIR/AAB-5432-2021	QANADLI, Salah Dine/0000-0003-1330-660X				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; BIELAK LF, 1994, RADIOLOGY, V192, P631, DOI 10.1148/radiology.192.3.8058926; Broderick LS, 2006, AM J ROENTGENOL, V167, P439; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Budoff MJ, 2008, VASC HEALTH RISK MAN, V4, P315, DOI 10.2147/VHRM.S1160; Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Groen JM, 2009, MED PHYS, V36, P438, DOI 10.1118/1.3049590; Hong C, 2003, RADIOLOGY, V227, P795, DOI 10.1148/radiol.2273020369; Hong C, 2002, RADIOLOGY, V223, P474, DOI 10.1148/radiol.2232010919; Moselewski F, 2006, EUR J RADIOL, V57, P390, DOI 10.1016/j.ejrad.2005.12.026; Muhlenbruch G, 2007, EUR RADIOL, V17, P321, DOI 10.1007/s00330-006-0332-0; Nelson JC, 2005, RADIOLOGY, V235, P403, DOI 10.1148/radiol.2352040515; Oudkerk M, 2008, INT J CARDIOVAS IMAG, V24, P907, DOI [10.1007/s10554-008-9350-0, DOI 10.1007/S10554-008-9350-0]; Qanadli SD, 2001, J COMPUT ASSIST TOMO, V25, P278, DOI 10.1097/00004728-200103000-00023; Raggi P, 2002, AM J ROENTGENOL, V178, P497, DOI 10.2214/ajr.178.2.1780497; Schmermund A, 2002, AM J CARDIOL, V90, p12L, DOI 10.1016/S0002-9149(02)02955-7	17	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124175	10.1371/journal.pone.0124175	http://dx.doi.org/10.1371/journal.pone.0124175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875629	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700058
J	Sun, XJ; Li, XQ; Wang, XL; Tan, WF; Wang, JK				Sun, Xi Jia; Li, Xiao Qian; Wang, Xiao Long; Tan, Wen Fei; Wang, Jun Ke			Sevoflurane Inhibits Nuclear Factor-kappa B Activation in Lipopolysaccharide-Induced Acute Inflammatory Lung Injury via Toll-Like Receptor 4 Signaling	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; ALVEOLAR MACROPHAGES; OXIDATIVE STRESS; TLR4 PATHWAY; ISOFLURANE; MICE; EXPRESSION; BINDING; LPS	Background Infection is a common cause of acute lung injury (ALI). This study was aimed to explore whether Toll-like receptors 4 (TLR4) of airway smooth muscle cells (ASMCs) play a role in lipopolysaccharide (LPS)-induced airway hyperresponsiveness and potential mechanisms. Methods In vivo: A sensitizing dose of LPS (50 mu g) was administered i.p. to female mice before anesthesia with either 3% sevoflurane or phenobarbital i.p. After stabilization, the mice were challenged with 5 mu g of intratracheal LPS to mimic inflammatory attack. The effects of sevoflurane were assessed by measurement of airway responsiveness to methacholine, histological examination, and IL-1, IL-6, TNF-alpha levels in bronchoalveolar lavage fluid (BALF). Protein and gene expression of TLR4 and NF-kappa B were also assessed. In vitro: After pre- sensitization of ASMCs and ASM segments for 24h, levels of TLR4 and NF-kappa B proteins in cultured ASMCs were measured after continuous LPS exposure for 1, 3, 5, 12 and 24h in presence or absence of sevoflurane. Constrictor and relaxant responsiveness of ASM was measured 24 h afterwards. Results The mRNA and protein levels of NF-kappa B and TLR4 in ASM were increased and maintained at high level after LPS challenge throughout 24h observation period, both in vivo and in vitro. Sevoflurane reduced LPS-induced airway hyperresponsiveness, lung inflammatory cell infiltration and proinflammatory cytokines release in BALF as well as maximal isometric contractile force of ASM segments to acetylcholine, but it increased maximal relaxation response to isoproterenol. Treatment with specific NF-kappa B inhibitor produced similar protections as sevoflurane, including decreased expressions of TLR4 and NF-kappa B in cultured ASMCs and improved pharmacodynamic responsiveness of ASM to ACh and isoproterenol. Conclusions This study demonstrates the crucial role of TLR4 activation in ASMCs during ALI in response to LPS. Sevoflurane exerts direct relaxant and anti-inflammatory effects in vivo and in vitro via inhibition of TLR4/NF-kappa B pathway.	[Sun, Xi Jia; Li, Xiao Qian; Wang, Xiao Long; Tan, Wen Fei; Wang, Jun Ke] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Wang, JK (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang 110001, Liaoning, Peoples R China.	junke45@yahoo.com			National Natural Science Foundation of China [30371376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this project was provided by National Natural Science Foundation of China, No. 30371376. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XD, 2000, ANESTH ANALG, V91, P996, DOI 10.1097/00000539-200010000-00042; Chiba Y, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-4; Chung IS, 2013, ANESTH ANALG, V116, P327, DOI 10.1213/ANE.0b013e31827aec06; Dong L, 2009, J ASTHMA, V46, P229, DOI 10.1080/02770900802610050; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Duran A, 2014, INVEST CLIN, V55, P61; Go H, 2014, RESP MED, V108, P783, DOI 10.1016/j.rmed.2013.12.007; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Howarth Peter H, 2004, J Allergy Clin Immunol, V114, pS32, DOI 10.1016/j.jaci.2004.04.041; Jiao H, 2013, J IMMUNOL, V191, P6191, DOI 10.4049/jimmunol.1300873; Joh EH, 2012, BIOCHEM PHARMACOL, V84, P331, DOI 10.1016/j.bcp.2012.04.020; Kalimeris K, 2014, MINERVA ANESTESIOL, V80, P635; Kojima A, 2013, ANESTHESIOLOGY, V119, P606, DOI 10.1097/ALN.0b013e318292ee52; Kuzemtseva L, 2014, VET IMMUNOL IMMUNOP, V158, P189, DOI 10.1016/j.vetimm.2014.01.009; Kvarnhammar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068701; Lajoie-Kadoch S, 2006, AM J PHYSIOL-LUNG C, V290, pL1238, DOI 10.1152/ajplung.00301.2005; Lavieri R, 2014, J IMMUNOL, V192, P5373, DOI 10.4049/jimmunol.1303480; Li QF, 2009, ANESTH ANALG, V109, P1591, DOI 10.1213/ANE.0b013e3181baf506; Li XQ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-28; Li XQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-62; Mansson A, 2009, J LEUKOCYTE BIOL, V85, P719, DOI 10.1189/jlb.0808494; Myers CF, 2011, CAN J ANESTH, V58, P1007, DOI 10.1007/s12630-011-9578-3; Ni JQ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/476856; Pang YL, 2012, J ANESTH, V26, P822, DOI 10.1007/s00540-012-1456-9; Qiao SG, 2013, J ANESTH, V27, P251, DOI 10.1007/s00540-012-1494-3; Reutershan J, 2006, ANESTHESIOLOGY, V104, P511, DOI 10.1097/00000542-200603000-00019; Rodgers A, 2000, BMJ-BRIT MED J, V16, P321; Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004; Shan XY, 2006, AM J PHYSIOL-LUNG C, V291, pL324, DOI 10.1152/ajplung.00056.2006; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Wang Hailian, 2011, Front Biosci (Elite Ed), V3, P604; Wei D, 2014, INFLAMMATION, V37, P1307, DOI 10.1007/s10753-014-9858-5; Xia ZY, 2009, ANESTHESIOLOGY, V111, P924, DOI 10.1097/ALN.0b013e3181b64c38; Xu XB, 2008, ANESTHESIOLOGY, V108, P643, DOI 10.1097/ALN.0b013e318167aeb4; Yang QZ, 2011, ANESTH ANALG, V112, P931, DOI 10.1213/ANE.0b013e31820bcfa4; Zhao SP, 2014, MOL MED REP, V9, P2435, DOI 10.3892/mmr.2014.2094	38	26	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122752	10.1371/journal.pone.0122752	http://dx.doi.org/10.1371/journal.pone.0122752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875290	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700024
J	Gallo, A; Tosti, E				Gallo, Alessandra; Tosti, Elisabetta			Reprotoxicity of the Antifoulant Chlorothalonil in Ascidians: An Ecological Risk Assessment	PLOS ONE			English	Article								Chlorothalonil is a widely used biocide in antifouling paint formulation that replaces tin-based compounds after their definitive ban. Although chlorothalonil inputs into the marine environment have significantly increased in recent years, little is known about its effect on marine animals and in particular on their reproductive processes. In this line, the aim of the present study was to investigate the effects of chlorothalonil exposure on the gamete physiology, fertilization rate and transmissible damage to offspring in the marine invertebrate Ciona intestinalis (ascidians). To identify a possible mechanism of action of chlorothalonil, electrophysiological techniques were used to study the impact on oocyte membrane excitability and on the electrical events occurring at fertilization. The pre-exposure of spermatozoa and oocytes to chlorothalonil did not affect the fertilization rate but caused damage to the offspring by inducing larval malformation. The highest toxicity was observed when fertilization was performed in chlorothalonil solutions with the lowest EC50 value. In particular, it was observed that low chlorothalonil concentrations interfered with embryo development and led to abnormal larvae, whereas high concentrations arrested embryo formation. In mature oocytes, a decrease in the amplitudes of the sodium and fertilization currents was observed, suggesting an involvement of plasma membrane ion currents in the teratogenic mechanism of chlorothalonil action. The risk estimation confirmed that the predicted no-effect concentration (PNEC) exceeded the predicted effect concentration (PEC), thus indicating that chlorothalonil may pose a risk to aquatic species.	[Gallo, Alessandra; Tosti, Elisabetta] Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Tosti, E (corresponding author), Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy.	tosti@szn.it	Gallo, Alessandra/AAA-3132-2022	Gallo, Alessandra/0000-0002-2558-4722	Stazione Zoologica Anton Dohrn institutional funds; Stazione Zoologica Anton Dohrn PhD fellowship	Stazione Zoologica Anton Dohrn institutional funds; Stazione Zoologica Anton Dohrn PhD fellowship	This work has been supported by Stazione Zoologica Anton Dohrn institutional funds. A.G. has been supported by a Stazione Zoologica Anton Dohrn PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcha F, 2012, AQUAT TOXICOL, V106, P104, DOI 10.1016/j.aquatox.2011.10.018; Alzieu C, 2000, ECOTOXICOLOGY, V9, P71, DOI 10.1023/A:1008968229409; Bao VWW, 2011, MAR POLLUT BULL, V62, P1147, DOI 10.1016/j.marpolbul.2011.02.041; Bellas J, 2005, BIOFOULING, V21, P289, DOI 10.1080/08927010500456589; Bellas J, 2001, WATER RES, V35, P2905, DOI 10.1016/S0043-1354(01)00004-5; Bellas J, 2007, AQUAT TOXICOL, V83, P52, DOI 10.1016/j.aquatox.2007.03.011; Bellas J, 2006, SCI TOTAL ENVIRON, V367, P573, DOI 10.1016/j.scitotenv.2006.01.028; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Caux PY, 1996, CRIT REV ENV SCI TEC, V26, P45, DOI 10.1080/10643389609388486; Cuomo A, 2006, MOL REPROD DEV, V73, P501, DOI 10.1002/mrd.20404; DALE B, 1984, DEV BIOL, V101, P235, DOI 10.1016/0012-1606(84)90135-0; Dale Brian, 1994, Zygote, V2, P373; De Simone ML, 1998, ZYGOTE, V6, P11, DOI 10.1017/S0967199400005037; DeLorenzo ME, 2012, MAR POLLUT BULL, V64, P1291, DOI 10.1016/j.marpolbul.2012.05.011; Emmens C. W., 1948, PRINCIPLES BIOL ASSA; ERNST W, 1991, ARCH ENVIRON CON TOX, V21, P1, DOI 10.1007/BF01055550; European Commission, 2003, EUR20418EN2 JOINT RE; Evans SM, 2000, MAR POLLUT BULL, V40, P204, DOI 10.1016/S0025-326X(99)00248-9; Franchet C, 1999, AQUAT TOXICOL, V44, P213; Gallo A, 2013, MAR DRUGS, V11, P3554, DOI 10.3390/md11093554; Gallo A, 2011, MAR ECOL-EVOL PERSP, V32, P222, DOI 10.1111/j.1439-0485.2011.00433.x; GIANAROLI L, 1994, MOL REPROD DEV, V38, P209, DOI 10.1002/mrd.1080380212; Glahn D, 2003, DEV GROWTH DIFFER, V45, P187; Harino H, 2004, COAST MAR SCI, V29, P28; Key PB, 2003, J ENVIRON SCI HEAL B, V38, P539, DOI 10.1081/PFC-120023512; Konstantinou IK, 2004, ENVIRON INT, V30, P235, DOI 10.1016/S0160-4120(03)00176-4; Koutsaftis A, 2007, SCI TOTAL ENVIRON, V387, P166, DOI 10.1016/j.scitotenv.2007.07.023; Lee S, 2011, J HAZARD MATER, V185, P1318, DOI 10.1016/j.jhazmat.2010.10.048; Llodra ER, 2002, ADV MAR BIOL, V43, P87; Mai H, 2013, MAR ENVIRON RES, V89, P1, DOI [10.1016/j.marenvres.2013.04.003, 10.1016/j.envres.2013.02.006]; Manzo S, 2006, ARCH ENVIRON CON TOX, V51, P61, DOI 10.1007/s00244-004-0167-0; Onduka T, 2012, FISHERIES SCI, V78, P1301, DOI 10.1007/s12562-012-0562-9; Readman JW, 2006, HANDB ENVIRON CHEM, V50, P1; Sakkas VA, 2002, CHEMOSPHERE, V48, P939, DOI 10.1016/S0045-6535(02)00121-2; Silvestre F, 2009, MOL REPROD DEV, V76, P1084, DOI 10.1002/mrd.21073; Tosti E, 2003, MOL REPROD DEV, V66, P72, DOI 10.1002/mrd.10332; Tosti E, 2002, REPRODUCTION, V124, P835, DOI 10.1530/reprod/124.6.835; Tosti E, 2011, MOL REPROD DEV, V78, P854, DOI 10.1002/mrd.21316; Voulvoulis N, 2000, MAR POLLUT BULL, V40, P938, DOI 10.1016/S0025-326X(00)00034-5; Voulvoulis N, 1999, APPL ORGANOMET CHEM, V13, P135, DOI 10.1002/(SICI)1099-0739(199903)13:3<135::AID-AOC831>3.0.CO;2-G; Voulvoulis N., ANTIFOULING PAINT BI; Wang H, 2011, ENVIRON TOXICOL CHEM, V30, P692, DOI 10.1002/etc.440; Yamada Hisashi, 2007, Bulletin of Fisheries Research Agency, P31; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001; Zega G, 2009, ISJ-INVERT SURVIV J, V6, pS29	45	98	100	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123074	10.1371/journal.pone.0123074	http://dx.doi.org/10.1371/journal.pone.0123074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VE8EG	25875759	Green Submitted, Green Published, gold			2022-12-26	WOS:000440564500001
J	Hebar, A; Koller, C; Seifert, JM; Chabicovsky, M; Bodenteich, A; Bernkop-Schnurch, A; Grassauer, A; Prieschl-Grassauer, E				Hebar, Alexandra; Koller, Christiane; Seifert, Jan-Marcus; Chabicovsky, Monika; Bodenteich, Angelika; Bernkop-Schnuerch, Andreas; Grassauer, Andreas; Prieschl-Grassauer, Eva			Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan	PLOS ONE			English	Article							SULFATED POLYSACCHARIDES; ANTIVIRAL ACTIVITY; DENGUE VIRUS; NASAL SPRAY; TNF-ALPHA; COMMON; INDUCTION; EFFICACY; POTENT	Carrageenan has been widely used as food additive for decades and therefore, an extended oral data set is available in the public domain. Less data are available for other routes of administration, especially intranasal administration. The current publication describes the nonclinical safety and toxicity of native (non-degraded) iota-carrageenan when applied intranasally or via inhalation. Intranasally applied iota-carrageenan is a topically applied, locally acting compound with no need of systemic bioavailability for the drug's action. Animal experiments included repeated dose local tolerance and toxicity studies with intranasally applied 0.12% iota-carrageenan for 7 or 28 days in New Zealand White rabbits and nebulized 0.12% iota-carrageenan administered to F344 rats for 7 days. Permeation studies revealed no penetration of iota-carrageenan across nasal mucosa, demonstrating that iota-carrageenan does not reach the blood stream. Consistent with this, no relevant toxic or secondary pharmacological effects due to systemic exposure were observed in the rabbit or rat repeated dose toxicity studies. Data do not provide any evidence for local intolerance or toxicity, when carrageenan is applied intranasally or by inhalation. No signs for immunogenicity or immunotoxicity have been observed in the in vivo studies. This is substantiated by in vitro assays showing no stimulation of a panel of pro-inflammatory cytokines by iota-carrageenan. In conclusion, 0.12% iota-carrageenan is safe for clinical use via intranasal application.	[Hebar, Alexandra; Chabicovsky, Monika] MC Toxicol Consulting GmbH, Vienna, Austria; [Koller, Christiane; Seifert, Jan-Marcus; Bodenteich, Angelika; Grassauer, Andreas; Prieschl-Grassauer, Eva] Marinomed Biotechnol GmbH, Vienna, Austria; [Bernkop-Schnuerch, Andreas] ThioMatriX, Innsbruck, Austria		Chabicovsky, M (corresponding author), MC Toxicol Consulting GmbH, Vienna, Austria.	MC@toxicology.cc	Bernkop-Schnürch, Andreas/HCH-3150-2022	Bernkop-Schnürch, Andreas/0000-0003-4187-8277	Marinomed Biotechnologie GmbH	Marinomed Biotechnologie GmbH	This work was supported by Marinomed Biotechnologie GmbH. Marinomed Biotechnologie GmbH (AG, EPG, AB, CK, JMS) had a role in study design, data collection and analysis, decision to publish, preparation of the manuscript and is financing the processing charge of the manuscript. MC Toxicology Consulting GmbH (MC, AH), as nonclinical consultant to Marinomed Biotechnologie GmbH, had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. MC Toxicology Consulting's work was financed by Marinomed Biotechnologie GmbH. ThioMatriX (ABS), as contract research organization to Marinomed Biotechnologie GmbH, had a role in study design, data collection and analysis and decision to publish. ThioMatrix's work was financed by Marinomed Biotechnologie GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; Batista JA, 2014, CARBOHYD POLYM, V99, P59, DOI 10.1016/j.carbpol.2013.08.071; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Carlucci MJ, 1999, ANTIVIR RES, V43, P93, DOI 10.1016/S0166-3542(99)00038-8; Cohen SM, 2002, CRIT REV TOXICOL, V32, P413, DOI 10.1080/20024091064282; Csonga R, 1998, J IMMUNOL, V160, P273; Eccles R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-108; Fazekas T, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-147; GONZALEZ ME, 1987, ANTIMICROB AGENTS CH, V31, P1388, DOI 10.1128/AAC.31.9.1388; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; IUCLID, 2000, IUCLID DAT CARR SUBS; JECFA, 2001, WHO TECHN REP SER, V891; JEFCA, 1974, WHO TECHN REP SER, V539; Li L, 2014, CARBOHYD POLYM, V103, P1, DOI 10.1016/j.carbpol.2013.12.008; Ludwig M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-124; Marino DJ, 2012, J TOXICOL ENV HEAL A, V75, P1484, DOI 10.1080/15287394.2012.722520; Mckim JM, 2014, CRIT REV TOXICOL, V44, P211, DOI 10.3109/10408444.2013.861797; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Necas J, 2013, VET MED-CZECH, V58, P187, DOI 10.17221/6758-VETMED; Paulsen FP, 2002, INVEST OPHTH VIS SCI, V43, P3137; Prieschl EE, 1996, J IMMUNOL, V157, P2645; Rowe R.C., 2009, HDB PHARM EXCIPIENTS, VSixth; SCF (Scientific Committee for Food), 2003, SCFCSADDEMU199; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; TARLO SM, 1995, J ALLERGY CLIN IMMUN, V95, P933, DOI 10.1016/S0091-6749(95)70091-9; Tobacman JK, 2001, MED HYPOTHESES, V56, P589, DOI 10.1054/mehy.2000.1208; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Wang W, 2012, MAR DRUGS, V10, P2795, DOI 10.3390/md10122795; WEINER ML, 1991, AGENTS ACTIONS, V32, P46, DOI 10.1007/BF01983307; Weiner ML, 2014, CRIT REV TOXICOL, V44, P244, DOI 10.3109/10408444.2013.861798	32	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122911	10.1371/journal.pone.0122911	http://dx.doi.org/10.1371/journal.pone.0122911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875737	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100117
J	Togo, S; Kagawa, T; Uno, Y				Togo, Shunta; Kagawa, Takahiro; Uno, Yoji			Control Model for Dampening Hand Vibrations Using Information of Internal and External Coordinates	PLOS ONE			English	Article							HUMAN ARM STIFFNESS; IMPEDANCE CONTROL; MOVEMENTS; SKYHOOK; MAINTENANCE; DIRECTION; GRAVITY; POSTURE; TORQUE; FORCE	In the present study, we investigate a control mechanism that dampens hand vibrations. Here, we propose a control method with two components to suppress hand vibrations. The first is a passive suppression method that lowers the joint stiffness to passively dampen the hand vibrations. The second is an active suppression method that adjusts an equilibrium point based on skyhook control to actively dampen the hand vibrations. In a simulation experiment, we applied these two methods to dampen hand vibrations during the shoulder's horizontal oscillation. We also conducted a measurement experiment wherein a subject's shoulder was sinusoidally oscillated by a platform that generated horizontal oscillations. The results of the measurement experiments showed that the jerk of each part of the arm in a task using a cup filled with water was smaller than the shoulder jerk and that in a task with a cup filled with stones was larger than the shoulder jerk. Moreover, the amplitude of the hand trajectory in both horizontal and vertical directions was smaller in a task using a cup filled with water than in a task using a cup filled with stones. The results of the measurement experiments were accurately reproduced by the active suppression method based on skyhook control. These results suggest that humans dampen hand vibrations by controlling the equilibrium point through the information of the external workspace and the internal body state rather than by lowering joint stiffness only by using internal information.	[Togo, Shunta] Adv Telecommun Res Inst Int, Cognit Mech Labs, Kyoto, Japan; [Togo, Shunta] Japan Soc Promot Sci, Tokyo, Japan; [Kagawa, Takahiro; Uno, Yoji] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648601, Japan	Advanced Telecommunications Research Institute International; Japan Society for the Promotion of Science; Nagoya University	Togo, S (corresponding author), Adv Telecommun Res Inst Int, Cognit Mech Labs, Kyoto, Japan.	togo@atr.jp	Kagawa, Takahiro/AAW-6244-2020	Kagawa, Takahiro/0000-0002-4539-1813	Japan Society for the Promotion of Science (JSPS) [267576, 26289129]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for JSPS Fellows 267576, and Grand-in-Aid for Scientific Research (B) 26289129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIZZI E, 1984, J NEUROSCI, V4, P2738; Choi SB, 2001, MECHATRONICS, V11, P345, DOI 10.1016/S0957-4158(00)00022-2; Crevecoeur F, 2009, J NEUROPHYSIOL, V102, P786, DOI 10.1152/jn.00113.2009; DOLAN JM, 1993, IEEE T SYST MAN CYB, V23, P698, DOI 10.1109/21.256543; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1990, EXP BRAIN RES, V82, P315; Foo E, 2000, CONTROL ENG PRACT, V8, P507, DOI 10.1016/S0967-0661(99)00188-4; Gaveau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022045; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hoshijima K, 2007, INT J CONTROL AUTOM, V5, P614; KARNOPP D, 1974, J ENG IND-T ASME, V96, P619, DOI 10.1115/1.3438373; Kavanagh JJ, 2005, HUM MOVEMENT SCI, V24, P574, DOI 10.1016/j.humov.2005.07.003; Koike Y, 2006, JPN PSYCHOL RES, V48, P174, DOI 10.1111/j.1468-5884.2006.00316.x; Li H, 1999, CONTROL ENG PRACT, V7, P843, DOI 10.1016/S0967-0661(99)00048-9; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; MILNER TE, 1993, EXP BRAIN RES, V94, P522; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Osu R, 2004, J NEUROPHYSIOL, V92, P1199, DOI 10.1152/jn.00519.2003; Osu R, 2009, NEUROSCI RES, V65, P6, DOI 10.1016/j.neures.2009.05.012; Papaxanthis C, 2003, NEUROSCIENCE, V117, P779, DOI 10.1016/S0306-4522(02)00964-8; Papaxanthis C, 1998, NEUROSCI LETT, V253, P103, DOI 10.1016/S0304-3940(98)00604-1; Papaxanthis C, 1998, EXP BRAIN RES, V120, P233, DOI 10.1007/s002210050397; Sammier D, 2003, VEHICLE SYST DYN, V39, P279, DOI 10.1076/vesd.39.4.279.14149; Shin D, 2009, J NEUROPHYSIOL, V101, P387, DOI 10.1152/jn.00584.2007; TAKEGAKI M, 1981, J DYN SYST-T ASME, V103, P119, DOI 10.1115/1.3139651; Togo S, 2014, EXP BRAIN RES, V232, P3101, DOI 10.1007/s00221-014-3994-x; Togo S, 2012, EXP BRAIN RES, V216, P81, DOI 10.1007/s00221-011-2909-3; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Winter D.A., 2004, BIOMECHANICS MOTOR C, V3rd, P63; Yoshida K, 2000, INT J COMPUT APPL T, V13, P52, DOI 10.1504/IJCAT.2000.000223	36	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125464	10.1371/journal.pone.0125464	http://dx.doi.org/10.1371/journal.pone.0125464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876037	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100295
J	Fu, LW; Rab, A; Tang, LP; Bebok, Z; Rowe, SM; Bartoszewski, R; Collawn, JF				Fu, Lianwu; Rab, Andras; Tang, Li Ping; Bebok, Zsuzsa; Rowe, Steven M.; Bartoszewski, Rafal; Collawn, James F.			Delta F508 CFTR Surface Stability Is Regulated by DAB2 and CHIP-Mediated Ubiquitination in Post-Endocytic Compartments	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; EARLY ENDOSOMES; KEY REGULATOR; MYOSIN-VI; CLATHRIN; DEGRADATION; DISABLED-2	The Delta F508 mutant form of the cystic fibrosis transmembrane conductance regulator (Delta F508 CFTR) that is normally degraded by the ER-associated degradative pathway can be rescued to the cell surface through low-temperature (27 degrees C) culture or small molecular corrector treatment. However, it is unstable on the cell surface, and rapidly internalized and targeted to the lysosomal compartment for degradation. To understand the mechanism of this rapid turnover, we examined the role of two adaptor complexes (AP-2 and Dab2) and three E3 ubiquitin ligases (c-Cbl, CHIP, and Nedd4-2) on low-temperature rescued Delta F508 CFTR endocytosis and degradation in human airway epithelial cells. Our results demonstrate that siRNA depletion of either AP-2 or Dab2 inhibits Delta F508 CFTR endocytosis by 69% and 83%, respectively. AP-2 or Dab2 depletion also increases the rescued protein half-life of Delta F508 CFTR by similar to 18% and similar to 91%, respectively. In contrast, the depletion of each of the E3 ligases had no effect on Delta F508 CFTR endocytosis, whereas CHIP depletion significantly increased the surface half-life of Delta F508 CFTR. To determine where and when the ubiquitination occurs during Delta F508 CFTR turnover, we monitored the ubiquitination of rescued Delta F508 CFTR during the time course of CFTR endocytosis. Our results indicate that ubiquitination of the surface pool of Delta F508 CFTR begins to increase 15 min after internalization, suggesting that CFTR is ubiquitinated in a postendocytic compartment. This post-endocytic ubiquination of Delta F508 CFTR could be blocked by either inhibiting endocytosis, by siRNA knockdown of CHIP, or by treating cells with the CFTR corrector, VX-809. Our results indicate that the post-endocytic ubiquitination of CFTR by CHIP is a critical step in the peripheral quality control of cell surface Delta F508 CFTR.	[Fu, Lianwu; Rab, Andras; Bebok, Zsuzsa; Collawn, James F.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35233 USA; [Tang, Li Ping; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Fu, Lianwu; Rab, Andras; Tang, Li Ping; Bebok, Zsuzsa; Rowe, Steven M.; Collawn, James F.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Bartoszewski, Rafal] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Fahrenheit Universities; Medical University Gdansk	Fu, LW (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35233 USA.	lianwufu@uab.edu; jcollawn@uab.edu	Rab, András/AAR-7804-2021; Rab, Andras/AAI-9402-2021; Bartoszewski, Rafal A/D-6311-2011	Rab, András/0000-0003-2154-0017; Bartoszewski, Rafal A/0000-0002-2864-6757; Collawn, James/0000-0002-2528-2759; Fu, Karl/0000-0001-5386-9429	CF Foundation [R464-CR07]; NIH [P30 DK072482, R01 DK60065, R01 HK076587]; Ministry of Science and Higher Education of the Republic of Poland, KNOW Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R01DK060065] Funding Source: NIH RePORTER	CF Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Higher Education of the Republic of Poland, KNOW Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by CF Foundation Grant R464-CR07 (www.cff.org) and NIH P30 DK072482 (www.nih.gov) through Dr. Eric Sorscher, R01 DK60065 to JFC and R01 HK076587 to ZB. RB was supported by the Ministry of Science and Higher Education of the Republic of Poland, KNOW Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Arora K, 2014, BIOCHEMISTRY-US, V53, P4169, DOI 10.1021/bi401263h; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bebok Z, 1998, J BIOL CHEM, V273, P29873, DOI 10.1074/jbc.273.45.29873; Bond LM, 2012, J BIOL CHEM; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Cihil KM, 2012, J BIOL CHEM, V287, P15087, DOI 10.1074/jbc.M112.341875; Collaco A, 2010, J BIOL CHEM, V285, P17177, DOI 10.1074/jbc.M110.127613; Collawn JF, 2010, EXPERT REV PROTEOMIC, V7, P495, DOI [10.1586/epr.10.45, 10.1586/EPR.10.45]; Collawn JF, 2009, AM J RESP CELL MOL, V40, P385, DOI 10.1165/rcmb.2008-0006ED; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jurkuvenaite A, 2006, J BIOL CHEM, V281, P3329, DOI 10.1074/jbc.M508131200; Koeppen K, 2012, AM J PHYSIOL-LUNG C, V303, pL720, DOI 10.1152/ajplung.00409.2011; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Loo TW, 2011, BIOCHEMISTRY-US, V50, P4393, DOI 10.1021/bi2004813; Madden Dean R, 2012, Commun Integr Biol, V5, P473, DOI 10.4161/cib.21375; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Polo S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-25; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rowe SM, 2006, CURR OPIN PEDIATR, V18, P604, DOI 10.1097/MOP.0b013e3280109b90; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Tjelle TE, 1996, J CELL SCI, V109, P2905; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Weixel KM, 2001, PFLUG ARCH EUR J PHY, V443, pS70; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Weixel KM, 2000, J BIOL CHEM, V275, P3655, DOI 10.1074/jbc.275.5.3655; White S, 1998, J BIOL CHEM, V273, P14355, DOI 10.1074/jbc.273.23.14355; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065	47	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123131	10.1371/journal.pone.0123131	http://dx.doi.org/10.1371/journal.pone.0123131			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879443	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500040
J	Benenson, JF; Markovits, H; Whitmore, B; Van, C; Margolius, S; Wrangham, RW				Benenson, Joyce F.; Markovits, Henry; Whitmore, Bjorn; Van, Christophe; Margolius, Sara; Wrangham, Richard W.			Do Young Children Understand Relative Value Comparisons?	PLOS ONE			English	Article							BEHAVIOR	Many forms of judgments, such as those used in economic games or measures of social comparison, require understanding relative value, as well as the more complex ability to make comparisons between relative values. To examine whether young children can accurately compare relative values, we presented children 4 to 7 years with simple judgments of relative value in two scenarios. Children then were asked to compare the relative values in the two scenarios. Results show that even the youngest children downgraded evaluations of a reward when another has a larger amount, indicating the ability to make relative value judgments. When asked to compare relative values however, only the oldest children were able to make these comparisons consistently. We then extended this analysis to economic game performance. Specifically, previous results using economic games suggest that younger children are more generous than older ones. We replicate this result, and then show that a simple change in procedure, based on the initial study, is sufficient to change young children's choices. Our results strongly suggest that conclusions regarding young children's pro-social motives based on relative value comparisons should be viewed cautiously.	[Benenson, Joyce F.; Whitmore, Bjorn; Van, Christophe; Wrangham, Richard W.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Benenson, Joyce F.; Margolius, Sara] Univ Cambridge Emmanuel Coll, Dept Psychol, Boston, MA USA; [Markovits, Henry] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada	Harvard University; University of Quebec; University of Quebec Montreal	Markovits, H (corresponding author), Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada.	henrymarkovits@gmail.com			Social Sciences and Humanities Research Council of Canada [435-2012-1713]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the Social Sciences and Humanities Research Council of Canada, 435-2012-1713; http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Bjorklund D.F., 2007, WHY YOUTH IS NOT WAS; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Boseovski JJ, 2010, CHILD DEV PERSPECT, V4, P212, DOI 10.1111/j.1750-8606.2010.00149.x; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Butler R, 1998, CHILD DEV, V69, P1054, DOI 10.1111/j.1467-8624.1998.tb06160.x; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; DAMON W, 1975, CHILD DEV, V46, P301, DOI 10.2307/1128122; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; HOOK JG, 1979, PSYCHOL BULL, V86, P429, DOI 10.1037/0033-2909.86.3.429; House BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103422; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; MASTERS JC, 1985, J EXP SOC PSYCHOL, V21, P407, DOI 10.1016/0022-1031(85)90027-7; MOESSINGER P, 1977, HUM DEV, V20, P178, DOI 10.1159/000271556; RUBLE DN, 1980, DEV PSYCHOL, V16, P105, DOI 10.1037/0012-1649.16.2.105	20	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122215	10.1371/journal.pone.0122215	http://dx.doi.org/10.1371/journal.pone.0122215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875949	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800045
J	Bermejo-Nogales, A; Calduch-Giner, JA; Perez-Sanchez, J				Bermejo-Nogales, Azucena; Alvar Calduch-Giner, Josep; Perez-Sanchez, Jaume			Unraveling the Molecular Signatures of Oxidative Phosphorylation to Cope with the Nutritionally Changing Metabolic Capabilities of Liver and Muscle Tissues in Farmed Fish	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; GENE-EXPRESSION PROFILE; SPARUS-AURATA L.; MITOCHONDRIAL-FUNCTION; NUTRIENT AVAILABILITY; ASSEMBLY FACTORS; PROTEIN COMPLEX; ATP SYNTHASE; NUCLEAR; EVOLUTION	Mitochondrial oxidative phosphorylation provides over 90% of the energy produced by aerobic organisms, therefore the regulation of mitochondrial activity is a major issue for coping with the changing environment and energy needs. In fish, there is a large body of evidence of adaptive changes in enzymatic activities of the OXPHOS pathway, but less is known at the transcriptional level and the first aim of the present study was to define the molecular identity of the actively transcribed subunits of the mitochondrial respiratory chain of a livestock animal, using gilthead sea bream as a model of farmed fish with a high added value for European aquaculture. Extensive BLAST searches in our transcriptomic database (www.nutrigroup-iats.org/seabreamdb) yielded 97 new sequences with a high coverage of catalytic, regulatory and assembly factors of Complex I to V. This was the basis for the development of a PCR array for the simultaneous profiling of 88 selected genes. This new genomic resource allowed the differential gene expression of liver and muscle tissues in a model of 10 fasting days. A consistent down-regulated response involving 72 genes was made by the liver, whereas an up-regulated response with 29 and 10 differentially expressed genes was found in white skeletal muscle and heart, respectively. This differential regulation was mostly mediated by nuclear-encoded genes (skeletal muscle) or both mitochondrial-and nuclear-encoded genes (liver, heart), which is indicative of a complex and differential regulation of mitochondrial and nuclear genomes, according to the changes in the lipogenic activity of liver and the oxidative capacity of glycolytic and highly oxidative muscle tissues. These insights contribute to the identification of the most responsive elements of OXPHOS in each tissue, which is of relevance for the appropriate gene targeting of nutritional and/or environmental metabolic disturbances in livestock animals.	[Bermejo-Nogales, Azucena; Alvar Calduch-Giner, Josep; Perez-Sanchez, Jaume] Inst Aquaculture Torre de la Sal CSIC IATS, Nutrigen & Fish Growth Endocrinol Grp, Ribera De Cabanes, Castellon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Perez-Sanchez, J (corresponding author), Inst Aquaculture Torre de la Sal CSIC IATS, Nutrigen & Fish Growth Endocrinol Grp, Ribera De Cabanes, Castellon, Spain.	jaime.perez.sanchez@csic.es	Sánchez, Jaume Pérez/AAJ-6628-2021; sanchez, jaume perez/K-3231-2014; Calduch-Giner, Josep/K-8253-2014; Calduch-Giner, Josep/AAY-1475-2021; Bermejo-Nogales, Azucena/K-7855-2014	Sánchez, Jaume Pérez/0000-0003-2506-1523; sanchez, jaume perez/0000-0003-2506-1523; Calduch-Giner, Josep/0000-0003-3124-5986; Calduch-Giner, Josep/0000-0003-3124-5986; Bermejo-Nogales, Azucena/0000-0002-7163-7338	EU AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research, FP7) [262336]; Generalitat Valenciana [PROMETEOII/2014/085]; Spanish Government through AQUAGENOMICS (Ingenio Programme)	EU AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research, FP7); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Government through AQUAGENOMICS (Ingenio Programme)	This work was funded by the EU AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research, FP7/2007/2013; grant agreement No. 262336; www.aquaexcel.eu) project. Additional funding was received by Generalitat Valenciana (PROMETEOII/2014/085; www.iats.csic.es/nisaam) and from the Spanish Government through AQUAGENOMICS (Ingenio-2010 Programme; www.aquagenomics.es) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Anttila K, 2010, J COMP PHYSIOL B, V180, P707, DOI 10.1007/s00360-010-0446-1; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baltzer C, 2010, MITOCHONDRION, V10, P589, DOI 10.1016/j.mito.2010.07.009; Barbour JA, 2014, INT J CELL BIOL; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Benedito-Palos L, 2014, GENE, V547, P34, DOI 10.1016/j.gene.2014.05.073; Bermejo-Nogales A, 2008, COMP BIOCHEM PHYS B, V149, P428, DOI 10.1016/j.cbpb.2007.11.003; Bermejo-Nogales A, 2014, GEN COMP ENDOCR, V205, P305, DOI 10.1016/j.ygcen.2014.04.016; Bermejo-Nogales A, 2014, FISH PHYSIOL BIOCHEM, V40, P751, DOI 10.1007/s10695-013-9882-7; Bermejo-Nogales A, 2011, COMP BIOCHEM PHYS A, V159, P296, DOI 10.1016/j.cbpa.2011.03.024; Bremer K, 2011, J EXP BIOL, V214, P1888, DOI 10.1242/jeb.053330; Calduch-Giner JA, 2014, MAR BIOTECHNOL, V16, P423, DOI 10.1007/s10126-014-9562-3; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; COLLINSON IR, 1994, J MOL BIOL, V242, P408; Coulibaly I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-203; da Costa N, 2004, J NUTR, V134, P2191, DOI 10.1093/jn/134.9.2191; Davies R, 2012, PHYSIOL BIOCHEM ZOOL, V85, P321, DOI 10.1086/666058; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611; Everett MV, 2012, J EXP ZOOL PART A, V317A, P9, DOI 10.1002/jez.717; Eya JC, 2012, COMP BIOCHEM PHYS B, V163, P211, DOI 10.1016/j.cbpb.2012.05.019; Eya JC, 2011, AQUACULTURE, V321, P71, DOI 10.1016/j.aquaculture.2011.08.037; Frick NT, 2010, AM J PHYSIOL-REG I, V298, pR608, DOI 10.1152/ajpregu.90815.2008; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Lam SH, 2013, BBA-GEN SUBJECTS, V1830, P4778, DOI 10.1016/j.bbagen.2013.06.008; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; LINDER D, 1995, COMP BIOCHEM PHYS B, V112, P461, DOI 10.1016/0305-0491(95)00093-3; Little AG, 2010, PHYSIOL GENOMICS, V42, P76, DOI 10.1152/physiolgenomics.00015.2010; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009; Lucassen M, 2003, AM J PHYSIOL-REG I, V285, pR1410, DOI 10.1152/ajpregu.00111.2003; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Miller KM, 2009, COMP BIOCHEM PHYS D, V4, P75, DOI 10.1016/j.cbd.2008.11.002; Mommsen TP, 2004, COMP BIOCHEM PHYS B, V139, P383, DOI 10.1016/j.cbpc.2004.09.018; O'Dowd C, 2009, RADIAT RES, V171, P464, DOI 10.1667/RR1484.1; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Orczewska JI, 2010, AM J PHYSIOL-REG I, V299, pR352, DOI 10.1152/ajpregu.00189.2010; Parsons WJ, 1996, AM J PHYSIOL-HEART C, V270, pH567, DOI 10.1152/ajpheart.1996.270.2.H567; Perez-Sanchez J, 2013, COMP BIOCHEM PHYS D, V8, P123, DOI 10.1016/j.cbd.2013.02.001; Pierron D, 2012, BBA-BIOENERGETICS, V1817, P590, DOI 10.1016/j.bbabio.2011.07.007; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Pujolar JM, 2013, AQUAT TOXICOL, V132, P157, DOI 10.1016/j.aquatox.2013.02.012; Pujolar JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-507; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Soares SS, 2007, AQUAT TOXICOL, V83, P1, DOI 10.1016/j.aquatox.2007.03.005; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; Zhang FF, 2013, GENOME BIOL EVOL, V5, P1781, DOI 10.1093/gbe/evt129	63	42	42	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122889	10.1371/journal.pone.0122889	http://dx.doi.org/10.1371/journal.pone.0122889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875231	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800080
J	Chow, S; Okazaki, M; Watanabe, T; Segawa, K; Yamamoto, T; Kurogi, H; Tanaka, H; Ai, K; Kawai, M; Yamamoto, S; Mochioka, N; Manabe, R; Miyake, Y				Chow, Seinen; Okazaki, Makoto; Watanabe, Tomowo; Segawa, Kyohei; Yamamoto, Toshihiro; Kurogi, Hiroaki; Tanaka, Hideki; Ai, Ken-ichiro; Kawai, Miho; Yamamoto, Shin-ichi; Mochioka, Noritaka; Manabe, Ryotaro; Miyake, Yoichi			Light-Sensitive Vertical Migration of the Japanese Eel Anguilla japonica Revealed by Real-Time Tracking and Its Utilization for Geolocation	PLOS ONE			English	Article							FRESH-WATER EELS; EUROPEAN EEL; BLUEFIN TUNA; SWIM BLADDER; DEPTH; DIEFFENBACHII; BEHAVIOR; MATURATION; DISCOVERY; CAPTIVITY	Short-time tracking (one to eight days) of the Japanese eel (Anguilla japonica) using ultrasonic transmitter was performed in the tropical-subtropical area adjacent to the spawning area and temperate area off the Japanese Archipelago. Of 16 eels (11 wild and five farmed) used, 10 wild eels displayed clear diel vertical migration (DVM) from the beginning, while the other five farmed eels tracked for 19 to 66 hours did not. During daytime, a significantly positive correlation between migration depth and light intensity recorded on the vessel was observed in the 10 wild eels, indicating that the eels were sensitive to sunlight even at the middle to lower mesopelagic zone (500 to 800 m). During nighttime, the eel migration depth was observed to be associated with the phase, rising and setting of the moon, indicating that the eels were sensitive to moonlight at the upper mesopelagic zone (<300 m). Two of 10 wild eels were in the yellow stage but shared similar DVM with the silver stage eels. Swimbladders of three silver stage eels were punctured before releasing, but very little effect on DVM was observed. The eels very punctually initiated descent upon nautical dawn and ascent upon sunset, enabling us to determine local times for sunrise and sunset, and hence this behavior may be used for geolocating eels. In fact, estimated positions of eels based on the depth trajectory data were comparable or even better than those obtained by light-based archival tag in other fish species.	[Chow, Seinen; Okazaki, Makoto; Watanabe, Tomowo; Segawa, Kyohei] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Yamamoto, Toshihiro; Kurogi, Hiroaki] Natl Res Inst Aquaculture, Yokosuka Lab, Yokosuka, Kanagawa, Japan; [Tanaka, Hideki] Natl Res Inst Aquaculture, Nakatsuhamaura, Mie, Japan; [Ai, Ken-ichiro; Kawai, Miho] Chiba Prefectural Fisheries Res Ctr Freshwater St, Sakura, Chiba, Japan; [Yamamoto, Shin-ichi] Kagoshima Prefectural Fisheries Technol & Dev Ctr, Ibusuki, Kagoshima, Japan; [Mochioka, Noritaka] Kyushu Univ, Fukuoka 812, Japan; [Manabe, Ryotaro] Nihon Univ, Fujisawa, Kanagawa, Japan; [Miyake, Yoichi] Univ Tokyo, Kashiwa, Chiba, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Kyushu University; Nihon University; University of Tokyo	Chow, S (corresponding author), Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan.	chow@affrc.go.jp	Miyake, Yoichi/I-5796-2017	Miyake, Yoichi/0000-0003-2799-7827; Chow, Seinen/0000-0001-9552-2669	Ministry of Agriculture, Forestry, and Fisheries of Japan (MAFF); Fisheries Agency of Japan; Fisheries Research Agency (FRA)	Ministry of Agriculture, Forestry, and Fisheries of Japan (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan); Fisheries Agency of Japan; Fisheries Research Agency (FRA)	This research was financially supported by the Ministry of Agriculture, Forestry, and Fisheries of Japan (MAFF), the Fisheries Agency of Japan, and the Fisheries Research Agency (FRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Aoyama J, 1999, MAR ECOL PROG SER, V186, P265, DOI 10.3354/meps186265; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Chow S, 2010, MAR ECOL PROG SER, V402, P233, DOI 10.3354/meps08448; Chow S, 2009, FISHERIES SCI, V75, P257, DOI 10.1007/s12562-008-0017-5; FRICKE H, 1995, NATURWISSENSCHAFTEN, V82, P32, DOI 10.1007/s001140050136; Itoh T, 2003, FISH B-NOAA, V101, P514; Jellyman D, 2005, MAR ECOL PROG SER, V286, P261, DOI 10.3354/meps286261; Jellyman D, 2002, MAR ECOL PROG SER, V233, P207, DOI 10.3354/meps233207; Jellyman D, 2010, MAR ECOL PROG SER, V404, P241, DOI 10.3354/meps08468; KLECKNER RC, 1980, COMP BIOCHEM PHYS A, V65, P351, DOI 10.1016/0300-9629(80)90041-9; KLECKNER RC, 1980, SCIENCE, V208, P1481, DOI 10.1126/science.7384792; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; Musyl M, 2001, ELECT TAGGING TRACKI, P343, DOI [10.1007/978-94-017-1402-0_19, DOI 10.3354/MEPS09899]; Okamura A, 2007, ENVIRON BIOL FISH, V80, P77, DOI 10.1007/s10641-006-9121-5; Pelster Bernd, 1997, P195; Reimer LW, 2003, EEL, P307; SADLER K, 1979, J FISH BIOL, V15, P499, DOI 10.1111/j.1095-8649.1979.tb03633.x; Schabetsberger R, 2013, MAR ECOL PROG SER, V475, P177, DOI 10.3354/meps10254; Sebert Philippe, 2009, V30, P99; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tanaka H, 2001, AQUACULTURE, V201, P51, DOI 10.1016/S0044-8486(01)00553-1; Tesch F.-W., 1989, Aquatic Living Resources, V2, P9, DOI 10.1051/alr:1989002; TESCH F-W, 1978, Environmental Biology of Fishes, V3, P203, DOI 10.1007/BF00691944; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; VOLLESTAD LA, 1986, CAN J FISH AQUAT SCI, V43, P1909, DOI 10.1139/f86-236; Westerberg H, 2007, ICES J MAR SCI, V64, P1457, DOI 10.1093/icesjms/fsm079; Westerberg H, 2014, MAR ECOL PROG SER, V496, P145, DOI 10.3354/meps10646; Wysujack K, 2014, J COAST CONSERV, V18, P121, DOI 10.1007/s11852-013-0274-z; Yamada Y, 2001, J FISH BIOL, V58, P804, DOI 10.1111/j.1095-8649.2001.tb00532.x	32	29	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121801	10.1371/journal.pone.0121801	http://dx.doi.org/10.1371/journal.pone.0121801			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875179	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800031
J	Sanderson, WC; Scherbov, S				Sanderson, Warren C.; Scherbov, Sergei			Faster Increases in Human Life Expectancy Could Lead to Slower Population Aging	PLOS ONE			English	Article								Counterintuitively, faster increases in human life expectancy could lead to slower population aging. The conventional view that faster increases in human life expectancy would lead to faster population aging is based on the assumption that people become old at a fixed chronological age. A preferable alternative is to base measures of aging on people's time left to death, because this is more closely related to the characteristics that are associated with old age. Using this alternative interpretation, we show that faster increases in life expectancy would lead to slower population aging. Among other things, this finding affects the assessment of the speed at which countries will age.	[Sanderson, Warren C.] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; [Sanderson, Warren C.; Scherbov, Sergei] Int Inst Appl Syst Anal, World Populat Program, A-2361 Laxenburg, Austria; [Sanderson, Warren C.; Scherbov, Sergei] IIASA, Wittgenstein Ctr Demog & Global Human Capital, VID OAW, WU, Laxenburg, Austria	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; International Institute for Applied Systems Analysis (IIASA); International Institute for Applied Systems Analysis (IIASA)	Sanderson, WC (corresponding author), SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA.	warren.sanderson@stonybrook.edu	Scherbov, Sergey/F-3158-2019; Sanderson, Warren/R-3398-2019	Scherbov, Sergey/0000-0001-5902-3790; Scherbov, Sergei/0000-0002-0881-1073; Sanderson, Warren/0000-0002-2205-948X	European Research Council under the European Union [ERC2013-AdG 323947-ReAgeing]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement no ERC2013-AdG 323947-ReAgeing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COUNTRIES WITH AGING; Bloomberg, BLOOMBERG; Brass W., 1971, BIOL ASPECTS DEMOGRA; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; European Commission, 2012, 22010 EUR COMM; FUCHS VR, 1984, MILBANK FUND Q, V62, P143; Lutz W., 2014, WORLD POPULATION HUM; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Miller T, 2001, DEMOGRAPHY, V38, P215, DOI 10.1353/dem.2001.0018; Preston S, 2000, DEMOGRAPHY MEASURING; Robine J.-M., 2013, ANN REV GERONTOLOGY, V33; RYDER NB, 1975, POPUL INDEX, V41, P3, DOI 10.2307/2734140; Sanderson W, 2008, RETHINKING AGE AGING; Sanderson WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096289; Sanderson WC, 2013, POPUL DEV REV, V39, P673, DOI 10.1111/j.1728-4457.2013.00633.x; Sanderson WC, 2010, SCIENCE, V329, P1287, DOI 10.1126/science.1193647; Sanderson WC, 2005, NATURE, V435, P811, DOI 10.1038/nature03593; Siegel J, 2008, DEMOGRAPHY EPIDEMIOL; Siegel Jacob S., 1984, SERIES US BUREAU CEN, V43; Siegel JS, 1993, GENERATION CHANGE PR, DOI [10.1371/journal.pone.0058669, DOI 10.1371/JOURNAL.PONE.0058669]; Skirbekk V, 2013, INTELLIGENCE, V41, P169, DOI 10.1016/j.intell.2013.02.001; UN, 2013, STESASERA348 UN; United Nations, 2013, WORLD POP AG 2013; University of California Berkley Max Planck Institute for Demographic Research, 2014, HUM MORT DAT; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; VID, 2014, EUR DEM DAT SHEET 20	26	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121922	10.1371/journal.pone.0121922	http://dx.doi.org/10.1371/journal.pone.0121922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25876033	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353015800035
J	Towle, EK; Enochs, IC; Langdon, C				Towle, Erica K.; Enochs, Ian C.; Langdon, Chris			Threatened Caribbean Coral Is Able to Mitigate the Adverse Effects of Ocean Acidification on Calcification by Increasing Feeding Rate	PLOS ONE			English	Article							2 SCLERACTINIAN CORALS; CO2 PARTIAL-PRESSURE; CLIMATE-CHANGE; ACROPORID CORALS; MORTALITY RISK; FATTY-ACIDS; FLORIDA; REEF; TEMPERATURE; HETEROTROPHY	Global climate change threatens coral growth and reef ecosystem health via ocean warming and ocean acidification (OA). Whereas the negative impacts of these stressors are increasingly well-documented, studies identifying pathways to resilience are still poorly understood. Heterotrophy has been shown to help corals experiencing decreases in growth due to either thermal or OA stress; however, the mechanism by which it mitigates these decreases remains unclear. This study tested the ability of coral heterotrophy to mitigate reductions in growth due to climate change stress in the critically endangered Caribbean coral Acropora cervicornis via changes in feeding rate and lipid content. Corals were either fed or unfed and exposed to elevated temperature (30 degrees C), enriched pCO(2) (800 ppm), or both (30 degrees C/800 ppm) as compared to a control (26 degrees C/390 ppm) for 8 weeks. Feeding rate and lipid content both increased in corals experiencing OA vs. present-day conditions, and were significantly correlated. Fed corals were able to maintain ambient growth rates at both elevated temperature and elevated CO2, while unfed corals experienced significant decreases in growth with respect to fed conspecifics. Our results show for the first time that a threatened coral species can buffer OA-reduced calcification by increasing feeding rates and lipid content.	[Towle, Erica K.; Enochs, Ian C.; Langdon, Chris] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Enochs, Ian C.] NOAA, AOML, Miami, FL 33149 USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Towle, EK (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	etowle@rsmas.miami.edu	/AAL-3738-2021; Langdon, Chris/A-1543-2016; Enochs, Ian/B-8051-2014	Langdon, Chris/0000-0002-3043-3806; Enochs, Ian/0000-0002-8867-0361	MOTE Marine Laboratories "Protect Our Reefs" Grant [POR-2012-22]; Mohamed bin Zayed Species Conservation Fund [12054710]	MOTE Marine Laboratories "Protect Our Reefs" Grant; Mohamed bin Zayed Species Conservation Fund	This study was supported by MOTE Marine Laboratories "Protect Our Reefs" Grant (#POR-2012-22) to EKT (http://mote.org/support/protect-our-reefs) and by the Mohamed bin Zayed Species Conservation Fund (#12054710) to EKT (http://www.speciesconservation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Belanger S, 2013, BIOGEOSCIENCES, V10, P4087, DOI 10.5194/bg-10-4087-2013; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; COUGHLAN J, 1969, MAR BIOL, V2, P356, DOI 10.1007/BF00355716; DAVIES PS, 1989, MAR BIOL, V101, P389; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Drenkard EJ, 2013, CORAL REEFS, V32, P727, DOI 10.1007/s00338-013-1021-5; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P1, DOI 10.1007/978-94-007-0114-4; Edmunds PJ, 2011, LIMNOL OCEANOGR, V56, P2402, DOI 10.4319/lo.2011.56.6.2402; Enochs IC, 2014, CORAL REEFS, V33, P477, DOI 10.1007/s00338-014-1132-7; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Field CB, 2012, IPCC SUMMARY POLICYM; Gagnon AC, 2012, EARTH PLANET SC LETT, V329, P150, DOI 10.1016/j.epsl.2012.03.005; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Imbs AB, 2010, MAR ECOL PROG SER, V409, P65, DOI 10.3354/meps08622; JACKSON JBC, 1994, SCIENCE, V264, P1412, DOI 10.1126/science.264.5164.1412; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; Lewis E., 1998, ORNLCDIAC105; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; McConnaughey T., 1989, ORIGIN EVOLUTION MOD, P57, DOI [10.1007/978-1-4757-6114-6_5, DOI 10.1007/978-1-4757-6114-6_5]; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; Palardy JE, 2006, J EXP MAR BIOL ECOL, V331, P99, DOI 10.1016/j.jembe.2005.10.001; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; Pansch C, 2014, GLOBAL CHANGE BIOL, V20, P765, DOI 10.1111/gcb.12478; Precht WF, 2002, CORAL REEFS, V21, P41, DOI 10.1007/s00338-001-0209-2; Renegar DA, 2005, MAR ECOL PROG SER, V293, P69, DOI 10.3354/meps293069; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries J, 2011, NAT CLIM CHANGE, V1, P294, DOI 10.1038/nclimate1204; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; Sebens KP, 1996, MAR BIOL, V127, P303, DOI 10.1007/BF00942116; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tambutte E, 2012, P ROY SOC B-BIOL SCI, V279, P19, DOI 10.1098/rspb.2011.0733; Teece MA, 2011, LIMNOL OCEANOGR, V56, P1285, DOI 10.4319/lo.2011.56.4.1285; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Wirt KE, 2013, APPL GEOGR, V39, P118, DOI 10.1016/j.apgeog.2012.12.009	49	83	84	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123394	10.1371/journal.pone.0123394	http://dx.doi.org/10.1371/journal.pone.0123394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874963	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800096
J	Liao, J; Wen, SC; Cao, LP; Zhou, YF; Feng, ZS				Liao, Juan; Wen, Shichao; Cao, Lipeng; Zhou, Yunfeng; Feng, Zhisong			Effect of Eradication of Helicobacter pylori on Expression Levels of FHIT, IL-8 and P73 in Gastric Mucosa of First-Degree Relatives of Gastric Cancer Patients	PLOS ONE			English	Article							PROTEIN EXPRESSION; CLINICOPATHOLOGICAL SIGNIFICANCE; ESOPHAGEAL CANCER; GENE ALTERATIONS; INFECTION; RISK; POLYMORPHISMS; CARCINOMA; ASSOCIATION; PROGRESSION	Objectives Helicobacter pylori (H. pylori) infection plays an important role in the carcinogenesis and development of gastric cancer. Eradication of H. pylori can effectively reduce the risk of gastric cancer, but the underlying mechanisms are not fully understood. This study aimed to investigate the effect of eradication of H. pylori on the expression levels of FHIT, IL-8 and P73 in the gastric mucosa of first-degree relatives of gastric cancer patients. Methods One hundred and thirty-two patients with functional dyspepsia having first-degree relatives with gastric cancer were prospectively recruited in this study. Nine patients presented with H. pylori infection and family histories of gastric cancer, 61 with H. pylori infection and without family histories of gastric cancer, 6 without H. pylori infection and with family histories of gastric cancer, and 56 without H. pylori infection and family histories of gastric cancer. The protein and mRNA expression levels of FHIT, IL-8 and P73 in gastric mucosa of the subjects were detected by immunohistochemical staining and polymerase chain reaction, respectively. Results Compared with the patients without H. pylori infection and family histories of gastric cancer, both the protein and mRNA levels of FIHT significantly decreased in patients with H. pylori infection and/or family histories of gastric cancer, and both the protein and mRNA levels of IL-8 significantly increased. After eradication of H. pylori, both the protein and mRNA levels of FHIT were significantly higher, and both the protein and mRNA levels of IL-8 were significantly lower. However, H. pylori infection and family histories of gastric cancer had no major effect on P73 expression. Conclusions Down-regulation of FHIT and up-regulation of IL-8 may be involved in the pathogenesis of H. pylori infection in the first-degree relatives of gastric cancer patients.	[Liao, Juan; Wen, Shichao; Cao, Lipeng; Zhou, Yunfeng; Feng, Zhisong] North Sichuan Med Coll, Affiliated Hosp, Dept Gastroenterol, Nanchong 637000, Sichuan Provinc, Peoples R China	North Sichuan Medical University	Feng, ZS (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Dept Gastroenterol, 63 Wenhua Rd, Nanchong 637000, Sichuan Provinc, Peoples R China.	fengzhisong2013@sohu.com		, Juan Liao/0000-0002-2446-9861				Baffa R, 1998, CANCER RES, V58, P4708; Bria E, 2013, ANN ONCOL, V24, P693, DOI 10.1093/annonc/mds506; Campiglio M, 1999, CANCER RES, V59, P3866; Carrasco G, 2010, CLIN CANCER RES, V16, P3253, DOI 10.1158/1078-0432.CCR-09-2491; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Demirel BB, 2013, ASIAN PAC J CANCER P, V14, P1797, DOI 10.7314/APJCP.2013.14.3.1797; Ernst PB, 2006, GASTROENTEROLOGY, V130, P188, DOI 10.1053/j.gastro.2005.06.032; Ge H, 2007, DIS ESOPHAGUS, V20, P290, DOI 10.1111/j.1442-2050.2007.00672.x; Hadaczek P, 1998, CANCER RES, V58, P2946; Hao XP, 2000, CANCER RES, V60, P18; Hao XP, 1997, VIRCHOWS ARCH, V431, P167, DOI 10.1007/s004280050084; Ishii H, 2004, CURR GENE THER, V4, P53, DOI 10.2174/1566523044578031; Ishii H, 2001, CANCER RES, V61, P1578; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kang MJ, 2000, CLIN CANCER RES, V6, P1767; Kim K, 2011, CRIT REV EUKAR GENE, V21, P237, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.20; Kitadai Y, 2003, BIOCHEM BIOPH RES CO, V311, P809, DOI 10.1016/j.bbrc.2003.10.077; Kitadai Y, 1998, AM J PATHOL, V152, P93; Kitamura K, 2008, ONCOL REP, V19, P847; Kondo T, 2009, INT J ONCOL, V35, P547, DOI 10.3892/ijo_00000366; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakachi N, 2000, FEMS IMMUNOL MED MIC, V29, P23, DOI 10.1111/j.1574-695X.2000.tb01500.x; Nishizaki M, 2004, CANCER RES, V64, P5745, DOI 10.1158/0008-5472.CAN-04-0195; Osborn JF, 2013, CANCER PREV RES, V6, P695, DOI 10.1158/1940-6207.CAPR-12-0428; Ouakaa-Kchaou Asma, 2010, Tunis Med, V88, P459; Petursdottir TE, 2002, ANTICANCER RES, V22, P3205; Rocco A, 2003, J CANCER RES CLIN, V129, P84, DOI 10.1007/s00432-002-0409-3; Safaee A, 2011, ASIAN PAC J CANCER P, V12, P3117; Sard L, 1999, P NATL ACAD SCI USA, V96, P8489, DOI 10.1073/pnas.96.15.8489; Sepulveda Antonia R, 2013, Curr Pathobiol Rep, V1, P9; Shin Cheol Min, 2010, J Clin Gastroenterol, V44, pe34, DOI 10.1097/MCG.0b013e3181a159c4; Skopelitou AS, 2003, EUR J GASTROEN HEPAT, V15, P515, DOI 10.1097/01.meg.0000059113.41030.67; Stec-Michalska K, 2005, WORLD J GASTROENTERO, V11, P17, DOI 10.3748/wjg.v11.i1.17; Stec-Michalska K, 2009, HELICOBACTER, V14, P126, DOI 10.1111/j.1523-5378.2009.00715.x; Sugimoto M, 2010, WORLD J GASTROENTERO, V16, P1188, DOI 10.3748/wjg.v16.i10.1188; TAHARA E, 1994, EUR J GASTROEN HEPAT, V6, pS97; Talley NJ, 2008, AM J GASTROENTEROL, V103, P510, DOI 10.1111/j.1572-0241.2008.01819.x; Tannapfel A, 2001, J PATHOL, V195, P163, DOI 10.1002/path.947; Thomopoulou GE, 2003, EUR J ENDOCRINOL, V148, P81, DOI 10.1530/eje.0.1480081; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wei A, 2008, GASTROENTEROLOGY, V134, P1412, DOI 10.1053/j.gastro.2008.01.072; Yamada H, 2001, BIOCHEM PHARMACOL, V61, P1595, DOI 10.1016/S0006-2952(01)00628-1; Yamaoka Y, 2001, HELICOBACTER, V6, P116, DOI 10.1046/j.1523-5378.2001.00017.x; Zhang LW, 2010, MOL BIOL REP, V37, P3983, DOI 10.1007/s11033-010-0057-7; Zhao P, 2005, WORLD J GASTROENTERO, V11, P5735, DOI 10.3748/wjg.v11.i36.5735; Zhu JH, 1998, CANCER RES, V58, P5061; Zou TT, 1997, ONCOGENE, V15, P101, DOI 10.1038/sj.onc.1201169	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124576	10.1371/journal.pone.0124576	http://dx.doi.org/10.1371/journal.pone.0124576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875960	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700070
J	Mizuuchi, H; Suda, K; Sato, K; Tomida, S; Fujita, Y; Kobayashi, Y; Maehara, Y; Sekido, Y; Nishio, K; Mitsudomi, T				Mizuuchi, Hiroshi; Suda, Kenichi; Sato, Katsuaki; Tomida, Shuta; Fujita, Yoshihiko; Kobayashi, Yoshihisa; Maehara, Yoshihiko; Sekido, Yoshitaka; Nishio, Kazuto; Mitsudomi, Tetsuya			Collateral Chemoresistance to Anti-Microtubule Agents in a Lung Cancer Cell Line with Acquired Resistance to Erlotinib	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; MET AMPLIFICATION; MESENCHYMAL TRANSITION; GEFITINIB RESISTANCE; MULTIDRUG-RESISTANCE; 1ST-LINE TREATMENT; DRUG-RESISTANCE; OPEN-LABEL; EGFR; EXPRESSION	Various alterations underlying acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have been described. Although treatment strategies specific for these mechanisms are under development, cytotoxic agents are currently employed to treat many patients following failure of EGFR-TKIs. However, the effect of TKI resistance on sensitivity to these cytotoxic agents is mostly unclear. This study investigated the sensitivity of erlotinib-resistant tumor cells to five cytotoxic agents using an in vitro EGFR-TKI-resistant model. Four erlotinib-sensitive lung adenocarcinoma cell lines and their resistant derivatives were tested. Of the resistant cell lines, all but one showed a similar sensitivity to the tested drugs as their parental cells. HCC4006ER cells with epithelial mesenchymal transition features acquired resistance to the three microtubule-targeting agents, docetaxel, paclitaxel and vinorelbine, but not to cisplatin and gemcitabine. Gene expression array and immunoblotting demonstrated that ATP-binding cassette subfamily B, member 1 (ABCB1) was up-regulated in HCC4006ER cells. ABCB1 knockdown by siRNA partially restored sensitivity to the anti-microtubule agents but not to erlotinib. Moreover, the histone deacetylase inhibitor entinostat sensitized HCC4006ER cells to anti-microtubule agents through ABCB1 suppression. Our study indicates that sensitivity of tumor cells to cytotoxic agents in general does not change before and after failure of EGFR-TKIs. However, we describe that two different molecular alterations confer acquired resistance to EGFR-TKIs and cytotoxic agents, respectively. This phenomenon should be kept in mind in selection of subsequent therapy after failure of EGFR-TKIs.	[Mizuuchi, Hiroshi; Suda, Kenichi; Sato, Katsuaki; Kobayashi, Yoshihisa; Mitsudomi, Tetsuya] Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan; [Mizuuchi, Hiroshi; Suda, Kenichi; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Tomida, Shuta; Fujita, Yoshihiko; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan; [Sekido, Yoshitaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan	Kindai University (Kinki University); Kyushu University; Kindai University (Kinki University); Aichi Cancer Center	Mitsudomi, T (corresponding author), Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan.	mitsudom@surg.med.kindai.ac.jp	Sekido, Yoshitaka/P-9756-2015	Sekido, Yoshitaka/0000-0002-2428-3848; Kobayashi, Yoshihisa/0000-0003-2057-408X; Mitsudomi, Tetsuya/0000-0001-9860-8505; Suda, Kenichi/0000-0002-0842-8832	Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan [25830119]; Kaibara Morikazu Medical Science Promotion Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kaibara Morikazu Medical Science Promotion Foundation(Kaibara Morikazu Medical Science Promotion Foundation)	This work was partly supported by Takeda Science Foundation to T.M., Grants-in-Aid for Scientific Research (25830119 to K.S.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and Kaibara Morikazu Medical Science Promotion Foundation to K.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DJ, 1995, INVEST NEW DRUG, V13, P13, DOI 10.1007/BF02614215; Breen L, 2008, TOXICOL IN VITRO, V22, P1234, DOI 10.1016/j.tiv.2008.04.005; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Chen LM, 2009, ANTICANCER RES, V29, P4597; Chin TM, 2008, CLIN CANCER RES, V14, P6867, DOI 10.1158/1078-0432.CCR-08-0093; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Furugaki K, 2014, LUNG CANCER, V83, P44, DOI 10.1016/j.lungcan.2013.10.003; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hurbin A, 2011, J PATHOL, V225, P83, DOI 10.1002/path.2897; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Kurahashi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063249; Kurokawa M, 2013, CANCER SCI, V104, P904, DOI 10.1111/cas.12171; Li WJ, 2013, MOL BIOL REP, V40, P6143, DOI 10.1007/s11033-013-2725-x; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McDonald SL, 2005, EUR J CANCER, V41, P1086, DOI 10.1016/j.ejca.2005.01.018; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Noguchi K, 2009, CANCER SCI, V100, P1701, DOI 10.1111/j.1349-7006.2009.01213.x; Puri Neelu, 2008, J Carcinog, V7, P9; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Suda K, 2014, INT J CANCER, V135, P1002, DOI 10.1002/ijc.28737; Suda K, 2012, CANCER METAST REV, V31, P807, DOI 10.1007/s10555-012-9391-7; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Yabuki N, 2007, CANCER GENET CYTOGEN, V173, P1, DOI 10.1016/j.cancergencyto.2006.07.020; Yamamoto C, 2010, CANCER RES, V70, P8715, DOI 10.1158/0008-5472.CAN-10-0043; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093997; Yoshida T, 2010, CANCER SCI, V101, P167, DOI 10.1111/j.1349-7006.2009.01368.x; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu YZ, 2013, MOL CANCER THER, V12, P1829, DOI 10.1158/1535-7163.MCT-13-0208	33	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123901	10.1371/journal.pone.0123901	http://dx.doi.org/10.1371/journal.pone.0123901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875914	Green Submitted, Green Published, gold			2022-12-26	WOS:000353014700051
J	Kawata, K; Iwai, A; Muramatsu, D; Aoki, S; Uchiyama, H; Okabe, M; Hayakawa, S; Takaoka, A; Miyazaki, T				Kawata, Koji; Iwai, Atsushi; Muramatsu, Daisuke; Aoki, Shiho; Uchiyama, Hirofumi; Okabe, Mitsuyasu; Hayakawa, Sumio; Takaoka, Akinori; Miyazaki, Tadaaki			Stimulation of Macrophages with the beta-Glucan Produced by Aureobasidium pullulans Promotes the Secretion of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL)	PLOS ONE			English	Article							NF-KAPPA-B; CASPASE ACTIVATION; CELL-DEATH; RECEPTOR; DECTIN-1; MICE; TRANSCRIPTION; ANTITUMOR; STRAIN; FAMILY	A beta-glucan produced by Aureobasidium pullulans (AP-PG) is consisting of a beta-(1,3)-linked main chain with beta-(1,6)-linked glucose side residues. Various beta-glucans consisting of beta-(1,3)-linked main chain including AP-PG are believed to exhibit anti-tumor activities, and actually, anti-tumor activities of AP-PG in mice have been demonstrated. In this study, we demonstrate that stimulation with AP-PG induces TRAIL expression in mouse and human macrophage-like cell lines. TRAIL is known to be a cytokine which specifically induces apoptosis in transformed cells, but not in untransformed cells. The expression of TRAIL mRNA after stimulation with AP-PG was increased in RAW264.7 cells, Mono Mac 6 cells, and macrophage-differentiated THP-1 cells. The mRNA expression of TNF-alpha and FasL is only weakly increased after stimulation with AP-PG. The induction activity of TRAIL by curdlan, a bacterial beta-glucan, was very similar to that by AP-PG in RAW264.7 cells, but weaker in macrophage-differentiated THP-1 cells. Activation of caspases was found in HeLa cells after treatment with the supernatant of cultured medium from AP-PG-stimulated Mono Mac 6 cells, and was inhibited by the anti-TRAIL neutralizing antibody. These findings suggest that the stimulation with AP-PG effectively induces TRAIL in macrophages, and that it may be related to apoptosis induction of tumor cells.	[Kawata, Koji; Iwai, Atsushi; Muramatsu, Daisuke; Aoki, Shiho] Aureo Sci Co Ltd, Sapporo, Hokkaido, Japan; [Kawata, Koji; Iwai, Atsushi] Aureo Co Ltd, Kimitsu, Chiba, Japan; [Hayakawa, Sumio; Takaoka, Akinori] Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Sapporo, Hokkaido, Japan; [Miyazaki, Tadaaki] Hokkaido Univ, Inst Med Genet, Dept Probiot Immunol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Iwai, A (corresponding author), Aureo Sci Co Ltd, Sapporo, Hokkaido, Japan.	iwai-atsushi@aureo.co.jp	Iwai, Atsushi/I-6469-2019	Iwai, Atsushi/0000-0002-1491-4693	Aureo Co., Ltd.; Aureo-Science Co., Ltd.	Aureo Co., Ltd.; Aureo-Science Co., Ltd.	This study was funded by by Aureo Co., Ltd., and Aureo-Science Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akramiene D, 2007, MEDICINA-LITHUANIA, V43, P597, DOI 10.3390/medicina43080076; Alberts B, 2008, MOL BIOL CELL TXB; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; CHIHARA G, 1970, CANCER RES, V30, P2776; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Cretney E, 2005, IMMUNOL CELL BIOL, V83, P511, DOI 10.1111/j.1440-1711.2005.01358.x; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Halaas O, 2000, SCAND J IMMUNOL, V51, P244; Hamada N, 2000, BIOSCI BIOTECH BIOCH, V64, P1801, DOI 10.1271/bbb.64.1801; HASHIMOTO K, 1991, INT J IMMUNOPHARMACO, V13, P437, DOI 10.1016/0192-0561(91)90014-X; KATAOKASHIRASUGI N, 1994, BIOSCI BIOTECH BIOCH, V58, P2145, DOI 10.1271/bbb.58.2145; Kimura Y, 2007, INT IMMUNOPHARMACOL, V7, P963, DOI 10.1016/j.intimp.2007.03.003; Kimura Y, 2006, ANTICANCER RES, V26, P4131; Kumar S, 1999, CELL DEATH DIFFER, V6, P1060, DOI 10.1038/sj.cdd.4400600; Li H, 2012, J NEUROIMMUNOL; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; MacKenzie SH, 2008, CURR CANCER DRUG TAR, V8, P98; MASHIBA H, 1979, GANN, V70, P687; Moriya N, 2013, BIOTECHNOL BIOPROC E, V18, P1083, DOI 10.1007/s12257-013-0516-9; Muramatsu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041399; Novak M., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P67; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; OHHASHI F, 1978, GANN, V69, P255; Ozment TR, 2012, J PHARMACOL EXP THER, V342, P808, DOI 10.1124/jpet.112.196329; RALPH P, 1977, J IMMUNOL, V119, P950; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Russo M, 2010, BIOCHEM PHARMACOL, V80, P674, DOI 10.1016/j.bcp.2010.03.011; SAKURAI T, 1992, INT J IMMUNOPHARMACO, V14, P821, DOI 10.1016/0192-0561(92)90080-5; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Su ZY, 2012, BIOCHEM BIOPH RES CO, V417, P777, DOI 10.1016/j.bbrc.2011.12.034; Tada R, 2011, BIOCHEM BIOPH RES CO, V404, P1105, DOI 10.1016/j.bbrc.2010.12.125; Tada R, 2008, GLYCOCONJUGATE J, V25, P851, DOI 10.1007/s10719-008-9147-3; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Xia Y, 1999, J IMMUNOL, V162, P7285; YAMAMOTO T, 1981, Invasion and Metastasis, V1, P71; Yatawara L, 2009, KOREAN J PARASITOL, V47, P345, DOI 10.3347/kjp.2009.47.4.345; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	50	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124809	10.1371/journal.pone.0124809	http://dx.doi.org/10.1371/journal.pone.0124809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875639	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100274
J	Kleinberg, B; Verschuere, B				Kleinberg, Bennett; Verschuere, Bruno			Memory Detection 2.0: The First Web-Based Memory Detection Test	PLOS ONE			English	Article							GUILTY KNOWLEDGE TEST; CONCEALED INFORMATION; SKIN-CONDUCTANCE; MECHANICAL TURK; DATA-COLLECTION; TIME MEASURES; VALIDITY; PSYCHOLOGY; PROBE	There is accumulating evidence that reaction times (RTs) can be used to detect recognition of critical (e.g., crime) information. A limitation of this research base is its reliance upon small samples (average n = 24), and indications of publication bias. To advance RT-based memory detection, we report upon the development of the first web-based memory detection test. Participants in this research (Study1: n = 255; Study2: n = 262) tried to hide 2 high salient (birthday, country of origin) and 2 low salient (favourite colour, favourite animal) autobiographical details. RTs allowed to detect concealed autobiographical information, and this, as predicted, more successfully so than error rates, and for high salient than for low salient items. While much remains to be learned, memory detection 2.0 seems to offer an interesting new platform to efficiently and validly conduct RT-based memory detection research.	[Kleinberg, Bennett; Verschuere, Bruno] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Verschuere, Bruno] Univ Ghent, Dept Psychol, B-9000 Ghent, Belgium; [Verschuere, Bruno] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands	University of Amsterdam; Ghent University; Maastricht University	Verschuere, B (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	b.j.verschuere@uva.nl		VERSCHUERE, BRUNO/0000-0002-6161-4415; Kleinberg, Bennett/0000-0003-1658-9086				Alexander A, 2012, PERSPECT PSYCHOL SCI, V7, P657, DOI 10.1177/1745691612462588; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Ben-Shakhar G, 2003, J APPL PSYCHOL, V88, P131, DOI 10.1037/0021-9010.88.1.131; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Carmel D, 2003, J EXP PSYCHOL-APPL, V9, P261, DOI 10.1037/1076-898X.9.4.261; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Dindo L, 2008, PSYCHOPHYSIOLOGY, V45, P111, DOI 10.1111/j.1469-8986.2007.00604.x; Gamer M, 2010, INT J PSYCHOPHYSIOL, V76, P19, DOI 10.1016/j.ijpsycho.2010.01.009; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Houben K, 2008, BEHAV RES METHODS, V40, P1134, DOI 10.3758/BRM.40.4.1134; Hu XQ, 2013, ACTA PSYCHOL, V142, P278, DOI 10.1016/j.actpsy.2012.12.006; Ipeirotis P, CEDER1001 NEW YORK U; Jokinen A, 2006, INT J PSYCHOPHYSIOL, V62, P175, DOI 10.1016/j.ijpsycho.2006.04.004; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; LIEBLICH I, 1976, J APPL PSYCHOL, V61, P89, DOI 10.1037/0021-9010.61.1.89; LYKKEN DT, 1959, J APPL PSYCHOL, V43, P385, DOI 10.1037/h0046060; Marszalek JM, 2011, PERCEPT MOTOR SKILL, V112, P331, DOI 10.2466/03.11.PMS.112.2.331-348; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Meijer, 2011, MEMORY DETECTION THE, P293, DOI DOI 10.1007/S10484-014-9244-Y; Meijer EH, 2014, PSYCHOPHYSIOLOGY, V51, P879, DOI 10.1111/psyp.12239; Meijer EH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00068; Nahari G, 2011, PSYCHOPHYSIOLOGY, V48, P733, DOI 10.1111/j.1469-8986.2010.01148.x; Noordraven E, 2013, APPL COGNITIVE PSYCH, V27, P328, DOI 10.1002/acp.2910; Osugi A., 2011, MEMORY DETECTION THE, P253, DOI DOI 10.1017/CBO9780511975196.015; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Reimers S, 2015, BEHAV RES METHODS, V47, P309, DOI 10.3758/s13428-014-0471-1; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Seymour TL, 2000, J APPL PSYCHOL, V85, P30, DOI 10.1037/0021-9010.85.1.30; Seymour TL, 2008, APPL COGNITIVE PSYCH, V22, P475, DOI 10.1002/acp.1375; Seymour TL, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00614; Seymour TL, 2009, APPL PSYCHOPHYS BIOF, V34, P177, DOI 10.1007/s10484-009-9092-3; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Suchotzki K, 2014, METAANALYSIS UNPUB; Suchotzki K, 2013, ACTA PSYCHOL, V144, P224, DOI 10.1016/j.actpsy.2013.06.014; Verschuere B, 2011, MEMORY DETECTION THE, P128, DOI [10.1017/CBO9780511975196.008, DOI 10.1017/CBO9780511975196.008, 10.1017/CBO9780511975196.004]; Verschuere B, 2010, APPL COGNITIVE PSYCH, V23, P1, DOI DOI 10.1002/ACP.1601; Verschuere B., 2014, DECEPTION DETECTION; Verschuere B, 2007, BIOL PSYCHOL, V74, P309, DOI 10.1016/j.biopsycho.2006.08.002; Verschuere B, 2015, J APPL RES MEM COGN, V4, P59, DOI 10.1016/j.jarmac.2015.01.001; Verschuere B, 2014, EUR PSYCHOL, V19, P162, DOI 10.1027/1016-9040/a000194; Visu-Petra G., 2011, INTERDISCIPLINARY J, V14, P19, DOI [DOI 10.1002/ACP.1827, 10.1002/acp.1827]; Visu-Petra G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00146; Visu-Petra G, 2012, APPL COGNITIVE PSYCH, V26, P342, DOI 10.1002/acp.1827; Vrij A, 2012, J APPL RES MEM COGN, V1, P110, DOI 10.1016/j.jarmac.2012.02.004; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828	54	43	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118715	10.1371/journal.pone.0118715	http://dx.doi.org/10.1371/journal.pone.0118715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25874966	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100010
J	Lovisa, F; Cozza, G; Cristiani, A; Cuzzolin, A; Albiero, A; Mussolin, L; Pillon, M; Moro, S; Basso, G; Rosolen, A; Bonvini, P				Lovisa, Federica; Cozza, Giorgio; Cristiani, Andrea; Cuzzolin, Alberto; Albiero, Alessandro; Mussolin, Lara; Pillon, Marta; Moro, Stefano; Basso, Giuseppe; Rosolen, Angelo; Bonvini, Paolo			ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							IMATINIB-BASED THERAPY; ACTIVATING MUTATIONS; LUNG-CANCER; DIFFERENTIAL SENSITIVITY; CONFER RESISTANCE; CHRONIC PHASE; CRIZOTINIB; NEUROBLASTOMA; EXPRESSION; MUTANTS	ALK inhibitor crizotinib has shown potent antitumor activity in children with refractory Anaplastic Large Cell Lymphoma (ALCL) and the opportunity to include ALK inhibitors in first-line therapies is oncoming. However, recent studies suggest that crizotinib-resistance mutations may emerge in ALCL patients. In the present study, we analyzed ALK kinase domain mutational status of 36 paediatric ALCL patients at diagnosis to identify point mutations and gene aberrations that could impact on NPM-ALK gene expression, activity and sensitivity to small-molecule inhibitors. Amplicon ultra-deep sequencing of ALK kinase domain detected 2 single point mutations, R335Q and R291Q, in 2 cases, 2 common deletions of exon 23 and 25 in all the patients, and 7 splicing-related INDELs in a variable number of them. The functional impact of missense mutations and INDELs was evaluated. Point mutations were shown to affect protein kinase activity, signalling output and drug sensitivity. INDELs, instead, generated kinase-dead variants with dominant negative effect on NPM-ALK kinase, in virtue of their capacity of forming non-functional heterocomplexes. Consistently, when co-expressed, INDELs increased crizotinib inhibitory activity on NPM-ALK signal processing, as demonstrated by the significant reduction of STAT3 phosphorylation. Functional changes in ALK kinase activity induced by both point mutations and structural rearrangements were resolved by molecular modelling and dynamic simulation analysis, providing novel insights into ALK kinase domain folding and regulation. Therefore, these data suggest that NPM-ALK pre-therapeutic mutations may be found at low frequency in ALCL patients. These mutations occur randomly within the ALK kinase domain and affect protein activity, while preserving responsiveness to crizotinib.	[Lovisa, Federica; Mussolin, Lara; Pillon, Marta; Basso, Giuseppe; Rosolen, Angelo; Bonvini, Paolo] Univ Padua, Azienda Osped, Clin Oncoematol Pediat Padova, Padua, Italy; [Cozza, Giorgio] Univ Padua, Dipartimento Sci Biomed, Padua, Italy; [Cristiani, Andrea; Cuzzolin, Alberto; Moro, Stefano] Univ Padua, Dipartimento Sci Farmaco, Padua, Italy; [Albiero, Alessandro] Univ Padua, CRIBI, Padua, Italy; [Mussolin, Lara; Bonvini, Paolo] Ist Ric Pediat Citta Speranza, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; University of Padua; University of Padua; Fondazione Citta della Speranza	Lovisa, F (corresponding author), Univ Padua, Azienda Osped, Clin Oncoematol Pediat Padova, Padua, Italy.	federica.lovisa@gmail.com	Pillon, Marta/AAB-9581-2022; MUSSOLIN, LARA/AAA-1931-2019; Moro, Stefano/A-2979-2012; Bonvini, Paolo/J-9877-2018	Pillon, Marta/0000-0002-1190-3198; MUSSOLIN, LARA/0000-0003-4802-1866; Moro, Stefano/0000-0002-7514-3802; Bonvini, Paolo/0000-0003-2889-108X; COZZA, GIORGIO/0000-0002-5155-4682; LOVISA, FEDERICA/0000-0001-9570-6150; BASSO, GIUSEPPE/0000-0002-2634-9302	"Associazione Italiana Leucemie Treviso", Italy; "Fondazione Cassa di Risparmio di Padova e Rovigo", Padua, Italy; "Istituto di Ricerca Pediatrica Citta della Speranza", Padua, Italy; University of Padua, Italy; Italian Ministry for University and Research (MIUR), Rome, Italy	"Associazione Italiana Leucemie Treviso", Italy; "Fondazione Cassa di Risparmio di Padova e Rovigo", Padua, Italy; "Istituto di Ricerca Pediatrica Citta della Speranza", Padua, Italy; University of Padua, Italy; Italian Ministry for University and Research (MIUR), Rome, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by "Associazione Italiana Leucemie Treviso", Italy (fellowship to FL), "Fondazione Cassa di Risparmio di Padova e Rovigo", Padua, Italy, and "Istituto di Ricerca Pediatrica Citta della Speranza", Padua, Italy. The molecular modelling work has been carried out with financial support of the University of Padua, Italy, and the Italian Ministry for University and Research (MIUR), Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila ME, 2013, MOL CANCER THER, V12, P220, DOI 10.1158/1535-7163.MCT-12-0620; Bonvini P, 2004, CANCER RES, V64, P3256, DOI 10.1158/0008-5472.CAN-03-3531; Bonvini P, 2012, LEUKEMIA, V26, P1375, DOI 10.1038/leu.2011.367; Boutterin MC, 2013, CELL SIGNAL, V25, P1505, DOI 10.1016/j.cellsig.2013.02.020; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Carella AM, 2010, LEUKEMIA LYMPHOMA, V51, P275, DOI 10.3109/10428190903503446; Ceccon M, 2013, MOL CANCER RES, V11, P122, DOI 10.1158/1541-7786.MCR-12-0569; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Chung KP, 2012, CLIN CANCER RES, V18, P3470, DOI 10.1158/1078-0432.CCR-11-2353; Coffin CM, 2001, MODERN PATHOL, V14, P569, DOI 10.1038/modpathol.3880352; Epstein LF, 2012, J BIOL CHEM, V287, P37447, DOI 10.1074/jbc.M112.391425; Ferreri AJM, 2012, CRIT REV ONCOL HEMAT, V83, P293, DOI 10.1016/j.critrevonc.2012.02.005; Fleuren EDG, 2013, INT J CANCER, V133, P427, DOI 10.1002/ijc.28047; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; He M, 2012, CLIN CANCER RES, V18, P1790, DOI 10.1158/1078-0432.CCR-11-2361; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; La Madrid AM, 2012, TARGET ONCOL, V7, P199, DOI 10.1007/s11523-012-0227-8; Lu LH, 2009, BIOCHEMISTRY-US, V48, P3600, DOI 10.1021/bi8020923; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; MURPHY SB, 1989, J CLIN ONCOL, V7, P186, DOI 10.1200/JCO.1989.7.2.186; Mussolin L, 2005, LEUKEMIA, V19, P1643, DOI 10.1038/sj.leu.2403888; Mussolin L, 2013, LEUKEMIA, V27, P416, DOI 10.1038/leu.2012.205; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Passerini CG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt378; Pfeifer H, 2012, LEUKEMIA, V26, P1475, DOI 10.1038/leu.2012.5; Pfeifer H, 2007, BLOOD, V110, P727, DOI 10.1182/blood-2006-11-052373; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Schonherr C, 2011, BIOCHEM J, V440, P405, DOI 10.1042/BJ20101796; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sherbenou DW, 2008, LEUKEMIA, V22, P1184, DOI 10.1038/leu.2008.65; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Soverini S, 2013, BLOOD, V122, P1634, DOI 10.1182/blood-2013-03-487728; Soverini S, 2011, HAEMATOL-HEMATOL J, V96, P552, DOI 10.3324/haematol.2010.034173; STEIN H, 1985, BLOOD, V66, P848; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; van Gaal JC, 2012, J CLIN ONCOL, V30, P308, DOI 10.1200/JCO.2011.37.8588; Wan WH, 2006, BLOOD, V107, P1617, DOI 10.1182/blood-2005-08-3254; Willis SG, 2005, BLOOD, V106, P2128, DOI 10.1182/blood-2005-03-1036; Woessmann W, 2011, J CLIN ONCOL, V29, P3065, DOI 10.1200/JCO.2011.34.8417; Zdzalik D, 2014, J CANCER RES CLIN, V140, P589, DOI 10.1007/s00432-014-1589-3; Zhang S, 2011, CHEM BIOL DRUG DES, V78, P999, DOI 10.1111/j.1747-0285.2011.01239.x	52	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121378	10.1371/journal.pone.0121378	http://dx.doi.org/10.1371/journal.pone.0121378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874976	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100040
J	Morton, SU; Joshi, M; Savic, T; Beggs, AH; Agrawal, PB				Morton, Sarah U.; Joshi, Mugdha; Savic, Talia; Beggs, Alan H.; Agrawal, Pankaj B.			Skeletal Muscle MicroRNA and Messenger RNA Profiling in Cofilin-2 Deficient Mice Reveals Cell Cycle Dysregulation Hindering Muscle Regeneration	PLOS ONE			English	Article							CONGENITAL MYOPATHIES; NEMALINE MYOPATHY; UP-REGULATION; P21; PROLIFERATION; MYOGENESIS; ARREST; GENE; CHOLESTEROL; APOPTOSIS	Congenital myopathies are rare skeletal muscle diseases presenting in early age with hypotonia and weakness often linked to a genetic defect. Mutations in the gene for cofilin-2 (CFL2) have been identified in several families as a cause of congenital myopathy with nemaline bodies and cores. Here we explore the global messenger and microRNA expression patterns in quadriceps muscle samples from cofillin-2-null mice and compare them with sibling-matched wild-type mice to determine the molecular pathways and mechanisms involved. Cell cycle processes are markedly dysregulated, with altered expression of genes involved in mitotic spindle formation, and evidence of loss of cell cycle checkpoint regulation. Importantly, alterations in cell cycle, apoptosis and proliferation pathways are present in both mRNA and miRNA expression patterns. Specifically, p21 transcript levels were increased, and the expression of p21 targets, such as cyclin D and cyclin E, was decreased. We therefore hypothesize that deficiency of cofilin-2 is associated with interruption of the cell cycle at several checkpoints, hindering muscle regeneration. Identification of these pathways is an important step towards developing appropriate therapies against various congenital myopathies.	[Morton, Sarah U.; Joshi, Mugdha; Agrawal, Pankaj B.] Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Morton, Sarah U.; Joshi, Mugdha; Savic, Talia; Beggs, Alan H.; Agrawal, Pankaj B.] Harvard Univ, Sch Med, Boston, MA USA; [Morton, Sarah U.; Joshi, Mugdha; Savic, Talia; Beggs, Alan H.; Agrawal, Pankaj B.] Boston Childrens Hosp, Dept Med, Div Genet & Genom, Boston, MA USA; [Morton, Sarah U.; Joshi, Mugdha; Savic, Talia; Beggs, Alan H.; Agrawal, Pankaj B.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Agrawal, PB (corresponding author), Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA.	pagrawal@enders.tch.harvard.edu	Agrawal, Pankaj/ABG-8957-2021	Beggs, Alan/0000-0001-8818-0568; Hitt, Talia/0000-0003-4491-3648; Morton, Sarah/0000-0002-7816-2646	National Institutes of Health [T32 HD 007466]; National Institute of Arthritis and Musculoskeletal and Skeletal Diseases (NIAMS) of NIH [K08 AR055072]; NIH [R01 AR044345, R01 HD075802, P30 HD018655]; Muscular Dystrophy Association of USA [MDA201302]; AUism Charitable Foundation; A Foundation Building Strength; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466, R01HD075802, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044345, K08AR055072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skeletal Diseases (NIAMS) of NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association of USA(Muscular Dystrophy Association); AUism Charitable Foundation; A Foundation Building Strength; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	SUM is supported via an National Institutes of Health T32 HD 007466 and PBA supported by K08 AR055072 from the National Institute of Arthritis and Musculoskeletal and Skeletal Diseases (NIAMS) of NIH. This work was also supported by NIH R01 AR044345 and R01 HD075802, the Muscular Dystrophy Association of USA (MDA201302), and generous gifts and grants from the AUism Charitable Foundation and A Foundation Building Strength (AHB). Microarray studies were performed by the IDDRC Molecular Genetics Core Facility at Boston Children's Hospital, supported by NIH P30 HD018655.	Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Agrawal PB, 2012, HUM MOL GENET, V21, P2341, DOI 10.1093/hmg/dds053; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Baron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026952; Briolay A, 2013, BBA-BIOMEMBRANES, V1828, P602, DOI 10.1016/j.bbamem.2012.10.006; Endesfelder S, 2005, J MOL MED, V83, P64, DOI 10.1007/s00109-004-0607-3; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Hawke TJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1019, DOI 10.1152/ajpcell.00055.2003; Kass EM, 2009, CELL CYCLE, V8, P430, DOI 10.4161/cc.8.3.7624; Kwon B, 2014, HUM MOL GENET, V23, P3681, DOI 10.1093/hmg/ddu077; Li J, 2014, STEM CELLS; Loro E, 2010, CELL DEATH DIFFER, V17, P1315, DOI 10.1038/cdd.2010.33; Moll UM, 2003, MOL CANCER RES, V1, P1001; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; North KN, 2014, NEUROMUSCULAR DISORD, V24, P97, DOI 10.1016/j.nmd.2013.11.003; Ockeloen CW, 2012, NEUROMUSCULAR DISORD, V22, P632, DOI 10.1016/j.nmd.2012.03.008; Ong RW, 2014, J NEUROL NEUROSURG P; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Papalouka V, 2009, MOL CELL BIOL, V29, P6046, DOI 10.1128/MCB.00654-09; Portilho DM, 2012, EUR J PHARMACOL, V694, P1, DOI 10.1016/j.ejphar.2012.07.035; Riechman SE, 2007, J GERONTOL A-BIOL, V62, P1164, DOI 10.1093/gerona/62.10.1164; Sakellariou A, 2011, IEEE T INF TECHNOL B, V15, P349, DOI 10.1109/TITB.2011.2130531; Sanoudou D, 2003, P NATL ACAD SCI USA, V100, P4666, DOI 10.1073/pnas.0330960100; Sanoudou D, 2004, PHYSIOL GENOMICS, V16, P222, DOI 10.1152/physiolgenomics.00137.2003; Sharma MC, 2009, ACTA NEUROL SCAND, V119, P281, DOI 10.1111/j.1600-0404.2008.01126.x; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Vandamme D, 2009, CELL MOTIL CYTOSKEL, V66, P179, DOI 10.1002/cm.20340; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Wattanasirichaigoon D, 2002, NEUROLOGY, V59, P613, DOI 10.1212/WNL.59.4.613; Weise C, 2006, ANAT EMBRYOL, V211, P639, DOI 10.1007/s00429-006-0117-x; Xu HL, 2014, BIOCHEM BIOPH RES CO, V446, P235, DOI 10.1016/j.bbrc.2014.02.105; Yamauchi J, 2013, HUM MOL GENET, V22, P4306, DOI 10.1093/hmg/ddt280; Zhu B, 2014, INT J CANCER, V135, P785, DOI 10.1002/ijc.28721	35	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123829	10.1371/journal.pone.0123829	http://dx.doi.org/10.1371/journal.pone.0123829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874796	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100216
J	Narang, S; Best, A; Curtis, S; Manocha, D				Narang, Sahil; Best, Andrew; Curtis, Sean; Manocha, Dinesh			Generating Pedestrian Trajectories Consistent with the Fundamental Diagram Based on Physiological and Psychological Factors	PLOS ONE			English	Article								Pedestrian crowds often have been modeled as many-particle system including microscopic multi-agent simulators. One of the key challenges is to unearth governing principles that can model pedestrian movement, and use them to reproduce paths and behaviors that are frequently observed in human crowds. To that effect, we present a novel crowd simulation algorithm that generates pedestrian trajectories that exhibit the speed-density relationships expressed by the Fundamental Diagram. Our approach is based on biomechanical principles and psychological factors. The overall formulation results in better utilization of free space by the pedestrians and can be easily combined with well-known multi-agent simulation techniques with little computational overhead. We are able to generate human-like dense crowd behaviors in large indoor and outdoor environments and validate the results with captured real-world crowd trajectories.	[Narang, Sahil; Best, Andrew; Curtis, Sean; Manocha, Dinesh] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Manocha, D (corresponding author), Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA.	dm@cs.unc.edu			NSF [1000579, 1117127, 1305286]; Intel; Boeing Company	NSF(National Science Foundation (NSF)); Intel(Intel Corporation); Boeing Company	This work was supported by NSF awards 1000579, 1117127, 1305286, Intel, and a grant from the Boeing Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Best A., 2014, P ACM SIGGRAPH EUR S, P97; Blue V.J., 1999, TRANSPORT RES REC, V1678, P135, DOI [10.3141/1678-17, DOI 10.3141/1678-17]; Burghardt S, 2012, PEDESTRIAN EVACUATIO; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; Chattaraj U, 2009, ADV COMPLEX SYST, V12, P393, DOI 10.1142/S0219525909002209; Chraibi M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046111; Curtis S., 2014, PEDESTRIAN EVACUATIO, P875, DOI 10.1007/978-3-319-02447-9_73; DEAN GA, 1965, ERGONOMICS, V8, P31, DOI 10.1080/00140136508930772; Degond P, 2013, J STAT PHYS, V152, P1033, DOI 10.1007/s10955-013-0805-x; Gerin-Lajoie M, 2005, MOTOR CONTROL, V9, P242, DOI 10.1123/mcj.9.3.242; Golas Abhinav, 2013, P ACM SIGGRAPH S INT, P29, DOI DOI 10.1145/2448196.2448200; Guy SJ, 2010, PROCEEDINGS OF THE TWENTY-SIXTH ANNUAL SYMPOSIUM ON COMPUTATIONAL GEOMETRY (SCG'10), P115, DOI 10.1145/1810959.1810981; Hartmann D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043032; He L, 2013, IEEE INT CONF ROBOT, P2839, DOI 10.1109/ICRA.2013.6630970; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2014, J STAT PHYS, P1; Hughes RL, 2002, TRANSPORT RES B-METH, V36, P507, DOI 10.1016/S0191-2615(01)00015-7; Inman V., 1981, HUMAN WALKING; Jaillet L, 2004, INT C INT ROB SYST, V2, P1606, DOI DOI 10.1109/IROS.2004.1389625; Kim S., 2013, P 12 ACM SIGGRAPHEUR, P125; Klupfel H, 2001, THEORETICAL AND PRACTICAL ISSUES ON CELLULAR AUTOMATA, P63; Kretz T., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P166, DOI 10.1109/ICCVW.2011.6130239; Kretz T, 2006, LECT NOTES COMPUT SC, V4173, P712; Kretz T, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03012; LaValle S.M., 2006, PLANNING ALGORITHMS, P1007; Lemercier S, 2012, COMPUT GRAPH FORUM, V31, P489, DOI 10.1111/j.1467-8659.2012.03028.x; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Narain R, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1618452.1618468; Ondrej J, 2010, P 2010 ACM SIGGRAPH, V123, P9; Pelechano N, 2007, SYMPOSIUM ON COMPUTER ANIMATION 2007: ACM SIGGRAPH/ EUROGRAPHICS SYMPOSIUM PROCEEDINGS, P99; Pettre J., 2009, SCA 09 P 2009 ACM SI, P189, DOI [10.1145/1599470.1599495, DOI 10.1145/1599470.1599495]; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Reynolds CW, 1999, GAME DEV C; Schadschneider A, 2002, PEDESTRIAN AND EVACUATION DYNAMICS, P75; Schadschneider A., 2011, PEDESTRIAN EVACUATIO, P557; Seyfried A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/P10002; Snook G., 2000, GAME PROGRAMMING GEM, P288; Sud A, 2007, VRST 2007: ACM SYMPOSIUM ON VIRTUAL REALITY SOFTWARE AND TECHNOLOGY, PROCEEDINGS, P99; Treuille A, 2006, ACM T GRAPHIC, V25, P1160, DOI 10.1145/1141911.1142008; van den Berg J., 2009, INT S ROB RES; van den Berg J, 2008, I3D 2008: SYMPOSIUM ON INTERACTIVE 3D GRAPHICS AND GAMES, PROCEEDINGS, P139; van Toll WG, 2012, COMPUT ANIMAT VIRT W, V23, P535, DOI 10.1002/cav.1468; van Toll WG, 2012, COMPUT ANIMAT VIRT W, V23, P59, DOI 10.1002/cav.1424; Weidmann U., 1993, TRANSPORTTECHNIK FUS; Zhang J, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/02/P02002; Zhang J, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/06/P06004	46	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0117856	10.1371/journal.pone.0117856	http://dx.doi.org/10.1371/journal.pone.0117856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875932	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100002
J	Saito, M; Takano, T; Nishimura, T; Kohara, M; Tsukiyama-Kohara, K				Saito, Makoto; Takano, Takashi; Nishimura, Tomohiro; Kohara, Michinori; Tsukiyama-Kohara, Kyoko			3 beta-Hydroxysterol Delta 24-Reductase on the Surface of Hepatitis C Virus-Related Hepatocellular Carcinoma Cells Can Be a Target for Molecular Targeting Therapy	PLOS ONE			English	Article							INTRACELLULAR CHOLESTEROL TRANSPORT; GRANULIN-EPITHELIN PRECURSOR; LIVER-TRANSPLANTATION; INDUCED APOPTOSIS; CYCLOSPORINE-A; EXPRESSION; ANTIBODY; GENE; CANCER; SORAFENIB	In our previous study, we demonstrated that 3 beta-hydroxysterol Delta 24-reductase (DHCR24) was overexpressed in hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), and that its expression was induced by HCV. Using a monoclonal antibody against DHCR24 (2-152a MAb), we found that DHCR24 was specifically expressed on the surface of HCC cell lines. Based on these findings, we aimed to establish a novel targeting strategy using 2-152a MAb to treat HCV-related HCC. In the present study, we examined the antitumor activity of 2-152a MAb. In the presence of complement, HCC-derived HuH-7 cells were killed by treatment with 2-152a MAb, which was mediated by complement-dependent cytotoxicity (CDC). In addition, the antigen recognition domain of 2-152a MAb was responsible for the unique anti-HCV activity. These findings demonstrate the feasibility of using 2-152a MAb for antibody therapy against HCV-related HCC. In addition, surface DHCR24 on HCC cells exhibited a functional property, agonist-induced internalization. We showed that 2-152a MAb-mediated binding of a cytotoxic agent (a saponin-conjugated secondary antibody) to surface DHCR24 led to significant cytotoxicity. This suggests that surface DHCR24 on HCC cells can function as a carrier for internalization. Therefore, surface DHCR24 could be a valuable target for HCV-related HCC therapy, and 2-152a MAb appears to be useful for this targeted therapy.	[Saito, Makoto; Takano, Takashi; Nishimura, Tomohiro; Tsukiyama-Kohara, Kyoko] Kumamoto Univ, Dept Expt Phylaxiol, Fac Life Sci, Kumamoto, Kumamoto, Japan; [Saito, Makoto; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Takano, Takashi] Nippon Vet & Life Sci Univ, Div Vet Publ Hlth, Musashino, Tokyo, Japan; [Nishimura, Tomohiro] Kikuchi Res Ctr, Chemo Sero Therapeut Res Inst, Kumamoto, Japan; [Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima, Kagoshima 890, Japan; [Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima, Kagoshima 890, Japan	Kumamoto University; Tokyo Metropolitan Institute of Medical Science; Nippon Veterinary & Life Science University; Kagoshima University; Kagoshima University	Tsukiyama-Kohara, K (corresponding author), Kumamoto Univ, Dept Expt Phylaxiol, Fac Life Sci, 1-1-1 Honjo, Kumamoto, Kumamoto, Japan.	kkohara@vet.kagoshima-u.ac.jp			Japan Science and Technology Agency [AS221Z04401G]; Ministry of Health and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases; Grants-in-Aid for Scientific Research [15H04739] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Science and Technology Agency (Grant Number AS221Z04401G), the Ministry of Health and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and the Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2014, J HEPATOL, V60, P319, DOI 10.1016/j.jhep.2013.09.008; Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9; Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Bonaccorsi L, 2008, LAB INVEST, V88, P1049, DOI 10.1038/labinvest.2008.80; Cabrera R, 2013, ALIMENT PHARM THER, V37, P91, DOI 10.1111/apt.12098; Corton JC, 1998, CANCER LETT, V134, P61, DOI 10.1016/S0304-3835(98)00241-9; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Di Stasi D, 2005, INT J CANCER, V115, P224, DOI 10.1002/ijc.20885; Fang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049717; Feng MQ, 2013, P NATL ACAD SCI USA, V110, pE1083, DOI 10.1073/pnas.1217868110; Gauthier A, 2013, HEPATOL RES, V43, P147, DOI 10.1111/j.1872-034X.2012.01113.x; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ishiguro T, 2008, CANCER RES, V68, P9832, DOI 10.1158/0008-5472.CAN-08-1973; Jiang H, 2014, CANCER LETT, V342, P113, DOI 10.1016/j.canlet.2013.08.038; Jiang H, 2011, J BIOL CHEM, V286, P5913, DOI 10.1074/jbc.M110.192252; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Koike K, 2008, J GASTROEN HEPATOL, V23, pS87, DOI 10.1111/j.1440-1746.2007.05292.x; Lim SO, 2002, BIOCHEM BIOPH RES CO, V291, P1031, DOI 10.1006/bbrc.2002.6547; Luciani P, 2005, J CLIN ENDOCR METAB, V90, P6156, DOI 10.1210/jc.2005-0633; Luciani P, 2004, J CLIN ENDOCR METAB, V89, P1332, DOI 10.1210/jc.2003-031065; Maluf DG, 2010, EXPERT REV GASTROENT, V4, P445, DOI 10.1586/EGH.10.39; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Mohr L, 2004, GASTROENTEROLOGY, V127, pS225, DOI 10.1053/j.gastro.2004.09.037; Mohr L, 1999, HEPATOLOGY, V29, P82, DOI 10.1002/hep.510290148; Nakano K, 2009, BIOCHEM BIOPH RES CO, V378, P279, DOI 10.1016/j.bbrc.2008.11.033; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; Nuti F, 2009, J PATHOL, V219, P491, DOI 10.1002/path.2622; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ranieri G, 2012, CURR MED CHEM, V19, P938, DOI 10.2174/092986712799320736; Rubin A, 2011, CLIN RES HEPATOL GAS, V35, P805, DOI 10.1016/j.clinre.2011.04.009; Saito M, 2012, J MED VIROL, V84, P733, DOI 10.1002/jmv.23250; Salem NE, 2013, MICROBIOL IMMUNOL, V57, P179, DOI 10.1111/1348-0421.12025; Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022; Satoh M, 2011, J INFECT DIS, V204, P1172, DOI 10.1093/infdis/jir501; Shiraishi S, 2000, NEUROSCI LETT, V293, P211, DOI 10.1016/S0304-3940(00)01513-5; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Takano T, 2011, J HEPATOL, V55, P512, DOI 10.1016/j.jhep.2010.12.011; Tran TT, 2000, J BIOL CHEM, V275, P35708, DOI 10.1074/jbc.M005636200; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Vainio S, 2003, ANN MED, V35, P146, DOI 10.1080/07853890310008198; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wong NCL, 2014, MOL CANCER THER, V13, P3001, DOI 10.1158/1535-7163.MCT-14-0012; Zhu AX, 2007, CANCER-AM CANCER SOC, V110, P581, DOI 10.1002/cncr.22829	46	5	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124197	10.1371/journal.pone.0124197	http://dx.doi.org/10.1371/journal.pone.0124197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875901	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100244
J	Stanley, ML; Simpson, SL; Dagenbach, D; Lyday, RG; Burdette, JH; Laurienti, PJ				Stanley, Matthew L.; Simpson, Sean L.; Dagenbach, Dale; Lyday, Robert G.; Burdette, Jonathan H.; Laurienti, Paul J.			Changes in Brain Network Efficiency and Working Memory Performance in Aging	PLOS ONE			English	Article							RESTING-STATE NETWORKS; AGE-RELATED-CHANGES; MINI-MENTAL STATE; FUNCTIONAL CONNECTIVITY; DECISION-MAKING; ADULT AGE; ACCURACY; MODEL; ARCHITECTURE; ATTENTION	Working memory is a complex psychological construct referring to the temporary storage and active processing of information. We used functional connectivity brain network metrics quantifying local and global efficiency of information transfer for predicting individual variability in working memory performance on an n- back task in both young (n = 14) and older (n = 15) adults. Individual differences in both local and global efficiency during the working memory task were significant predictors of working memory performance in addition to age (and an interaction between age and global efficiency). Decreases in local efficiency during the working memory task were associated with better working memory performance in both age cohorts. In contrast, increases in global efficiency were associated with much better working performance for young participants; however, increases in global efficiency were associated with a slight decrease in working memory performance for older participants. Individual differences in local and global efficiency during resting-state sessions were not significant predictors of working memory performance. Significant group whole-brain functional network decreases in local efficiency also were observed during the working memory task compared to rest, whereas no significant differences were observed in network global efficiency. These results are discussed in relation to recently developed models of age-related differences in working memory.	[Stanley, Matthew L.; Simpson, Sean L.; Dagenbach, Dale; Lyday, Robert G.; Burdette, Jonathan H.; Laurienti, Paul J.] Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27157 USA; [Simpson, Sean L.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Dagenbach, Dale] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA; [Burdette, Jonathan H.; Laurienti, Paul J.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Stanley, ML (corresponding author), Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27157 USA.	stanleymattl9@gmail.com			Wake Forest Older Americans Independence Center [P3021332]; Sticht Center on Aging at Wake Forest School of Medicine; Translational Science Center at Wake Forest University; NIBIB [K25 EB012236-01A1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB012236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021332] Funding Source: NIH RePORTER	Wake Forest Older Americans Independence Center; Sticht Center on Aging at Wake Forest School of Medicine; Translational Science Center at Wake Forest University; NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially supported by the Wake Forest Older Americans Independence Center (P3021332), the Sticht Center on Aging at Wake Forest School of Medicine, and the Translational Science Center at Wake Forest University. Sean Simpson was supported by NIBIB K25 EB012236-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Barrett LF, 2013, CURR OPIN NEUROBIOL, V23, P361, DOI 10.1016/j.conb.2012.12.012; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Behrmann M, 2013, TRENDS COGN SCI, V17, P210, DOI 10.1016/j.tics.2013.03.007; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Botwinick J, 1973, AGING AND BEHAVIOR A; Bravo G, 1997, INT J GERIATR PSYCH, V12, P1008, DOI 10.1002/(SICI)1099-1166(199710)12:10<1008::AID-GPS676>3.0.CO;2-A; Brinley JF, 1965, BEHAV AGING NERVOUS, P114; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cao H, 2014, NEUROIMAGE, V84, P888, DOI 10.1016/j.neuroimage.2013.09.013; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2011, J NEUROSCI, V31, P17242, DOI 10.1523/JNEUROSCI.0309-11.2011; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Gilbert B, 2005, NEUROPSYCHOLOGY, V19, P106, DOI 10.1037/0894-4105.19.1.106; Grossman M, 2002, NEUROIMAGE, V15, P302, DOI 10.1006/nimg.2001.0971; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Haatveit BC, 2010, J CLIN EXP NEUROPSYC, V32, P871, DOI 10.1080/13803391003596421; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Ishihara S, 1917, TESTS FOR COLOR BLIN; Jolles DD, 2011, DEVELOPMENTAL SCI, V14, P713, DOI 10.1111/j.1467-7687.2010.01016.x; Kensinger EA, 2003, NEUROPSYCHOLOGY, V17, P230, DOI 10.1037/0894-4105.17.2.230; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Macmillan NA, 1997, SPATIAL VISION, V11, P141; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; Meunier D, 2014, NEUROIMAGE, V95, P264, DOI 10.1016/j.neuroimage.2014.03.041; Moussa MN, 2014, BRAIN CONNECT, V4, P193, DOI 10.1089/brain.2013.0184; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; Pessoa L, 2012, BEHAV BRAIN SCI, V35, P158, DOI 10.1017/S0140525X11001567; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; PRADHAN SN, 1980, LIFE SCI, V26, P1643, DOI 10.1016/0024-3205(80)90172-1; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ratcliff R, 2007, PSYCHOL AGING, V22, P56, DOI 10.1037/0882-7974.22.1.56; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rzucidlo JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070275; Sala-Llonch R, 2014, NEUROBIOL AGING, V35, P2193, DOI 10.1016/j.neurobiolaging.2014.04.007; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; SALTHOUSE TA, 1979, ERGONOMICS, V22, P811, DOI 10.1080/00140137908924659; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schneider W, 2001, E PRIME USERS GUIDE, DOI [10.3758/s13428-012-0302-1, DOI 10.3758/S13428-012-0302-1]; SMITH GA, 1985, BRIT J PSYCHOL, V76, P199, DOI 10.1111/j.2044-8295.1985.tb01943.x; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stanley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00954; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Starns JJ, 2010, PSYCHOL AGING, V25, P377, DOI 10.1037/a0018022; Stevens AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030468; Stopford CL, 2007, CORTEX, V43, P846, DOI 10.1016/S0010-9452(08)70684-1; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; SWETS JA, 1961, PSYCHOL REV, V68, P301, DOI 10.1037/0033-295X.68.5.301; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Telesford QK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00067; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055347	96	58	58	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123950	10.1371/journal.pone.0123950	http://dx.doi.org/10.1371/journal.pone.0123950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875001	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100226
J	Li, PP; Shi, JX; Zhang, P; Wang, K; Li, JL; Liu, HJ; Zhou, Y; Xu, X; Hao, J; Sun, XY; Pang, XW; Li, Y; Wu, HN; Chen, XP; Ge, Q				Li, Pingping; Shi, Junxiu; Zhang, Peng; Wang, Ke; Li, Jinglong; Liu, Hongju; Zhou, Yu; Xu, Xi; Hao, Jie; Sun, Xiuyuan; Pang, Xuewen; Li, Yan; Wu, Hounan; Chen, Xiaoping; Ge, Qing			Simulated microgravity disrupts intestinal homeostasis and increases colitis susceptibility	FASEB JOURNAL			English	Article						IL-10; neutrophil; microbiota	IMMUNE-SYSTEM DYSREGULATION; HEAD-DOWN TILT; SHORT-DURATION; BED REST; CYTOKINE PRODUCTION; SPACEFLIGHT; MUCOSAL; CELLS; INFLAMMATION; DEFICIENCY	The immune systems can be altered by spaceflight in many aspects, but microgravity-related mucosal immune changes and its clinical significance have not been well studied. The purpose of this study was to investigate whether simulated microgravity influences the intestinal homeostasis and increases the susceptibility to colon inflammation. The hindlimb unloading (HU) mouse model was used to simulate the microgravity condition. Three percent dextran sulfate sodium (DSS) was given to mice to induce colitis. Compared to ground control (Ctrl) mice, the HU ones revealed an impaired intestinal homeostasis and increased susceptibility to DSS-induced colitis. This includes an early-onset, 4-fold expansion of segmented filamentous bacteria (SFB), more than 2-fold decrease in regulatory T (T-reg) cell numbers and IL-10 production, similar to 2-fold increase in colonic IL-1 beta expression, 2-fold increase in circulating neutrophils, and colonic neutrophil infiltration. The application of antibiotics ameliorated the T-reg and IL-10 reductions but did not significantly dampen neutrophilia and elevated expression of colonic IL-1 beta. These results indicate that the intestinal microflora and innate immune system both respond to simulated microgravity and together, contribute to the proinflammatory shift in the gut microenvironment. The data also emphasize the necessity for evaluating the susceptibility to inflammatory bowel diseases (IBDs) in distant space travels.	[Li, Pingping; Shi, Junxiu; Wang, Ke; Zhou, Yu; Xu, Xi; Hao, Jie; Sun, Xiuyuan; Pang, Xuewen; Li, Yan; Ge, Qing] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Key Lab Med Immunol,Minist Hlth,Dept Immunol, Beijing 100191, Peoples R China; [Wu, Hounan] Peking Univ, Hlth Sci Ctr, Med & Hlth Analyt Ctr, Beijing 100191, Peoples R China; [Zhang, Peng; Liu, Hongju; Chen, Xiaoping] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Li, Jinglong] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Li, Jinglong] Shaanxi Normal Univ, Key Lab Modern Teaching Technol, Xian, Peoples R China	Peking University; Peking University; Shaanxi Normal University; Shaanxi Normal University	Ge, Q (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Sch Basic Med Sci, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	xpchen2009@163.com; qingge@bjmu.edu.cn	Li, Ping/GYV-4914-2022; Shi, Junxiu/GXH-8588-2022; Shi, Junxiu/M-1393-2019		Natural Basic Research Program of China [2011CB711000, 2010CB945300]; National Natural Science Foundation of China [31270935, 81471525, 31171144, 81272177]; Beijing Natural Science Foundation [5152010]; State Key Laboratory Grant of Space Medicine Fundamentals and Application [SMFA10A01]	Natural Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); State Key Laboratory Grant of Space Medicine Fundamentals and Application	The authors thank Professors Xiaohuan Guo (Qinghua University), Zhihua Liu (Institute of Biophysics, Chinese Academy of Sciences), Yu Zhang, Wenling Han, and Lu Wang (Peking University Health Science Center) for helpful discussions. This work was supported by grants from the Natural Basic Research Program of China (2011CB711000 and 2010CB945300; to Q.G.), National Natural Science Foundation of China (31270935 and 81471525, to Q.G.; 31171144 and 81272177, to X.C.), Beijing Natural Science Foundation (5152010; to Q.G.), and State Key Laboratory Grant of Space Medicine Fundamentals and Application (SMFA10A01; to X.C.). The authors declare no conflicts of interest.	Arunasri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057860; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bernstein CN, 2005, GASTROENTEROLOGY, V129, P827, DOI 10.1053/j.gastro.2005.06.021; Brazil JC, 2013, INFLAMM BOWEL DIS, V19, P1556, DOI 10.1097/MIB.0b013e318281f54e; Chakraborty N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-659; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Crucian B, 2013, J CLIN IMMUNOL, V33, P456, DOI 10.1007/s10875-012-9824-7; Crucian B, 2011, AVIAT SPACE ENVIR MD, V82, P857, DOI 10.3357/ASEM.3047.2011; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Foster JS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01340; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Furusawa Y, 2015, SEMIN IMMUNOPATHOL, V37, P17, DOI 10.1007/s00281-014-0455-3; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Girardi C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/296747; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Huang BL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00013; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kaur I, 2004, BRAIN BEHAV IMMUN, V18, P443, DOI 10.1016/j.bbi.2003.10.005; Kaur I, 2008, CLIN VACCINE IMMUNOL, V15, P1523, DOI 10.1128/CVI.00065-08; Kelsen J, 2012, CYTOKINE, V59, P403, DOI 10.1016/j.cyto.2012.04.032; Klaus D, 1997, MICROBIOL-SGM, V143, P449, DOI 10.1099/00221287-143-2-449; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Lynch SV, 2004, J BACTERIOL, V186, P8207, DOI 10.1128/JB.186.24.8207-8212.2004; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; McCarville JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068961; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Noor SO, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-134; Novoselova E. G., 2014, IMMUNOBIOLOGY, V220, P500; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Ruby E, 2004, SCIENCE, V303, P1305, DOI 10.1126/science.1094662; Sanz Y, 2014, ADV EXP MED BIOL, V817, P291, DOI 10.1007/978-1-4939-0897-4_14; SAWYER HR, 1992, J APPL PHYSIOL, V73, pS148, DOI 10.1152/jappl.1992.73.2.S148; Schmitt DA, 2000, PFLUG ARCH EUR J PHY, V441, pR79, DOI 10.1007/s004240000349; Schmitt DA, 1996, J INTERF CYTOK RES, V16, P151, DOI 10.1089/jir.1996.16.151; Shih VFS, 2014, P NATL ACAD SCI USA, V111, P13942, DOI 10.1073/pnas.1323852111; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Xiang L, 2010, APPL BIOCHEM BIOTECH, V162, P654, DOI 10.1007/s12010-009-8836-0; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077401; Xu XR, 2014, WORLD J GASTROENTERO, V20, P3255, DOI 10.3748/wjg.v20.i12.3255; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044329; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	53	34	41	1	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3263	3273		10.1096/fj.15-271700	http://dx.doi.org/10.1096/fj.15-271700			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25877215				2022-12-26	WOS:000358796900015
J	Sahoo, SK; Shaikh, SA; Sopariwala, DH; Bal, NC; Bruhn, DS; Kopec, W; Khandelia, H; Periasamy, M				Sahoo, Sanjaya K.; Shaikh, Sana A.; Sopariwala, Danesh H.; Bal, Naresh C.; Bruhn, Dennis Skjoth; Kopec, Wojciech; Khandelia, Himanshu; Periasamy, Muthu			The N Terminus of Sarcolipin Plays an Important Role in Uncoupling Sarco-endoplasmic Reticulum Ca2+-ATPase (SERCA) ATP Hydrolysis from Ca2+ Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; FUNCTIONAL ASSOCIATION; CRYSTAL-STRUCTURES; HEAT-PRODUCTION; AMINO-ACIDS; PHOSPHOLAMBAN INHIBITION; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; PROTEIN	The sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) is responsible for intracellular Ca2+ homeostasis. SERCA activity in muscle can be regulated by phospholamban (PLB), an affinity modulator, and sarcolipin (SLN), an uncoupler. Although PLB gets dislodged from Ca2+-bound SERCA, SLN continues to bind SERCA throughout its kinetic cycle and promotes uncoupling of Ca2+ transport from ATP hydrolysis. To determine the structural regions of SLN that mediate uncoupling of SERCA, we employed mutagenesis and generated chimeras of PLB and SLN. In this study we demonstrate that deletion of SLN N-terminal residues (2)ERSTQ leads to loss of the uncoupling function even though the truncated peptide can target and constitutively bind SERCA. Furthermore, molecular dynamics simulations of SLN and SERCA interaction showed a rearrangement of SERCA residues that is altered when the SLN N terminus is deleted. Interestingly, transfer of the PLB cytosolic domain to the SLN transmembrane (TM) and luminal tail causes the chimeric protein to lose SLN-like function. Further introduction of the PLB TM region into this chimera resulted in conversion to full PLB-like function. We also found that swapping PLB N and C termini with those from SLN caused the resulting chimera to acquire SLN-like function. Swapping the C terminus alone was not sufficient for this conversion. These results suggest that domains can be switched between SLN and PLB without losing the ability to regulate SERCA activity; however, the resulting chimeras acquire functions different from the parent molecules. Importantly, our studies highlight that the N termini of SLN and PLB influence their respective unique functions.	[Shaikh, Sana A.; Sopariwala, Danesh H.; Bal, Naresh C.; Periasamy, Muthu] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bruhn, Dennis Skjoth; Kopec, Wojciech; Khandelia, Himanshu] Univ Southern Denmark, Ctr Biomembrane Phys, MEMPHYS, DK-5230 Odense M, Denmark; [Sahoo, Sanjaya K.; Periasamy, Muthu] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA	University System of Ohio; Ohio State University; University of Southern Denmark; Sanford Burnham Prebys Medical Discovery Institute	Periasamy, M (corresponding author), 013 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Regan, Clinton/E-6250-2012	Bruhn, Dennis Skjoth/0000-0003-1362-4747; Khandelia, Himanshu/0000-0001-9913-6394	National Institutes of Health [RO1-HL088555, RO1-DK098240-01]; American Heart Association [14POST20380847, 13PRE17000059]; Lundbeckfonden Young Investigator Grant; Lundbeck Foundation [R82-2011-7280] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Lundbeckfonden Young Investigator Grant; Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL088555 and RO1-DK098240-01 (to M. P.).; Supported by Postdoctoral Fellowship 14POST20380847 from the American Heart Association.; Supported by Pre-doctoral Fellowship 13PRE17000059 from the American Heart Association.; Supported by a Lundbeckfonden Young Investigator Grant.	Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; ANDERSEN JP, 1995, J BIOL CHEM, V270, P908, DOI 10.1074/jbc.270.2.908; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Chen Z., 2005, J BIOL CHEM, V280, P10530; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2014, J BIOL CHEM, V289, P31241, DOI 10.1074/jbc.M114.584086; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Meis L, 2002, J MEMBRANE BIOL, V188, P1, DOI 10.1007/s00232-001-0171-5; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; Espinoza-Fonseca LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095979; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Ji Y, 1999, ANAL BIOCHEM, V269, P236, DOI 10.1006/abio.1999.4059; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; KISS E, 1995, CIRC RES, V77, P759, DOI 10.1161/01.RES.77.4.759; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Loubet B, 2014, J CHEM THEORY COMPUT, V10, P5690, DOI 10.1021/ct500100f; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Mascioni A, 2002, BIOCHEMISTRY-US, V41, P475, DOI 10.1021/bi011243m; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Sopariwala DH, 2015, J APPL PHYSIOL, V118, P1050, DOI 10.1152/japplphysiol.01066.2014; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; TOYOFUKU T, 1993, J BIOL CHEM, V268, P2809; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Zheng JY, 2014, CIRC-HEART FAIL, V7, P194, DOI 10.1161/CIRCHEARTFAILURE.113.000519	60	42	43	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14057	14067		10.1074/jbc.M115.636738	http://dx.doi.org/10.1074/jbc.M115.636738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882845	Green Published, hybrid			2022-12-26	WOS:000355313000035
J	Etokebe, GE; Zienolddiny, S; Kupanovac, Z; Enersenl, M; Balen, S; Flego, V; Bulat-Kardum, L; Radojcic-Badovinac, A; Skaug, V; Bakke, P; Haugen, A; Dembic, Z				Etokebe, Godfrey Essien; Zienolddiny, Shanbeh; Kupanovac, Zeljko; Enersen, Morten; Balen, Sanja; Flego, Veljko; Bulat-Kardum, Ljiljana; Radojcic-Badovinac, Andelka; Skaug, Vidar; Bakke, Per; Haugen, Aage; Dembic, Zlatko			Association of the FAM46A Gene VNTRs and BAG6 rs3117582 SNP with Non Small Cell Lung Cancer (NSCLC) in Croatian and Norwegian Populations	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; KNEE OSTEOARTHRITIS; ANTAGONIST GENE; RISK; SUSCEPTIBILITY; POLYMORPHISMS; IDENTIFICATION; VARIANTS; FAMILIES; C6ORF37	We analyzed for associations between a variable number of tandem repeat (VNTR) polymorphism in the Family with sequence similarity 46, member A (FAM46A) gene and a single nucleotide polymorphism (rs3117582) in the BCL2-Associated Athanogene 6 (BAG6) with non small cell lung cancer in Croatian and Norwegian subjects. A total of 503 (262 Croatian and 241 Norwegian) non small cell lung cancer patients and 897 controls (568 Croatian and 329 Norwegian) were analyzed. We found that the frequency of allele b (three VNTR repeats) of FAM46A gene was significantly increased in the patients compared to the healthy controls in the Croatian and the combined Croatian and Norwegian subjects. Genotype frequencies of cd (four and five VNTR repeats) and cc (four VNTR repeats homozygote) of the FAM46A gene were significantly decreased in the patients compared to the healthy controls in the Croatian and Norwegian subjects, respectively. Logistic regression analyses revealed FAM46A genotype cc to be an independent predictive factor for non small cell lung cancer risk in the Norwegian subjects after adjustment for age, gender and smoking status. This is the first study to suggest an association between the FAM46A gene VNTR polymorphisms and non small cell lung cancer. We found also that BAG6 rs3117582 SNP was associated with non small cell lung cancer in the Norwegian subjects and the combined Croatian-Norwegian subjects corroborating the earlier finding that BAG6 rs3117582 SNP was associated with lung cancer in Europeans. Logistic regression analyses revealed that genotypes and alleles of BAG6 were independent predictive factor for non small cell lung cancer risk in the Norwegian and combined Croatian-Norwegian subjects, after adjustment for age and gender.	[Etokebe, Godfrey Essien; Kupanovac, Zeljko; Enersen, Morten; Dembic, Zlatko] Univ Oslo, Fac Dent, Inst Oral Biol, Oslo, Norway; [Kupanovac, Zeljko; Flego, Veljko; Bulat-Kardum, Ljiljana] Univ Rijeka, Clin Hosp Ctr, Dept Internal Med, Sect Pulmol, Rijeka, Croatia; [Zienolddiny, Shanbeh; Skaug, Vidar; Haugen, Aage] Natl Inst Occupat Hlth, Dept Chem & Biol Working Environm, Oslo, Norway; [Balen, Sanja] Univ Rijeka, Clin Hosp Ctr, Inst Transfus Med, Rijeka, Croatia; [Bakke, Per] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Radojcic-Badovinac, Andelka] Univ Rijeka, Fac Med, Dept Biol & Med Genet, Rijeka, Croatia	University of Oslo; University of Rijeka; University of Rijeka; University of Bergen; University of Rijeka	Etokebe, GE (corresponding author), Univ Oslo, Fac Dent, Inst Oral Biol, Oslo, Norway.	godfreye@odontuio.no	Zienolddiny, Shanbeh/O-7392-2015; Badovinac, Andelka Radojcic/R-3366-2018; Balen, Sanja/S-5253-2018; Dembic, Zlatko/A-1833-2008	Badovinac, Andelka Radojcic/0000-0001-5949-5245; Balen, Sanja/0000-0003-2408-6868; Dembic, Zlatko/0000-0002-9970-6497; Zienolddiny, Shan/0000-0001-9747-9625				Aguillon JC, 2006, IMMUNOBIOLOGY, V211, P75, DOI 10.1016/j.imbio.2005.09.005; Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Azzoli CG, 2008, J THORAC ONCOL, V3, P84, DOI 10.1097/JTO.0b013e31815efe24; Barragan I, 2008, ANN HUM GENET, V72, P26, DOI 10.1111/j.1469-1809.2007.00393.x; Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Campbell L, 2010, EXPERT OPIN PHARMACO, V11, P1343, DOI 10.1517/14656566.2010.481283; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cote ML, 2012, EUR J CANCER, V48, P1957, DOI 10.1016/j.ejca.2012.01.038; Cui J, 2006, CLIN CHIM ACTA, V368, P155, DOI 10.1016/j.cca.2005.12.043; Dong J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003190; Etokebe GE, 2014, J ORTHOP RES; Etokebe GE, 2009, ARCH ORAL BIOL, V54, P1002, DOI 10.1016/j.archoralbio.2009.08.005; Etokebe GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091385; Fan WC, 2014, LUNG CANCER, V85, P472, DOI 10.1016/j.lungcan.2014.07.001; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Gridelli C, 2010, ANTICANCER RES, V30, P1301; Hannan AJ, 2010, DISCOV MED, V10, P314; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Hart K, 2011, LUNG CANCER, V71, P123, DOI 10.1016/j.lungcan.2010.04.016; Hu ZB, 2006, CANCER LETT, V236, P269, DOI 10.1016/j.canlet.2005.05.015; Jacobsen B, 2014, WORLD J CLIN ONCOL, V5, P621, DOI 10.5306/wjco.v5.i4.621; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jotanovic Z, 2012, RHEUMATOL INT, V32, P2135, DOI 10.1007/s00296-011-1946-3; Jotanovic Z, 2011, J ORTHOP RES, V29, P1137, DOI 10.1002/jor.21378; Kaarvatn MH, 2013, SCAND J IMMUNOL, V77, P151, DOI 10.1111/sji.12016; Kamper N, 2012, FASEB J, V26, P104, DOI 10.1096/fj.11-189670; Kawabata M, 1999, ANN NY ACAD SCI, V886, P73, DOI 10.1111/j.1749-6632.1999.tb09402.x; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Lagali PS, 2002, BIOCHEM BIOPH RES CO, V293, P356, DOI 10.1016/S0006-291X(02)00228-0; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lind H, 2005, LUNG CANCER, V50, P285, DOI 10.1016/j.lungcan.2005.07.003; Lindstedt BA, 1999, ANTICANCER RES, V19, P5523; Liu B, 2012, AM J HUM GENET, V91, P384, DOI 10.1016/j.ajhg.2012.07.003; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; RYBERG D, 1995, CANCER RES, V55, P3996; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Truong T, 2010, CARCINOGENESIS, V31, P625, DOI 10.1093/carcin/bgq001; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Walsh KM, 2013, CANCER EPIDEM BIOMAR, V22, P251, DOI 10.1158/1055-9965.EPI-12-1007-T; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200	46	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122651	10.1371/journal.pone.0122651	http://dx.doi.org/10.1371/journal.pone.0122651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884493	Green Published, gold			2022-12-26	WOS:000353017000038
J	Wang, JX; He, LY; Jia, LP; Tian, J; Benson, V				Wang, Jingxin; He, Liyuan; Jia, Liping; Tian, Jing; Benson, Valerie			The 'Positive Effect' Is Present in Older Chinese Adults: Evidence from an Eye Tracking Study	PLOS ONE			English	Article							CULTURAL VARIATION; NEGATIVE IMAGES; MEMORY; AGE; MOVEMENTS; COGNITION; EMOTION	The 'Positive Effect'is defined as the phenomenon of preferential cognitive processing of positive affective information, and avoidance or dismissal of negative affective information in the social environment. The 'Positive Effect'is found for older people compared with younger people in western societies and is believed to reflect a preference for positive emotional regulation in older adults. It is not known whether such an effect is Universal, and in East Asian cultures, there is a highly controversial debate concerning this question. In the current experiment we explored whether Chinese older participants showed a 'Positive Effect' when they inspected picture pairs that were either a positive or a negative picture presented with a neutral picture, or a positive and negative picture paired together. The results indicated that both groups of participants showed an attentional bias to both pleasant (more processing of) and unpleasant pictures (initial orienting to) when these were paired with neutral pictures. When pleasant and unpleasant pictures were paired together both groups showed an initial orientation bias for the pleasant picture, but the older participants showed this bias for initial orienting and increased processing measures, providing evidence of a 'Positive Effect'in older Chinese adults.	[Wang, Jingxin; He, Liyuan; Jia, Liping; Tian, Jing] Tianjin Normal Univ, Acad Psychol & Behav, Tianjin, Peoples R China; [Benson, Valerie] Univ Southampton, Sch Psychol, Ctr Visual Cognit, Southampton, Hants, England	Tianjin Normal University; University of Southampton	Benson, V (corresponding author), Univ Southampton, Sch Psychol, Ctr Visual Cognit, Southampton, Hants, England.	Vb1@soton.ac.uk	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022	Benson, Valerie/0000-0002-0351-4563	Chinese Department of Education Social Science Key Research Grant [13JJD190005]	Chinese Department of Education Social Science Key Research Grant	The study was funded by an award to Dr Jingxin Wang from the Chinese Department of Education Social Science Key Research Grant - 13JJD190005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carstensen L.L., 2006, HDB PSYCHOL AGING, P343, DOI DOI 10.1016/B978-012101264-9/50018-5; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Charles S. T., 2003, J EXP PSYCHOL, V85, P163; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Chung C, 2012, INT J AGING HUM DEV, V75, P31, DOI 10.2190/AG.75.1.d; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; Fung HH, 2008, PSYCHOL AGING, V23, P440, DOI 10.1037/0882-7974.23.2.440; Gruhn D, 2007, PSYCHOL AGING, V22, P644, DOI 10.1037/0882-7974.22.3.644; Gruhn D, 2005, PSYCHOL AGING, V20, P579, DOI 10.1037/0882-7974.20.4.579; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; Ko SG, 2011, PSYCHOL AGING, V26, P48, DOI 10.1037/a0020222; Kwon Y, 2009, PSYCHOL AGING, V24, P748, DOI 10.1037/a0016054; Leigland LA, 2004, NEUROBIOL AGING, V25, P1117, DOI 10.1016/j.neurobiolaging.2003.10.015; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Mather M, 2000, PSYCHOL AGING, V15, P596, DOI 10.1037/0882-7974.15.4.596; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mikels JA, 2005, PSYCHOL AGING, V20, P542, DOI 10.1037/0882-7974.20.4.542; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Qiu L., 2008, APPL PSYCHOL, P249, DOI 10.1093/molbev/msx285/4596561; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Scheibe S, 2009, PSYCHOL AGING, V24, P217, DOI 10.1037/a0013807; Tsai JL, 2006, J PERS SOC PSYCHOL, V90, P288, DOI 10.1037/0022-3514.90.2.288; Wang JX, 2010, CONSTRUCTION MANAGEM, V8, P61; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	32	5	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121372	10.1371/journal.pone.0121372	http://dx.doi.org/10.1371/journal.pone.0121372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25880585	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500010
J	Alba, A; Dorea, FC; Arinero, L; Sanchez, J; Cordon, R; Puig, P; Revie, CW				Alba, Anna; Dorea, Fernanda C.; Arinero, Lucas; Sanchez, Javier; Cordon, Ruben; Puig, Pere; Revie, Crawford W.			Exploring the Surveillance Potential of Mortality Data: Nine Years of Bovine Fallen Stock Data Collected in Catalonia (Spain)	PLOS ONE			English	Article							OUTBREAK	The potential of fallen stock data to monitor the health status of animal populations has been noted in previous studies. However, further research is required to implement these systems for surveillance. This work presents a novel approach to determining the baselines associated with bovine fallen stock, comparing patterns between subpopulations and identifying subpopulations in which an abnormal event may occur. This study was based on data from 193,873 disposal visits carried out between 2004 and 2012 across a total of 2,991 bovine farms. Proxy measurements such as the number of collections carried out and the weight of carcasses collected were used. Both outcomes were aggregated weekly at different geographical scales for three production types (beef cattle, dairy cattle and heifer fattening). The analysis of these data combined autoregressive integrated moving average modelling and hierarchical time series methods. The three production types exhibited historical baselines that differed notably from one another. Based on the 757 beef cattle farms monitored, the mean number of collections registered per week at the regional level was 37 (range: 10-83). This series was relatively constant over time and showed a marked yearly seasonality. In contrast, for the 426 dairy cattle farms the mean number of disposal visits registered weekly was 121 (range: 71-180), showing half-yearly and yearly seasonality and a marked increase over the period monitored. From the 1,808 heifer fattening farms the mean number of disposal visits was 248 (range: 166-357) and the pattern presented a marked alternating trend over time. These patterns were assessed and compared at regional, provincial, county and municipal levels. The use of hierarchical time series approaches appeared to be a useful tool for comparing the patterns within different subpopulations over time as well as for assessing the spatial extent to which various abnormal events could be detected.	[Alba, Anna; Cordon, Ruben] IRTA, CReSA, Barcelona 08193, Spain; [Dorea, Fernanda C.] Natl Vet Inst SVA, Dept Dis Control & Epidemiol, Uppsala, Sweden; [Arinero, Lucas] Govt Catalonia, Minist Agr Livestock Fisheries Food & Nat Environ, Barcelona, Spain; [Sanchez, Javier] UPEI, AVC, Ctr Vet Epidemiol Res, Charlottetown, PE, Canada; [Puig, Pere] Univ Autonoma Barcelona, Dept Matemat, E-08193 Barcelona, Spain	IRTA; National Veterinary Institute SVA; University of Prince Edward Island; Autonomous University of Barcelona	Alba, A (corresponding author), IRTA, CReSA, Campus UAB, Barcelona 08193, Spain.	ana.alba@cresa.uab.es	Puig, Pedro/K-4414-2014; sanchez, javier/AAA-4179-2022; Revie, Crawford/B-5002-2011	Puig, Pedro/0000-0002-6607-9642; Revie, Crawford/0000-0002-5018-0340; Dorea, Fernanda/0000-0001-8638-8525				Backer JA, 2011, PREV VET MED, V99, P38, DOI 10.1016/j.prevetmed.2010.10.008; Benschop J, 2008, EPIDEMIOL INFECT, V136, P1511, DOI 10.1017/S0950268807000234; Biswas PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098471; Chatfield Ch, 2004, THE ANALYSIS OF TIME, P33; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Dorea FC, 2014, PREV VET MED, V116, P313, DOI 10.1016/j.prevetmed.2014.04.001; Dorea FC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0114; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Dupuy C, 2013, PREV VET MED, V111, P220, DOI 10.1016/j.prevetmed.2013.06.005; HILLERS JK, 1984, J DAIRY SCI, V67, P861, DOI 10.3168/jds.S0022-0302(84)81378-8; Hyndman RJ, 2013, HTS AN R PACKAGE FOR; Hyndman RJ, 2011, COMPUT STAT DATA AN, V55, P2579, DOI 10.1016/j.csda.2011.03.006; Lee HS, 2013, PREV VET MED, V110, P190, DOI 10.1016/j.prevetmed.2012.12.003; Morignat E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093176; Morina D, 2011, STAT MED, V30, P3125, DOI 10.1002/sim.4336; Neumann EJ, 2014, NEW ZEAL VET J, V62, P110, DOI 10.1080/00480169.2013.853278; Perrin JB, 2012, PREV VET MED, V105, P244, DOI 10.1016/j.prevetmed.2011.12.015; Perrin JB, 2010, EPIDEMICS-NETH, V2, P207, DOI 10.1016/j.epidem.2010.10.002; R Core Team, 2021, R LANGUAGE ENV STAT; Roy JHB, 1980, STUDIES IN THE AGRIC, P67; Seegers H, 1998, J NATL GTV, P57; Skvortsov A, 2012, MATH BIOSCI, V240, P12, DOI 10.1016/j.mbs.2012.05.010; UAB-Produccio Animal. Fac.Veterinaria, 2013, MANUAL DE PRODUCCIO; Van der Loo MPJ, 2012, LEARNING R STUDIO FO; Van Horn HH, 1992, LARGE DAIRY HERD MAN, P597; Vial F, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-33	27	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122547	10.1371/journal.pone.0122547	http://dx.doi.org/10.1371/journal.pone.0122547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876036	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353015800063
J	Gil, A; Rodriguez-Escudero, I; Stumpf, M; Molina, M; Cid, VJ; Pulido, R				Gil, Anabel; Rodriguez-Escudero, Isabel; Stumpf, Miriam; Molina, Maria; Cid, Victor J.; Pulido, Rafael			A Functional Dissection of PTEN N-Terminus: Implications in PTEN Subcellular Targeting and Tumor Suppressor Activity	PLOS ONE			English	Article							NUCLEAR PTEN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEMBRANE ASSOCIATION; PHOSPHATASE-ACTIVITY; BINDING MOTIF; PROTEIN; CANCER; LOCALIZATION; ACTIVATION; CELLS	Spatial regulation of the tumor suppressor PTEN is exerted through alternative plasma membrane, cytoplasmic, and nuclear subcellular locations. The N-terminal region of PTEN is important for the control of PTEN subcellular localization and function. It contains both an active nuclear localization signal (NLS) and an overlapping PIP2-binding motif (PBM) involved in plasma membrane targeting. We report a comprehensive mutational and functional analysis of the PTEN N-terminus, including a panel of tumor-related mutations at this region. Nuclear/cytoplasmic partitioning in mammalian cells and PIP3 phosphatase assays in reconstituted S. cerevisiae defined categories of PTEN N-terminal mutations with distinct PIP3 phosphatase and nuclear accumulation properties. Noticeably, most tumor-related mutations that lost PIP3 phosphatase activity also displayed impaired nuclear localization. Cell proliferation and soft-agar colony formation analysis in mammalian cells of mutations with distinctive nuclear accumulation and catalytic activity patterns suggested a contribution of both properties to PTEN tumor suppressor activity. Our functional dissection of the PTEN N-terminus provides the basis for a systematic analysis of tumor-related and experimentally engineered PTEN mutations.	[Gil, Anabel; Stumpf, Miriam] Ctr Invest Principe Felipe, Valencia, Spain; [Rodriguez-Escudero, Isabel; Molina, Maria; Cid, Victor J.] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain; [Gil, Anabel; Stumpf, Miriam] Inst Ramon & Cajal Invest Sanitarias IRYCIS, Madrid, Spain; [Stumpf, Miriam] Hubrecht Inst, Utrecht, Netherlands; [Pulido, Rafael] BioCruces Hlth Res Inst, Baracaldo, Spain; [Pulido, Rafael] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain	Prince Felipe Research Center; Complutense University of Madrid; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Basque Foundation for Science	Cid, VJ (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain.	vicjcid@ucm.es; rpulidomurillo@gmail.com	Molina, Maria/ABE-7186-2021; Rodríguez, Isabel/I-5955-2017; JIMENEZ CID, VICTOR/ABC-4858-2021; CID, VICTOR JIMENEZ/I-1240-2015	Molina, Maria/0000-0003-0074-3309; Rodríguez, Isabel/0000-0002-1792-1143; JIMENEZ CID, VICTOR/0000-0002-3933-2016; CID, VICTOR JIMENEZ/0000-0002-3933-2016; Pulido, Rafael/0000-0001-9100-248X	Ministerio Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional) [SAF2009-10226]; Ministerio de Economia y Competitividad (Spain) [SAF2013-48812-R]; Ministerio de Ciencia e Innovacion (Spain) [BIO2010-22369-C02-01]; Comunidad Autonoma de Madrid (Spain) [S2011/BMD-2414]; Instituto de Salud Carlos III (Spain) [CP04/00318]	Ministerio Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional); Ministerio de Economia y Competitividad (Spain)(Spanish Government); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III)	This work was supported in part by grants SAF2009-10226 from Ministerio Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional), SAF2013-48812-R from Ministerio de Economia y Competitividad (Spain), BIO2010-22369-C02-01 from Ministerio de Ciencia e Innovacion (Spain), and S2011/BMD-2414 from Comunidad Autonoma de Madrid (Spain). A. Gil has been the recipient of CP04/00318 research contract from Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Pons A, 2005, CANCER LETT, V223, P303, DOI 10.1016/j.canlet.2004.09.047; Andres-Pons A, 2007, CANCER RES, V67, P9731, DOI 10.1158/0008-5472.CAN-07-1278; Andres-Pons A, 2012, CELL SIGNAL, V24, P577, DOI 10.1016/j.cellsig.2011.10.012; Bartholomeusz C, 2012, EXPERT OPIN THER TAR, V16, P121, DOI 10.1517/14728222.2011.644788; Bassi C, 2013, CELL DEATH DIFFER, V20, P1595, DOI 10.1038/cdd.2013.127; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234, DOI 10.2174/1568009611313030002; Cid VJ, 2008, ONCOGENE, V27, P5431, DOI 10.1038/onc.2008.240; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Fan C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-98; Farras R, 2008, MOL CELL BIOL, V28, P4173, DOI 10.1128/MCB.01620-07; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Jang KS, 2010, HISTOPATHOLOGY, V56, P229, DOI 10.1111/j.1365-2559.2009.03468.x; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Lobo GP, 2009, HUM MOL GENET, V18, P2851, DOI 10.1093/hmg/ddp220; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Mester J, 2013, AM J MED GENET C, V163C, P114, DOI 10.1002/ajmg.c.31364; Nguyen HN, 2015, ONCOGENE, V34, P3737, DOI 10.1038/onc.2014.293; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Pulido R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005560; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Redfern RE, 2010, PROTEIN SCI, V19, P1948, DOI 10.1002/pro.483; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Rodriguez-Escudero I, 2015, METHODS, V77-78, P172, DOI 10.1016/j.ymeth.2014.10.020; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004	55	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0119287	10.1371/journal.pone.0119287	http://dx.doi.org/10.1371/journal.pone.0119287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875300	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000353015800004
J	Hausler, AN; Becker, B; Bartling, M; Weber, B				Haeusler, Alexander Niklas; Becker, Benjamin; Bartling, Marcel; Weber, Bernd			Goal or Gold: Overlapping Reward Processes in Soccer Players upon Scoring and Winning Money	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; POSTERIOR CINGULATE; PREDICTION ERRORS; PREFRONTAL CORTEX; DISSOCIATION; MEMORY; RESPONSES; MEDIATE	Social rewards are important incentives for human behavior. This is especially true in team sports such as the most popular one worldwide: soccer. We investigated reward processing upon scoring a soccer goal in a standard two-versus-one situation and in comparison to winning in a monetary incentive task. The results show a strong overlap in brain activity between the two conditions in established reward regions of the mesolimbic dopaminergic system, including the ventral striatum and ventromedial pre-frontal cortex. The three main components of reward-associated learning i.e. reward probability (RP), reward reception (RR) and reward prediction errors (RPE) showed highly similar activation in both con-texts, with only the RR and RPE components displaying overlapping reward activity. Passing and shooting behavior did not correlate with individual egoism scores, but we observe a positive correlation be-tween egoism and activity in the left middle frontal gyrus upon scoring after a pass versus a direct shot. Our findings suggest that rewards in the context of soccer and monetary incentives are based on similar neural processes.	[Haeusler, Alexander Niklas; Weber, Bernd] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany; [Haeusler, Alexander Niklas; Weber, Bernd] Univ Hosp Bonn, Dept Epileptol, Bonn, Germany; [Haeusler, Alexander Niklas; Bartling, Marcel; Weber, Bernd] Life & Brain Res Ctr, Dept NeuroCognit Imaging, Bonn, Germany; [Becker, Benjamin] Univ Bonn, Dept Psychiat, Bonn, Germany; [Becker, Benjamin] Univ Bonn, Div Med Psychol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn	Hausler, AN (corresponding author), Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany.	anh@uni-bonn.de	Weber, Bernd/H-5244-2012; Becker, Benjamin/W-4971-2017	Weber, Bernd/0000-0002-7811-9605; Becker, Benjamin/0000-0002-9014-9671; Hausler, Dr. Alexander Niklas/0000-0003-3506-7566	Heisenberg Grant of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [WE 4427(3-1)]	Heisenberg Grant of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG))	BW was supported by a Heisenberg Grant of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)), WE 4427(3-1), http://www.dfg.de/en/research_funding/programmes/individual/heisenberg/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Ashton M.C., 2013, INDIVIDUAL DIFFERENC; Ashton MC, 2005, J PERS, V73, P1321, DOI 10.1111/j.1467-6494.2005.00351.x; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Baumgartner T, 2014, SOC COGN AFFECT NEUR, V9, P653, DOI 10.1093/scan/nst023; Belger A, 1998, HUM BRAIN MAPP, V6, P14, DOI 10.1002/(SICI)1097-0193(1998)6:1<14::AID-HBM2>3.0.CO;2-O; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Brosch T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00398; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; de Vries RE, 2009, EUR J PERSONALITY, V23, P635, DOI 10.1002/per.733; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; EMERSON RM, 1976, ANNU REV SOCIOL, V2, P335, DOI 10.1146/annurev.so.02.080176.002003; Erdeniz B, 2013, FRONTIERS NEUROSCIEN, V7, P1, DOI [10.3389/fnins.2013.00001, DOI 10.3389/FNINS.2013.00001]; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Fliessbach K, 2010, NEUROIMAGE, V50, P1168, DOI 10.1016/j.neuroimage.2010.01.036; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Goel V, 1998, J COGNITIVE NEUROSCI, V10, P293, DOI 10.1162/089892998562744; Harris LT, 2007, COGN AFFECT BEHAV NE, V7, P309, DOI 10.3758/CABN.7.4.309; Hilbig BE, 2009, J RES PERS, V43, P516, DOI 10.1016/j.jrp.2009.01.003; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kohls G, 2013, NEUROPSYCHOLOGIA, V51, P2062, DOI 10.1016/j.neuropsychologia.2013.07.020; Korn CW, 2012, J NEUROSCI, V32, P16832, DOI 10.1523/JNEUROSCI.3016-12.2012; Kuss K, 2013, SOC COGN AFFECT NEUR, V8, P216, DOI 10.1093/scan/nsr088; Lallement JH, 2014, SOC COGN AFFECT NEUR, V9, P342, DOI 10.1093/scan/nss147; Lee K, 2012, H FACTOR OF PERSONALITY: WHY SOME PEOPLE ARE MANIPULATIVE, SELF-ENTITLED, MATERIALISTIC, AND EXPLOITIVE - AND WHY IT MATTERS FOR EVERYONE, P1; Lin A, 2012, SOC COGN AFFECT NEUR, V7, P274, DOI 10.1093/scan/nsr006; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mars RB, 2012, CEREB CORTEX, V22, P1894, DOI 10.1093/cercor/bhr268; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McLean J, 2009, PSYCHIAT RES-NEUROIM, V171, P33, DOI 10.1016/j.pscychresns.2008.02.005; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Nielsen FA, 2005, NEUROIMAGE, V27, P520, DOI 10.1016/j.neuroimage.2005.04.034; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Prohovnik I, 2004, PSYCHIAT RES-NEUROIM, V132, P239, DOI 10.1016/j.pscychresns.2004.03.005; Race EA, 2010, CEREB CORTEX, V20, P1726, DOI 10.1093/cercor/bhp233; Race EA, 2009, J COGNITIVE NEUROSCI, V21, P1766, DOI 10.1162/jocn.2009.21132; Rohe T, 2012, EUR J NEUROSCI, V36, P2376, DOI 10.1111/j.1460-9568.2012.08125.x; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Simon D, 2014, NEUROIMAGE, V99, P1, DOI 10.1016/j.neuroimage.2014.05.071; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Strang S, 2015, SOC COGN AFFECT NEUR, V10, P790, DOI 10.1093/scan/nsu114; Strang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087654; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733	54	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122798	10.1371/journal.pone.0122798	http://dx.doi.org/10.1371/journal.pone.0122798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875594	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800075
J	Liu, G; Huang, TZ; Liu, J; Lv, XG				Liu, Gang; Huang, Ting-Zhu; Liu, Jun; Lv, Xiao-Guang			Total Variation with Overlapping Group Sparsity for Image Deblurring under Impulse Noise	PLOS ONE			English	Article							TOTAL VARIATION MINIMIZATION; AUGMENTED LAGRANGIAN METHOD; PRIMAL-DUAL METHOD; SPLITTING METHOD; RESTORATION; ALGORITHM; MULTIPLIERS; MODELS	The total variation (TV) regularization method is an effective method for image deblurring in preserving edges. However, the TV based solutions usually have some staircase effects. In order to alleviate the staircase effects, we propose a new model for restoring blurred images under impulse noise. The model consists of an l(1)-fidelity term and a TV with overlapping group sparsity (OGS) regularization term. Moreover, we impose a box constraint to the proposed model for getting more accurate solutions. The solving algorithm for our model is under the framework of the alternating direction method of multipliers (ADMM). We use an inner loop which is nested inside the majorization minimization (MM) iteration for the sub-problem of the proposed method. Compared with other TV-based methods, numerical results illustrate that the proposed method can significantly improve the restoration quality, both in terms of peak signal-to-noise ratio (PSNR) and relative error (ReE).	[Liu, Gang; Huang, Ting-Zhu; Liu, Jun] Univ Elect Sci & Technol China, Res Ctr Image & Vis Comp, Sch Math Sci, Chengdu 610054, Sichuan, Peoples R China; [Lv, Xiao-Guang] Huaihai Inst Technol, Sch Sci, Lianyungang, Jiangsu, Peoples R China	University of Electronic Science & Technology of China; Jiangsu Ocean University	Huang, TZ (corresponding author), Univ Elect Sci & Technol China, Res Ctr Image & Vis Comp, Sch Math Sci, Chengdu 610054, Sichuan, Peoples R China.	tingzhuhuang@126.com			China 973 Program [2013CB329404]; NSFC [61370147, 61170311, 61401172]; Sichuan Province Sci. and Tech. Research Project [2012GZX0080]; Nature Science Foundation of Jiangsu Province [BK20131209]	China 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Sichuan Province Sci. and Tech. Research Project; Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The work of GL, TZH and JL is supported by China 973 Program (2013CB329404), NSFC (61370147, 61170311), Sichuan Province Sci. and Tech. Research Project (2012GZX0080). The work of XGL is supported by Nature Science Foundation of Jiangsu Province (BK20131209), NSFC (61401172).	Afonso MV, 2011, IEEE T IMAGE PROCESS, V20, P681, DOI 10.1109/TIP.2010.2076294; ALLINEY S, 1994, IEEE T SIGNAL PROCES, V42, P618, DOI 10.1109/78.277854; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Bredies K, 2010, SIAM J IMAGING SCI, V3, P492, DOI 10.1137/090769521; Cai JF, 2008, INVERSE PROBL IMAG, V2, P187; Cai JF, 2009, MULTISCALE MODEL SIM, V8, P337, DOI 10.1137/090753504; Chambolle A, 1997, NUMER MATH, V76, P167, DOI 10.1007/s002110050258; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan RH, 2013, SIAM J IMAGING SCI, V6, P680, DOI 10.1137/110860185; Chan T, 2000, SIAM J SCI COMPUT, V22, P503, DOI 10.1137/S1064827598344169; Chan TF, 1999, SIAM J SCI COMPUT, V20, P1964, DOI 10.1137/S1064827596299767; Chen PY, 2014, SIGNAL PROCESS, V94, P476, DOI 10.1016/j.sigpro.2013.06.011; Clason C, 2010, SIAM J SCI COMPUT, V32, P1484, DOI 10.1137/090768217; Dong YQ, 2009, SIAM J IMAGING SCI, V2, P1168, DOI 10.1137/090758490; ECKSTEIN J, 1992, MATH PROGRAM, V55, P293, DOI 10.1007/BF01581204; Esser E., 2009, CAM REP, P9; Figueiredo MAT, 2007, IEEE T IMAGE PROCESS, V16, P2980, DOI 10.1109/TIP.2007.909318; Gabay D., 1976, Computers & Mathematics with Applications, V2, P17, DOI 10.1016/0898-1221(76)90003-1; Glowinski R, 1984, NUMERICAL METHODS NO, P1434; Goldstein T., 2012, FAST ALTERNATING DIR, P12; Guo XX, 2009, SIAM J SCI COMPUT, V31, P2322, DOI 10.1137/080724435; Hansen P.C., 2006, DEBLURRING IMAGES MA; He BS, 1998, OPER RES LETT, V23, P151, DOI 10.1016/S0167-6377(98)00044-3; KARAYIANNIS NB, 1990, IEEE T ACOUST SPEECH, V38, P1155, DOI 10.1109/29.57544; Liu G, 2013, EPRINTS13126813 ARXI; Liu G, 2014, COMPUT MATH APPL, V67, P2015, DOI 10.1016/j.camwa.2014.04.008; Lysaker M, 2006, INT J COMPUT VISION, V66, P5, DOI 10.1007/s11263-005-3219-7; Lysaker M, 2003, IEEE T IMAGE PROCESS, V12, P1579, DOI 10.1109/TIP.2003.819229; Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Oliveira JP, 2009, SIGNAL PROCESS, V89, P1683, DOI 10.1016/j.sigpro.2009.03.018; Peyre G, 2011, EUR SIGNAL PR CONF, P303; PHILLIPS DL, 1962, J ACM, V9, P84, DOI 10.1145/321105.321114; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Selesnick IW, 2013, INT CONF ACOUST SPEE, P5696, DOI 10.1109/ICASSP.2013.6638755; Steidl G, 2006, COMPUTING, V76, P135, DOI 10.1007/s00607-005-0129-z; Tikhonov A, 1995, NUMERICAL METHODS SO, V328; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wu CL, 2011, INVERSE PROBL IMAG, V5, P237, DOI 10.3934/ipi.2011.5.237; Wu CL, 2010, SIAM J IMAGING SCI, V3, P300, DOI 10.1137/090767558; Yan M, 2013, SIAM J IMAGING SCI, V6, P1227, DOI 10.1137/12087178X; Yang JF, 2009, SIAM J IMAGING SCI, V2, P569, DOI 10.1137/080730421; Yang JF, 2009, SIAM J SCI COMPUT, V31, P2842, DOI 10.1137/080732894; Yin W, 2007, MULTISCALE MODEL SIM, V6, P190, DOI 10.1137/060663027	45	18	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122562	10.1371/journal.pone.0122562	http://dx.doi.org/10.1371/journal.pone.0122562			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874860	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800065
J	Rausch, MP; Hastings, KT				Rausch, Matthew P.; Hastings, Karen Taraszka			An Exhaustion-Like Phenotype Constrains the Activity of CD4+T Cells Specific for a Self and Melanoma Antigen	PLOS ONE			English	Article							CD4(+) T-CELLS; UP-REGULATION; PD-1 PATHWAY; TOLERANCE; TYROSINASE; EXPRESSION; AUTOIMMUNITY; LYMPHOCYTES; INDUCTION; RECEPTOR	While the immune system has the capacity to recognize and destroy melanoma, tolerance mechanisms often hinder the development of effective anti-tumor immune responses. Since many melanoma antigens are self proteins expressed in normal melanocytes, self antigen exposure before tumor development can negatively impact the function of T cells specific for these self/tumor antigens. However, the contribution of self tolerance to anti-melanoma T cell dysfunction remains largely unexplored. We have previously described a TCR transgenic (Tg) mouse model in which T cells specific for the self/melanoma antigen, tyrosinase-related protein 1 (TRP1), develop in the presence of endogenous TRP1 expression (Ag+) and diminished antigen presentation due to the absence of gamma-interferoninducible lysosomal thiol reductase (GILT-/-). We show that TRP1-specific T cells from these Ag+ GILT-/-Tg mice do not protect from melanoma tumor growth, fail to induce autoimmune vitiligo, and undergo diminished proliferation compared to T cells from Ag-GILT+/+ Tg mice. Despite an increased frequency of TRP1-specific Treg cells in Ag+ GILT-/-Tg mice compared to Ag-GILT+/+ Tg animals, Treg cell depletion only partially rescues the proliferative capacity of T cells from TRP1-expressing mice, suggesting the involvement of additional suppressive mechanisms. An increased percentage of melanoma-specific T cells from Ag+ GILT-/-Tg animals express PD-1, an inhibitory receptor associated with the maintenance of T cell exhaustion. Antibody blockade of PD-1 partially improves the ability of TRP1-specific T cells from Ag+ GILT-/-Tg mice to produce IL-2. These findings demonstrate that melanoma-specific T cells exposed to a self/melanoma antigen in healthy tissue develop an exhaustion-like phenotype characterized by PD-1-mediated immunosuppression prior to encounter with tumor.	[Rausch, Matthew P.; Hastings, Karen Taraszka] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85021 USA; [Rausch, Matthew P.; Hastings, Karen Taraszka] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Hastings, Karen Taraszka] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ USA	University of Arizona; Arizona Center Cancer Care; University of Arizona; University of Arizona	Hastings, KT (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85021 USA.	khasting@email.arizona.edu	Hastings, Karen Taraszka/AAX-9487-2020	Hastings, Karen Taraszka/0000-0003-1502-8033	National Institutes of Health [K08-AR054388, R03-AR063259, T32-CA09213]; Arizona Biomedical Research Commission; NATIONAL CANCER INSTITUTE [T32CA009213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063259, K08AR054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Biomedical Research Commission; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health grants K08-AR054388 (KTH) and R03-AR063259 (KTH) and T32-CA09213 (MPR) and a grant from the Arizona Biomedical Research Commission (KTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogen B, 1996, EUR J IMMUNOL, V26, P2671, DOI 10.1002/eji.1830261119; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Fife BT, 2011, ANN NY ACAD SCI, V1217, P45, DOI 10.1111/j.1749-6632.2010.05919.x; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6; Kobayashi H, 1998, CANCER RES, V58, P296; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Parkhurst MR, 2004, J IMMUNOTHER, V27, P79, DOI 10.1097/00002371-200403000-00001; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rausch MP, 2012, J INVEST DERMATOL, V132, P154, DOI 10.1038/jid.2011.236; Rausch MP, 2010, J IMMUNOL, V185, P2828, DOI 10.4049/jimmunol.1000945; Robbins PF, 2002, J IMMUNOL, V169, P6036, DOI 10.4049/jimmunol.169.10.6036; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Topalian SL, 1996, J EXP MED, V183, P1965, DOI 10.1084/jem.183.5.1965; Touloukian CE, 2002, CANCER RES, V62, P5144; Touloukian CE, 2000, J IMMUNOL, V164, P3535, DOI 10.4049/jimmunol.164.7.3535; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	37	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123332	10.1371/journal.pone.0123332	http://dx.doi.org/10.1371/journal.pone.0123332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875653	Green Submitted, gold, Green Published			2022-12-26	WOS:000353015800091
J	Xiao, CW; Ji, QA; Wei, Q; Liu, Y; Pan, LJ; Bao, GL				Xiao, Chen-Wen; Ji, Quan-An; Wei, Qiang; Liu, Yan; Pan, Li-Jun; Bao, Guo-Lian			Digital Gene Expression Analysis of Microsporum canis Exposed to Berberine Chloride	PLOS ONE			English	Article							CANDIDA-ALBICANS; SALT-TOLERANCE; ZINC; IDENTIFICATION; APOPTOSIS; GENOME; CELLS	Berberine, a natural isoquinoline alkaloid of many medicinal herbs, has an active function against a variety of microbial infections including Microsporum canis (M. canis). However, the underlying mechanisms are poorly understood. To study the effect of berberine chloride on M. canis infection, a Digital Gene Expression (DGE) tag profiling was constructed and a transcriptome analysis of the M. canis cellular responses upon berberine treatment was performed. Illimina/Hisseq sequencing technique was used to generate the data of gene expression profile, and the following enrichment analysis of Gene Ontology (GO) and Pathway function were conducted based on the data of transcriptome. The results of DGE showed that there were 8476945, 14256722, 7708575, 5669955, 6565513 and 9303468 tags respectively, which was obtained from M. canis incubated with berberine or control DMSO. 8,783 genes were totally mapped, and 1,890 genes have shown significant changes between the two groups. 1,030 genes were up-regulated and 860 genes were down-regulated (P<0.05) in berberine treated group compared to the control group. Besides, twenty-three GO terms were identified by Gene Ontology functional enrichment analysis, such as calcium-transporting ATPase activity, 2-oxoglutarate metabolic process, valine catabolic process, peroxisome and unfolded protein binding. Pathway significant enrichment analysis indicated 6 signaling pathways that are significant, including steroid biosynthesis, steroid hormone biosynthesis, Parkinson's disease, 2,4-Dichlorobenzoate degradation, and tropane, piperidine and Isoquinoline alkaloid biosynthesis. Among these, eleven selected genes were further verified by qRT-PCR. Our findings provide a comprehensive view on the gene expression profile of M. canis upon berberine treatment, and shed light on its complicated effects on M. canis.	[Xiao, Chen-Wen; Ji, Quan-An; Wei, Qiang; Liu, Yan; Pan, Li-Jun; Bao, Guo-Lian] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Bao, GL (corresponding author), Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China.	baoguolian@163.com			China agricultural research system [CARS-44-C-2]; Zhejiang Provincial Natural Science Foundation Project [LQ12C18002]	China agricultural research system; Zhejiang Provincial Natural Science Foundation Project	This study was supported by grant from the China agricultural research system (CARS-44-C-2) and Zhejiang Provincial Natural Science Foundation Project (LQ12C18002).	Benjamini Y, 2001, ANN STAT, V29, P1165; Cafarchia C, 2012, VET MICROBIOL, V154, P395, DOI 10.1016/j.vetmic.2011.07.021; Cao YB, 2004, PHARM CARE RES, V1, P22; Chen LH, 2008, TRANSGENIC RES, V17, P121, DOI 10.1007/s11248-007-9085-z; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Fan JJ, 2005, FEMS MICROBIOL LETT, V245, P107, DOI 10.1016/j.femsle.2005.02.031; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Lah L, 2013, FUNGAL GENET BIOL, V50, P72, DOI 10.1016/j.fgb.2012.10.002; Lang C, 2007, AM J PHYSIOL-LUNG C, V292, pL577, DOI 10.1152/ajplung.00280.2006; Liang D, 2012, BIOL TRACE ELEM RES, V148, P420, DOI 10.1007/s12011-012-9387-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Park KS, 1999, J ANTIMICROB CHEMOTH, V43, P667, DOI 10.1093/jac/43.5.667; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; [谭生建 Tan Shengjian], 2004, [中国药学杂志, Chinese Pharmaceutical Journal], V39, P546; Thambiayya K, 2012, AM J PHYSIOL-LUNG C, V302, pL1287, DOI 10.1152/ajplung.00385.2011; Thumm M, 2000, MICROSC RES TECHNIQ, V51, P563, DOI 10.1002/1097-0029(20001215)51:6<563::AID-JEMT6>3.0.CO;2-8; Tian J, 2008, CHINESE J MODERN DRU, V15, P21; Wang DC, 2008, FEMS MICROBIOL LETT, V279, P217, DOI 10.1111/j.1574-6968.2007.01031.x; Wang YX, 2012, ACTA PHARM SIN B, V2, P581, DOI 10.1016/j.apsb.2012.10.008; Xiao CW, 2014, PAK VET J, V34, P219; Xu K, 2009, J PLANT BIOL, V52, P453, DOI 10.1007/s12374-009-9058-2; Xue JB, 2002, CHINESE J RABBIT FAR, V4, P9; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XL, 2013, CELL SIGNAL, V25, P999, DOI 10.1016/j.cellsig.2012.12.013	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124265	10.1371/journal.pone.0124265	http://dx.doi.org/10.1371/journal.pone.0124265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874937	Green Submitted, Green Published, gold			2022-12-26	WOS:000353014700062
J	Hu, JX; Qian, MR; Zhang, Q; Cui, JL; Yu, CN; Su, XM; Shen, CF; Hashmi, MZ; Shi, JY				Hu, Jinxing; Qian, Mingrong; Zhang, Qian; Cui, Jinglan; Yu, Chunna; Su, Xiaomei; Shen, Chaofeng; Hashmi, Muhammad Z.; Shi, Jiyan			Sphingobium fuliginis HC3: A Novel and Robust Isolated Biphenyl- and Polychlorinated Biphenyls-Degrading Bacterium without Dead-End Intermediates Accumulation	PLOS ONE			English	Article							LOW-CHLORINATED BIPHENYLS; WASTE RECYCLING SITES; MICROBIAL-DEGRADATION; AGRICULTURAL SOILS; STRAIN LB400; TAIZHOU AREA; SP-NOV.; METABOLISM; GENES; IDENTIFICATION	Biphenyl and polychlorinated biphenyls (PCBs) are typical environmental pollutants. However, these pollutants are hard to be totally mineralized by environmental microorganisms. One reason for this is the accumulation of dead-end intermediates during biphenyl and PCBs biodegradation, especially benzoate and chlorobenzoates (CBAs). Until now, only a few microorganisms have been reported to have the ability to completely mineralize biphenyl and PCBs. In this research, a novel bacterium HC3, which could degrade biphenyl and PCBs without dead-end intermediates accumulation, was isolated from PCBs-contaminated soil and identified as Sphingobium fuliginis. Benzoate and 3-chlorobenzoate (3-CBA) transformed from biphenyl and 3-chlorobiphenyl (3-CB) could be rapidly degraded by HC3. This strain has strong degradation ability of biphenyl, lower chlorinated (mono-, di- and tri-) PCBs as well as mono-CBAs, and the biphenyl/PCBs catabolic genes of HC3 are cloned on its plasmid. It could degrade 80.7% of 100 mg L-1 biphenyl within 24 h and its biphenyl degradation ability could be enhanced by adding readily available carbon sources such as tryptone and yeast extract. As far as we know, HC3 is the first reported that can degrade biphenyl and 3-CB without accumulation of benzoate and 3-CBA in the genus Sphingobium, which indicates the bacterium has the potential to totally mineralize biphenyl/PCBs and might be a good candidate for restoring biphenyl/PCBs-polluted environments.	[Hu, Jinxing; Zhang, Qian; Cui, Jinglan; Su, Xiaomei; Shen, Chaofeng; Hashmi, Muhammad Z.; Shi, Jiyan] Zhejiang Univ, Coll Environm & Resource Sci, Dept Environm Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Qian, Mingrong] Zhejiang Acad Agr Sci, Inst Qual & Standard Agr Prod, Hangzhou, Zhejiang, Peoples R China; [Yu, Chunna] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences; Hangzhou Normal University	Shen, CF (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Dept Environm Engn, Hangzhou 310027, Zhejiang, Peoples R China.	ysxzt@zju.edu.cn	Hashmi, Muhammad Zaffar/F-3427-2015; Shen, Chaofeng/I-7138-2013	Shen, Chaofeng/0000-0002-6394-7416; qian, mingrong/0000-0001-6011-872X	National High Technology Research and Development Program of China [2012AA06A203]; Zhejiang Provincial Natural Science Foundation of China [LR12D01001]; International Cooperation Project of Zhejiang Academy of Agricultural Sciences; National Risk Assessment on the Quality and Safety of Poultry Products [GJFP2014007]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); International Cooperation Project of Zhejiang Academy of Agricultural Sciences; National Risk Assessment on the Quality and Safety of Poultry Products	This study was supported by the National High Technology Research and Development Program of China (2012AA06A203), Zhejiang Provincial Natural Science Foundation of China (LR12D01001), International Cooperation Project of Zhejiang Academy of Agricultural Sciences 2013 and National Risk Assessment on the Quality and Safety of Poultry Products (GJFP2014007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebusoye SA, 2008, CHEMOSPHERE, V70, P656, DOI 10.1016/j.chemosphere.2007.06.079; Adebusoye SA, 2008, WORLD J MICROB BIOT, V24, P1203, DOI 10.1007/s11274-007-9594-1; AMBROSE AM, 1960, FOOD RES, V25, P328; Aoki Y, 2001, ENVIRON RES, V86, P2, DOI 10.1006/enrs.2001.4244; BEDARD DL, 1986, APPL ENVIRON MICROB, V51, P761, DOI 10.1128/AEM.51.4.761-768.1986; BHAT MA, 1994, APPL ENVIRON MICROB, V60, P307, DOI 10.1128/AEM.60.1.307-312.1994; Boehncke A, 1999, 6 WHO CONC INT CHEM; Brul S, 1999, INT J FOOD MICROBIOL, V50, P1, DOI 10.1016/S0168-1605(99)00072-0; Chadhain SMN, 2007, J IND MICROBIOL BIOT, V34, P605, DOI 10.1007/s10295-007-0235-3; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chang YC, 2013, APPL BIOCHEM BIOTECH, V170, P381, DOI 10.1007/s12010-013-0191-5; Chen YQ, 2005, J IND MICROBIOL BIOT, V32, P561, DOI 10.1007/s10295-005-0039-2; Denef VJ, 2004, APPL ENVIRON MICROB, V70, P4961, DOI 10.1128/AEM.70.8.4961-4970.2004; Di Toro S, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-11; DON RH, 1985, J BACTERIOL, V161, P85, DOI 10.1128/JB.161.1.85-90.1985; EKLUND T, 1985, INT J FOOD MICROBIOL, V2, P159, DOI 10.1016/0168-1605(85)90035-2; ERICKSON BD, 1992, J BACTERIOL, V174, P2903, DOI 10.1128/JB.174.9.2903-2912.1992; Faroon O, 2000, TOXICOL IND HEALTH, V16, P307, DOI 10.1177/074823370001600708; Fava F, 1998, BIOTECHNOL BIOENG, V58, P345, DOI 10.1002/(SICI)1097-0290(19980520)58:4&lt;345::AID-BIT1&gt;3.0.CO;2-J; FAVA F, 1994, APPL MICROBIOL BIOT, V41, P117, DOI 10.1007/BF00166092; FELICIELLO I, 1993, ANAL BIOCHEM, V212, P394, DOI 10.1006/abio.1993.1346; Focht DD, 1996, APPL ENVIRON MICROB, V62, P3910, DOI 10.1128/AEM.62.10.3910-3913.1996; FURUKAWA K, 1982, APPL ENVIRON MICROB, V44, P619, DOI 10.1128/AEM.44.3.619-626.1982; Furukawa K, 2004, J BACTERIOL, V186, P5189, DOI 10.1128/JB.186.16.5189-5196.2004; FURUKAWA K, 1979, APPL ENVIRON MICROB, V38, P301, DOI 10.1128/AEM.38.2.301-310.1979; Furukawa K, 2000, J GEN APPL MICROBIOL, V46, P283, DOI 10.2323/jgam.46.283; Gan S, 2009, J HAZARD MATER, V172, P532, DOI 10.1016/j.jhazmat.2009.07.118; Hawley GG, 1971, CONDENSED CHEM DICT, V8th; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; HICKEY WJ, 1993, APPL ENVIRON MICROB, V59, P1194, DOI 10.1128/AEM.59.4.1194-1200.1993; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; Hong Q, 2009, INT BIODETER BIODEGR, V63, P365, DOI 10.1016/j.ibiod.2008.10.009; Keshavarz MH, 2012, J HAZARD MATER, V237, P79, DOI 10.1016/j.jhazmat.2012.07.048; KOHLER HPE, 1988, APPL ENVIRON MICROB, V54, P1940, DOI 10.1128/AEM.54.8.1940-1945.1988; Lambo AJ, 2006, J BASIC MICROB, V46, P94, DOI 10.1002/jobm.200510006; Lee K, 2003, J HAZARD MATER, V105, P157, DOI 10.1016/j.jhazmat.2003.08.005; Li A, 2009, APPL BIOCHEM BIOTECH, V159, P687, DOI 10.1007/s12010-008-8513-8; Li A, 2009, J ENVIRON SCI-CHINA, V21, P211, DOI 10.1016/S1001-0742(08)62253-6; Luo W, 2008, CHEMOSPHERE, V70, P364, DOI 10.1016/j.chemosphere.2007.07.022; Man YB, 2011, J HAZARD MATER, V195, P92, DOI 10.1016/j.jhazmat.2011.08.010; Mayes BA, 1998, TOXICOL SCI, V41, P62; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; MONDELLO FJ, 1989, J BACTERIOL, V171, P1725, DOI 10.1128/jb.171.3.1725-1732.1989; Moody JD, 2002, APPL MICROBIOL BIOT, V58, P364, DOI 10.1007/s00253-001-0878-3; Ortega-Calvo JJ, 2013, J HAZARD MATER, V261, P733, DOI 10.1016/j.jhazmat.2013.03.042; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; Pinyakong O, 2003, BIOCHEM BIOPH RES CO, V301, P350, DOI 10.1016/S0006-291X(02)03036-X; Potrawfke T, 1998, APPL MICROBIOL BIOT, V50, P440, DOI 10.1007/s002530051318; Prakash O, 2006, INT J SYST EVOL MICR, V56, P2147, DOI 10.1099/ijs.0.64080-0; PROVIDENTI MA, 1993, J IND MICROBIOL, V12, P379, DOI 10.1007/BF01569669; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai M, 2002, J BIOSCI BIOENG, V93, P421, DOI 10.1263/jbb.93.421; SEEGER M, 1995, APPL ENVIRON MICROB, V61, P2654, DOI 10.1128/AEM.61.7.2654-2658.1995; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Shen CF, 2008, ENVIRON SCI TECHNOL, V42, P49, DOI 10.1021/es071162z; Shen CF, 2009, ENVIRON INT, V35, P50, DOI 10.1016/j.envint.2008.07.005; Stratford J, 1996, ARCH MICROBIOL, V165, P213, DOI 10.1007/BF01692864; Suenaga H, 2002, J BACTERIOL, V184, P3682, DOI 10.1128/JB.184.13.3682-3688.2002; Taguchi K, 2007, BIOSCI BIOTECH BIOCH, V71, P1136, DOI 10.1271/bbb.60551; TAIRA K, 1992, J BIOL CHEM, V267, P4844; TANABE S, 1988, ENVIRON POLLUT, V50, P5, DOI 10.1016/0269-7491(88)90183-2; Toyama T, 2010, APPL ENVIRON MICROB, V76, P6733, DOI 10.1128/AEM.00258-10; Tu C, 2011, J HAZARD MATER, V186, P1438, DOI 10.1016/j.jhazmat.2010.12.008; Ushiba Y, 2003, INT J SYST EVOL MICR, V53, P2045, DOI 10.1099/ijs.0.02581-0; Van Aken B, 2010, ENVIRON SCI TECHNOL, V44, P2767, DOI 10.1021/es902514d; Watanabe T, 2003, J BACTERIOL, V185, P3575, DOI 10.1128/JB.185.12.3575-3582.2003; Weaver WC, 1979, KIRK OTHMER ENCY CHE, P789; Yang XQ, 2004, J IND MICROBIOL BIOT, V31, P415, DOI 10.1007/s10295-004-0162-5; Yuan SY, 2000, CHEMOSPHERE, V41, P1463, DOI 10.1016/S0045-6535(99)00522-6; ZACHE G, 1989, APPL MICROBIOL BIOT, V30, P426, DOI 10.1007/BF00296635; Zhao LJ, 2010, J HAZARD MATER, V179, P729, DOI 10.1016/j.jhazmat.2010.03.062; Zylstra GJ, 1997, J IND MICROBIOL BIOT, V19, P408, DOI 10.1038/sj.jim.2900475	72	21	24	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122740	10.1371/journal.pone.0122740	http://dx.doi.org/10.1371/journal.pone.0122740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875180	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100097
J	Strudwick, XL; Lang, DL; Smith, LE; Cowin, AJ				Strudwick, Xanthe L.; Lang, Debbie L.; Smith, Louise E.; Cowin, Allison J.			Combination of Low Calcium with Y-27632 Rock Inhibitor Increases the Proliferative Capacity, Expansion Potential and Lifespan of Primary Human Keratinocytes while Retaining Their Capacity to Differentiate into Stratified Epidermis in a 3D Skin Model	PLOS ONE			English	Article							P53 MUTATIONS; CELL-LINE; CULTURE; HACAT; GROWTH; SUNLIGHT; CANCER; RHO	Human keratinocytes are difficult to isolate and have a limited lifespan. Traditionally, immortalised keratinocyte cell lines are used in vitro due to their ability to bypass senescence and survive indefinitely. However these cells do not fully retain their ability to differentiate in vitro and they are unable to form a normal stratum corneum in organotypic culture. Here we aimed to generate a pool of phenotypically similar keratinocytes from human donors that could be used in monolayer culture, without a fibroblast feeder layer, and in 3D human skin equivalent models. Primary human neonatal epidermal keratinocytes (HEKn) were cultured in low calcium, (0.07mM) media, +/-10 mu M Y-27632 ROCK inhibitor (HEKn-CaY). mRNA and protein was extracted and expression of differentiation markers Keratin 14 (K14), Keratin 10 (K10) and Involucrin (Inv) assessed by qRT-PCR and Western blotting. The differentiation potential of the HEKn-CaY cultures was assessed by increasing calcium levels and removing the Y-27632 for 72hrs prior to assessment of K14, K10 and Inv. The ability of the HEKn-CaY, to form a stratified epithelium was assessed using a human skin equivalent (HSE) model in the absence of Y-27632. Increased proliferative capacity, expansion potential and lifespan of HEKn was observed with the combination of low calcium and 10 mu M ROCK inhibitor Y-27632. The removal of Y-27632 and the addition of high calcium to induce differentiation allowed the cells to behave as primary keratinocytes even after extended serial passaging. Prolonged lifespan HEK-CaYs were capable of forming an organised stratified epidermis in 3D HSE cultures, demonstrating their ability to fully stratify and retain their original, primary characteristics. In conclusion, the use of 0.07mM Calcium and 10 mu M Y-27632 in HEKn monocultures provides the opportunity to culture primary human keratinocytes without a cell feeder layer for extended periods of culture whilst retaining their ability to differentiate and form a stratified epithelium.	[Strudwick, Xanthe L.; Lang, Debbie L.; Smith, Louise E.; Cowin, Allison J.] Univ S Australia, Mawson Inst, Regenerat Med, Mawson Lakes, Australia	University of South Australia	Cowin, AJ (corresponding author), Univ S Australia, Mawson Inst, Regenerat Med, Mawson Lakes, Australia.	allison.cowin@unisa.edu.au	Cowin, Allison/F-4281-2013; Strudwick, Xanthe/C-9708-2013; Smith, Louise E/V-6186-2019; Smith, Louise/C-8855-2011; Cowin, Allison/AAM-3105-2020	Cowin, Allison/0000-0003-2885-2080; Strudwick, Xanthe/0000-0002-8557-3857; Smith, Louise E/0000-0003-0659-0884; Smith, Louise/0000-0003-0659-0884; Cowin, Allison/0000-0003-2885-2080	Wound Management Innovation Cooperative Research Centre - Commonwealth Government of Australia	Wound Management Innovation Cooperative Research Centre - Commonwealth Government of Australia	This study was supported by the Wound Management Innovation Cooperative Research Centre a program funded by the Commonwealth Government of Australia. Regarding the role of the funders in the study: the authors confirm that the funders, the Wound Management Innovation Cooperative Research Centre, did not take any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boukamp P, 1997, GENE CHROMOSOME CANC, V19, P201, DOI 10.1002/(SICI)1098-2264(199708)19:4<201::AID-GCC1>3.0.CO;2-0; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Chapman S, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt449; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; De Corte P, 2012, CELL TISSUE BANK, V13, P175, DOI 10.1007/s10561-011-9247-3; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Hayflick L, 1973, TISSUE CULTURE METHO, P220, DOI DOI 10.1016/B978-0-12-427150-0.50060-7; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; MacNeil S, 2011, METHODS MOL BIOL, V695, P129, DOI 10.1007/978-1-60761-984-0_9; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Rheinwald J G, 1980, Methods Cell Biol, V21A, P229, DOI 10.1016/S0091-679X(08)60769-4; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; TENCHINI ML, 1992, BURNS, V18, pS11, DOI 10.1016/0305-4179(92)90104-3; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	21	27	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123651	10.1371/journal.pone.0123651	http://dx.doi.org/10.1371/journal.pone.0123651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874771	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000352845100194
J	Samse, K; Emathinger, J; Hariharan, N; Quijada, P; Ilves, K; Volkers, M; Ormachea, L; De La Torre, A; Orogo, AM; Alvarez, R; Din, S; Mohsin, S; Monsanto, M; Fischer, KM; Dembitsky, WP; Gustafsson, AB; Sussman, MA				Samse, Kaitlen; Emathinger, Jacqueline; Hariharan, Nirmala; Quijada, Pearl; Ilves, Kelli; Voelkers, Mirko; Ormachea, Lucia; De La Torre, Andrea; Orogo, Amabel M.; Alvarez, Roberto; Din, Shabana; Mohsin, Sadia; Monsanto, Megan; Fischer, Kimberlee M.; Dembitsky, Walter P.; Gustafsson, Asa B.; Sussman, Mark A.			Functional Effect of Pim1 Depends upon Intracellular Localization in Human Cardiac Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; CELLULAR SENESCENCE; NUCLEOSTEMIN; ACTIVATION; PROLIFERATION; REGENERATION; MULTIPOTENT; MAINTAINS; MECHANISM; SURVIVAL	Human cardiac progenitor cells (hCPC) improve heart function after autologous transfer in heart failure patients. Regenerative potential of hCPCs is severely limited with age, requiring genetic modification to enhance therapeutic potential. A legacy of work from our laboratory with Pim1 kinase reveals effects on proliferation, survival, metabolism, and rejuvenation of hCPCs in vitro and in vivo. We demonstrate that subcellular targeting of Pim1 bolsters the distinct cardioprotective effects of this kinase in hCPCs to increase proliferation and survival, and antagonize cellular senescence. Adult hCPCs isolated from patients undergoing left ventricular assist device implantation were engineered to overexpress Pim1 throughout the cell (PimWT) or targeted to either mitochondrial (Mito-Pim1) or nuclear (Nuc-Pim1) compartments. Nuc-Pim1 enhances stem cell youthfulness associated with decreased senescence-associated beta-galactosidase activity, preserved telomere length, reduced expression of p16 and p53, and up-regulation of nucleo-stemin relative to PimWT hCPCs. Alternately, Mito-Pim1 enhances survival by increasing expression of Bcl-2 and Bcl-XL and decreasing cell death after H2O2 treatment, thereby preserving mitochondrial integrity superior to PimWT. Mito-Pim1 increases the proliferation rate by up-regulation of cell cycle modulators Cyclin D, CDK4, and phospho-Rb. Optimal stem cell traits such as proliferation, survival, and increased youthful properties of aged hCPCs are enhanced after targeted Pim1 localization to mitochondrial or nuclear compartments. Targeted Pim1 overexpression in hCPCs allows for selection of the desired phenotypic properties to overcome patient variability and improve specific stem cell characteristics.	[Samse, Kaitlen; Emathinger, Jacqueline; Hariharan, Nirmala; Quijada, Pearl; Ilves, Kelli; Voelkers, Mirko; Ormachea, Lucia; De La Torre, Andrea; Alvarez, Roberto; Din, Shabana; Mohsin, Sadia; Monsanto, Megan; Fischer, Kimberlee M.; Sussman, Mark A.] San Diego State Univ, San Diego Heart Res Inst, San Diego, CA 92182 USA; [Orogo, Amabel M.; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Dembitsky, Walter P.] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA 92123 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Sharp Memorial Hospital Rehabilitation & Physical Therapy	Sussman, MA (corresponding author), 5500 Campanile Dr, San Diego, CA 92182 USA.	heartman4ever@icloud.com	Regan, Clinton/E-6250-2012; Völkers, Mirko/E-7947-2010; Sussman, Mark/H-2284-2014	Völkers, Mirko/0000-0003-2344-1856; Sussman, Mark/0000-0002-0104-4799	National Institutes of Health [R01HL067245, R37HL091102, R01HL105759, R01 HL113656, R01 HL117163, R01 HL113647, R01HL087023, R01HL101217, P01HL085577]; Fondation Leducq; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117163, R01HL113647, R01HL087023, R01HL105759, R37HL091102, R01HL067245, R01HL113656, R01HL101217, P01HL085577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL067245, R37HL091102, R01HL105759, R01 HL113656, R01 HL117163, and R01 HL113647, and an award from Fondation Leducq (to M. A. S.).; Supported National Institutes of Health Grants R01HL087023, R01HL101217, and P01HL085577 and an American Heart Association Established Investigator Award.	Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Bailey B, 2009, REGEN MED, V4, P823, DOI [10.2217/rme.09.51, 10.2217/RME.09.51]; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Borillo GA, 2010, CIRC RES, V106, P1265, DOI 10.1161/CIRCRESAHA.109.212035; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Cottage CT, 2012, STEM CELLS, V30, P2512, DOI 10.1002/stem.1211; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; Del Re DP, 2012, CIRC RES, V110, P1154, DOI 10.1161/CIRCRESAHA.112.269183; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Din S, 2014, CIRC RES, V115, P376, DOI 10.1161/CIRCRESAHA.115.304441; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Gonzalez A, 2008, CIRC RES, V102, P597, DOI 10.1161/CIRCRESAHA.107.165464; Hariharan N, 2015, J AM COLL CARDIOL, V65, P133, DOI 10.1016/j.jacc.2014.09.086; Hsu JK, 2012, J CELL BIOL, V197, P613, DOI 10.1083/jcb.201109038; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Kim JH, 2003, BIOCHEM J, V373, P523, DOI 10.1042/BJ20030363; Kimura W, 2014, ANTIOXID REDOX SIGN, V21, P1660, DOI 10.1089/ars.2014.6029; Leri A, 2003, J MOL CELL CARDIOL, V35, P595, DOI 10.1016/S0022-2828(03)00116-0; Liu ZH, 2013, CELL CYCLE, V12, P2210, DOI 10.4161/cc.25265; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Meng LJ, 2013, P NATL ACAD SCI USA, V110, P11415, DOI 10.1073/pnas.1301672110; Mohsin S, 2012, J AM COLL CARDIOL, V60, P1278, DOI 10.1016/j.jacc.2012.04.047; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Pereira SL, 2014, HUM REPROD UPDATE, V20, P924, DOI 10.1093/humupd/dmu034; Qu J, 2012, J CELL BIOL, V197, P731, DOI 10.1083/jcb.201103071; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shugo H, 2012, STEM CELLS DEV, V21, P3044, DOI 10.1089/scd.2011.0725; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	41	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13935	13947		10.1074/jbc.M114.617431	http://dx.doi.org/10.1074/jbc.M114.617431			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882843	hybrid, Green Published			2022-12-26	WOS:000355313000025
J	Mohamed, MA; Gadeau, AP; Fliegel, L; Lopaschuk, G; Mlih, M; Abdulrahman, N; Fillmore, N; Mraiche, F				Mohamed, Man A.; Gadeau, Alain-Pierre; Fliegel, Larry; Lopaschuk, Gary; Mlih, Mohamed; Abdulrahman, Nabeel; Fillmore, Natasha; Mraiche, Fatima			Na+/H+ Exchanger Isoform 1-Induced Osteopontin Expression Facilitates Cardiomyocyte Hypertrophy	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; THERAPEUTIC-TARGET; GENE-EXPRESSION; CALCINEURIN ACTIVATION; HEART-FAILURE; SMOOTH-MUSCLE; CELL-LINE; IN-VITRO; T-CELLS; DIFFERENTIATION	Enhanced expression and activity of the Na+/H+ exchanger isoform 1 (NHE1) has been implicated in cardiomyocyte hypertrophy in various experimental models. The upregulation of NHE1 was correlated with an increase in osteopontin (OPN) expression in models of cardiac hypertrophy (CH), and the mechanism for this remains to be delineated. To determine whether the expression of active NHE1-induces OPN and contributes to the hypertrophic response in vitro, cardiomyocytes were infected with the active form of the NHE1 adenovirus or transfected with OPN silencing RNA (siRNA-OPN) and characterized for cardiomyocyte hypertrophy. Expression of NHE1 in cardiomyocytes resulted in a significant increase in cardiomyocyte hypertrophy markers: cell surface area, protein content, ANP mRNA and expression of phosphorylated-GATA4. NHE1 activity was also significantly increased in cardiomyocytes expressing active NHE1. Interestingly, transfection of cardiomyocytes with siRNA-OPN significantly abolished the NHE1-induced cardiomyocyte hypertrophy. siRNA-OPN also significantly reduced the activity of NHE1 in cardiomyocytes expressing NHE1 (68.5 +/- 0.24%; P< 0.05), confirming the role of OPN in the NHE1-induced hypertrophic response. The hypertrophic response facilitated by NHE1-induced OPN occurred independent of the extracellular-signal-regulated kinases and Akt, but required p90-ribosomal S6 kinase (RSK). The ability of OPN to facilitate the NHE1-induced hypertrophic response identifies OPN as a potential therapeutic target to reverse the hypertrophic effect induced by the expression of active NHE1.	[Mohamed, Man A.; Mlih, Mohamed; Abdulrahman, Nabeel; Mraiche, Fatima] Qatar Univ, Coll Pharm, Doha, Qatar; [Gadeau, Alain-Pierre] Univ Bordeaux, Adaptat Cardiovasc Ischemie, UMR1034, Pessac, France; [Fliegel, Larry] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada; [Lopaschuk, Gary; Fillmore, Natasha] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	Qatar University; UDICE-French Research Universities; Universite de Bordeaux; University of Alberta; University of Alberta	Mraiche, F (corresponding author), Qatar Univ, Coll Pharm, Doha, Qatar.	fatima.mraiche@qu.edu.qa	Gadeau, Alain-Pierre/H-7889-2016; Mlih, Mohamed/O-4834-2019	Gadeau, Alain-Pierre/0000-0003-1312-6481; Mlih, Mohamed/0000-0003-3491-9616	National Priorities Research Program grant by the Qatar National Research Fund, Doha, Qatar [NPRP 5 - 330 - 3 - 090]	National Priorities Research Program grant by the Qatar National Research Fund, Doha, Qatar	This work was supported by the National Priorities Research Program grant (NPRP 5 - 330 - 3 - 090) provided by the Qatar National Research Fund, Doha, Qatar (http://www.qnrf.org). Lead principal investigator (PI): FM, PI: LF, AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Avkiran M, 2008, CURR OPIN PHARMACOL, V8, P133, DOI 10.1016/j.coph.2007.12.007; Chen MZ, 2012, MOL CELL BIOCHEM, V371, P77, DOI 10.1007/s11010-012-1424-6; Coccaro E, 2007, MOL CELL BIOCHEM, V302, P145, DOI 10.1007/s11010-007-9436-3; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; Dai J, 2014, CIRC-HEART FAIL, V7, P184, DOI 10.1161/CIRCHEARTFAILURE.113.000649; Diao HY, 2008, P NATL ACAD SCI USA, V105, P15884, DOI 10.1073/pnas.0806089105; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Ennis IL, 2003, HYPERTENSION, V41, P1324, DOI 10.1161/01.HYP.0000071180.12012.6E; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Fu GX, 2012, ENDOCRINE, V42, P676, DOI 10.1007/s12020-012-9675-2; Gao YA, 2004, MATRIX BIOL, V23, P457, DOI 10.1016/j.matbio.2004.09.003; Graf K, 1997, CIRCULATION, V96, P3063, DOI 10.1161/01.CIR.96.9.3063; Guo JA, 2011, CIRC-HEART FAIL, V4, P79, DOI 10.1161/CIRCHEARTFAILURE.110.957969; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hisamitsu T, 2012, MOL CELL BIOL, V32, P3265, DOI 10.1128/MCB.00145-12; Huber JD, 2012, J MED CHEM; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Jalvy S, 2007, CARDIOVASC RES, V75, P738, DOI 10.1016/j.cardiores.2007.05.019; Kageyama K, 2002, J BIOL CHEM, V277, P19255, DOI 10.1074/jbc.M112377200; Karki P, 2010, BBA-BIOMEMBRANES, V1798, P1565, DOI 10.1016/j.bbamem.2010.05.005; Karmazyn M, 2013, J MOL CELL CARDIOL, V61, P77, DOI 10.1016/j.yjmcc.2013.02.006; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kilic A, 2005, CIRCULATION, V112, P2307, DOI 10.1161/CIRCULATIONAHA.105.542209; Kilic A, 2010, CARDIOVASC RES, V88, P434, DOI 10.1093/cvr/cvq254; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Ku PM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-57; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Lyle AN, 2013, J BIOL CHEM; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Marian AJ, 2007, CARDIAC HYPERTROPHY, P1177; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Merten KE, 2006, J PHARMACOL EXP THER, V319, P934, DOI 10.1124/jpet.106.108845; Mraiche F, 2011, MOL CELL BIOCHEM, V358, P179, DOI 10.1007/s11010-011-0933-z; Mraiche F, 2011, BASIC RES CARDIOL, V106, P603, DOI 10.1007/s00395-011-0161-4; Nakamura TY, 2008, CIRC RES, V103, P891, DOI 10.1161/CIRCRESAHA.108.175141; Nilsson-Berglund LM, 2010, ARTERIOSCL THROM VAS, V30, P218, DOI 10.1161/ATVBAHA.109.199299; Paradise RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015746; Pereira SL, 2011, CARDIOVASC TOXICOL, V11, P180, DOI 10.1007/s12012-011-9112-4; Prasad V, 2013, J MOL CELL CARDIOL; Renault MA, 2010, CIRC-HEART FAIL, V3, P431, DOI 10.1161/CIRCHEARTFAILURE.109.898114; Rittling SR, 1998, BIOCHEM BIOPH RES CO, V250, P287, DOI 10.1006/bbrc.1998.9306; Sardao VA, 2009, CELL BIOL TOXICOL, V25, P227, DOI 10.1007/s10565-008-9070-1; Schunke KJ, 2013, J CELL PHYSIOL, V228, P2006, DOI 10.1002/jcp.24367; Shibata M, 2011, AM J PHYSIOL-HEART C, V301, pH2154, DOI 10.1152/ajpheart.00483.2011; Sodhi CP, 2001, DIABETES, V50, P1482, DOI 10.2337/diabetes.50.6.1482; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Voelkl J, 2013, CELL PHYSIOL BIOCHEM, V32, P25, DOI 10.1159/000350120; Voelkl J, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0236-2; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; Waller AH, 2010, CARDIOL REV, V18, P125, DOI 10.1097/CRD.0b013e3181cfb646; Wang YG, 2009, HEART VESSELS, V24, P116, DOI 10.1007/s00380-008-1094-1; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; World Health Organization, 2017, CARD DIS CVDS; Xia Y, 2007, J PHARMACOL EXP THER, V320, P14, DOI 10.1124/jpet.106.110494; Xie ZL, 2004, HYPERTENSION, V44, P826, DOI 10.1161/01.HYP.0000148458.03202.48; Xie ZL, 2004, J CELL PHYSIOL, V198, P399, DOI 10.1002/jcp.10419; Xue J, 2010, PHYSIOL GENOMICS, V42, P374, DOI 10.1152/physiolgenomics.00064.2010; Young M, 2003, ENDOCRINOLOGY, V144, P3848, DOI 10.1210/en.2003-0039; Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499	63	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123318	10.1371/journal.pone.0123318	http://dx.doi.org/10.1371/journal.pone.0123318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884410	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000057
J	El Daker, S; Sacchi, A; Tempestilli, M; Carducci, C; Goletti, D; Vanini, V; Colizzi, V; Lauria, FN; Martini, F; Martino, A				El Daker, Sary; Sacchi, Alessandra; Tempestilli, Massimo; Carducci, Claudia; Goletti, Delia; Vanini, Valentina; Colizzi, Vittorio; Lauria, Francesco Nicola; Martini, Federico; Martino, Angelo			Granulocytic Myeloid Derived Suppressor Cells Expansion during Active Pulmonary Tuberculosis Is Associated with High Nitric Oxide Plasma Level	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; AUTOPHAGIC FLUX; INFECTION; MACROPHAGES	Tuberculosis (TB) is still the principal cause of death caused by a single infectious agent, and the balance between the bacillus and host defense mechanisms reflects the different manifestations of the pathology. The aim of this work was to study the role of myeloid-derived suppressor cells (MDSCs) during active pulmonary tuberculosis at the site of infection. We observed an expansion of MDSCs in the lung and blood of patients with active TB, which are correlated with an enhanced amount of nitric oxide in the plasma. We also found that these cells have the remarkable ability to suppress T-cell response, suggesting an important role in the modulation of the immune response against TB. Interestingly, a trend in the diminution of MDSCs was found after an efficacious anti-TB therapy, suggesting that these cells may be used as a potential biomarker for monitoring anti-TB therapy efficacy.	[El Daker, Sary; Sacchi, Alessandra; Martini, Federico; Martino, Angelo] Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol Lab, Rome, Italy; [El Daker, Sary] Inst Pasteur, Dept Immunol, Unite Biol Populat Lymphocytaires, F-75724 Paris, France; [El Daker, Sary; Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Tempestilli, Massimo] Lazzaro Spallanzani Natl Inst Infect Dis, Clin Biochem & Pharmacol Lab, Rome, Italy; [Carducci, Claudia] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Goletti, Delia; Vanini, Valentina] Lazzaro Spallanzani Natl Inst Infect Dis, Translat Res Unit, Rome, Italy; [Lauria, Francesco Nicola] Lazzaro Spallanzani Natl Inst Infect Dis, Resp Infect Dis Unit, Rome, Italy	IRCCS Lazzaro Spallanzani; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Rome Tor Vergata; IRCCS Lazzaro Spallanzani; Sapienza University Rome; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	El Daker, S (corresponding author), Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol Lab, Rome, Italy.	saryeldaker@yahoo.it	carducci, claudia/K-5412-2018; Vanini, Valentina/K-4475-2016; goletti, delia/AAM-6577-2020; Sacchi, Alessandra/K-7782-2016; tempestilli, massimo/K-5952-2016	Vanini, Valentina/0000-0001-8476-964X; Sacchi, Alessandra/0000-0003-4964-386X; tempestilli, massimo/0000-0003-3107-7441; Goletti, Delia/0000-0001-8360-4376; CARDUCCI, Claudia/0000-0003-0515-9208	INMI Lazzaro Spallanzani Ricerca Corrente grants from Italian Ministry of Health	INMI Lazzaro Spallanzani Ricerca Corrente grants from Italian Ministry of Health	This work was supported by INMI Lazzaro Spallanzani Ricerca Corrente grants from Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; du Plessis N, 2013, AM J RESP CRIT CARE, V188, P724, DOI 10.1164/rccm.201302-0249OC; El Daker S, 2013, CELL IMMUNOL, V282, P106, DOI 10.1016/j.cellimm.2013.05.001; Goletti D, 2013, CYTOKINE GROWTH F R, V24, P335, DOI 10.1016/j.cytogfr.2013.01.002; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Herzmann C, 2012, EUR RESPIR J, V40, P1450, DOI 10.1183/09031936.00214611; Obregon-Henao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080669; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Petruccioli E, 2012, J INFECT DIS, V205, P1425, DOI 10.1093/infdis/jis226; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Schuster R, 1998, J CHROMATOGR, V43, P271; Sendide K, 2004, INFECT IMMUN, V72, P4200, DOI 10.1128/IAI.72.7.4200-4209.2004; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; WADEE AA, 1995, CLIN EXP IMMUNOL, V100, P434; Yang BF, 2014, IMMUNOL LETT, V158, P66, DOI 10.1016/j.imlet.2013.12.003; YOUNG MR, 1987, CANCER RES, V47, P100; Zuniga J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/193923	21	54	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123772	10.1371/journal.pone.0123772	http://dx.doi.org/10.1371/journal.pone.0123772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879532	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500061
J	How, C; Pintilie, M; Bruce, JP; Hui, ABY; Clarke, BA; Wong, P; Yin, SM; Yan, R; Waggott, D; Boutros, PC; Fyles, A; Hedley, DW; Hill, RP; Milosevic, M; Liu, FF				How, Christine; Pintilie, Melania; Bruce, Jeff P.; Hui, Angela B. Y.; Clarke, Blaise A.; Wong, Philip; Yin, Shaoming; Yan, Rui; Waggott, Daryl; Boutros, Paul C.; Fyles, Anthony; Hedley, David W.; Hill, Richard P.; Milosevic, Michael; Liu, Fei-Fei			Developing a Prognostic Micro-RNA Signature for Human Cervical Carcinoma	PLOS ONE			English	Article							INTRATUMORAL HETEROGENEITY; EXPRESSION PROFILES; MESSENGER-RNA; CANCER; TUMOR; IDENTIFICATION; SURVIVAL; GENE; PREDICTION; FROZEN	Cervical cancer remains the third most frequently diagnosed and fourth leading cause of cancer death in women worldwide. We sought to develop a micro-RNA signature that was prognostic for disease-free survival, which could potentially allow tailoring of treatment for cervical cancer patients. A candidate prognostic 9-micro-RNA signature set was identified in the training set of 79 frozen specimens. However, three different approaches to validate this signature in an independent cohort of 87 patients with formalin-fixed paraffin-embedded (FFPE) specimens, were unsuccessful. There are several challenges and considerations associated with developing a prognostic micro-RNA signature for cervical cancer, namely: tumour heterogeneity, lack of concordance between frozen and FFPE specimens, and platform selection for global micro-RNA expression profiling in this disease. Our observations provide an important cautionary tale for future miRNA signature studies for cervical cancer, which can also be potentially applicable to miRNA profiling studies involving other types of human malignancies.	[How, Christine; Bruce, Jeff P.; Hui, Angela B. Y.; Wong, Philip; Hedley, David W.; Hill, Richard P.; Liu, Fei-Fei] Ontario Canc Inst, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [How, Christine; Bruce, Jeff P.; Boutros, Paul C.; Hedley, David W.; Hill, Richard P.; Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Pintilie, Melania] Princess Margaret Canc Ctr, Univ Hlth Network, Div Biostat, Toronto, ON, Canada; [Clarke, Blaise A.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Wong, Philip; Fyles, Anthony; Milosevic, Michael; Liu, Fei-Fei] Princess Margaret Canc Ctr, Univ Hlth Network, Dept Radiat Oncol, Toronto, ON, Canada; [Wong, Philip; Fyles, Anthony; Milosevic, Michael; Liu, Fei-Fei] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Yin, Shaoming; Yan, Rui; Waggott, Daryl; Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp Platform, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Hedley, David W.] Princess Margaret Canc Ctr, Univ Hlth Network, Div Med Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	How, C (corresponding author), Ontario Canc Inst, Ontario Canc Inst, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca	Bruce, Jeff/AAF-1350-2019	Bruce, Jeff/0000-0001-5509-9990; Boutros, Paul/0000-0003-0553-7520; Hedley, David/0000-0003-1323-2655; Spence, Tara/0000-0001-7098-4103; Clarke, Blaise/0000-0002-2585-8391; Liu, Fei-Fei/0000-0003-4344-6486; Fyles, Anthony/0000-0002-3633-2483; Hill, Richard Peter/0000-0001-5331-8045; Milosevic, Michael/0000-0002-9620-6876	Ontario Institute for Cancer Research [10NOV-399]; Lawrence, Ila and William Gifford Scholarship Fund; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning	Ontario Institute for Cancer Research; Lawrence, Ila and William Gifford Scholarship Fund; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning	This work was supported by funds from the Ontario Institute for Cancer Research (Grant Number: 10NOV-399). Christine How is a CIHR Strategic Training Fellow in the Excellence in Radiation Research for the 21st Century (EIRR21) Program, and is supported by the Lawrence, Ila and William Gifford Scholarship Fund. Support is also provided from the Campbell Family Institute for Cancer Research and the Ministry of Health and Long-term Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; American Cancer Society, 2012, CANC FACTS FIG 2012; Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CHANG AR, 1994, INT J GYNECOL PATHOL, V13, P330, DOI 10.1097/00004347-199410000-00006; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; de Biase D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035596; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Fyles A, 2002, J CLIN ONCOL, V20, P680, DOI 10.1200/JCO.2002.20.3.680; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Guo ZM, 2001, MODERN PATHOL, V14, P54, DOI 10.1038/modpathol.3880256; Hanke Merle, 2010, Urol Oncol, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelly AD, 2013, GENOMICS, V102, P8, DOI 10.1016/j.ygeno.2013.03.008; Kolbert CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052517; Koopman LA, 2000, J EXP MED, V191, P961, DOI 10.1084/jem.191.6.961; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P533, DOI 10.1016/j.urolonc.2009.05.008; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Lovendorf MB, 2012, EXP DERMATOL, V21, P299, DOI 10.1111/j.1600-0625.2012.01445.x; Lyng H, 2004, INT J CANCER, V111, P358, DOI 10.1002/ijc.20258; Lyng H, 2001, INT J CANCER, V96, P182; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027; NGUYEN HN, 1993, CANCER, V71, P2543, DOI 10.1002/1097-0142(19930415)71:8<2543::AID-CNCR2820710818>3.0.CO;2-U; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Raychaudhuri M, 2012, J MOL DIAGN, V14, P376, DOI 10.1016/j.jmoldx.2012.01.016; Ries LAG EM, 2003, SEER CANC STAT REV 1, DOI [10.1016/j.healun.2014.01.862, DOI 10.1016/J.HEALUN.2014.01.862]; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Waggott D, 2012, BIOINFORMATICS, V28, P1546, DOI 10.1093/bioinformatics/bts188; Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Wong RKW, 1997, INT J RADIAT ONCOL, V39, P405, DOI 10.1016/S0360-3016(97)00328-3; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	54	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123946	10.1371/journal.pone.0123946	http://dx.doi.org/10.1371/journal.pone.0123946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880806	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500072
J	Kudo, T; Kanetaka, H; Mochizuki, K; Tominami, K; Nunome, S; Abe, G; Kosukegawa, H; Abe, T; Mori, H; Mori, K; Takagi, T; Izumi, S				Kudo, Tada-aki; Kanetaka, Hiroyasu; Mochizuki, Kentaro; Tominami, Kanako; Nunome, Shoko; Abe, Genji; Kosukegawa, Hiroyuki; Abe, Toshihiko; Mori, Hitoshi; Mori, Kazumi; Takagi, Toshiyuki; Izumi, Shin-ichi			Induction of Neurite Outgrowth in PC12 Cells Treated with Temperature-Controlled Repeated Thermal Stimulation	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEIN-2; NEURONAL DIFFERENTIATION; HEAT-SHOCK; IN-VITRO; NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; GENE-EXPRESSION; AXONAL GROWTH	To promote the functional restoration of the nervous system following injury, it is necessary to provide optimal extracellular signals that can induce neuronal regenerative activities, particularly neurite formation. This study aimed to examine the regulation of neuritogenesis by temperature-controlled repeated thermal stimulation (TRTS) in rat PC12 pheochromocytoma cells, which can be induced by neurotrophic factors to differentiate into neuron-like cells with elongated neurites. A heating plate was used to apply thermal stimulation, and the correlation of culture medium temperature with varying surface temperature of the heating plate was monitored. Plated PC12 cells were exposed to TRTS at two different temperatures via heating plate (preset surface temperature of the heating plate, 39.5 degrees C or 42 degrees C) in growth or differentiating medium for up to 18 h per day. We then measured the extent of growth, neuritogenesis, or acetylcholine esterase (AChE) activity (a neuronal marker). To analyze the mechanisms underlying the effects of TRTS on these cells, we examined changes in intracellular signaling using the following: tropomyosin-related kinase A inhibitor GW441756; p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580; and MAPK/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor U0126 with its inactive analog, U0124, as a control. While a TRTS of 39.5 degrees C did not decrease the growth rate of cells in the cell growth assay, it did increase the number of neurite-bearing PC12 cells and AChE activity without the addition of other neuritogenesis inducers. Furthermore, U0126, and SB203580, but not U0124 and GW441756, considerably inhibited TRTS-induced neuritogenesis. These results suggest that TRTS can induce neuritogenesis and that participation of both the ERK1/2 and p38 MAPK signaling pathways is required for TRTS-dependent neuritogenesis in PC12 cells. Thus, TRTS may be an effective technique for regenerative neuromedicine.	[Kudo, Tada-aki] Tohoku Univ, Grad Sch Dent, Div Oral Physiol, Sendai, Miyagi 980, Japan; [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Dent, Liaison Ctr Innovat Dent, Sendai, Miyagi 980, Japan; [Kanetaka, Hiroyasu; Tominami, Kanako; Izumi, Shin-ichi] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan; [Mochizuki, Kentaro] Tohoku Univ, Inst Dev Aging & Canc, Cell Resource Ctr Biomed Res, Sendai, Miyagi 980, Japan; [Nunome, Shoko] Tohoku Univ, Grad Sch Dent, Div Oral Dysfunct Sci, Sendai, Miyagi 980, Japan; [Abe, Genji; Izumi, Shin-ichi] Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Sendai, Miyagi 980, Japan; [Kosukegawa, Hiroyuki; Takagi, Toshiyuki] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 980, Japan; [Abe, Toshihiko; Mori, Hitoshi; Mori, Kazumi] IFG Co Ltd, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kudo, T (corresponding author), Tohoku Univ, Grad Sch Dent, Div Oral Physiol, Sendai, Miyagi 980, Japan.	tkudo@m.tohoku.ac.jp	Kosukegawa, Hiroyuki/AAC-3014-2019; TAKAGI, Toshiyuki/S-9785-2019	TAKAGI, Toshiyuki/0000-0003-1283-4320; Tominami, Kanako/0000-0003-4342-6979; Kudo, Tada-aki/0000-0003-1666-9588; Kanetaka, Hiroyasu/0000-0001-7744-3879	Japan Society for the Promotion of Science KAKENHI grant [25861880]; Cooperative Research Project of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University	This work was supported in part by the Japan Society for the Promotion of Science (www.jsps.go.jp) KAKENHI grant number 25861880, and by the Cooperative Research Project of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University (www.idac.tohoku.ac.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn N.G., 1999, PROMEGA NOTES, V71, P4; Ahn TB, 2006, BRAIN RES, V1087, P159, DOI 10.1016/j.brainres.2006.02.097; Cheng BC, 2008, NEUROSCI LETT, V443, P140, DOI 10.1016/j.neulet.2008.07.083; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; El Omri A, 2010, J ETHNOPHARMACOL, V131, P451, DOI 10.1016/j.jep.2010.07.006; Fantetti KN, 2012, DEV NEUROBIOL, V72, P1213, DOI 10.1002/dneu.20988; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1981, J BIOL CHEM, V256, P6363; Hansen TV, 2003, NEUROSCI LETT, V347, P57, DOI 10.1016/S0304-3940(03)00581-0; Hardiansyah A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-497; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Heo DK, 2012, CELL SIGNAL, V24, P899, DOI 10.1016/j.cellsig.2011.12.011; Higgins S, 2013, BIORESEARCH OPEN ACC, V2, P212, DOI 10.1089/biores.2013.0008; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Iwasaki S, 1996, J BIOL CHEM, V271, P17360, DOI 10.1074/jbc.271.29.17360; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; Jang Y, 2012, J BIOL CHEM, V287, P6014, DOI 10.1074/jbc.M111.316315; Jung EJ, 2008, EXP MOL MED, V40, P276, DOI 10.3858/emm.2008.40.3.276; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kim HS, 2006, EXP MOL MED, V38, P85, DOI 10.1038/emm.2006.10; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Koike T, 2006, NEUROSCI LETT, V410, P212, DOI 10.1016/j.neulet.2006.10.008; Kudo T, 2013, CELL STRUCT FUNCT, V38, P15, DOI 10.1247/csf.12030; Kudo T, 2011, GENES CELLS, V16, P1121, DOI 10.1111/j.1365-2443.2011.01556.x; Kudo T, 2010, TOHOKU J EXP MED, V222, P121, DOI 10.1620/tjem.222.121; Li ZX, 2012, J MATER SCI-MATER M, V23, P2461, DOI 10.1007/s10856-012-4735-y; Li ZX, 2012, J BIOMED MATER RES A, V100A, P2537, DOI 10.1002/jbm.a.34185; Liang P, 1997, J CELL SCI, V110, P1431; Liu JH, 2003, INT J DEV NEUROSCI, V21, P277, DOI 10.1016/S0736-5748(03)00040-6; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Muramatsu R, 2009, BIOSCI TRENDS, V3, P179; Omori H, 2014, NEUROSCI RES, V79, P13, DOI 10.1016/j.neures.2013.11.005; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; Rakhit S, 2001, MOL PHARMACOL, V60, P63, DOI 10.1124/mol.60.1.63; Read DE, 2008, BRAIN RES, V1221, P14, DOI 10.1016/j.brainres.2008.05.028; Ruggeri P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094568; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yan SY, 2014, BRAZ J MED BIOL RES, V47, P947, DOI 10.1590/1414-431X20143808; Yanagisawa M, 2001, GENES CELLS, V6, P1091, DOI 10.1046/j.1365-2443.2001.00483.x; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; Yung LY, 2008, CELL SIGNAL, V20, P1538, DOI 10.1016/j.cellsig.2008.04.007	47	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124024	10.1371/journal.pone.0124024	http://dx.doi.org/10.1371/journal.pone.0124024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879210	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500079
J	Wan, K; Zhao, JX; Huang, H; Zhang, Q; Chen, X; Zeng, Z; Zhang, L; Chen, YC				Wan, Ke; Zhao, Jianxun; Huang, Hao; Zhang, Qing; Chen, Xi; Zeng, Zhi; Zhang, Li; Chen, Yucheng			The Association between Triglyceride/High-Density Lipoprotein Cholesterol Ratio and All-Cause Mortality in Acute Coronary Syndrome after Coronary Revascularization	PLOS ONE			English	Article							HDL-CHOLESTEROL; INSULIN-RESISTANCE; HEART-DISEASE; ARTERIAL STIFFNESS; PHENOTYPE-B; RISK; CHILDREN; ADOLESCENTS; ACCURACY; EVENTS	Aims High triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) are cardiovascular risk factors. A positive correlation between elevated TG/HDL-C ratio and all-cause mortality and cardiovascular events exists in women. However, utility of TG to HDL-C ratio for prediction is unknown among acute coronary syndrome (ACS). Methods Fasting lipid profiles, detailed demographic data, and clinical data were obtained at baseline from 416 patients with ACS after coronary revascularization. Subjects were stratified into three levels of TG/HDL-C. We constructed multivariate Cox-proportional hazard models for all-cause mortality over a median follow-up of 3 years using log TG to HDL-C ratio as a predictor variable and analyzing traditional cardiovascular risk factors. We constructed a logistic regression model for major adverse cardiovascular events (MACEs) to prove that the TG/HDL-C ratio is a risk factor. Results The subject's mean age was 64 +/- 11 years; 54.5% were hypertensive, 21.8% diabetic, and 61.0% current or prior smokers. TG/HDL-C ratio ranged from 0.27 to 14.33. During the follow-up period, there were 43 deaths. In multivariate Cox models after adjusting for age, smoking, hypertension, diabetes, and severity of angiographic coronary disease, patients in the highest tertile of ACS had a 5.32-fold increased risk of mortality compared with the lowest tertile. After adjusting for conventional coronary heart disease risk factors by the logistic regression model, the TG/HDL-C ratio was associated with MACEs. Conclusion The TG to HDL-C ratio is a powerful independent predictor of all-cause mortality and is a risk factor of cardiovascular events.	[Wan, Ke; Zhao, Jianxun; Zhang, Qing; Chen, Xi; Zeng, Zhi; Zhang, Li; Chen, Yucheng] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Sichuan Provinc, Peoples R China; [Huang, Hao] Peoples Hosp Sichuan Prov, Div Cardiol, Chengdu, Sichuan, Peoples R China	Sichuan University	Wan, K (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Sichuan Provinc, Peoples R China.	LiZhangdoc@yahoo.com; chenyucheng2003@126.com	Chen, Yu/Y-3292-2019; Chen, Yucheng/AAF-6181-2020; Chen, Yi/HIR-2608-2022	Huang, Hao/0000-0003-1748-1245				Ballantyne CM, 2001, CIRCULATION, V104, P3046, DOI 10.1161/hc5001.100624; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Bhalodkar NC, 2006, AM J CARDIOL, V97, P1007, DOI 10.1016/j.amjcard.2005.10.036; Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014; Brehm A, 2004, CLIN CHEM, V50, P2316, DOI 10.1373/clinchem.2004.037556; Cordero A, 2008, AM J CARDIOL, V102, P424, DOI 10.1016/j.amjcard.2008.03.079; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; de Giorgis T, 2014, EUR J ENDOCRINOL, V170, P173, DOI 10.1530/EJE-13-0452; deGoma EM, 2008, J AM COLL CARDIOL, V51, P49, DOI 10.1016/j.jacc.2007.07.086; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Fuster V, 2011, J AM COLL CARDIOL, V58, P1208, DOI 10.1016/j.jacc.2011.05.038; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Hanak V, 2004, AM J CARDIOL, V94, P219, DOI 10.1016/j.amjcard.2004.03.069; Hermans MP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-132; Hermans MP, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-88; Maki KC, 2011, J CLIN LIPIDOL, V5, P141, DOI 10.1016/j.jacl.2011.02.003; Maruyama Chizuko, 2003, J Atheroscler Thromb, V10, P186; Neil HAW, 2010, ATHEROSCLEROSIS, V211, P618, DOI 10.1016/j.atherosclerosis.2010.03.006; Pacifico L, 2014, NUTR METAB CARDIOVAS, V24, P737, DOI 10.1016/j.numecd.2014.01.010; Shimizu Y, 2013, ATHEROSCLEROSIS, V228, P491, DOI 10.1016/j.atherosclerosis.2013.03.021; St-Pierre AC, 2004, METAB SYNDR RELAT D, V2, P57, DOI 10.1089/met.2004.2.57; Sumner AE, 2010, METAB SYNDR RELAT D, V8, P511, DOI 10.1089/met.2010.0028; Thomas GS, 2013, J AM COLL CARDIOL, V62, P2178, DOI 10.1016/j.jacc.2013.07.081; Urbina EM, 2013, PEDIATRICS, V131, pE1082, DOI 10.1542/peds.2012-1726; Wakabayashi I, 2013, AM J HYPERTENS, V26, P888, DOI 10.1093/ajh/hpt033; Winkler L, 1989, Przegl Lek, V46, P595	28	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123521	10.1371/journal.pone.0123521	http://dx.doi.org/10.1371/journal.pone.0123521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880982	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500054
J	Wei, ZZ; Vatcher, G; Tin, AHY; Teng, JL; Wang, J; Cui, QH; Chen, JG; Yu, ACH				Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Teng, Jun Lin; Wang, Juan; Cui, Qing Hua; Chen, Jian Guo; Yu, Albert Cheung Hoi			Positively-Charged Semi-Tunnel Is a Structural and Surface Characteristic of Polyphosphate-Binding Proteins: An In-Silico Study	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; CRYSTAL-STRUCTURE; EXOPOLYPHOSPHATASE; KINASE; IDENTIFICATION; PHOSPHATASE; METABOLISM; EUKARYOTE; ALIGNMENT; COMPLEX	Phosphate is essential for all major life processes, especially energy metabolism and signal transduction. A linear phosphate polymer, polyphosphate (polyP), linked by high-energy phosphoanhydride bonds, can interact with various proteins, playing important roles as an energy source and regulatory factor. However, polyP-binding structures are largely unknown. Here we proposed a putative polyP binding site, a positively-charged semi-tunnel (PCST), identified by surface electrostatics analyses in polyP kinases (PPKs) and many other polyP-related proteins. We found that the PCSTs in varied proteins were folded in different secondary structure compositions. Molecular docking calculations revealed a significant value for binding affinity to polyP in PCST-containing proteins. Utilizing the PCST identified in the beta subunit of PPK3, we predicted the potential polyP-binding domain of PPK3. The discovery of this feature facilitates future searches for polyP-binding proteins and discovery of the mechanisms for polyP-binding activities. This should greatly enhance the understanding of the many physiological functions of protein-bound polyP and the involvement of polyP and polyP-binding proteins in various human diseases.	[Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Yu, Albert Cheung Hoi] Peking Univ, Neurosci Res Inst, Beijing 100191, Peoples R China; [Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Yu, Albert Cheung Hoi] Peking Univ, Dept Neurobiol, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Yu, Albert Cheung Hoi] Peking Univ, Key Lab Neurosci, Minist Educ, Beijing 100191, Peoples R China; [Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Yu, Albert Cheung Hoi] Peking Univ, Key Lab Neurosci, Natl Hlth & Family Planning Commiss, Beijing 100191, Peoples R China; [Teng, Jun Lin; Chen, Jian Guo] Peking Univ, Key Lab Cell Proliferat & Differentiat, State Key Lab Biomembrane & Membrane Bioengn, Minist Educ,Coll Life Sci, Beijing 100871, Peoples R China; [Wang, Juan; Cui, Qing Hua] Peking Univ, Sch Basic Med Sci, Dept Med Informat, Beijing 100191, Peoples R China; [Yu, Albert Cheung Hoi] Peking Univ, Ctr Infect Dis, Beijing 100191, Peoples R China; [Yu, Albert Cheung Hoi] Peking Univ, Inst Syst Biomed, Lab Translat Med, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; Peking University	Wei, ZZ (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100191, Peoples R China.	achy@hsc.pku.edu.cn	Wei, Zheng Zachory/I-2109-2019	Wei, Zheng Zachory/0000-0001-7682-9286	National Basic Research Program of China (973 program) [2011CB504400]; National Natural Science Foundation of China [31070974, 31171009, 81221002]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81221002]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this study was provided by the National Basic Research Program of China (973 program, 2011CB504400), the National Natural Science Foundation of China (31070974, 31171009, 81221002) and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81221002).	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarado J, 2006, STRUCTURE, V14, P1263, DOI 10.1016/j.str.2006.06.009; Ariganello MB, 2014, J CELL BIOCHEM, V115, P2089, DOI 10.1002/jcb.24886; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Bates PA, 2001, PROTEINS, P39; Campos E, 2007, INSECT BIOCHEM MOLEC, V37, P1103, DOI 10.1016/j.ibmb.2007.06.003; Dedkova EN, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00260; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Diaz JM, 2010, ENVIRON SCI TECHNOL, V44, P4665, DOI 10.1021/es100191h; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gomez-Garcia MR, 2004, P NATL ACAD SCI USA, V101, P15876, DOI 10.1073/pnas.0406923101; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Han KY, 2007, BIOCHEM J, V406, P49, DOI 10.1042/BJ20061542; Harada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078612; Harada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074650; Hernandez-Ruiz L, 2006, HAEMATOLOGICA, V91, P1180; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmstrom KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2364; Hooley P, 2008, TRENDS BIOCHEM SCI, V33, P577, DOI 10.1016/j.tibs.2008.09.007; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jain S, 2012, P NATL ACAD SCI USA, V109, P12938, DOI 10.1073/pnas.1204928109; Kawai S, 2005, J BIOSCI BIOENG, V99, P320, DOI 10.1263/jbb.99.320; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lee A, 2010, ANAL CHEM, V82, P6838, DOI 10.1021/ac1008018; Lieberman L, 1888, BER CHEM GES, V21, P598, DOI DOI 10.1002/CBER.188802101109; Liu XQ, 2009, NUCLEIC ACIDS RES, V37, pW33, DOI 10.1093/nar/gkp428; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5; Mukai T, 2004, J BIOL CHEM, V279, P50591, DOI 10.1074/jbc.M408126200; Mutch NJ, 2010, J THROMB HAEMOST, V8, P548, DOI 10.1111/j.1538-7836.2009.03723.x; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Seidlmayer LK, 2012, J GEN PHYSIOL, V139, P321, DOI 10.1085/jgp.201210788; Seufferheld MJ, 2010, PLANT MOL BIOL REP, V28, P549, DOI 10.1007/s11105-010-0187-z; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stotz SC, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-42; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsutsumi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086834; Ugochukwu E, 2007, J MOL BIOL, V371, P1007, DOI 10.1016/j.jmb.2007.05.066; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wrench AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076428; Yang ZX, 2010, MOL MICROBIOL, V77, P618, DOI 10.1111/j.1365-2958.2010.07233.x; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0; Zakharian E, 2007, BIOPHYS J, V92, P588, DOI 10.1529/biophysj.106.095273; Zhang HY, 2007, P NATL ACAD SCI USA, V104, P16486, DOI 10.1073/pnas.0706847104; Zhao J, 2008, PLOS BIOL, V6, P1306, DOI 10.1371/journal.pbio.0060150; Zhu Y, 2005, EMBO REP, V6, P681, DOI 10.1038/sj.embor.7400448	65	5	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123713	10.1371/journal.pone.0123713	http://dx.doi.org/10.1371/journal.pone.0123713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879219	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500059
J	Wolf, S; Grunewald, S				Wolf, Steffen; Gruenewald, Stefan			Sequence, Structure and Ligand Binding Evolution of Rhodopsin-Like G Protein-Coupled Receptors: A Crystal Structure-Based Phylogenetic Analysis	PLOS ONE			English	Article							OPIOID RECEPTOR; MOLECULAR RECOGNITION; OLFACTORY RECEPTOR; GPCR; COMPLEX; ACTIVATION; PREDICTION; ALIGNMENT; REVEALS; SODIUM	G protein-coupled receptors (GPCRs) form the largest family of membrane receptors in the human genome. Advances in membrane protein crystallization so far resulted in the determination of 24 receptors available as high-resolution atomic structures. We performed the first phylogenetic analysis of GPCRs based on the available set of GPCR structures. We present a new phylogenetic tree of known human rhodopsin-like GPCR sequences based on this structure set. We can distinguish the three separate classes of small-ligand binding GPCRs, peptide binding GPCRs, and olfactory receptors. Analyzing different structural sub-domains, we found that small molecule binding receptors most likely have evolved from peptide receptor precursors, with a rhodopsin/S1PR1 ancestor, most likely an ancestral opsin, forming the link between both classes. A light-activated receptor therefore seems to be the origin of the small molecule hormone receptors of the central nervous system. We find hints for a common evolutionary path of both ligand binding site and central sodium/water binding site. Surprisingly, opioid receptors exhibit both a binding cavity and a central sodium/water binding site similar to the one of biogenic amine receptors instead of peptide receptors, making them seemingly prone to bind small molecule ligands, e.g. opiates. Our results give new insights into the relationship and the pharmacological properties of rhodopsin-like GPCRs.	[Wolf, Steffen] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, Dept Biophys,CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Wolf, Steffen] Ruhr Univ Bochum, Dept Biophys, Bochum, Germany; [Gruenewald, Stefan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Ruhr University Bochum; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Wolf, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, Dept Biophys,CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	swolf@picb.ac.cn	Wolf, Steffen/A-1721-2010	Wolf, Steffen/0000-0003-1752-6175	Chinese Academy of Sciences Fellowship for Young International Scientists; National Natural Science Foundation of China (NSFC) Research Fund for International Young Scientists [31250110070]	Chinese Academy of Sciences Fellowship for Young International Scientists; National Natural Science Foundation of China (NSFC) Research Fund for International Young Scientists	SW is funded by a Chinese Academy of Sciences Fellowship for Young International Scientists. This work was supported by a grant from the National Natural Science Foundation of China (NSFC) Research Fund for International Young Scientists (grant No. 31250110070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Allaby RG, 2007, EVOL BIOINFORM, V3, P357; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chung S, 2008, BRIT J PHARMACOL, V153, pS339, DOI 10.1038/sj.bjp.0707606; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Feigin ME, 2014, P NATL ACAD SCI USA, V111, P4191, DOI 10.1073/pnas.1320239111; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gehring WJ, 2014, WIRES DEV BIOL, V3, P1, DOI 10.1002/wdev.96; Gelis L, 2012, ANGEW CHEM INT EDIT, V51, P1274, DOI 10.1002/anie.201103980; Gerwert K, 2014, BBA-BIOENERGETICS, V1837, P606, DOI 10.1016/j.bbabio.2013.09.006; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez-de-Teran H, 2013, STRUCTURE, V21, P2175, DOI 10.1016/j.str.2013.09.020; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jafurulla M, 2012, CMC, V20, P47, DOI DOI 10.2174/0929867311302010006; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kane BE, 2006, AAPS J, V8, pE126, DOI 10.1208/aapsj080115; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Miller-Gallacher JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092727; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Mombaerts P, 2001, ANNU REV GENOM HUM G, V2, P493, DOI 10.1146/annurev.genom.2.1.493; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park JH, 2013, ANGEW CHEM INT EDIT, V52, P11021, DOI 10.1002/anie.201302374; Pele J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019094; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schrodinger L, 2010, THE PYMOL MOLECULAR; Schuenke M, 2010, THIEME ATLAS OF ANAT; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Stewart A, 2011, REV NEUROSCIENCE, V22, P95, DOI 10.1515/RNS.2011.011; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yuan S, 2015, ANGEW CHEM INT EDIT, V127, P566; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	96	41	42	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123533	10.1371/journal.pone.0123533	http://dx.doi.org/10.1371/journal.pone.0123533			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881057	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500055
J	Yoon, YE; Lee, KS; Choi, KH; Kim, KH; Yang, SC; Han, WK				Yoon, Young Eun; Lee, Kwang Suk; Choi, Kyung Hwa; Kim, Kwang Hyun; Yang, Seung Choul; Han, Woong Kyu			Preconditioning Strategies for Kidney Ischemia Reperfusion Injury: Implications of the "Time-Window" in Remote Ischemic Preconditioning	PLOS ONE			English	Article							GENE-EXPRESSION; RENAL ISCHEMIA; NITRIC-OXIDE; PROTECTION; RAT; CELLS; MECHANISMS; BIOMARKERS; ADENOSINE; HEART	Remote ischemic preconditioning (IP) is a potential renoprotective strategy. However, there has been no demonstrated result in large animals and the role of time window in remote IP remains to be defined. Using a single-kidney porcine model, we evaluated organ protective function of remote IP in renal ischemia reperfusion injury. Fifteen Yorkshire pigs, 20 weeks old and weighing 35-38 kg were used. One week after left nephrectomy, we performed remote IP (clamping right external iliac artery, 2 cycles of 10 minutes) and right renal artery clamping (warm ischemia; 90 minutes). The animals were randomly divided into three groups: control group, warm ischemia without IP; group 1 (remote IP with early window [IP-E]), IP followed by warm ischemia with a 10-minute time window; and group 2 (remote IP with late window [IP-L]), IP followed by warm ischemia after a 24-hour time window. There were no differences in serum creatinine changes between groups. The IP-L group had lower urinary neutrophil gelatinase-associated lipocalin than control and IP-E at 72 hours post-ischemia. At 72 hours post-ischemia, the urinary kidney injury molecule-1 (KIM-1) was lower in the IP-L group than in the control and IP-E groups, and the IP-L group KIM-1 was near pre-ischemic levels, whereas the control and IP-E group KIM-1 levels were rising. Microalbumin also tended to be lower in the IP-L group. Taken together, remote IP showed a significant reduction in renal injury biomarkers from ischemia reperfusion injury. To effectively provide kidney protection, remote IP might require a considerable, rather than short, time window of ischemia.	[Yoon, Young Eun; Lee, Kwang Suk; Yang, Seung Choul; Han, Woong Kyu] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea; [Choi, Kyung Hwa] CHA Univ, CHA Bundang Med Ctr, Dept Urol, Songnam, South Korea; [Kim, Kwang Hyun] Ewha Womans Univ, Mokdong Hosp, Dept Urol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Ewha Womans University	Han, WK (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea.	hanwk@yuhs.ac		Yoon, Young Eun/0000-0001-8059-6649; Han, Woong Kyu/0000-0002-2527-4046; Lee, Kwang Suk/0000-0002-7961-8393	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [NRF-2012R1A1A1042968]	National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This work (No. NRF-2012R1A1A1042968) was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST).	Ayupova DA, 2009, AM J PHYSIOL-RENAL, V297, pF95, DOI 10.1152/ajprenal.90632.2008; Bellomo R, 2004, INTENS CARE MED, V30, P33, DOI 10.1007/s00134-003-2078-3; Burne-Taney MJ, 2006, J IMMUNOL, V176, P7015, DOI 10.4049/jimmunol.176.11.7015; Cernaro V, 2011, CURR PHARM DESIGN, V17, P844, DOI 10.2174/138161211795428939; Das M, 2008, IUBMB LIFE, V60, P199, DOI 10.1002/iub.31; Devarajan P, 2003, MOL GENET METAB, V80, P365, DOI 10.1016/j.ymgme.2003.09.012; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Fu WJ, 2012, DIABETES RES CLIN PR, V95, P105, DOI 10.1016/j.diabres.2011.09.031; Gardner DS, 2014, AM J PHYSIOL-RENAL, V306, pF873, DOI 10.1152/ajprenal.00576.2013; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hernandez DJ, 2008, J ENDOUROL, V22, P2531, DOI 10.1089/end.2008.0145; Hotter G, 1996, BIOCHEM BIOPH RES CO, V222, P27, DOI 10.1006/bbrc.1996.0692; Huang JW, 2013, BJU INT, V112, P74, DOI 10.1111/bju.12004; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Ishida T, 1997, SHOCK, V8, P86, DOI 10.1097/00024382-199708000-00003; JEROME SN, 1995, AM J PHYSIOL-HEART C, V268, pH2063, DOI 10.1152/ajpheart.1995.268.5.H2063; Joo JD, 2006, J AM SOC NEPHROL, V17, P3115, DOI 10.1681/ASN.2006050424; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Kosieradzki M, 2003, SURGERY, V133, P81, DOI 10.1067/msy.2003.93; Li FZ, 2005, ACTA PHARMACOL SIN, V26, P851, DOI 10.1111/j.1745-7254.2005.00109.x; Li L, 2006, NAT CLIN PRACT NEPHR, V2, P432, DOI 10.1038/ncpneph0238; Maulik N, 1996, FEBS LETT, V396, P233, DOI 10.1016/0014-5793(96)01109-X; Moon SJ, 2013, J KOREAN MED SCI, V28, P1181, DOI 10.3346/jkms.2013.28.8.1181; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Orvieto MA, 2007, UROLOGY, V69, P984, DOI 10.1016/j.urology.2007.01.100; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; Salehipour M, 2007, UROL INT, V79, P328, DOI 10.1159/000109718; Soni SS, 2009, BLOOD PURIFICAT, V28, P165, DOI 10.1159/000227785; SPEECHLYDICK ME, 1994, CIRC RES, V75, P586, DOI 10.1161/01.RES.75.3.586; Treska Vladislav, 2006, Exp Clin Transplant, V4, P439; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Yamashita N, 1998, J MOL CELL CARDIOL, V30, P1181, DOI 10.1006/jmcc.1998.0682; Yin DP, 1998, TRANSPLANTATION, V66, P152, DOI 10.1097/00007890-199807270-00002	36	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124130	10.1371/journal.pone.0124130	http://dx.doi.org/10.1371/journal.pone.0124130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879855	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500084
J	Chen, S; Liu, BQ; Kong, DH; Li, S; Li, C; Wang, HQ; Sun, YX				Chen, Shuang; Liu, Baoqin; Kong, Dehui; Li, Si; Li, Chao; Wang, Huaqin; Sun, Yingxian			Atorvastatin Calcium Inhibits Phenotypic Modulation of PDGF-BB-Induced VSMCs via Down-Regulation the Akt Signaling Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; INDUCED PROLIFERATION; MAMMALIAN TARGET; VASCULAR INJURY; IN-VIVO; MIGRATION; ATHEROSCLEROSIS; EXPRESSION; DIFFERENTIATION	Plasticity of vascular smooth muscle cells (VSMCs) plays a central role in the onset and progression of proliferative vascular diseases. In adult tissue, VSMCs exist in a physiological contractile-quiescent phenotype, which is defined by lack of the ability of proliferation and migration, while high expression of contractile marker proteins. After injury to the vessel, VSMC shifts from a contractile phenotype to a pathological synthetic phenotype, associated with increased proliferation, migration and matrix secretion. It has been demonstrated that PDGF-BB is a critical mediator of VSMCs phenotypic switch. Atorvastatin calcium, a selective inhibitor of 3-hydroxy-3-methyl-glutaryl l coenzyme A (HMG-CoA) reductase, exhibits various protective effects against VSMCs. In this study, we investigated the effects of atorvastatin calcium on phenotype modulation of PDGF-BB-induced VSMCs and the related intracellular signal transduction pathways. Treatment of VSMCs with atorvastatin calcium showed dose-dependent inhibition of PDGF-BB-induced proliferation. Atorvastatin calcium co-treatment inhibited the phenotype modulation and cytoskeleton rearrangements and improved the expression of contractile phenotype marker proteins such as alpha-SM actin, SM22 alpha and calponin in comparison with PDGF-BB alone stimulated VSMCs. Although Akt phosphorylation was strongly elicited by PDGF-BB, Akt activation was attenuated when PDGFBB was co-administrated with atorvastatin calcium. In conclusion, atorvastatin calcium inhibits phenotype modulation of PDGF-BB-induced VSMCs and activation of the Akt signaling pathway, indicating that Akt might play a vital role in the modulation of phenotype.	[Chen, Shuang; Sun, Yingxian] China Med Univ, Hosp 1, Dept Cardiol, Shenyang 110001, Liaoning, Peoples R China; [Liu, Baoqin; Kong, Dehui; Li, Si; Li, Chao; Wang, Huaqin] China Med Univ, Dept Biochem & Mol Biol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University	Sun, YX (corresponding author), China Med Univ, Hosp 1, Dept Cardiol, Shenyang 110001, Liaoning, Peoples R China.	yxsun@mail.cmu.edu.cn						Axel DI, 2000, J CARDIOVASC PHARM, V35, P619, DOI 10.1097/00005344-200004000-00016; Babapulle MN, 2002, CIRCULATION, V106, P2859, DOI 10.1161/01.CIR.0000038984.30279.89; Bea F, 2002, ARTERIOSCL THROM VAS, V22, P1832, DOI 10.1161/01.ATV.0000036081.01231.16; Bilder G, 1999, CIRCULATION, V99, P3292, DOI 10.1161/01.CIR.99.25.3292; BLANK RS, 1990, J CELL PHYSIOL, V142, P635, DOI 10.1002/jcp.1041420325; Bochaton-Piallat ML, 2005, HANDB EXP PHARM, V170, P645; Braun-Dullaeus RC, 2001, ARTERIOSCL THROM VAS, V21, P1152, DOI 10.1161/hq0701.092104; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Coats W D Jr, 1997, Semin Interv Cardiol, V2, P167; CORJAY MH, 1989, J BIOL CHEM, V264, P10501; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; DiNicolantonio JJ, 2013, POSTGRAD MED, V125, P7, DOI 10.3810/pgm.2013.01.2620; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Goncharova EA, 2002, AM J PHYSIOL-LUNG C, V283, pL354, DOI 10.1152/ajplung.00010.2002; Guijarro C, 1998, CIRC RES, V83, P490, DOI 10.1161/01.RES.83.5.490; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Heldin CH, 1997, FEBS LETT, V410, P17, DOI 10.1016/S0014-5793(97)00318-9; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Liu DM, 2014, CELL PHYSIOL BIOCHEM, V33, P129, DOI 10.1159/000356656; Mandegar M, 2004, MICROVASC RES, V68, P75, DOI 10.1016/j.mvr.2004.06.001; Owens GK, 1997, AGENT ACTION SUPPL, V48, P3; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Park ES, 2013, EXP CELL RES, V319, P982, DOI 10.1016/j.yexcr.2012.12.024; Rani PU, 2013, J NUTR BIOCHEM, V24, P1830, DOI 10.1016/j.jnutbio.2013.04.004; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Sun L, 2012, MOLECULES, V17, P3333, DOI 10.3390/molecules17033333; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zhao Y, 2011, CHINESE MED J-PEKING, V124, P4286, DOI 10.3760/cma.j.issn.0366-6999.2011.24.029; Zhu LH, 2013, MOL CELL BIOCHEM, V373, P53, DOI 10.1007/s11010-012-1474-9	39	69	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122577	10.1371/journal.pone.0122577	http://dx.doi.org/10.1371/journal.pone.0122577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874930	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800066
J	de Kerckhove, DT; Minns, CK; Chu, C				de Kerckhove, Derrick Tupper; Minns, Charles Kenneth; Chu, Cindy			Estimating Fish Exploitation and Aquatic Habitat Loss across Diffuse Inland Recreational Fisheries	PLOS ONE			English	Article							TROUT SALVELINUS-NAMAYCUSH; NO NET LOSS; PRODUCTIVE CAPACITY; UNITED-STATES; LAKE TROUT; CANADA; MANAGEMENT; CONSERVATION; BIODIVERSITY; COMPENSATION	The current state of many freshwater fish stocks worldwide is largely unknown but suspected to be vulnerable to exploitation from recreational fisheries and habitat degradation. Both these factors, combined with complex ecological dynamics and the diffuse nature of inland fisheries could lead to an invisible collapse: the drastic decline in fish stocks without great public or management awareness. In this study we provide a method to address the pervasive knowledge gaps in regional rates of exploitation and habitat degradation, and demonstrate its use in one of North America's largest and most diffuse recreational freshwater fisheries (Ontario, Canada). We estimated that 1) fish stocks were highly exploited and in apparent danger of collapse in management zones close to large population centres, and 2) fish habitat was under a low but constant threat of degradation at rates comparable to deforestation in Ontario and throughout Canada. These findings confirm some commonly held, but difficult to quantify, beliefs in inland fisheries management but also provide some further insights including 1) large anthropogenic projects greater than one hectare could contribute much more to fish habitat loss on an area basis than the cumulative effect of smaller projects within one year, 2) hooking mortality from catch-and-release fisheries is likely a greater source of mortality than the harvest itself, and 3) in most northern management zones over 50% of the fisheries resources are not yet accessible to anglers. While this model primarily provides a framework to prioritize management decisions and further targeted stock assessments, we note that our regional estimates of fisheries productivity and exploitation were similar to broadscale monitoring efforts by the Province of Ontario. We discuss the policy implications from our results and extending the model to other jurisdictions and countries.	[de Kerckhove, Derrick Tupper; Minns, Charles Kenneth; Chu, Cindy] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	de Kerckhove, DT (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	fish.research@gmail.com	Minns, Charles/GYU-2209-2022	Chu, Cindy/0000-0002-1914-3218	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding provided by Natural Science and Engineering Research Council of Canada Post Graduate Scholarship to DDK and Natural Science and Engineering Research Council of Canada Postdoctoral Fellowship to CC, http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GF, 1977, J FISH RES BOARD CAN, V34, P1613, DOI 10.1139/f77-226; Arlinghaus R, 2005, SCIENCE, V307, P1561, DOI 10.1126/science.307.5715.1561; Arlinghaus R, 2006, ENVIRON CONSERV, V33, P46, DOI 10.1017/S0376892906002700; Bigford TE, 2013, FISHERIES, V38, P196, DOI 10.1080/03632415.2013.792608; Cardoso AC, 2007, HYDROBIOLOGIA, V584, P3, DOI 10.1007/s10750-007-0584-y; CARLANDER KD, 1977, J FISH RES BOARD CAN, V34, P1602, DOI 10.1139/f77-225; Chu C, 2003, CAN J FISH AQUAT SCI, V60, P624, DOI 10.1139/F03-048; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Cote D, 2007, J FISH BIOL, V70, P1134, DOI 10.1111/j.1095-8649.2007.01384.x; Cowx IG, 2010, J FISH BIOL, V76, P2194, DOI 10.1111/j.1095-8649.2010.02686.x; de Kerckhove DT, 2013, CAN J FISH AQUAT SCI, V70, P517, DOI 10.1139/cjfas-2012-0411; Downing JA, 2014, INLAND WATERS, V4, P215, DOI 10.5268/IW-4.2.753; Drake DAR, 2010, ECOL APPL, V20, P2286, DOI 10.1890/09-2005.1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Edwards SF, EC GUIDE ALLOCATION; Esselman Peter C., 2011, Ecological Restoration, V29, P133, DOI 10.3368/er.29.1-2.133; EVANS DO, 1991, CAN J FISH AQUAT SCI, V48, P134, DOI 10.1139/f91-312; Favaro B, 2012, SCIENCE, V337, P154, DOI 10.1126/science.1225523; Fisheries and Oceans Canada, 2014, FISH PROT PROGR; Fisheries and Oceans Canada, 2012, SURV RECR FISH CAN 2; Foley NS, 2012, INT J ECOL, V2012, DOI DOI 10.1155/2012/861635; Gale MK, 2013, FISH FISH, V14, P1, DOI 10.1111/j.1467-2979.2011.00441.x; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Government of Ontario, 2012, GEON S ONT; Griffiths D, 2006, ECOL FRESHW FISH, V15, P86, DOI 10.1111/j.1600-0633.2006.00125.x; Gunn JM, 2000, CAN J FISH AQUAT SCI, V57, P97, DOI 10.1139/cjfas-57-S2-97; Halverson MA, 2008, FISHERIES, V33, P69, DOI 10.1577/1548-8446-33.2.69; Hanson PC, 2007, FRESHWATER BIOL, V52, P814, DOI 10.1111/j.1365-2427.2007.01730.x; Harper DJ, 2005, ENVIRON MANAGE, V36, P343, DOI 10.1007/s00267-004-0114-x; Hogg SE, 2010, 2005 SURVEY RECREATI; Hogg SE, 2010, EFFECTIVENESS 2005 R; Hunt LM, 2011, ECOL APPL, V21, P2555, DOI 10.1890/10-1237.1; Hutchings JA, 2013, FISHERIES, V38, P497, DOI 10.1080/03632415.2013.848345; Kaufman SD, 2009, CAN J FISH AQUAT SCI, V66, P212, DOI 10.1139/F08-205; Killen SS, 2003, N AM J FISH MANAGE, V23, P1238, DOI 10.1577/M02-164; Knowler DJ, 2003, J ENVIRON MANAGE, V69, P261, DOI 10.1016/j.jenvman.2003.09.001; Lange M, 2001, CAN MS REP FISH AQUA, V2576, P1; Lester NP, 2003, N AM J FISH MANAGE, V23, P1312, DOI 10.1577/M01-230AM; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Linke J, 2012, REMOTE SENS ENVIRON, V125, P112, DOI 10.1016/j.rse.2012.07.011; MacNeil J. E., 2008, Canadian Manuscript Report of Fisheries and Aquatic Sciences, V2840, P1; MAHON R, 1985, CAN J FISH AQUAT SCI, V42, P1211, DOI 10.1139/f85-148; McGarvey DJ, 2010, J N AM BENTHOL SOC, V29, P1212, DOI 10.1899/09-094.1; McKenna JE, 2005, N AM J FISH MANAGE, V25, P391, DOI 10.1577/M04-022.1; McKenney DW, 2010, CLIMATE CHANGE RES R, V16, P1; McMurtry M. J., 1997, Lake and Reservoir Management, V13, P199; Minns CK, 2010, AQUAT ECOSYST HEALTH, V13, P107, DOI 10.1080/14634981003788821; Minns CK, 2008, CAN J FISH AQUAT SCI, V65, P1763, DOI 10.1139/F08-110; Minns CK, 2006, CAN J FISH AQUAT SCI, V63, P1172, DOI 10.1139/F06-025; Minns CK, 2011, CAN J FISH AQUAT SCI, V68, P2204, DOI 10.1139/F2011-130; Minns CK, 2009, AQUAT ECOSYST HEALTH, V12, P152, DOI 10.1080/14634980902905775; Minns CK, 2003, CAN J FISH AQUAT SCI, V60, P100, DOI 10.1139/F02-168; Moilanen A, 2009, RESTOR ECOL, V17, P470, DOI 10.1111/j.1526-100X.2008.00382.x; Noges T, 2009, HYDROBIOLOGIA, V633, P33, DOI 10.1007/s10750-009-9874-x; Office of the Auditor General of Canada, 2009, SPRING REP COMM ENV; Post JR, 2008, ECOL APPL, V18, P1038, DOI 10.1890/07-0465.1; Post JR, 2013, FISHERIES MANAG ECOL, V20, P99, DOI 10.1111/fme.12008; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; Quigley JT, 2006, ENVIRON MANAGE, V37, P351, DOI 10.1007/s00267-004-0263-y; Radford A, EC EVALUATION INLAND, P1; Radomski P, 2010, FISHERIES, V35, P489, DOI 10.1577/1548-8446-35.10.489; RANDALL RG, 1995, CAN J FISH AQUAT SCI, V52, P631, DOI 10.1139/f95-063; Rosenfeld JS, 2008, N AM J FISH MANAGE, V28, P1108, DOI 10.1577/M07-027.1; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Scarborough G.C., 1993, LAKE RESERV MANAGE, V10, P155; SCHLESINGER DA, 1982, T AM FISH SOC, V111, P141, DOI 10.1577/1548-8659(1982)111<141:CAMIOF>2.0.CO;2; Schlesinger DA, 1983, ONTARIO FISHERIES TE, V10; Soranno PA, 2010, BIOSCIENCE, V60, P440, DOI 10.1525/bio.2010.60.6.8; Stammler KL, 2008, CAN J FISH AQUAT SCI, V65, P509, DOI 10.1139/F07-183; Stanfield L, 2010, ONTARIO RIVER ASSESS; Stanfield LW, 2006, AM FISH S S, V48, P577; Swales S, 2006, LAKE RESERV MANAGE, V22, P167, DOI 10.1080/07438140609353894; Sweeney BW, 2004, P NATL ACAD SCI USA, V101, P14132, DOI 10.1073/pnas.0405895101; U.S. Fish and Wildlife, 2012, NAT SURV FISH HUNT W; Velez-Espino LA, 2009, AQUAT CONSERV, V19, P676, DOI 10.1002/aqc.1023; Water Service of Canada, 1977, REF IND HYDSR MAP SU	77	7	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121895	10.1371/journal.pone.0121895	http://dx.doi.org/10.1371/journal.pone.0121895			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875790	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800034
J	Fuzita, FJ; Pinkse, MWH; Patane, JSL; Juliano, MA; Verhaert, PDEM; Lopes, AR				Fuzita, Felipe J.; Pinkse, Martijn W. H.; Patane, Jose S. L.; Juliano, Maria A.; Verhaert, Peter D. E. M.; Lopes, Adriana R.			Biochemical, Transcriptomic and Proteomic Analyses of Digestion in the Scorpion Tityus serrulatus: Insights into Function and Evolution of Digestion in an Ancient Arthropod	PLOS ONE			English	Article							CARCINOGENIC LIVER FLUKE; CATHEPSIN-F; CYSTEINE PROTEASE; MOLECULAR-CLONING; ASPARAGINYL ENDOPEPTIDASE; HARD TICK; ENZYMATIC CHARACTERIZATION; OPISTHORCHIS-VIVERRINI; SUBSTRATE-SPECIFICITY; PERITROPHIC MEMBRANES	Scorpions are among the oldest terrestrial arthropods and they have passed through small morphological changes during their evolutionary history on land. They are efficient predators capable of capturing and consuming large preys and due to envenomation these animals can become a human health challenge. Understanding the physiology of scorpions can not only lead to evolutionary insights but also is a crucial step in the development of control strategies. However, the digestive process in scorpions has been scarcely studied. In this work, we describe the combinatory use of next generation sequencing, proteomic analysis and biochemical assays in order to investigate the digestive process in the yellow scorpion Tityus serrulatus, mainly focusing in the initial protein digestion. The transcriptome generated database allowed the quantitative identification by mass spectrometry of different enzymes and proteins involved in digestion. All the results suggested that cysteine cathepsins play an important role in protein digestion. Two digestive cysteine cathepsins were isolated and characterized presenting acidic characteristics (pH optima and stability), zymogen conversion to the mature form after acidic activation and a cross-class inhibition by pepstatin. A more elucidative picture of the molecular mechanism of digestion in a scorpion was proposed based on our results from Tityus serrulatus. The midgut and midgut glands (MMG) are composed by secretory and digestive cells. In fasting animals, the secretory granules are ready for the next predation event, containing enzymes needed for alkaline extra-oral digestion which will compose the digestive fluid, such as trypsins, astacins and chitinase. The digestive vacuoles are filled with an acidic proteolytic cocktail to the intracellular digestion composed by cathepsins L, B, F, D and legumain. Other proteins as lipases, carbohydrases, ctenitoxins and a chitolectin with a perithrophin domain were also detected. Evolutionarily, a large gene duplication of cathepsin L occurred in Arachnida with the sequences from ticks being completely divergent from other arachnids probably due to the particular selective pressures over this group.	[Fuzita, Felipe J.; Lopes, Adriana R.] Inst Butantan, Biochem & Biophys Lab, Sao Paulo, Brazil; [Fuzita, Felipe J.] Univ Sao Paulo, Biotechnol Program, Sao Paulo, Brazil; [Pinkse, Martijn W. H.; Verhaert, Peter D. E. M.] Delft Univ Technol, Lab Analyt Biotechnol & Innovat Peptide Biol, Delft, Netherlands; [Patane, Jose S. L.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Juliano, Maria A.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Delft University of Technology; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Lopes, AR (corresponding author), Inst Butantan, Biochem & Biophys Lab, Sao Paulo, Brazil.	adriana.lopes@butantan.gov.br	Lopes, Adriana Rios/Y-9957-2019; Lopes, Adriana/I-9551-2014	Lopes, Adriana Rios/0000-0002-9741-2110; Lopes, Adriana/0000-0002-9741-2110; Fuzita, Felipe/0000-0002-0966-4183; Verhaert, Peter/0000-0002-6921-087X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2005/02486-1, 2006/03474-0]; Conselho Nacional de desenvolvimento cientifico e tecnologico Science [237706/2012-1]; Coordenacao de aperfeicoamento de pessoal de nivel superior; Netherlands Proteomics Centre	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de desenvolvimento cientifico e tecnologico Science(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de aperfeicoamento de pessoal de nivel superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Netherlands Proteomics Centre	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2005/02486-1) (www.fapesp.br) to ARL, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2006/03474-0 to FJF and ARL, Conselho Nacional de desenvolvimento cientifico e tecnologico Science without Borders 237706/2012-1 to FJF (www.cnpq.br), Coordenacao de aperfeicoamento de pessoal de nivel superior to FJF (www.capes.gov.br), and Netherlands Proteomics Centre to PDEMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110; Ahn SJ, 2009, COMP BIOCHEM PHYS B, V154, P211, DOI 10.1016/j.cbpb.2009.06.005; ALBERTI G, 1983, ZOOL ANZ, V211, P145; Alexandre D, 2014, COMP BIOCHEM PHYS B, V172, P90, DOI [10.1016/j.cbpb.201404.010, 10.1016/j.cbpb.2014.04.010]; Alim MA, 2008, J INSECT PHYSIOL, V54, P573, DOI 10.1016/j.jinsphys.2007.12.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aoki H, 2003, J BIOCHEM, V133, P799, DOI 10.1093/jb/mvg102; BECKER A, 1985, ZOOMORPHOLOGY, V105, P326, DOI 10.1007/BF00312064; Beynon R, 2001, PROTEOLYTIC ENZYMES, P340; Brusca RC, 2002, INVERTEBRATES, P895; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Chajec L, 2012, INVERTEBR BIOL, V131, P119, DOI 10.1111/j.1744-7410.2012.00264.x; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Cristofoletti PT, 2005, INSECT BIOCHEM MOLEC, V35, P883, DOI 10.1016/j.ibmb.2005.03.006; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fontanetti Carmem Silvia, 2001, Naturalia (Rio Claro), V26, P35; Foradori MJ, 2006, COMP BIOCHEM PHYS B, V143, P257, DOI 10.1016/j.cbpb.2005.08.012; Franta Z, 2011, INT J PARASITOL, V41, P1253, DOI 10.1016/j.ijpara.2011.06.006; Franta Z, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-119; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gouzy J, 2009, BIOINFORMATICS, V25, P670, DOI 10.1093/bioinformatics/btp024; GOYFFON M, 1983, CELL TISSUE RES, V228, P661, DOI 10.1007/BF00211482; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu KJ, 2007, COMP BIOCHEM PHYS B, V146, P69, DOI 10.1016/j.cbpb.2006.09.010; Hu KJ, 2004, COMP BIOCHEM PHYS B, V137, P21, DOI 10.1016/j.cbpc.2003.09.010; INOMATA M, 1984, J BIOCHEM-TOKYO, V95, P1661, DOI 10.1093/oxfordjournals.jbchem.a134779; Jensen AG, 2007, BIOCHEM J, V402, P449, DOI 10.1042/BJ20061205; Kang JM, 2010, MOL BIOCHEM PARASIT, V170, P7, DOI 10.1016/j.molbiopara.2009.11.006; Kang TH, 2004, PARASITOLOGY, V128, P195, DOI 10.1017/S0031182003004335; KAVANAGH EJ, 1983, COMP BIOCHEM PHYS B, V74, P365, DOI 10.1016/0305-0491(83)90026-3; Kjellesvig-Waering EN, 1986, RESTUDY FOSSIL SCORP, P287; Laha T, 2008, INT J INFECT DIS, V12, pE49, DOI 10.1016/j.ijid.2008.03.033; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Legros C, 1998, FEBS LETT, V431, P375, DOI 10.1016/S0014-5793(98)00780-7; Liebensteiner MG, 2013, SCIENCE, V340, P85, DOI 10.1126/science.1233957; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu XW, 2010, MOL CELL PROTEOMICS, V9, P2772, DOI 10.1074/mcp.M110.002766; Lopes AR, 2006, INSECT BIOCHEM MOLEC, V36, P130, DOI 10.1016/j.ibmb.2005.11.006; Louati H, 2011, LIPIDS HLTH DIS, V858, P853; Louati H, 2010, J CHROMATOGR B, V878, P853, DOI 10.1016/j.jchromb.2010.01.047; LUDWIG M, 1990, Acta Zoologica Fennica, P255; Martinez R, 2011, AQUACULT INT, V19, P445, DOI 10.1007/s10499-010-9360-5; Melo RL, 2001, ANAL BIOCHEM, V293, P71, DOI 10.1006/abio.2001.5115; Miyaji T, 2010, INSECT BIOCHEM MOLEC, V40, P835, DOI 10.1016/j.ibmb.2010.08.003; Miyoshi T, 2004, J VET MED SCI, V66, P1195, DOI 10.1292/jvms.66.1195; Mohien CU, 2013, MOL CELL PROTEOMICS, V12, P120, DOI 10.1074/mcp.M112.019596; MOMMSEN TP, 1978, J COMP PHYSIOL, V127, P355, DOI 10.1007/BF00738421; MOMMSEN TP, 1978, COMP BIOCHEM PHYS A, V60, P365, DOI 10.1016/0300-9629(78)90001-4; Mulenga A, 1999, JPN J VET RES, V46, P179; Muth T, 2010, PROTEOMICS, V10, P1522, DOI 10.1002/pmic.200900759; Myers J, 2008, J PARASITOL, V94, P659, DOI 10.1645/GE-1410.1; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Oliver EM, 2006, PARASITOLOGY, V133, P237, DOI 10.1017/S0031182006000229; Padilha MHP, 2009, INSECT BIOCHEM MOLEC, V39, P782, DOI 10.1016/j.ibmb.2009.09.003; Pavlovsky EN, 1926, Q J MICROSC SCI, V70, P221; Pinlaor P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000398; Polis GA, 1990, BIOL SCORPIONS, P233; Pough F.H., 2012, VERTEBRATE LIFE; Rates B, 2008, TOXICON, V52, P611, DOI 10.1016/j.toxicon.2008.07.010; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1; Redmond DL, 2006, INT J PARASITOL, V36, P277, DOI 10.1016/j.ijpara.2005.10.011; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Renard G, 2002, INSECT MOL BIOL, V11, P325, DOI 10.1046/j.1365-2583.2002.00342.x; Rojo L, 2010, MAR BIOTECHNOL, V12, P696, DOI 10.1007/s10126-010-9257-3; Said EE, 1958, P EGIPTIAL ACAD SCI, V13, P55; Sarin E, 1922, BIOCHEM Z, V129, P359; SCHMIDT PG, 1982, BIOCHEMISTRY-US, V21, P6710, DOI 10.1021/bi00269a015; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Segel I.H., 1975, ENZYME KINETICS; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; SHUTOV AD, 1982, BIOCHEMISTRY-MOSCOW+, V47, P678; Shutov AD, 2012, J PLANT PHYSIOL, V169, P319, DOI 10.1016/j.jplph.2011.11.005; SMITH DJ, 1975, BIOCHEMISTRY-US, V14, P766, DOI 10.1021/bi00675a019; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sobotnik J, 2008, J MORPHOL, V269, P54, DOI 10.1002/jmor.10573; Sojka D, 2007, INT J PARASITOL, V37, P713, DOI 10.1016/j.ijpara.2006.12.020; Sojka D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-7; Sripa J, 2010, CELL MICROBIOL, V12, P781, DOI 10.1111/j.1462-5822.2010.01433.x; Stephens A, 2012, COMP BIOCHEM PHYS B, V161, P32, DOI 10.1016/j.cbpb.2011.09.004; Strojan P, 2000, CLIN CANCER RES, V6, P1052; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teng L, 2010, BIOSCIENCE REP, V30, P177, DOI 10.1042/BSR20090049; Terra WR, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P365, DOI 10.1016/B978-0-12-384747-8.10011-X; Turk B, 1999, EUR J BIOCHEM, V259, P926, DOI 10.1046/j.1432-1327.1999.00145.x; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; VANDERBO.O, 1966, NATURE, V210, P751, DOI 10.1038/210751b0; Wang B, 1998, J BIOL CHEM, V273, P32000, DOI 10.1074/jbc.273.48.32000; Yamaji K, 2009, PARASITOL INT, V58, P232, DOI 10.1016/j.parint.2009.05.003; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zouari N, 2005, BBA-GEN SUBJECTS, V1726, P67, DOI 10.1016/j.bbagen.2005.08.005; Zouari N, 2006, BBA-GEN SUBJECTS, V1760, P1386, DOI 10.1016/j.bbagen.2006.02.009	97	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123841	10.1371/journal.pone.0123841	http://dx.doi.org/10.1371/journal.pone.0123841			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875018	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800119
J	Georges, JF; Liu, XW; Eschbacher, J; Nichols, J; Mooney, MA; Joy, A; Spetzler, RF; Feuerstein, BG; Preul, MC; Anderson, T; Yan, H; Nakaji, P				Georges, Joseph F.; Liu, Xiaowei; Eschbacher, Jennifer; Nichols, Joshua; Mooney, Michael A.; Joy, Anna; Spetzler, Robert F.; Feuerstein, Burt G.; Preul, Mark C.; Anderson, Trent; Yan, Hao; Nakaji, Peter			Use of a Conformational Switching Aptamer for Rapid and Specific Ex Vivo Identification of Central Nervous System Lymphoma in a Xenograft Model	PLOS ONE			English	Article							IN-VIVO; CELLS; GLIOBLASTOMA; SELECTION; EVOLUTION; LIGANDS; PROBE	Improved tools for providing specific intraoperative diagnoses could improve patient care. In neurosurgery, intraoperatively differentiating non-operative lesions such as CNS B-cell lymphoma from operative lesions can be challenging, often necessitating immunohistochemical (IHC) procedures which require up to 24-48 hours. Here, we evaluate the feasibility of generating rapid ex vivo specific labeling using a novel lymphoma-specific fluorescent switchable aptamer. Our B-cell lymphoma-specific switchable aptamer produced only low-level fluorescence in its unbound conformation and generated an 8-fold increase in fluorescence once bound to its target on CD20-positive lymphoma cells. The aptamer demonstrated strong binding to B-cell lymphoma cells within 15 minutes of incubation as observed by flow cytometry. We applied the switchable aptamer to ex vivo xenograft tissue harboring B-cell lymphoma and astrocytoma, and within one hour specific visual identification of lymphoma was routinely possible. In this proof-of-concept study in human cell culture and orthotopic xenografts, we conclude that a fluorescent switchable aptamer can provide rapid and specific labeling of B-cell lymphoma, and that developing aptamer-based labeling approaches could simplify tissue staining and drastically reduce time to histopathological diagnoses compared with IHC-based methods. We propose that switchable aptamers could enhance expeditious, accurate intraoperative decision-making.	[Georges, Joseph F.; Joy, Anna] St Josephs Hosp, Barrow Neurol Inst, Div Neurosci, Phoenix, AZ USA; [Georges, Joseph F.; Mooney, Michael A.; Spetzler, Robert F.; Preul, Mark C.; Nakaji, Peter] St Josephs Hosp, Barrow Neurol Inst, Div Neurol Surg, Phoenix, AZ 85013 USA; [Eschbacher, Jennifer] St Josephs Hosp, Barrow Neurol Inst, Div Neuropathol, Phoenix, AZ USA; [Liu, Xiaowei; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Nichols, Joshua; Feuerstein, Burt G.; Anderson, Trent] Univ Arizona, Coll Med, Phoenix, AZ USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Arizona State University; Arizona State University-Tempe; University of Arizona	Nakaji, P (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol Surg, Phoenix, AZ 85013 USA.	Neuropub@dignityhealth.org	Feuerstein, Burt G/A-5186-2015; Liu, Xiaowei/L-2383-2016	Feuerstein, Burt G/0000-0001-7276-8842; 				Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Chu PGG, 2006, AM J CLIN PATHOL, V126, P534, DOI 10.1309/3WG32YRAMQ7RB9D4; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Foersch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041760; Georges JF, 2014, J CLIN NEUROSCI, V21, P846, DOI 10.1016/j.jocn.2014.02.007; Haybaeck J, 2012, PATHOLOGE, V33, P379, DOI 10.1007/s00292-012-1604-x; Hicke BJ, 2006, J NUCL MED, V47, P668; Hofman F.M., 2013, CURR PROTOC IMMUNOL, V103, P4; Hokfelt T, 1999, BRAIN RES BULL, V50, P371, DOI 10.1016/S0361-9230(99)00109-4; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Liu XW, 2011, SMALL, V7, P1673, DOI 10.1002/smll.201002292; Mallikaratchy PR, 2011, NUCLEIC ACIDS RES, V39, P2458, DOI 10.1093/nar/gkq996; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Plesec TP, 2007, ARCH PATHOL LAB MED, V131, P1532; Safi MAA, 2010, SAUDI MED J, V31, P359; Sankar T, 2010, NEUROSURGERY, V66, P410, DOI 10.1227/01.NEU.0000365772.66324.6F; SCHIFFER D, 1986, BASIC APPL HISTOCHEM, V30, P253; Sefah K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014269; Shi H, 2011, P NATL ACAD SCI USA, V108, P3900, DOI 10.1073/pnas.1016197108; Tang ZW, 2008, J AM CHEM SOC, V130, P11268, DOI 10.1021/ja804119s; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wu CC, 2013, ACS NANO, V7, P5724, DOI 10.1021/nn402517v	23	13	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123607	10.1371/journal.pone.0123607	http://dx.doi.org/10.1371/journal.pone.0123607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876071	Green Published, gold			2022-12-26	WOS:000353015800107
J	Visram, A; Chan, KKW; McGee, P; Boro, J; Hicks, LK; Feld, JJ				Visram, Alissa; Chan, Kelvin K. W.; McGee, Phyllis; Boro, Jordana; Hicks, Lisa K.; Feld, Jordan J.			Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; VIRUS HBV REACTIVATION; CYTOTOXIC CHEMOTHERAPY; RHEUMATOID-ARTHRITIS; COST-EFFECTIVENESS; CANCER-PATIENTS; INFECTION; MANAGEMENT; LAMIVUDINE; LYMPHOMA	Background Reactivation of hepatitis B virus (HBV) during immunosuppressive therapy (IST) can lead to severe and even fatal hepatitis but can be largely prevented with prophylactic antiviral therapy. Screening for HBV prior to starting IST is recommended. Both risk-based and universal screening have been recommended by different societies. For effective risk-based screening, physicians must be aware of risk factors for chronic HBV infection. Methods The HBV screening practices prior to starting IST of rheumatologists, medical and hematological oncologists were evaluated by survey and chart review. Country of origin, the primary risk factor for HBV exposure, was determined in all patients. Results Of 140 rheumatology, 79 medical oncology and 53 hematology patients reviewed, 81%, 11% and 81% were deemed to be at high risk of HBV reactivation by their physicians respectively, however only 27%, 6% and 62% (p<0.0001) were actually screened for HBV prior to starting IST. For patients from HBV-endemic regions, more hematology patients (53%) were correctly identified by their physicians as being at high risk of reactivation than rheumatology patients (2.4%, p=0.0001) or medical oncology patients (15%, p=0.009). However actual screening rates were not increased in patients from endemic regions. A total of 81 patients were screened for HBsAg; 2 were positive. Of the 33 patients screened for anti-HBc, 10 (30%) were positive. Conclusions Hematologists, rheumatologists and medical oncologists had low rates of screening for HBV prior to prescribing IST, largely due to poor identification of those at risk for infection. Risk-based screening strategies are unlikely to be effective and should be replaced by universal screening.	[Visram, Alissa; Feld, Jordan J.] Univ Toronto, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada; [Hicks, Lisa K.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Chan, Kelvin K. W.; Boro, Jordana] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [McGee, Phyllis] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Visram, A (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada.	avisram@toh.on.ca	Feld, Jordan/AAH-5628-2020	Feld, Jordan/0000-0003-2640-2211; Hicks, Lisa/0000-0003-1858-7420	Canadian Liver Foundation	Canadian Liver Foundation	AV received the Summer Studentship Research Grant from the Canadian Liver Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL is listed below: http://www.liver.ca/liver-education-liver-research/research/grant-programs/Grant_Recipients.aspx.	Artz AS, 2010, J CLIN ONCOL, V28, P3199, DOI 10.1200/JCO.2010.30.0673; Corporation A, 2014, PROD MON; Corporation I, 2013, PROD MON; Day FL, 2011, J ONCOL PRACT, V7, P141, DOI 10.1200/JOP.2010.000133; Day FL, 2011, J CLIN ONCOL, V29, P3270, DOI 10.1200/JCO.2011.35.1635; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; HOOFNAGLE JH, 1982, ANN INTERN MED, V96, P447, DOI 10.7326/0003-4819-96-4-447; Hsu C, 2008, HEPATOLOGY, V47, P844, DOI 10.1002/hep.22106; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Inc. J. Remicade (infliximab), 2011, PROD MON; Khokhar OS, 2009, CHEMOTHERAPY, V55, P69, DOI 10.1159/000183731; KWAK LW, 1990, J CLIN ONCOL, V8, P963, DOI 10.1200/JCO.1990.8.6.963; Lau GKK, 2003, GASTROENTEROLOGY, V125, P1742, DOI 10.1053/j.gastro.2003.09.026; Lee RSM, 2012, J ONCOL PRACT, V8, P325, DOI 10.1200/JOP.2012.000597; LeFevre ML, 2014, ANN INTERN MED, V161, P58, DOI 10.7326/M14-1018; Li YH, 2006, CANCER-AM CANCER SOC, V106, P1320, DOI 10.1002/cncr.21701; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; Minuk G Y, 2001, Can J Infect Dis, V12, P351; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Perez-Alvarez R, 2011, MEDICINE, V90, P359, DOI 10.1097/MD.0b013e3182380a76; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; STEVENS CE, 1985, JAMA-J AM MED ASSOC, V253, P1740, DOI 10.1001/jama.253.12.1740; Stine JG, 2010, ARTHRIT CARE RES, V62, P704, DOI 10.1002/acr.20209; Tran TT, 2010, ALIMENT PHARM THER, V31, P240, DOI 10.1111/j.1365-2036.2009.04158.x; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051; Yeo W, 2004, J CLIN ONCOL, V22, P927, DOI 10.1200/JCO.2004.05.161; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Zurawska U, 2012, J CLIN ONCOL, V30, P3167, DOI 10.1200/JCO.2011.40.7510	35	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0120749	10.1371/journal.pone.0120749	http://dx.doi.org/10.1371/journal.pone.0120749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875198	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800013
J	Kollewe, K; Wurster, U; Sinzenich, T; Korner, S; Dengler, R; Mohammadi, B; Petri, S				Kollewe, Katja; Wurster, Ulrich; Sinzenich, Thomas; Koerner, Sonja; Dengler, Reinhard; Mohammadi, Bahram; Petri, Susanne			Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; ANTI-GM1 GANGLIOSIDE ANTIBODIES; MILLER-FISHER; IGM ANTIBODIES; PERIPHERAL NEUROPATHIES; MULTIPLE-SCLEROSIS; GM1 GANGLIOSIDE; HUMAN MOTOR; ALSFRS-R; SERUM	Background Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disorder with typical onset in the 5th-6th decade of life. The hypothesis of an autoimmune origin of ALS receives less attention today, but immunological phenomena still seem to be involved and mechanisms such as protective autoimmunity may be important. Detection of antibodies against a variety of gangliosides has been repeatedly described in ALS-patients by several authors, but widely differing frequencies and titres have been reported. Therefore, we investigated the presence of six common antibodies with a commercially available test panel for GA1, GM1, GM2, GD1a, GD1b and GQ1b in a large group of clinically well-characterized ALS patients and compared them to a collective of 200 healthy blood donors. Methods IgG and IgM antibodies to the six gangliosides asialoGM1 (GA1), GM1, GM2, GD1a, GD1b, GQ1b were determined by GanglioCombi ELISA in sera of 84 ALS patients. Results were expressed as a %-ratio of a highly positive control and categorized as negative (<30%), borderline (30-50%), moderately (50-100%) and strongly positive (>100%). The values obtained from 200 Swiss blood donors served as a reference group. Results In twenty-two (26.2%) ALS-patients elevated anti-ganglioside antibodies could be detected: Taking all subspecific antibodies together, IgG antibodies were found in 9/84 (10.7%) and IgM in 15/84 (17.9%) patients. There was no correlation between age, gender, site of onset or survival and anti-ganglioside-positive/-negative titres in ALS-patients. No statistically significant difference in the frequency of anti-ganglioside antibodies compared to the group of healthy blood donors was found. Conclusion Even with this more comprehensive approach, anti-ganglioside antibody frequencies and patterns in our ALS cohort closely resembled the values measured in healthy controls. In accordance with other studies, we did not observe any association of a distinct ALS phenotype with elevated anti-ganglioside antibodies or an impact on survival.	[Kollewe, Katja; Wurster, Ulrich; Sinzenich, Thomas; Koerner, Sonja; Dengler, Reinhard; Petri, Susanne] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Mohammadi, Bahram] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Mohammadi, Bahram] Int Neurosci Inst, CNS LAB, Hannover, Germany	Hannover Medical School; University of Lubeck	Kollewe, K (corresponding author), Hannover Med Sch, Dept Neurol, Hannover, Germany.	kollewe.katja@mh-hannover.de	Petri, Susanne/AID-7665-2022					ADAMS D, 1991, J NEUROIMMUNOL, V32, P223, DOI 10.1016/0165-5728(91)90192-A; Ariga T, 2014, J NEUROSCI RES, V92, P1227, DOI 10.1002/jnr.23411; Benkler M, 2009, INT J NEUROSCI, V119, P2133, DOI 10.3109/00207450903178786; BENYOUNESCHENNOUFI A, 1992, NEUROCHEM INT, V20, P353; Biessels GJ, 1997, J NEUROL, V244, P143, DOI 10.1007/s004150050065; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Carpo M, 1996, ANN NEUROL, V39, P539, DOI 10.1002/ana.410390417; Cats EA, 2010, NEUROLOGY, V75, P1961, DOI 10.1212/WNL.0b013e3181ff94c2; Caudie C, 2013, CLIN LAB, V59, P1277, DOI 10.7754/Clin.Lab.2013.121116; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; CHAPMAN J, 1988, NEUROSCI LETT, V86, P235, DOI 10.1016/0304-3940(88)90577-0; Chiba A, 1997, BRAIN RES, V745, P32, DOI 10.1016/S0006-8993(96)01123-7; CHIBA A, 1993, NEUROLOGY, V43, P1911, DOI 10.1212/WNL.43.10.1911; CORBO M, 1992, ANN NEUROL, V32, P487, DOI 10.1002/ana.410320402; CORBO M, 1993, NEUROLOGY, V43, P809, DOI 10.1212/WNL.43.4.809; Czaplinski A, 2006, J NEUROL, V253, P1428, DOI 10.1007/s00415-006-0226-8; Czaplinski A, 2006, MUSCLE NERVE, V34, P702, DOI 10.1002/mus.20658; Eisele L, 2012, ANN HEMATOL, V91, P243, DOI 10.1007/s00277-011-1293-1; ENDO T, 1984, J IMMUNOL, V132, P1793; Farbu E, 2003, J NEUROIMMUNOL, V139, P141, DOI 10.1016/S0165-5728(03)00123-1; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; GURNEY ME, 1984, NEW ENGL J MED, V311, P933, DOI 10.1056/NEJM198410113111501; HAMBERGER A, 1971, J NEUROCHEM, V18, P1821, DOI 10.1111/j.1471-4159.1971.tb09587.x; ILYAS AA, 1992, J NEUROL SCI, V107, P111, DOI 10.1016/0022-510X(92)90217-9; ILYAS AA, 1992, J NEUROIMMUNOL, V36, P69, DOI 10.1016/0165-5728(92)90031-F; Khandelwal D, 2006, NEUROL INDIA, V54, P399; Kollewe K, 2008, J NEUROL SCI, V275, P69, DOI 10.1016/j.jns.2008.07.016; KORNBERG AJ, 1994, MUSCLE NERVE, V17, P100, DOI 10.1002/mus.880170115; Kornberg AJ, 2000, J CLIN NEUROSCI, V7, P191, DOI 10.1054/jocn.1999.0194; Kornberg AJ, 1996, NEUROLOGY, V47, P1317, DOI 10.1212/WNL.47.5.1317; Kusunoki S, 2011, J NEUROCHEM, V116, P828, DOI 10.1111/j.1471-4159.2010.07029.x; LAMB NL, 1991, MUSCLE NERVE, V14, P1021, DOI 10.1002/mus.880141014; LATOV N, 1988, NEUROLOGY, V38, P763, DOI 10.1212/WNL.38.5.763; Ledeen RW, 2006, CAN J PHYSIOL PHARM, V84, P393, DOI 10.1139/Y05-133; Liu JX, 2009, INVEST OPHTH VIS SCI, V50, P3226, DOI 10.1167/iovs.08-3333; Lloyd KO, 1998, GLYCOCONJUGATE J, V15, P627, DOI 10.1023/A:1006924128550; Marconi S, 2006, MULT SCLER J, V12, P302, DOI 10.1191/135248506ms1279oa; Meuth SG, 2010, EUR NEUROL, V63, P193, DOI 10.1159/000282734; Niebroj-Dobosz I, 1999, ACTA NEUROL SCAND, V100, P238; Niebroj-Dobosz I, 2004, EUR J NEUROL, V11, P13, DOI 10.1046/j.1351-5101.2003.00697.x; NOBILEORAZIO E, 1990, NEUROLOGY, V40, P1747, DOI 10.1212/WNL.40.11.1747; NOBILEORAZIO E, 1992, J NEUROL SCI, V109, P200, DOI 10.1016/0022-510X(92)90169-L; OGAWAGOTO K, 1990, J NEUROCHEM, V55, P1486, DOI 10.1111/j.1471-4159.1990.tb04930.x; OGAWAGOTO K, 1992, J NEUROCHEM, V59, P1844, DOI 10.1111/j.1471-4159.1992.tb11018.x; PESTRONK A, 1989, ANN NEUROL, V25, P98, DOI 10.1002/ana.410250118; PESTRONK A, 1988, NEUROLOGY, V38, P1457, DOI 10.1212/WNL.38.9.1457; Plomp JJ, 2009, J PHYSIOL-LONDON, V587, P3979, DOI 10.1113/jphysiol.2009.171702; SADIQ SA, 1990, NEUROLOGY, V40, P1067, DOI 10.1212/WNL.40.7.1067; SIMONE IL, 1993, J NEUROL SCI, V114, P49, DOI 10.1016/0022-510X(93)90048-4; Susuki K, 2007, GLIA, V55, P746, DOI 10.1002/glia.20503; Taylor BV, 1996, NEUROLOGY, V47, P951, DOI 10.1212/WNL.47.4.951; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; VANSCHAIK IN, 1995, NEUROLOGY, V45, P1570, DOI 10.1212/WNL.45.8.1570; Vlam L, 2012, NAT REV NEUROL, V8, P48, DOI 10.1038/nrneurol.2011.175; Willison HJ, 1999, J NEUROIMMUNOL, V100, P3, DOI 10.1016/S0165-5728(99)00213-1; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; WOLFGRAM F, 1973, SCIENCE, V179, P579, DOI 10.1126/science.179.4073.579; YOUNESCHENNOUFI AB, 1992, ANN NEUROL, V32, P18, DOI 10.1002/ana.410320105; YU RK, 1994, PROG BRAIN RES, V101, P31; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200; Yuki N, 2014, J NEUROIMMUNOL, V272, P62, DOI 10.1016/j.jneuroim.2014.04.014; Zappia M, 2002, ACTA NEUROL SCAND, V106, P54, DOI 10.1034/j.1600-0404.2002.01240.x	62	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0125339	10.1371/journal.pone.0125339	http://dx.doi.org/10.1371/journal.pone.0125339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875836	Green Submitted, Green Published, gold			2022-12-26	WOS:000353014700075
J	Bernardes, PTT; Rezende, BM; Resende, CB; De Paula, TP; Reis, AC; Goncalves, WA; Vieira, EG; Pinheiro, MVB; Souza, DG; Castor, MGM; Teixeira, MM; Pinho, V				Bernardes, Priscila T. T.; Rezende, Barbara M.; Resende, Carolina B.; De Paula, Talles P.; Reis, Alesandra C.; Goncalves, William A.; Vieira, Elias G.; Pinheiro, Mauricio V. B.; Souza, Danielle G.; Castor, Marina G. M.; Teixeira, Mauro M.; Pinho, Vanessa			Nanocomposite Treatment Reduces Disease and Lethality in a Murine Model of Acute Graft-versus-Host Disease and Preserves Anti-Tumor Effects	PLOS ONE			English	Article							FULLERENOL C-60(OH)(24); MARROW-TRANSPLANTATION; LEUKOCYTE RECRUITMENT; TISSUE-INJURY; LIFE-SPAN; IN-VIVO; LIVER; RATS; HEPATOTOXICITY; PATHOGENESIS	Graft versus host disease (GVHD) is an immunological disorder triggered by bone marrow transplantation that affects several organs, including the gastrointestinal tract and liver. Fullerenes and their soluble forms, fullerols, are nanocomposites with a closed symmetrical structure with anti-inflammatory and anti-oxidant properties. The present study evaluated the effects of treatment with the fullerol (C60(OH)18-20) in the development and pathogenesis of GVHD in a murine model. Mice with experimental GVHD that were treated with the fullerol showed reduced clinical signs of disease and mortality compared with untreated mice. Treatment with the fullerol decreased the hepatic damage associated with reduced hepatic levels of reactive oxygen species, pro-inflammatory cytokines and chemokines (IFN-gamma TNF-alpha, CCL2, CCL3 and CCL5) and reduced leukocyte accumulation. The amelioration of GVHD after treatment with the fullerol was also associated with reduced intestinal lesions and consequent bacterial translocation to the blood, liver and peritoneal cavity. Moreover, the fullerol treatment alleviated the GVHD while preserving effects of the graft against a leukemia cell line (GFP+P815). In summary, the fullerol was effective in reducing the GVHD inflammatory response in mice and may suggest novel ways to treat this disease.	[Bernardes, Priscila T. T.; Rezende, Barbara M.; Resende, Carolina B.; Reis, Alesandra C.; Goncalves, William A.; Castor, Marina G. M.; Pinho, Vanessa] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Resolucao Resposta Inflamatoria, Belo Horizonte, MG, Brazil; [De Paula, Talles P.; Souza, Danielle G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Interacao Microorganismo & Hospedeiro, Belo Horizonte, MG, Brazil; [Vieira, Elias G.; Pinheiro, Mauricio V. B.] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Fis, Lab Ressonancia Paramagnet, Belo Horizonte, MG, Brazil; [Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Pinho, V (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Resolucao Resposta Inflamatoria, Belo Horizonte, MG, Brazil.	vpinho@icb.ufmg.br	Pinho, Vanessa/GXM-8532-2022; pinho, vanessa/AAC-8437-2020; Gonçalves, William Antonio/AAC-7156-2021; Rezende, BM/G-7071-2018; Pinho, Vanessa/AAR-1686-2021; Teixeira, Mauro M/A-4587-2008; Pinheiro, Maurício Veloso Brant/N-7746-2017	pinho, vanessa/0000-0003-1038-2324; Rezende, BM/0000-0001-7959-7732; Teixeira, Mauro M/0000-0002-6944-3008; Pinheiro, Maurício Veloso Brant/0000-0001-5722-6260; Gomes Miranda e Castor, Marina/0000-0003-4129-8715; Goncalves, William/0000-0001-6960-4337	Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); NANOVALID	Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NANOVALID	This work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and NANOVALID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves GC, 2006, J BRAZIL CHEM SOC, V17, P1186, DOI 10.1590/S0103-50532006000600017; Amaral SS, 2013, CELL COMMUN SIGNAL, V11, P2, DOI [10.1186/1478-811X-11-2, DOI 10.1186/1478-811X-11-2]; Baati T, 2012, BIOMATERIALS, V33, P4936, DOI 10.1016/j.biomaterials.2012.03.036; Bao SS, 2011, IMMUNOL CELL BIOL, V89, P853, DOI 10.1038/icb.2011.4; Barcelos LS, 2004, INFLAMM RES, V53, P576, DOI 10.1007/s00011-004-1299-4; BEELEN DW, 1992, BLOOD, V80, P2668; Beelen DW, 1999, BLOOD, V93, P3267, DOI 10.1182/blood.V93.10.3267.410k22_3267_3275; Bouazzaoui A, 2009, GENES IMMUN, V10, P687, DOI 10.1038/gene.2009.49; Britto RS, 2012, AQUAT TOXICOL, V114, P80, DOI 10.1016/j.aquatox.2012.02.018; Castor MGM, 2012, J LEUKOCYTE BIOL, V91, P629, DOI 10.1189/jlb.1111561; Castor MGM, 2011, J LEUKOCYTE BIOL, V89, P955, DOI 10.1189/jlb.0810464; Castor MGM, 2010, J IMMUNOL, V184, P2646, DOI 10.4049/jimmunol.0902614; Choi Jung Hwa, 2011, Immune Netw, V11, P68, DOI 10.4110/in.2011.11.1.68; Choi SW, 2010, IMMUNOL ALLERGY CLIN, V30, P75, DOI 10.1016/j.iac.2009.10.001; da Rocha AM, 2013, COMP BIOCHEM PHYS A, V165, P460, DOI 10.1016/j.cbpa.2013.03.025; Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X; El-Hayek JM, 2005, J LEUKOCYTE BIOL, V78, P1001, DOI 10.1189/jlb.1204730; Ferrara JLM, 2007, BEST PRACT RES CL HA, V20, P91, DOI 10.1016/j.beha.2006.11.004; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fujii N, 2001, BONE MARROW TRANSPL, V27, P1007, DOI 10.1038/sj.bmt.1702997; Gharbi N, 2005, NANO LETT, V5, P2578, DOI 10.1021/nl051866b; Husebo LO, 2004, J AM CHEM SOC, V126, P12055, DOI 10.1021/ja047593o; Injac R, 2008, BIOMATERIALS, V29, P3451, DOI 10.1016/j.biomaterials.2008.04.048; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Irani JL, 2008, ARCH SURG-CHICAGO, V143, P1041, DOI 10.1001/archsurg.143.11.1041; Jacobsohn DA, 2004, CURR PHARM DESIGN, V10, P1195, DOI 10.2174/1381612043452569; Kim BK, 2000, BONE MARROW TRANSPL, V26, P193, DOI 10.1038/sj.bmt.1702453; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; KRUSIC PJ, 1991, SCIENCE, V254, P1183, DOI 10.1126/science.254.5035.1183; ordevic A., 2008, ARCH ONCOL, V16, P42, DOI [10.2298/AOO0804042D, DOI 10.2298/AOO0804042D, DOI 10.2298/AOO0804042]; Penack O, 2010, BLOOD, V115, P1865, DOI 10.1182/blood-2009-09-242784; Quick KL, 2008, NEUROBIOL AGING, V29, P117, DOI 10.1016/j.neurobiolaging.2006.09.014; Rezende BM, 2013, MAR DRUGS, V11, P2595, DOI 10.3390/md11072595; Robb RJ, 2012, BLOOD, V119, P5351, DOI 10.1182/blood-2012-02-368076; Roberts JE, 2008, TOXICOL APPL PHARM, V228, P49, DOI 10.1016/j.taap.2007.12.010; Sardenberg RB, 2011, ACS NANO, V5, P2681, DOI 10.1021/nn102913p; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; Serody JS, 2000, BLOOD, V96, P2973; Souza DG, 2002, EUR J PHARMACOL, V440, P61, DOI 10.1016/S0014-2999(02)01313-4; Strasser SI, 2000, HEPATOLOGY, V32, P1265, DOI 10.1053/jhep.2000.20067; Terwey TH, 2005, BLOOD, V106, P3322, DOI 10.1182/blood-2005-05-1860; Trpkovic A, 2012, ARCH TOXICOL, V86, P1809, DOI 10.1007/s00204-012-0859-6; Tuncer HH, 2012, WORLD J GASTROENTERO, V18, P1851, DOI 10.3748/wjg.v18.i16.1851; Vago L, 2012, SEMIN ONCOL, V39, P707, DOI 10.1053/j.seminoncol.2012.09.009; Wysocki CA, 2005, BLOOD, V105, P4191, DOI 10.1182/blood-2004-12-4726; Yudoh K, 2009, INT J NANOMED, V4, P217	46	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123004	10.1371/journal.pone.0123004	http://dx.doi.org/10.1371/journal.pone.0123004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875016	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100126
J	Kong, LB; Li, SS; Huang, MJ; Xiong, Y; Zhang, QH; Ye, L; Liu, J; Zhu, XD; Sun, RN; Guo, YL				Kong, Lingbao; Li, Shanshan; Huang, Mingjie; Xiong, Ying; Zhang, Qinghua; Ye, Li; Liu, Jing; Zhu, Xiangdong; Sun, Ruina; Guo, Yunli			The Roles of Endoplasmic Reticulum Overload Response Induced by HCV and NS4B Protein in Human Hepatocyte Viability and Virus Replication	PLOS ONE			English	Article							NF-KAPPA-B; MEDIATED APOPTOSIS; EXPRESSION; ACTIVATION; CANCER; CORE; INFLAMMATION; INHIBITION; STRESS; ALPHA	Hepatitis C virus (HCV) replication is associated with endoplasmic reticulum (ER) and its infection triggers ER stress. In response to ER stress, ER overload response (EOR) can be activated, which involves the release of Ca2+ from ER, production of reactive oxygen species (ROS) and activation of nuclear factor kappa B (NF-kappa B). We have previously reported that HCV NS4B expression activates NF-kappa B via EOR-Ca2+-ROS pathway. Here, we showed that NS4B expression and HCV infection activated cancer-related NF-kappa B signaling pathway and induced the expression of cancer-related NF-kappa B target genes via EOR-Ca2+-ROS pathway. Moreover, we found that HCV-activated EOR-Ca2+-ROS pathway had profound effects on host cell viability and HCV replication. HCV infection induced human hepatocyte death by EOR-Ca2+-ROS pathway, whereas activation of EOR-Ca2+-ROS-NF-kappa B pathway increased the cell viability. Meanwhile, EOR-Ca2+-ROS-NF-kappa B pathway inhibited acute HCV replication, which could alleviate the detrimental effect of HCV on cell viability and enhance chronic HCV infection. Together, our findings provide new insights into the functions of EOR-Ca2+-ROS-NF-kappa B pathway in natural HCV replication and pathogenesis.	[Kong, Lingbao; Huang, Mingjie; Zhang, Qinghua; Zhu, Xiangdong; Sun, Ruina; Guo, Yunli] Jiangxi Agr Univ, Coll Biosci & Engn, Nanchang, Jiangxi, Peoples R China; [Li, Shanshan] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Xiong, Ying] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China; [Ye, Li] Guangxi Med Univ, Sch Publ Hlth, Nanning, Peoples R China; [Liu, Jing] Wuhan Univ, Sch Pharmaceut Sci, Minist Educ Lab Combinatorial Biosynthesis & Drug, Wuhan, Hubei, Peoples R China	Jiangxi Agricultural University; Iowa State University; Guangxi Medical University; Wuhan University	Kong, LB (corresponding author), Jiangxi Agr Univ, Coll Biosci & Engn, Nanchang, Jiangxi, Peoples R China.	lingbaok@hotmail.com; shanshanyxl@hotmail.com			National Nature Science Foundation of China [31160034]; China Scholarship Council [201208360008]; Jiangxi Province [20142BAB205067, 2010GZY0059, 20133ACG70005, GJJ12219]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work was funded by grants from the National Nature Science Foundation of China (No. 31160034, http://www.nsfc.gov.cn/) to L. Kong, the China Scholarship Council (201208360008, http://www.csc.edu.cn/) to L. Kong, and Jiangxi Province (Nos. 20142BAB205067, 2010GZY0059, 20133ACG70005 and GJJ12219, http://www.jxstc.gov.cn/ and http://www.jxedu.gov.cn/) to L. Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Einav S, 2008, HEPATOLOGY, V47, P827, DOI 10.1002/hep.22108; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Gong J, 2013, ONCOGENE, V32, P3071, DOI 10.1038/onc.2012.318; Gupta SC, 2013, CLIN CANCER RES, V19, P4465, DOI 10.1158/1078-0432.CCR-13-0080; Hikita H, 2012, J HEPATOL, V57, P92, DOI 10.1016/j.jhep.2012.01.027; Ip PP, 2012, ANTIVIR RES, V96, P36, DOI 10.1016/j.antiviral.2012.07.006; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kong LB, 2007, VIRUS RES, V128, P9, DOI 10.1016/j.virusres.2007.03.020; Kong LB, 2013, ANTIVIR RES, V98, P44, DOI 10.1016/j.antiviral.2013.02.003; Casella ML, 2014, MOL NUTR FOOD RES, V58, P289, DOI 10.1002/mnfr.201300362; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Li S., 2013, CRIT REV MICROBIOL, P1, DOI DOI 10.1109/ANTHOLOGY.2013.6784885; Li SS, 2012, CELL MICROBIOL, V14, P994, DOI 10.1111/j.1462-5822.2012.01773.x; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Li XY, 2013, THYROID, V23, P209, DOI 10.1089/thy.2012.0237; Li YX, 2012, J VIROL, V86, P12531, DOI 10.1128/JVI.01136-12; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu HD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-98; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Marusawa H, 1999, J VIROL, V73, P4713, DOI 10.1128/JVI.73.6.4713-4720.1999; Mosialos G, 1997, SEMIN CANCER BIOL, V8, P121, DOI 10.1006/scbi.1997.0063; Nevzorova YA, 2013, BBA-MOL BASIS DIS, V1832, P1765, DOI 10.1016/j.bbadis.2013.06.001; Ordonez R, 2014, J PINEAL RES, V56, P20, DOI 10.1111/jpi.12092; Pannem RR, 2014, CARCINOGENESIS, V35, P461, DOI 10.1093/carcin/bgt335; Rance E, 2012, J VIRAL HEPATITIS, V19, pE73, DOI 10.1111/j.1365-2893.2011.01505.x; Ruggieri A, 1997, VIROLOGY, V229, P68, DOI 10.1006/viro.1996.8420; Sato Y, 2006, GUT, V55, P1801, DOI 10.1136/gut.2005.070417; Siavoshian S, 2005, J MED VIROL, V75, P402, DOI 10.1002/jmv.20283; Starkel P, 2010, EUR J CLIN INVEST, V40, P575, DOI 10.1111/j.1365-2362.2010.02295.x; Tai DI, 2000, HEPATOLOGY, V31, P656, DOI 10.1002/hep.510310316; Tang WL, 2007, AM J PATHOL, V171, P1831, DOI 10.2353/ajpath.2007.070413; Victoriano AFB, 2012, AIDS RES HUM RETROV, V28, P125, DOI [10.1089/aid.2011.0263, 10.1089/AID.2011.0263]; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715; Zhang LM, 2013, VIROLOGY, V438, P28, DOI 10.1016/j.virol.2013.01.015; Zhao P, 2012, VIRUS RES, V169, P1, DOI 10.1016/j.virusres.2012.04.006; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	44	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123190	10.1371/journal.pone.0123190	http://dx.doi.org/10.1371/journal.pone.0123190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875501	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100147
J	Sharei, A; Trifonova, R; Jhunjhunwala, S; Hartoularos, GC; Eyerman, AT; Lytton-Jean, A; Angin, M; Sharma, S; Poceviciute, R; Mao, S; Heimann, M; Liu, S; Talkar, T; Khan, OF; Addo, M; von Andrian, UH; Anderson, DG; Langer, R; Lieberman, J; Jensen, KF				Sharei, Armon; Trifonova, Radiana; Jhunjhunwala, Siddharth; Hartoularos, George C.; Eyerman, Alexandra T.; Lytton-Jean, Abigail; Angin, Mathieu; Sharma, Siddhartha; Poceviciute, Roberta; Mao, Shirley; Heimann, Megan; Liu, Sophia; Talkar, Tanya; Khan, Omar F.; Addo, Marylyn; von Andrian, Ulrich H.; Anderson, Daniel G.; Langer, Robert; Lieberman, Judy; Jensen, Klavs F.			Ex Vivo Cytosolic Delivery of Functional Macromolecules to Immune Cells	PLOS ONE			English	Article							APTAMER-SIRNA CHIMERAS; SMALL INTERFERING RNAS; INTRACELLULAR DELIVERY; DENDRITIC CELLS; T-CELLS; ELECTROPORATION; INFECTION; NANOPARTICLES; PEPTIDES; PROTEINS	Intracellular delivery of biomolecules, such as proteins and siRNAs, into primary immune cells, especially resting lymphocytes, is a challenge. Here we describe the design and testing of microfluidic intracellular delivery systems that cause temporary membrane disruption by rapid mechanical deformation of human and mouse immune cells. Dextran, antibody and siRNA delivery performance is measured in multiple immune cell types and the approach's potential to engineer cell function is demonstrated in HIV infection studies.	[Sharei, Armon; Hartoularos, George C.; Eyerman, Alexandra T.; Poceviciute, Roberta; Mao, Shirley; Heimann, Megan; Liu, Sophia; Talkar, Tanya; Anderson, Daniel G.; Langer, Robert; Jensen, Klavs F.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Angin, Mathieu; Sharma, Siddhartha; Addo, Marylyn; von Andrian, Ulrich H.] MIT, MGH, Ragon Inst, Cambridge, MA 02139 USA; [Angin, Mathieu; Sharma, Siddhartha; Addo, Marylyn; von Andrian, Ulrich H.] Harvard Univ, Cambridge, MA 02138 USA; [Sharei, Armon; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Sharei, Armon; Jhunjhunwala, Siddharth; Lytton-Jean, Abigail; Khan, Omar F.; Anderson, Daniel G.; Langer, Robert] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Trifonova, Radiana; Lieberman, Judy] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02163 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02163 USA.	judy.lieberman@childrens.harvard.edu; kfjensen@mit.edu	Liu, Sophia/GYU-0250-2022; Lieberman, Judy/A-2717-2015; Jensen, Klavs F/F-2462-2012; Addo, Marylyn M./GNP-2548-2022; Jhunjhunwala, Siddharth/K-1526-2013; Khan, Omar/G-6952-2014	Jensen, Klavs F/0000-0001-7192-580X; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Lytton-Jean, Abigail/0000-0002-1582-0066; Angin, Mathieu/0000-0002-6867-4680; Liu, Sophia/0000-0003-3614-9731; Khan, Omar/0000-0003-3811-2369; Addo, Marylyn/0000-0003-2836-9224	National Institutes of Health Grant [R01GM101420-01A1]; Kathy and Curt Marble Cancer Research Fund; Ragon Institute of Harvard/MIT/MGH; National Cancer Institute Cancer Center Support (Core) Grant [P30-CA14051]; Mazumdar-Shaw International Oncology Fellowship; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI112521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101420] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kathy and Curt Marble Cancer Research Fund; Ragon Institute of Harvard/MIT/MGH; National Cancer Institute Cancer Center Support (Core) Grant; Mazumdar-Shaw International Oncology Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM101420-01A1, the Kathy and Curt Marble Cancer Research Fund, the Ragon Institute of Harvard/MIT/MGH and partially by the National Cancer Institute Cancer Center Support (Core) Grants P30-CA14051. SJ is in receipt of the Mazumdar-Shaw International Oncology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angin M, 2013, JOVE-J VIS EXP, DOI 10.3791/50244; Angin M, 2012, J INFECT DIS, V205, P1495, DOI 10.1093/infdis/jis236; Bonehill A, 2008, MOL THER, V16, P1170, DOI 10.1038/mt.2008.77; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Derfus AM, 2004, ADV MATER, V16, P961, DOI 10.1002/adma.200306111; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Huang LF, 2013, NAT BIOTECHNOL, V31, P350, DOI 10.1038/nbt.2537; Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]; Jhunjhunwala S, 2009, J CONTROL RELEASE, V133, P191, DOI 10.1016/j.jconrel.2008.10.011; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Koshkaryev A, 2013, ADV DRUG DELIVER REV, V65, P24, DOI 10.1016/j.addr.2012.08.009; LAMBERT H, 1990, BIOCHEM CELL BIOL, V68, P729, DOI 10.1139/o90-105; Lee J, 2012, NANO LETT, V12, P6322, DOI 10.1021/nl303421h; MARRERO MB, 1995, J BIOL CHEM, V270, P15734, DOI 10.1074/jbc.270.26.15734; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Schaft N, 2006, CANCER IMMUNOL IMMUN, V55, P1132, DOI 10.1007/s00262-005-0098-2; Sharei A, 2013, P NATL ACAD SCI USA, V110, P2082, DOI 10.1073/pnas.1218705110; Small EJ, 2006, J CLIN ONCOL, V24, P3089, DOI 10.1200/JCO.2005.04.5252; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Wheeler LA, 2011, J CLIN INVEST, V121, P2401, DOI 10.1172/JCI45876; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	25	36	47	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118803	10.1371/journal.pone.0118803	http://dx.doi.org/10.1371/journal.pone.0118803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875117	gold, Green Published			2022-12-26	WOS:000352845100011
J	Zhong, LL; Yeh, TYJ; Hao, J; Pourtabatabaei, N; Mahata, SK; Shao, JH; Chessler, SD; Chi, NW				Zhong, Linlin; Yeh, Tsung-Yin J.; Hao, Jun; Pourtabatabaei, Nasim; Mahata, Sushil K.; Shao, Jianhua; Chessler, Steven D.; Chi, Nai-Wen			Nutritional Energy Stimulates NAD(+) Production to Promote Tankyrase-Mediated PARsylation in Insulinoma Cells	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; METABOLISM; SECRETION; GLUCOSE; GLUT4; NAMPT; SIRT1; IRAP; GLYCOHYDROLASE; BIOSYNTHESIS	The poly-ADP-ribosylation (PARsylation) activity of tankyrase (TNKS) regulates diverse physiological processes including energy metabolism and wnt/beta-catenin signaling. This TNKS activity uses NAD(+) as a co-substrate to post-translationally modify various acceptor proteins including TNKS itself. PARsylation by TNKS often tags the acceptors for ubiquitination and proteasomal degradation. Whether this TNKS activity is regulated by physiological changes in NAD(+) levels or, more broadly, in cellular energy charge has not been investigated. Because the NAD(+) biosynthetic enzyme nicotinamide phosphoribosyltransferase (NAMPT) in vitro is robustly potentiated by ATP, we hypothesized that nutritional energy might stimulate cellular NAMPT to produce NAD(+) and thereby augment TNKS catalysis. Using insulin-secreting cells as a model, we showed that glucose indeed stimulates the autoPARsylation of TNKS and consequently its turnover by the ubiquitin-proteasomal system. This glucose effect on TNKS is mediated primarily by NAD(+) since it is mirrored by the NAD(+) precursor nicotinamide mononucleotide (NMN), and is blunted by the NAMPT inhibitor FK866. The TNKS-destabilizing effect of glucose is shared by other metabolic fuels including pyruvate and amino acids. NAD(+) flux analysis showed that glucose and nutrients, by increasing ATP, stimulate NAMPT-mediated NAD(+) production to expand NAD(+) stores. Collectively our data uncover a metabolic pathway whereby nutritional energy augments NAD(+) production to drive the PARsylating activity of TNKS, leading to autoPARsylation-dependent degradation of the TNKS protein. The modulation of TNKS catalytic activity and protein abundance by cellular energy charge could potentially impose a nutritional control on the many processes that TNKS regulates through PARsylation. More broadly, the stimulation of NAD(+) production by ATP suggests that nutritional energy may enhance the functions of other NAD(+)-driven enzymes including sirtuins.	[Zhong, Linlin; Mahata, Sushil K.; Chi, Nai-Wen] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Zhong, Linlin; Yeh, Tsung-Yin J.; Hao, Jun; Pourtabatabaei, Nasim; Mahata, Sushil K.; Chi, Nai-Wen] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hao, Jun] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China; [Shao, Jianhua] Univ Calif San Diego, La Jolla, CA 92093 USA; [Chessler, Steven D.] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Hebei Medical University; University of California System; University of California San Diego; University of California System; University of California Irvine	Chi, NW (corresponding author), VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA.	nwchi@ucsd.edu	Mahata, Sushil/AAF-8781-2021		Department of Veterans Affairs Merit Award [5-I01-BX000702]; American Diabetes Association Career Development Award [7-05-CD-05]	Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); American Diabetes Association Career Development Award(American Diabetes Association)	Funding provided by Department of Veterans Affairs (http://www.research.va.gov) Merit Award 5-I01-BX000702; American Diabetes Association (http://www.diabetes.org) Career Development Award 7-05-CD-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Burgos ES, 2011, CURR MED CHEM, V18, P1947; Burgos ES, 2009, P NATL ACAD SCI USA, V106, P13748, DOI 10.1073/pnas.0903898106; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Dezaki K, 2011, DIABETES, V60, P2315, DOI 10.2337/db11-0368; Feng XX, 2013, INT REV CEL MOL BIO, V304, P227, DOI 10.1016/B978-0-12-407696-9.00005-1; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; FURST P, 1989, METABOLISM, V38, P67, DOI 10.1016/0026-0495(89)90145-5; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022781; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kover K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058767; KRONFELD DS, 1964, BIOCHEM J, V93, P517, DOI 10.1042/bj0930517; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Lee SJ, 2009, MOL CELLS, V28, P167, DOI 10.1007/s10059-009-0119-7; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Lehtio L, 2013, FEBS J, V280, P3576, DOI 10.1111/febs.12320; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rippmann JF, 2002, J MOL BIOL, V323, P217, DOI 10.1016/S0022-2836(02)00946-4; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Seimiya H, 2004, MOL CELL BIOL, V24, P1944, DOI 10.1128/MCB.24.5.1944-1955.2004; SERVICE FJ, 1995, NEW ENGL J MED, V332, P1144, DOI 10.1056/NEJM199504273321707; SHIMOYAMA M, 1970, BIOCHIM BIOPHYS ACTA, V215, P207, DOI 10.1016/0304-4165(70)90410-1; Suckow AT, 2010, AM J PHYSIOL-ENDOC M, V299, pE23, DOI 10.1152/ajpendo.00664.2009; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeh TYJ, 2006, BIOCHEM J, V399, P415, DOI 10.1042/BJ20060713; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Yeh TYJ, 2005, MOL CELL BIOCHEM, V276, P183, DOI 10.1007/s11010-005-4059-z; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhao Y, 2014, CNS NEUROSCI THER, V20, P539, DOI 10.1111/cns.12273	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122948	10.1371/journal.pone.0122948	http://dx.doi.org/10.1371/journal.pone.0122948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876076	Green Published, gold			2022-12-26	WOS:000352845100120
J	Kim, WJ; Wittner, BS; Amzallag, A; Brannigan, BW; Ting, DT; Ramaswamy, S; Maheswaran, S; Haber, DA				Kim, Woo Jae; Wittner, Ben S.; Amzallag, Arnaud; Brannigan, Brian W.; Ting, David T.; Ramaswamy, Sridhar; Maheswaran, Shyamala; Haber, Daniel A.			The WTX Tumor Suppressor Interacts with the Transcriptional Corepressor TRIM28	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNAI SCREEN; EXPRESSION; PROTEIN; GENE; INACTIVATION; REGULATOR; TIF1-BETA; PHD	WTX encodes a tumor suppressor implicated in the pediatric kidney cancer Wilms tumor and in mesenchymal differentiation with potentially distinct functions in the cytoplasm, at the plasma membrane, and in the nucleus. Although modulating components of the WNT signaling pathway is a proposed function for cytoplasmic and membrane-bound WTX, its nuclear properties are not well understood. Here we report that the transcriptional corepressor TRIM28 is the major binding partner for nuclear WTX. WTX interacted with the coiled coil domain of TRIM28 required for its binding to Kruppel-associated box domains of transcription factors and for its chromatin recruitment through its own coiled coil and proline-rich domains. Knockdown of endogenous WTX reduced the recruitment of TRIM28 to a chromatinized reporter sequence and its ability to repress a target transcript. In mouse embryonic stem cells where TRIM28 plays a major role in repressing endogenous retroviruses and long interspersed elements, knockdown of either TRIM28 or WTX combined with single molecule RNA sequencing revealed a highly significant shared set of differentially regulated transcripts, including derepression of non-coding repetitive sequences and their neighboring protein encoding genes (p < 1e - 20). In mesenchymal precursor cells, depletion of WTX and TRIM28 resulted in analogous beta-catenin-independent defects in adipogenic and osteogenic differentiation, and knockdown of WTX reduced TRIM28 binding to Ppar gamma promoter. Together, the physical and functional interaction between WTX and TRIM28 suggests that the nuclear fraction of WTX plays a role in epigenetic silencing, an effect that may contribute to its function as a regulator of cellular differentiation and tumorigenesis.	[Ting, David T.; Ramaswamy, Sridhar; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Charlestown, MA 02129 USA; [Maheswaran, Shyamala] Massachusetts Gen Hosp, Ctr Canc, Dept Surg, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, CNY 7,Bldg 149, Charlestown, MA 02129 USA.	Haber@helix.mgh.harvard.edu	Amzallag, Arnaud/Y-5802-2019; Ting, David/F-4389-2017	Amzallag, Arnaud/0000-0001-7467-1227; Ting, David/0000-0002-3261-2322	Howard Hughes Medical Institute; American Cancer Society	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society)	This work was supported by the Howard Hughes Medical Institute (to D. A. H.) and an American Cancer Society institutional research grant (to W. J. K.).	Akhavanfard S, 2014, GENE CHROMOSOME CANC, V53, P67, DOI 10.1002/gcc.22118; Baek SH, 2008, DEV CELL, V14, P459, DOI 10.1016/j.devcel.2008.03.018; Barde I, 2013, SCIENCE, V340, P350, DOI 10.1126/science.1232398; Cammas F, 2000, DEVELOPMENT, V127, P2955; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Filipponi D, 2013, CANCER CELL, V24, P528, DOI 10.1016/j.ccr.2013.08.022; Hohn O, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00246; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Katoh L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00234; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Moisan A, 2011, DEV CELL, V20, P583, DOI 10.1016/j.devcel.2011.03.013; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Rodic N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003402; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Singh K, 2015, GENE DEV, V29, P513, DOI 10.1101/gad.254532.114; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weber P, 2002, DEVELOPMENT, V129, P2329; Wegert J, 2009, GENE CHROMOSOME CANC, V48, P1102, DOI 10.1002/gcc.20712; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	35	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14381	14390		10.1074/jbc.M114.631945	http://dx.doi.org/10.1074/jbc.M114.631945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25882849	Green Published, hybrid			2022-12-26	WOS:000355754600010
J	Dulermo, R; Onodera, T; Coste, G; Passot, F; Dutertre, M; Porteron, M; Confalonieri, F; Sommer, S; Pasternak, C				Dulermo, Remi; Onodera, Takefumi; Coste, Genevieve; Passot, Fanny; Dutertre, Murielle; Porteron, Martine; Confalonieri, Fabrice; Sommer, Suzanne; Pasternak, Cecile			Identification of New Genes Contributing to the Extreme Radioresistance of Deinococcus radiodurans Using a Tn5-Based Transposon Mutant Library	PLOS ONE			English	Article							C-DI-AMP; RADIATION-RESISTANT BACTERIUM; STRAND BREAK REPAIR; FE-S CLUSTER; ESCHERICHIA-COLI; TN5 TRANSPOSASE; IONIZING-RADIATION; PROTEIN-KINASE; CATALASE KATA; DNA-REPAIR	Here, we have developed an extremely efficient in vivo Tn5-based mutagenesis procedure to construct a Deinococcus radiodurans insertion mutant library subsequently screened for sensitivity to genotoxic agents such as. and UV radiations or mitomycin C. The genes inactivated in radiosensitive mutants belong to various functional categories, including DNA repair functions, stress responses, signal transduction, membrane transport, several metabolic pathways, and genes of unknown function. Interestingly, preliminary characterization of previously undescribed radiosensitive mutants suggests the contribution of cyclic di-AMP signaling in the recovery of D. radiodurans cells from genotoxic stresses, probably by modulating several pathways involved in the overall cell response. Our analyses also point out a new transcriptional regulator belonging to the GntR family, encoded by DR0265, and a predicted RNase belonging to the newly described Y family, both contributing to the extreme radioresistance of D. radiodurans. Altogether, this work has revealed new cell responses involved either directly or indirectly in repair of various cell damage and confirmed that D. radiodurans extreme radiation resistance is determined by a multiplicity of pathways acting as a complex network.	[Dulermo, Remi; Onodera, Takefumi; Coste, Genevieve; Passot, Fanny; Dutertre, Murielle; Porteron, Martine; Confalonieri, Fabrice; Sommer, Suzanne; Pasternak, Cecile] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, CEA,CNRS, Orsay, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pasternak, C (corresponding author), Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, CEA,CNRS, Orsay, France.	cecile.pasternak@igmors.u-psud.fr		Passot, Fanny/0000-0002-0257-816X; Pasternak, Cecile/0000-0002-7884-2422	Agence Nationale de la Recherche, ANR [Radioresistance-11-BSV3-01701]	Agence Nationale de la Recherche, ANR(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche, ANR Radioresistance-11-BSV3-01701 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Bender RA, 2012, MICROBIOL MOL BIOL R, V76, P565, DOI 10.1128/MMBR.00014-12; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Buchan BW, 2008, APPL ENVIRON MICROB, V74, P2637, DOI 10.1128/AEM.02882-07; Byrne RT, 2014, J BACTERIOL, V196, P3534, DOI 10.1128/JB.01589-14; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Confalonieri F, 2011, J PHYS CONF SER, V261, DOI 10.1088/1742-6596/261/1/012005; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Das AD, 2012, BBA-GEN SUBJECTS, V1820, P1052, DOI 10.1016/j.bbagen.2012.03.014; Das S, 2005, J MICROBIOL METH, V63, P89, DOI 10.1016/j.mimet.2005.02.011; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; DEAN CJ, 1970, BIOCHEM BIOPH RES CO, V39, P126, DOI 10.1016/0006-291X(70)90767-9; Devigne A, 2015, MOL MICROBI IN PRESS; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002520; Figaro S, 2013, J BACTERIOL, V195, P2340, DOI 10.1128/JB.00164-13; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; Goryshin IY, 2000, NAT BIOTECHNOL, V18, P97, DOI 10.1038/72017; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Knobloch JKM, 2003, APPL ENVIRON MICROB, V69, P5812, DOI 10.1128/AEM.69.10.5812-5818.2003; Kobayashi I, 2006, J BIOSCI BIOENG, V101, P315, DOI 10.1263/jbb.101.315; Kostner M, 2006, APPL ENVIRON MICROB, V72, P4717, DOI 10.1128/AEM.00492-06; Kota S, 2014, J GENET, V93, P349, DOI 10.1007/s12041-014-0382-z; Kota S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085288; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Laalami S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054062; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Lecointe F, 2004, GENE, V336, P25, DOI 10.1016/j.gene.2004.04.006; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Liedert C, 2012, J BACTERIOL, V194, P1552, DOI 10.1128/JB.06429-11; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; Luan HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085649; Ludanyi M, 2014, MOL MICROBIOL, V94, P434, DOI 10.1111/mmi.12774; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mailloux RJ, 2011, ANTON LEEUW INT J G, V99, P433, DOI 10.1007/s10482-010-9538-x; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; MATTIMORE V, 1995, J BACTERIOL, V177, P5232, DOI 10.1128/jb.177.18.5232-5237.1995; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Meima R, 2001, J BACTERIOL, V183, P3169, DOI 10.1128/JB.183.10.3169-3175.2001; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Nguyen HH, 2009, MOL MICROBIOL, V73, P240, DOI 10.1111/j.1365-2958.2009.06766.x; Norais C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056558; Ogura Y, 2001, J BACTERIOL, V183, P3833, DOI 10.1128/JB.183.13.3833-3841.2001; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Rajpurohit YS, 2010, MOL MICROBIOL, V77, P1470, DOI 10.1111/j.1365-2958.2010.07301.x; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Schroder J, 2012, FEMS MICROBIOL LETT, V331, P136, DOI 10.1111/j.1574-6968.2012.02564.x; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Solovjev V, 2011, METAGENOMICITAPP, P61; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; UDUPA KS, 1994, J BACTERIOL, V176, P7439, DOI 10.1128/JB.176.24.7439-7446.1994; Vujicic-Zagar A, 2009, J MOL BIOL, V386, P704, DOI 10.1016/j.jmb.2008.12.062; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; WEINREICH MD, 1994, GENE DEV, V8, P2363, DOI 10.1101/gad.8.19.2363; WEINREICH MD, 1994, J BACTERIOL, V176, P5494, DOI 10.1128/JB.176.17.5494-5504.1994; WIEGAND TW, 1992, J BACTERIOL, V174, P1229, DOI 10.1128/jb.174.4.1229-1239.1992; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10; Yigit H, 1997, J BACTERIOL, V179, P1704, DOI 10.1128/jb.179.5.1704-1713.1997; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zeevi MK, 2013, J BACTERIOL, V195, P5250, DOI 10.1128/JB.00794-13; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zhou M, 1998, J MOL BIOL, V276, P913, DOI 10.1006/jmbi.1997.1579; Zhou M, 1997, J MOL BIOL, V271, P362, DOI 10.1006/jmbi.1997.1188; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17	94	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124358	10.1371/journal.pone.0124358	http://dx.doi.org/10.1371/journal.pone.0124358			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884619	Green Submitted, Green Published, gold			2022-12-26	WOS:000353017000119
J	Castino, MR; Cornish, JL; Clemens, KJ				Castino, Matthew R.; Cornish, Jennifer L.; Clemens, Kelly J.			Inhibition of Histone Deacetylases Facilitates Extinction and Attenuates Reinstatement of Nicotine Self-Administration in Rats	PLOS ONE			English	Article							LONG-TERM-MEMORY; CUE-INDUCED REINSTATEMENT; COCAINE-SEEKING BEHAVIOR; SODIUM-BUTYRATE; PREFRONTAL CORTEX; ACQUISITION; RECONSOLIDATION; ACETYLATION; EXPRESSION; PREFERENCE	Chromatin remodelling is integral to the formation of long-term memories. Recent evidence suggests that histone modification may play a role in the persistence of memories associated with drug use. The present series of experiments aimed to examine the effect of histone deacetylase (HDAC) inhibition on the extinction and reinstatement of nicotine self-administration. Rats were trained to intravenously self-administer nicotine for 12 days on a fixed-ratio 1 schedule. In Experiment 1, responding was then extinguished through removal of nicotine and response-contingent cues. After each extinction session, the HDAC inhibitor, sodium butyrate (NaB), was administered immediately, or six hours after each session. In Experiment 2, response-contingent cues remained available across extinction to increase rates of responding during this phase, and NaB was administered immediately after the session. Finally, in Experiment 3, the effect of NaB treatment on extinction of responding for sucrose pellets was assessed. Across all experiments reinstatement to the cue and/or the reward itself was then tested. In the first experiment, treatment with NaB significantly attenuated nicotine and nicotine + cue reinstatement when administered immediately, but not six hours after each extinction session. When administered after cue-extinction (Expt. 2), NaB treatment specifically facilitated the rate of extinction across sessions, indicating that HDAC inhibition enhanced consolidation of the extinction memory. In contrast, there was no effect of NaB on the extinction and reinstatement of sucrose-seeking (Expt. 3), indicating that the observed effects are specific to a drug context. These results provide the first demonstration that HDAC inhibition facilitates the extinction of responding for an intravenously self-administered drug of abuse and further highlight the potential of HDAC inhibitors in the treatment of drug addiction.	[Castino, Matthew R.; Cornish, Jennifer L.; Clemens, Kelly J.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Castino, Matthew R.; Clemens, Kelly J.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Macquarie University; University of New South Wales Sydney	Clemens, KJ (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	k.clemens@unsw.edu.au		Cornish, Jennifer/0000-0002-9754-8069; Clemens, Kelly/0000-0003-2709-218X; Castino, Matthew/0000-0002-2100-5914	Australian Research Council (ARC) [DE120100235]	Australian Research Council (ARC)(Australian Research Council)	This funding was supported by an Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA) to KJC (Grant No. DE120100235; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Bird KD, 2004, ANALYSIS OF VARIANCE; Bouton ME, 2012, BEHAV PROCESS, V90, P130, DOI 10.1016/j.beproc.2012.03.004; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Caggiula AR, 2001, PHARMACOL BIOCHEM BE, V70, P515, DOI 10.1016/S0091-3057(01)00676-1; Clemens KJ, 2010, PSYCHOPHARMACOLOGY, V211, P43, DOI 10.1007/s00213-010-1866-z; Cooper J, 2011, AUST NZ J PUBL HEAL, V35, P368, DOI 10.1111/j.1753-6405.2011.00733.x; Donny EC, 1998, PSYCHOPHARMACOLOGY, V136, P83, DOI 10.1007/s002130050542; Gipson CD, 2013, P NATL ACAD SCI USA, V110, P9124, DOI 10.1073/pnas.1220591110; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Itzhak Y, 2013, NEUROBIOL LEARN MEM, V102, P34, DOI 10.1016/j.nlm.2013.03.007; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Liu X, 2006, PSYCHOPHARMACOLOGY, V184, P417, DOI 10.1007/s00213-005-0134-0; Liu X, 2008, PSYCHOPHARMACOLOGY, V196, P365, DOI 10.1007/s00213-007-0967-9; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Malvaez M, 2011, J NEUROSCI, V31, P16941, DOI 10.1523/JNEUROSCI.2747-11.2011; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Motbey CP, 2013, J PSYCHOPHARMACOL, V27, P823, DOI 10.1177/0269881113490325; Pastor V, 2011, J NEUROCHEM, V116, P636, DOI 10.1111/j.1471-4159.2010.07149.x; Paterson NE, 2005, NEUROPSYCHOPHARMACOL, V30, P119, DOI 10.1038/sj.npp.1300524; Peterson AB, 2014, PSYCHOPHARMACOLOGY, V231, P1305, DOI 10.1007/s00213-013-3321-4; Ploense KL, 2013, BEHAV PHARMACOL, V24, P164, DOI 10.1097/FBP.0b013e32836104ea; Portero-Tresserra M, 2013, NEUROBIOL LEARN MEM, V100, P1, DOI 10.1016/j.nlm.2012.11.003; Raybuck JD, 2013, PHARMACOL BIOCHEM BE, V106, P109, DOI 10.1016/j.pbb.2013.02.009; Romieu P, 2008, J NEUROSCI, V28, P9342, DOI 10.1523/JNEUROSCI.0379-08.2008; Romieu P, 2011, CURR NEUROPHARMACOL, V9, P21, DOI 10.2174/157015911795017317; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Simon-O'Brien E, 2015, ADDICT BIOL, V20, P676, DOI 10.1111/adb.12161; Sun J, 2008, NEUROSCI LETT, V441, P72, DOI 10.1016/j.neulet.2008.05.010; Wang R, 2010, NEUROSCI LETT, V483, P137, DOI 10.1016/j.neulet.2010.07.080; Wang YP, 2015, J MOL NEUROSCI, V55, P269, DOI 10.1007/s12031-014-0317-4	39	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124796	10.1371/journal.pone.0124796	http://dx.doi.org/10.1371/journal.pone.0124796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880762	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500112
J	Falcone, PH; Tai, CY; Carson, LR; Joy, JM; Mosman, MM; Vogel, RM; McCann, TR; Crona, KP; Griffin, JD; Kim, MP; Moon, JR				Falcone, Paul H.; Tai, Chih Yin; Carson, Laura R.; Joy, Jordan M.; Mosman, Matt M.; Vogel, Roxanne M.; McCann, Tyler R.; Crona, Kevin P.; Griffin, J. Daniel; Kim, Michael P.; Moon, Jordan R.			Subcutaneous and Segmental Fat Loss with and without Supportive Supplements in Conjunction with a Low-Calorie High Protein Diet in Healthy Women	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; BODY-COMPOSITION CHANGES; X-RAY ABSORPTIOMETRY; WEIGHT-LOSS; ENERGY-EXPENDITURE; RANDOMIZED-TRIAL; GREEN TEA; BEHAVIOR-THERAPY; METABOLIC-RATE; ABDOMINAL FAT	Background Weight loss benefits of multi-ingredient supplements in conjunction with a low-calorie, high-protein diet in young women are unknown. Therefore, the purpose of this study was to investigate the effects of a three-week low-calorie diet with and without supplementation on body composition. Methods Thirty-seven recreationally-trained women (n = 37; age = 27.1 +/- 4.2; height = 165.1 +/- 6.4; weight = 68.5 +/- 10.1; BMI = 25.1 +/- 3.4) completed one of the following three-week interventions: no change in diet (CON); a high-protein, low-calorie diet supplemented with a thermogenic, conjugated linoleic acid (CLA), a protein gel, and a multi-vitamin (SUP); or the high-protein diet with isocaloric placebo supplements (PLA). Before and after the three-week intervention, body weight, % Fat via dual X-ray absorptiometry (DXA), segmental fat mass via DXA, % Fat via skinfolds, and skinfold thicknesses at seven sites were measured. Results SUP and PLA significantly decreased body weight (SUP: PRE, 70.47 +/- 8.01 kg to POST, 67.51 +/- 8.10 kg; PLA: PRE, 67.88 +/- 12.28 kg vs. POST, 66.38 +/- 11.94 kg; p +/- 0.05) with a greater (p +/- 0.05) decrease in SUP than PLA or CON. SUP and PLA significantly decreased % Fat according to DXA (SUP: PRE, 34.98 +/- 7.05% to POST, 32.99 +/- 6.89%; PLA: PRE, 34.22 +/- 6.36% vs. POST, 32.69 +/- 5.84%; p <= 0.05), whereas only SUP significantly decreased % Fat according to skinfolds (SUP: PRE, 27.40 +/- 4.09% to POST, 24.08 +/- 4.31%; p <= 0.05). SUP significantly (p <= 0.05) decreased thicknesses at five skinfolds (chest, waist, hip, subscapular, and tricep) compared to PLA, but not at two skinfolds (axilla and thigh). Conclusions The addition of a thermogenic, CLA, protein, and a multi-vitamin to a three-week low-calorie diet improved weight loss, total fat loss and subcutaneous fat loss, compared to diet alone.	[Falcone, Paul H.; Tai, Chih Yin; Carson, Laura R.; Joy, Jordan M.; Mosman, Matt M.; Kim, Michael P.; Moon, Jordan R.] MusclePharm Sports Sci Inst, Denver, CO USA; [Vogel, Roxanne M.] Metropolitan State Univ Denver, Denver, CO USA; [McCann, Tyler R.] Univ Colorado, Boulder, CO 80309 USA; [Crona, Kevin P.] Univ Colorado, Denver, CO 80202 USA; [Griffin, J. Daniel] Widener Univ, Chester, PA 19013 USA; [Moon, Jordan R.] US Sports Acad, Dept Sports Exercise Sci, Daphne, AL USA	Metropolitan State University of Denver; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Denver; Widener University	Moon, JR (corresponding author), MusclePharm Sports Sci Inst, Denver, CO USA.	jordan@musclepharm.com	Biguzzi, Felipe A/E-4724-2015		MusclePharm Corporation	MusclePharm Corporation	MusclePharm Corporation funded this study. The funder provided support in the form of salaries for authors PHF, CYT, LRC, JMJ, MMM, MPK, TRM and JRM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acheson KJ, 2013, EUR J CLIN NUTR, V67, P462, DOI 10.1038/ejcn.2012.194; Alvarez VP, 2007, OBES SURG, V17, P211, DOI 10.1007/s11695-007-9032-3; ANDERSEN T, 1984, NEW ENGL J MED, V310, P352, DOI 10.1056/NEJM198402093100604; Baba NH, 1999, INT J OBESITY, V23, P1202, DOI 10.1038/sj.ijo.0801064; Ball S, 2004, RES Q EXERCISE SPORT, V75, P248, DOI 10.1080/02701367.2004.10609158; Berube-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502; Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943; BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671; Cha YS, 2012, NUTR RES PRACT, V6, P520, DOI 10.4162/nrp.2012.6.6.520; Chen SC, 2012, NUTRITION, V28, P559, DOI 10.1016/j.nut.2011.09.008; Claessens M, 2009, INT J OBESITY, V33, P296, DOI 10.1038/ijo.2008.278; Delbridge EA, 2009, AM J CLIN NUTR, V90, P1203, DOI 10.3945/ajcn.2008.27209; Di Pierro F, 2009, ALTERN MED REV, V14, P154; DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Jebb SA, 2000, BRIT J NUTR, V83, P115, DOI 10.1017/S0007114500000155; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kamphuis MMJW, 2003, INT J OBESITY, V27, P840, DOI 10.1038/sj.ijo.0802304; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; Lejeune MPGM, 2005, BRIT J NUTR, V93, P281, DOI 10.1079/BJN20041305; Leung FW, 2014, PROG DRUG RES, V68, P171, DOI 10.1007/978-3-0348-0828-6_7; Lopez HL, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-22; Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293; Minderico CS, 2008, BRIT J NUTR, V99, P432, DOI 10.1017/S0007114507815789; Moon JR, 2009, EUR J APPL PHYSIOL, V105, P119, DOI 10.1007/s00421-008-0881-9; Najafpanah MJ, 2014, GENE, V543, P253, DOI 10.1016/j.gene.2014.04.006; Norris LE, 2009, AM J CLIN NUTR, V90, P468, DOI 10.3945/ajcn.2008.27371; Outlaw J, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-25; Pfeuffer M, 2011, J AM COLL NUTR, V30, P19, DOI 10.1080/07315724.2011.10719940; Riserus U, 2001, INT J OBESITY, V25, P1129, DOI 10.1038/sj.ijo.0801659; Rosenblum JL, 2012, AM J CLIN NUTR, V95, P101, DOI 10.3945/ajcn.111.019489; Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529; Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848; Sillanpaa E, 2013, EUR J APPL PHYSIOL, V113, P2331, DOI 10.1007/s00421-013-2669-9; Sites CK, 2007, FERTIL STERIL, V88, P1609, DOI 10.1016/j.fertnstert.2007.01.061; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7; Vasudev Sudha, 2004, J Assoc Physicians India, V52, P877; WADDEN TA, 1990, JAMA-J AM MED ASSOC, V263, P83, DOI 10.1001/jama.263.1.83; WADDEN TA, 1986, J CONSULT CLIN PSYCH, V54, P482, DOI 10.1037/0022-006X.54.4.482; WADDEN TA, 1988, J CONSULT CLIN PSYCH, V56, P925, DOI 10.1037/0022-006X.56.6.925; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Wang J, 2002, OBES RES, V10, P885, DOI 10.1038/oby.2002.121; Wang J, 2000, ANN NY ACAD SCI, V904, P317; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321	52	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123854	10.1371/journal.pone.0123854	http://dx.doi.org/10.1371/journal.pone.0123854			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875200	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800121
J	Hu, FN; Li, H; Liu, XM; Li, S; Ding, WQ; Xu, CY; Li, Y; Zhu, LH				Hu, Feinan; Li, Hang; Liu, Xinmin; Li, Song; Ding, Wuquan; Xu, Chenyang; Li, Yue; Zhu, Longhui			Quantitative Characterization of Non-Classic Polarization of Cations on Clay Aggregate Stability	PLOS ONE			English	Article							EXCHANGEABLE POTASSIUM; HYDRAULIC CONDUCTIVITY; INTERACTION FORCES; HOFMEISTER SERIES; ION SPECIFICITY; ORGANIC-MATTER; DLVO THEORY; WATER; DISPERSION; SALT	Soil particle interactions are strongly influenced by the concentration, valence and ion species and the pH of the bulk solution, which will also affect aggregate stability and particle transport. In this study, we investigated clay aggregate stability in the presence of different alkali ions (Li+, Na+, K+, and Cs+) at concentrations from 10(-5) to 10(-1) mol L-1. Strong specific ion effects on clay aggregate stability were observed, and showed the order Cs+>K+>Na+>Li+. We found that it was not the effects of ion size, hydration, and dispersion forces in the cation-surface interactions but strong non-classic polarization of adsorbed cations that resulted in these specific effects. In this study, the non-classic dipole moments of each cation species resulting from the non-classic polarization were estimated. By comparing non-classic dipole moments with classic values, the observed dipole moments of adsorbed cations were up to 104 times larger than the classic values for the same cation. The observed non-classic dipole moments sharply increased with decreasing electrolyte concentration. We conclude that strong non-classic polarization could significantly suppress the thickness of the diffuse layer, thereby weakening the electric field near the clay surface and resulting in improved clay aggregate stability. Even though we only demonstrated specific ion effects on aggregate stability with several alkali ions, our results indicate that these effects could be universally important in soil aggregate stability.	[Hu, Feinan; Li, Hang; Liu, Xinmin; Li, Song; Ding, Wuquan; Xu, Chenyang; Li, Yue; Zhu, Longhui] Southwest Univ, Chongqing Key Lab Soil Multiscale Interfacial Pro, Coll Resources & Environm, Chongqing, Peoples R China	Southwest University - China	Li, H (corresponding author), Southwest Univ, Chongqing Key Lab Soil Multiscale Interfacial Pro, Coll Resources & Environm, Chongqing, Peoples R China.	lihangswu@163.com			National Natural Science Foundation of China [41371249, 41101223, 41201223]; Fundamental Research Funds for the Central Universities [XDJK2013D025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (41371249, 41101223, 41201223)(http://www.nsfc.gov.cn/), and the Fundamental Research Funds for the Central Universities (XDJK2013D025)(http://www.swu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk Z, 1999, ADV COLLOID INTERFAC, V83, P137, DOI 10.1016/S0001-8686(99)00009-3; Amezketa E, 1999, J SUSTAIN AGR, V14, P83, DOI 10.1300/J064v14n02_08; Ao Z, 2011, J PHYS CHEM C, V115, P2284, DOI 10.1021/jp110782g; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Bin G, 2011, CRIT REV ENV SCI TEC, V41, P336, DOI 10.1080/10643380902871464; Borah JM, 2011, LANGMUIR, V27, P8710, DOI 10.1021/la2006277; Bostrom M, 2004, PROG COLL POL SCI S, V123, P110, DOI 10.1007/b11652; Bostrom M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168103; Bostrom M, 2003, J PHYS CHEM B, V107, P2875, DOI 10.1021/jp026804d; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; Das MR, 2010, J COLLOID INTERF SCI, V344, P482, DOI 10.1016/j.jcis.2009.12.048; Denef K, 2002, PLANT SOIL, V246, P185, DOI 10.1023/A:1020668013524; Dishon M, 2009, LANGMUIR, V25, P2831, DOI 10.1021/la803022b; Duiker SW, 2003, SOIL SCI SOC AM J, V67, P606, DOI 10.2136/sssaj2003.0606; Flores SC, 2012, J PHYS CHEM C, V116, P5730, DOI 10.1021/jp210791j; FRENKEL H, 1978, SOIL SCI SOC AM J, V42, P32, DOI 10.2136/sssaj1978.03615995004200010008x; Funkner S, 2012, J AM CHEM SOC, V134, P1030, DOI 10.1021/ja207929u; Gao XD, 2014, ACTA PHYS-CHIM SIN, V30, P2272, DOI 10.3866/PKU.WHXB201410231; Hashemi M, 2011, ANAL BIOANAL CHEM, V400, P643, DOI 10.1007/s00216-011-4722-z; Hess B, 2009, P NATL ACAD SCI USA, V106, P14008; Holthusen D, 2010, SOIL TILL RES, V111, P75, DOI 10.1016/j.still.2010.08.002; Hribar B, 2002, J AM CHEM SOC, V124, P12302, DOI 10.1021/ja026014h; Itami K, 2005, COLLOID SURFACE A, V265, P55, DOI 10.1016/j.colsurfa.2004.10.138; Jungwirth P, 2014, NAT CHEM, V6, P261, DOI 10.1038/nchem.1899; Kowacz M, 2008, GEOCHIM COSMOCHIM AC, V72, P4476, DOI 10.1016/j.gca.2008.07.005; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P1, DOI 10.1016/j.cocis.2004.05.004; Kunz W, 2010, CURR OPIN COLLOID IN, V15, P34, DOI 10.1016/j.cocis.2009.11.008; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; LEVY GJ, 1995, SOIL SCI, V160, P352, DOI 10.1097/00010694-199511000-00004; LEVY GJ, 1990, SOIL SCI, V149, P69, DOI 10.1097/00010694-199002000-00002; Li H, 2004, J COLLOID INTERF SCI, V275, P172, DOI 10.1016/j.jcis.2003.12.055; Li H, 2011, SOIL SCI SOC AM J, V75, P2128, DOI 10.2136/sssaj2010.0301; Li H, 2009, J PHYS CHEM C, V113, P4419, DOI 10.1021/jp808372r; Li S, 2013, SOIL SCI SOC AM J, V77, P1563, DOI 10.2136/sssaj2013.01.0009; Liang Y, 2007, ADV COLLOID INTERFAC, V134-35, P151, DOI 10.1016/j.cis.2007.04.003; Liu XM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05047; Liu XM, 2013, J PHYS CHEM C, V117, P6245, DOI 10.1021/jp312682u; Lo Nostro P, 2002, BIOMACROMOLECULES, V3, P1217, DOI 10.1021/bm0255692; Long YC, 2013, LANGMUIR, V29, P3645, DOI 10.1021/la400035e; Lopez-Leon T, 2008, J PHYS CHEM C, V112, P16060, DOI 10.1021/jp803796a; McBride MB, 2002, SOIL SCI SOC AM J, V66, P1207, DOI 10.2136/sssaj2002.1207; MINHAS PS, 1986, IRRIGATION SCI, V7, P159; Ninham BW, 1997, LANGMUIR, V13, P2097, DOI 10.1021/la960974y; Noah-Vanhoucke J, 2009, P NATL ACAD SCI USA, V106, P15125, DOI 10.1073/pnas.0905168106; NocitoGobel J, 1996, COLLOID SURFACE A, V107, P223, DOI 10.1016/0927-7757(95)03340-8; Omta AW, 2003, SCIENCE, V301, P347, DOI 10.1126/science.1084801; Parsons DF, 2010, LANGMUIR, V26, P3323, DOI 10.1021/la903061h; Parsons DF, 2011, PHYS CHEM CHEM PHYS, V13, P12352, DOI 10.1039/c1cp20538b; Parsons DF, 2010, LANGMUIR, V26, P6430, DOI 10.1021/la9041265; Patil S., 2011, Journal of Urban and Environmental Engineering (JUEE), V5, P84, DOI 10.4090/juee.2011.v5n2.084090; Plaza-Bonilla D, 2013, SOIL SCI SOC AM J, V77, P284, DOI 10.2136/sssaj2012.0258; Richter DD, 2009, SCIENCE, V326, P1067, DOI 10.1126/science.1179117; RIESKAUTT MM, 1989, J BIOL CHEM, V264, P745; Ruiz-Agudo E, 2010, GEOCHIM COSMOCHIM AC, V74, P1256, DOI 10.1016/j.gca.2009.11.004; Ruiz-Agudo E, 2011, CHEM GEOL, V281, P364, DOI 10.1016/j.chemgeo.2011.01.003; Santos APd, 2011, PHYS REV LETT, V106; Schwartz CP, 2010, P NATL ACAD SCI USA, V107, P14008, DOI 10.1073/pnas.1006435107; Tian R, 2014, PHYS CHEM CHEM PHYS, V16, P8828, DOI 10.1039/c3cp54813a; TISDALL JM, 1994, PLANT SOIL, V159, P115, DOI 10.1007/BF00000100; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Tobias DJ, 2008, SCIENCE, V319, P1197, DOI 10.1126/science.1152799; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Wang LF, 2013, ENVIRON SCI TECHNOL, V47, P5042, DOI 10.1021/es304993j; Xu CY, 2015, EUROPEAN J IN PRESS; Yang JL, 2009, SOIL TILL RES, V105, P292, DOI 10.1016/j.still.2009.04.003; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P15249, DOI 10.1073/pnas.0907616106	67	27	31	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122460	10.1371/journal.pone.0122460	http://dx.doi.org/10.1371/journal.pone.0122460			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874864	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800060
J	Kornej, J; Schmidl, J; Ueberham, L; John, S; Daneschnejad, S; Dinov, B; Hindricks, G; Adams, V; Husser, D; Bollmann, A				Kornej, Jelena; Schmidl, Josephin; Ueberham, Laura; John, Silke; Daneschnejad, Sait; Dinov, Borislav; Hindricks, Gerhard; Adams, Volker; Husser, Daniela; Bollmann, Andreas			Galectin-3 in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; INFLAMMATION; BIOMARKERS; MARKERS	Background Galectin-3 (Gal-3) is an emerging biomarker in heart failure that is involved in fibrosis and inflammation. However, its potential value as a prognostic marker in atrial fibrillation (AF) is unknown. The aim of this study was to assess the impact of AF catheter ablation on Gal-3 and evaluate its prognostic impact for predicting rhythm outcome after catheter ablation. Methods Gal-3 was measured at baseline and after 6 months using specific ELISA. AF recurrences were defined as any atrial arrhythmia lasting longer than 30 sec within 6 months after ablation. Results In 105 AF patients (65% males, age 62 +/- 9 years, 52% paroxysmal AF) undergoing catheter ablation, Gal-3 was measured at baseline and after 6 months and compared with an AF-free control cohort (n=14, 50 % males, age 58 +/- 11 years). Gal-3 was higher in AF patients compared with AF-free controls (7.8 +/- 2.9 vs. 5.8 +/- 1.8, ng/mL, p=0.013). However, on multi-variable analysis, BMI (p=0.007) but not AF (p=0.068) was associated with Gal-3. In the AF cohort, on univariable analysis higher Gal-3 levels were associated with female gender (p=0.028), higher BMI (p=0.005) and both CHADS2 (p=0.008) and CHA2DS2-VASC (p=0.016) scores, however, on multivariable analysis only BMI remained significantly associated with baseline Gal-3 (p=0.016). Gal-3 was similar 6 months after AF catheter ablation and was not associated with sinus rhythm maintenance. Conclusions Although galectin-3 levels are higher in AF patients, this is driven by cardiometabolic comorbidities and not heart rhythm. Gal-3 is not useful for predicting rhythm outcome of catheter ablation.	[Kornej, Jelena; Schmidl, Josephin; Ueberham, Laura; John, Silke; Daneschnejad, Sait; Dinov, Borislav; Hindricks, Gerhard; Husser, Daniela; Bollmann, Andreas] Ctr Heart, Dept Electrophysiol, Leipzig, Germany; [Adams, Volker] Ctr Heart, Dept Cardiol, Leipzig, Germany	Heart Center Leipzig GMBH; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heart Center Leipzig GMBH; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kornej, J (corresponding author), Ctr Heart, Dept Electrophysiol, Leipzig, Germany.	jelena.kornej@gmx.de						Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; D'Ascenzo F, 2013, INT J CARDIOL, V167, P1984, DOI 10.1016/j.ijcard.2012.05.008; de Boer Rudolf A, 2010, Curr Heart Fail Rep, V7, P1, DOI 10.1007/s11897-010-0004-x; de Boer RA, 2013, EUR J HEART FAIL, V15, P1095, DOI 10.1093/eurjhf/hft077; den Uijl DW, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.031; Doyama K, 1998, J AM COLL CARDIOL, V32, P1832, DOI 10.1016/S0735-1097(98)00494-X; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Gould PA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P18, DOI 10.1161/CIRCEP.108.831586; Gurses KM, 2014, AM J CARDIOL; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Ho JE, 2014, AM HEART J, V167, P729, DOI 10.1016/j.ahj.2014.02.009; Hussein AA, 2011, CIRCULATION, V123, P2077, DOI 10.1161/CIRCULATIONAHA.110.007252; Kornej J, 2014, HAMOSTASEOLOGIE, V34, P9, DOI 10.5482/HAMO-13-09-0051; Kornej J, 2014, CIRC-ARRHYTHMIA ELEC, V7, P281, DOI 10.1161/CIRCEP.113.001182; Kornej J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-49; Kornej J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044165; Marcus GM, 2008, HEART RHYTHM, V5, P215, DOI 10.1016/j.hrthm.2007.10.007; Marcus GM, 2010, HEART RHYTHM, V7, P149, DOI 10.1016/j.hrthm.2009.10.004; Okumura Y, 2011, J CARDIOVASC ELECTR, V22, P987, DOI 10.1111/j.1540-8167.2011.02059.x; van Kimmenade R, 2006, J AM COLL CARDIOL, V47, P886, DOI 10.1016/j.jacc.2005.11.022; van Kimmenade RR, 2006, J AM COLL CARDIOL, V48, P1217, DOI 10.1016/j.jacc.2006.03.061; Weigert J, 2010, J CLIN ENDOCR METAB, V95, P1404, DOI 10.1210/jc.2009-1619; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168	23	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123574	10.1371/journal.pone.0123574	http://dx.doi.org/10.1371/journal.pone.0123574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875595	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800105
J	Li, CY; Lin, CP; Lin, YS; Wu, LS; Chang, CJ; Chu, PH				Li, Chen-Yu; Lin, Chia-Pin; Lin, Yu-Sheng; Wu, Lung-Sheng; Chang, Chee-Jen; Chu, Pao-Hsien			Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events	PLOS ONE			English	Article							RISK-FACTORS; HEART-FAILURE; FOLLOW-UP; HOSPITAL DIAGNOSIS; MORTALITY; TAIWAN; STROKE; DISEASE; TRENDS; CARE	Objectives This study aims to investigate the impact of newly diagnosed atrial fibrillation (AF) on future major adverse cardiac events (MACE). AF is the most common form of cardiac arrhythmia and is associated with several other cardiovascular (CV) events. Little is known about whether newly diagnosed AF is an independent factor for future MACE, especially in patients without such a history. Methods and Results We evaluated data from the National Health Insurance Research Database, which represented a retrospective cohort of 713,288 adults in Taiwan from 2006 to 2010. Individuals with previous MACE were excluded. Newly diagnosed AF patients were identified by assigning International Classification of Diseases codes. Propensity score matching adjusted for gender, age, hypertension, diabetes mellitus and dyslipidemia. Cox proportional hazard models estimated future MACE ratios. We compared a total of 3,737 patients with newly diagnosed AF and 704,225 patients without. After matching, there was no difference in baseline demographic characteristics in patients across newly diagnosed AF and non-AF groups. The result showed that newly diagnosed AF in multivariate analysis were associated with increased incidents of MACE (hazard ratio: 3.11-3.51 in different models) and mortality. Newly diagnosed AF without other CV risk factors had 8.45 times the risk of developing future MACE than healthy adults. The more associated CV risk factors in addition to AF, the increased rate of future CV events. Conclusions Newly diagnosed AF is an independent factor that leads to future CV events after gender, age, hypertension, diabetes mellitus and dyslipidemia matching. AF is associated with a higher mortality rate.	[Lin, Chia-Pin; Lin, Yu-Sheng; Wu, Lung-Sheng; Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Cardiol, Taipei, Taiwan; [Lin, Chia-Pin; Lin, Yu-Sheng; Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Healthcare Ctr, Taipei, Taiwan; [Li, Chen-Yu; Chang, Chee-Jen] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taipei, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Heart Failure Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chang, CJ (corresponding author), Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taipei, Taiwan.	cjchang@mail.cgu.edu.tw; pchu@adm.cgmh.org.tw	Chu, Pao-Hsien/P-5249-2019; Chu, Pao-Hsien/G-3685-2010	Chu, Pao-Hsien/0000-0003-0361-6348; Li, Chen-Yu/0000-0003-1097-838X	Ministry of Science and Technology [99-2314-B-182A-106-MY3, 102-2314-B-182A-060-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Dr. Chu P-H is supported by the Ministry of Science and Technology (99-2314-B-182A-106-MY3 and 102-2314-B-182A-060-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Frost L, 1999, EUR HEART J, V20, P1592, DOI 10.1053/euhj.1999.1713; Frost L, 2005, INT J CARDIOL, V103, P78, DOI 10.1016/j.ijcard.2004.08.024; Kempler P, 2005, DIABETES RES CLIN PR, V68, pS43, DOI 10.1016/j.diabres.2005.03.005; Kober L, 2006, EUR J HEART FAIL, V8, P591, DOI 10.1016/j.ejheart.2005.11.007; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Lin YS, 2011, AM J CARDIOL, V107, P325, DOI 10.1016/j.amjcard.2010.08.073; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; McManus DD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005694; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Nieuwlaat R, 2008, EUR HEART J, V29, P1181, DOI 10.1093/eurheartj/ehn139; Olsson LG, 2006, J AM COLL CARDIOL, V47, P1997, DOI 10.1016/j.jacc.2006.01.060; Patel PJ, 2004, AM J CARDIOL, V94, P1379, DOI 10.1016/j.amjcard.2004.08.011; Sedlak TL, 2013, AM HEART J, V166, P38, DOI 10.1016/j.ahj.2013.03.015; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stevenson WG, 1996, J AM COLL CARDIOL, V28, P1458, DOI 10.1016/S0735-1097(96)00358-0; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tang CH, 2009, STROKE, V40, P1162, DOI 10.1161/STROKEAHA.108.540880; Vidaillet H, 2002, AM J MED, V113, P365, DOI 10.1016/S0002-9343(02)01253-6; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wu LS, 2012, AM J MED SCI	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123211	10.1371/journal.pone.0123211	http://dx.doi.org/10.1371/journal.pone.0123211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875922	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800088
J	Lundy, ME; Parrella, MP				Lundy, Mark E.; Parrella, Michael P.			Crickets Are Not a Free Lunch: Protein Capture from Scalable Organic Side-Streams via High-Density Populations of Acheta domesticus	PLOS ONE			English	Article							GROWTH-RATES; FOOD WASTE; FEED; ORTHOPTERA; INSECTS; CONVERSION; NITROGEN; WEIGHT; VALUES; ENERGY	It has been suggested that the ecological impact of crickets as a source of dietary protein is less than conventional forms of livestock due to their comparatively efficient feed conversion and ability to consume organic side-streams. This study measured the biomass output and feed conversion ratios of house crickets (Acheta domesticus) reared on diets that varied in quality, ranging from grain-based to highly cellulosic diets. The measurements were made at a much greater population scale and density than any previously reported in the scientific literature. The biomass accumulation was strongly influenced by the quality of the diet (p<0.001), with the nitrogen (N) content, the ratio of N to acid detergent fiber (ADF) content, and the crude fat (CF) content (y=N/ADF+CF) explaining most of the variability between feed treatments (p=0.02; R-2=0.96). In addition, for populations of crickets that were able to survive to a harvestable size, the feed conversion ratios measured were higher (less efficient) than those reported from studies conducted at smaller scales and lower population densities. Compared to the industrial-scale production of chickens, crickets fed a poultry feed diet showed little improvement in protein conversion efficiency, a key metric in determining the ecological footprint of grain-based livestock protein. Crickets fed the solid filtrate from food waste processed at an industrial scale via enzymatic digestion were able to reach a harvestable size and achieve feed and protein efficiencies similar to that of chickens. However, crickets fed minimally-processed, municipal-scale food waste and diets composed largely of straw experienced >99% mortality without reaching a harvestable size. Therefore, the potential for A. domesticus to sustainably supplement the global protein supply, beyond what is currently produced via grain-fed chickens, will depend on capturing regionally scalable organic side-streams of relatively high-quality that are not currently being used for livestock production.	[Lundy, Mark E.] Univ Calif, Div Agr & Nat Resources, Colusa, CA 95932 USA; [Parrella, Michael P.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA	University of California System; University of California Davis	Lundy, ME (corresponding author), Univ Calif, Div Agr & Nat Resources, Colusa, CA 95932 USA.	melundy@ucanr.edu		Lundy, Mark/0000-0003-4043-0841	Jastro Fellowship through the Graduate Group in Horticulture and Agronomy; Department of Plant Sciences Graduate Student Research Fellowship at the University of California Davis, Davis, California, USA	Jastro Fellowship through the Graduate Group in Horticulture and Agronomy; Department of Plant Sciences Graduate Student Research Fellowship at the University of California Davis, Davis, California, USA	Vestergaard Inc. provided partial support for this research by purchasing the materials used in the experiment. The remainder of the experiment was funded via a Jastro Fellowship through the Graduate Group in Horticulture and Agronomy and a Department of Plant Sciences Graduate Student Research Fellowship at the University of California Davis, Davis, California, USA (www.ucdavis.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ECONOMIST; AOAC, 2006, OFFICIAL METHODS ANA; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; California Safe Soil, 2014, FERT FOOD H2HT; CLIFFORD CW, 1990, J APPL ENTOMOL, V109, P1, DOI 10.1111/j.1439-0418.1990.tb00012.x; Collavo Alberto, 2005, P519; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Dossey AT, 2013, SCIENTIST; Elferink EV, 2008, J CLEAN PROD, V16, P1227, DOI 10.1016/j.jclepro.2007.06.008; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Feddes JJR, 2002, POULTRY SCI, V81, P774, DOI 10.1093/ps/81.6.774; Fiala N, 2008, ECOL ECON, V67, P412, DOI 10.1016/j.ecolecon.2007.12.021; Finnveden G, 2005, J CLEAN PROD, V13, P213, DOI 10.1016/j.jclepro.2004.02.023; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; Lyn JC, 2011, AGE, V33, P509, DOI 10.1007/s11357-010-9195-z; NAKAGAKI BJ, 1991, J ECON ENTOMOL, V84, P891, DOI 10.1093/jee/84.3.891; Offenberg J, 2011, J APPL ENTOMOL, V135, P575, DOI 10.1111/j.1439-0418.2010.01588.x; Oji UI, 2007, SMALL RUMINANT RES, V69, P232, DOI 10.1016/j.smallrumres.2006.01.015; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; PATTON RL, 1978, ANN ENTOMOL SOC AM, V71, P40, DOI 10.1093/aesa/71.1.40; PATTON RL, 1967, ANN ENTOMOL SOC AM, V60, P1238, DOI 10.1093/aesa/60.6.1238; Peckham M, 2013, UN TIME         0515; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; R Core Team, 2013, R LANG ENV STAT COMP; Ramos-Elorduy J, 2002, J ECON ENTOMOL, V95, P214, DOI 10.1603/0022-0493-95.1.214; Ramos-Elorduy Julieta, 2005, P263; Roy K, 2007, WORLD DEV REPORT 200; Rumpold BA, 2013, INNOV FOOD SCI EMERG, V17, P1, DOI 10.1016/j.ifset.2012.11.005; Runyon L., 2014, WILL AM BUY BUG SNAC; Saha UK, 2010, THE UNIVERSITY OF GE, V1367; SLANSKY F, 1985, ENTOMOL EXP APPL, V39, P47, DOI 10.1007/BF00338524; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Tiquia SM, 2002, NUTR CYCL AGROECOSYS, V62, P15, DOI 10.1023/A:1015137922816; Van Huis A., 2013, EDIBLE INSECTS FUTUR; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Verheyen L, 1996, MANAGEMENT WASTE ANI; Vogel G, 2010, SCIENCE, V327, P811, DOI 10.1126/science.327.5967.811; White T, 2000, ECOL ECON, V34, P145, DOI 10.1016/S0921-8009(00)00175-0; Zhang RH, 2007, BIORESOURCE TECHNOL, V98, P929, DOI 10.1016/j.biortech.2006.02.039	45	96	97	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0118785	10.1371/journal.pone.0118785	http://dx.doi.org/10.1371/journal.pone.0118785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875026	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800003
J	Marqueze, EC; Vasconcelos, S; Garefelt, J; Skene, DJ; Moreno, CR; Lowden, A				Marqueze, Elaine Cristina; Vasconcelos, Suleima; Garefelt, Johanna; Skene, Debra J.; Moreno, Claudia Roberta; Lowden, Arne			Natural Light Exposure, Sleep and Depression among Day Workers and Shiftworkers at Arctic and Equatorial Latitudes	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; LOW-BACK-PAIN; BRIGHT LIGHT; CIRCADIAN-RHYTHMS; MOOD; PREVALENCE; IMPACT; ASSOCIATION; PHOTOPERIOD; ALERTNESS	Objectives This study aimed to investigate the relationship between individual natural light exposure, sleep need, and depression at two latitudes, one extreme with a few hours of light per day during winter, and the other with equal hours of light and darkness throughout the year. Methods This cross-sectional study included a sample of Brazilian workers (Equatorial, n = 488 workers) and a Swedish sample (Arctic, n = 1,273). Results The reported mean total natural light exposure per 4-week cycle differed significantly between the Equatorial and Arctic regions. However, shiftworkers from both sites reported similar hours of natural light exposure. Short light exposure was a predictor for insufficient sleep. Conclusion Reduced exposure to natural light appears to increase the perception of obtaining insufficient sleep. Arctic workers were more prone to develop depression than Equatorial workers.	[Marqueze, Elaine Cristina; Vasconcelos, Suleima; Moreno, Claudia Roberta] Univ Sao Paulo, Sch Publ Hlth, Dept Environm Hlth, BR-09500900 Sao Paulo, Brazil; [Marqueze, Elaine Cristina; Garefelt, Johanna; Moreno, Claudia Roberta; Lowden, Arne] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Marqueze, Elaine Cristina] Univ Catolica Santos, UNISANTOS, Publ Hlth Grad Program, Epidemiol, Sao Paulo, Brazil; [Skene, Debra J.] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England; [Vasconcelos, Suleima] Univ Fed Acre, UFAC, Dept Hlth Sci, Rio Branco, Acre, Brazil	Universidade de Sao Paulo; Stockholm University; Universidade Catolica de Santos; University of Surrey; Universidade Federal do Acre (UFAC)	Marqueze, EC (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Environm Hlth, BR-09500900 Sao Paulo, Brazil.	elaine.marqueze@unisantos.br	Moreno, Claudia/GRJ-1036-2022; Marqueze, Elaine Cristina/V-3077-2019; de Castro Moreno, Claudia Roberta/I-3298-2012; Lowden, Arne/AAH-5305-2019; Garefelt, Johanna/AAQ-7356-2020	Marqueze, Elaine Cristina/0000-0002-4987-7757; de Castro Moreno, Claudia Roberta/0000-0003-1839-9673; Garefelt, Johanna/0000-0003-3658-6448; PEDROZA VASCONCELOS, SULEIMA/0000-0002-0850-9659; Skene, Debra/0000-0001-8202-6180	FAPESP/Surrey; FAPESP [2011/19563-0, 2014/01514-0]; CNPq [471085/2010-3]; UGPN; Funtac/FDCT [752618171/11]; Swedish Research Council for Health, Working Life and Welfare [2011-0488]; CAPES/STINT Program [18886/12-4]; Royal Society;  [CAPES/STINT-004/12]	FAPESP/Surrey; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UGPN; Funtac/FDCT; Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); CAPES/STINT Program; Royal Society(Royal Society of London); 	We would like to acknowledge funding from the CAPES/STINT-004/12 (Mobility funding), FAPESP/Surrey (Mobility funding), FAPESP (Project 2011/19563-0), CNPq (Project 471085/2010-3), UGPN (Mobility funding), Funtac/FDCT (Project 752618171/11) and Swedish Research Council for Health, Working Life and Welfare (2011-0488). E.C.M. was awarded by CAPES/STINT Program-18886/12-4 and C.R.C.M. by FAPESP 2014/01514-0. D.J.S. is a Royal Society Wolfson Research Merit Award holder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1994, J SLEEP RES, V3, P152, DOI 10.1111/j.1365-2869.1994.tb00122.x; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Alsaadi SM, 2014, CLIN J PAIN, V30, P755, DOI 10.1097/AJP.0000000000000055; [Anonymous], 1997, WORK ABILITY INDEX; Arendt J, 2012, CHRONOBIOL INT, V29, P379, DOI 10.3109/07420528.2012.668997; Bech P, 2009, ACTA PSYCHIAT SCAND, V119, P298, DOI 10.1111/j.1600-0447.2008.01289.x; Benedetti F, 2013, BIOL PSYCHIAT, V74, P236, DOI 10.1016/j.biopsych.2013.05.037; Bjorvatn B, 1999, J SLEEP RES, V8, P105, DOI 10.1046/j.1365-2869.1999.00146.x; Borisenkov MF, 2012, CHRONOBIOL INT, V29, P305, DOI 10.3109/07420528.2011.653612; Brancaleoni G, 2009, EPIDEMIOL PSICHIAT S, V18, P336, DOI 10.1017/S1121189X00000312; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Burke TM, 2013, SLEEP, V36, P1617, DOI 10.5665/sleep.3110; Cardinali DP, 2000, NEUROENDOCRINOL LETT, V21, P9; Chapman DP, 2013, PSYCHIAT SERV, V64, P385, DOI 10.1176/appi.ps.201200226; Ciesielczyk Katarzyna, 2004, Psychiatr Pol, V38, P1105; Czeisler C, 2013, NATURE, V497, pS13, DOI 10.1038/497S13a; Dumont M, 2007, SLEEP MED, V8, P557, DOI 10.1016/j.sleep.2006.11.008; Faestel PM, 2013, J CLIN SLEEP MED, V9, P577, DOI 10.5664/jcsm.2754; Fetveit A, 2003, INT J GERIATR PSYCH, V18, P520, DOI 10.1002/gps.852; Friborg O, 2012, J SLEEP RES, V21, P176, DOI 10.1111/j.1365-2869.2011.00982.x; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Grandner MA, 2012, J CLIN SLEEP MED, V8, P77, DOI 10.5664/jcsm.1668; Grimaldi S, 2009, NORD J PSYCHIAT, V63, P397, DOI 10.1080/08039480902878729; Guillemette J, 1998, BIOL PSYCHIAT, V44, P622, DOI 10.1016/S0006-3223(97)00543-X; Hanson LLM, 2014, SCAND J WORK ENV HEA, V40, P66, DOI 10.5271/sjweh.3378; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hayashi M, 2003, CLIN NEUROPHYSIOL, V114, P2268, DOI 10.1016/S1388-2457(03)00255-4; Horowitz TS, 2002, IND HEALTH, V40, P223, DOI 10.2486/indhealth.40.223; Juzeniene A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/6/066701; Kakooei H, 2010, INT J OCCUP SAF ERGO, V16, P477, DOI 10.1080/10803548.2010.11076860; Kegel M, 2009, NORD J PSYCHIAT, V63, P331, DOI 10.1080/08039480902799040; Kelly GA, 2011, CLIN J PAIN, V27, P169, DOI 10.1097/AJP.0b013e3181f3bdd5; Kripke D, 2011, PSYCHOPHARMACOLOGY, V213, P833, DOI 10.1007/s00213-010-2045-y; Kuller R, 2006, ERGONOMICS, V49, P1496, DOI 10.1080/00140130600858142; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Leger D, 2011, J PSYCHOSOM RES, V70, P29, DOI 10.1016/j.jpsychores.2010.09.006; Levitt AJ, 2002, CAN J PSYCHIAT, V47, P361, DOI 10.1177/070674370204700407; Lindblom N, 2002, CHRONOBIOL INT, V19, P441, DOI 10.1081/CBI-120002880; Lowden A, 2004, J SLEEP RES, V13, P37, DOI 10.1046/j.1365-2869.2003.00381.x; Martinez MC, 2009, REV SAUDE PUBL, V43; Martinez-Nicolas A, 2011, CHRONOBIOL INT, V28, P617, DOI 10.3109/07420528.2011.593278; Matos FB, 2011, RENEW SUST ENERG REV, V15, P3196, DOI 10.1016/j.rser.2011.04.012; McLaughlin C, 2008, CHRONOBIOL INT, V25, P455, DOI 10.1080/07420520802118269; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mersch PPA, 1999, J AFFECT DISORDERS, V53, P35, DOI 10.1016/S0165-0327(98)00097-4; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; Palinkas L A, 2000, Int J Circumpolar Health, V59, P63; Pallesen S, 2010, SCAND J WORK ENV HEA, V36, P109, DOI 10.5271/sjweh.2886; Park DH, 2007, CHRONOBIOL INT, V24, P905, DOI 10.1080/07420520701669677; Sadeghniiat-Haghighi K, 2011, SCAND J WORK ENV HEA, V37, P77, DOI 10.5271/sjweh.3086; Sivertsen B, 2011, AM J EPIDEMIOL, V174, P147, DOI 10.1093/aje/kwr052; Terao T, 2011, PSYCHOPHARMACOLOGY, V213, P831, DOI 10.1007/s00213-010-2046-x; TUOMI K, 2005, INDICE CAPACIDADE TR; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Volinn E, 1997, SPINE, V22, P1747, DOI 10.1097/00007632-199708010-00013; Vorcaro CMR, 2001, ACTA PSYCHIAT SCAND, V104, P257, DOI 10.1034/j.1600-0447.2001.00440.x; Waage S, 2013, IND HEALTH, V51, P172; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wheaton A. G., 2011, Morbidity and Mortality Weekly Report, V60, P239; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	62	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122078	10.1371/journal.pone.0122078	http://dx.doi.org/10.1371/journal.pone.0122078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25874859	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800037
J	Pickering, BS; Tyler, S; Smith, G; Burton, L; Li, MY; Dallaire, A; Weingartl, H				Pickering, Brad S.; Tyler, Shaun; Smith, Greg; Burton, Lynn; Li, Mingyi; Dallaire, Andre; Weingartl, Hana			Identification of a Novel Afipia Species Isolated from an Indian Flying Fox	PLOS ONE			English	Article							AMOEBAL PATHOGENS; FELIS; BATS; BACTERIAL; GROWTH; AGENTS	An old world fruit bat Pteropus giganteus, held in captivity and suffering from necrosis of its wing digits, failed to respond to antibiotic therapy and succumbed to the infection. Samples submitted to the National Centre for Foreign Animal Disease were tested for viral infection. Vero E6 cells exhibited minor but unique cytopathic effects on second blind passage, and full CPE by passage four. Utilizing an unbiased random amplification technique from cell culture supernatant, we identified a bacterium belonging to the Bradyrhizobiaceae. Purification of cell culture supernatant on TY media revealed a slow growing bacterial isolate. In this study using electron microscopy, 16S rRNA gene analysis and whole genome sequencing, we identify a novel bacterial species associated with the site of infection belonging to the genus Afipia. This genus of bacteria is very diverse, with only a limited number of species characterized. Afipia felis, previously described as the etiological agent to cause cat scratch disease, and Afipia septicemium, most recently shown to cause disease in humans, highlight the potential for members of this genus to form a branch of opportunistic pathogens within the Bradyrhizobiaceae. Increased utilization of next generation sequencing and genomics will aid in classifying additional members of this intriguing bacterial genera.	[Pickering, Brad S.; Smith, Greg; Burton, Lynn; Li, Mingyi; Weingartl, Hana] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Pickering, Brad S.; Weingartl, Hana] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Tyler, Shaun] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Dallaire, Andre] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada	Canadian Food Inspection Agency; University of Manitoba; Public Health Agency of Canada; Universite de Montreal	Pickering, BS (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	Bradley.pickering@inspection.gc.ca			Canadian Food Inspection Agency	Canadian Food Inspection Agency	The authors received technical development funds of the Canadian Food Inspection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BIRKNESS KA, 1992, INFECT IMMUN, V60, P2281, DOI 10.1128/IAI.60.6.2281-2287.1992; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; BRENNER DJ, 1991, J CLIN MICROBIOL, V29, P2450, DOI 10.1128/JCM.29.11.2450-2460.1991; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cox TE, 2005, J WILDLIFE DIS, V41, P753, DOI 10.7589/0090-3558-41.4.753; Fullner KJ, 1996, SCIENCE, V273, P1107, DOI 10.1126/science.273.5278.1107; Jerris RC, 1996, ANNU REV MICROBIOL, V50, P707, DOI 10.1146/annurev.micro.50.1.707; Kuzmin IV, 2006, EMERG INFECT DIS, V12, P486, DOI 10.3201/eid1203.050333; La Scola B, 1999, LANCET, V353, P1330, DOI 10.1016/S0140-6736(99)00906-X; La Scola B, 2002, INFECT CONT HOSP EP, V23, P462, DOI 10.1086/502086; La Scola B, 2002, INT J SYST EVOL MICR, V52, P1773, DOI [10.1099/ijs.0.02149-0, 10.1099/00207713-52-5-1773]; Lamoth F, 2010, FEMS MICROBIOL REV, V34, P260, DOI 10.1111/j.1574-6976.2009.00207.x; Li MY, 2010, VET RES, V41, DOI 10.1051/vetres/2010005; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082673; Lo SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076142; Luhrmann A, 2001, P NATL ACAD SCI USA, V98, P7271, DOI 10.1073/pnas.121190398; Marrie TJ, 2001, EMERG INFECT DIS, V7, P1026, DOI 10.3201/eid0706.010619; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Nanda S, 2008, J VIROL METHODS, V152, P18, DOI 10.1016/j.jviromet.2008.06.007; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Schneider B, 2007, TRAFFIC, V8, P226, DOI 10.1111/j.1600-0854.2006.00525.x; Schueller C, 2007, MICROBES INFECT, V9, P355, DOI 10.1016/j.micinf.2006.12.007; Schueller C, 2010, FEMS MICROBIOL LETT, V302, P203, DOI 10.1111/j.1574-6968.2009.01858.x; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas V, 2007, SYST APPL MICROBIOL, V30, P572, DOI 10.1016/j.syapm.2007.06.004; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zhai JH, 2007, J CLIN MICROBIOL, V45, P224, DOI 10.1128/JCM.01893-06	32	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121274	10.1371/journal.pone.0121274	http://dx.doi.org/10.1371/journal.pone.0121274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874801	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800017
J	Reddy, PJ; Sinha, S; Ray, S; Sathe, GJ; Chatterjee, A; Prasad, TSK; Dhali, S; Srikanth, R; Panda, D; Srivastava, S				Reddy, Panga Jaipal; Sinha, Sneha; Ray, Sandipan; Sathe, Gajanan J.; Chatterjee, Aditi; Prasad, T. S. Keshava; Dhali, Snigdha; Srikanth, Rapole; Panda, Dulal; Srivastava, Sanjeeva			Comprehensive Analysis of Temporal Alterations in Cellular Proteome of Bacillus subtilis under Curcumin Treatment	PLOS ONE			English	Article							CLP-DEPENDENT PROTEOLYSIS; DIVISION; PROTEINS; GENE; BIOSYNTHESIS; LOCALIZATION; INSTABILITY; SPORULATION; MECHANISM; PATHWAYS	Curcumin is a natural dietary compound with antimicrobial activity against various gram positive and negative bacteria. This study aims to investigate the proteome level alterations in Bacillus subtilis due to curcumin treatment and identification of its molecular/cellular targets to understand the mechanism of action. We have performed a comprehensive proteomic analysis of B. subtilis AH75 strain at different time intervals of curcumin treatment (20, 60 and 120 min after the drug exposure, three replicates) to compare the protein expression profiles using two complementary quantitative proteomic techniques, 2D-DIGE and iTRAQ. To the best of our knowledge, this is the first comprehensive longitudinal investigation describing the effect of curcumin treatment on B. subtilis proteome. The proteomics analysis revealed several interesting targets such UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1, putative septation protein SpoVG and ATP-dependent Clp protease proteolytic subunit. Further, in silico pathway analysis using DAVID and KOBAS has revealed modulation of pathways related to the fatty acid metabolism and cell wall synthesis, which are crucial for cell viability. Our findings revealed that curcumin treatment lead to inhibition of the cell wall and fatty acid synthesis in addition to differential expression of many crucial proteins involved in modulation of bacterial metabolism. Findings obtained from proteomics analysis were further validated using 5-cyano-2,3-ditolyl tetrazolium chloride (CTC) assay for respiratory activity, resazurin assay for metabolic activity and membrane integrity assay by potassium and inorganic phosphate leakage measurement. The gene expression analysis of selected cell wall biosynthesis enzymes has strengthened the proteomics findings and indicated the major effect of curcumin on cell division.	[Reddy, Panga Jaipal; Sinha, Sneha; Ray, Sandipan; Panda, Dulal; Srivastava, Sanjeeva] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Dhali, Snigdha; Srikanth, Rapole] Natl Ctr Cell Sci, Prote Lab, Pune, Maharashtra, India; [Sathe, Gajanan J.; Chatterjee, Aditi; Prasad, T. S. Keshava] Inst Bioinformat, Bangalore, Karnataka, India; [Sathe, Gajanan J.; Chatterjee, Aditi] Manipal Univ, Manipal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Manipal Academy of Higher Education (MAHE)	Srivastava, S (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	sanjeeva@iitb.ac.in	RAY, SANDIPAN/AAQ-4064-2021; panga, jaipalreddy/A-6591-2019; Prasad, Keshava/F-7631-2010	RAY, SANDIPAN/0000-0002-9960-5768; panga, jaipalreddy/0000-0002-4481-3631; Prasad, Keshava/0000-0002-6206-2384; Sathe, Gajanan/0000-0002-6239-5365	IIT Bombay [09IRCC007]; Department of Science and Technology, Government of India	IIT Bombay; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by a start-up grant 09IRCC007 from the IIT Bombay to Sanjeeva Srivastava and grant from Department of Science and Technology, Government of India to Dulal Panda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Bandow JE, 2003, ANTIMICROB AGENTS CH, V47, P948, DOI 10.1128/AAC.47.3.948-955.2003; Banerjee M, 2010, FEBS J, V277, P3437, DOI 10.1111/j.1742-4658.2010.07750.x; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; Chimerel C, 2012, BBA-BIOMEMBRANES, V1818, P1590, DOI 10.1016/j.bbamem.2012.02.022; Christian Kira A, 2013, Emerg Health Threats J, V6, P20632, DOI 10.3402/ehtj.v6i0.20632; D'Aguanno S, 2012, MOL BIOSYST, V8, P1068, DOI 10.1039/c2mb05498a; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Ribeiro APD, 2013, LASER MED SCI, V28, P391, DOI 10.1007/s10103-012-1064-9; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Foss MH, 2013, MEDCHEMCOMM, V4, P112, DOI 10.1039/c2md20127e; Gerth U, 2004, J BACTERIOL, V186, P179, DOI 10.1128/JB.186.1.179-191.2004; Gerth U, 2008, J BACTERIOL, V190, P321, DOI 10.1128/JB.01233-07; Gupta KK, 2006, FEBS J, V273, P5320, DOI 10.1111/j.1742-4658.2006.05525.x; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Hegge AB, 2012, J PHARM SCI-US, V101, P1524, DOI 10.1002/jps.23046; Hoper D, 2006, PROTEOMICS, V6, P1550, DOI 10.1002/pmic.200500197; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kock H, 2004, MOL MICROBIOL, V51, P1087, DOI 10.1046/j.1365-2958.2003.03875.x; Kruger E, 2000, J BACTERIOL, V182, P3259, DOI 10.1128/JB.182.11.3259-3265.2000; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Liebeke M, 2008, MOL MICROBIOL, V69, P1513, DOI 10.1111/j.1365-2958.2008.06382.x; Madden K, 2009, PROSTAG LEUKOTR ESS, V80, P9, DOI 10.1016/j.plefa.2008.10.003; Mariscal A, 2009, APPL MICROBIOL BIOT, V82, P773, DOI 10.1007/s00253-009-1879-x; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; McAuliffe O, 1998, APPL ENVIRON MICROB, V64, P439; Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864; Newman EB, 1998, J BACTERIOL, V180, P3614, DOI 10.1128/JB.180.14.3614-3619.1998; Ogino H, 2004, GENES CELLS, V9, P765, DOI 10.1111/j.1365-2443.2004.00770.x; Paoletti L, 2007, J BACTERIOL, V189, P5816, DOI 10.1128/JB.00602-07; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Perry MC, 2010, MOL NUTR FOOD RES, V54, P1192, DOI 10.1002/mnfr.200900277; Ragunathan Irulappan, 2007, Journal of Zhejiang University-Science B, V8, P470, DOI 10.1631/jzus.2007.B0470; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Ray S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041751; Real G, 2006, J BACTERIOL, V188, P1721, DOI 10.1128/JB.188.5.1721-1732.2006; Reddy PJ, 2013, CURR PROTEOMICS, V10, P298, DOI 10.2174/15701646113106660004; RODRIGUEZ GG, 1992, APPL ENVIRON MICROB, V58, P1801, DOI 10.1128/AEM.58.6.1801-1808.1992; Sa G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-14; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Thompson LS, 2006, J BACTERIOL, V188, P7677, DOI 10.1128/JB.01072-06; van Baarle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009850; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang S, 2005, MOL MICROBIOL, V58, P791, DOI 10.1111/j.1365-2958.2005.04864.x; Wehrl W, 2000, J BACTERIOL, V182, P3870, DOI 10.1128/JB.182.13.3870-3873.2000; Wenzel M, 2012, ANTIMICROB AGENTS CH, V56, P5749, DOI 10.1128/AAC.01380-12; Wolff S, 2006, MOL CELL PROTEOMICS, V5, P1183, DOI 10.1074/mcp.M600069-MCP200; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483	59	7	7	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0120620	10.1371/journal.pone.0120620	http://dx.doi.org/10.1371/journal.pone.0120620			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25874956	Green Published, gold			2022-12-26	WOS:000353014700004
J	Gonzalez-Miguel, J; Morchon, R; Siles-Lucas, M; Simon, F				Gonzalez-Miguel, Javier; Morchon, Rodrigo; Siles-Lucas, Mar; Simon, Fernando			Fibrinolysis and Proliferative Endarteritis: Two Related Processes in Chronic Infections? The Model of the Blood-Borne Pathogen Dirofilaria immitis	PLOS ONE			English	Article							PLASMINOGEN-BINDING PROTEINS; CELL-SURFACE; EXCRETORY/SECRETORY ANTIGENS; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; DOGS; LESIONS; SYSTEM; IDENTIFICATION; ACTIVATION	The interaction between blood-borne pathogens and fibrinolysis is one of the most important mechanisms that mediate invasion and the establishment of infectious agents in their hosts. However, overproduction of plasmin (final product of the route) has been related in other contexts to proliferation and migration of the arterial wall cells and degradation of the extracellular matrix. We have recently identified fibrinolysis-activating antigens from Dirofilaria immitis, a blood-borne parasite whose key pathological event (proliferative endarteritis) is produced by similar mechanisms to those indicated above. The objective of this work is to study how two of this antigens [actin (ACT) and fructose-bisphosphate aldolase (FBAL)] highly conserved in pathogens, activate fibrinolysis and to establish a relationship between this activation and the development of proliferative endarteritis during cardiopulmonary dirofilariasis. We demonstrate that both proteins bind plasminogen, enhance plasmin generation, stimulate the expression of the fibrinolytic activators tPA and uPA in endothelial cell cultures and are located on the surface of the worm in contact with the host's blood. ELISA, western blot and immunofluorescence techniques were employed for this purpose. Additionally, the implication of lysine residues in this interaction was analyzed by bioinformatics. The involvement of plasmin generated by the ACT/FBAL and plasminogen binding in cell proliferation and migration, and degradation of the extracellular matrix were shown in an "in vitro" model of endothelial and smooth muscle cells in culture. The obtained results indicate that ACT and FBAL from D. immitis activate fibrinolysis, which could be used by the parasite like a survival mechanism to avoid the clot formation. However, long-term overproduction of plasmin can trigger pathological events similar to those described in the emergence of proliferative endarteritis. Due to the high degree of evolutionary conservation of these antigens, similar processes may occur in other blood-borne pathogens.	[Gonzalez-Miguel, Javier; Morchon, Rodrigo; Simon, Fernando] Inst Biomed Res Salamanca IBSAL, Parasitol Lab, Fac Pharm, Salamanca, Spain; [Siles-Lucas, Mar] CSIC, Parasitol Lab, IRNASA, Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA)	Gonzalez-Miguel, J (corresponding author), Inst Biomed Res Salamanca IBSAL, Parasitol Lab, Fac Pharm, Salamanca, Spain.	jglez@usal.es	Siles-Lucas, Mar/B-1113-2012; González-Miguel, Javier/A-4922-2019; Morchón, Rodrigo/A-4889-2019; González-Miguel, Javier/AAA-3563-2021; Simón, Fernando/A-4903-2019	Siles-Lucas, Mar/0000-0002-1257-2562; González-Miguel, Javier/0000-0003-4279-4761; Morchón, Rodrigo/0000-0003-2699-1482; González-Miguel, Javier/0000-0003-4279-4761; Simón, Fernando/0000-0002-8177-6083	Agencia de Desarrollo Economico de Castilla y Leon; FEDER; Junta de Castilla y Leon, Spain [SA090/A09]	Agencia de Desarrollo Economico de Castilla y Leon; FEDER(European Commission); Junta de Castilla y Leon, Spain(Junta de Castilla y Leon)	This research was supported by Agencia de Desarrollo Economico de Castilla y Leon (cofinanced with FEDER funds), Junta de Castilla y Leon (grant SA090/A09), Spain.	ADCOCK JL, 1961, AM J VET RES, V22, P655; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATWELL RB, 1986, BRIT J EXP PATHOL, V67, P395; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; Bou-Gharios G, 2004, CELL PROLIFERAT, V37, P207, DOI 10.1111/j.1365-2184.2004.00306.x; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; de la Torre-Escudero E, 2010, VET PARASITOL, V173, P76, DOI 10.1016/j.vetpar.2010.06.011; Dudani AK, 2005, BIOCHEM CELL BIOL, V83, P28, DOI 10.1139/O04-109; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Eisenhaber B, 2000, TRENDS BIOCHEM SCI, V25, P340, DOI 10.1016/S0968-0004(00)01601-7; Figuera L, 2013, ACTA TROP, V128, P116, DOI 10.1016/j.actatropica.2013.06.023; Fuhrman B, 2012, ATHEROSCLEROSIS, V222, P8, DOI 10.1016/j.atherosclerosis.2011.10.044; Geary J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-140; Gebbink MFBG, 2011, J THROMB HAEMOST, V9, P174, DOI 10.1111/j.1538-7836.2011.04278.x; Gomez-Arreaza A, 2014, MOL BIOCHEM PARASIT, V193, P75, DOI 10.1016/j.molbiopara.2014.02.005; Gonzalez-Miguel J, 2013, VET PARASITOL, V196, P235, DOI 10.1016/j.vetpar.2013.01.028; Gonzalez-Miguel J, 2012, MOL BIOCHEM PARASIT, V181, P134, DOI 10.1016/j.molbiopara.2011.10.010; Hawley SB, 2000, THROMB HAEMOSTASIS, V84, P882; Hayashi M, 2009, MOL CELL BIOCHEM, V322, P1, DOI 10.1007/s11010-008-9934-y; Hidaka Y, 2004, J VET MED SCI, V66, P1457, DOI 10.1292/jvms.66.1457; Kawabata A, 2008, J VET MED SCI, V70, P301, DOI 10.1292/jvms.70.301; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; LIND SE, 1991, J BIOL CHEM, V266, P17673; Marangoni NR, 2011, PARASITE IMMUNOL, V33, P330, DOI 10.1111/j.1365-3024.2011.01285.x; McCall JW, 2008, ADV PARASIT, V66, P193, DOI 10.1016/S0065-308X(08)00204-2; Mebius MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003781; Morchon R, 2008, PARASITOL INT, V57, P441, DOI 10.1016/j.parint.2008.05.004; Morchon R, 2010, VET PARASITOL, V170, P331, DOI 10.1016/j.vetpar.2010.02.034; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nicholl Suzanne M., 2006, Current Vascular Pharmacology, V4, P101, DOI 10.2174/157016106776359880; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Prato M, 2011, CELL MICROBIOL, V13, P1275, DOI 10.1111/j.1462-5822.2011.01620.x; Ramajo-Hernandez A, 2007, EXP PARASITOL, V115, P83, DOI 10.1016/j.exppara.2006.07.003; Simon F, 2012, CLIN MICROBIOL REV, V25, P507, DOI 10.1128/CMR.00012-12; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Urano T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/208108; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Venco L., 2007, Mappe Parassitologiche, V8, P117; Wang H, 2006, CANCER RES, V66, P7211, DOI 10.1158/0008-5472.CAN-05-4331; Wang JS, 2005, VET PARASITOL, V131, P261, DOI 10.1016/j.vetpar.2005.04.041; Yamaguchi M, 2011, INVEST OPHTH VIS SCI, V52, P679, DOI 10.1167/iovs.10-5555; Yang Z, 2005, J VASC SURG, V42, P532, DOI 10.1016/j.jvs.2005.05.035	47	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124445	10.1371/journal.pone.0124445	http://dx.doi.org/10.1371/journal.pone.0124445			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875022	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100259
J	Madeleneau, D; Aubelle, MS; Pierron, C; Lopez, E; Patkai, J; Roze, JC; Jarreau, PH; Gascoin, G				Madeleneau, Doriane; Aubelle, Marie-Stephanie; Pierron, Charlotte; Lopez, Emmanuel; Patkai, Juliana; Roze, Jean-Christophe; Jarreau, Pierre-Henri; Gascoin, Geraldine			Efficacy of a First Course of Ibuprofen for Patent Ductus Arteriosus Closure in Extremely Preterm Newborns According to Their Gestational Age-Specific Z-Score for Birth Weight	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; PREMATURE-INFANTS; DOUBLE-BLIND; INDOMETHACIN	Objective Therapeutic strategies for patent ductus arteriosus (PDA) in very preterm infants remain controversial. To identify infants likely to benefit from treatment, we analysed the efficacy of a first course of ibuprofen in small-for-gestational age (SGA) newborns. Study design This single-centre retrospective study included 185 infants born at 24+0-27+6 weeks of gestation with haemodynamically significant PDA, who were treated by intravenous ibuprofen (Pedea): 10 mg/kg on day one and 5 mg/kg on days two and three. Birth weight and gestational age (GA) were analysed with reference to the standard deviations from the Olsen growth curve to define GA-specific Z-scores for birth weights. The efficacy of treatment was evaluated by echocardiography 48 hours after the last dose of ibuprofen. The primary outcome was failure of the first course of ibuprofen associated in a composite criterion with the most severe outcomes. Results The risk of treatment failure increased according to a continuous gradient in SGA neonates. A higher risk was observed on multiple regression analysis (crude OR: 3.8; 95% CI [1.2-12.3] p = 0.02; adjusted OR: 12.8; 95% CI [2.3-70.5] p=0.003). Conclusion There is a linear relationship between infant birth weight and PDA treatment: the failure rate of a first course of ibuprofen increases with increasing degree of growth restriction.	[Madeleneau, Doriane; Aubelle, Marie-Stephanie; Pierron, Charlotte; Lopez, Emmanuel; Patkai, Juliana; Jarreau, Pierre-Henri] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Dept Neonatal Med Port Royal, Paris, France; [Roze, Jean-Christophe] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Gascoin, Geraldine] Angers Univ Hosp, Dept Neonatal Med, Angers, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Gascoin, G (corresponding author), Angers Univ Hosp, Dept Neonatal Med, Angers, France.	gegascoin@chu-angers.fr	Rozé, Jean-Christophe/AAS-1314-2021; Gascoin, Geraldine/ABE-4950-2020	Roze, Jean-Christophe/0000-0003-3367-512X				Aranda JV, 2009, AM J PERINAT, V26, P235, DOI 10.1055/s-0028-1103515; Clyman RI, 2000, NEW ENGL J MED, V343, P728, DOI 10.1056/NEJM200009073431009; Coceani F, 2012, SEMIN PERINATOL, V36, P92, DOI 10.1053/j.semperi.2011.09.018; Dani C, 2012, CLIN PHARMACOL THER, V91, P590, DOI 10.1038/clpt.2011.284; Desfrere L, 2005, J CLIN PHARM THER, V30, P121, DOI 10.1111/j.1365-2710.2005.00630.x; Guellec I, 2011, PEDIATRICS, V127, pE883, DOI 10.1542/peds.2010-2442; Hirt D, 2008, BRIT J CLIN PHARMACO, V65, P629, DOI 10.1111/j.1365-2125.2008.03118.x; Koch J, 2006, PEDIATRICS, V117, P1113, DOI 10.1542/peds.2005-1528; MAHONY L, 1985, J PEDIATR-US, V106, P801, DOI 10.1016/S0022-3476(85)80361-9; Malviya MN, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003951.pub3; Ohlsson A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003481.pub5; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Rakza T, 2007, J PEDIATR-US, V151, P624, DOI 10.1016/j.jpeds.2007.04.058; Regev RH, 2003, J PEDIATR-US, V143, P186, DOI 10.1067/S0022-3476(03)00181-1; Robel-Tillig E, 2003, EARLY HUM DEV, V72, P123, DOI 10.1016/S0378-3782(03)00045-8; Van Overmeire B, 2000, NEW ENGL J MED, V343, P674, DOI 10.1056/NEJM200009073431001; Van Overmeire B, 2004, LANCET, V364, P1945, DOI 10.1016/S0140-6736(04)17477-1; Van Overmeire B, 2001, CLIN PHARMACOL THER, V70, P336, DOI 10.1067/mcp.2001.118453; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002	19	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124804	10.1371/journal.pone.0124804	http://dx.doi.org/10.1371/journal.pone.0124804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875583	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100273
J	Mardones-Toledo, DA; Montory, JA; Joyce, A; Thompson, RJ; Diederich, CM; Pechenik, JA; Mardones, ML; Chaparro, OR				Mardones-Toledo, Daniela A.; Montory, Jaime A.; Joyce, Alyssa; Thompson, Raymond J.; Diederich, Casey M.; Pechenik, Jan A.; Mardones, Maria L.; Chaparro, Oscar R.			Brooding in the Chilean Oyster Ostrea chilensis: Unexpected Complexity in the Movements of Brooded Offspring within the Mantle Cavity	PLOS ONE			English	Article							GASTROPOD CREPIPATELLA-DILATATA; PARTICLE-TRANSPORT; NEW-ZEALAND; PLACOPECTEN-MAGELLANICUS; CAPSULE WALLS; GILL FUNCTION; BIVALVES; MOLLUSKS; PHILIPPI; MUSSEL	Brooding in invertebrates serves to protect embryos from stressful external conditions by retaining progeny inside the female body, effectively reducing the risk of pelagic stages being exposed to predation or other environmental stressors, but with accompanying changes in pallial fluid characteristics, including reduced oxygen availability. Brooded embryos are usually immobile and often encapsulated, but in some Ostrea species the embryos move freely inside the female pallial cavity in close association with the mother's gills for as long as eight weeks. We used endoscopic techniques to characterize the circulation pattern of embryos brooded by females of the oyster, Ostrea chilensis. Progeny at embryonic and veliger stages typically circulated in established patterns that included the use of dorsal and ventral food grooves (DFG, VFG) to move anteriorly on the gills. Both embryos and veligers accumulated around the mother's palps, and remained there until an active maternal countercurrent moved them to the gill inhalant area. Both food grooves were able to move embryos, veligers, and food-particle aggregates anteriorly, but the DFG was more important in progeny transport; early embryos were moved more rapidly than veligers in the DFG. A microcirculation pattern of embryos was apparent when they were moved by gill lamellae: when they were close to the VFG, most embryos lost gill contact and "fell" down to the DFG. Those that actually reached the DFG moved anteriorly, but others came into contact with the base of the lamellae and again moved towards the VFG. The circulation pattern of the progeny appears well-suited for both cleaning them and directing them posteriorly to an area where there is more oxygen and food than in the palp region. This process for actively circulating progeny involves the feeding structures (gill and palps) and appears to be energetically costly for the female. It also interferes with feeding, which could explain the poor energy balance previously documented for brooding females of this species.	[Mardones-Toledo, Daniela A.; Montory, Jaime A.; Mardones, Maria L.; Chaparro, Oscar R.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Joyce, Alyssa] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Thompson, Raymond J.] Mem Univ Newfoundland, NFLD, Ctr Ocean Sci, St John, NF, Canada; [Diederich, Casey M.; Pechenik, Jan A.] Tufts Univ, Dept Biol, Medford, MA 02155 USA	Universidad Austral de Chile; University of Gothenburg; Memorial University Newfoundland; Tufts University	Chaparro, OR (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	ochaparr@uach.cl	Montory, Jaime/E-6077-2010; Chaparro, Oscar R/A-5070-2009; Montory, Jaime/AAL-5187-2020	Montory, Jaime/0000-0003-3383-7467; Montory, Jaime/0000-0003-3383-7467	Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile [1141052]	Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile grant 1141052 to ORC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SM, 2000, BIOL BULL, V199, P116, DOI 10.2307/1542871; Ben-Ami F, 2005, J MORPHOL, V263, P322, DOI 10.1002/jmor.10307; BENINGER PG, 1993, MAR ECOL PROG SER, V98, P275, DOI 10.3354/meps098275; Beninger PG, 1997, MAR ECOL PROG SER, V150, P157, DOI 10.3354/meps150157; BENINGER PG, 1992, MAR BIOL, V114, P281, DOI 10.1007/BF00349531; BUROKER NE, 1985, J EXP MAR BIOL ECOL, V90, P233, DOI 10.1016/0022-0981(85)90169-8; BYRNE RA, 1994, AM ZOOL, V34, P194; CASTRO NF, 1988, J MAR BIOL ASSOC UK, V68, P399, DOI 10.1017/S0025315400043290; CHANLEY P, 1980, NEW ZEAL J MAR FRESH, V14, P103, DOI 10.1080/00288330.1980.9515851; Chaparro OR, 2008, J EXP MAR BIOL ECOL, V365, P38, DOI 10.1016/j.jembe.2008.07.038; Chaparro OR, 2008, J EXP MAR BIOL ECOL, V359, P18, DOI 10.1016/j.jembe.2008.02.008; CHAPARRO OR, 1993, BIOL BULL-US, V185, P365, DOI 10.2307/1542477; Chaparro OR, 1999, BIOL BULL, V197, P104, DOI 10.2307/1543001; Chaparro OR, 1998, MAR ECOL PROG SER, V171, P151, DOI 10.3354/meps171151; Chaparro OR, 2001, MAR BIOL, V138, P199, DOI 10.1007/s002270000447; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; CRANFIELD HJ, 1989, NEW ZEAL J MAR FRESH, V23, P51, DOI 10.1080/00288330.1989.9516340; DIX T G, 1976, Journal of the Malacological Society of Australia, V3, P209; Garrido MV, 2012, MAR BIOL, V159, P987, DOI 10.1007/s00227-012-1879-8; Gillespie JM, 2007, J EXP MAR BIOL ECOL, V342, P191, DOI 10.1016/j.jembe.2006.10.055; Hopkins AE, 1936, ECOLOGY, V17, P551, DOI 10.2307/1932760; Ituarte C, 2009, INVERTEBR BIOL, V128, P243, DOI 10.1111/j.1744-7410.2009.00171.x; Joyce A, J SHELLF RE IN PRESS; KIORBOE T, 1981, MAR ECOL PROG SER, V5, P291, DOI 10.3354/meps005291; MILLAR RH, 1963, NATURE, V197, P512, DOI 10.1038/197512b0; MORRICONI E, 1980, REV INVEST DESARROLL, V2, P57; Navarro JM, 2011, J MAR BIOL ASSOC UK, V91, P1607, DOI 10.1017/S0025315410000925; NELSON TC, 1946, ANAT REC, V94, P355; Ojeda JA, 2004, MAR BIOL, V144, P263, DOI 10.1007/s00227-003-1194-5; PECHENIK JA, 1986, AM MALACOL BULL, V4, P165; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Richoux NB, 2001, J EXP MAR BIOL ECOL, V260, P199, DOI 10.1016/S0022-0981(01)00254-4; Segura CJ, 2010, J EXP MAR BIOL ECOL, V390, P49, DOI 10.1016/j.jembe.2010.04.007; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; TANKERSLEY RA, 1992, BIOL BULL, V182, P145, DOI 10.2307/1542189; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Toro JE, 1990, CULTIVO MOLUSCOS AM; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; VANCE RR, 1973, AM NAT, V107, P339, DOI 10.1086/282838; Walne R., 1964, J MAR BIOL ASSOC UK, V44, P293; Ward JE, 1996, INVERTEBR BIOL, V115, P218, DOI 10.2307/3226932; Ward JE, 2003, J EXP MAR BIOL ECOL, V293, P129, DOI 10.1016/S0022-0981(03)00218-1; WARD JE, 1991, MAR BIOL, V111, P287, DOI 10.1007/BF01319711; Ward JE, 1998, MAR BIOL, V131, P283, DOI 10.1007/s002270050321	44	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122859	10.1371/journal.pone.0122859	http://dx.doi.org/10.1371/journal.pone.0122859			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874932	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100111
J	Sangket, U; Vijasika, S; Noh, H; Chantratita, W; Klungthong, C; Yoon, IK; Fernandez, S; Rutvisuttinunt, W				Sangket, Unitsa; Vijasika, Sukanya; Noh, Hasnee; Chantratita, Wasun; Klungthong, Chonticha; Yoon, In Kyu; Fernandez, Stefan; Rutvisuttinunt, Wiriya			SNPer: An R Library for Quantitative Variant Analysis on Single Nucleotide Polymorphisms among Influenza Virus Populations	PLOS ONE			English	Article							DNA-SEQUENCING DATA; FRAMEWORK	Influenza virus (IFV) can evolve rapidly leading to genetic drifts and shifts resulting in human and animal influenza epidemics and pandemics. The genetic shift that gave rise to the 2009 influenza A/H1N1 pandemic originated from a triple gene reassortment of avian, swine and human IFVs. More minor genetic alterations in genetic drift can lead to influenza drug resistance such as the H274Y mutation associated with oseltamivir resistance. Hence, a rapid tool to detect IFV mutations and the potential emergence of new virulent strains can better prepare us for seasonal influenza outbreaks as well as potential pandemics. Furthermore, identification of specific mutations by closely examining single nucleotide polymorphisms (SNPs) in IFV sequences is essential to classify potential genetic markers associated with potentially dangerous IFV phenotypes. In this study, we developed a novel R library called "SNPer" to analyze quantitative variants in SNPs among IFV subpopulations. The computational SNPer program was applied to three different subpopulations of published IFV genomic information. SNPer queried SNPs data and grouped the SNPs into (1) universal SNPs, (2) likely common SNPs, and (3) unique SNPs. SNPer outperformed manual visualization in terms of time and labor. SNPer took only three seconds with no errors in SNP comparison events compared with 40 hours with errors using manual visualization. The SNPer tool can accelerate the capacity to capture new and potentially dangerous IFV strains to mitigate future influenza outbreaks.	[Sangket, Unitsa; Vijasika, Sukanya; Noh, Hasnee] Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Thailand; [Chantratita, Wasun] Mahidol Univ, Ramathibodhi Hosp, Fac Med, Dept Pathol, Bangkok 10700, Thailand; [Klungthong, Chonticha; Yoon, In Kyu; Fernandez, Stefan; Rutvisuttinunt, Wiriya] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand	Prince of Songkla University; Mahidol University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Sangket, U (corresponding author), Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Thailand.	unitsa.s@psu.ac.th			Thailand Center of Excellence for Life Sciences (TCELS)	Thailand Center of Excellence for Life Sciences (TCELS)	This work was funded by Thailand Center of Excellence for Life Sciences (TCELS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ebbert MTW, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S12; GENTLEMAN R, 1996, J COMPUTATIONAL GRAP, V5, P299; Grada A, 2013, J INVEST DERMATOL, V133, pE1, DOI 10.1038/jid.2013.248; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rutvisuttinunt W, 2014, J CLIN VIRO IN PRESS; Rutvisuttinunt W, 2013, J VIROL METHODS, V193, P394, DOI 10.1016/j.jviromet.2013.07.001; Sangket U, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-217; Schaefer C, 2012, BIOINFORMATICS, V28, P601, DOI 10.1093/bioinformatics/btr705; Schwarz DF, 2008, BIOINFORMATICS, V24, P146, DOI 10.1093/bioinformatics/btm551; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030	17	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122812	10.1371/journal.pone.0122812	http://dx.doi.org/10.1371/journal.pone.0122812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876137	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100105
J	Tirani, M; Meregaglia, M; Melegaro, A				Tirani, Marcello; Meregaglia, Michela; Melegaro, Alessia			Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme	PLOS ONE			English	Article							MENINGOCOCCAL SEROGROUP-B; MULTICOMPONENT VACCINE; NEW-ZEALAND; BACTERICIDAL ANTIBODY; COST-EFFECTIVENESS; CONJUGATE VACCINE; 4CMENB VACCINE; DISEASE; IMMUNOGENICITY; MENINGITIS	Introduction In January 2013 a novel type of multicomponent protein-based vaccine against group B meningococcal disease was licensed by the European Medicines Agency. With the widespread use of the meningococcal serogroup C conjugate vaccines, serogroup B remains now the major cause of bacterial meningitis and septicaemia in young children in Europe. The aim of this study is to investigate the health and the economic outcomes of MenB vaccine introduction into the Italian routine mass vaccination programme. Methods The present work is structured in two main parts. Firstly, we assess the epidemiological burden of group B meningococcal disease using official hospitalisation and notification data from two of the most populated Italian regions (Lombardia and Piemonte) during a 6-year study period (2007-2012). Secondly, we evaluate the cost-effectiveness of the immunisation programme in Italy from the public health payer perspective under base case parameters assumptions and performing a comprehensive sensitivity analysis to assess the robustness and the uncertainty of our model results. Results MenB serotype is responsible for 59% of the 341 cases of Invasive Meningococcal Disease in Lombardia and Piemonte. Incidence rate for MenB infection is estimated to be 0.21/100,000/y resulting at the highest level in children <= 4 years of age. Although the new MenB vaccine can potentially prevent about one third of the disease cases in the Italian population, model results show this strategy is unlikely to be cost-effective (ICER value over (sic)350,000/QALY) with a vaccine that prevents disease only. These results are robust under most of the sensitivity scenarios except when allowing for lower discount rates. Discussion The introduction of the novel vaccine into the routine immunisation schedule needs to be carefully evaluated. The new MenB vaccine has the potential to reduce the disease burden at the population level. However, from the Italian Health Service perspective, the immunisation programme is unlikely to be cost-effective at the current incidence levels and vaccine price.	[Tirani, Marcello] Univ Milan, Dept Biomed Sci Hlth, Postgrad Sch Publ Hlth, Milan, Italy; [Meregaglia, Michela] Bocconi Univ, Ctr Res Hlth & Social Care Management, CeRGAS, Milan, Italy; [Melegaro, Alessia] Bocconi Univ, Dept Policy Anal & Publ Management, Milan, Italy; [Melegaro, Alessia] Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy	University of Milan; Bocconi University; Bocconi University; Bocconi University	Tirani, M (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Postgrad Sch Publ Hlth, Milan, Italy.	marcello.tirani@unimi.it	Tirani, Marcello/H-9433-2017; Tirani, Marcello/GZK-5114-2022; Meregaglia, Michela/K-1178-2018	Tirani, Marcello/0000-0002-7512-9162; Tirani, Marcello/0000-0002-7512-9162; Melegaro, Alessia/0000-0003-2221-8898; Meregaglia, Michela/0000-0003-0092-5970				Ahmed F, 2011, VACCINE, V29, P9171, DOI 10.1016/j.vaccine.2011.08.005; Andrews SM, 2014, LANCET INFECT DIS, V14, P426, DOI 10.1016/S1473-3099(13)70341-4; Andrus JK, 2007, PUBLIC HEALTH REP, V122, P811; [Anonymous], 2010, RIC OSP SIST TAR REG; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Bettinger JA, 2013, VACCINE, V32, P124, DOI 10.1016/j.vaccine.2013.03.063; Bos JM, 2001, VACCINE, V20, P202, DOI 10.1016/S0264-410X(01)00254-7; Brown MM, 2001, BRIT J OPHTHALMOL, V85, P327, DOI 10.1136/bjo.85.3.327; Burchett HED, 2012, HEALTH POLICY PLANN, V27, pII62, DOI 10.1093/heapol/czr049; Caban-Martinez AJ, 2011, AM J PUBLIC HEALTH, V101, P1729, DOI 10.2105/AJPH.2011.300173; Capri S, 2001, DRUG INF J, V35, P189, DOI 10.1177/009286150103500122; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Christensen H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5725; Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Committee on Immunisation Programmes and Registries, 2013, CRIT ASS CHANG IMM P; Dellicour S, 2007, TROP MED INT HEALTH, V12, P1409, DOI 10.1111/j.1365-3156.2007.01929.x; di Pietro ML, 2013, ITALIAN J PUBLIC HLT, V2; Donev D, 2010, MEASURING BURDEN DIS; ECDC, 2011, SURV INV BACT DIS EU; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Santolaya ME, 2013, HUM VACC IMMUNOTHER, V9, P2304, DOI 10.4161/hv.25505; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; Erickson LJ, 2001, CLIN INFECT DIS, V33, P737, DOI 10.1086/322587; EU-IBIS Network, 2006, INV NEISS MEN EUR 20; European Centre for Disease Prevention and Control, 2009, SURV INV BACT DIS EU; European Centre for Disease Prevention and Control, 2013, EUR INV BACT DIS SUR; European Medicines Agency, 2013, BEXS SUMM PROD CHAR; Fattore G., 2009, PHARMACOECONOMICS, V11, P83, DOI [10.1007/BF03320660, DOI 10.1007/BF03320660]; Feavers I, 2012, BIOLOGICALS, V40, P507, DOI 10.1016/j.biologicals.2012.09.008; FINNE J, 1987, J IMMUNOL, V138, P4402; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Ginsberg L, 2004, J NEUROL NEUROSUR PS, V75, pI16, DOI 10.1136/jnnp.2003.034272; Giorgi-Rossi P, 2009, HEALTH POLICY, V89, P225, DOI 10.1016/j.healthpol.2008.05.016; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2010, VACCINE, V28, P5023, DOI 10.1016/j.vaccine.2010.05.014; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85; Gottfredsson M, 2011, CLIN INFECT DIS, V53, pE117, DOI 10.1093/cid/cir500; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Health Council (GezondheidsRaad; GR), 2007, FUT NAT IMM PROGR PR; HILLMAN AL, 1995, PHARMACOECONOMICS, V7, P198, DOI 10.2165/00019053-199507030-00003; Hong AT, 2013, 35 ANN M SOC MED DEC; Husereau D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-80; Hutubessy R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-55; Istituto Nazionale di Statistica, 2013, DEM CIFR; Istituto Superiore di Sanita-Gruppo di Lavoro del CNESPS, 2014, DAT EV DISP INTR VAC; Joint Committee on Vaccination and Immunisation, 2014, JCVI INT POS STAT US; Joint Committee on Vaccination and Immunisation, 2013, JCVI INT POS STAT US; Kelly C, 2007, AM J EPIDEMIOL, V166, P817, DOI 10.1093/aje/kwm147; Kinlin LM, 2009, VACCINE, V27, P1735, DOI 10.1016/j.vaccine.2009.01.026; Krabbe PFM, 2000, INT J TECHNOL ASSESS, V16, P864, DOI 10.1017/S0266462300102132; Ladhani SN, 2012, VACCINE, V30, P3710, DOI 10.1016/j.vaccine.2012.03.011; Le Haut Conseil de la sante publique, 2013, VACC INF INV MEN B P; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Lucioni C, 2005, PHARMACOECONOMICS IT, V7, P177, DOI DOI 10.1007/BF03320548; McNicholas A, 2007, HUM VACCINES, V3, P196, DOI 10.4161/hv.3.5.4458; Meyerhoff AS, 2005, PREV MED, V41, P540, DOI 10.1016/j.ypmed.2004.12.001; Ministero della Salute, 2014, SCHED DIM OSP SDO; Ministero della Salute, 2013, SIST DRG; National Institute for Health and Clinical Excellence, 2013, GUID METH TECHN APPR; NEDELEC J, 1990, J NEUROIMMUNOL, V29, P49, DOI 10.1016/0165-5728(90)90146-E; Oostenbrink R, 2002, J CLIN EPIDEMIOL, V55, P791, DOI 10.1016/S0895-4356(02)00448-1; Ortega-Sanchez IR, 2008, CLIN INFECT DIS, V46, P1, DOI 10.1086/524041; Oster P, 2007, VACCINE, V25, P3075, DOI 10.1016/j.vaccine.2007.01.023; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Piso B, 2009, VACCINE, V27, P5923, DOI 10.1016/j.vaccine.2009.07.105; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Pollard AJ, 2007, ARCH DIS CHILD, V92, P283, DOI 10.1136/adc.2006.102384; Pouwels KB, 2013, HUM VACC IMMUNOTHER, V9, P1129, DOI 10.4161/hv.23888; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Read RC, 2013, 31 ANN M EUR SOC PAE; Rossi PG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-13; Saarni SI, 2007, BRIT J PSYCHIAT, V190, P326, DOI 10.1192/bjp.bp.106.025106; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Severens JL, 2004, VALUE HEALTH, V7, P397, DOI 10.1111/j.1524-4733.2004.74002.x; Snape MD, 2013, PEDIATR INFECT DIS J, V32, P1116, DOI 10.1097/INF.0b013e31829cfff2; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357; Tasset A, 1999, VACCINE, V17, pS75, DOI 10.1016/S0264-410X(99)00298-4; Thein HH, 2010, QUAL LIFE RES, V19, P81, DOI 10.1007/s11136-009-9563-2; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Trotter CL, 2006, MED DECIS MAKING, V26, P38, DOI 10.1177/0272989X05284109; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; U.S. Food and Drug Administration, 2015, VACC BLOOD BIOL TRUM; Vesikari T, 2013, LANCET, V381, P825, DOI 10.1016/S0140-6736(12)61961-8; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1; Visintin Cristina, 2010, BMJ, V340, pc3209, DOI 10.1136/bmj.c3209; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; WHO, 2005, VACC INTR GUID ADD V; Wyld M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001307; Xu RF, 2011, QUAL LIFE RES, V20, P601, DOI 10.1007/s11136-010-9783-5; Yfantopoulos J., 2001, ARCH HELL MED, V18, P114	93	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123383	10.1371/journal.pone.0123383	http://dx.doi.org/10.1371/journal.pone.0123383			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874805	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100169
J	Wan, DL; Wan, YQ; Hou, XY; Ren, WB; Ding, Y; Sa, RL				Wan, Dongli; Wan, Yongqing; Hou, Xiangyang; Ren, Weibo; Ding, Yong; Sa, Rula			De novo Assembly and Transcriptomic Profiling of the Grazing Response in Stipa grandis	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; ABSCISIC-ACID BIOSYNTHESIS; INNER-MONGOLIA; GENE-EXPRESSION; DISEASE RESISTANCE; JASMONIC ACID; PSEUDOMONAS-SYRINGAE; DROUGHT TOLERANCE; RNA-SEQ; 9-CIS-EPOXYCAROTENOID DIOXYGENASE	Background Stipa grandis (Poaceae) is one of the dominant species in a typical steppe of the Inner Mongolian Plateau. However, primarily due to heavy grazing, the grasslands have become seriously degraded, and S. grandis has developed a special growth-inhibition phenotype against the stressful habitat. Because of the lack of transcriptomic and genomic information, the understanding of the molecular mechanisms underlying the grazing response of S. grandis has been prohibited. Results Using the Illumina HiSeq 2000 platform, two libraries prepared from non-grazing (FS) and overgrazing samples (OS) were sequenced. De novo assembly produced 94,674 unigenes, of which 65,047 unigenes had BLAST hits in the National Center for Biotechnology Information (NCBI) non-redundant (nr) database (E-value < 10(-5)). In total, 47,747, 26,156 and 40,842 unigenes were assigned to the Gene Ontology (GO), Clusters of Orthologous Group (COG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, respectively. A total of 13,221 unigenes showed significant differences in expression under the overgrazing condition, with a threshold false discovery rate <= 0.001 and an absolute value of log(2)Ratio >= 1. These differentially expressed genes (DEGs) were assigned to 43,257 GO terms and were significantly enriched in 32 KEGG pathways (q-value <= 0.05). The alterations in the wound-, drought-and defense-related genes indicate that stressors have an additive effect on the growth inhibition of this species. Conclusions This first large-scale transcriptome study will provide important information for further gene expression and functional genomics studies, and it facilitated our investigation of the molecular mechanisms of the S. grandis grazing response and the associated morphological and physiological characteristics.	[Wan, Dongli; Hou, Xiangyang; Ren, Weibo; Ding, Yong; Sa, Rula] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China; [Wan, Yongqing] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Inner Mongolia Agricultural University	Hou, XY (corresponding author), Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China.	Houxy16@126.com			National Basic Research Program of China ("973") [2014CB138804]; Natural Science Foundation of Inner Mongolia Autonomous Region of China [2014BS0330]; Fundamental Research Funds for Central nonprofit research institutes [1610332014027]	National Basic Research Program of China ("973")(National Basic Research Program of China); Natural Science Foundation of Inner Mongolia Autonomous Region of China; Fundamental Research Funds for Central nonprofit research institutes	This work was supported by the National Basic Research Program of China ("973", 2014CB138804), the Natural Science Foundation of Inner Mongolia Autonomous Region of China (2014BS0330) and the Fundamental Research Funds for Central nonprofit research institutes (1610332014027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Chen SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089495; Chen SY, 2009, CURR ISSUES MOL BIOL, V11, P81; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chouinard A, 2005, ECOSCIENCE, V12, P506, DOI 10.2980/i1195-6860-12-4-506.1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Evju M, 2009, OECOLOGIA, V161, P77, DOI 10.1007/s00442-009-1358-1; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Holmstrom KO, 1996, NATURE, V379, P683, DOI 10.1038/379683a0; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jia MA, 2012, MOL PLANT PATHOL, V13, P251, DOI 10.1111/j.1364-3703.2011.00743.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; Kawamura K, 2005, AGR ECOSYST ENVIRON, V107, P83, DOI 10.1016/j.agee.2004.09.008; Kim KC, 2006, PLANT PHYSIOL, V142, P1180, DOI 10.1104/pp.106.082487; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Li XX, 2014, ACTA PHYSIOL PLANT, V36, P1251, DOI 10.1007/s11738-014-1505-0; Liang C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-146; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishiuchi T, 1997, PLANT CELL, V9, P1701, DOI 10.1105/tpc.9.10.1701; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Schiborra A, 2009, AGR ECOSYST ENVIRON, V132, P82, DOI 10.1016/j.agee.2009.03.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Su M, 2013, PLANT MOL BIOL REP, V31, P1184, DOI 10.1007/s11105-013-0582-3; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Wan DL, 2012, PLANT CELL REP, V31, P1269, DOI 10.1007/s00299-012-1247-7; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wang XT, 2014, CHINESE SCI BULL, V59, P1405, DOI 10.1007/s11434-014-0142-8; Wu JB, 2010, BIOCHEM SYST ECOL, V38, P471, DOI 10.1016/j.bse.2010.04.008; Wu JB, 2010, RANGELAND J, V32, P427, DOI 10.1071/RJ09038; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; XIAO XM, 1995, J ARID ENVIRON, V31, P283, DOI 10.1016/S0140-1963(05)80033-3; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin XR, 2000, CHINESE J PLANT ECOL, V34, P39; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; Zhang TH, 2004, NEW ZEAL J AGR RES, V47, P307, DOI 10.1080/00288233.2004.9513599; Zhang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003699; Zhao NX, 2008, BIOCHEM SYST ECOL, V36, P1, DOI 10.1016/j.bse.2007.08.004; Zhao W, 2009, ECOL RES, V24, P99, DOI 10.1007/s11284-008-0486-0	78	12	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122641	10.1371/journal.pone.0122641	http://dx.doi.org/10.1371/journal.pone.0122641			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875617	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100090
J	Barbosa, C; Garcia-Martinez, J; Perez-Ortin, JE; Mendes-Ferreiral, A				Barbosa, Catarina; Garcia-Martinez, Jose; Perez-Ortin, Jose E.; Mendes-Ferreiral, Ana			Comparative Transcriptomic Analysis Reveals Similarities and Dissimilarities in Saccharomyces cerevisiae Wine Strains Response to Nitrogen Availability	PLOS ONE			English	Article							GLOBAL GENE-EXPRESSION; ALCOHOLIC FERMENTATION; STRESS-RESPONSE; YEAST STRAINS; SLUGGISH FERMENTATIONS; CHEMOSTAT CULTURES; AROMA COMPOUNDS; MOLECULAR-BASIS; GROWTH; WINEMAKING	Nitrogen levels in grape-juices are of major importance in winemaking ensuring adequate yeast growth and fermentation performance. Here we used a comparative transcriptome analysis to uncover wine yeasts responses to nitrogen availability during fermentation. Gene expression was assessed in three genetically and phenotypically divergent commercial wine strains (CEG, VL1 and QA23), under low (67 mg/L) and high nitrogen (670 mg/L) regimes, at three time points during fermentation (12h, 24h and 96h). Two-way ANOVA analysis of each fermentation condition led to the identification of genes whose expression was dependent on strain, fermentation stage and on the interaction of both factors. The high fermenter yeast strain QA23 was more clearly distinct from the other two strains, by differential expression of genes involved in flocculation, mitochondrial functions, energy generation and protein folding and stabilization. For all strains, higher transcriptional variability due to fermentation stage was seen in the high nitrogen fermentations. A positive correlation between maximum fermentation rate and the expression of genes involved in stress response was observed. The finding of common genes correlated with both fermentation activity and nitrogen up-take underlies the role of nitrogen on yeast fermentative fitness. The comparative analysis of genes differentially expressed between both fermentation conditions at 12h, where the main difference was the level of nitrogen available, showed the highest variability amongst strains revealing strain-specific responses. Nevertheless, we were able to identify a small set of genes whose expression profiles can quantitatively assess the common response of the yeast strains to varying nitrogen conditions. The use of three contrasting yeast strains in gene expression analysis prompts the identification of more reliable, accurate and reproducible biomarkers that will facilitate the diagnosis of deficiency of this nutrient in the grape-musts and the development of strategies to optimize yeast performance in industrial fermentations.	[Barbosa, Catarina; Mendes-Ferreiral, Ana] Univ Tras Os Montes & Alto Douro, Ctr Agr Genom & Biotechnol CGBA, Vila Real, Portugal; [Garcia-Martinez, Jose] Univ Valencia, Dept Genet, Valencia, Spain; [Garcia-Martinez, Jose] ERI Biotecmed, Valencia, Spain; [Barbosa, Catarina; Perez-Ortin, Jose E.] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain; [Barbosa, Catarina; Perez-Ortin, Jose E.] ERI Biotecmed, Valencia, Spain	University of Tras-os-Montes & Alto Douro; University of Valencia; University of Valencia	Mendes-Ferreiral, A (corresponding author), Univ Tras Os Montes & Alto Douro, Ctr Agr Genom & Biotechnol CGBA, Vila Real, Portugal.	anamf@utad.pt	Pérez-Ortín, José E./K-8582-2014; Garcia-Martinez, Jose/X-4995-2019; Barbosa, Catarina/B-6066-2018; Ferreira, Ana Mendes/I-6211-2012; Garcia-Martinez, Jose/F-6790-2016	Pérez-Ortín, José E./0000-0002-1992-513X; Garcia-Martinez, Jose/0000-0001-5866-5994; Barbosa, Catarina/0000-0003-2383-2101; Ferreira, Ana Mendes/0000-0002-2624-0761; Garcia-Martinez, Jose/0000-0001-5866-5994	FEDER [COMPETE-FCOMP-01-0124-FEDER-014043 (PTDC/AGR-ALI/111224/2009)]; North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN) through the European Regional Development Fund (FEDER) [NORTE-07-0124-FEDER-000032]; National Funds (PIDDAC) through the Portuguese Foundation for Science and Technology (FCT/MEC); FCT [SFRH/BD/61881/2009]	FEDER(European Commission); North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN) through the European Regional Development Fund (FEDER); National Funds (PIDDAC) through the Portuguese Foundation for Science and Technology (FCT/MEC); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The research presented in this paper was financially supported by FEDER through COMPETE-FCOMP-01-0124-FEDER-014043 (PTDC/AGR-ALI/111224/2009) and Project ENOEXEL - FROM VINEYARD TO WINE: TARGETING GRAPE AND WINE EXCELLENCY - NORTE-07-0124-FEDER-000032, financed by the North Portugal Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (QREN), through the European Regional Development Fund (FEDER), as well as by National Funds (PIDDAC) through the Portuguese Foundation for Science and Technology (FCT/MEC). C.B. is a recipient of a Ph.D. granted by FCT (SFRH/BD/61881/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola TM, 2004, INT MICROBIOL, V7, P199; Albers E, 2007, APPL ENVIRON MICROB, V73, P4839, DOI 10.1128/AEM.00425-07; Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; Backhus LE, 2001, FEMS YEAST RES, V1, P111, DOI 10.1016/S1567-1356(01)00019-8; Barbosa C, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0039-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BEZENGER MC, 1988, BIOTECHNOL BIOENG, V31, P747, DOI 10.1002/bit.260310719; Bisson LF, 2000, AM J ENOL VITICULT, V51, P168; Bisson LF, 1999, AM J ENOL VITICULT, V50, P107; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brice C, 2014, APPL ENVIRON MICROB, V80, P1330, DOI 10.1128/AEM.03856-13; Brion C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-681; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carrasco P, 2003, SYST APPL MICROBIOL, V26, P471, DOI 10.1078/072320203322497518; Carreto L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-201; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; Davey HM, 2012, ENVIRON MICROBIOL, V14, P1249, DOI 10.1111/j.1462-2920.2012.02705.x; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Erasmus DJ, 2003, FEMS YEAST RES, V3, P375, DOI 10.1016/S1567-1356(02)00203-9; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Govender P, 2008, APPL ENVIRON MICROB, V74, P6041, DOI 10.1128/AEM.00394-08; Griffioen G, 1996, MICROBIOL-UK, V142, P2279, DOI 10.1099/13500872-142-8-2279; Gutierrez A, 2013, FOOD MICROBIOL, V34, P227, DOI 10.1016/j.fm.2012.12.004; Gutierrez A, 2012, FOOD MICROBIOL, V31, P25, DOI 10.1016/j.fm.2012.02.012; Henschke P. A., 1993, WINE MICROBIOLOGY BI, P77, DOI DOI 10.1089/END.2014.0018; HUEY B, 1989, J BACTERIOL, V171, P2528, DOI 10.1128/jb.171.5.2528-2532.1989; Jimenez-Marti E, 2007, ANTON LEEUW INT J G, V92, P61, DOI 10.1007/s10482-006-9135-1; JIRANEK V, 1995, AM J ENOL VITICULT, V46, P75; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Legras JL, 2003, FEMS MICROBIOL LETT, V221, P249, DOI 10.1016/S0378-1097(03)00205-2; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marks VD, 2003, FEMS YEAST RES, V3, P269, DOI 10.1016/S1567-1356(02)00201-5; Marks VD, 2008, FEMS YEAST RES, V8, P35, DOI 10.1111/j.1567-1364.2007.00338.x; Martinez C, 2014, ELECTRON J BIOTECHN, V17, P150, DOI 10.1016/j.ejbt.2014.04.006; Mendes-Ferreira A, 2007, APPL ENVIRON MICROB, V73, P5363, DOI 10.1128/AEM.01029-07; Mendes-Ferreira A, 2007, APPL ENVIRON MICROB, V73, P3049, DOI 10.1128/AEM.02754-06; Mendes-Ferreira A, 2004, J APPL MICROBIOL, V97, P540, DOI 10.1111/j.1365-2672.2004.02331.x; Mendes-Ferreira A, 2010, APPL ENVIRON MICROB, V76, P7918, DOI 10.1128/AEM.01535-10; Mendes-Ferreira A, 2009, J IND MICROBIOL BIOT, V36, P571, DOI 10.1007/s10295-009-0527-x; Orozco H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-1; Parrou JL, 1999, YEAST, V15, P191, DOI 10.1002/(SICI)1097-0061(199902)15:3<191::AID-YEA358>3.0.CO;2-O; Penacho V, 2012, INT J FOOD MICROBIOL, V153, P176, DOI 10.1016/j.ijfoodmicro.2011.11.005; Petti AA, 2011, P NATL ACAD SCI USA, V108, pE1089, DOI 10.1073/pnas.1101494108; Piggott N, 2011, G3-GENES GENOM GENET, V1, P353, DOI 10.1534/g3.111.000836; Pizarro FJ, 2008, APPL ENVIRON MICROB, V74, P6358, DOI 10.1128/AEM.00602-08; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rossignol T, 2003, YEAST, V20, P1369, DOI 10.1002/yea.1046; Rossouw D, 2012, GENETICS, V190, P251, DOI 10.1534/genetics.111.132720; Rossouw D, 2009, APPL ENVIRON MICROB, V75, P6600, DOI 10.1128/AEM.01251-09; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Soares EV, 2011, J APPL MICROBIOL, V110, P1, DOI 10.1111/j.1365-2672.2010.04897.x; Tai SL, 2007, MICROBIOL-SGM, V153, P877, DOI 10.1099/mic.0.2006/002873-0; Tesniere C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061645; Treu L, 2014, APPL MICROBIOL BIOT, V98, P4119, DOI 10.1007/s00253-014-5679-6; Varela C, 2005, YEAST, V22, P369, DOI 10.1002/yea.1217; Walker ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-552; Wu H, 2006, APPL ENVIRON MICROB, V72, P7353, DOI 10.1128/AEM.01097-06; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Zuzuarregui A, 2006, APPL ENVIRON MICROB, V72, P836, DOI 10.1128/AEM.72.1.836-847.2006	70	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122709	10.1371/journal.pone.0122709	http://dx.doi.org/10.1371/journal.pone.0122709			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884705	gold, Green Published, Green Submitted			2022-12-26	WOS:000353017000040
J	de la Mora-de la Mora, I; Torres-Larios, A; Enriquez-Flores, S; Mendez, ST; Castillo-Villanueva, A; Gomez-Manzo, S; Lopez-Velazquez, G; Marcial-Quino, J; Torres-Arroyo, A; Garcia-Torres, I; Reyes-Vivas, H; Oria-Hernandez, J				de la Mora-de la Mora, Ignacio; Torres-Larios, Alfredo; Enriquez-Flores, Sergio; Mendez, Sara-Teresa; Castillo-Villanueva, Adriana; Gomez-Manzo, Saul; Lopez-Velazquez, Gabriel; Marcial-Quino, Jaime; Torres-Arroyo, Angelica; Garcia-Torres, Itzhel; Reyes-Vivas, Horacio; Oria-Hernandez, Jesus			Structural Effects of Protein Aging: Terminal Marking by Deamidation in Human Triosephosphate Isomerase	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; GIARDIA-LAMBLIA; ENZYME; EVOLUTION; ELECTROPHORESIS; SUSCEPTIBILITY; ASPARAGINE; PREDICTION; CATALYSIS; PEPTIDES	Deamidation, the loss of the ammonium group of asparagine and glutamine to form aspartic and glutamic acid, is one of the most commonly occurring post-translational modifications in proteins. Since deamidation rates are encoded in the protein structure, it has been proposed that they can serve as molecular clocks for the timing of biological processes such as protein turnover, development and aging. Despite the importance of this process, there is a lack of detailed structural information explaining the effects of deamidation on the structure of proteins. Here, we studied the effects of deamidation on human triosephosphate isomerase (HsTIM), an enzyme for which deamidation of N15 and N71 has been long recognized as the signal for terminal marking of the protein. Deamidation was mimicked by site directed mutagenesis; thus, three mutants of HsTIM (N15D, N71D and N15D/N71D) were characterized. The results show that the N71D mutant resembles, structurally and functionally, the wild type enzyme. In contrast, the N15D mutant displays all the detrimental effects related to deamidation. The N15D/N71D mutant shows only minor additional effects when compared with the N15D mutation, supporting that deamidation of N71 induces negligible effects. The crystal structures show that, in contrast to the N71D mutant, where minimal alterations are observed, the N15D mutation forms new interactions that perturb the structure of loop 1 and loop 3, both critical components of the catalytic site and the interface of HsTIM. Based on a phylogenetic analysis of TIM sequences, we propose the conservation of this mechanism for mammalian TIMs.	[de la Mora-de la Mora, Ignacio; Enriquez-Flores, Sergio; Mendez, Sara-Teresa; Castillo-Villanueva, Adriana; Gomez-Manzo, Saul; Lopez-Velazquez, Gabriel; Marcial-Quino, Jaime; Torres-Arroyo, Angelica; Garcia-Torres, Itzhel; Reyes-Vivas, Horacio; Oria-Hernandez, Jesus] Inst Nacl Pediat, Lab Bioquim Genet, Secretaria Salud, Mexico City, DF, Mexico; [Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Oria-Hernandez, J (corresponding author), Inst Nacl Pediat, Lab Bioquim Genet, Secretaria Salud, Mexico City, DF, Mexico.	hreyesvivas@yahoo.com.mx; jesus.oria.inp@gmail.com	Lopez-Velazquez, Gabriel/F-2411-2013; Oria-Hernández, Jesús/AAG-1243-2019; De la Mora, José Ignacio De la Mora/AAB-5370-2020	Lopez-Velazquez, Gabriel/0000-0003-0470-1069; Oria-Hernández, Jesús/0000-0001-7147-1879; De la Mora, José Ignacio De la Mora/0000-0002-5654-8089; enriquez flores, sergio/0000-0003-2058-5707; Torres-Arroyo, Angelica/0000-0003-3236-5779; Torres-Larios, Alfredo/0000-0002-0702-350X; Reyes-Vivas, Horacio/0000-0002-3604-9629; Garcia, Itzhel/0000-0002-3018-060X; Castillo-Villanueva, Adriana/0000-0001-5582-6940; Marcial Quino, Jaime/0000-0002-4591-7379; Mendez-Cruz, Sara Teresa/0000-0001-8619-1220; Gomez-Manzo, Saul/0000-0003-2095-9182	Consejo Nacional de Ciencia y Tecnologia [106126, 104841, CB2011-164838]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-DGAPA) [IN201213]; U.S. DOE [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-DGAPA); U.S. DOE(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor	JOH was supported by Consejo Nacional de Ciencia y Tecnologia grant 106126. HRV was supported by Consejo Nacional de Ciencia y Tecnologia grant 104841. ATL was supported by Consejo Nacional de Ciencia y Tecnologia grant CB2011-164838 and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-DGAPA) grant IN201213. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy ( DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor, Grant 085P1000817. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021035; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENNER SA, 1994, PROTEIN ENG, V7, P1323, DOI 10.1093/protein/7.11.1323; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; De La Mora ID, 2013, BBA-PROTEINS PROTEOM, V1834, P2702, DOI 10.1016/j.bbapap.2013.08.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enriquez-Flores S, 2008, MOL BIOCHEM PARASIT, V157, P179, DOI 10.1016/j.molbiopara.2007.10.013; Enriquez-Flores S, 2011, PROTEINS, V79, P2711, DOI 10.1002/prot.23100; Eschenburg S, 2000, PROTEINS, V40, P290, DOI 10.1002/(SICI)1097-0134(20000801)40:2<290::AID-PROT90>3.0.CO;2-0; Esposito L, 2000, J MOL BIOL, V297, P713, DOI 10.1006/jmbi.2000.3597; Go MK, 2010, BIOCHEMISTRY-US, V49, P5377, DOI 10.1021/bi100538b; Gracy RW, 1998, J EXP ZOOL, V282, P18; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kinoshita T, 2005, ACTA CRYSTALLOGR F, V61, P346, DOI 10.1107/S1744309105008341; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noguchi S, 1998, J MOL BIOL, V278, P231, DOI 10.1006/jmbi.1998.1674; Noguchi S, 2010, BIOPOLYMERS, V93, P1003, DOI 10.1002/bip.21514; Oesper P, 1950, THE DETERMINATION OF; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rester U, 2000, ACTA CRYSTALLOGR D, V56, P581, DOI 10.1107/S0907444900003048; Reyes-Vivas H, 2002, PROTEINS, V48, P580, DOI 10.1002/prot.10179; Richard JP, 2012, BIOCHEMISTRY-US, V51, P2652, DOI 10.1021/bi300195b; Robinson A B, 1974, Curr Top Cell Regul, V8, P247; ROBINSON AB, 1970, P NATL ACAD SCI USA, V66, P753, DOI 10.1073/pnas.66.3.753; ROBINSON AB, 1979, MECH AGEING DEV, V9, P225, DOI 10.1016/0047-6374(79)90101-5; ROBINSON AB, 1974, P NATL ACAD SCI USA, V71, P885, DOI 10.1073/pnas.71.3.885; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P4367, DOI 10.1073/pnas.071066498; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Robinson NE, 2004, MOLECULAR CLOCKS DEA; Robinson NE, 2008, BIOPOLYMERS, V90, P297, DOI 10.1002/bip.20852; Rodriguez-Almazan C, 2008, J BIOL CHEM, V283, P23254, DOI 10.1074/jbc.M802145200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shi YH, 2013, J AM CHEM SOC, V135, P15897, DOI 10.1021/ja407801x; SUN AQ, 1995, ARCH BIOCHEM BIOPHYS, V322, P361, DOI 10.1006/abbi.1995.1476; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ugur I, 2012, J PHYS CHEM B, V116, P6288, DOI 10.1021/jp3013305; Verma A, 2013, INFECT IMMUN, V81, P278, DOI 10.1128/IAI.00863-12; Wierenga RK, 2010, CELL MOL LIFE SCI, V67, P3961, DOI 10.1007/s00018-010-0473-9; YUAN PM, 1981, MECH AGEING DEV, V17, P151, DOI 10.1016/0047-6374(81)90081-6; YUKSEL KU, 1986, ARCH BIOCHEM BIOPHYS, V248, P452, DOI 10.1016/0003-9861(86)90498-4; Zarate-Perez F, 2008, PROG MOL BIOL TRANSL, V84, P251, DOI 10.1016/S0079-6603(08)00407-8	50	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123379	10.1371/journal.pone.0123379	http://dx.doi.org/10.1371/journal.pone.0123379			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884638	gold, Green Submitted, Green Published			2022-12-26	WOS:000353017000059
J	Li, ZQ; Zhao, BZ; Wang, QY; Cao, XY; Zhang, JB				Li, Zengqiang; Zhao, Bingzi; Wang, Qingyun; Cao, Xiaoyan; Zhang, Jiabao			Differences in Chemical Composition of Soil Organic Carbon Resulting From Long-Term Fertilization Strategies	PLOS ONE			English	Article							C-13 NMR-SPECTROSCOPY; SOLID-STATE NMR; MANURE APPLICATION; MICROBIAL BIOMASS; PADDY SOIL; LAND-USE; MATTER; NITROGEN; FRACTIONS; DENSITY	Chemical composition of soil organic carbon (SOC) is central to soil fertility. We hypothesize that change in SOC content resulting from various long-term fertilization strategies accompanies the shift in SOC chemical structure. This study examined the effect of fertilization strategies along with the time of fertilizer application on the SOC composition by C-13 nuclear magnetic resonance (NMR) spectroscopy. The soils (Aquic Inceptisol) subjected to seven fertilizer treatments were collected in 1989, 1999 and 2009, representing 0, 10 and 20 years of fertilization, respectively. The seven fertilizer treatments were (1-3) balanced fertilization with application of nitrogen (N), phosphorus (P) and potassium (K) including organic compost (OM), half organic compost plus half chemical fertilizer (1/2OM), and pure chemical NPK fertilizer (NPK); (4-6) unbalanced chemical fertilization without application of one of the major elements including NP fertilizer (NP), PK fertilizer (PK), and NK fertilizer (NK); and (7) an unamended control (CK). The SOC content in the balanced fertilization treatments were 2.3-52.6% and 9.4-64.6% higher than in the unbalanced fertilization/CK treatments in 1999 and 2009, respectively, indicating significant differences in SOC content with time of fertilizer application between the two treatment groups. There was a significantly greater proportion of O-alkyl C and a lower proportion of aromatic C in the balanced fertilization than in unbalanced fertilization/CK treatments in 1999, but not in 2009, because their proportions in the former treatments approached the latter in 2009. Principal component analysis further showed that the C functional groups from various fertilization strategies tended to become compositionally similar with time. The results suggest that a shift in SOC chemical composition may be firstly dominated by fertilization strategies, followed by fertilization duration.	[Li, Zengqiang; Zhao, Bingzi; Wang, Qingyun; Zhang, Jiabao] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Li, Zengqiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cao, Xiaoyan] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Brandeis University	Zhao, BZ (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	bzhao@issas.ac.cn	Cao, Xiaoyan/E-3492-2012	Cao, Xiaoyan/0000-0001-7571-6482	National Basic Research Program of China [2011CB100506]; National Natural Science Foundation of China [41271311]; National Key Technology Support Program [2012BAD05B0203]; Chinese Academy of Sciences [CXJQ120111, ISSASIP1118]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program); Chinese Academy of Sciences(Chinese Academy of Sciences)	This project was supported by the National Basic Research Program of China (2011CB100506), the National Natural Science Foundation of China (41271311), National Key Technology Support Program (2012BAD05B0203), and the Knowledge Innovation Program of the Chinese Academy of Sciences (CXJQ120111, ISSASIP1118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaria A, 2009, SOIL SCI SOC AM J, V73, P812, DOI 10.2136/sssaj2008.0075; Brown S, 2011, ENVIRON SCI TECHNOL, V45, P7451, DOI 10.1021/es2010418; Cai ZC, 2006, GEODERMA, V136, P708, DOI 10.1016/j.geoderma.2006.05.008; Cao XY, 2011, SOIL SCI SOC AM J, V75, P1374, DOI 10.2136/sssaj2010.0382; Carter MR, 2003, CAN J SOIL SCI, V83, P11, DOI 10.4141/S01-087; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Dieckow J, 2005, EUR J SOIL SCI, V56, P705, DOI 10.1111/j.1365-2389.2005.00705.x; Ding WX, 2007, SOIL BIOL BIOCHEM, V39, P669, DOI 10.1016/j.soilbio.2006.09.024; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; Fan JL, 2014, GEODERMA, V230, P22, DOI 10.1016/j.geoderma.2014.03.027; Fortuna A, 2003, SOIL SCI, V168, P434, DOI [10.1097/00010694-200306000-00005, 10.1097/01.ss.0000075288.53382.91]; Gallo ME, 2005, GLOBAL CHANGE BIOL, V11, P1514, DOI 10.1111/j.1365-2486.2005.01001.x; Guinto DF, 1999, AUST J SOIL RES, V37, P123, DOI 10.1071/S97034; HAGEMEYER A, 1991, J MAGN RESON, V92, P628, DOI 10.1016/0022-2364(91)90360-6; Helfrich M, 2006, GEODERMA, V136, P331, DOI 10.1016/j.geoderma.2006.03.048; Hsu JH, 1999, ENVIRON POLLUT, V104, P189, DOI 10.1016/S0269-7491(98)00193-6; Kogel-Knabner I, 1997, GEODERMA, V80, P243, DOI 10.1016/S0016-7061(97)00055-4; Mahieu N, 1999, SOIL SCI SOC AM J, V63, P307, DOI 10.2136/sssaj1999.03615995006300020008x; Mao JD, 2000, SOIL SCI SOC AM J, V64, P873, DOI 10.2136/sssaj2000.643873x; Mao JD, 2008, GEODERMA, V146, P353, DOI 10.1016/j.geoderma.2008.06.003; Mathers NJ, 2007, SOIL BIOL BIOCHEM, V39, P993, DOI 10.1016/j.soilbio.2006.11.009; Mathers NJ, 2003, GEODERMA, V114, P19, DOI 10.1016/S0016-7061(02)00339-7; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Ng EL, 2014, SOIL BIOL BIOCHEM, V70, P54, DOI 10.1016/j.soilbio.2013.12.004; Nierop KGJ, 1999, GEODERMA, V90, P111, DOI 10.1016/S0016-7061(98)00095-0; Olk DC, 2006, SOIL BIOL BIOCHEM, V38, P3303, DOI 10.1016/j.soilbio.2006.04.009; Qin ShengWu, 1998, Acta Pedologica Sinica, V35, P367; REID ID, 1991, CAN J BOT, V69, P156, DOI 10.1139/b91-022; Schmidt MWI, 1997, EUR J SOIL SCI, V48, P319, DOI 10.1111/j.1365-2389.1997.tb00552.x; SKJEMSTAD JO, 1994, AUST J SOIL RES, V32, P1215, DOI 10.1071/SR9941215; Spaccini R, 2009, SOIL BIOL BIOCHEM, V41, P1164, DOI 10.1016/j.soilbio.2009.02.026; Wang QJ, 2012, J PLANT NUTR SOIL SC, V175, P920, DOI 10.1002/jpln.201100350; Wang QJ, 2012, SOIL USE MANAGE, V28, P337, DOI 10.1111/j.1475-2743.2012.00414.x; Wang XY, 2012, ENVIRON SCI TECHNOL, V46, P7159, DOI 10.1021/es300522x; Yan X, 2013, SOIL TILL RES, V130, P42, DOI 10.1016/j.still.2013.01.013; Yu HY, 2012, SOIL TILL RES, V124, P170, DOI 10.1016/j.still.2012.06.011; Zhang JC, 2013, EUR J SOIL SCI, V64, P797, DOI 10.1111/ejss.12104; Zhang JJ, 2009, EUR J SOIL SCI, V60, P966, DOI 10.1111/j.1365-2389.2009.01191.x; Zhao BZ, 2013, J PLANT NUTR SOIL SC, V176, P99, DOI 10.1002/jpln.201200076; Zhao BZ, 2010, GEODERMA, V160, P218, DOI 10.1016/j.geoderma.2010.09.024; Zheng SX, 2009, SOIL BIOL BIOCHEM, V41, P2094, DOI 10.1016/j.soilbio.2009.07.019; Zhou P, 2010, EUR J SOIL SCI, V61, P231, DOI 10.1111/j.1365-2389.2009.01223.x	43	17	22	7	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124359	10.1371/journal.pone.0124359	http://dx.doi.org/10.1371/journal.pone.0124359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884713	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000120
J	Martinez-Ramirez, D; Giugni, JC; Little, CS; Chapman, JP; Ahmed, B; Monari, E; Shukla, AW; Hess, CW; Okun, MS				Martinez-Ramirez, Daniel; Giugni, Juan C.; Little, Christopher S.; Chapman, John P.; Ahmed, Bilal; Monari, Erin; Shukla, Aparna Wagle; Hess, Christopher W.; Okun, Michael S.			Missing Dosages and Neuroleptic Usage May Prolong Length of Stay in Hospitalized Parkinson's Disease Patients	PLOS ONE			English	Article							MEDICATION; ADMISSIONS; OUTCOMES; MULTICENTER; ADHERENCE; PEOPLE; RISK	Background Parkinson's disease patients are more likely to be hospitalized, have higher rates of hospital complications, and have an increased risk of deterioration during hospitalization. Length of stay is an important underlying factor for these increased risks. We aimed to investigate potential medication errors that may occur during hospitalization and its impact on length of hospital stay. Methods A cross-sectional chart review of 339 consecutive hospital encounters from 212 PD subjects was performed. Medication errors were defined as wrong timing or omission of administration for dopaminergic drugs and administration of contraindicated dopamine blockers. An analysis of covariance was applied to examine whether these medication errors were related to increased length of hospital stays. Results A significant effect for dopaminergic administration (p<0.01) on length of hospital stay was observed. Subjects who had delayed administration or missed at least one dose stayed longer (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4). Contraindicated dopamine blocking agents were administered in 23% (71/339) of cases, and this was also significantly related to an increased length of stay (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4), p<0.05. Participants who received a contraindicated dopamine blocker stayed in the hospital longer (M=7.5 days, SD=9.1) compared to those who did not (M=5.9 days, SD=6.8). Neurologists were consulted in 24.5% of encounters. Specialty consultation had no effect on the medication related errors. Conclusions Missing dopaminergic dosages and administration of dopamine blockers occur frequently in hospitalized Parkinson's disease patients and this may impact length of stay. These potentially modifiable factors may reduce the risk of a longer stay related to hospitalization.	[Martinez-Ramirez, Daniel; Giugni, Juan C.; Little, Christopher S.; Chapman, John P.; Ahmed, Bilal; Monari, Erin; Shukla, Aparna Wagle; Hess, Christopher W.; Okun, Michael S.] Univ Florida, Coll Med, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Coll Med, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okun, MS (corresponding author), Univ Florida, Coll Med, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.	okun@neurology.ufl.edu	Ramirez, Daniel Martinez/O-6719-2018; Martinez-Ramirez, Daniel/H-2546-2016; Ahmed, Bilal/A-6926-2016; Shukla, Aparna Wagle/AAN-1344-2020	Ramirez, Daniel Martinez/0000-0001-8003-0610; Martinez-Ramirez, Daniel/0000-0001-8003-0610; Ahmed, Bilal/0000-0001-9110-4136; Hess, Christopher/0000-0002-7317-8999; Hastings Monari, Erin/0000-0002-4075-3360; Okun, Michael/0000-0002-6247-9358; WAGLE SHUKLA, APARNA/0000-0002-9757-9973	National Parkinson Foundation; Tyler's Hope; Bachmann-Strauss Foundation	National Parkinson Foundation; Tyler's Hope; Bachmann-Strauss Foundation	We would like to acknowledge the support of the National Parkinson Foundation, Tyler's Hope and the Bachmann-Strauss Foundation to the Center. Also we would like to acknowledge the UF Foundation and the UF INFORM database, as well as Dr. Masa-aki Higuchi and Caroline Mignacca for helping obtaining data.	Aminoff MJ, 2011, PARKINSONISM RELAT D, V17, P139, DOI 10.1016/j.parkreldis.2010.11.009; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Braga M, 2014, PARKINSONISM RELAT D, V20, P488, DOI 10.1016/j.parkreldis.2014.01.022; Buetow S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/432983; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chou KL, 2011, PARKINSONISM RELAT D, V17, P440, DOI 10.1016/j.parkreldis.2011.03.002; Cilia R, 2014, J NEUROL NEUROSURG P; Dent E, 2014, AGE AGEING, V43, P477, DOI 10.1093/ageing/aft181; Derry CP, 2010, POSTGRAD MED J, V86, P334, DOI 10.1136/pgmj.2009.080432; Driver JA, 2008, NEUROLOGY, V70, P1423, DOI 10.1212/01.wnl.0000310414.85144.ee; Gerlach OHH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-13; Gerlach OHH, 2011, PARKINSONISM RELAT D, V17, P498, DOI 10.1016/j.parkreldis.2011.04.004; Gerlach OHH, 2011, MOVEMENT DISORD, V26, P197, DOI 10.1002/mds.23449; Gilboy N, 2012, EMERGENCY SEVERITY I; Goldman JG, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0281-2; Grosset D, 2009, MOVEMENT DISORD, V24, P826, DOI 10.1002/mds.22112; Hassan A, 2013, PARKINSONISM RELAT D, V19, P949, DOI 10.1016/j.parkreldis.2013.06.006; Hassan Anhar, 2012, Parkinsonism Relat Disord, V18 Suppl 3, pS10, DOI 10.1016/j.parkreldis.2012.06.014; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Hou JG, 2012, PARKINSONISM RELAT D, V18, P377, DOI 10.1016/j.parkreldis.2011.12.007; Kulkarni AS, 2008, MOVEMENT DISORD, V23, P359, DOI 10.1002/mds.21831; Lubomski M, 2014, J NEUROL NEUROSURG P; Magdalinou KN, 2007, PARKINSONISM RELAT D, V13, P539, DOI 10.1016/j.parkreldis.2006.11.006; Martignoni E, 2004, NEUROL SCI, V25, P66, DOI 10.1007/s10072-004-0232-5; Skelly R, 2014, PARKINSONISM RELAT D, V20, P1242, DOI 10.1016/j.parkreldis.2014.09.015; Vossius C, 2010, ACTA NEUROL SCAND, V121, P38, DOI 10.1111/j.1600-0404.2009.01239.x; Woodford H, 2005, MOVEMENT DISORD, V20, P1104, DOI 10.1002/mds.20485; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	28	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124356	10.1371/journal.pone.0124356	http://dx.doi.org/10.1371/journal.pone.0124356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884484	Green Submitted, gold, Green Published			2022-12-26	WOS:000353017000118
J	Grizard, S; Versteegh, MA; Ndithia, HK; Salles, JF; Tieleman, BI				Grizard, Stephanie; Versteegh, Maaike A.; Ndithia, Henry K.; Salles, Joana F.; Tieleman, B. Irene			Shifts in Bacterial Communities of Eggshells and Antimicrobial Activities in Eggs during Incubation in a Ground-Nesting Passerine	PLOS ONE			English	Article							MICROBIAL DIVERSITY; PIED FLYCATCHERS; BARN SWALLOW; LIFE-HISTORY; SHELF-LIFE; AVIAN EGG; TEMPERATURE; BIRDS; PROTEINS; EMBRYO	Microbial invasion of egg contents is a cause of embryonic death. To counter infection risks, the embryo is protected physically by the eggshell and chemically by antimicrobial proteins. If microbial pressure drives embryo mortality, then females may have evolved, through natural selection, to adapt their immune investment into eggs. Although frequently hypothesized, this match between immune allocation and microorganisms has not been explored yet. To examine if correlations between microbes on eggs and immunity in eggs exist, we collected eggs from red-capped larks (Calandrella cinerea) and simultaneously examined their bacterial communities and antimicrobial components-pH, lysozyme and ovotransferrin-during natural incubation. Using molecular techniques, we find that bacterial communities are highly dynamic: bacterial abundance increases from the onset to late incubation, Shannon's a-diversity index increases during early incubation stages, and beta-diversity analysis shows that communities from 1 day-old clutches are phylogenetically more similar to each other than the older ones. Regarding the antimicrobials, we notice a decrease of pH and lysozyme concentration, while ovotransferrin concentration increases during incubation. Interestingly, we show that two eggs of the same clutch share equivalent immune protection, independent of clutch age. Lastly, our results provide limited evidence of significant correlation between antimicrobial compounds and bacterial communities. Our study examined simultaneously, for the first time in a wild bird, the dynamics of bacterial communities present on eggshells and of albumen-associated antimicrobial components during incubation and investigated their relationship. However, the link between microorganisms and immunity of eggs remains to be elucidated further. Identifying invading microbes and their roles in embryo mortality, as well as understanding the role of the eggshell microbiome, might be key to better understand avian strategies of immune maternal investment.	[Grizard, Stephanie; Versteegh, Maaike A.; Ndithia, Henry K.; Tieleman, B. Irene] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Grizard, Stephanie; Salles, Joana F.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Dept Microbial Ecol, Groningen, Netherlands; [Ndithia, Henry K.] Natl Museums Kenya, Ornithol Sect, Dept Zool, Nairobi, Kenya	University of Groningen; University of Groningen	Grizard, S (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands.	s.grizard@rug.nl	Falcao Salles, Joana/A-7313-2008; Salles, Joana Falcao/AAG-7070-2020	Falcao Salles, Joana/0000-0003-4317-7263; Salles, Joana Falcao/0000-0003-4317-7263	Netherlands Organisation for Scientific Research	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Financial support was provided by a VIDI grant from the Netherlands Organisation for Scientific Research (to BIT).	AR A, 1980, AM ZOOL, V20, P373; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bedrani L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-128; Beissinger SR, 2005, ECOLOGY, V86, P2164, DOI 10.1890/04-1624; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Bisson IA, 2007, MICROB ECOL, V54, P65, DOI 10.1007/s00248-006-9173-2; Board R.G., 1995, EGG SCI TECHNOLOGY, V4th, P81; BOARD RG, 1974, BIOL REV, V49, P15, DOI 10.1111/j.1469-185X.1974.tb01297.x; BOARD RG, 1982, BIOL REV, V57, P1, DOI 10.1111/j.1469-185X.1982.tb00362.x; Bonisoli-Alquati A, 2010, BEHAV ECOL SOCIOBIOL, V64, P845, DOI 10.1007/s00265-010-0901-8; BROOKS J, 1959, BIOCHIM BIOPHYS ACTA, V32, P237, DOI 10.1016/0006-3002(59)90574-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Clarke A, 2008, FUNCT ECOL, V22, P58, DOI 10.1111/j.1365-2435.2007.01341.x; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Cucco M, 2011, ETHOL ECOL EVOL, V23, P343, DOI 10.1080/03949370.2011.584565; Cucco M, 2007, COMP BIOCHEM PHYS A, V147, P1038, DOI 10.1016/j.cbpa.2007.03.014; CUNNINGHAM FE, 1974, POULTRY SCI, V53, P1561, DOI 10.3382/ps.0531561; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; Del Hoyo J, 2004, HDB BIRDS WORLD CONT, V9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fang J, 2012, ITAL J ANIM SCI, V11, DOI 10.4081/ijas.2012.e17; Fang J, 2012, J FOOD AGRIC ENVIRON, V10, P423; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Giraudeau M, 2014, J ORNITHOL, V155, P671, DOI 10.1007/s10336-014-1050-z; Godard RD, 2007, J AVIAN BIOL, V38, P709, DOI 10.1111/j.0908-8857.2007.04052.x; Goodenough AE, 2012, MICROB ECOL, V63, P986, DOI 10.1007/s00248-011-9992-7; Goodenough AE, 2010, MICROB ECOL, V59, P221, DOI 10.1007/s00248-009-9591-z; Grizard S, 2014, ECOL EVOL, V4, P1140, DOI 10.1002/ece3.1011; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; He XS, 2014, ISME J, V8, P564, DOI 10.1038/ismej.2013.172; Horrocks NPC, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-49; Horrocks NPC, 2012, PHYSIOL BIOCHEM ZOOL, V85, P504, DOI 10.1086/666988; Horrocks NPC, 2011, METHODS ECOL EVOL, V2, P518, DOI 10.1111/j.2041-210X.2011.00096.x; Javurkova V, 2014, IBIS, V156, P374, DOI 10.1111/ibi.12126; KATO A, 1975, AGR BIOL CHEM TOKYO, V39, P541, DOI 10.1080/00021369.1975.10861614; Ko KY, 2009, POULTRY SCI, V88, P406, DOI 10.3382/ps.2008-00218; Lee WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103959; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Peralta-Sanchez JM, 2014, MICROB ECOL, V67, P480, DOI 10.1007/s00248-013-0338-5; Peralta-Sanchez JM, 2012, IBIS, V154, P725, DOI 10.1111/j.1474-919X.2012.01256.x; Mine Y, 2003, J AGR FOOD CHEM, V51, P249, DOI 10.1021/jf020597x; Monteiro RA, 2012, PLANT SOIL, V356, P175, DOI 10.1007/s11104-012-1125-7; Pinheiro J., 2011, R PACKAGE VERSION, V3, P1; Potter Beth A., 2013, Open Ornithology Journal, V6, P32; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Reijrink IAM, 2008, WORLD POULTRY SCI J, V64, P581, DOI 10.1017/S0043933908000214; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P31; Romanoff AL, 1929, BIOL BULL-US, V57, P300, DOI 10.2307/1537038; Rosconi F, 2013, ENVIRON MICROBIOL, V15, P916, DOI 10.1111/1462-2920.12075; Ruiz-De-Castaneda R, 2011, BEHAV PROCESS, V88, P142, DOI 10.1016/j.beproc.2011.08.012; Ruiz-de-Castaneda R, 2011, J ZOO WILDLIFE MED, V42, P313, DOI 10.1638/2010-0056.1; Ruiz-de-Castaneda R, 2011, J FIELD ORNITHOL, V82, P215, DOI 10.1111/j.1557-9263.2011.00324.x; Saha R, 2013, J BASIC MICROB, V53, P303, DOI 10.1002/jobm.201100552; Saino N, 2004, FUNCT ECOL, V18, P50, DOI 10.1046/j.0269-8463.2004.00808.x; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Shawkey MD, 2008, BEHAV ECOL, V19, P920, DOI 10.1093/beheco/arn019; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Shawkey MD, 2005, MICROB ECOL, V50, P40, DOI 10.1007/s00248-004-0089-4; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tieleman BI, 2004, FUNCT ECOL, V18, P571, DOI 10.1111/j.0269-8463.2004.00882.x; TRANTER HS, 1984, J APPL BACTERIOL, V56, P53, DOI 10.1111/j.1365-2672.1984.tb04696.x; Versteegh MA, 2008, COMP BIOCHEM PHYS A, V150, P452, DOI 10.1016/j.cbpa.2008.05.006; Wang JM, 2009, WILSON J ORNITHOL, V121, P512, DOI 10.1676/08-116.1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wellman-Labadie O, 2007, WORLD POULTRY SCI J, V63, P421, DOI 10.1017/S0043933907001559; Wellman-Labadie O, 2008, COMP BIOCHEM PHYS B, V149, P640, DOI 10.1016/j.cbpb.2008.01.001; Wellman-Labadie O, 2008, PHYSIOL BIOCHEM ZOOL, V81, P235, DOI 10.1086/524149; Xin YH, 2009, INT J SYST EVOL MICR, V59, P139, DOI 10.1099/ijs.0.000547-0	76	20	21	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121716	10.1371/journal.pone.0121716	http://dx.doi.org/10.1371/journal.pone.0121716			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880684	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500011
J	Lee, ZM; Steger, L; Corman, JR; Neveu, M; Poret-Peterson, AT; Souza, V; Elser, JJ				Lee, Zarraz M.; Steger, Laura; Corman, Jessica R.; Neveu, Marc; Poret-Peterson, Amisha T.; Souza, Valeria; Elser, James J.			Response of a Stoichiometrically Imbalanced Ecosystem to Manipulation of Nutrient Supplies and Ratios	PLOS ONE			English	Article							SHALLOW LAKES; FRESH-WATER; PHOSPHORUS LIMITATION; CUATRO CIENEGAS; NITROGEN; EUTROPHICATION; PHYTOPLANKTON; TERRESTRIAL; COMMUNITIES; WETLANDS	Cuatro Cienegas Basin (CCB) is a desert ecosystem that hosts a large diversity of water bodies. Many surface waters in this basin have imbalanced nitrogen (N) to phosphorus (P) stoichiometry (total N:P > 100 by atoms), where P is likely to be a limiting nutrient. To investigate the effects of nutrient stoichiometry on planktonic and sediment ecosystem components and processes, we conducted a replicated in situ mesocosm experiment in Lagunita, a shallow pond located in the southwest region of the basin. Inorganic N and P were periodically added to mesocosms under three different N:P regimes (P only, N:P = 16 and N:P = 75) while the control mesocosms were left unamended. After three weeks of fertilization, more than two thirds of the applied P was immobilized into seston or sediment. The rapid uptake of P significantly decreased biomass C:P and N:P ratios, supporting the hypothesis that Lagunita is P-limited. Meanwhile, simultaneous N and P enrichment significantly enhanced planktonic growth, increasing total planktonic biomass by more than 2-fold compared to the unenriched control. With up to 76% of added N sequestered into the seston, it is suspected that the Lagunita microbial community also experienced strong N-limitation. However, when N and P were applied at N:P = 75, the microbes remained in a P-limitation state as in the untreated control. Two weeks after the last fertilizer application, seston C:P and N:P ratios returned to initial levels but chlorophyll a and seston C concentrations remained elevated. Additionally, no P release from the sediment was observed in the fertilized mesocosms. Overall, this study provides evidence that Lagunita is highly sensitive to nutrient perturbation because the biota is primarily P-limited and experiences a secondary N-limitation despite its high TN:TP ratio. This study serves as a strong basis to justify the need for protection of CCB ecosystems and other low-nutrient microbe-dominated systems from anthropogenic inputs of both N and P.	[Lee, Zarraz M.; Steger, Laura; Corman, Jessica R.; Elser, James J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Neveu, Marc; Poret-Peterson, Amisha T.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Souza, Valeria] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Universidad Nacional Autonoma de Mexico	Lee, ZM (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	leezarraz@gmail.com	Elser, James J/AAL-6199-2020; LEE, ZARRAZ/AAK-7459-2020; Elser, James/A-7082-2008; Neveu, Marc/H-4766-2019	Elser, James J/0000-0002-1460-2155; Elser, James/0000-0002-1460-2155; Neveu, Marc/0000-0002-6220-2869; souza, valeria/0000-0002-2992-4229; Poret-Peterson, Amisha/0000-0002-7329-5175; Corman, Jessica/0000-0002-2633-8080	U.S. National Science Foundation (NSF) grant [DEB-0950175]; National Aeronautics and Space Administration Astrobiology (NASA) grant [NAI5-0018]; Direct For Biological Sciences [0950179] Funding Source: National Science Foundation	U.S. National Science Foundation (NSF) grant(National Science Foundation (NSF)); National Aeronautics and Space Administration Astrobiology (NASA) grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by the U.S. National Science Foundation (NSF) grant DEB-0950175 and the National Aeronautics and Space Administration Astrobiology (NASA) grant NAI5-0018 awarded to JJE.	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Arar E.J., 1997, 4450 US ENV PROT AG; Bergstrom AK, 2010, AQUAT SCI, V72, P277, DOI 10.1007/s00027-010-0132-0; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Bushaw KL, 1996, NATURE, V381, P404, DOI 10.1038/381404a0; COLE JJ, 1990, LIMNOL OCEANOGR, V35, P1230, DOI 10.4319/lo.1990.35.6.1230; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Dittrich M, 2002, HYDROBIOLOGIA, V469, P49, DOI 10.1023/A:1015571410442; DOWNING JA, 1992, LIMNOL OCEANOGR, V37, P936, DOI 10.4319/lo.1992.37.5.0936; Edwards GP, 1965, J AM WATER WORKS ASS, V57, P917, DOI DOI 10.1002/J.1551-8833.1965.TB01479.X; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x; Elser JJ, 2000, ECOSYSTEMS, V3, P293, DOI 10.1007/s100210000027; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; Evans S.B., 2005, USING CHEM DATA DEFI; Havens KE, 1999, FRESHWATER BIOL, V42, P329, DOI 10.1046/j.1365-2427.1999.444479.x; HOLLIS GE, 1990, HYDROLOG SCI J, V35, P411, DOI 10.1080/02626669009492443; JANSSON M, 1994, AMBIO, V23, P320; Jeppesen E, 2007, HYDROBIOLOGIA, V581, P269, DOI 10.1007/s10750-006-0507-3; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lopez-Lozano NE, 2012, ASTROBIOLOGY, V12, P699, DOI 10.1089/ast.2012.0840; Moss B, 1997, HYDROBIOLOGIA, V342, P257, DOI 10.1023/A:1017059928028; Moss B, 2013, HYDROBIOLOGIA, V710, P3, DOI 10.1007/s10750-012-1033-0; Neveu M, 2014, LIMNOL OCEANOGR-METH, V12, P519, DOI 10.4319/lom.2014.12.519; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Ramos J, 2012, EC SOC AM 97 ANN M P; Schindler DW, 2006, LIMNOL OCEANOGR, V51, P356, DOI 10.4319/lo.2006.51.1_part_2.0356; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Schindler DW, 2012, P ROY SOC B-BIOL SCI, V279, P4322, DOI 10.1098/rspb.2012.1032; Scott JT, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00042; Sondergaard M, 2003, HYDROBIOLOGIA, V506, P135, DOI 10.1023/B:HYDR.0000008611.12704.dd; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Souza V., 2007, PROTECTING WINDOW AN; Souza V, 2008, NAT REV MICROBIOL, V6, P559, DOI 10.1038/nrmicro1917; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; Stevens L. E., 2008, ARIDLAND SPRINGS N A; Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2; Urabe J, 2002, ECOLOGY, V83, P619, DOI 10.2307/3071868; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140	41	18	18	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123949	10.1371/journal.pone.0123949	http://dx.doi.org/10.1371/journal.pone.0123949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881015	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500074
J	Dziak, RP; Bohnenstiehl, DR; Stafford, KM; Matsumoto, H; Park, M; Lee, WS; Fowler, MJ; Lau, TK; Haxel, JH; Mellinger, DK				Dziak, Robert P.; Bohnenstiehl, DelWayne R.; Stafford, Kathleen M.; Matsumoto, Haruyoshi; Park, Minkyu; Lee, Won Sang; Fowler, Matt J.; Lau, Tai-Kwan; Haxel, Joseph H.; Mellinger, David K.			Sources and Levels of Ambient Ocean Sound near the Antarctic Peninsula	PLOS ONE			English	Article							MARINE MAMMALS; ICE-SHELF; SEA; NOISE; BLUE; PACIFIC; ICEBERGS; RETREAT; WATERS; RANGE	Arrays of hydrophones were deployed within the Bransfield Strait and Scotia Sea (Antarctic Peninsula region) from 2005 to 2009 to record ambient ocean sound at frequencies of up to 125 and 500 Hz. Icequakes, which are broadband, short duration signals derived from fracturing of large free-floating icebergs, are a prominent feature of the ocean soundscape. Ice quake activity peaks during austral summer and is minimum during winter, likely following freeze-thaw cycles. Iceberg grounding and rapid disintegration also releases significant acoustic energy, equivalent to large-scale geophysical events. Overall ambient sound levels can be as much as similar to 10-20 dB higher in the open, deep ocean of the Scotia Sea compared to the relatively shallow Bransfield Strait. Noise levels become lowest during the austral winter, as sea-ice cover suppresses wind and wave noise. Ambient noise levels are highest during austral spring and summer, as surface noise, ice cracking and biological activity intensifies. Vocalizations of blue (Balaenoptera musculus) and fin (B. physalus) whales also dominate the long-term spectra records in the 15-28 and 89 Hz bands. Blue whale call energy is a maximum during austral summer-fall in the Drake Passage and Bransfield Strait when ambient noise levels are a maximum and sea-ice cover is a minimum. Fin whale vocalizations were also most common during austral summer-early fall months in both the Bransfield Strait and Scotia Sea. The hydrophone data overall do not show sustained anthropogenic sources (ships and airguns), likely due to low coastal traffic and the typically rough weather and sea conditions of the Southern Ocean.	[Dziak, Robert P.; Matsumoto, Haruyoshi; Fowler, Matt J.; Lau, Tai-Kwan; Haxel, Joseph H.; Mellinger, David K.] Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA; [Dziak, Robert P.; Matsumoto, Haruyoshi; Fowler, Matt J.; Lau, Tai-Kwan; Haxel, Joseph H.; Mellinger, David K.] NOAA, Pacific Marine Environm Lab, Newport, OR 97365 USA; [Bohnenstiehl, DelWayne R.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Stafford, Kathleen M.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Park, Minkyu; Lee, Won Sang] Korea Polar Res Inst, Polar Environm Res Div, Inchon 406840, South Korea	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of North Carolina; North Carolina State University; University of Washington; University of Washington Seattle; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Dziak, RP (corresponding author), Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA.	robert.p.dziak@noaa.gov	Dziak, Robert/AAC-6107-2020; Matsumoto, Haru/J-6812-2017	Matsumoto, Haru/0000-0002-0202-4060; Lee, Won Sang/0000-0002-1074-7672	Department of Energy [09NA28654]; NOAA Ocean Exploration and Research Program; Korea Ocean and Polar Research Institute [08NA28654, PE13050, PM12020, PM14020]	Department of Energy(United States Department of Energy (DOE)); NOAA Ocean Exploration and Research Program; Korea Ocean and Polar Research Institute	This work was sponsored by the Department of Energy contract number 09NA28654, NOAA Ocean Exploration and Research Program and the Korea Ocean and Polar Research Institute, projects number 08NA28654, PE13050, PM12020 and PM14020, respectively. The research analysis was performed at the NOAA/Pacific Marine Environmental Laboratory, PMEL contribution number 4162.	Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; Berzin Alfred A., 2008, U S National Marine Fisheries Service Marine Fisheries Review, V70, P4; Bevington PR., 2002, DATA REDUCTION ERROR; Bliss A, 2013, ANN GLACIOL, V54, P191, DOI 10.3189/2013AoG63A377; Branch T. A., 2001, Journal of Cetacean Research and Management, V3, P251; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; CATO DH, 1976, J ACOUST SOC AM, V60, P320, DOI 10.1121/1.381109; Cavalieri D. J., 2004, AMSR E AQUA DAILY L3; Chapp E, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000889; CLAPHAM PJ, 2002, ENCY MARINE MAMMALS, P1328; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Curtis KR, 1999, J ACOUST SOC AM, V106, P3189, DOI 10.1121/1.428173; Domack E, 2005, NATURE, V436, P681, DOI 10.1038/nature03908; Dowdeswell JA, 2007, MAR GEOL, V243, P120, DOI 10.1016/j.margeo.2007.04.008; Dziak RP, 2013, OCEANOGRAPHY, V26, P10, DOI 10.5670/oceanog.2013.20; Dziak RP, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006295; Dziak RP, 2001, GEOPHYS RES LETT, V28, P2537, DOI 10.1029/2001GL012939; Fox CG, 2001, J GEOPHYS RES-SOL EA, V106, P4183, DOI 10.1029/2000JB900404; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Jansen D, 2008, GEOPH RES ABSTR, V10; Jansen D, 2007, REMOTE SENS ENVIRON, V111, P195, DOI 10.1016/j.rse.2007.03.022; Klinck H, 2012, J ACOUST SOC AM, V132, pEL176, DOI 10.1121/1.4740226; MacAyeal DR, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF001005; Madsen PT, 2005, J ACOUST SOC AM, V117, P3952, DOI 10.1121/1.1921508; Martin S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006700; Matsumoto H, 2012, SCI COMM ANT RES ANT; Matsumoto H, 2011, USE AUTONOMOUS HYDRO; Matsumoto K, 2001, J GEODETIC SOC JPN, V47, P243, DOI DOI 10.11366/SOKUCHI1954.47.243; Maurice SDR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002416; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Miksis-Olds JL, 2013, PROG OCEANOGR, V111, P38, DOI 10.1016/j.pocean.2012.10.010; Miksis-Olds JL, 2012, ADV EXP MED BIOL, V730, P597, DOI 10.1007/978-1-4419-7311-5_135; Muller C, 2005, SCIENCE, V310, P1299, DOI 10.1126/science.1117145; National Aeronautic and Space Administration Earth Observatory, 2008, LARG TERR MODIS IM; Pelayo AM, 1989, SEISMOTECTONICS RELA; PRITCHARD RS, 1990, J ACOUST SOC AM, V88, P2830, DOI 10.1121/1.399687; Rankin Shannon, 2005, Journal of Cetacean Research and Management, V7, P13; Romero MCR, 2004, THESIS NM I MIN TECH; Roth EH, 2012, J ACOUST SOC AM, V131, P104, DOI 10.1121/1.3664096; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; Scambos T, 2008, J GLACIOL, V54, P579, DOI 10.3189/002214308786570836; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; Slack PD, 1999, J GEOPHYS RES-SOL EA, V104, P13061, DOI 10.1029/1999JB900112; Stein PJ, 2000, J GEOPHYS RES-OCEANS, V105, P8813, DOI 10.1029/2000JC900009; Talandier J, 2002, EARTH PLANET SC LETT, V203, P519, DOI 10.1016/S0012-821X(02)00867-1; Urick R. J., 1975, PRINCIPLES UNDERWATE; Warren K, 2011, THESIS N CAROLINA ST; Wilcock WSD, 2014, ANNU REV MAR SCI, V6, P117, DOI 10.1146/annurev-marine-121211-172423	51	20	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123425	10.1371/journal.pone.0123425	http://dx.doi.org/10.1371/journal.pone.0123425			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875205	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700031
J	Chang, PC; Wo, HT; Lee, HL; Lin, SF; Wen, MS; Chu, Y; Yeh, SJ; Chou, CC				Chang, Po-Cheng; Wo, Hung-Ta; Lee, Hui-Ling; Lin, Shien-Fong; Wen, Ming-Shien; Chu, Yen; Yeh, San-Jou; Chou, Chung-Chuan			Role of Sarcoplasmic Reticulum Calcium in Development of Secondary Calcium Rise and Early Afterdepolarizations in Long QT Syndrome Rabbit Model	PLOS ONE			English	Article							TORSADE-DE-POINTES; INTRACELLULAR CALCIUM; INTERVAL PROLONGATION; VENTRICULAR MYOCYTES; CARDIAC MYOCYTES; REPOLARIZATION; AMIODARONE; MECHANISMS; ALTERNANS; HEART	Background L-type calcium current reactivation plays an important role in development of early afterdepolarizations (EADs) and torsades de pointes (TdP). Secondary intracellular calcium (Ca-i) rise is associated with initiation of EADs. Objective To test whether inhibition of sarcoplasmic reticulum (SR) Ca2+ cycling suppresses secondary Ca-i rise and genesis of EADs. Methods Langendorff perfusion and dual voltage and Cai optical mapping were conducted in 10 rabbit hearts. Atrioventricular block (AVB) was created by radiofrequency ablation. After baseline studies, E4031, SR Ca2+ cycling inhibitors (ryanodine plus thapsigargin) and nifedipine were then administrated subsequently, and the protocols were repeated. Results At baseline, there was no spontaneous or pacing-induced TdP. After E4031 administration, action potential duration (APD) was significantly prolonged and the amplitude of secondary Cai rise was enhanced, and 7 (70%) rabbits developed spontaneous or pacing-induced TdP. In the presence of ryanodine plus thapsigargin, TdP inducibility was significantly reduced (2 hearts, 20%, p = 0.03). Although APD was significantly prolonged (from 298 +/- 30 ms to 457 +/- 75 ms at pacing cycle length of 1000 m, p = 0.007) by ryanodine plus thapsigargin, the secondary Ca-i rise was suppressed ( from 8.8 +/- 2.6% to 1.2 +/- 0.9%, p = 0.02). Nifedipine inhibited TdP inducibility in all rabbit hearts. Conclusion In this AVB and long QT rabbit model, inhibition of SR Ca2+ cycyling reduces the inducibility of TdP. The mechanism might be suppression of secondary Ca-i rise and genesis of EADs.	[Chang, Po-Cheng; Wo, Hung-Ta; Wen, Ming-Shien; Yeh, San-Jou; Chou, Chung-Chuan] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan; [Chang, Po-Cheng; Wen, Ming-Shien; Chu, Yen; Yeh, San-Jou; Chou, Chung-Chuan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Hui-Ling] Chang Gung Mem Hosp, Dept Anesthesia, Taipei 10591, Taiwan; [Lin, Shien-Fong; Chu, Yen] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Chu, Yen] Chang Gung Mem Hosp, Div Thorac Surg, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Chou, CC (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan.	2867@cgmh.org.tw	Lin, Shien-fong/AAQ-1608-2020; Chou, Chung-Chuan/AAZ-9776-2021; Chang, Po-Cheng/ABA-4979-2020	Lin, Shien-fong/0000-0003-1270-3961; Chang, Po-Cheng/0000-0002-6901-5951; Chu, Yen/0000-0002-7712-8331	Taiwan National Science Council [NSC 102-2314-B-182A-038-MY2]; Chang Gung Memorial Hospital [CMRPG3C1651]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by Taiwan National Science Council Grant (NSC 102-2314-B-182A-038-MY2) to PCC and by Chang Gung Memorial Hospital Medical Research Programs (CMRPG3C1651) to CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev SA, 2002, B EXP BIOL MED+, V133, P205, DOI 10.1023/A:1015832710818; Asano Y, 1997, J AM COLL CARDIOL, V29, P831, DOI 10.1016/S0735-1097(96)00588-8; Chang PC, 2014, J CARDIOL; Chang PC, 2013, HEART RHYTHM, V10, P1516, DOI 10.1016/j.hrthm.2013.07.003; Choi BR, 2002, J PHYSIOL-LONDON, V543, P615, DOI 10.1113/jphysiol.2002.024570; Chou CC, 2013, PACE, V36, P596, DOI 10.1111/pace.12091; Driessen HE, 2014, NETH HEART J, V22, P198, DOI 10.1007/s12471-014-0549-5; Goldhaber JI, 2005, CIRC RES, V96, P459, DOI 10.1161/01.RES.0000156891.66893.83; Hancox JC, 1997, GEN PHARMACOL, V29, P429, DOI 10.1016/S0306-3623(96)00465-X; Hoffmann Peter, 2006, Journal of Pharmacological and Toxicological Methods, V53, P87, DOI 10.1016/j.vascn.2005.07.003; Lacampagne A, 1996, BIOPHYS J, V70, P370, DOI 10.1016/S0006-3495(96)79580-2; Maruyama M, 2011, CIRC-ARRHYTHMIA ELEC, V4, P103, DOI 10.1161/CIRCEP.110.959064; Milberg P, 2012, BRIT J PHARMACOL, V166, P557, DOI 10.1111/j.1476-5381.2011.01721.x; Moss AJ, 2003, JAMA-J AM MED ASSOC, V289, P2041, DOI 10.1001/jama.289.16.2041; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pollard CE, 2010, BRIT J PHARMACOL, V159, P12, DOI 10.1111/j.1476-5381.2009.00207.x; PRIORI SG, 1990, AM J PHYSIOL, V258, pH1796, DOI 10.1152/ajpheart.1990.258.6.H1796; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Qu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043587; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Takamatsu H, 2003, J PHYSIOL-LONDON, V552, P415, DOI 10.1113/jphysiol.2003.050823; Terentyev D, 2014, CIRC RES, V115, P919, DOI 10.1161/CIRCRESAHA.115.305146; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123868	10.1371/journal.pone.0123868	http://dx.doi.org/10.1371/journal.pone.0123868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875599	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100219
J	Goldfarb, JW; Hasan, U				Goldfarb, James W.; Hasan, Usama			Imaging of Reperfused Intramyocardial Hemorrhage with Cardiovascular Magnetic Resonance Susceptibility Weighted Imaging (SWI)	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; MICROVASCULAR OBSTRUCTION; CORONARY REPERFUSION; MR; CONTRAST; INJURY; DETERMINANTS; COMPONENTS; EDEMA; HEART	Purpose To report initial experience with TE-averaged susceptibility weighted imaging (SWI) in normal subjects and acute myocardial infarction (AMI) patients for the detection of intramyocardial hemorrhage (IMH). Materials and Methods 15 healthy control and 11 AMI subjects were studied at 1.5T before contrast agent administration with a dark blood double inversion recovery multiple spoiled gradient-echo sequence. Magnitude, susceptibility weighted and TE-averaged images were reconstructed from raw data. Contrast and signal-difference-to-noise were measured and compared between methods for IMH detection. Results There were six patients with microvascular obstruction (MVO) and four patients with IMH detected by TE-averaged SWI imaging. All patients with IMH on SWI scans had MVO on late gadolinium-enhanced (LGE) imaging. There was a three-fold increase in IMH contrast with SWI compared to magnitude images. IMH contrast decreased and signal-to-noise increased with increased TE averages. Conclusions TE-averaged SWI imaging is a promising method for myocardial tissue characterization in the setting of AMI for the detection of IMH. Along with gray-scale colormap inversion, it combines not only magnitude and phase information, but also images across TEs to provide a single image sensitive to IMH with characteristics similar to LGE imaging.	[Goldfarb, James W.; Hasan, Usama] St Francis Hosp, Dept Res & Educ, Roslyn, NY 11576 USA; [Goldfarb, James W.] SUNY Stony Brook, Biomed Engn Program, Stony Brook, NY 11794 USA; [Hasan, Usama] New York Coll Osteopath Med, Old Westbury, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York Institute Technology	Goldfarb, JW (corresponding author), St Francis Hosp, Dept Res & Educ, Roslyn, NY 11576 USA.	James.Goldfarb.PhD@gmail.com			American Heart Association Scientist Development Grant [0635029N]	American Heart Association Scientist Development Grant(American Heart Association)	This work was supported by American Heart Association Scientist Development Grant, 0635029N.	Abdel-Aty H, 2007, J MAGN RESON IMAGING, V26, P452, DOI 10.1002/jmri.21028; Amado LC, 2004, J AM COLL CARDIOL, V44, P2383, DOI 10.1016/j.jacc.2004.09.020; Asanuma T, 1997, CIRCULATION, V96, P448; Basso C, 2006, HEART, V92, P1559, DOI 10.1136/hrt.2005.086959; Basso C, 2007, AM J CARDIOL, V100, P1322, DOI 10.1016/j.amjcard.2007.05.062; Beek AM, 2010, INT J CARDIOVAS IMAG, V26, P49, DOI 10.1007/s10554-009-9499-1; Brainovich V, 2009, MAGN RESON IMAGING, V27, P23, DOI 10.1016/j.mri.2008.05.006; Cannan C, 2010, JACC-CARDIOVASC IMAG, V3, P665, DOI 10.1016/j.jcmg.2009.12.019; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Croisille P, 2012, RADIOLOGY, V265, P12, DOI 10.1148/radiol.12111769; Denk C, 2010, J MAGN RESON IMAGING, V31, P185, DOI 10.1002/jmri.21995; Edelman RR, 2004, RADIOLOGY, V232, P653, DOI 10.1148/radiol.2323031558; Eitel I, 2011, CIRC-CARDIOVASC IMAG, V4, P354, DOI 10.1161/CIRCIMAGING.110.960500; El Aidi H, 2014, J AM COLL CARDIOL, V63, P1031, DOI 10.1016/j.jacc.2013.11.048; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Foltz WD, 2006, MAGN RESON MED, V56, P1311, DOI 10.1002/mrm.21079; Francone M, 2011, RADIOL MED, V116, P32, DOI 10.1007/s11547-010-0594-0; Ganame J, 2009, EUR HEART J, V30, P1440, DOI 10.1093/eurheartj/ehp093; GARCIADORADO D, 1990, AM J PATHOL, V137, P301; Gilbert G, 2012, MAGN RESON IMAGING, V30, P722, DOI 10.1016/j.mri.2012.02.008; Goldfarb JW, 2007, RADIOLOGY, V245, P245, DOI 10.1148/radiol.2451061590; Goldfarb JW, 2007, MAGN RESON MED, V57, P828, DOI 10.1002/mrm.21207; Goldfarb JW, 2014, MAGN RESON MED, V71, P1210, DOI 10.1002/mrm.24747; Greenwood JP, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-62; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Huber AM, 2005, RADIOLOGY, V237, P854, DOI 10.1148/radiol.2373041483; Jackowski C, 2006, EUR HEART J, V27, P2459, DOI 10.1093/eurheartj/ehl255; Kali A, 2013, RADIOLOGY, V269, P386, DOI 10.1148/radiol.13122397; Kumar A, 2011, JACC-CARDIOVASC IMAG, V4, P1274, DOI 10.1016/j.jcmg.2011.08.016; LOTAN CS, 1990, CATHETER CARDIO DIAG, V20, P205, DOI 10.1002/ccd.1810200313; LOTAN CS, 1992, CIRCULATION, V86, P1018, DOI 10.1161/01.CIR.86.3.1018; Marra MP, 2011, EUR HEART J, V32, P284, DOI 10.1093/eurheartj/ehq409; Mather AN, 2011, HEART, V97, P453, DOI 10.1136/hrt.2010.202028; Mikami Y, 2009, AM J ROENTGENOL, V193, pW321, DOI 10.2214/AJR.09.2335; O'Regan DP, 2010, HEART, V96, P1885, DOI 10.1136/hrt.2010.200634; O'Regan DP, 2009, RADIOLOGY, V250, P916, DOI 10.1148/radiol.2503081154; Ochiai K, 1999, J CARDIOV MAGN RESON, V1, P247, DOI 10.3109/10976649909088337; Pedersen SF, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-59; Porto I, 2011, AM HEART J, V162, P372, DOI 10.1016/j.ahj.2011.04.014; Quinn MP, 2013, AJNR AM J NEURORADIO; Rajiah P, 2013, RADIOGRAPHICS, V33, P1383, DOI 10.1148/rg.335125722; Rochitte CE, 1998, CIRCULATION, V98, P1006, DOI 10.1161/01.CIR.98.10.1006; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Saeed M, 2010, WORLD J RADIOL, V2, P1, DOI 10.4329/wjr.v2.i1.1; Saeed M, 2010, ACTA RADIOL, V51, P1093, DOI 10.3109/02841851.2010.520025; Salerno M, 2013, JACC-CARDIOVASC IMAG, V6, P806, DOI 10.1016/j.jcmg.2013.05.005; Schwartz RS, 2005, CATHETER CARDIO INTE, V66, P170, DOI 10.1002/ccd.20510; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Vargas-Barron J, 2014, REV INVEST CLIN, V66, P107; Wolff SD, 1997, RADIOLOGY, V202, P25, DOI 10.1148/radiology.202.1.8988186; Wu KC, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-68; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Yellon D.M, 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]; Zia MI, 2012, CIRC-CARDIOVASC IMAG, V5, P566, DOI 10.1161/CIRCIMAGING.112.973222	55	1	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123560	10.1371/journal.pone.0123560	http://dx.doi.org/10.1371/journal.pone.0123560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875478	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100188
J	Wagner, EYN; Wagner, JT; Glaus, J; Vandeleur, CL; Castelao, E; Strippoli, MPF; Vollenweider, P; Preisig, M; von Kanel, R				Wagner, En-Young N.; Wagner, Jan T.; Glaus, Jennifer; Vandeleur, Caroline L.; Castelao, Enrique; Strippoli, Marie-Pierre F.; Vollenweider, Peter; Preisig, Martin; von Kaenel, Roland			Evidence for Chronic Low-Grade Systemic Inflammation in Individuals with Agoraphobia from a Population-Based Prospective Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; POSTTRAUMATIC-STRESS-DISORDER; TEST-RETEST RELIABILITY; GENETIC-STUDIES DIGS; DIAGNOSTIC INTERVIEW; ANXIETY DISORDERS; PREVALENCE; RISK; INTERRATER	Background Anxiety disorders have been linked to an increased risk of incident coronary heart disease in which inflammation plays a key pathogenic role. To date, no studies have looked at the association between proinflammatory markers and agoraphobia. Methods In a random Swiss population sample of 2890 persons (35-67 years, 53% women), we diagnosed a total of 124 individuals (4.3%) with agoraphobia using a validated semi-structured psychiatric interview. We also assessed socioeconomic status, traditional cardiovascular risk factors (i.e., body mass index, hypertension, blood glucose levels, total cholesterol/ high-density lipoprotein-cholesterol ratio), and health behaviors (i.e., smoking, alcohol consumption, and physical activity), and other major psychiatric diseases (other anxiety disorders, major depressive disorder, drug dependence) which were treated as covariates in linear regression models. Circulating levels of inflammatory markers, statistically controlled for the baseline demographic and health-related measures, were determined at a mean follow-up of 5.5 +/- 0.4 years (range 4.7 -8.5). Results Individuals with agoraphobia had significantly higher follow-up levels of C-reactive protein (p = 0.007) and tumor-necrosis-factor-alpha (p = 0.042) as well as lower levels of the cardioprotective marker adiponectin (p = 0.032) than their non-agoraphobic counterparts. Follow-up levels of interleukin (IL)-1 beta and IL-6 did not significantly differ between the two groups. Conclusions Our results suggest an increase in chronic low-grade inflammation in agoraphobia over time. Such a mechanism might link agoraphobia with an increased risk of atherosclerosis and coronary heart disease, and needs to be tested in longitudinal studies.	[Wagner, En-Young N.] Univ Hosp Bern, Inselspital, Div Psychosomat Med, CH-3010 Bern, Switzerland; [Wagner, En-Young N.; von Kaenel, Roland] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Wagner, Jan T.] Swissmed, Div Clin Review, Bern, Switzerland; [Glaus, Jennifer; Vandeleur, Caroline L.; Castelao, Enrique; Strippoli, Marie-Pierre F.; Preisig, Martin] Univ Lausanne Hosp, Ctr Res Psychiat Epidemiol & Psychopathol, Dept Psychiat, Prilly, Switzerland; [Vollenweider, Peter] Univ Lausanne Hosp, Dept Med, Internal Med, Lausanne, Switzerland; [von Kaenel, Roland] Clin Barmelweid, Dept Psychosomat Med, Barmelweid, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Wagner, EYN (corresponding author), Univ Hosp Bern, Inselspital, Div Psychosomat Med, CH-3010 Bern, Switzerland.	en-young.wagner@insel.ch	Glaus, Jennifer/C-7887-2017; von Känel, Roland/B-1811-2019; Strippoli, Marie-Pierre F/K-8164-2013; Colaus, PsyColaus/K-6607-2013	Glaus, Jennifer/0000-0001-8883-9473; von Känel, Roland/0000-0002-8929-5129; Strippoli, Marie-Pierre F/0000-0003-3053-484X; Castelao, Enrique/0000-0003-1966-3683; Preisig, Martin/0000-0001-5689-4259; Vandeleur, Caroline/0000-0001-9092-6648	GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468, 33CS30-148401]	GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Peter Vollenweider, Gerard Waeber and Martin Preisig received two unrestricted grants from GlaxoSmithKline to build the cohort and to complete the physical and psychiatric baseline investigations. The CoLaus|PsyCoLaus study was and is supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (grants 3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468 and 33CS30-148401). The funders had no role in the study design, in the collection, management, analysis or interpretation of the data, in the preparation, review or approval of the manuscript, and the decision to submit the manuscript for publication.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bankier B, 2008, EUR HEART J, V29, P2212, DOI 10.1093/eurheartj/ehn326; Bekker MHJ, 2007, GENDER MED, V4, pS178, DOI 10.1016/S1550-8579(07)80057-X; Berney A, 2002, DRUG ALCOHOL DEPEN, V65, P149, DOI 10.1016/S0376-8716(01)00156-9; Bettschart W, 1996, EVALUATION CLIN STAN, VI; Buist-Bouwman MA, 2006, ACTA PSYCHIAT SCAND, V113, P492, DOI 10.1111/j.1600-0447.2005.00684.x; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; de Vries GJ, 2009, J TRAUMA STRESS, V22, P259, DOI 10.1002/jts.20429; Dufour MC, 1999, ALCOHOL RES HEALTH, V23, P5; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Emmelkamp PMG, 2009, STRESS-INDUCED AND FEAR CIRCUITRY DISORDERS: ADVANCING THE RESEARCH AGENDA FOR DSM-V, P77; Eraly SA, 2014, JAMA PSYCHIAT, V71, P423, DOI 10.1001/jamapsychiatry.2013.4374; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Flower L, 2000, CYTOKINE, V12, P1712, DOI 10.1006/cyto.2000.0764; Gill JM, 2009, PERSPECT PSYCHIATR C, V45, P262, DOI 10.1111/j.1744-6163.2009.00229.x; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Hamer M, 2006, BRAIN BEHAV IMMUN, V20, P456, DOI 10.1016/j.bbi.2006.01.001; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Leboyer M., 1995, INTERVIEW DIAGNOSTIQ; Libby P, 2001, CIRCULATION, V103, P1718, DOI 10.1161/01.CIR.103.13.1718; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; O'Donovan A, 2012, BRAIN BEHAV IMMUN, V26, P642, DOI 10.1016/j.bbi.2012.02.003; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pervanidou P, 2007, PSYCHONEUROENDOCRINO, V32, P991, DOI 10.1016/j.psyneuen.2007.07.001; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Preisig M, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-9; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Rothman K J, 1990, Epidemiology, V1, P232, DOI 10.1097/00001648-199005000-00009; Rougemont-Buecking A, 2008, PSYCHIAT RES, V157, P211, DOI 10.1016/j.psychres.2006.04.022; Skeppholm M, 2008, CLIN CHEM LAB MED, V46, P1175, DOI 10.1515/CCLM.2008.219; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; SURMAN OS, 1986, BIOL PSYCHIAT, V21, P768, DOI 10.1016/0006-3223(86)90242-8; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; van Zuiden M, 2013, BRAIN BEHAV IMMUN, V30, P12, DOI 10.1016/j.bbi.2012.08.015; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; von Kanel R, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13502; Wittchen HU, 2010, DEPRESS ANXIETY, V27, P113, DOI 10.1002/da.20646; World Health Organization, 2000, WHO TECH REP SER, V894, pi	51	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123757	10.1371/journal.pone.0123757	http://dx.doi.org/10.1371/journal.pone.0123757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875094	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100209
J	Zhao, PS; Lieu, T; Barlow, N; Sostegni, S; Haerteis, S; Korbmacher, C; Liedtke, W; Jimenez-Vargas, NN; Vanner, SJ; Bunnett, NW				Zhao, Peishen; Lieu, TinaMarie; Barlow, Nicholas; Sostegni, Silvia; Haerteis, Silke; Korbmacher, Christoph; Liedtke, Wolfgang; Jimenez-Vargas, Nestor N.; Vanner, Stephen J.; Bunnett, Nigel W.			Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR(2)) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; ARRESTIN-DEPENDENT ENDOCYTOSIS; SODIUM-CHANNEL ENAC; PROTEOLYTIC ACTIVATION; INDUCE INFLAMMATION; SERINE-PROTEASE; BIASED AGONIST; TRYPSIN-IV; PROTEINASE; KALLIKREIN	Proteases that cleave protease-activated receptor-2 (PAR(2)) at Arg(362) down arrow Ser(37) reveal a tethered ligand that binds to the cleaved receptor. PAR(2) activates transient receptor potential (TRP) channels of nociceptive neurons to induce neurogenic inflammation and pain. Although proteases that cleave PAR(2) at non-canonical sites can trigger distinct signaling cascades, the functional importance of the PAR(2)-biased agonism is uncertain. We investigated whether neutrophil elastase, a biased agonist of PAR(2), causes inflammation and pain by activating PAR(2) and TRP vanilloid 4 (TRPV4). Elastase cleaved human PAR(2) at Ala(662) down arrow Ser(67) and Ser(672) down arrow Val(68). Elastase stimulated PAR(2)-dependent cAMP accumulation and ERK1/2 activation, but not Ca2+ mobilization, in KNRK cells. Elastase induced PAR(2) coupling to G alpha(s) but not G alpha(q) in HEK293 cells. Although elastase did not promote recruitment of G protein-coupled receptor kinase-2 (GRK2) or beta-arrestin to PAR(2), consistent with its inability to promote receptor endocytosis, elastase did stimulate GRK6 recruitment. Elastase caused PAR(2)-dependent sensitization of TRPV4 currents in Xenopus laevis oocytes by adenylyl cyclase-and protein kinase A (PKA)-dependent mechanisms. Elastase stimulated PAR(2)-dependentc AMP formation and ERK1/2 phosphorylation, and a PAR(2)- and TRPV4-mediated influx of extracellular Ca2+ in mouse nociceptors. Adenylyl cyclase and PKA-mediated elastase-induced activation of TRPV4 and hyperexcitability of nociceptors. Intraplantar injection of elastase to mice caused edema and mechanical hyperalgesia by PAR(2)- and TRPV4-mediated mechanisms. Thus, the elastase-biased agonism of PAR(2) causes G alpha(s)-dependent activation of adenylyl cyclase and PKA, which activates TRPV4 and sensitizes nociceptors to cause inflammation and pain. Our results identify a novel mechanism of elastase-induced activation of TRPV4 and expand the role of PAR(2) as a mediator of protease-driven inflammation and pain.	[Zhao, Peishen; Lieu, TinaMarie; Barlow, Nicholas; Bunnett, Nigel W.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Bunnett, Nigel W.] Monash Univ, ARC Ctr Excellence Convergent Bionano Sci & Techn, Parkville, Vic 3052, Australia; [Sostegni, Silvia; Haerteis, Silke; Korbmacher, Christoph] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany; [Liedtke, Wolfgang] Duke Univ, Sch Med, Dept Neurol, Durham, NC 27710 USA; [Jimenez-Vargas, Nestor N.; Vanner, Stephen J.] Queens Univ, Div Gastroenterol, Gastrointestinal Dis Res Unit, Kingston, ON N7L 3N6, Canada; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	Monash University; Monash University; University of Erlangen Nuremberg; Duke University; Queens University - Canada; University of Melbourne	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	Nigel.Bunnett@Monash.edu	Zhao, Peishen/AFQ-6840-2022; Barlow, Nicholas/W-8442-2019; Lieu, TinaMarie/AAM-7691-2020; Liedtke, Wolfgang/GNH-1878-2022; Haerteis, Silke/AGS-5314-2022	Jimenez-Vargas, Nestor N/0000-0001-6595-1884; Barlow, Nicholas/0000-0002-5749-3542; Bunnett, Nigel W./0000-0003-3367-0644; Haerteis, Silke/0000-0002-9440-3307	NHMRC [63303, 1049682, 1031886]; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology; Monash University; Bayerische Forschungsstiftung; Else Kroner-Fresenius-Stiftung	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); Monash University(Monash University); Bayerische Forschungsstiftung; Else Kroner-Fresenius-Stiftung	This work was supported by NHMRC Grants 63303, 1049682, and 1031886, grants from the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Monash University (to N. W. B.), a Ph.D. fellowship from the Bayerische Forschungsstiftung (to S. S.), and the Else Kroner-Fresenius-Stiftung (to S. H.).	Amadesi S, 2004, CURR OPIN PHARMACOL, V4, P551, DOI 10.1016/j.coph.2004.08.004; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2009, J COMP NEUROL, V516, P141, DOI 10.1002/cne.22104; Ayoub Mohammed Akli, 2013, Front Endocrinol (Lausanne), V4, P196, DOI 10.3389/fendo.2013.00196; Bledsoe G, 2008, TOXICOL SCI, V102, P433, DOI 10.1093/toxsci/kfn008; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; de Garavilla L, 2001, BRIT J PHARMACOL, V133, P975, DOI 10.1038/sj.bjp.0704152; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Eijkelkamp N, 2009, BRAIN BEHAV IMMUN, V23, P18, DOI 10.1016/j.bbi.2008.07.006; Elmariah SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099702; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Haerteis S, 2012, PFLUG ARCH EUR J PHY, V464, P353, DOI 10.1007/s00424-012-1138-3; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Henriksen PA, 2014, CURR OPIN HEMATOL, V21, P23, DOI 10.1097/MOH.0000000000000001; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Kayssi A, 2007, J PHYSIOL-LONDON, V580, P977, DOI 10.1113/jphysiol.2006.126599; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Kocan Martina, 2010, Front Endocrinol (Lausanne), V1, P12, DOI 10.3389/fendo.2010.00012; Li JJ, 2011, ENVIRON HEALTH PERSP, V119, P784, DOI 10.1289/ehp.1002807; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Mihara K, 2013, J BIOL CHEM, V288, P32979, DOI 10.1074/jbc.M113.483123; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Poole DP, 2013, J BIOL CHEM, V288, P5790, DOI 10.1074/jbc.M112.438184; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramsay AJ, 2008, BIOL CHEM, V389, P653, DOI 10.1515/BC.2008.078; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Reed DE, 2003, J PHYSIOL-LONDON, V547, P531, DOI 10.1113/jphysiol.2002.032011; Sipe WEB, 2008, AM J PHYSIOL-GASTR L, V294, pG1288, DOI 10.1152/ajpgi.00002.2008; Smith R, 2000, FEBS LETT, V484, P285, DOI 10.1016/S0014-5793(00)02146-3; Sostegni S, 2015, PFLUG ARCH EUR J PHY, V467, P687, DOI 10.1007/s00424-014-1539-6; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Sun BB, 2013, J MOL HISTOL, V44, P259, DOI 10.1007/s10735-013-9486-7; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Vergnolle N, 2010, BRIT J PHARMACOL, V159, P1161, DOI 10.1111/j.1476-5381.2009.00590.x; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Willoughby D, 2012, BIOCHEM SOC T, V40, P246, DOI 10.1042/BST20110613; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712; Zhou Y, 2013, NEUROCHEM RES, V38, P2168, DOI 10.1007/s11064-013-1125-x	64	106	114	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13875	13887		10.1074/jbc.M115.642736	http://dx.doi.org/10.1074/jbc.M115.642736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25878251	Green Published, hybrid			2022-12-26	WOS:000355313000020
J	Yang, XL; Zhao, JY; Wang, C; Duan, YG; Zhao, ZP; Chen, R; Zhang, LY; Xing, L; Lai, CC; Zhang, SG; Wang, XL; Yang, PH				Yang, Xiaolan; Zhao, Jianyu; Wang, Cheng; Duan, Yuegiang; Zhao, Zhongpeng; Chen, Rui; Zhang, Liangyan; Xing, Li; Lai, Chengcai; Zhang, Shaogeng; Wang, Xiliang; Yang, Penghui			Immunization with a Live Attenuated H7N9 Influenza Vaccine Protects Mice against Lethal Challenge	PLOS ONE			English	Article							VIRUS-VACCINE; A VIRUS; PROVIDES PROTECTION; REVERSE GENETICS; IMMUNE-RESPONSES; HUMAN INFECTION; FERRETS; CANDIDATE; LAIV	The emergence of severe cases of human influenza A (H7N9) viral infection in China in the spring of 2003 resulted in a global effort to rapidly develop an effective candidate vaccine. In this study, a cold-adapted (ca), live attenuated monovalent reassortant influenza H7N9 virus (Ah01/AA ca) was generated using reverse genetics that contained hemagglutinin (HA) and neuraminidase (NA) genes from a 2013 pandemic A H7N9 isolate, A/Anhui/01/2013 virus (Ah01/H7N9); the remaining six backbone genes derived from the cold-adapted influenza H2N2 A/Ann Arbor/6/60 virus (AA virus). Ah01/AA ca virus exhibited temperature sensitivity (ts), ca, and attenuation (att) phenotypes. Intranasal immunization of female BALB/c mice with Ah01/AA ca twice at a 2-week interval induced robust humoral, mucosal, and cell-mediated immune responses in a dose-dependent manner. Furthermore, the candidate Ah01/AA ca virus was immunogenic and offered partial or complete protection of mice against a lethal challenge by the live 2013 influenza A H7N9 (A/Anhui/01/2013). Protection was demonstrated by the inhibition of viral replication and the attenuation of histopathological changes in the challenged mouse lung. Taken together, these data support the further evaluation of this Ah01/AA ca candidate vaccine in primates.	[Yang, Xiaolan; Duan, Yuegiang; Zhao, Zhongpeng; Chen, Rui; Zhang, Liangyan; Xing, Li; Lai, Chengcai; Wang, Xiliang; Yang, Penghui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhao, Jianyu] China Astronaut Res & Training Ctr, Beijing, Peoples R China; [Wang, Cheng] Acad Med Sci, Beijing Hosp 307, Beijing, Peoples R China; [Zhang, Shaogeng; Yang, Penghui] Beijing 302 Hosp, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Beijing Hospital; Fifth Medical Center of Chinese PLA General Hospital	Wang, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiliangw@126.com; ypenghuiamms@hotmail.com		zhongpeng, zhao/0000-0002-9147-6252	National Natural Scientific Foundation [81370518]; National Programs for High Technology Research and Development of China [SS2015AA020924]; Ministry of Science and Technology of China [2012CB518905, 2013ZX10004003, SS2012AA020905]; Beijing Nova Program [Z141107001814054]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); National Programs for High Technology Research and Development of China(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by funding from the National Natural Scientific Foundation (81370518), National Programs for High Technology Research and Development of China (SS2015AA020924), and the Ministry of Science and Technology of China (2012CB518905, 2013ZX10004003, and SS2012AA020905). PY was supported by Beijing Nova Program (No. Z141107001814054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors declare no financial or commercial conflicts of interest.	Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Chang FY, 2013, NEW ENGL J MED, V369, P879, DOI 10.1056/NEJMc1308255; Chen HL, 2003, VACCINE, V21, P1974, DOI 10.1016/S0264-410X(02)00809-5; Chen ZY, 2014, J VIROL, V88, P7016, DOI 10.1128/JVI.00100-14; Chen ZY, 2009, J VIROL, V83, P65, DOI 10.1128/JVI.01775-08; Dormitzer PR, 2012, HUM VACC IMMUNOTHER, V8, P45, DOI 10.4161/hv.8.1.18859; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; HERLOCHER ML, 1993, P NATL ACAD SCI USA, V90, P6032, DOI 10.1073/pnas.90.13.6032; Jang YH, 2013, VACCINE, V31, P1320, DOI 10.1016/j.vaccine.2012.12.072; Joseph T, 2008, VIROLOGY, V378, P123, DOI 10.1016/j.virol.2008.05.021; Krammer F, 2014, CLIN VACCINE IMMUNOL, V21, P1153, DOI 10.1128/CVI.00272-14; Krammer F, 2014, J VIROL, V88, P3976, DOI 10.1128/JVI.03095-13; Lanthier PA, 2011, VACCINE, V29, P7849, DOI 10.1016/j.vaccine.2011.07.093; Lee Chang-Won, 2008, V436, P99, DOI 10.1007/978-1-59745-279-3_12; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; Voeten JTM, 2010, ARCH VIROL, V155, P1391, DOI 10.1007/s00705-010-0719-8; Yang PH, 2011, VACCINE, V29, P698, DOI 10.1016/j.vaccine.2010.11.026; Yang PH, 2010, CELL MOL IMMUNOL, V7, P116, DOI 10.1038/cmi.2009.116	21	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123659	10.1371/journal.pone.0123659	http://dx.doi.org/10.1371/journal.pone.0123659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884801	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000080
J	Cui, H; Wang, L; Gong, PH; Zhao, CC; Zhang, SD; Zhang, K; Zhou, RP; Zhao, ZJ; Fan, H				Cui, He; Wang, Ling; Gong, Pihai; Zhao, Chengcheng; Zhang, Shaodan; Zhang, Kun; Zhou, Rongping; Zhao, Zhujiang; Fan, Hong			Deregulation between miR-29b/c and DNMT3A Is Associated with Epigenetic Silencing of the CDH1 Gene, Affecting Cell Migration and Invasion in Gastric Cancer	PLOS ONE			English	Article							DNA METHYLTRANSFERASE PROTEINS; CLINICAL-SIGNIFICANCE; MICRORNA; EXPRESSION; METHYLATION; FAMILY; HYPERMETHYLATION; INVOLVEMENT; PROMOTER; RISK	The de-regulation of the miR-29 family and DNA methyltransferase 3A (DNMT3A) is associated with gastric cancer (GC). While increasing evidence indicates miR-29b/c could regulate DNA methylation by targeting DNMT3A, it is currently unknown if epigenetic silencing of miR-29b/c via promoter hypermethylation in GC is caused by abnormal expression of DNMT3A. Thus, we aimed to evaluate whether cross-talk regulation exists between miR-29b/c and DNMT3A and whether it is associated with a malignant phenotype in GC. First, wound healing and Transwell assays revealed that miR-29b/c suppresses tumor metastasis in GC. A luciferase reporter assay demonstrated that DNMT3A is a direct target of miR-29b/c. We used bisulfite genomic sequencing to analyze the DNA methylation status of miR-29b/c. The percentage of methylated CpGs was significantly decreased in DNMT3A-depleted cells compared to the controls. Furthermore, the involvement of DNMT3A in promoting GC cell migration was associated with the promoter methylation-mediated repression of CDH1. In 50 paired clinical GC tissue specimens, decreased miR-29b/c was significantly correlated with the degree of differentiation and invasion of the cells and was negatively correlated with DNMT3A expression. Together, our preliminary results suggest that the following process may be involved in GC tumorigenesis. miR-29b/c suppresses the downstream gene DNMT3A, and in turn, miR-29b/c is suppressed by DNMT3A in a DNA methylation-dependent manner. The de-regulation of both of miR-29b/c and DNMT3A leads to the epigenetic silencing of CDH1 and contributes to the metastasis phenotype in GC. This finding reveals that DNA methylation-associated silencing of miR-29b/c is critical for GC development and thus may be a therapeutic target.	[Cui, He; Wang, Ling; Gong, Pihai; Zhao, Chengcheng; Zhang, Shaodan; Zhao, Zhujiang; Fan, Hong] Southeast Univ, Dept Med Genet & Dev Biol, Sch Med, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing 210009, Jiangsu, Peoples R China; [Zhang, Kun] Harbin Med Univ, Affiliated Hosp 3, Canc Hosp, Harbin 150081, Peoples R China; [Zhou, Rongping] Nanjing Med Univ, Affiliated Jiangning Hosp, Nanjing 210000, Jiangsu, Peoples R China	Southeast University - China; Harbin Medical University; Nanjing Medical University	Fan, H (corresponding author), Southeast Univ, Dept Med Genet & Dev Biol, Sch Med, Key Lab Dev Genes & Human Dis,Minist Educ, Nanjing 210009, Jiangsu, Peoples R China.	fanh@seu.edu.cn			National Natural Science Foundation of China [81171915, 91229107, 81472548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81171915, No. 91229107 and No. 81472548), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cao XY, 2014, WORLD J GASTROENTERO, V20, P8201, DOI 10.3748/wjg.v20.i25.8201; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Ding WJ, 2008, DIGEST DIS SCI, V53, P2083, DOI 10.1007/s10620-007-0145-2; Eyholzer M, 2010, BRIT J CANCER, V103, P275, DOI 10.1038/sj.bjc.6605751; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fesler A, 2014, ONCOTARGETS THER, V7, P7, DOI 10.2147/OTT.S65548; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Gong JA, 2014, CARCINOGENESIS, V35, P497, DOI 10.1093/carcin/bgt337; Han L, 2007, CANCER BIOL THER, V6, P1284; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lang Nan, 2010, Chin J Cancer, V29, P603; Lordick Florian, 2005, Gastric Cancer, V8, P78, DOI 10.1007/s10120-005-0321-z; Lujambio A, 2007, CELL CYCLE, V6, P1455; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; MAEHARA Y, 1991, SURGERY, V110, P820; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Rodriguez Luis G, 2005, Methods Mol Biol, V294, P23; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Tamura G, 2000, J NATL CANCER I, V92, P569, DOI 10.1093/jnci/92.7.569; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang HJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-121; Wang JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078393, 10.1371/journal.pone.0073683, 10.1371/journal.pone.0063924, 10.1371/journal.pone.0066563, 10.1371/journal.pone.0070587]; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Weissmann-Brenner A, 2012, INT J ONCOL, V40, P2097, DOI 10.3892/ijo.2012.1403; Xia JZ, 2014, J CANCER RES CLIN, V140, P1451, DOI 10.1007/s00432-014-1649-8; Yang J, 2011, MOL MED REP, V4, P1139, DOI 10.3892/mmr.2011.578; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhao Z, 2010, J BIOMED BIOTECHNOL, V2010, DOI [10.1155/2010/737535, DOI 10.1155/2010/73753]	36	54	57	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123926	10.1371/journal.pone.0123926	http://dx.doi.org/10.1371/journal.pone.0123926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874772	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800125
J	Shimizu, M; Li, J; Inoue, J; Sato, R				Shimizu, Makoto; Li, Juan; Inoue, Jun; Sato, Ryuichiro			Quercetin Represses Apolipoprotein B Expression by Inhibiting the Transcriptional Activity of C/EBP beta	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; GENE PROMOTER; RECEPTOR EXPRESSION; HEPG2 CELLS; ABSORPTION; SECRETION; ELEMENT; PLASMA; KINASE; BIND	Quercetin is one of the most abundant polyphenolic flavonoids found in fruits and vegetables and has anti-oxidative and anti-obesity effects. Because the small intestine is a major absorptive organ of dietary nutrients, it is likely that highly concentrated food constituents, including polyphenols, are present in the small intestinal epithelial cells, suggesting that food factors may have a profound effect in this tissue. To identify novel targets of quercetin in the intestinal enterocytes, mRNA profiling using human intestinal epithelial Caco-2 cells was performed. We found that mRNA levels of some apolipoproteins, particularly apolipoprotein B (apoB), are downregulated in the presence of quercetin. On the exposure of Caco-2 cells to quercetin, both mRNA and protein levels of apoB were decreased. Promoter analysis of the human apoB revealed that quercetin response element is localized at the 5'-proximal promoter region, which contains a conserved CCAAT enhancer-binding protein (C/EBP)-response element. We found that quercetin reduces the promoter activity of apoB, driven by the enforced expression of C/EBP beta. Quercetin had no effect on either mRNA or protein levels of C/EBP beta. In contrast, we found that quercetin inhibits the transcriptional activity of C/EBP beta but not its recruitment to the apoB promoter. On the exposure of Caco-2 cells to quercetin 3-O-glucuronide, which is in a cell-impermeable form, no notable change in apoB mRNA was observed, suggesting an intracellular action of quercetin. In vitro interaction experiments using quercetin-conjugated beads revealed that quercetin binds to C/EBP beta. Our results describe a novel regulatory mechanism of transcription of apolipoprotein genes by quercetin in the intestinal enterocytes.	[Shimizu, Makoto; Li, Juan; Inoue, Jun; Sato, Ryuichiro] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Sato, R (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	INOUE, Jun/O-7352-2016	INOUE, Jun/0000-0003-4145-3754	Ministry of Agriculture, Forestry and Fisheries; Nestle Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP) [14533567]	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Nestle Research Foundation(Nestle SA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP)	This study was supported by grants for project research from the Ministry of Agriculture, Forestry and Fisheries (Development of Fundamental Technology for analysis and evaluation of functional agricultural products and functional foods), Nestle Research Foundation, and research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP Project ID 14533567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Dimple, 2005, BMC Cardiovasc Disord, V5, P30, DOI 10.1186/1471-2261-5-30; Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; Alam MM, 2014, LIFE SCI, V109, P8, DOI 10.1016/j.lfs.2014.06.005; Antes TJ, 2000, J BIOL CHEM, V275, P26637, DOI 10.1074/jbc.M003025200; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; CARLSSON P, 1990, GENE, V94, P295, DOI 10.1016/0378-1119(90)90401-C; Casaschi A, 2002, LIPIDS, V37, P647, DOI 10.1007/s11745-002-0945-8; de Vries JHM, 1998, AM J CLIN NUTR, V68, P60, DOI 10.1093/ajcn/68.1.60; Duez H, 2008, ATHEROSCLEROSIS SUPP, V9, P33, DOI 10.1016/j.atherosclerosissup.2008.05.013; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Hungness ES, 2002, BIOCHEM BIOPH RES CO, V290, P469, DOI 10.1006/bbrc.2001.6168; Inoue J, 2011, FEBS J, V278, P2739, DOI 10.1111/j.1742-4658.2011.08204.x; Iqbal J, 2013, J BIOL CHEM, V288, P30432, DOI 10.1074/jbc.M113.501247; Kanazawa K, 2006, ARCH BIOCHEM BIOPHYS, V455, P197, DOI 10.1016/j.abb.2006.09.003; KARDASSIS D, 1992, J BIOL CHEM, V267, P2622; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kobori M, 2009, MOL NUTR FOOD RES, V53, P859, DOI 10.1002/mnfr.200800310; Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Luchoomun J, 1997, ARTERIOSCL THROM VAS, V17, P2955, DOI 10.1161/01.ATV.17.11.2955; METZGER S, 1990, J BIOL CHEM, V265, P9978; METZGER S, 1993, J BIOL CHEM, V268, P16831; Moon JH, 2000, AM J PHYSIOL-REG I, V279, pR461, DOI 10.1152/ajpregu.2000.279.2.R461; Mullen W, 2006, BRIT J NUTR, V96, P107, DOI 10.1079/BJN20061809; Murota K, 2000, ARCH BIOCHEM BIOPHYS, V384, P391, DOI 10.1006/abbi.2000.2123; Pal S, 2003, J NUTR, V133, P700, DOI 10.1093/jn/133.3.700; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Takahashi M, 2008, BIOCHEM BIOPH RES CO, V372, P395, DOI 10.1016/j.bbrc.2008.04.136; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; Zannis VI, 2001, FRONT BIOSCI-LANDMRK, V6, pD456, DOI 10.2741/Zannis	35	11	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121784	10.1371/journal.pone.0121784	http://dx.doi.org/10.1371/journal.pone.0121784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875015	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800029
J	Nguyen, NUN; Wang, HV				Ngoc-Uyen-Nhi Nguyen; Wang, Hao-Ven			Dual Roles of Palladin Protein in In Vitro Myogenesis: Inhibition of Early Induction but Promotion of Myotube Maturation	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; ACTIN-ASSOCIATED PROTEIN; MOLECULAR REGULATION; PROGENITOR CELLS; ALPHA-ACTININ; MYOSTATIN; EXPRESSION; ORGANIZATION; CYTOSKELETON; MIGRATION	Palladin is a microfilament-associated phosphoprotein whose function in skeletal muscle has rarely been studied. Therefore, we investigate whether myogenesis is influenced by the depletion of palladin expression known to interfere with the actin cytoskeleton dynamic required for skeletal muscle differentiation. The inhibition of palladin in C2C12 myoblasts leads to precocious myogenic differentiation with a concomitant reduction in cell apoptosis. This premature myogenesis is caused, in part, by an accelerated induction of p21, myogenin, and myosin heavy chain, suggesting that palladin acts as a negative regulator in early differentiation phases. Paradoxically, palladin-knockdown myoblasts are unable to differentiate terminally, despite their ability to perform some initial steps of differentiation. Cells with attenuated palladin expression form thinner myotubes with fewer myonuclei compared to those of the control. It is noteworthy that a negative regulator of myogenesis, myostatin, is activated in palladin-deficient myotubes, suggesting the palladin- mediated impairment of late-stage myogenesis. Additionally, overexpression of 140-kDa palladin inhibits myoblast differentiation while 200-kDa and 90-kDa palladin-overexpressed cells display an enhanced differentiation rate. Together, our data suggest that palladin might have both positive and negative roles in maintaining the proper skeletal myogenic differentiation in vitro.	[Ngoc-Uyen-Nhi Nguyen; Wang, Hao-Ven] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Wang, Hao-Ven] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Ngoc-Uyen-Nhi Nguyen; Wang, Hao-Ven] Natl Cheng Kung Univ, Ctr Cell Dynam, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Wang, HV (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	hvwang@mail.ncku.edu.tw		Nguyen, Ngoc Uyen Nhi/0000-0003-0694-3176; Wang, Hao-Ven/0000-0001-7523-087X	Ministry of Sciences and Technology (MOST) [1022320-B-006-036]; National Cheng Kung University's Aim for the Top University Project	Ministry of Sciences and Technology (MOST); National Cheng Kung University's Aim for the Top University Project	This work was supported by grants from the Ministry of Sciences and Technology (MOST 1022320-B-006-036) and National Cheng Kung University's Aim for the Top University Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029338; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Beck MR, 2011, J MOL BIOL, V413, P712, DOI 10.1016/j.jmb.2011.08.059; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; DIAS P, 1994, SEMIN DIAGN PATHOL, V11, P3; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Huygens W, 2004, PHYSIOL GENOMICS, V17, P264, DOI 10.1152/physiolgenomics.00224.2003; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012823; Johnston APW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015212; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Joulia-Ekaza D, 2006, EXP CELL RES, V312, P3458, DOI 10.1016/j.yexcr.2006.07.010; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Milan G, 2004, J CLIN ENDOCR METAB, V89, P2724, DOI 10.1210/jc.2003-032047; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Nguyen NUN, 2014, BIOCHEM BIOPH RES CO, V452, P728, DOI 10.1016/j.bbrc.2014.08.143; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; PATERSON B, 1972, DEV BIOL, V29, P113, DOI 10.1016/0012-1606(72)90050-4; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Rios R, 2001, BIOCHEM BIOPH RES CO, V280, P561, DOI 10.1006/bbrc.2000.4159; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255; Zhang YJ, 2005, PROG BIOCHEM BIOPHYS, V32, P607; Zhou W, 2011, BIOCHEM BIOPH RES CO, V411, P768, DOI 10.1016/j.bbrc.2011.07.022	53	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124762	10.1371/journal.pone.0124762	http://dx.doi.org/10.1371/journal.pone.0124762			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875253	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700072
J	Bewley, KD; Dey, M; Bjork, RE; Mitra, S; Chobot, SE; Drennan, CL; Elliott, SJ				Bewley, Kathryn D.; Dey, Mishtu; Bjork, Rebekah E.; Mitra, Sangha; Chobot, Sarah E.; Drennan, Catherine L.; Elliott, Sean J.			Rheostat Re-Wired: Alternative Hypotheses for the Control of Thioredoxin Reduction Potentials	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; ESCHERICHIA-COLI THIOREDOXIN; SITE CYSTEINE RESIDUES; ACTIVE-SITE; REDOX PROPERTIES; DESTABILIZING DISULFIDE; REDUCED FORM; DSBA; BOND; IONIZATION	Thioredoxins are small soluble proteins that contain a redox-active disulfide (CXXC). These disulfides are tuned to oxidizing or reducing potentials depending on the function of the thioredoxin within the cell. The mechanism by which the potential is tuned has been controversial, with two main hypotheses: first, that redox potential (Em) is specifically governed by a molecular 'rheostat'-the XX amino acids, which influence the Cys pK(a) values, and thereby, Em; and second, the overall thermodynamics of protein folding stability regulates the potential. Here, we use protein film voltammetry (PFV) to measure the pH dependence of the redox potentials of a series of wild-type and mutant archaeal Trxs, PFV and glutathionine-equilibrium to corroborate the measured potentials, the fluorescence probe BADAN to measure pKa values, guanidinium-based denaturation to measure protein unfolding, and X-ray crystallography to provide a structural basis for our functional analyses. We find that when these archaeal thioredoxins are probed directly using PFV, both the high and low potential thioredoxins display consistent 2H(+):2e-coupling over a physiological pH range, in conflict with the conventional 'rheostat' model. Instead, folding measurements reveals an excellent correlation to reduction potentials, supporting the second hypothesis and revealing the molecular mechanism of reduction potential control in the ubiquitous Trx family.	[Bewley, Kathryn D.; Mitra, Sangha; Chobot, Sarah E.; Elliott, Sean J.] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Dey, Mishtu; Bjork, Rebekah E.; Drennan, Catherine L.] Howard Hughes Med Inst, Cambridge, MA USA; [Dey, Mishtu; Bjork, Rebekah E.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA USA	Boston University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Elliott, SJ (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.	elliott@bu.edu		Hokanson, Sarah Chobot/0000-0002-7348-4312; Elliott, Sean/0000-0003-0096-9551	National Science Foundation [MCB 1122977]; Smith Family New Investigator Award; Boston University Undergraduate Research Opportunities Program; Direct For Biological Sciences [1122977] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Smith Family New Investigator Award; Boston University Undergraduate Research Opportunities Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (MCB 1122977), a Smith Family New Investigator Award (SJE) and the Boston University Undergraduate Research Opportunities Program (SEC). CLD is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Chobot S. E., 2007, ANGEW CHEM INT EDIT, V119, P4223; Clark W. M., 1960, OXIDATION REDUCTION; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Dawson RMC., 1989, DATA BIOCH RES; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P4129, DOI 10.1021/bi00469a016; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fourmond V, 2009, BIOELECTROCHEMISTRY, V76, P141, DOI 10.1016/j.bioelechem.2009.02.010; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Hamill MJ, 2008, BIOCHEMISTRY-US, V47, P9738, DOI 10.1021/bi800676g; HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Hiniker A, 2003, BIOCHEMISTRY-US, V42, P1179, DOI 10.1021/bi027141t; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jacobi A, 1997, J BIOL CHEM, V272, P21692, DOI 10.1074/jbc.272.35.21692; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mossner E, 1998, PROTEIN SCI, V7, P1233; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nordstrand K, 1999, FEBS LETT, V449, P196, DOI 10.1016/S0014-5793(99)00401-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C N, 1986, Methods Enzymol, V131, P266; ROST J, 1964, NATURE, V201, P185, DOI 10.1038/201185a0; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Slaby I, 1996, J BIOL CHEM, V271, P3091, DOI 10.1074/jbc.271.6.3091; Takahashi N, 1996, BIOCHEMISTRY-US, V35, P8342, DOI 10.1021/bi960465v; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	43	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122466	10.1371/journal.pone.0122466	http://dx.doi.org/10.1371/journal.pone.0122466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874934	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100074
J	Kim, HL; Jin, KN; Seo, JB; Choi, YH; Chung, WY; Kim, SH; Kim, MA; Zo, JH				Kim, Hack-Lyoung; Jin, Kwang Nam; Seo, Jae-Bin; Choi, Young Ho; Chung, Woo-Young; Kim, Sang-Hyun; Kim, Myung-A; Zo, Joo-Hee			The Association of Brachial-Ankle Pulse Wave Velocity with Coronary Artery Disease Evaluated by Coronary Computed Tomography Angiography	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR EVENTS; INDEPENDENT PREDICTOR; PROGNOSTIC VALUE; CT ANGIOGRAPHY; STIFFNESS; PLAQUE; SEVERITY; CALCIUM; INDEX	The aim of this study was to investigate whether brachial-ankle pulse wave velocity (baPWV) is associated with the severity of coronary artery disease (CAD) assessed by coronary computed tomography angiography (CCTA), and to evaluate baPWV as a predictor of obstructive CAD on CCTA. A total of 470 patients who underwent both baPWV and CCTA were included. We evaluated stenosis degree and plaque characteristics on CCTA. To estimate the severity of CAD, we calculated the number of segment with plaque (segment involvement score; SIS), stenosis degree-weighted plaque score (segment stenosis score; SSS), and coronary artery calcium score (CACS). The mean baPWV was 1,485 +/- 315 cm/s (range, 935-3,175 cm/s). Non-obstructive (stenosis < 50%) and obstructive (stenosis >= 50%) CAD was found in 129 patients (27.4%) and 144 (30.6%), respectively. baPWV in patients with obstructive CAD was higher than that of patients with non-obstructive (1,680 +/- 396 cm/s versus 1,477 +/- 244 cm/s, P < 0.001) or no CAD (1,680 +/- 396 cm/s versus +/- 196 1,389 cm/s, P < 0.001). baPWV showed significant correlation with SSS (r = 0.429, P < 0.001), SIS (r = 0.395, P < 0.001), CACS (r 0.346, P < 0.001), and the number of segment with non-calcified plaque (r 0.092, P = 0.047), mixed plaque (r = 0.267, P < 0.001), and calcified plaque (r = 0.348, P < 0.001), respectively. The optimal baPWV cut-off value for the detection of obstructive CAD was 1,547 cm/s. baPWV >= 1,547 cm/s was independent predictor for the obstructive CAD. In conclusion, baPWV is well correlated with the severity of CAD evaluated by CCTA. baPWV has the potential to predict severity of coronary artery atherosclerosis.	[Kim, Hack-Lyoung; Seo, Jae-Bin; Chung, Woo-Young; Kim, Sang-Hyun; Kim, Myung-A; Zo, Joo-Hee] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Internal Med,Div Cardiol, Seoul, South Korea; [Jin, Kwang Nam; Choi, Young Ho] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Zo, JH (corresponding author), Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Internal Med,Div Cardiol, Seoul, South Korea.	jooheezo@hanmail.net	Kim, Hack-Lyoung/AAL-5038-2020; Stefanadis, Christodoulos/ABH-2232-2020	Kim, Hack-Lyoung/0000-0002-6703-1472; Stefanadis, Christodoulos/0000-0001-5974-6454; Kim, Sang-Hyun/0000-0001-8026-1582				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Austen W G, 1975, Circulation, V51, P5; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Cecelja M, 2011, J AM COLL CARDIOL, V57, P1480, DOI 10.1016/j.jacc.2010.09.079; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; FARRAR DJ, 1991, CIRCULATION, V83, P1754, DOI 10.1161/01.CIR.83.5.1754; Gao DF, 2011, ATHEROSCLEROSIS, V219, P603, DOI 10.1016/j.atherosclerosis.2011.08.022; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hoffmann U, 2006, CIRCULATION, V114, P2251, DOI 10.1161/CIRCULATIONAHA.106.634808; Hope SA, 2007, J HYPERTENS, V25, P2105, DOI 10.1097/HJH.0b013e3282a9be41; Imanishi R, 2004, HYPERTENS RES, V27, P71, DOI 10.1291/hypres.27.71; Kim HL, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-2; Kullo IJ, 2006, HYPERTENSION, V47, P174, DOI 10.1161/01.HYP.0000199605.35173.14; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Leung MCH, 2006, AM J PHYSIOL-HEART C, V290, pH624, DOI 10.1152/ajpheart.00380.2005; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Munakata M, 2003, AM J HYPERTENS, V16, P653, DOI 10.1016/S0895-7061(03)00918-X; Nakamura M, 2010, HYPERTENS RES, V33, P1018, DOI 10.1038/hr.2010.126; Nakazato R, 2012, ATHEROSCLEROSIS, V225, P148, DOI 10.1016/j.atherosclerosis.2012.08.002; Nam HJ, 2012, INT J CARDIOL, V157, P227, DOI 10.1016/j.ijcard.2011.01.045; Nance JW, 2012, RADIOLOGY, V264, P679, DOI 10.1148/radiol.12112350; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; Pundziute G, 2008, JACC-CARDIOVASC INTE, V1, P176, DOI 10.1016/j.jcin.2008.01.007; Schroeder S, 2001, J AM COLL CARDIOL, V37, P1430, DOI 10.1016/S0735-1097(01)01115-9; Seo Won-Woo, 2010, Korean Circ J, V40, P224, DOI 10.4070/kcj.2010.40.5.224; Shmilovich H, 2011, ATHEROSCLEROSIS, V219, P588, DOI 10.1016/j.atherosclerosis.2011.07.128; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Tomiyama H, 2005, CIRC J, V69, P815, DOI 10.1253/circj.69.815; Tomlinson LA, 2012, CURR OPIN NEPHROL HY, V21, P655, DOI 10.1097/MNH.0b013e32835856e3; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Waddell TK, 2001, HYPERTENSION, V38, P927, DOI 10.1161/hy1001.096107; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3; WITTEMAN JCM, 1994, LANCET, V343, P504, DOI 10.1016/S0140-6736(94)91459-1; Xiong ZJ, 2012, J ATHEROSCLER THROMB, V19, P970, DOI 10.5551/jat.13326; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Zureik M, 2003, HYPERTENSION, V41, P519, DOI 10.1161/01.HYP.0000054978.86286.92; 한승환, 2004, Korean Circulation Journal, V34, P468	45	17	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123164	10.1371/journal.pone.0123164	http://dx.doi.org/10.1371/journal.pone.0123164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875036	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100143
J	Laurent, A; Calabrese, M; Warnatz, HJ; Yaspo, ML; Tkachuk, V; Torres, M; Blasi, F; Penkov, D				Laurent, Audrey; Calabrese, Manuela; Warnatz, Hans-Joerg; Yaspo, Marie-Laure; Tkachuk, Vsevolod; Torres, Miguel; Blasi, Francesco; Penkov, Dmitry			ChIP-Seq and RNA-Seq Analyses Identify Components of the Wnt and Fgf Signaling Pathways as Prep1 Target Genes in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; HOX PROTEIN; PBX; DNA; COMPLEX; PKNOX1; DIFFERENTIATION; EMBRYOGENESIS; PLURIPOTENT; EXPRESSION	The Prep1 (Pknox1) homeodomain transcription factor is essential at multiple stages of embryo development. In the E11.5 embryo trunk, we previously estimated that Prep1 binds about 3,300 genomic sites at a highly specific decameric consensus sequence, mainly governing basal cellular functions. We now show that in embryonic stem (ES) cells Prep1 binding pattern only partly overlaps that of the embryo trunk, with about 2,000 novel sites. Moreover, in ES cells Prep1 still binds mostly to promoters, as in total embryo trunk but, among the peaks bound exclusively in ES cells, the percentage of enhancers was threefold higher. RNA-seq identifies about 1800 genes down-regulated in Prep1(-/-) ES cells which belong to gene ontology categories not enriched in the E11.5 Prep1(i/i) differentiated embryo, including in particular essential components of the Wnt and Fgf pathways. These data agree with aberrant Wnt and Fgf expression levels in the Prep1(-/-) ES cells with a deficient embryoid bodies (EBs) formation and differentiation. Re-establishment of the Prep1 level rescues the phenotype.	[Laurent, Audrey; Calabrese, Manuela; Blasi, Francesco; Penkov, Dmitry] IFOM FIRC Inst Mol Oncol, Milan, Italy; [Warnatz, Hans-Joerg; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Tkachuk, Vsevolod] Moscow MV Lomonosov State Univ, Fac Basic Med, Moscow, Russia; [Torres, Miguel] CNIC, Dept Cardiovasc Dev & Repair, Madrid, Spain; [Penkov, Dmitry] Russian Cardiol Res & Prod Complex, Dept Expt Cardiol, Moscow, Russia	IFOM - FIRC Institute of Molecular Oncology; Max Planck Society; Lomonosov Moscow State University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); National Medical Research Center of Cardiology	Blasi, F (corresponding author), IFOM FIRC Inst Mol Oncol, IFOM IEO Campus, Milan, Italy.	francesco.blasi@ifom.eu; dmitry.penkov@ifom.eu	Torres, Miguel/CAG-0003-2022; Tkachuk, Vsevolod/AAE-1136-2022; Torres, Miguel/A-7388-2013; Tkachuk, Vsevolod A/J-9357-2012	Torres, Miguel/0000-0003-0906-4767; Torres, Miguel/0000-0003-0906-4767; Warnatz, Hans-Jorg/0000-0002-0327-9209; Blasi, Francesco/0000-0001-9406-1784; LAURENT, Audrey/0000-0002-7643-6017	FUV (Fondazione Umberto Veronesi); AIRC (Italian Association for Cancer Research) [BM0805]; Cariplo Foundation; Italian Ministry of Health; Max Planck Society (Munich, Germany); European Commission (FP6, grant AnEUploidy) [LSHG-CT-2006-037627]; Spanish Ministerio de Economia y Competitividad [BFU2012-31086]; Russian Foundation for Basic Research [12-04-01659-a]; Russian Research Foundation Grant [14-24-00086]	FUV (Fondazione Umberto Veronesi)(Fondazione Umberto Veronesi); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); Cariplo Foundation(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); Max Planck Society (Munich, Germany)(Max Planck Society); European Commission (FP6, grant AnEUploidy); Spanish Ministerio de Economia y Competitividad(Spanish Government); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Research Foundation Grant	Without the support of COST BM0805 action and the ensuing inter-laboratory exchanges, this work would have not been possible. AL was supported by a fellowship of FUV (Fondazione Umberto Veronesi). FB was supported by AIRC (Italian Association for Cancer Research, grant n. BM0805), Cariplo Foundation and Italian Ministry of Health. JIW and MLY were supported by the Max Planck Society (Munich, Germany) and the European Commission under its sixth Framework Programme (FP6, grant AnEUploidy [LSHG-CT-2006-037627]). Work in MT laboratory was supported by grant BFU2012-31086 from the Spanish Ministerio de Economia y Competitividad. DP was funded from the Russian Foundation for Basic Research (12-04-01659-a); VT was supported by Russian Research Foundation Grant (project 14-24-00086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223; Chen CCG, 2013, DEVELOPMENT, V140, P719, DOI 10.1242/dev.083741; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Ferretti E, 2000, DEVELOPMENT, V127, P155; Ferretti E, 1999, MECH DEVELOP, V83, P53, DOI 10.1016/S0925-4773(99)00031-3; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Gemel J, 1999, J BIOL CHEM, V274, P6020, DOI 10.1074/jbc.274.9.6020; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Iotti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048353; Iotti G, 2011, P NATL ACAD SCI USA, V108, pE314, DOI 10.1073/pnas.1105216108; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Longobardi E, 2003, J BIOL CHEM, V278, P39235, DOI 10.1074/jbc.M304704200; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Martinez-Ceballos E, 2008, J NEUROSCI RES, V86, P2809, DOI 10.1002/jnr.21729; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Modica L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107916; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oriente F, 2008, MOL CELL BIOL, V28, P5634, DOI 10.1128/MCB.00117-08; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122518	10.1371/journal.pone.0122518	http://dx.doi.org/10.1371/journal.pone.0122518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875616	Green Submitted, Green Published, gold			2022-12-26	WOS:000352845100080
J	Maki, K; Nagai, K; Suzuki, M; Inomata, T; Yoshida, T; Nishimura, M				Maki, Kanako; Nagai, Katsura; Suzuki, Masaru; Inomata, Takashi; Yoshida, Takayuki; Nishimura, Masaharu			Temporal Changes in Glutaredoxin 1 and Protein S-Glutathionylation in Allergic Airway Inflammation	PLOS ONE			English	Article							FACTOR-KAPPA-B; QUANTITATIVE-DETERMINATION; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; REDOX CONTROL; MOUSE MODEL; MODULATION; ACTIVATION; MICE	Introduction Asthma is a chronic inflammatory disorder of the airways, involving oxidative stress. Upon oxidative stress, glutathione covalently binds to protein thiols to protect them against irreversible oxidation. This posttranslational modification, known as protein S-glutathionylation, can be reversed by glutaredoxin 1 (Glrx1) under physiological condition. Glrx1 is known to increase in the lung tissues of a murine model of allergic airway inflammation. However, the temporal relationship between levels of Glrx1, protein S-glutathionylation, and glutathione in the lungs with allergic airway inflammation is not clearly understood. Methods BALB/c mice received 3 aerosol challenges with ovalbumin (OVA) following sensitization to OVA. They were sacrificed at 6, 24, 48, or 72 h, or 8 days (5 mice per group), and the levels of Glrx1, protein S-glutathionylation, glutathione, and 25 cytokines/chemokines were evaluated in bronchoalveolar lavage fluid (BALF) and/or lung tissue. Results Levels of Glrx1 in BALF were significantly elevated in the OVA 6 h (final challenge) group compared to those in the control, with concurrent increases in protein S-glutathionylation levels in the lungs, as well as total glutathione (reduced and oxidized) and oxidized glutathione in BALF. Protein S-glutathionylation levels were attenuated at 24 h, with significant increases in Glrx1 levels in lung tissues at 48 and 72 h. Glrx1 in alveolar macrophages was induced after 6 h. Glrx1 levels concomitantly increased with Th2/NF-kappa B-related cytokines and chemokines in BALF. Conclusions The temporal relationships of Glrx1 with protein S-glutathionylation, glutathione, and cytokines/chemokines were observed as dynamic changes in lungs with allergic airway inflammation, suggesting that Glrx1 and protein-SSG redox status may play important roles in the development of allergic airway inflammation.	[Maki, Kanako; Nagai, Katsura; Suzuki, Masaru; Inomata, Takashi; Yoshida, Takayuki; Nishimura, Masaharu] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan	Hokkaido University	Nagai, K (corresponding author), Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan.	katnagai@med.hokudai.ac.jp	Suzuki, Masaru/H-2087-2012; Nishimura, Masaharu/A-4062-2012	Suzuki, Masaru/0000-0002-2124-6793; Nishimura, Masaharu/0000-0002-6456-4361	Ministry of Education, Culture, Sports, Science and Technology, Japan [25461181]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A scientific research grant was obtained from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25461181) http://www.mext.go.jp/english/.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Aesif SW, 2011, FREE RADICAL BIO MED, V51, P1249, DOI 10.1016/j.freeradbiomed.2011.06.025; Aesif SW, 2011, AM J RESP CELL MOL, V44, P491, DOI 10.1165/rcmb.2009-0136OC; Aesif SW, 2009, AM J PATHOL, V175, P36, DOI 10.2353/ajpath.2009.080736; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Broide DH, 2005, P NATL ACAD SCI USA, V102, P17723, DOI 10.1073/pnas.0509235102; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Chung S, 2010, AM J PHYSIOL-LUNG C, V299, pL192, DOI 10.1152/ajplung.00426.2009; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Fitzpatrick AM, 2012, ANTIOXID REDOX SIGN, V17, P375, DOI 10.1089/ars.2011.4198; Hoffman SM, 2012, AM J PHYSIOL-LUNG C, V303, pL528, DOI 10.1152/ajplung.00167.2012; Ito W, 2008, INT ARCH ALLERGY IMM, V145, P324, DOI 10.1159/000110891; Kanda M, 2006, J BIOL CHEM, V281, P28518, DOI 10.1074/jbc.M604359200; Kuipers I, 2013, EUR RESPIR J, V41, P469, DOI 10.1183/09031936.00115212; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Park CS, 2009, ANN ALLERG ASTHMA IM, V103, P238, DOI 10.1016/S1081-1206(10)60188-3; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Poynter ME, 2002, AM J PATHOL, V160, P1325, DOI 10.1016/S0002-9440(10)62559-X; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Reynaert NL, 2011, BBA-GEN SUBJECTS, V1810, P1045, DOI 10.1016/j.bbagen.2011.01.010; Reynaert NL, 2006, BBA-GEN SUBJECTS, V1760, P380, DOI 10.1016/j.bbagen.2006.01.006; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shelton MD, 2009, J BIOL CHEM, V284, P4759, DOI 10.1074/jbc.M805464200; Shimizu K, 2012, CLIN EXP ALLERGY, V42, P1273, DOI 10.1111/j.1365-2222.2012.04007.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Wang J, 2003, P NATL ACAD SCI USA, V100, P5103, DOI 10.1073/pnas.0931345100; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122986	10.1371/journal.pone.0122986	http://dx.doi.org/10.1371/journal.pone.0122986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874776	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100123
J	Schnoor, T; Bruun, HH; Olsson, PA				Schnoor, Tim; Bruun, Hans Henrik; Olsson, Pal Axel			Soil Disturbance as a Grassland Restoration Measure-Effects on Plant Species Composition and Plant Functional Traits	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; LAND-USE; DIVERSITY; COMMUNITIES; CONSERVATION; BIODIVERSITY; RICHNESS; CONVERGENCE; DIVERGENCE; MANAGEMENT	Soil disturbance is recognized as an important driver of biodiversity in dry grasslands, and can therefore be implemented as a restoration measure. However, because community re-assembly following disturbance includes stochastic processes, a focus only on species richness or establishment success of particular species will not inform on how plant communities respond ecologically to disturbance. We therefore evaluated vegetation development following disturbance by quantifying species richness, species composition and functional trait composition. Degraded calcareous sandy grassland was subjected to experimental disturbance treatments (ploughing or rotavation), and the vegetation was surveyed during four subsequent years of succession. Treated plots were compared with control plots representing untreated grassland, as well as nearby plots characterized by plant communities representing the restoration target. Species richness and functional diversity both increased in response to soil disturbance, and rotavation, but not ploughing, had a persistent positive effect on the occurrence of specialist species of calcareous sandy grassland. However, no type of soil disturbance caused the plant species composition to develop towards the target vegetation. The disturbance had an immediate and large impact on the vegetation, but the vegetation developed rapidly back towards the control sites. Plant functional composition analysis indicated that the treatments created habitats different both from control sites and target sites. Community-weighted mean Ellenberg indicator values suggested that the observed plant community response was at least partially due to an increase in nitrogen and water availability following disturbance. This study shows that a mild type of disturbance, such as rotavation, may be most successful in promoting specialist species in calcareous sandy grassland, but that further treatments are needed to reduce nutrient availability. We conclude that a functional trait based analysis provides additional information of the vegetation response and the abiotic conditions created, complementing the information from the species composition.	[Schnoor, Tim; Olsson, Pal Axel] Lund Univ, Dept Biol, Biodivers, SE-22362 Lund, Sweden; [Bruun, Hans Henrik] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen O, Denmark	Lund University; University of Copenhagen	Olsson, PA (corresponding author), Lund Univ, Dept Biol, Biodivers, Ecol Bldg, SE-22362 Lund, Sweden.	pal_axel.olsson@biol.lu.se	Bruun, Hans Henrik/C-4476-2008	Bruun, Hans Henrik/0000-0003-0674-2577	Swedish research council FORMAS; Swedish Research Council	Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish research council FORMAS and The Swedish Research Council. HHB thanks the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON O., 1950, Botaniska Notiser, P145; Ansquer P, 2009, ANN BOT-LONDON, V103, P117, DOI 10.1093/aob/mcn215; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bossuyt B, 2006, J ENVIRON MANAGE, V79, P364, DOI 10.1016/j.jenvman.2005.08.005; Brown GG, 2009, PESQUI AGROPECU BRAS, V44, pI, DOI 10.1590/S0100-204X2009000800001; Brunbjerg AK, 2014, BIOL CONSERV, V174, P101, DOI 10.1016/j.biocon.2014.04.002; Callaway JC, 2003, ECOL APPL, V13, P1626, DOI 10.1890/02-5144; Cingolani AM, 2007, J VEG SCI, V18, P911, DOI 10.1111/j.1654-1103.2007.tb02607.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Dahlstrom A., 2006, Environment and History, V12, P191, DOI 10.3197/096734006776680218; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Dupre C, 2001, ECOGRAPHY, V24, P275, DOI 10.1034/j.1600-0587.2001.240305.x; Eichberg C, 2010, APPL VEG SCI, V13, P425, DOI 10.1111/j.1654-109X.2010.01082.x; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; Ellenberg H., 1991, SCRIPTA GEOBOT, V18; Emanuelsson U., 2002, SKANSKA KULTURLANDSK; Faust C, 2011, FLORA, V206, P611, DOI 10.1016/j.flora.2010.09.013; Fischer SF, 1996, J APPL ECOL, V33, P1206, DOI 10.2307/2404699; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gardenfors U., 2010, RED LIST SWEDISH SPE; GARNIER E, 1992, J ECOL, V80, P665, DOI 10.2307/2260858; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; HARLEY J L, 1987, New Phytologist, V105, P1, DOI 10.1111/j.1469-8137.1987.tb00674.x; Hill M, 1999, ECOFACT RES REPORT B, V2b; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jentsch A, 2009, RESTOR ECOL, V17, P107, DOI 10.1111/j.1526-100X.2007.00339.x; Johansson LJ, 2008, LANDSCAPE URBAN PLAN, V84, P200, DOI 10.1016/j.landurbplan.2007.08.001; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; Kent Martin, 2003, Botanical Journal of Scotland, V55, P161; Kew Royal Botanic Gardens, 2008, SEED INFORM DATABASE; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Kleyer M, 1999, J VEG SCI, V10, P697, DOI 10.2307/3237084; Knevel I.C., 2005, LEDA TRAITBASE COLLE; Laliberte E, 2010, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lansstyrelsen Skane, 2005, CONS PLAN RINK SKJ N; Lavorel S, 2013, J VEG SCI, V24, P942, DOI 10.1111/jvs.12083; Martensson LM, 2010, PLANT ECOL, V206, P127, DOI 10.1007/s11258-009-9629-9; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; McLaughlin A, 1995, AGR ECOSYST ENVIRON, V55, P201, DOI 10.1016/0167-8809(95)00609-V; Murray BR, 1999, ECOLOGY, V80, P1806, DOI 10.1890/0012-9658(1999)080[1806:SITTOR]2.0.CO;2; Odman AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090998; Odman AM, 2012, BIODIVERS CONSERV, V21, P1921, DOI 10.1007/s10531-012-0292-4; Odman AM, 2011, BIODIVERS CONSERV, V20, P3039, DOI 10.1007/s10531-011-0108-y; Olsson K-A, 1994, LUNDS BOT FORENING M, V2, P4; Olsson PA, 2014, J INSECT CONSERV, V18, P827, DOI 10.1007/s10841-014-9689-6; Olsson PA, 2014, RESTOR ECOL, V22, P49, DOI 10.1111/rec.12024; Olsson PA, 2009, APPL VEG SCI, V12, P350, DOI 10.1111/j.1654-109X.2009.01029.x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Pokorny ML, 2005, RESTOR ECOL, V13, P448, DOI 10.1111/j.1526-100X.2005.00056.x; Poschlod P, 2005, BASIC APPL ECOL, V6, P93, DOI 10.1016/j.baae.2004.12.001; Purschke O, 2013, J ECOL, V101, P857, DOI 10.1111/1365-2745.12098; Pywell RF, 2003, J APPL ECOL, V40, P65, DOI 10.1046/j.1365-2664.2003.00762.x; Quetier F, 2007, ECOL MONOGR, V77, P33, DOI 10.1890/06-0054; Raunkiaer C., 1905, OVERSIGT KONGELIGE D, V1905, P347; Rehounkova K, 2008, RESTOR ECOL, V16, P305, DOI 10.1111/j.1526-100X.2007.00316.x; Rodwell JS, 2002, DVERSITY EUROPEAN VE; Romermann C, 2009, J VEG SCI, V20, P1086, DOI 10.1111/j.1654-1103.2009.01106.x; Sasaki T, 2009, ECOLOGY, V90, P2598, DOI 10.1890/08-1850.1; Schnoor TK, 2010, AGR ECOSYST ENVIRON, V139, P714, DOI 10.1016/j.agee.2010.10.018; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sonnier G, 2010, J VEG SCI, V21, P1014, DOI 10.1111/j.1654-1103.2010.01210.x; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Tyler Torbjorn, 2003, Botaniska Notiser, V136, P1; Tyler Torbjorn, 2005, Lindbergia, V30, P11; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WHITTAKER R H, 1975, P385; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	74	15	18	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123698	10.1371/journal.pone.0123698	http://dx.doi.org/10.1371/journal.pone.0123698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875745	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100200
J	Yu, GY; Jiang, P; Xiang, Y; Zhang, Y; Zhu, Z; Zhang, CR; Lee, S; Lee, W; Zhang, Y				Yu, Guoyu; Jiang, Ping; Xiang, Yang; Zhang, Yong; Zhu, Zhu; Zhang, Chuanrao; Lee, Siman; Lee, Wenhui; Zhang, Yun			Increased Expression of Protease-Activated Receptor 4 and Trefoil Factor 2 in Human Colorectal Cancer	PLOS ONE			English	Article							DECREASED EXPRESSION; ABERRANT EXPRESSION; CELL-PROLIFERATION; MIGRATION; MOTILITY; TFF2; SKIN	Protease-activated receptor 4 (PAR4), a member of G-protein coupled receptors family, was recently reported to exhibit decreased expression in gastric cancer and esophageal squamous cancer, yet increased expression during the progression of prostate cancer. Trefoil factor 2 (TFF2), a small peptide constitutively expressed in the gastric mucosa, plays a protective role in restitution of gastric mucosa. Altered TFF2 expression was also related to the development of gastrointestinal cancer. TFF2 has been verified to promote cell migration via PAR4, but the roles of PAR4 and TFF2 in the progress of colorectal cancer are still unknown. In this study, the expression level of PAR4 and TFF2 in colorectal cancer tissues was measured using real-time PCR (n = 38), western blotting (n = 38) and tissue microarrays (n = 66). The mRNA and protein expression levels of PAR4 and TFF2 were remarkably increased in colorectal cancer compared with matched noncancerous tissues, especially in positive lymph node and poorly differentiated cancers. The colorectal carcinoma cell LoVo showed an increased response to TFF2 as assessed by cell invasion upon PAR4 expression. However, after intervention of PAR4 expression, PAR4 positive colorectal carcinoma cell HT-29 was less responsive to TFF2 in cell invasion. Genomic bisulfite sequencing showed the hypomethylation of PAR4 promoter in colorectal cancer tissues and the hypermethylation in the normal mucosa that suggested the low methylation of promoter was correlated to the increased PAR4 expression. Taken together, the results demonstrated that the up-regulated expression of PAR4 and TFF2 frequently occurs in colorectal cancer tissues, and that overexpression of PAR4 may be resulted from promoter hypomethylation. While TFF2 promotes invasion activity of LoVo cells overexpressing PAR4, and this effect was significantly decreased when PAR4 was knockdowned in HT-29 cells. Our findings will be helpful in further investigations into the functions and molecular mechanisms of Proteinase-activated receptors (PARs) and Trefoil factor factors (TFFs) during the progression of colorectal cancer.	[Yu, Guoyu; Jiang, Ping; Xiang, Yang; Zhang, Yong; Lee, Wenhui; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Yu, Guoyu; Lee, Siman] Kunming Med Univ, Dept Biochem, Kunming 650500, Yunnan, Peoples R China; [Jiang, Ping] Kunming Med Univ, Dept Pathol & Pathophysiol, Kunming 650500, Yunnan, Peoples R China; [Zhu, Zhu] Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Kunming 650032, Peoples R China; [Zhang, Chuanrao] Kunming Med Univ, Dept Funct Expt Ctr, Kunming 650500, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; Kunming Medical University; Kunming Medical University; Kunming Medical University	Xiang, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.	yang_xiang000@hotmail.com; zhangy@mail.kiz.ac.cn			Chinese National Natural Science Foundation [81160302, 31270835]; Chinese Academy of Sciences [KJZD-EW-L03]; Yunnan Province Science and Technology Department Basic Research Foundation [2011FZ109]; State Key Laboratory of Genetic Resource and Evolution [GREKF11-13]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Province Science and Technology Department Basic Research Foundation; State Key Laboratory of Genetic Resource and Evolution	This work was supported by grants from the Chinese National Natural Science Foundation (81160302, 31270835), the Chinese Academy of Sciences (KJZD-EW-L03), Yunnan Province Science and Technology Department Basic Research Foundation (2011FZ109) and State Key Laboratory of Genetic Resource and Evolution (GREKF11-13).	Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Camerer E, 2007, THROMB RES, V120, pS75, DOI 10.1016/S0049-3848(07)70134-2; Chuang YY, 2004, CANCER RES, V64, P8271, DOI 10.1158/0008-5472.CAN-04-2097; Chung DC, 2000, GASTROENTEROLOGY, V119, P854, DOI 10.1053/gast.2000.16507; Darmoul D, 2003, AM J PATHOL, V162, P1503, DOI 10.1016/S0002-9440(10)64283-6; Dhar DK, 2003, LAB INVEST, V83, P1343, DOI 10.1097/01.LAB.0000085190.99749.15; Elste AP, 2010, J MOL HISTOL, V41, P89, DOI 10.1007/s10735-010-9274-6; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Gratio V, 2009, INT J CANCER, V124, P1517, DOI 10.1002/ijc.24070; Hu GY, 2003, WORLD J GASTROENTERO, V9, P910; Jiang P, 2014, ONCOL LETT, V7, P1525, DOI 10.3892/ol.2014.1904; Jiang P, 2013, ASIAN PAC J CANCER P, V14, P3793, DOI 10.7314/APJCP.2013.14.6.3793; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kaufmann R, 2002, INT J ONCOL, V20, P177; Kaufmann R, 2007, J CELL PHYSIOL, V211, P699, DOI 10.1002/jcp.21027; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee S, 2014, NEOPLASMA, V61, P546, DOI 10.4149/neo_2014_067; Liu SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001770; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Moss SF, 2008, CLIN CANCER RES, V14, P4161, DOI 10.1158/1078-0432.CCR-07-4381; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Rattenholl A, 2007, J INVEST DERMATOL, V127, P2245, DOI 10.1038/sj.jid.5700847; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thim L, 1997, CELL MOL LIFE SCI, V53, P888, DOI 10.1007/s000180050108; Venkatachalam R, 2010, CANCER GENET CYTOGEN, V203, P1, DOI 10.1016/j.cancergencyto.2010.08.013; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zhang Y, 2011, CELL MOL LIFE SCI, V68, P3771, DOI 10.1007/s00018-011-0678-6; Zhang Y, 2011, INT J BIOCHEM CELL B, V43, P1277, DOI 10.1016/j.biocel.2011.05.008	33	20	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122678	10.1371/journal.pone.0122678	http://dx.doi.org/10.1371/journal.pone.0122678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876034	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100093
J	Clairfeuille, T; Norwood, SJ; Qi, XY; Teasdale, RD; Collins, BM				Clairfeuille, Thomas; Norwood, Suzanne J.; Qi, Xiaying; Teasdale, Rohan D.; Collins, Brett M.			Structure and Membrane Binding Properties of the Endosomal Tetratricopeptide Repeat (TPR) Domain-containing Sorting Nexins SNX20 and SNX21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOX-HOMOLOGY DOMAIN; MITOCHONDRIAL FISSION; CARGO; ENDOCYTOSIS; COMPLEXES; PROTEINS; REVEALS	Sorting nexins (SNX) orchestrate membrane trafficking and signaling events required for the proper distribution of proteins within the endosomal network. Their phox homology (PX) domain acts as a phosphoinositide (PI) recognition module that targets them to specific endocytic membrane domains. The modularity of SNX proteins confers a wide variety of functions from signaling to membrane deformation and cargo binding, and many SNXs are crucial modulators of endosome dynamics and are involved in a myriad of physiological and pathological processes such as neurodegenerative diseases, cancer, and inflammation. Here, we have studied the poorly characterized SNX20 and its paralogue SNX21, which contain an N-terminal PX domain and a C-terminal PX-associated B (PXB) domain of unknown function. The two proteins share similar PI-binding properties and are recruited to early endosomal compartments by their PX domain. The crystal structure of the SNX21 PXB domain reveals a tetratricopeptide repeat (TPR)-fold, a module that typically binds short peptide motifs, with three TPR alpha-helical repeats. However, the C-terminal capping helix adopts a highly unusual and potentially self-inhibitory topology. SAXS solution structures of SNX20 and SNX21 show that these proteins adopt a compact globular architecture, and membrane interaction analyses indicate the presence of overlapping PI-binding sites that may regulate their intracellular localization. This study provides the first structural analysis of this poorly characterized subfamily of SNX proteins, highlighting a likely role as endosome-associated scaffolds.	[Clairfeuille, Thomas; Norwood, Suzanne J.; Qi, Xiaying; Teasdale, Rohan D.; Collins, Brett M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Collins, BM (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	b.collins@imb.uq.edu.au	Qi, Xiaying/D-2640-2017; Teasdale, Rohan D/B-2538-2009; Teasdale, Rohan/AAD-6698-2019; Collins, Brett/J-1563-2014	Qi, Xiaying/0000-0002-1793-1974; Teasdale, Rohan D/0000-0001-7455-5269; Teasdale, Rohan/0000-0001-7455-5269; Collins, Brett/0000-0002-6070-3774	Australian Research Council ARC [DP0985029]; National Health and Medical Research Council (NHMRC) [APP1042082, APP1058734]; NHMRC [APP1041929, APP1061574]; ARC [FT100100027]	Australian Research Council ARC(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	This work is supported in part by Australian Research Council ARC Grant DP0985029 and National Health and Medical Research Council (NHMRC) Grants APP1042082 and APP1058734.r Supported by NHMRC Senior Research Fellowship APP1041929.r Supported by NHMRC Career Development Fellowship APP1061574 and previously held ARC Future Fellowship Grant FT100100027.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bawono P, 2014, METHODS MOL BIOL, V1079, P245, DOI 10.1007/978-1-62703-646-7_16; Blatner NR, 2007, EMBO J, V26, P3709, DOI 10.1038/sj.emboj.7601800; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Danson C, 2013, J CELL SCI, V126, P4885, DOI 10.1242/jcs.125732; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Ghai R, 2015, J CELL SCI, V128, P553, DOI 10.1242/jcs.158204; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schaff UY, 2008, EUR J IMMUNOL, V38, P550, DOI 10.1002/eji.200737777; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zeng WQ, 2002, BIOCHEM BIOPH RES CO, V299, P542, DOI 10.1016/S0006-291X(02)02695-5; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104	36	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14504	14517		10.1074/jbc.M115.650598	http://dx.doi.org/10.1074/jbc.M115.650598			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25882846	hybrid, Green Published			2022-12-26	WOS:000355754600022
J	Yildirim, C; Vogel, DYS; Hollander, MR; Baggen, JM; Fontijn, RD; Nieuwenhuis, S; Haverkamp, A; de Vries, MR; Quax, PHA; Garcia-Vallejo, JJ; van der Laan, AM; Dijkstra, CD; Kraan, TCTMV; van Royen, N; Horrevoets, AJG				Yildirim, Cansu; Vogel, Daphne Y. S.; Hollander, Maurits R.; Baggen, Josefien M.; Fontijn, Ruud D.; Nieuwenhuis, Sylvia; Haverkamp, Anouk; de Vries, Margreet R.; Quax, Paul H. A.; Garcia-Vallejo, Juan J.; van der Laan, Anja M.; Dijkstra, Christine D.; Kraan, Tineke C. T. M. van der Pouw; van Royen, Niels; Horrevoets, Anton J. G.			Galectin-2 Induces a Proinflammatory, Anti-Arteriogenic Phenotype in Monocytes and Macrophages	PLOS ONE			English	Article							GROWTH FACTOR-A; FACTOR-B; POLARIZATION; MECHANISMS; ROLES; ANGIOGENESIS; STIMULATION; ACTIVATION; EXPRESSION; MOLECULES	Galectin-2 is a monocyte-expressed carbohydrate-binding lectin, for which increased expression is genetically determined and associated with decreased collateral arteriogenesis in obstructive coronary artery disease patients. The inhibiting effect of galectin-2 on arteriogenesis was confirmed in vivo, but the mechanism is largely unknown. In this study we aimed to explore the effects of galectin-2 on monocyte/macrophage phenotype in vitro and vivo, and to identify the receptor by which galectin-2 exerts these effects. We now show that the binding of galectin-2 to different circulating human monocyte subsets is dependent on monocyte surface expression levels of CD14. The high affinity binding is blocked by an anti-CD14 antibody but not by carbohydrates, indicating a specific protein-protein interaction. Galectin-2 binding to human monocytes modulated their transcriptome by inducing proinflammatory cytokines and inhibiting pro-arteriogenic factors, while attenuating monocyte migration. Using specific knock-out mice, we show that galectin-2 acts through the CD14/toll-like receptor (TLR)-4 pathway. Furthermore, galectin-2 skews human macrophages to a M1-like proinflammatory phenotype, characterized by a reduced motility and expression of an anti-arteriogenic cytokine/growth factor repertoire. This is accompanied by a switch in surface protein expression to CD40-high and CD206-low (M1). In a murine model we show that galectin-2 administration, known to attenuate arteriogenesis, leads to increased numbers of CD40-positive (M1) and reduced numbers of CD206-positive (M2) macrophages surrounding actively remodeling collateral arteries. In conclusion galectin-2 is the first endogenous CD14/TLR4 ligand that induces a proinflammatory, non-arteriogenic phenotype in monocytes/macrophages. Interference with CD14-Galectin-2 interaction may provide a new intervention strategy to stimulate growth of collateral arteries in genetically compromised cardiovascular patients.	[Yildirim, Cansu; Vogel, Daphne Y. S.; Baggen, Josefien M.; Fontijn, Ruud D.; Nieuwenhuis, Sylvia; Haverkamp, Anouk; Garcia-Vallejo, Juan J.; Dijkstra, Christine D.; Kraan, Tineke C. T. M. van der Pouw; Horrevoets, Anton J. G.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Hollander, Maurits R.; van Royen, Niels] Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [de Vries, Margreet R.; Quax, Paul H. A.] Leiden Univ, Med Ctr, Einthoven Labs, Dept Vasc Surg, Leiden, Netherlands; [van der Laan, Anja M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Horrevoets, AJG (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	aj.horrevoets@vumc.nl	Quax, Paul/W-8520-2019; Vallejo, Juan Garcia/AAA-3765-2020; Quax, Paul/ABD-5294-2020; de Vries, Margreet/Z-5653-2019; Garcia-Vallejo, Juan/H-4162-2012; van Royen, Niels/Q-1097-2017; YILDIRIM, CANSU/ABB-8045-2021	Quax, Paul/0000-0002-6853-5760; Garcia-Vallejo, Juan/0000-0001-6238-7069; YILDIRIM, CANSU/0000-0002-9015-6636	ICaR-VU (Institute for Cardiovascular Research) of the VU Medical Center in the Netherlands	ICaR-VU (Institute for Cardiovascular Research) of the VU Medical Center in the Netherlands	This work was supported by an interinstitutional grant from ICaR-VU (Institute for Cardiovascular Research, http://www.vumc.nl/afdelingen/ICar-VU/) of the VU Medical Center in the Netherlands to AJGH and TvdPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGAWA KS, 1985, J EXP MED, V162, P1444, DOI 10.1084/jem.162.5.1444; Al-Ansari S, 2009, TRENDS CARDIOVAS MED, V19, P164, DOI 10.1016/j.tcm.2009.10.001; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Beyer M, 2012, PLOS ONE, V7, P1; Buschmann I, 2003, MICROCIRCULATION, V10, P371, DOI 10.1038/sj.mn.7800199; Cho M, 1996, BIOCHEMISTRY-US, V35, P13081, DOI 10.1021/bi961181d; Clayton JA, 2008, CIRC RES, V103, P1027, DOI 10.1161/CIRCRESAHA.108.181115; Cole JE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/393946; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Fung E, 2012, FRONT PHYSIOL, V3, P1, DOI [10.3389/fphys.2012.00001, DOI 10.3389/FPHYS.2012.00001]; Gal P, 2011, ACTA HISTOCHEM CYTOC, V44, P191, DOI 10.1267/ahc.11014; Gao YF, 2011, CHINESE MED J-PEKING, V124, P127, DOI 10.3760/cma.j.issn.0366-6999.2011.01.023; Grundmann S, 2007, EUR J CLIN INVEST, V37, P755, DOI 10.1111/j.1365-2362.2007.01861.x; Hamm A, 2013, EMBO MOL MED, V5, P843, DOI 10.1002/emmm.201302695; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hokama A, 2008, WORLD J GASTROENTERO, V14, P5133, DOI 10.3748/wjg.14.5133; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Kupatt C, 2010, J AM COLL CARDIOL, V56, P414, DOI 10.1016/j.jacc.2010.03.050; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Paclik D, 2008, INFLAMM BOWEL DIS, V14, P1366, DOI 10.1002/ibd.20499; Paclik D, 2011, CELL IMMUNOL, V271, P97, DOI 10.1016/j.cellimm.2011.06.003; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Powell RJ, 2008, CIRCULATION, V118, P58, DOI 10.1161/CIRCULATIONAHA.107.727347; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Seiler C, 2010, EUR J CLIN INVEST, V40, P465, DOI 10.1111/j.1365-2362.2010.02282.x; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Troidl C, 2013, CURR VASC PHARMACOL, V11, P5, DOI 10.2174/157016113804547629; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Van den Akker NMS, 2008, DEV DYNAM, V237, P494, DOI 10.1002/dvdy.21436; van der Laan AM, 2012, EUR HEART J, V33, P1076, DOI 10.1093/eurheartj/ehr220; van Oostrom MC, 2008, J LEUKOCYTE BIOL, V84, P1379, DOI 10.1189/jlb.0508281; van Royen N, 2002, FASEB J, V16, P432, DOI 10.1096/fj.01-0563fje; Vogel DYS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-23; Wafai R, 2009, J VASC RES, V46, P45, DOI 10.1159/000139132; Wu S, 2010, MOL CELL BIOCHEM, V343, P223, DOI 10.1007/s11010-010-0517-3; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zajac E, 2013, BLOOD, V122, P4054, DOI 10.1182/blood-2013-05-501494; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860; Zivkovic A, 2011, J IMMUNOL, V186, P1608, DOI 10.4049/jimmunol.1001665	49	38	40	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124347	10.1371/journal.pone.0124347	http://dx.doi.org/10.1371/journal.pone.0124347			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884209	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000116
J	Majeed, A; Piah, AM; Gobithaasan, RU; Yahya, ZR				Majeed, Abdul; Piah, Abd Rahni Mt; Gobithaasan, R. U.; Yahya, Zainor Ridzuan			Craniofacial Reconstruction Using Rational Cubic Ball Curves	PLOS ONE			English	Article							ALGORITHM	This paper proposes the reconstruction of craniofacial fracture using rational cubic Ball curve. The idea of choosing Ball curve is based on its robustness of computing efficiency over Bezier curve. The main steps are conversion of Digital Imaging and Communications in Medicine (Dicom) images to binary images, boundary extraction and corner point detection, Ball curve fitting with genetic algorithm and final solution conversion to Dicom format. The last section illustrates a real case of craniofacial reconstruction using the proposed method which clearly indicates the applicability of this method. A Graphical User Interface (GUI) has also been developed for practical application.	[Majeed, Abdul] Univ Educ, Div Sci & Technol, Town Ship Lahore, Pakistan; [Piah, Abd Rahni Mt] Univ Sains Malaysia, Sch Math Sci, George Town 11800, Malaysia; [Gobithaasan, R. U.] Univ Malaysia Terengganu, Sch Informat & Appl Math, Kuala Terengganu 21030, Malaysia; [Yahya, Zainor Ridzuan] Univ Malaysia Perlis, Inst Engn Math, Pauh 02600, Perlis, Malaysia	Universiti Sains Malaysia; Universiti Malaysia Terengganu; Universiti Malaysia Perlis	Majeed, A (corresponding author), Univ Educ, Div Sci & Technol, Town Ship Lahore, Pakistan.	abdulmajeed@ue.edu.pk	Rudrusamy, Gobithaasan/H-8891-2018; Yahya, Zainor/GNH-4483-2022	Rudrusamy, Gobithaasan/0000-0003-3077-8772; 	Ministry of Education of Malaysia; Universiti Sains Malaysia [203/PMATHS/6711365]	Ministry of Education of Malaysia; Universiti Sains Malaysia(Universiti Sains Malaysia)	The authors would like to extend their gratitude to the Ministry of Education of Malaysia and Universiti Sains Malaysia for supporting this work under its Fundamental Research Grant Scheme (FRGS), Account No. 203/PMATHS/6711365. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball A. A., 1974, Computer Aided Design, V6, P243, DOI 10.1016/0010-4485(74)90009-8; Bhatt A.D., 2008, COMPUT AIDED DES APP, V5, P194; Eck M., 1996, P SIGGRAPH, V96, P325; FANG Z., 2005, THESIS DREXEL U; Farin G., 2002, CURVES SURFACES CAGD; GOODMAN TNT, 1991, COMPUT AIDED DESIGN, V23, P554, DOI 10.1016/0010-4485(91)90056-3; Kou XY, 2007, COMPUT AIDED DESIGN, V39, P284, DOI 10.1016/j.cad.2006.12.007; Li WS, 2005, COMPUT AIDED DESIGN, V37, P791, DOI 10.1016/j.cad.2004.09.008; Lian Q, 2006, COMPUT AIDED DESIGN, V38, P507, DOI 10.1016/j.cad.2005.12.001; Magnenat-Thalmann N, 2000, IEEE T INF TECHNOL B, V4, P137, DOI 10.1109/4233.845206; Majeed A., 2014, APPL MATH SCI, V8, P3683, DOI DOI 10.12988/AMS.2014.43201; Park H, 2007, COMPUT AIDED DESIGN, V39, P439, DOI 10.1016/j.cad.2006.12.006; Piah ARM, 2011, SAINS MALAYS, V40, P1173; SAID HB, 1989, ACM T GRAPHIC, V8, P360, DOI 10.1145/77269.77275; Sarfraz M, 2006, COMPUT IMAGING VIS, V32, P528; Vandermeulen D, 2006, FORENSIC SCI INT, V159, pS164, DOI 10.1016/j.forsciint.2006.02.036; Yahya ZR, 2012, COMM COM INF SC, V295, P379; Yoshimoto F, 2003, COMPUT AIDED DESIGN, V35, P751, DOI 10.1016/S0010-4485(03)00006-X	18	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122854	10.1371/journal.pone.0122854	http://dx.doi.org/10.1371/journal.pone.0122854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880632	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500030
J	Wei, XJ; Zhang, JY; Niu, JR; Zhou, XZ; Li, JY; Li, B				Wei, Xiaojuan; Zhang, Jiyu; Niu, Jianrong; Zhou, Xuzheng; Li, Jianyong; Li, Bing			Evaluation of Arecoline Hydrobromide Toxicity after a 14-Day Repeated Oral Administration in Wistar Rats	PLOS ONE			English	Article								A subchronic toxicity test was conducted in rats on the basis of a previous acute toxicity test to evaluate the safety of arecoline hydrobromide (Ah), to systematically study its pharmacological effects and to provide experimental support for a safe clinical dose. Eighty rats were randomly divided into four groups: a high-dose group (1000 mg/kg), medium-dose group (200 mg/kg), low-dose group (100mg/kg) and blank control group. The doses were administered daily via gastric lavage for 14 consecutive days. There were no significant differences in the low-dose Ah group compared to the control group (P> 0.05) with regard to body weight, organ coefficients, hematological parameters and histopathological changes. The high-dose of Ah influenced some of these parameters, which requires further study. The results of this study indicated that a long-term, continuous high dose of Ah was toxic. However, it is safe to use Ah according to the clinically recommended dosing parameters. The level of Ah at which no adverse effects were observed was 100 mg/kg/day under the present study conditions.	[Wei, Xiaojuan; Zhang, Jiyu; Niu, Jianrong; Zhou, Xuzheng; Li, Jianyong; Li, Bing] Lanzhou Inst Husb & Pharmaceut Sci CAAS, Lanzhou 730050, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Wei, XJ (corresponding author), Lanzhou Inst Husb & Pharmaceut Sci CAAS, Lanzhou 730050, Gansu, Peoples R China.	wxjsqss@163.com			China Agriculture Research System [cars-38]	China Agriculture Research System	The project was supported by the earmarked fund for China Agriculture Research System (cars-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARJUNGI KN, 1976, ARZNEIMITTEL-FORSCH, V26, P951; Azeez S., 2007, KUWAIT MED J, V39, P48; BEVERIDGE I, 1976, AUST VET J, V52, P369, DOI 10.1111/j.1751-0813.1976.tb09491.x; Burkhill IH, 1935, DICT ECONOMICPRODUCT, V1, P222; Chempakam B., 1993, Indian Journal of Experimental Biology, V31, P474; CHRISTIE JE, 1981, BRIT J PSYCHIAT, V138, P46, DOI 10.1192/bjp.138.1.46; El Hilaly J, 2004, J ETHNOPHARMACOL, V91, P43, DOI 10.1016/j.jep.2003.11.009; Feng Q, 1999, Zhong Yao Cai, V22, P572; Jaiswal P, 2008, PESTIC BIOCHEM PHYS, V92, P164, DOI 10.1016/j.pestbp.2008.07.011; Kaplan A, 1995, CLIN CHEM INTERPRETA; Kuo FC, 2005, J PERINAT MED, V33, P399, DOI 10.1515/JPM.2005.072; Li B, 2014, J CHROMATOGR B, V969, P12, DOI 10.1016/j.jchromb.2014.07.043; Rahman MF, 2001, HUM EXP TOXICOL, V20, P243, DOI 10.1191/096032701678227730; Tofovic SP, 1999, J CARDIOVASC PHARM, V33, P360, DOI 10.1097/00005344-199903000-00003; van der Ven LTM, 2006, TOXICOL SCI, V94, P281, DOI 10.1093/toxsci/kfl113; Zha Chuanlong, 1990, J NANJING U TRADITIO, V6, P266; Zhao WA, 2003, MODERN J INTEGRATED, V12, P237	17	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120165	10.1371/journal.pone.0120165	http://dx.doi.org/10.1371/journal.pone.0120165			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880067	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500006
J	Li, YX; Wu, P; Liang, FR; Huang, WH				Li, Yongxin; Wu, Ping; Liang, Fanrong; Huang, Wenhua			The Microstructural Status of the Corpus Callosum Is Associated with the Degree of Motor Function and Neurological Deficit in Stroke Patients	PLOS ONE			English	Article							SUBJECT DIFFUSION DATA; WHITE-MATTER ANATOMY; SUBCORTICAL STROKE; STRUCTURAL CONNECTIVITY; WALLERIAN DEGENERATION; SPATIAL STATISTICS; VOXELWISE ANALYSIS; TRACT INTEGRITY; TENSOR; RECOVERY	Human neuroimaging studies and animal models have suggested that white matter damage from ischemic stroke leads to the functional and structural reorganization of perilesional and remote brain regions. However, the quantitative relationship between the transcallosal tract integrity and clinical motor performance score after stroke remains unexplored. The current study employed a tract-based spatial statistics (TBSS) analysis on diffusion tensor imaging (DTI) to investigate the relationship between white matter diffusivity changes and the clinical scores in stroke patients. Probabilistic fiber tracking was also used to identify structural connectivity patterns in the patients. Thirteen ischemic stroke patients and fifteen healthy control subjects participated in this study. TBSS analyses showed that the corpus callosum (CC) and bilateral corticospinal tracts (CST) in the stroke patients exhibited significantly decreased fractional anisotropy and increased axial and radial diffusivity compared with those of the controls. Correlation analyses revealed that the motor and neurological deficit scores in the stroke patients were associated with the value of diffusivity indices in the CC. Compared with the healthy control group, probabilistic fiber tracking analyses revealed that significant changes in the inter-hemispheric fiber connections between the left and right motor cortex in the stroke patients were primarily located in the genu and body of the CC, left anterior thalamic radiation and inferior fronto-occipital fasciculus, bilateral CST, anterior/superior corona radiate, cingulum and superior longitudinal fasciculus, strongly suggesting that ischemic induces inter-hemispheric network disturbances and disrupts the white matter fibers connecting motor regions. In conclusion, the results of the present study show that DTI-derived measures in the CC can be used to predict the severity of motor skill and neurological deficit in stroke patients. Changes in structural connectivity pattern tracking between the left and right motor areas, particularly in the body of the CC, might reflect functional reorganization and behavioral deficit.	[Li, Yongxin; Huang, Wenhua] Southern Med Univ, Sch Basic Med Sci, Inst Clin Anat, Guangzhou, Guangdong, Peoples R China; [Wu, Ping; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China	Southern Medical University - China; Chengdu University of Traditional Chinese Medicine	Liang, FR (corresponding author), Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China.	0001170@cdutcm.edu.cn; huangwenhua2009@139.com	huang, wenhua/AAO-5990-2020	huang, wenhua/0000-0003-2382-9180; Liang, Fanrong/0000-0003-2210-2027	Natural Science Foundation of China [81072864]; Specialized Research Fund for the Doctoral Program of Higher Education [20134433110012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	PW, FRL, the Natural Science Foundation of China (No. 81072864), http://www.nsfc.gov.cn/. WHH, Specialized Research Fund for the Doctoral Program of Higher Education (No. 20134433110012), http://www.cutech.edu.cn/cn/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bhadelia RA, 2009, STROKE, V40, P3816, DOI 10.1161/STROKEAHA.109.564765; Borich MR, 2012, NEUROIMAGE, V59, P2393, DOI 10.1016/j.neuroimage.2011.09.009; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048079; Carter AR, 2012, NEUROIMAGE, V62, P2271, DOI 10.1016/j.neuroimage.2012.02.070; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chen C, 2009, STROKE, V40, P859, DOI 10.1161/STROKEAHA.108.531616; Chen JL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00178; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; FRIES W, 1993, BRAIN, V116, P369, DOI 10.1093/brain/116.2.369; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Grol MJ, 2007, J NEUROSCI, V27, P11877, DOI 10.1523/JNEUROSCI.3923-07.2007; Gupta RK, 2006, J MAGN RESON IMAGING, V24, P549, DOI 10.1002/jmri.20677; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Jayaram G, 2012, CLIN NEUROPHYSIOL, V123, P2422, DOI 10.1016/j.clinph.2012.04.026; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Koldewyn K, 2014, P NATL ACAD SCI USA, V111, P1981, DOI 10.1073/pnas.1324037111; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Lindenberg R, 2012, HUM BRAIN MAPP, V33, P1040, DOI 10.1002/hbm.21266; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Mori S, 2002, ANN NEUROL, V51, P377, DOI 10.1002/ana.10137; Perez MA, 2009, J PHYSIOL-LONDON, V587, P725, DOI 10.1113/jphysiol.2008.166926; Radlinska BA, 2012, J CEREBR BLOOD F MET, V32, P1515, DOI 10.1038/jcbfm.2012.37; Righini A, 2010, NEURORADIOLOGY, V52, P1025, DOI 10.1007/s00234-010-0745-y; Saini J, 2012, NEURORADIOLOGY, V54, P771, DOI 10.1007/s00234-011-0983-7; Schaechter JD, 2008, NEUROIMAGE, V39, P1370, DOI 10.1016/j.neuroimage.2007.09.071; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Schmahmann J.D., 2009, FIBER PATHWAYS BRAIN; Serbruyns L, 2013, BRAIN STRUCTURE FUNC, P1; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Takenobu Y, 2014, NEUROIMAGE-CLIN, V4, P201, DOI 10.1016/j.nicl.2013.12.003; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; van Eimeren L, 2010, NEUROIMAGE, V52, P358, DOI 10.1016/j.neuroimage.2010.04.001; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wang CH, 2014, J CEREBR BLOOD F MET, V34, P597, DOI 10.1038/jcbfm.2013.238; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wang LE, 2012, HUM BRAIN MAPP, V33, P2941, DOI 10.1002/hbm.21417; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009; Zhu D, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00167; Zhu LL, 2010, STROKE, V41, P910, DOI 10.1161/STROKEAHA.109.577023	64	41	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122615	10.1371/journal.pone.0122615	http://dx.doi.org/10.1371/journal.pone.0122615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875333	Green Published, Green Submitted, gold			2022-12-26	WOS:000353015800068
J	Wanner, J; Romashko, D; Werner, DS; May, EW; Peng, Y; Schulz, R; Foreman, KW; Russo, S; Arnold, LD; Pingle, M; Bergstrom, DE; Barany, F; Thomson, S				Wanner, Jutta; Romashko, Darlene; Werner, Douglas S.; May, Earl W.; Peng, Yue; Schulz, Ryan; Foreman, Kenneth W.; Russo, Suzanne; Arnold, Lee D.; Pingle, Maneesh; Bergstrom, Donald E.; Barany, Francis; Thomson, Stuart			Reversible Linkage of Two Distinct Small Molecule Inhibitors of Myc Generates a Dimeric Inhibitor with Improved Potency That Is Active in Myc Over-Expressing Cancer Cell Lines	PLOS ONE			English	Article							C-MYC; BORONIC ESTERS; MUTATIONS; BINDING; INACTIVATION; ONCOPROTEIN; DISRUPTION; LANDSCAPE; STABILITY; LYMPHOMA	We describe the successful application of a novel approach for generating dimeric Myc inhibitors by modifying and reversibly linking two previously described small molecules. We synthesized two directed libraries of monomers, each comprised of a ligand, a connector, and a bioorthogonal linker element, to identify the optimal dimer configuration required to inhibit Myc. We identified combinations of monomers, termed self-assembling dimeric inhibitors, which displayed synergistic inhibition of Myc-dependent cell growth. We confirmed that these dimeric inhibitors directly bind to Myc blocking its interaction with Max and affect transcription of MYC dependent genes. Control combinations that are unable to form a dimer do not show any synergistic effects in these assays. Collectively, these data validate our new approach to generate more potent and selective inhibitors of Myc by self-assembly from smaller, lower affinity components. This approach provides an opportunity for developing novel therapeutics against Myc and other challenging protein: protein interaction (PPI) target classes.	[Wanner, Jutta; Romashko, Darlene; Werner, Douglas S.; May, Earl W.; Peng, Yue; Schulz, Ryan; Foreman, Kenneth W.; Russo, Suzanne; Arnold, Lee D.; Pingle, Maneesh; Thomson, Stuart] Coferon Inc, Stony Brook, NY 11790 USA; [Bergstrom, Donald E.] Purdue Univ, W Lafayette, IN 47907 USA; [Barany, Francis] Weill Cornell Med Coll, Dept Microbiol, New York, NY USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University	Thomson, S (corresponding author), Coferon Inc, 25 Hlth Sci Dr, Stony Brook, NY 11790 USA.	sthomson@coferon.com	Foreman, Kenneth/AAI-2249-2020		Coferon, Inc.	Coferon, Inc.	Coferon, Inc. provided support in the form of salaries for authors JW, DR, DSW, EWM, YP, RS, KWF, SR, MP and ST, and LDA at the time of the study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section.	Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Barany F, 2009, WO, Patent No. [2009126290 A3, 2009126290]; Bernardini R, 2009, CHEM LETT, V38, P750, DOI 10.1246/cl.2009.750; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Chauhan J, 2014, CHEMMEDCHEM, V9, P2274, DOI 10.1002/cmdc.201402189; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Demetriades M, 2012, ANGEW CHEM INT EDIT, V51, P6672, DOI 10.1002/anie.201202000; Fletcher S, 2015, BBA-GENE REGUL MECH, V1849, P525, DOI 10.1016/j.bbagrm.2014.03.005; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Hall DG, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, P1; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hart JR, 2014, P NATL ACAD SCI USA, V111, P12556, DOI 10.1073/pnas.1319488111; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Metallo S, 2012, WO, Patent No. [2010083404 A2, 2010083404]; Muller I, 2014, PLOS, V9, P1; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Roy CD, 2007, J ORGANOMET CHEM, V692, P784, DOI 10.1016/j.jorganchem.2006.10.013; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shin SBY, 2010, CHEM BIOL, V17, P1171, DOI 10.1016/j.chembiol.2010.09.008; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Tansey WP, 2014, NEW J SCI, DOI DOI 10.1155/2014/757534; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang HB, 2013, ONCOTARGET, V4, P936, DOI 10.18632/oncotarget.1108; Yan J, 2004, TETRAHEDRON, V60, P11205, DOI 10.1016/j.tet.2004.08.051; Yap JL, 2013, BIOORG MED CHEM LETT, V23, P370, DOI 10.1016/j.bmcl.2012.10.013; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	37	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121793	10.1371/journal.pone.0121793	http://dx.doi.org/10.1371/journal.pone.0121793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875098	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800030
J	Xu, H; Sun, YJ; Wang, XJ; Wang, J; Fu, Y				Xu Hao; Sun Yujun; Wang Xinjie; Wang Jin; Fu Yao			Linear Mixed-Effects Models to Describe Individual Tree Crown Width for China-Fir in Fujian Province, Southeast China	PLOS ONE			English	Article								A multiple linear model was developed for individual tree crown width of Cunninghamia lanceolata (Lamb.) Hook in Fujian province, southeast China. Data were obtained from 55 sample plots of pure China-fir plantation stands. An Ordinary Linear Least Squares (OLS) regression was used to establish the crown width model. To adjust for correlations between observations from the same sample plots, we developed one level linear mixed-effects (LME) models based on the multiple linear model, which take into account the random effects of plots. The best random effects combinations for the LME models were determined by the Akaike's information criterion, the Bayesian information criterion and the -2logarithm likelihood. Heteroscedasticity was reduced by three residual variance functions: the power function, the exponential function and the constant plus power function. The spatial correlation was modeled by three correlation structures: the first-order autoregressive structure [AR(1)], a combination of first-order autoregressive and moving average structures [ARMA (1,1)], and the compound symmetry structure (CS). Then, the LME model was compared to the multiple linear model using the absolute mean residual (AMR), the root mean square error (RMSE), and the adjusted coefficient of determination (adj-R-2). For individual tree crown width models, the one level LME model showed the best performance. An independent dataset was used to test the performance of the models and to demonstrate the advantage of calibrating LME models.	[Xu Hao; Sun Yujun; Wang Xinjie; Wang Jin; Fu Yao] Beijing Forestry Univ, Coll Forestry, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China	Beijing Forestry University	Sun, YJ (corresponding author), Beijing Forestry Univ, Coll Forestry, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China.	sunyj@bjfu.edu			Special Public Interest Research and Industry Fund of Forestry [200904003-1]; project of forestry science and technology research [2012-07]	Special Public Interest Research and Industry Fund of Forestry; project of forestry science and technology research	This work was supported by the Special Public Interest Research and Industry Fund of Forestry (No. 200904003-1) and the project of forestry science and technology research (No. 2012-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame P, 2008, FOREST ECOL MANAG, V256, P88, DOI 10.1016/j.foreco.2008.04.006; Adame P, 2006, ANN FOREST SCI, V63, P929, DOI 10.1051/forest:2006076; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P667, DOI 10.1109/TAC.1974.1100707; Alexander ME, 2011, SYNTHESIS KNOWLEDGE, VI; BIGING GS, 1985, FOREST SCI, V31, P248; Bragg DC, 2001, NORTH J APPL FOR, V18, P1; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Calama R, 2004, CAN J FOREST RES, V34, P150, DOI [10.1139/x03-199, 10.1139/X03-199]; Canavan SJ, 2000, NORTH J APPL FOR, V17, P2; Crecente-Campo F, 2013, FORESTRY, V86, P481, DOI 10.1093/forestry/cpt019; Crecente-Campo F, 2010, FOREST ECOL MANAG, V259, P943, DOI 10.1016/j.foreco.2009.11.036; Davidian M., 1995, NONLINEAR MODELS REP; Dutilleul P, 1998, CAN J FOREST RES, V28, P56, DOI 10.1139/cjfr-28-1-56; Fang Z, 2001, FOREST SCI, V47, P3; Fox JC, 2001, FOREST ECOL MANAG, V154, P261, DOI 10.1016/S0378-1127(00)00632-0; Fu L, 2013, FOREST ECOL MANAG, V302; Gomez-Vazquez I, 2013, ANN FOREST SCI; Gonzalez-Benecke CA, 2014, J FORESTRY RES, V25, P43, DOI 10.1007/s11676-014-0427-4; Gregoire TG, 1995, CAN J FOREST RES, V1, P25, DOI DOI 10.1139/X95-017; Gregorie TG, 1987, FOREST SCI, V33, P2; IHAKA R, 2004, R LANG ENV STAT COMP; Keselman HJ, 1999, BRIT J MATH STAT PSY, V52, P63, DOI 10.1348/000711099158964; KJELGREN RK, 1992, INT J BIOMETEOROL, V36, P165, DOI 10.1007/BF01224821; LAPPI J, 1994, FOREST SCI, V40, P715; Leak W, 1996, FOREST SCI, V1, P12; Leites LP, 2009, CAN J FOREST RES, V39, P655, DOI 10.1139/X08-205; Lhotka JM, 2011, FOREST ECOL MANAG, V261, P3; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Matos LA, 2012, COMPUT STAT DATA AN, V57, P1; Meng SX, 2009, FOREST SCI, V55, P238; Nigh G, 2012, FOREST CHRON, V88, P340, DOI 10.5558/tfc2012-061; OMULE SAY, 1991, CAN J FOREST RES, V21, P1418, DOI 10.1139/x91-199; PALMER MJ, 1991, BIOMETRICS, V47, P623, DOI 10.2307/2532151; Peper PJ, 2001, J ARBORICULT, V27, P6; Peugh JL, 2005, EDUC PSYCHOL MEAS, V65, P5; Pinheiro JC, 2000, MIXED EFFECTS MODELS, P291; Schabenberger Oliver, 1995, Silva Fennica, V29, P49; Sonmez T, 2009, AFRICAN J AGR RES, V4, P3; Tahvanainen T, 2008, FOREST ECOL MANAG, V255, P455, DOI 10.1016/j.foreco.2007.09.035; Timilsina N, 2013, FOREST SCI, V59, P27, DOI 10.5849/forsci.10-028; Uzoh FCC, 2008, FOREST ECOL MANAG, V256, P438, DOI 10.1016/j.foreco.2008.04.046; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; Warbington R, 1993, STAND INVENTORY TECH, P319; WARING RH, 1982, CAN J FOREST RES, V12, P556, DOI 10.1139/x82-086; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; WYKOFF WR, 1990, FOREST SCI, V36, P1077; Zhao L, 2012, J FOREST RES, V18, P4	47	31	43	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122257	10.1371/journal.pone.0122257	http://dx.doi.org/10.1371/journal.pone.0122257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876178	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800047
J	Buckner, CA; Buckner, AL; Koren, SA; Persinger, MA; Lafrenie, RM				Buckner, Carly A.; Buckner, Alison L.; Koren, Stan A.; Persinger, Michael A.; Lafrenie, Robert M.			Inhibition of Cancer Cell Growth by Exposure to a Specific Time-Varying Electromagnetic Field Involves T-Type Calcium Channels	PLOS ONE			English	Article							MAGNETIC-FIELDS; MELANOMA-CELLS; WEAK; PROLIFERATION; CYCLE; DIFFERENTIATION; ACTIVATION; EXPRESSION; INDUCTION; CARCINOMA	Electromagnetic field (EMF) exposures affect many biological systems. The reproducibility of these effects is related to the intensity, duration, frequency, and pattern of the EMF. We have shown that exposure to a specific time-varying EMF can inhibit the growth of malignant cells. Thomas-EMF is a low-intensity, frequency-modulated (25-6 Hz) EMF pattern. Daily, 1 h, exposures to Thomas-EMF inhibited the growth of malignant cell lines including B16-BL6, MDA-MB-231, MCF-7, and HeLa cells but did not affect the growth of non-malignant cells. Thomas-EMF also inhibited B16-BL6 cell proliferation in vivo. B16-BL6 cells implanted in syngeneic C57b mice and exposed daily to Thomas-EMF produced smaller tumours than in sham-treated controls. In vitro studies showed that exposure of malignant cells to Thomas-EMF for > 15 min promoted Ca2+ influx which could be blocked by inhibitors of voltage-gated T-type Ca2+ channels. Blocking Ca2+ uptake also blocked Thomas-EMF-dependent inhibition of cell proliferation. Exposure to Thomas-EMF delayed cell cycle progression and altered cyclin expression consistent with the decrease in cell proliferation. Non-malignant cells did not show any EMF-dependent changes in Ca2+ influx or cell growth. These data confirm that exposure to a specific EMF pattern can affect cellular processes and that exposure to Thomas-EMF may provide a potential anti-cancer therapy.	[Buckner, Carly A.; Buckner, Alison L.; Persinger, Michael A.; Lafrenie, Robert M.] Laurentian Univ, Dept Biomol Sci, Sudbury, ON P3E 2C6, Canada; [Buckner, Carly A.; Buckner, Alison L.; Lafrenie, Robert M.] Hlth Sci North, Reg Canc Program, Sudbury, ON, Canada; [Koren, Stan A.; Persinger, Michael A.] Laurentian Univ, Behav Neurosci, Sudbury, ON P3E 2C6, Canada; [Lafrenie, Robert M.] Northern Ontario Sch Med, Sudbury, ON, Canada	Laurentian University; Health Sciences North; Northern Ontario School of Medicine; Laurentian University; Northern Ontario School of Medicine	Lafrenie, RM (corresponding author), Laurentian Univ, Dept Biomol Sci, Sudbury, ON P3E 2C6, Canada.	rlafrenie@amric.ca		Lafrenie, Robert/0000-0001-9981-997X	Northern Cancer Foundation, Sudbury, Ontario; Natural Sciences and Engineering Research Council, Canada	Northern Cancer Foundation, Sudbury, Ontario; Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Northern Cancer Foundation, Sudbury, Ontario and Natural Sciences and Engineering Research Council, Canada (MAP, primary). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS MJ, 1990, AM J PATHOL, V136, P593; Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24; BIANCHI S, 1994, BIOCHEM BIOPH RES CO, V204, P691, DOI 10.1006/bbrc.1994.2515; BLANCHARD JP, 1994, BIOELECTROMAGNETICS, V15, P217, DOI 10.1002/bem.2250150306; Blank Martin, 2009, Pathophysiology, V16, P71, DOI 10.1016/j.pathophys.2009.01.006; Brizhik L, 1998, J BIOL PHYS, V24, P19, DOI 10.1023/A:1005096714234; Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; Cifra M, 2011, PROG BIOPHYS MOL BIO, V105, P223, DOI 10.1016/j.pbiomolbio.2010.07.003; CONTI P, 1986, FEBS LETT, V199, P130, DOI 10.1016/0014-5793(86)81238-8; Costa FP, 2011, BRIT J CANCER, V105, P640, DOI 10.1038/bjc.2011.292; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; Cui YJ, 2014, CELL CALCIUM, V55, P48, DOI 10.1016/j.ceca.2013.11.002; FIDLER IJ, 1975, CANCER RES, V35, P218; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; GAFFNEY EV, 1982, CELL TISSUE RES, V227, P563, DOI 10.1007/BF00204786; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GERDES J, 1984, J IMMUNOL, V133, P1710; Guo BQ, 2005, EUR J CELL BIOL, V84, P927, DOI 10.1016/j.ejcb.2005.09.016; Guo LF, 2011, ELECTROMAGN BIOL MED, V30, P21, DOI 10.3109/15368378.2011.566775; Hirooka K, 2002, J NEUROPHYSIOL, V88, P196, DOI 10.1152/jn.2002.88.1.196; Hu JH, 2010, INT J RADIAT BIOL, V86, P79, DOI 10.3109/09553000903419932; Iftinca M C, 2011, J Med Life, V4, P126; Lam K, 2005, J CELL PHYSIOL, V203, P353, DOI 10.1002/jcp.20247; Lange S, 2004, CELL PROLIFERAT, V37, P337, DOI 10.1111/j.1365-2184.2004.00317.x; Li XP, 2012, ELECTROMAGN BIOL MED, V31, P356, DOI 10.3109/15368378.2012.662194; Lin H, 2001, J CELL BIOCHEM, V81, P143, DOI 10.1002/1097-4644(20010401)81:1<143::AID-JCB1030>3.0.CO;2-4; Lisi A, 2006, BIOELECTROMAGNETICS, V27, P641, DOI 10.1002/bem.20255; Martin LJ, 2004, PHARMACOL BIOCHEM BE, V78, P217, DOI 10.1016/j.pbb.2004.03.016; Nie K, 2003, J CELL BIOCHEM, V90, P1197, DOI 10.1002/jcb.10704; Nie YZ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-582; Novikov VV, 2009, BIOELECTROMAGNETICS, V30, P343, DOI 10.1002/bem.20487; Ohkubo T, 2012, INT J ONCOL, V41, P267, DOI 10.3892/ijo.2012.1422; Pall ML, 2013, J CELL MOL MED, V17, P958, DOI 10.1111/jcmm.12088; Panagopoulos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062663; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Pilla A, 2011, BBA-GEN SUBJECTS, V1810, P1236, DOI 10.1016/j.bbagen.2011.10.001; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; Sadeghipour R, 2012, ELECTROMAGN BIOL MED, V31, P425, DOI 10.3109/15368378.2012.683844; Saliev Timur, 2014, Front Biosci (Elite Ed), V6, P175; Schimmelpfeng J, 1997, BIOELECTROMAGNETICS, V18, P177, DOI 10.1002/(SICI)1521-186X(1997)18:2<177::AID-BEM11>3.0.CO;2-O; Schimmelpfeng J, 1995, BIOELECTROMAGNETICS, V16, P381, DOI 10.1002/bem.2250160606; See V, 2004, J CELL BIOL, V166, P661, DOI 10.1083/jcb.200402136; Shupak NM, 2004, NEUROSCI LETT, V363, P157, DOI 10.1016/j.neulet.2004.03.069; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; Stratton D, 2013, BIOCHEM BIOPH RES CO, V430, P470, DOI 10.1016/j.bbrc.2012.12.012; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Taylor JT, 2008, CANCER LETT, V267, P116, DOI 10.1016/j.canlet.2008.03.032; Thumm S, 1999, RADIAT ENVIRON BIOPH, V38, P195, DOI 10.1007/s004110050155; Tokalov SV, 2004, ENVIRON RES, V94, P145, DOI 10.1016/S0013-9351(03)00088-4; Tomitsch J, 2015, BIOELECTROMAGNETICS, V36, P77, DOI 10.1002/bem.21887; Ushiyama A, 2004, IN VIVO, V18, P125; Vijayalaxmi, 2009, INT J RADIAT BIOL, V85, P196, DOI 10.1080/09553000902748575; Wang TT, 2011, BIOELECTROMAGNETICS, V32, P443, DOI 10.1002/bem.20654; Weaver JC, 1999, BIOPHYS J, V76, P3026, DOI 10.1016/S0006-3495(99)77455-2; Whissell PD, 2007, CURR NEUROPHARMACOL, V5, P278, DOI 10.2174/157015907782793603; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yamaguchi S, 2006, BIOELECTROMAGNETICS, V27, P64, DOI 10.1002/bem.20177; Yan JH, 2010, ELECTROMAGN BIOL MED, V29, P165, DOI 10.3109/01676830.2010.505490; Zahradnikova A, 2007, J PHARMACOL EXP THER, V322, P638, DOI 10.1124/jpet.107.122176; Zimmerman JW, 2012, BRIT J CANCER, V106, P307, DOI 10.1038/bjc.2011.523	62	45	46	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124136	10.1371/journal.pone.0124136	http://dx.doi.org/10.1371/journal.pone.0124136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875081	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700055
J	Liu, XL; Gheno, T; Lindahl, BB; Lindwall, G; Gleeson, B; Liu, ZK				Liu, Xuan L.; Gheno, Thomas; Lindahl, Bonnie B.; Lindwall, Greta; Gleeson, Brian; Liu, Zi-Kui			First-Principles Calculations, Experimental Study, and Thermodynamic Modeling of the Al-Co-Cr System	PLOS ONE			English	Article							PHASE-EQUILIBRIA; TERNARY-SYSTEM; TEMPERATURE; STABILITY; ALLOYS; NI; TECHNOLOGY; COATINGS; PROGRESS; TI	The phase relations and thermodynamic properties of the condensed Al-Co-Cr ternary alloy system are investigated using first-principles calculations based on density functional theory (DFT) and phase-equilibria experiments that led to X-ray diffraction (XRD) and electron probe micro-analysis (EPMA) measurements. A thermodynamic description is developed by means of the calculations of phase diagrams (CALPHAD) method using experimental and computational data from the present work and the literature. Emphasis is placed on modeling the bcc-A2, B2, fcc-gamma, and tetragonal-sigma phases in the temperature range of 1173 to 1623 K. Liquid, bcc-A2 and fcc-gamma phases are modeled using substitutional solution descriptions. First-principles special quasirandom structures (SQS) calculations predict a large bcc-A2 (disordered)/B2 (ordered) miscibility gap, in agreement with experiments. A partitioning model is then used for the A2/B2 phase to effectively describe the order-disorder transitions. The critically assessed thermodynamic description describes all phase equilibria data well. A2/B2 transitions are also shown to agree well with previous experimental findings.	[Liu, Xuan L.; Lindwall, Greta; Liu, Zi-Kui] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Gheno, Thomas; Gleeson, Brian] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15261 USA; [Lindahl, Bonnie B.] KTH Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Royal Institute of Technology	Liu, XL (corresponding author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.	xul119@psu.edu	Gheno, Thomas/AAI-5552-2020; Liu, Zi-Kui/A-8196-2009	Liu, Zi-Kui/0000-0003-3346-3696; Lindwall, Greta/0000-0003-4221-8510; Gheno, Thomas/0000-0002-9343-8559; Gleeson, Brian/0000-0001-5531-7337; Hagen, Bonnie/0000-0001-9010-525X	NSF Industry/University Cooperative Research Center for Computational Materials Design (CCMD) [IIP-1034965, IIP-1034968]; Office of Naval Research (ONR) - the University Turbine Systems Research (UTSR) Program run by the National Energy Technology Laboratory (NTEL) [N0014-07-1-0638]; Department of Energy [DE-FE0007271]; European Research Fund for Coal and Steel (RFCS) [RFSR-CT-2010-00018]; National Science Foundation [ACI-1053575]	NSF Industry/University Cooperative Research Center for Computational Materials Design (CCMD); Office of Naval Research (ONR) - the University Turbine Systems Research (UTSR) Program run by the National Energy Technology Laboratory (NTEL); Department of Energy(United States Department of Energy (DOE)); European Research Fund for Coal and Steel (RFCS); National Science Foundation(National Science Foundation (NSF))	XLL, GL, and ZKL acknowledges that the computational aspects of this work were financially supported by the NSF Industry/University Cooperative Research Center for Computational Materials Design (CCMD, http://www.ccmd.psu.edu/), including dues contributions of CCMD members, through grants IIP-1034965 (Penn State) and IIP-1034968 (Georgia Tech) and the Office of Naval Research (ONR, http://www.onr.navy.mil/) with the contract number N0014-07-1-0638 managed by David Shifler. TG and BG acknowledges that the experimental aspects of this work were partly supported by the Department of Energy under grant number DE-FE0007271 through the University Turbine Systems Research (UTSR) Program run by the National Energy Technology Laboratory (NTEL, http://www.netl.doe.gov/), with Dr. Seth Lawson being the Project Manager. One of the authors, BL, acknowledges funding from the European Research Fund for Coal and Steel (RFCS, http://cordis.europa.eu/coal-steel-rtd/) project "Precipitation in High Manganese Steels" under the grant agreement no. RFSR-CT-2010-00018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Computing clusters LION and Cyberstar are provided by the Materials Simulation Center and the Research Computing and Cyberinfrastructure Group at the Pennsylvania State University. Additionally, this work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575. We would like to also thank Dr. Yi Wang and Richard Otis for stimulating discussions about the computational aspects of this work.	Achar DRG, 2004, SURF COAT TECH, V187, P272, DOI [10.1016/j.surfcoat.2004.02.018, 10.1016/j.surfocat.2004.02.018]; Alers G.A., 1965, PHYS ACOUSTICS, VIII, P1; Andersson JO, 2002, CALPHAD, V26, P273, DOI 10.1016/S0364-5916(02)00037-8; Ansara I., 1998, COST 507 DEFINITION, V2; Bell H. B., 1973, Metal Science Journal, V7, P185; BIRCH F, 1947, PHYS REV AM PHYS SOC, P71; BLOCHL PE, 1994, PHYS REV B, V49, P16223, DOI 10.1103/PhysRevB.49.16223; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Chen Q, 2001, ACTA MATER, V49, P947, DOI 10.1016/S1359-6454(01)00002-7; Clarke DR, 2003, ANNU REV MATER RES, V33, P383, DOI 10.1146/annurev.matsci.33.011403.113718; Darolia R, 2013, INT MATER REV, V58, P315, DOI 10.1179/1743280413Y.0000000019; DICKINS GJ, 1956, ACTA CRYSTALLOGR, V9, P297, DOI 10.1107/S0365110X56000826; DINSDALE AT, 1991, CALPHAD, V15, P317, DOI 10.1016/0364-5916(91)90030-N; DOWNIE DB, 1983, J CHEM THERMODYN, V15, P645, DOI 10.1016/0021-9614(83)90078-2; Dupin N, 2001, CALPHAD, V25, P279, DOI 10.1016/S0364-5916(01)00049-9; Dupin N, 1998, REV METALL-PARIS, V95, P1121, DOI 10.1051/metal/199895091121; Dupin N, 1999, Z METALLKD, V90, P76; Dupin N, 1995, THESIS INP GRENOBLE; Evans AG, 2001, PROG MATER SCI, V46, P505, DOI 10.1016/S0079-6425(00)00020-7; Goward GW, 1998, SURF COAT TECH, V108, P73, DOI 10.1016/S0257-8972(98)00667-7; Hafner R, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.184432; Hammer L, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075413; Havrankova J, 1999, KOVOVE MATER, V37, P34; Helander T, 1999, J PHASE EQUILIB, V20, P57, DOI 10.1361/105497199770335947; Hillert M, 2001, J ALLOY COMPD, V320, P161, DOI 10.1016/S0925-8388(00)01481-X; HILLERT M, 1978, CALPHAD, V2, P227, DOI 10.1016/0364-5916(78)90011-1; INDEN G, 1981, PHYSICA B & C, V103, P82, DOI 10.1016/0378-4363(81)91004-4; Ishikawa K, 1998, BER BUNSEN PHYS CHEM, V102, P1206, DOI 10.1002/bbpc.19981020924; JANSSON B, 1984, TRITAMAC0234; Jiang C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214202; Jiang C, 2005, ACTA MATER, V53, P2643, DOI 10.1016/j.actamat.2005.02.026; Jiang C, 2009, ACTA MATER, V57, P4716, DOI 10.1016/j.actamat.2009.06.026; Joubert JM, 2008, PROG MATER SCI, V53, P528, DOI 10.1016/j.pmatsci.2007.04.001; KAMM GN, 1964, J APPL PHYS, V35, P327, DOI 10.1063/1.1713309; KATTNER UR, 2002, CONSTRUCTION THERMOD; KITTEL C, 1995, INTRO SOLID STATE PH; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G., 2013, VASP GUIDE; Lieser AC, 2012, CALPHAD, V38, P92, DOI 10.1016/j.calphad.2012.04.005; Liu XL, 2015, COMP MATER SCI, V98, P34, DOI 10.1016/j.commatsci.2014.10.056; Liu XL, 2013, CALPHAD, V41, P119, DOI 10.1016/j.calphad.2013.02.006; Liu ZK, 2009, J PHASE EQUILIB DIFF, V30, P517, DOI 10.1007/s11669-009-9570-6; Lu XG, 2007, ACTA MATER, V55, P1215, DOI 10.1016/j.actamat.2006.05.054; MEHL MJ, 1990, PHYS REV B, V41, P10311, DOI 10.1103/PhysRevB.41.10311; METHFESSEL M, 1989, PHYS REV B, V40, P3616, DOI 10.1103/PhysRevB.40.3616; MORI N, 1988, PHYSICA B & C, V149, P226, DOI 10.1016/0378-4363(88)90246-X; MORUZZI VL, 1990, PHYS REV B, V42, P8361, DOI 10.1103/PhysRevB.42.8361; MOSKVITINA ES, 1992, VESTN MOSK U KHIM+, V33, P373; Nicholls JR, 2000, JOM-J MIN MET MAT S, V52, P28, DOI 10.1007/s11837-000-0112-2; Oikawa K, 2002, ACTA MATER, V50, P2223, DOI 10.1016/S1359-6454(01)00433-5; Pavlu J, 2010, INTERMETALLICS, V18, P212, DOI 10.1016/j.intermet.2009.07.018; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; REDLICH O, 1948, IND ENG CHEM, V40, P345, DOI 10.1021/ie50458a036; Reed R.C., 2006, SUPERALLOYS; Shang S., 2007, APPL PHYS LETT, V90; Shang SL, 2010, COMP MATER SCI, V48, P813, DOI 10.1016/j.commatsci.2010.03.041; Shang SL, 2010, COMP MATER SCI, V47, P1040, DOI 10.1016/j.commatsci.2009.12.006; Stein F, 2013, INTERMETALLICS, V39, P58, DOI 10.1016/j.intermet.2013.03.011; Sundman B, 2009, ACTA MATER, V57, P2896, DOI 10.1016/j.actamat.2009.02.046; Toscano J, 2007, SURF COAT TECH, V202, P603, DOI 10.1016/j.surfcoat.2007.06.044; Wang Y, 2004, CALPHAD, V28, P79, DOI 10.1016/j.calphad.2004.05.002; Wang Y, 2004, ACTA MATER, V52, P2665, DOI 10.1016/j.actamat.2004.02.014; WOOD JH, 1987, SUPERALLOYS, V2; Wright IG, 2007, INT J HYDROGEN ENERG, V32, P3610, DOI 10.1016/j.ijhydene.2006.08.049; Yang SY, 2012, RARE METALS, V31, P75, DOI 10.1007/s12598-012-0466-y; Zacherl CL, 2012, CALPHAD, V38, P71, DOI 10.1016/j.calphad.2012.05.001; ZUNGER A, 1990, PHYS REV LETT, V65, P353, DOI 10.1103/PhysRevLett.65.353	68	13	13	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121386	10.1371/journal.pone.0121386	http://dx.doi.org/10.1371/journal.pone.0121386			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875037	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000352845100312
J	Peugnet, P; Robles, M; Mendoza, L; Wimel, L; Dubois, C; Dahirel, M; Guillaume, D; Camous, S; Berthelot, V; Toquet, MP; Richard, E; Sandersen, C; Chaffaux, S; Lejeune, JP; Tarrade, A; Serteyn, D; Chavatte-Palmer, P				Peugnet, Pauline; Robles, Morgane; Mendoza, Luis; Wimel, Laurence; Dubois, Cedric; Dahirel, Michele; Guillaume, Daniel; Camous, Sylvaine; Berthelot, Valerie; Toquet, Marie-Pierre; Richard, Eric; Sandersen, Charlotte; Chaffaux, Stephane; Lejeune, Jean-Philippe; Tarrade, Anne; Serteyn, Didier; Chavatte-Palmer, Pascale			Effects of Moderate Amounts of Barley in Late Pregnancy on Growth, Glucose Metabolism and Osteoarticular Status of Pre-Weaning Horses	PLOS ONE			English	Article							INSULIN-SECRETION; POSTNATAL-GROWTH; EMBRYO-TRANSFER; BODY CONDITION; MATERNAL SIZE; YOUNG HORSES; FETAL-GROWTH; RESPONSES; MARES; FOALS	In stud management, broodmares are commonly fed concentrates in late pregnancy. This practice, however, was shown to correlate with an increased incidence of osteochondrosis in foals, which may be related to insulin sensitivity. We hypothesized that supplementation of the mare with barley in the last trimester of pregnancy alters the pre-weaning foal growth, glucose metabolism and osteoarticular status. Here, pregnant multiparous saddlebred mares were fed forage only (group F, n=13) or both forage and cracked barley (group B, n=12) from the 7th month of pregnancy until term, as calculated to cover nutritional needs of broodmares. Diets were given in two daily meals. All mares and foals returned to pasture after parturition. Post-natal growth, glucose metabolism and osteoarticular status were investigated in pre-weaning foals. B mares maintained an optimal body condition score (>3.5), whereas that of F mares decreased and remained low (<2.5) up to 3 months of lactation, with a significantly lower bodyweight (-7%) than B mares throughout the last 2 months of pregnancy. B mares had increased plasma glucose and insulin after the first meal and after the second meal to a lesser extent, which was not observed in F mares. B mares also had increased insulin secretion during an intravenous glucose tolerance test (IVGTT). Plasma NEFA and leptin were only temporarily affected by diet in mares during pregnancy or in early lactation. Neonatal B foals had increased serum osteocalcin and slightly increased glucose increments and clearance after glucose injection, but these effects had vanished at weaning. Body measurements, plasma IGF-1, T4, T3, NEFA and leptin concentrations, insulin secretion during IVGTT, as well as glucose metabolism rate during euglycemic hyperinsulinemic clamps after weaning, did not differ between groups. Radiographic examination of joints indicated increased osteochondrosis relative risk in B foals, but this was not significant. These data demonstrate that B or F maternal nutrition has very few effects on foal growth, endocrinology and glucose homeostasis until weaning, but may induce cartilage lesions.	[Peugnet, Pauline; Robles, Morgane; Dahirel, Michele; Camous, Sylvaine; Chaffaux, Stephane; Tarrade, Anne; Chavatte-Palmer, Pascale] INRA, Biol Dev & Reprod UMR1198, F-78350 Jouy En Josas, France; [Wimel, Laurence; Dubois, Cedric] IFCE, Stn Expt Valade, F-19370 Chamberet, France; [Guillaume, Daniel] INRA, CNRS, Physiol Reprod & Comportements, UMR85,UMR7247, F-37380 Nouzilly, France; [Guillaume, Daniel] Univ Tours, F-37000 Tours, France; [Berthelot, Valerie] AgroParis Tech, F-75005 Paris 5, France; [Toquet, Marie-Pierre; Richard, Eric] Normandie Univ, UNICAEN, ICORE LABEO Frank Duncombe Lab SF4206, F-14000 Caen, France; [Mendoza, Luis; Sandersen, Charlotte; Lejeune, Jean-Philippe; Serteyn, Didier] Univ Liege, Equine Clin, Fac Med Vet, B-4000 Liege, Belgium	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; AgroParisTech; Universite de Caen Normandie; University of Liege	Peugnet, P (corresponding author), INRA, Biol Dev & Reprod UMR1198, F-78350 Jouy En Josas, France.	peugnetpauline@gmail.com	Richard, Eric A./T-9257-2017; Robles, Morgane/AAA-4407-2020; Chavatte-Palmer, Pascale/K-7349-2012	Richard, Eric A./0000-0002-5890-8658; Robles, Morgane/0000-0003-4821-4684; Chavatte-Palmer, Pascale/0000-0002-4581-6092; TOQUET, MARIE-PIERRE/0000-0001-6510-3957; Couturier-Tarrade, Anne/0000-0003-1559-5476; Sandersen, charlotte/0000-0002-3404-2757	"Institut Francais du Cheval et de l'Equitation" under grant name "FOETALIM"; "Institut National de la Recherche Agronomique" Department "Physiology and Breeding Systems"	"Institut Francais du Cheval et de l'Equitation" under grant name "FOETALIM"; "Institut National de la Recherche Agronomique" Department "Physiology and Breeding Systems"	This work was funded through a grant from the "Institut Francais du Cheval et de l'Equitation" under grant name "FOETALIM" and through funding from the "Institut National de la Recherche Agronomique" Department "Physiology and Breeding Systems". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WR, 2004, REPRODUCTION, V127, P67, DOI 10.1530/rep.1.00024; Allen WR, 2002, J ENDOCRINOL, V172, P237, DOI 10.1677/joe.0.1720237; Anderson ST, 2012, AUSTR EQ SCI S GOLD; Anderson ST, 2014, AUSTR EQ SCI S GOLD; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Arnaud G, 2000, NOTATION ETAT CORPOR; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Cavinder C. A., 2012, Professional Animal Scientist, V28, P344; Denoix J. M., 1990, Pratique Veterinaire Equine, V22, P14; DEPEW CL, 1994, J ANIM SCI, V72, P1530, DOI 10.2527/1994.7261530x; Dobbs TN, 2012, AUSTR EQ SCI S GOLD; DOREAU M, 1994, LAIT, V74, P401, DOI 10.1051/lait:1994633; Forhead AJ, 2004, J ENDOCRINOL, V181, P459, DOI 10.1677/joe.0.1810459; FOWDEN AL, 1984, EQUINE VET J, V16, P239, DOI 10.1111/j.2042-3306.1984.tb01919.x; Gentry LR, 2002, J ANIM SCI, V80, P2695; George LA, 2009, DOMEST ANIM ENDOCRIN, V37, P23, DOI 10.1016/j.domaniend.2009.01.003; Giussani DA, 2003, J PHYSIOL-LONDON, V547, P67, DOI 10.1113/jphysiol.2002.027409; Glade M. J., 1986, Journal of Equine Veterinary Science, V6, P151, DOI 10.1016/S0737-0806(86)80066-1; GLADE MJ, 1984, GROWTH, V48, P473; GLADE MJ, 1984, J ANIM SCI, V59, P658, DOI 10.2527/jas1984.593658x; GLADE MJ, 1985, J ENDOCRINOL, V104, P93, DOI 10.1677/joe.0.1040093; Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001; Henson FMD, 1997, EQUINE VET J, V29, P441, DOI 10.1111/j.2042-3306.1997.tb03156.x; JAESCHKE G, 1975, ZBL VET MED A, V22, P89; KautzkyWiller A, 1997, DIABETES CARE, V20, P1717, DOI 10.2337/diacare.20.11.1717; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Martin-Rosset W, 2012, NUTR ALIMENTATION CH, P624; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Ousey JC, 2008, EQUINE VET J, V40, P673, DOI 10.2746/042516408X322175; Pagan JD, 2001, RELATIONSHIP GLYCEMI; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Peugnet P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102044; Ralston SL, 1996, PFERDEHEILKUNDE, V12, P320; Salazar-Ortiz J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-130; Savage C., 1993, EQUINE VET J S, V25, P74; Song X, 2014, AUSTR EQ SCI S GOLD; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; STICKER LS, 1995, J ANIM SCI, V73, P136; STULL CL, 1988, J NUTR, V118, P206, DOI 10.1093/jn/118.2.206; Thorson JF, 2010, J ANIM SCI, V88, P982, DOI 10.2527/jas.2008-1646; Valette J. P., 2007, Equine and Comparative Exercise Physiology, V4, P23, DOI 10.1017/S1478061507747758; Vander Heyden L, 2013, VET REC, V172, P68, DOI 10.1136/vr.101034; Weeren P. R. van, 2006, Clinical Techniques in Equine Practice, V5, P248, DOI 10.1053/j.ctep.2006.08.002; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887	44	21	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122596	10.1371/journal.pone.0122596	http://dx.doi.org/10.1371/journal.pone.0122596			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875166	Green Published, gold			2022-12-26	WOS:000352845100086
J	Takahashi, K; Endo, M; Miyoshi, T; Tsuritani, M; Shimazu, Y; Hosoda, H; Saga, K; Tamai, K; Flake, AW; Yoshimatsu, J; Kimura, T				Takahashi, Kei; Endo, Masayuki; Miyoshi, Takekazu; Tsuritani, Mitsuhiro; Shimazu, Yukiko; Hosoda, Hiroshi; Saga, Kotaro; Tamai, Katsuto; Flake, Alan W.; Yoshimatsu, Jun; Kimura, Tadashi			Immune Tolerance Induction Using Fetal Directed Placental Injection in Rodent Models: A Murine Model	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; ENGRAFTMENT; MICE	Objectives Induction of the immune response is a major problem in replacement therapies for inherited protein deficiencies. Tolerance created in utero can facilitate postnatal treatment. In this study, we aimed to induce immune tolerance towards a foreign protein with early gestational cell transplantation into the chorionic villi under ultrasound guidance in the murine model. Methods Pregnant C57BL/6 (B6) mice on day 10 of gestation were anesthetized and imaged by high resolution ultrasound. Murine embryos and their placenta were positioned to get a clear view in B-mode with power mode of the labyrinth, which is the equivalent of chorionic villi in the human. Bone marrow cells (BMCs) from B6-Green Fluorescence Protein (B6GFP) transgenic mice were injected into the fetal side of the placenta which includes the labyrinth with glass microcapillary pipettes. Each fetal mouse received 2 x 10(5) viable GFP-BMCs. After birth, we evaluated the humoral and cell-mediated immune response against GFP. Results Bone marrow transfer into fetal side of placenta efficiently distributed donor cells to the fetal mice. The survival rate of this procedure was 13.5%(5 out of 37). Successful engraftment of the B6-GFP donor skin grafts was observed in all recipient (5 out of 5) mice 6 weeks after birth. Induction of anti-GFP antibodies was completely inhibited. Cytotoxic immune reactivity of thymic cells against cells harboring GFP was suppressed by ELISPOT assay. Conclusions In this study, we utilized early gestational placental injection targeting the murine fetus, to transfer donor cells carrying a foreign protein into the fetal circulation. This approach is sufficient to induce both humoral and cell-mediated immune tolerance against the foreign protein.	[Takahashi, Kei; Endo, Masayuki; Shimazu, Yukiko; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan; [Miyoshi, Takekazu; Tsuritani, Mitsuhiro; Yoshimatsu, Jun] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol & Gynecol, Suita, Osaka, Japan; [Hosoda, Hiroshi] Natl Cerebral & Cardiovasc Ctr, Dept Biochem, Suita, Osaka, Japan; [Saga, Kotaro] Osaka Univ, Grad Sch Med, Dept Gene Therapy Sci, Suita, Osaka, Japan; [Tamai, Katsuto] Osaka Univ, Grad Sch Med, Dept Stem Cell Therapy Sci, Suita, Osaka, Japan; [Flake, Alan W.] Childrens Hosp Philadelphia, Ctr Fetal Diag & Treatment, Philadelphia, PA 19104 USA	Osaka University; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Osaka University; Osaka University; University of Pennsylvania; Childrens Hospital of Philadelphia	Endo, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan.	endoh@gyne.med.osaka-u.ac.jp	Yoshimatsu, Jun/AFD-9150-2022; Yoshimatsu, Jun/AAE-9474-2022					Aboussaouira T, 1998, FETAL DIAGN THER, V13, P216, DOI 10.1159/000020841; Billingham RE, 1953, NATURE; Bruscia EM, 2006, STEM CELLS, V24, P2299, DOI 10.1634/stemcells.2006-0166; Chino T, 2008, AM J PATHOL, V173, P803, DOI 10.2353/ajpath.2008.070977; Christensen G, 2000, CIRCULATION; Endoh M, 2002, MOL THER, V5, P501, DOI 10.1006/mthe.2002.0577; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P683, DOI 10.1016/j.bpobgyn.2012.06.005; Nijagal A, 2012, CLIN PERINATOL, V39, P301, DOI 10.1016/j.clp.2012.04.004; Palmer AC, 2011, ADV NUTR, V2, P377, DOI 10.3945/an.111.000570; Peranteau WH, 2006, BLOOD, V108, P4268, DOI 10.1182/blood-2006-04-018986; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Shaaban AF, 2006, EXP HEMATOL, V34, P1278, DOI 10.1016/j.exphem.2006.05.007; Soper BW, 2003, J IMMUNOL, V171, P3270, DOI 10.4049/jimmunol.171.6.3270; Vanleene M, 2011, BLOOD, V117, P1053, DOI 10.1182/blood-2010-05-287565; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; WHITELAW A, 1988, BRIT MED BULL, V44, P1037, DOI 10.1093/oxfordjournals.bmb.a072288	17	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123712	10.1371/journal.pone.0123712	http://dx.doi.org/10.1371/journal.pone.0123712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876079	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100201
J	Zakynthinaki, MS				Zakynthinaki, Maria S.			Modelling Heart Rate Kinetics	PLOS ONE			English	Article							OXYGEN-UPTAKE KINETICS; TIME-DELAYED PHASES; STOCHASTIC OPTIMIZATION; MUSCULAR EXERCISE; RECOVERY	The objective of the present study was to formulate a simple and at the same time effective mathematical model of heart rate kinetics in response to movement (exercise). Based on an existing model, a system of two coupled differential equations which give the rate of change of heart rate and the rate of change of exercise intensity is used. The modifications introduced to the existing model are justified and discussed in detail, while models of blood lactate accumulation in respect to time and exercise intensity are also presented. The main modification is that the proposed model has now only one parameter which reflects the overall cardiovascular condition of the individual. The time elapsed after the beginning of the exercise, the intensity of the exercise, as well as blood lactate are also taken into account. Application of the model provides information regarding the individual's cardiovascular condition and is able to detect possible changes in it, across the data recording periods. To demonstrate examples of successful numerical fit of the model, constant intensity experimental heart rate data sets of two individuals have been selected and numerical optimization was implemented. In addition, numerical simulations provided predictions for various exercise intensities and various cardiovascular condition levels. The proposed model can serve as a powerful tool for a complete means of heart rate analysis, not only in exercise physiology (for efficiently designing training sessions for healthy subjects) but also in the areas of cardiovascular health and rehabilitation (including application in population groups for which direct heart rate recordings at intense exercises are not possible or not allowed, such as elderly or pregnant women).	[Zakynthinaki, Maria S.] Tech Univ Crete, Technol Educ Inst Crete, Dept Elect, Khania, Greece; [Zakynthinaki, Maria S.] Tech Univ Crete, Appl Math & Comp Lab, Khania, Greece	Hellenic Mediterranean University; Technical University of Crete; Technical University of Crete	Zakynthinaki, MS (corresponding author), Tech Univ Crete, Technol Educ Inst Crete, Dept Elect, Khania, Greece.	marzak@science.tuc.gr						Arrowsmith D.K., 1990, INTRO DYNAMICAL SYST; Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Bangsbo J, 2000, AM J PHYSIOL-REG I, V279, pR899, DOI 10.1152/ajpregu.2000.279.3.R899; BARSTOW TJ, 1991, J APPL PHYSIOL, V71, P2099, DOI 10.1152/jappl.1991.71.6.2099; Bowers RW, 1992, SPORTS PHYSL; Brooks G. A., 2004, EXERCISE PHYSL HUMAN; Burke E., 1998, PRECISION HEART RATE; Carter H, 2000, J APPL PHYSIOL, V89, P1744, DOI 10.1152/jappl.2000.89.5.1744; DAVIES CTM, 1972, J APPL PHYSIOL, V32, P618, DOI 10.1152/jappl.1972.32.5.618; Goodwin Matthew L, 2007, J Diabetes Sci Technol, V1, P558; Guckenheimer J., 2002, NONLINEAR OSCILLATIO; Hairer E., 1993, SOLVING ORDINARY DIF; Hill AV, 1923, Q J MED, V16, P135, DOI 10.1093/qjmed/os-16.62.135; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Jones AM, 2011, MED SCI SPORT EXER, V43, P2046, DOI 10.1249/MSS.0b013e31821fcfc1; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; LINNARSSON D, 1974, ACTA PHYSIOL SCAND, P1; Maffetone P, 1996, HIGH PERFORMANCE HEA; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Maughan RJ, 2004, BIOCH BASIS SPORTS P; McArdle W, 2010, EXERCISE PHYSL ENERG; Miller T, 2012, NSCAS GUIDE TESTS AS; Noakes T., 2003, LORE RUNNING; Powers S.K., 2007, EXERCISE PHYSL THEOR; Stirling JR, 2009, J APPL PHYSIOL, V107, P1665, DOI 10.1152/japplphysiol.00158.2009a; Stirling J, 2008, J NONLINEAR MATH PHY, V15, P426, DOI 10.2991/jnmp.2008.15.s3.41; Sherwood L, 2010, HUMAN PHYSL CELLS SY; Stirling JR, 2008, B MATH BIOL, V70, P1348, DOI 10.1007/s11538-008-9302-9; Stirling JR, 2005, B MATH BIOL, V67, P989, DOI 10.1016/j.bulm.2004.12.005; Wasserman K., 1999, PRINCIPLES EXERCISE; Weltman A, 1995, HUMAN KINETICS; WHIPP BJ, 1972, J APPL PHYSIOL, V33, P351, DOI 10.1152/jappl.1972.33.3.351; Whipp BJ, 2009, J APPL PHYSIOL, V107, P1663, DOI 10.1152/japplphysiol.00158.2009; Wilmore JK, 2007, PHYSL SPORT EXERCISE; Zakynthinaki MS, 2007, COMPUT PHYS COMMUN, V176, P98, DOI 10.1016/j.cpc.2006.08.005; Zakynthinaki MS, 2011, COMPUT PHYS COMMUN, V182, P683, DOI 10.1016/j.cpc.2010.11.027; Zakynthinaki MS, 2008, COMPUT PHYS COMMUN, V179, P888, DOI 10.1016/j.cpc.2008.07.012; Zakynthinaki M.S., 2010, CHAOS, V20, DOI DOI 10.1063/1.3337690; Zakynthinaki MS, 2013, APPL MATH COMPUT, V219, P8910, DOI 10.1016/j.amc.2013.03.030	39	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118263	10.1371/journal.pone.0118263	http://dx.doi.org/10.1371/journal.pone.0118263			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876164	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100004
J	Pandey, JL; Wang, B; Diehl, BG; Richard, TL; Chen, G; Anderson, CT				Pandey, Jyotsna L.; Wang, Bo; Diehl, Brett G.; Richard, Tom L.; Chen, Gong; Anderson, Charles T.			A Versatile Click-Compatible Monolignol Probe to Study Lignin Deposition in Plant Cell Walls	PLOS ONE			English	Article							FLUORESCENCE-TAGGED MONOLIGNOLS; CONFOCAL RAMAN MICROSCOPY; RADIATA D DON; STATE 2D NMR; BIOFUEL PRODUCTION; QUANTITATIVE C-13; LIVE CELLS; LIGNIFICATION; VISUALIZATION; BIOSYNTHESIS	Lignin plays important structural and functional roles in plants by forming a hydrophobic matrix in secondary cell walls that enhances mechanical strength and resists microbial decay. While the importance of the lignin matrix is well documented and the biosynthetic pathways for monolignols are known, the process by which lignin precursors or monolignols are transported and polymerized to form this matrix remains a subject of considerable debate. In this study, we have synthesized and tested an analog of coniferyl alcohol that has been modified to contain an ethynyl group at the C-3 position. This modification enables fluorescent tagging and imaging of this molecule after its incorporation into plant tissue by click chemistry- assisted covalent labeling with a fluorescent azide dye, and confers a distinct Raman signature that could be used for Raman imaging. We found that this monolignol analog is incorporated into in vitro-polymerized dehydrogenation polymer (DHP) lignin and into root epidermal cell walls of 4-day-old Arabidopsis seedlings. Incorporation of the analog in stem sections of 6-week-old Arabidopsis thaliana plants and labeling with an Alexa-594 azide dye revealed the precise locations of new lignin polymerization. Results from this study indicate that this molecule can provide high-resolution localization of lignification during plant cell wall maturation and lignin matrix assembly.	[Pandey, Jyotsna L.; Diehl, Brett G.; Richard, Tom L.] Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA; [Wang, Bo; Chen, Gong] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Anderson, Charles T.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Pandey, Jyotsna L.; Wang, Bo; Diehl, Brett G.; Richard, Tom L.; Chen, Gong; Anderson, Charles T.] Penn State Univ, Ctr Lignocellulose Struct & Format, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Anderson, CT (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	cta3@psu.edu	Chen, Gong/A-8063-2013	Chen, Gong/0000-0002-5067-9889; Pandey, Jyotsna L./0000-0001-8173-0424; Richard, Tom/0000-0002-0833-4844	Center for LignoCellulose Structure and Formation, an Energy Frontier Research Center - U. S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001090]	Center for LignoCellulose Structure and Formation, an Energy Frontier Research Center - U. S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported as part of The Center for LignoCellulose Structure and Formation, an Energy Frontier Research Center funded by the U. S. Department of Energy, Office of Science, Basic Energy Sciences under Award # DE-SC0001090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal UP, 2006, PLANTA, V224, P1141, DOI 10.1007/s00425-006-0295-z; Alejandro S, 2012, CURR BIOL, V22, P1207, DOI 10.1016/j.cub.2012.04.064; Anderson CT, 2012, P NATL ACAD SCI USA, V109, P1329, DOI 10.1073/pnas.1120429109; Azoulay M, 2006, BIOORG MED CHEM LETT, V16, P3147, DOI 10.1016/j.bmcl.2006.03.073; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bukowski N, 2014, BIOCONJUGATE CHEM, V25, P2189, DOI 10.1021/bc500411u; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Capanema EA, 2004, J AGR FOOD CHEM, V52, P1850, DOI 10.1021/jf035282b; Chabannes M, 2001, PLANT J, V28, P271, DOI 10.1046/j.1365-313X.2001.01159.x; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Coletta VC, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-43; Donaldson LA, 2001, PHYTOCHEMISTRY, V57, P859, DOI 10.1016/S0031-9422(01)00049-8; DONALDSON LA, 1991, WOOD SCI TECHNOL, V25, P15, DOI 10.1007/BF00195553; DONALDSON LA, 1992, IAWA BULL, V13, P381, DOI 10.1163/22941932-90001291; Flors C, 2013, J MICROSC-OXFORD, V251, P1, DOI 10.1111/jmi.12054; Gierlinger N, 2006, PLANT PHYSIOL, V140, P1246, DOI 10.1104/pp.105.066993; Gierlinger N, 2007, SPECTROSC-INT J, V21, P69, DOI 10.1155/2007/498206; Gierlinger N, 2012, NAT PROTOC, V7, P1694, DOI 10.1038/nprot.2012.092; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Grabber JH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-114; Holtman KM, 2006, J WOOD CHEM TECHNOL, V26, P21, DOI 10.1080/02773810600582152; Hsu TL, 2007, P NATL ACAD SCI USA, V104, P2614, DOI 10.1073/pnas.0611307104; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; Jones L, 2001, PLANT J, V26, P205, DOI 10.1046/j.1365-313x.2001.01021.x; Kaneda M, 2011, J EXP BOT, V62, P2063, DOI 10.1093/jxb/erq416; Kaneda M, 2010, J INTEGR PLANT BIOL, V52, P234, DOI 10.1111/j.1744-7909.2010.00925.x; Kim H, 2008, BIOENERG RES, V1, P56, DOI 10.1007/s12155-008-9004-z; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Lawoko M, 2006, HOLZFORSCHUNG, V60, P156, DOI 10.1515/HF.2006.025; Link AJ, 2004, J AM CHEM SOC, V126, P10598, DOI 10.1021/ja047629c; Liu CJ, 2012, MOL PLANT, V5, P304, DOI 10.1093/mp/ssr121; Lu FC, 2008, ORG BIOMOL CHEM, V6, P3681, DOI 10.1039/b809464k; Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064; Miao YC, 2010, P NATL ACAD SCI USA, V107, P22728, DOI 10.1073/pnas.1007747108; Palonpon AF, 2013, NAT PROTOC, V8, P677, DOI 10.1038/nprot.2013.030; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Rohrig UF, 2012, J MED CHEM, V55, P5270, DOI 10.1021/jm300260v; SAKA S, 1982, WOOD SCI TECHNOL, V16, P167, DOI 10.1007/BF00353866; Schmidt M, 2009, PLANTA, V230, P589, DOI 10.1007/s00425-009-0963-x; Schuetz M, 2014, PLANT PHYSIOL, V166, P798, DOI 10.1104/pp.114.245597; Seo TS, 2004, P NATL ACAD SCI USA, V101, P5488, DOI 10.1073/pnas.0401138101; Shadle G, 2007, PHYTOCHEMISTRY, V68, P1521, DOI 10.1016/j.phytochem.2007.03.022; Shieh P, 2014, P NATL ACAD SCI USA, V111, P5456, DOI 10.1073/pnas.1322727111; Simmons BA, 2010, CURR OPIN PLANT BIOL, V13, P313, DOI 10.1016/j.pbi.2010.03.001; Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386; TERASHIMA N, 1995, HOLZFORSCHUNG, V49, P521, DOI 10.1515/hfsg.1995.49.6.521; Tobimatsu Y, 2014, CHEM COMMUN, V50, P12262, DOI 10.1039/c4cc04692g; Tobimatsu Y, 2013, PLANT J, V76, P357, DOI 10.1111/tpj.12299; Tobimatsu Y, 2011, BIOMACROMOLECULES, V12, P1752, DOI 10.1021/bm200136x; Tronchet M, 2010, MOL PLANT PATHOL, V11, P83, DOI [10.1111/j.1364-3703.2009.00578.x, 10.1111/j.1364-3703.2009.00578.X]; Vallet C, 1996, ANN BOT-LONDON, V78, P625, DOI 10.1006/anbo.1996.0170; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vishnoi S, 2009, J AGR FOOD CHEM, V57, P3261, DOI 10.1021/jf8034385; Wang Y, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00220, 10.3389/fpls.2013.00314]; Wardrop A. B., 1957, TAPPI, V40, P225; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161; Yamakoshi H, 2012, J AM CHEM SOC, V134, P20681, DOI 10.1021/ja308529n; Yuan TQ, 2011, J AGR FOOD CHEM, V59, P10604, DOI 10.1021/jf2031549; Zessin PJM, 2012, J STRUCT BIOL, V177, P344, DOI 10.1016/j.jsb.2011.12.015	65	17	17	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121334	10.1371/journal.pone.0121334	http://dx.doi.org/10.1371/journal.pone.0121334			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884205	Green Published, Green Submitted, gold			2022-12-26	WOS:000353017000016
J	Kamilar, JM; Beaudrot, L; Reed, KE				Kamilar, Jason M.; Beaudrot, Lydia; Reed, Kaye E.			Climate and Species Richness Predict the Phylogenetic Structure of African Mammal Communities	PLOS ONE			English	Article							PRIMATE COMMUNITIES; FUNCTIONAL TRAIT; EVOLUTION; COOCCURRENCE; PATTERNS; ECOLOGY; SCALE; DIET; CONSERVATISM; DIVERSITY	We have little knowledge of how climatic variation (and by proxy, habitat variation) influences the phylogenetic structure of tropical communities. Here, we quantified the phylogenetic structure of mammal communities in Africa to investigate how community structure varies with respect to climate and species richness variation across the continent. In addition, we investigated how phylogenetic patterns vary across carnivores, primates, and ungulates. We predicted that climate would differentially affect the structure of communities from different clades due to between-clade biological variation. We examined 203 communities using two metrics, the net relatedness (NRI) and nearest taxon (NTI) indices. We used simultaneous autoregressive models to predict community phylogenetic structure from climate variables and species richness. We found that most individual communities exhibited a phylogenetic structure consistent with a null model, but both climate and species richness significantly predicted variation in community phylogenetic metrics. Using NTI, species rich communities were composed of more distantly related taxa for all mammal communities, as well as for communities of carnivorans or ungulates. Temperature seasonality predicted the phylogenetic structure of mammal, carnivoran, and ungulate communities, and annual rainfall predicted primate community structure. Additional climate variables related to temperature and rainfall also predicted the phylogenetic structure of ungulate communities. We suggest that both past interspecific competition and habitat filtering have shaped variation in tropical mammal communities. The significant effect of climatic factors on community structure has important implications for the diversity of mammal communities given current models of future climate change.	[Kamilar, Jason M.; Reed, Kaye E.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Kamilar, Jason M.] Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, Glendale, AZ USA; [Beaudrot, Lydia] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Beaudrot, Lydia] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Reed, Kaye E.] Arizona State Univ, Inst Human Origins, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Midwestern University; University of California System; University of California Davis; University of California System; University of California Davis; Arizona State University; Arizona State University-Tempe	Kamilar, JM (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.	jason.kamilar@asu.edu	; Beaudrot, L./M-6936-2017	Kamilar, Jason/0000-0001-6082-9396; Beaudrot, L./0000-0001-8135-7519	UC Davis Open Access Fund; Midwestern University	UC Davis Open Access Fund; Midwestern University	We thank Jillian DeBenney and Joshua Kohn for African mammal data compilation. In addition, we appreciate the helpful comments provided by two anonymous reviewers and the academic editor, Karen Samonds. We are thankful to the UC Davis Open Access Fund and Midwestern University for assisting with publication fees.	Algar AC, 2011, ECOLOGY, V92, P903, DOI 10.1890/10-0606.1; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Beaudrot LH, 2011, J ANIM ECOL, V80, P332, DOI 10.1111/j.1365-2656.2010.01777.x; Belmaker J, 2013, AM NAT, V181, P464, DOI 10.1086/669906; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blair ME, 2013, J EVOLUTION BIOL, V26, P1790, DOI 10.1111/jeb.12179; Cantalapiedra JL, 2014, ECOGRAPHY, V37, P1, DOI 10.1111/j.1600-0587.2013.00236.x; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1549, DOI 10.1098/rspb.2008.0262; Cardillo M, 2011, PHILOS T R SOC B, V366, P2545, DOI 10.1098/rstb.2011.0021; Cardillo M, 2010, GLOBAL ECOL BIOGEOGR, V19, P465, DOI 10.1111/j.1466-8238.2010.00537.x; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Codron D, 2007, S AFR J WILDL RES, V37, P117, DOI 10.3957/0379-4369-37.2.117; Codron D, 2007, J ANIM ECOL, V76, P526, DOI 10.1111/j.1365-2656.2007.01222.x; Cooper N, 2008, P ROY SOC B-BIOL SCI, V275, P2031, DOI 10.1098/rspb.2008.0420; Cooper N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042190; Cooper N, 2011, P ROY SOC B-BIOL SCI, V278, P2384, DOI 10.1098/rspb.2010.2207; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; Davies TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1096, DOI 10.1111/j.1466-8238.2012.00759.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gavilanez MM, 2013, GLOBAL ECOL BIOGEOGR, V22, P607, DOI 10.1111/geb.12011; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gouveia SF, J ANIM ECOL IN PRESS; Graham CH, 2012, ECOLOGY, V93, pS99, DOI 10.1890/11-0493.1; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hothorn T, 2013, COIN CONDITIONAL INF; Hurlbert AH, 2005, ECOL LETT, V8, P319, DOI 10.1111/j.1461-0248.2005.00726.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jones KE, 2011, PHILOS T R SOC B, V366, P2451, DOI 10.1098/rstb.2011.0090; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kamilar JM, 2014, INT J PRIMATOL, V35, P1105, DOI 10.1007/s10764-014-9784-2; Kamilar JM, 2013, EVOL ANTHROPOL, V22, P174, DOI 10.1002/evan.21361; Kamilar JM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0341; Kamilar JM, 2011, AM J PHYS ANTHROPOL, V144, P131, DOI 10.1002/ajpa.21380; Kamilar JM, 2010, BIOL LETTERS, V6, P736, DOI 10.1098/rsbl.2010.0348; Kamilar JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011073; Kamilar JM, 2010, J BIOGEOGR, V37, P801, DOI 10.1111/j.1365-2699.2009.02267.x; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Perez-Barberia FJ, 2004, P ROY SOC B-BIOL SCI, V271, P1081, DOI 10.1098/rspb.2004.2714; Pointer MA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-103; Pontzer H, 2009, P NATL ACAD SCI USA, V106, P192, DOI 10.1073/pnas.0806105106; Qian H, ECOGRAPHY IN PRESS; R Development Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Razafindratsima O. H., 2012, ECOGRAPHY, V35, P1; Reed KE, 1998, PALEOBIOLOGY, V24, P384; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Thibault K. M., 2011, ECOLOGY, V92, P2316, DOI DOI 10.1890/11-0262.1; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; VANVALKENBURGH B, 1988, PALEOBIOLOGY, V14, P155, DOI 10.1017/S0094837300011891; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; WHITTAKER R H, 1975, P385; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	74	32	32	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121808	10.1371/journal.pone.0121808	http://dx.doi.org/10.1371/journal.pone.0121808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875361	Green Published, gold			2022-12-26	WOS:000353015800033
J	Lin, MH; Shu, JC; Lin, LP; Chong, KY; Cheng, YW; Du, JF; Liu, ST				Lin, Mei Hui; Shu, Jwu Ching; Lin, Li Ping; Chong, Kowit Yu; Cheng, Ya Wen; Du, Jia Fu; Liu, Shih-Tung			Elucidating the Crucial Role of Poly N-Acetylglucosamine from Staphylococcus aureus in Cellular Adhesion and Pathogenesis	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; BIOFILM FORMATION; EPIDERMIDIS; BINDING; RESTRICTION; SYSTEMS; PROTEIN; ACID; GENE; PIA	Staphylococcus aureus is an important pathogen that forms biofilms on the surfaces of medical implants. Biofilm formation by S. aureus is associated with the production of poly N-acetylglucosamine (PNAG), also referred to as polysaccharide intercellular adhesin (PIA), which mediates bacterial adhesion, leading to the accumulation of bacteria on solid surfaces. This study shows that the ability of S. aureus SA113 to adhere to nasal epithelial cells is reduced after the deletion of the ica operon, which contains genes encoding PIA/PNAG synthesis. However, this ability is restored after a plasmid carrying the entire ica operon is transformed into the mutant strain, S. aureus SA113 Delta ica, showing that the synthesis of PIA/PNAG is important for adhesion to epithelial cells. Additionally, S. carnosus TM300, which does not produce PIA/PNAG, forms a biofilm and adheres to epithelial cells after the bacteria are transformed with a PIA/PNAG-expressing plasmid, pTXicaADBC. The adhesion of S. carnosus TM300 to epithelial cells is also demonstrated by adding purified exopolysaccharide (EPS), which contains PIA/PNAG, to the bacteria. In addition, using a mouse model, we find that the abscess lesions and bacterial burden in lung tissues is higher in mice infected with S. aureus SA113 than in those infected with the mutant strain, S. aureus-SA113 Delta ica. The results indicate that PIA/PNAG promotes the adhesion of S. aureus to human nasal epithelial cells and lung infections in a mouse model. This study elucidates a mechanism that is important to the pathogenesis of S. aureus infections.	[Lin, Mei Hui; Shu, Jwu Ching; Lin, Li Ping; Chong, Kowit Yu; Cheng, Ya Wen; Du, Jia Fu] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan; [Liu, Shih-Tung] Chang Gung Univ, Dept Microbiol & Immunol, Coll Med, Taoyuan, Taiwan; [Liu, Shih-Tung] Chang Gung Mem Hosp, Chiayi Branch, Dept Med Res & Dev, Chiayi, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Liu, ST (corresponding author), Chang Gung Univ, Dept Microbiol & Immunol, Coll Med, Taoyuan, Taiwan.	cgliu@mail.cgu.edu.tw	lin, liping/HGE-0871-2022	Chong, Kowit Yu/0000-0003-0974-0673; Lin, Mei-Hui/0000-0002-3498-9377	Chang Gung Memorial Hospital [CMRPD1B0071-3, CMRPD190281-3]; National Science Council of the Republic of China, Taiwan [NSC 102-2320-B-182-027-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Chang Gung Memorial Hospital (grant number CMRPD1B0071-3 and CMRPD190281-3) and from the National Science Council of the Republic of China, Taiwan (grant number NSC 102-2320-B-182-027-MY3). (The funders' websites are: http://web1.nsc.gov.tw/mp.aspx?mp=7, http://www.cgmh.org.tw/eng2002/index.asp.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Costa AR, 2009, EUR J CLIN MICROBIOL, V28, P623, DOI 10.1007/s10096-008-0684-2; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014; Gotz F, 1990, Soc Appl Bacteriol Symp Ser, V19, p49S; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63, DOI DOI 10.1016/0076-6879(91)04006-A; Heilmann C, 1996, INFECT IMMUN, V64, P277, DOI 10.1128/IAI.64.1.277-282.1996; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Hussain M, 2002, INFECT IMMUN, V70, P2933, DOI 10.1128/IAI.70.6.2933-2940.2002; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Jang JH, 2005, BIOTECHNOL LETT, V27, P13, DOI 10.1007/s10529-004-6305-y; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Krevvata MI, 2011, CONNECT TISSUE RES, V52, P183, DOI 10.3109/03008207.2010.505309; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Lin MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034388; Lin MH, 2011, ANTIMICROB AGENTS CH, V55, P1021, DOI 10.1128/AAC.00843-10; Lin TP, 1999, J BACTERIOL, V181, P5060, DOI 10.1128/JB.181.16.5060-5067.1999; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; PATTI JM, 1995, J BIOL CHEM, V270, P12005, DOI 10.1074/jbc.270.20.12005; Rosenstein R, 2009, APPL ENVIRON MICROB, V75, P811, DOI 10.1128/AEM.01982-08; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001	36	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124216	10.1371/journal.pone.0124216	http://dx.doi.org/10.1371/journal.pone.0124216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876106	gold, Green Submitted, Green Published			2022-12-26	WOS:000353015800134
J	Reed, SJ; Plourde, G				Reed, Sean J.; Plourde, Gilles			Attenuation of High-Frequency (50-200 Hz) Thalamocortical EEG Rhythms by Propofol in Rats Is More Pronounced for the Thalamus than for the Cortex	PLOS ONE			English	Article							IN-VITRO TOXICITY; OXIDATIVE STRESS; DNA-DAMAGE; POLYSTYRENE NANOPARTICLES; SILVER NANOPARTICLES; RESAZURIN METABOLISM; SURFACE-CHEMISTRY; HUMAN MACROPHAGES; CELLS; PARTICLES	Background Thalamocortical EEG rhythms in gamma (30-80 Hz) and high-gamma (80-200 Hz) ranges have been linked to arousal and conscious processes. To test the hypothesis that general anesthetics attenuate these rhythms, we characterized the concentration-effect relationship of propofol on the spectral power of these rhythms. In view of the ongoing debate about cortex versus thalamus as the primary site of anesthetic action for unconsciousness, we also compared the relative sensitivity of cortex and thalamus to this effect propofol. Methods Adult male Long-Evans rats were chronically implanted with electrodes in somatosensory (barrel) cortex and ventroposteromedial thalamus. Propofol was delivered by a computer-controlled infusion using real-time pharmacokinetic modeling to obtain the desired plasma concentration. Spectral power was assessed during baseline, at four stable propofol plasma-concentrations (0, 3,6,9,12 mu g/ml) and during recovery over four frequency ranges (3050, 51-75, 76-125, 126-200 Hz). Unconsciousness was defined as complete loss of righting reflex. Multiple regression was used to model the change of power (after logarithmic transformation) as a function of propofol concentration and recording site. Results Unconsciousness occurred at the 9 mu g/ml concentration in all animals. Propofol caused a robust linear concentration-dependent attenuation of cortical power in the 76-200 Hz range and of thalamic power in the 51-200 Hz range. In all instances the concentration-effect slope for the thalamus was markedly steeper than for the cortex. Furthermore the lowest concentration causing unconsciousness significantly reduced cortical power in the 126-200 Hz range and thalamic power in the 51-200 Hz range. Conclusions Propofol causes a concentration-dependent attenuation of the power of thalamocortical rhythms in the 51-200 Hz range and this effect is far more pronounced for the thalamus, where the attenuation provides a robust correlate of the hypnotic action of propofol.	[Reed, Sean J.] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada; [Plourde, Gilles] McGill Univ, Dept Anesthesia, Montreal, PQ, Canada	McGill University; McGill University	Plourde, G (corresponding author), McGill Univ, Dept Anesthesia, Montreal, PQ, Canada.	gilles.plourde@mcgill.ca			Canadian Anesthesiologists Society; Fondation d'Anesthesiologie et Reanimation du Quebec; McGill University from Le Fonds de la Recherche du Quebec	Canadian Anesthesiologists Society; Fondation d'Anesthesiologie et Reanimation du Quebec; McGill University from Le Fonds de la Recherche du Quebec	This work was supported by grants from the Canadian Anesthesiologists Society and from the Fondation d'Anesthesiologie et Reanimation du Quebec to GP and by a studentships from McGill University from Le Fonds de la Recherche du Quebec to SJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Anguissola S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108025; Bhabra G, 2009, NAT NANOTECHNOL, V4, P876, DOI [10.1038/NNANO.2009.313, 10.1038/nnano.2009.313]; Bhattacharjee S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-25; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P2525; Dekali S, 2013, NANOTOXICOLOGY, V7, P1302, DOI 10.3109/17435390.2012.735269; Donaldson Ken, 2012, Swiss Med Wkly, V142, pw13547, DOI 10.4414/smw.2012.13547; Donaldson K, 2010, NANOTOXICOLOGY, V4, P414, DOI 10.3109/17435390.2010.482751; Frohlich E, 2013, TOXICOL IN VITRO, V27, P409, DOI 10.1016/j.tiv.2012.08.008; Frohlich E, 2012, NANOTOXICOLOGY, V6, P424, DOI 10.3109/17435390.2011.586478; Frohlich E, 2009, J TOXICOL SCI, V34, P363; Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2; Geys J, 2007, TOXICOL IN VITRO, V21, P1215, DOI 10.1016/j.tiv.2007.05.012; Geys J, 2006, TOXICOL LETT, V160, P218, DOI 10.1016/j.toxlet.2005.07.005; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Holder AL, 2012, CHEM RES TOXICOL, V25, P1885, DOI 10.1021/tx3001708; ISO, 2008, 276872008 ISOTS, P7; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Karlsson HL, 2010, ANAL BIOANAL CHEM, V398, P651, DOI 10.1007/s00216-010-3977-0; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim JA, 2013, ACS NANO, V7, P7483, DOI 10.1021/nn403126e; Klein SG, 2011, TOXICOL IN VITRO, V25, P1516, DOI 10.1016/j.tiv.2011.09.006; Kroll A, 2012, ARCH TOXICOL, V86, P1123, DOI 10.1007/s00204-012-0837-z; Lanone S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-14; Lehmann AD, 2011, EUR J PHARM BIOPHARM, V77, P398, DOI 10.1016/j.ejpb.2010.10.014; Lewis DJ, 2010, NANOMEDICINE-UK, V5, P1547, DOI [10.2217/nnm.10.96, 10.2217/NNM.10.96]; Lunov O, 2011, ACS NANO, V5, P9648, DOI 10.1021/nn203596e; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Matthews JB, 2001, J MATER SCI-MATER M, V12, P249, DOI 10.1023/A:1008967200706; McCarthy J, 2011, INT J NANOMED, V6, P1343, DOI 10.2147/IJN.S21145; Mukhopadhyay A, 2012, APPL BIOCHEM BIOTECH, V167, P327, DOI 10.1007/s12010-012-9666-z; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Ong KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090650; Osseni RA, 1999, TOXICOL IN VITRO, V13, P683, DOI 10.1016/S0887-2333(99)00050-8; Paget V, 2014, NANOTOXICOLOGY, V8, P46, DOI 10.3109/17435390.2013.855828; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Paur HR, 2011, J AEROSOL SCI, V42, P668, DOI 10.1016/j.jaerosci.2011.06.005; Perrot S, 2003, TOXICOL SCI, V72, P122, DOI 10.1093/toxsci/kfg014; Perrot SB, 2003, CYTOM PART A, V55A, P7, DOI 10.1002/cyto.a.10067; Redon CE, 2011, AGING-US, V3, P168, DOI 10.18632/aging.100284; Ruenraroengsak P, 2012, NANOTOXICOLOGY, V6, P94, DOI 10.3109/17435390.2011.558643; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shukla RK, 2011, TOXICOL IN VITRO, V25, P231, DOI 10.1016/j.tiv.2010.11.008; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; Stentebjerg-Andersen A, 2011, EUR J PHARM BIOPHARM, V78, P19, DOI 10.1016/j.ejpb.2010.12.030; Stone V, 2009, CRIT REV TOXICOL, V39, P613, DOI 10.1080/10408440903120975; Team RDC, 2005, R LANG ENV STAT COMP; Tetley TD, 2007, BIOCHEM SOC T, V35, P527, DOI 10.1042/BST0350527; Thubagere A, 2010, ACS NANO, V4, P3611, DOI 10.1021/nn100389a; Tsamou M, 2012, MUTAGENESIS, V27, P645, DOI 10.1093/mutage/ges030; Wang FJ, 2013, NANOSCALE, V5, P10868, DOI 10.1039/c3nr03249c; Wang XZ, 2014, NANOTOXICOLOGY, V8, P465, DOI 10.3109/17435390.2013.796534; Warheit David B, 2009, Inhal Toxicol, V21 Suppl 1, P61, DOI 10.1080/08958370902942640; Wottrich R, 2004, INT J HYG ENVIR HEAL, V207, P353, DOI 10.1078/1438-4639-00300; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Xie H, 2010, REV ENV HLTH, V26, P251; Zaqout Mazen S. K., 2012, Environmental Health and Preventive Medicine, V17, P341, DOI 10.1007/s12199-011-0245-7; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; Zhu MT, 2009, TOXICOL SCI, V107, P342, DOI 10.1093/toxsci/kfn245; Zucker RM, 2010, CYTOM PART A, V77A, P677, DOI 10.1002/cyto.a.20927	64	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123287	10.1371/journal.pone.0123287	http://dx.doi.org/10.1371/journal.pone.0123287			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875024	gold, Green Published			2022-12-26	WOS:000353015800090
J	Feng, W; Cui, XQ; Liu, B; Liu, CY; Xiao, Y; Lu, W; Guo, H; He, MA; Zhang, XM; Yuan, J; Chen, WH; Wu, TC				Feng, Wei; Cui, Xiuqing; Liu, Bing; Liu, Chuanyao; Xiao, Yang; Lu, Wei; Guo, Huan; He, Meian; Zhang, Xiaomin; Yuan, Jing; Chen, Weihong; Wu, Tangchun			Association of Urinary Metal Profiles with Altered Glucose Levels and Diabetes Risk: A Population-Based Study in China	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; ARSENIC EXPOSURE; NATIONAL-HEALTH; BIOLOGICAL SAMPLES; TRACE-ELEMENTS; BLOOD-GLUCOSE; MELLITUS; INSULIN	Background Elevated heavy metals and fasting plasma glucose (FPG) levels were both associated with increased risk of cardiovascular diseases. However, studies on the associations of heavy metals and essential elements with altered FPG and diabetes risk were limited or conflicting. The objective of this study was to evaluate the potential associations of heavy metals and essential trace elements with FPG and diabetes risk among general Chinese population. Methods We conducted a cross-sectional study to investigate the associations of urinary concentrations of 23 metals with FPG, impaired fasting glucose (IFG) and diabetes among 2242 community-based Chinese adults in Wuhan. We used the false discovery rate (FDR) method to correct for multiple hypothesis tests. Results After adjusting for potential confounders, urinary aluminum, titanium, cobalt, nickel, copper, zinc, selenium, rubidium, strontium, molybdenum, cadmium, antimony, barium, tungsten and lead were associated with altered FPG, IFG or diabetes risk (all P < 0.05); arsenic was only dose-dependently related to diabetes (P < 0.05). After additional adjustment for multiple testing, titanium, copper, zinc, selenium, rubidium, tungsten and lead were still significantly associated with one or more outcomes (all FDR-adjusted P < 0.05). Conclusions Our results suggest that multiple metals in urine are associated with FPG, IFG or diabetes risk. Because the cross-sectional design precludes inferences about causality, further prospective studies are warranted to validate our findings.	[Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430030, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Environm Protect, Wuhan 430030, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubat, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wu, TC (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430030, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/GVT-8927-2022; Zhang, Xiaomin/F-3206-2018; XIAO, YANG/GPW-5529-2022		National Key Basic Research and Development Program (973 project) [2011CB503804, 2011CB503806, 2011CB512102]	National Key Basic Research and Development Program (973 project)(National Basic Research Program of China)	This study is supported by the funds from the National Key Basic Research and Development Program (973 project, grant No. 2011CB503804, 2011CB503806, and 2011CB512102) (Dr. T. Wu, W. Chen and J. Yuan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2008, DIABETES RES CLIN PR, V80, P280, DOI 10.1016/j.diabres.2007.12.021; Agarwal S, 2011, ANGIOLOGY, V62, P422, DOI 10.1177/0003319710395562; Aguilar V, 2007, ANN NUTR METAB, V51, P402, DOI 10.1159/000108108; Akbaraly TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-21; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; BELL RR, 1990, TOXICOL LETT, V54, P199, DOI 10.1016/0378-4274(90)90184-N; Brandao-Neto J, 2001, BIOMETALS, V14, P75, DOI 10.1023/A:1016662324626; BROOKS AP, 1980, LANCET, V2, P141; CARTANA J, 1992, TOXICOLOGY, V71, P181, DOI 10.1016/0300-483X(92)90065-M; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Czernichow S, 2006, AM J CLIN NUTR, V84, P395; Eskandari MR, 2015, ENVIRON TOXICOL, V30, P232, DOI 10.1002/tox.21900; Feng W, 2015, ENVIRON HEALTH PERSP, V123, P217, DOI 10.1289/ehp.1307563; Ferdousi S, 2012, Mymensingh Med J, V21, P475; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Fukui Y, 1999, INT ARCH OCC ENV HEA, V72, P516, DOI 10.1007/s004200050409; Gallieni M, 1996, NEPHROL DIAL TRANSPL, V11, P1232, DOI 10.1093/ndt/11.7.1232; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hegde KR, 2005, FREE RADICAL RES, V39, P513, DOI 10.1080/10715760400013755; Heitland P, 2006, CLIN CHIM ACTA, V365, P310, DOI 10.1016/j.cca.2005.09.013; Jayawardena R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-13; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; KOENIG RJ, 1976, DIABETES, V25, P230, DOI 10.2337/diabetes.25.3.230; Kumar V, 2014, NEUROTOXICOLOGY, V41, P154, DOI 10.1016/j.neuro.2014.02.004; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Lilley TM, 2013, COMP BIOCHEM PHYS C, V157, P298, DOI 10.1016/j.cbpc.2013.01.003; Linsinger T, 2005, 1 ERM; MAHAFFEY K R, 1974, Environmental Health Perspectives, V7, P107, DOI 10.2307/3428003; Masad A, 2007, FEBS LETT, V581, P3489, DOI 10.1016/j.febslet.2007.06.061; Maxwell P, 2004, CANCER BIOL THER, V3, P29, DOI 10.4161/cbt.3.1.547; Molgat ASD, 2014, CIRCULATION, V130, pS70, DOI 10.1161/CIRCULATIONAHA.113.007908; Moon SS, 2013, DIABETIC MED, V30, pe143, DOI 10.1111/dme.12103; Nakhaee A, 2010, BIOL TRACE ELEM RES, V136, P221, DOI 10.1007/s12011-009-8537-0; Navas-Acien A, 2006, ENVIRON HEALTH PERSP, V114, P641, DOI 10.1289/ehp.8551; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Navas-Acien A, 2009, EPIDEMIOLOGY, V20, P816, DOI 10.1097/EDE.0b013e3181afef88; Paul DS, 2007, ENVIRON HEALTH PERSP, V115, P734, DOI 10.1289/ehp.9867; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Purdey M, 2004, MED HYPOTHESES, V62, P746, DOI 10.1016/j.mehy.2003.12.034; Rajpathak S, 2005, J AM COLL NUTR, V24, P250, DOI 10.1080/07315724.2005.10719472; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Schisterman EF, 2005, ENVIRON HEALTH PERSP, V113, P853, DOI 10.1289/ehp.7640; Schwartz GG, 2003, DIABETES CARE, V26, P468, DOI 10.2337/diacare.26.2.468; Serdar MA, 2009, INT J DIABETES DEV C, V29, P35, DOI 10.4103/0973-3930.50713; Sha BY, 2013, FOOD CHEM TOXICOL, V58, P280, DOI 10.1016/j.fct.2013.04.050; Shan ZL, 2014, DIABETES, V63, P1796, DOI 10.2337/db13-0606; Siddiqui K, 2014, THESCIENTIFICWORLDJO, V2014, DOI [10.1155/2014/461591, DOI 10.1155/2014/461591]; Steinmaus C, 2009, EPIDEMIOLOGY, V20, P807, DOI 10.1097/EDE.0b013e3181b0fd29; Swaddiwudhipong W, 2010, ENVIRON RES, V110, P612, DOI 10.1016/j.envres.2010.06.002; Thompson KH, 2004, J INORG BIOCHEM, V98, P683, DOI 10.1016/j.jinorgbio.2004.01.006; Vicente-Vicente L, 2010, TOXICOL SCI, V118, P324, DOI 10.1093/toxsci/kfq178; Walton FS, 2004, TOXICOL APPL PHARM, V198, P424, DOI 10.1016/j.taap.2003.10.026; World Health Organization (WHO), 1996, BIOL MON CHEM EXP WO, P1; Wu FC, 2011, SCI TOTAL ENVIRON, V409, P3344, DOI 10.1016/j.scitotenv.2011.05.033; Xu M, 2010, EXP CLIN ENDOCR DIAB, V118, P459, DOI 10.1055/s-0030-1248325; Yang CY, 2012, CLIN NUTR, V31, P630, DOI 10.1016/j.clnu.2012.02.008; YARAT A, 1992, BIOL TRACE ELEM RES, V35, P273, DOI 10.1007/BF02783771; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zeng Q, 2013, REPROD TOXICOL, V41, P109, DOI 10.1016/j.reprotox.2013.06.062; Zierold KM, 2004, AM J PUBLIC HEALTH, V94, P1936, DOI 10.2105/AJPH.94.11.1936	66	64	70	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123742	10.1371/journal.pone.0123742	http://dx.doi.org/10.1371/journal.pone.0123742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874871	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100207
J	Lee, J; Martinez, N; West, K; Kornfeld, H				Lee, Jinhee; Martinez, Nuria; West, Kim; Kornfeld, Hardy			Differential Adjuvant Activities of TLR7 and TLR9 Agonists Inversely Correlate with Nitric Oxide and PGE(2) Production	PLOS ONE			English	Article							T-CELL PROLIFERATION; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; INNATE IMMUNITY; SIGNALING PATHWAY; ADAPTIVE IMMUNITY; PROSTAGLANDIN E-2; VACCINE ADJUVANT; LYMPHOCYTES-T; IFN-GAMMA	Activation of different pattern recognition receptors causes distinct profiles of innate immune responses, which in turn dictate the adaptive immune response. We found that mice had higher CD4(+) T cell expansion to an immunogen, ovalbumin, when coadministered with CpG than with CL097 in vivo. To account for this differential adjuvanticity, we assessed the activities of CpG and CL097 on antigen-specific CD4(+) T cell expansion in vitro using an OT-II CD4(+) T cell/bone marrow-derived dendritic cell (DC) co-culture system. Unexpectedly, oval-bumin-stimulated expansion of OT-II CD4(+) T cells in vitro was potently suppressed by both TLR agonists, with CL097 being stronger than CpG. The suppression was synergistically reversed by co-inhibition of cyclooxygenases 1 and 2, and inducible nitric oxide (NO) synthase. In addition, stimulation of OT-II CD4(+) T cell/DC cultures with CL097 induced higher levels of CD4(+) T cell death than stimulation with CpG, and this CD4(+) T cell turnover was reversed by NO and PGE2 inhibition. Consistently, the co-cultures stimulated with CL097 produced higher levels of prostaglandin E-2 (PGE(2)) and NO than stimulation with CpG. CL097 induced higher PGE(2) production in DC cultures and higher IFN-gamma in the OT-II CD4(+) T cell/DC cultures, accounting for the high levels of PGE(2) and NO. This study demonstrates that the adjuvant activities of immunostimulatory molecules may be determined by differential induction of negative regulators, including NO and PGE(2) suppressing clonal expansion and promoting cell death of CD4(+) T cells.	[Lee, Jinhee; Martinez, Nuria; West, Kim; Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Lee, J (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA.	Jinhee.lee@umassmed.edu	Kornfeld, Hardy/AAS-2903-2021		American Thoracic Society [ATS-06-099]; Grand Challenge Explore [OPP1007703]; National Institutes of Health [1R21AI094074-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094074] Funding Source: NIH RePORTER	American Thoracic Society; Grand Challenge Explore; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by American Thoracic Society ATS-06-099 [http://www.thoracic.org/] (JL, PI); Grand Challenge Explore OPP1007703 [http://www.grandchallenges.org/explorations/Pages/introduction.aspx] (JL, PI); and National Institutes of Health grant 1R21AI094074-01A1 [http://www.nih.gov/] (JL, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINA JE, 1991, J IMMUNOL, V147, P144; BAKER PE, 1981, CELL IMMUNOL, V61, P52, DOI 10.1016/0008-8749(81)90353-1; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barchet W, 2008, CURR OPIN IMMUNOL, V20, P389, DOI 10.1016/j.coi.2008.07.007; Bauer H, 1997, IMMUNOLOGY, V90, P205, DOI 10.1046/j.1365-2567.1997.00161.x; Beharka AA, 1997, MECH AGEING DEV, V93, P59, DOI 10.1016/S0047-6374(96)01819-2; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Beutner KR, 1998, J AM ACAD DERMATOL, V38, P230, DOI 10.1016/S0190-9622(98)70243-9; Bhattacharya P, 2011, J LEUKOCYTE BIOL, V89, P235, DOI 10.1189/jlb.0310154; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bonham CA, 1996, TRANSPLANTATION, V62, P1871, DOI 10.1097/00007890-199612270-00033; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; CHOUDHRY MA, 1995, INFECT IMMUN, V63, P3101, DOI 10.1128/IAI.63.8.3101-3105.1995; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Dearman RJ, 2009, IMMUNOLOGY, V126, P475, DOI 10.1111/j.1365-2567.2008.02922.x; Fiorucci S, 2004, J IMMUNOL, V173, P874, DOI 10.4049/jimmunol.173.2.874; FLORQUIN S, 1994, J EXP MED, V180, P1153, DOI 10.1084/jem.180.3.1153; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Gnjatic S, 2010, CANCER J, V16, P382, DOI 10.1097/PPO.0b013e3181eaca65; GOODWIN JS, 1978, J CLIN INVEST, V62, P753, DOI 10.1172/JCI109186; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Harrison CJ, 2001, VACCINE, V19, P1820, DOI 10.1016/S0264-410X(00)00387-X; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hilkens C M, 1996, Eur Respir J Suppl, V22, p90s; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Johnston D, 2007, CANCER IMMUNOL IMMUN, V56, P1133, DOI 10.1007/s00262-006-0262-3; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LERNER A, 1988, J IMMUNOL, V140, P936; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; LIANG S, 1989, INT J IMMUNOPHARMACO, V11, P809, DOI 10.1016/0192-0561(89)90135-5; MacFarlane AS, 1999, INFECT IMMUN, V67, P891, DOI 10.1128/IAI.67.2.891-898.1999; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; Moser M, 2010, VACCINE, V28, pC2, DOI 10.1016/j.vaccine.2010.07.022; NARISAWA T, 1981, CANCER RES, V41, P1954; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; RAPPAPORT RS, 1982, J EXP MED, V155, P943, DOI 10.1084/jem.155.3.943; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Schonhoff CM, 2003, J BIOL CHEM, V278, P18265, DOI 10.1074/jbc.M212459200; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sriskandan S, 1996, J IMMUNOL, V156, P2430; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TETSUKA T, 1994, P NATL ACAD SCI USA, V91, P12168, DOI 10.1073/pnas.91.25.12168; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; VERCAMMEN C, 1987, CELL IMMUNOL, V104, P24, DOI 10.1016/0008-8749(87)90003-7; Zech B, 2003, BIOCHEM J, V371, P1055, DOI 10.1042/BJ20021720; Zepp F, 2010, VACCINE, V28, pC14, DOI 10.1016/j.vaccine.2010.07.020; Zuber AK, 2004, VACCINE, V22, P1791, DOI 10.1016/j.vaccine.2003.10.051	70	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123165	10.1371/journal.pone.0123165	http://dx.doi.org/10.1371/journal.pone.0123165			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875128	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100144
J	Moualeu-Ngangue, DP; Roblitz, S; Ehrig, R; Deuflhard, P				Moualeu-Ngangue, Dany Pascal; Roeblitz, Susanna; Ehrig, Rainald; Deuflhard, Peter			Parameter Identification in a Tuberculosis Model for Cameroon	PLOS ONE			English	Article							DISEASE; TRANSMISSION; HIV; EPIDEMICS; THERAPY; NUMBERS; IMPACT; TB	A deterministic model of tuberculosis in Cameroon is designed and analyzed with respect to its transmission dynamics. The model includes lack of access to treatment and weak diagnosis capacity as well as both frequency-and density-dependent transmissions. It is shown that the model is mathematically well-posed and epidemiologically reasonable. Solutions are non-negative and bounded whenever the initial values are non-negative. A sensitivity analysis of model parameters is performed and the most sensitive ones are identified by means of a state-of-the-art Gauss-Newton method. In particular, parameters representing the proportion of individuals having access to medical facilities are seen to have a large impact on the dynamics of the disease. The model predicts that a gradual increase of these parameters could significantly reduce the disease burden on the population within the next 15 years.	[Moualeu-Ngangue, Dany Pascal] Leibniz Univ Hannover, Inst Hort Prod Syst, Hannover, Germany; [Roeblitz, Susanna; Ehrig, Rainald; Deuflhard, Peter] Zuse Inst Berlin, Dept Numer Math, Berlin, Germany; [Deuflhard, Peter] Beijing Univ Technol, Beijing Ctr Sci & Engn Comp, Beijing, Peoples R China	Leibniz University Hannover; Zuse Institute Berlin; Beijing University of Technology	Roblitz, S (corresponding author), Zuse Inst Berlin, Dept Numer Math, Berlin, Germany.	susanna.roeblitz@zib.de	Röblitz, Susanna/AAB-8447-2021; Moualeu-Ngangue, Dany/C-6608-2018	Moualeu-Ngangue, Dany/0000-0003-3356-7209; Roblitz, Susanna/0000-0002-2735-0030	IMU Berlin Einstein Foundation Program	IMU Berlin Einstein Foundation Program	D.M. received funding from the IMU Berlin Einstein Foundation Program (http://www.math-berlin.de/efp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Aparicio JP, 2002, J THEOR BIOL, V215, P227, DOI 10.1006/jtbi.2001.2489; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; Balabanova Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-276; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Bhunu CP, 2008, B MATH BIOL, V70, P1163, DOI 10.1007/s11538-008-9295-4; Blower SM, 2002, LANCET INFECT DIS, V2, P374, DOI 10.1016/S1473-3099(02)00292-X; Blower SM, 1996, SCIENCE, V273, P497, DOI 10.1126/science.273.5274.497; Blower SM, 1999, MATHEMATICAL MODELS; CastilloChavez C, 1997, J MATH BIOL, V35, P629, DOI 10.1007/s002850050069; Chaulk CP, 2000, INT J TUBERC LUNG D, V4, P201; Chintu C, 1999, LANCET, V353, P997, DOI 10.1016/S0140-6736(99)01141-1; DEUFLHARD P, 1980, LINEAR ALGEBRA APPL, V29, P91, DOI 10.1016/0024-3795(80)90232-3; Deuflhard P, 2004, SPRINGER SERIES IN C, V35; Deuflhard P, 2003, NUMERICAL ANALYSIS I; Dierkes T, 2013, ARXIV 1303 4928; Feng ZL, 2000, THEOR POPUL BIOL, V57, P235, DOI 10.1006/tpbi.2000.1451; Ferebee SH, 1967, B NATL TUBERCULO JAN, V53, P4; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Iggidr A., 2007, DISCRETE CONT DYN-S, V2007, P506; Kamgang JC, 2008, MATH BIOSCI, V213, P1, DOI 10.1016/j.mbs.2008.02.005; Kumar V, 2007, ROBBINS BASIC PATHOL; Ministere de la Sante Publique`, 1995, CADR CONC DISTR SANT; Moualeu DP, 2012, MATH MODEL NAT PHENO, V7, P117, DOI 10.1051/mmnp/20127309; Moualeu DP, 2011, J BIOL SYST, V19, P683, DOI 10.1142/S0218339011004159; Moualeu Dany Pascal, 2011, Journal of Applied Mathematics and Informatics, V29, P1097; Murphy BM, 2003, J THEOR BIOL, V223, P391, DOI 10.1016/S0022-5193(03)00038-9; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Mushayabasa S, 2013, J BIOL PHYS, V39, P723, DOI 10.1007/s10867-013-9328-6; National Institute of Statistics Bureau Central des Recensements et des Etudes de Popu lation, 2010, RAPPORT SUR LA PRESE; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Okuonghae D, 2007, MATH MODEL NAT PHENO, V2, P113, DOI 10.1051/mmnp:2008013; REVELLE CS, 1967, AM REV RESPIR DIS, V96, P893; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Tewa JJ, 2009, CHAOS SOLITON FRACT, V39, P936, DOI 10.1016/j.chaos.2007.01.069; Thieme H, 2003, MATHEMATICS IN POPUL; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; WAALER H, 1962, AM J PUBLIC HEALTH N, V56, P1002; Waaler HT, 1968, TUBERCLE           S, V49, P2, DOI [10.1016/S0041-3879(68)80031-5, DOI 10.1016/S0041-3879(68)80031-5]; WHO, 2012, TECHNICAL REPORT; WHO, 2006, THE STOP TB STRATEGY; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2008, TECHNICAL REPORT	44	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120607	10.1371/journal.pone.0120607	http://dx.doi.org/10.1371/journal.pone.0120607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874885	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100025
J	Narayanaswamy, R; Iyer, V; Khare, P; Bodziak, ML; Badgett, D; Zivadinov, R; Weinstock-Guttman, B; Rideout, TC; Ramanathan, M; Browne, RW				Narayanaswamy, Rohini; Iyer, Vignesh; Khare, Prachi; Bodziak, Mary Lou; Badgett, Darlene; Zivadinov, Robert; Weinstock-Guttman, Bianca; Rideout, Todd C.; Ramanathan, Murali; Browne, Richard W.			Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; VITAMIN-D; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; LIPID PROFILES; BRAIN; SERUM; 24S-HYDROXYCHOLESTEROL; PRECURSORS; QUANTIFICATION	Background Oxysterols are promising biomarkers of neurodegenerative diseases that are linked with cholesterol and vitamin D metabolism. There is an unmet need for methods capable of sensitive, and simultaneous quantitation of multiple oxysterols, vitamin D and cholesterol pathway biomarkers. Methods A method for simultaneous determination of 5 major oxysterols, 25-hydroxy vitamin D3 and cholesterol in human plasma was developed. Total oxysterols were prepared by room temperature saponification followed by solid phase extraction from plasma spiked with deuterated internal standards. Oxysterols were resolved by reverse phase HPLC using a methanol/water/0.1% formic acid gradient. Oxysterols and 25-hydroxy vitamin D3 were detected with atmospheric pressure chemical ionization mass spectrometry in positive ion mode; in-series photodiode array detection at 204nm was used for cholesterol. Method validation studies were performed. Oxysterol levels in 220 plasma samples from healthy control subjects, multiple sclerosis and other neurological disorders patients were quantitated. Results Our method quantitated 5 oxysterols, cholesterol and 25-hydroxy vitamin D3 from 200 mu L plasma in 35 minutes. Recoveries were >85% for all analytes and internal standards. The limits of detection were 3-10 ng/mL for oxysterols and 25-hydroxy vitamin D3 and 1 mu g/mL for simultaneous detection of cholesterol. Analytical imprecision was < 10 %CV for 24(S)-, 25-, 27-, 7 alpha-hydroxycholesterol (HC) and cholesterol and <= 15% for 7-keto-cholesterol. Multiple Sclerosis and other neurological disorder patients had lower 27-hydroxycholesterol levels compared to controls whereas 7 alpha-hydroxycholesterol was lower specifically in Multiple Sclerosis. Conclusion The method is suitable for measuring plasma oxysterols levels in human health and disease. Analysis of human plasma indicates that the oxysterol, bile acid precursors 7 alpha-hydroxycholesterol and 27-hydroxycholesterol are lower in Multiple Sclerosis and may serve as potential biomarkers of disease.	[Narayanaswamy, Rohini; Iyer, Vignesh; Khare, Prachi; Bodziak, Mary Lou; Browne, Richard W.] SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA; [Rideout, Todd C.] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Badgett, Darlene; Ramanathan, Murali] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Zivadinov, Robert; Weinstock-Guttman, Bianca; Ramanathan, Murali] SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Browne, RW (corresponding author), SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA.	rwbrowne@buffalo.edu	Zivadinov, Robert/Q-2054-2019; IYER, VIGNESH/AAK-6751-2021; Weinstock-Guttman, Bianca/AAI-4694-2021	Zivadinov, Robert/0000-0002-7799-1485; IYER, VIGNESH/0000-0002-5874-4964; Weinstock-Guttman, Bianca/0000-0001-6732-151X; Rideout, Todd C/0000-0002-1834-7083	National Multiple Sclerosis Society [RG4836-A-5]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	Funding provided by National Multiple Sclerosis Society, Grant # RG4836-A-5 to MR; http://www.nationalmssociety.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; [Anonymous], 2001, GUIDANCE IND BIOANAL; Bjorkhem I, 2006, ACTA NEUROL SCAND, V114, P43, DOI 10.1111/j.1600-0404.2006.00684.x; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Boenzi S, 2014, CLIN CHIM ACTA, V437, P93, DOI 10.1016/j.cca.2014.07.010; Brown AJ, 1996, J LIPID RES, V37, P320; Browne RW, 2014, J STEROID BIOCHEM, V143, P424, DOI 10.1016/j.jsbmb.2014.06.007; Duan XT, 2010, ANAL CHEM, V82, P2488, DOI 10.1021/ac902869y; Gosselet F, 2014, BIOCHEM BIOPH RES CO, V446, P687, DOI 10.1016/j.bbrc.2013.11.059; Griffiths WJ, 2013, BIOCHEM PHARMACOL, V86, P3, DOI 10.1016/j.bcp.2013.01.027; Griffiths WJ, 2011, BBA-MOL CELL BIOL L, V1811, P784, DOI 10.1016/j.bbalip.2011.05.012; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Horakova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053996; Kantarci O, 2006, CURR OPIN NEUROL, V19, P248, DOI 10.1097/01.wco.0000227033.47458.82; Leoni V, 2002, NEUROSCI LETT, V331, P163, DOI 10.1016/S0304-3940(02)00887-X; Leoni V, 2011, CHEM PHYS LIPIDS, V164, P515, DOI 10.1016/j.chemphyslip.2011.04.002; Marwarha G, 2015, EXP GERONTOL, V68, P13, DOI 10.1016/j.exger.2014.09.013; Matysik S, 2012, CLIN CHEM, V58, P1557, DOI 10.1373/clinchem.2012.189605; McDonald GR, 2008, SCIENCE, V322, P917, DOI 10.1126/science.1162395; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Olkkonen VM, 2012, BIOMOLECULES, V2, P76, DOI 10.3390/biom2010076; Olkkonen VM, 2004, ANN MED, V36, P562, DOI 10.1080/07853890410018907; Ponsonby A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1267, DOI 10.1562/2005-02-15-IR-441; Teunissen CE, 2003, NEUROSCI LETT, V347, P159, DOI 10.1016/S0304-3940(03)00667-0; van de Kraats C, 2014, MULT SCLER J, V20, P412, DOI 10.1177/1352458513499421; van de Merbel NC, 2008, TRAC-TREND ANAL CHEM, V27, P924, DOI 10.1016/j.trac.2008.09.002; Weinstock-Guttman B, 2013, J NEUROL NEUROSUR PS, V84, P1186, DOI 10.1136/jnnp-2012-304740; Weinstock-Guttman B, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-127; Weinstock-Guttman B, 2011, J NEUROL SCI, V311, P86, DOI 10.1016/j.jns.2011.07.024; Wong J, 2007, J NEUROCHEM, V103, P1764, DOI 10.1111/j.1471-4159.2007.04913.x	30	23	25	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123771	10.1371/journal.pone.0123771	http://dx.doi.org/10.1371/journal.pone.0123771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875771	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100212
J	Zhang, ZW; Tang, XQ; Wang, D; Zhang, Q; Li, PW; Ding, XX				Zhang, Zhaowei; Tang, Xiaoqian; Wang, Du; Zhang, Qi; Li, Peiwu; Ding, Xiaoxia			Rapid On-Site Sensing Aflatoxin B-1 in Food and Feed via a Chromatographic Time-Resolved Fluoroimmunoassay	PLOS ONE			English	Article							IMMUNOSENSOR; FLUORESCENCE	Aflatoxin B-1 poses grave threats to food and feed safety due to its strong carcinogenesis and toxicity, thus requiring ultrasensitive rapid on-site determination. Herein, a portable immunosensor based on chromatographic time-resolved fluoroimmunoassay was developed for sensitive and on-site determination of aflatoxin B-1 in food and feed samples. Chromatographic time-resolved fluoroimmunoassay offered a magnified positive signal and low signal-to-noise ratio in time-resolved mode due to the absence of noise interference caused by excitation light sources. Compared with the immunosensing performance in previous studies, this platform demonstrated a wider dynamic range of 0.2-60 mu g/kg, lower limit of detection from 0.06 to 0.12 mu g/kg, and considerable recovery from 80.5% to 116.7% for different food and feed sample matrices. It was found to be little cross-reactivity with other aflatoxins (B-2, G(1), G(2), and M-1). In the case of determination of aflatoxin B-1 in peanuts, corn, soy sauce, vegetable oil, and mouse feed, excellent agreement was found when compared with aflatoxin B-1 determination via the conversational high-performance liquid chromatography method. The chromatographic time-resolved fluoroimmunoassay affords a powerful alternative for rapid on-site determination of aflatoxin B1 and holds a promise for food safety in consideration of practical food safety and environmental monitoring.	[Zhang, Zhaowei; Tang, Xiaoqian; Wang, Du; Zhang, Qi; Li, Peiwu; Ding, Xiaoxia] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan 430062, Peoples R China; [Zhang, Zhaowei; Zhang, Qi; Li, Peiwu] Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan 430062, Peoples R China; [Tang, Xiaoqian; Zhang, Qi; Li, Peiwu] Minist Agr, Key Lab Detect Mycotoxins, Wuhan 430062, Peoples R China; [Wang, Du; Zhang, Qi; Li, Peiwu; Ding, Xiaoxia] Minist Agr, Lab Risk Assessment Oilseeds Prod Wuhan, Wuhan 430062, Peoples R China; [Ding, Xiaoxia] Minist Agr, Qual Inspect & Test Ctr Oilseeds Prod, Wuhan 430062, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Zhang, ZW (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan 430062, Peoples R China.	zwzhang@whu.edu.cn; zhangqi01@caas.cn; peiwuli@oilcrops.cn		, Zhaowei/0000-0002-6686-2995	Project of National Science & Technology Pillar Plan [2012BAB19B09]; Special Fund for Agro-scientific Research in the Public Interest [201203094-4]; National Natural Science Foundation of China [31101299]	Project of National Science & Technology Pillar Plan; Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Project of National Science & Technology Pillar Plan to PL (Grant: 2012BAB19B09) (URL: http://www.most.gov.cn/), Special Fund for Agro-scientific Research in the Public Interest to ZZ(Grant: 201203094-4) (URL: http://www.moa.gov.cn/), National Natural Science Foundation of China to ZZ (Grant: 31101299) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adanyi N, 2007, BIOSENS BIOELECTRON, V22, P797, DOI 10.1016/j.bios.2006.02.015; Bunzli JCG, 2005, CHEM SOC REV, V34, P1048, DOI 10.1039/b406082m; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gehring AG, 2011, ANNU REV ANAL CHEM, V4, P151, DOI 10.1146/annurev-anchem-061010-114010; Hu H, 2013, IEEE SENS J, V13, P1835, DOI 10.1109/JSEN.2013.2242057; Hu WH, 2013, BIOSENS BIOELECTRON, V50, P338, DOI 10.1016/j.bios.2013.06.037; Li PW, 2013, MASS SPECTROM REV, V32, P420, DOI 10.1002/mas.21377; Li PW, 2012, ELECTROPHORESIS, V33, P2253, DOI 10.1002/elps.201200050; Loock HP, 2012, SENSOR ACTUAT B-CHEM, V173, P157, DOI 10.1016/j.snb.2012.06.071; Park JH, 2014, FOOD CONTROL, V36, P183, DOI 10.1016/j.foodcont.2013.08.038; Tang DP, 2013, ANAL CHEM, V85, P10589, DOI 10.1021/ac402713a; Thevenot DR, 2001, BIOSENS BIOELECTRON, V16, P121, DOI 10.1081/AL-100103209; Weissman SI, 1942, J CHEM PHYS, V10, P214, DOI 10.1063/1.1723709; Xu W, 2014, BIOSENS BIOELECTRON, V56, P144, DOI 10.1016/j.bios.2014.01.007; Xu X, 2013, BIOSENS BIOELECTRON, V47, P361, DOI 10.1016/j.bios.2013.03.048; Zhang DH, 2011, TALANTA, V85, P736, DOI 10.1016/j.talanta.2011.04.061; Zhang DH, 2011, BIOSENS BIOELECTRON, V26, P2877, DOI 10.1016/j.bios.2010.11.031; Zhang DH, 2009, ANAL CHIM ACTA, V636, P63, DOI 10.1016/j.aca.2009.01.010; Zhang ZW, 2014, ELECTROPHORESIS, V35, P1547, DOI 10.1002/elps.201300570; Zhang ZW, 2012, SENSORS-BASEL, V12, P9234, DOI 10.3390/s120709234	20	26	28	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123266	10.1371/journal.pone.0123266	http://dx.doi.org/10.1371/journal.pone.0123266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25874803	Green Submitted, gold, Green Published			2022-12-26	WOS:000352845100157
J	Li, ZH; Li, P; Shi, ZC				Li, Zhi-Hua; Li, Ping; Shi, Ze-Chao			Chronic Exposure to Tributyltin Induces Brain Functional Damage in Juvenile Common Carp (Cyprinus carpio)	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED OXIDATIVE STRESS; NA+-K+-ATPASE; RAT-LIVER; MONOAMINE-OXIDASE; SEBASTISCUS-MARMORATUS; INTEGRATED ASSESSMENT; LIPID-PEROXIDATION; DIFFERENT TISSUES; RESPONSES	The aim of the present study was to investigate the effect of Tributyltin (TBT) on brain function and neurotoxicity of freshwater teleost. The effects of long-term exposure to TBT on antioxidant related indices (MDA, malondialdehyde; SOD, superoxide dismutase; CAT, catalase; GR, glutathione reductase; GPx, glutathione peroxidase), Na+-K+-ATPase and neurological parameters (AChE, acetylcholinesterase; MAO, monoamine oxidase; NO, nitric oxide) in the brain of common carp were evaluated. Fish were exposed to sublethal concentrations of TBT (75 ng/L, 0.75 mu g/L and 7.5 mu g/L) for 15, 30, and 60 days. Based on the results, a low level and short-term TBT-induced stress could not induce the notable responses of the fish brain, but long-term exposure (more than 15 days) to TBT could lead to obvious physiological-biochemical responses (based on the measured parameters). The results also strongly indicated that neurotoxicity of TBT to fish. Thus, the measured physiological responses in fish brain could provide useful information to better understand the mechanisms of TBT-induced bio-toxicity.	[Li, Zhi-Hua; Li, Ping; Shi, Ze-Chao] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Key Field Stn Fishery Resource & Environm Upper M, Key Lab Freshwater Biodivers Conservat,Minist Agr, Wuhan 430223, Peoples R China; [Li, Zhi-Hua; Li, Ping] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Res Inst Fish Culture & Hydrobiol, Vodnany 38925, Czech Republic	Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; University of South Bohemia Ceske Budejovice	Li, ZH (corresponding author), Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Key Field Stn Fishery Resource & Environm Upper M, Key Lab Freshwater Biodivers Conservat,Minist Agr, Wuhan 430223, Peoples R China.	zhihuali06@yahoo.com	LI, ZHIHUA/G-2896-2015; LI, PING/G-2915-2015; Li, ZhiHua/GYU-9914-2022	LI, ZHIHUA/0000-0002-6484-657X; LI, PING/0000-0002-8663-8552; 	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences [2014A02YQ01]; Technology Foundation for Selected Overseas Chinese Scholar of MOHRSS; CENAKVA [CZ.1.05/2.1.00/01.0024]; MEYS of the CR under the NPU I program [LO1205]; Grant agency of Czech Republic [P503/11/1130]	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences; Technology Foundation for Selected Overseas Chinese Scholar of MOHRSS; CENAKVA; MEYS of the CR under the NPU I program; Grant agency of Czech Republic(Grant Agency of the Czech Republic)	This study was supported by Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2014A02YQ01), Technology Foundation for Selected Overseas Chinese Scholar of MOHRSS, and the CENAKVA CZ.1.05/2.1.00/01.0024, the project LO1205 with financial support from the MEYS of the CR under the NPU I program, the project P503/11/1130 of the Grant agency of Czech Republic.	Agrahari S, 2008, PESTIC BIOCHEM PHYS, V92, P57, DOI 10.1016/j.pestbp.2008.06.003; ALDRIDGE WN, 1970, BIOCHEM J, V118, P171, DOI 10.1042/bj1180171; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Antizar-Ladislao B, 2008, ENVIRON INT, V34, P292, DOI 10.1016/j.envint.2007.09.005; ARNAIZ GRD, 1967, J NEUROCHEM, V14, P215; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; Basha DC, 2012, INT J DEV NEUROSCI, V30, P343, DOI 10.1016/j.ijdevneu.2012.01.004; Beliaeff B, 2002, ENVIRON TOXICOL CHEM, V21, P1316, DOI 10.1002/etc.5620210629; Broeg K, 2006, MAR POLLUT BULL, V53, P508, DOI 10.1016/j.marpolbul.2006.02.004; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Casalino E, 2002, TOXICOLOGY, V179, P37, DOI 10.1016/S0300-483X(02)00245-7; Devi CB, 2005, INT J DEV NEUROSCI, V23, P375, DOI 10.1016/j.ijdevneu.2004.11.003; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Elsabbagh HS, 2002, PHARMACOL RES, V45, P201, DOI 10.1006/phrs.2001.0909; Feng MB, 2014, ENVIRON TOXICOL, V29, P1460, DOI 10.1002/tox.21876; Gennari A, 2000, TOXICOL APPL PHARM, V169, P185, DOI 10.1006/taap.2000.9076; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Hartl MGJ, 2001, AQUAT TOXICOL, V55, P125, DOI 10.1016/S0166-445X(01)00184-9; Holmqvist B, 1997, BRAIN RES, V745, P67, DOI 10.1016/S0006-8993(96)01128-6; Horiguchi Toshihiro, 2006, Environmental Sciences, V13, P77; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; John S, 2001, J NUTR BIOCHEM, V12, P500, DOI 10.1016/S0955-2863(01)00160-7; Kavitha P, 2009, ECOTOX ENVIRON SAFE, V72, P1727, DOI 10.1016/j.ecoenv.2009.05.010; Kim S, 2011, BIOL TRACE ELEM RES, V142, P683, DOI 10.1007/s12011-010-8791-1; Kim WK, 2010, J HAZARD MATER, V180, P395, DOI 10.1016/j.jhazmat.2010.04.044; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Li ZH, 2011, J HAZARD MATER, V185, P870, DOI 10.1016/j.jhazmat.2010.09.102; Li ZH, 2010, COMP BIOCHEM PHYS C, V152, P392, DOI 10.1016/j.cbpc.2010.06.006; Li ZH, 2010, AQUAT TOXICOL, V98, P297, DOI 10.1016/j.aquatox.2010.02.017; Li ZH, 2010, COMP BIOCHEM PHYS C, V151, P137, DOI 10.1016/j.cbpc.2009.09.006; Liu CM, 2013, ENVIRON TOXICOL PHAR, V35, P502, DOI 10.1016/j.etap.2013.02.009; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mitra S, 2015, ENVIRON TOXICOL, V30, P1393, DOI 10.1002/tox.22009; Mitra S, 2014, ENVIRON TOXICOL PHAR, V37, P1048, DOI 10.1016/j.etap.2014.03.020; Morcillo Y, 2000, ENVIRON POLLUT, V107, P47, DOI 10.1016/S0269-7491(99)00133-5; Mortensen AS, 2007, COMP BIOCHEM PHYS C, V145, P431, DOI 10.1016/j.cbpc.2007.01.013; Nakayama K, 2004, CHEMOSPHERE, V55, P1331, DOI 10.1016/j.chemosphere.2003.11.050; Nava-Ruiz C, 2010, EXP TOXICOL PATHOL, V62, P311, DOI 10.1016/j.etp.2009.04.006; Nesci S, 2011, TOXICOL IN VITRO, V25, P951, DOI 10.1016/j.tiv.2011.03.004; Oruc EO, 2002, B ENVIRON CONTAM TOX, V69, P271, DOI 10.1007/s00128-002-0057-y; Pandey S, 2003, SCI TOTAL ENVIRON, V309, P105, DOI 10.1016/S0048-9697(03)00006-8; Park K, 2012, FISH SHELLFISH IMMUN, V32, P426, DOI 10.1016/j.fsi.2011.11.031; Porte C, 2006, COMP BIOCHEM PHYS C, V143, P303, DOI 10.1016/j.cbpc.2006.03.004; Rajeshkumar S, 2013, ECOTOX ENVIRON SAFE, V98, P8, DOI 10.1016/j.ecoenv.2013.07.029; Reddy GR, 2007, NEUROTOXICOLOGY, V28, P402, DOI 10.1016/j.neuro.2006.03.018; Sahin E, 2004, BEHAV BRAIN RES, V155, P241, DOI 10.1016/j.bbr.2004.04.022; Samuel PM, 1998, J APPL TOXICOL, V18, P383, DOI 10.1002/(SICI)1099-1263(1998090)18:5<383::AID-JAT523>3.3.CO;2-S; St-Jean SD, 2002, MAR ECOL PROG SER, V236, P155, DOI 10.3354/meps236155; STUEHR DJ, 1989, BIOCHEM BIOPH RES CO, V161, P420, DOI 10.1016/0006-291X(89)92615-6; TABAKOFF B, 1972, ANAL CHEM, V44, P427, DOI 10.1021/ac60310a040; Tiano L, 2003, BBA-MOL CELL RES, V1640, P105, DOI 10.1016/S0167-4889(03)00025-9; Tiano L, 2001, APPL ORGANOMET CHEM, V15, P575, DOI 10.1002/aoc.207; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; YADWAD VB, 1990, B ENVIRON CONTAM TOX, V44, P585, DOI 10.1007/BF01700880; Zhang JL, 2008, CHEMOSPHERE, V73, P337, DOI 10.1016/j.chemosphere.2008.05.072; Zhang JL, 2007, AQUAT TOXICOL, V83, P174, DOI 10.1016/j.aquatox.2007.03.018; Zhang X, 2008, AQUAT TOXICOL, V86, P4, DOI 10.1016/j.aquatox.2007.07.002; Zhou J, 2010, J HAZARD MATER, V183, P428, DOI 10.1016/j.jhazmat.2010.07.042	60	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123091	10.1371/journal.pone.0123091	http://dx.doi.org/10.1371/journal.pone.0123091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879203	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500039
J	Maas, F; Spoorenberg, A; Brouwer, E; Bos, R; Efde, M; Chaudhry, RN; Veeger, NJGM; van Ooijen, PMA; Wolf, R; Bootsma, H; van der Veer, E; Arends, S				Maas, Fiona; Spoorenberg, Anneke; Brouwer, Elisabeth; Bos, Reinhard; Efde, Monique; Chaudhry, Rizwana N.; Veeger, Nic J. G. M.; van Ooijen, Peter M. A.; Wolf, Rinze; Bootsma, Hendrika; van der Veer, Eveline; Arends, Suzanne			Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-alpha Blocking Therapy: A Prospective Longitudinal Observational Cohort Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVITY SCORE ASDAS; DAMAGE; DISCONTINUATION; PREDICTORS; LEAD	Objectives To evaluate spinal radiographic damage over time and to explore the associations of radiographic progression with patient characteristics and clinical assessments including disease activity in ankylosing spondylitis (AS) patients treated with tumor necrosis factor-alpha (TNF-alpha) blocking therapy in daily clinical practice. Methods Consecutive outpatients from the Groningen Leeuwarden AS (GLAS) cohort were included based on the availability of cervical and lumbar radiographs before start of TNF-alpha blocking therapy and after 2, 4, and/or 6 years of follow-up. Clinical data were assessed at the same time points. Radiographs were scored by two independent readers using the modified Stoke AS Spine Score (mSASSS). Spinal radiographic progression in relation to clinical assessments was analyzed using generalized estimating equations. Results 176 AS patients were included, 58% had syndesmophytes at baseline. Median mSASSS increased significantly from 10.7 (IQR: 4.6-24.0) at baseline to 14.8 (IQR: 7.9-32.8) at 6 years. At the group level, spinal radiographic progression was linear with a mean progression rate of 1.3 mSASSS units per 2 years. Both spinal radiographic damage at baseline and radiographic progression were highly variable between AS patients. Male gender, older age, longer disease duration, higher BMI, longer smoking duration, high CRP, and high ASDAS were significantly associated with syndesmophytes at baseline. Significantly more radiographic progression was seen in patients with versus without syndesmophytes (2.0 vs. 0.5 mSASSS units per 2 years) and in patients >40 versus <= 40 years of age (1.8 vs. 0.7 mSASSS units per 2 years). No longitudinal associations between radiographic progression and clinical assessments were found. Conclusions This prospective longitudinal observational cohort study in daily clinical practice shows overall slow and linear spinal radiographic progression in AS patients treated with TNF-alpha blocking therapy. At the individual level, progression was highly variable. Patients with syndesmophytes at baseline showed a 4-fold higher radiographic progression rate than patients without syndesmophytes.	[Maas, Fiona; Spoorenberg, Anneke; Brouwer, Elisabeth; Chaudhry, Rizwana N.; Bootsma, Hendrika; Arends, Suzanne] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Spoorenberg, Anneke; Bos, Reinhard; Efde, Monique; Arends, Suzanne] Med Ctr Leeuwarden, Dept Rheumatol, Leeuwarden, Netherlands; [Veeger, Nic J. G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Ooijen, Peter M. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Wolf, Rinze] Med Ctr Leeuwarden, Dept Radiol, Leeuwarden, Netherlands; [van der Veer, Eveline] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; Medical Center Leeuwarden; University of Groningen; University of Groningen; Medical Center Leeuwarden; University of Groningen	Maas, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	f.maas@umcg.nl	Arends, Suzanne/M-5436-2015; Veeger, Nic JGM/F-2966-2013; van Ooijen, Peter/B-9150-2008; Bos, Reinhard/AAS-1726-2020; Brouwer, Elisabeth/AAL-9029-2020; Brouwer, Elisabeth/A-3198-2015	Arends, Suzanne/0000-0002-4422-7640; Veeger, Nic JGM/0000-0002-1492-7937; van Ooijen, Peter/0000-0002-8995-1210; Brouwer, Elisabeth/0000-0002-5652-4423; Brouwer, Elisabeth/0000-0002-5652-4423; Bos, Reinhard/0000-0003-1094-5596	Pfizer pharmaceuticals	Pfizer pharmaceuticals(Pfizer)	The GLAS cohort was supported by an unrestricted grant from Pfizer pharmaceuticals. Pfizer had no role in the design, conduct, interpretation, or publication of this study.	Arends S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3823; Arends S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3369; Baraliakos X, 2007, RHEUMATOLOGY, V46, P1450, DOI 10.1093/rheumatology/kem166; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2005, ANN RHEUM DIS, V64, P1462, DOI 10.1136/ard.2004.033472; Baraliakos X, 2014, ANN RHEUM DIS, V73, P710, DOI 10.1136/annrheumdis-2012-202698; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Braun J, 2014, ANN RHEUM DIS, V73, P1107, DOI 10.1136/annrheumdis-2012-203075; Dougados M, 2011, ANN RHEUM DIS, V70, P249, DOI 10.1136/ard.2010.133488; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Kroon F, 2012, ANN RHEUM DIS, V71, P1623, DOI 10.1136/annrheumdis-2012-201370; Lukas C, 2009, ANN RHEUM DIS, V68, P18, DOI 10.1136/ard.2008.094870; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; Poddubnyy D, 2012, ANN RHEUM DIS, V71, P1616, DOI 10.1136/annrheumdis-2011-201252; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Ramiro S, 2015, ANN RHEUM DIS, V74, P52, DOI 10.1136/annrheumdis-2013-204055; Ramiro S, 2014, ANN RHEUM DIS, V73, P1455, DOI 10.1136/annrheumdis-2014-205178; Rudwaleit M, 2009, ARTHRITIS RHEUM-US, V60, P717, DOI 10.1002/art.24483; Spoorenberg A, 2004, J RHEUMATOL, V31, P125; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P1324, DOI 10.1002/art.23471; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P3063, DOI 10.1002/art.23901; van der Heijde D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2794; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; van Tuyl LHD, 2014, ANN RHEUM DIS, V73, P391, DOI 10.1136/annrheumdis-2012-202876; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446	30	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122693	10.1371/journal.pone.0122693	http://dx.doi.org/10.1371/journal.pone.0122693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879956	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500025
J	Puccetti, P; Fallarino, F; Italiano, A; Soubeyran, I; MacGrogan, G; Debled, M; Velasco, V; Bodet, D; Eimer, S; Veldhoen, M; Prendergast, GC; Platten, M; Bessede, A; Guillemin, GJ				Puccetti, Paolo; Fallarino, Francesca; Italiano, Antoine; Soubeyran, Isabelle; MacGrogan, Gaetan; Debled, Marc; Velasco, Valerie; Bodet, Dominique; Eimer, Sandrine; Veldhoen, Marc; Prendergast, Georges C.; Platten, Michael; Bessede, Alban; Guillemin, Gilles J.			Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; TUMORAL IMMUNE RESISTANCE; 3-HYDROXYANTHRANILIC ACID; KYNURENINE PATHWAY; T-CELLS; IMMUNOTHERAPY; DEGRADATION; MECHANISM; PREDICTS; TARGET	Tumor immune escape mechanisms are being regarded as suitable targets for tumor therapy. Among these, tryptophan catabolism plays a central role in creating an immunosuppressive environment, leading to tolerance to potentially immunogenic tumor antigens. Tryptophan catabolism is initiated by either indoleamine 2,3-dioxygenase (IDO-1/-2) or tryptophan 2,3-dioxygenase 2 (TDO2), resulting in biostatic tryptophan starvation and L-kynurenine production, which participates in shaping the dynamic relationship of the host's immune system with tumor cells. Current immunotherapy strategies include blockade of IDO-1/-2 or TDO2, to restore efficient antitumor responses. Patients who might benefit from this approach are currently identified based on expression analyses of IDO-1/-2 or TDO2 in tumor tissue and/or enzymatic activity assessed by kynurenine/tryptophan ratios in the serum. We developed a monoclonal antibody targeting L-kynurenine as an in situ biomarker of IDO-1/-2 or TDO2 activity. Using Tissue Micro Array technology and immunostaining, colorectal and breast cancer patients were phenotyped based on L-kynurenine production. In colorectal cancer L-kynurenine was not unequivocally associated with IDO-1 expression, suggesting that the mere expression of tryptophan catabolic enzymes is not sufficiently informative for optimal immunotherapy.	[Puccetti, Paolo; Fallarino, Francesca] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Italiano, Antoine; Soubeyran, Isabelle; MacGrogan, Gaetan; Debled, Marc; Velasco, Valerie] Inst Bergonie, Dept Med Oncol, Bordeaux, France; [Bodet, Dominique; Bessede, Alban] ImmuSmol, Pessac, France; [Eimer, Sandrine] Univ Bordeaux Segalen, Histol & Mol Pathol Tumors Lab EA 2406, Bordeaux, France; [Veldhoen, Marc] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Prendergast, Georges C.] Lankenau Inst Med Res, Wynnewood, PA USA; [Platten, Michael] German Canc Res Ctr, CCU Neuroimmunol & Brain Tumor Immunol, Heidelberg, Germany; [Platten, Michael] Univ Hosp, Dept Neurooncol, Heidelberg, Germany; [Guillemin, Gilles J.] Macquarie Univ, Fac Med, Neuroinflammat Grp, Sydney, NSW 2109, Australia; [Guillemin, Gilles J.] St Vincents Ctr Appl Med Res, Peter Duncan Neurosci Res Unit, Appl Neurosci Program, Darlinghurst, NSW, Australia	University of Perugia; UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Lankenau Medical Center; Lankenau Institute for Medical Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Macquarie University	Bessede, A (corresponding author), ImmuSmol, Pessac, France.	abessede@immusmol.com; gilles.guillemin@mq.edu.au	Veldhoen, Marc/AAM-5357-2021; Platten, Michael/F-2902-2013; Guillemin, Gilles J/C-3878-2015; Veldhoen, Marc/AAJ-2759-2020; Fallarino, Francesca/O-3358-2013	Platten, Michael/0000-0002-4746-887X; Guillemin, Gilles J/0000-0001-8105-4470; Veldhoen, Marc/0000-0002-1478-9562; MacGrogan, Gaetan/0000-0002-3483-9758; Puccetti, Paolo/0000-0001-6674-2128; Fallarino, Francesca/0000-0002-8501-2136	ImmuSmol; Italian Association for Cancer Research (AIRC); BBSRC [BB/E021638/1, BBS/E/B/0000S042, BBS/E/B/000C0409] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021638/1, BBS/E/B/000C0409, BBS/E/B/0000S042] Funding Source: researchfish	ImmuSmol; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was fully supported by ImmuSmol (DB, AB) and the Italian Association for Cancer Research (AIRC) (PP). ImmuSmol, through Dr. Alban Bessede, contributed to study design, decision to publish and preparation of the manuscript The Italian Association for Cancer Research (AIRC) (http://www.airc.it/) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112945; Adams S, 2012, CANCER RES, V72, P5649, DOI 10.1158/0008-5472.CAN-12-0549; Arpinati M, 2014, IMMUNOTHERAPY-UK, V6, P95, DOI 10.2217/imt.13.152; Austin CJ, 2014, DRUG DISCOVERY TODAY; Bessede A, 2014, NATURE; Blaschitz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021774; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Chevolet I, 2014, BRIT J DERMATOL, V171, P987, DOI 10.1111/bjd.13100; Choe JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-335; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Gao YF, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-71; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Hiramatsu R, 2008, J CELL BIOCHEM, V103, P42, DOI 10.1002/jcb.21384; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Mezrich JD, 2010, J IMMUNOL; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Opitz CA, 2011, NATURE; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pardoll DM, 2012, NAT IMMUNOL, V13, P1129, DOI 10.1038/ni.2392; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Rodriguez-Blanco G, 2014, CLIN BIOCH; Sakurai Kenichi, 2013, Gan To Kagaku Ryoho, V40, P1590; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schroecksnadel K, 2007, J CANCER RES CLIN, V133, P477, DOI 10.1007/s00432-007-0191-3; Sperner-Unterweger B, 2011, IMMUNOBIOLOGY, V216, P296, DOI 10.1016/j.imbio.2010.07.010; Stone TW, 2013, BRIT J PHARMACOL, V169, P1211, DOI 10.1111/bph.12230; Suzuki Y, 2010, LUNG CANCER, V67, P361, DOI 10.1016/j.lungcan.2009.05.001; Theate I, 2014, CANC IMMUNOLOGY RES; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vanderstraeten A, 2014, CANCER IMMUNOL IMMUN, V63, P545, DOI 10.1007/s00262-014-1537-8; Weber WP, 2006, EUR J IMMUNOL, V36, P296, DOI 10.1002/eji.200535616; Weinlich G, 2007, DERMATOLOGY, V214, P8, DOI 10.1159/000096906; Yoshikawa T, 2010, EUR J HAEMATOL, V84, P304, DOI 10.1111/j.1600-0609.2009.01393.x	36	51	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122046	10.1371/journal.pone.0122046	http://dx.doi.org/10.1371/journal.pone.0122046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881064	Green Published, gold			2022-12-26	WOS:000353016500015
J	Brenner, S; De Allegri, M; Gabrysch, S; Chinkhumba, J; Sarker, M; Muula, AS				Brenner, Stephan; De Allegri, Manuela; Gabrysch, Sabine; Chinkhumba, Jobiba; Sarker, Malabika; Muula, Adamson S.			The Quality of Clinical Maternal and Neonatal Healthcare - A Strategy for Identifying 'Routine Care Signal Functions'	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; LOW-RESOURCE SETTINGS; OVERCOME CHALLENGES; MEDICAL-CARE; 3 DISTRICTS; SURVIVAL 1; INDICATORS; ATTENDANTS; COUNTRIES; SERVICES	Background A variety of clinical process indicators exists to measure the quality of care provided by maternal and neonatal health (MNH) programs. To allow comparison across MNH programs in low-and middle-income countries (LMICs), a core set of essential process indicators is needed. Although such a core set is available for emergency obstetric care (EmOC), the 'EmOC signal functions', a similar approach is currently missing for MNH routine care evaluation. We describe a strategy for identifying core process indicators for routine care and illustrate their usefulness in a field example. Methods We first developed an indicator selection strategy by combining epidemiological and programmatic aspects relevant to MNH in LMICs. We then identified routine care process indicators meeting our selection criteria by reviewing existing quality of care assessment protocols. We grouped these indicators into three categories based on their main function in addressing risk factors of maternal or neonatal complications. We then tested this indicator set in a study assessing MNH quality of clinical care in 33 health facilities in Malawi. Results Our strategy identified 51 routine care processes: 23 related to initial patient risk assessment, 17 to risk monitoring, 11 to risk prevention. During the clinical performance assessment a total of 82 cases were observed. Birth attendants' adherence to clinical standards was lowest in relation to risk monitoring processes. In relation to major complications, routine care processes addressing fetal and newborn distress were performed relatively consistently, but there were major gaps in the performance of routine care processes addressing bleeding, infection, and pre-eclampsia risks. Conclusion The identified set of process indicators could identify major gaps in the quality of obstetric and neonatal care provided during the intra-and immediate postpartum period. We hope our suggested indicators for essential routine care processes will contribute to streamlining MNH program evaluations in LMICs.	[Brenner, Stephan; De Allegri, Manuela; Gabrysch, Sabine; Sarker, Malabika] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Chinkhumba, Jobiba; Muula, Adamson S.] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi	Ruprecht Karls University Heidelberg; University of Malawi	Brenner, S (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.	stephan.brenner@uni-heidelberg.de	Muula, Adamson/AAF-1153-2020; Gabrysch, Sabine/A-3503-2013	Gabrysch, Sabine/0000-0002-7081-0506; Sarker, Malabika/0000-0001-7293-8805	United States Agency for International Development (USAID) [GHS-A-00-09-00015-00]; Norwegian Ministry of Foreign Affairs [MWI 12/0010]; Malawi College of Medicine	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Ministry of Foreign Affairs; Malawi College of Medicine	This research project is made possible through Translating Research into Action, TRAction, and is funded by United States Agency for International Development (USAID) under cooperative agreement number GHS-A-00-09-00015-00. The project team includes prime recipient, University Research Co., LLC (URC), Harvard University School of Public Health (HSPH), and sub-recipient research organization, University of Heidelberg. This research project is co-funded through a grant by the Norwegian Ministry of Foreign Affairs to the Government of Malawi under Programme Title MWI 12/0010 Effect Evaluation of Performance Based Financing in Health Sector. The Malawi College of Medicine as implementing institution is recipient of this grant. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MAL STAND TREATM GUI; [Anonymous], 2005, MAL NAT ROAD MAP ACC; [Anonymous], 2009, INT MAN PREGN CHILDB, DOI [10.1186/1471-2393-9-20, DOI 10.1186/1471-2393-9-20]; [Anonymous], 2006, MAL NAT REPR HLTH SE; [Anonymous], 2010, COUNTD 2015 DEC REP, DOI [10.1016/S0140-6736(10)60678-2, DOI 10.1016/S0140-6736(10)60678-2]; [Anonymous], 2010, CLIN MAN HIV CHILDR; [Anonymous], 2010, NAT INT INF PREV REP; Ashebir Getachew, 2011, QUALITY CARE PREVENT; Bates I, 2008, BJOG-INT J OBSTET GY, V115, P1331, DOI 10.1111/j.1471-0528.2008.01866.x; Bayley O, 2013, MALAWI MED J, V25, P105; Betran Ana P., 2006, MONITORING EVALUATIO; Brenner S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-180; Chin MH, 2003, PERSPECT BIOL MED, V46, P5, DOI 10.1353/pbm.2003.0002; de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017; Diana B, 2010, EXPLORING EVIDENCE D; Edmond K., 2006, OPTIMAL FEEDING LOW; Fidele Ngabo, 2012, QUALITY CARE PREVENT; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Hermida J, 1999, INT J QUAL HEALTH C, V11, P429, DOI 10.1093/intqhc/11.5.429; Hirshon JM, 2013, B WORLD HEALTH ORGAN, V91, P386, DOI 10.2471/BLT.12.112664; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Hussein J, 2005, HEALTH POLICY, V73, P294, DOI 10.1016/j.healthpol.2004.11.021; Ith P, 2013, MIDWIFERY, V29, P300, DOI 10.1016/j.midw.2012.01.010; Kagema F, 2011, QUALITY CARE PREVENT; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kobusingye OC, 2005, B WORLD HEALTH ORGAN, V83, P626; Kongnyuy E J, 2008, Women Birth, V21, P149, DOI 10.1016/j.wombi.2008.08.002; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lidia Chongo, 2013, QUALITY HUMANIZATION; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Makaula P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-328; Marya Plotkin, 2011, QUALITY CARE PREVENT; Marya Plotkin, 2012, QUALITY MATERNAL NEW; Ministry of Health Malawi, 2011, MAL HLTH SECT STRAT; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Ranjalahy Justin, 2011, QUALITY CARE PREVENT; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Samuel Rigbe, 2005, Afr Health Sci, V5, P4; Tawfik Y, 2010, FINDING COMMON GROUN; The Partnership for Maternal Newborn and Child Health, 2011, MAT NEWB CHILD HLTH; United Nations Children's Fund (UNICEF), STAT WORLDS CHILDR R; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, 2011, IMCI INS TRAIN; WHO UNICEF UNFPA The World Bank United Nations Population Division., 2014, WHO TRENDS MAT MORT; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2010, PACK INT FAM PLANN S; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2011, WHO REC PREV TREATM; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; World Health Organization (WHO), 2003, KANGAROO MOTHER CARE; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S7	62	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123968	10.1371/journal.pone.0123968	http://dx.doi.org/10.1371/journal.pone.0123968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875252	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353015800126
J	Chabot, D; Craik, SR; Bird, DM				Chabot, Dominique; Craik, Shawn R.; Bird, David M.			Population Census of a Large Common Tern Colony with a Small Unmanned Aircraft	PLOS ONE			English	Article							INVESTIGATOR-DISTURBANCE; AERIAL VEHICLES; WATERBIRDS; MANAGEMENT; ACCURACY; SEABIRDS; ECOLOGY; SUCCESS; SYSTEMS; COUNTS	Small unmanned aircraft systems (UAS) may be useful for conducting high-precision, low-disturbance waterbird surveys, but limited data exist on their effectiveness. We evaluated the capacity of a small UAS to census a large (>6,000 nests) coastal Common tern (Sterna hirundo) colony of which ground surveys are particularly disruptive and time-consuming. We compared aerial photographic tern counts to ground nest counts in 45 plots (5-m radius) throughout the colony at three intervals over a nine-day period in order to identify sources of variation and establish a coefficient to estimate nest numbers from UAS surveys. We also compared a full colony ground count to full counts from two UAS surveys conducted the following day. Finally, we compared colony disturbance levels over the course of UAS flights to matched control periods. Linear regressions between aerial and ground counts in plots had very strong correlations in all three comparison periods (R-2 = 0.972-0.989, P < 0.001) and regression coefficients ranged from 0.928-0.977 terns/nest. Full colony aerial counts were 93.6% and 94.0%, respectively, of the ground count. Varying visibility of terns with ground cover, weather conditions and image quality, and changing nest attendance rates throughout incubation were likely sources of variation in aerial detection rates. Optimally timed UAS surveys of Common tern colonies following our method should yield population estimates in the 93-96% range of ground counts. Although the terns were initially disturbed by the UAS flying overhead, they rapidly habituated to it. Overall, we found no evidence of sustained disturbance to the colony by the UAS. We encourage colonial waterbird researchers and managers to consider taking advantage of this burgeoning technology.	[Chabot, Dominique] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada; [Craik, Shawn R.] Univ St Anne, Dept Sci, Pointe De Leglise, NS, Canada; [Chabot, Dominique; Bird, David M.] McGill Univ, Avian Sci & Conservat Ctr, Ste Anne De Bellevue, PQ, Canada	McGill University; McGill University	Chabot, D (corresponding author), McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada.	dominique.chabot@mail.mcgill.ca		Chiaradia, Andre/0000-0002-6178-4211	Kenneth M. Molson Foundation; New Brunswick Wildlife Trust Fund [W202-002]; Canadian Wildlife Federation; Fonds Quebecois de la Recherche sur la Nature et les Technologies [135289]	Kenneth M. Molson Foundation; New Brunswick Wildlife Trust Fund; Canadian Wildlife Federation; Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	Funds for this research were provided by the Kenneth M. Molson Foundation (www.kennethmolsonfoundation.ca), the New Brunswick Wildlife Trust Fund (www.nbwtf.ca; grant #W202-002), the Canadian Wildlife Federation (www.cwf-fcf.org), and the Fonds Quebecois de la Recherche sur la Nature et les Technologies (www.frqnt.gouv.qc.ca; scholarship #135289). In-kind contributions were provided by Parks Canada (www.pc.gc.ca), Aerial Insight (www.aerialinsight.co.uk), and MicroPilot (www.micropilot.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elrahman A, 2005, SURVEYING LAND INFOR, V65, P37; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Bechet A, 2004, J WILDLIFE MANAGE, V68, P639, DOI 10.2193/0022-541X(2004)068[0639:ETSOTG]2.0.CO;2; Blackmer AL, 2004, BIOL CONSERV, V116, P141, DOI 10.1016/S0006-3207(03)00185-X; BOLLINGER PB, 1990, AUK, V107, P696, DOI 10.2307/4088000; Boyd WS, 2000, J FIELD ORNITHOL, V71, P686, DOI 10.1648/0273-8570-71.4.686; Boyne AW, 2002, TECHNICAL REPORT SER, V999; Burger J., 1991, COMMON TERN ITS BREE; Carey MJ, 2009, NEW ZEAL J ZOOL, V36, P367, DOI 10.1080/03014220909510161; Carney KM, 1999, WATERBIRDS, V22, P68, DOI 10.2307/1521995; Chabot D, 2013, J UNMANNED VEH SYST, V1, P15, DOI 10.1139/juvs-2013-0014; Chabot D, 2012, WATERBIRDS, V35, P170, DOI 10.1675/063.035.0119; Cordts SD, 2002, WILDLIFE SOC B, V30, P317; COURTNEY P, 1979, IBIS, V121, P207, DOI 10.1111/j.1474-919X.1979.tb04964.x; Craik SR, 2009, WATERBIRDS, V32, P282, DOI 10.1675/063.032.0208; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Frederick PC, 1996, CONDOR, V98, P837, DOI 10.2307/1369865; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Kingsford RT, 2009, WILDLIFE RES, V36, P29, DOI 10.1071/WR08034; Kingsford RT, 1999, FRESHWATER BIOL, V41, P425, DOI 10.1046/j.1365-2427.1999.00440.x; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; KUSHLAN JA, 1993, COLON WATERBIRD, V16, P223, DOI 10.2307/1521444; Laursen K, 2008, WILDLIFE BIOL, V14, P165, DOI 10.2981/0909-6396(2008)14[165:AOTCOW]2.0.CO;2; McGarigal K., 1994, FRAGSTATS SPATIAL PA, V2, P128; MORRIS RD, 1986, WILSON BULL, V98, P101; Mulac BL, 2011, GEOCARTO INT, V26, P71, DOI 10.1080/10106049.2010.537786; Nisbet ICT, 2000, WATERBIRDS, V23, P312; PARNELL JF, 1988, COLON WATERBIRD, V11, P129, DOI 10.2307/1520996; Rango A, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3474649; Rodgers JA, 2005, WATERBIRDS, V28, P230, DOI 10.1675/1524-4695(2005)028[0230:AOASOW]2.0.CO;2; Rodway MS, 1996, BIOL CONSERV, V76, P311, DOI 10.1016/0006-3207(94)00118-9; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Vertigan C, 2012, ANIM WELFARE, V21, P101, DOI 10.7120/096272812799129493; Watts AC, 2012, REMOTE SENS-BASEL, V4, P1671, DOI 10.3390/rs4061671; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; [No title captured]	36	92	97	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122588	10.1371/journal.pone.0122588	http://dx.doi.org/10.1371/journal.pone.0122588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25874997	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800067
J	Jeong, BH; Ko, MG; Nam, J; Yoo, H; Chung, CR; Suh, GY; Jeon, K				Jeong, Byeong Ho; Ko, Myeong Gyun; Nam, Jimyoung; Yoo, Hongseok; Chung, Chi Ryang; Suh, Gee Young; Jeon, Kyeongman			Differences in Clinical Outcomes According to Weaning Classifications in Medical Intensive Care Units	PLOS ONE			English	Article							MECHANICAL VENTILATION; FAILURE	Background Although the weaning classification based on the difficulty and duration of the weaning process has been evaluated in the different type of intensive care units (ICUs), little is known about clinical outcomes and validity among the three groups in medical ICU. The objectives of this study were to evaluate the clinical relevance of weaning classification and its association with hospital mortality in a medical ICU with a protocol-based weaning program. Methods All consecutive patients admitted to the medical ICU and requiring mechanical ventilation (MV) for more than 24 hours were prospectively registered and screened for weaning readiness by a standardized weaning program between July 2010 and June 2013. Baseline characteristics and outcomes were compared across weaning classifications. Results During the study period, a total of 680 patients were weaned according to the standardized weaning protocol. Of these, 457 (67%) were classified as simple weaning, 136 (20%) as difficult weaning, and 87 (13%) as prolonged weaning. Ventilator-free days within 28 days decreased significantly from simple to difficult to prolonged weaning groups (P < 0.001, test for trends). In addition, reintubation within 48 hours after extubation (P < 0.001) and need for tracheostomy during the weaning process (P < 0.001) increased significantly across weaning groups. Finally, ICU (P < 0.001), post-ICU (P = 0.001), and hospital (P < 0.001) mortalities significantly increased across weaning groups. In a multiple logistic regression model, prolonged weaning but not difficult weaning was still independently associated with ICU (adjusted OR 8.265, 95% CI 3.484-19.605, P < 0.001), and post-ICU (adjusted OR 3.180, 95% CI 1.349-7.497, P = 0.005), and hospital (adjusted OR 5.528, 95% CI 2.801-10.910, P < 0.001) mortalities. Conclusions Weaning classification based on the difficulty and duration of the weaning process may provide prognostic information for mechanically ventilated patients who undergo the weaning process.	[Jeong, Byeong Ho; Yoo, Hongseok; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Ko, Myeong Gyun; Nam, Jimyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Intens Care Unit,Nursing Dept, Seoul, South Korea; [Chung, Chi Ryang; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea.	kjeon@skku.edu	Yoo, Hongseok/AAZ-8139-2020; Suh, Gee Young/O-3676-2019; Jeon, Kyeongman/F-5963-2019	Suh, Gee Young/0000-0001-5473-1712; Jeon, Kyeongman/0000-0002-4822-1772; Yoo, Hongseok/0000-0002-2227-6441; Jeong, Byeong-Ho/0000-0002-3124-1718	Samsung Medical Center grant [CRO1121611]	Samsung Medical Center grant(Samsung)	This work was supported by Samsung Medical Center grant (CRO1121611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; Bewick Viv, 2004, Crit Care, V8, P196, DOI 10.1186/cc2857; Blackwood B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7237; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Cheng KC, 2006, CRIT CARE MED, V34, P1345, DOI 10.1097/01.CCM.0000214678.92134.BD; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Epstein SK, 2009, CURR OPIN CRIT CARE, V15, P36, DOI 10.1097/MCC.0b013e3283220e07; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Frutos-Vivar F, 2006, CHEST, V130, P1664, DOI 10.1378/chest.130.6.1664; Funk GC, 2010, EUR RESPIR J, V35, P88, DOI 10.1183/09031936.00056909; Kriner Eric J, 2005, Respir Care, V50, P1632; McConville JF, 2012, NEW ENGL J MED, V367, P2233, DOI 10.1056/NEJMra1203367; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Patel KN, 2009, RESP CARE, V54, P1462; Penuelas O, 2011, AM J RESP CRIT CARE, V184, P430, DOI 10.1164/rccm.201011-1887OC; Sellares J, 2011, INTENS CARE MED, V37, P775, DOI 10.1007/s00134-011-2179-3; Tonnelier A, 2011, RESP CARE, V56, P583, DOI 10.4187/respcare.00842; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	20	35	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122810	10.1371/journal.pone.0122810	http://dx.doi.org/10.1371/journal.pone.0122810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876004	gold, Green Published, Green Submitted			2022-12-26	WOS:000353015800077
J	Alvarez-Filip, L; Paddack, MJ; Ben Collen; Robertson, DR; Cote, IM				Alvarez-Filip, Lorenzo; Paddack, Michelle J.; Ben Collen; Robertson, D. Ross; Cote, Isabelle M.			Simplification of Caribbean Reef-Fish Assemblages over Decades of Coral Reef Degradation	PLOS ONE			English	Article							REGION-WIDE DECLINES; MONITORING CHANGE; SPARISOMA-VIRIDE; ADULT ABUNDANCE; BIODIVERSITY; POPULATION; RISK; HOMOGENIZATION; SPECIALIZATION; DAMSELFISHES	Caribbean coral reefs are becoming structurally simpler, largely due to human impacts. The consequences of this trend for reef-associated communities are currently unclear, but expected to be profound. Here, we assess whether changes in fish assemblages have been non-random over several decades of declining reef structure. More specifically, we predicted that species that depend exclusively on coral reef habitat (i.e., habitat specialists) should be at a disadvantage compared to those that use a broader array of habitats (i.e., habitat generalists). Analysing 3727 abundance trends of 161 Caribbean reef-fishes, surveyed between 1980 and 2006, we found that the trends of habitat-generalists and habitat-specialists differed markedly. The abundance of specialists started to decline in the mid-1980s, reaching a low of similar to 60% of the 1980 baseline by the mid-1990s. Both the average and the variation in abundance of specialists have increased since the early 2000s, although the average is still well below the baseline level of 1980. This modest recovery occurred despite no clear evidence of a regional recovery in coral reef habitat quality in the Caribbean during the 2000s. In contrast, the abundance of generalist fishes remained relatively stable over the same three decades. Few specialist species are fished, thus their population declines are most likely linked to habitat degradation. These results mirror the observed trends of replacement of specialists by generalists, observed in terrestrial taxa across the globe. A significant challenge that arises from our findings is now to investigate if, and how, such community-level changes in fish populations affect ecosystem function.	[Alvarez-Filip, Lorenzo] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico; [Alvarez-Filip, Lorenzo; Paddack, Michelle J.; Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Paddack, Michelle J.] Santa Barbara City Coll, Dept Biol, Santa Barbara, CA 93109 USA; [Ben Collen] UCL, Ctr Biodivers & Environm Res, London WC1E 6BT, England; [Robertson, D. Ross] Smithsonian Trop Res Inst, Balboa, Panama	Universidad Nacional Autonoma de Mexico; Simon Fraser University; University of London; University College London; Smithsonian Institution; Smithsonian Tropical Research Institute	Alvarez-Filip, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico.	lorenzo@cmarl.unam.mx.com	Collen, Ben/F-2543-2016; Cote, Isabelle/ABD-5898-2021; Alvarez-Filip, Lorenzo/C-9552-2011	Collen, Ben/0000-0003-2564-4243; Alvarez-Filip, Lorenzo/0000-0002-5726-7238	UK's Natural Environment Resource Council [NE/C004442/1]; Mexican Council of Science and Technology (CONACYT) [160230]; Natural Sciences and Engineering Council of Canada (NSERC); Rufford Foundation; NSERC; Smithsonian Tropical Research Institute; Natural Environment Research Council [NE/C004442/1] Funding Source: researchfish; NERC [NE/C004442/1] Funding Source: UKRI	UK's Natural Environment Resource Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Mexican Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Rufford Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Compilation of the original database by MJP was funded by the UK's Natural Environment Resource Council, NE/C004442/1. LA-F was supported by the Mexican Council of Science and Technology (CONACYT; 160230), and by the Natural Sciences and Engineering Council of Canada (NSERC). BC is supported by the Rufford Foundation, IMC is funded by a Discovery Grant from NSERC, and DRR is supported by the Smithsonian Tropical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Alvarez-Filip L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03486; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Alvarez-Filip L, 2011, GLOBAL CHANGE BIOL, V17, P2470, DOI 10.1111/j.1365-2486.2010.02385.x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bruckner A.W., 2003, P CAR ACR WORKSH POT; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Collen B, 2014, SCIENCE, V346, P166, DOI 10.1126/science.1255772; Collen B, 2011, PHILOS T R SOC B, V366, P2577, DOI 10.1098/rstb.2011.0015; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Froese R, FISHBASE; Galewski T, 2011, BIOL CONSERV, V144, P1392, DOI 10.1016/j.biocon.2010.10.030; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Haughton EO, 2004, ANN P GULF CARIBB FI, V54, P188; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Le Viol I, 2012, BIOL LETTERS, V8, P780, DOI 10.1098/rsbl.2012.0496; Lirman D, 1999, B MAR SCI, V65, P235; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Luiz OJ, 2012, P ROY SOC B-BIOL SCI, V279, P1033, DOI 10.1098/rspb.2011.1525; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Mace GM, 2010, PHILOS T R SOC B, V365, P3743, DOI 10.1098/rstb.2010.0264; McClenachan Loren, 2009, Endangered Species Research, V7, P175, DOI 10.3354/esr00167; McManus E, 2005, FISHERIES REGULATION; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Paddack MJ, 2008, MAR ECOL PROG SER, V369, P205, DOI 10.3354/meps07632; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2012, ECOL EVOL, V2, P2168, DOI 10.1002/ece3.321; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; ROBERTSON DR, 1984, ECOLOGY, V65, P1121, DOI 10.2307/1938320; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Tolimieri N, 1998, B MAR SCI, V62, P253; Tolimieri N, 1998, MAR ECOL PROG SER, V167, P227, DOI 10.3354/meps167227; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	54	41	42	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0126004	10.1371/journal.pone.0126004	http://dx.doi.org/10.1371/journal.pone.0126004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875218	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700078
J	Song, N; Choi, JY; Sung, H; Jeon, S; Chung, S; Song, M; Park, SK; Han, W; Lee, JW; Kim, MK; Yoo, KY; Ahn, SH; Noh, DY; Kang, D				Song, Nan; Choi, Ji-Yeob; Sung, Hyuna; Jeon, Sujee; Chung, Seokang; Song, Minkyo; Park, Sue K.; Han, Wonshik; Lee, Jong Won; Kim, Mi Kyung; Yoo, Keun-Young; Ahn, Sei-Hyun; Noh, Dong-Young; Kang, Daehee			Tumor Subtype-Specific Associations of Hormone-Related Reproductive Factors on Breast Cancer Survival	PLOS ONE			English	Article							RISK-FACTORS; PROGNOSTIC FACTOR; RECEPTOR STATUS; YOUNG-WOMEN; LAST BIRTH; SHORT-TERM; PARITY; MORTALITY; PROLACTIN; DIAGNOSIS	Purpose It is inconclusive whether reproductive factors, which are known as risk factors of breast cancer, also influence survival. We investigated overall and subtype-specific associations between reproductive factors and breast cancer survival. Methods Among 3,430 incident breast cancer patients who enrolled in the Seoul Breast Cancer Study, 269 patients (7.8%) died and 528 patients (15.4%) recurred. The overall and subtype-specific associations of reproductive factors including age at menarche and menopause, duration of estrogen exposure, menstrual cycle, parity, age at first full-term pregnancy, number of children, age at last birth, time since the last birth, and duration of breastfeeding, on overall and disease-free survival (OS and DFS) were estimated by hazard ratios (HRs) and 95% confidence intervals (95% CIs) using a multivariate Cox proportional hazard model. Results An older age at menarche (HR for OS=1.10, 95% CI=1.03-1.19), a greater number of children (>= 4 vs. 2, HR for DFS=1.58, 95% CI=1.11-2.26), and a shorter time since last birth (<5 vs. >= 20 years, HR for DFS=1.67, 95% CI=1.07-2.62) were associated with worse survival while longer duration of estrogen exposure with better survival (HR for DFS=0.97, 95% CI=0.96-0.99). In the stratified analyses by subtypes, those associations were more pronounced among women with hormone receptor and human epidermal growth factor 2 positive (HR+ HER2+) tumors. Conclusions It is suggested that reproductive factors, specifically age at menarche, number of children, time since last birth, and duration of estrogen exposure, could influence breast tumor progression, especially in the HR+ HER2+ subtype.	[Song, Nan; Choi, Ji-Yeob; Park, Sue K.; Han, Wonshik; Noh, Dong-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Choi, Ji-Yeob; Sung, Hyuna; Chung, Seokang; Song, Minkyo; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Choi, Ji-Yeob; Jeon, Sujee; Song, Minkyo; Park, Sue K.; Yoo, Keun-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Sung, Hyuna] NCI, Div Epidemiol & Genet, Rockville, MD USA; [Han, Wonshik; Noh, Dong-Young] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Jong Won; Ahn, Sei-Hyun] Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Jong Won] ASAN Med Ctr, Seoul, South Korea; [Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Management, Goyang Si, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); University of Ulsan; National Cancer Center - Korea (NCC)	Choi, JY (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	jiyeob.choi@gmail.com	Song, Minkyo/AAE-9095-2020; Han, Wonshik/B-3699-2008; Song, Nan/F-5774-2019	Song, Minkyo/0000-0002-9412-2871; Han, Wonshik/0000-0001-7310-0764; Song, Nan/0000-0002-9182-1060; Kang, Daehee/0000-0003-4031-5878	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2010-0028631]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2010-0028631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaker MDK, 2013, INT J CANCER, V132, P174, DOI 10.1002/ijc.27593; Andersen SW, 2011, BREAST CANCER RES TR, V130, P975, DOI 10.1007/s10549-011-1666-0; Anderson KN, 2014, BREAST CANCER RES TR, V144, P1, DOI 10.1007/s10549-014-2852-7; Arendt LM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2819; Baglin T, 2010, J THROMB HAEMOST, V8, P228, DOI 10.1111/j.1538-7836.2009.03702.x; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Bhatavdekar J M, 1993, Eur J Surg Oncol, V19, P409; BLACK MM, 1983, JNCI-J NATL CANCER I, V70, P27; Bladstrom Anna, 2003, Clin Breast Cancer, V4, P280, DOI 10.3816/CBC.2003.n.033; Bonnier P, 1997, INT J CANCER, V72, P720, DOI 10.1002/(SICI)1097-0215(19970904)72:5<720::AID-IJC3>3.0.CO;2-U; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Butt S, 2009, EJSO-EUR J SURG ONC, V35, P702, DOI 10.1016/j.ejso.2008.03.017; Choi HK, 2014, NAT REV RHEUMATOL, V10, P403, DOI 10.1038/nrrheum.2014.36; Chung S, 2013, BREAST CANCER RES TR, V140, P557, DOI 10.1007/s10549-013-2645-4; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Conroy SM, 2011, BREAST CANCER RES TR, V129, P565, DOI 10.1007/s10549-011-1468-4; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; Daling JR, 2002, CANCER EPIDEM BIOMAR, V11, P235; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Grundy E, 2005, SOC SCI MED, V61, P217, DOI 10.1016/j.socscimed.2004.11.046; GUINEE VF, 1994, LANCET, V343, P1587; Harlow BL, 2000, MATURITAS, V35, P3, DOI 10.1016/S0378-5122(00)00092-X; Jaffe DH, 2009, EUR J EPIDEMIOL, V24, P9, DOI 10.1007/s10654-008-9310-y; JURET P, 1976, EUR J CANCER, V12, P701, DOI 10.1016/0014-2964(76)90019-0; KORZENIOWSKI S, 1994, CANCER, V74, P1591, DOI 10.1002/1097-0142(19940901)74:5<1591::AID-CNCR2820740515>3.0.CO;2-#; Kroman N, 2003, BREAST, V12, P516, DOI 10.1016/S0960-9776(03)00159-0; Kroman N, 1997, BRIT MED J, V315, P851, DOI 10.1136/bmj.315.7112.851; Kroman N, 1998, BRIT J CANCER, V78, P1529, DOI 10.1038/bjc.1998.718; Kwan ML, 2014, AM J EPIDEMIOL, V179, P95, DOI 10.1093/aje/kwt233; Largent JA, 2005, BREAST CANCER RES, V7, pR541, DOI 10.1186/bcr1198; LEES AW, 1989, BREAST CANCER RES TR, V13, P143, DOI 10.1007/BF01806526; Maus MV, 1999, ENDOCRINOLOGY, V140, P5447, DOI 10.1210/en.140.11.5447; MOHLEBOETANI JC, 1988, PREV MED, V17, P634, DOI 10.1016/0091-7435(88)90056-4; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; Niraula S, 2012, BREAST CANCER RES TR, V134, P769, DOI 10.1007/s10549-012-2073-x; Olson SH, 1998, EPIDEMIOLOGY, V9, P669, DOI 10.1097/00001648-199811000-00019; Orgeas CC, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2212; PAPATESTAS AE, 1980, CANCER, V45, P191, DOI 10.1002/1097-0142(19800101)45:1<191::AID-CNCR2820450130>3.0.CO;2-6; Perks CC, 2004, BRIT J CANCER, V91, P305, DOI 10.1038/sj.bjc.6601947; Phillips KA, 2004, J CLIN ONCOL, V22, P699, DOI 10.1200/JCO.2004.07.062; Phillips KA, 2009, CANCER EPIDEM BIOMAR, V18, P1792, DOI 10.1158/1055-9965.EPI-08-1014; Reeves GK, 2000, INT J CANCER, V89, P293, DOI 10.1002/1097-0215(20000520)89:3<293::AID-IJC13>3.0.CO;2-R; Rich JD, 2010, J AM COLL CARDIOL, V56, P1376, DOI 10.1016/j.jacc.2010.06.028; Rosenberg L, 2004, INT J CANCER, V111, P772, DOI 10.1002/ijc.20323; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Schouten LJ, 1997, BREAST CANCER RES TR, V43, P217, DOI 10.1023/A:1005790531122; Song N, 2014, INT J CANCER, V135, P669, DOI 10.1002/ijc.28685; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spitale A, 2009, ANN ONCOL, V20, P628, DOI 10.1093/annonc/mdn675; Struman I, 1999, P NATL ACAD SCI USA, V96, P1246, DOI 10.1073/pnas.96.4.1246; Trivers KF, 2007, BREAST CANCER RES TR, V103, P93, DOI 10.1007/s10549-006-9346-1; WANG DY, 1995, J CLIN EPIDEMIOL, V48, P959, DOI 10.1016/0895-4356(94)00201-Z; WANG DY, 1985, INT J CANCER, V36, P427, DOI 10.1002/ijc.2910360403; Whiteman MK, 2004, OBSTET GYNECOL, V104, P146, DOI 10.1097/01.AOG.0000128173.01611.ff; Yamauchi T, 2000, J BIOL CHEM, V275, P33937, DOI 10.1074/jbc.M000743200	55	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123994	10.1371/journal.pone.0123994	http://dx.doi.org/10.1371/journal.pone.0123994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875532	Green Published, gold, Green Submitted			2022-12-26	WOS:000353014700053
J	Cavalcanti, AS; Ribeiro-Alves, M; Pereira, LDR; Mestre, GL; Ferreira, ABR; Morgado, FN; Boite, MC; Cupolillo, E; Moraes, MO; Porrozzi, R				Cavalcanti, Amanda S.; Ribeiro-Alves, Marcelo; Pereira, Luiza de O. R.; Mestre, Gustavo Leandro; Robottom Ferreira, Anna Beatriz; Morgado, Fernanda N.; Boite, Mariana C.; Cupolillo, Elisa; Moraes, Milton O.; Porrozzi, Renato			Parasite Load Induces Progressive Spleen Architecture Breakage and Impairs Cytokine mRNA Expression in Leishmania infantum-Naturally Infected Dogs	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CANINE VISCERAL LEISHMANIASIS; T-CELL EXHAUSTION; IMMUNE-RESPONSES; FACTOR-ALPHA; TNF-ALPHA; MURINE MACROPHAGES; LYMPH-NODES; CHAGASI; TISSUE	Canine Visceral Leishmaniasis (CVL) shares many aspects with the human disease and dogs are considered the main urban reservoir of L. infantum in zoonotic VL. Infected dogs develop progressive disease with a large clinical spectrum. A complex balance between the parasite and the genetic/immunological background of the host are decisive for infection evolution and clinical outcome. This study comprised 92 Leishmania infected mongrel dogs of various ages from Mato Grosso, Brazil. Spleen samples were collected for determining parasite load, humoral response, cytokine mRNA expression and histopathology alterations. By real-time PCR for the ssrRNA Leishmania gene, two groups were defined; a low (lowP, n = 46) and a high parasite load groups (highP, n = 42). When comparing these groups, results show variable individual humoral immune response with higher specific IgG production in infected animals but with a notable difference in CVL rapid test optical densities (DPP) between highP and lowP groups. Splenic architecture disruption was characterized by disorganization of white pulp, more evident in animals with high parasitism. All cytokine transcripts in spleen were less expressed in highP than lowP groups with a large heterogeneous variation in response. Individual correlation analysis between cytokine expression and parasite load revealed a negative correlation for both pro-inflammatory cytokines: IFN gamma, IL-12, IL-6; and anti-inflammatory cytokines: IL-10 and TGF beta. TNF showed the best negative correlation (r(2) = 0.231; p<0.001). Herein we describe impairment on mRNA cytokine expression in leishmania infected dogs with high parasite load associated with a structural modification in the splenic lymphoid micro-architecture. We also discuss the possible mechanism responsible for the uncontrolled parasite growth and clinical outcome.	[Cavalcanti, Amanda S.; Morgado, Fernanda N.; Boite, Mariana C.; Cupolillo, Elisa; Porrozzi, Renato] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Leishmaniose, BR-21045900 Rio De Janeiro, Brazil; [Ribeiro-Alves, Marcelo] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin DST AIDS, BR-21045900 Rio De Janeiro, Brazil; [Pereira, Luiza de O. R.] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, Brazil; [Mestre, Gustavo Leandro] Secretaria Municipal Saude, Ctr Controle Zoonoses, Cuiaba, Brazil; [Robottom Ferreira, Anna Beatriz; Moraes, Milton O.] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Cavalcanti, AS (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisas Leishmaniose, BR-21045900 Rio De Janeiro, Brazil.	amandacavalcanti.ac@gmail.com	Moraes, Milton/AFF-1842-2022; Porrozzi, Renato/U-2059-2019; Porrozzi, Renato/U-2166-2019; Morgado, Fernanda/O-3577-2017; Cupolillo, Elisa/U-1667-2019; Morgado, Fernanda/AAV-4435-2021; Pereira, Luiza O R/P-7606-2018; Boité, Mariana C/F-8784-2012; Morgado, Fernanda N/K-2527-2013; Moraes, Milton Ozório/G-9753-2011	Porrozzi, Renato/0000-0003-2167-316X; Morgado, Fernanda/0000-0002-7188-251X; Cupolillo, Elisa/0000-0002-0620-3250; Morgado, Fernanda/0000-0002-7188-251X; Pereira, Luiza O R/0000-0002-8132-1724; Morgado, Fernanda N/0000-0002-7188-251X; Moraes, Milton Ozório/0000-0003-2653-0037; Robottom Ferreira, Anna Beatriz/0000-0003-3553-1744; Ribeiro-Alves, Marcelo/0000-0002-8663-3364; Cavalcanti, Amanda/0000-0002-8792-7524	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	ASC was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guerreiro LTA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064748; Almeida MAO, 2005, VET IMMUNOL IMMUNOP, V106, P151, DOI 10.1016/j.vetimm.2004.08.024; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Association AVM, 2013, AVMA GUID EUTH AN; Bhadra R, 2012, J INFECT DIS, V206, P125, DOI 10.1093/infdis/jis304; Boggiatto PM, 2010, CLIN VACCINE IMMUNOL, V17, P267, DOI 10.1128/CVI.00456-09; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Borja-Cabrera GP, 2008, VACCINE, V26, P4991, DOI 10.1016/j.vaccine.2008.07.029; CGaL Lara Saraiva, 2012, J TROPICALMEDICINE, V2012, P9, DOI [10.1186/1687-9856-2012-9, DOI 10.1186/1687-9856-2012-9]; CHIOFALO MS, 1992, MICROB PATHOGENESIS, V12, P9, DOI 10.1016/0882-4010(92)90061-R; Costa DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060535; Costa JD, 2007, EXP PARASITOL, V117, P390, DOI 10.1016/j.exppara.2007.05.015; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; De Leonardis F, 2009, CLIN EXP RHEUMATOL, V27, P503; DYE C, 1988, PARASITOLOGY, V96, P19, DOI 10.1017/S0031182000081622; Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2; Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; de Lima VMF, 2012, VET PARASITOL, V184, P147, DOI 10.1016/j.vetpar.2011.08.024; Ferrer L, 1999, P INT CAN LEISHM FOR; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gautam S, 2014, J INFECT DIS, V209, P290, DOI 10.1093/infdis/jit401; Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001; Jayakumar A, 2008, J PARASITOL, V94, P84, DOI 10.1645/GE-1153.1; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Correa APFL, 2007, VET PARASITOL, V143, P267, DOI 10.1016/j.vetpar.2006.08.023; Maia C, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/541571; Manna L, 2009, RES VET SCI, V87, P76, DOI 10.1016/j.rvsc.2008.12.009; McLachlan G., 2000, WILEY SER PROB STAT; Melo GD, 2011, VET J, V188, P243, DOI 10.1016/j.tvjl.2010.03.017; Mendez-Samperio P, 2010, INT J INFECT DIS, V14, pE366, DOI 10.1016/j.ijid.2009.06.022; Menezes-Souza D, 2011, VET PARASITOL, V177, P39, DOI 10.1016/j.vetpar.2010.11.025; Michelin AD, 2011, ANN TROP MED PARASIT, V105, P373, DOI 10.1179/1364859411Y.0000000027; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; NACY CA, 1991, PATHOBIOLOGY, V59, P182, DOI 10.1159/000163640; Nascimento MSL, 2013, VET IMMUNOL IMMUNOP, V153, P202, DOI 10.1016/j.vetimm.2013.02.015; Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI 10.1590/S0037-86822011005000014; Osnes LT, 2013, AUTOIMMUN REV, V12, P967, DOI 10.1016/j.autrev.2013.02.003; Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510; Panaro MA, 2009, PARASITOLOGY, V136, P823, DOI 10.1017/S0031182009006155; PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994; Prieto-Perez R, 2013, PHARMACOGENOMICS J, V13, P297, DOI 10.1038/tpj.2012.53; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Quinnell RJ, 2001, J INFECT DIS, V183, P1421, DOI 10.1086/319869; Raeymaeckers S, 2012, EUR J RADIOL, V81, P2550, DOI 10.1016/j.ejrad.2011.11.021; Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Sanchez MA, 2004, AM J TROP MED HYG, V70, P618, DOI 10.4269/ajtmh.2004.70.618; Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x; Santos-Gomes GM, 2002, VET IMMUNOL IMMUNOP, V88, P21, DOI 10.1016/S0165-2427(02)00134-4; Savage RS, 2010, BIOINFORMATICS, V26, pi158, DOI 10.1093/bioinformatics/btq210; Saxena AK, 2011, INDIAN J PEDIATR, V78, P753, DOI 10.1007/s12098-010-0333-5; Silva JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029103; Silva LC, 2013, INT J EXP PATHOL; Stanley AC, 2007, IMMUNOL CELL BIOL, V85, P138, DOI 10.1038/sj.icb7100011; Stanley AC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000158; Strauss-Ayali D, 2007, VET RES, V38, P547, DOI 10.1051/vetres:2007015; Team RDC, 2009, R LANG ENV STAT COMP; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERESS B, 1977, IMMUNOLOGY, V33, P605; Waters JP, 2013, J PATHOL, V230, P132, DOI 10.1002/path.4187; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; WHO, 2010, WHO TECH REP SER, V949, P1; Yurdakul P, 2011, AM J PATHOL, V179, P23, DOI 10.1016/j.ajpath.2011.03.009	65	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123009	10.1371/journal.pone.0123009	http://dx.doi.org/10.1371/journal.pone.0123009			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875101	gold, Green Published			2022-12-26	WOS:000352845100127
J	Ismail, S; Dadrasnia, A				Ismail, Salmah; Dadrasnia, Arezoo			Biotechnological Potential of Bacillus salmalaya 139SI: A Novel Strain for Remediating Water Polluted with Crude Oil Waste	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOSURFACTANT; BIODEGRADATION; BIOREMEDIATION	Environmental contamination by petroleum hydrocarbons, mainly crude oil waste from refineries, is becoming prevalent worldwide. This study investigates the bioremediation of water contaminated with crude oil waste. Bacillus salamalaya 139SI, a bacterium isolated from a private farm soil in the Kuala Selangor in Malaysia, was found to be a potential degrader of crude oil waste. When a microbial population of 10(8) CFU ml(-1) was used, the 139SI strain degraded 79% and 88% of the total petroleum hydrocarbons after 42 days of incubation in mineral salt media containing 2% and 1% of crude oil waste, respectively, under optimum conditions. In the uninoculated medium containing 1% crude oil waste, 6% was degraded. Relative to the control, the degradation was significantly greater when a bacteria count of 99 x 10(8) CFU ml(-1) was added to the treatments polluted with 1% oil. Thus, this isolated strain is useful for enhancing the biotreatment of oil in wastewater.	[Ismail, Salmah; Dadrasnia, Arezoo] Univ Malaya, Fac Sci, Inst Biol Sci, Dept Biohlth Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Ismail, S (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Dept Biohlth Sci, Kuala Lumpur, Malaysia.	salmah_r@um.edu.my	Dadrasnia, Arezoo/A-8413-2012; Ismail, Salmah/A-6504-2016; ISMAIL, SALMAH/B-9680-2010	Dadrasnia, Arezoo/0000-0002-0160-6333; ISMAIL, SALMAH/0000-0001-5595-8222	University Malaya [A-21010-DA674, A-21010-DA677]; University of Malaya Research Program (UMRP) [RP023A-14AFR]	University Malaya(Universiti Malaya); University of Malaya Research Program (UMRP)	The authors would like to acknowledge the support of chancellery of University Malaya with special grants numbered A-21010-DA674 and A-21010-DA677. Also, the authors would like to acknowledge the support of the University of Malaya Research Program (UMRP) with grant number RP023A-14AFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J KOREAN SOC APPL BI, V57, P5; Bao MT, 2014, ENVIRON SCI-PROC IMP, V16, P897, DOI 10.1039/c3em00600j; Bento FM, 2005, BIORESOURCE TECHNOL, V96, P1049, DOI 10.1016/j.biortech.2004.09.008; Carrillo PG, 1996, WORLD J MICROB BIOT, V12, P82, DOI 10.1007/BF00327807; Chand Raza A, 2010, BIOLOGIA, V56, P77; Dadrasnia A, 2015, PETROL SCI TECHNOL, V33, P1030, DOI 10.1080/10916466.2014.925920; Dadrasnia A., 2014, INT J ENV SCI, V4, P241; Das Nilanjana, 2011, Biotechnol Res Int, V2011, P941810, DOI 10.4061/2011/941810; Eddouaouda K, 2012, J BASIC MICROB, V52, P408, DOI 10.1002/jobm.201100268; Hassanshahian M, 2014, MAR ENVIRON RES, V95, P28, DOI 10.1016/j.marenvres.2013.12.010; Ismail S, 2012, BIOLOGIA, V67, P1031, DOI 10.2478/s11756-012-0117-7; Joo MH, 2013, J KOREAN SOC APPL BI, V56, P193, DOI 10.1007/s13765-012-3269-9; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kumari B, 2012, PROCESS BIOCHEM, V47, P2463, DOI 10.1016/j.procbio.2012.10.010; Makkar RS, 2003, ENVIRON TOXICOL CHEM, V22, P2280, DOI 10.1897/02-472; Maliji D., 2013, International Journal of Current Microbiology and Applied Sciences, V2, P1; Moghadam MS, 2014, IRAN J BIOTECHNOL, V12, DOI 10.5812/ijb.15392; Norman RS, 2002, APPL ENVIRON MICROB, V68, P5096, DOI 10.1128/AEM.68.10.5096-5103.2002; Rufino RD, 2014, ELECTRON J BIOTECHN, V17, DOI 10.1016/j.ejbt.2013.12.006; Sharma D, 2014, INT J MICROBIOL, V7; Xu YH, 2010, J HAZARD MATER, V183, P395, DOI 10.1016/j.jhazmat.2010.07.038	21	13	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120931	10.1371/journal.pone.0120931	http://dx.doi.org/10.1371/journal.pone.0120931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875763	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100028
J	Jansen, H; Wijga, AH; Scholtens, S; Koppelman, GH; Postma, DS; Brunekreef, B; de Jongste, JC; Smit, HA; Stolk, RP				Jansen, Hanneke; Wijga, Alet H.; Scholtens, Salome; Koppelman, Gerard H.; Postma, Dirkje S.; Brunekreef, Bert; de Jongste, Johan C.; Smit, Henriette A.; Stolk, Ronald P.			Change in HbA1c Levels between the Age of 8 Years and the Age of 12 Years in Dutch Children without Diabetes: The PIAMA Birth Cohort Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; GLYCATED HEMOGLOBIN; INSULIN-RESISTANCE; HBA(1C) LEVELS; BODY-FAT; GLUCOSE; ADULTS; ASSOCIATION; CANCER	Objective HbA1c is associated with cardiovascular risk in persons without diabetes and cardiovascular risk accumulates over the life course. Therefore, insight in factors determining HbA1c from childhood onwards is important. We investigated (lifestyle) determinants of HbA1c at age 12 years and the effects of growth on change in HbA1c and the tracking of HbA1c between the age of 8 and 12 years. Study Design and Methods Anthropometric measurements were taken and HbA1c levels were assessed in 955 children without diabetes aged around 12 years participating in the PIAMA birth cohort study. In 363 of these children HbA1c was also measured at age 8 years. Data on parents and children were collected prospectively by questionnaires. Results We found no significant association between known risk factors for diabetes and HbA1c at age 12 years. Mean(SD) change in HbA1c between ages 8 and 12 years was 0.6(0.7) mmol/mol per year (or 0.1(0.1) %/yr). Anthropometric measures at age 8 and their change between age 8 and 12 years were not associated with the change in HbA1c. 68.9% of the children remained in the same quintile or had an HbA1c one quintile higher or lower at age 8 years compared to age 12 years. Conclusion The lack of association between known risk factors for diabetes and HbA1c suggest that HbA1c in children without diabetes is relatively unaffected by factors associated with glycaemia. HbA1c at age 8 years is by far the most important predictor of HbA1c at age 12. Therefore, the ranking of HbA1c levels appear to be fairly stable over time.	[Jansen, Hanneke; Scholtens, Salome; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, GRIAC Res Inst, Groningen, Netherlands; [Wijga, Alet H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Jongste, Johan C.] Erasmus MC, Sophia Childrens Hosp, Dept Paediat, Rotterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Wijga, AH (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	alet.wijga@rivm.nl	Koppelman, Gerard/AAG-9187-2020	Stolk, Ronald/0000-0002-0518-1205; Koppelman, Gerard/0000-0001-8567-3252; Scholtens, Salome/0000-0002-0651-5203	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing and the Environment; Netherlands Ministry of Health, Welfare and Sport	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing and the Environment; Netherlands Ministry of Health, Welfare and Sport	Research relating to this manuscript was funded by The Netherlands Organization for Health Research and Development, The Netherlands Organization for Scientific Research, The Netherlands Asthma Fund, The Netherlands Ministry of Spatial Planning Housing and the Environment, and The Netherlands Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeing H, 2000, AM J CLIN NUTR, V71, P1115; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DUNN PJ, 1979, ANN INTERN MED, V91, P390, DOI 10.7326/0003-4819-91-3-390; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Fredriks AM, 2005, EUR J PEDIATR, V164, P216, DOI 10.1007/s00431-004-1586-7; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Jansen H, 2009, DIABETIC MED, V26, P122, DOI 10.1111/j.1464-5491.2008.02641.x; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Meigs JB, 1996, J CLIN EPIDEMIOL, V49, P411, DOI 10.1016/0895-4356(95)00513-7; MODAN M, 1988, DIABETES CARE, V11, P422, DOI 10.2337/diacare.11.5.422; Pettitt DJ, 2004, DIABETES RES CLIN PR, V65, P45, DOI 10.1016/j.diabres.2003.11.010; Roemmich JN, 2002, INT J OBESITY, V26, P701, DOI 10.1038/sj.ijo.0801975; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Shultis WA, 2006, DIABETIC MED, V23, P1357, DOI 10.1111/j.1464-5491.2006.01990.x; World Health Organization, 2011, US GLYC HAEM HBA1C D	19	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0119615	10.1371/journal.pone.0119615	http://dx.doi.org/10.1371/journal.pone.0119615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875773	gold, Green Published			2022-12-26	WOS:000352845100017
J	Ouedraogo, O; Chetelat, J; Amyot, M				Ouedraogo, Ousseni; Chetelat, John; Amyot, Marc			Bioaccumulation and Trophic Transfer of Mercury and Selenium in African Sub-Tropical Fluvial Reservoirs Food Webs (Burkina Faso)	PLOS ONE			English	Article							STABLE-ISOTOPES; LAKE VICTORIA; CHAIN STRUCTURE; WINAM GULFS; BIOMAGNIFICATION; FISH; POSITION; WATER; DELTA-N-15; METHYLMERCURY	The bioaccumulation and biomagnification of mercury (Hg) and selenium (Se) were investigated in sub-tropical freshwater food webs from Burkina Faso, West Africa, a region where very few ecosystem studies on contaminants have been performed. During the 2010 rainy season, samples of water, sediment, fish, zooplankton, and mollusks were collected from three water reservoirs and analysed for total Hg (THg), methylmercury (MeHg), and total Se (TSe). Ratios of delta C-13 and delta N-15 were measured to determine food web structures and patterns of contaminant accumulation and transfer to fish. Food chain lengths (FCLs) were calculated using mean delta N-15 of all primary consumer taxa collected as the site-specific baseline. We report relatively low concentrations of THg and TSe in most fish. We also found in all studied reservoirs short food chain lengths, ranging from 3.3 to 3.7, with most fish relying on a mixture of pelagic and littoral sources for their diet. Mercury was biomagnified in fish food webs with an enrichment factor ranging from 2.9 to 6.5 for THg and from 2.9 to 6.6 for MeHg. However, there was no evidence of selenium biomagnification in these food webs. An inverse relationship was observed between adjusted delta N-15 and log-transformed Se: Hg ratios, indicating that Se has a lesser protective effect in top predators, which are also the most contaminated animals with respect to MeHg. Trophic position, carbon source, and fish total length were the factors best explaining Hg concentration in fish. In a broader comparison of our study sites with literature data for other African lakes, the THg biomagnification rate was positively correlated with FCL. We conclude that these reservoir systems from tropical Western Africa have low Hg biomagnification associated with short food chains. This finding may partly explain low concentrations of Hg commonly reported in fish from this area.	[Ouedraogo, Ousseni; Amyot, Marc] Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol, Montreal, PQ H3C 3J7, Canada; [Chetelat, John] Carleton Univ, Natl Wildlife Res Ctr, Environm Canada, Ottawa, ON K1S 5B6, Canada	Universite de Montreal; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Amyot, M (corresponding author), Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol, CP 6128, Montreal, PQ H3C 3J7, Canada.	m.amyot@umontreal.ca	Chételat, John/AAE-4711-2020; Amyot, Marc/A-7182-2008	Chételat, John/0000-0002-9380-7203; Amyot, Marc/0000-0002-0340-3249	Natural Sciences and Engineering Research Council of Canada [217099]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	MA received funds from the Natural Sciences and Engineering Research Council of Canada (Discovery; 217099; www.crsng-nserc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2007, J N AM BENTHOL SOC, V26, P273, DOI 10.1899/0887-3593(2007)26[273:ETTPOA]2.0.CO;2; Arnot JA, 2006, ENVIRON REV, V14, P257, DOI 10.1139/a06-005; Belzile N, 2006, CAN J FISH AQUAT SCI, V63, P1, DOI 10.1139/F05-202; Black FJ, 2011, SCI TOTAL ENVIRON, V409, P1967, DOI 10.1016/j.scitotenv.2010.11.027; Boelee E, 2009, HLTH IMPACTS SMALL R; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; CABANA G, 1994, CAN J FISH AQUAT SCI, V51, P381, DOI 10.1139/f94-039; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Campbell L, 2008, SCI TOTAL ENVIRON, V402, P184, DOI 10.1016/j.scitotenv.2008.04.017; Campbell LM, 2003, J GREAT LAKES RES, V29, P267, DOI 10.1016/S0380-1330(03)70554-1; Campbell LM, 2003, J GREAT LAKES RES, V29, P243, DOI 10.1016/S0380-1330(03)70552-8; Campbell LM, 2003, J TOXICOL ENV HEAL B, V6, P325, DOI 10.1080/10937400306474; Chen CY, 2000, LIMNOL OCEANOGR, V45, P1525, DOI 10.4319/lo.2000.45.7.1525; Chen YW, 2001, LIMNOL OCEANOGR, V46, P1814, DOI 10.4319/lo.2001.46.7.1814; Chetelat J, 2015, SCI TOTAL ENVIRON, V509, P41, DOI 10.1016/j.scitotenv.2014.05.151; Chetelat J, 2011, ENVIRON POLLUT, V159, P10, DOI 10.1016/j.envpol.2010.09.034; Clayden MG, 2013, ENVIRON SCI TECHNOL, V47, P12047, DOI 10.1021/es4022975; CORNS WT, 1993, J ANAL ATOM SPECTROM, V8, P71, DOI 10.1039/ja9930800071; Cossa D, 2012, ENVIRON SCI TECHNOL, V46, P4885, DOI 10.1021/es204269w; Dang F, 2011, ENVIRON SCI TECHNOL, V45, P3116, DOI 10.1021/es103705a; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Desta Z, 2008, J FISH BIOL, V73, P477, DOI 10.1111/j.1095-8649.2008.01920.x; Desta Z, 2006, ECOL FRESHW FISH, V15, P532, DOI 10.1111/j.1600-0633.2006.00193.x; Desta Z, 2007, SCI TOTAL ENVIRON, V376, P134, DOI 10.1016/j.scitotenv.2007.01.091; Donkor AK, 2006, SCI TOTAL ENVIRON, V368, P164, DOI 10.1016/j.scitotenv.2005.09.046; FAO/WHO, 2004, SAF EV CERT ADD CONT; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; Gailer J, 2007, COORDIN CHEM REV, V251, P234, DOI 10.1016/j.ccr.2006.07.018; Gorski PR, 2003, SCI TOTAL ENVIRON, V304, P327, DOI 10.1016/S0048-9697(02)00579-X; Hallanger IG, 2011, ENVIRON TOXICOL CHEM, V30, P1026, DOI 10.1002/etc.488; Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Hong YS, 2013, ENVIRON TOXICOL CHEM, V32, P1143, DOI 10.1002/etc.2169; Ikemoto T, 2008, ARCH ENVIRON CON TOX, V54, P504, DOI 10.1007/s00244-007-9058-5; Jardine TD, 2006, ENVIRON SCI TECHNOL, V40, P7501, DOI 10.1021/es061263h; Jardine TD, 2012, SCI TOTAL ENVIRON, V416, P385, DOI 10.1016/j.scitotenv.2011.11.022; Jardine TD, 2011, SCI TOTAL ENVIRON, V409, P785, DOI 10.1016/j.scitotenv.2010.11.013; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Karimi R, 2013, PLOS ONE, V8; Kidd K., 2012, ENV CHEM TOXICOLOGY, P455; KIDD KA, 1995, SCI TOTAL ENVIRON, V160-61, P381, DOI 10.1016/0048-9697(95)04371-7; KIDD KA, 1995, WATER AIR SOIL POLL, V80, P1011, DOI 10.1007/BF01189756; Kidd KA, 2003, J GREAT LAKES RES, V29, P258, DOI 10.1016/S0380-1330(03)70553-X; Kidd KA, 2004, B ENVIRON CONTAM TOX, V73, P249, DOI 10.1007/s00128-004-0420-2; Kidd KA, 2012, SCI TOTAL ENVIRON, V438, P135, DOI 10.1016/j.scitotenv.2012.08.057; Lavoie RA, 2013, ENVIRON SCI TECHNOL, V47, P13385, DOI 10.1021/es403103t; Lemly AD, 2004, ECOTOX ENVIRON SAFE, V59, P44, DOI 10.1016/S0147-6513(03)00095-2; LEMLY AD, 1993, ENVIRON MONIT ASSESS, V28, P83, DOI 10.1007/BF00547213; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; N'guessan Sylvain Yao, 2010, European Journal of Scientific Research, V46, P275; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; Orr PL, 2006, ECOTOX ENVIRON SAFE, V63, P175, DOI 10.1016/j.ecoenv.2005.09.004; Oueda A, 2009, THESIS U QUAGADOUGOU; Oueda Adama, 2008, Journal of Fisheries and Aquatic Sciences, V3, P240; Ouedraogo O, 2013, THESIS U MONTREAL; Ouedraogo O, 2013, SCI TOTAL ENVIRON, V444, P243, DOI 10.1016/j.scitotenv.2012.11.095; PARIZEK J, 1967, EXPERIENTIA, V23, P142, DOI 10.1007/BF02135970; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson SA, 2009, ENVIRON SCI TECHNOL, V43, P3919, DOI 10.1021/es803203g; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Poste AE, 2015, SCI TOTAL ENVIRON, V506, P126, DOI 10.1016/j.scitotenv.2014.10.094; Power M, 2002, J APPL ECOL, V39, P819, DOI 10.1046/j.1365-2664.2002.00758.x; Ralston NVC, 2006, NEUROTOXICOLOGY, V27, P1172; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; Razavi NR, 2014, ECOTOXICOLOGY, V23, P133, DOI 10.1007/s10646-013-1158-6; Simmons DBD, 2005, ENVIRON TOXICOL CHEM, V24, P1331, DOI 10.1897/04-176R.1; Swanson HK, 2010, ENVIRON SCI TECHNOL, V44, P3286, DOI 10.1021/es100439t; Tadiso TM, 2011, ECOTOX ENVIRON SAFE, V74, P953, DOI 10.1016/j.ecoenv.2011.01.005; U.S. E.P.A, 1996, 1669 US EPA; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Verburg P, 2014, SCI TOTAL ENVIRON, V493, P342, DOI 10.1016/j.scitotenv.2014.05.097; Yang DY, 2008, ENVIRON REV, V16, P71, DOI 10.1139/A08-001; Yang DY, 2010, SCI TOTAL ENVIRON, V408, P1676, DOI 10.1016/j.scitotenv.2009.11.049	78	39	40	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123048	10.1371/journal.pone.0123048	http://dx.doi.org/10.1371/journal.pone.0123048			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875292	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100129
J	Ravi, S; Chacko, B; Sawada, H; Kramer, PA; Johnson, MS; Benavides, GA; O'Donnell, V; Marques, MB; Darley-Usmar, VM				Ravi, Saranya; Chacko, Balu; Sawada, Hirotaka; Kramer, Philip A.; Johnson, Michelle S.; Benavides, Gloria A.; O'Donnell, Valerie; Marques, Marisa B.; Darley-Usmar, Victor M.			Metabolic Plasticity in Resting and Thrombin Activated Platelets	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; FATTY-ACID-METABOLISM; ENERGY-METABOLISM; ADENOSINE-TRIPHOSPHATE; MICROPLATE READER; GLUCOSE-OXIDATION; MITOCHONDRIAL; AGGREGATION; BLOOD; MECHANISMS	Platelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that can be utilized to serve the energetic and metabolic needs for resting and thrombin-dependent platelet aggregation. Using platelets from healthy human donors, we found that there was a rapid thrombin-dependent increase in oxidative phosphorylation which required both glutamine and fatty acids but not glucose. Inhibition of fatty acid oxidation or glutamine utilization could be compensated for by increased glycolytic flux. No evidence for significant mitochondrial dysfunction was found, and ATP/ADP ratios were maintained following the addition of thrombin, indicating the presence of functional and active mitochondrial oxidative phosphorylation during the early stages of aggregation. Interestingly, inhibition of fatty acid oxidation and glutaminolysis alone or in combination is not sufficient to prevent platelet aggregation, due to compensation from glycolysis, whereas inhibitors of glycolysis inhibited aggregation approximately 50%. The combined effects of inhibitors of glycolysis and oxidative phosphorylation were synergistic in the inhibition of platelet aggregation. In summary, both glycolysis and oxidative phosphorylation contribute to platelet metabolism in the resting and activated state, with fatty acid oxidation and to a smaller extent glutaminolysis contributing to the increased energy demand.	[Ravi, Saranya; Chacko, Balu; Sawada, Hirotaka; Kramer, Philip A.; Johnson, Michelle S.; Benavides, Gloria A.; Marques, Marisa B.; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Ravi, Saranya; Chacko, Balu; Sawada, Hirotaka; Kramer, Philip A.; Johnson, Michelle S.; Benavides, Gloria A.; Darley-Usmar, Victor M.] Univ Alabama Birmingham, UAB Mitochondrial Med Lab, Birmingham, AL 35294 USA; [Ravi, Saranya; Chacko, Balu; Sawada, Hirotaka; Kramer, Philip A.; Johnson, Michelle S.; Benavides, Gloria A.; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [O'Donnell, Valerie] Cardiff Univ, Dept Med Biochem, Cardiff CF10 3AX, S Glam, Wales	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cardiff University	Darley-Usmar, VM (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	darley@uab.edu	Kramer, Philip/GYJ-8215-2022	Darley-Usmar, Victor/0000-0001-8921-7086; Marques, Marisa/0000-0002-6689-7856; Kramer, Philip/0000-0001-6554-631X; Sawada, Hirotaka/0000-0001-9785-750X; /0000-0003-4089-8460	American Heart Association [13PRE16390001]; NIDDK Diabetic Complications Consortium (DiaComp) [DK076169]; O'Brien Center [P30 DK079337]; British Heart Foundation [RG/12/11/29815] Funding Source: researchfish	American Heart Association(American Heart Association); NIDDK Diabetic Complications Consortium (DiaComp); O'Brien Center; British Heart Foundation(British Heart Foundation)	This work was supported by American Heart Association 13PRE16390001 (SR), NIDDK Diabetic Complications Consortium (DiaComp, www.diacomp.org) grant DK076169 (subaward VDU), and the O'Brien Center P30 DK079337 (VDU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKERMAN JWN, 1981, BLOOD, V57, P956; ASTARIEDEQUEKER C, 1994, J CARDIOVASC PHARM, V23, P401, DOI 10.1097/00005344-199423030-00007; ATKINSON DE, 1969, ANNU REV MICROBIOL, V23, P47, DOI 10.1146/annurev.mi.23.100169.000403; Barile CJ, 2012, P NATL ACAD SCI USA, V109, P2539, DOI 10.1073/pnas.1120645109; Bassit RA, 2002, NUTRITION, V18, P376, DOI 10.1016/S0899-9007(02)00753-0; BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y; BORST P, 1962, BIOCHIM BIOPHYS ACTA, V62, P509, DOI 10.1016/0006-3002(62)90232-9; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; CHAUDHRY AA, 1973, BLOOD, V41, P249, DOI 10.1182/blood.V41.2.249.249; COHEN P, 1970, J CLIN INVEST, V49, P128, DOI 10.1172/JCI106211; Coolen EJCM, 2008, J CHROMATOGR B, V864, P43, DOI 10.1016/j.jchromb.2008.01.033; DERKSEN A, 1975, J BIOL CHEM, V250, P9342; DOERY JCG, 1970, BLOOD-J HEMATOL, V36, P159, DOI 10.1182/blood.V36.2.159.159; DONABEDIAN R, 1971, AM J PHYSIOL, V221, P1283, DOI 10.1152/ajplegacy.1971.221.5.1283; FUKAMI MH, 1976, BIOCHIM BIOPHYS ACTA, V444, P633, DOI 10.1016/0304-4165(76)90310-X; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Galbusera M, 2009, SEMIN DIALYSIS, V22, P279, DOI 10.1111/j.1525-139X.2008.00556.x; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; HOLMSEN H, 1974, BIOCHEM J, V144, P385, DOI 10.1042/bj1440385; HOLMSEN H, 1982, BIOCHEM J, V208, P9, DOI 10.1042/bj2080009; Jobe SM, 2008, BLOOD, V111, P1257, DOI 10.1182/blood-2007-05-092684; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; KATTLOVE HE, 1974, AM J PHYSIOL, V226, P325, DOI 10.1152/ajplegacy.1974.226.2.325; Kim SJ, 2013, CONTRIB NEPHROL, V179, P119, DOI 10.1159/000346730; Kramer PA, 2014, JOVE-J VIS EXP, DOI 10.3791/51301; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Levi M, 2013, SEMIN THROMB HEMOST, V39, P559, DOI 10.1055/s-0033-1343894; Leytin V, 2006, J THROMB HAEMOST, V4, P2656, DOI 10.1111/j.1538-7836.2006.02200.x; Leytin V, 2009, LAB INVEST, V89, P374, DOI 10.1038/labinvest.2009.13; Liu F, 2013, J BIOL CHEM, V288, P30672, DOI 10.1074/jbc.M113.472688; MAJERUS PW, 1969, J CLIN INVEST, V48, P156, DOI 10.1172/JCI105964; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; MISSELWITZ F, 1987, THROMB RES, V46, P233, DOI 10.1016/0049-3848(87)90285-4; Misztal T, 2013, THROMB RES, V131, pE17, DOI 10.1016/j.thromres.2012.11.010; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Niu X, 1997, BRIT J HAEMATOL, V97, P908, DOI 10.1046/j.1365-2141.1997.1442963.x; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; REAVEN GM, 1988, DIABETES, V37, P28, DOI 10.2337/diabetes.37.1.28; Remenyi G, 2005, ARTERIOSCL THROM VAS, V25, P467, DOI 10.1161/01.ATV.0000152726.49229.bf; ROTTENBERG H, 1986, FEBS LETT, V202, P314, DOI 10.1016/0014-5793(86)80708-6; Rusak T, 2006, ACTA BIOCHIM POL, V53, P769, DOI 10.18388/abp.2006_3305; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Samartsev V. N., 2013, Biofizika, V58, P481; Siddiqui TI, 2013, CURR MED CHEM, V20, P2779, DOI 10.2174/0929867311320220004; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; Thon Jonathan N, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-29423-5_1; VASTA V, 1995, BBA-GEN SUBJECTS, V1243, P43, DOI 10.1016/0304-4165(94)00118-H; VASTA V, 1993, J BIOCHEM-TOKYO, V114, P163, DOI 10.1093/oxfordjournals.jbchem.a124148; Walkowiak B, 1997, THROMB RES, V87, P95, DOI 10.1016/S0049-3848(97)00108-4; Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250; Willoughby SR, 1998, EUR J PHARMACOL, V356, P207, DOI 10.1016/S0014-2999(98)00527-5; Yamagishi S, 2001, DIABETES, V50, P1491, DOI 10.2337/diabetes.50.6.1491	55	66	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123597	10.1371/journal.pone.0123597	http://dx.doi.org/10.1371/journal.pone.0123597			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875958	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000352845100192
J	Gabaldon, C; Carmona, MJ; Montero-Pau, J; Serra, M				Gabaldon, Carmen; Jose Carmona, Maria; Montero-Pau, Javier; Serra, Manuel			Long-Term Competitive Dynamics of Two Cryptic Rotifer Species: Diapause and Fluctuating Conditions	PLOS ONE			English	Article							RESOURCE COMPETITION; MORPHOLOGICAL STASIS; NICHE CONSERVATISM; EGG BANKS; BRACHIONUS; COEXISTENCE; COMPLEX; DIVERSITY; PATTERNS; POPULATIONS	Life-history traits may have an important role in promoting species coexistence. However, the complexity of certain life cycles makes it difficult to draw conclusions about the conditions for coexistence or exclusion based on the study of short-term competitive dynamics. Brachionus plicatilis and B. manjavacasare two cryptic rotifer species co-occurring in many lakes on the Iberian Peninsula. They have a complex life cycle in which cyclical parthenogenesis occurs with diapausing stages being the result of sexual reproduction. B. plicatilis and B. manjavacasare identical in morphology and size, their biotic niches are broadly overlapping, and they have similar competitive abilities. However, the species differ in life-history traits involving sexual reproduction and diapause, and respond differently to salinity and temperature. As in the case of certain other species that are extremely similar in morphology, a fluctuating environment are considered to be important for their coexistence. We studied the long-term competitive dynamics of B. plicatilis and B. manjavacas under different salinity regimes (constant and fluctuating). Moreover, we focused on the dynamics of the diapausing egg bank to explore how the outcome of the entire life cycle of these rotifers can work to mediate stable coexistence. We demonstrated that these species do not coexist under constant-salinity environment, as the outcome of competition is affected by the level of salinity-at low salinity, B. plicatilis excluded B. manjavacas, and the opposite outcome occurred at high salinity. Competitive dynamics under fluctuating salinity showed that the dominance of one species over the other also tended to fluctuate. The duration of co-occurrence of these species was favoured by salinity fluctuation and perhaps by the existence of a diapausing egg bank. Stable coexistence was not found in our system, which suggests that other factors or other salinity fluctuation patterns might act as stabilizing processes in the wild.	[Gabaldon, Carmen; Jose Carmona, Maria; Montero-Pau, Javier; Serra, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain	University of Valencia	Gabaldon, C (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	carmen.gabaldon-tebar@uv.es	Carmona, María José/H-6452-2015; Montero-Pau, Javier/H-6711-2015; GABALDÓN, CARMEN/N-3245-2017; Serra, Manuel/H-7817-2015; Carmona, María José/AAM-4340-2020	Carmona, María José/0000-0002-4835-6933; Montero-Pau, Javier/0000-0002-0864-8157; Serra, Manuel/0000-0003-1731-1529; Carmona, María José/0000-0002-4835-6933	Ministerio de Ciencia; FEDER funds [CGL2009-07364]; Spanish Ministerio de Ciencia e Innovacion [BES2010-036384]	Ministerio de Ciencia(Spanish Government); FEDER funds(European Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by a grant to M.S. from the Ministerio de Ciencia co-financed by FEDER funds (project CGL2009-07364). C.G. was supported by a fellowship by the Spanish Ministerio de Ciencia e Innovacion (BES2010-036384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; [Anonymous], 1877, DIFFERENT FORMS FLOW; [Anonymous], 2014, R LANG ENV STAT COMP; BOERSMA M, 1995, OECOLOGIA, V103, P309, DOI 10.1007/BF00328619; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; CHESSON P, 1989, TRENDS ECOL EVOL, V4, P293, DOI 10.1016/0169-5347(89)90024-4; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Ciros-Perez J, 2004, LIMNOL OCEANOGR, V49, P40, DOI 10.4319/lo.2004.49.1.0040; Ciros-Perez J, 2001, J PLANKTON RES, V23, P1311, DOI 10.1093/plankt/23.12.1311; Ciros-Perez J, 2002, OECOLOGIA, V131, P35, DOI 10.1007/s00442-001-0856-6; Ciros-Perez J, 2001, LIMNOL OCEANOGR, V46, P1511, DOI 10.4319/lo.2001.46.6.1511; Comin F.A., 1992, Limnetica, V8, P79; Fontaneto D, 2007, HYDROBIOLOGIA, V583, P297, DOI 10.1007/s10750-007-0573-1; Fournet S, 2000, ENTOMOL EXP APPL, V96, P205, DOI 10.1023/A:1004009205480; Gabaldon C, 2015, J PLANKTON RES; Gabaldon C, 2015, J EXP MAR BIOL ECOL, V465, P142, DOI 10.1016/j.jembe.2015.01.016; Gabaldon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057087; Garcia-Roger EM, 2006, J EXP MAR BIOL ECOL, V336, P198, DOI 10.1016/j.jembe.2006.05.009; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 1996, J EVOLUTION BIOL, V9, P953, DOI 10.1046/j.1420-9101.1996.9060953.x; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HAGIWARA A, 1985, B JPN SOC SCI FISH, V51, P755; HAGIWARA A, 1989, HYDROBIOLOGIA, V186, P415, DOI 10.1007/BF00048940; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HEBERT PDN, 1982, ANN ZOOL FENN, V19, P349; IBM Corp R, 2010, IBM SPSS STAT WIND V; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Kotani T, 2001, HYDROBIOLOGIA, V446, P283, DOI 10.1023/A:1017584230439; Levin S. A., 2000, ENCY BIODIVERSITY, P79; LOREAU M, 1994, THEOR POPUL BIOL, V46, P58, DOI 10.1006/tpbi.1994.1019; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MINKOFF G, 1983, HYDROBIOLOGIA, V104, P61, DOI 10.1007/BF00045953; Moll JD, 2008, AM NAT, V171, P839, DOI 10.1086/587517; Montero-Pau J, 2014, ECOL MODEL, V272, P76, DOI 10.1016/j.ecolmodel.2013.09.020; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021530; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020314; Montes C., 1987, SEM BAS CIENT PROT H; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; Ortells R, 2000, ARCH HYDROBIOL, V149, P529; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; SEITZ A, 1980, OECOLOGIA, V45, P117, DOI 10.1007/BF00346716; Spaak P, 1994, GENETICAL ECOLOGY CO; Stelzer CP, 2006, LIMNOL OCEANOGR, V51, P125, DOI 10.4319/lo.2006.51.1.0125; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Tilman D., 1982, Monographs in Population Biology, pi; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x	53	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124406	10.1371/journal.pone.0124406	http://dx.doi.org/10.1371/journal.pone.0124406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881307	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500098
J	Pegurri, E; Konings, E; Crandall, B; Haile-Selassie, H; Matinhure, N; Naamara, W; Assefa, Y				Pegurri, Elisabetta; Konings, Elke; Crandall, Bud; Haile-Selassie, Hiwot; Matinhure, Nelia; Naamara, Warren; Assefa, Yibeltal			The Missed HIV-Positive Children of Ethiopia	PLOS ONE			English	Article							ADOLESCENTS; INFECTION; AFRICA; ADULTS	Objective As elsewhere, due to scarcity of data and limited awareness of HIV infection, especially in older children, the HIV epidemic among Ethiopian children appears neglected in national programs (children ART coverage is of only 12% in 2013). This paper estimates the country burden of HIV in older children and investigates the prevalence of HIV in orphans and vulnerable children (OVC) households. Design/Methods We analyzed national HIV data for Ethiopia, using Spectrum/Estimation and Projection Package (EPP) and primary data on children living in households with at least one HIV-positive adult in the Amhara and Tigrai regions. Descriptive analysis of the age and sex distribution of HIV-positive OVC in Ethiopia was performed. Results Our Spectrum/EPP analysis estimated the population of HIV-positive children under 15 years old to be 160,000 in 2013. The majority of children (81.6%) were aged five to 14 years. The estimated number of orphans due to AIDS was 800,000. The empirical data from almost 10,000 OVC under 18 years showed 11. 9% were HIV-positive, the majority of whom were between five and 10 years old with no significant difference between males and females. Conclusions There is a large population of children living with HIV in Ethiopia, the magnitude of which not previously recognized. The majority were vertically infected and never identified nor linked into treatment. OVC represent a reachable group which could account for a substantial proportion of the HIV infected older children. We recommend that HIV programs urgently synergize with social protection sectors and address these children with HIV testing and related services.	[Pegurri, Elisabetta; Naamara, Warren] Joint United Nations Programme HIV AIDS UNAIDS, Addis Ababa, Ethiopia; [Konings, Elke; Crandall, Bud] Management Sci Hlth, Addis Ababa, Ethiopia; [Matinhure, Nelia] Save Children, Addis Ababa, Ethiopia; [Assefa, Yibeltal] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia	Save the Children	Pegurri, E (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, Addis Ababa, Ethiopia.	pegurrie@unaids.org	Assefa, Yibeltal/N-5984-2016; Assefa, Yibeltal/ABI-8057-2020	Assefa, Yibeltal/0000-0003-2393-1492; Assefa, Yibeltal/0000-0003-2393-1492	PEPFAR; United States Agency for International Development (USAID) [RFA: 663-11-000005]	PEPFAR; United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The empirical data from Amhara and Tigrai was obtained through the USAID ENHAT-CS program, which is funded by PEPFAR and implemented by an MSH-led consortium of international and Ethiopian organizations; the publication thereof was made possible by the generous support of the American People through the United States Agency for International Development (USAID) under RFA: 663-11-000005. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government nor the Joint United Nations Programme on HIV/AIDS (UNAIDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto GF, 2012, LANCET INFECT DIS, V12, P664, DOI 10.1016/S1473-3099(12)70211-6; Braitstein P, 2011, 6 IAS C HIV PATH TRE; EFMOH, 2013, NAT STRAT PLAN EL MO; Ethiopia CSA, 2012, ETH DEM HLTH SURV 20; Ethiopian Health and Nutrition Institute (EHNRI) and Ethiopia Ministry of Health (EMOH), 2012, HIV REL EST PROJ ETH; Ferrand RA, 2011, AM J PUBLIC HEALTH, V101, P2325, DOI 10.2105/AJPH.2011.300250; Ferrand RA, 2011, TROP MED INT HEALTH, V16, P349, DOI 10.1111/j.1365-3156.2010.02708.x; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; FHAPCO, 2013, ANN PERF REP EFY 200; FHAPCO, 2007, GUID HIV COUNS TEST; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Marston M, 2011, INT J EPIDEMIOL, V40, P385, DOI 10.1093/ije/dyq255; MOWCYA, 2010, STAND SERV DEL GUID; Musoke P., 2011, 3 HIV PED WORKSH 201; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Operario D, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-25; Pitorak H, 2013, MAPPING HIV SERVICES; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; TRHB/THAPCO FHAPCO UNAIDS, 2012, TIGR REG STAT SYNTH; UNAIDS, 2013, REP GLOB AIDS EP; UNAIDS, 2014, THE GAP REP; UNAIDS (Joint United Nations Programme on HIV/AIDS), 2015, TREATM 2015; Vreeman RC, 2011, PRESENTED AT THE 3TH; WHO, 2011, WHOHIV1102	26	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124041	10.1371/journal.pone.0124041	http://dx.doi.org/10.1371/journal.pone.0124041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879446	gold, Green Submitted, Green Published			2022-12-26	WOS:000353016500080
J	Ramsay, DS; Al-Noori, S; Shao, JS; Leroux, BG; Woods, SC; Kaiyala, KJ				Ramsay, Douglas S.; Al-Noori, Salwa; Shao, Jason; Leroux, Brian G.; Woods, Stephen C.; Kaiyala, Karl J.			Predicting Addictive Vulnerability: Individual Differences in Initial Responding to a Drug's Pharmacological Effects	PLOS ONE			English	Article							NITROUS-OXIDE; SUBJECTIVE RESPONSE; ALCOHOL CHALLENGE; NUCLEUS-ACCUMBENS; GENERAL-THEORY; STRESS; TOLERANCE; LEVEL; HYPOTHERMIA; TRANSITION	Considerable data suggest that individuals who appear minimally disrupted during an initial drug administration have elevated risk for abusing the drug later. A better understanding of this association could lead to more effective strategies for preventing and treating drug addiction. To investigate this phenomenon using a rigorous experimental model, we first administered the abused inhalant nitrous oxide (N2O) to rats in a total calorimetry and temperature system to identify groups that were sensitive or insensitive to the drug's hypothermic effect. We then enrolled the two groups in a novel N2O self-administration paradigm. The initially insensitive rats self-administered significantly more N2O than sensitive rats, an important step in the transition to addiction. Continuous non-invasive measurement of core temperature and its underlying determinants during screening revealed that both groups had similarly increased heat loss during initial N2O administration, but that insensitive rats generated more heat and thereby remained relatively normothermic. Calorimetry testing conducted after self-administration revealed that whereas N2O's effect on heat loss persisted comparably for both groups, initially insensitive rats actually over-responded by generating excess heat and becoming hyperthermic. Thus, rats with the greatest initial heat-producing compensatory response(s) appeared initially insensitive to N2O-induced hypothermia, subsequently self-administered more N2O, and developed hyperthermic overcompensation during N2O inhalation, consistent with increased abuse potential and an allostatic model of addictive vulnerability.	[Ramsay, Douglas S.; Al-Noori, Salwa; Leroux, Brian G.; Kaiyala, Karl J.] Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Shao, Jason; Leroux, Brian G.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Cincinnati	Ramsay, DS (corresponding author), Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA.	ramsay@uw.edu	Leroux, Brian G/H-2254-2015		National Institute on Drug Abuse [R01DA023484]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023484] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grant #R01DA023484 (DSR) from the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 2003, STAT ANAL COMPOSITIO; Balster RL, 1998, DRUG ALCOHOL DEPEN, V51, P207, DOI 10.1016/S0376-8716(98)00078-7; Barrot M, 2000, EUR J NEUROSCI, V12, P973, DOI 10.1046/j.1460-9568.2000.00996.x; Belin D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011940; Blanchard MM, 2009, NEUROSCI BIOBEHAV R, V33, P1145, DOI 10.1016/j.neubiorev.2009.05.009; Crabbe JC, 2010, ADDICT BIOL, V15, P125, DOI 10.1111/j.1369-1600.2009.00191.x; de Wit H, 2012, NEUROSCI BIOBEHAV R, V36, P1565, DOI 10.1016/j.neubiorev.2012.04.005; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dworkin BR, 1993, LEARNING PHYSL REGUL; Grubman J, 1982, INT C SERIES, V620, P259; HAEFELY W, 1986, PHARMACOPSYCHIATRY, V19, P353, DOI 10.1055/s-2007-1025061; Kaiyala KJ, 2007, PSYCHOPHARMACOLOGY, V191, P243, DOI 10.1007/s00213-006-0657-z; Kaiyala KJ, 2007, PSYCHOPHARMACOLOGY, V191, P233, DOI 10.1007/s00213-006-0655-1; Kaiyala KJ, 2012, J THERM BIOL, V37, P30, DOI 10.1016/j.jtherbio.2011.10.004; Kaiyala KJ, 2011, COMP BIOCHEM PHYS A, V158, P252, DOI 10.1016/j.cbpa.2010.04.013; Kaiyala KJ, 2005, AM J PHYSIOL-REG I, V288, pR692, DOI 10.1152/ajpregu.00412.2004; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Pawlowsky-Glahn V, 2006, GEOL SOC SPEC PUBL, V264, P1, DOI 10.1144/GSL.SP.2006.264.01.01; Peters A, 2012, PHYSIOL BEHAV, V106, P1, DOI 10.1016/j.physbeh.2011.12.019; Piazza PV, 2014, PSYCHOPHARMACOLOGY, V231, P3929, DOI 10.1007/s00213-014-3628-9; Piazza PV, 2013, PSYCHOPHARMACOLOGY, V229, P387, DOI 10.1007/s00213-013-3224-4; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; Quinn PD, 2011, ALCOHOL CLIN EXP RES, V35, P1759, DOI 10.1111/j.1530-0277.2011.01521.x; Ramsay Douglas S, 2014, Temperature (Austin), V1, P157, DOI 10.4161/23328940.2014.982048; Ramsay DS, 2014, PSYCHOL REV, V121, P225, DOI 10.1037/a0035942; Ramsay DS, 2005, PSYCHOPHARMACOLOGY, V181, P48, DOI 10.1007/s00213-005-2219-1; Ramsay DS, 2003, PHARMACOL BIOCHEM BE, V74, P623, DOI 10.1016/S0091-3057(02)01048-1; Ramsay DS, 1997, PSYCHOL REV, V104, P170, DOI 10.1037/0033-295X.104.1.170; Ramsay DS, 2014, TEMPERATURE, V1, P162, DOI [10.1093/emph/eou030, DOI 10.1093/EMPH/E0U030]; Ramsay DS, 2014, TEMPERATURE, V1, P151, DOI [10.1182/asheducation-2014.1.151, DOI 10.1182/ASHEDUCATION-2014.1.151]; Rouge-Pont F, 1998, EUR J NEUROSCI, V10, P3903, DOI 10.1046/j.1460-9568.1998.00438.x; Schilling K, 2012, J NEUROSCI, V32, P12651, DOI 10.1523/JNEUROSCI.1452-12.2012; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; SCHUCKIT MA, 1980, J STUD ALCOHOL, V41, P242, DOI 10.15288/jsa.1980.41.242; SCHUCKIT MA, 1988, ARCH GEN PSYCHIAT, V45, P211; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schuckit MA, 2011, ALCOHOL CLIN EXP RES, V35, P1723, DOI 10.1111/j.1530-0277.2011.01561.x; Schuckit MA, 2009, J SUBST ABUSE TREAT, V36, pS5, DOI 10.1016/j.jsat.2008.05.012; Siegel S, 2000, EXP CLIN PSYCHOPHARM, V8, P276, DOI 10.1037/1064-1297.8.3.276; Trudell J.R., 1985, NITROUS OXIDE N2O, P203; van den Boogaart K, 2013, ANAL COMPOSITIONAL D; Walker DJ, 2002, DRUG ALCOHOL DEPEN, V66, P93, DOI 10.1016/S0376-8716(01)00188-0; WOOD RW, 1977, J PHARMACOL EXP THER, V202, P491	48	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124740	10.1371/journal.pone.0124740	http://dx.doi.org/10.1371/journal.pone.0124740			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880426	gold, Green Published, Green Submitted			2022-12-26	WOS:000353016500109
J	Wang, SX; Zhai, X; Li, SY; McCabe, MF; Wang, X; Rong, PJ				Wang, Shuxing; Zhai, Xu; Li, Shaoyuan; McCabe, Michael F.; Wang, Xing; Rong, Peijing			Transcutaneous Vagus Nerve Stimulation Induces Tidal Melatonin Secretion and Has an Antidiabetic Effect in Zucker Fatty Rats	PLOS ONE			English	Article							FAR-FIELD POTENTIALS; BRAIN-STEM; HALF-LIFE; CELLS; RECEPTORS; INSULIN; MOUSE; OBESITY; PLASMA	Melatonin plays a protective role in type 2 diabetes (T2D) through regulation of glucose metabolism. Whether transcutaneous vagus nerve stimulation (taVNS) is antidiabetic and whether a modulated melatonin production is involved in the antidiabetic mechanism of taVNS is unknown. In this study, once daily 30min noninvasive taVNS was administered in Zucker diabetic fatty (ZDF, fa/fa) and Zucker lean (ZL, +/fa) littermates under anesthesia for 5 consecutive weeks. The acute and chronic influences of taVNS on the secretion of melatonin were studied as well as the effects of taVNS on blood glucose metabolism. We found that naive ZDF rats develop hyperglycemia naturally with age. Each taVNS session would trigger a tidal secretion of melatonin both during and after the taVNS procedure and induce an acute two-phase glycemic change, a steep increase followed by a gradual decrease. Once daily taVNS sessions eventually reduced the glucose concentration to a normal level in seven days and effectively maintained the normal glycemic and plasma glycosylated hemoglobin (HbA(lc)) levels when applied for five consecutive weeks. These beneficial effects of taVNS also exist in pinealectomized rats, which otherwise would show overt and continuous hyperglycemia, hyperinsulinemia, and high HbA(lc) levels. We concluded that multiple taVNS sessions are antidiabetic in T2D through triggering of tidal secretion of melatonin. This finding may have potential importance in developing new approaches to the treatment of T2D, which is highly prevalent, incurable with any current approaches, and very costly to the world.	[Wang, Shuxing; Wang, Xing] Xinxiang Med Univ, Dept Anat, Xinxiang, Henan Province, Peoples R China; [Wang, Shuxing; Zhai, Xu; Li, Shaoyuan; Rong, Peijing] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China; [Wang, Shuxing; McCabe, Michael F.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Ctr Translat Pain Res,Dept Anesthesia Crit Ca, Boston, MA USA; [Wang, Shuxing] Guangdong Landau Biotechnol Inc Ltd, Guangzhou, Guangdong, Peoples R China	Xinxiang Medical University; China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wang, SX (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	shuxingw@yahoo.com; rongpj@hotmail.com			National Natural Science Foundation of China [81271243, 81473780]; Natural Science Foundation of Beijing [7111007]; National Basic Research Program of China (973 Program) [2012CB518503];  [2012BAF14B10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); National Basic Research Program of China (973 Program)(National Basic Research Program of China); 	This work was supported by National Natural Science Foundation of China-81271243, 81473780; Natural Science Foundation of Beijing, 7111007; National Basic Research Program of China (973 Program) -2012CB518503; and Project Supported National Science and Technology Ministry-2012BAF14B10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr I, 2011, J PINEAL RES, V50, P336, DOI 10.1111/j.1600-079X.2010.00848.x; Belivani M, 2013, ACUPUNCT MED, V31, P88, DOI 10.1136/acupmed-2012-010247; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Conti A, 2000, J PINEAL RES, V28, P193, DOI 10.1034/j.1600-079X.2000.280401.x; Contreras-Alcantara S, 2010, OBESITY, V18, P1861, DOI 10.1038/oby.2010.24; Dantzer R, 2000, AUTON NEUROSCI-BASIC, V85, P60, DOI 10.1016/S1566-0702(00)00220-4; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Fallgatter AJ, 2005, INT J PSYCHOPHYSIOL, V56, P37, DOI 10.1016/j.ijpsycho.2004.09.007; Fallgatter AJ, 2003, J NEURAL TRANSM, V110, P1437, DOI 10.1007/s00702-003-0087-6; Frese T, 2009, LIFE SCI, V85, P526, DOI 10.1016/j.lfs.2009.08.004; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Gerdin MJ, 2004, BIOCHEM PHARMACOL, V67, P2023, DOI 10.1016/j.bcp.2004.01.027; GIBBS FP, 1981, ENDOCRINOLOGY, V109, P1796, DOI 10.1210/endo-109-5-1796; Kniaz'kin I V, 2008, Adv Gerontol, V21, P80; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Li SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111100; Liu RP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789674; Maganhin CC, 2009, ACTA CIR BRAS, V24, P321, DOI 10.1590/S0102-86502009000400013; MATTHEWS DR, 1985, CLIN ENDOCRINOL, V23, P71, DOI 10.1111/j.1365-2265.1985.tb00185.x; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Muhlbauer E, 2012, J PINEAL RES, V52, P446, DOI 10.1111/j.1600-079X.2012.00959.x; Nagorny CLF, 2011, J PINEAL RES, V50, P412, DOI 10.1111/j.1600-079X.2011.00859.x; Nogueira TC, 2011, ENDOCRINOLOGY, V152, P1253, DOI 10.1210/en.2010-1088; Oleson T, 2002, NEUROREHABILITATION, V17, P49; OZAKI Y, 1976, ENDOCRINOLOGY, V99, P641, DOI 10.1210/endo-99-2-641; Peplow PV, 2012, J ACUPUNCT MERIDIAN, V5, P1, DOI 10.1016/j.jams.2011.11.018; Peschke E, 2007, J PINEAL RES, V42, P350, DOI 10.1111/j.1600-079X.2007.00426.x; Rong PJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-255; Round R., 2013, EVID-BASED COMPL ALT, V2013, P984763, DOI DOI 10.1155/2013/984763; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Stumpf I, 2009, J PINEAL RES, V46, P140, DOI 10.1111/j.1600-079X.2008.00638.x; Vinik AI, 2011, DIABETIC MED, V28, P643, DOI 10.1111/j.1464-5491.2010.03184.x; WURTMAN RJ, 1978, J NEURAL TRANSM, P59	34	22	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124195	10.1371/journal.pone.0124195	http://dx.doi.org/10.1371/journal.pone.0124195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880500	Green Published, Green Submitted, gold			2022-12-26	WOS:000353016500089
J	Zhang, Q; Zhou, W; Liang, GQ; Wang, XB; Sun, JW; He, P; Li, LJ				Zhang, Qian; Zhou, Wei; Liang, Guoqing; Wang, Xiubin; Sun, Jingwen; He, Ping; Li, Lujiu			Effects of Different Organic Manures on the Biochemical and Microbial Characteristics of Albic Paddy Soil in a Short-Term Experiment	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; ENZYME-ACTIVITY; AGRICULTURAL MANAGEMENT; INORGANIC FERTILIZERS; CARBON; NITROGEN; DIVERSITY; BIOMASS; DECOMPOSITION; AMENDMENTS	This study aimed to evaluate the effects of chemical fertilizer (NPK), NPK with livestock manure (NPK+M), NPK with straw (NPK+S), and NPK with green manure (NPK+G) on soil enzyme activities and microbial characteristics of albic paddy soil, which is a typical soil with low productivity in China. The responses of extracellular enzyme activities and the microbial community diversity (determined by phospholipid fatty acid analysis [PLFA] and denaturing gradient gel electrophoresis [DGGE]) were measured. The results showed that NPK+M and NPK+S significantly increased rice yield, with NPK+M being approximately 24% greater than NPK. The NPK+M significantly increased soil organic carbon (SOC) and available phosphate (P) and enhanced phosphatase, beta-cellobiosidase, L-leucine aminopeptidase and urease activities. The NPK+S significantly increased SOC and available potassium (K) and significantly enhanced N-acetyl-glucosamidase, beta-xylosidase, urease, and phenol oxidase activities. The NPK+G significantly improved total nitrogen (N), ammonium N, available P, and N-acetyl-glucosamidase activity. The PLFA biomass was highest under NPK+S, followed by NPK+M and NPK+G treatments. Principal component analysis (PCA) of the PLFA indicated that soils with NPK+M and NPK+S contained higher proportions of unsaturated and cyclopropane fatty acids (biomarkers of fungi and gram-negative bacteria) and soil under NPK+G contained more straight chain saturated fatty acids (representing gram-positive bacteria). PCA of the DGGE patterns showed that organic amendments had a greater influence on fungal community. Cluster analysis of fungal DGGE patterns revealed that NPK+G was clearly separated. Meanwhile, the bacterial community of NPK+M treatment was the most distinct. RDA analysis revealed changes of microbial community composition mostly depended on beta-xylosidase, beta-cellobiosidase activities, total N and available K contents. The abundances of gram-negative bacterial and fungal PLFAs probably effective in improving fertility of low-yield albic paddy soil because of their significant influence on DGGE profile.	[Zhang, Qian; Zhou, Wei; Liang, Guoqing; Wang, Xiubin; Sun, Jingwen; He, Ping] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Plant Nutr & Fertilizat, Beijing 100193, Peoples R China; [Li, Lujiu] Anhui Acad Agr Sci, Inst Soil & Fertilizer, Hefei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Anhui Academy of Agricultural Sciences	Zhou, W (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Plant Nutr & Fertilizat, Beijing 100193, Peoples R China.	wzhou@caas.ac.cn; gqliang@caas.ac.cn	Zhang, Kevin/F-5215-2010; He, Ping/HGD-5389-2022		earmarked fund for China Agriculture Research System [CARS-01-31]; National Basic Research Program of China [2013CB127405]; National Natural Science Foundation of China [31471943]; Special Fund for Agro-scientific Research in the Public Interest [201003016]	earmarked fund for China Agriculture Research System; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This research was supported by the earmarked fund for China Agriculture Research System (CARS-01-31), the National Basic Research Program of China (2013CB127405), the National Natural Science Foundation of China (Grant no. 31471943), and the Special Fund for Agro-scientific Research in the Public Interest (201003016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C, 2015, BIOL FERT SOILS, V51, P465, DOI 10.1007/s00374-015-0994-3; Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P3245, DOI 10.1016/j.soilbio.2006.04.011; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Anderson TH, 2003, AGR ECOSYST ENVIRON, V98, P285, DOI 10.1016/S0167-8809(03)00088-4; Barzegar AR, 2002, PLANT SOIL, V247, P295, DOI 10.1023/A:1021561628045; Bending GD, 2004, SOIL BIOL BIOCHEM, V36, P1785, DOI 10.1016/j.soilbio.2004.04.035; Bohme L, 2006, EUR J SOIL BIOL, V42, P1, DOI 10.1016/j.ejsobi.2005.08.001; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; BOWEN RM, 1990, SOIL BIOL BIOCHEM, V22, P393, DOI 10.1016/0038-0717(90)90118-J; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Buyer JS, 2010, SOIL BIOL BIOCHEM, V42, P831, DOI 10.1016/j.soilbio.2010.01.020; Caliz J, 2011, FEMS MICROBIOL ECOL, V78, P150, DOI 10.1111/j.1574-6941.2011.01093.x; CHRISTENSEN BT, 1986, SOIL BIOL BIOCHEM, V18, P523, DOI 10.1016/0038-0717(86)90010-6; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Dai ZhiGang, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P272; de Vries FT, 2006, SOIL BIOL BIOCHEM, V38, P2092, DOI 10.1016/j.soilbio.2006.01.008; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Deng SP, 2006, APPL SOIL ECOL, V33, P258, DOI 10.1016/j.apsoil.2005.10.004; Dinesh R, 2010, BIORESOURCE TECHNOL, V101, P4697, DOI 10.1016/j.biortech.2010.01.108; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Esperschutz J, 2009, SOIL BIOL BIOCHEM, V41, P1976, DOI 10.1016/j.soilbio.2009.07.002; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Gil-Sotres F, 2005, SOIL BIOL BIOCHEM, V37, P877, DOI 10.1016/j.soilbio.2004.10.003; Green CT, 2000, HYDROGEOL J, V8, P126, DOI 10.1007/s100400050013; Hao XH, 2008, NUTR CYCL AGROECOSYS, V81, P17, DOI 10.1007/s10705-007-9145-z; Helgason BL, 2010, APPL SOIL ECOL, V46, P390, DOI 10.1016/j.apsoil.2010.10.002; Hill GT, 2000, APPL SOIL ECOL, V15, P25, DOI 10.1016/S0929-1393(00)00069-X; Horwath W.R., 1996, METHODS SOIL ANAL PA, P753; Huang QR, 2009, PEDOSPHERE, V19, P727, DOI 10.1016/S1002-0160(09)60168-5; Jin G, 2007, J ENVIRON SCI HEAL A, V42, P1639, DOI 10.1080/10934520701518125; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; KENNEDY AC, 1995, PLANT SOIL, V170, P75, DOI 10.1007/BF02183056; Kimura M, 2006, BIOL FERT SOILS, V43, P20, DOI 10.1007/s00374-005-0057-2; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Larkin RP, 2006, BIOL FERT SOILS, V43, P51, DOI 10.1007/s00374-005-0060-7; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li FengYu, 2009, Plant Nutrition and Fertilizer Science, V15, P374; Ling N, 2014, BIOL FERT SOILS, V50, P901, DOI 10.1007/s00374-014-0911-1; Liu MQ, 2009, APPL SOIL ECOL, V42, P166, DOI 10.1016/j.apsoil.2009.03.006; Lu RK, 2000, AGR SCI TECHNOLOGY; Mandal A, 2007, BIORESOURCE TECHNOL, V98, P3585, DOI 10.1016/j.biortech.2006.11.027; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Mele PM, 2008, AGR ECOSYST ENVIRON, V126, P139, DOI 10.1016/j.agee.2007.12.008; Moeskops B, 2012, PEDOBIOLOGIA, V55, P175, DOI 10.1016/j.pedobi.2012.03.001; Moeskops B, 2010, APPL SOIL ECOL, V45, P112, DOI 10.1016/j.apsoil.2010.03.005; Muyzer G, 1999, CURR OPIN MICROBIOL, V2, P317, DOI 10.1016/S1369-5274(99)80055-1; Nakatsu CH, 2000, SOIL SCI SOC AM J, V64, P1382, DOI 10.2136/sssaj2000.6441382x; Nannipieri P, 2012, BIOL FERT SOILS, V48, P743, DOI 10.1007/s00374-012-0723-0; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Nelson P. N., 1998, SODIC SOILS DISTRIBU, P51; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; Potthoff M, 2001, SOIL BIOL BIOCHEM, V33, P583, DOI 10.1016/S0038-0717(00)00200-5; Rajendran N, 1997, MAR POLLUT BULL, V34, P26, DOI 10.1016/S0025-326X(96)00057-4; Ramesh P, 2006, INDIAN J AGR SCI, V76, P252; Rashid MI, 2013, SOIL BIOL BIOCHEM, V57, P320, DOI 10.1016/j.soilbio.2012.10.005; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Stark C, 2007, APPL SOIL ECOL, V35, P79, DOI 10.1016/j.apsoil.2006.05.001; Stark CH, 2008, SOIL BIOL BIOCHEM, V40, P1352, DOI 10.1016/j.soilbio.2007.09.025; Gil SV, 2011, EUR J SOIL BIOL, V47, P55, DOI 10.1016/j.ejsobi.2010.11.006; Wang QL, 2008, GEODERMA, V144, P502, DOI 10.1016/j.geoderma.2008.01.003; Wittmann C, 2004, SOIL BIOL BIOCHEM, V36, P425, DOI 10.1016/j.soilbio.2003.10.019; Wu YP, 2009, GEODERMA, V150, P171, DOI 10.1016/j.geoderma.2009.02.003; Yao H, 2000, MICROB ECOL, V40, P223; [于群英 Yu Qunying], 2004, [安徽农业科学, Journal of anhui agricultural sciences], V32, P1161; Zhao JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085054, 10.1371/journal.pone.0108005]; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001; Zhong WH, 2007, PEDOSPHERE, V17, P419, DOI 10.1016/S1002-0160(07)60051-4; Zhong WH, 2010, PLANT SOIL, V326, P511, DOI 10.1007/s11104-009-9988-y	76	39	41	7	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124096	10.1371/journal.pone.0124096	http://dx.doi.org/10.1371/journal.pone.0124096			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879759	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500083
J	Morlais, I; Nsango, SE; Toussile, W; Abate, L; Annan, Z; Tchioffo, MT; Cohuet, A; Awono-Ambene, PH; Fontenille, D; Rousset, F; Berry, A				Morlais, Isabelle; Nsango, Sandrine E.; Toussile, Wilson; Abate, Luc; Annan, Zeinab; Tchioffo, Majoline T.; Cohuet, Anna; Awono-Ambene, Parfait H.; Fontenille, Didier; Rousset, Francois; Berry, Antoine			Plasmodium falciparum Mating Patterns and Mosquito Infectivity of Natural Isolates of Gametocytes	PLOS ONE			English	Article							DIVERSE MALARIA INFECTIONS; POPULATION-STRUCTURE; TRANSMISSION; PARASITES; COMPETITION; ANOPHELES; VIRULENCE; EVOLUTION; DYNAMICS; CAMEROON	Plasmodium falciparum infections in malaria endemic areas often harbor multiple clones of parasites. However, the transmission success of the different genotypes within the mosquito vector has remained elusive so far. The genetic diversity of malaria parasites was measured by using microsatellite markers in gametocyte isolates from 125 asymptomatic carriers. For a subset of 49 carriers, the dynamics of co-infecting genotypes was followed until their development within salivary glands. Also, individual oocysts from midguts infected with blood from 9 donors were genotyped to assess mating patterns. Multiplicity of infection (MOI) was high both in gametocyte isolates and sporozoite populations, reaching up to 10 genotypes. Gametocyte isolates with multiple genotypes gave rise to lower infection prevalence and intensity. Fluctuations of genotype number occurred during the development within the mosquito and sub-patent genotypes, not detected in gametocyte isolates, were identified in the vector salivary glands. The inbreeding coefficient Fis was positively correlated to the oocyst loads, suggesting that P. falciparum parasites use different reproductive strategies according to the genotypes present in the gametocyte isolate. The number of parasite clones within an infection affects the transmission success and the mosquito has an important role in maintaining P. falciparum genetic diversity. Our results emphasize the crucial importance of discriminating between the different genotypes within an infection when studying the A. gambiae natural resistance to P. falciparum, and the need to monitor parasite diversity in areas where malaria control interventions are implemented.	[Morlais, Isabelle; Nsango, Sandrine E.; Awono-Ambene, Parfait H.] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Morlais, Isabelle; Nsango, Sandrine E.; Abate, Luc; Annan, Zeinab; Tchioffo, Majoline T.; Cohuet, Anna; Fontenille, Didier] Inst Rech Dev, Montpellier, France; [Nsango, Sandrine E.] Fac Med & Sci Pharmaceut, Douala, Cameroon; [Toussile, Wilson] Univ Paris 11, Villejuif, France; [Rousset, Francois] Inst Sci Evolut, Montpellier, France; [Berry, Antoine] Ctr Hosp Univ Toulouse, Toulouse, France; [Berry, Antoine] Ctr Physiopathol Toulouse Purpan, Toulouse, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Morlais, I (corresponding author), Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon.	isabelle.morlais@ird.fr	Rousset, Francois/GRJ-3980-2022; Cohuet, Anna/B-2745-2017; Berry, Antoine/J-9352-2014; Morlais, Isabelle/F-5078-2014; Rousset, Francois/C-7360-2008; TSAPI, Majoline TCHIOFFO/S-3007-2019; Morlais, Isabelle/Q-2171-2019	Rousset, Francois/0000-0003-4670-0371; Cohuet, Anna/0000-0002-1876-5656; Morlais, Isabelle/0000-0002-2962-7670; Rousset, Francois/0000-0003-4670-0371; TSAPI, Majoline TCHIOFFO/0000-0001-9517-3665; Morlais, Isabelle/0000-0002-2962-7670; FONTENILLE, didier/0000-0002-0544-3885; abate, luc/0000-0003-3973-3036; Berry, Antoine/0000-0002-6626-7766	Institut de Recherche pour le Developpement; Institut de Medecine et d'Epidemiologie Appliquee [IMEA-AO-07]; Agence Nationale de la Recherche [ANR-11-BSV7-009-01]; European Union Seventh Framework Programme [GA242095-EviMalaR]	Institut de Recherche pour le Developpement; Institut de Medecine et d'Epidemiologie Appliquee; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union Seventh Framework Programme(European Commission)	This work was supported by the Institut de Recherche pour le Developpement (scholarships awarded to SEN and WT), the Institut de Medecine et d'Epidemiologie Appliquee (IMEA-AO-07 to AB), the Agence Nationale de la Recherche (ANR-11-BSV7-009-01 to IM), and the European Union Seventh Framework Programme (GA242095-EviMalaR to DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 2000, GENET RES, V75, P285, DOI 10.1017/S0016672300004481; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; Arez AP, 2003, AM J TROP MED HYG, V68, P161, DOI 10.4269/ajtmh.2003.68.2.0680161; Babiker HA, 2008, TRENDS PARASITOL, V24, P525, DOI 10.1016/j.pt.2008.08.001; Boissiere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054820; Boissiere A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002742; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; Bousema T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042821; Campino S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020251; Choisy M, 2010, AM NAT, V175, pE105, DOI 10.1086/651587; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harris C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030849; Hastings IM, 2006, PARASITOLOGY, V132, P615, DOI 10.1017/S0031182005009790; Lefevre T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003365; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Molina-Cruz A, 2012, PROC NATL ACAD SCI U; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Mzilahowa T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000613; NEI M, 1978, GENETICS, V89, P583; Nkhoma SC, 2012, P BIOL SCI; Nsango SE, 2012, INT J PARASITOL, V42, P589, DOI 10.1016/j.ijpara.2012.03.008; Nwakanma D, 2008, INT J PARASITOL, V38, P219, DOI 10.1016/j.ijpara.2007.07.003; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Razakandrainibe FG, 2005, P NATL ACAD SCI USA, V102, P17388, DOI 10.1073/pnas.0508871102; Reece SE, 2008, NATURE, V453, P609, DOI 10.1038/nature06954; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; Skaug H, 2012, GLMMADMB GENERALIZED; Team RDC, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Wampfler R, 2014, J INFECT DIS, V210, P1188, DOI 10.1093/infdis/jiu236; Wargo AR, 2007, P ROY SOC B-BIOL SCI, V274, P2629, DOI 10.1098/rspb.2007.0873; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	42	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123777	10.1371/journal.pone.0123777	http://dx.doi.org/10.1371/journal.pone.0123777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875840	Green Published, Green Submitted, gold			2022-12-26	WOS:000353014700043
J	Fan, LC; Yang, MZ; Han, WY				Fan, Li-Chao; Yang, Ming-Zhen; Han, Wen-Yan			Soil Respiration under Different Land Uses in Eastern China	PLOS ONE			English	Article							CO2 EFFLUX; TEMPERATURE SENSITIVITY; TROPICAL FOREST; ORGANIC-MATTER; LOESS PLATEAU; WATER-CONTENT; CARBON; RESPONSES; VEGETATION; DYNAMICS	Land-use change has a crucial influence on soil respiration, which further affects soil nutrient availability and carbon stock. We monitored soil respiration rates under different land-use types (tea gardens with three production levels, adjacent woodland, and a vegetable field) in Eastern China at weekly intervals over a year using the dynamic closed chamber method. The relationship between soil respiration and environmental factors was also evaluated. The soil respiration rate exhibited a remarkable single peak that was highest in July/August and lowest in January. The annual cumulative respiration flux increased by 25.6% and 20.9% in the tea garden with high production (HP) and the vegetable field (VF), respectively, relative to woodland (WL). However, no significant differences were observed between tea gardens with medium production (MP), low production (LP), WL, and VF. Soil respiration rates were significantly and positively correlated with organic carbon, total nitrogen, and available phosphorous content. Each site displayed a significant exponential relationship between soil respiration and soil temperature measured at 5 cm depth, which explained 84-98% of the variation in soil respiration. The model with a combination of soil temperature and moisture was better at predicting the temporal variation of soil respiration rate than the single temperature model for all sites. Q(10) was 2.40, 2.00, and 1.86-1.98 for VF, WL, and tea gardens, respectively, indicating that converting WL to VF increased and converting to tea gardens decreased the sensitivity of soil respiration to temperature. The equation of the multiple linear regression showed that identical factors, including soil organic carbon (SOC), soil water content (SWC), pH, and water soluble aluminum (WSAl), drove the changes in soil respiration and Q(10) after conversion of land use. Temporal variations of soil respiration were mainly controlled by soil temperature, whereas spatial variations were influenced by SOC, SWC, pH, and WSAl.	[Fan, Li-Chao; Yang, Ming-Zhen; Han, Wen-Yan] Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China; [Fan, Li-Chao] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Graduate School, CAAS	Han, WY (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China.	hanwy@mail.tricaas.com	fan, lichao/J-6206-2019	fan, lichao/0000-0003-1349-3134	National Natural Science Foundation of China [41171218]; Innovation Project of the Chinese Academy of Agricultural Sciences; Key Innovation Team of Tea Industry in Zhejiang Province [2011R50024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of the Chinese Academy of Agricultural Sciences; Key Innovation Team of Tea Industry in Zhejiang Province	This work was supported by the National Natural Science Foundation of China (project No. 41171218), the Innovation Project of the Chinese Academy of Agricultural Sciences, and the Key Innovation Team of Tea Industry in Zhejiang Province (2011R50024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Bahn M, 2010, NEW PHYTOL, V186, P292, DOI 10.1111/j.1469-8137.2010.03237.x; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Bossio DA, 2005, MICROB ECOL, V49, P50, DOI 10.1007/s00248-003-0209-6; Brito P, 2013, ACTA OECOL, V48, P1, DOI 10.1016/j.actao.2013.01.006; Cable JM, 2009, PLANT SOIL, V320, P153, DOI 10.1007/s11104-008-9880-1; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cui Xiaoyong, 2000, Yingyong Shengtai Xuebao, V11, P390; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Deng Q, 2013, ECOL ENG, V61, P65, DOI 10.1016/j.ecoleng.2013.09.063; Devine S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084988; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; [范利超 Fan Lichao], 2014, [土壤通报, Chinese Journal of Soil Science], V45, P1383; Fenn KM, 2010, SOIL BIOL BIOCHEM, V42, P1685, DOI 10.1016/j.soilbio.2010.05.028; Foti S, 2014, GEODERMA, V213, P245, DOI 10.1016/j.geoderma.2013.08.009; Han GX, 2007, PLANT SOIL, V291, P15, DOI 10.1007/s11104-006-9170-8; Han GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091182; Han WY, 2012, SOIL SCI PLANT NUTR, V58, P173, DOI 10.1080/00380768.2012.664783; Han WY, 2007, SOIL BIOL BIOCHEM, V39, P1468, DOI 10.1016/j.soilbio.2006.12.029; Jia B, 2006, J ARID ENVIRON, V67, P60, DOI 10.1016/j.jaridenv.2006.02.002; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lai LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077659; Lai LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048011; Leff JW, 2012, GLOBAL CHANGE BIOL, V18, P2969, DOI 10.1111/j.1365-2486.2012.02749.x; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Liu J, 2011, FOREST ECOL MANAG, V262, P1131, DOI 10.1016/j.foreco.2011.06.015; McGuire AD, 1992, GLOBAL BIOGEOCHEM CY, V6, P101, DOI 10.1029/92GB00219; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Motavalli PP, 2000, AGR ECOSYST ENVIRON, V79, P17, DOI 10.1016/S0167-8809(99)00139-5; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; Pang XY, 2013, AGR FOREST METEOROL, V171, P57, DOI 10.1016/j.agrformet.2012.12.001; Qi Y, 2002, ECOL MODEL, V153, P131, DOI 10.1016/S0304-3800(01)00506-3; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; REINKE JJ, 1981, SOIL SCI SOC AM J, V45, P620, DOI 10.2136/sssaj1981.03615995004500030036x; Ross DJ, 1999, SOIL BIOL BIOCHEM, V31, P803, DOI 10.1016/S0038-0717(98)00180-1; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Shi WY, 2012, SOIL BIOL BIOCHEM, V52, P99, DOI 10.1016/j.soilbio.2012.04.020; Sotta ED, 2004, GLOBAL CHANGE BIOL, V10, P601, DOI 10.1111/j.1529-8817.2003.00761.x; Tian SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073450; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Tufekcioglu A, 2001, PLANT SOIL, V229, P117, DOI 10.1023/A:1004818422908; Wang ChunYan, 2013, Acta Pedologica Sinica, V50, P974; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071986; Wang XW, 2010, J ENVIRON SCI-CHINA, V22, P1057, DOI 10.1016/S1001-0742(09)60217-5; [王小国 WANG XiaoGuo], 2007, [生态学报, Acta Ecologica Sinica], V27, P1960; Xiaojun Nie, 2013, PLoS One, V8, pe64059, DOI 10.1371/journal.pone.0064059; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028397; Zhang T, 2013, ATMOS ENVIRON, V77, P856, DOI 10.1016/j.atmosenv.2013.06.011; Zhou WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092531; Zhou ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081793; Zhou ZY, 2013, SOIL BIOL BIOCHEM, V57, P135, DOI 10.1016/j.soilbio.2012.08.010; Zhu LQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088900	55	17	18	8	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124198	10.1371/journal.pone.0124198	http://dx.doi.org/10.1371/journal.pone.0124198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875998	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100245
J	Gandji, LY; Proust, R; Larue, L; Gesbert, F				Gandji, Leslie Yewakon; Proust, Richard; Larue, Lionel; Gesbert, Franck			The Tyrosine Phosphatase SHP2 Associates with CUB Domain-Containing Protein-1 (CDCP1), Regulating Its Expression at the Cell Surface in a Phosphorylation-Dependent Manner	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FOCAL ADHESION KINASE; PKC-DELTA; SRC; IDENTIFICATION; SUBSTRATE; SPECIFICITY; RECOGNITION; ACTIVATION; SURVIVAL	CUB domain-containing protein-1 (CDCP1) is a transmembrane glycoprotein that is phosphorylated by SRC family kinases (SFK) before recruiting and activating PKC delta. CDCP1 is overproduced in many cancers. It promotes metastasis and resistance to anoikis. The robust production of CDCP1 would be associated with stemness and has been proposed as a novel prognosis marker. The natural transmembrane location of CDCP1 makes it an ideal therapeutic target and treatments based on the use of appropriate antibodies are currently being evaluated. However, we still know very little about the molecular fate of CDCP1 and its downstream signaling events. Improvements in our understanding of the molecular events occurring downstream of CDCP1 are required to make use of changes of CDCP1 production or functions for therapeutic purposes. By the mean of co-immunoprecipitation and affinity precipitation we show here, for the first time, that CDCP1 interacts directly, with the cytosolic tyrosine phosphatase SHP2. Point mutants of CDCP1 show that residues Y734 and Y743 are responsible for its interaction with SHP2. It may therefore compete with SFK. We also demonstrate that a shRNA-mediated down regulation of SHP2 is associated with a stronger CDCP1 phosphorylation and an impairment of antibody-mediated CDCP1 internalization.	[Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] Inst Curie, Normal & Pathol Dev Melanocytes, F-91405 Orsay, France; [Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] Univ Paris 11, Orsay, France; [Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] CNRS, UMR3347, F-91405 Orsay, France; [Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] Univ Paris 11, INSERM, U1021, F-91405 Orsay, France; [Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] Equipe Labellisee Ligue Natl Canc, Orsay, France; [Proust, Richard] Hop Paul Brousse, INSERM, UMR S972, Villejuif, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gesbert, F (corresponding author), Inst Curie, Normal & Pathol Dev Melanocytes, F-91405 Orsay, France.	franck.gesbert@u-psud.fr	Larue, Lionel/I-6532-2016	Gesbert, Franck/0000-0002-5800-8385	Ministere de l'Education Nationale et de l'Enseignement Superieur Ph.D. fellowship; Ligue Nationale Contre le Cancer (Equipe labellisee); Institut National du Cancer (INCa); Pair Melanome	Ministere de l'Education Nationale et de l'Enseignement Superieur Ph.D. fellowship; Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Pair Melanome	LG was supported by a Ministere de l'Education Nationale et de l'Enseignement Superieur Ph.D. fellowship. This work was supported by the Ligue Nationale Contre le Cancer (Equipe labellisee), Institut National du Cancer (INCa) and Pair Melanome (LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; CASE RD, 1994, J BIOL CHEM, V269, P10467; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Conze T, 2003, ANN NY ACAD SCI, V996, P222, DOI 10.1111/j.1749-6632.2003.tb03249.x; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Gesbert F, 1998, J BIOL CHEM, V273, P18273, DOI 10.1074/jbc.273.29.18273; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Hara K, 2011, CANCER RES, V71, P1229, DOI 10.1158/0008-5472.CAN-10-3431; Hartman ZR, 2013, MOL CANCER RES, V11, P651, DOI 10.1158/1541-7786.MCR-12-0578; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Jo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091582; Kollmorgen G, 2013, MOL ONCOL, V7, P1142, DOI 10.1016/j.molonc.2013.08.009; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Spassov DS, 2012, ONCOGENE, V31, P419, DOI 10.1038/onc.2011.246; Spassov DS, 2013, CANCER RES, V73, P1168, DOI 10.1158/0008-5472.CAN-12-2496; Spassov DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019154; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; ZHOU GC, 1994, J BIOL CHEM, V269, P28084; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123472	10.1371/journal.pone.0123472	http://dx.doi.org/10.1371/journal.pone.0123472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876044	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100180
J	Ishikawa, T; Kobayashi, M; Yanagi, S; Kato, C; Takashima, R; Kobayashi, E; Hagiwara, K; Ochiya, T				Ishikawa, Tetsuya; Kobayashi, Momoko; Yanagi, Satoshi; Kato, Chika; Takashima, Ryokichi; Kobayashi, Eiji; Hagiwara, Keitaro; Ochiya, Takahiro			Human Induced Hepatic Lineage-Oriented Stem Cells: Autonomous Specification of Human iPS Cells toward Hepatocyte-Like Cells without Any Exogenous Differentiation Factors	PLOS ONE			English	Article							LONG-TERM CULTURE; GENERATION; EFFICIENT; EXPRESSION; INDUCTION; MOUSE; LIVER; EXPANSION	Preparing targeted cells for medical applications from human induced pluripotent stem cells (hiPSCs) using growth factors, compounds, or gene transfer has been challenging. Here, we report that human induced hepatic lineage-oriented stem cells (hiHSCs) were generated and expanded as a new type of hiPSC under non-typical coculture with feeder cells in a chemically defined hiPSC medium at a very high density. Self-renewing hiHSCs expressed markers of both human embryonic stem cells (hESCs) and hepatocytes. Those cells were highly expandable, markedly enhancing gene expression of serum hepatic proteins and cytochrome P450 enzymes with the omission of FGF-2 from an undefined hiPSC medium. The hepatic specification of hiHSCs was not attributable to the genetic and epigenetic backgrounds of the starting cells, as they were established from distinct donors and different types of cells. Approximately 90% of hiHSCs autonomously differentiated to hepatocyte-like cells, even in a defined minimum medium without any of the exogenous growth factors necessary for hepatic specification. After 12 days of this culture, the differentiated cells significantly enhanced gene expression of serum hepatic proteins (ALB, SERPINA1, TTR, TF, FABP1, FGG, AGT, RBP4, and AHSG), conjugating enzymes (UGT2B4, UGT2B7, UGT2B10, GSTA2, and GSTA5), transporters (SULT2A1, SLC13A5, and SLCO2B1), and urea cycle-related enzymes (ARG1 and CPS1). In addition, the hepatocyte-like cells performed key functions of urea synthesis, albumin secretion, glycogen storage, indocyanine green uptake, and low-density lipoprotein uptake. The autonomous hepatic specification of hiHSCs was due to their culture conditions (coculture with feeder cells in a defined hiPSC medium at a very high density) in self-renewal rather than in differentiation. These results suggest the feasibility of preparing large quantities of hepatocytes as a convenient and inexpensive hiPSC differentiation. Our study also suggests the necessity of optimizing culture conditions to generate other specific lineage-oriented hiPSCs, allowing for a very simple differentiation.	[Ishikawa, Tetsuya; Kobayashi, Momoko] Natl Canc Ctr, Res Inst, Chuo Ku, Core Facil Res & Innovat Med, Tokyo 104, Japan; [Yanagi, Satoshi; Kato, Chika; Takashima, Ryokichi; Kobayashi, Eiji] Takara Bio Inc, Otsu, Shiga, Japan; [Hagiwara, Keitaro; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Chuo Ku, Div Mol & Cellular Med, Tokyo 104, Japan	National Cancer Center - Japan; Takara Bio Inc.; National Cancer Center - Japan	Ishikawa, T (corresponding author), Natl Canc Ctr, Res Inst, Chuo Ku, Core Facil Res & Innovat Med, Tokyo 104, Japan.	teishika@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019		Ministry of Health, Labor, and Welfare of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Takara Bio, Inc.	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Takara Bio, Inc.	T.O. was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan. T.I. was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Takara Bio, Inc., provided support in the form of salaries for authors SY, CK, RT, and EK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Baxter M, 2015, J HEPATOL, V62, P581, DOI 10.1016/j.jhep.2014.10.016; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237; Gerbal-Chaloin S, 2014, AM J PATHOL, V184, P332, DOI 10.1016/j.ajpath.2013.09.026; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098; Ishikawa T, 2012, METHODS MOL BIOL, V826, P103, DOI 10.1007/978-1-61779-468-1_9; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Lubberstedt M, 2011, J PHARMACOL TOX MET, V63, P59, DOI 10.1016/j.vascn.2010.04.013; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Matsunaga T, 2012, DRUG METAB PHARMACOK, V27, P653, DOI 10.2133/dmpk.DMPK-12-NT-018; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohnuki Mari, 2009, Curr Protoc Stem Cell Biol, VChapter 4, DOI 10.1002/9780470151808.sc04a02s9; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; STOCKERT RJ, 1983, HEPATOLOGY, V3, P750; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama K, 2013, STEM CELL REP, V1, P322, DOI 10.1016/j.stemcr.2013.08.006; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vosough M, 2013, STEM CELLS DEV, V22, P2693, DOI 10.1089/scd.2013.0088; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yamazoe T, 2013, J CELL SCI, V126, P5391, DOI 10.1242/jcs.129767; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123193	10.1371/journal.pone.0123193	http://dx.doi.org/10.1371/journal.pone.0123193			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875613	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100148
J	Ruan, RQ; Zou, LL; Sun, SJ; Liu, J; Wen, LP; Gao, DY; Ding, WP				Ruan, Renquan; Zou, Lili; Sun, Sijie; Liu, Jing; Wen, Longping; Gao, Dayong; Ding, Weiping			Cell Blebbing upon Addition of Cryoprotectants: A Self-Protection Mechanism	PLOS ONE			English	Article							AUTOPHAGY; STRESS; BLEBS; 33258-HOECHST; ACTIVATION; APOPTOSIS; MIGRATION; POLARITY; SHAPE	In this work, the mechanism of cell bleb formation upon the addition of cryoprotectants (CPAs) was investigated, and the role of cell blebs in protecting cells was determined. The results show that after adding CPAs, the hyperosmotic stress results in the breakage of the cortical cytoskeleton and the detachment of the cell membrane from the cortical cytoskeleton, causing the formation of cell blebs. Multiple blebs decrease the intracellular hydrostatic pressure induced by the extracellular hyperosmotic shock and alleviate the osmotic damage to cells, which reduces the cell mortality rate. In the presence of a low concentration of CPAs, cell blebs can effectively protect cells. In contrast, in the presence of a high concentration of CPAs, the protective effect is limited because of severe disruption in the cortical cytoskeleton. To determine the relationship between blebs and the mortality rate of cells, we defined a bleb index and found that the bleb index of 0.065 can be regarded as a reference value for the safe addition of DMSO to HeLa cells. The bleb index can also explain why the stepwise addition of CPAs is better than the single-step addition of CPAs. Moreover, the mechanism of the autophagy of cells induced by the hyperosmotic stress was studied, and the protective effect associated with the autophagy was compared with the effect of the blebbing. The findings reported here elucidate a self-protection mechanism of cells experiencing the hyperosmotic stress in the presence of CPAs, and they provide significant evidence for cell tolerance in the field of cryopreservation.	[Ruan, Renquan; Zou, Lili; Liu, Jing; Ding, Weiping] Univ Sci & Technol China, Ctr Biomed Engn, Hefei 230027, Anhui, Peoples R China; [Ruan, Renquan; Zou, Lili; Liu, Jing; Ding, Weiping] Univ Sci & Technol China, Dept Elect Sci & Technol, Hefei 230027, Anhui, Peoples R China; [Sun, Sijie] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wen, Longping] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Gao, Dayong] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Washington; University of Washington Seattle	Ding, WP (corresponding author), Univ Sci & Technol China, Ctr Biomed Engn, Hefei 230027, Anhui, Peoples R China.	wpdings@ustc.edu.cn	Ding, Weiping/K-5292-2012	Ding, Weiping/0000-0002-3331-1011; Wen, Longping/0000-0003-0384-4578	Fundamental Research Funds for the Central Universities of China [WK2100000001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20133402120033]; Natural Science Foundation of Anhui Province [1408085ME96]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This work was supported by the Fundamental Research Funds for the Central Universities of China (WK2100000001), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20133402120033), and the Natural Science Foundation of Anhui Province (1408085ME96). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cooper RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033528; Copp J, 2005, AM J PHYSIOL-CELL PH, V288, pC403, DOI 10.1152/ajpcell.00095.2004; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Fedier A, 1997, CELL MOTIL CYTOSKEL, V37, P326; Fessard V., 1994, Natural Toxins, V2, P322, DOI 10.1002/nt.2620020512; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Guan N, 2012, CRYOBIOLOGY, V65, P179, DOI 10.1016/j.cryobiol.2012.05.011; Guthe HJT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031332; Heo YS, 2011, LAB CHIP, V11, P3530, DOI 10.1039/c1lc20377k; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hotamisligil S, 1996, BIOL REPROD, V55, P161, DOI 10.1095/biolreprod55.1.161; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lai KP, 2013, INT J BIOCHEM CELL B, V45, P1921, DOI 10.1016/j.biocel.2013.05.023; LATT SA, 1975, J HISTOCHEM CYTOCHEM, V23, P493, DOI 10.1177/23.7.1095650; LATT SA, 1976, J HISTOCHEM CYTOCHEM, V24, P24, DOI 10.1177/24.1.943439; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; McFarland AJ, 2012, ARCH TOXICOL, V86, P275, DOI 10.1007/s00204-011-0755-5; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6; Mills JC, 1999, J CELL BIOL, V146, P703, DOI 10.1083/jcb.146.4.703; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Nunes P, 2013, AUTOPHAGY, V9, P550, DOI 10.4161/auto.23662; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sam R, 2012, AM J NEPHROL, V36, P97, DOI 10.1159/000339625; Sharma P, 2013, INTEGR BIOL-UK, V5, P1036, DOI 10.1039/c3ib40073e; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; Song YS, 2009, LAB CHIP, V9, P1874, DOI 10.1039/b823062e; Spangler EJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051906; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Wei PF, 2014, BIOMATERIALS, V35, P899, DOI 10.1016/j.biomaterials.2013.10.024; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	46	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125746	10.1371/journal.pone.0125746	http://dx.doi.org/10.1371/journal.pone.0125746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875076	gold, Green Submitted, Green Published			2022-12-26	WOS:000352845100301
J	Wei, HX; Chiba, S; Moriwaki, C; Kitamura, H; Ina, K; Aosa, T; Tomonari, K; Gotoh, K; Masaki, T; Katsuragi, I; Noguchi, H; Kakuma, T; Hamaguchi, K; Shimada, T; Fujikura, Y; Shibata, H				Wei, Huixing; Chiba, Seiichi; Moriwaki, Chinatsu; Kitamura, Hirokazu; Ina, Keisuke; Aosa, Taishi; Tomonari, Kenichiro; Gotoh, Koro; Masaki, Takayuki; Katsuragi, Isao; Noguchi, Hitoshi; Kakuma, Tetsuya; Hamaguchi, Kazuyuki; Shimada, Tatsuo; Fujikura, Yoshihisa; Shibata, Hirotaka			A Clinical Approach to Brown Adipose Tissue in the Para-Aortic Area of the Human Thorax	PLOS ONE			English	Article							UNCOUPLING PROTEIN-1; F-18-FDG UPTAKE; FAT; MUSCLE; ADIPOCYTES; EXPRESSION; OBESITY; MOUSE; PET	Background Human thoracic brown adipose tissue (BAT), composed of several subdivisions, is a well-known target organ of many clinical studies; however, the functional contribution of each part of human thoracic BAT remains unknown. The present study analyzed the significance of each part of human thoracic BAT in the association between regional distribution, cellularity, and factors involved in the functional regulation of thoracic BAT. Methods We analyzed 1550 healthy adults who underwent medical check-ups by positron-emission tomography and computed tomography (PET-CT) imaging, 8 cadavers, and 78 autopsy cases in an observational study. We first characterized the difference between the mediastinum and the supraclavicular areas using counts of BAT detection and conditions based on PET-CT outcomes. The measurable important area was then subjected to systematic anatomical and immunohistochemical analyses using anti-uncoupling protein 1 (UCP1) antibody to characterize the cellularity in association with age and sex. Results In PET-CT scanning, the main site of thoracic BAT was the mediastinum rather than the supraclavicular area (P < 0.05). Systemic macroanatomy revealed that the thumb-sized BAT in the posterior mediastinal descending para-aortic area (paBAT) had feeding vessels from the posterior intercostal arteries and veins and sympathetic/parasympathetic innervation from trunks of the sympathetic and vagus nerves, respectively. Immunohistochemical analysis indicated that the paBAT exhibited immunoreactivity for tyrosine hydroxylase and vesicular acetylcholine transporter located in the pericellular nervous fibers and intracellular UCP1. The brown adipose cells of paBAT showed age-dependent decreases in UCP1 expression (P < 0.05), accompanied by a significant increase in vacuole formation, indicating fat accumulation (P < 0.05), from 10 to 37 years of age (P < 0.01). Conclusions paBAT may be one of the essential sites for clinical application in BAT study because of its visible anatomy with feeding vessels and sympathetic/parasympathetic innervation functionally affected by outer condition and senescence.	[Wei, Huixing; Moriwaki, Chinatsu; Gotoh, Koro; Masaki, Takayuki; Katsuragi, Isao; Kakuma, Tetsuya; Shibata, Hirotaka] Oita Univ, Fac Med, Dept Endocrinol Metab Rheumatol & Nephrol, Yufu, Oita, Japan; [Wei, Huixing; Chiba, Seiichi; Moriwaki, Chinatsu; Kitamura, Hirokazu; Ina, Keisuke; Aosa, Taishi; Fujikura, Yoshihisa] Oita Univ, Fac Med, Dept Mol Anat, Yufu, Oita, Japan; [Tomonari, Kenichiro] Shonin Hosp, Oita Diagnost Imaging Ctr, Bepu, Oita, Japan; [Noguchi, Hitoshi] Noguchi Thyroid Clin & Hosp Fdn, Bepu, Oita, Japan; [Hamaguchi, Kazuyuki; Shimada, Tatsuo] Oita Univ, Sch Nursing, Fac Med, Yufu, Oita, Japan	Oita University; Oita University; Oita University	Chiba, S (corresponding author), Oita Univ, Fac Med, Dept Mol Anat, 1-1 Idaigaoka Hasama, Yufu, Oita, Japan.	schiba@oita-u.ac.jp		Masaki, Takayuki/0000-0002-2378-849X	Health and Labour Sciences Research Grants of Research on Measures for Intractable Diseases of Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [25461397] Funding Source: KAKEN	Health and Labour Sciences Research Grants of Research on Measures for Intractable Diseases of Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Health and Labour Sciences Research Grants of Research on Measures for Intractable Diseases of Ministry of Health, Labour and Welfare, Japan. The researchers were financed independently from the funding organisations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chang L, 2012, CIRCULATION, V126, P1067, DOI 10.1161/CIRCULATIONAHA.112.104489; Cheung L, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.6; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Fitzgibbons TP, 2011, AM J PHYSIOL-HEART C, V301, pH1425, DOI 10.1152/ajpheart.00376.2011; Giordano A, 2004, J HISTOCHEM CYTOCHEM, V52, P923, DOI 10.1369/jhc.3A6246.2004; Hashimoto Y, 2006, J NUCL MED, V47, P426; HEATON JM, 1972, J ANAT, V112, P35; HORKA J, 1990, Folia Morphologica (Prague), V38, P38; Jarmuszkiewicz W, 2010, BBA-BIOENERGETICS, V1797, P792, DOI 10.1016/j.bbabio.2009.12.005; Jastroch M, 2008, PHYSIOL GENOMICS, V32, P161, DOI 10.1152/physiolgenomics.00183.2007; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; KORTELAINEN ML, 1993, J HISTOCHEM CYTOCHEM, V41, P759, DOI 10.1177/41.5.8468458; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Manieri M, 2010, NUTR METAB CARDIOVAS, V20, P567, DOI 10.1016/j.numecd.2009.04.020; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Perkins AC, 2013, NUCL MED COMMUN, V34, P168, DOI 10.1097/MNM.0b013e32835bbbf0; Police SB, 2009, ARTERIOSCL THROM VAS, V29, P1458, DOI 10.1161/ATVBAHA.109.192658; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rossmeisl M, 2002, EUR J BIOCHEM, V269, P19, DOI 10.1046/j.0014-2956.2002.02627.x; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092608; Tam CS, 2012, CIRCULATION, V125, P2782, DOI 10.1161/CIRCULATIONAHA.111.042929; TANUMA Y, 1975, ARCH HISTOL JAPON, V38, P43, DOI 10.1679/aohc1950.38.43; Truong MT, 2004, AM J ROENTGENOL, V183, P1127, DOI 10.2214/ajr.183.4.1831127; Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006; Vijgen GHEJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077221; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yeung HWD, 2003, J NUCL MED, V44, P1789; Yoneshiro T, 2015, ANN MED, V47, P133, DOI 10.3109/07853890.2014.911595; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	43	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122594	10.1371/journal.pone.0122594	http://dx.doi.org/10.1371/journal.pone.0122594			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875082	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100085
J	Xiao, D; Wu, KJ; Tan, X; Le, J; Li, HT; Yan, YP; Xu, ZK				Xiao, Dan; Wu, Kejian; Tan, Xin; Le, Jing; Li, Haitao; Yan, Yongping; Xu, Zhikai			Modeling and Predicting Hemorrhagic Fever with Renal Syndrome Trends Based on Meteorological Factors in Hu County, China	PLOS ONE			English	Article							HANTAVIRUS INFECTIONS; RISK-FACTORS; TRANSMISSION; VARIABILITY; EPIDEMIC	Background Hu County is a serious hemorrhagic fever with renal syndrome (HFRS) epidemic area, with notable fluctuation of the HFRS epidemic in recent years. This study aimed to explore the optimal model for HFRS epidemic prediction in Hu. Methods Three models were constructed and compared, including a generalized linear model (GLM), a generalized additive model (GAM), and a principal components regression model (PCRM). The fitting and predictive adjusted R-2 of each model were calculated. Ljung-Box Q tests for fitted and predicted residuals of each model were conducted. The study period was stratified into before (1971-1993) and after (1994-2012) vaccine implementation epochs to avoid the confounding factor of vaccination. Results The autocorrelation of fitted and predicted residuals of the GAM in the two epochs were not significant (Ljung-Box Q test, P>. 05). The adjusted R-2 for the predictive abilities of the GLM, GAM, and PCRM were 0.752, 0.799, and 0.665 in the early epoch, and 0.669, 0.756, and 0.574 in the recent epoch. The adjusted R-2 values of the three models were lower in the early epoch than in the recent epoch. Conclusions GAM is superior to GLM and PCRM for monthly HFRS case number prediction in Hu County. A shift in model reliability coincident with vaccination implementation demonstrates the importance of vaccination in HFRS control and prevention.	[Xiao, Dan; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China; [Wu, Kejian; Li, Haitao] Fourth Mil Med Univ, Sch Biomed & Engn, Dept Math & Phys, Xian 710032, Peoples R China; [Tan, Xin] Hu Cty Ctr Dis Control & Prevent, Xian, Peoples R China; [Le, Jing] Hu Cty Meteorol Bur, Xian, Peoples R China; [Xu, Zhikai] Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yan, YP (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China.	yanyping@fmmu.edu.cn; zhikaixu@fmmu.edu.cn	Yan, Yongping/K-9634-2019		China Postdoctoral Science Foundation [2012M512104, 2014T07967]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by two foundations: China Postdoctoral Science Foundation (No: 2012M512104 and No: 2014T07967). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Erbas B, 2005, INT J ENVIRON HEAL R, V15, P437, DOI 10.1080/09603120500289192; Gunnes N, 2013, EPIDEMIOLOGY, V24, P906, DOI 10.1097/01.ede.0000434435.52506.f5; Han SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-347; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hu W, 2007, EPIDEMIOL INFECT, V135, P245, DOI 10.1017/S0950268806006649; Huang Li-Yong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P685; Knoblauch K, 2008, J VISION, V8, DOI 10.1167/8.16.10; Li CP, 2013, AM J TROP MED HYG, V89, P1006, DOI 10.4269/ajtmh.12-0473; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Lin HL, 2014, INT J BIOMETEOROL, V58, P1031, DOI 10.1007/s00484-013-0688-1; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Ministry of Health of China, 2012, CHIN HLTH STAT YB; Sargianou M, 2012, CRIT REV MICROBIOL, V38, P317, DOI 10.3109/1040841X.2012.673553; Tan X, 2012, CHIN J VECTOR BIOL C, V23, P573; The central people's government of the people's republic of China website, NAT KIDN SYNDR HEM F; Viel JF, 2011, EPIDEMIOL INFECT, V139, P867, DOI 10.1017/S0950268810002062; Wang De-zheng, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P478; Wang L, 2010, FOREIGN MED SCI SECT, V31, P216; Wanka ER, 2014, INT J BIOMETEOROL, V58, P249, DOI 10.1007/s00484-013-0730-3; Watson DC, 2014, CRIT REV MICROBIOL, V40, P261, DOI 10.3109/1040841X.2013.783555; Xiao D, 2014, VACCINE, V32, P740, DOI 10.1016/j.vaccine.2013.11.024; Xiao H, 2013, EPIDEMIOL INFECT, V141, P1867, DOI 10.1017/S0950268812002555; Xiao H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002260; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470	27	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123166	10.1371/journal.pone.0123166	http://dx.doi.org/10.1371/journal.pone.0123166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875211	Green Published, gold, Green Submitted			2022-12-26	WOS:000352845100145
J	Venderbosch, S; van Lent-van Vliet, S; de Haan, AFJ; Ligtenberg, MJ; Goossens, M; Punt, CJA; Koopman, M; Nagtegaal, ID				Venderbosch, Sabine; van Lent-van Vliet, Shannon; de Haan, Anton F. J.; Ligtenberg, Marjolijn J.; Goossens, Monique; Punt, Cornelis J. A.; Koopman, Miriam; Nagtegaal, Iris D.			EMAST Is Associated with a Poor Prognosis in Microsatellite Instable Metastatic Colorectal Cancer	PLOS ONE			English	Article							TETRANUCLEOTIDE REPEATS; COLON-CANCER; MUTATOR PHENOTYPE; HMLH1 PROMOTER; INSTABILITY; REPAIR; MUTATIONS; CARCINOMA; CELLS; HMSH6	Purpose To determine the frequency and prognostic value of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in metastatic colorectal cancer (mCRC) patients in relation to microsatellite instability (MSI) status and MSH3 protein expression. Material and Methods The frequency of EMAST was evaluated in mCRC patients with MSI tumors and microsatellite stable (MSS) tumors. A literature overview was performed to compare the frequency of EMAST in our study with existing data. Immunohistochemistry for MSH3 was compared with EMAST status. Outcome was studied in terms of overall survival (OS) of mCRC patients with MSI and MSS tumors. Results EMAST was evaluated in 89 patients with MSI tumors (including 39 patients with Lynch syndrome) and 94 patients with MSS tumors. EMAST was observed in 45.9% (84 out of 183) of patients, with an increased frequency in MSI tumors (79.8% versus 13.8%, p < 0.001). We found no correlation between EMAST and MSH3 protein expression. There was no effect of EMAST on prognosis in patients with MSS tumors, but patients with MSI/non-EMAST tumors had a significantly better prognosis than patients with MSI/EMAST tumors (OS: HR 3.22, 95% CI 1.25-8.30). Conclusion Frequency of EMAST was increased in mCRC patients with MSI tumors, compared to MSS tumors. Our data suggest that the presence of EMAST correlates with worse OS in these patients. There was no effect of EMAST on the prognosis of patients with MSS tumors. A limitation of our study is the small number of patients in our subgroup analysis.	[Venderbosch, Sabine; van Lent-van Vliet, Shannon; Ligtenberg, Marjolijn J.; Goossens, Monique; Nagtegaal, Iris D.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [de Haan, Anton F. J.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6500 HB Nijmegen, Netherlands; [Venderbosch, Sabine; Punt, Cornelis J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1100 DD Amsterdam, Netherlands; [Ligtenberg, Marjolijn J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Koopman, Miriam] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 GA Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Nagtegaal, ID (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pathol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Iris.Nagtegaal@radboudumc.nl	Nagtegaal, Iris D/A-2448-2014; de Haan, Antonius F J/L-4344-2015; Ligtenberg, Marjolijn/N-9666-2013	Nagtegaal, Iris D/0000-0003-0887-4127; Ligtenberg, Marjolijn/0000-0003-1290-1474	Dutch Colorectal Cancer Group (DCCG)	Dutch Colorectal Cancer Group (DCCG)	This study was supported by a grant from the Dutch Colorectal Cancer Group (DCCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Ahrendt SA, 2000, CANCER RES, V60, P2488; Baranovskaya S, 2001, P NATL ACAD SCI USA, V98, P15107, DOI 10.1073/pnas.251234498; Burger M, 2006, J MOL MED, V84, P833, DOI 10.1007/s00109-006-0074-0; Campregher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050541; Chang DK, 2000, J BIOL CHEM, V275, P29178; Choi YD, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-88; Cunningham JM, 1998, CANCER RES, V58, P3455; Danaee H, 2002, ONCOGENE, V21, P4894, DOI 10.1038/sj.onc.1205619; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Garcia M, 2012, GASTROENTEROLOGY, V143, P48, DOI 10.1053/j.gastro.2012.03.034; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Heideman DAM, 2012, J MOL DIAGN, V14, P247, DOI 10.1016/j.jmoldx.2012.01.011; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 2006, WORLD J GASTROENTERO, V12, P4943, DOI 10.3748/wjg.v12.i31.4943; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Kane MF, 1997, CANCER RES, V57, P808; Klarskov L, 2011, AM J SURG PATHOL, V35, P1391, DOI 10.1097/PAS.0b013e318225c3f0; Koopman M, 2009, BRIT J CANCER, V100, P266, DOI 10.1038/sj.bjc.6604867; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Lee SY, 2012, DIGEST DIS SCI, V57, P72, DOI 10.1007/s10620-011-1825-5; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Ohmiya N, 2001, GENE, V272, P301, DOI 10.1016/S0378-1119(01)00517-0; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; Samowitz WS, 2008, EXP MOL PATHOL, V85, P64, DOI 10.1016/j.yexmp.2008.03.008; Samowitz WS, 2001, AM J PATHOL, V158, P1517, DOI 10.1016/S0002-9440(10)64102-8; Singer G, 2004, INT J CANCER, V112, P643, DOI 10.1002/ijc.20455; Slebos RJC, 2002, CANCER RES, V62, P6052; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tseng-Rogenski SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050616; Xu LH, 2001, INT J CANCER, V91, P200, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1031>3.0.CO;2-0; Yamada K, 2010, ONCOL REP, V23, P551, DOI 10.3892/or_00000669	39	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124538	10.1371/journal.pone.0124538	http://dx.doi.org/10.1371/journal.pone.0124538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884216	Green Published, gold, Green Submitted			2022-12-26	WOS:000353017000136
J	Dhondt, AA; Dhondt, KV; Hochachka, WM				Dhondt, Andre A.; Dhondt, Keila V.; Hochachka, Wesley M.			Response of Black-Capped Chickadees to House Finch Mycoplasma gallisepticum	PLOS ONE			English	Article							CARPODACUS-MEXICANUS; EXPERIMENTAL-INFECTION; WILDLIFE DISEASE; NORTH-AMERICA; CONJUNCTIVITIS; SONGBIRDS; DYNAMICS; BIRDS	Tests for the presence of pathogen DNA or antibodies are routinely used to survey for current or past infections. In diseases that emerge following a host jump estimates of infection rate might be under-or overestimated. We here examine whether observed rates of infection are biased for a non-focal host species in a model system. The bacterium Mycoplasma gallisepticum is a widespread pathogen in house finches (Haemorhous mexicanus), a fringillid finch, but an unknown proportion of individuals of other songbird species are also infected. Our goal is to determine the extent to which detection of M. gallisepticum DNA or antibodies against the bacteria in a non-fringillid bird species is over-or underestimated using black-capped chickadees Poecile atricapillus, a species in which antibodies against M. gallisepticum are frequently detected in free-living individuals. After keeping black-capped chickadees in captivity for 12 weeks, during which period the birds remained negative for M. gallisepticum, four were inoculated with M. gallisepticum and four were sham inoculated in both eyes to serve as negative controls. Simultaneously we inoculated six house finches with the same isolate of M. gallisepticum as a positive control. All inoculated birds of both species developed infections detectable by qPCR in the conjunctiva. For the 6 weeks following inoculation we detected antibodies in all M. gallisepticum-inoculated house finches but in only three of the four M. gallisepticum-inoculated black-capped chickadees. All house finches developed severe eye lesions but none of the black-capped chickadees did. Modeling the Rapid Plate Agglutination test results of black-capped chickadees shows that the rate of false-positive tests would be not more than 3.2%, while the estimated rate of false negatives is 55%. We conclude that the proportion of wild-caught individuals in which we detect M. gallisepticum-specific antibodies using Rapid Plate Agglutination is, if anything, substantially underestimated.	[Dhondt, Andre A.; Hochachka, Wesley M.] Cornell Univ, Ornithol Lab, Bird Populat Studies, Ithaca, NY 14850 USA; [Dhondt, Keila V.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14850 USA	Cornell University; Cornell University	Dhondt, AA (corresponding author), Cornell Univ, Ornithol Lab, Bird Populat Studies, Ithaca, NY 14850 USA.	aad4@cornell.edu	Hochachka, Wesley M./J-9768-2012	Hochachka, Wesley M./0000-0002-0595-7827; Dhondt, Andre/0000-0002-4946-1401	National Institutes of Health [R01GM085232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085232, R01GM105245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health Grant #R01GM085232 to Dana M. Hawley as part of the joint NIH-NSF-USDA Ecology and Evolution of Infectious Diseases program.	Dhondt AA, 1998, J WILDLIFE DIS, V34, P265, DOI 10.7589/0090-3558-34.2.265; Dhondt AA, 2007, AVIAN PATHOL, V36, P205, DOI 10.1080/03079450701286277; Dhondt AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103553; Dhondt AA, 2012, J ANIM ECOL, V81, P996, DOI 10.1111/j.1365-2656.2012.01986.x; Dhondt AA, 2008, AVIAN PATHOL, V37, P635, DOI 10.1080/03079450802499100; Farmer KL, 2005, J WILDLIFE DIS, V41, P317, DOI 10.7589/0090-3558-41.2.317; Feberwee A, 2005, AVIAN DIS, V49, P260, DOI 10.1637/7274-090804R; Fischer JR, 1997, EMERG INFECT DIS, V3, P69, DOI 10.3201/eid0301.970110; Grodio JL, 2008, AVIAN PATHOL, V37, P385, DOI 10.1080/03079450802216629; Hartup BK, 2000, J WILDLIFE DIS, V36, P257, DOI 10.7589/0090-3558-36.2.257; Hartup BK, 2001, J WILDLIFE DIS, V37, P72, DOI 10.7589/0090-3558-37.1.72; Hawley DM, 2010, J EVOLUTION BIOL, V23, P1680, DOI 10.1111/j.1420-9101.2010.02035.x; Hawley DM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001570; Hawley DM, 2011, AVIAN PATHOL, V40, P321, DOI 10.1080/03079457.2011.571660; Hill GE, 2005, NATURWISSENSCHAFTEN, V92, P30, DOI 10.1007/s00114-004-0582-0; Hochachka WM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1068; Kleven SH, 2008, LAB MANUAL ISOLATION; Kollias GV, 2004, J WILDLIFE DIS, V40, P79, DOI 10.7589/0090-3558-40.1.79; Ley DH, 1996, AVIAN DIS, V40, P480, DOI 10.2307/1592250; Luttrell MP, 2001, AVIAN DIS, V45, P321, DOI 10.2307/1592971; Luttrell MP, 1996, AVIAN DIS, V40, P335, DOI 10.2307/1592229; Mikaelian I, 2001, J WILDLIFE DIS, V37, P826, DOI 10.7589/0090-3558-37.4.826; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Sydenstricker KV, 2005, J WILDLIFE DIS, V41, P326, DOI 10.7589/0090-3558-41.2.326	24	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124820	10.1371/journal.pone.0124820	http://dx.doi.org/10.1371/journal.pone.0124820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880849	Green Submitted, gold, Green Published			2022-12-26	WOS:000353016500113
J	Harris, JW; Cowper-Smith, CD; Klein, RM; Westwood, DA				Harris, Jonathan W.; Cowper-Smith, Christopher D.; Klein, Raymond M.; Westwood, David A.			Further Evidence against a Momentum Explanation for IOR	PLOS ONE			English	Article							ATTENTIONAL MOMENTUM; RETURN; INHIBITION	Reaction times to targets presented in the same location as a preceding cue are greater than those to targets presented opposite the cued location. This observation can be explained as a result of inhibition at the attended location (IOR), or as facilitation at the location opposite the cue (opposite facilitation effect or OFE). Past research has demonstrated that IOR is observed reliably, whereas OFE is observed only occasionally. The present series of four experiments allows us to determine whether or not OFE can be explained by eye movements as suggested by previous authors. Participants' eye movements were monitored as they were presented with an array of four placeholders aligned with the four cardinal axes. Exogenous cues and targets were presented successively. Participants (N=37) completed either: i.) cue-manual and cue-saccade experiments, ignoring the cue and then responding with a keypress or saccade, respectively, or ii.) manual-manual and saccade-saccade experiments, responding to both the cue and the target with a keypress or saccade respectively. Results demonstrated a reliable IOR effect in each of the four experiments (reaction time greater for same versus adjacent and opposite cue-target trials). None of the four experiments demonstrated evidence of an OFE (reaction times were not significantly lower for opposite versus adjacent cue-target trials). These results are inconsistent with a momentum-based account of cue-target task performance, and furthermore suggest that the OFE cannot be attributed to occasional eye movements to the cue and/or target in previous studies.	[Harris, Jonathan W.; Westwood, David A.] Dalhousie Univ, Fac Hlth Profess, Div Kinesiol, Sch Hlth & Human Performance, Halifax, NS, Canada; [Cowper-Smith, Christopher D.; Klein, Raymond M.] Dalhousie Univ, Fac Sci, Dept Psychol & Neurosci, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Harris, JW (corresponding author), Dalhousie Univ, Fac Hlth Profess, Sch Occupat Therapy, Halifax, NS, Canada.	David.Westwood@dal.ca		Westwood, David/0000-0003-3317-0447	Natural Sciences and Engineering Research Council (Canada) Discovery Grant [250235]	Natural Sciences and Engineering Research Council (Canada) Discovery Grant	DAW: Natural Sciences and Engineering Research Council (Canada) Discovery Grant 250235 (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeois A, 2013, CORTEX, V49, P2229, DOI 10.1016/j.cortex.2012.10.017; Machado L, 2004, Q J EXP PSYCHOL-A, V57, P789, DOI 10.1080/02724980343000486; MAYLOR EA, 1985, J EXP PSYCHOL HUMAN, V11, P777, DOI 10.1037/0096-1523.11.6.777; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Pratt J, 1999, J EXP PSYCHOL HUMAN, V25, P730, DOI 10.1037/0096-1523.25.3.730; Snyder JJ, 2009, J EXP PSYCHOL HUMAN, V35, P1726, DOI 10.1037/a0016885; Snyder JJ, 2001, J EXP PSYCHOL HUMAN, V27, P1420, DOI 10.1037//0096-1523.27.6.1420; Spalek TM, 2004, PERCEPT PSYCHOPHYS, V66, P219, DOI 10.3758/BF03194874	9	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123666	10.1371/journal.pone.0123666	http://dx.doi.org/10.1371/journal.pone.0123666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881269	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500058
J	Maggioli, MF; Palmer, MV; Thacker, TC; Vordermeier, HM; Waters, WR				Maggioli, Mayara F.; Palmer, Mitchell V.; Thacker, Tyler C.; Vordermeier, H. Martin; Waters, W. Ray			Characterization of Effector and Memory T Cell Subsets in the Immune Response to Bovine Tuberculosis in Cattle	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; GAMMA-INTERFERON; HISTORICAL PERSPECTIVES; BCG; PROTECTION; INFECTION; VACCINES; VACCINATION; EXPRESSION; MIGRATION	Cultured IFN-gamma ELISPOT assays are primarily a measure of central memory T cell (Tcm) responses with humans; however, this important subset of lymphocytes is poorly characterized in cattle. Vaccine-elicited cultured IFN-gamma ELISPOT responses correlate with protection against bovine tuberculosis in cattle. However, whether this assay measures cattle Tcm responses or not is uncertain. The objective of the present study was to characterize the relative contribution of Tcm (CCR7(+), CD62L(hi), CD45RO(+)), T effector memory (Tem, defined as: CCR7(-), CD62L(low/int), CD45RO(+)), and T effector cells (CCR7(-), CD62L(-/low), CD45RO(-)), in the immune response to Mycobacterium bovis. Peripheral blood mononuclear cells (PBMC) from infected cattle were stimulated with a cocktail of M. bovis purified protein derivative, rTb10.4 and rAg85A for 13 days with periodic addition of fresh media and rIL-2. On day 13, cultured PBMC were re-stimulated with medium alone, rESAT-6:CFP10 or PPDb with fresh autologous adherent cells for antigen presentation. Cultured cells (13 days) or fresh PBMCs (ex vivo response) from the same calves were analyzed for IFN-gamma production, proliferation, and CD4, CD45RO, CD62L, CD44, and CCR7 expression via flow cytometry after overnight stimulation. In response to mycobacterial antigens, similar to 75% of CD4(+) IFN-gamma(+) cells in long-term cultures expressed a Tcm phenotype while less than 10% of the ex vivo response consisted of Tcm cells. Upon re-exposure to antigen, long-term cultured cells were highly proliferative, a distinctive characteristic of Tcm, and the predominant phenotype within the long-term cultures switched from Tcm to Tem. These findings suggest that proliferative responses of Tcm cells to some extent occurs simultaneously with reversion to effector phenotypes (mostly Tem). The present study characterizes Tcm cells of cattle and their participation in the response to M. bovis infection.	[Maggioli, Mayara F.; Palmer, Mitchell V.; Thacker, Tyler C.; Waters, W. Ray] Natl Anim Dis Ctr, Infect Bacterial Dis Livestock Res Unit, Ames, IA 50010 USA; [Maggioli, Mayara F.] Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA USA; [Vordermeier, H. Martin] Anim Hlth & Vet Labs Agcy Weybridge, TB Res Grp, Addlestone, Surrey, England	United States Department of Agriculture (USDA); Iowa State University; Veterinary Laboratories Agency	Maggioli, MF (corresponding author), Natl Anim Dis Ctr, Infect Bacterial Dis Livestock Res Unit, Ames, IA 50010 USA.	mayaramaggioli@gmail.com	Palmer, Mitchell/R-7091-2018; Vordermeier, H Martin/C-6936-2011	Palmer, Mitchell/0000-0002-5902-3333; 				Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Baaten BJG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00023; Baaten BJG, 2010, IMMUNITY, V32, P104, DOI 10.1016/j.immuni.2009.10.011; Bass KE, 2013, CLIN VACCINE IMMUNOL, V20, P1827, DOI 10.1128/CVI.00519-13; Beaulieu AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015120; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Bold TD, 2009, CELL, V136, P17, DOI 10.1016/j.cell.2008.12.032; Caccamo N, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P313; Calarota SA, 2008, J IMMUNOL, V180, P5907, DOI 10.4049/jimmunol.180.9.5907; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dailey MO, 1998, CRIT REV IMMUNOL, V18, P153, DOI 10.1615/CritRevImmunol.v18.i3.10; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Dean G, 2014, VACCINE, V32, P1304, DOI 10.1016/j.vaccine.2013.11.045; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Hogg AE, 2009, VACCINE, V27, P270, DOI 10.1016/j.vaccine.2008.10.053; Houlihan MG, 2008, VET REC, V163, P357, DOI 10.1136/vr.163.12.357; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kovjazin R, 2013, CLIN VACCINE IMMUNOL, V20, P328, DOI 10.1128/CVI.00586-12; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; MacHugh ND, 1997, IMMUNOLOGY, V92, P340, DOI 10.1046/j.1365-2567.1997.00350.x; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Maue AC, 2005, INFECT IMMUN, V73, P6659, DOI 10.1128/IAI.73.10.6659-6667.2005; Millington KA, 2010, J INFECT DIS, V202, P1685, DOI 10.1086/656772; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Rhodes SG, 2014, CLIN VACCINE IMMUNOL, V21, P39, DOI 10.1128/CVI.00522-13; Rodriguez-Campos S, 2014, RES VET SCI, V97, pS5, DOI 10.1016/j.rvsc.2014.02.009; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Thom ML, 2012, CLIN VACCINE IMMUNOL, V19, P1254, DOI 10.1128/CVI.00301-12; Todryk SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002027; Todryk SM, 2009, IMMUNOLOGY, V128, P83, DOI 10.1111/j.1365-2567.2009.03073.x; Torrado E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002196; Totte P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057509; Totte P, 2010, CLIN VACCINE IMMUNOL, V17, P1211, DOI 10.1128/CVI.00132-10; Totte P, 2010, DEV COMP IMMUNOL, V34, P177, DOI 10.1016/j.dci.2009.09.005; Van Pittius NCG, 2001, GENOME BIOL, V2; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2004, IMMUNOLOGY, V112, P461, DOI 10.1111/j.1365-2567.2004.01903.x; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier M, 2011, EXPERT REV VACCINES, V10, P1083, DOI [10.1586/erv.11.22, 10.1586/ERV.11.22]; Vrieling M, 2012, J IMMUNOL, V188, P578, DOI 10.4049/jimmunol.1101972; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; Waters WR, 2014, J COMP PATHOL, V151, P410, DOI 10.1016/j.jcpa.2014.08.007; Waters WR, 2014, VET IMMUNOL IMMUNOP, V159, P113, DOI 10.1016/j.vetimm.2014.02.009; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Waters WR, 2009, VACCINE, V27, P1201, DOI 10.1016/j.vaccine.2008.12.018; Waters WR, 2003, CLIN DIAGN LAB IMMUN, V10, P960, DOI 10.1128/CDLI.10.5.960-966.2003; Waters WR, 2003, INFECT IMMUN, V71, P317, DOI 10.1128/IAI.71.1.317-326.2003; Wedlock DN, 2007, VET IMMUNOL IMMUNOP, V118, P50, DOI 10.1016/j.vetimm.2007.04.005; Whelan AO, 2008, VACCINE, V26, P166, DOI 10.1016/j.vaccine.2007.11.005; Whelan AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029194; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Yang SH, 2006, GENE THER, V13, P1110, DOI 10.1038/sj.gt.3302751	76	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122571	10.1371/journal.pone.0122571	http://dx.doi.org/10.1371/journal.pone.0122571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879774	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500023
J	Thachil, A; Gerber, PF; Xiao, CT; Huang, YW; Opriessnig, T				Thachil, Anil; Gerber, Priscilla F.; Xiao, Chao-Ting; Huang, Yao-Wei; Opriessnig, Tanja			Development and Application of an ELISA for the Detection of Porcine Deltacoronavirus IgG Antibodies	PLOS ONE			English	Article							EPIDEMIC-DIARRHEA-VIRUS; TRANSMISSIBLE GASTROENTERITIS VIRUS; PHYLOGENETIC ANALYSIS; AVIAN CORONAVIRUSES; COMPETITION ELISA; SERUM; PROTEIN; PLASMA; STATES; SWINE	Porcine deltacoronavirus (PDCoV), also known as porcine coronavirus HKU15, was first detected in North America in early 2014 and associated with enteric disease in pigs, resulting in an urgent need to further investigate the ecology of this virus. While assays detecting nucleic acids were implemented quickly, assays to detect anti-PDCoV antibodies have not been available. In this study, an indirect anti-PDCoV IgG enzyme-linked immunosorbent assay (ELISA) based on the putative S1 portion of the spike protein was developed and utilized to determine the prevalence of anti-PDCoV IgG in U.S. pigs. The diagnostic sensitivity of the PDCoV ELISA was 91% with a diagnostic specificity of 95%. A total of 968 serum samples were tested including samples with confirmed infection with PDCoV, porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus or porcine respiratory coronavirus. There was no cross-reactivity with any of the other coronaviruses. Among 355 arbitrarily selected serum samples collected in 2014 and originating from 51 farms across 18 U.S. states, anti-PDCoV IgG antibodies were detected in 8.7% of the samples and in 25.5% of the farms whereas anti-PEDV IgG was detected in 22.8% of the samples and in 54.9% of the farms. In addition, anti-PDCoV IgG antibodies were detected in archived samples collected in 2010, perhaps indicating an earlier undetected introduction into the U.S. pig population. Overall, the obtained data suggest that PDCoV seroprevalence in U.S. pigs is lower compared to PEDV and PDCoV may have been introduced to the U.S. prior to PEDV.	[Thachil, Anil; Xiao, Chao-Ting; Opriessnig, Tanja] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Gerber, Priscilla F.; Opriessnig, Tanja] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Gerber, Priscilla F.; Opriessnig, Tanja] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland; [Huang, Yao-Wei] Zhejiang Univ, Coll Anim Sci, Inst Prevent Vet Med, Hangzhou 310003, Zhejiang, Peoples R China	Iowa State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Zhejiang University	Opriessnig, T (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	Tanja.Opriessnig@roslin.ed.ac.uk	Gerber, Priscilla F/K-4771-2012; Huang, Yaowei/B-1468-2009; Opriessnig, Tanja/F-2984-2012; Huang, Yao-Wei/Q-9409-2019; Gerber, Priscilla/U-9385-2019; Hegde, Nagendra/J-5920-2014; Xiao, Chaoting/H-3997-2014	Gerber, Priscilla F/0000-0002-8343-8299; Huang, Yaowei/0000-0001-9755-8411; Opriessnig, Tanja/0000-0001-9642-0904; Huang, Yao-Wei/0000-0001-9755-8411; Gerber, Priscilla/0000-0002-8343-8299; Hegde, Nagendra/0000-0001-5260-2159; Xiao, Chaoting/0000-0001-5299-5650	BBSRC [BBS/E/D/20241864] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Dong BQ, 2007, J VIROL, V81, P6920, DOI 10.1128/JVI.00299-07; DYCKMAN JD, 1980, J CLIN MICROBIOL, V11, P16, DOI 10.1128/JCM.11.1.16-18.1980; Elia G, 2010, J VIROL METHODS, V163, P309, DOI 10.1016/j.jviromet.2009.10.015; Gerber PF, 2014, VET J, V202, P33, DOI 10.1016/j.tvjl.2014.07.018; Glor SB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-85; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; KNUCHEL M, 1992, VET MICROBIOL, V32, P117, DOI 10.1016/0378-1135(92)90100-8; Li G, 2014, GENOME ANNOUNC, V2, P2, DOI DOI 10.1128/GEN0MEA.00278-14; Liu DQ, 2012, APPL MICROBIOL BIOT, V93, P2437, DOI 10.1007/s00253-011-3734-0; Marthaler D, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00218-14, DOI 10.1128/GEN0MEA.00218-14]; Marthaler D, 2014, EMERG INFECT DIS, V20, P1347, DOI [10.3201/eid2008.14-0526, 10.3201/eid2008.140526]; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Mole B, 2013, NATURE, V499, P388, DOI 10.1038/499388a; National Pork Board PEDV Research Updates, 2014, NAT PORK BOARD PEDV; OIE, 2013, MANUAL DIAGNOSTIC TE; Opriessnig T, 2014, VET MICROBIOL, V173, P9, DOI 10.1016/j.vetmic.2014.06.024; Scott Y, 1996, TRANSFUSION MED, V6, P65, DOI 10.1046/j.1365-3148.1996.d01-54.x; Sestak K, 1999, J VET DIAGN INVEST, V11, P205, DOI 10.1177/104063879901100301; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Shen HG, 2012, J GEN VIROL, V93, P1345, DOI 10.1099/vir.0.039552-0; Siev M, 2011, CLIN VACCINE IMMUNOL, V18, P173, DOI 10.1128/CVI.00325-10; SIMKINS RA, 1993, AM J VET RES, V54, P254; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Sun DB, 2007, ACTA VIROL, V51, P149; United States Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services, 2014, SWIN ENT COR DIS TES; USDA, 2014, REP HERD MON MAN NOV; Wang LY, 2014, EMERG INFECT DIS, V20, P1594, DOI 10.3201/eid2009.140756; Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08	34	37	59	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124363	10.1371/journal.pone.0124363	http://dx.doi.org/10.1371/journal.pone.0124363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881086	Green Published, gold, Green Submitted			2022-12-26	WOS:000353016500095
J	Kawchuk, GN; Fryer, J; Jaremko, JL; Zeng, HB; Rowe, L; Thompson, R				Kawchuk, Gregory N.; Fryer, Jerome; Jaremko, Jacob L.; Zeng, Hongbo; Rowe, Lindsay; Thompson, Richard			Real-Time Visualization of Joint Cavitation	PLOS ONE			English	Article							VELOCITY THRUST MANIPULATION; SPINAL HIGH-VELOCITY; LOW-BACK-PAIN; ZYGAPOPHYSEAL JOINTS; KNUCKLE CRACKING; AUDIBLE POP; GAS-BUBBLES; INDIVIDUALS	Cracking sounds emitted from human synovial joints have been attributed historically to the sudden collapse of a cavitation bubble formed as articular surfaces are separated. Unfortunately, bubble collapse as the source of joint cracking is inconsistent with many physical phenomena that define the joint cracking phenomenon. Here we present direct evidence from real-time magnetic resonance imaging that the mechanism of joint cracking is related to cavity formation rather than bubble collapse. In this study, ten metacarpophalangeal joints were studied by inserting the finger of interest into a flexible tube tightened around a length of cable used to provide long-axis traction. Before and after traction, static 3D T1-weighted magnetic resonance images were acquired. During traction, rapid cine magnetic resonance images were obtained from the joint midline at a rate of 3.2 frames per second until the cracking event occurred. As traction forces increased, real-time cine magnetic resonance imaging demonstrated rapid cavity inception at the time of joint separation and sound production after which the resulting cavity remained visible. Our results offer direct experimental evidence that joint cracking is associated with cavity inception rather than collapse of a pre-existing bubble. These observations are consistent with tribonucleation, a known process where opposing surfaces resist separation until a critical point where they then separate rapidly creating sustained gas cavities. Observed previously in vitro, this is the first in-vivo macroscopic demonstration of tribonucleation and as such, provides a new theoretical framework to investigate health outcomes associated with joint cracking.	[Kawchuk, Gregory N.] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada; [Jaremko, Jacob L.] Univ Alberta, Fac Med & Dent, Dept Radiol & Diagnost Imaging, Edmonton, AB, Canada; [Zeng, Hongbo] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Rowe, Lindsay] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Thompson, Richard] Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Newcastle; University of Alberta	Kawchuk, GN (corresponding author), Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada.	greg.kawchuk@ualberta.ca	Zeng, Hongbo/C-8491-2011; Fryer, Jerome/AAP-3950-2020	Zeng, Hongbo/0000-0002-1432-5979; Thompson, Richard/0000-0003-3319-4377	Canadian Chiropractic Research Foundation (CCRF); Canada Research Chairs program	Canadian Chiropractic Research Foundation (CCRF); Canada Research Chairs program(Canada Research Chairs)	Imaging costs in the study were funded by an operating grant from the Canadian Chiropractic Research Foundation (CCRF). http://www.canadianchiropracticresearchfoundation.com/. GK is supported by the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljishia S, 1991, WHY DOES HEATING WAT, P628; Barrow MS, 2003, P ROY SOC A-MATH PHY, V459, P2885, DOI 10.1098/rspa.2003.1128; Beffa Roberto, 2004, J Manipulative Physiol Ther, V27, pe2; BENJAMIN TB, 1966, PHILOS TR R SOC S-A, V260, P221, DOI 10.1098/rsta.1966.0046; Bereznick DE, 2008, J MANIP PHYSIOL THER, V31, P199, DOI 10.1016/j.jmpt.2008.02.002; BRODEUR R, 1995, J MANIP PHYSIOL THER, V18, P155; Bronfort G, 2008, SPINE J, V8, P213, DOI 10.1016/j.spinee.2007.10.023; CAMPBELL J, 1968, J PHYS D APPL PHYS, V1, P1085, DOI 10.1088/0022-3727/1/8/421; Cascioli V, 2003, J MANIP PHYSIOL THER, V26, P356, DOI 10.1016/S0161-4754(03)00075-7; CASTELLANOS J, 1990, ANN RHEUM DIS, V49, P308, DOI 10.1136/ard.49.5.308; CHEN YL, 1991, SCIENCE, V252, P1157, DOI 10.1126/science.252.5009.1157; Christen T, 1911, ANAT HEFTE, V43, P379; Cramer GD, 2012, J MANIP PHYSIOL THER, V35, P614, DOI 10.1016/j.jmpt.2012.06.007; Crisco JJ, 2007, J BIOMECH, V40, P2767, DOI 10.1016/j.jbiomech.2006.12.013; Davies MS, 1999, J BONE JOINT SURG BR, V81B, P203, DOI 10.1302/0301-620X.81B2.9084; deWeber K, 2011, J AM BOARD FAM MED, V24, P169, DOI 10.3122/jabfm.2011.02.100156; DiGiorgi D, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-14; Evans DW, 2010, MANUAL THER, V15, P286, DOI 10.1016/j.math.2009.12.009; Evans DW, 2006, J MANIP PHYSIOL THER, V29, P72, DOI 10.1016/j.jmpt.2005.11.011; Evans DW, 2002, J MANIP PHYSIOL THER, V25, P251, DOI 10.1067/mmt.2002.123166; Fick R, 1911, STREIT GELENKDRUCK, V43, P397; Flynn TW, 2003, ARCH PHYS MED REHAB, V84, P1057, DOI 10.1016/S0003-9993(03)00048-0; Flynn TW, 2006, J MANIP PHYSIOL THER, V29, P40, DOI 10.1016/j.jmpt.2005.11.005; Gibbons P., 2001, J MANIP PHYSIOL THER, V5, P110, DOI [10.1054/jbmt.2000.0208, DOI 10.1054/JBMT.2000.0208]; Hung WC, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500498; IKELS KG, 1970, J APPL PHYSIOL, V28, P524, DOI 10.1152/jappl.1970.28.4.524; Knapp R, 1970, CAVITATION, P728; LaFond E, 1997, J AM VET MED ASSOC, V210, P1294; Levick J. R., 1995, Microcirculation (New York), V2, P217, DOI 10.3109/10739689509146768; MEAL GM, 1986, J MANIP PHYSIOL THER, V9, P189; Mierau D, 1988, MANUAL MED, V3, P135; Nordheim Y, 1938, ROFO FORTSCHR RONTG, P57; Protapapas Marina G., 2002, Journal of the American Osteopathic Association, V102, P283; RAMAMURTHY AS, 1979, J FLUID ENG-T ASME, V101, P69, DOI 10.1115/1.3448737; RAMAMURTHY AS, 1991, J FLUID ENG-T ASME, V113, P278, DOI 10.1115/1.2909492; Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681; Reggars J W, 1996, Australas Chiropr Osteopathy, V5, P39; Reggars J W, 1999, Australas Chiropr Osteopathy, V8, P16; ROSTON JB, 1947, J ANAT, V81, P165; Rubinstein SM, 2013, SPINE, V38, pE158, DOI 10.1097/BRS.0b013e31827dd89d; Sandoz R., 1976, ANN SWISS CHIROPR AS, V6, P91; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SWEZEY RL, 1975, WESTERN J MED, V122, P377; TREVENA DH, 1984, J PHYS D APPL PHYS, V17, P2139, DOI 10.1088/0022-3727/17/11/003; UNSWORTH A, 1971, ANN RHEUM DIS, V30, P348, DOI 10.1136/ard.30.4.348; Watson P, 1989, Proc Inst Mech Eng H, V203, P109, DOI 10.1243/PIME_PROC_1989_203_019_01; WATSON P, 1989, CLIN ORTHOP RELAT R, P288; WATSON P, 1990, BRIT J RADIOL, V63, P145, DOI 10.1259/0007-1285-63-746-145; Werner D, 2003, J HAND SURG-AM, V28A, P1044, DOI 10.1016/S0363-5023(03)00425-8; Zeng HB, 2010, MACROMOLECULES, V43, P538, DOI 10.1021/ma901845z	50	29	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0119470	10.1371/journal.pone.0119470	http://dx.doi.org/10.1371/journal.pone.0119470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875374	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800005
J	Scheinpflug, K; Krylova, O; Nikolenko, H; Thurm, C; Dathe, M				Scheinpflug, Kathi; Krylova, Oxana; Nikolenko, Heike; Thurm, Charley; Dathe, Margitta			Evidence for a Novel Mechanism of Antimicrobial Action of a Cyclic R-,W-Rich Hexapeptide	PLOS ONE			English	Article							ESCHERICHIA-COLI MEMBRANES; HOST-DEFENSE PEPTIDES; ANIONIC PHOSPHOLIPIDS; TITRATION CALORIMETRY; BACTERIAL-MEMBRANES; BACILLUS-SUBTILIS; ACRIDINE-ORANGE; LIPID DOMAINS; ARGININE-RICH; BUFORIN-II	The development of antimicrobial peptides as new class of antibiotic agents requires structural characterisation and understanding of their diverse mechanisms of action. As the cyclic hexapeptide cWFW(cyclo(RRRWFW)) does not exert its rapid cell killing activity by membrane permeabilisation, in this study we investigated alternative mechanisms of action, such as peptide translocation into the cytoplasm and peptide interaction with components of the phospholipid matrix of the bacterial membrane. Using fluorescence microscopy and an HPLC-based strategy to analyse peptide uptake into the cells we could confirm the cytoplasmic membrane as the major peptide target. However, unexpectedly we observed accumulation of cWFW at distinct sites of the membrane. Further characterisation of peptide-membrane interaction involved live cell imaging to visualise the distribution of the lipid cardiolipin (CL) and isothermal titration calorimetry to determine the binding affinity to model membranes with different bacterial lipid compositions. Our results demonstrate a distribution of the cyclic peptide similar to that of cardiolipin within the membrane and highly preferred affinity of cWFW for CL-rich phosphatidylethanolamine (POPE) matrices. These observations point to a novel mechanism of antimicrobial killing for the cyclic hexapeptide cWFW which is neither based on membrane permeabilisation nor translocation into the cytoplasm but rather on preferred partitioning into particular lipid domains. As the phospholipids POPE/CL play a key role in the dynamic organisation of bacterial membranes we discuss the consequences of this peptide-lipid-interaction and outline the impact on antimicrobial peptide research.	[Scheinpflug, Kathi; Krylova, Oxana; Nikolenko, Heike; Thurm, Charley; Dathe, Margitta] Leibniz Inst Mol Pharmakol FMP, Dept Biol Chem, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Dathe, M (corresponding author), Leibniz Inst Mol Pharmakol FMP, Dept Biol Chem, Berlin, Germany.	dathe@fmp-berlin.de						Appelt C, 2005, CHEMBIOCHEM, V6, P1654, DOI 10.1002/cbic.200500095; Appelt C, 2008, J PEPT SCI, V14, P524, DOI 10.1002/psc.924; Arouri A, 2009, BBA-BIOMEMBRANES, V1788, P650, DOI 10.1016/j.bbamem.2008.11.022; Bagheri M, 2011, ANTIMICROB AGENTS CH, V55, P788, DOI 10.1128/AAC.01098-10; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Bishop RE, 2014, J BACTERIOL, V196, P3209, DOI 10.1128/JB.02043-14; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Dathe M, 2004, BIOCHEMISTRY-US, V43, P9140, DOI 10.1021/bi035948v; Dathe M, 2002, BBA-BIOMEMBRANES, V1558, P171, DOI 10.1016/S0005-2736(01)00429-1; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Epand RM, 2009, MOL BIOSYST, V5, P580, DOI 10.1039/b900278m; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fleming E, 2008, PROTEINS, V73, P480, DOI 10.1002/prot.22074; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Hwang PM, 1998, BIOCHEM CELL BIOL, V76, P235, DOI 10.1139/bcb-76-2-3-235; Junkes C, 2008, J PEPT SCI, V14, P535, DOI 10.1002/psc.940; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Keller S, 2006, J AM CHEM SOC, V128, P1279, DOI 10.1021/ja056389d; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kobayashi S, 2004, BIOCHEMISTRY-US, V43, P15610, DOI 10.1021/bi048206q; Laan EVDD, 2003, J BACTERIOL, V185, P3773, DOI 10.1128/JB.185.3773.3779.2003; Lopez CS, 2006, MICROBIOL-SGM, V152, P605, DOI 10.1099/mic.0.28345-0; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; OEHLKE J, 1994, EUR J PHARM SCI, V2, P365, DOI 10.1016/0928-0987(94)00063-8; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; Olofsson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073040; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Renner LD, 2012, J BIOL CHEM, V287, P38835, DOI 10.1074/jbc.M112.407817; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; REYNOLDS JA, 1974, P NATL ACAD SCI USA, V71, P2925, DOI 10.1073/pnas.71.8.2925; Scheinpflug K, 2013, PHARMACEUTICALS, V6, P1130, DOI 10.3390/ph6091130; SCHUHMANN E, 1969, Z ALLG MIKROBIOL, V9, P297, DOI 10.1002/jobm.3630090407; Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6; Uyterhoeven ET, 2008, FEBS LETT, V582, P1715, DOI 10.1016/j.febslet.2008.04.036; Vogel HJ, 2002, BIOCHEM CELL BIOL, V80, P49, DOI 10.1139/o01-213; Wang JP, 2014, BBA-BIOMEMBRANES, V1838, P2870, DOI 10.1016/j.bbamem.2014.07.002; Wang Q, 2010, J PHYS CHEM B, V114, P13726, DOI 10.1021/jp1069362; Wessolowski A, 2004, J PEPT RES, V64, P159, DOI 10.1111/j.1399-3011.2004.00182.x; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Yaroslavov AA, 2007, LANGMUIR, V23, P7539, DOI 10.1021/la700637d; Zhang TH, 2014, J BIOL CHEM, V289, P11584, DOI 10.1074/jbc.M114.554444; Zweytick D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090228	56	33	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0125056	10.1371/journal.pone.0125056	http://dx.doi.org/10.1371/journal.pone.0125056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875357	Green Submitted, gold, Green Published			2022-12-26	WOS:000353015800155
J	Stewart, R; Hardy, R; Richards, M				Stewart, Robert; Hardy, Rebecca; Richards, Marcus			Associations between Skeletal Growth in Childhood and Cognitive Function in Mid-Life in a 53-Year Prospective Birth Cohort Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HEAD CIRCUMFERENCE; EARLY-LIFE; LEG LENGTH; HEIGHT; RISK; DEMENTIA; ABILITY; ENVIRONMENT; EDUCATION	Background Several studies have found that shorter stature (height and limb length) in late life is associated with dementia and cognitive impairment. The extent to which childhood environment and early life cognitive function accounts for these associations is not clear. Methods We investigated associations of adult trunk height and leg length with cognitive function in middle age, analysing data from the MRC National Survey of Health and Development: a cohort followed from birth to age 53, 1677 of whom had data on all covariates. The four cognitive tests measured verbal ability, word list memory, verbal fluency and speed/concentration. Early life environmental measures included parental education, poverty, parental divorce, physical health, cognitive ability at age 15, own education and own adult social class. Results After adjusting for gender, shorter trunk length was associated with lower cognitive function on all four tests and shorter leg length with lower verbal intelligence and word list memory. These associations were only partially attenuated following adjustment for childhood adversity/health but were substantially accounted for by cognitive ability at age 15. Conclusions Shorter stature was associated with lower cognitive function at age 53, the majority of this association being accounted for by cognitive function at age 15. Reduced cognitive reserve may well account for later associations between anthropometric measures and dementia.	[Stewart, Robert] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Hardy, Rebecca; Richards, Marcus] MRC Unit Lifelong Hlth & Ageing, London, England; [Hardy, Rebecca; Richards, Marcus] MRC Natl Survey Hlth & Dev, London, England	University of London; King's College London	Stewart, R (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	r.stewart@iop.kcl.ac.uk	Stewart, Robert/B-1667-2010; Hardy, Rebecca/AFR-1989-2022	Stewart, Robert/0000-0002-4435-6397; Richards, Marcus/0000-0001-9191-2192; Hardy, Rebecca/0000-0001-9949-0799	National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust; King's College London; UK Medical Research Council; MRC [MC_UU_12019/3] Funding Source: UKRI; Medical Research Council [MC_UU_12019/3] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RS is part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. Funding to MR and RH is provided by the UK Medical Research Council. No specific funding was obtained for the analysis presented here and no funding agency had input into its design or execution.	Abbott RD, 1998, PEDIATRICS, V102, P602, DOI 10.1542/peds.102.3.602; [Anonymous], 1970, CLASS OCC; Beeri MS, 2005, AM J GERIAT PSYCHIAT, V13, P116, DOI 10.1097/00019442-200502000-00005; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P267, DOI 10.1111/j.2044-8260.1989.tb01376.x; Department of Education and Science, 1972, BURNH FURTH ED COMM; Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006; Forsen TJ, 2004, ANN MED, V36, P389, DOI 10.1080/07853890410028438; Graves AB, 2001, NEUROLOGY, V57, P1453, DOI 10.1212/WNL.57.8.1453; Gunnell D, 2002, INT J EPIDEMIOL, V31, P390, DOI 10.1093/ije/31.2.390; Huang TL, 2008, NEUROLOGY, V70, P1818, DOI 10.1212/01.wnl.0000311444.20490.98; Jeong SK, 2005, INT J GERIATR PSYCH, V20, P406, DOI 10.1002/gps.1295; Kim JM, 2008, INT J GERIATR PSYCH, V23, P41, DOI 10.1002/gps.1833; Kim JM, 2003, J NEUROL NEUROSUR PS, V74, P427, DOI 10.1136/jnnp.74.4.427; Mak Z, 2006, INT J GERIATR PSYCH, V21, P266, DOI 10.1002/gps.1458; McGurn B, 2008, NEUROLOGY, V71, P1051, DOI 10.1212/01.wnl.0000319692.20283.10; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Moceri VM, 2001, EPIDEMIOLOGY, V12, P383, DOI 10.1097/00001648-200107000-00007; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; MORTIMER JA, 1993, NEUROLOGY, V43, pS39; Nelson H., 1991, NATL ADULT READING T; Petot GJ, 2007, J ALZHEIMERS DIS, V11, P337; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; Reynolds MD, 1999, NEUROLOGY, V53, P228, DOI 10.1212/WNL.53.1.228; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; SCHOFIELD PW, 1995, ARCH NEUROL-CHICAGO, V52, P95, DOI 10.1001/archneur.1995.00540250103019; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; TANNER JM, 1982, ANN HUM BIOL, V9, P411, DOI 10.1080/03014468200005951; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wadsworth MEJ, 2003, SOC SCI MED, V57, P2193, DOI 10.1016/S0277-9536(03)00083-2; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455; Yano K, 2000, J AM GERIATR SOC, V48, P199, DOI 10.1111/j.1532-5415.2000.tb03912.x; Yliharsila H, 2003, HYPERTENSION, V41, P446, DOI 10.1161/01.HYP.0000055780.21222.96	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124163	10.1371/journal.pone.0124163	http://dx.doi.org/10.1371/journal.pone.0124163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875444	Green Submitted, Green Published, gold			2022-12-26	WOS:000353015800133
J	Yin, J; Liu, MF; Ren, WK; Duan, JL; Yang, G; Zhao, YR; Fang, RJ; Chen, LX; Li, TJ; Yin, YL				Yin, Jie; Liu, Mingfeng; Ren, Wenkai; Duan, Jielin; Yang, Guan; Zhao, Yurong; Fang, Rejun; Chen, Lixiang; Li, Tiejun; Yin, Yulong			Effects of Dietary Supplementation with Glutamate and Aspartate on Diquat-Induced Oxidative Stress in Piglets	PLOS ONE			English	Article							GROWTH-PERFORMANCE; INDUCED LIVER; AMINO-ACIDS; EXPRESSION; METABOLISM; SYSTEM	This study aimed to investigate the protective effects of dietary glutamate and aspartate supplementations on diquat-induced oxidative stress in piglets. Diquat injection significantly reduced growth performance, including body weight, average daily weight gain, and feed intake (P<0.05). Meanwhile, diquat administration induced oxidative stress evidenced by the decreased serum nitric oxide (NO) and elevated malondialdeyhde (MDA) concentration (P<0.05). Furthermore, diquat-induced oxidative stress disrupted intestinal absorption system and decreased serum threonine, serine, and glycine levels. Dietary supplementation with glutamate improved final body weight, antioxidant system, and expressions of amino acids transporters and enhanced serum glutamate concentration compared with diquat group (P<0.05). While aspartate failed to alleviate diquat-induced oxidative stress, growth depression, and dysfunction of nutrients absorption except for liver relative weight. In conclusion, dietary supplementation with glutamate confers beneficial effects on diquat-induced oxidative stress in piglets, while aspartate exhibits little effects.	[Yin, Jie; Ren, Wenkai; Duan, Jielin; Li, Tiejun; Yin, Yulong] Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Hunan Prov Engn Res Ctr Hlth Livestock, Minist Agr,Key Lab Agroecol Proc Subtrop Reg,Inst, Changsha 410125, Hunan, Peoples R China; [Yin, Jie; Ren, Wenkai; Duan, Jielin] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Liu, Mingfeng; Zhao, Yurong; Fang, Rejun; Chen, Lixiang] Univ Hunan Agr, Dept Anim Sci, Changsha 410128, Hunan, Peoples R China; [Yang, Guan] Univ Florida, Dept Anim Sci, Gainesville, FL 32610 USA; [Yin, Yulong] Southwest Collaborat Innovat Ctr Swine Qual & Saf, Chengdu, Peoples R China	Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; State University System of Florida; University of Florida	Li, TJ (corresponding author), Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Hunan Prov Engn Res Ctr Hlth Livestock, Minist Agr,Key Lab Agroecol Proc Subtrop Reg,Inst, Changsha 410125, Hunan, Peoples R China.	tjli@isa.ac.cn; yinyulong@isa.ac.cn	YIN, Jie/H-3578-2019	YIN, Jie/0000-0003-1852-1042; YANG, Guan/0000-0002-2131-8435	National Natural Science Foundation of China [31330075, 31110103909, 31101729, 31402088, 31201813, 31272463]; Hunan Provincial Natural Science Foundation of China [12JJ2014, 2013RS4065, 12JJ2020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	The present work was supported by grants from the National Natural Science Foundation of China (Nos. 31330075, 31110103909, 31101729, 31402088, 31201813, and 31272463) and the Hunan Provincial Natural Science Foundation of China (Nos. 12JJ2014, 2013RS4065, and 12JJ2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrin DG, 2009, AM J CLIN NUTR, V90, p850S, DOI 10.3945/ajcn.2009.27462Y; Chen G, 2014, AMINO ACIDS, V46, P245, DOI 10.1007/s00726-013-1615-9; Deng Y, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/534705; Duan JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112357; Enomoto A, 2012, FREE RADICAL BIO MED, V52, P507, DOI 10.1016/j.freeradbiomed.2011.11.006; Feng ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084533; JOHNSON JL, 1972, BRAIN RES, V37, P1, DOI 10.1016/0006-8993(72)90343-5; LEFLOCH N, 1994, J NUTR, V124, P1987, DOI 10.1093/jn/124.10.1987; Li LL, 2007, ASIAN AUSTRAL J ANIM, V20, P761, DOI 10.5713/ajas.2007.761; Liang Y, 2014, J IMMUNOL, V192, P1277, DOI 10.4049/jimmunol.1203428; Libao-Mercado AJ, 2006, J ANIM SCI, V84, P1351, DOI 10.2527/2006.8461351x; Lu T, 2010, FOOD CHEM TOXICOL, V48, P764, DOI 10.1016/j.fct.2009.12.018; Lv M, 2012, ANIMAL, V6, P928, DOI 10.1017/S1751731111002382; Pi DA, 2014, J NUTR BIOCHEM, V25, P456, DOI 10.1016/j.jnutbio.2013.12.006; Qiang M, 2014, PROTEIN CELL, V5, P484, DOI 10.1007/s13238-014-0052-1; Ren WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088335; Ren WK, 2012, AMINO ACIDS, V42, P2089, DOI 10.1007/s00726-011-0942-y; Rogers LK, 2006, TOXICOL APPL PHARM, V217, P289, DOI 10.1016/j.taap.2006.08.012; Sanchez-Piris M, 2002, J BIOL CHEM, V277, P17722, DOI 10.1074/jbc.M200104200; Senthilkumar R, 2004, PHARMAZIE, V59, P55; Tan B, 2012, AMINO ACIDS, V43, P2481, DOI 10.1007/s00726-012-1328-5; Watford M, 2008, J NUTR, V138, p2003S, DOI 10.1093/jn/138.10.2003S; Wu GY, 2013, AMINO ACIDS, V45, P241, DOI 10.1007/s00726-013-1515-z; Wu KC, 2012, FREE RADICAL RES, V46, P1220, DOI 10.3109/10715762.2012.700709; Wu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069502; Wu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100591; Wu X, 2012, J ANIM SCI, V90, P337, DOI 10.2527/jas.53752; Wu X, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-63; Xin W, 2013, BIOL TRACE ELEM RES, V153, P191, DOI 10.1007/s12011-013-9668-x; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin J, 2014, J ANIM SCI, V92, P612, DOI 10.2527/jas.2013-6986; Yin J, 2013, FREE RADICAL RES, V47, P643, DOI 10.3109/10715762.2013.812206; Yin J, 2015, RSC ADV, V5, P15479, DOI 10.1039/c4ra13557a; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin J, 2013, J FOOD AGRIC ENVIRON, V11, P132; Yin YL, 2010, AMINO ACIDS, V39, P1581, DOI 10.1007/s00726-010-0577-4; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2; Zoerner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064792	38	120	136	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122893	10.1371/journal.pone.0122893	http://dx.doi.org/10.1371/journal.pone.0122893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875335	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800081
J	Gorressen, S; Stern, M; van de Sandt, AM; Cortese-Krott, MM; Ohlig, J; Rassaf, T; Godecke, A; Fischer, JW; Heusch, G; Merx, MW; Kelm, M				Gorressen, Simone; Stern, Manuel; van de Sandt, Annette M.; Cortese-Krott, Miriam M.; Ohlig, Jan; Rassaf, Tienush; Goedecke, Axel; Fischer, Jens W.; Heusch, Gerd; Merx, Marc W.; Kelm, Malte			Circulating NOS3 Modulates Left Ventricular Remodeling following Reperfused Myocardial Infarction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RED-BLOOD-CELLS; HEART-FAILURE; MESSENGER-RNAS; COLLAGEN; EXPRESSION; BIGLYCAN; MICE; ENDOTHELIUM; ISCHEMIA	Purpose Nitric oxide (NO) is constitutively produced and released from the endothelium and several blood cell types by the isoform 3 of the NO synthase (NOS3). We have shown that NO protects against myocardial ischemia/reperfusion (I/R) injury and that depletion of circulating NOS3 increases within 24h of ischemia/reperfusion the size of myocardial infarction (MI) in chimeric mice devoid of circulating NOS3. In the current study we hypothesized that circulating NOS3 also affects remodeling of the left ventricle following reperfused MI. Methods To analyze the role of circulating NOS3 we transplanted bone marrow of NOS3(-/-) and wild type (WT) mice into WT mice, producing chimerae expressing NOS3 only in vascular endothelium (BC-/EC+) or in both, blood cells and vascular endothelium (BC+/EC+). Both groups underwent 60 min of coronary occlusion in a closed-chest model of reperfused MI. During the 3 weeks post MI, structural and functional LV remodeling was serially assessed (24h, 4d, 1w, 2w and 3w) by echocardiography. At 72 hours post MI, gene expression of several extracellular matrix (ECM) modifying molecules was determined by quantitative RTPCR analysis. At 3 weeks post MI, hemodynamics were obtained by pressure catheter, scar size and collagen content were quantified post mortem by Gomori's One-step trichrome staining. Results Three weeks post MI, LV end-systolic (53.2 +/- 5.9 mu l;*** p <= 0.001;n = 5) and end-diastolic volumes (82.7 +/- 5.6 mu l;*p<0.05; n = 5) were significantly increased in BC-/EC+, along with decreased LV developed pressure (67.5 +/- 1.8mmHg;n = 18;*** p <= 0.001) and increased scar size/left ventricle (19.5 +/- 1.5%;n = 13;**p <= 0.01) compared to BC+/EC+ (ESV: 35.6 +/- 2.2 mu l; EDV: 69.1 +/- 2.6 mu l n = 8; LVDP:83.2 +/- 3.2mmHg;n = 24; scar size/LV13.8 +/- 0.7%;n = 16). Myocardial scar of BC-/EC+ was characterized by increased total collagen content (20.2 +/- 0.8%;n = 13;*** p <= 0.001) compared to BC+/EC+ (15.9 +/- 0.5;n = 16), and increased collagen type I and III subtypes. Conclusion Circulating NOS3 ameliorates maladaptive left ventricular remodeling following reperfused myocardial infarction.	[Gorressen, Simone; Stern, Manuel; van de Sandt, Annette M.; Cortese-Krott, Miriam M.; Ohlig, Jan; Rassaf, Tienush; Merx, Marc W.; Kelm, Malte] Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Fac Med, Dusseldorf, Germany; [Goedecke, Axel] Univ Dusseldorf, Dept Cardiovasc Physiol, Fac Med, Dusseldorf, Germany; [Goedecke, Axel; Fischer, Jens W.] CARID, Cardiovasc Res Inst Dusseldorf, Dusseldorf, Germany; [Fischer, Jens W.] Univ Dusseldorf, Cardiovasc Res Inst Dusseldorf CARID, Fac Med, Inst Pharmacol & Clin Pharmacol, Dusseldorf, Germany; [Merx, Marc W.] Univ Essen Gesamthsch, Sch Med, Inst Pathophysiol, West German Heart & Vasc Ctr Essen, Essen, Germany; [Merx, Marc W.] Klinikum Reg Hannover, Robert Koch Krankenhaus, Dept Cardiol Vasc Med & Intens Care Med, Hannover, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Duisburg Essen	Kelm, M (corresponding author), Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Fac Med, Dusseldorf, Germany.	malte.kelm@med.uni-duesseldorf.de	Cortese-Krott, Miriam/I-7513-2012; Heusch, Gerd/ABE-6675-2020	Cortese-Krott, Miriam/0000-0002-0593-1192; Kelm, Malte/0000-0003-0060-1052	Susanne-Bunnenberg-Stiftung at Dusseldorf Heart Center;  [ME1821/2-3];  [ME1821/3-1 [FOR809]];  [RA969/4-2];  [RA969/7-2];  [KE405/5-1];  [SFB1116]	Susanne-Bunnenberg-Stiftung at Dusseldorf Heart Center; ; ; ; ; ; 	This work was supported in part by ME1821/2-3 to MWM and ME1821/3-1 [FOR809] to MWM and MK, RA969/4-2 and RA969/7-2 to TR, KE405/5-1 and the SFB1116 to MK and the Susanne-Bunnenberg-Stiftung at Dusseldorf Heart Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MR, 1997, CIRCULATION, V95, P662, DOI 10.1161/01.CIR.95.3.662; Agarwal Anil K, 2010, Heart Fail Clin, V6, P323, DOI 10.1016/j.hfc.2010.03.006; Anand I, 2004, CIRCULATION, V110, P149, DOI 10.1161/01.CIR.0000134279.79571.73; Campbell Patrick H., 2008, Molecular & Cellular Biomechanics, V5, P27; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Csont T, 2010, J MOL CELL CARDIOL, V48, P649, DOI 10.1016/j.yjmcc.2010.01.013; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; EGHBALI M, 1989, J MOL CELL CARDIOL, V21, P103, DOI 10.1016/0022-2828(89)91498-3; EGHBALI M, 1988, J MOL CELL CARDIOL, V20, P267, DOI 10.1016/S0022-2828(88)80059-2; EGHBALI M, 1990, MOL CELL BIOCHEM, V96, P1; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; French Brent A, 2007, Drug Discov Today Dis Mech, V4, P185, DOI 10.1016/j.ddmec.2007.12.006; Godecke A, 1998, CIRC RES, V82, P186; Heusch G, 2000, CIRC RES, V87, P146, DOI 10.1161/01.RES.87.2.146; Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0; Hofmann U, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0356-y; Jivraj N, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0397-2; Jugdutt Bodh I, 2002, Heart Fail Rev, V7, P391, DOI 10.1023/A:1020718619155; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Krusche CA, 2011, BASIC RES CARDIOL, V106, P617, DOI 10.1007/s00395-011-0175-y; Ky B, 2013, J AM COLL CARDIOL, V62, P1165, DOI 10.1016/j.jacc.2013.03.085; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2415, DOI 10.1016/j.jacc.2011.08.033; MA XL, 1993, CIRC RES, V72, P403, DOI 10.1161/01.RES.72.2.403; Merx MW, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0398-1; MITCHELL GF, 1992, J AM COLL CARDIOL, V19, P1136, DOI 10.1016/0735-1097(92)90314-D; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Reiling N, 1996, EUR J IMMUNOL, V26, P511, DOI 10.1002/eji.1830260302; Roy S, 2006, PHYSIOL GENOMICS, V25, P364, DOI 10.1152/physiolgenomics.00013.2006; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Szelid Z, 2010, BASIC RES CARDIOL, V105, P169, DOI 10.1007/s00395-009-0077-4; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; van de Sandt AM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0330-8; Weber KT, 1997, CIRCULATION, V96, P2488; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; Westermann D, 2008, CIRCULATION, V117, P1269, DOI 10.1161/CIRCULATIONAHA.107.714147; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Wood KC, 2013, ARTERIOSCL THROM VAS, V33, P1861, DOI 10.1161/ATVBAHA.112.301068; Yamamoto K, 1998, J MOL CELL CARDIOL, V30, P1749, DOI 10.1006/jmcc.1998.0737; Zanardo RCO, 1997, P NATL ACAD SCI USA, V94, P14111, DOI 10.1073/pnas.94.25.14111	43	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0120961	10.1371/journal.pone.0120961	http://dx.doi.org/10.1371/journal.pone.0120961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875863	Green Submitted, Green Published, gold			2022-12-26	WOS:000353014700007
J	Enwerem, II; Wu, GW; Yu, YT; Hebert, MD				Enwerem, Isioma I.; Wu, Guowei; Yu, Yi Tao; Hebert, Michael D.			Cajal Body Proteins Differentially Affect the Processing of Box C/D scaRNPs	PLOS ONE			English	Article							MUSCULAR-ATROPHY PROTEIN; SNRNP BIOGENESIS; GENE-PRODUCT; SMN COMPLEX; HELA-CELLS; GUIDE RNAS; IN-VIVO; COILIN; BODIES; LOCALIZATION	Small nuclear ribonucleoproteins (snRNPs), which are required for pre-mRNA splicing, contain extensively modified snRNA. Small Cajal body-specific ribonucleoproteins (scaRNPs) mediate these modifications. It is unknown how the box C/D class of scaRNPs localizes to Cajal Bodies (CBs). The processing of box C/D scaRNA is also unclear. Here, we explore the processing of box C/D scaRNA 2 and 9 by coilin. We also broaden our investigation to include WRAP53 and SMN, which accumulate in CBs, play a role in RNP biogenesis and associate with coilin. These studies demonstrate that the processing of an ectopically expressed scaRNA2 is altered upon the reduction of coilin, WRAP53 or SMN, but the extent and direction of this change varies depending on the protein reduced. We also show that box C/D scaRNP activity is reduced in a cell line derived from coilin knockout mice. Collectively, the findings presented here further implicate coilin as being a direct participant in the formation of box C/D scaRNPs, and demonstrate that WRAP53 and SMN may also play a role, but the activity of these proteins is divergent to coilin.	[Enwerem, Isioma I.; Hebert, Michael D.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Wu, Guowei; Yu, Yi Tao] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Mississippi; University of Mississippi Medical Center; University of Rochester	Hebert, MD (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	mhebert@umc.edu			University of Mississippi Medical Center; National Institute of General Medical Sciences of the National Institutes of Health [R01GM081448, R01GM104077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081448, R01GM104077] Funding Source: NIH RePORTER	University of Mississippi Medical Center; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Intramural Research Support Program of the University of Mississippi Medical Center supported this work. This work was also supported by The National Institute of General Medical Sciences of the National Institutes of Health under award number R01GM081448 (MDH) and award number R01GM104077 (YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Bellini M, 1998, MOL BIOL CELL, V9, P2987, DOI 10.1091/mbc.9.10.2987; Broome HJ, 2013, BIOL OPEN, V2, P407, DOI 10.1242/bio.20133863; Broome HJ, 2013, J MOL BIOL, V425, P713, DOI 10.1016/j.jmb.2012.12.014; Broome HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036300; Carrero ZI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025743; Coady TH, 2011, WIRES RNA, V2, P546, DOI 10.1002/wrna.76; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Enwerem II, 2014, BIOL OPEN, V3, P240, DOI 10.1242/bio.20147443; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Gerard MA, 2010, NUCLEIC ACIDS RES, V38, P370, DOI 10.1093/nar/gkp988; Girard C, 2006, NUCLEIC ACIDS RES, V34, P2925, DOI 10.1093/nar/gkl374; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2010, ARCH BIOCHEM BIOPHYS, V496, P69, DOI 10.1016/j.abb.2010.02.012; Huang C, 2010, MOL CELL BIOL, V30, P4368, DOI 10.1128/MCB.00384-10; Jady BE, 2003, EMBO J, V22, P1878, DOI 10.1093/emboj/cdg187; Jones KW, 2001, J BIOL CHEM, V276, P38645, DOI 10.1074/jbc.M106161200; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kishore S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r45; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Machyna M, 2014, MOL CELL, V56, P389, DOI 10.1016/j.molcel.2014.10.004; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Marnef A, 2014, NUCLEIC ACIDS RES, V42, P6616, DOI 10.1093/nar/gku287; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Richard P, 2003, EMBO J, V22, P4283, DOI 10.1093/emboj/cdg394; SPECTOR DL, 1992, MOL BIOL CELL, V3, P555, DOI 10.1091/mbc.3.5.555; Sun J, 2005, J CELL SCI, V118, P4995, DOI 10.1242/jcs.02613; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Tycowski KT, 2004, CURR BIOL, V14, P1985, DOI 10.1016/j.cub.2004.11.003; Velma V, 2012, CHROMOSOMA, V121, P629, DOI 10.1007/s00412-012-0387-4; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Whittom AA, 2008, CELL MOL LIFE SCI, V65, P1256, DOI 10.1007/s00018-008-7587-3; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122348	10.1371/journal.pone.0122348	http://dx.doi.org/10.1371/journal.pone.0122348			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875178	gold, Green Published, Green Submitted			2022-12-26	WOS:000352845100065
J	Perez, LM; Bernal, A; de Lucas, B; San Martin, N; Mastrangelo, A; Garcia, A; Barbas, C; Galvez, BG				Perez, Laura M.; Bernal, Aurora; de Lucas, Beatriz; San Martin, Nuria; Mastrangelo, Annalaura; Garcia, Antonia; Barbas, Coral; Galvez, Beatriz G.			Altered Metabolic and Stemness Capacity of Adipose Tissue-Derived Stem Cells from Obese Mouse and Human	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; ENERGY-METABOLISM; PROGENITOR CELLS; SELF-RENEWAL; EXPRESSION; OCT4; RESPIRATION; ADIPOCYTES; TELOMERASE; FACTOR-1	Adipose stem cells (ASCs) are an appealing source of cells for therapeutic intervention; however, the environment from which ASCs are isolated may impact their usefulness. Using a range of functional assays, we have evaluated whether ASCs isolated from an obese environment are comparable to cells from non-obese adipose tissue. Results showed that ASCs isolated from obese tissue have a reduced proliferative ability and a loss of viability together with changes in telomerase activity and DNA telomere length, suggesting a decreased self-renewal capacity. Metabolic analysis demonstrated that mitochondrial content and function was impaired in obese-derived ASCs resulting in changes in favored oxidative substrates. These findings highlight the impact of obesity on adult stem properties. Hence, caution should be exercised when considering the source of ASCs for cellular therapies since their therapeutic potential may be impaired.	[Perez, Laura M.; Bernal, Aurora; de Lucas, Beatriz; San Martin, Nuria; Galvez, Beatriz G.] CNIC, Madrid, Spain; [Mastrangelo, Annalaura; Garcia, Antonia; Barbas, Coral] Univ San Pablo, CEU, Madrid, Spain; [Galvez, Beatriz G.] UEM, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); San Pablo CEU University; European University of Madrid	Galvez, BG (corresponding author), CNIC, Madrid, Spain.	b.gonzalez@uem.es	de Lucas Moreno, Beatriz/P-1378-2019; Bernal, Aurora/AAG-1926-2019; Garcia, Antonia/C-4296-2008; Gálvez, Beatriz G./H-1644-2015; Barbas, Coral/K-3871-2014; Pérez, Laura M./E-7818-2016	de Lucas Moreno, Beatriz/0000-0002-2852-0118; Bernal, Aurora/0000-0002-5741-7865; Garcia, Antonia/0000-0002-1521-8489; Gálvez, Beatriz G./0000-0002-8082-9323; Barbas, Coral/0000-0003-4722-491X; Pérez, Laura M./0000-0003-0649-7778; Mastrangelo, Annalaura/0000-0003-2650-0444	Spanish Ministry of Science and Innovation (SAF) [2010-15239]; Spanish Ministry of Science and Innovation [RYC2009-04669]; Spanish Ministry of Science and Innovation; Pro-CNIC Foundation; Spanish Ministry; Spanish Ministry of Economy and Competitiveness (MINECO) [CTQ2011-23562]	Spanish Ministry of Science and Innovation (SAF); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Pro-CNIC Foundation; Spanish Ministry(Spanish Government); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government)	This study was supported by grants from the Spanish Ministry of Science and Innovation (SAF 2010-15239) to BGG. BGG also acknowledges support from the "Ramon y Cajal" tenure track programme from the Spanish Ministry of Science and Innovation (RYC2009-04669). The CNIC is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. LMP and AB are supported by FPI fellowships from the Spanish Ministry. AM is supported by a fellowship from the Spanish Ministry of Economy and Competitiveness (MINECO, CTQ2011-23562). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Bernal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053215; Canuto GAB, 2014, ANAL BIOANAL CHEM, V406, P3459, DOI 10.1007/s00216-014-7772-1; Chia N, 2011, EPIGENETICS-US, V6, P853, DOI 10.4161/epi.6.7.16461; Choi JR, 2014, BIOCHEM BIOPHYS RES; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Covarrubias P, 2013, AESTHET PLAST SURG, V37, P778, DOI 10.1007/s00266-013-0126-0; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Ferrer-Lorente R, 2014, DIABETOLOGIA, V57, P246, DOI 10.1007/s00125-013-3081-z; Frazier TP, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-34; Galvez BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004444; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Holvoet P, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/205027; Insinga A, 2014, BLOOD CELL MOL DIS, V52, P147, DOI 10.1016/j.bcmd.2013.12.005; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Moreno L, 2014, ANTIOXID REDOX SIGN, V20, P1, DOI 10.1089/ars.2012.4752; Onate B, 2012, FASEB J; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Panfilov Ilia Alexander, 2013, Methods Mol Biol, V1036, P207, DOI 10.1007/978-1-62703-511-8_16; Park E, 2010, CELL BIOL INT, V34, P979, DOI 10.1042/CBI20100124; Perez LM, 2013, ARCH PHYSIOL BIOCHEM, V119, P195, DOI 10.3109/13813455.2013.784339; Perez LM, 2013, DIABETES, V62, P2368, DOI 10.2337/db12-1220; Pintus F, 2012, AGING-US, V4, P734, DOI 10.18632/aging.100505; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Roldan M, 2011, FASEB J, V25, P4111, DOI 10.1096/fj.10-171439; Rosso A, 2006, J BIOL CHEM, V281, P4339, DOI 10.1074/jbc.M509293200; San Martin N, 2011, STEM CELLS, V29, P1064, DOI 10.1002/stem.654; San Martin Nuria, 2011, Archives of Physiology and Biochemistry, V117, P188, DOI 10.3109/13813455.2011.571700; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Shynkar VV, 2007, J AM CHEM SOC, V129, P2187, DOI 10.1021/ja068008h; Szivek JA, 2014, J BIOMED MATER RES B; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Tzanetakou IP, 2012, AGEING RES REV, V11, P220, DOI 10.1016/j.arr.2011.12.003; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.292; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wilson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-229; Wu YY, 2013, MOL BIOL REP, V40, P2897, DOI 10.1007/s11033-012-2305-5; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	56	63	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123397	10.1371/journal.pone.0123397	http://dx.doi.org/10.1371/journal.pone.0123397			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875023	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100171
J	van Andel, J; Leijten, F; van Delden, H; van Thiel, G				van Andel, Judith; Leijten, Frans; van Delden, Hans; van Thiel, Ghislaine			What Makes a Good Home-Based Nocturnal Seizure Detector? A Value Sensitive Design	PLOS ONE			English	Article							SUDDEN UNEXPECTED DEATH; EPILEPSY; ETHICS	A device for the in-home detection of nocturnal seizures is currently being developed in the Netherlands, to improve care for patients with severe epilepsy. It is recognized that the design of medical technology is not value neutral: perspectives of users and developers are influential in design, and design choices influence these perspectives. However, during development processes, these influences are generally ignored and value-related choices remain implicit and poorly argued for. In the development process of the seizure detector we aimed to take values of all stakeholders into consideration. Therefore, we performed a parallel ethics study, using "value sensitive design." Analysis of stakeholder communication (in meetings and e-mail messages) identified five important values, namely, health, trust, autonomy, accessibility, and reliability. Stakeholders were then asked to give feedback on the choice of these values and how they should be interpreted. In a next step, the values were related to design choices relevant for the device, and then the consequences (risks and benefits) of these choices were investigated. Currently the process of design and testing of the device is still ongoing. The device will be validated in a trial in which the identified consequences of design choices are measured as secondary endpoints. Value sensitive design methodology is feasible for the development of new medical technology and can help designers substantiate the choices in their design.	[van Andel, Judith; Leijten, Frans] Univ Med Ctr Utrecht, Dept Clin Neurophysiol, Utrecht, Netherlands; [van Delden, Hans; van Thiel, Ghislaine] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Andel, J (corresponding author), Univ Med Ctr Utrecht, Dept Clin Neurophysiol, Utrecht, Netherlands.	j.m.vanandel@umcutrecht.nl	Van Thiel, Ghislaine/R-8977-2019	van Thiel, Ghislaine/0000-0003-1799-1894	ZonMW [300040003]	ZonMW(Netherlands Organization for Health Research and Development)	This study was funded by ZonMW, grant number 300040003. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp Tom L., 2019, PRINCIPLES BIOMEDICA, V8th; Cummings ML, 2006, SCI ENG ETHICS, V12, P701, DOI 10.1007/s11948-006-0065-0; Flanagan M, 2008, HDB INFORM COMPUTER, P69; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Friedman B., 2002, U WAHINGTON TECHNICA; FRIEDMAN B., 2003, HUM FAC ER, P1177; JACKO J. A., 2007, HUMAN COMPUTER INTER; Lamberts RJ, 2012, EPILEPSIA, V53, P253, DOI 10.1111/j.1528-1167.2011.03360.x; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; Shankar R, 2013, SEIZURE-EUR J EPILEP, V22, P812, DOI 10.1016/j.seizure.2013.07.014; Timmermans Job, 2011, Nanoethics, V5, P269, DOI 10.1007/s11569-011-0135-x; van Wynsberghe A, 2013, SCI ENG ETHICS, V19, P407, DOI 10.1007/s11948-011-9343-6; Zwart SD, 2006, SCI ENG ETHICS, V12, P663, DOI 10.1007/s11948-006-0063-2	14	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121446	10.1371/journal.pone.0121446	http://dx.doi.org/10.1371/journal.pone.0121446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875320	Green Published, Green Submitted, gold			2022-12-26	WOS:000352845100041
J	Borner, J; Kis-Katos, K; Hargrave, J; Konig, K				Boerner, Jan; Kis-Katos, Krisztina; Hargrave, Jorge; Koenig, Konstantin			Post-Crackdown Effectiveness of Field-Based Forest Law Enforcement in the Brazilian Amazon	PLOS ONE			English	Article							PROPENSITY SCORE; PROTECTED AREAS; DEFORESTATION; POLICY; ISSUES; FIRE; BEEF	Regulatory enforcement of forest conservation laws is often dismissed as an ineffective approach to reducing tropical forest loss. Yet, effective enforcement is often a precondition for alternative conservation measures, such as payments for environmental services, to achieve desired outcomes. Fair and efficient policies to reducing emissions from deforestation and forest degradation (REDD) will thus crucially depend on understanding the determinants and requirements of enforcement effectiveness. Among potential REDD candidate countries, Brazil is considered to possess the most advanced deforestation monitoring and enforcement infrastructure. This study explores a unique dataset of over 15 thousand point coordinates of enforcement missions in the Brazilian Amazon during 2009 and 2010, after major reductions of deforestation in the region. We study whether local deforestation patterns have been affected by field-based enforcement and to what extent these effects vary across administrative boundaries. Spatial matching and regression techniques are applied at different spatial resolutions. We find that field-based enforcement operations have not been universally effective in deterring deforestation during our observation period. Inspections have been most effective in reducing large-scale deforestation in the states of Mato Grosso and Para, where average conservation effects were 4.0 and 9.9 hectares per inspection, respectively. Despite regional and actor-specific heterogeneity in inspection effectiveness, field-based law enforcement is highly cost-effective on average and might be enhanced by closer collaboration between national and state-level authorities.	[Boerner, Jan] Univ Bonn, Res Dev Ctr, Bonn, Germany; [Boerner, Jan] Ctr Int Forestry Res, Bogor, Indonesia; [Kis-Katos, Krisztina] Univ Freiburg, Inst Econ Res, D-79106 Freiburg, Germany; [Hargrave, Jorge] Boston Consulting Grp Inc, Sao Paulo, Brazil; [Koenig, Konstantin] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10099 Berlin, Germany	University of Bonn; CGIAR; Center for International Forestry Research (CIFOR); University of Freiburg; Boston Consulting Group (BCG); Humboldt University of Berlin	Borner, J (corresponding author), Univ Bonn, Res Dev Ctr, Bonn, Germany.	jborner@uni-bonn.de	Wunder, Sven/ABE-7773-2020; Börner, Jan JB/I-2139-2015; Kis-Katos, Krisztina/ABC-3624-2021; Börner, Jan/ABF-8775-2021	Wunder, Sven/0000-0002-9422-0260; Börner, Jan/0000-0003-3034-5360	Robert Bosch Foundation [32.5.8043.0012.0]; European Commission [DCI-ENV/2011/269520]	Robert Bosch Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Robert Bosch Foundation (Grant: 32.5.8043.0012.0; www.bosch-stiftung.de) and the European Commission (Grant: DCI-ENV/2011/269520; http://ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HJ, 2010, RESOUR ENERGY ECON, V32, P165, DOI 10.1016/j.reseneeco.2009.11.011; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Anselin L, 2002, AGR ECON-BLACKWELL, V27, P247, DOI 10.1111/j.1574-0862.2002.tb00120.x; Arima EY, 2007, J REGIONAL SCI, V47, P541, DOI 10.1111/j.1467-9787.2007.00519.x; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Assunu║ao JJ., 2013, DETERRING DEFORESTAT; Barretto AGOP, 2013, GLOBAL CHANGE BIOL, V19, P1804, DOI 10.1111/gcb.12174; Bartolini F, 2012, J AGR ECON, V63, P310, DOI 10.1111/j.1477-9552.2012.00339.x; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Borner J., 2011, REDD STICKS CARROTS; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; CEPAL-IPEA-GIZ, 2011, AVALIACAO PLANO ACAO, DOI [10.1016/j.rpsm.2014.10.004, DOI 10.1016/J.RPSM.2014.10.004]; CLARKE HR, 1993, RESOUR ENERGY ECON, V15, P271, DOI 10.1016/0928-7655(93)90009-J; Dalla-Nora EL, 2014, LAND USE POLICY, V39, P403, DOI 10.1016/j.landusepol.2014.02.004; Aguiar APD, 2007, ECOL MODEL, V209, P169, DOI 10.1016/j.ecolmodel.2007.06.019; Ezzine-de-Blas D, 2011, ENVIRON SCI POLICY, V14, P188, DOI 10.1016/j.envsci.2010.11.009; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Garoupa Nuno, 1997, J ECON SURV, V11, P267, DOI DOI 10.1111/1467-6419.00034; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Godar J, 2014, P NATL ACAD SCI USA; Godar J, 2012, FOREST ECOL MANAG, V267, P58, DOI 10.1016/j.foreco.2011.11.046; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Mitchell Polinsky A., 2000, AM LAW ECON REV, V2, P223, DOI [10.1093/aler/2.2.223, DOI 10.1093/ALER/2.2.223]; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Pacheco P, 2012, GEOFORUM, V43, P864, DOI 10.1016/j.geoforum.2012.02.003; Piquero AR, 2011, ANNU REV LAW SOC SCI, V7, P335, DOI 10.1146/annurev-lawsocsci-102510-105404; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Robinson EJZ., 2010, J NAT RES POLICY RES, V2, P25, DOI 10.1080/19390450903350820; Rosa IMD, 2012, CONSERV BIOL, V26, P932, DOI 10.1111/j.1523-1739.2012.01901.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; STIGLER GJ, 1970, J POLIT ECON, V78, P526, DOI 10.1086/259646; Weber JG, 2011, LAND ECON, V87, P661, DOI 10.3368/le.87.4.661; Wooldridge JM, 2003, AM ECON REV, V93, P133, DOI 10.1257/000282803321946930	46	86	87	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121544	10.1371/journal.pone.0121544	http://dx.doi.org/10.1371/journal.pone.0121544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875656	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800022
J	Lin, CK; Hung, CC; Peng, CY; Chao, E; Lee, TSH				Lin, Chao-Kuang; Hung, Chia-Chun; Peng, Ching-Yi; Chao, En; Lee, Tony Szu-Hsien			Factors Associated with Methadone Treatment Duration: A Cox Regression Analysis	PLOS ONE			English	Article							HEROIN USERS; MAINTENANCE TREATMENT; DRUG-USERS; FOLLOW-UP; RETENTION; PREDICTORS; MORTALITY; THERAPY; COHORT	This study examined retention rates and associated predictors of methadone maintenance treatment (MMT) duration among 128 newly admitted patients in Taiwan. A semi-structured questionnaire was used to obtain demographic and drug use history. Daily records of methadone taken and test results for HIV, HCV, and morphine toxicology were taken from a computerized medical registry. Cox regression analyses were performed to examine factors associated with MMT duration. MMT retention rates were 80.5%, 68.8%, 53.9%, and 41.4% for 3, 6, 12, and 18 months, respectively. Excluding 38 patients incarcerated during the study period, retention rates were 81.1%, 73.3%, 61.1%, and 48.9% for 3 months, 6 months, 12 months, and 18 months, respectively. No participant seroconverted to HIV and 1 died during the 18-months follow-up. Results showed that being female, imprisonment, a longer distance from house to clinic, having a lower methadone dose after 30 days, being HCV positive, and in the New Taipei city program predicted early patient dropout. The findings suggest favorable MMT outcomes of HIV seroincidence and mortality. Results indicate that the need to minimize travel distance and to provide programs that meet women's requirements justify expansion of MMT clinics in Taiwan.	[Lin, Chao-Kuang] Natl Yang Ming Univ, Educ Ctr Humanities & Social Sci, Taipei 112, Taiwan; [Hung, Chia-Chun] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Peng, Ching-Yi; Chao, En; Lee, Tony Szu-Hsien] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Taiwan Normal University	Lee, TSH (corresponding author), Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan.	tonylee@ntnu.edu.tw	Hung, chiachun/AAV-7181-2020; Popescu, Sorin C/D-5981-2015	Popescu, Sorin C/0000-0002-8155-8801; Tsogt, Khongor/0000-0003-0431-2688; Lee, Tony Szu-Hsien/0000-0003-2574-3372; Hung, Chia Chun/0000-0003-1118-8187; Lin, Chinsu/0000-0002-4513-8674; Chao, En/0000-0002-2117-2886	Taiwan Ministry of Health and Welfare [DOH97-NNB-1044, DOH98-NNB-1032, DOH99-FDA-61501]; National Taiwan Normal University (NTNU), Taiwan, ROC	Taiwan Ministry of Health and Welfare; National Taiwan Normal University (NTNU), Taiwan, ROC	This study was funded by the Taiwan Ministry of Health and Welfare (DOH97-NNB-1044, DOH98-NNB-1032 and DOH99-FDA-61501). The funders of the study had no role in study design, data collection, data analysis, data interpretation, and writing of the report. This article was subsidized by the National Taiwan Normal University (NTNU), Taiwan, ROC.	Borisova NN, 2004, J SUBST ABUSE TREAT, V26, P345, DOI 10.1016/S0740-5472(03)00157-0; Deck D, 2005, J BEHAV HEALTH SER R, V32, P43, DOI 10.1007/BF02287327; Dolan KA, 2005, ADDICTION, V100, P820, DOI 10.1111/j.1360-0443.2005.01050.x; Hartel DM, 1999, PUBLIC HEALTH, V113, P107; Hser YI, 2004, PSYCHIAT SERV, V55, P767, DOI 10.1176/appi.ps.55.7.767; Huang YF, 2011, ADDICTION, V106, P1437, DOI 10.1111/j.1360-0443.2011.03443.x; Kelly SM, 2011, DRUG ALCOHOL DEPEN, V117, P170, DOI 10.1016/j.drugalcdep.2011.01.008; Kerr T, 2005, DRUG ALCOHOL DEPEN, V80, P329, DOI 10.1016/j.drugalcdep.2005.05.002; Lee TSH, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-6; Lee TSH, 2006, TAIWAN J PUBLIC HLTH, V25, P214; Liao DL, 2013, J PSYCHIATR RES, V47, P1530, DOI 10.1016/j.jpsychires.2013.07.001; Lin HC, 2013, J ADDICT DIS, V32, P140, DOI 10.1080/10550887.2013.795466; Magura S, 1998, ADDICTION, V93, P51, DOI 10.1046/j.1360-0443.1998.931516.x; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; Peles E, 2006, DRUG ALCOHOL DEPEN, V82, P211, DOI 10.1016/j.drugalcdep.2005.09.004; Qian HZ, 2008, J SUBST ABUSE TREAT, V34, P391, DOI 10.1016/j.jsat.2007.07.002; SIMPSON DD, 1981, ARCH GEN PSYCHIAT, V38, P875; UNODC, 2002, COMTEMPORARY DRUG AB; Villafranca SW, 2006, DRUG ALCOHOL DEPEN, V83, P218, DOI 10.1016/j.drugalcdep.2005.11.020; Wang PW, 2012, AM J DRUG ALCOHOL AB, V38, P213, DOI 10.3109/00952990.2011.649222; Wong KH, 2003, J SUBST ABUSE TREAT, V24, P233, DOI 10.1016/S0740-5472(03)00029-1; World Health Organization, 2012, WHO UNODC UNAIDS TEC, DOI [10.1016/j.drugpo.2007.12.002, DOI 10.1016/J.DRUGPO.2007.12.002]; Yang F, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-3; Zhang ZW, 2003, ADDICTION, V98, P673, DOI 10.1046/j.1360-0443.2003.00354.x	24	57	59	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123687	10.1371/journal.pone.0123687	http://dx.doi.org/10.1371/journal.pone.0123687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EB	25875531	gold, Green Published, Green Submitted			2022-12-26	WOS:000353014700038
J	Lin, CS; Popescu, SC; Thomson, G; Tsogt, K; Chang, CI				Lin, Chinsu; Popescu, Sorin C.; Thomson, Gavin; Tsogt, Khongor; Chang, Chein-I			Classification of Tree Species in Overstorey Canopy of Subtropical Forest Using QuickBird Images	PLOS ONE			English	Article							HIGH-RESOLUTION; LIDAR DATA; VEGETATION; KAPPA; IDENTIFICATION; PREVALENCE; ALGORITHMS; DENSITY; SYSTEM; CROWNS	This paper proposes a supervised classification scheme to identify 40 tree species (2 coniferous, 38 broadleaf) belonging to 22 families and 36 genera in high spatial resolution QuickBird multispectral images (HMS). Overall kappa coefficient (OKC) and species conditional kappa coefficients (SCKC) were used to evaluate classification performance in training samples and estimate accuracy and uncertainty in test samples. Baseline classification performance using HMS images and vegetation index (VI) images were evaluated with an OKC value of 0.58 and 0.48 respectively, but performance improved significantly (up to 0.99) when used in combination with an HMS spectral-spatial texture image (SpecTex). One of the 40 species had very high conditional kappa coefficient performance (SCKC >= 0.95) using 4-band HMS and 5-band VIs images, but, only five species had lower performance (0.68 <= SCKC <= 0.94) using the SpecTex images. When SpecTex images were combined with a Visible Atmospherically Resistant Index (VARI), there was a significant improvement in performance in the training samples. The same level of improvement could not be replicated in the test samples indicating that a high degree of uncertainty exists in species classification accuracy which may be due to individual tree crown density, leaf greenness (inter-canopy gaps), and noise in the background environment (intra-canopy gaps). These factors increase uncertainty in the spectral texture features and therefore represent potential problems when using pixel-based classification techniques for multi-species classification.	[Lin, Chinsu; Tsogt, Khongor] Natl Chiayi Univ, Dept Forestry & Nat Resources, Chiayi 60004, Taiwan; [Popescu, Sorin C.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA; [Thomson, Gavin] Natl Formosa Univ, Dept Appl Foreign Languages, Huwei Township 63201, Yunlin, Taiwan; [Chang, Chein-I] Univ Maryland Baltimore Cty, Dept Comp Sci & Elect Engn, Baltimore, MD 21250 USA	National Chiayi University; Texas A&M University System; Texas A&M University College Station; National Formosa University; University System of Maryland; University of Maryland Baltimore County	Lin, CS (corresponding author), Natl Chiayi Univ, Dept Forestry & Nat Resources, 300 Univ Rd, Chiayi 60004, Taiwan.	chinsu@mail.ncyu.edu.tw	Hung, chiachun/AAV-7181-2020; Popescu, Sorin C/D-5981-2015	Popescu, Sorin C/0000-0002-8155-8801; Tsogt, Khongor/0000-0003-0431-2688; Lee, Tony Szu-Hsien/0000-0003-2574-3372; Hung, Chia Chun/0000-0003-1118-8187; Lin, Chinsu/0000-0002-4513-8674; Chao, En/0000-0002-2117-2886				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081478; Boschetti M, 2007, INT J REMOTE SENS, V28, P1251, DOI 10.1080/01431160600928542; Brandtberg T, 1998, MACH VISION APPL, V11, P64, DOI 10.1007/s001380050091; CHAVEZ PS, 1991, PHOTOGRAMM ENG REM S, V57, P295; Chinsu Lin, 2015, Information Processing in Agriculture, V2, P25, DOI 10.1016/j.inpa.2015.01.003; Chytry M, 2011, APPL VEG SCI, V14, P435, DOI 10.1111/j.1654-109X.2011.01154.x; Cochrane MA, 2000, INT J REMOTE SENS, V21, P2075, DOI 10.1080/01431160050021303; Du YZ, 2004, OPT ENG, V43, P1777, DOI 10.1117/1.1766301; Duro DC, 2012, REMOTE SENS ENVIRON, V118, P259, DOI 10.1016/j.rse.2011.11.020; Dwivedi Ravi Shankar, 2009, P73; Feilhauer H, 2012, REMOTE SENS-BASEL, V4, P2057, DOI 10.3390/rs4072057; Frampton CM, 2001, ENVIRON MONIT ASSESS, V72, P227, DOI 10.1023/A:1012049205475; Franklin SE, 2000, INT J REMOTE SENS, V21, P61, DOI 10.1080/014311600210993; Gaikwad RN, 2006, ISPRS ARCH 4, VXXXVI; Gairola S, 2013, INT J REMOTE SENS, V34, P2006, DOI 10.1080/01431161.2012.730161; Ghiyamat A, 2010, INT J REMOTE SENS, V31, P1837, DOI 10.1080/01431160902926681; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Gougeon F.A., 1995, CANADIAN J REMOTE SE, V21, P274, DOI [DOI 10.1080/07038992.1995.10874622, 10.1080/07038992.1995.10874622]; Hantson W, 2012, APPL VEG SCI, V15, P536, DOI 10.1111/j.1654-109X.2012.01194.x; Hill RA, 2010, APPL VEG SCI, V13, P86, DOI 10.1111/j.1654-109X.2009.01053.x; Hill RA, 2005, INT J REMOTE SENS, V26, P3763, DOI 10.1080/01431160500114706; Hoare D, 2004, APPL VEG SCI, V7, P19, DOI 10.1111/j.1654-109X.2004.tb00591.x; Holmgren J, 2008, INT J REMOTE SENS, V29, P1537, DOI 10.1080/01431160701736471; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Ishihama F, 2012, APPL VEG SCI, V15, P383, DOI 10.1111/j.1654-109X.2012.01184.x; Jensen JR., 2004, INTRO DIGITAL IMAGE, V3; Jones TG, 2010, INT J REMOTE SENS, V31, P1121, DOI 10.1080/01431160903349040; Kang JY, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL III, PROCEEDINGS, P315, DOI 10.1109/IITA.2008.269; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; Ke Y, REMOTE SENSING ENV, V114, P1141; Krause K., 2005, RADIOMETRIC USE QUIC; KRUSE FA, 1993, AIP CONF PROC, P192, DOI 10.1016/0034-4257(93)90013-N; Larcher W, 2003, PHYSL PLANT ECOLOGY; Leckie DG, 2005, CAN J REMOTE SENS, V31, P175, DOI 10.5589/m05-004; LEE JS, 1980, IEEE T PATTERN ANAL, V2, P165, DOI 10.1109/TPAMI.1980.4766994; Li CF, 2012, S E AS FLOR ROL FORM; Lin C, 2015, BIOGEOSCIENCES, V12, P49, DOI 10.5194/bg-12-49-2015; Lin C, 2003, J NATL CHIAYI U, V75, P181; Lin C., 2011, J EARTH SCI ENG, V1, P35; Lin C, 2005, Q J CHINESE FORESTRY, V38, P163; Lin C, 2011, P 4 INT C IM SIGN PR, V3, P1633; Lin CS, 2012, J ENVIRON MANAGE, V113, P440, DOI 10.1016/j.jenvman.2012.09.001; Lin CS, 2011, PHOTOGRAMM ENG REM S, V77, P241, DOI 10.14358/PERS.77.3.241; Lin Chinsu, 1999, Taiwan Journal of Forest Science, V14, P289; Lo CS, 2013, IEEE T GEOSCI REMOTE, V51, P2216, DOI 10.1109/TGRS.2012.2211023; Hernandez-Stefanoni JL, 2009, APPL VEG SCI, V12, P398, DOI 10.1111/j.1654-109X.2009.01044.x; McDanold RI, 2007, APPL VEG SCI, V10, P193; Ouyang ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067315; Pu RL, 2009, INT J REMOTE SENS, V30, P2759, DOI 10.1080/01431160802555820; Reitberger J, 2008, INT J REMOTE SENS, V29, P1407, DOI 10.1080/01431160701736448; Richards J.A., 1999, REMOTE SENSING DIGIT, DOI [DOI 10.1007/978-3-642-30062-2, 10.1007/978-3-662-03978-6, DOI 10.1007/978-3-662-03978-6]; Rocchini D, 2007, APPL VEG SCI, V10, P325, DOI 10.1111/j.1654-109X.2007.tb00431.x; Schowengerdt R. A., 1997, REMOTE SENSING MODEL; Stehman SV, 1996, PHOTOGRAMM ENG REM S, V62, P401; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Vach W, 2005, J CLIN EPIDEMIOL, V58, P655, DOI 10.1016/j.jclinepi.2004.02.021; Vina A, 2004, AGRON J, V96, P1139, DOI 10.2134/agronj2004.1139; Wang L, 2009, INT J REMOTE SENS, V30, P1267, DOI 10.1080/01431160802474014; Wu TF, 2004, J MACH LEARN RES, V5, P975	62	57	59	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2015	10	5							e0125554	10.1371/journal.pone.0125554	http://dx.doi.org/10.1371/journal.pone.0125554			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7AU	25875531	Green Published, Green Submitted, gold			2022-12-26	WOS:000354916100031
J	Borner, J; Marinho, E; Wunder, S				Boerner, Jan; Marinho, Eduardo; Wunder, Sven			Mixing Carrots and Sticks to Conserve Forests in the Brazilian Amazon: A Spatial Probabilistic Modeling Approach	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; POLICY MIX; DEFORESTATION; PAYMENTS	Annual forest loss in the Brazilian Amazon had in 2012 declined to less than 5,000 sqkm, from over 27,000 in 2004. Mounting empirical evidence suggests that changes in Brazilian law enforcement strategy and the related governance system may account for a large share of the overall success in curbing deforestation rates. At the same time, Brazil is experimenting with alternative approaches to compensate farmers for conservation actions through economic incentives, such as payments for environmental services, at various administrative levels. We develop a spatially explicit simulation model for deforestation decisions in response to policy incentives and disincentives. The model builds on elements of optimal enforcement theory and introduces the notion of imperfect payment contract enforcement in the context of avoided deforestation. We implement the simulations using official deforestation statistics and data collected from field-based forest law enforcement operations in the Amazon region. We show that a large-scale integration of payments with the existing regulatory enforcement strategy involves a tradeoff between the cost-effectiveness of forest conservation and landholder incomes. Introducing payments as a complementary policy measure increases policy implementation cost, reduces income losses for those hit hardest by law enforcement, and can provide additional income to some land users. The magnitude of the tradeoff varies in space, depending on deforestation patterns, conservation opportunity and enforcement costs. Enforcement effectiveness becomes a key determinant of efficiency in the overall policy mix.	[Boerner, Jan] Univ Bonn, Ctr Dev Res ZEF, D-53113 Bonn, Germany; [Boerner, Jan; Marinho, Eduardo; Wunder, Sven] Ctr Int Forestry Res CIFOR, Rio De Janeiro, Brazil	University of Bonn; CGIAR; Center for International Forestry Research (CIFOR)	Borner, J (corresponding author), Univ Bonn, Ctr Dev Res ZEF, Walter Flex Str 3, D-53113 Bonn, Germany.	jborner@uni-bonn.de	Wunder, Sven/ABE-7773-2020; Börner, Jan JB/I-2139-2015; Kis-Katos, Krisztina/ABC-3624-2021; Börner, Jan/ABF-8775-2021	Wunder, Sven/0000-0002-9422-0260; Börner, Jan/0000-0003-3034-5360	Robert Bosch Foundation; European Commission [DCI-ENV/2011/269520]; Forest, Trees, and Agroforestry Program	Robert Bosch Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Forest, Trees, and Agroforestry Program	This work was funded by the Robert Bosch Foundation (www.bosch-stiftung.de), European Commission (http://ec.europa.eu/index_en.htm; Grant number: DCI-ENV/2011/269520), and Forest, Trees, and Agroforestry Program (http://foreststreesagroforestry.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HJ, 2010, RESOUR ENERGY ECON, V32, P165, DOI 10.1016/j.reseneeco.2009.11.011; Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; Armsworth PR, 2012, ECOL LETT, V15, P406, DOI 10.1111/j.1461-0248.2012.01747.x; Assuncao J., 2013, DOES CREDIT AFFECT D; Assuncao Juliano., 2012, DEFORESTATION SLOWDO; Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727; Barton DN, 2014, TECHINCAL BRIEF; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Borner J, 2010, ECOL ECON, V69, P1272, DOI 10.1016/j.ecolecon.2009.11.003; Borner J., 2013, GOVERNING PROVISION, P21, DOI [10.1007/978-94-007-5176-7_2, DOI 10.1007/978-94-007-5176-7]; Borner J, 2013, COMPENSACAO PORSERVI; Borner J, 2014, GLOBAL ENV IN PRESS; Cattaneo A., 2002, RES REPORT; Ezzine-de-Blas D, 2011, ENVIRON SCI POLICY, V14, P188, DOI 10.1016/j.envsci.2010.11.009; Garoupa Nuno, 1997, J ECON SURV, V11, P267, DOI DOI 10.1111/1467-6419.00034; Godar J, 2014, P NATL ACAD SCI USA; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Lehmann P, 2012, J ECON SURV, V26, P71, DOI 10.1111/j.1467-6419.2010.00628.x; Merger Eduard, 2012, Carbon Balance Manag, V7, P9, DOI 10.1186/1750-0680-7-9; MMA, 2009, BRAZ REDD STRAT DOC; Moxey A, 2014, LAND USE POLICY, V39, P397, DOI 10.1016/j.landusepol.2014.04.008; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Persson UM, 2013, WORLD DEV, V43, P124, DOI 10.1016/j.worlddev.2012.10.006; Prager K, 2011, LAND DEGRAD DEV, V22, P111, DOI 10.1002/ldr.1038; Sandmo A, 2002, ENVIRON RESOUR ECON, V23, P85, DOI 10.1023/A:1020236324130; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Sohngen B, 2004, CAN J FOREST RES, V34, P829, DOI [10.1139/x03-249, 10.1139/X03-249]; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; Tinbergen Jan, 1952, THEORY EC POLICY; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S, 2014, EARTHSCAN FOR LIBR, P202; Wunder S, 2013, CONSERV LETT, V6, P230, DOI 10.1111/conl.12034	37	86	87	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116846	10.1371/journal.pone.0116846	http://dx.doi.org/10.1371/journal.pone.0116846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25875656	Green Published, Green Submitted, gold			2022-12-26	WOS:000349250700007
